data_2m5c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m5c _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.807 0.337 . . . . 73.3 111.067 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.82 91.82 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.44 111.101 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -111.88 117.84 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 73.32 110.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -60.79 168.96 2.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.873 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.96 -47.94 64.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 72.55 110.881 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -61.08 -37.54 83.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.15 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.3 13.32 61.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.669 -0.777 . . . . 64.12 112.542 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.4 m -79.14 -44.8 21.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 75.24 111.092 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.1 mt -103.59 117.46 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 74.31 111.176 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -124.46 129.12 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 74.45 110.843 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.44 112.55 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 63.44 111.105 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.31 128.76 44.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 75.13 110.86 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -73.55 110.93 8.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 74.2 110.89 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.8 mt -65.37 -32.99 74.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 70.13 110.879 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.448 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.85 -97.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 64.44 110.872 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.8 OUTLIER -150.09 9.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 73.15 110.864 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.405 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.53 8.25 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 75.4 110.829 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -150.89 141.14 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 74.03 111.095 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 19.6 m95 -130.0 -179.39 5.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 71.51 110.878 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.0 t -132.0 89.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 72.11 111.096 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -72.78 124.38 25.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 75.5 110.834 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -119.93 104.2 9.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 74.23 111.128 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -88.13 123.27 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 73.25 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.8 117.8 28.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 72.14 110.874 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 52.22 112.514 179.836 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.58 0.705 . . . . 75.24 111.181 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 118.33 5.62 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.738 2.292 . . . . 71.25 112.348 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -110.21 99.91 8.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 71.41 110.812 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -62.42 170.37 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 75.42 110.93 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -159.28 -147.46 4.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 71.43 112.527 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -159.58 116.28 2.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 74.33 110.885 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.5 t -99.52 121.83 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 74.11 111.155 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.7 mt -98.7 118.23 34.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 64.2 110.966 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.39 85.93 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.936 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.78 177.15 4.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 73.03 111.092 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -97.94 -20.84 17.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 72.53 110.823 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -10.4 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 71.12 110.902 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.62 153.54 5.91 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 72.24 112.523 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -68.54 154.95 40.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 71.44 110.905 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.15 142.99 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 75.43 111.107 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.56 124.61 21.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.905 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -71.51 112.44 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 63.12 111.137 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.629 ' HD2' HG21 ' A' ' 85' ' ' THR . 1.8 m-20 73.4 121.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 71.0 110.882 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 p -66.12 -166.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.01 110.844 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.6 t -91.9 169.48 10.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.85 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -50.38 -60.25 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.828 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -129.82 158.51 39.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 75.15 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.656 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 52.3 m-20 -51.37 -33.75 31.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.972 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.21 -38.11 76.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 74.3 110.926 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.1 mt -81.15 -45.54 16.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.934 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -45.14 61.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.132 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -52.93 -51.59 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 75.04 110.952 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -63.71 -19.71 65.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 71.13 110.913 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 tp -87.94 -26.86 22.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.877 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.75 -23.09 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 74.51 111.265 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.09 18.18 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 74.33 110.865 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.3 ptm -132.9 -40.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 72.52 110.866 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.435 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 33.1 m -81.07 -22.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 72.33 111.163 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.491 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.81 -21.95 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.902 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -109.04 -33.27 6.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 75.22 110.851 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.93 -43.48 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 75.44 110.908 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.17 -10.87 48.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 71.41 110.895 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 67.42 13.27 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 74.31 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -131.33 138.76 49.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.01 110.954 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -85.8 137.94 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.22 110.833 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.491 HG22 ' HE2' ' A' ' 72' ' ' GLU . 98.8 t -76.91 126.39 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.35 111.103 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -143.79 13.89 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.11 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -155.89 144.15 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.04 110.906 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 t -154.41 131.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.4 111.161 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.6 mt -89.4 130.73 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.105 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -106.28 124.94 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.12 111.157 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 ' HD2' ' A' ' 56' ' ' ASP . 30.7 p -82.53 -39.54 22.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 72.01 111.167 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -165.94 -175.29 3.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 71.11 110.931 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.24 95.83 10.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 71.21 111.108 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.475 ' CE1' ' HE2' ' A' ' 149' ' ' HIS . 0.3 OUTLIER -150.88 154.08 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.35 110.832 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.13 -20.19 51.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 73.5 111.049 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.8 5.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 61.52 110.918 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -122.11 -77.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 75.52 110.791 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.14 8.48 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 74.1 111.086 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.38 -42.32 33.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 72.12 112.476 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.61 13.1 58.15 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 64.41 112.468 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 tt -51.42 -29.63 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 74.21 111.086 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.656 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -53.15 -32.11 45.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 72.22 110.984 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.6 m -89.78 -22.72 22.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 74.42 111.132 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.3 mt -80.54 -25.98 38.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.906 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.73 15.3 29.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.913 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.03 -40.93 3.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.24 110.89 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -83.19 -58.14 2.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 74.42 110.928 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.56 38.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 73.21 112.545 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.05 115.12 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 74.34 111.111 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -78.84 116.31 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 64.24 110.911 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.43 93.15 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 71.14 111.127 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -67.66 129.44 39.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.912 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.11 -178.98 7.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 73.13 110.924 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.634 ' HB ' ' HD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -90.89 157.75 17.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.133 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.03 -36.94 30.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 72.53 111.109 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 -39.42 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.99 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.6 m -57.87 -27.72 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 73.53 111.186 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.31 4.7 53.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 70.4 111.018 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -103.61 -44.81 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.889 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.07 -13.86 49.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 74.14 110.959 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.12 99.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.03 111.097 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.15 62.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.944 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -35.55 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.838 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.39 -23.53 22.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.25 110.917 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.59 22.99 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 54.13 112.447 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -94.84 179.14 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.344 . . . . 72.21 110.883 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -77.41 -176.18 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 74.3 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -115.35 101.52 54.37 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.634 0.73 . . . . 75.32 110.852 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -179.85 3.2 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.742 2.295 . . . . 72.44 112.341 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 29.4 mt -51.24 -52.55 43.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.21 110.858 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 58.75 21.94 52.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 74.22 112.444 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.37 24.14 6.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 74.02 110.886 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.99 -175.9 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 61.5 110.942 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.99 -171.55 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 70.23 110.826 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.6 m -50.94 -70.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 72.04 111.087 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.11 104.06 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 73.32 111.218 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -135.15 164.2 28.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 73.12 111.22 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.93 126.61 54.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.283 -0.417 . . . . 75.13 111.0 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.0 mt -111.49 155.7 22.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 74.2 110.912 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -137.87 117.19 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 62.54 110.872 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.19 48.93 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.886 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.33 94.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.751 . . . . 72.02 112.45 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.35 15.36 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 65.01 110.887 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.8 tpp -137.45 101.37 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 74.4 110.898 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -90.81 132.56 35.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 75.44 110.773 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.5 114.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.061 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -107.6 129.58 54.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 75.04 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 46.9 p -86.08 178.09 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 72.11 111.183 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -161.63 133.69 5.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 70.05 110.858 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -121.78 86.48 45.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 75.33 110.872 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -8.04 22.6 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.767 2.311 . . . . 74.53 112.31 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.36 -160.94 24.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 74.14 112.434 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -87.77 140.76 29.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 74.24 110.844 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.6 -91.11 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 62.43 112.459 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.475 ' HE2' ' CE1' ' A' ' 88' ' ' HIS . 68.6 t60 -73.79 -23.51 59.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 71.33 110.959 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -150.29 -167.38 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 61.13 111.167 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.32 -15.98 38.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 74.1 110.853 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.634 ' HD2' ' HB ' ' A' ' 108' ' ' THR . 41.0 t0 -135.53 17.96 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.871 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.45 129.59 25.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 64.42 110.818 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.8 pt -136.54 175.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.08 -0.509 . . . . 74.5 111.065 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.35 119.51 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.162 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.47 126.58 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 62.44 111.108 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -115.25 138.8 50.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 71.42 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.34 98.91 46.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.652 0.739 . . . . 75.44 110.846 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -4.13 13.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.707 2.271 . . . . 63.1 112.287 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -85.16 -22.97 28.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.317 -0.401 . . . . 73.03 110.974 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.41 12.28 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.042 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.3 m120 54.68 25.68 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 62.2 110.819 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 93.5 mt -90.48 142.95 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 70.4 111.196 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.2 tp -128.43 146.38 50.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 74.2 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 42.1 t -115.17 76.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 64.41 111.126 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.09 -28.99 19.91 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.808 -0.711 . . . . 70.22 112.49 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.41 -161.72 20.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 73.41 112.465 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -33.18 60.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 71.42 110.868 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.1 tp -51.85 -35.86 46.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.924 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.91 111.16 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.42 111.078 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.71 159.73 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 73.35 110.858 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.7 p -100.27 162.78 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.21 110.812 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 65.21 111.075 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.778 0.323 . . . . 64.2 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.98 90.49 3.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.959 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.96 -17.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 73.42 111.271 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -74.39 -27.81 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 71.42 110.949 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -110.97 -12.92 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 61.21 110.857 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -54.09 -62.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 72.55 110.918 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.56 -23.73 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 75.14 110.822 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.2 m -81.43 -30.48 33.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 73.15 111.168 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -43.63 41.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.889 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.7 mm -61.83 -45.2 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 74.13 111.144 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.52 -23.96 53.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 64.53 110.883 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.99 -22.79 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.864 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.4 t -86.11 -9.0 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 72.43 111.137 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.69 -6.93 13.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 71.33 110.941 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.46 -31.06 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 75.35 110.939 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -55.98 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.856 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -94.89 38.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.84 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -55.53 -47.97 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 75.23 110.948 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -60.05 102.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 73.24 110.829 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.9 mt -144.69 125.12 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 75.03 111.151 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -24.2 41.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 55.25 110.905 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.15 133.71 1.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 65.15 111.089 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 88.8 t -115.02 131.61 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 65.41 111.092 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.6 t -110.15 108.88 58.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 74.34 111.13 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 -176.01 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 74.54 112.353 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.41 -17.36 80.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 71.52 112.476 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -152.43 141.15 20.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 74.5 110.972 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 110.21 -117.64 4.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 74.05 112.488 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.63 176.16 11.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.358 . . . . 73.03 110.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.8 t -70.09 151.12 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 72.23 111.146 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.99 -102.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.737 -0.744 . . . . 65.15 112.447 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.67 -168.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 74.25 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -60.93 -18.14 55.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 75.23 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.77 -19.79 37.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.799 -0.715 . . . . 72.44 112.506 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.23 -31.78 64.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 73.04 110.878 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.8 -57.3 11.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 72.21 111.027 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.12 -17.93 59.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.31 110.937 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.24 -40.99 90.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.874 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.8 m -60.94 -47.98 83.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 71.32 111.169 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.97 -21.99 65.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.949 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -75.4 -6.54 50.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 72.23 110.905 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.7 mt -125.13 -35.68 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 72.5 110.859 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.45 -0.82 56.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.912 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 75.45 110.894 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.842 0.353 . . . . 71.01 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mt -110.48 97.17 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 71.52 111.201 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.94 121.01 39.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 75.02 110.906 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -66.78 168.16 10.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 71.42 110.837 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -52.18 -48.14 65.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.45 110.844 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.98 -37.83 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 75.12 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.93 13.12 62.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 60.54 112.55 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 m -80.47 -44.26 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.278 . . . . 74.32 111.134 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 52.8 mt -101.97 113.02 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 73.43 111.097 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.4 p -121.15 129.06 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 61.3 110.871 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -120.41 111.83 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 72.04 111.121 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.2 t -97.01 126.53 42.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.894 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -72.15 109.34 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.892 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.0 -35.26 79.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.964 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.448 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.68 -96.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.915 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.24 9.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.944 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.4 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.15 8.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 75.31 110.981 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -150.91 140.34 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 73.11 111.245 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -129.58 -179.71 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.437 . . . . 74.22 110.973 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.28 88.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 75.32 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -71.3 123.17 21.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 62.41 110.851 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.1 m -119.78 105.1 10.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 75.31 111.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -87.05 122.64 31.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.882 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.53 108.5 19.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 74.42 110.896 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.786 -0.721 . . . . 74.33 112.513 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.553 0.692 . . . . 73.12 111.228 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.63 116.9 4.76 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.738 2.292 . . . . 60.24 112.405 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.2 p -104.44 98.34 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 74.13 110.839 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.51 169.25 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.893 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -148.71 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.839 -0.696 . . . . 54.53 112.586 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.8 tp -158.62 115.19 2.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 71.11 110.943 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.56 121.8 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 63.51 111.139 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -98.84 116.51 31.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.958 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -87.38 85.49 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.44 110.953 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.6 176.18 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 65.42 111.115 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -96.67 -21.5 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 71.11 110.831 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -11.18 57.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 74.22 110.868 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.08 153.67 5.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 72.1 112.466 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tp -68.39 155.03 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 72.35 110.951 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.57 142.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 73.13 111.153 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.53 122.84 19.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 75.25 110.959 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -69.2 110.51 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 74.15 111.109 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.2 129.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 73.25 110.91 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -165.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.52 110.809 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -91.37 172.66 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 63.42 110.839 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -49.94 -52.04 36.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 74.05 110.978 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -141.63 162.6 35.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 74.33 110.874 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.71 -30.59 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.428 . . . . 64.04 110.832 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -59.74 -42.08 92.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 71.24 110.951 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.08 -45.37 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 74.32 110.866 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -45.87 59.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 74.04 111.167 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -55.58 -48.12 75.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 71.34 110.872 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.98 -18.91 65.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.901 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.1 tp -89.59 -27.14 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 54.14 110.915 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.08 -22.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 71.31 111.145 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.55 15.72 13.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.871 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.46 -39.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -80.39 -22.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 60.12 111.097 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.75 -23.07 65.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 72.23 110.842 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 -33.52 7.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 74.24 110.842 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -69.91 -39.24 76.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 73.55 110.894 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -92.71 -10.44 37.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.879 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.65 12.05 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 65.15 110.916 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.48 137.83 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 64.01 110.868 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -86.49 138.21 31.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 73.33 110.898 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.702 HG23 ' HE2' ' A' ' 72' ' ' GLU . 71.4 t -76.4 121.94 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 74.12 111.134 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.7 t -134.32 6.59 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 73.04 111.134 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -151.23 145.7 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.31 110.837 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.8 t -154.03 132.22 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 75.31 111.075 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -93.89 123.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 75.43 111.163 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.6 mm -96.55 143.45 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 75.22 111.175 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.0 p -94.11 -51.42 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 75.2 111.176 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.581 ' HA ' ' HD2' ' A' ' 152' ' ' ASP . 1.7 p-80 -156.1 -175.88 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.829 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.86 97.13 10.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 73.35 111.117 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -158.11 150.92 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 75.04 110.858 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.07 -19.61 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 61.42 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -92.29 21.83 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.809 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -144.0 -77.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 71.55 110.837 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.87 8.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 73.34 111.136 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -41.8 38.37 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.709 -0.758 . . . . 74.55 112.503 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.45 12.04 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 72.24 112.458 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.5 tt -51.97 -28.49 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 73.43 111.104 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -53.58 -39.84 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 75.04 110.87 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.9 m -79.94 -17.29 53.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 73.12 111.192 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.3 mt -84.99 -32.34 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 75.54 110.906 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.71 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.0 110.87 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -119.63 -45.74 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -77.36 -53.41 7.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.31 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.31 44.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 50.14 112.474 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.0 121.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.945 0.403 . . . . 74.4 111.14 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -82.05 111.42 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 71.51 110.968 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.12 91.28 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.077 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -62.98 142.16 58.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.01 110.865 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.4 p -172.9 179.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 64.31 110.882 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.85 157.47 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.41 111.208 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.99 -31.74 13.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 64.42 111.029 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -39.38 44.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 73.11 110.908 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 152' ' ' ASP . 10.2 m -57.37 -27.7 62.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 74.54 111.151 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.33 8.58 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.12 111.084 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.99 -28.78 11.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 75.41 110.898 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.36 -8.64 20.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.884 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.46 79.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 71.43 111.146 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -26.68 57.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 72.42 110.901 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -57.58 -30.75 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 71.11 110.933 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -92.11 -24.8 19.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 74.43 110.947 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.18 25.76 4.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 73.14 112.48 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.33 -176.08 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 75.54 110.955 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.61 167.75 17.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 71.34 110.853 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.6 mt-10 -101.25 103.25 24.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.7 0.762 . . . . 74.15 110.818 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.0 Cg_endo -69.73 -178.63 2.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 71.45 112.313 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 28.9 mt -51.64 -51.29 56.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.92 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.11 24.72 36.7 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.729 . . . . 73.32 112.437 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.78 29.31 5.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 72.34 110.898 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -108.91 -175.8 2.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 71.34 110.903 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.87 -172.63 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 74.45 110.938 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.5 m -50.91 -70.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 71.55 111.127 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.8 t -117.77 103.1 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 75.01 111.111 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -131.78 174.34 10.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 72.04 111.152 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.32 129.36 50.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 73.24 110.878 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.8 mt -113.29 156.98 22.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.934 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -139.36 115.31 10.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.869 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -113.36 48.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 65.52 110.918 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.43 94.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 72.12 112.382 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 m120 65.1 14.2 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 70.14 110.885 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.5 tpp -133.43 104.29 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 70.43 110.88 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.68 123.78 36.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.883 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.92 117.86 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 73.23 111.116 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -111.13 127.91 55.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.51 110.884 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.58 -172.49 4.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 72.15 111.175 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -172.83 135.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 74.11 110.899 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -120.95 89.63 46.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.742 . . . . 73.03 110.89 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.76 -7.89 22.2 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.661 2.241 . . . . 75.1 112.401 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.28 -150.08 19.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 75.14 112.527 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -96.53 139.12 33.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 75.41 110.886 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.0 -95.22 0.12 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 74.04 112.461 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -69.6 -24.44 63.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 73.32 110.982 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 p -151.4 -171.45 3.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 62.33 111.145 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.91 -8.4 57.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 75.24 110.89 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.581 ' HD2' ' HA ' ' A' ' 86' ' ' HIS . 3.7 p-10 -136.86 14.98 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.07 137.95 32.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 72.1 110.906 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.69 -179.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.114 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.12 126.58 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 72.31 111.16 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.9 t -85.96 122.94 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.35 111.094 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -110.7 133.05 53.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.91 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.01 98.65 50.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 74.34 110.978 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -4.02 13.14 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 62.22 112.339 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -83.36 -23.85 32.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.954 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.25 14.49 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 75.22 110.922 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.19 27.36 7.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 72.52 110.858 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.2 mt -92.54 129.87 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 71.13 111.166 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 23.0 tp -115.5 147.68 40.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 74.13 110.947 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 37.6 t -117.73 74.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 72.42 111.124 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.79 -41.49 51.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 74.35 112.534 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.49 -160.48 53.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.832 -0.699 . . . . 62.43 112.419 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 45.8 m -51.72 -30.1 21.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.368 . . . . 71.22 110.893 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.83 -32.49 67.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 70.4 110.947 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.1 t -105.98 109.73 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 72.24 111.16 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -51.54 161.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 73.35 110.884 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.86 168.62 9.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 73.13 110.907 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 73.42 111.107 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.879 0.371 . . . . 75.15 111.047 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.61 91.91 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 74.01 110.932 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.49 -21.31 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 72.03 111.088 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.41 -21.71 60.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 75.41 110.82 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -114.93 -12.9 11.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 75.41 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.73 -62.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 73.41 110.897 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.5 -23.63 17.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.865 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 58.0 m -80.66 -33.31 35.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 73.31 111.155 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -43.75 62.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 72.11 110.885 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.1 mm -59.56 -47.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 74.12 111.143 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.41 -27.78 62.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 64.01 110.852 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -77.43 -20.69 54.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 74.42 110.86 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.4 t -86.57 -13.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 65.33 111.156 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -108.38 -16.55 14.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.867 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -30.6 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.44 110.849 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 -50.4 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 74.33 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.84 66.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 73.31 110.847 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.3 mtm-85 -72.91 -59.78 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 74.14 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -51.63 107.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 72.32 110.9 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 85.0 mt -146.61 122.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 74.34 111.12 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.93 -32.13 45.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.863 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -161.72 147.62 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 64.35 111.09 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.47 126.74 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 62.23 111.108 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.0 t -103.29 104.07 38.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.565 0.697 . . . . 64.25 111.166 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -174.78 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.784 2.323 . . . . 64.23 112.33 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.1 75.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.786 . . . . 54.33 112.548 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.33 140.64 20.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 71.33 110.86 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.6 -117.26 4.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 73.31 112.397 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -157.02 149.14 22.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 65.2 110.916 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.55 137.6 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 71.23 111.115 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -135.03 -88.58 0.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 60.11 112.469 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -171.65 -168.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.963 0.411 . . . . 65.15 110.829 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -61.73 -17.26 55.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.43 110.92 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.81 -19.93 38.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 70.34 112.46 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.7 mt -77.4 -47.13 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 73.31 110.82 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.72 -54.61 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 75.44 110.978 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.72 -21.24 62.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.01 110.913 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -37.65 76.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 71.43 110.889 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 m -55.39 -54.88 38.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 72.3 111.15 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.88 -19.87 53.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 74.14 110.897 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -83.58 -5.17 59.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.897 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 mt -129.14 -4.56 4.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 71.14 110.869 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.77 -0.19 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 74.14 110.961 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.098 -0.501 . . . . 72.13 110.988 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.728 0.299 . . . . 74.31 111.182 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 mt -136.43 92.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 74.34 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -113.79 115.09 27.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.493 . . . . 74.23 110.909 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -58.96 168.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 63.43 110.874 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -51.3 -47.79 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.42 110.912 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 34.5 p -61.24 -37.45 83.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 73.54 111.075 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.66 14.13 61.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.746 . . . . 72.52 112.527 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.3 m -80.14 -44.34 20.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.308 . . . . 61.42 111.118 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.54 114.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 71.52 111.14 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -121.55 127.52 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.838 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.97 112.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 74.5 111.13 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.5 t -99.05 125.97 44.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 63.1 110.84 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -69.83 111.3 5.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.872 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.17 -32.69 74.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.907 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.449 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -152.04 -96.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.52 110.977 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.449 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.33 9.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.13 110.947 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.402 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.84 7.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.911 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.99 141.9 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.42 111.183 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 18.8 m95 -130.04 -177.81 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.94 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.7 t -133.4 91.76 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.311 -0.404 . . . . 63.12 111.191 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -75.16 123.55 25.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 70.3 110.824 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.5 m -120.33 104.24 9.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 52.12 111.212 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 124.34 31.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 73.54 110.824 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.5 113.77 23.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 74.15 110.938 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 64.44 112.477 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.713 0.768 . . . . 75.22 111.163 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.65 117.43 5.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.735 2.29 . . . . 75.32 112.394 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -109.41 97.4 6.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 70.11 110.792 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -58.25 166.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 73.44 110.892 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.05 -149.39 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 64.42 112.477 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.5 tp -158.28 119.31 3.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 75.1 110.917 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.6 t -103.16 122.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 74.41 111.07 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.5 mt -100.42 120.74 40.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.963 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.47 84.67 5.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 74.04 110.893 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -99.54 -176.53 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.169 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 -26.47 13.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.2 110.886 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -18.7 55.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 73.25 110.86 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.17 151.47 5.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 61.11 112.479 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.9 mt -62.94 154.8 29.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.339 . . . . 73.23 110.839 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.22 141.27 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 72.1 111.131 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.55 121.82 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 74.02 110.891 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 79.8 t -68.24 111.97 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.14 111.054 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.8 129.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 74.23 110.792 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -167.14 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.917 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.3 t -91.24 170.53 9.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 73.35 110.864 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -51.07 -60.28 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 72.31 110.91 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.02 159.26 35.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.258 -0.428 . . . . 61.51 110.876 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.656 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 73.1 m-20 -51.44 -32.8 28.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.872 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -58.57 -44.13 89.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 73.2 110.918 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.53 -45.5 37.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 75.55 110.96 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.6 -48.52 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 75.44 111.14 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -53.54 -48.4 69.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.931 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -65.61 -18.97 65.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.47 . . . . 71.02 110.9 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 tp -88.62 -27.1 21.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 74.53 110.936 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.2 mt -90.47 -23.01 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 72.31 111.105 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -92.81 17.32 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 73.43 110.895 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.8 ptm -131.95 -39.89 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 62.34 110.867 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.4 m -80.18 -24.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 75.35 111.205 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.663 ' HE2' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.37 -23.14 66.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 65.11 110.929 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 -32.14 7.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 65.22 110.946 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -40.93 67.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.41 110.953 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -89.43 -12.12 41.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.53 110.923 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.34 11.71 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 63.41 110.861 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.8 141.4 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 72.13 110.936 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -86.2 140.99 29.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.275 -0.421 . . . . 74.13 110.846 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.663 HG21 ' HE2' ' A' ' 72' ' ' GLU . 85.0 t -82.07 126.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.4 111.137 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -142.46 13.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -153.75 144.74 22.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 71.45 110.874 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 t -154.31 132.61 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 75.51 111.167 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.58 126.72 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 72.3 111.097 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -102.85 136.32 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.21 111.066 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 -44.59 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.13 111.265 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -152.46 174.94 13.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.901 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.65 88.9 5.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 72.13 111.061 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.95 156.04 43.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 75.21 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -21.72 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.43 111.04 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 20.49 7.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 62.22 110.883 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -140.62 -75.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.99 8.14 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 70.41 111.074 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -36.56 28.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 63.44 112.46 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.03 15.26 51.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 65.41 112.534 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -56.57 -29.98 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 75.34 111.087 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.656 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -55.97 -30.67 62.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.23 110.86 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -90.0 -11.81 40.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 71.45 111.166 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.4 mt -91.01 -28.77 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.971 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -100.03 22.21 11.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.916 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -121.7 -36.51 3.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.32 110.932 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -87.41 -53.94 4.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.088 -0.505 . . . . 73.03 110.894 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.1 38.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 64.52 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.25 124.36 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.35 . . . . 74.41 111.132 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -89.79 118.44 29.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 65.04 110.894 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.9 92.05 8.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.42 111.113 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -66.29 144.03 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 75.51 110.751 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.38 -174.19 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 72.3 110.857 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.97 155.37 16.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 74.21 111.144 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.62 -39.98 37.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.12 111.16 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.0 -43.45 87.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.934 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 93.5 m -58.77 -21.61 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 72.34 111.098 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.43 12.26 37.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.33 111.138 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -25.81 9.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 74.44 110.943 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.98 -7.61 20.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 71.04 110.961 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.02 64.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.23 111.093 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -21.69 52.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 75.4 110.843 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -31.32 72.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 54.32 110.904 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -90.22 -25.62 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.895 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 25.42 2.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 74.44 112.488 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.42 170.6 7.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 74.54 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.54 179.0 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.524 . . . . 74.35 110.912 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -111.34 106.09 57.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.729 . . . . 73.31 110.938 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 178.42 4.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.699 2.266 . . . . 73.14 112.361 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.0 mt -53.3 -47.44 69.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.915 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.17 27.82 24.51 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 72.31 112.487 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.845 0.355 . . . . 71.3 110.881 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.4 mt -113.76 -175.32 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 74.24 110.901 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.16 -171.64 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.964 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.1 m -50.86 -70.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 73.23 111.222 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.1 t -118.58 102.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 74.22 111.12 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -132.25 169.12 16.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.151 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.27 132.84 56.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 75.53 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 50.2 mt -119.41 157.84 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 75.22 110.889 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -142.62 112.31 6.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 62.35 110.908 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -107.65 47.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 70.53 110.835 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.74 92.73 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 72.3 112.469 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.65 13.6 9.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 75.23 110.825 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.1 tpp -136.48 93.51 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.933 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -83.68 132.09 34.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.2 t -137.25 117.74 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 74.14 111.176 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -110.16 126.99 54.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 73.45 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.4 p -83.38 -174.05 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 75.32 111.126 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -171.82 133.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.877 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -120.43 88.53 42.62 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.662 0.744 . . . . 74.32 110.937 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -7.93 22.3 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 72.24 112.333 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.2 -158.25 23.07 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 74.42 112.441 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -90.17 139.34 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 74.42 110.812 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.67 -95.56 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.727 -0.749 . . . . 73.51 112.435 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -70.36 -24.17 62.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 75.13 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.3 p -151.7 -175.24 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 75.25 111.111 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.77 -2.34 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 60.53 110.841 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -140.21 11.45 2.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 61.12 110.906 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.65 141.38 20.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 75.34 110.892 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.67 -178.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 73.05 111.106 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.77 120.1 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 75.21 111.198 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.25 133.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.161 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -118.69 131.34 56.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 74.45 110.987 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.4 mt -112.8 98.83 46.25 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.595 0.712 . . . . 74.1 110.917 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -4.26 13.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.279 . . . . 73.54 112.336 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -83.08 -23.8 32.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 73.54 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.82 14.05 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.95 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.4 m120 54.21 27.15 7.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 75.43 111.006 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.1 mt -91.98 136.66 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 74.23 111.111 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 26.6 tp -121.96 147.75 45.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 71.42 110.992 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.33 76.47 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 74.35 111.078 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.59 -40.77 48.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 71.11 112.556 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 71.6 -162.82 54.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 62.3 112.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 78.6 m -51.46 -33.1 29.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.77 0.319 . . . . 73.54 110.777 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.4 tp -51.63 -44.56 62.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 74.14 110.945 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.08 111.6 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.44 111.061 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -55.31 164.85 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.864 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.9 p -114.98 170.33 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.14 110.835 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 73.43 111.088 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.808 0.337 . . . . 40.12 111.073 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -119.73 91.75 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 73.41 110.961 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.6 -19.07 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.15 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.78 -20.89 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.893 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -116.81 -16.18 10.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 72.22 110.85 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -55.0 -61.41 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.2 -0.455 . . . . 74.4 110.906 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -24.64 19.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.858 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -80.72 -31.97 35.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 74.15 111.065 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -45.45 49.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 64.43 110.848 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.6 mm -59.11 -47.63 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 75.41 111.087 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.33 -28.65 59.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.879 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -77.31 -22.48 51.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.3 110.848 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.37 -10.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 62.03 111.154 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.96 -10.28 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 71.22 110.936 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.8 -30.43 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 73.11 110.845 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 -45.73 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 72.14 110.835 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.41 37.06 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.41 110.93 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.61 -48.06 75.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 73.22 110.914 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -61.2 102.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.948 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.3 mt -144.86 126.53 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 75.03 111.139 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.75 -22.71 34.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 72.13 110.908 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.74 125.31 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 75.32 111.083 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 92.5 t -104.22 137.23 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 75.53 111.051 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 t -110.8 108.44 57.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.573 0.701 . . . . 73.15 111.146 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 173.33 11.17 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.66 2.24 . . . . 72.53 112.301 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.52 -13.81 74.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.602 -0.809 . . . . 64.34 112.525 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -152.61 147.6 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 72.13 110.785 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 99.47 -113.94 4.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 71.34 112.476 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -156.58 168.6 26.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 61.23 110.875 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.34 163.27 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.31 111.135 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.99 -104.72 0.2 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 72.32 112.492 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.95 -169.6 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.34 . . . . 62.51 110.874 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -59.81 -19.19 49.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 71.41 110.89 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.04 -22.69 36.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.74 . . . . 72.42 112.471 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 5.0 mt -72.56 -32.73 66.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 73.4 110.919 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.7 mp -62.03 -59.98 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 71.44 110.924 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -20.66 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.912 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.26 -37.69 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 64.15 110.902 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.1 m -58.44 -51.62 69.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 74.1 111.126 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.5 mp -68.77 -16.71 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 71.22 110.972 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.86 -11.07 59.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 74.01 110.864 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.3 mt -121.24 -31.76 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 71.04 110.991 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.6 8.24 37.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.31 110.953 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 73.3 110.868 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.825 0.345 . . . . 75.0 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.02 92.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 72.31 111.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.27 119.46 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.894 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -61.87 168.47 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 72.42 110.861 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.85 -47.9 64.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.804 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.77 -37.75 82.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 74.1 111.079 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.04 12.72 61.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 50.45 112.539 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -80.39 -44.1 19.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 75.11 111.179 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -102.57 116.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.45 111.09 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.4 p -123.89 131.75 53.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 64.5 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.16 109.95 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 74.22 111.066 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.2 t -101.01 125.25 47.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.745 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.72 110.93 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 70.12 110.899 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.7 mt -65.41 -31.86 73.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 73.51 110.926 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.47 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.71 -97.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 73.44 110.879 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.3 OUTLIER -151.47 9.89 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.897 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.58 6.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 71.53 110.931 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.2 t -151.09 139.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 70.4 111.138 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -126.92 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.864 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.69 96.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 72.55 111.213 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -81.27 120.66 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 75.2 110.876 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -115.78 100.99 8.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 72.01 111.205 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.16 121.51 26.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 73.53 110.912 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.29 107.04 18.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 73.54 110.928 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 73.2 112.501 179.872 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.587 0.708 . . . . 64.4 111.007 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 118.24 5.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.264 . . . . 73.35 112.295 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.83 99.89 9.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 72.1 110.871 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -52.56 170.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.45 110.812 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.55 -164.01 16.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.416 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 tp -153.04 114.16 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 74.12 110.902 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.28 116.8 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.02 111.113 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.5 mt -94.86 120.83 35.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 71.43 110.965 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.66 83.21 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.12 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.5 p -90.77 -178.5 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 72.34 111.126 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -105.26 -1.15 25.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 55.34 110.777 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -23.14 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 75.41 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.57 144.42 4.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 62.33 112.471 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.51 154.54 17.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 71.32 110.93 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 t -145.11 142.94 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 73.42 111.122 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -137.51 123.12 19.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 73.43 110.835 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.78 112.72 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 75.14 111.107 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.65 129.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.03 110.94 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -167.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.854 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -92.34 170.27 9.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 63.43 110.853 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -50.34 -60.26 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.873 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -128.93 160.56 32.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 64.23 110.854 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -52.72 -31.24 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 72.15 110.864 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -59.82 -43.52 94.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 72.24 110.88 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.47 -45.85 36.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 71.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -47.11 63.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 73.42 111.169 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -50.98 61.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 74.2 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.37 -19.87 65.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.86 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 tp -87.45 -26.16 23.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 74.12 110.871 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.6 mt -90.87 -23.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 75.22 111.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.69 16.5 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.882 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.85 -39.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.34 110.783 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.416 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 33.9 m -80.85 -23.76 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 74.32 111.158 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.641 ' HE2' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.01 -23.43 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.51 110.866 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -106.8 -33.57 7.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 75.51 110.906 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -70.58 -44.12 68.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 72.31 110.783 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -86.59 -12.8 47.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 74.52 110.907 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.43 11.75 8.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 53.34 110.89 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.95 141.1 50.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 73.42 110.894 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.41 140.4 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 74.43 110.883 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.641 HG21 ' HE2' ' A' ' 72' ' ' GLU . 86.3 t -81.95 121.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 73.44 111.111 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.78 9.65 2.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 63.34 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -148.86 145.02 27.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.87 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.3 t -154.14 131.47 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 73.13 111.125 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.6 mt -94.66 123.49 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 74.4 111.077 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.7 mm -94.58 150.33 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 64.42 111.119 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 p -109.31 -40.82 4.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 72.33 111.149 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.62 -178.53 7.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 62.41 110.844 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -98.89 96.87 8.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 75.22 111.186 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -155.72 154.84 32.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 63.23 110.866 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.22 -20.59 28.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.3 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.92 16.25 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 74.25 110.838 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.02 -76.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 74.24 110.832 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.79 8.39 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.135 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.9 -36.38 33.66 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.698 -0.763 . . . . 73.43 112.476 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.24 16.16 49.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 64.2 112.401 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -58.16 -23.29 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 75.34 111.077 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -30.08 68.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.919 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.5 m -88.97 -19.92 25.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 62.41 111.1 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.0 mt -82.79 -32.44 27.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 74.42 110.892 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -95.15 23.76 5.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -122.13 -41.45 2.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 74.13 110.999 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -83.03 -49.8 9.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.805 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.45 39.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 52.43 112.479 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.69 120.0 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 72.11 111.159 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -83.35 118.68 23.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.35 110.92 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.42 92.82 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.51 111.127 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -64.98 143.3 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 73.24 110.841 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.49 -179.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.908 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.99 153.92 19.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 74.25 111.195 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.68 -35.1 13.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 74.02 111.105 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -47.76 64.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 74.51 110.92 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.9 m -59.42 -18.61 40.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 73.53 111.081 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.57 11.4 39.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 74.1 111.049 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -113.91 -31.76 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 71.25 110.889 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.49 -13.33 27.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.866 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.049 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -24.95 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 75.4 110.928 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.59 -32.61 70.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 74.05 110.849 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -89.54 -24.82 21.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.897 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.24 23.16 3.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 70.12 112.484 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -98.38 177.59 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 75.03 110.973 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -76.34 178.99 6.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 72.03 110.885 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mp0 -112.58 105.66 55.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.609 0.718 . . . . 64.31 110.867 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.9 Cg_endo -69.82 178.68 4.37 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.709 2.273 . . . . 74.25 112.327 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.1 mt -51.3 -48.34 62.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.52 110.862 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.09 38.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 74.04 112.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -107.11 41.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 75.34 110.9 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -124.93 -173.81 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 72.42 110.879 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.01 -172.92 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.842 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.6 m -50.58 -71.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 74.32 111.161 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.51 94.35 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 71.03 111.18 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.3 t -118.36 167.0 11.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 73.34 111.066 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.51 106.83 10.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 60.12 110.877 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 28.8 mt -79.72 -173.21 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.939 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.04 112.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 73.52 110.944 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -110.49 74.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 74.34 110.83 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.51 -83.06 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 62.42 112.505 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -120.29 24.85 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.3 . . . . 64.44 110.893 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.4 tpp -129.48 142.55 50.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.909 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.32 133.28 56.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 73.54 110.827 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.5 t -144.97 117.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 74.5 111.117 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -112.5 126.55 55.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 62.32 110.919 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 p -82.69 -178.19 7.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.183 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -166.49 134.06 2.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 73.13 110.929 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -121.06 89.31 46.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.723 0.773 . . . . 75.44 110.971 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -8.12 22.8 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.706 2.27 . . . . 71.31 112.374 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.53 -157.67 20.38 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 73.34 112.495 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -84.66 137.69 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.724 0.297 . . . . 75.42 110.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.33 -89.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 63.54 112.516 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -75.1 -25.64 58.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 75.2 110.843 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.9 p -147.32 -162.26 1.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.162 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -84.53 -25.42 28.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 71.23 110.886 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.8 24.05 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 72.01 110.961 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.41 128.06 18.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 62.4 110.88 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.6 pt -135.12 173.0 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 75.22 111.074 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.8 m -124.42 150.0 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.41 111.076 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.87 111.77 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.15 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -101.28 132.83 46.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 6.3 mp -112.22 97.64 39.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 72.42 110.91 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.81 -4.86 14.91 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.619 2.212 . . . . 64.4 112.373 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.55 -26.56 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 75.52 110.958 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.53 19.14 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 75.32 111.005 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 50.51 29.28 3.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.524 . . . . 62.41 110.941 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.64 120.01 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.117 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.3 tp -104.53 147.15 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 61.23 110.882 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.53 79.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 71.52 111.136 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.84 -49.81 46.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.734 -0.745 . . . . 65.22 112.456 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.32 -166.29 53.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 44.14 112.436 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -35.38 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 75.2 110.838 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 23.5 tp -51.59 -52.19 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 71.04 110.967 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.02 109.44 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 75.12 111.161 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -51.86 148.12 6.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.872 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 153.97 17.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 72.25 110.872 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 71.34 111.08 -179.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.755 0.312 . . . . 74.05 111.057 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.24 87.06 2.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.33 110.947 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.2 t -60.78 -18.18 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 61.45 111.141 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -74.28 -28.09 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 71.55 110.814 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.59 -12.34 14.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 52.31 110.796 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -53.28 -62.0 1.93 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.857 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.17 -24.09 16.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 71.21 110.831 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -82.39 -30.93 29.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 71.53 111.141 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -43.27 58.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 74.01 110.782 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 28.9 mm -62.95 -43.0 98.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 75.2 111.172 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.44 -22.5 54.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.907 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -82.74 -22.4 34.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 74.21 110.94 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.14 -9.77 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 73.24 111.198 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.73 -12.49 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.933 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -100.51 -31.22 11.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 75.55 110.94 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.63 -49.28 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 73.32 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -95.81 60.73 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.926 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -71.28 -64.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.478 . . . . 74.03 110.819 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -51.49 104.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.916 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 89.9 mt -142.77 124.8 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.072 -0.513 . . . . 72.43 111.183 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -34.85 50.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.999 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.28 129.91 1.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 71.43 111.085 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 95.5 t -103.52 133.58 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 73.23 111.181 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.5 t -109.58 106.92 59.06 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.604 0.716 . . . . 72.45 111.029 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 -168.61 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.679 2.253 . . . . 72.3 112.361 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.84 -13.43 57.94 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.68 -0.772 . . . . 72.04 112.574 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -152.32 138.52 18.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.853 0.358 . . . . 74.52 110.829 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.94 -106.41 2.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 74.35 112.539 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -167.47 162.12 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 71.24 110.923 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.5 m -52.74 161.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.12 111.202 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.66 -98.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 64.42 112.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -169.01 -168.86 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.868 0.366 . . . . 75.11 110.937 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -61.69 -17.36 55.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.4 110.889 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.36 -19.21 39.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 63.22 112.463 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.04 -32.92 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.859 0.361 . . . . 72.03 110.871 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.18 -58.52 6.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 62.32 110.986 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.02 -18.16 56.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.45 110.913 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -65.15 -51.42 61.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.861 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.7 m -52.22 -49.91 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 72.25 111.196 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.42 -18.31 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 65.53 110.932 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -92.1 -2.67 56.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 63.12 110.816 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.9 mt -126.25 -5.98 6.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 73.21 110.962 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.92 2.46 11.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.913 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 73.51 110.862 179.85 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.85 0.357 . . . . 71.33 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.9 mt -136.2 91.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 73.51 111.177 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 116.39 30.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.909 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -59.82 168.15 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.889 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.7 -47.9 63.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 65.12 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.8 p -60.68 -37.68 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 74.44 111.172 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.77 13.15 61.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.674 -0.774 . . . . 54.22 112.505 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -80.36 -43.96 20.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 75.15 111.108 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -102.95 116.54 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 73.23 111.135 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 71.35 110.851 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.87 112.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 63.43 111.087 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.7 t -98.82 125.66 44.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 64.21 110.82 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -68.6 110.57 4.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.94 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.83 -31.35 72.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.33 110.971 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.449 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -153.48 -96.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 75.1 110.889 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.449 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.44 9.66 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 72.42 110.929 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.402 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.77 7.74 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 61.4 110.883 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.74 143.27 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 74.15 111.094 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -131.02 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.23 110.959 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.7 t -135.43 89.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 73.45 111.19 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -72.27 121.66 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 73.04 110.871 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.4 m -119.62 104.67 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 63.32 111.143 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.497 ' HE2' ' C ' ' A' ' 63' ' ' LEU . 2.7 mm-40 -87.59 125.78 34.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.944 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 110.39 21.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.878 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.702 -0.761 . . . . 72.13 112.468 179.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.614 0.721 . . . . 72.3 111.177 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 117.87 5.34 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.683 2.255 . . . . 75.14 112.31 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 p -109.67 97.63 7.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 42.31 110.811 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -63.22 164.62 8.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 75.13 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.99 -144.81 4.0 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.69 -0.767 . . . . 74.25 112.466 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.4 tp -158.81 120.12 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 73.54 110.862 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -105.29 122.29 58.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.126 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 16.0 mt -102.14 121.01 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 73.02 110.944 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.63 85.08 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 74.04 110.831 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.14 173.01 8.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 75.12 111.149 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.25 4.26 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 73.42 110.817 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 -20.58 9.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 72.41 110.91 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.31 138.36 2.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 73.1 112.5 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.9 mt -54.63 157.63 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 71.41 110.896 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 19.0 t -145.32 141.0 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 74.14 111.112 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.61 124.16 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.42 110.945 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.57 107.66 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 74.41 111.034 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.407 ' HD2' ' CG2' ' A' ' 85' ' ' THR . 1.5 m-20 71.51 134.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 62.21 110.927 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -165.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 74.23 110.806 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 t -92.37 175.01 7.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.41 110.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -51.27 -60.41 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.918 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -132.55 161.71 33.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.24 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.675 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 64.4 m-20 -51.77 -33.47 35.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 54.1 110.854 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -59.03 -33.76 71.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.897 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.497 ' C ' ' HE2' ' A' ' 30' ' ' GLU . 92.4 mt -89.25 -45.73 9.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.903 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -50.8 -47.45 59.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 73.23 111.147 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -54.45 -47.48 72.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.872 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.31 -19.4 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.863 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.5 tp -88.4 -27.96 21.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 71.51 110.881 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.5 mt -89.41 -22.99 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.35 111.12 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.88 16.84 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptm -131.01 -39.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 73.42 110.899 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.95 -24.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 61.34 111.071 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.653 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.85 -21.86 66.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 74.11 110.861 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -109.49 -32.31 7.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.898 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -72.18 -41.95 66.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.826 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -88.05 -12.35 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.855 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.37 13.73 8.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.43 110.983 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.15 140.14 46.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 75.33 110.863 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -86.1 140.45 30.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.885 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.653 HG22 ' HE2' ' A' ' 72' ' ' GLU . 99.4 t -80.07 122.3 35.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.12 111.11 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -136.67 8.16 3.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 65.24 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.28 136.08 17.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 73.24 110.927 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.0 t -147.68 127.75 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 72.22 111.09 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.4 mt -93.49 122.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 73.21 111.132 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.3 mm -94.33 140.18 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 73.14 111.144 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.407 ' CG2' ' HD2' ' A' ' 56' ' ' ASP . 65.9 p -86.86 -55.83 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 64.31 111.12 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -152.15 -175.2 5.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.419 . . . . 74.51 110.96 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.21 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.42 111.054 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.72 149.84 22.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.3 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.45 -19.53 24.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 75.14 111.143 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.5 9.76 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.13 -77.27 0.52 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.81 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.71 8.14 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 64.23 111.048 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.39 -41.5 40.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 74.55 112.438 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 14.46 56.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.746 . . . . 74.52 112.498 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 tt -51.7 -29.92 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 74.5 111.139 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.675 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -54.43 -35.56 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 73.3 110.87 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -79.94 -23.99 41.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.31 111.161 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.93 -28.25 30.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.989 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -94.04 19.47 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.956 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -121.71 -45.51 2.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 71.13 110.846 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -74.35 -52.39 12.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 75.12 110.856 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.8 42.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.683 -0.77 . . . . 65.34 112.463 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.6 mp -106.31 128.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 70.34 111.23 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -84.19 105.86 15.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.937 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.02 92.83 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 73.12 111.205 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -69.65 146.14 51.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 73.23 110.886 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -174.26 179.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 74.22 110.901 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.45 154.27 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 64.12 111.07 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.11 40.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 52.5 111.081 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.426 HD13 ' HE2' ' A' ' 113' ' ' GLU . 0.9 OUTLIER -69.94 -41.18 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.91 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 99.8 m -58.44 -20.69 46.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.02 111.123 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.56 8.44 41.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 74.13 111.055 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.426 ' HE2' HD13 ' A' ' 110' ' ' LEU . 3.7 pt-20 -107.81 -31.56 7.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 73.52 110.838 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.09 -12.83 24.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 71.43 110.967 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.14 81.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 71.22 111.104 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.47 -24.45 59.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.927 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.52 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.898 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -90.29 -22.06 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 62.43 110.951 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.53 25.51 4.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.829 -0.7 . . . . 60.25 112.434 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.59 175.68 5.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.899 0.381 . . . . 74.13 110.935 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.83 162.17 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.951 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -94.89 108.4 37.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.57 0.7 . . . . 70.03 110.916 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.5 Cg_endo -69.71 -177.42 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.282 . . . . 60.05 112.363 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.8 mt -54.21 -54.46 39.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 62.23 110.878 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.52 73.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 62.14 112.428 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -99.03 33.54 2.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 74.44 110.848 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -116.65 -174.6 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.923 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 -170.45 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.871 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 48.5 m -50.49 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.43 111.21 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.22 93.56 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 70.55 111.1 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -113.05 164.97 12.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.11 111.116 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.18 102.96 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.907 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 28.4 mt -76.02 -173.06 2.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 74.12 110.918 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -171.31 110.23 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.843 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.92 -167.57 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 60.5 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -57.63 95.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.765 -0.731 . . . . 73.32 112.461 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 53.75 25.92 5.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.391 . . . . 73.21 110.912 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.4 tpp -129.19 140.03 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.47 135.91 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.53 110.912 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.72 116.88 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 73.44 111.179 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -112.88 126.58 55.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 63.2 110.893 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.8 p -83.39 174.27 10.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.127 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -158.78 137.61 11.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.937 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -127.82 89.31 51.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.738 0.78 . . . . 75.22 110.985 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 -7.61 21.47 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.671 2.247 . . . . 70.11 112.374 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.03 -150.17 19.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 52.44 112.484 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -95.24 141.1 29.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 72.54 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.43 -90.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 62.53 112.535 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -74.76 -23.05 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.332 . . . . 74.41 110.759 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 69.2 p -151.23 -171.39 3.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 64.01 111.177 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -84.94 -3.32 58.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 75.12 110.893 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -150.18 19.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.944 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.57 130.72 24.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.11 110.887 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.17 175.48 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 73.24 111.138 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.87 123.93 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.03 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.96 119.04 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.129 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -107.79 139.12 42.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 87.7 mt -119.79 99.73 49.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.63 0.728 . . . . 75.21 110.862 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -4.79 14.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.688 2.259 . . . . 74.41 112.289 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -84.78 -30.38 24.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.947 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -131.49 11.21 4.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 72.34 110.923 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.5 m120 55.05 26.0 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.846 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 86.8 mt -90.95 143.83 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.129 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -125.54 145.43 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 62.33 110.916 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.17 81.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 63.22 111.219 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.44 -31.42 28.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.703 -0.76 . . . . 75.45 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 56.69 -168.63 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 63.32 112.453 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -29.68 20.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.336 . . . . 74.1 110.842 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.8 tp -55.65 -55.14 35.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 75.1 110.946 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.9 t -87.55 107.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 75.1 111.13 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -52.15 170.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.53 110.904 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.31 158.63 26.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 52.22 110.883 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.081 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.796 0.332 . . . . 75.51 111.108 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.35 92.39 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 74.23 110.982 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.0 t -63.46 -22.92 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 73.42 111.134 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -71.65 -31.3 66.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 73.45 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.29 -13.05 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.03 110.916 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -55.09 -62.56 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.918 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -24.51 16.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 61.35 110.829 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 57.7 m -80.39 -32.23 37.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 72.2 111.1 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -42.74 58.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.833 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.1 mm -62.91 -44.39 99.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.42 111.134 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.23 -22.89 53.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 54.3 110.807 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -82.45 -22.31 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 74.11 110.895 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 16.1 t -87.19 -8.89 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 75.41 111.064 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.5 -6.79 13.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 73.52 110.946 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.6 -31.19 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 72.13 110.897 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -104.22 -55.95 2.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 75.35 110.871 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -94.99 38.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 75.34 110.827 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -55.97 -47.71 77.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.889 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -59.97 101.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.03 110.951 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 mt -143.65 127.54 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 63.33 111.161 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.01 -23.13 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.934 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.04 132.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.073 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.79 132.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 75.12 111.163 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.7 t -110.35 109.33 58.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 75.2 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 178.02 4.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.658 2.239 . . . . 73.4 112.381 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.51 -18.86 74.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 71.21 112.486 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -152.83 141.67 21.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 74.54 110.879 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.49 -117.48 4.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 75.41 112.474 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -152.25 174.07 14.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 75.24 110.918 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.4 t -69.31 149.98 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 72.01 111.129 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.81 -101.47 0.31 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 72.13 112.515 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.25 -169.0 1.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 71.0 110.823 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -17.83 54.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 74.33 110.872 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.37 -20.11 43.14 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.772 -0.727 . . . . 73.34 112.41 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.2 mt -73.48 -30.07 62.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 74.1 110.921 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.12 -22.5 60.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.901 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.24 -44.67 95.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.12 110.826 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.5 m -56.48 -56.62 18.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 55.12 111.003 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.82 -28.86 24.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.432 . . . . 72.31 110.929 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -32.52 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.92 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.9 mt -88.39 -18.18 28.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.849 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.94 18.84 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.91 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 74.44 110.933 179.762 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.832 0.349 . . . . 71.11 111.147 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.3 mt -110.73 98.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 74.35 111.166 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -118.17 115.39 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 75.43 110.879 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -60.57 166.41 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 71.42 110.897 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -51.45 -48.43 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 74.21 110.923 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 p -62.57 -36.97 84.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 62.44 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 13.9 63.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 34.31 112.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 m -78.84 -45.4 20.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 63.12 111.197 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mt -103.85 112.36 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 73.14 111.129 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -118.04 133.95 55.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.04 110.814 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.51 112.24 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 71.02 111.162 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -98.46 125.57 43.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.864 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -69.34 109.94 4.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 75.32 110.966 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -63.51 -32.69 74.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.94 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.446 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -152.58 -96.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 72.52 110.884 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' N ' HD21 ' A' ' 22' ' ' ASN . 10.0 mttp -150.24 9.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.873 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.401 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.75 8.17 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.861 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -150.89 141.82 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.086 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.403 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 18.9 m95 -130.21 -176.8 4.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 71.22 110.916 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.3 t -134.69 90.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 73.14 111.215 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -73.79 122.17 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 72.13 110.838 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.5 m -119.89 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.097 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.99 125.34 33.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 73.33 110.812 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.37 110.62 20.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 74.34 110.949 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 71.35 112.478 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.584 0.707 . . . . 64.45 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 117.67 5.23 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.736 2.291 . . . . 74.42 112.362 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.9 p -109.96 97.08 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 71.35 110.892 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -59.37 165.36 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 73.24 110.859 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -156.13 -148.89 5.19 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.712 -0.756 . . . . 62.45 112.437 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -158.49 118.34 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 74.01 110.909 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.4 t -103.16 122.31 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 74.13 111.084 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 14.4 mt -100.77 120.57 40.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.907 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -90.52 84.7 5.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.82 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -97.52 -175.32 3.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.33 111.194 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.4 -21.97 13.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 72.11 110.878 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -83.99 -15.73 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 74.43 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.4 150.25 5.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.815 -0.707 . . . . 73.23 112.539 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mt -61.75 156.94 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.23 110.948 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 16.8 t -145.48 141.96 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 70.42 111.163 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.87 124.62 21.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 73.13 110.895 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.59 106.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.22 111.162 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 70.81 131.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 65.42 110.893 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -164.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 64.11 110.87 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -90.38 -179.85 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 61.1 110.876 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -57.86 -51.54 69.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.483 . . . . 75.12 110.937 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -139.69 161.81 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 60.43 110.77 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.04 -32.62 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.24 110.818 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -59.86 -42.53 93.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 75.22 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.01 -46.89 15.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.898 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.12 -45.74 53.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 75.01 111.121 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -54.78 -48.39 72.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 72.43 110.848 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.49 -19.82 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.945 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.2 -27.04 22.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.872 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -90.59 -23.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.14 111.181 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.16 15.0 14.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.496 . . . . 74.32 110.953 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.7 ptm -129.83 -39.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 71.44 110.889 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 33.1 m -80.45 -22.76 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.14 111.153 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.42 -21.93 65.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.22 110.822 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -109.2 -32.37 7.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.92 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -37.64 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 75.41 110.837 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -92.58 -11.62 33.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 74.34 110.879 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.36 11.71 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.883 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.25 141.0 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 75.33 110.898 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -87.46 140.56 29.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 71.21 110.93 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.558 HG22 ' HE2' ' A' ' 72' ' ' GLU . 97.3 t -80.71 124.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 73.54 111.117 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -138.98 10.14 2.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 73.43 111.08 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.3 135.61 14.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 75.43 110.836 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 t -148.02 125.55 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 74.22 111.13 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.5 mt -91.28 124.59 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 75.13 111.097 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mm -95.99 138.71 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 74.04 111.154 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.6 p -84.45 -49.13 8.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 72.44 111.176 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -159.71 -175.37 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 60.01 110.932 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.58 98.36 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 64.34 111.071 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.32 149.61 24.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.857 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.46 30.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 72.52 111.055 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.04 10.04 28.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.882 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -129.83 -77.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 72.24 110.91 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 8.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.25 111.102 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.47 -41.75 41.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.703 -0.761 . . . . 75.21 112.494 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.9 12.71 62.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 71.43 112.374 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 tt -51.52 -28.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 62.42 111.132 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -38.26 64.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.834 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -79.86 -27.5 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.142 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.8 mt -75.05 -30.74 61.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 72.54 110.9 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -92.51 16.26 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 72.32 110.859 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -119.48 -48.23 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.816 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -72.73 -56.13 5.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.243 -0.435 . . . . 72.21 110.855 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.95 42.63 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.807 -0.711 . . . . 55.04 112.447 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.64 120.33 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.429 . . . . 74.41 111.17 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -78.1 109.76 12.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 74.33 110.911 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.63 101.25 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 74.13 111.054 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 64.0 110.91 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.64 -176.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.881 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 154.47 20.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 50.3 111.14 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.77 -40.65 55.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 72.41 111.068 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.95 -40.72 83.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.94 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.7 m -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 73.44 111.133 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.55 52.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 63.32 111.095 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.37 -59.23 1.74 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.13 110.893 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.39 -13.14 60.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.956 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.9 -43.43 92.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 65.04 111.072 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -26.3 63.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 74.42 110.895 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -55.2 -35.96 65.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 74.3 110.852 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -89.65 -20.85 23.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 72.45 110.872 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.85 21.75 5.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 73.25 112.401 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -94.65 170.46 9.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 74.52 110.883 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -70.83 -176.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 72.05 110.867 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -117.23 103.92 50.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 74.35 110.923 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.7 Cg_endo -69.8 -171.69 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.717 2.278 . . . . 74.32 112.391 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.39 -54.66 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 62.3 110.959 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.48 24.18 63.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.821 -0.704 . . . . 73.32 112.4 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 24.62 6.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 75.21 110.944 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.09 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.2 110.935 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.33 -170.28 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 54.22 110.885 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.8 m -49.93 -70.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 70.54 111.154 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.31 110.25 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.41 111.123 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -139.77 172.47 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 71.45 111.157 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 75.11 110.914 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 52.4 mt -115.34 167.35 10.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 74.11 110.898 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -147.64 137.09 22.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 73.24 110.93 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.19 40.47 3.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.898 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 93.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 74.14 112.4 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.38 14.12 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 65.31 110.877 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.5 tpp -138.39 100.9 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 75.02 110.874 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -90.69 137.84 32.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 72.41 110.781 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.67 117.42 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 74.03 111.099 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.96 129.17 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 74.22 110.942 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.8 p -85.54 -179.44 6.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 75.14 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -164.39 133.6 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.883 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -123.96 88.44 52.42 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.796 0.808 . . . . 75.42 110.95 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.569 2.179 . . . . 75.23 112.352 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.92 -144.88 16.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.802 -0.713 . . . . 74.0 112.504 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -101.5 141.64 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 72.31 110.901 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.45 -90.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.705 -0.759 . . . . 71.13 112.475 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -74.78 -23.43 58.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 73.3 110.858 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 65.5 p -150.57 -169.36 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 74.54 111.153 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -85.81 -12.94 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.871 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -138.61 20.93 2.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 63.1 110.911 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.77 130.38 24.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.3 110.897 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.19 169.04 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 73.41 111.125 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.32 122.52 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 74.14 111.176 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 80.5 t -75.72 131.76 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 73.03 111.148 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -117.54 130.07 56.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 75.54 110.826 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.8 mt -110.68 98.64 38.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 61.14 110.909 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -4.42 13.99 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.659 2.24 . . . . 60.13 112.336 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.21 -23.64 32.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 75.44 110.832 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -144.0 14.15 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 70.34 110.941 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.9 m120 54.26 26.79 7.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 74.51 110.844 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 97.4 mt -91.9 128.79 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 73.53 111.089 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.6 tp -113.49 145.92 40.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.887 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.62 83.64 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 71.21 111.175 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.51 -34.84 35.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.617 -0.801 . . . . 73.25 112.58 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.33 -167.92 26.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 73.3 112.531 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -29.65 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 63.15 110.813 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.8 tp -54.84 -61.82 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 73.42 110.933 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.2 t -78.33 110.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 55.45 111.168 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -51.8 169.02 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.941 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.53 146.4 42.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 74.32 110.857 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 75.52 111.245 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.823 0.344 . . . . 74.32 111.067 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -106.74 86.76 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.911 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.7 -19.64 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 73.4 111.127 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -73.3 -31.21 63.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 65.21 110.886 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -104.84 -11.62 16.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.953 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -55.0 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 73.3 110.846 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -24.71 16.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 61.51 110.865 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -81.08 -31.82 34.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 71.44 111.241 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -42.77 60.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 71.0 110.826 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mm -61.95 -44.69 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 71.31 111.106 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -58.44 -23.89 58.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 64.42 110.882 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -83.59 -22.19 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.766 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 5.4 t -87.61 -9.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 74.11 111.142 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -111.94 -8.4 14.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.958 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -104.09 -30.96 9.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 74.51 110.895 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.9 -52.27 2.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -97.24 37.78 1.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.95 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -56.46 -47.73 78.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 71.24 110.894 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -59.34 98.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 73.02 110.939 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.8 mt -140.23 127.89 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 71.5 111.18 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.18 -22.88 30.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.87 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.75 123.51 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.13 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 93.2 t -102.5 137.9 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 73.42 111.05 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.84 108.81 46.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.693 0.759 . . . . 45.52 111.129 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 179.21 3.82 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.664 2.242 . . . . 74.25 112.348 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.74 -13.58 82.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.761 -0.733 . . . . 60.42 112.532 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -152.89 138.1 17.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 74.23 110.854 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.74 -118.67 5.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 73.21 112.5 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -150.91 163.93 37.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 72.34 110.95 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.3 m -60.3 161.43 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 70.41 111.127 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.13 -93.09 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 54.33 112.389 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -174.83 -167.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 72.21 110.895 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -58.05 -20.26 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.932 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.35 -23.45 26.5 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.647 -0.787 . . . . 71.41 112.452 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.8 mt -75.97 -33.1 59.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.894 0.378 . . . . 74.43 110.944 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.58 -62.84 1.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.913 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -22.44 47.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.942 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.69 -46.67 88.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.83 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.4 m -51.27 -53.31 36.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.45 111.116 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.77 -20.15 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 74.33 110.971 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.41 -4.32 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 72.13 110.868 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.2 mt -125.27 -7.2 7.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 72.15 110.875 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.67 10.26 11.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 73.01 110.91 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.965 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.829 0.347 . . . . 72.41 111.145 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.4 mt -136.31 92.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 74.3 111.115 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -111.52 118.07 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.891 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -58.37 -176.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.856 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.21 -45.34 73.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 64.12 110.851 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.4 p -61.9 -37.67 85.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.45 111.133 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.05 12.32 60.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 65.5 112.533 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -80.78 -43.32 20.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.74 0.305 . . . . 74.21 111.175 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.36 125.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 61.22 111.17 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -133.02 129.92 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.54 110.836 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mt -120.9 111.12 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.11 111.138 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.5 t -100.76 127.6 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 62.21 110.862 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -71.23 111.64 6.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 75.34 110.873 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.3 mt -65.19 -31.55 72.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 75.3 110.955 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.451 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.73 -97.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 62.13 110.908 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.7 OUTLIER -151.44 10.14 0.57 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.43 . . . . 73.12 110.975 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.51 6.37 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 64.51 110.856 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.84 139.46 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 74.54 111.126 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.5 m95 -127.23 -179.58 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 73.54 110.957 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.1 t -131.99 97.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 65.43 111.144 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.467 ' CE1' ' HE2' ' A' ' 30' ' ' GLU . 20.5 p80 -80.51 121.14 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 74.2 110.901 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -117.62 104.81 11.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.11 111.146 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HE2' ' CE1' ' A' ' 28' ' ' HIS . 5.3 mp0 -89.27 120.94 31.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 75.1 110.865 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -85.43 101.55 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 71.43 110.831 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 72.01 112.448 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 121.613 0.72 . . . . 75.32 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 119.4 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.698 2.265 . . . . 72.05 112.417 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.1 p -99.76 96.92 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.866 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -49.51 159.8 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 65.25 110.845 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -155.65 -168.15 18.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.678 -0.772 . . . . 61.42 112.483 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.5 tp -152.49 113.56 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.354 . . . . 75.35 110.895 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.77 120.47 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.11 111.097 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.3 mt -97.78 115.95 29.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 73.33 110.903 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.42 87.44 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 60.52 110.92 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 179.8 4.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 61.3 111.17 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -100.28 -22.8 14.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 70.53 110.859 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -11.44 58.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 73.21 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.37 153.34 5.86 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.646 -0.787 . . . . 74.35 112.471 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 tp -67.25 155.04 39.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 75.42 110.957 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 t -145.91 142.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.43 111.104 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -137.07 125.48 23.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.32 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -71.21 112.18 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 75.31 111.114 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.405 ' HB2' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 72.64 132.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 65.45 110.921 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -166.98 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 71.33 110.853 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.1 t -91.41 169.1 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 70.45 110.911 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -49.5 -60.57 2.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.994 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -125.44 165.18 18.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 72.45 110.833 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.24 -37.69 75.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 62.44 110.852 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.21 -33.74 67.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.6 -47.2 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 74.34 110.956 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.61 -46.44 58.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.102 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.05 -49.63 65.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 72.31 110.89 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -64.76 -19.85 66.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.968 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 tp -87.8 -27.16 22.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 73.15 110.904 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.83 -23.13 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.081 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.69 16.0 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 64.33 110.901 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.87 -39.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 73.21 110.872 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 m -81.21 -22.43 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.112 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.711 ' HE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.89 -24.48 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 64.45 110.813 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -106.31 -34.24 7.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.471 . . . . 75.52 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -41.3 79.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.82 -10.75 38.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 65.31 110.886 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 67.52 11.97 8.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 73.23 110.875 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.93 137.62 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.856 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.74 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.2 110.875 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.711 HG23 ' HE2' ' A' ' 72' ' ' GLU . 80.0 t -76.26 121.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 75.22 111.146 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 t -135.68 7.78 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 75.44 111.118 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -150.8 145.03 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.14 110.877 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 t -154.53 132.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 73.1 111.189 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.19 125.84 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 73.22 111.158 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.35 147.7 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 74.32 111.215 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -98.16 -55.54 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 62.21 111.222 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -152.96 -175.16 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 74.21 110.812 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.01 97.46 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 74.24 111.139 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.18 150.13 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 71.21 110.792 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.38 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 75.52 111.046 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.12 23.6 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 64.02 110.791 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 56' ' ' ASP . 27.3 mmt180 -144.89 -76.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.51 110.912 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.12 7.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 75.03 111.113 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.74 -40.08 40.4 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 75.32 112.477 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.41 14.88 59.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 73.1 112.492 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.2 tt -55.45 -27.33 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.397 . . . . 73.51 111.125 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -54.91 -34.36 63.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 74.2 110.928 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -84.57 -22.7 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.54 111.138 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.7 mt -82.13 -28.67 32.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.915 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -96.92 22.22 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 74.53 110.952 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -122.63 -43.14 2.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 75.11 110.94 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -80.36 -52.78 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 70.52 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.79 43.96 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 41.22 112.534 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.07 118.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 74.25 111.159 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -77.77 111.33 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.51 110.915 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.84 90.91 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 72.32 111.077 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -62.47 143.15 57.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 73.22 110.905 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -173.96 176.7 2.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.908 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.33 157.92 19.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 73.32 111.16 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.89 -38.96 52.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 52.31 111.097 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.9 tp -73.63 -37.52 65.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.894 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.1 m -57.82 -29.36 64.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 73.42 111.115 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.88 0.21 57.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 65.14 111.058 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -99.25 -58.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 73.34 110.792 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.32 -12.27 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 73.21 110.925 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.1 -44.58 83.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 71.33 111.162 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -28.82 65.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.878 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -37.26 49.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 72.52 110.886 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -88.9 -21.89 23.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 54.1 110.854 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.89 20.63 5.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.734 -0.746 . . . . 71.23 112.491 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.56 172.07 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 72.15 110.974 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -70.92 -176.16 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 74.55 110.905 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.3 mt-10 -117.05 102.13 52.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.614 0.721 . . . . 72.34 110.849 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.2 Cg_endo -69.85 -176.22 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.621 2.214 . . . . 64.42 112.321 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.4 mt -51.84 -60.08 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.913 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.43 21.37 72.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 73.42 112.527 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -99.53 28.41 4.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 72.43 110.849 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.8 mt -109.52 -175.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 74.13 110.916 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.25 -170.77 3.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.937 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.8 m -50.79 -70.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.04 111.147 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.82 103.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 74.11 111.165 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -135.42 163.33 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 72.51 111.124 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.13 132.49 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.35 110.864 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 24.1 mt -115.08 167.2 11.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.939 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 133.5 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.12 110.941 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -134.2 49.09 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 65.32 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.19 92.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 62.24 112.539 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.89 14.59 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 75.32 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.0 tpp -134.13 110.31 9.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.832 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 131.14 44.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.34 117.33 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 74.44 111.064 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -110.75 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 75.35 110.887 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 p -86.62 177.29 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 62.11 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -159.3 134.78 8.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.45 110.865 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -124.41 87.23 54.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.648 0.737 . . . . 74.03 110.901 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -7.95 22.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.744 2.296 . . . . 64.32 112.313 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.68 -158.48 22.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 72.15 112.399 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -86.81 138.83 31.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 74.51 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.7 -87.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 54.33 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -78.39 -23.38 46.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 63.34 110.872 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.5 p -149.61 -165.62 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 63.15 111.153 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.08 -18.44 32.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 75.11 110.851 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -136.54 20.38 3.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 75.45 110.884 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.75 129.04 25.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 72.42 110.872 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.3 pt -135.8 176.47 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.23 111.177 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.49 123.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 74.44 111.13 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.25 122.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 73.34 111.137 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -109.24 132.18 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.41 . . . . 72.43 110.888 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 11.4 mt -112.9 97.98 43.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.52 0.676 . . . . 75.13 110.893 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.75 -4.84 14.83 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 75.11 112.31 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -82.66 -23.32 34.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 75.21 110.949 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 13.88 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.909 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.6 m120 54.49 27.92 8.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 64.33 110.912 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.1 mt -93.41 126.69 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 74.5 111.141 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 19.6 tp -110.61 147.31 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 75.13 110.967 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.28 78.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 64.44 111.181 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.31 -32.02 21.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.723 -0.751 . . . . 70.12 112.55 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 61.23 -160.44 27.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 71.32 112.508 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -28.38 64.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.863 0.363 . . . . 72.43 110.885 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 28.0 tp -56.26 -56.97 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 73.5 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 38.2 t -81.01 107.65 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 71.21 111.073 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -50.81 161.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.919 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.47 156.65 25.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 73.01 110.9 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.9 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 72.44 111.102 -179.896 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.767 0.318 . . . . 72.3 111.063 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -110.06 88.78 2.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 75.22 110.924 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.63 -17.47 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 75.24 111.195 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.74 -25.68 60.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 74.11 110.861 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -114.16 -11.95 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 63.22 110.85 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -55.1 -61.33 2.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.227 -0.442 . . . . 75.55 110.92 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -25.57 13.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 70.54 110.816 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -80.66 -32.68 36.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 75.44 111.14 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -42.3 65.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 63.44 110.881 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.52 -47.83 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 71.52 111.111 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -57.4 -28.57 63.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.919 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.71 -21.86 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.44 110.941 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.9 t -85.74 -11.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.02 111.144 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -111.28 -8.4 14.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.476 . . . . 75.52 110.938 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -30.49 10.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 63.45 110.955 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 -48.76 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.07 37.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.24 110.936 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -51.82 -48.58 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 71.32 110.848 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -60.08 105.1 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 75.24 110.936 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -145.95 125.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 72.55 111.093 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -26.83 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 55.45 110.899 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.6 134.6 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 70.11 111.163 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 98.0 t -109.92 134.58 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 71.23 111.029 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.1 t -110.82 104.22 55.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 53.2 111.129 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 174.18 9.87 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.709 2.273 . . . . 75.23 112.36 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.6 -13.08 83.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 71.24 112.42 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -152.85 150.17 29.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 73.42 110.799 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.59 -99.67 2.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 64.2 112.406 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -175.43 158.82 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 73.14 110.88 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.1 m -51.63 163.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 74.15 111.116 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -162.64 -105.31 0.19 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.735 -0.745 . . . . 61.45 112.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 -167.69 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.782 0.325 . . . . 74.42 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -21.11 25.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 64.24 110.819 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.83 -22.79 27.94 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 72.03 112.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.8 mt -74.87 -33.76 62.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 73.21 110.956 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.88 -62.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 74.21 110.974 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -22.13 51.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 62.33 110.945 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -63.27 -36.91 85.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.33 110.898 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.7 m -62.78 -56.95 12.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 72.42 111.137 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.91 -29.47 56.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 73.42 110.859 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.04 -35.44 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 74.21 110.869 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.3 mt -86.66 -16.11 37.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.921 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.04 20.71 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.8 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 73.32 110.822 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.813 0.339 . . . . 73.54 111.147 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.6 mt -113.36 101.2 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.21 111.11 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -121.07 120.46 35.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.912 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.491 ' ND2' ' HG1' ' A' ' 13' ' ' THR . 36.9 p-10 -66.28 167.56 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 70.43 110.918 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -51.71 -48.46 63.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 72.2 110.919 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.491 ' HG1' ' ND2' ' A' ' 11' ' ' ASN . 18.1 p -61.69 -37.52 84.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.12 111.095 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 10.59 67.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.828 -0.701 . . . . 74.14 112.47 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -77.48 -45.33 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 62.32 111.132 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.1 mt -101.7 110.9 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.257 -0.429 . . . . 63.5 111.155 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 p -117.83 138.13 52.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.4 110.819 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mt -129.74 109.81 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 74.31 111.113 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 t -100.27 124.63 45.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 73.1 110.849 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -68.74 109.64 3.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 72.32 110.914 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.44 -33.38 75.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 71.04 110.848 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.467 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -149.02 -97.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 74.53 110.935 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' N ' HD21 ' A' ' 22' ' ' ASN . 2.9 tttm -151.84 10.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.813 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.96 6.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 62.42 110.958 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.4 t -151.16 138.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 73.14 111.181 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -126.1 -174.51 3.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 74.41 110.95 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.6 t -136.84 96.17 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 74.3 111.139 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -81.22 121.36 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.35 110.826 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.0 m -116.45 104.32 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 72.44 111.143 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.81 120.15 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 70.21 110.889 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.52 106.22 18.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.937 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.632 -0.794 . . . . 71.24 112.489 179.941 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.616 0.722 . . . . 74.15 111.092 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 116.72 4.7 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.632 2.221 . . . . 73.12 112.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.6 p -101.97 100.2 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.844 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -51.38 165.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 64.43 110.866 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.01 -163.61 12.97 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.683 -0.77 . . . . 72.44 112.43 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.9 tp -154.39 113.85 3.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 51.43 110.904 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.37 115.34 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 73.53 111.144 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.9 mt -92.74 117.86 30.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 74.32 110.945 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.33 83.9 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.1 110.908 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.61 176.01 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 64.2 111.14 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.73 -22.97 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 75.3 110.895 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -12.85 59.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.908 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.2 155.21 6.46 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.727 -0.749 . . . . 64.1 112.542 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 tp -68.66 154.26 42.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.923 0.392 . . . . 74.3 110.882 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 t -145.68 143.68 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 75.31 111.13 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mt -138.51 123.06 18.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.969 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -68.62 111.07 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 74.03 111.211 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.37 128.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.448 . . . . 63.14 110.849 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.52 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.816 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 t -90.52 170.07 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 71.21 110.841 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -51.29 -60.74 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 71.13 110.967 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -125.33 159.46 31.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 72.13 110.891 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -51.99 -33.18 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 61.12 110.829 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -59.43 -42.14 91.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 75.51 110.902 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.64 -48.88 17.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.957 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.07 -45.8 52.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.165 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -54.63 -49.09 71.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.893 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.13 -19.77 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.873 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.0 tp -88.23 -26.78 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 74.42 110.947 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.28 -22.44 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 75.34 111.11 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.4 15.66 13.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 65.35 110.928 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.0 ptm -130.32 -40.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.756 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.23 -22.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 75.31 111.153 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.69 ' HE2' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.1 -23.25 64.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 71.15 110.915 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -107.53 -33.09 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 73.53 110.859 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -40.47 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 75.15 110.863 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -90.79 -10.48 42.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 71.32 110.908 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.41 12.15 8.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 72.22 110.959 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.88 138.34 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 73.13 110.932 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.08 138.14 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 74.42 110.834 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 72' ' ' GLU . 71.9 t -74.59 124.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 73.15 111.088 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -137.67 8.34 2.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.123 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -154.54 146.18 23.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 72.02 110.767 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.6 t -153.71 128.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 72.43 111.176 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.5 mt -84.88 129.08 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 71.1 111.182 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.57 123.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 74.22 111.125 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p -83.76 -45.85 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 73.3 111.196 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -153.44 178.06 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.55 110.845 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.71 91.62 5.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 73.32 111.052 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.33 156.56 43.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.786 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.53 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 71.22 111.085 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.84 20.03 10.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 74.53 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.83 -77.43 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.896 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.79 7.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.32 111.096 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.45 -37.85 41.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 71.14 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 10.57 64.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 63.45 112.395 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.38 -28.41 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 71.43 111.201 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -38.81 67.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 75.21 110.887 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -84.07 -10.45 57.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 72.23 111.077 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.86 -33.94 15.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.34 110.925 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -94.42 17.9 12.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.973 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -116.3 -39.25 3.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.93 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -87.33 -55.75 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 70.5 110.848 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.91 47.87 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.75 -0.738 . . . . 71.34 112.524 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.32 110.79 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 70.35 111.087 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -72.1 107.88 5.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 72.31 110.861 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.62 89.41 7.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 72.32 111.093 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -62.08 135.82 57.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.885 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.92 168.98 10.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 63.11 110.844 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.87 154.23 25.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.141 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.91 7.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 62.44 111.053 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -46.38 63.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 70.55 111.011 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.7 m -57.03 -25.59 58.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 60.55 111.174 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.89 14.12 28.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.143 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -26.75 7.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.825 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.74 -10.35 16.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.911 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.53 70.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 71.24 111.061 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -24.54 55.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.55 110.889 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -61.48 -32.63 72.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 61.54 110.897 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -89.36 -24.82 21.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 72.34 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.05 24.06 3.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.696 -0.764 . . . . 71.34 112.443 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.72 166.48 10.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 75.45 110.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.99 162.95 28.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 73.51 110.928 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.09 111.93 56.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.607 0.718 . . . . 72.15 110.891 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -176.1 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.6 2.2 . . . . 75.35 112.323 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.5 mt -51.79 -43.7 63.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 74.45 110.831 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.6 50.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 63.35 112.485 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.11 43.52 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 72.14 110.782 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.2 mt -129.14 -175.55 3.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 73.11 110.878 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.6 -171.72 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 75.12 110.871 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.9 m -50.62 -71.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 70.25 111.089 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.2 t -116.85 102.79 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 64.54 111.04 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 t -135.63 170.56 15.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.25 111.156 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.68 133.88 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.44 110.884 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.9 mt -114.84 155.52 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 74.51 110.942 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -137.59 124.17 20.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.22 110.857 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -125.86 49.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.923 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.44 92.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 74.35 112.547 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.7 m120 64.6 15.05 9.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 70.31 110.941 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.3 tpp -135.16 108.65 7.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.863 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -98.33 129.06 45.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 20.2 t -134.91 115.15 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 71.0 111.184 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -107.64 130.63 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 63.24 110.814 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.5 p -86.75 -176.54 5.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 72.01 111.164 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -168.4 130.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.835 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -115.57 88.01 18.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 71.03 110.957 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -7.99 22.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.646 2.231 . . . . 53.1 112.411 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.56 -162.29 21.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.674 -0.774 . . . . 62.23 112.381 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -81.04 137.61 36.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 71.32 110.878 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.13 -88.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.472 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -76.36 -25.21 54.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 73.14 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.2 p -147.15 -158.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 74.11 111.067 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.47 -22.01 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.872 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.18 8.66 4.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.853 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.414 HD21 ' N ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -41.12 128.37 2.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.01 110.891 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.0 pt -132.79 -176.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 71.34 111.101 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 m -133.82 131.76 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 64.41 111.043 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.1 t -86.27 126.44 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 74.54 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -114.33 131.09 56.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.43 110.812 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 11.6 mt -111.84 97.19 36.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 74.31 110.885 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.4 Cg_endo -69.87 -5.1 15.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.664 2.242 . . . . 74.12 112.301 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -81.81 -23.63 36.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 65.53 110.952 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.4 13.76 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.917 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.42 29.75 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.41 110.907 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 98.3 mt -96.07 130.3 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.31 111.092 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.4 tp -112.67 146.0 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.867 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.22 79.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 74.42 111.145 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.67 42.79 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.656 -0.783 . . . . 73.44 112.542 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.5 -163.85 53.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 45.14 112.515 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -33.55 35.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.361 . . . . 44.12 110.909 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 22.6 tp -53.69 -56.38 17.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.934 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.55 114.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 74.12 111.076 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 150.57 19.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 72.53 110.889 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.0 p -97.96 155.11 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.865 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.123 -179.864 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.866 0.365 . . . . 75.13 111.091 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -113.73 90.94 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.3 110.94 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 t -67.12 -19.18 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 75.42 111.137 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -74.84 -24.83 58.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 73.14 110.876 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.39 -10.76 13.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 72.02 110.852 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -55.3 -61.44 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 62.31 110.93 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.63 -24.48 14.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 65.34 110.894 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.9 m -81.57 -31.97 32.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 74.41 111.058 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -43.1 61.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.859 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.68 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.35 111.14 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.39 -27.64 56.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 64.41 110.92 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -76.98 -22.27 53.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 73.34 110.939 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.18 -11.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 73.03 111.143 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.4 -10.02 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 73.52 110.916 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.86 -30.76 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.833 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -58.48 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.11 110.897 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -93.08 61.68 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 74.02 110.893 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -72.36 -58.14 3.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 74.32 110.94 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -53.03 102.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.3 110.845 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 73.9 mt -142.04 121.68 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.03 111.16 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -29.83 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.447 . . . . 70.24 110.84 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.06 143.18 2.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 64.54 111.178 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 98.1 t -121.48 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.35 111.1 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.9 t -108.48 112.57 60.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 74.52 111.274 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.62 -169.48 0.32 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.769 2.313 . . . . 53.22 112.397 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.65 -13.66 59.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.828 -0.701 . . . . 73.14 112.5 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.45 129.71 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.354 . . . . 72.41 110.838 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 116.78 -117.69 3.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.812 -0.709 . . . . 74.24 112.494 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -150.79 164.75 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 75.23 110.841 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.8 m -54.87 163.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.23 111.176 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.26 -111.58 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.803 -0.713 . . . . 70.34 112.522 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.15 -169.32 2.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.418 . . . . 75.32 110.809 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -18.31 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 75.41 110.856 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.88 -16.75 48.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.75 -0.738 . . . . 74.21 112.47 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.95 -30.35 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 74.21 110.967 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.64 -57.5 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.52 110.899 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.54 -17.78 56.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 73.44 110.918 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -65.6 -50.42 65.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.1 110.873 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.9 m -51.78 -51.43 56.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 74.13 111.138 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -18.74 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 75.04 110.915 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -87.53 -5.07 58.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.13 110.804 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.3 mt -126.09 -6.4 6.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 75.03 110.876 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.34 8.48 11.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.918 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 73.04 110.877 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.78 0.324 . . . . 71.1 111.131 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -114.2 100.23 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 74.41 111.127 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -121.4 116.3 24.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 73.54 110.906 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -58.52 165.23 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 71.22 110.96 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.8 -48.29 63.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 74.43 110.896 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -60.74 -38.01 83.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.13 111.206 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.97 64.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.728 -0.749 . . . . 73.22 112.525 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -71.34 -45.42 62.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.7 0.286 . . . . 75.51 111.085 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.96 123.3 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.419 . . . . 74.5 111.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.1 p -129.2 132.64 47.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 75.04 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mt -127.28 107.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 72.32 111.12 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -98.6 125.07 43.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.34 110.836 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -68.58 108.78 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.12 110.843 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.1 mt -62.61 -33.1 74.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 70.44 110.936 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.451 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.26 -96.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 54.33 110.883 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.6 OUTLIER -151.42 9.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.925 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.98 6.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.892 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 t -150.69 139.74 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 74.21 111.126 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -128.03 -174.78 3.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 74.34 110.92 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.83 94.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 70.1 111.057 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -79.01 122.07 25.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 72.0 110.866 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.7 m -118.7 104.92 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 73.11 111.167 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.41 124.48 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 74.4 110.888 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.23 114.2 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.877 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.66 -0.781 . . . . 63.1 112.437 179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.641 0.734 . . . . 75.11 111.193 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 118.29 5.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 71.2 112.305 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.8 p -97.38 98.08 9.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.799 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -51.79 159.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.31 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -154.67 -167.3 16.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.77 . . . . 62.14 112.435 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.3 tp -152.68 112.84 4.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 74.25 110.964 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.66 116.5 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.19 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.7 mt -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 73.55 110.906 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.86 86.64 7.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.888 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.47 179.98 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 65.24 111.112 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.4 -23.32 14.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.9 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -13.24 58.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.919 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.11 151.81 5.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 74.21 112.539 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.571 HD22 ' HE2' ' A' ' 72' ' ' GLU . 10.6 tp -63.62 153.7 35.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.808 0.337 . . . . 73.34 110.969 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.74 141.09 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 73.32 111.031 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -136.87 122.07 19.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.43 110.943 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -67.43 111.43 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.152 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 72.1 130.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.34 110.903 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.85 -166.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.228 -0.442 . . . . 75.11 110.914 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -91.62 169.19 10.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.12 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -48.98 -58.5 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.983 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -130.48 161.53 31.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.13 110.883 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -54.21 -32.83 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 60.22 110.815 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -59.22 -39.84 84.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 75.02 110.868 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.7 mt -78.91 -45.39 20.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.909 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -46.33 62.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 74.41 111.093 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.05 -49.46 66.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 74.24 110.905 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.08 -15.27 63.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 74.4 110.936 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.3 tp -92.53 -24.89 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 65.05 110.958 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.407 HG12 HG13 ' A' ' 79' ' ' VAL . 15.3 mt -91.24 -26.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.42 111.125 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -86.55 7.77 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.857 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.7 ptm -123.53 -38.6 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 71.35 110.913 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.55 -23.68 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 75.13 111.133 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.571 ' HE2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -71.62 -20.68 61.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.896 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -107.79 -30.71 8.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 73.24 110.873 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -45.79 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -83.55 -11.97 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 71.31 110.838 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 67.65 12.78 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 74.1 110.916 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 139.7 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.97 136.8 38.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 73.45 110.799 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.407 HG13 HG12 ' A' ' 68' ' ' ILE . 14.4 p -77.02 128.75 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 72.41 111.12 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -155.41 19.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.159 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -154.24 142.68 20.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 74.22 110.871 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.4 t -156.58 104.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 71.1 111.16 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.5 mt -69.97 119.82 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.41 111.111 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.7 mm -93.45 147.46 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 72.43 111.106 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -104.24 -50.33 3.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 71.03 111.074 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -155.84 -174.58 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 74.23 110.88 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.37 99.58 12.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 54.02 111.139 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.487 ' CE1' ' HE2' ' A' ' 149' ' ' HIS . 0.5 OUTLIER -154.45 151.88 29.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 70.34 110.866 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.18 -19.94 49.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.401 . . . . 73.41 111.028 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.58 6.25 48.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 65.22 110.956 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.68 -77.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.875 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.13 7.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 73.35 111.188 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.78 -37.44 34.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.816 -0.707 . . . . 72.13 112.414 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.2 10.77 58.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.751 . . . . 74.12 112.534 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.89 -28.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.924 0.392 . . . . 73.35 111.159 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -53.64 -36.94 62.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 64.44 110.921 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -87.17 -13.71 43.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.42 111.147 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.2 mt -86.42 -31.55 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 75.21 110.923 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.92 15.73 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 74.51 110.88 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -116.46 -45.37 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 74.2 110.942 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -78.15 -56.86 4.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 71.51 110.804 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.816 -0.706 . . . . 75.31 112.498 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.98 119.24 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.928 0.394 . . . . 74.23 111.121 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -76.17 119.32 19.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 71.14 110.852 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.0 93.53 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 61.33 111.116 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -65.86 145.67 55.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.03 110.906 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -178.87 171.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 60.11 110.889 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.749 ' CB ' ' HD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -86.89 158.94 19.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 65.21 111.105 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -39.26 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.42 111.065 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.06 -44.17 85.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.906 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.6 m -57.5 -25.35 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 72.52 111.121 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.11 10.86 38.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 73.4 111.121 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.9 -33.2 6.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 71.15 110.892 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.59 -13.9 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.878 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.57 98.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 75.24 111.105 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -24.41 58.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 70.32 110.925 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -32.5 70.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 75.12 110.826 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -89.87 -24.35 21.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 72.32 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.18 23.93 4.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 55.33 112.568 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -98.07 -175.5 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 72.22 110.923 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -85.5 176.14 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 73.43 110.93 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.9 mt-10 -106.59 104.38 50.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.684 0.754 . . . . 73.32 110.863 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.8 Cg_endo -69.77 -178.75 2.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.635 2.223 . . . . 73.4 112.367 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.2 mt -51.08 -47.04 61.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.981 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.07 26.55 28.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 71.5 112.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -107.84 45.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 72.33 110.817 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -127.1 -174.96 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 75.03 110.972 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.57 -172.31 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 73.43 110.932 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 49.6 m -50.89 -70.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.33 111.166 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 t -117.06 103.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 62.04 111.097 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t -135.42 175.23 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 64.23 111.122 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -120.64 136.39 54.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 70.54 110.901 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.2 mt -115.23 154.34 29.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 73.22 110.844 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -134.08 126.89 31.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.857 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -129.9 32.8 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.797 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.66 95.37 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.672 -0.775 . . . . 55.22 112.487 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.88 13.49 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 72.23 110.969 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.6 tpp -135.03 106.43 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 70.22 110.821 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -94.58 126.0 39.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.22 110.852 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.9 t -134.77 116.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.174 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.95 131.22 55.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 71.25 110.88 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.5 p -85.04 -176.03 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.33 111.199 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -166.67 133.08 2.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.877 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -122.01 87.33 47.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.612 0.72 . . . . 73.53 110.87 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 -7.68 21.69 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.672 2.248 . . . . 70.33 112.335 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.48 -160.81 23.86 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.742 -0.742 . . . . 62.13 112.442 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -86.26 139.48 30.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.886 0.374 . . . . 74.41 110.91 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.17 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 62.43 112.435 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.487 ' HE2' ' CE1' ' A' ' 88' ' ' HIS . 68.6 t60 -75.6 -22.92 56.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 64.23 110.86 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.3 p -150.69 -169.21 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 63.42 111.122 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -86.63 -5.71 59.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 62.35 110.926 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.749 ' HD2' ' CB ' ' A' ' 108' ' ' THR . 47.6 t0 -145.75 16.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 64.21 110.838 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -49.8 126.14 13.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 53.12 110.904 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 24.1 pt -133.72 174.92 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.15 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.5 m -128.06 120.38 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 72.14 111.088 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.37 119.18 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 72.42 111.167 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.4 t-105 -107.94 136.45 47.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.52 110.816 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.63 98.35 51.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 72.0 110.808 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -4.52 14.2 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.675 2.25 . . . . 73.11 112.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -85.12 -21.22 29.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.11 110.98 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -143.52 13.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 74.11 110.929 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.1 m120 53.12 27.54 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.952 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.9 mt -89.96 142.82 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 73.51 111.156 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 27.7 tp -125.62 147.79 49.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.53 110.915 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.02 79.2 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.074 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.03 -34.0 37.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.781 -0.723 . . . . 73.32 112.427 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.17 -163.31 16.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 71.42 112.478 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -32.65 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 54.42 110.892 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 23.0 tp -52.02 -51.38 57.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 70.13 110.929 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.63 110.84 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 73.43 111.143 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.34 156.27 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 74.3 110.95 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 45.5 p -98.77 159.82 14.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 70.41 110.91 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 71.04 111.107 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.8 0.333 . . . . 73.34 111.135 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -114.01 90.69 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.89 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.0 -16.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 73.22 111.131 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.28 -23.43 59.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 70.45 110.877 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -117.12 -13.0 10.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 72.53 110.823 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -53.58 -62.01 1.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.108 -0.496 . . . . 73.54 110.881 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -23.62 23.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 53.41 110.839 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.54 -30.07 33.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 70.11 111.176 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -44.12 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 63.13 110.891 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.6 mm -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 74.32 111.102 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.3 -27.4 55.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 71.22 110.918 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -77.66 -22.32 50.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 64.33 110.853 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.2 t -85.26 -10.84 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.012 0.434 . . . . 75.43 111.204 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.56 -12.7 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.914 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 -30.79 12.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.928 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -59.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 75.33 110.876 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -91.49 61.71 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 73.44 110.947 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -72.78 -58.52 3.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.903 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -52.64 101.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 60.14 110.905 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 71.6 mt -141.14 118.22 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 74.11 111.117 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.1 -28.08 63.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.825 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -166.9 145.08 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.438 . . . . 71.13 111.139 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 93.0 t -123.45 131.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.196 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 15.9 t -110.15 105.87 57.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 72.22 111.187 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.2 Cg_endo -69.82 -171.3 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 70.2 112.319 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.4 -20.24 67.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 72.22 112.54 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.46 144.48 23.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.795 0.331 . . . . 74.11 110.917 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.38 -101.86 1.36 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.772 -0.728 . . . . 74.53 112.544 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -172.03 170.98 5.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.92 0.391 . . . . 73.44 110.868 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 10.9 t -65.23 148.47 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 70.31 111.188 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.51 -101.96 0.31 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.768 -0.729 . . . . 60.34 112.559 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -163.57 -169.12 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 63.13 110.903 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -17.75 54.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 71.32 110.907 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.55 -20.72 39.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.771 -0.728 . . . . 61.32 112.511 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.6 mt -72.87 -29.84 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 73.02 110.949 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.52 -60.67 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 73.01 110.9 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.76 -19.92 44.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 73.32 110.902 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.86 -50.93 70.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.12 110.959 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.8 m -51.7 -51.02 59.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 74.41 111.173 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.49 -18.23 50.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 74.22 110.936 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.69 -2.64 57.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 74.11 110.833 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.1 mt -125.22 -8.02 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 70.41 110.88 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.61 9.42 9.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 65.25 110.947 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.846 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 18' ' ' ILE . 3.8 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.681 0.277 . . . . 75.35 111.236 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.6 mt -135.78 102.55 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 54.54 111.184 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -110.71 122.64 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 75.3 110.95 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -65.62 166.39 10.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 72.43 110.849 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.65 -48.69 63.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.836 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -60.61 -37.72 82.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.476 . . . . 75.3 111.178 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.86 11.93 61.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.35 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.9 m -84.55 -41.61 16.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 74.45 111.098 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.22 103.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 74.2 111.107 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.1 p -120.62 125.97 49.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 70.12 110.852 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -101.52 -164.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.094 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.23 115.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 70.01 110.876 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -68.17 106.48 2.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 74.21 110.904 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.73 -32.62 74.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.01 110.96 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.472 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -148.43 -96.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 71.13 110.876 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.449 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.5 OUTLIER -152.62 10.44 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 71.25 110.944 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.51 5.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 64.3 110.944 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.8 t -151.4 138.95 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 72.43 111.196 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 13.2 m95 -125.02 -173.86 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 75.42 110.953 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.2 t -137.17 89.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 75.03 111.151 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -73.96 125.16 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.776 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -118.97 96.76 5.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 63.02 111.076 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.22 117.68 18.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 71.14 110.954 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.16 114.77 22.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 75.43 110.915 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 73.21 112.43 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.553 0.692 . . . . 75.3 111.108 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 117.69 5.23 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.688 2.259 . . . . 73.01 112.327 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -107.85 98.76 8.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.8 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.97 161.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.881 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -154.7 -155.81 7.44 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.739 . . . . 73.35 112.455 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.1 tp -157.6 112.05 2.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 74.2 110.874 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 2.0 t -96.88 112.37 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.098 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.9 mt -90.86 120.01 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.973 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.75 82.17 5.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 73.23 110.886 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -97.22 -179.51 4.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 72.25 111.105 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -25.81 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 70.04 110.859 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -20.16 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.45 110.953 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.5 149.63 5.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.22 112.562 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.56 154.16 25.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.817 0.342 . . . . 70.31 110.918 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.59 141.79 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 72.34 111.187 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -137.2 121.97 18.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 73.25 110.898 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.82 111.66 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.45 111.157 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.77 128.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.874 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 p -70.84 -167.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 55.35 110.833 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.1 t -89.94 166.84 13.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 54.11 110.907 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -49.69 -59.86 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 73.31 110.892 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.86 158.0 37.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 75.2 110.823 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.672 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 73.2 m-20 -51.57 -33.36 32.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 73.33 110.955 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.05 -45.58 90.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 75.23 110.921 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.32 -46.93 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 74.02 110.956 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.46 -47.71 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.43 111.164 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.07 -49.96 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.834 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -64.76 -20.54 66.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 74.11 110.837 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 tp -87.24 -25.19 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 71.23 110.871 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.23 -24.03 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 75.53 111.145 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -92.17 16.18 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 71.21 110.882 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.8 ptm -131.65 -39.99 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.834 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.1 m -80.23 -22.86 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 75.12 111.052 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.666 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.37 -24.81 65.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 73.14 110.858 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -105.36 -33.37 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 70.31 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -44.48 68.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 72.41 110.903 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -85.81 -12.29 51.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 70.54 110.941 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 69.44 11.43 8.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.893 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.59 141.49 49.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.53 110.918 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.97 140.42 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 71.31 110.959 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.666 HG22 ' HE2' ' A' ' 72' ' ' GLU . 89.6 t -81.78 121.28 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 74.12 111.169 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -138.09 14.23 2.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 73.35 111.153 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -154.45 144.83 22.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 64.04 110.935 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.3 t -153.85 132.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.13 111.046 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.7 mt -92.66 128.41 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 71.45 111.048 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.52 153.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.51 111.129 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.0 p -112.32 -49.87 2.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 64.31 111.154 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.6 -176.15 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 72.53 110.841 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -98.39 90.9 4.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 64.34 111.072 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.2 152.84 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 74.55 110.831 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.23 12.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 74.44 111.1 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.53 27.12 2.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 73.33 110.856 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -71.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 74.51 110.849 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.85 7.61 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 73.4 111.211 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.55 -42.22 43.45 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.722 -0.751 . . . . 71.13 112.451 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.61 16.89 58.3 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.639 -0.791 . . . . 73.22 112.491 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.4 tt -56.71 -30.23 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 64.42 111.186 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -55.89 -30.01 60.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 71.22 110.864 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -89.11 -15.14 34.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 63.54 111.175 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.88 -28.74 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.834 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -97.27 13.4 29.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.263 -0.426 . . . . 71.35 110.895 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -112.35 -43.01 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 73.3 110.868 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -78.84 -57.56 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.52 110.939 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.84 38.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.642 -0.789 . . . . 74.52 112.441 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.27 124.53 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.39 . . . . 75.34 111.124 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -86.67 120.15 27.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 71.14 110.898 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.11 96.36 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.066 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -68.99 144.7 54.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.41 . . . . 72.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.01 -177.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 64.11 110.895 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.58 155.83 17.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 73.21 111.161 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.83 -37.87 45.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 72.13 111.086 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.4 tp -67.94 -45.85 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 72.23 110.915 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.9 m -58.49 -21.61 52.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 61.45 111.136 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.26 12.06 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 75.52 111.186 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -111.68 -28.55 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.876 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.58 -9.57 21.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.958 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 64.42 110.998 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -27.13 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 75.13 110.917 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.34 -34.45 66.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 52.22 110.863 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.44 -23.7 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 54.54 110.808 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.81 21.79 4.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 71.44 112.557 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -95.73 177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 71.05 110.942 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -78.12 176.03 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 72.32 110.904 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mt-10 -108.58 104.8 55.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 75.24 110.933 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.5 Cg_endo -69.82 178.74 4.3 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.653 2.235 . . . . 73.11 112.358 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 28.3 mt -51.37 -51.09 57.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 75.13 110.938 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.52 40.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 71.15 112.522 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -99.23 34.47 2.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 70.43 110.929 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.96 -174.35 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 64.11 110.851 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.1 -171.12 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.835 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 99.5 m -50.56 -69.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 65.41 111.058 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 t -120.49 102.61 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 70.12 111.121 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -132.71 164.29 27.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.507 . . . . 61.45 111.154 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.3 129.15 56.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 74.25 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.6 mt -115.89 157.97 23.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 74.54 110.998 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -136.99 112.15 9.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.92 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -107.6 45.42 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.947 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.01 87.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 54.03 112.492 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.73 14.66 9.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 73.43 110.949 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.2 tpp -131.31 89.87 2.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.86 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 130.58 38.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 70.15 110.924 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.55 117.02 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 71.23 111.145 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -108.24 132.73 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.9 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 37.7 p -90.14 171.01 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 70.43 111.112 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -154.29 130.28 10.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 72.25 110.865 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -118.44 85.56 26.24 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.613 0.72 . . . . 73.44 110.868 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.56 23.9 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.705 2.27 . . . . 73.52 112.306 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.24 -169.62 15.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.8 -0.714 . . . . 73.22 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -76.79 147.81 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 73.52 110.868 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.26 -64.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.11 112.486 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -89.56 -30.93 17.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.873 0.368 . . . . 75.14 110.913 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.9 p -139.83 -87.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 75.34 111.162 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -160.56 -32.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 75.11 110.812 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -127.58 14.56 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 74.2 110.795 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -50.41 125.57 13.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.14 110.861 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 12.6 pt -123.36 164.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 64.03 111.107 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.6 m -115.74 118.99 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 75.42 111.139 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 43.7 t -70.77 118.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 62.35 111.076 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -104.89 131.14 52.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.926 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 11.7 mt -113.1 97.02 41.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.573 0.702 . . . . 74.31 110.985 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.61 -4.68 14.41 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.781 2.321 . . . . 71.54 112.352 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -83.18 -23.03 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.914 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.46 13.4 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 75.55 110.922 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.46 29.13 10.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 73.15 110.981 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.1 130.14 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 73.52 111.16 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 24.8 tp -113.54 147.73 37.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 75.43 110.865 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.05 78.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 74.2 111.157 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.07 -35.37 41.06 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 74.4 112.49 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 63.04 -159.26 36.64 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.801 -0.714 . . . . 60.54 112.505 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.8 m -59.94 -30.82 69.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.876 0.369 . . . . 70.43 110.904 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 27.3 tp -53.63 -49.15 68.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 75.54 110.904 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.0 t -89.77 105.43 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 70.51 111.105 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.38 147.99 7.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 70.22 110.902 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 54.2 p -99.92 167.11 10.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 72.54 110.882 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 75.24 111.149 -179.877 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.833 0.349 . . . . 55.15 111.12 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.4 85.99 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.95 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.22 -21.34 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.11 111.143 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -72.38 -28.11 62.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 63.31 110.878 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -106.75 -14.94 14.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.05 110.905 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -55.36 -61.05 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.1 110.876 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.15 -25.43 13.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.842 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -80.92 -32.86 34.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.077 -0.511 . . . . 74.11 111.116 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -41.72 65.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 72.33 110.842 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.4 mm -64.96 -46.89 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.32 111.162 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.27 -28.59 63.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 75.05 110.837 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -76.96 -22.78 52.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.889 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.19 -10.51 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 73.35 111.094 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -112.22 -10.15 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.439 . . . . 74.35 110.926 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.01 -30.73 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 75.14 110.872 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -46.68 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.823 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.06 37.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 74.1 110.909 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -48.07 69.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.946 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -59.92 103.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 64.15 110.85 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.8 mt -146.07 123.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 62.55 111.067 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -25.48 46.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.879 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.53 130.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 72.41 111.091 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.23 147.33 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.19 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.2 t -122.57 101.12 40.54 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.639 0.733 . . . . 74.23 111.04 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 177.34 5.69 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.639 2.226 . . . . 74.12 112.385 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.68 -11.65 79.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 75.23 112.488 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -152.77 148.39 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 72.12 110.843 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.29 -99.89 2.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 73.42 112.436 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -174.39 153.87 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 74.21 110.95 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.3 m -53.98 163.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.31 111.172 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.55 -93.84 0.1 OUTLIER Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.725 -0.75 . . . . 65.15 112.444 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -171.47 -166.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 71.14 110.884 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -56.8 -20.74 24.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.847 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.53 -23.0 18.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 72.13 112.455 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.6 mt -77.38 -32.5 54.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 75.52 110.857 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.08 -62.33 1.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 64.21 110.885 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -22.74 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 71.4 110.864 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.13 -45.86 92.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 70.31 110.877 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 m -51.28 -54.95 21.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 74.23 111.153 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.58 -18.43 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 73.22 110.89 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.804 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.8 mt -124.68 -10.5 7.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 73.11 110.893 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.46 14.07 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.94 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.894 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.849 0.357 . . . . 62.35 111.114 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.14 93.69 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 61.43 111.154 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.01 115.3 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 75.05 110.872 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.493 ' ND2' ' HG1' ' A' ' 13' ' ' THR . 38.3 p-10 -59.28 166.36 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 73.53 110.858 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -51.77 -47.86 63.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.04 110.909 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.493 ' HG1' ' ND2' ' A' ' 11' ' ' ASN . 19.3 p -60.26 -38.23 82.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.15 111.142 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.92 12.73 60.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 75.41 112.433 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.4 m -81.14 -42.95 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.679 0.276 . . . . 74.31 111.115 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.31 125.45 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 72.24 111.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -131.93 126.95 35.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.861 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.3 112.86 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 74.53 111.119 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.0 t -100.45 127.54 46.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 74.14 110.878 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -70.58 111.61 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 62.32 110.927 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.22 -32.29 73.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.89 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.452 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.06 -97.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 63.24 110.837 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.26 9.48 0.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 74.31 110.906 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.406 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.09 7.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.856 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.78 141.14 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 75.21 111.1 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -129.01 -178.32 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.937 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.3 t -133.04 89.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.384 . . . . 74.24 111.052 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -72.39 123.79 23.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.913 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -119.68 104.01 9.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 33.35 111.106 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -86.62 122.64 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.54 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.29 114.11 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.844 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 72.53 112.518 179.883 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.676 0.751 . . . . 74.4 111.107 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.82 118.99 6.01 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.601 2.201 . . . . 65.24 112.364 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.3 p -112.3 96.95 6.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.888 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -57.83 164.74 2.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.04 110.813 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -155.49 -148.16 4.94 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.778 -0.725 . . . . 62.14 112.509 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.7 tp -159.85 115.27 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.856 0.36 . . . . 70.03 110.886 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.4 122.15 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.145 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.5 mt -99.39 115.42 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.891 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.55 87.59 7.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.89 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.14 179.58 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 72.43 111.157 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -100.33 -21.97 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.842 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -12.2 56.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 64.3 110.871 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.95 150.87 5.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.769 . . . . 73.32 112.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.72 154.58 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 71.53 110.925 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.76 141.57 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.112 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.84 125.13 23.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 75.41 110.946 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.04 111.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 75.45 111.193 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.58 128.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.31 110.807 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 p -71.6 -167.1 0.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.832 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.9 t -90.28 168.87 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 72.33 110.882 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -50.35 -60.43 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 74.05 110.938 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -126.67 159.37 33.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 74.04 110.818 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -52.66 -35.06 54.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 73.1 110.862 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.79 -38.02 74.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.995 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.62 -46.7 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.95 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.71 -45.44 58.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -57.79 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 74.43 110.946 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.99 -22.69 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 74.43 110.859 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.3 tp -84.8 -25.88 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 64.51 110.924 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.46 -22.99 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 75.43 111.132 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -92.38 15.94 12.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 71.13 110.939 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.95 -40.03 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.25 -22.2 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.12 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.708 ' HE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.22 -24.53 64.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 60.14 110.885 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -105.69 -33.85 7.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.924 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -43.29 73.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 73.54 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -88.69 -11.35 45.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.883 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.89 11.88 8.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 65.31 110.966 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -130.01 139.22 51.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.83 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -85.35 138.27 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.267 -0.424 . . . . 75.22 110.803 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.708 HG23 ' HE2' ' A' ' 72' ' ' GLU . 94.4 t -78.39 123.09 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.197 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -140.07 13.44 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 73.42 111.169 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -154.85 143.79 20.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.03 110.917 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -154.07 128.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 72.31 111.081 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.3 mt -85.42 131.37 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.113 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.9 mm -109.91 136.62 45.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 73.12 111.145 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.0 p -96.17 -45.36 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 75.33 111.158 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -153.46 -175.52 5.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 63.23 110.845 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.13 86.73 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 72.31 111.162 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 71.41 110.859 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.24 -23.67 9.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.119 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -95.37 30.11 2.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 73.43 110.842 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.94 -70.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.878 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.16 7.34 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 73.44 111.127 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.69 -41.91 51.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.816 -0.707 . . . . 64.31 112.451 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.7 14.46 64.09 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.668 -0.777 . . . . 61.25 112.518 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 tt -55.12 -28.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 74.13 111.153 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -34.57 63.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.946 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.1 m -86.8 -12.53 47.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 73.21 111.181 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.63 -24.92 20.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.927 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.13 20.19 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.883 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -120.97 -34.06 3.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 72.31 110.881 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -90.86 -42.56 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 74.42 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.79 37.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.769 -0.729 . . . . 70.05 112.492 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.16 111.24 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 74.45 111.166 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -72.74 112.05 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 72.51 110.923 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.54 90.56 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 75.22 111.107 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -61.93 145.19 53.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 74.43 110.862 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -177.04 179.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 74.44 110.809 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.2 158.14 18.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 71.41 111.106 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.72 49.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.23 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.3 tp -72.27 -37.82 68.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 71.4 110.924 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.5 m -58.07 -28.1 64.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 73.21 111.192 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.59 0.95 57.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 74.23 111.073 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.52 -55.54 2.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 74.03 110.928 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.21 -10.29 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 73.33 110.897 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.78 -46.24 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.081 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -29.51 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 73.24 110.866 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -52.14 -36.71 52.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.935 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -89.51 -17.19 29.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 75.14 110.848 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.64 19.63 8.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.706 -0.759 . . . . 75.03 112.475 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.74 171.83 8.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 74.51 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.63 -176.3 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 74.02 110.972 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.37 101.53 53.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 74.13 110.948 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 -179.68 3.04 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.741 2.294 . . . . 70.33 112.351 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 24.6 mt -51.1 -57.67 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 72.32 110.919 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.42 68.64 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.66 -0.781 . . . . 74.3 112.51 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.55 36.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 74.11 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -119.23 -175.23 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.979 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.38 -171.13 3.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 70.5 110.898 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.6 m -50.73 -70.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 75.2 111.153 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.3 t -120.51 103.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.44 111.177 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -133.04 170.22 15.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 75.02 111.125 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.32 128.11 52.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 72.45 110.886 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 63.9 mt -116.08 155.95 27.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.914 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -136.1 114.83 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.887 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -110.08 51.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 74.51 110.866 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.44 89.46 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.718 -0.753 . . . . 75.35 112.574 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.96 14.57 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 75.33 110.845 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.4 tpp -133.13 98.22 4.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 73.11 110.844 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 131.13 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 72.02 110.908 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 90.1 t -136.78 119.09 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 71.41 111.114 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -111.66 125.55 54.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 70.41 110.914 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.3 p -81.0 -172.52 3.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.136 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -170.84 130.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.43 110.923 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -119.93 86.13 35.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.763 0.792 . . . . 74.34 110.911 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.707 2.271 . . . . 74.33 112.351 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.39 -162.1 23.22 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 72.43 112.443 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.2 135.86 33.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.736 0.303 . . . . 74.43 110.921 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.68 -85.19 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 73.43 112.506 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -79.8 -24.3 41.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.393 . . . . 75.44 110.905 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.3 p -147.05 -162.97 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 74.4 111.111 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -88.45 -20.94 24.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.927 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -133.22 18.27 4.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.86 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.92 131.42 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 70.31 110.771 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.72 169.95 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 71.4 111.09 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.6 m -121.88 135.36 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 72.04 111.2 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.22 122.57 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.07 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -107.73 132.13 53.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.919 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.06 98.55 42.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.542 0.687 . . . . 75.31 110.825 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -4.93 15.03 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.272 . . . . 73.41 112.291 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.24 -23.64 35.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.42 110.951 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.04 14.6 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.908 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.7 m120 53.95 27.64 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 74.43 110.958 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 97.0 mt -92.75 125.93 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 74.41 111.078 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.2 148.68 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 75.15 110.908 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.43 81.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 74.2 111.129 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.42 48.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 64.3 112.453 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.23 -167.5 46.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 63.51 112.522 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.02 -34.42 29.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 74.54 110.871 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 14.3 tp -51.26 -60.3 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 73.14 110.915 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.2 116.17 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.144 -0.48 . . . . 71.44 111.076 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.456 ' HD2' ' HB3' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -51.66 171.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.907 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.34 138.11 54.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.0 110.883 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 72.03 111.168 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.794 0.33 . . . . 73.24 111.073 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -110.43 88.18 2.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.974 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.32 -20.08 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 72.51 111.133 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.66 -23.02 59.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.956 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -114.33 -13.78 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 71.23 110.891 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -54.19 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 74.21 110.947 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.2 p -54.24 -24.65 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 63.22 110.821 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.1 m -80.55 -30.21 37.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 74.43 111.163 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -44.55 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 72.04 110.929 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.9 mm -58.91 -46.19 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 73.32 111.086 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -55.62 -29.06 58.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.866 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -77.17 -22.3 52.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 74.02 110.862 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 20.7 t -84.76 -11.13 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 71.14 111.122 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.12 -15.47 13.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.896 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 -30.98 13.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 73.11 110.98 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -50.13 3.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 73.25 110.843 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -97.41 61.59 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 75.2 110.961 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -74.33 -63.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 74.2 110.902 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -51.99 103.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 71.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 79.3 mt -141.42 123.22 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 73.13 111.182 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.57 -29.38 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.3 110.833 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.3 133.51 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.45 111.124 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 83.9 t -109.42 130.07 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 71.31 111.115 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.2 t -105.73 111.17 64.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.561 0.696 . . . . 74.24 111.039 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -175.73 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.675 2.25 . . . . 71.44 112.349 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.75 -12.57 79.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.739 -0.743 . . . . 73.45 112.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -152.11 147.25 26.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 72.4 110.796 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.37 -117.93 5.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.7 -0.762 . . . . 73.15 112.454 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.85 175.26 10.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.945 0.402 . . . . 74.42 110.85 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.2 m -72.07 156.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 74.35 111.059 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.51 -105.7 0.41 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.68 -0.771 . . . . 53.43 112.441 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.82 -178.13 6.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 73.23 110.963 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -16.55 52.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 72.32 110.874 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.39 -23.7 42.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.75 -0.738 . . . . 75.05 112.473 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.6 mt -65.07 -25.66 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 65.23 110.834 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.36 -59.49 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.41 110.924 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -15.24 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 65.12 110.895 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 171' ' ' LYS . 1.2 t-80 -77.58 -42.57 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 72.0 110.954 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 47.1 m -52.98 -48.59 67.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 74.52 111.16 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.64 -14.52 52.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.217 -0.447 . . . . 72.44 110.887 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -88.33 3.01 51.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.02 110.882 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.5 mt -133.62 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.912 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.06 -4.43 44.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 75.3 110.896 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 73.01 110.929 179.888 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.828 0.347 . . . . 74.03 111.077 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.4 mt -136.2 93.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 70.43 111.227 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.26 121.11 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.852 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -63.84 167.63 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 55.34 110.876 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.04 -44.86 64.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 55.25 110.86 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.0 p -62.04 -38.11 87.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 71.51 111.159 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.25 14.54 62.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.798 -0.715 . . . . 55.11 112.495 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -83.59 -39.25 20.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.818 0.342 . . . . 74.54 111.174 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.14 117.54 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 73.24 111.1 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -124.36 132.43 53.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.24 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.92 108.63 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 64.3 111.101 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -100.95 127.53 47.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.866 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -69.77 111.21 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.909 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 23.0 mt -64.23 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.915 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.455 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.07 -97.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.911 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.2 OUTLIER -151.54 10.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.825 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.56 6.35 0.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.89 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -150.73 140.16 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 71.01 111.14 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -127.55 -178.05 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.909 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -133.67 95.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.156 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -77.56 118.32 19.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.813 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 m -113.67 107.34 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 70.33 111.157 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.24 126.93 38.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.44 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.47 105.04 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.916 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.537 179.822 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.599 0.714 . . . . 72.44 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.703 2.269 . . . . 73.41 112.352 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.9 p -100.43 107.77 19.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 62.51 110.818 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.06 162.61 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.885 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.19 -155.27 6.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.743 -0.741 . . . . 74.43 112.472 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.8 tp -158.61 112.62 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 74.32 110.927 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -97.5 121.49 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 75.31 111.135 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.5 mt -99.67 118.0 35.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.985 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.2 85.83 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.02 110.826 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -100.81 -174.29 2.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 74.4 111.073 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -103.23 -27.79 12.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 73.21 110.844 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -18.16 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.52 110.873 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.4 150.73 5.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 63.54 112.484 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.8 mt -62.14 155.09 25.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 72.43 110.937 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.78 141.84 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 73.51 111.099 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.61 122.91 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.893 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.68 112.23 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 73.33 111.139 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.94 128.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 74.5 110.852 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 p -71.92 -168.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 65.21 110.821 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -89.94 171.65 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.11 110.936 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -50.85 -60.77 2.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 74.21 110.96 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.47 159.04 36.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 64.12 110.896 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.56 -34.04 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.51 110.904 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.76 -39.47 77.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.798 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.09 -43.83 21.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 73.32 110.939 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.25 -48.53 62.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.152 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.99 -49.43 66.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 73.44 110.931 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.75 -19.48 65.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 74.12 110.967 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 tp -88.65 -26.14 22.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 65.25 110.91 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.5 -23.11 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 74.32 111.15 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -92.29 15.54 13.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 72.03 110.872 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.6 ptm -130.5 -39.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 70.41 110.887 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.7 m -79.76 -23.44 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 75.35 111.109 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.661 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.0 -25.03 66.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.3 110.827 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -104.77 -33.49 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 75.34 110.899 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -45.14 67.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.44 111.012 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -85.21 -12.59 52.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 74.52 110.852 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.5 11.21 7.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 72.43 110.829 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.93 141.37 50.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.412 . . . . 73.35 110.899 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -85.82 140.55 30.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.55 110.819 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.661 HG22 ' HE2' ' A' ' 72' ' ' GLU . 87.4 t -82.04 125.01 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 71.41 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -140.89 12.11 2.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 75.1 111.13 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -152.48 146.12 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.849 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.7 t -154.29 131.27 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.22 111.169 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.5 mt -92.68 126.75 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 62.01 111.082 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mm -101.85 150.42 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 74.53 111.16 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -45.43 3.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 72.44 111.109 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -149.32 175.76 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 73.4 110.872 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -98.27 87.07 3.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 72.03 111.047 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -143.73 156.23 44.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.897 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.79 -21.32 27.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 73.42 111.018 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.55 18.02 10.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.828 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -137.87 -76.52 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 72.24 110.796 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.5 7.42 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 71.3 111.072 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.68 -39.76 39.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 72.44 112.534 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.21 15.92 58.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.659 -0.781 . . . . 71.23 112.402 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.3 tt -57.14 -28.61 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 75.35 111.147 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -55.89 -30.22 61.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.939 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -88.87 -17.5 29.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 74.11 111.132 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.5 mt -88.5 -28.63 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 75.33 110.913 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -92.34 7.89 40.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.11 110.917 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -106.86 -55.27 2.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 70.13 110.917 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -63.97 -57.11 10.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 74.41 110.807 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.0 39.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.674 -0.774 . . . . 73.44 112.384 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.99 126.56 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 74.43 111.095 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -86.05 117.59 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 70.53 110.94 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.27 94.95 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 70.33 111.127 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -66.58 146.07 54.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 61.22 110.907 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -179.97 176.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 64.5 110.938 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.73 154.06 21.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 65.41 111.091 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.4 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 61.43 111.028 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.0 tp -67.25 -43.73 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.429 . . . . 74.54 110.861 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.0 m -59.65 -18.4 41.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 70.42 111.17 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.7 10.22 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.42 111.036 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.23 -27.31 8.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 54.52 110.917 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.14 -7.44 26.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 71.52 110.927 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.38 -38.39 63.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.01 111.068 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -26.84 61.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.862 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -58.74 -33.52 70.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.916 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -88.07 -21.35 24.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 75.31 110.93 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.36 5.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 75.01 112.466 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.38 175.2 6.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 74.11 110.9 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -74.17 -176.2 2.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.513 . . . . 75.15 110.933 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.44 106.93 45.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 54.42 110.853 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 178.4 4.65 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 71.34 112.273 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.4 mt -51.78 -42.92 62.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 73.22 110.972 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.31 27.57 24.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.735 -0.745 . . . . 62.51 112.519 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -108.1 43.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 72.33 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.7 mt -126.86 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 72.35 110.918 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.47 -172.05 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.941 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 55.5 m -50.9 -70.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.32 111.083 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.2 t -117.39 102.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 74.54 111.071 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t -132.45 174.7 9.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 70.3 111.106 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -120.96 134.44 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.903 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.4 mt -115.16 160.21 19.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 72.14 110.903 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -142.6 124.62 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.91 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -125.1 44.36 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 75.35 110.868 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.1 94.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.741 . . . . 72.54 112.45 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 m120 66.22 12.94 8.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.748 0.309 . . . . 74.13 110.91 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 53.5 tpp -135.74 109.8 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 74.22 110.777 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.81 133.34 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.886 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 20.0 t -138.79 115.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.31 111.122 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.6 129.98 55.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 72.1 110.844 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 p -86.8 -179.13 6.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 74.43 111.204 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -164.35 134.05 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.882 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -121.83 89.79 48.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.647 0.737 . . . . 75.31 110.936 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.78 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.73 2.286 . . . . 73.02 112.338 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 125.99 -160.91 20.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 70.12 112.553 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -79.33 134.83 36.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.903 0.383 . . . . 74.05 110.829 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.17 -89.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.559 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -74.26 -27.8 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 74.04 110.83 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.2 p -145.68 -159.96 1.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 73.3 111.091 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -86.79 -23.0 25.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 74.44 110.924 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -136.74 20.34 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 75.23 110.876 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.8 129.88 27.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 55.54 110.926 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 14.5 pt -134.99 179.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 74.21 111.111 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.6 m -129.24 152.06 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 70.34 111.101 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.8 t -103.21 119.18 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 75.21 111.144 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -107.62 138.09 44.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 74.02 110.9 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 32.3 mt -119.26 98.7 50.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.678 0.752 . . . . 65.31 110.911 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.1 Cg_endo -69.89 -4.72 14.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.763 2.308 . . . . 74.31 112.312 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -85.39 -22.4 28.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.32 110.886 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.64 12.41 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.4 110.958 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.1 26.25 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 71.13 110.905 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 99.4 mt -90.87 142.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 74.11 111.12 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.22 155.94 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 75.02 110.921 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.26 74.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 74.04 111.181 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.7 -39.49 46.59 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 75.31 112.547 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.44 -159.42 41.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.684 -0.77 . . . . 54.22 112.482 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 74.6 m -54.68 -38.37 66.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 74.52 110.83 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.2 tp -51.26 -33.49 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.3 110.937 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.97 108.05 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 61.33 111.066 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.46 163.1 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 72.32 110.86 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.21 167.56 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 61.34 110.827 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.43 111.208 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.856 0.36 . . . . 74.5 111.108 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.77 88.19 2.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 73.45 110.981 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.1 t -63.0 -15.69 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 75.34 111.146 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -77.4 -22.14 52.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -118.42 -11.39 10.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 75.55 110.867 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -55.09 -60.91 2.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.959 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.7 p -53.8 -24.66 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.997 0.427 . . . . 73.51 110.927 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -81.58 -31.44 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 65.42 111.129 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -43.17 58.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.851 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.2 mm -61.58 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 71.42 111.133 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.31 -27.22 54.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 65.22 110.945 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -77.17 -22.19 52.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 71.34 110.891 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.26 -11.04 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 60.15 111.194 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.72 -12.09 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 73.42 110.883 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -31.03 11.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 72.13 110.888 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -59.41 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 75.21 110.907 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -91.83 62.5 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.966 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -72.78 -60.22 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 73.4 110.858 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -52.03 102.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 70.55 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 75.0 mt -141.21 116.93 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 73.22 111.209 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.06 -26.77 63.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.924 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.98 134.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 62.1 111.091 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 95.2 t -106.87 144.9 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 71.23 111.166 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.84 104.77 48.56 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.594 0.711 . . . . 62.34 111.138 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -177.7 2.01 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.756 2.304 . . . . 72.21 112.322 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.3 -12.1 65.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.843 -0.694 . . . . 75.44 112.461 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -153.35 140.62 19.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.871 0.367 . . . . 71.43 110.83 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.32 -99.27 1.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 72.21 112.579 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.76 157.35 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.893 0.378 . . . . 72.43 110.882 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.2 m -54.73 162.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 74.32 111.134 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.65 -95.03 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.73 -0.747 . . . . 72.04 112.463 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -168.34 -169.01 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 72.14 110.842 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -61.02 -18.09 55.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.858 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.72 -21.45 36.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 72.32 112.501 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.25 -28.24 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 75.52 110.937 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.98 -59.61 3.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 74.03 110.877 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -17.32 55.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.422 . . . . 72.12 110.975 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -69.04 -46.8 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 74.14 110.894 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.6 m -51.73 -52.31 49.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.176 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.98 -18.47 46.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 73.14 110.941 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.88 -5.7 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 65.35 110.894 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.6 mt -128.42 -5.4 5.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 72.53 110.874 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.5 -4.6 11.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 65.14 110.844 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.12 110.901 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.795 0.331 . . . . 75.0 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -135.88 92.66 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.33 111.096 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -112.73 115.01 27.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 71.53 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -58.22 169.47 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 74.2 110.815 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.46 -48.31 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 72.15 110.93 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -61.35 -37.42 83.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 75.11 111.114 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.43 61.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 75.43 112.43 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.3 m -79.56 -44.82 20.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 60.41 111.144 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -101.6 113.0 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.05 111.083 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 p -120.82 127.58 52.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.45 110.843 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.52 112.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 73.53 111.116 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.4 t -99.82 127.1 46.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 75.35 110.875 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -70.23 110.93 5.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 64.45 110.917 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.5 mt -64.2 -31.74 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.878 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.451 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.93 -97.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.908 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' N ' HD21 ' A' ' 22' ' ' ASN . 18.6 tttt -150.64 9.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 74.22 110.87 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.408 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.28 7.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 72.21 110.904 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.9 141.71 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 75.42 111.171 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 17.1 m95 -129.44 -177.25 4.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.967 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -133.83 91.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 75.01 111.134 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -74.1 123.78 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.894 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.5 m -120.02 105.87 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.42 111.143 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.01 122.43 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.894 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 116.88 28.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.967 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 71.51 112.514 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.588 0.709 . . . . 74.21 111.169 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 115.89 4.31 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.663 2.242 . . . . 62.05 112.342 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -103.0 98.16 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 73.12 110.829 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -59.19 163.75 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.816 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.81 -148.12 4.84 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.705 -0.759 . . . . 72.22 112.507 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.4 tp -159.08 115.2 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 74.42 110.949 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.5 t -99.67 122.27 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 62.4 111.108 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.3 mt -101.03 120.51 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 55.12 110.953 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -91.26 85.42 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 74.35 110.892 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -171.95 2.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 75.23 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.42 -15.06 14.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.862 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -5.77 43.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 74.13 110.864 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.13 8.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 72.13 112.439 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -73.74 155.44 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.389 . . . . 73.42 110.932 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.07 138.14 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 71.2 111.128 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.05 123.46 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 70.12 110.904 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.96 114.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 72.54 111.142 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.54 127.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 73.02 110.827 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 p -72.35 -166.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 65.1 110.859 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -91.68 168.52 11.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 70.03 110.886 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -48.92 -60.31 2.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 75.33 110.863 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -129.57 159.51 36.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.55 110.751 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.578 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 72.9 m-20 -50.91 -32.29 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 74.31 110.941 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -58.29 -46.66 85.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 75.34 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.3 mt -74.38 -43.14 57.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.908 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.19 -49.54 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 71.43 111.128 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -53.43 -48.38 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 72.1 110.956 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -65.09 -18.92 65.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.14 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.5 tp -89.78 -26.82 20.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 74.31 110.892 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.9 mt -90.67 -22.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 74.54 111.222 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -92.56 16.25 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 75.43 110.907 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.9 ptm -131.35 -40.3 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.9 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.434 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 29.6 m -80.56 -22.06 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.5 111.213 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HE2' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -68.12 -23.08 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 71.12 110.919 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -107.75 -33.01 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 64.01 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 -40.41 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.924 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.25 -10.22 42.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.52 110.952 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.12 12.49 8.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 75.3 110.886 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -131.25 138.44 49.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 64.45 110.963 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.65 136.75 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.907 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.0 134.66 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 75.43 111.127 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.9 t -155.24 20.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 75.31 111.125 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -164.72 138.46 5.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.873 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -151.71 160.19 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 73.24 111.204 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.8 mt -116.42 135.43 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.137 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.54 121.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 65.41 111.104 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.1 p -78.45 -33.27 48.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.3 111.115 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -167.95 -174.89 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.32 110.931 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -98.89 97.69 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 74.42 111.047 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -156.77 155.25 31.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 72.04 110.903 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.11 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 73.13 111.129 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.45 26.35 3.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 73.1 110.792 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.48 -74.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.848 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.09 8.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.4 111.121 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.14 -39.8 27.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.684 -0.77 . . . . 52.41 112.612 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.81 12.95 56.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 74.5 112.506 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 tt -54.38 -27.97 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 64.25 111.128 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.578 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 25.3 mmtp -56.66 -35.62 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 65.1 110.87 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.3 m -85.12 -22.57 28.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 73.42 111.114 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 mt -80.92 -30.19 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.95 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.91 21.9 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.909 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.86 -41.56 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.912 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -80.07 -50.1 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.912 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.09 39.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.795 -0.716 . . . . 63.13 112.525 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -101.77 126.19 55.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.894 0.378 . . . . 71.53 111.127 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -85.89 112.35 21.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.904 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.67 100.73 12.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.44 111.058 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -71.61 132.33 44.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 73.44 110.858 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.5 166.13 29.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 75.54 110.961 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.724 ' HB ' ' HD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -81.98 156.75 24.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.158 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.31 -40.53 35.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 72.25 111.114 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.423 HD13 ' HE2' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -70.72 -40.88 72.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 72.32 110.982 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.6 m -58.55 -20.96 50.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.107 -0.497 . . . . 73.33 111.097 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.43 8.08 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 74.33 111.105 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.423 ' HE2' HD13 ' A' ' 110' ' ' LEU . 3.6 pt-20 -108.4 -31.98 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 71.43 110.849 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.1 -11.42 26.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.54 110.984 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.42 -37.58 77.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 63.41 111.049 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.67 60.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 72.44 110.904 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -57.18 -33.28 67.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.14 110.848 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -89.85 -23.43 21.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 74.35 110.901 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.44 23.82 4.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 75.42 112.464 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -98.04 172.63 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 74.14 110.906 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.0 170.58 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 71.21 110.878 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -101.94 108.63 57.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.581 0.705 . . . . 75.34 110.881 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.6 Cg_endo -69.69 -176.58 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.701 2.268 . . . . 73.14 112.362 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.8 mt -51.29 -42.56 61.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.869 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 27.58 23.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 51.24 112.458 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.03 26.1 11.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.891 0.377 . . . . 64.3 110.923 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.8 mt -103.87 -175.48 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 74.03 110.861 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.69 -172.86 4.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 72.33 110.893 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.2 m -51.02 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 73.32 111.096 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.62 104.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 74.15 111.134 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t -127.76 160.47 31.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 75.01 111.16 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.34 107.3 13.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.881 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.17 -172.7 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.905 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -176.15 112.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.3 110.871 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -106.73 74.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.031 0.444 . . . . 73.21 110.898 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.21 -86.91 0.18 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.749 . . . . 65.02 112.476 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -114.95 24.95 11.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 75.11 110.881 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.1 tpp -132.82 142.6 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.04 110.898 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.42 130.17 55.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.835 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.8 t -139.87 120.2 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 72.33 111.165 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -113.85 130.63 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 65.55 110.801 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.2 p -88.28 171.18 10.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 75.33 111.105 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -156.58 138.76 14.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.885 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -125.59 89.7 51.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.627 0.727 . . . . 74.45 110.842 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -7.89 22.21 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.599 2.199 . . . . 65.2 112.352 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.26 -154.31 20.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.866 -0.683 . . . . 74.34 112.548 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -90.01 139.96 30.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 72.3 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.52 -87.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 62.11 112.481 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -77.06 -25.93 52.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 64.01 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.1 p -146.47 -161.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.43 111.193 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -90.1 -17.72 27.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.911 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.724 ' HD2' ' HB ' ' A' ' 108' ' ' THR . 18.5 t0 -135.26 17.42 3.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 74.15 110.835 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.07 129.77 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 71.33 110.854 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.9 pt -135.3 -177.77 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 74.33 111.127 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.9 m -136.24 133.4 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.095 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.3 t -85.59 114.2 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 65.31 111.225 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -102.45 133.82 46.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.89 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.8 mt -113.59 97.76 44.87 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.575 0.702 . . . . 74.35 110.903 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 -4.11 13.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.719 2.279 . . . . 71.44 112.347 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -85.18 -23.28 28.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 74.11 110.967 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -142.04 13.01 2.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.41 110.954 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.37 27.42 8.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.882 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.13 124.67 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.462 . . . . 73.52 111.176 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.7 tp -106.08 146.97 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.884 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.15 80.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.44 111.115 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.53 -40.48 47.29 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.38 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 68.89 -165.09 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.799 -0.715 . . . . 71.41 112.505 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -27.45 25.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 61.33 110.916 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 23.3 tp -57.25 -61.14 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.826 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 35.1 t -75.28 112.38 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 72.21 111.054 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -54.0 151.15 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 63.33 110.839 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.8 p -99.74 157.28 16.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 74.01 110.85 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 63.32 111.164 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.814 0.34 . . . . 73.02 111.106 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -107.44 86.79 2.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.931 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 24.0 t -61.16 -17.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 73.43 111.114 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -74.27 -25.91 59.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.958 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.66 -11.97 13.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 74.21 110.954 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -54.37 -61.7 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 72.44 110.972 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -24.29 16.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.855 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.92 -32.34 30.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.18 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -43.31 63.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.882 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.8 mm -62.15 -43.94 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 73.21 111.104 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.07 -24.07 62.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 65.25 110.956 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.31 -21.56 36.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.844 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.3 t -88.13 -8.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 74.53 111.1 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.36 -8.21 13.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.941 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -104.57 -30.93 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -104.31 -48.93 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 74.31 110.873 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -102.13 39.44 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 73.41 111.008 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.79 -47.9 76.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.502 . . . . 72.14 110.867 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -60.31 99.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.03 110.863 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.8 mt -140.16 123.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.047 -0.524 . . . . 74.43 111.107 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.94 -16.0 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.915 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -173.58 132.69 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.44 111.048 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.9 128.62 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 72.45 111.179 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 19.6 t -108.43 104.12 53.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.644 0.735 . . . . 72.31 111.083 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 52.9 Cg_endo -69.82 -169.54 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.274 . . . . 71.44 112.32 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.47 -15.5 66.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.701 -0.761 . . . . 45.21 112.476 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -152.01 139.72 19.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.976 0.417 . . . . 75.21 110.803 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 109.52 -117.29 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.812 -0.709 . . . . 60.01 112.543 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.65 173.44 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 75.11 110.897 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.1 t -70.5 144.85 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 72.52 111.154 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.66 -93.32 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.671 -0.775 . . . . 73.1 112.474 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -172.13 -167.17 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 72.54 110.899 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -19.37 38.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 71.42 110.864 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.72 -23.14 20.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.695 -0.764 . . . . 65.01 112.534 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 7.0 mt -76.87 -32.68 57.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.318 . . . . 73.55 110.882 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.12 -61.98 2.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.898 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.19 -22.24 60.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.939 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.0 -44.69 96.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.901 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.2 m -51.45 -53.97 31.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 63.22 111.12 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.28 -18.72 51.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 75.12 110.902 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 73.2 110.88 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.7 mt -126.01 -6.37 6.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 73.51 110.938 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.83 9.72 11.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.951 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.12 110.896 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.818 0.342 . . . . 75.53 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -136.38 94.41 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 74.41 111.131 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -112.53 115.26 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.34 110.919 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -57.64 167.88 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 65.01 110.894 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -51.71 -48.08 63.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.859 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.74 -37.84 83.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.103 -0.498 . . . . 74.31 111.158 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.16 60.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.784 -0.722 . . . . 65.02 112.528 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.3 m -80.92 -43.53 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 75.34 111.126 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.48 118.42 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 64.21 111.115 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 p -124.02 131.37 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.749 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.96 110.4 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 63.42 111.14 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -100.6 123.69 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 74.12 110.872 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.15 110.98 4.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 71.53 110.893 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.75 -31.83 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.11 110.818 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.472 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.02 -97.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 73.34 110.894 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -151.5 10.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 74.11 110.922 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.59 6.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.54 110.806 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -151.0 139.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 73.25 111.108 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -127.44 -173.99 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.937 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.27 97.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 74.44 111.092 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -81.47 121.36 26.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 70.53 110.888 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.2 m -116.19 92.27 3.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 72.11 111.136 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -72.97 117.6 14.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 71.25 110.85 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.34 111.49 21.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.898 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 65.34 112.458 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 121.656 0.741 . . . . 75.24 111.084 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 118.27 5.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.581 2.187 . . . . 75.11 112.395 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -103.54 100.68 10.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 74.55 110.852 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -49.36 162.4 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 65.21 110.885 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -157.48 -166.8 17.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 70.2 112.477 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -153.12 113.27 3.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 72.03 110.903 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.59 117.98 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 74.44 111.049 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.7 mt -95.9 122.74 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 72.14 110.918 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.03 84.41 5.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 53.2 110.853 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.55 178.87 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.53 111.189 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.82 -26.66 14.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 74.03 110.837 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -18.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 75.33 110.864 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.79 151.33 5.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 35.51 112.476 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 mt -62.0 153.72 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 73.25 110.923 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.56 139.73 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 74.11 111.139 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -136.1 122.92 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.918 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.11 111.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 70.33 111.104 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.596 ' HD2' ' CG2' ' A' ' 85' ' ' THR . 1.6 m-20 72.98 125.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 73.25 110.905 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.7 p -69.6 -166.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 73.53 110.819 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -90.96 168.45 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 74.11 110.906 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -50.71 -60.42 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 74.13 110.945 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -126.03 160.87 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.806 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -53.63 -37.82 63.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 61.04 110.884 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.94 -37.52 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 72.34 110.878 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.28 -43.55 21.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.2 110.91 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.58 62.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 73.41 111.125 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -52.71 -48.37 66.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.95 -18.79 65.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 72.5 110.835 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.1 tp -89.43 -25.45 21.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.879 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.3 mt -91.93 -24.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.057 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.87 12.36 19.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.911 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ptm -127.48 -39.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 71.21 110.923 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 m -79.84 -22.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 74.53 111.115 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -22.69 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 65.35 110.949 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -107.41 -31.08 8.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 72.11 110.826 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -73.15 -44.68 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 71.31 110.951 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -85.95 -13.11 48.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.873 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.72 15.35 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.936 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 139.5 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 65.22 111.002 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -77.76 139.21 39.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 74.13 110.937 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.39 134.67 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 71.35 111.137 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 t -160.37 20.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 72.2 111.124 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -155.37 143.6 20.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 65.55 110.902 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 t -156.84 105.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 73.24 111.076 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.8 mt -71.11 121.27 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 72.33 111.144 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mm -94.36 149.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 74.05 111.17 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.596 ' CG2' ' HD2' ' A' ' 56' ' ' ASP . 29.6 p -108.44 -42.12 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.13 111.15 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -164.54 -175.17 3.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 62.31 110.823 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.19 98.4 11.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 62.51 111.052 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.483 ' CE1' ' HE2' ' A' ' 149' ' ' HIS . 0.3 OUTLIER -153.81 153.81 32.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 64.43 110.868 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.19 -19.98 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 61.44 111.124 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -91.81 4.48 52.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 55.13 110.844 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -120.69 -78.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.02 110.932 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.78 7.08 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 73.1 111.176 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.36 -41.47 48.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 71.22 112.539 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.15 13.21 60.36 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.734 -0.746 . . . . 74.42 112.491 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.8 tt -54.79 -26.39 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 73.53 111.144 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -54.54 -35.35 63.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 73.35 110.932 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.6 m -88.92 -12.86 40.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 63.25 111.159 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.56 -35.86 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 74.13 110.95 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -84.24 2.67 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 74.42 110.912 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.68 -51.07 3.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.31 110.842 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -69.83 -59.91 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.2 110.835 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.87 43.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.722 . . . . 54.44 112.557 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -103.34 120.31 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 74.33 111.147 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -73.2 114.39 11.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 74.14 110.858 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.06 85.58 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 45.13 111.1 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -56.92 144.54 33.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.785 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.6 169.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.14 110.89 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.77 157.34 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 72.44 111.122 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.87 -40.41 29.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 73.3 111.062 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -47.54 79.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 72.53 110.937 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 52.3 m -58.63 -20.73 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 74.54 111.094 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.76 12.39 36.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 73.3 111.191 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -114.97 -31.74 5.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 75.34 110.934 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.68 -13.87 23.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 75.22 110.866 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.44 78.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.971 0.415 . . . . 71.32 111.133 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -20.86 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 75.51 110.956 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.01 -32.43 74.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.826 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -90.25 -18.22 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 72.33 110.865 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.67 27.2 5.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 61.21 112.45 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.34 173.95 6.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 74.34 110.923 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -80.35 160.56 25.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 71.23 110.883 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -92.71 111.85 52.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.713 0.768 . . . . 74.31 110.954 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 72.53 112.393 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.8 mt -51.68 -45.54 63.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.885 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.49 34.94 43.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 73.14 112.527 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.12 36.26 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.827 0.346 . . . . 70.35 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.6 mt -120.07 -172.34 2.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.848 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.75 -171.84 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 73.03 110.921 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.0 m -50.56 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.02 111.121 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.39 103.88 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 73.12 111.131 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 t -135.37 175.63 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 71.14 111.193 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -120.34 131.36 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.849 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 31.4 mt -109.07 152.2 25.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.882 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -130.74 125.36 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 74.24 110.918 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -129.0 26.53 5.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.867 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.28 95.67 0.21 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 44.03 112.536 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 66.07 13.09 8.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.735 0.303 . . . . 74.24 110.882 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.9 tpp -133.71 106.29 7.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 75.21 110.97 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.98 127.43 37.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 74.25 110.87 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.69 113.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 61.22 111.142 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -109.74 131.41 55.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.798 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.7 p -85.09 178.65 7.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 71.02 111.189 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -161.05 133.27 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.843 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -122.82 86.45 50.15 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.699 0.761 . . . . 71.33 110.94 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -7.99 22.45 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.757 2.305 . . . . 60.01 112.373 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.39 -160.06 23.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.74 . . . . 54.43 112.536 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -87.61 140.63 29.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 74.14 110.924 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.66 -88.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 74.11 112.435 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.483 ' HE2' ' CE1' ' A' ' 88' ' ' HIS . 67.5 t60 -76.95 -22.97 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.31 110.815 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.4 p -151.18 -168.85 3.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 75.32 111.183 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -86.09 -5.53 59.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 72.52 110.902 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -147.07 16.47 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 54.43 110.857 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -49.33 127.38 14.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.8 pt -133.72 175.06 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 74.43 111.123 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.6 m -129.33 119.74 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 75.42 111.105 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.61 120.26 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 71.05 111.141 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -108.45 136.55 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.11 110.929 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 71.6 mt -118.59 98.64 51.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 72.33 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.1 Cg_endo -69.79 -3.87 12.91 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.635 2.223 . . . . 74.32 112.322 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -86.53 -23.42 25.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 74.02 110.86 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -139.35 11.13 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 75.23 110.968 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.4 m120 55.2 25.79 7.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 75.42 110.818 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 87.6 mt -90.8 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 75.41 111.086 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.1 tp -126.14 146.53 49.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 75.43 110.925 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.02 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 74.11 111.163 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.81 -29.45 26.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.771 -0.728 . . . . 60.13 112.458 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.95 -160.13 12.51 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.694 -0.765 . . . . 62.3 112.422 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -26.66 65.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 74.11 110.896 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.15 -35.67 71.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 73.33 110.843 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.66 111.78 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 63.44 111.132 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -51.79 164.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 73.32 110.904 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.2 p -103.18 163.47 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 72.42 110.836 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.52 111.093 -179.866 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.759 0.314 . . . . 71.23 111.133 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -119.88 91.94 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.928 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -62.8 -16.13 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 74.43 111.09 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -75.53 -22.58 56.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 64.13 110.878 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.67 -13.49 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 73.55 110.915 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -54.02 -62.46 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 74.41 110.941 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.81 -23.55 18.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 71.21 110.905 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.2 m -81.3 -31.11 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 72.41 111.164 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -43.11 50.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.135 -0.484 . . . . 63.43 110.98 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.0 mm -62.09 -45.52 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 74.02 111.151 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -57.04 -24.1 51.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 64.21 110.799 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -81.68 -22.28 37.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 64.42 110.941 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.5 t -86.7 -9.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 75.51 111.126 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.69 -6.59 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.924 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.57 -31.15 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.925 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 -55.48 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.55 110.859 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.13 38.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 73.14 110.904 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -56.34 -47.66 78.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 74.31 110.814 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -59.59 99.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.842 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.7 mt -142.61 124.26 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 70.22 111.206 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.84 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 71.04 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.71 133.73 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 74.32 111.107 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.56 134.05 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 75.04 111.117 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.405 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 9.6 t -112.82 108.94 53.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.657 0.741 . . . . 74.14 111.146 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.73 -169.82 0.35 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 73.41 112.333 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.42 -17.88 63.44 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 73.45 112.474 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -152.49 151.28 30.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 75.15 110.868 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 102.68 -101.02 2.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 73.54 112.49 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -173.51 161.56 4.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 72.51 110.943 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 m -51.85 163.02 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 71.51 111.128 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.73 -106.81 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.666 -0.778 . . . . 61.32 112.443 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -169.48 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.34 . . . . 73.03 110.851 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -60.78 -18.25 53.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 62.12 110.878 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.42 -18.72 44.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 73.24 112.472 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.3 mt -71.53 -31.03 66.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 74.41 110.976 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.77 -56.93 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.87 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -16.3 60.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 71.15 110.785 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -68.36 -41.76 80.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 71.31 110.911 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 25.4 m -61.16 -50.22 74.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.161 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -24.41 67.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 73.22 110.887 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.49 -12.28 60.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.9 mt -117.85 -19.5 9.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.895 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.03 0.9 22.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 75.21 110.871 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.893 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.798 0.332 . . . . 71.1 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -113.1 96.48 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 73.42 111.081 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -117.54 115.89 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.916 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -60.54 166.3 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.52 110.877 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.68 -48.31 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.885 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.0 p -61.66 -37.5 84.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.47 63.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 72.42 112.541 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.5 m -80.52 -44.2 19.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 75.41 111.131 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.6 mt -104.63 109.09 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 73.2 111.166 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -115.62 140.28 49.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 71.41 110.893 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mt -131.35 110.23 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 73.11 111.127 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -98.31 126.75 43.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 73.21 110.816 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -71.88 110.01 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 75.34 110.914 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.23 -33.81 76.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 72.22 110.905 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.45 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.1 -97.0 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.921 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.34 9.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.926 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.404 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.75 7.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.829 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 t -150.96 140.95 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.162 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 17.2 m95 -129.19 -176.26 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 74.13 110.927 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -134.15 89.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 72.32 111.115 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -73.03 125.24 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.886 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.8 m -121.57 103.49 8.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.04 111.076 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.75 118.7 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.15 110.955 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.34 127.9 34.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 72.34 110.931 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 73.22 112.573 179.82 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.632 0.729 . . . . 73.35 111.251 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 121.26 7.96 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.631 2.221 . . . . 73.1 112.422 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.05 96.99 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.86 167.05 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 73.23 110.923 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -157.83 -146.65 4.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 74.52 112.493 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.1 tp -159.16 120.02 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 73.24 110.927 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -103.8 123.0 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.156 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.6 mt -100.54 121.45 41.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 75.0 110.972 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.22 85.99 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.32 110.948 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -101.73 -179.87 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 75.32 111.176 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.4 m -99.98 -24.37 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 61.44 110.881 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -19.0 50.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.43 110.874 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.64 145.34 4.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 34.13 112.43 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mt -58.23 155.04 12.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.921 0.391 . . . . 63.14 110.87 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.62 141.55 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 73.14 111.109 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.1 122.45 19.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 71.22 110.941 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.16 111.72 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.198 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 73.5 141.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 74.1 110.843 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -83.11 -164.72 0.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 70.15 110.838 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 t -96.25 169.78 9.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 65.22 110.8 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -50.61 -59.24 4.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.925 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.64 163.48 23.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 73.55 110.872 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.21 -37.17 71.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 72.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -57.44 -34.9 69.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.24 110.893 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.51 -48.13 12.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.991 0.424 . . . . 73.11 110.864 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -49.06 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 74.41 111.133 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -52.31 -50.73 61.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.04 110.899 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.0 -20.62 66.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 72.1 110.959 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.09 -26.02 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 74.44 110.965 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.3 mt -92.39 -24.54 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 71.5 111.131 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.14 1.87 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 73.3 110.87 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ptm -119.61 -35.67 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 71.34 110.957 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.19 -26.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 75.22 111.062 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.94 -21.05 63.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 74.24 110.864 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.37 -32.01 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 74.43 110.837 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -44.02 59.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.914 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -85.91 -12.85 49.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 63.42 110.944 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.49 11.26 7.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.94 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 139.17 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.973 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -82.81 139.36 33.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.41 110.891 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.5 t -82.74 121.06 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.43 111.188 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.2 8.14 2.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 64.31 111.118 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -147.09 145.2 29.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.185 -0.461 . . . . 63.14 110.91 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 t -156.09 138.41 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 72.31 111.225 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.3 mt -94.09 136.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 75.44 111.18 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mm -100.94 149.47 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.111 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -115.39 -38.4 3.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.43 111.162 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -169.93 172.06 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.844 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.11 89.15 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 64.34 111.143 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -148.67 154.97 40.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 73.02 110.895 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.64 -23.5 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 74.52 111.131 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -92.23 27.23 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.25 110.85 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.435 ' HE ' HG22 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -152.24 -70.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.928 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.435 HG22 ' HE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -90.17 3.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 73.23 111.122 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -44.39 54.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 72.2 112.51 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.51 13.97 63.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 74.11 112.526 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 tt -57.61 -26.06 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 74.51 111.214 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -55.1 -27.43 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 74.41 110.847 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -95.33 -38.46 10.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 71.24 111.196 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.9 mt -56.22 -46.09 79.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.34 110.897 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -0.99 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.94 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.53 -44.97 8.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.94 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -79.48 -61.39 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.81 39.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 62.33 112.394 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -101.9 120.3 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.798 0.332 . . . . 74.35 111.164 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -78.5 118.02 20.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.868 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.35 85.01 4.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.024 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -55.01 110.43 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 74.04 110.849 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 t -139.67 -175.6 4.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.844 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.17 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 72.53 111.03 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.32 -36.75 44.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.062 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -48.45 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.921 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.9 m -59.09 -18.78 38.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 72.22 111.207 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.37 13.07 36.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 73.35 111.083 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -115.6 -27.44 7.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.889 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.37 -11.74 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.2 110.879 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.11 69.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 73.34 111.068 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -20.72 60.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 64.24 110.907 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.37 -32.41 73.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 71.12 110.946 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -88.48 -14.86 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.843 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 22.53 7.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.753 -0.737 . . . . 73.51 112.437 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -102.59 170.76 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.9 0.381 . . . . 64.14 110.844 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -72.78 -170.73 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 51.44 110.915 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.58 121.66 29.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.613 0.72 . . . . 74.44 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -169.96 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.692 2.261 . . . . 62.02 112.328 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mt -59.5 -39.87 85.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 72.02 110.925 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.69 26.0 30.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.729 -0.748 . . . . 70.13 112.471 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.35 39.97 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 62.43 110.926 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.8 mt -131.62 -172.81 2.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.948 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.65 -169.71 2.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 74.04 110.972 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.8 m -48.3 -67.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 73.33 111.199 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.7 t -120.53 109.31 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 70.2 111.13 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.2 t -138.68 176.15 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 74.23 111.049 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -122.87 137.39 54.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.2 mt -118.84 151.88 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 73.53 110.914 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.31 126.74 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 65.41 110.92 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.24 34.04 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 73.23 110.909 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.04 94.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 50.22 112.471 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.15 12.48 8.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.857 0.36 . . . . 72.42 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.5 tpp -134.76 101.11 4.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.147 -0.479 . . . . 75.32 110.878 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -89.34 130.3 35.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.15 110.909 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.6 t -138.41 115.56 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 70.25 111.12 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -110.5 130.15 55.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 71.4 110.872 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.9 p -84.87 -174.13 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 72.34 111.133 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -170.1 137.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.914 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -123.83 89.61 51.36 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.664 0.745 . . . . 71.34 110.89 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -8.25 23.12 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.717 2.278 . . . . 73.24 112.302 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.05 -149.11 19.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 74.3 112.566 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -97.11 138.97 33.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 74.34 110.853 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.15 -96.31 0.15 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 71.2 112.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.8 -24.9 63.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 72.4 110.901 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.8 p -152.2 -175.72 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 72.24 111.184 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.64 0.58 52.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 73.14 111.01 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -141.72 12.09 2.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 71.12 110.902 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.81 140.97 28.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.24 110.889 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.8 pt -146.32 -179.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 71.42 111.054 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.68 124.95 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 74.14 111.128 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.8 t -82.8 138.92 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 73.1 111.122 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -123.66 130.52 52.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 74.42 110.871 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.3 mt -111.84 98.17 40.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 74.24 110.89 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -4.21 13.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.802 2.334 . . . . 73.55 112.282 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -83.53 -23.32 32.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 72.31 110.841 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.27 14.29 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 74.42 110.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.5 m120 53.84 27.22 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.74 136.56 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.137 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.4 tp -119.6 144.42 47.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.981 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.13 76.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 74.34 111.074 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.92 49.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.733 . . . . 73.21 112.511 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.28 -162.56 51.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.74 . . . . 62.0 112.525 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 61.0 m -51.74 -29.64 19.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 62.54 110.815 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.4 tp -55.2 -53.96 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 74.43 110.889 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.6 t -83.39 114.68 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.32 111.128 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -57.08 149.79 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.977 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.1 p -95.14 158.56 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 73.22 110.978 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.2 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.807 0.337 . . . . 73.14 111.152 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -106.59 86.26 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 74.13 110.936 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.37 -18.66 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 75.41 111.099 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.51 -29.27 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.861 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -108.87 -13.78 14.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.862 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -53.59 -62.23 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.123 -0.489 . . . . 74.23 110.999 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.56 -24.01 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.43 . . . . 73.42 110.862 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.0 m -81.73 -31.57 31.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 52.52 111.139 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -45.4 48.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.865 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mm -58.35 -46.62 89.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 73.33 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.68 -29.36 62.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 72.35 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.28 -20.35 55.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 72.4 110.873 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 38.3 t -87.58 -12.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 73.41 111.214 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.2 pp -108.9 -7.08 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 73.05 110.884 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.1 -30.78 10.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 74.44 110.871 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.83 -49.76 3.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.853 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.15 40.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 64.52 110.863 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -55.51 -47.76 75.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 63.34 110.766 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -59.07 103.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.44 110.944 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -146.06 126.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 71.11 111.085 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.83 -27.21 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.03 110.941 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.24 146.42 10.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 74.43 111.105 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.85 132.63 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 74.4 111.126 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 10.8 t -113.69 107.58 52.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 64.53 111.068 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.8 Cg_endo -69.7 -176.27 1.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.708 2.272 . . . . 75.13 112.41 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.17 -14.27 80.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 64.42 112.573 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -152.36 130.66 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 73.1 110.811 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 118.59 -118.37 4.0 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 65.33 112.454 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -153.47 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 71.13 110.849 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.2 t -72.07 145.08 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.015 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -141.5 -91.25 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.812 -0.708 . . . . 64.12 112.552 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.82 -168.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 75.05 110.888 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -15.14 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.31 110.913 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.22 -18.59 42.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.658 -0.782 . . . . 75.54 112.602 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 11.0 mt -74.03 -44.35 54.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 71.31 110.878 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.06 -57.32 12.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 63.43 110.891 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.0 pp -58.22 -22.6 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.91 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.2 -34.98 75.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.12 110.918 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 m -57.77 -55.44 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 65.34 111.173 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.06 -19.69 61.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.851 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -12.01 58.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.822 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.4 mt -117.63 -16.59 10.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.874 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.73 3.85 19.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 75.44 110.878 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.4 110.968 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.79 0.328 . . . . 73.34 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -135.83 91.76 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 74.44 111.091 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -111.76 118.13 34.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 75.35 110.95 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -61.38 168.34 2.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.14 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.78 -47.88 64.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 74.55 110.779 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.42 -37.87 82.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.4 111.082 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 13.4 61.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 62.31 112.493 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -80.79 -43.8 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.756 0.312 . . . . 72.43 111.15 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 mt -103.54 117.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.08 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -125.04 129.99 51.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 70.33 110.843 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.41 110.05 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 71.02 111.033 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -101.26 128.44 47.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 64.05 110.842 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -71.1 111.03 6.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 73.44 110.875 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.07 -32.08 73.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 74.33 110.855 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.47 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.12 -97.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 73.21 110.88 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' N ' HD21 ' A' ' 22' ' ' ASN . 1.5 tptp -151.52 9.98 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 71.03 110.926 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.52 6.19 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 71.44 110.899 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -150.99 139.73 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.437 . . . . 70.52 111.109 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -126.87 -174.97 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 71.42 110.966 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.85 95.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 73.33 111.175 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -80.33 122.24 26.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.775 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.9 m -118.2 100.36 7.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 71.04 111.133 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.9 117.08 23.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.15 110.937 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.41 115.31 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 75.04 110.95 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.676 -0.773 . . . . 75.12 112.514 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.611 0.72 . . . . 53.43 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 118.16 5.52 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.615 2.21 . . . . 71.21 112.304 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.1 p -105.52 99.7 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 65.11 110.838 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.76 164.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 63.21 110.835 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -157.89 -164.32 13.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 74.2 112.447 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.0 tp -153.69 115.36 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 71.13 110.929 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.56 116.76 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.44 111.138 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.42 121.23 35.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.905 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -90.98 84.37 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 41.34 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -97.45 -177.03 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 75.35 111.117 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -103.97 -19.41 14.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.764 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -16.41 37.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 75.41 110.926 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 146.85 4.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.791 -0.719 . . . . 74.13 112.584 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.8 tp -60.13 155.26 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.37 . . . . 74.42 110.9 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.8 142.6 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 63.15 111.211 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -138.53 125.66 21.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.918 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -69.88 110.18 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 74.55 111.136 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.91 141.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.23 110.823 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.77 -160.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.949 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.6 t -98.44 170.06 9.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.881 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -53.06 -59.99 3.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 72.2 110.962 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.67 158.53 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.22 110.903 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.412 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 67.1 m-20 -52.85 -39.58 62.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 63.25 110.889 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -55.72 -25.79 42.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.2 110.958 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.11 -50.01 5.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 71.42 110.892 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.19 -43.6 52.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.152 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.4 -48.23 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.891 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.36 -21.08 66.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.926 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 tp -87.37 -27.3 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.87 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.56 -22.58 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 75.15 111.143 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -91.96 14.28 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 73.12 110.927 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ptm -129.49 -40.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 65.22 110.881 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.37 -22.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 75.32 111.096 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.721 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.82 -25.27 65.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 72.22 110.834 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -104.14 -32.73 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.13 110.85 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -47.01 58.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 75.4 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -82.61 -11.17 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 73.45 110.828 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 68.07 11.73 8.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 65.12 110.931 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -132.24 140.43 48.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.55 110.904 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.854 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.721 HG22 ' HE2' ' A' ' 72' ' ' GLU . 71.9 t -79.47 120.22 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 75.54 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.6 t -132.88 4.28 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 75.05 111.135 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -147.58 146.53 29.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.868 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 t -155.35 129.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 75.54 111.118 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.6 mt -84.5 133.33 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 73.32 111.132 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mm -97.44 147.55 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 54.51 111.172 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.7 p -110.91 -35.64 5.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 73.21 111.119 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -173.15 -176.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.841 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.88 84.74 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 74.13 111.112 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -145.05 154.46 42.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 75.52 110.907 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.84 -23.1 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 64.02 111.079 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.46 26.31 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.853 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.43 ' HE ' HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -151.28 -70.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 75.2 110.89 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.43 HG23 ' HE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.9 2.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 72.53 111.18 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -45.06 43.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.803 -0.713 . . . . 72.23 112.395 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.43 15.93 58.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 71.33 112.54 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 tt -54.24 -26.77 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 71.12 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.412 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 32.9 mmtm -58.75 -27.61 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.35 110.979 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -90.16 -20.21 23.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 72.24 111.097 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.7 mt -82.45 -37.47 25.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 74.32 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -92.51 20.42 6.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.923 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -118.42 -43.07 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 71.55 110.821 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -84.43 -54.0 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.871 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.76 39.19 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 65.12 112.488 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -103.85 113.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.852 0.358 . . . . 71.11 111.179 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -79.74 113.96 18.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.904 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.88 91.4 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 63.23 111.058 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -64.38 112.09 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.85 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.05 -175.01 4.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.882 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.7 158.05 15.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 74.44 111.11 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.5 -40.36 51.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 74.52 111.098 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.9 tp -75.09 -39.12 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.24 110.937 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.0 m -58.84 -21.69 57.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.132 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.61 0.87 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 73.0 111.083 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.48 -50.62 3.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.905 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.31 110.92 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.45 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 64.43 111.121 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -26.23 61.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.51 110.902 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -31.93 62.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 75.53 110.882 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -93.23 -21.22 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 64.44 110.837 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.36 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 73.24 112.574 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.41 ' CD1' HG12 ' A' ' 92' ' ' ILE . 85.7 m-85 -97.34 178.47 5.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 71.01 110.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -76.17 -176.39 3.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 71.11 110.841 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -118.86 110.96 37.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 74.14 110.899 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -169.76 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.614 2.209 . . . . 71.31 112.398 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.6 mt -61.81 -49.49 76.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 64.21 110.913 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 60.19 20.26 53.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.75 . . . . 75.11 112.506 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.42 31.31 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 71.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.2 mt -116.51 -174.48 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.93 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.24 -171.02 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 75.51 110.915 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.1 m -50.79 -70.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.24 111.182 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.37 102.03 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 72.21 111.153 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -124.78 162.28 24.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 63.4 111.209 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.96 100.94 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 74.43 110.916 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 27.4 mt -78.71 -179.89 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 72.41 110.969 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -171.74 112.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 71.44 110.961 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -106.73 73.93 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 75.22 110.807 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.43 -84.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.843 -0.694 . . . . 73.24 112.445 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.19 26.95 9.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.352 . . . . 75.1 110.833 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.6 tpp -130.43 142.93 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 70.43 110.932 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.54 125.33 48.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 74.03 110.897 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.4 t -138.85 119.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 74.35 111.195 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -113.54 127.86 56.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.964 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.5 p -82.78 -173.6 4.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 74.22 111.145 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -170.89 135.9 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 73.12 110.861 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -125.12 90.34 51.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.816 0.817 . . . . 75.22 110.962 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.86 -7.78 21.94 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.662 2.241 . . . . 73.11 112.309 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.86 -150.8 18.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 73.35 112.554 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -91.63 139.7 30.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 74.42 110.957 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.67 -89.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.692 -0.765 . . . . 71.34 112.507 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -76.12 -25.47 55.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 74.13 110.933 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 46.9 p -146.95 -167.95 2.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 74.03 111.123 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -85.34 -16.25 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.925 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.99 25.83 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.883 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.08 131.83 48.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.909 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.3 pt -139.28 171.06 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 75.42 111.164 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.94 142.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 74.52 111.049 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.67 114.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 74.31 111.183 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -103.74 142.07 34.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 73.32 110.923 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 56.5 mt -122.41 98.69 43.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.631 0.729 . . . . 72.01 110.888 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.9 Cg_endo -69.74 -5.01 15.16 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.13 112.358 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.74 -31.36 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.08 11.6 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.41 110.901 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.3 27.49 9.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 71.33 110.8 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 87.2 mt -93.18 143.62 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 74.31 111.117 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 61.5 tp -124.81 153.68 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.92 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 76.0 t -123.16 79.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 75.1 111.137 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.83 -36.64 41.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 63.31 112.522 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 67.28 -165.09 43.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.712 -0.756 . . . . 75.35 112.437 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.7 m -51.95 -34.45 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 74.22 110.889 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 27.7 tp -51.64 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 72.41 110.888 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.25 109.19 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.22 111.122 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -51.29 169.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 75.43 110.895 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 89.2 p -117.78 157.26 26.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 62.5 110.847 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.107 -0.497 . . . . 64.2 111.173 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.79 0.328 . . . . 74.53 111.138 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.42 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 72.1 110.919 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.56 -19.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.24 111.173 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.54 -27.16 61.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 64.45 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.37 -12.41 14.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.01 110.87 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -54.28 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.936 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.51 -24.5 13.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.818 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.0 m -81.45 -32.55 32.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.14 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -42.53 62.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 63.11 110.796 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.3 mm -62.47 -44.72 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 75.31 111.102 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.49 -23.49 50.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.868 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -81.74 -20.73 38.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.45 110.888 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.44 -9.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.33 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.69 -10.33 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 73.53 110.903 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -101.95 -31.91 10.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.888 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 -49.92 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 73.24 110.852 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -101.12 65.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.94 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -78.42 -55.49 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 74.11 110.838 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.15 100.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.828 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.1 mt -141.23 116.08 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 75.42 111.181 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.13 -26.07 64.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.32 110.96 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -171.99 137.76 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 74.03 111.093 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 85.7 t -113.91 144.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 63.35 111.093 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.68 109.19 38.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.722 . . . . 62.2 111.141 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -170.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.72 2.28 . . . . 74.12 112.327 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.07 -14.93 61.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 61.42 112.467 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.71 142.1 21.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 74.02 110.87 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.7 -101.81 1.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 64.51 112.497 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.81 162.76 4.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 55.55 110.972 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.6 m -51.56 163.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.53 111.141 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.67 -102.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.661 -0.781 . . . . 52.04 112.48 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.82 -172.24 3.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 75.35 110.841 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -61.87 -17.38 56.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.897 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.3 -17.59 46.84 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.715 -0.755 . . . . 44.41 112.491 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.01 -30.2 67.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 73.22 110.987 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.93 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -17.39 57.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.12 110.913 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.86 -50.68 63.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 75.12 110.924 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 4.4 m -51.84 -51.7 54.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 74.25 111.129 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.52 -21.27 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.5 110.908 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -86.81 -2.96 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 74.04 110.843 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.25 -4.87 5.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 74.3 110.947 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.12 0.61 9.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.897 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 74.22 110.846 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.799 0.333 . . . . 73.21 111.086 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.08 99.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 72.03 111.082 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -118.43 114.87 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.962 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -59.42 165.61 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 74.13 110.856 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.01 -48.7 61.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.823 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -63.11 -36.75 84.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.051 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.58 13.63 62.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 72.23 112.582 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 m -78.26 -45.88 21.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 64.42 111.12 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.6 mt -103.27 113.92 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 70.51 111.159 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.0 p -118.08 138.12 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.904 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.25 112.14 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 75.52 111.041 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -98.22 125.8 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 74.21 110.801 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -69.14 109.17 3.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 53.04 110.916 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.4 -33.73 76.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 71.44 110.895 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.447 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.96 -96.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 74.32 110.958 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.447 ' N ' HD21 ' A' ' 22' ' ' ASN . 8.0 tttt -150.7 9.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.853 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.24 7.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 75.55 110.844 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 t -151.01 141.33 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.22 111.213 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 18.4 m95 -129.8 -174.76 3.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 72.45 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.64 90.49 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 75.3 111.13 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -73.55 124.47 25.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.84 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -121.03 104.58 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 64.51 111.142 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.401 ' HE2' ' C ' ' A' ' 63' ' ' LEU . 3.5 mm-40 -86.3 122.18 29.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.939 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.16 106.5 16.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 74.5 110.872 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.728 . . . . 55.03 112.489 179.886 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.618 0.723 . . . . 72.22 111.19 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 118.83 5.92 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.687 2.258 . . . . 73.44 112.268 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.4 p -109.7 96.27 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.891 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -60.32 167.96 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.526 . . . . 62.13 110.941 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -159.29 -147.23 4.81 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 62.01 112.504 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.9 tp -160.52 118.13 2.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.34 . . . . 74.25 110.969 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.8 t -100.88 122.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 75.1 111.093 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.2 mt -99.41 119.57 38.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.49 . . . . 72.03 110.952 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.91 87.08 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 52.45 110.899 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.54 -179.87 4.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.464 . . . . 63.22 111.205 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -101.05 -23.78 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 64.33 110.809 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 -13.58 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 70.44 110.854 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.5 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.798 . . . . 71.54 112.442 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.9 tp -63.18 154.96 29.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.858 0.361 . . . . 75.42 110.818 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.92 143.14 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.43 111.181 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -138.75 124.41 19.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 75.5 111.008 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.5 t -69.82 112.49 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 74.04 111.139 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 73.75 139.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 71.34 110.894 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -83.1 -165.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.89 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -94.89 165.77 12.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 64.41 110.951 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -50.3 -59.61 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.449 . . . . 75.44 110.927 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -123.96 160.59 27.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.832 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.05 -39.84 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.932 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.88 -40.55 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.41 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' C ' ' HE2' ' A' ' 30' ' ' GLU . 95.9 mt -74.46 -48.44 27.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 74.43 110.93 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.76 -44.39 58.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 74.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.43 -50.5 67.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -63.9 -18.79 64.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 71.21 110.907 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.71 -27.77 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.907 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -89.72 -23.12 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 74.13 111.169 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.57 16.4 12.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.865 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.5 ptm -130.75 -39.71 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 75.14 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.43 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 34.3 m -81.21 -22.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.207 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HE2' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -68.11 -22.05 64.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 74.33 110.868 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.85 -33.5 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 64.35 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.4 -39.56 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.45 110.905 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.31 -11.29 35.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.2 110.914 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 68.08 12.15 8.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.949 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -130.59 138.97 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 75.13 110.898 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -85.44 138.79 32.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.43 110.864 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.9 t -79.44 121.75 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 72.42 111.185 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 t -136.89 8.33 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 75.31 111.112 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -150.81 145.85 25.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.865 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.0 t -155.33 132.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 65.41 111.198 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.2 mt -86.4 133.61 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 74.12 111.159 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mm -98.43 147.69 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.108 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.7 p -111.61 -34.18 6.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.44 111.082 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -175.11 -175.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.921 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.83 93.49 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 62.34 111.085 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -153.79 154.96 34.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 73.33 110.875 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.67 -21.77 7.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 72.23 111.124 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.31 18.23 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 75.45 110.823 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.436 ' HE ' HG22 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -143.54 -70.75 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.52 110.855 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.436 HG22 ' HE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.88 3.89 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 74.31 111.086 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.44 -45.62 45.75 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.695 -0.764 . . . . 64.12 112.44 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.52 15.81 59.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.644 -0.788 . . . . 71.41 112.454 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -56.35 -25.97 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 75.25 111.143 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -59.7 -21.36 60.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 72.53 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.9 m -98.28 -20.62 17.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 72.02 111.166 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.98 -36.13 25.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.879 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -88.86 9.8 23.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 64.44 110.897 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -112.45 -55.29 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 71.13 110.879 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -65.16 -58.59 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 73.3 110.862 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.18 39.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 53.51 112.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.88 117.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.868 0.366 . . . . 74.34 111.104 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -82.03 117.92 22.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 72.42 110.88 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.26 94.65 9.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.33 111.139 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.18 113.49 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 75.0 110.831 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.66 -174.53 4.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 75.04 110.854 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.34 158.39 16.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 65.12 111.127 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.76 -38.89 50.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 71.34 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.5 tp -77.45 -37.61 51.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.948 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.9 m -58.37 -22.09 52.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 72.24 111.151 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.46 -3.16 47.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.099 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -95.8 -54.43 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.902 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -13.95 57.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 73.32 110.843 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.5 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 74.03 111.059 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.69 -25.99 60.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 74.54 110.83 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -55.93 -33.05 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 74.2 110.845 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -91.75 -20.96 20.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 63.23 110.9 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.91 25.42 5.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.808 -0.71 . . . . 75.21 112.491 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.29 -174.55 2.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 73.12 110.905 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.14 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 64.14 110.877 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -120.77 108.75 36.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.663 0.744 . . . . 73.01 110.853 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.7 Cg_endo -69.75 -169.84 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.711 2.274 . . . . 75.3 112.343 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.7 mt -61.48 -48.78 79.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 62.1 110.931 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 57.04 23.07 45.02 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.73 -0.748 . . . . 75.4 112.528 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.02 33.74 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 75.13 110.899 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.34 -175.04 2.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 71.42 110.917 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.73 -170.94 3.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 75.44 110.935 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.7 m -50.25 -70.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 71.3 111.111 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.91 104.03 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 71.13 111.131 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -135.48 165.53 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 71.34 111.167 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.59 133.03 54.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 64.42 110.814 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.0 mt -118.92 158.01 26.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.976 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -140.68 123.18 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.93 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -120.22 45.52 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 74.43 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.84 92.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 62.15 112.479 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.52 15.01 9.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.827 0.346 . . . . 73.42 110.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 tpp -136.72 94.9 3.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 74.33 110.863 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.4 131.23 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.861 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.52 119.0 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.12 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -111.62 131.11 55.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.842 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.9 p -84.96 -172.82 4.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.122 -0.49 . . . . 74.03 111.167 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -170.82 135.55 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.814 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -123.39 87.39 51.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 72.34 110.881 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -7.98 22.42 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 63.32 112.348 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.69 -155.67 21.51 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 71.11 112.435 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -92.12 140.34 29.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 73.53 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.17 -89.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.676 -0.773 . . . . 62.31 112.463 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -75.36 -25.16 57.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 75.3 110.823 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.9 p -147.26 -168.3 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 75.54 111.189 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -86.37 -15.2 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 74.43 110.798 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.42 23.06 2.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 63.03 110.803 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.05 130.42 41.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 71.15 110.882 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.0 pt -135.0 172.77 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 75.43 111.125 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.92 128.32 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 71.51 111.066 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.8 t -81.82 132.15 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 73.25 111.06 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -118.76 131.91 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 74.22 110.908 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 11.5 mt -113.45 98.28 46.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.644 0.735 . . . . 65.11 110.899 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.8 Cg_endo -69.87 -4.41 14.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 75.44 112.384 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -82.67 -23.92 33.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.843 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.72 14.11 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.911 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.6 m120 54.46 27.74 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 72.54 110.895 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.46 130.26 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 75.11 111.079 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 50.0 tp -114.74 150.75 34.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.53 110.938 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.21 75.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.46 . . . . 72.51 111.069 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.54 -45.97 53.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 70.25 112.495 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 74.79 -161.26 53.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.747 . . . . 73.21 112.417 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 12.8 m -51.41 -34.73 35.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 62.42 110.803 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.9 tp -51.64 -39.78 58.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.966 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.3 t -104.65 111.31 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 74.41 111.07 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -53.49 155.76 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.883 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.7 p -101.78 160.44 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 62.51 110.845 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 72.42 111.112 -179.936 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.878 0.37 . . . . 75.24 111.024 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -121.95 92.16 3.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.933 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.54 -20.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 63.4 111.191 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -73.92 -20.26 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 73.34 110.911 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.63 -17.42 10.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.949 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -53.76 -61.25 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.3 110.923 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -24.75 22.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.837 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.0 m -81.13 -29.91 34.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 72.45 111.167 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -43.97 39.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.856 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.3 mm -60.64 -47.25 93.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 75.31 111.173 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.15 -27.91 56.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.14 -0.482 . . . . 71.41 110.856 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -77.14 -22.46 52.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.826 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.2 t -85.47 -10.22 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.072 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.95 -8.06 13.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 54.34 110.926 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -31.16 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 75.32 110.887 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -104.47 -55.34 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 74.14 110.937 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -95.91 39.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.236 -0.438 . . . . 71.4 110.913 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -56.42 -47.69 78.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 74.04 110.888 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -60.72 102.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.901 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.6 mt -144.76 129.55 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.31 111.131 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.69 -24.75 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 65.44 110.907 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.21 126.66 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.15 111.111 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 87.0 t -107.14 129.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 74.24 111.177 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 16.4 t -104.41 111.63 65.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 75.32 111.093 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.82 -173.25 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 70.25 112.231 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.95 -12.21 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 72.43 112.47 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -152.56 131.28 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 74.12 110.853 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.23 -119.99 5.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.767 -0.73 . . . . 60.1 112.473 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.16 172.26 13.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 74.51 110.881 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.8 m -61.06 164.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.084 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.64 -115.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.714 . . . . 71.33 112.538 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.21 -169.97 3.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.377 . . . . 64.45 110.839 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -19.92 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 70.11 110.908 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.1 -18.22 47.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.721 . . . . 75.41 112.438 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 11.0 mt -72.12 -31.78 66.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 74.54 110.932 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.41 -58.62 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.959 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -19.66 55.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.884 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -44.02 95.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.827 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 16.1 m -57.11 -52.77 63.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 63.52 111.18 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -25.04 65.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 73.44 110.903 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -75.22 -11.75 60.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 74.41 110.887 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.7 mt -119.07 -15.56 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.22 110.871 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 2.22 15.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 74.54 110.903 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 74.21 110.846 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.843 0.354 . . . . 73.24 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.69 103.33 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.33 111.088 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -122.08 116.87 25.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 73.12 110.872 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.486 ' ND2' ' HG1' ' A' ' 13' ' ' THR . 35.3 p-10 -62.46 166.72 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 72.51 110.895 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.23 -48.71 62.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.83 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.486 ' HG1' ' ND2' ' A' ' 11' ' ' ASN . 17.5 p -62.65 -36.7 83.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 63.14 111.206 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.34 14.56 63.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 70.34 112.572 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -80.4 -45.02 18.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 72.54 111.077 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.5 mt -102.55 107.98 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 75.33 111.077 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.2 p -113.14 137.01 52.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 71.05 110.887 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.79 109.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 74.1 111.154 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -99.96 123.84 44.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.03 110.896 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -67.5 109.55 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 72.53 110.939 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.62 -32.49 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.888 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.11 -97.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 71.35 110.843 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -151.15 9.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.03 110.969 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.55 6.47 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 75.2 110.859 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -150.96 140.48 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 74.34 111.158 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -127.7 -173.71 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.906 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.0 t -137.83 92.87 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 75.43 111.175 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -77.52 120.54 22.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.861 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.4 m -115.29 98.57 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 63.4 111.185 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.01 117.27 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 71.22 110.947 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.18 116.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.858 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.731 . . . . 72.24 112.499 179.864 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.527 0.68 . . . . 74.32 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.658 2.238 . . . . 61.34 112.389 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.56 102.16 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 74.41 110.799 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.81 170.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.067 -0.515 . . . . 74.35 110.911 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -158.0 8.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 71.53 112.501 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.2 tp -156.18 113.49 3.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 72.41 110.87 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 t -99.25 113.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 74.41 111.161 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 18.9 mt -93.63 119.27 32.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 65.13 110.915 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.81 84.49 6.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.822 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -172.54 2.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 72.32 111.091 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -105.34 -25.79 12.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 63.41 110.906 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.4 -13.35 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.886 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.83 155.44 6.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 64.33 112.504 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.87 157.82 26.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 75.54 110.842 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 17.1 t -146.5 142.37 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 71.11 111.145 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mt -139.32 120.52 14.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.904 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.59 111.81 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.12 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.92 128.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 74.13 110.9 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 p -71.96 -164.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 71.22 110.906 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -93.08 171.67 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 75.32 110.898 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -55.53 -60.69 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 72.05 110.92 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.19 157.63 34.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 74.35 110.817 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -51.86 -39.97 59.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 74.41 110.889 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -53.42 -41.1 65.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 72.43 110.894 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.97 -45.55 34.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 74.0 110.924 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.97 -48.83 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.0 111.132 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -52.46 -50.01 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.906 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -64.06 -19.71 65.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 73.23 110.806 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 tp -89.18 -26.21 21.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 74.4 110.84 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.18 -23.07 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 71.12 111.103 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.05 15.4 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.875 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.2 ptm -130.43 -40.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.24 110.94 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -80.67 -21.7 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 71.43 111.146 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.715 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -69.04 -23.01 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.884 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.8 -33.07 7.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 73.22 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -43.52 67.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 74.44 110.859 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -87.1 -10.66 52.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.827 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.19 12.45 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 71.32 110.919 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.19 140.4 48.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 74.34 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.0 137.15 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.954 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.715 HG22 ' HE2' ' A' ' 72' ' ' GLU . 89.5 t -75.56 117.51 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 72.32 111.1 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -133.09 10.95 4.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 63.13 110.996 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.83 137.88 14.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 52.31 110.832 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.1 t -146.15 129.15 9.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 75.45 111.065 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.6 mt -92.95 125.21 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 72.41 111.104 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -94.24 158.36 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 74.3 111.08 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.7 p -115.31 -39.88 3.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 73.31 111.148 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.22 -174.36 4.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.824 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.32 97.37 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 74.14 111.127 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.98 154.96 26.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 71.14 110.932 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.64 -19.7 28.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 75.12 111.175 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.66 14.3 13.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 71.31 110.897 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -135.32 -76.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.53 110.973 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.405 ' O ' HG12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -92.35 11.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 74.24 111.079 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.81 -34.03 14.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.769 . . . . 73.21 112.483 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.38 17.77 23.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 63.05 112.497 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.534 HG12 ' CG ' ' A' ' 121' ' ' GLU . 4.5 tt -58.09 -33.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 75.1 111.085 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -55.82 -24.2 34.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.256 -0.429 . . . . 65.1 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m -95.84 -12.25 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 73.43 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.01 -30.6 17.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.901 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -88.09 -6.65 57.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 64.45 110.914 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -91.53 -52.7 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 73.0 110.966 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -61.86 -60.65 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.13 110.952 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.09 40.0 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.753 -0.737 . . . . 74.41 112.502 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.04 140.08 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 72.53 111.157 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -98.17 110.33 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.0 110.914 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.48 9.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 72.43 111.09 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -72.83 145.21 47.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.89 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -173.75 -175.12 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.33 110.919 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.41 154.96 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 62.3 111.21 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.08 39.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 71.42 111.036 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.34 -41.63 84.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.89 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 86.9 m -61.96 -16.8 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 64.31 111.121 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.06 11.71 34.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 74.52 111.14 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.35 -26.07 9.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 54.44 110.767 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.25 -9.49 22.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 75.52 110.976 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.34 -36.88 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.45 111.057 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -28.14 60.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 73.25 110.983 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -55.44 -35.36 65.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 74.11 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -86.14 -25.65 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 72.43 110.941 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.73 14.6 4.69 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 71.44 112.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -95.1 177.36 5.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 74.11 110.977 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.534 ' CG ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.24 -171.86 3.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 75.22 110.853 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.1 mt-10 -115.49 111.95 43.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.72 0.772 . . . . 65.32 110.878 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.529 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 54.2 Cg_endo -69.66 -178.89 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.772 2.314 . . . . 64.33 112.32 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.4 mt -53.57 -43.87 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 74.24 110.932 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.76 27.78 21.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 62.43 112.463 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -101.19 31.31 3.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 73.1 110.825 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.7 mt -116.13 -175.21 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 72.12 110.964 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.66 -170.93 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 72.52 110.894 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.2 m -50.43 -70.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 74.42 111.034 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.0 t -118.08 105.86 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 70.53 111.118 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -138.82 166.78 23.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.32 111.169 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.83 134.04 55.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.788 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.1 mt -113.08 167.46 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.933 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.48 134.39 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 71.23 110.939 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -137.21 36.15 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 75.01 110.869 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.74 93.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.736 . . . . 54.41 112.518 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.4 m120 65.55 13.67 9.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 74.22 110.917 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.7 tpp -135.37 105.34 6.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.941 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -96.45 130.62 43.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 74.5 110.879 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.67 117.39 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 74.42 111.13 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.99 129.5 55.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 53.4 110.89 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.36 -176.29 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 70.23 111.185 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -166.74 133.4 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 70.4 110.929 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -124.07 89.26 51.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.727 0.775 . . . . 73.52 110.941 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 -21.75 32.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 64.13 112.33 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.18 -157.64 27.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 75.25 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -88.02 138.14 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 75.15 110.837 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.23 -88.82 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 62.44 112.494 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -75.48 -25.62 57.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 72.54 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 p -146.82 -165.33 2.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 74.52 111.166 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -85.85 -19.67 30.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 75.13 110.89 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -137.87 24.27 2.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 73.43 110.863 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.83 129.29 33.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.837 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.21 174.47 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 72.55 111.105 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.19 136.24 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.14 111.161 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.5 121.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.4 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -110.02 139.14 45.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.509 . . . . 72.34 110.947 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 21.1 mt -120.14 99.21 48.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.529 0.68 . . . . 75.12 110.914 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.62 -4.53 14.12 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.711 2.274 . . . . 75.43 112.382 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -85.73 -22.81 27.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.34 110.937 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.3 12.15 2.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.4 110.97 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.36 25.17 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 75.12 110.939 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.3 mt -89.04 142.34 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 73.3 111.1 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 57.7 tp -122.32 156.39 33.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.3 t -123.56 74.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 64.15 111.157 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.99 -41.71 52.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.732 -0.747 . . . . 73.21 112.458 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.66 -162.54 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 74.22 112.494 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 16.7 m -51.84 -34.51 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 45.43 110.882 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.76 -41.35 61.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.878 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.83 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 74.53 111.116 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.5 147.85 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.924 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.4 p -98.29 159.64 14.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.43 110.926 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.172 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.763 0.316 . . . . 74.23 111.057 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.14 92.43 3.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 74.21 110.942 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.1 t -62.86 -18.43 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 72.24 111.165 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.62 -20.67 58.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 73.23 110.952 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.6 -14.72 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.887 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -55.0 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.498 . . . . 75.12 110.853 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -24.75 17.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 75.0 110.841 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -81.56 -31.46 32.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 72.32 111.127 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.67 -43.82 58.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 63.23 110.886 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.26 -44.61 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 75.31 111.18 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.97 -23.83 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.872 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.14 -21.43 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.758 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.5 t -87.97 -9.56 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.54 111.151 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.43 -8.5 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.881 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -104.11 -31.08 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 73.44 110.809 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 -53.84 2.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -98.1 60.3 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 74.02 110.868 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -72.57 -59.48 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.23 110.901 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -52.13 102.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.904 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.0 mt -139.43 116.72 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 74.43 111.138 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.95 -22.74 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.833 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.97 129.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 71.3 111.088 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 88.1 t -102.22 130.86 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 73.34 111.073 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.4 t -107.92 103.75 50.89 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.568 0.699 . . . . 73.31 111.077 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -170.64 0.41 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.736 2.291 . . . . 75.12 112.311 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.49 -11.74 59.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.838 -0.696 . . . . 74.25 112.57 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.44 144.43 23.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 65.04 110.881 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 100.77 -102.31 2.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.793 -0.718 . . . . 74.4 112.431 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -170.86 159.52 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.41 . . . . 74.22 110.905 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.0 m -53.39 163.29 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 75.41 111.176 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.78 -99.68 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 43.41 112.514 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -167.29 -168.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 65.44 110.825 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -20.25 42.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 65.54 110.961 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.17 -23.73 26.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 73.01 112.473 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.6 mt -73.17 -34.7 66.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 62.21 110.956 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.84 -59.34 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 75.12 110.964 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.54 -20.58 56.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.282 -0.417 . . . . 75.01 110.911 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.62 -34.35 77.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.22 110.811 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.7 m -62.52 -55.54 26.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 72.4 111.152 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -20.95 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 73.0 110.924 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.09 -12.11 60.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 64.42 110.879 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.7 mt -119.88 -26.34 5.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 73.23 110.935 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 75.24 110.964 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 mttt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.83 179.808 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.841 0.353 . . . . 74.23 111.074 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.19 94.05 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 44.01 111.137 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -112.49 117.35 32.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.947 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -61.82 170.21 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 65.35 110.918 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.032 0.444 . . . . 74.41 110.899 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.7 p -60.98 -38.51 86.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 74.31 111.119 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.77 13.88 62.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.799 -0.715 . . . . 65.13 112.563 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.4 m -83.45 -35.56 24.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.363 . . . . 73.43 111.216 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -110.08 122.5 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 74.2 111.109 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 p -129.86 128.79 42.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 73.13 110.776 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.5 112.95 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 72.33 111.15 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 t -99.09 129.11 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 62.13 110.87 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -72.91 111.14 7.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 63.45 110.933 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.8 mt -64.62 -32.54 74.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.854 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.447 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.84 -97.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 72.31 110.874 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.447 ' N ' HD21 ' A' ' 22' ' ' ASN . 23.3 tttt -150.3 9.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 75.13 110.904 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.403 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.46 7.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 72.04 110.977 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.86 141.14 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 71.44 111.112 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.405 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 18.0 m95 -129.52 -179.42 5.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 74.35 110.929 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -131.43 90.2 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 65.02 111.118 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -74.15 125.19 27.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 62.32 110.907 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -124.45 105.54 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 63.53 111.181 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -91.64 124.39 35.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 74.11 110.869 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -80.32 127.55 32.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.905 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.87 -0.681 . . . . 63.0 112.491 179.844 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.666 0.746 . . . . 70.31 111.212 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.46 6.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.243 . . . . 72.04 112.336 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -101.55 89.09 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 63.4 110.877 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -56.66 158.66 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.42 110.877 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.94 -146.9 4.51 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.737 -0.744 . . . . 72.04 112.523 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp -160.22 117.32 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.84 0.352 . . . . 75.43 110.891 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.5 t -99.43 122.36 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.54 111.171 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.6 mt -100.0 119.14 37.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 71.24 110.942 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -89.31 86.68 6.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.439 . . . . 75.44 110.945 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -99.83 -172.31 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 74.13 111.212 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -20.76 12.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.823 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -86.89 -13.34 45.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.848 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.51 4.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 60.01 112.43 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 tp -63.13 156.01 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 73.55 110.994 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.31 142.59 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.55 111.087 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -138.07 125.03 21.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 75.25 110.854 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.5 t -70.45 111.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 62.42 111.134 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 73.57 138.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 65.54 110.833 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 p -81.21 -164.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 71.43 110.816 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.7 t -95.36 168.34 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.909 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -50.32 -59.94 3.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 74.35 110.929 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -128.13 158.92 36.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.83 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -52.08 -34.75 45.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.891 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -57.5 -36.31 71.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 72.35 110.921 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.82 -46.64 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 72.24 110.971 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.67 -47.57 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.1 111.143 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -53.18 -50.36 64.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 75.41 110.887 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.56 -19.04 65.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.939 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.59 -26.16 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 75.52 110.862 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.17 -23.34 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 74.03 111.151 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.17 15.2 14.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 75.15 110.916 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.5 ptm -129.83 -39.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 75.21 110.879 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.433 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 31.9 m -80.44 -22.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.01 111.113 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HE2' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -68.35 -24.02 64.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 62.12 110.836 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -106.37 -33.23 7.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 73.53 110.942 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -70.21 -42.26 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 75.22 110.885 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -89.34 -11.17 44.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.874 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.95 12.03 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.924 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.67 139.56 50.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.877 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -85.45 138.62 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 75.33 110.97 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.8 t -79.18 122.29 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.4 111.093 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -137.33 8.14 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 70.43 111.215 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -149.89 145.84 26.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.941 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 t -155.7 131.68 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 75.41 111.069 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.0 mt -86.18 133.96 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.53 111.15 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mm -98.96 148.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 72.22 111.125 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 79.8 p -114.57 -39.19 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 75.33 111.162 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 152' ' ' ASP . 2.1 p-80 -166.84 177.03 6.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.834 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.75 83.45 3.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 72.43 111.173 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 75.03 110.839 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.46 -22.03 7.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 75.2 111.078 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.06 19.69 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 51.5 110.919 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.438 ' HE ' HG22 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -144.33 -70.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.868 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.438 HG22 ' HE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.76 3.55 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 75.31 111.146 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.84 -45.12 49.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 62.13 112.565 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.14 15.17 60.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 75.55 112.425 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.8 tt -55.4 -28.48 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.879 0.371 . . . . 72.23 111.08 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -21.84 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 73.34 110.929 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -98.58 -14.57 19.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.41 111.191 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.5 mt -89.53 -35.85 15.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 74.44 110.92 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -94.44 23.97 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.85 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -124.94 -43.37 1.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 74.02 110.784 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -81.59 -52.51 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 72.51 110.891 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.27 41.01 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.713 -0.756 . . . . 72.14 112.485 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.59 112.82 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 72.14 111.132 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -79.79 116.65 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 63.12 110.92 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.2 90.15 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.429 . . . . 75.52 111.114 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -63.09 113.97 3.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.87 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.21 -174.71 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 64.5 110.849 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.68 157.14 16.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 72.22 111.133 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.08 -40.94 33.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 63.33 111.101 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -35.65 74.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 72.54 110.968 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.4 m -63.77 -21.54 66.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 73.22 111.129 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.37 11.63 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.25 111.154 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.79 -24.38 12.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 64.23 110.868 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.34 -7.4 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 72.43 110.958 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.63 -41.04 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.197 -0.456 . . . . 75.33 111.052 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -24.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.93 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -33.57 71.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 74.4 110.857 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -87.81 -22.87 24.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.841 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.45 23.15 4.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.795 -0.717 . . . . 74.51 112.57 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.54 -177.64 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 73.44 110.92 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -79.65 -172.19 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 74.03 110.895 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.47 112.99 32.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 75.31 110.915 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.28 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 72.11 112.27 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.0 mt -60.63 -51.52 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 70.41 110.899 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.81 18.22 45.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 43.3 112.489 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -96.79 33.01 1.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 71.13 110.847 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.7 mt -119.09 -175.09 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 73.5 110.944 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.68 -170.74 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 73.13 110.911 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.5 m -50.02 -70.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 65.41 111.138 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.7 t -116.6 96.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 74.2 111.148 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -117.78 169.37 9.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 71.23 111.167 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.21 103.9 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.931 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.04 165.44 22.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.1 110.918 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -151.77 112.06 4.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.779 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.02 69.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.932 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.63 -93.29 0.3 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.834 -0.698 . . . . 75.14 112.42 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -110.01 24.39 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 75.13 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.9 tpp -132.48 135.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.886 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.86 130.53 56.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 72.4 110.989 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 t -139.59 121.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 72.41 111.124 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.31 126.07 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 72.42 110.898 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.8 p -83.34 -174.66 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.11 111.051 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -170.66 139.72 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 64.42 110.894 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -125.78 89.02 53.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.737 0.78 . . . . 71.51 110.976 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -8.05 22.61 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.291 . . . . 65.13 112.33 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.59 -149.04 19.42 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.673 -0.775 . . . . 74.42 112.448 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -98.47 140.22 33.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 73.13 110.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.06 -93.19 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.744 -0.741 . . . . 51.13 112.538 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.59 -23.66 61.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 75.22 110.83 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.2 p -151.71 -175.35 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.33 111.124 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.16 -3.38 58.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.855 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.487 ' HD2' ' HA ' ' A' ' 86' ' ' HIS . 7.4 p-10 -141.66 13.78 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 75.24 110.832 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.6 141.56 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.88 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.7 pt -146.91 176.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.3 111.078 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.1 m -132.53 129.02 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.32 111.11 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.9 t -86.84 133.1 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.33 111.101 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -120.16 137.48 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 73.14 110.951 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.5 99.28 50.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.647 0.737 . . . . 75.32 110.945 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -3.13 11.36 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 63.32 112.407 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -86.54 -24.6 25.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 73.53 110.827 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.32 13.01 2.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.942 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.4 m120 54.18 25.42 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.02 110.942 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.7 mt -89.69 133.45 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 74.22 111.162 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.0 tp -121.68 140.62 52.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 75.45 110.931 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.42 75.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 72.11 111.193 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.06 -35.88 42.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.692 -0.765 . . . . 72.52 112.607 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.27 -157.9 53.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.817 -0.706 . . . . 72.44 112.51 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 98.0 m -50.7 -33.68 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 61.31 110.922 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.45 -37.83 57.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 75.14 110.936 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 86.0 t -105.75 108.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.11 111.127 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -50.78 168.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 71.3 110.904 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.88 160.16 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.2 110.807 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 71.14 111.146 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.783 0.325 . . . . 73.4 111.095 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.94 92.66 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.898 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.12 -25.95 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.0 111.089 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -69.5 -32.26 71.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.32 110.885 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.19 -14.44 18.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.4 110.849 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -57.34 -61.83 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.54 110.927 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.8 -24.46 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.873 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.6 m -80.15 -33.64 38.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 75.51 111.169 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -43.01 64.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.803 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.9 -47.17 92.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 73.11 111.175 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.33 -28.5 63.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 73.31 110.905 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -77.94 -20.93 51.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 54.45 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 22.8 t -87.08 -11.44 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 73.43 111.205 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -110.36 -14.17 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 74.33 110.906 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.92 -30.95 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.964 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -103.46 -51.42 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 74.25 110.8 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -101.07 64.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 72.24 110.899 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -71.73 -59.9 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 74.33 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -50.97 107.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 70.2 110.854 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 91.3 mt -146.26 118.94 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 74.34 111.126 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.54 -29.6 52.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 72.44 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -159.65 146.4 16.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 52.21 111.118 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 49.9 t -121.92 122.37 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 72.51 111.088 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.21 101.94 22.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.723 . . . . 75.22 111.148 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 178.12 4.94 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 65.42 112.327 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.28 -17.97 76.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 63.31 112.536 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -152.52 148.98 28.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 75.52 110.915 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.9 -115.4 4.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.653 -0.784 . . . . 73.14 112.498 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -159.63 148.73 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 44.43 110.92 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.49 130.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 75.21 111.044 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -127.63 -98.13 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.689 -0.767 . . . . 35.13 112.443 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.84 -169.72 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.874 0.368 . . . . 74.04 110.918 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -16.96 55.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.902 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.29 -18.96 37.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.806 -0.712 . . . . 53.1 112.406 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.08 -45.58 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 73.33 110.945 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.32 -56.24 18.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.983 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.3 pp -59.39 -20.36 54.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 64.23 110.919 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.173 -0.467 . . . . 75.21 110.82 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.1 m -63.86 -56.75 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 73.31 111.132 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.55 -29.78 52.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 74.31 110.955 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -29.22 61.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 75.13 110.898 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.42 -16.43 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.925 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.3 18.19 15.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 74.04 110.95 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 74.43 110.845 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.5 t . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.836 0.35 . . . . 62.32 111.157 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.1 mt -112.66 101.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.41 111.121 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -120.52 115.03 22.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.55 110.997 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.47 ' ND2' ' HG1' ' A' ' 13' ' ' THR . 37.2 p-10 -58.25 165.04 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 73.41 110.894 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -51.62 -48.51 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 72.01 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.47 ' HG1' ' ND2' ' A' ' 11' ' ' ASN . 18.9 p -61.15 -37.72 83.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.13 111.06 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.1 62.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 71.12 112.486 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.2 m -75.92 -45.36 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 72.32 111.115 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.47 123.25 54.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 71.44 111.16 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.5 p -127.22 133.56 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 60.32 110.84 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.9 mt -127.22 110.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 75.12 111.127 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -98.83 126.58 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 73.45 110.846 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -71.14 108.85 4.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.848 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.07 -33.34 74.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.926 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.443 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.32 -96.74 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.911 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.4 OUTLIER -150.87 9.7 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 75.05 110.849 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.401 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.61 6.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.906 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -151.0 140.81 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 74.54 111.122 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.402 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 15.9 m95 -128.51 -173.25 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 71.15 110.947 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.1 t -137.79 88.2 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.079 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.43 124.13 23.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.792 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -123.65 105.29 9.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 73.14 111.166 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -91.89 125.8 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.864 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mt -83.53 123.79 30.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 72.22 110.935 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 75.4 112.443 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.23 0.061 0 CA-C-O 121.579 0.704 . . . . 72.41 111.119 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 121.81 8.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.741 2.294 . . . . 63.04 112.373 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.5 p -103.95 88.16 2.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 74.42 110.934 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -58.33 156.8 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.11 110.968 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -150.81 -142.54 3.55 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.81 -0.71 . . . . 72.54 112.515 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp -160.68 116.97 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 73.02 110.822 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -100.94 122.82 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 71.24 111.114 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 17.7 mt -101.08 122.31 43.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 62.31 110.83 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.78 86.48 5.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.22 110.839 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.09 -174.59 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 73.31 111.135 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.3 t -105.69 -24.18 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 75.33 110.838 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -81.73 -10.63 59.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 73.41 110.867 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.39 153.78 5.99 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.702 -0.761 . . . . 65.3 112.53 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.86 154.59 41.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 71.33 110.889 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 2.5 t -142.09 137.44 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 73.1 111.096 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.29 121.73 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 70.33 110.914 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.82 111.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.54 111.104 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 72.56 146.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.01 110.939 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 p -85.52 -165.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 72.5 110.817 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 t -95.09 171.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 74.23 110.883 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -51.63 -60.07 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.34 110.952 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -129.5 159.59 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.917 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 65.0 m-20 -51.37 -33.41 29.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 61.15 110.902 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.65 -38.92 79.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.868 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.2 mt -82.34 -46.01 14.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.51 110.902 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.89 -49.11 60.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 72.54 111.069 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.64 -51.47 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 74.45 110.911 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.41 -21.91 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 75.45 110.872 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 tp -84.64 -29.83 25.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 73.44 110.886 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.4 mt -88.72 -26.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 72.53 111.171 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.14 -0.12 47.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.942 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.8 ptm -116.58 -36.62 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 65.44 110.908 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -78.23 -29.32 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 72.42 111.115 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.62 -32.31 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.892 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -97.2 -33.33 11.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 73.1 110.809 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -48.86 54.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 74.23 110.869 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -84.18 -11.96 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.864 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.76 12.05 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 73.34 110.924 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.56 137.7 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 72.4 110.899 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -84.84 136.18 33.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 64.14 110.865 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.6 128.98 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 74.2 111.087 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 t -146.53 14.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 74.12 111.082 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -159.58 136.04 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 64.43 110.871 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.14 153.17 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 75.13 111.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.11 143.55 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 72.43 111.11 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 mm -106.02 145.97 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.3 111.164 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.2 p -112.32 -37.28 5.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 64.14 111.224 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -168.41 177.97 5.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 73.4 110.807 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.02 79.63 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.42 111.158 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -137.69 155.35 49.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 73.24 110.897 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -20.62 10.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 63.22 111.012 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.99 11.45 18.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 55.14 110.913 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.409 ' HE ' HG22 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -135.97 -70.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 75.42 110.825 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.409 HG22 ' HE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -88.9 2.87 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 74.42 111.163 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.02 -45.78 41.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.734 . . . . 73.35 112.517 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.19 15.91 57.43 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 74.44 112.55 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -52.87 -28.93 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 74.22 111.136 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 29.4 mmtm -59.07 -28.38 66.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.895 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 m -88.22 -16.59 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 73.02 111.17 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.4 mt -90.38 -41.9 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.885 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -79.51 -5.34 54.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.915 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.06 -54.99 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.845 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -64.04 -62.27 1.73 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.859 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 152.92 39.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 43.02 112.497 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -97.57 139.21 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.11 111.202 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -96.67 111.0 23.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.4 110.931 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.89 93.7 9.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.044 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -66.49 113.85 5.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.282 -0.417 . . . . 74.15 110.865 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.45 179.67 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 64.43 110.838 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.87 157.58 17.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 74.02 111.1 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.55 -40.14 51.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 52.35 111.168 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.5 tp -75.14 -39.45 60.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 71.51 110.937 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 82.8 m -58.62 -21.81 54.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 73.35 111.136 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.06 -0.63 50.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 73.44 111.054 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -52.76 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 73.31 110.84 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -13.53 60.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 73.3 110.925 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.55 -45.25 72.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.15 111.0 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.79 63.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -34.14 71.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.256 -0.429 . . . . 72.33 110.873 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -90.5 -19.1 24.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 71.45 110.894 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 24.62 5.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 72.55 112.561 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -99.66 177.82 5.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.864 0.364 . . . . 75.54 110.895 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -76.39 -172.95 2.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 70.31 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.11 113.8 32.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.686 0.755 . . . . 74.25 110.882 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.9 -168.33 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.595 2.196 . . . . 75.34 112.342 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.74 -44.36 93.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.913 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 54.79 25.29 36.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 60.52 112.434 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -108.0 36.25 2.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.915 0.388 . . . . 74.43 110.903 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.9 mt -122.57 -174.47 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.928 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.38 -170.05 3.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 75.31 110.912 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.5 m -50.08 -69.95 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.431 . . . . 61.43 111.14 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.3 t -118.51 99.75 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 63.34 111.138 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -127.91 174.8 8.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 54.44 111.144 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.47 133.92 53.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 74.02 110.93 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 39.0 mt -112.35 179.44 3.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 75.14 110.894 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 126.64 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.817 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -130.24 54.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 75.53 110.842 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.58 90.31 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 53.13 112.52 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.1 m120 64.39 14.72 9.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 73.45 110.896 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.0 tpp -133.91 97.57 3.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.15 110.936 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 136.49 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 73.35 110.954 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.04 117.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 73.24 111.052 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -109.11 129.96 55.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 71.54 110.883 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.8 p -85.37 -171.64 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 73.15 111.222 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -170.69 134.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 70.44 110.845 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -123.22 88.38 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.71 0.767 . . . . 72.52 110.917 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.99 22.47 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.607 2.205 . . . . 62.15 112.367 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.45 -151.7 19.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 74.23 112.485 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -92.15 140.01 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 73.35 110.936 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.34 -88.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.706 -0.759 . . . . 72.24 112.453 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -75.02 -24.02 58.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.877 0.37 . . . . 71.43 110.838 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 70.3 p -151.64 -170.23 3.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 73.33 111.097 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.64 -12.18 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.88 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.0 25.43 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 63.12 110.805 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 132.23 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 75.31 110.92 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 28.4 pt -136.89 169.88 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 74.44 111.089 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.0 m -126.37 134.13 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 75.34 111.129 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.03 133.89 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 72.04 111.163 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -121.48 130.94 53.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 72.22 110.902 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 10.6 mt -110.59 98.66 38.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.662 0.744 . . . . 73.14 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.4 Cg_endo -69.73 -4.53 14.19 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.719 2.279 . . . . 75.24 112.358 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -82.95 -24.14 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 75.34 110.938 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.63 14.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.877 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.25 27.52 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.856 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.2 mt -92.42 126.47 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 63.04 111.132 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 23.2 tp -110.89 148.26 32.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 73.54 110.852 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 72.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.42 111.148 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.46 -42.06 49.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 63.32 112.445 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.31 -155.95 44.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 72.55 112.493 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 66.1 m -51.51 -30.58 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 71.35 110.868 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 27.5 tp -57.51 -33.56 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 74.12 110.845 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 95.6 t -105.51 104.69 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 65.3 111.176 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -51.91 156.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.859 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.2 p -99.67 157.59 16.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.913 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 72.12 111.081 -179.901 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.781 0.324 . . . . 74.4 111.059 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -107.49 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 34.5 t -60.85 -17.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 74.51 111.121 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.99 -21.14 59.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 72.51 110.85 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -117.79 -12.47 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.851 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -54.97 -60.78 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 74.02 110.929 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -24.93 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 72.31 110.819 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.4 m -81.36 -31.98 33.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 74.24 111.18 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -42.16 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 73.43 110.851 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.5 mm -61.85 -47.43 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.23 111.083 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -57.23 -28.07 62.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.911 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -76.59 -19.54 57.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.89 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.36 -16.09 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 75.54 111.187 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.2 pp -104.95 -5.74 20.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 74.33 110.994 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.61 -30.69 9.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 73.0 110.876 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -104.37 -51.18 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 65.52 110.835 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.14 39.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 73.42 110.882 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -52.56 -48.67 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 73.31 110.852 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -60.44 106.25 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.929 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 42.8 mt -145.95 123.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 72.2 111.146 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.41 -35.47 54.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 74.11 110.843 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -157.83 129.38 6.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 74.2 111.082 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.95 136.46 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 71.51 111.128 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.5 t -113.16 113.4 49.1 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.72 0.771 . . . . 75.15 111.082 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.86 -173.41 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 71.5 112.34 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.24 -15.38 69.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 74.13 112.47 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.71 139.45 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 74.1 110.884 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.62 -117.93 5.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.827 -0.701 . . . . 71.3 112.475 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -148.94 169.09 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 73.51 110.928 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.17 161.58 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 74.1 111.071 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.06 -88.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 64.21 112.429 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -179.8 -170.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 73.15 110.875 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -60.98 -18.0 54.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 74.31 110.955 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.98 52.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.671 -0.776 . . . . 74.15 112.455 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.6 -47.83 30.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.862 0.363 . . . . 74.14 110.903 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -55.16 32.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.96 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.83 -20.04 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 71.23 110.856 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -69.74 -39.32 76.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 72.44 110.851 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.8 m -53.19 -50.38 64.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 64.45 111.106 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.36 -17.73 55.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.919 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -87.44 -5.67 58.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.878 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.62 -5.28 6.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 75.44 110.968 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.87 4.87 11.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 73.42 110.965 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 75.45 110.857 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.823 0.344 . . . . 72.14 110.81 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -85.61 121.41 28.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 75.14 110.918 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -150.55 156.56 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.843 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.55 168.01 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 74.2 111.261 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -118.42 72.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 74.12 110.851 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -122.06 173.38 7.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.7 m -114.66 -53.33 2.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 65.32 111.127 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 m -58.86 -176.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 73.3 111.067 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.82 91.82 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.44 111.101 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -111.88 117.84 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 73.32 110.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -60.79 168.96 2.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.873 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.96 -47.94 64.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 72.55 110.881 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -61.08 -37.54 83.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 75.21 111.15 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.3 13.32 61.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.669 -0.777 . . . . 64.12 112.542 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.4 m -79.14 -44.8 21.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 75.24 111.092 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.1 mt -103.59 117.46 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 74.31 111.176 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -124.46 129.12 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 74.45 110.843 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.44 112.55 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 63.44 111.105 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.31 128.76 44.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 75.13 110.86 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -73.55 110.93 8.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 74.2 110.89 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.8 mt -65.37 -32.99 74.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 70.13 110.879 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.448 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.85 -97.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 64.44 110.872 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.8 OUTLIER -150.09 9.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 73.15 110.864 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.405 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.53 8.25 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 75.4 110.829 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -150.89 141.14 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 74.03 111.095 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 19.6 m95 -130.0 -179.39 5.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 71.51 110.878 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.0 t -132.0 89.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 72.11 111.096 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -72.78 124.38 25.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 75.5 110.834 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -119.93 104.2 9.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 74.23 111.128 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -88.13 123.27 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 73.25 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.8 117.8 28.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 72.14 110.874 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.43 -124.87 3.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 52.22 112.514 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.2 p -175.18 116.71 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.893 0.378 . . . . 73.24 110.823 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.21 42.33 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 65.22 110.85 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 64.2 69.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.907 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.17 -18.28 36.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.804 -0.712 . . . . 61.15 112.5 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -119.48 -177.42 3.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.83 0.347 . . . . 75.22 110.933 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.86 143.92 39.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 52.34 111.07 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.6 79.89 71.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.58 0.705 . . . . 75.24 111.181 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 118.33 5.62 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.738 2.292 . . . . 71.25 112.348 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -110.21 99.91 8.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 71.41 110.812 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -62.42 170.37 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 75.42 110.93 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -159.28 -147.46 4.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 71.43 112.527 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -159.58 116.28 2.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 74.33 110.885 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.5 t -99.52 121.83 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 74.11 111.155 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.7 mt -98.7 118.23 34.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 64.2 110.966 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.39 85.93 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.936 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.78 177.15 4.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 73.03 111.092 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -97.94 -20.84 17.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 72.53 110.823 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -10.4 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 71.12 110.902 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.62 153.54 5.91 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 72.24 112.523 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -68.54 154.95 40.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 71.44 110.905 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -145.15 142.99 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 75.43 111.107 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.56 124.61 21.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.905 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -71.51 112.44 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 63.12 111.137 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.629 ' HD2' HG21 ' A' ' 85' ' ' THR . 1.8 m-20 73.4 121.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 71.0 110.882 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 p -66.12 -166.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.01 110.844 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.6 t -91.9 169.48 10.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.85 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -50.38 -60.25 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.828 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -129.82 158.51 39.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 75.15 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.656 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 52.3 m-20 -51.37 -33.75 31.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.972 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.21 -38.11 76.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 74.3 110.926 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.1 mt -81.15 -45.54 16.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.934 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -45.14 61.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.132 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -52.93 -51.59 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 75.04 110.952 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -63.71 -19.71 65.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 71.13 110.913 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 tp -87.94 -26.86 22.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.877 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.75 -23.09 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 74.51 111.265 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.09 18.18 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 74.33 110.865 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.3 ptm -132.9 -40.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 72.52 110.866 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.435 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 33.1 m -81.07 -22.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 72.33 111.163 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.491 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.81 -21.95 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.902 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -109.04 -33.27 6.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 75.22 110.851 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.93 -43.48 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 75.44 110.908 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.17 -10.87 48.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 71.41 110.895 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 67.42 13.27 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 74.31 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -131.33 138.76 49.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.01 110.954 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -85.8 137.94 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.22 110.833 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.491 HG22 ' HE2' ' A' ' 72' ' ' GLU . 98.8 t -76.91 126.39 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.35 111.103 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -143.79 13.89 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.11 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -155.89 144.15 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.04 110.906 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 t -154.41 131.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.4 111.161 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.6 mt -89.4 130.73 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.105 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -106.28 124.94 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.12 111.157 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 ' HD2' ' A' ' 56' ' ' ASP . 30.7 p -82.53 -39.54 22.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 72.01 111.167 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -165.94 -175.29 3.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 71.11 110.931 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.24 95.83 10.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 71.21 111.108 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.475 ' CE1' ' HE2' ' A' ' 149' ' ' HIS . 0.3 OUTLIER -150.88 154.08 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.35 110.832 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.13 -20.19 51.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 73.5 111.049 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.8 5.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 61.52 110.918 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -122.11 -77.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 75.52 110.791 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.14 8.48 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 74.1 111.086 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.38 -42.32 33.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 72.12 112.476 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.61 13.1 58.15 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 64.41 112.468 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 tt -51.42 -29.63 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 74.21 111.086 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.656 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -53.15 -32.11 45.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 72.22 110.984 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.6 m -89.78 -22.72 22.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 74.42 111.132 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.3 mt -80.54 -25.98 38.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.906 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.73 15.3 29.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.913 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.03 -40.93 3.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.24 110.89 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -83.19 -58.14 2.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 74.42 110.928 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.56 38.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 73.21 112.545 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.05 115.12 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 74.34 111.111 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -78.84 116.31 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 64.24 110.911 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.43 93.15 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 71.14 111.127 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -67.66 129.44 39.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.912 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.11 -178.98 7.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 73.13 110.924 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.634 ' HB ' ' HD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -90.89 157.75 17.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.133 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.03 -36.94 30.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 72.53 111.109 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.11 -39.42 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.99 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.6 m -57.87 -27.72 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 73.53 111.186 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.31 4.7 53.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 70.4 111.018 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -103.61 -44.81 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.889 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.07 -13.86 49.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 74.14 110.959 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.12 99.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.03 111.097 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.15 62.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.944 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -35.55 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.838 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.39 -23.53 22.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.25 110.917 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.59 22.99 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 54.13 112.447 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -94.84 179.14 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.344 . . . . 72.21 110.883 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -77.41 -176.18 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 74.3 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -115.35 101.52 54.37 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.634 0.73 . . . . 75.32 110.852 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 -179.85 3.2 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.742 2.295 . . . . 72.44 112.341 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 29.4 mt -51.24 -52.55 43.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.21 110.858 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 58.75 21.94 52.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 74.22 112.444 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.37 24.14 6.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 74.02 110.886 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.99 -175.9 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 61.5 110.942 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.99 -171.55 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 70.23 110.826 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.6 m -50.94 -70.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 72.04 111.087 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -119.11 104.06 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 73.32 111.218 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -135.15 164.2 28.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 73.12 111.22 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.93 126.61 54.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.283 -0.417 . . . . 75.13 111.0 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.0 mt -111.49 155.7 22.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 74.2 110.912 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -137.87 117.19 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 62.54 110.872 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.19 48.93 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 75.34 110.886 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.33 94.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.751 . . . . 72.02 112.45 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.35 15.36 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 65.01 110.887 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.8 tpp -137.45 101.37 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 74.4 110.898 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -90.81 132.56 35.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 75.44 110.773 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.5 114.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.061 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -107.6 129.58 54.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 75.04 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 46.9 p -86.08 178.09 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 72.11 111.183 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -161.63 133.69 5.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 70.05 110.858 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -121.78 86.48 45.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 75.33 110.872 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -8.04 22.6 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.767 2.311 . . . . 74.53 112.31 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.36 -160.94 24.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 74.14 112.434 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -87.77 140.76 29.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 74.24 110.844 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.6 -91.11 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 62.43 112.459 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.475 ' HE2' ' CE1' ' A' ' 88' ' ' HIS . 68.6 t60 -73.79 -23.51 59.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 71.33 110.959 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.2 p -150.29 -167.38 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 61.13 111.167 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.32 -15.98 38.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 74.1 110.853 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.634 ' HD2' ' HB ' ' A' ' 108' ' ' THR . 41.0 t0 -135.53 17.96 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.871 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.45 129.59 25.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 64.42 110.818 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.8 pt -136.54 175.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.08 -0.509 . . . . 74.5 111.065 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.35 119.51 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.162 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.47 126.58 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 62.44 111.108 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -115.25 138.8 50.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 71.42 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.34 98.91 46.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.652 0.739 . . . . 75.44 110.846 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -4.13 13.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.707 2.271 . . . . 63.1 112.287 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -85.16 -22.97 28.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.317 -0.401 . . . . 73.03 110.974 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.41 12.28 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.042 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.3 m120 54.68 25.68 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 62.2 110.819 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 93.5 mt -90.48 142.95 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 70.4 111.196 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 13.2 tp -128.43 146.38 50.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 74.2 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 42.1 t -115.17 76.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 64.41 111.126 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.09 -28.99 19.91 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.808 -0.711 . . . . 70.22 112.49 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.41 -161.72 20.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 73.41 112.465 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -33.18 60.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 71.42 110.868 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.1 tp -51.85 -35.86 46.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.924 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.91 111.16 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.42 111.078 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.71 159.73 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 73.35 110.858 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.7 p -100.27 162.78 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.21 110.812 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 t -54.63 -28.7 48.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 65.21 111.075 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.46 44.96 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 74.02 110.854 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -130.14 156.1 45.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 73.24 111.021 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 -4.94 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 75.44 110.832 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.73 175.63 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.01 110.86 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.6 mt -74.77 -44.46 49.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 74.15 110.918 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.71 123.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.802 -0.713 . . . . 75.15 112.446 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.11 103.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 73.33 110.995 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.0 m -123.72 19.76 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 72.53 111.081 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.3 -44.02 84.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 62.23 111.061 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -98.25 13.76 30.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.874 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -123.64 167.01 14.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 64.2 111.104 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.98 90.49 3.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.959 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.96 -17.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 73.42 111.271 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -74.39 -27.81 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 71.42 110.949 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -110.97 -12.92 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 61.21 110.857 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -54.09 -62.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 72.55 110.918 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.56 -23.73 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 75.14 110.822 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.2 m -81.43 -30.48 33.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 73.15 111.168 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -43.63 41.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.889 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.7 mm -61.83 -45.2 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 74.13 111.144 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.52 -23.96 53.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 64.53 110.883 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.99 -22.79 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.864 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.4 t -86.11 -9.0 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 72.43 111.137 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.69 -6.93 13.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 71.33 110.941 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.46 -31.06 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 75.35 110.939 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -55.98 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.856 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -94.89 38.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.84 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -55.53 -47.97 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 75.23 110.948 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -60.05 102.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 73.24 110.829 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.9 mt -144.69 125.12 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 75.03 111.151 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -24.2 41.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 55.25 110.905 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.15 133.71 1.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 65.15 111.089 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 88.8 t -115.02 131.61 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 65.41 111.092 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.6 t -110.15 108.88 58.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 74.34 111.13 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 -176.01 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 74.54 112.353 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.41 -17.36 80.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 71.52 112.476 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -152.43 141.15 20.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 74.5 110.972 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 110.21 -117.64 4.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 74.05 112.488 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.63 176.16 11.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.358 . . . . 73.03 110.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.8 t -70.09 151.12 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 72.23 111.146 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.99 -102.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.737 -0.744 . . . . 65.15 112.447 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.67 -168.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 74.25 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -60.93 -18.14 55.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 75.23 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.77 -19.79 37.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.799 -0.715 . . . . 72.44 112.506 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.23 -31.78 64.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 73.04 110.878 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.8 -57.3 11.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 72.21 111.027 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.12 -17.93 59.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.31 110.937 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.24 -40.99 90.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.874 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.8 m -60.94 -47.98 83.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 71.32 111.169 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.97 -21.99 65.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.949 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -75.4 -6.54 50.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 72.23 110.905 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.7 mt -125.13 -35.68 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 72.5 110.859 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.45 -0.82 56.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.912 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 75.45 110.894 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.742 0.306 . . . . 73.32 110.87 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -138.74 179.08 6.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 74.45 110.931 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -170.56 141.85 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 74.41 110.864 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -56.54 146.86 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 73.34 111.096 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.29 169.67 15.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.503 . . . . 74.11 110.874 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -68.74 -176.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.41 110.899 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -86.76 -68.68 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 75.1 111.141 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t -50.53 147.31 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 71.01 111.171 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mt -110.48 97.17 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 71.52 111.201 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.94 121.01 39.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 75.02 110.906 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -66.78 168.16 10.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 71.42 110.837 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -52.18 -48.14 65.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.45 110.844 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.98 -37.83 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 75.12 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.93 13.12 62.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 60.54 112.55 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 m -80.47 -44.26 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.278 . . . . 74.32 111.134 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 52.8 mt -101.97 113.02 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 73.43 111.097 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.4 p -121.15 129.06 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 61.3 110.871 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -120.41 111.83 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 72.04 111.121 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.2 t -97.01 126.53 42.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.894 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -72.15 109.34 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.892 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.0 -35.26 79.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.964 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.448 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.68 -96.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.915 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.24 9.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.944 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.4 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.15 8.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 75.31 110.981 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -150.91 140.34 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 73.11 111.245 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -129.58 -179.71 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.437 . . . . 74.22 110.973 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.28 88.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 75.32 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -71.3 123.17 21.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 62.41 110.851 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.1 m -119.78 105.1 10.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 75.31 111.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -87.05 122.64 31.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.882 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.53 108.5 19.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 74.42 110.896 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.69 -128.34 1.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.786 -0.721 . . . . 74.33 112.513 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 p -175.1 115.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 71.02 110.831 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.37 41.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 71.42 110.918 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 64.31 68.23 0.56 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 74.33 110.909 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.49 -15.8 41.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 61.13 112.478 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -121.69 159.31 26.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 71.13 110.885 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.66 134.24 41.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 74.14 111.044 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.07 81.89 56.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.553 0.692 . . . . 73.12 111.228 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.63 116.9 4.76 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.738 2.292 . . . . 60.24 112.405 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.2 p -104.44 98.34 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 74.13 110.839 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.51 169.25 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.893 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -148.71 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.839 -0.696 . . . . 54.53 112.586 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.8 tp -158.62 115.19 2.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 71.11 110.943 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.56 121.8 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 63.51 111.139 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.4 mt -98.84 116.51 31.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.958 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -87.38 85.49 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.44 110.953 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.6 176.18 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 65.42 111.115 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -96.67 -21.5 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 71.11 110.831 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -11.18 57.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 74.22 110.868 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.08 153.67 5.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 72.1 112.466 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tp -68.39 155.03 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 72.35 110.951 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.57 142.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 73.13 111.153 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.53 122.84 19.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 75.25 110.959 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -69.2 110.51 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 74.15 111.109 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.2 129.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 73.25 110.91 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -165.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.52 110.809 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -91.37 172.66 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 63.42 110.839 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -49.94 -52.04 36.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 74.05 110.978 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -141.63 162.6 35.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 74.33 110.874 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.71 -30.59 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.428 . . . . 64.04 110.832 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -59.74 -42.08 92.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 71.24 110.951 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.08 -45.37 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 74.32 110.866 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -45.87 59.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 74.04 111.167 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -55.58 -48.12 75.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 71.34 110.872 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.98 -18.91 65.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.901 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.1 tp -89.59 -27.14 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 54.14 110.915 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.08 -22.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 71.31 111.145 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.55 15.72 13.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.871 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.46 -39.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -80.39 -22.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 60.12 111.097 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.702 ' HE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.75 -23.07 65.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 72.23 110.842 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 -33.52 7.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 74.24 110.842 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -69.91 -39.24 76.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 73.55 110.894 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -92.71 -10.44 37.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.879 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.65 12.05 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 65.15 110.916 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.48 137.83 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 64.01 110.868 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -86.49 138.21 31.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 73.33 110.898 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.702 HG23 ' HE2' ' A' ' 72' ' ' GLU . 71.4 t -76.4 121.94 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 74.12 111.134 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.7 t -134.32 6.59 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 73.04 111.134 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -151.23 145.7 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.31 110.837 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.8 t -154.03 132.22 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 75.31 111.075 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -93.89 123.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 75.43 111.163 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.6 mm -96.55 143.45 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 75.22 111.175 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.0 p -94.11 -51.42 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 75.2 111.176 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.581 ' HA ' ' HD2' ' A' ' 152' ' ' ASP . 1.7 p-80 -156.1 -175.88 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.829 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.86 97.13 10.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 73.35 111.117 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -158.11 150.92 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 75.04 110.858 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.07 -19.61 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 61.42 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -92.29 21.83 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.809 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -144.0 -77.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 71.55 110.837 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.87 8.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 73.34 111.136 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -41.8 38.37 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.709 -0.758 . . . . 74.55 112.503 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.45 12.04 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 72.24 112.458 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.5 tt -51.97 -28.49 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 73.43 111.104 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -53.58 -39.84 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 75.04 110.87 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.9 m -79.94 -17.29 53.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 73.12 111.192 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.3 mt -84.99 -32.34 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 75.54 110.906 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.71 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.0 110.87 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -119.63 -45.74 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -77.36 -53.41 7.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.31 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.31 44.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 50.14 112.474 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.0 121.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.945 0.403 . . . . 74.4 111.14 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt -82.05 111.42 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 71.51 110.968 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.12 91.28 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.077 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -62.98 142.16 58.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.01 110.865 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.4 p -172.9 179.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 64.31 110.882 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.85 157.47 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.41 111.208 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.99 -31.74 13.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 64.42 111.029 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -39.38 44.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 73.11 110.908 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 152' ' ' ASP . 10.2 m -57.37 -27.7 62.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 74.54 111.151 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.33 8.58 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.12 111.084 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.99 -28.78 11.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 75.41 110.898 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.36 -8.64 20.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.884 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.46 79.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 71.43 111.146 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -26.68 57.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 72.42 110.901 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -57.58 -30.75 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 71.11 110.933 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -92.11 -24.8 19.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 74.43 110.947 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.18 25.76 4.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 73.14 112.48 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.33 -176.08 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 75.54 110.955 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.61 167.75 17.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 71.34 110.853 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.6 mt-10 -101.25 103.25 24.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.7 0.762 . . . . 74.15 110.818 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.0 Cg_endo -69.73 -178.63 2.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 71.45 112.313 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 28.9 mt -51.64 -51.29 56.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.92 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.11 24.72 36.7 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.729 . . . . 73.32 112.437 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.78 29.31 5.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 72.34 110.898 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -108.91 -175.8 2.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 71.34 110.903 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.87 -172.63 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 74.45 110.938 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.5 m -50.91 -70.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 71.55 111.127 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.8 t -117.77 103.1 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 75.01 111.111 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -131.78 174.34 10.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 72.04 111.152 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.32 129.36 50.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 73.24 110.878 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.8 mt -113.29 156.98 22.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.934 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -139.36 115.31 10.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.869 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -113.36 48.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 65.52 110.918 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.43 94.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 72.12 112.382 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 m120 65.1 14.2 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 70.14 110.885 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.5 tpp -133.43 104.29 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 70.43 110.88 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.68 123.78 36.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.883 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.92 117.86 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 73.23 111.116 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -111.13 127.91 55.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.51 110.884 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.58 -172.49 4.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 72.15 111.175 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -172.83 135.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 74.11 110.899 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -120.95 89.63 46.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.742 . . . . 73.03 110.89 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.76 -7.89 22.2 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.661 2.241 . . . . 75.1 112.401 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.28 -150.08 19.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 75.14 112.527 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -96.53 139.12 33.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 75.41 110.886 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.0 -95.22 0.12 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 74.04 112.461 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -69.6 -24.44 63.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 73.32 110.982 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 p -151.4 -171.45 3.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 62.33 111.145 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.91 -8.4 57.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 75.24 110.89 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.581 ' HD2' ' HA ' ' A' ' 86' ' ' HIS . 3.7 p-10 -136.86 14.98 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.07 137.95 32.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 72.1 110.906 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.69 -179.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.114 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.12 126.58 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 72.31 111.16 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.9 t -85.96 122.94 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.35 111.094 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -110.7 133.05 53.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.91 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.01 98.65 50.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 74.34 110.978 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -4.02 13.14 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 62.22 112.339 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -83.36 -23.85 32.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.954 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.25 14.49 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 75.22 110.922 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.19 27.36 7.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 72.52 110.858 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.2 mt -92.54 129.87 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 71.13 111.166 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 23.0 tp -115.5 147.68 40.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 74.13 110.947 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 37.6 t -117.73 74.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 72.42 111.124 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.79 -41.49 51.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 74.35 112.534 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.49 -160.48 53.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.832 -0.699 . . . . 62.43 112.419 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 45.8 m -51.72 -30.1 21.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.368 . . . . 71.22 110.893 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.83 -32.49 67.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 70.4 110.947 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.1 t -105.98 109.73 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 72.24 111.16 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -51.54 161.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 73.35 110.884 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.86 168.62 9.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 73.13 110.907 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -62.14 146.85 49.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 73.42 111.107 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 m 65.7 20.78 11.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 70.14 110.882 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.81 153.84 40.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 73.4 111.165 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -118.8 -16.82 9.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.946 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.95 176.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.853 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.7 mt -83.39 -38.56 21.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 73.1 110.942 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 105.96 -152.41 17.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 75.41 112.514 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -57.41 107.38 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.902 0.382 . . . . 74.32 110.879 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.2 m -96.84 24.49 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 75.51 111.097 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -69.36 -27.82 65.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 74.44 111.087 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -114.1 24.94 11.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 75.31 110.81 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -141.73 164.86 29.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 75.15 111.047 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.61 91.91 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 74.01 110.932 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.49 -21.31 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 72.03 111.088 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.41 -21.71 60.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 75.41 110.82 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -114.93 -12.9 11.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 75.41 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.73 -62.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 73.41 110.897 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.5 -23.63 17.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.865 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 58.0 m -80.66 -33.31 35.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 73.31 111.155 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -43.75 62.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 72.11 110.885 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.1 mm -59.56 -47.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 74.12 111.143 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.41 -27.78 62.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 64.01 110.852 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -77.43 -20.69 54.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 74.42 110.86 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.4 t -86.57 -13.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 65.33 111.156 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -108.38 -16.55 14.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.867 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -30.6 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.44 110.849 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 -50.4 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 74.33 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.84 66.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 73.31 110.847 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.3 mtm-85 -72.91 -59.78 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 74.14 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -51.63 107.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 72.32 110.9 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 85.0 mt -146.61 122.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 74.34 111.12 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.93 -32.13 45.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.863 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -161.72 147.62 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 64.35 111.09 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.47 126.74 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 62.23 111.108 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.0 t -103.29 104.07 38.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.565 0.697 . . . . 64.25 111.166 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -174.78 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.784 2.323 . . . . 64.23 112.33 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.1 75.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.786 . . . . 54.33 112.548 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.33 140.64 20.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 71.33 110.86 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.6 -117.26 4.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 73.31 112.397 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -157.02 149.14 22.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 65.2 110.916 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.55 137.6 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 71.23 111.115 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -135.03 -88.58 0.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 60.11 112.469 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -171.65 -168.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.963 0.411 . . . . 65.15 110.829 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -61.73 -17.26 55.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 72.43 110.92 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.81 -19.93 38.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 70.34 112.46 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.7 mt -77.4 -47.13 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 73.31 110.82 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.72 -54.61 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 75.44 110.978 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.72 -21.24 62.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.01 110.913 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -37.65 76.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 71.43 110.889 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 m -55.39 -54.88 38.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 72.3 111.15 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.88 -19.87 53.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 74.14 110.897 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -83.58 -5.17 59.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.897 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 mt -129.14 -4.56 4.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 71.14 110.869 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.77 -0.19 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 74.14 110.961 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.098 -0.501 . . . . 72.13 110.988 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.841 0.353 . . . . 73.11 110.898 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -99.41 162.77 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 64.51 110.937 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 165.87 26.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 65.43 110.815 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.3 m -93.28 -179.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 55.22 111.118 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -137.24 72.39 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 71.33 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -136.64 169.24 18.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 73.12 110.926 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -88.47 -51.98 5.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 64.41 111.159 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 m -59.13 -175.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.31 111.182 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 mt -136.43 92.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 74.34 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -113.79 115.09 27.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.493 . . . . 74.23 110.909 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -58.96 168.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 63.43 110.874 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -51.3 -47.79 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.42 110.912 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 34.5 p -61.24 -37.45 83.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 73.54 111.075 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.66 14.13 61.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.746 . . . . 72.52 112.527 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.3 m -80.14 -44.34 20.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.308 . . . . 61.42 111.118 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.54 114.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 71.52 111.14 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -121.55 127.52 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.838 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.97 112.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 74.5 111.13 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.5 t -99.05 125.97 44.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 63.1 110.84 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -69.83 111.3 5.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.872 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.17 -32.69 74.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.907 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.449 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -152.04 -96.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.52 110.977 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.449 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.33 9.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.13 110.947 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.402 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.84 7.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.911 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.99 141.9 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.42 111.183 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 18.8 m95 -130.04 -177.81 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.94 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.7 t -133.4 91.76 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.311 -0.404 . . . . 63.12 111.191 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -75.16 123.55 25.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 70.3 110.824 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.5 m -120.33 104.24 9.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 52.12 111.212 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 124.34 31.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 73.54 110.824 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.5 113.77 23.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 74.15 110.938 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.77 -145.41 10.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 64.44 112.477 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.91 119.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 74.02 110.92 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -144.84 136.23 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 72.42 110.957 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 50.48 27.75 3.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 71.43 110.919 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 41.92 23.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.661 -0.781 . . . . 71.23 112.473 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -147.73 130.82 16.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.36 . . . . 72.2 110.818 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.02 149.09 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 63.53 111.081 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -139.41 79.65 24.55 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.713 0.768 . . . . 75.22 111.163 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.65 117.43 5.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.735 2.29 . . . . 75.32 112.394 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -109.41 97.4 6.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 70.11 110.792 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -58.25 166.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 73.44 110.892 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.05 -149.39 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 64.42 112.477 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.5 tp -158.28 119.31 3.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 75.1 110.917 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.6 t -103.16 122.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 74.41 111.07 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.5 mt -100.42 120.74 40.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.963 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.47 84.67 5.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 74.04 110.893 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -99.54 -176.53 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.169 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 -26.47 13.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.2 110.886 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -18.7 55.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 73.25 110.86 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.17 151.47 5.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 61.11 112.479 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.9 mt -62.94 154.8 29.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.339 . . . . 73.23 110.839 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.22 141.27 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 72.1 111.131 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.55 121.82 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 74.02 110.891 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 79.8 t -68.24 111.97 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.14 111.054 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.8 129.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 74.23 110.792 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -167.14 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.917 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.3 t -91.24 170.53 9.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 73.35 110.864 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -51.07 -60.28 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 72.31 110.91 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.02 159.26 35.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.258 -0.428 . . . . 61.51 110.876 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.656 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 73.1 m-20 -51.44 -32.8 28.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.872 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -58.57 -44.13 89.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 73.2 110.918 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.4 mt -75.53 -45.5 37.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 75.55 110.96 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.6 -48.52 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 75.44 111.14 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -53.54 -48.4 69.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.931 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -65.61 -18.97 65.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.47 . . . . 71.02 110.9 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 tp -88.62 -27.1 21.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 74.53 110.936 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.2 mt -90.47 -23.01 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 72.31 111.105 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -92.81 17.32 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 73.43 110.895 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.8 ptm -131.95 -39.89 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 62.34 110.867 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.4 m -80.18 -24.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 75.35 111.205 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.663 ' HE2' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.37 -23.14 66.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 65.11 110.929 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 -32.14 7.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 65.22 110.946 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -40.93 67.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.41 110.953 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -89.43 -12.12 41.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.53 110.923 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.34 11.71 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 63.41 110.861 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.8 141.4 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 72.13 110.936 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -86.2 140.99 29.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.275 -0.421 . . . . 74.13 110.846 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.663 HG21 ' HE2' ' A' ' 72' ' ' GLU . 85.0 t -82.07 126.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.4 111.137 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -142.46 13.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -153.75 144.74 22.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 71.45 110.874 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 t -154.31 132.61 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 75.51 111.167 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.9 mt -92.58 126.72 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 72.3 111.097 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -102.85 136.32 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.21 111.066 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 -44.59 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.13 111.265 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -152.46 174.94 13.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.901 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.65 88.9 5.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 72.13 111.061 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.95 156.04 43.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 75.21 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -21.72 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.43 111.04 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 20.49 7.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 62.22 110.883 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -140.62 -75.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.99 8.14 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 70.41 111.074 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -36.56 28.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 63.44 112.46 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.03 15.26 51.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 65.41 112.534 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 tt -56.57 -29.98 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 75.34 111.087 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.656 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -55.97 -30.67 62.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.23 110.86 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -90.0 -11.81 40.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 71.45 111.166 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.4 mt -91.01 -28.77 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.971 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -100.03 22.21 11.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.916 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -121.7 -36.51 3.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.32 110.932 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -87.41 -53.94 4.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.088 -0.505 . . . . 73.03 110.894 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.1 38.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 64.52 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.25 124.36 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.35 . . . . 74.41 111.132 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -89.79 118.44 29.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 65.04 110.894 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.9 92.05 8.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.42 111.113 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -66.29 144.03 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 75.51 110.751 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.38 -174.19 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 72.3 110.857 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.97 155.37 16.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 74.21 111.144 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.62 -39.98 37.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.12 111.16 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.0 -43.45 87.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.934 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 93.5 m -58.77 -21.61 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 72.34 111.098 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.43 12.26 37.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.33 111.138 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -25.81 9.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 74.44 110.943 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.98 -7.61 20.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 71.04 110.961 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.02 64.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.23 111.093 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -21.69 52.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 75.4 110.843 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -31.32 72.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 54.32 110.904 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -90.22 -25.62 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.895 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 25.42 2.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 74.44 112.488 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.42 170.6 7.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 74.54 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.54 179.0 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.524 . . . . 74.35 110.912 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -111.34 106.09 57.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.729 . . . . 73.31 110.938 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 178.42 4.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.699 2.266 . . . . 73.14 112.361 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.0 mt -53.3 -47.44 69.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.915 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.17 27.82 24.51 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 72.31 112.487 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.845 0.355 . . . . 71.3 110.881 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.4 mt -113.76 -175.32 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 74.24 110.901 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.16 -171.64 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.964 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.1 m -50.86 -70.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 73.23 111.222 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.1 t -118.58 102.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 74.22 111.12 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -132.25 169.12 16.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.151 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.27 132.84 56.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 75.53 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 50.2 mt -119.41 157.84 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 75.22 110.889 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -142.62 112.31 6.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 62.35 110.908 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -107.65 47.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 70.53 110.835 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.74 92.73 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 72.3 112.469 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.65 13.6 9.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 75.23 110.825 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.1 tpp -136.48 93.51 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.933 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -83.68 132.09 34.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.2 t -137.25 117.74 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 74.14 111.176 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -110.16 126.99 54.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 73.45 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.4 p -83.38 -174.05 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 75.32 111.126 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -171.82 133.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.877 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -120.43 88.53 42.62 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.662 0.744 . . . . 74.32 110.937 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -7.93 22.3 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 72.24 112.333 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.2 -158.25 23.07 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 74.42 112.441 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -90.17 139.34 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 74.42 110.812 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.67 -95.56 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.727 -0.749 . . . . 73.51 112.435 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -70.36 -24.17 62.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 75.13 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.3 p -151.7 -175.24 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 75.25 111.111 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.77 -2.34 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 60.53 110.841 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -140.21 11.45 2.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 61.12 110.906 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.65 141.38 20.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 75.34 110.892 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.67 -178.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 73.05 111.106 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.77 120.1 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 75.21 111.198 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.25 133.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.161 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -118.69 131.34 56.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 74.45 110.987 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.4 mt -112.8 98.83 46.25 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.595 0.712 . . . . 74.1 110.917 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -4.26 13.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.279 . . . . 73.54 112.336 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -83.08 -23.8 32.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 73.54 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.82 14.05 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.95 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.4 m120 54.21 27.15 7.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 75.43 111.006 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.1 mt -91.98 136.66 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 74.23 111.111 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 26.6 tp -121.96 147.75 45.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 71.42 110.992 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.33 76.47 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 74.35 111.078 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.59 -40.77 48.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 71.11 112.556 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 71.6 -162.82 54.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 62.3 112.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 78.6 m -51.46 -33.1 29.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.77 0.319 . . . . 73.54 110.777 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.4 tp -51.63 -44.56 62.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 74.14 110.945 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.08 111.6 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.44 111.061 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -55.31 164.85 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.864 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.9 p -114.98 170.33 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.14 110.835 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.3 t -59.89 153.75 20.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 73.43 111.088 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.9 16.88 10.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 54.42 110.817 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -79.61 153.55 29.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.54 111.036 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -116.79 -22.21 8.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 74.03 110.92 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 179.01 173.36 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.83 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.7 mt -71.86 -31.72 66.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 72.34 110.933 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 66.39 114.35 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 54.43 112.538 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 59.56 102.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.93 0.395 . . . . 74.02 110.923 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 29.5 m -114.04 13.93 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 74.43 111.163 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.42 88.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 75.12 111.15 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -90.04 10.59 23.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 75.15 110.898 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.79 165.0 20.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 40.12 111.073 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -119.73 91.75 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 73.41 110.961 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.6 -19.07 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.15 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.78 -20.89 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.893 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -116.81 -16.18 10.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 72.22 110.85 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -55.0 -61.41 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.2 -0.455 . . . . 74.4 110.906 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -24.64 19.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.858 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -80.72 -31.97 35.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 74.15 111.065 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -45.45 49.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 64.43 110.848 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.6 mm -59.11 -47.63 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 75.41 111.087 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.33 -28.65 59.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.879 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -77.31 -22.48 51.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.3 110.848 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.37 -10.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 62.03 111.154 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.96 -10.28 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 71.22 110.936 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.8 -30.43 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 73.11 110.845 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 -45.73 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 72.14 110.835 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.41 37.06 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.41 110.93 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.61 -48.06 75.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 73.22 110.914 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -61.2 102.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.948 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 52.3 mt -144.86 126.53 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 75.03 111.139 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.75 -22.71 34.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 72.13 110.908 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.74 125.31 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 75.32 111.083 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 92.5 t -104.22 137.23 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 75.53 111.051 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.6 t -110.8 108.44 57.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.573 0.701 . . . . 73.15 111.146 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 173.33 11.17 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.66 2.24 . . . . 72.53 112.301 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.52 -13.81 74.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.602 -0.809 . . . . 64.34 112.525 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -152.61 147.6 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 72.13 110.785 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 99.47 -113.94 4.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 71.34 112.476 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -156.58 168.6 26.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 61.23 110.875 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.34 163.27 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.31 111.135 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.99 -104.72 0.2 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 72.32 112.492 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.95 -169.6 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.34 . . . . 62.51 110.874 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -59.81 -19.19 49.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 71.41 110.89 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.04 -22.69 36.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.74 . . . . 72.42 112.471 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 5.0 mt -72.56 -32.73 66.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 73.4 110.919 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.7 mp -62.03 -59.98 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 71.44 110.924 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -20.66 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.912 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.26 -37.69 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 64.15 110.902 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.1 m -58.44 -51.62 69.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 74.1 111.126 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.5 mp -68.77 -16.71 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 71.22 110.972 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.86 -11.07 59.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 74.01 110.864 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.3 mt -121.24 -31.76 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 71.04 110.991 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.6 8.24 37.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 75.31 110.953 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 73.3 110.868 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.811 0.339 . . . . 75.03 110.855 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.88 155.94 30.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 74.52 110.926 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -144.7 167.9 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 71.3 110.882 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.35 169.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.1 111.137 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -155.57 129.63 8.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.51 110.858 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -66.99 176.55 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.913 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -70.51 -40.77 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 60.12 111.19 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.57 -177.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 75.0 111.101 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.02 92.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 72.31 111.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.27 119.46 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.894 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -61.87 168.47 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 72.42 110.861 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.85 -47.9 64.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.804 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.77 -37.75 82.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 74.1 111.079 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.04 12.72 61.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 50.45 112.539 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -80.39 -44.1 19.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 75.11 111.179 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -102.57 116.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.45 111.09 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.4 p -123.89 131.75 53.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 64.5 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.16 109.95 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 74.22 111.066 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.2 t -101.01 125.25 47.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.745 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.72 110.93 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 70.12 110.899 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.7 mt -65.41 -31.86 73.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 73.51 110.926 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.47 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.71 -97.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 73.44 110.879 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.3 OUTLIER -151.47 9.89 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.897 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.58 6.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 71.53 110.931 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.2 t -151.09 139.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 70.4 111.138 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -126.92 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.864 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.69 96.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 72.55 111.213 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -81.27 120.66 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 75.2 110.876 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -115.78 100.99 8.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 72.01 111.205 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.16 121.51 26.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 73.53 110.912 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.29 107.04 18.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 73.54 110.928 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -127.97 1.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 73.2 112.501 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 p -175.17 116.18 0.16 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 73.03 110.858 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.15 41.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.807 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 64.48 67.96 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.15 110.859 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.39 -15.57 42.33 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.791 -0.719 . . . . 72.55 112.425 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -121.52 159.15 26.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.373 . . . . 74.02 110.825 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.25 134.29 41.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 74.32 111.136 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.15 79.61 59.04 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.587 0.708 . . . . 64.4 111.007 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 118.24 5.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.264 . . . . 73.35 112.295 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.83 99.89 9.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 72.1 110.871 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -52.56 170.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.45 110.812 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.55 -164.01 16.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.416 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 tp -153.04 114.16 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 74.12 110.902 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.28 116.8 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.02 111.113 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.5 mt -94.86 120.83 35.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 71.43 110.965 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.66 83.21 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.12 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.5 p -90.77 -178.5 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 72.34 111.126 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -105.26 -1.15 25.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 55.34 110.777 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -23.14 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 75.41 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.57 144.42 4.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 62.33 112.471 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.51 154.54 17.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 71.32 110.93 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 t -145.11 142.94 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 73.42 111.122 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -137.51 123.12 19.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 73.43 110.835 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.78 112.72 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 75.14 111.107 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.65 129.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.03 110.94 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.18 -167.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.854 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -92.34 170.27 9.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 63.43 110.853 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -50.34 -60.26 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.873 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -128.93 160.56 32.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 64.23 110.854 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -52.72 -31.24 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 72.15 110.864 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -59.82 -43.52 94.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 72.24 110.88 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.47 -45.85 36.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 71.0 110.947 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -47.11 63.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 73.42 111.169 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -50.98 61.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 74.2 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.37 -19.87 65.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.86 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 tp -87.45 -26.16 23.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 74.12 110.871 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.6 mt -90.87 -23.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 75.22 111.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.69 16.5 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.882 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.85 -39.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.34 110.783 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.416 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 33.9 m -80.85 -23.76 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 74.32 111.158 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.641 ' HE2' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.01 -23.43 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.51 110.866 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -106.8 -33.57 7.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 75.51 110.906 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -70.58 -44.12 68.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 72.31 110.783 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -86.59 -12.8 47.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 74.52 110.907 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.43 11.75 8.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 53.34 110.89 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.95 141.1 50.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 73.42 110.894 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.41 140.4 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 74.43 110.883 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.641 HG21 ' HE2' ' A' ' 72' ' ' GLU . 86.3 t -81.95 121.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 73.44 111.111 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.78 9.65 2.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 63.34 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -148.86 145.02 27.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.87 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.3 t -154.14 131.47 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 73.13 111.125 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.6 mt -94.66 123.49 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 74.4 111.077 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.7 mm -94.58 150.33 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 64.42 111.119 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 p -109.31 -40.82 4.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 72.33 111.149 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.62 -178.53 7.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 62.41 110.844 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -98.89 96.87 8.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 75.22 111.186 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -155.72 154.84 32.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 63.23 110.866 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.22 -20.59 28.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.3 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.92 16.25 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 74.25 110.838 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.02 -76.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 74.24 110.832 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.79 8.39 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.135 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.9 -36.38 33.66 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.698 -0.763 . . . . 73.43 112.476 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.24 16.16 49.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 64.2 112.401 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -58.16 -23.29 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 75.34 111.077 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -30.08 68.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.919 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.5 m -88.97 -19.92 25.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 62.41 111.1 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.0 mt -82.79 -32.44 27.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 74.42 110.892 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -95.15 23.76 5.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -122.13 -41.45 2.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 74.13 110.999 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -83.03 -49.8 9.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.805 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.45 39.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 52.43 112.479 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.69 120.0 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 72.11 111.159 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -83.35 118.68 23.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.35 110.92 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.42 92.82 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.51 111.127 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -64.98 143.3 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 73.24 110.841 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.49 -179.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.908 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.99 153.92 19.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 74.25 111.195 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.68 -35.1 13.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 74.02 111.105 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -47.76 64.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 74.51 110.92 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.9 m -59.42 -18.61 40.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 73.53 111.081 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.57 11.4 39.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 74.1 111.049 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -113.91 -31.76 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 71.25 110.889 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.49 -13.33 27.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.866 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.049 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -24.95 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 75.4 110.928 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.59 -32.61 70.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 74.05 110.849 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -89.54 -24.82 21.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.897 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.24 23.16 3.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 70.12 112.484 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -98.38 177.59 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 75.03 110.973 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -76.34 178.99 6.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 72.03 110.885 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mp0 -112.58 105.66 55.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.609 0.718 . . . . 64.31 110.867 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.9 Cg_endo -69.82 178.68 4.37 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.709 2.273 . . . . 74.25 112.327 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.1 mt -51.3 -48.34 62.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.52 110.862 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.09 38.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 74.04 112.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -107.11 41.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 75.34 110.9 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -124.93 -173.81 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 72.42 110.879 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.01 -172.92 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 73.34 110.842 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.6 m -50.58 -71.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 74.32 111.161 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.2 t -113.51 94.35 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 71.03 111.18 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.3 t -118.36 167.0 11.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 73.34 111.066 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.51 106.83 10.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 60.12 110.877 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 28.8 mt -79.72 -173.21 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.939 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.04 112.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 73.52 110.944 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -110.49 74.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 74.34 110.83 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.51 -83.06 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 62.42 112.505 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -120.29 24.85 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.3 . . . . 64.44 110.893 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.4 tpp -129.48 142.55 50.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.909 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.32 133.28 56.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 73.54 110.827 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.5 t -144.97 117.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 74.5 111.117 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -112.5 126.55 55.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 62.32 110.919 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 p -82.69 -178.19 7.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.183 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -166.49 134.06 2.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 73.13 110.929 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -121.06 89.31 46.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.723 0.773 . . . . 75.44 110.971 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -8.12 22.8 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.706 2.27 . . . . 71.31 112.374 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.53 -157.67 20.38 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 73.34 112.495 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -84.66 137.69 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.724 0.297 . . . . 75.42 110.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.33 -89.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 63.54 112.516 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -75.1 -25.64 58.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 75.2 110.843 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 29.9 p -147.32 -162.26 1.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.162 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -84.53 -25.42 28.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 71.23 110.886 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.8 24.05 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 72.01 110.961 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.41 128.06 18.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 62.4 110.88 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.6 pt -135.12 173.0 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 75.22 111.074 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.8 m -124.42 150.0 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.41 111.076 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.87 111.77 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.15 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -101.28 132.83 46.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 6.3 mp -112.22 97.64 39.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 72.42 110.91 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.81 -4.86 14.91 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.619 2.212 . . . . 64.4 112.373 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.55 -26.56 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 75.52 110.958 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.53 19.14 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 75.32 111.005 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 50.51 29.28 3.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.524 . . . . 62.41 110.941 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.64 120.01 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.117 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 34.3 tp -104.53 147.15 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 61.23 110.882 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.53 79.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 71.52 111.136 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.84 -49.81 46.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.734 -0.745 . . . . 65.22 112.456 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.32 -166.29 53.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 44.14 112.436 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -35.38 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 75.2 110.838 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 23.5 tp -51.59 -52.19 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 71.04 110.967 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.02 109.44 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 75.12 111.161 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -51.86 148.12 6.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.872 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 153.97 17.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 72.25 110.872 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.8 t -51.23 -28.95 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 71.34 111.08 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 27.6 m -93.49 41.39 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.88 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -137.28 150.95 48.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 70.21 111.108 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.6 tttp -130.29 10.73 5.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 72.32 110.897 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.53 156.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.867 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mt -67.71 -36.9 81.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 75.24 110.957 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.97 -137.39 13.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.736 . . . . 74.21 112.58 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.34 110.75 3.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.366 . . . . 63.42 110.915 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.4 m -109.7 28.76 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 71.14 111.186 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.22 -30.01 70.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 75.0 111.081 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -116.8 22.15 12.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 75.05 110.827 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.66 155.3 46.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 74.05 111.057 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.24 87.06 2.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.33 110.947 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.2 t -60.78 -18.18 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 61.45 111.141 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -74.28 -28.09 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 71.55 110.814 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.59 -12.34 14.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 52.31 110.796 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -53.28 -62.0 1.93 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.857 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.17 -24.09 16.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 71.21 110.831 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -82.39 -30.93 29.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 71.53 111.141 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -43.27 58.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 74.01 110.782 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 28.9 mm -62.95 -43.0 98.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 75.2 111.172 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.44 -22.5 54.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.907 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -82.74 -22.4 34.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 74.21 110.94 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.14 -9.77 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 73.24 111.198 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.73 -12.49 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.933 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -100.51 -31.22 11.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 75.55 110.94 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.63 -49.28 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 73.32 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -95.81 60.73 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.926 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -71.28 -64.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.478 . . . . 74.03 110.819 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -51.49 104.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.916 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 89.9 mt -142.77 124.8 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.072 -0.513 . . . . 72.43 111.183 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -34.85 50.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.999 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.28 129.91 1.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 71.43 111.085 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 95.5 t -103.52 133.58 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 73.23 111.181 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.5 t -109.58 106.92 59.06 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.604 0.716 . . . . 72.45 111.029 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 -168.61 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.679 2.253 . . . . 72.3 112.361 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.84 -13.43 57.94 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.68 -0.772 . . . . 72.04 112.574 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -152.32 138.52 18.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.853 0.358 . . . . 74.52 110.829 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.94 -106.41 2.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 74.35 112.539 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -167.47 162.12 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 71.24 110.923 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.5 m -52.74 161.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.12 111.202 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.66 -98.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 64.42 112.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -169.01 -168.86 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.868 0.366 . . . . 75.11 110.937 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -61.69 -17.36 55.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.4 110.889 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.36 -19.21 39.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 63.22 112.463 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.04 -32.92 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.859 0.361 . . . . 72.03 110.871 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.18 -58.52 6.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 62.32 110.986 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.02 -18.16 56.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.45 110.913 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -65.15 -51.42 61.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.861 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.7 m -52.22 -49.91 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 72.25 111.196 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.42 -18.31 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 65.53 110.932 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -92.1 -2.67 56.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 63.12 110.816 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.9 mt -126.25 -5.98 6.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 73.21 110.962 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.92 2.46 11.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.913 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 73.51 110.862 179.85 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.875 0.369 . . . . 73.34 110.871 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -117.48 85.12 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 62.02 110.895 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -126.19 93.48 3.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 72.13 110.895 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.74 147.37 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.53 111.135 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -151.04 137.97 19.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 72.14 110.987 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -114.14 172.43 7.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 72.53 110.858 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 m -73.5 -53.65 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 73.32 111.157 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.47 -176.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 71.33 111.104 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.9 mt -136.2 91.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 73.51 111.177 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 116.39 30.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.909 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -59.82 168.15 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.889 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.7 -47.9 63.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 65.12 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.8 p -60.68 -37.68 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 74.44 111.172 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.77 13.15 61.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.674 -0.774 . . . . 54.22 112.505 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -80.36 -43.96 20.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 75.15 111.108 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -102.95 116.54 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 73.23 111.135 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 71.35 110.851 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.87 112.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 63.43 111.087 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.7 t -98.82 125.66 44.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 64.21 110.82 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -68.6 110.57 4.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.94 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.83 -31.35 72.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.33 110.971 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.449 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -153.48 -96.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 75.1 110.889 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.449 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.44 9.66 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 72.42 110.929 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.402 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.77 7.74 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 61.4 110.883 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.74 143.27 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 74.15 111.094 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -131.02 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 64.23 110.959 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.7 t -135.43 89.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 73.45 111.19 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -72.27 121.66 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 73.04 110.871 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.4 m -119.62 104.67 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 63.32 111.143 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.497 ' HE2' ' C ' ' A' ' 63' ' ' LEU . 2.7 mm-40 -87.59 125.78 34.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.944 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 110.39 21.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.878 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.53 -125.62 1.34 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.702 -0.761 . . . . 72.13 112.468 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 p -175.07 116.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.949 0.404 . . . . 74.01 110.835 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.49 43.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 72.15 110.826 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 63.73 69.34 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 74.42 110.8 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.43 -17.37 40.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 61.54 112.528 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -118.27 -176.16 3.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.895 0.378 . . . . 74.12 110.922 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.6 145.48 37.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 71.24 111.131 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.72 79.5 58.5 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.614 0.721 . . . . 72.3 111.177 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 117.87 5.34 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.683 2.255 . . . . 75.14 112.31 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 p -109.67 97.63 7.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 42.31 110.811 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -63.22 164.62 8.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 75.13 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.99 -144.81 4.0 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.69 -0.767 . . . . 74.25 112.466 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.4 tp -158.81 120.12 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 73.54 110.862 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -105.29 122.29 58.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.126 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 16.0 mt -102.14 121.01 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 73.02 110.944 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.63 85.08 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 74.04 110.831 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.14 173.01 8.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 75.12 111.149 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.25 4.26 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 73.42 110.817 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 -20.58 9.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 72.41 110.91 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.31 138.36 2.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 73.1 112.5 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.9 mt -54.63 157.63 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 71.41 110.896 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 19.0 t -145.32 141.0 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 74.14 111.112 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.61 124.16 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.42 110.945 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.57 107.66 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 74.41 111.034 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.407 ' HD2' ' CG2' ' A' ' 85' ' ' THR . 1.5 m-20 71.51 134.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 62.21 110.927 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -165.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 74.23 110.806 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 t -92.37 175.01 7.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.41 110.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -51.27 -60.41 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.918 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -132.55 161.71 33.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.24 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.675 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 64.4 m-20 -51.77 -33.47 35.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 54.1 110.854 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -59.03 -33.76 71.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.897 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.497 ' C ' ' HE2' ' A' ' 30' ' ' GLU . 92.4 mt -89.25 -45.73 9.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.903 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 m -50.8 -47.45 59.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 73.23 111.147 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -54.45 -47.48 72.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.872 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.31 -19.4 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.863 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.5 tp -88.4 -27.96 21.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 71.51 110.881 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.5 mt -89.41 -22.99 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.35 111.12 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.88 16.84 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptm -131.01 -39.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 73.42 110.899 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.95 -24.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 61.34 111.071 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.653 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.85 -21.86 66.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 74.11 110.861 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -109.49 -32.31 7.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.898 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -72.18 -41.95 66.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.826 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -88.05 -12.35 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.855 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.37 13.73 8.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.43 110.983 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.15 140.14 46.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 75.33 110.863 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -86.1 140.45 30.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.885 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.653 HG22 ' HE2' ' A' ' 72' ' ' GLU . 99.4 t -80.07 122.3 35.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.12 111.11 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -136.67 8.16 3.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 65.24 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.28 136.08 17.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 73.24 110.927 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.0 t -147.68 127.75 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 72.22 111.09 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.4 mt -93.49 122.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 73.21 111.132 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.3 mm -94.33 140.18 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 73.14 111.144 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.407 ' CG2' ' HD2' ' A' ' 56' ' ' ASP . 65.9 p -86.86 -55.83 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 64.31 111.12 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -152.15 -175.2 5.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.419 . . . . 74.51 110.96 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.21 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.42 111.054 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.72 149.84 22.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.3 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.45 -19.53 24.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 75.14 111.143 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.5 9.76 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.13 -77.27 0.52 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.81 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.71 8.14 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 64.23 111.048 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.39 -41.5 40.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 74.55 112.438 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 14.46 56.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.746 . . . . 74.52 112.498 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 tt -51.7 -29.92 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 74.5 111.139 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.675 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -54.43 -35.56 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 73.3 110.87 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -79.94 -23.99 41.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.31 111.161 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.93 -28.25 30.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.989 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -94.04 19.47 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.956 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -121.71 -45.51 2.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 71.13 110.846 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -74.35 -52.39 12.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 75.12 110.856 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.8 42.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.683 -0.77 . . . . 65.34 112.463 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.6 mp -106.31 128.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 70.34 111.23 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -84.19 105.86 15.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 74.23 110.937 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.02 92.83 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 73.12 111.205 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -69.65 146.14 51.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 73.23 110.886 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -174.26 179.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 74.22 110.901 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.45 154.27 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 64.12 111.07 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.11 40.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 52.5 111.081 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD13 ' HE2' ' A' ' 113' ' ' GLU . 0.9 OUTLIER -69.94 -41.18 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.91 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 99.8 m -58.44 -20.69 46.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.02 111.123 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.56 8.44 41.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 74.13 111.055 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.426 ' HE2' HD13 ' A' ' 110' ' ' LEU . 3.7 pt-20 -107.81 -31.56 7.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 73.52 110.838 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.09 -12.83 24.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 71.43 110.967 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.14 81.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 71.22 111.104 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.47 -24.45 59.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.927 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.52 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.898 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -90.29 -22.06 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 62.43 110.951 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.53 25.51 4.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.829 -0.7 . . . . 60.25 112.434 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.59 175.68 5.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.899 0.381 . . . . 74.13 110.935 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.83 162.17 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.951 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -94.89 108.4 37.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.57 0.7 . . . . 70.03 110.916 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.5 Cg_endo -69.71 -177.42 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.282 . . . . 60.05 112.363 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.8 mt -54.21 -54.46 39.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 62.23 110.878 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.52 73.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 62.14 112.428 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -99.03 33.54 2.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 74.44 110.848 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -116.65 -174.6 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.923 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 -170.45 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.871 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 48.5 m -50.49 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.43 111.21 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.22 93.56 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 70.55 111.1 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -113.05 164.97 12.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 72.11 111.116 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.18 102.96 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.907 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 28.4 mt -76.02 -173.06 2.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 74.12 110.918 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -171.31 110.23 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.843 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.92 -167.57 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 60.5 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -57.63 95.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.765 -0.731 . . . . 73.32 112.461 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 53.75 25.92 5.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.391 . . . . 73.21 110.912 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.4 tpp -129.19 140.03 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.47 135.91 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.53 110.912 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.72 116.88 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 73.44 111.179 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -112.88 126.58 55.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 63.2 110.893 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.8 p -83.39 174.27 10.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.127 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -158.78 137.61 11.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.937 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -127.82 89.31 51.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.738 0.78 . . . . 75.22 110.985 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 -7.61 21.47 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.671 2.247 . . . . 70.11 112.374 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.03 -150.17 19.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 52.44 112.484 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -95.24 141.1 29.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 72.54 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.43 -90.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 62.53 112.535 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -74.76 -23.05 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.332 . . . . 74.41 110.759 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 69.2 p -151.23 -171.39 3.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 64.01 111.177 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -84.94 -3.32 58.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 75.12 110.893 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -150.18 19.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 74.43 110.944 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.57 130.72 24.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.11 110.887 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.17 175.48 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 73.24 111.138 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.87 123.93 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.03 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.96 119.04 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.129 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -107.79 139.12 42.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 87.7 mt -119.79 99.73 49.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.63 0.728 . . . . 75.21 110.862 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -4.79 14.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.688 2.259 . . . . 74.41 112.289 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -84.78 -30.38 24.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.947 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -131.49 11.21 4.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 72.34 110.923 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.5 m120 55.05 26.0 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.846 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 86.8 mt -90.95 143.83 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.129 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.2 tp -125.54 145.43 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 62.33 110.916 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.17 81.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 63.22 111.219 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.44 -31.42 28.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.703 -0.76 . . . . 75.45 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 56.69 -168.63 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 63.32 112.453 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -29.68 20.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.336 . . . . 74.1 110.842 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.8 tp -55.65 -55.14 35.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 75.1 110.946 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.9 t -87.55 107.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 75.1 111.13 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -52.15 170.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.53 110.904 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.31 158.63 26.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 52.22 110.883 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 13.7 t -50.03 158.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.081 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.01 10.93 7.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 75.12 110.817 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -85.74 146.07 26.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 75.04 111.116 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.27 -16.81 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 74.12 110.862 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.68 158.54 7.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 74.14 110.919 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 9.7 mt -65.66 -31.97 73.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.182 -0.463 . . . . 75.1 110.978 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 100.05 -120.39 6.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 50.35 112.583 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.51 132.97 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 72.53 110.869 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 16.7 m -129.23 24.57 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.468 . . . . 73.43 111.153 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.04 80.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 74.23 111.045 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -112.84 25.17 11.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 75.31 110.875 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.12 164.96 23.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 75.51 111.108 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.35 92.39 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 74.23 110.982 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.0 t -63.46 -22.92 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 73.42 111.134 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -71.65 -31.3 66.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 73.45 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.29 -13.05 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.03 110.916 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -55.09 -62.56 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.918 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -24.51 16.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 61.35 110.829 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 57.7 m -80.39 -32.23 37.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 72.2 111.1 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -42.74 58.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.833 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.1 mm -62.91 -44.39 99.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.42 111.134 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.23 -22.89 53.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 54.3 110.807 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -82.45 -22.31 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 74.11 110.895 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 16.1 t -87.19 -8.89 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 75.41 111.064 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.5 -6.79 13.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 73.52 110.946 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.6 -31.19 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 72.13 110.897 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -104.22 -55.95 2.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 75.35 110.871 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -94.99 38.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 75.34 110.827 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -55.97 -47.71 77.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.889 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -59.97 101.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.03 110.951 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 mt -143.65 127.54 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 63.33 111.161 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.01 -23.13 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.934 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.04 132.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.073 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.79 132.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 75.12 111.163 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.7 t -110.35 109.33 58.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 75.2 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 178.02 4.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.658 2.239 . . . . 73.4 112.381 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.51 -18.86 74.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 71.21 112.486 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -152.83 141.67 21.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 74.54 110.879 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.49 -117.48 4.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 75.41 112.474 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -152.25 174.07 14.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 75.24 110.918 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.4 t -69.31 149.98 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 72.01 111.129 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.81 -101.47 0.31 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 72.13 112.515 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.25 -169.0 1.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 71.0 110.823 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -17.83 54.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 74.33 110.872 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.37 -20.11 43.14 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.772 -0.727 . . . . 73.34 112.41 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.2 mt -73.48 -30.07 62.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 74.1 110.921 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.12 -22.5 60.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.901 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.24 -44.67 95.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.12 110.826 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.5 m -56.48 -56.62 18.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 55.12 111.003 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.82 -28.86 24.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.432 . . . . 72.31 110.929 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -32.52 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.92 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.9 mt -88.39 -18.18 28.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.849 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.94 18.84 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.91 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 74.44 110.933 179.762 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.737 0.303 . . . . 61.32 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -116.2 89.52 3.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 65.33 110.952 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? 62.48 164.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.95 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.62 159.62 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.15 111.091 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.11 120.01 23.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 75.22 110.919 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -123.93 -171.07 2.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.071 -0.513 . . . . 75.52 110.926 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -115.66 -68.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 75.14 111.128 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -50.03 146.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 71.11 111.147 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.3 mt -110.73 98.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 74.35 111.166 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -118.17 115.39 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 75.43 110.879 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -60.57 166.41 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 71.42 110.897 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -51.45 -48.43 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 74.21 110.923 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 p -62.57 -36.97 84.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 62.44 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 13.9 63.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 34.31 112.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 m -78.84 -45.4 20.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 63.12 111.197 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mt -103.85 112.36 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 73.14 111.129 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -118.04 133.95 55.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.04 110.814 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.51 112.24 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 71.02 111.162 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -98.46 125.57 43.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.864 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -69.34 109.94 4.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 75.32 110.966 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -63.51 -32.69 74.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.94 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.446 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -152.58 -96.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 72.52 110.884 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' N ' HD21 ' A' ' 22' ' ' ASN . 10.0 mttp -150.24 9.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.873 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.401 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.75 8.17 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.861 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -150.89 141.82 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.086 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.403 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 18.9 m95 -130.21 -176.8 4.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 71.22 110.916 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.3 t -134.69 90.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 73.14 111.215 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -73.79 122.17 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 72.13 110.838 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.5 m -119.89 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.097 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.99 125.34 33.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 73.33 110.812 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.37 110.62 20.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 74.34 110.949 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.17 -146.19 7.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 71.35 112.478 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.81 120.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 73.21 110.826 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.22 136.34 24.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.923 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 50.58 27.71 3.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 70.24 110.912 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.4 42.11 23.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.783 -0.722 . . . . 51.1 112.483 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -147.65 130.26 15.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.371 . . . . 64.01 110.872 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.13 149.55 27.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 64.43 111.108 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.44 79.91 19.91 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.584 0.707 . . . . 64.45 111.149 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 117.67 5.23 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.736 2.291 . . . . 74.42 112.362 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.9 p -109.96 97.08 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 71.35 110.892 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -59.37 165.36 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 73.24 110.859 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -156.13 -148.89 5.19 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.712 -0.756 . . . . 62.45 112.437 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -158.49 118.34 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 74.01 110.909 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.4 t -103.16 122.31 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 74.13 111.084 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 14.4 mt -100.77 120.57 40.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.907 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -90.52 84.7 5.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.82 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -97.52 -175.32 3.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.33 111.194 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.4 -21.97 13.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 72.11 110.878 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -83.99 -15.73 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 74.43 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.4 150.25 5.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.815 -0.707 . . . . 73.23 112.539 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 mt -61.75 156.94 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.23 110.948 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 16.8 t -145.48 141.96 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 70.42 111.163 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.87 124.62 21.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 73.13 110.895 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.59 106.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.22 111.162 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 70.81 131.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 65.42 110.893 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -164.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 64.11 110.87 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -90.38 -179.85 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 61.1 110.876 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -57.86 -51.54 69.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.483 . . . . 75.12 110.937 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -139.69 161.81 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 60.43 110.77 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.04 -32.62 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.24 110.818 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -59.86 -42.53 93.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 75.22 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.01 -46.89 15.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.898 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.12 -45.74 53.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 75.01 111.121 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -54.78 -48.39 72.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 72.43 110.848 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.49 -19.82 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.945 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 tp -88.2 -27.04 22.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.872 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -90.59 -23.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.14 111.181 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.16 15.0 14.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.496 . . . . 74.32 110.953 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.7 ptm -129.83 -39.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 71.44 110.889 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 33.1 m -80.45 -22.76 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.14 111.153 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.42 -21.93 65.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.22 110.822 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -109.2 -32.37 7.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.92 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -37.64 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 75.41 110.837 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -92.58 -11.62 33.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 74.34 110.879 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.36 11.71 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.883 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.25 141.0 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 75.33 110.898 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -87.46 140.56 29.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 71.21 110.93 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.558 HG22 ' HE2' ' A' ' 72' ' ' GLU . 97.3 t -80.71 124.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 73.54 111.117 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -138.98 10.14 2.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 73.43 111.08 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.3 135.61 14.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 75.43 110.836 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 t -148.02 125.55 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 74.22 111.13 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.5 mt -91.28 124.59 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 75.13 111.097 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mm -95.99 138.71 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 74.04 111.154 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.6 p -84.45 -49.13 8.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 72.44 111.176 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -159.71 -175.37 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 60.01 110.932 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.58 98.36 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 64.34 111.071 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.32 149.61 24.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.857 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.46 30.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 72.52 111.055 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.04 10.04 28.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.882 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -129.83 -77.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 72.24 110.91 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 8.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.25 111.102 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.47 -41.75 41.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.703 -0.761 . . . . 75.21 112.494 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.9 12.71 62.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 71.43 112.374 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.8 tt -51.52 -28.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 62.42 111.132 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -38.26 64.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.834 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -79.86 -27.5 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.142 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.8 mt -75.05 -30.74 61.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 72.54 110.9 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -92.51 16.26 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 72.32 110.859 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -119.48 -48.23 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.816 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -72.73 -56.13 5.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.243 -0.435 . . . . 72.21 110.855 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.95 42.63 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.807 -0.711 . . . . 55.04 112.447 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.64 120.33 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.429 . . . . 74.41 111.17 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -78.1 109.76 12.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 74.33 110.911 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.63 101.25 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 74.13 111.054 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 64.0 110.91 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.64 -176.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.881 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 154.47 20.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 50.3 111.14 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.77 -40.65 55.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 72.41 111.068 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.95 -40.72 83.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.94 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.7 m -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 73.44 111.133 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.55 52.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 63.32 111.095 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.37 -59.23 1.74 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.13 110.893 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.39 -13.14 60.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.956 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.9 -43.43 92.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 65.04 111.072 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -26.3 63.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 74.42 110.895 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -55.2 -35.96 65.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 74.3 110.852 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -89.65 -20.85 23.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 72.45 110.872 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.85 21.75 5.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 73.25 112.401 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -94.65 170.46 9.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 74.52 110.883 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -70.83 -176.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 72.05 110.867 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -117.23 103.92 50.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 74.35 110.923 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.7 Cg_endo -69.8 -171.69 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.717 2.278 . . . . 74.32 112.391 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.39 -54.66 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 62.3 110.959 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.48 24.18 63.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.821 -0.704 . . . . 73.32 112.4 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 24.62 6.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 75.21 110.944 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.09 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.2 110.935 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.33 -170.28 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 54.22 110.885 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.8 m -49.93 -70.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 70.54 111.154 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.31 110.25 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.41 111.123 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -139.77 172.47 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 71.45 111.157 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 75.11 110.914 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 52.4 mt -115.34 167.35 10.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 74.11 110.898 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -147.64 137.09 22.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 73.24 110.93 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.19 40.47 3.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.898 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 93.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 74.14 112.4 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.38 14.12 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 65.31 110.877 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.5 tpp -138.39 100.9 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 75.02 110.874 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -90.69 137.84 32.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 72.41 110.781 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.67 117.42 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 74.03 111.099 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.96 129.17 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 74.22 110.942 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.8 p -85.54 -179.44 6.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 75.14 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -164.39 133.6 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.883 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -123.96 88.44 52.42 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.796 0.808 . . . . 75.42 110.95 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.569 2.179 . . . . 75.23 112.352 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.92 -144.88 16.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.802 -0.713 . . . . 74.0 112.504 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -101.5 141.64 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 72.31 110.901 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.45 -90.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.705 -0.759 . . . . 71.13 112.475 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -74.78 -23.43 58.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 73.3 110.858 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 65.5 p -150.57 -169.36 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 74.54 111.153 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -85.81 -12.94 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.871 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -138.61 20.93 2.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 63.1 110.911 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.77 130.38 24.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.3 110.897 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.19 169.04 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 73.41 111.125 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.7 m -127.32 122.52 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 74.14 111.176 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 80.5 t -75.72 131.76 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 73.03 111.148 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -117.54 130.07 56.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 75.54 110.826 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.8 mt -110.68 98.64 38.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 61.14 110.909 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -4.42 13.99 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.659 2.24 . . . . 60.13 112.336 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.21 -23.64 32.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 75.44 110.832 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -144.0 14.15 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 70.34 110.941 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.9 m120 54.26 26.79 7.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 74.51 110.844 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 97.4 mt -91.9 128.79 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 73.53 111.089 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.6 tp -113.49 145.92 40.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.887 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.62 83.64 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 71.21 111.175 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.51 -34.84 35.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.617 -0.801 . . . . 73.25 112.58 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.33 -167.92 26.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 73.3 112.531 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -29.65 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 63.15 110.813 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.8 tp -54.84 -61.82 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 73.42 110.933 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.2 t -78.33 110.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 55.45 111.168 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -51.8 169.02 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.941 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.53 146.4 42.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 74.32 110.857 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.04 156.68 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 75.52 111.245 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 t 70.29 11.08 7.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 74.04 110.831 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.544 ' H ' ' HE2' ' A' ' 221' ' ' HIS . . . -82.85 147.68 28.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 74.13 111.187 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -119.12 -12.22 9.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 73.31 110.821 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.93 155.82 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.875 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 11.2 mt -62.22 -45.23 94.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 70.41 110.912 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.35 119.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.842 -0.694 . . . . 74.3 112.448 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.08 104.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 72.31 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.9 m -131.97 27.53 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 74.22 111.08 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.47 -49.26 78.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 73.22 111.055 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.5 25.56 6.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.266 -0.425 . . . . 71.54 110.845 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.2 152.24 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 74.32 111.067 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -106.74 86.76 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.911 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.7 -19.64 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 73.4 111.127 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -73.3 -31.21 63.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 65.21 110.886 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -104.84 -11.62 16.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.953 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -55.0 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 73.3 110.846 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -24.71 16.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 61.51 110.865 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -81.08 -31.82 34.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 71.44 111.241 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -42.77 60.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 71.0 110.826 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mm -61.95 -44.69 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 71.31 111.106 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -58.44 -23.89 58.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 64.42 110.882 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -83.59 -22.19 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.766 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 5.4 t -87.61 -9.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 74.11 111.142 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -111.94 -8.4 14.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.958 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -104.09 -30.96 9.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 74.51 110.895 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.9 -52.27 2.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -97.24 37.78 1.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.95 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -56.46 -47.73 78.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 71.24 110.894 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -59.34 98.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 73.02 110.939 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.8 mt -140.23 127.89 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 71.5 111.18 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.18 -22.88 30.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.87 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.75 123.51 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.15 111.13 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 93.2 t -102.5 137.9 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 73.42 111.05 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.84 108.81 46.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.693 0.759 . . . . 45.52 111.129 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 179.21 3.82 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.664 2.242 . . . . 74.25 112.348 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.74 -13.58 82.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.761 -0.733 . . . . 60.42 112.532 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -152.89 138.1 17.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 74.23 110.854 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.74 -118.67 5.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 73.21 112.5 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -150.91 163.93 37.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 72.34 110.95 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.3 m -60.3 161.43 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 70.41 111.127 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.13 -93.09 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 54.33 112.389 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -174.83 -167.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 72.21 110.895 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -58.05 -20.26 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.932 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.35 -23.45 26.5 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.647 -0.787 . . . . 71.41 112.452 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.8 mt -75.97 -33.1 59.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.894 0.378 . . . . 74.43 110.944 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.58 -62.84 1.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.913 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -22.44 47.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.942 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.544 ' HE2' ' H ' ' A' ' 175' ' ' ALA . 1.7 t60 -61.69 -46.67 88.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.83 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.4 m -51.27 -53.31 36.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.45 111.116 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.77 -20.15 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 74.33 110.971 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.41 -4.32 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 72.13 110.868 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.2 mt -125.27 -7.2 7.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 72.15 110.875 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.67 10.26 11.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 73.01 110.91 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.965 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.787 0.327 . . . . 75.05 110.849 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -148.98 -65.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.929 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -154.22 154.79 34.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 75.55 110.879 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 m -103.14 155.2 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 75.14 111.117 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -145.35 143.41 30.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 72.1 110.864 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -81.93 -175.21 5.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.849 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 m -53.41 -55.94 20.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 64.15 111.145 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -59.12 -176.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 72.41 111.145 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.4 mt -136.31 92.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 74.3 111.115 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -111.52 118.07 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.891 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -58.37 -176.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.856 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.21 -45.34 73.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 64.12 110.851 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.4 p -61.9 -37.67 85.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.45 111.133 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.05 12.32 60.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 65.5 112.533 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -80.78 -43.32 20.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.74 0.305 . . . . 74.21 111.175 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.36 125.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 61.22 111.17 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -133.02 129.92 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.54 110.836 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mt -120.9 111.12 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.11 111.138 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.5 t -100.76 127.6 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 62.21 110.862 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -71.23 111.64 6.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 75.34 110.873 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 27.3 mt -65.19 -31.55 72.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 75.3 110.955 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.451 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.73 -97.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 62.13 110.908 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.7 OUTLIER -151.44 10.14 0.57 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.43 . . . . 73.12 110.975 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.51 6.37 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 64.51 110.856 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.84 139.46 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 74.54 111.126 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.5 m95 -127.23 -179.58 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 73.54 110.957 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.1 t -131.99 97.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 65.43 111.144 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.467 ' CE1' ' HE2' ' A' ' 30' ' ' GLU . 20.5 p80 -80.51 121.14 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 74.2 110.901 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -117.62 104.81 11.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.11 111.146 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HE2' ' CE1' ' A' ' 28' ' ' HIS . 5.3 mp0 -89.27 120.94 31.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 75.1 110.865 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -85.43 101.55 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 71.43 110.831 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.57 -39.43 95.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 72.01 112.448 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.78 103.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 75.42 110.842 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -88.51 46.65 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.911 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 60.56 67.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 65.04 110.931 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.38 -30.11 6.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.789 -0.719 . . . . 73.34 112.558 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -110.12 118.99 37.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.864 0.364 . . . . 73.04 110.875 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.3 118.02 11.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 74.33 111.182 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.51 73.32 1.99 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.613 0.72 . . . . 75.32 111.111 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 119.4 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.698 2.265 . . . . 72.05 112.417 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.1 p -99.76 96.92 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.866 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -49.51 159.8 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 65.25 110.845 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -155.65 -168.15 18.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.678 -0.772 . . . . 61.42 112.483 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.5 tp -152.49 113.56 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.354 . . . . 75.35 110.895 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.77 120.47 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.11 111.097 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.3 mt -97.78 115.95 29.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 73.33 110.903 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.42 87.44 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 60.52 110.92 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 179.8 4.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 61.3 111.17 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -100.28 -22.8 14.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 70.53 110.859 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -11.44 58.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 73.21 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.37 153.34 5.86 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.646 -0.787 . . . . 74.35 112.471 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 tp -67.25 155.04 39.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 75.42 110.957 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 t -145.91 142.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.43 111.104 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -137.07 125.48 23.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.32 110.879 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -71.21 112.18 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 75.31 111.114 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.405 ' HB2' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 72.64 132.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 65.45 110.921 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.36 -166.98 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 71.33 110.853 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.1 t -91.41 169.1 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 70.45 110.911 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -49.5 -60.57 2.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.994 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -125.44 165.18 18.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 72.45 110.833 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.24 -37.69 75.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 62.44 110.852 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.21 -33.74 67.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 83.7 mt -82.6 -47.2 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 74.34 110.956 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.61 -46.44 58.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.102 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.05 -49.63 65.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 72.31 110.89 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -64.76 -19.85 66.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.968 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 tp -87.8 -27.16 22.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 73.15 110.904 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.83 -23.13 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.081 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.69 16.0 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 64.33 110.901 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.87 -39.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 73.21 110.872 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 m -81.21 -22.43 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.112 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.711 ' HE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.89 -24.48 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 64.45 110.813 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -106.31 -34.24 7.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.471 . . . . 75.52 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -41.3 79.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.82 -10.75 38.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 65.31 110.886 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 67.52 11.97 8.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 73.23 110.875 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.93 137.62 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.856 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.74 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.2 110.875 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.711 HG23 ' HE2' ' A' ' 72' ' ' GLU . 80.0 t -76.26 121.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 75.22 111.146 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 t -135.68 7.78 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 75.44 111.118 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -150.8 145.03 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.14 110.877 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 t -154.53 132.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 73.1 111.189 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.19 125.84 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 73.22 111.158 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.35 147.7 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 74.32 111.215 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -98.16 -55.54 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 62.21 111.222 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -152.96 -175.16 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 74.21 110.812 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.01 97.46 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 74.24 111.139 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.18 150.13 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 71.21 110.792 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.38 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 75.52 111.046 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.12 23.6 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 64.02 110.791 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 56' ' ' ASP . 27.3 mmt180 -144.89 -76.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.51 110.912 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.12 7.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 75.03 111.113 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.74 -40.08 40.4 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 75.32 112.477 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.41 14.88 59.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 73.1 112.492 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.2 tt -55.45 -27.33 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.397 . . . . 73.51 111.125 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -54.91 -34.36 63.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 74.2 110.928 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -84.57 -22.7 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.54 111.138 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.7 mt -82.13 -28.67 32.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.915 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -96.92 22.22 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 74.53 110.952 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -122.63 -43.14 2.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 75.11 110.94 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -80.36 -52.78 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 70.52 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.79 43.96 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 41.22 112.534 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.07 118.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 74.25 111.159 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -77.77 111.33 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.51 110.915 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.84 90.91 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 72.32 111.077 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -62.47 143.15 57.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 73.22 110.905 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -173.96 176.7 2.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.908 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.33 157.92 19.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 73.32 111.16 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.89 -38.96 52.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 52.31 111.097 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.9 tp -73.63 -37.52 65.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.894 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.1 m -57.82 -29.36 64.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 73.42 111.115 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.88 0.21 57.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 65.14 111.058 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -99.25 -58.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 73.34 110.792 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.32 -12.27 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 73.21 110.925 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.1 -44.58 83.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 71.33 111.162 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -28.82 65.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.878 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -37.26 49.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 72.52 110.886 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -88.9 -21.89 23.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 54.1 110.854 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.89 20.63 5.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.734 -0.746 . . . . 71.23 112.491 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.56 172.07 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 72.15 110.974 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -70.92 -176.16 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 74.55 110.905 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.3 mt-10 -117.05 102.13 52.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.614 0.721 . . . . 72.34 110.849 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.2 Cg_endo -69.85 -176.22 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.621 2.214 . . . . 64.42 112.321 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.4 mt -51.84 -60.08 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.913 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.43 21.37 72.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 73.42 112.527 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -99.53 28.41 4.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 72.43 110.849 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.8 mt -109.52 -175.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 74.13 110.916 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.25 -170.77 3.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.937 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.8 m -50.79 -70.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.04 111.147 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.7 t -119.82 103.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 74.11 111.165 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -135.42 163.33 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 72.51 111.124 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.13 132.49 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.35 110.864 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 24.1 mt -115.08 167.2 11.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.939 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 133.5 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.12 110.941 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -134.2 49.09 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 65.32 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.19 92.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 62.24 112.539 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.89 14.59 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 75.32 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.0 tpp -134.13 110.31 9.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.832 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 131.14 44.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.34 117.33 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 74.44 111.064 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -110.75 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 75.35 110.887 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 p -86.62 177.29 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 62.11 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -159.3 134.78 8.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.45 110.865 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -124.41 87.23 54.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.648 0.737 . . . . 74.03 110.901 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -7.95 22.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.744 2.296 . . . . 64.32 112.313 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.68 -158.48 22.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 72.15 112.399 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -86.81 138.83 31.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 74.51 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.7 -87.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 54.33 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -78.39 -23.38 46.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 63.34 110.872 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.5 p -149.61 -165.62 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 63.15 111.153 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -86.08 -18.44 32.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 75.11 110.851 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -136.54 20.38 3.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 75.45 110.884 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.75 129.04 25.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 72.42 110.872 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.3 pt -135.8 176.47 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.23 111.177 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.49 123.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 74.44 111.13 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.25 122.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 73.34 111.137 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -109.24 132.18 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.41 . . . . 72.43 110.888 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 11.4 mt -112.9 97.98 43.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.52 0.676 . . . . 75.13 110.893 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.75 -4.84 14.83 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 75.11 112.31 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -82.66 -23.32 34.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 75.21 110.949 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 13.88 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.909 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.6 m120 54.49 27.92 8.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 64.33 110.912 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.1 mt -93.41 126.69 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 74.5 111.141 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 19.6 tp -110.61 147.31 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 75.13 110.967 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.28 78.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 64.44 111.181 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.31 -32.02 21.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.723 -0.751 . . . . 70.12 112.55 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 61.23 -160.44 27.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 71.32 112.508 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -28.38 64.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.863 0.363 . . . . 72.43 110.885 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 28.0 tp -56.26 -56.97 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 73.5 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 38.2 t -81.01 107.65 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 71.21 111.073 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -50.81 161.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.919 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.47 156.65 25.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 73.01 110.9 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.9 t -49.23 156.34 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 72.44 111.102 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.2 11.4 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 73.41 110.908 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -82.79 146.1 29.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 73.2 111.064 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -118.03 -16.56 9.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.852 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -177.86 168.55 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 74.33 110.89 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.96 -35.96 28.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 74.11 110.923 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 124.99 -157.65 19.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 71.44 112.485 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -79.59 -1.76 39.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 65.14 110.923 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 180' ' ' ASN . 27.6 m 36.56 45.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 74.32 111.106 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.56 -29.63 62.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 70.34 111.048 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -129.53 26.49 5.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.316 -0.402 . . . . 65.25 110.937 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.47 153.44 41.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 72.3 111.063 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -110.06 88.78 2.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 75.22 110.924 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.63 -17.47 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 75.24 111.195 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.74 -25.68 60.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 74.11 110.861 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -114.16 -11.95 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 63.22 110.85 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -55.1 -61.33 2.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.227 -0.442 . . . . 75.55 110.92 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -25.57 13.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 70.54 110.816 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -80.66 -32.68 36.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 75.44 111.14 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -42.3 65.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 63.44 110.881 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.52 -47.83 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 71.52 111.111 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -57.4 -28.57 63.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.919 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.71 -21.86 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.44 110.941 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 9.9 t -85.74 -11.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.02 111.144 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -111.28 -8.4 14.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.476 . . . . 75.52 110.938 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -30.49 10.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 63.45 110.955 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 -48.76 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.07 37.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.24 110.936 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -51.82 -48.58 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 71.32 110.848 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -60.08 105.1 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 75.24 110.936 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.5 mt -145.95 125.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 72.55 111.093 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -26.83 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 55.45 110.899 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.6 134.6 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 70.11 111.163 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 98.0 t -109.92 134.58 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 71.23 111.029 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.1 t -110.82 104.22 55.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 53.2 111.129 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 174.18 9.87 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.709 2.273 . . . . 75.23 112.36 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.6 -13.08 83.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 71.24 112.42 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -152.85 150.17 29.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 73.42 110.799 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.59 -99.67 2.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 64.2 112.406 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -175.43 158.82 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 73.14 110.88 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.1 m -51.63 163.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 74.15 111.116 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -162.64 -105.31 0.19 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.735 -0.745 . . . . 61.45 112.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 -167.69 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.782 0.325 . . . . 74.42 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -21.11 25.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 64.24 110.819 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.83 -22.79 27.94 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 72.03 112.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.8 mt -74.87 -33.76 62.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 73.21 110.956 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.88 -62.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 74.21 110.974 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -22.13 51.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 62.33 110.945 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -63.27 -36.91 85.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.33 110.898 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.7 m -62.78 -56.95 12.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 72.42 111.137 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.91 -29.47 56.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 73.42 110.859 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.04 -35.44 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 74.21 110.869 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.3 mt -86.66 -16.11 37.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.921 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.04 20.71 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.8 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 73.32 110.822 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.816 0.341 . . . . 72.42 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.73 73.13 1.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 75.13 110.977 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.14 155.67 45.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 74.34 110.852 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -102.35 177.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.42 111.064 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -178.17 160.42 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.9 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -65.43 -175.01 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 70.31 110.878 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -75.68 -68.59 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 73.53 111.153 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -49.4 146.99 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 73.54 111.147 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.6 mt -113.36 101.2 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.21 111.11 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -121.07 120.46 35.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.912 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.491 ' ND2' ' HG1' ' A' ' 13' ' ' THR . 36.9 p-10 -66.28 167.56 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 70.43 110.918 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -51.71 -48.46 63.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 72.2 110.919 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.491 ' HG1' ' ND2' ' A' ' 11' ' ' ASN . 18.1 p -61.69 -37.52 84.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.12 111.095 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 10.59 67.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.828 -0.701 . . . . 74.14 112.47 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -77.48 -45.33 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 62.32 111.132 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.1 mt -101.7 110.9 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.257 -0.429 . . . . 63.5 111.155 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 p -117.83 138.13 52.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.4 110.819 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 mt -129.74 109.81 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 74.31 111.113 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 t -100.27 124.63 45.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 73.1 110.849 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -68.74 109.64 3.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 72.32 110.914 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.9 mt -64.44 -33.38 75.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 71.04 110.848 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.467 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -149.02 -97.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 74.53 110.935 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' N ' HD21 ' A' ' 22' ' ' ASN . 2.9 tttm -151.84 10.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 74.13 110.813 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.96 6.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 62.42 110.958 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.4 t -151.16 138.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 73.14 111.181 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -126.1 -174.51 3.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 74.41 110.95 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.6 t -136.84 96.17 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 74.3 111.139 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -81.22 121.36 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.35 110.826 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.0 m -116.45 104.32 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 72.44 111.143 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.81 120.15 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 70.21 110.889 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.52 106.22 18.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.937 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.9 -141.12 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.632 -0.794 . . . . 71.24 112.489 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 93.8 p -175.27 83.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 73.23 110.895 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.76 84.26 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 74.51 110.887 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 62.43 17.1 9.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 73.43 110.887 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.18 -0.17 9.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.676 -0.773 . . . . 73.55 112.449 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -103.77 120.16 40.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 71.01 110.895 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.98 121.25 11.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 62.44 111.072 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.83 81.79 55.52 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.616 0.722 . . . . 74.15 111.092 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 116.72 4.7 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.632 2.221 . . . . 73.12 112.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.6 p -101.97 100.2 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.844 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -51.38 165.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 64.43 110.866 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.01 -163.61 12.97 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.683 -0.77 . . . . 72.44 112.43 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.9 tp -154.39 113.85 3.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 51.43 110.904 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.37 115.34 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 73.53 111.144 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.9 mt -92.74 117.86 30.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 74.32 110.945 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.33 83.9 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.1 110.908 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.61 176.01 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 64.2 111.14 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.73 -22.97 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 75.3 110.895 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -12.85 59.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.908 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.2 155.21 6.46 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.727 -0.749 . . . . 64.1 112.542 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 tp -68.66 154.26 42.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.923 0.392 . . . . 74.3 110.882 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 t -145.68 143.68 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 75.31 111.13 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mt -138.51 123.06 18.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.969 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -68.62 111.07 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 74.03 111.211 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.37 128.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.448 . . . . 63.14 110.849 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.52 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.816 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 t -90.52 170.07 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 71.21 110.841 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -51.29 -60.74 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 71.13 110.967 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -125.33 159.46 31.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 72.13 110.891 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -51.99 -33.18 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 61.12 110.829 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -59.43 -42.14 91.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 75.51 110.902 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.64 -48.88 17.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.957 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.07 -45.8 52.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.165 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -54.63 -49.09 71.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.893 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.13 -19.77 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.873 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.0 tp -88.23 -26.78 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 74.42 110.947 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.28 -22.44 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 75.34 111.11 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.4 15.66 13.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 65.35 110.928 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.0 ptm -130.32 -40.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.756 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.23 -22.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 75.31 111.153 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.69 ' HE2' HG21 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.1 -23.25 64.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 71.15 110.915 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -107.53 -33.09 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 73.53 110.859 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -40.47 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 75.15 110.863 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -90.79 -10.48 42.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 71.32 110.908 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.41 12.15 8.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 72.22 110.959 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.88 138.34 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 73.13 110.932 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.08 138.14 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 74.42 110.834 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 72' ' ' GLU . 71.9 t -74.59 124.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 73.15 111.088 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -137.67 8.34 2.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.123 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -154.54 146.18 23.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 72.02 110.767 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.6 t -153.71 128.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 72.43 111.176 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.5 mt -84.88 129.08 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 71.1 111.182 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.57 123.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 74.22 111.125 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p -83.76 -45.85 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 73.3 111.196 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -153.44 178.06 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.55 110.845 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.71 91.62 5.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 73.32 111.052 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.33 156.56 43.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.786 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.53 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 71.22 111.085 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.84 20.03 10.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 74.53 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.83 -77.43 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.896 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.79 7.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.32 111.096 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.45 -37.85 41.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 71.14 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 10.57 64.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 63.45 112.395 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.38 -28.41 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 71.43 111.201 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -38.81 67.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 75.21 110.887 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -84.07 -10.45 57.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 72.23 111.077 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.86 -33.94 15.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.34 110.925 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -94.42 17.9 12.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.973 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -116.3 -39.25 3.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.93 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -87.33 -55.75 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 70.5 110.848 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.91 47.87 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.75 -0.738 . . . . 71.34 112.524 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.32 110.79 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 70.35 111.087 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt -72.1 107.88 5.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 72.31 110.861 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.62 89.41 7.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 72.32 111.093 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -62.08 135.82 57.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.885 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.92 168.98 10.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 63.11 110.844 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.87 154.23 25.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.141 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.91 7.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 62.44 111.053 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -46.38 63.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 70.55 111.011 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.7 m -57.03 -25.59 58.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 60.55 111.174 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.89 14.12 28.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.143 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -26.75 7.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.825 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.74 -10.35 16.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.911 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.53 70.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 71.24 111.061 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -24.54 55.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.55 110.889 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -61.48 -32.63 72.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 61.54 110.897 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -89.36 -24.82 21.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 72.34 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.05 24.06 3.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.696 -0.764 . . . . 71.34 112.443 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.72 166.48 10.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 75.45 110.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.99 162.95 28.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 73.51 110.928 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -95.09 111.93 56.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.607 0.718 . . . . 72.15 110.891 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -176.1 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.6 2.2 . . . . 75.35 112.323 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 17.5 mt -51.79 -43.7 63.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 74.45 110.831 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.6 50.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 63.35 112.485 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.11 43.52 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 72.14 110.782 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 59.2 mt -129.14 -175.55 3.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 73.11 110.878 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.6 -171.72 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 75.12 110.871 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.9 m -50.62 -71.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 70.25 111.089 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.2 t -116.85 102.79 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 64.54 111.04 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 t -135.63 170.56 15.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.25 111.156 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.68 133.88 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.44 110.884 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.9 mt -114.84 155.52 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 74.51 110.942 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -137.59 124.17 20.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.22 110.857 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -125.86 49.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.923 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.44 92.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 74.35 112.547 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.7 m120 64.6 15.05 9.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 70.31 110.941 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.3 tpp -135.16 108.65 7.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.863 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -98.33 129.06 45.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 20.2 t -134.91 115.15 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 71.0 111.184 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -107.64 130.63 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 63.24 110.814 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.5 p -86.75 -176.54 5.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 72.01 111.164 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -168.4 130.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.835 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -115.57 88.01 18.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 71.03 110.957 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -7.99 22.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.646 2.231 . . . . 53.1 112.411 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.56 -162.29 21.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.674 -0.774 . . . . 62.23 112.381 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -81.04 137.61 36.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 71.32 110.878 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.13 -88.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.472 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -76.36 -25.21 54.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 73.14 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.2 p -147.15 -158.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 74.11 111.067 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.47 -22.01 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.872 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -132.18 8.66 4.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.853 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.414 HD21 ' N ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -41.12 128.37 2.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.01 110.891 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.0 pt -132.79 -176.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 71.34 111.101 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.2 m -133.82 131.76 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 64.41 111.043 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.1 t -86.27 126.44 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 74.54 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -114.33 131.09 56.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.43 110.812 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 11.6 mt -111.84 97.19 36.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 74.31 110.885 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.4 Cg_endo -69.87 -5.1 15.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.664 2.242 . . . . 74.12 112.301 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -81.81 -23.63 36.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 65.53 110.952 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.4 13.76 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.917 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.42 29.75 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.41 110.907 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 98.3 mt -96.07 130.3 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.31 111.092 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.4 tp -112.67 146.0 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.867 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.22 79.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 74.42 111.145 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.67 42.79 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.656 -0.783 . . . . 73.44 112.542 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.5 -163.85 53.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 45.14 112.515 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -33.55 35.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.361 . . . . 44.12 110.909 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 22.6 tp -53.69 -56.38 17.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.934 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.55 114.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 74.12 111.076 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 150.57 19.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 72.53 110.889 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.0 p -97.96 155.11 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.865 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t -51.44 -29.22 15.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.123 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.6 m -93.36 42.34 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 73.03 110.864 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -137.76 155.94 48.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 64.05 111.103 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -136.59 11.26 3.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 72.3 110.859 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.73 157.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 74.3 110.913 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.96 -32.88 63.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 75.52 110.891 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.95 -151.34 22.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.761 -0.733 . . . . 73.33 112.434 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -52.4 115.92 2.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 75.44 110.922 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.9 m -109.19 35.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 73.31 111.028 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.07 81.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 74.05 111.099 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -112.86 33.06 5.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.897 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.43 158.68 43.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 75.13 111.091 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -113.73 90.94 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.3 110.94 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 t -67.12 -19.18 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 75.42 111.137 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -74.84 -24.83 58.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 73.14 110.876 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.39 -10.76 13.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 72.02 110.852 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -55.3 -61.44 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 62.31 110.93 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.63 -24.48 14.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 65.34 110.894 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.9 m -81.57 -31.97 32.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 74.41 111.058 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -43.1 61.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.859 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.68 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.35 111.14 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.39 -27.64 56.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 64.41 110.92 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -76.98 -22.27 53.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 73.34 110.939 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.18 -11.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 73.03 111.143 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.4 -10.02 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 73.52 110.916 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.86 -30.76 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.833 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -58.48 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.11 110.897 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -93.08 61.68 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 74.02 110.893 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -72.36 -58.14 3.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 74.32 110.94 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -53.03 102.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.3 110.845 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 73.9 mt -142.04 121.68 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.03 111.16 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -29.83 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.447 . . . . 70.24 110.84 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.06 143.18 2.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 64.54 111.178 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 98.1 t -121.48 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.35 111.1 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.9 t -108.48 112.57 60.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 74.52 111.274 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.62 -169.48 0.32 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.769 2.313 . . . . 53.22 112.397 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.65 -13.66 59.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.828 -0.701 . . . . 73.14 112.5 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.45 129.71 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.354 . . . . 72.41 110.838 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 116.78 -117.69 3.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.812 -0.709 . . . . 74.24 112.494 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -150.79 164.75 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 75.23 110.841 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.8 m -54.87 163.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.23 111.176 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.26 -111.58 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.803 -0.713 . . . . 70.34 112.522 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.15 -169.32 2.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.418 . . . . 75.32 110.809 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -18.31 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 75.41 110.856 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.88 -16.75 48.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.75 -0.738 . . . . 74.21 112.47 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.95 -30.35 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 74.21 110.967 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.64 -57.5 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.52 110.899 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.54 -17.78 56.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 73.44 110.918 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -65.6 -50.42 65.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.1 110.873 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.9 m -51.78 -51.43 56.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 74.13 111.138 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -18.74 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 75.04 110.915 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -87.53 -5.07 58.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.13 110.804 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.3 mt -126.09 -6.4 6.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 75.03 110.876 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.34 8.48 11.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.918 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 73.04 110.877 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.793 0.33 . . . . 73.13 110.844 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -117.71 152.93 34.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 75.13 110.868 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -166.56 160.11 14.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.965 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.6 147.62 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 72.22 111.107 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -148.33 96.38 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 71.45 110.886 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -93.68 -177.47 4.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 74.24 110.887 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -88.14 -68.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 74.23 111.196 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -49.7 147.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.48 . . . . 71.1 111.131 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -114.2 100.23 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 74.41 111.127 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -121.4 116.3 24.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 73.54 110.906 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -58.52 165.23 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 71.22 110.96 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.8 -48.29 63.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 74.43 110.896 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -60.74 -38.01 83.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.13 111.206 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.97 64.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.728 -0.749 . . . . 73.22 112.525 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -71.34 -45.42 62.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.7 0.286 . . . . 75.51 111.085 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.96 123.3 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.419 . . . . 74.5 111.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.1 p -129.2 132.64 47.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 75.04 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mt -127.28 107.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 72.32 111.12 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -98.6 125.07 43.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.34 110.836 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -68.58 108.78 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.12 110.843 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.1 mt -62.61 -33.1 74.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 70.44 110.936 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.451 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.26 -96.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 54.33 110.883 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.6 OUTLIER -151.42 9.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.925 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.98 6.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.892 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 t -150.69 139.74 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 74.21 111.126 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -128.03 -174.78 3.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 74.34 110.92 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.83 94.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 70.1 111.057 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -79.01 122.07 25.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 72.0 110.866 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.7 m -118.7 104.92 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 73.11 111.167 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.41 124.48 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 74.4 110.888 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.23 114.2 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.877 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.94 -35.99 53.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.66 -0.781 . . . . 63.1 112.437 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m 58.53 98.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 75.52 110.825 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -129.66 137.66 50.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.059 -0.519 . . . . 73.03 110.848 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 54.08 40.45 31.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 74.3 110.881 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.81 8.67 61.16 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.678 -0.772 . . . . 53.54 112.512 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -100.18 -166.46 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.343 . . . . 65.53 110.889 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.42 113.38 12.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 72.34 111.107 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.44 77.63 2.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.641 0.734 . . . . 75.11 111.193 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 118.29 5.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 71.2 112.305 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.8 p -97.38 98.08 9.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.799 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -51.79 159.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.31 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -154.67 -167.3 16.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.77 . . . . 62.14 112.435 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.3 tp -152.68 112.84 4.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 74.25 110.964 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -95.66 116.5 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.19 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.7 mt -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 73.55 110.906 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.86 86.64 7.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.888 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.47 179.98 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 65.24 111.112 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.4 -23.32 14.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.9 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -13.24 58.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.919 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.11 151.81 5.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 74.21 112.539 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.571 HD22 ' HE2' ' A' ' 72' ' ' GLU . 10.6 tp -63.62 153.7 35.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.808 0.337 . . . . 73.34 110.969 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.74 141.09 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 73.32 111.031 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -136.87 122.07 19.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.43 110.943 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -67.43 111.43 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.152 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 72.1 130.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.34 110.903 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.85 -166.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.228 -0.442 . . . . 75.11 110.914 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -91.62 169.19 10.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.12 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -48.98 -58.5 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.983 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -130.48 161.53 31.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.13 110.883 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -54.21 -32.83 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 60.22 110.815 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -59.22 -39.84 84.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 75.02 110.868 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.7 mt -78.91 -45.39 20.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.909 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -46.33 62.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 74.41 111.093 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.05 -49.46 66.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 74.24 110.905 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.08 -15.27 63.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 74.4 110.936 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.3 tp -92.53 -24.89 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 65.05 110.958 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.407 HG12 HG13 ' A' ' 79' ' ' VAL . 15.3 mt -91.24 -26.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.42 111.125 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -86.55 7.77 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.857 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.7 ptm -123.53 -38.6 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 71.35 110.913 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.55 -23.68 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 75.13 111.133 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.571 ' HE2' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -71.62 -20.68 61.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.896 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -107.79 -30.71 8.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 73.24 110.873 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -45.79 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -83.55 -11.97 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 71.31 110.838 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 67.65 12.78 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 74.1 110.916 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 139.7 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.97 136.8 38.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 73.45 110.799 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.407 HG13 HG12 ' A' ' 68' ' ' ILE . 14.4 p -77.02 128.75 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 72.41 111.12 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -155.41 19.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.159 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -154.24 142.68 20.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 74.22 110.871 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.4 t -156.58 104.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 71.1 111.16 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.5 mt -69.97 119.82 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.41 111.111 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.7 mm -93.45 147.46 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 72.43 111.106 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -104.24 -50.33 3.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 71.03 111.074 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -155.84 -174.58 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 74.23 110.88 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.37 99.58 12.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 54.02 111.139 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.487 ' CE1' ' HE2' ' A' ' 149' ' ' HIS . 0.5 OUTLIER -154.45 151.88 29.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 70.34 110.866 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.18 -19.94 49.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.401 . . . . 73.41 111.028 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.58 6.25 48.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 65.22 110.956 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.68 -77.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.875 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.13 7.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 73.35 111.188 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.78 -37.44 34.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.816 -0.707 . . . . 72.13 112.414 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.2 10.77 58.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.751 . . . . 74.12 112.534 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.0 tt -53.89 -28.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.924 0.392 . . . . 73.35 111.159 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -53.64 -36.94 62.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 64.44 110.921 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -87.17 -13.71 43.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.42 111.147 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.2 mt -86.42 -31.55 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 75.21 110.923 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.92 15.73 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 74.51 110.88 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -116.46 -45.37 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 74.2 110.942 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -78.15 -56.86 4.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 71.51 110.804 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.816 -0.706 . . . . 75.31 112.498 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.98 119.24 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.928 0.394 . . . . 74.23 111.121 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -76.17 119.32 19.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 71.14 110.852 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.0 93.53 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 61.33 111.116 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -65.86 145.67 55.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.03 110.906 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -178.87 171.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 60.11 110.889 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.749 ' CB ' ' HD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -86.89 158.94 19.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 65.21 111.105 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -39.26 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.42 111.065 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.06 -44.17 85.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.906 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.6 m -57.5 -25.35 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 72.52 111.121 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.11 10.86 38.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 73.4 111.121 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.9 -33.2 6.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 71.15 110.892 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.59 -13.9 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.878 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.57 98.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 75.24 111.105 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -24.41 58.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 70.32 110.925 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -32.5 70.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 75.12 110.826 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -89.87 -24.35 21.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 72.32 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.18 23.93 4.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 55.33 112.568 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -98.07 -175.5 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 72.22 110.923 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -85.5 176.14 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 73.43 110.93 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.9 mt-10 -106.59 104.38 50.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.684 0.754 . . . . 73.32 110.863 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.8 Cg_endo -69.77 -178.75 2.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.635 2.223 . . . . 73.4 112.367 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.2 mt -51.08 -47.04 61.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.981 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.07 26.55 28.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 71.5 112.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -107.84 45.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 72.33 110.817 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.4 mt -127.1 -174.96 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 75.03 110.972 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.57 -172.31 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 73.43 110.932 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 49.6 m -50.89 -70.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.33 111.166 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 t -117.06 103.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 62.04 111.097 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t -135.42 175.23 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 64.23 111.122 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -120.64 136.39 54.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 70.54 110.901 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.2 mt -115.23 154.34 29.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 73.22 110.844 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -134.08 126.89 31.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.857 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -129.9 32.8 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.797 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.66 95.37 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.672 -0.775 . . . . 55.22 112.487 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.88 13.49 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 72.23 110.969 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.6 tpp -135.03 106.43 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 70.22 110.821 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -94.58 126.0 39.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.22 110.852 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.9 t -134.77 116.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.174 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.95 131.22 55.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 71.25 110.88 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.5 p -85.04 -176.03 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.33 111.199 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -166.67 133.08 2.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.877 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -122.01 87.33 47.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.612 0.72 . . . . 73.53 110.87 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 -7.68 21.69 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.672 2.248 . . . . 70.33 112.335 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.48 -160.81 23.86 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.742 -0.742 . . . . 62.13 112.442 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -86.26 139.48 30.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.886 0.374 . . . . 74.41 110.91 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.17 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 62.43 112.435 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.487 ' HE2' ' CE1' ' A' ' 88' ' ' HIS . 68.6 t60 -75.6 -22.92 56.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 64.23 110.86 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.3 p -150.69 -169.21 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 63.42 111.122 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -86.63 -5.71 59.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 62.35 110.926 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.749 ' HD2' ' CB ' ' A' ' 108' ' ' THR . 47.6 t0 -145.75 16.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 64.21 110.838 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -49.8 126.14 13.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 53.12 110.904 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 24.1 pt -133.72 174.92 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.15 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.5 m -128.06 120.38 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 72.14 111.088 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.37 119.18 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 72.42 111.167 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.4 t-105 -107.94 136.45 47.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.52 110.816 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.63 98.35 51.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 72.0 110.808 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -4.52 14.2 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.675 2.25 . . . . 73.11 112.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -85.12 -21.22 29.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.11 110.98 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -143.52 13.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 74.11 110.929 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.1 m120 53.12 27.54 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.952 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.9 mt -89.96 142.82 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 73.51 111.156 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 27.7 tp -125.62 147.79 49.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.53 110.915 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.3 t -115.02 79.2 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.074 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.03 -34.0 37.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.781 -0.723 . . . . 73.32 112.427 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.17 -163.31 16.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 71.42 112.478 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -32.65 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 54.42 110.892 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 23.0 tp -52.02 -51.38 57.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 70.13 110.929 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.63 110.84 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 73.43 111.143 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.34 156.27 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 74.3 110.95 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 45.5 p -98.77 159.82 14.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 70.41 110.91 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -51.07 -29.91 14.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 71.04 111.107 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.6 m -93.5 46.3 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.288 -0.414 . . . . 72.13 110.818 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.77 48.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 74.41 111.055 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -124.82 -2.08 7.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 74.34 110.814 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -170.46 172.31 6.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.311 -0.404 . . . . 70.52 110.905 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.3 mt -86.32 -36.29 19.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 75.01 110.976 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 125.52 -138.23 10.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.727 -0.749 . . . . 63.24 112.494 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 181' ' ' VAL . 6.2 p-10 -97.87 -1.17 43.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 64.24 110.857 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 180' ' ' ASN . 27.3 m 36.73 44.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.455 . . . . 72.21 111.079 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.3 -26.94 66.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 71.41 111.125 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -134.2 29.09 3.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.875 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.68 158.48 36.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 73.34 111.135 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -114.01 90.69 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.89 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.0 -16.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 73.22 111.131 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.28 -23.43 59.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 70.45 110.877 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -117.12 -13.0 10.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 72.53 110.823 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -53.58 -62.01 1.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.108 -0.496 . . . . 73.54 110.881 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -23.62 23.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 53.41 110.839 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.54 -30.07 33.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 70.11 111.176 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -44.12 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 63.13 110.891 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.6 mm -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 74.32 111.102 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.3 -27.4 55.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 71.22 110.918 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -77.66 -22.32 50.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 64.33 110.853 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.2 t -85.26 -10.84 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.012 0.434 . . . . 75.43 111.204 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.56 -12.7 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.914 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.75 -30.79 12.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.928 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -59.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 75.33 110.876 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -91.49 61.71 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 73.44 110.947 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -72.78 -58.52 3.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.903 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -52.64 101.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 60.14 110.905 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 71.6 mt -141.14 118.22 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 74.11 111.117 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.1 -28.08 63.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.825 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -166.9 145.08 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.438 . . . . 71.13 111.139 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 93.0 t -123.45 131.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.196 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 15.9 t -110.15 105.87 57.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 72.22 111.187 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.2 Cg_endo -69.82 -171.3 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 70.2 112.319 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.4 -20.24 67.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 72.22 112.54 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.46 144.48 23.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.795 0.331 . . . . 74.11 110.917 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.38 -101.86 1.36 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.772 -0.728 . . . . 74.53 112.544 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -172.03 170.98 5.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.92 0.391 . . . . 73.44 110.868 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 10.9 t -65.23 148.47 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 70.31 111.188 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.51 -101.96 0.31 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.768 -0.729 . . . . 60.34 112.559 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -163.57 -169.12 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 63.13 110.903 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -17.75 54.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 71.32 110.907 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -57.55 -20.72 39.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.771 -0.728 . . . . 61.32 112.511 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.6 mt -72.87 -29.84 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 73.02 110.949 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.52 -60.67 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 73.01 110.9 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.76 -19.92 44.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 73.32 110.902 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.86 -50.93 70.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.12 110.959 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.8 m -51.7 -51.02 59.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 74.41 111.173 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.49 -18.23 50.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 74.22 110.936 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.69 -2.64 57.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 74.11 110.833 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.1 mt -125.22 -8.02 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 70.41 110.88 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.61 9.42 9.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 65.25 110.947 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.846 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.823 0.344 . . . . 62.15 110.853 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -128.3 -46.57 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.913 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.19 169.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 75.52 110.896 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.7 m -86.23 -177.67 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 74.14 111.134 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -116.36 55.95 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.874 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -124.74 168.02 13.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 72.41 110.915 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 m -82.57 -50.45 8.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 74.04 111.085 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 18' ' ' ILE . 3.8 m -60.16 179.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 75.35 111.236 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.6 mt -135.78 102.55 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 54.54 111.184 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -110.71 122.64 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 75.3 110.95 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -65.62 166.39 10.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 72.43 110.849 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.65 -48.69 63.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.836 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -60.61 -37.72 82.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.476 . . . . 75.3 111.178 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.86 11.93 61.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.35 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.9 m -84.55 -41.61 16.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 74.45 111.098 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.22 103.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 74.2 111.107 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.1 p -120.62 125.97 49.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 70.12 110.852 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -101.52 -164.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.094 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.23 115.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 70.01 110.876 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -68.17 106.48 2.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 74.21 110.904 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 28.8 mt -65.73 -32.62 74.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.01 110.96 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.472 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -148.43 -96.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 71.13 110.876 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.449 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.5 OUTLIER -152.62 10.44 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 71.25 110.944 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.51 5.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 64.3 110.944 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.8 t -151.4 138.95 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 72.43 111.196 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 13.2 m95 -125.02 -173.86 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 75.42 110.953 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.2 t -137.17 89.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 75.03 111.151 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -73.96 125.16 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.776 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -118.97 96.76 5.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 63.02 111.076 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.22 117.68 18.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 71.14 110.954 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.16 114.77 22.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 75.43 110.915 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.77 -139.64 5.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 73.21 112.43 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.7 119.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.904 0.383 . . . . 73.54 110.815 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -148.97 136.8 20.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 75.42 110.9 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 49.67 28.68 2.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.875 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.32 40.96 32.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.734 -0.746 . . . . 62.53 112.551 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -147.43 135.71 21.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 72.23 110.827 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.0 145.65 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 73.4 111.108 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.52 79.72 68.6 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.553 0.692 . . . . 75.3 111.108 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 117.69 5.23 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.688 2.259 . . . . 73.01 112.327 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -107.85 98.76 8.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.8 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.97 161.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.881 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -154.7 -155.81 7.44 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.739 . . . . 73.35 112.455 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.1 tp -157.6 112.05 2.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 74.2 110.874 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 2.0 t -96.88 112.37 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.098 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.9 mt -90.86 120.01 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.973 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.75 82.17 5.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 73.23 110.886 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -97.22 -179.51 4.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 72.25 111.105 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -25.81 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 70.04 110.859 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -20.16 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.45 110.953 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.5 149.63 5.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.22 112.562 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.56 154.16 25.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.817 0.342 . . . . 70.31 110.918 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.59 141.79 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 72.34 111.187 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -137.2 121.97 18.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 73.25 110.898 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.82 111.66 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.45 111.157 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.77 128.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.874 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 p -70.84 -167.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 55.35 110.833 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.1 t -89.94 166.84 13.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 54.11 110.907 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -49.69 -59.86 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 73.31 110.892 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.86 158.0 37.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 75.2 110.823 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.672 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 73.2 m-20 -51.57 -33.36 32.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 73.33 110.955 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.05 -45.58 90.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 75.23 110.921 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.32 -46.93 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 74.02 110.956 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.46 -47.71 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.43 111.164 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.07 -49.96 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.834 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -64.76 -20.54 66.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 74.11 110.837 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 tp -87.24 -25.19 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 71.23 110.871 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.23 -24.03 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 75.53 111.145 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -92.17 16.18 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 71.21 110.882 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.8 ptm -131.65 -39.99 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.834 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.1 m -80.23 -22.86 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 75.12 111.052 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.666 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.37 -24.81 65.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 73.14 110.858 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -105.36 -33.37 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 70.31 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -44.48 68.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 72.41 110.903 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -85.81 -12.29 51.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 70.54 110.941 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 69.44 11.43 8.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.893 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.59 141.49 49.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.53 110.918 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.97 140.42 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 71.31 110.959 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.666 HG22 ' HE2' ' A' ' 72' ' ' GLU . 89.6 t -81.78 121.28 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 74.12 111.169 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -138.09 14.23 2.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 73.35 111.153 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -154.45 144.83 22.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 64.04 110.935 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.3 t -153.85 132.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.13 111.046 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.7 mt -92.66 128.41 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 71.45 111.048 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.52 153.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.51 111.129 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.0 p -112.32 -49.87 2.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 64.31 111.154 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.6 -176.15 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 72.53 110.841 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -98.39 90.9 4.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 64.34 111.072 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.2 152.84 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 74.55 110.831 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.23 12.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 74.44 111.1 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.53 27.12 2.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 73.33 110.856 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -71.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 74.51 110.849 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.85 7.61 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 73.4 111.211 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.55 -42.22 43.45 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.722 -0.751 . . . . 71.13 112.451 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.61 16.89 58.3 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.639 -0.791 . . . . 73.22 112.491 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.4 tt -56.71 -30.23 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 64.42 111.186 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -55.89 -30.01 60.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 71.22 110.864 179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -89.11 -15.14 34.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 63.54 111.175 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.0 mt -89.88 -28.74 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.834 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -97.27 13.4 29.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.263 -0.426 . . . . 71.35 110.895 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -112.35 -43.01 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 73.3 110.868 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -78.84 -57.56 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.52 110.939 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.84 38.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.642 -0.789 . . . . 74.52 112.441 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.27 124.53 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.39 . . . . 75.34 111.124 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -86.67 120.15 27.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 71.14 110.898 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.11 96.36 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.066 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -68.99 144.7 54.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.41 . . . . 72.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.01 -177.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 64.11 110.895 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.58 155.83 17.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 73.21 111.161 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.83 -37.87 45.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 72.13 111.086 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.4 tp -67.94 -45.85 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 72.23 110.915 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.9 m -58.49 -21.61 52.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 61.45 111.136 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.26 12.06 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 75.52 111.186 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -111.68 -28.55 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.876 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.58 -9.57 21.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.958 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 64.42 110.998 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -27.13 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 75.13 110.917 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.34 -34.45 66.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 52.22 110.863 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.44 -23.7 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 54.54 110.808 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.81 21.79 4.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 71.44 112.557 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -95.73 177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 71.05 110.942 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -78.12 176.03 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 72.32 110.904 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mt-10 -108.58 104.8 55.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 75.24 110.933 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.5 Cg_endo -69.82 178.74 4.3 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.653 2.235 . . . . 73.11 112.358 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 28.3 mt -51.37 -51.09 57.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 75.13 110.938 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.52 40.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 71.15 112.522 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -99.23 34.47 2.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 70.43 110.929 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.96 -174.35 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 64.11 110.851 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.1 -171.12 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.835 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 99.5 m -50.56 -69.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 65.41 111.058 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.5 t -120.49 102.61 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 70.12 111.121 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -132.71 164.29 27.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.507 . . . . 61.45 111.154 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.3 129.15 56.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 74.25 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.6 mt -115.89 157.97 23.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 74.54 110.998 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -136.99 112.15 9.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.92 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -107.6 45.42 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.947 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.01 87.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 54.03 112.492 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.73 14.66 9.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 73.43 110.949 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.2 tpp -131.31 89.87 2.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.86 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 130.58 38.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 70.15 110.924 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.55 117.02 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 71.23 111.145 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -108.24 132.73 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.9 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 37.7 p -90.14 171.01 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 70.43 111.112 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -154.29 130.28 10.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 72.25 110.865 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -118.44 85.56 26.24 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.613 0.72 . . . . 73.44 110.868 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.56 23.9 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.705 2.27 . . . . 73.52 112.306 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.24 -169.62 15.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.8 -0.714 . . . . 73.22 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -76.79 147.81 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 73.52 110.868 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.26 -64.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.11 112.486 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -89.56 -30.93 17.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.873 0.368 . . . . 75.14 110.913 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.9 p -139.83 -87.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 75.34 111.162 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -160.56 -32.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 75.11 110.812 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -127.58 14.56 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 74.2 110.795 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -50.41 125.57 13.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.14 110.861 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 12.6 pt -123.36 164.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 64.03 111.107 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.6 m -115.74 118.99 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 75.42 111.139 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 43.7 t -70.77 118.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 62.35 111.076 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -104.89 131.14 52.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.926 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 11.7 mt -113.1 97.02 41.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.573 0.702 . . . . 74.31 110.985 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.61 -4.68 14.41 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.781 2.321 . . . . 71.54 112.352 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -83.18 -23.03 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.914 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.46 13.4 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 75.55 110.922 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.46 29.13 10.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 73.15 110.981 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.1 130.14 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 73.52 111.16 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 24.8 tp -113.54 147.73 37.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 75.43 110.865 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.9 t -111.05 78.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 74.2 111.157 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.07 -35.37 41.06 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 74.4 112.49 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 63.04 -159.26 36.64 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.801 -0.714 . . . . 60.54 112.505 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.8 m -59.94 -30.82 69.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.876 0.369 . . . . 70.43 110.904 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 27.3 tp -53.63 -49.15 68.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 75.54 110.904 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.0 t -89.77 105.43 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 70.51 111.105 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.38 147.99 7.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 70.22 110.902 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 54.2 p -99.92 167.11 10.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 72.54 110.882 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t -54.13 -26.15 26.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 75.24 111.149 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 m -93.08 43.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 73.15 110.832 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.72 138.02 45.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 72.15 111.067 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 30.7 tttm -122.84 -4.22 8.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.896 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.99 151.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 70.11 110.909 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.3 mt -65.73 -31.47 72.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 52.44 110.968 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.32 -138.1 21.34 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.735 -0.745 . . . . 65.21 112.456 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.38 95.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.894 0.378 . . . . 53.13 110.905 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 15.6 m -100.94 21.85 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.44 111.164 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.26 -25.1 63.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 73.54 111.094 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -110.73 18.19 19.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.464 . . . . 70.24 110.883 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -135.01 156.25 49.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 55.15 111.12 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.4 85.99 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.95 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.22 -21.34 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.11 111.143 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -72.38 -28.11 62.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 63.31 110.878 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -106.75 -14.94 14.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.05 110.905 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -55.36 -61.05 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.1 110.876 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.15 -25.43 13.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.842 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -80.92 -32.86 34.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.077 -0.511 . . . . 74.11 111.116 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -41.72 65.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 72.33 110.842 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.4 mm -64.96 -46.89 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.32 111.162 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.27 -28.59 63.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 75.05 110.837 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -76.96 -22.78 52.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.889 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.0 t -85.19 -10.51 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 73.35 111.094 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -112.22 -10.15 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.439 . . . . 74.35 110.926 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.01 -30.73 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 75.14 110.872 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -46.68 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.823 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.06 37.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 74.1 110.909 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -48.07 69.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.946 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -59.92 103.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 64.15 110.85 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.8 mt -146.07 123.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 62.55 111.067 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -25.48 46.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.879 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.53 130.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 72.41 111.091 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.23 147.33 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.19 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.2 t -122.57 101.12 40.54 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.639 0.733 . . . . 74.23 111.04 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 177.34 5.69 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.639 2.226 . . . . 74.12 112.385 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.68 -11.65 79.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 75.23 112.488 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -152.77 148.39 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 72.12 110.843 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.29 -99.89 2.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 73.42 112.436 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -174.39 153.87 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 74.21 110.95 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.3 m -53.98 163.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.31 111.172 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.55 -93.84 0.1 OUTLIER Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.725 -0.75 . . . . 65.15 112.444 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -171.47 -166.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 71.14 110.884 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -56.8 -20.74 24.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.847 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.53 -23.0 18.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 72.13 112.455 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.6 mt -77.38 -32.5 54.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 75.52 110.857 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.08 -62.33 1.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 64.21 110.885 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -22.74 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 71.4 110.864 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -61.13 -45.86 92.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 70.31 110.877 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.5 m -51.28 -54.95 21.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 74.23 111.153 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.58 -18.43 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 73.22 110.89 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.804 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.8 mt -124.68 -10.5 7.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 73.11 110.893 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.46 14.07 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.94 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.894 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.0 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.774 0.321 . . . . 65.23 110.804 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -121.63 170.05 10.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 75.41 110.924 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -137.18 141.17 42.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 72.33 110.899 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.4 p -51.65 147.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 74.45 111.178 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.37 171.49 20.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.12 110.866 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -73.05 179.8 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 64.12 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.4 m -62.02 -42.96 99.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 75.12 111.136 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 m -62.3 -177.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 62.35 111.114 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.14 93.69 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 61.43 111.154 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.01 115.3 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 75.05 110.872 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.493 ' ND2' ' HG1' ' A' ' 13' ' ' THR . 38.3 p-10 -59.28 166.36 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 73.53 110.858 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -51.77 -47.86 63.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.04 110.909 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.493 ' HG1' ' ND2' ' A' ' 11' ' ' ASN . 19.3 p -60.26 -38.23 82.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.15 111.142 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.92 12.73 60.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 75.41 112.433 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.4 m -81.14 -42.95 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.679 0.276 . . . . 74.31 111.115 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.31 125.45 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 72.24 111.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -131.93 126.95 35.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.861 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.3 112.86 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 74.53 111.119 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.0 t -100.45 127.54 46.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 74.14 110.878 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -70.58 111.61 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 62.32 110.927 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.7 mt -65.22 -32.29 73.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.89 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.452 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.06 -97.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 63.24 110.837 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.26 9.48 0.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 74.31 110.906 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.406 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.09 7.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.856 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.78 141.14 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 75.21 111.1 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -129.01 -178.32 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.937 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.3 t -133.04 89.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.384 . . . . 74.24 111.052 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -72.39 123.79 23.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.913 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -119.68 104.01 9.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 33.35 111.106 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -86.62 122.64 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.54 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.29 114.11 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.844 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.06 -139.13 4.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 72.53 112.518 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.3 119.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 72.11 110.826 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -147.49 136.71 22.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 72.32 110.83 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 49.92 28.93 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 74.12 110.979 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.87 41.44 33.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 61.53 112.507 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -147.21 134.36 20.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 73.2 110.87 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.48 146.83 52.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 74.43 111.142 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.48 80.61 56.91 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.676 0.751 . . . . 74.4 111.107 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.82 118.99 6.01 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.601 2.201 . . . . 65.24 112.364 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.3 p -112.3 96.95 6.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.888 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -57.83 164.74 2.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.04 110.813 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -155.49 -148.16 4.94 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.778 -0.725 . . . . 62.14 112.509 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.7 tp -159.85 115.27 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.856 0.36 . . . . 70.03 110.886 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.4 122.15 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.145 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.5 mt -99.39 115.42 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.891 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.55 87.59 7.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.89 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.14 179.58 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 72.43 111.157 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -100.33 -21.97 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.842 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -12.2 56.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 64.3 110.871 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.95 150.87 5.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.769 . . . . 73.32 112.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.72 154.58 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 71.53 110.925 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.76 141.57 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.112 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.84 125.13 23.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 75.41 110.946 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.04 111.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 75.45 111.193 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.58 128.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.31 110.807 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 p -71.6 -167.1 0.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.832 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.9 t -90.28 168.87 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 72.33 110.882 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -50.35 -60.43 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 74.05 110.938 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -126.67 159.37 33.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 74.04 110.818 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -52.66 -35.06 54.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 73.1 110.862 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.79 -38.02 74.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.995 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.62 -46.7 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.95 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.71 -45.44 58.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -57.79 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 74.43 110.946 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.99 -22.69 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 74.43 110.859 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.3 tp -84.8 -25.88 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 64.51 110.924 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.46 -22.99 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 75.43 111.132 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -92.38 15.94 12.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 71.13 110.939 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.95 -40.03 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.25 -22.2 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.12 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.708 ' HE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.22 -24.53 64.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 60.14 110.885 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -105.69 -33.85 7.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.924 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -43.29 73.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 73.54 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -88.69 -11.35 45.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.883 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.89 11.88 8.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 65.31 110.966 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -130.01 139.22 51.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.83 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -85.35 138.27 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.267 -0.424 . . . . 75.22 110.803 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.708 HG23 ' HE2' ' A' ' 72' ' ' GLU . 94.4 t -78.39 123.09 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.197 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -140.07 13.44 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 73.42 111.169 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -154.85 143.79 20.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.03 110.917 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 t -154.07 128.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 72.31 111.081 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.3 mt -85.42 131.37 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 71.24 111.113 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.9 mm -109.91 136.62 45.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 73.12 111.145 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.0 p -96.17 -45.36 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 75.33 111.158 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -153.46 -175.52 5.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 63.23 110.845 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.13 86.73 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 72.31 111.162 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 71.41 110.859 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.24 -23.67 9.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.119 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -95.37 30.11 2.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 73.43 110.842 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.94 -70.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.878 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.16 7.34 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 73.44 111.127 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.69 -41.91 51.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.816 -0.707 . . . . 64.31 112.451 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.7 14.46 64.09 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.668 -0.777 . . . . 61.25 112.518 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 tt -55.12 -28.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 74.13 111.153 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -34.57 63.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.946 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.1 m -86.8 -12.53 47.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 73.21 111.181 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.63 -24.92 20.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.927 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.13 20.19 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.883 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -120.97 -34.06 3.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 72.31 110.881 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -90.86 -42.56 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 74.42 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.79 37.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.769 -0.729 . . . . 70.05 112.492 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.0 mp -103.16 111.24 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 74.45 111.166 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -72.74 112.05 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 72.51 110.923 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.54 90.56 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 75.22 111.107 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -61.93 145.19 53.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 74.43 110.862 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -177.04 179.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 74.44 110.809 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.2 158.14 18.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 71.41 111.106 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.72 49.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.23 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.3 tp -72.27 -37.82 68.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 71.4 110.924 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.5 m -58.07 -28.1 64.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 73.21 111.192 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.59 0.95 57.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 74.23 111.073 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.52 -55.54 2.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 74.03 110.928 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.21 -10.29 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 73.33 110.897 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.78 -46.24 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.081 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -29.51 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 73.24 110.866 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -52.14 -36.71 52.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.935 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -89.51 -17.19 29.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 75.14 110.848 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.64 19.63 8.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.706 -0.759 . . . . 75.03 112.475 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.74 171.83 8.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 74.51 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.63 -176.3 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 74.02 110.972 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.37 101.53 53.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 74.13 110.948 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 -179.68 3.04 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.741 2.294 . . . . 70.33 112.351 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 24.6 mt -51.1 -57.67 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 72.32 110.919 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.42 68.64 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.66 -0.781 . . . . 74.3 112.51 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.55 36.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 74.11 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -119.23 -175.23 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.979 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.38 -171.13 3.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 70.5 110.898 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.6 m -50.73 -70.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 75.2 111.153 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.3 t -120.51 103.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.44 111.177 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -133.04 170.22 15.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 75.02 111.125 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.32 128.11 52.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 72.45 110.886 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 63.9 mt -116.08 155.95 27.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.914 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -136.1 114.83 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.887 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -110.08 51.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 74.51 110.866 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.44 89.46 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.718 -0.753 . . . . 75.35 112.574 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.96 14.57 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 75.33 110.845 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.4 tpp -133.13 98.22 4.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 73.11 110.844 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 131.13 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 72.02 110.908 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 90.1 t -136.78 119.09 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 71.41 111.114 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -111.66 125.55 54.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 70.41 110.914 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.3 p -81.0 -172.52 3.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.136 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -170.84 130.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.43 110.923 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -119.93 86.13 35.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.763 0.792 . . . . 74.34 110.911 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.707 2.271 . . . . 74.33 112.351 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.39 -162.1 23.22 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 72.43 112.443 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.2 135.86 33.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.736 0.303 . . . . 74.43 110.921 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.68 -85.19 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 73.43 112.506 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -79.8 -24.3 41.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.393 . . . . 75.44 110.905 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.3 p -147.05 -162.97 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 74.4 111.111 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -88.45 -20.94 24.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.927 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -133.22 18.27 4.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.86 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.92 131.42 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 70.31 110.771 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.72 169.95 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 71.4 111.09 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.6 m -121.88 135.36 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 72.04 111.2 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.22 122.57 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.07 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -107.73 132.13 53.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.919 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.7 mt -112.06 98.55 42.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.542 0.687 . . . . 75.31 110.825 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -4.93 15.03 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.272 . . . . 73.41 112.291 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.24 -23.64 35.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.42 110.951 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.04 14.6 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.908 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.7 m120 53.95 27.64 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 74.43 110.958 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 97.0 mt -92.75 125.93 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 74.41 111.078 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.2 148.68 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 75.15 110.908 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.43 81.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 74.2 111.129 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.42 48.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 64.3 112.453 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.23 -167.5 46.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 63.51 112.522 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.02 -34.42 29.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 74.54 110.871 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 14.3 tp -51.26 -60.3 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 73.14 110.915 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.2 116.17 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.144 -0.48 . . . . 71.44 111.076 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.456 ' HD2' ' HB3' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -51.66 171.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.907 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.34 138.11 54.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.0 110.883 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.411 ' O ' ' CB ' ' A' ' 174' ' ' SER . 0.0 OUTLIER -39.49 149.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 72.03 111.168 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 173' ' ' THR . 0.9 OUTLIER 77.14 13.18 2.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 75.52 110.819 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -107.07 146.04 31.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 73.11 111.121 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -114.0 12.97 18.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 63.43 110.866 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.46 164.18 0.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 73.44 110.902 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 18.5 mt -61.9 -48.01 82.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.903 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 129.82 -106.02 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.805 -0.712 . . . . 64.51 112.467 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -110.08 110.48 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.879 0.371 . . . . 74.1 110.853 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.7 m -100.47 30.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 73.55 111.122 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.92 -28.68 67.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.141 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.36 24.04 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.868 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -118.98 157.13 28.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 73.24 111.073 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -110.43 88.18 2.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.974 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.32 -20.08 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 72.51 111.133 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.66 -23.02 59.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.956 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -114.33 -13.78 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 71.23 110.891 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -54.19 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 74.21 110.947 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.2 p -54.24 -24.65 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 63.22 110.821 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.1 m -80.55 -30.21 37.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 74.43 111.163 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -44.55 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 72.04 110.929 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.9 mm -58.91 -46.19 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 73.32 111.086 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -55.62 -29.06 58.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.866 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -77.17 -22.3 52.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 74.02 110.862 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 20.7 t -84.76 -11.13 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 71.14 111.122 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.12 -15.47 13.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.896 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.42 -30.98 13.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 73.11 110.98 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -50.13 3.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 73.25 110.843 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -97.41 61.59 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 75.2 110.961 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -74.33 -63.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 74.2 110.902 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -51.99 103.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 71.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 79.3 mt -141.42 123.22 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 73.13 111.182 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.57 -29.38 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.3 110.833 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.3 133.51 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.45 111.124 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 83.9 t -109.42 130.07 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 71.31 111.115 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 4.2 t -105.73 111.17 64.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.561 0.696 . . . . 74.24 111.039 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -175.73 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.675 2.25 . . . . 71.44 112.349 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.75 -12.57 79.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.739 -0.743 . . . . 73.45 112.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -152.11 147.25 26.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 72.4 110.796 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.37 -117.93 5.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.7 -0.762 . . . . 73.15 112.454 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.85 175.26 10.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.945 0.402 . . . . 74.42 110.85 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.2 m -72.07 156.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 74.35 111.059 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.51 -105.7 0.41 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.68 -0.771 . . . . 53.43 112.441 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.82 -178.13 6.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 73.23 110.963 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -16.55 52.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 72.32 110.874 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.39 -23.7 42.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.75 -0.738 . . . . 75.05 112.473 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.6 mt -65.07 -25.66 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 65.23 110.834 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.36 -59.49 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.41 110.924 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -15.24 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 65.12 110.895 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 171' ' ' LYS . 1.2 t-80 -77.58 -42.57 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 72.0 110.954 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 47.1 m -52.98 -48.59 67.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 74.52 111.16 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.64 -14.52 52.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.217 -0.447 . . . . 72.44 110.887 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -88.33 3.01 51.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.02 110.882 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.5 mt -133.62 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.912 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.06 -4.43 44.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 75.3 110.896 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 73.01 110.929 179.888 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.791 0.329 . . . . 65.23 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -120.79 179.43 4.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 75.42 110.873 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -135.89 128.84 31.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.934 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 p -51.7 147.58 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 75.5 111.115 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.35 177.33 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 63.01 110.877 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -60.38 -174.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.942 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 m -84.7 -40.42 17.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 74.24 111.187 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.17 -177.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 74.03 111.077 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.4 mt -136.2 93.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 70.43 111.227 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.26 121.11 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.852 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -63.84 167.63 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 55.34 110.876 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.04 -44.86 64.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 55.25 110.86 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.0 p -62.04 -38.11 87.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 71.51 111.159 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.25 14.54 62.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.798 -0.715 . . . . 55.11 112.495 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 m -83.59 -39.25 20.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.818 0.342 . . . . 74.54 111.174 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.14 117.54 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 73.24 111.1 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -124.36 132.43 53.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.24 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.92 108.63 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 64.3 111.101 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -100.95 127.53 47.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.866 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -69.77 111.21 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.909 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 23.0 mt -64.23 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.12 110.915 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.455 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.07 -97.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.911 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.2 OUTLIER -151.54 10.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.825 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.56 6.35 0.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.89 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -150.73 140.16 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 71.01 111.14 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -127.55 -178.05 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.909 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.3 t -133.67 95.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.156 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -77.56 118.32 19.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.813 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 m -113.67 107.34 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 70.33 111.157 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.24 126.93 38.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.44 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.47 105.04 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.916 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.13 -128.62 0.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.537 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.59 74.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 74.31 110.818 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.78 96.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 73.24 110.856 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 56.51 21.55 5.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.499 . . . . 63.54 110.88 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.58 6.56 23.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.638 -0.792 . . . . 62.12 112.424 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -108.63 113.98 27.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.852 0.358 . . . . 70.13 110.863 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.98 103.57 0.28 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.504 . . . . 73.0 111.159 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.05 99.19 51.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.599 0.714 . . . . 72.44 111.121 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.703 2.269 . . . . 73.41 112.352 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.9 p -100.43 107.77 19.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 62.51 110.818 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.06 162.61 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.885 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.19 -155.27 6.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.743 -0.741 . . . . 74.43 112.472 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.8 tp -158.61 112.62 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 74.32 110.927 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.4 t -97.5 121.49 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 75.31 111.135 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.5 mt -99.67 118.0 35.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.985 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.2 85.83 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.02 110.826 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -100.81 -174.29 2.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 74.4 111.073 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -103.23 -27.79 12.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 73.21 110.844 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -18.16 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.52 110.873 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.4 150.73 5.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 63.54 112.484 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.8 mt -62.14 155.09 25.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 72.43 110.937 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.78 141.84 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 73.51 111.099 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -136.61 122.91 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.893 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.68 112.23 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 73.33 111.139 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.94 128.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 74.5 110.852 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 p -71.92 -168.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 65.21 110.821 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -89.94 171.65 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.11 110.936 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -50.85 -60.77 2.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 74.21 110.96 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.47 159.04 36.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 64.12 110.896 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.56 -34.04 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.51 110.904 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.76 -39.47 77.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.798 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.09 -43.83 21.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 73.32 110.939 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.25 -48.53 62.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.152 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.99 -49.43 66.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 73.44 110.931 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.75 -19.48 65.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 74.12 110.967 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 tp -88.65 -26.14 22.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 65.25 110.91 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.5 -23.11 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 74.32 111.15 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -92.29 15.54 13.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 72.03 110.872 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.6 ptm -130.5 -39.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 70.41 110.887 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.7 m -79.76 -23.44 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 75.35 111.109 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.661 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.0 -25.03 66.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.3 110.827 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -104.77 -33.49 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 75.34 110.899 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -45.14 67.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.44 111.012 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -85.21 -12.59 52.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 74.52 110.852 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.5 11.21 7.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 72.43 110.829 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.93 141.37 50.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.412 . . . . 73.35 110.899 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -85.82 140.55 30.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.55 110.819 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.661 HG22 ' HE2' ' A' ' 72' ' ' GLU . 87.4 t -82.04 125.01 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 71.41 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -140.89 12.11 2.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 75.1 111.13 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -152.48 146.12 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.849 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.7 t -154.29 131.27 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.22 111.169 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.5 mt -92.68 126.75 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 62.01 111.082 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mm -101.85 150.42 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 74.53 111.16 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -45.43 3.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 72.44 111.109 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -149.32 175.76 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 73.4 110.872 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -98.27 87.07 3.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 72.03 111.047 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -143.73 156.23 44.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.897 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.79 -21.32 27.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 73.42 111.018 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.55 18.02 10.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.828 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -137.87 -76.52 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 72.24 110.796 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.5 7.42 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 71.3 111.072 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.68 -39.76 39.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 72.44 112.534 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.21 15.92 58.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.659 -0.781 . . . . 71.23 112.402 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.3 tt -57.14 -28.61 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 75.35 111.147 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -55.89 -30.22 61.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.939 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -88.87 -17.5 29.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 74.11 111.132 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.5 mt -88.5 -28.63 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 75.33 110.913 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -92.34 7.89 40.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.11 110.917 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -106.86 -55.27 2.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 70.13 110.917 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -63.97 -57.11 10.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 74.41 110.807 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.0 39.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.674 -0.774 . . . . 73.44 112.384 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.99 126.56 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 74.43 111.095 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -86.05 117.59 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 70.53 110.94 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.27 94.95 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 70.33 111.127 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -66.58 146.07 54.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 61.22 110.907 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -179.97 176.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 64.5 110.938 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.73 154.06 21.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 65.41 111.091 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.4 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 61.43 111.028 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 56.0 tp -67.25 -43.73 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.429 . . . . 74.54 110.861 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.0 m -59.65 -18.4 41.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 70.42 111.17 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.7 10.22 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.42 111.036 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.23 -27.31 8.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 54.52 110.917 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.14 -7.44 26.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 71.52 110.927 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.38 -38.39 63.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.01 111.068 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -26.84 61.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.862 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -58.74 -33.52 70.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.916 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -88.07 -21.35 24.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 75.31 110.93 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.36 5.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 75.01 112.466 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.38 175.2 6.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 74.11 110.9 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -74.17 -176.2 2.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.513 . . . . 75.15 110.933 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.44 106.93 45.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 54.42 110.853 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 178.4 4.65 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 71.34 112.273 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.4 mt -51.78 -42.92 62.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 73.22 110.972 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.31 27.57 24.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.735 -0.745 . . . . 62.51 112.519 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -108.1 43.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 72.33 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.7 mt -126.86 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 72.35 110.918 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.47 -172.05 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.941 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 55.5 m -50.9 -70.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.32 111.083 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.2 t -117.39 102.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 74.54 111.071 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t -132.45 174.7 9.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 70.3 111.106 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -120.96 134.44 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.903 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.4 mt -115.16 160.21 19.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 72.14 110.903 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -142.6 124.62 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.91 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -125.1 44.36 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 75.35 110.868 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.1 94.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.741 . . . . 72.54 112.45 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 m120 66.22 12.94 8.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.748 0.309 . . . . 74.13 110.91 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 53.5 tpp -135.74 109.8 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 74.22 110.777 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.81 133.34 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.886 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 20.0 t -138.79 115.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.31 111.122 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.6 129.98 55.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 72.1 110.844 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 p -86.8 -179.13 6.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 74.43 111.204 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -164.35 134.05 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.882 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -121.83 89.79 48.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.647 0.737 . . . . 75.31 110.936 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.78 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.73 2.286 . . . . 73.02 112.338 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 125.99 -160.91 20.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 70.12 112.553 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -79.33 134.83 36.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.903 0.383 . . . . 74.05 110.829 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.17 -89.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.559 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -74.26 -27.8 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 74.04 110.83 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.2 p -145.68 -159.96 1.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 73.3 111.091 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -86.79 -23.0 25.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 74.44 110.924 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -136.74 20.34 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 75.23 110.876 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -51.8 129.88 27.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 55.54 110.926 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 14.5 pt -134.99 179.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 74.21 111.111 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.6 m -129.24 152.06 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 70.34 111.101 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.8 t -103.21 119.18 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 75.21 111.144 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -107.62 138.09 44.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 74.02 110.9 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.41 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 32.3 mt -119.26 98.7 50.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.678 0.752 . . . . 65.31 110.911 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.1 Cg_endo -69.89 -4.72 14.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.763 2.308 . . . . 74.31 112.312 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -85.39 -22.4 28.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.32 110.886 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.64 12.41 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.4 110.958 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.1 26.25 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 71.13 110.905 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 99.4 mt -90.87 142.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 74.11 111.12 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.22 155.94 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 75.02 110.921 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.26 74.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 74.04 111.181 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.7 -39.49 46.59 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 75.31 112.547 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.44 -159.42 41.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.684 -0.77 . . . . 54.22 112.482 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 74.6 m -54.68 -38.37 66.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 74.52 110.83 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 24.2 tp -51.26 -33.49 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.3 110.937 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.97 108.05 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 61.33 111.066 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.46 163.1 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 72.32 110.86 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.21 167.56 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 61.34 110.827 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -62.46 147.24 49.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.43 111.208 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.62 20.65 10.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 61.13 110.839 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -79.9 155.15 27.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 74.4 111.02 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -119.21 -13.7 9.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 73.35 110.82 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.9 159.68 0.84 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 74.4 110.831 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.76 -38.3 86.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 73.4 110.987 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 105.88 -148.91 16.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 74.05 112.451 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -52.07 105.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.873 0.368 . . . . 63.44 110.869 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.7 m -107.18 24.4 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.35 111.176 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.36 62.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 73.03 111.069 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -116.33 24.71 11.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 72.33 110.846 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.53 172.65 11.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 74.5 111.108 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.77 88.19 2.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 73.45 110.981 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.1 t -63.0 -15.69 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 75.34 111.146 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -77.4 -22.14 52.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -118.42 -11.39 10.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 75.55 110.867 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -55.09 -60.91 2.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.959 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.7 p -53.8 -24.66 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.997 0.427 . . . . 73.51 110.927 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -81.58 -31.44 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 65.42 111.129 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -43.17 58.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.851 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.2 mm -61.58 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 71.42 111.133 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.31 -27.22 54.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 65.22 110.945 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -77.17 -22.19 52.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 71.34 110.891 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.26 -11.04 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 60.15 111.194 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.9 pp -111.72 -12.09 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 73.42 110.883 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -31.03 11.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 72.13 110.888 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -59.41 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 75.21 110.907 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -91.83 62.5 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.966 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -72.78 -60.22 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 73.4 110.858 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -52.03 102.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 70.55 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 75.0 mt -141.21 116.93 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 73.22 111.209 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.06 -26.77 63.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.924 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.98 134.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 62.1 111.091 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 95.2 t -106.87 144.9 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 71.23 111.166 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.84 104.77 48.56 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.594 0.711 . . . . 62.34 111.138 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -177.7 2.01 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.756 2.304 . . . . 72.21 112.322 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.3 -12.1 65.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.843 -0.694 . . . . 75.44 112.461 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -153.35 140.62 19.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.871 0.367 . . . . 71.43 110.83 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.32 -99.27 1.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 72.21 112.579 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.76 157.35 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.893 0.378 . . . . 72.43 110.882 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.2 m -54.73 162.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 74.32 111.134 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.65 -95.03 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.73 -0.747 . . . . 72.04 112.463 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -168.34 -169.01 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 72.14 110.842 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -61.02 -18.09 55.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.858 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.72 -21.45 36.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 72.32 112.501 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.25 -28.24 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 75.52 110.937 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.98 -59.61 3.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 74.03 110.877 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -17.32 55.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.422 . . . . 72.12 110.975 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -69.04 -46.8 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 74.14 110.894 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.6 m -51.73 -52.31 49.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.176 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.98 -18.47 46.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 73.14 110.941 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.88 -5.7 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 65.35 110.894 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.6 mt -128.42 -5.4 5.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 72.53 110.874 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.5 -4.6 11.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 65.14 110.844 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.12 110.901 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.7 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.819 0.343 . . . . 62.34 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -111.3 153.32 26.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.836 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -167.08 131.31 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 74.51 110.833 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.05 156.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 74.31 111.093 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.67 167.5 21.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.889 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -85.95 167.14 15.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 65.41 110.896 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.1 m -57.77 -55.02 40.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 75.11 111.114 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 m -58.31 -176.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 75.0 111.082 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -135.88 92.66 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.33 111.096 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -112.73 115.01 27.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 71.53 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -58.22 169.47 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 74.2 110.815 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.46 -48.31 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 72.15 110.93 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -61.35 -37.42 83.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 75.11 111.114 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.43 61.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 75.43 112.43 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.3 m -79.56 -44.82 20.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 60.41 111.144 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -101.6 113.0 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.05 111.083 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 p -120.82 127.58 52.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 74.45 110.843 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.52 112.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 73.53 111.116 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.4 t -99.82 127.1 46.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 75.35 110.875 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -70.23 110.93 5.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 64.45 110.917 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.5 mt -64.2 -31.74 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.878 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.451 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.93 -97.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.908 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' N ' HD21 ' A' ' 22' ' ' ASN . 18.6 tttt -150.64 9.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 74.22 110.87 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.408 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.28 7.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 72.21 110.904 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.9 141.71 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 75.42 111.171 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 17.1 m95 -129.44 -177.25 4.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.967 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -133.83 91.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 75.01 111.134 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -74.1 123.78 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.894 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.5 m -120.02 105.87 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.42 111.143 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.01 122.43 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.894 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 116.88 28.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 74.33 110.967 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.41 -141.48 8.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 71.51 112.514 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.9 p -175.35 81.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 74.22 110.86 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.66 88.66 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 73.45 110.936 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 63.63 18.47 11.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 73.33 110.866 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.34 -0.91 18.81 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.753 -0.737 . . . . 72.41 112.502 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -101.22 121.29 41.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 74.42 110.903 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.73 123.8 19.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 62.24 111.142 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.08 84.0 59.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 74.21 111.169 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 115.89 4.31 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.663 2.242 . . . . 62.05 112.342 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -103.0 98.16 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 73.12 110.829 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -59.19 163.75 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.816 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.81 -148.12 4.84 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.705 -0.759 . . . . 72.22 112.507 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.4 tp -159.08 115.2 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 74.42 110.949 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.5 t -99.67 122.27 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 62.4 111.108 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.3 mt -101.03 120.51 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 55.12 110.953 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -91.26 85.42 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 74.35 110.892 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -171.95 2.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 75.23 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.42 -15.06 14.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.862 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -5.77 43.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 74.13 110.864 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.13 8.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 72.13 112.439 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.0 tp -73.74 155.44 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.389 . . . . 73.42 110.932 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.07 138.14 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 71.2 111.128 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.05 123.46 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 70.12 110.904 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.96 114.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 72.54 111.142 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.54 127.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 73.02 110.827 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 p -72.35 -166.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 65.1 110.859 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -91.68 168.52 11.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 70.03 110.886 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -48.92 -60.31 2.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 75.33 110.863 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -129.57 159.51 36.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.55 110.751 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.578 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 72.9 m-20 -50.91 -32.29 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 74.31 110.941 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -58.29 -46.66 85.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 75.34 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.3 mt -74.38 -43.14 57.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.908 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.19 -49.54 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 71.43 111.128 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -53.43 -48.38 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 72.1 110.956 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -65.09 -18.92 65.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.14 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.5 tp -89.78 -26.82 20.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 74.31 110.892 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.9 mt -90.67 -22.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 74.54 111.222 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -92.56 16.25 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 75.43 110.907 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.9 ptm -131.35 -40.3 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.9 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.434 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 29.6 m -80.56 -22.06 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.5 111.213 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HE2' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -68.12 -23.08 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 71.12 110.919 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -107.75 -33.01 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 64.01 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 -40.41 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.924 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.25 -10.22 42.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.52 110.952 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.12 12.49 8.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 75.3 110.886 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -131.25 138.44 49.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 64.45 110.963 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.65 136.75 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.907 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.0 134.66 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 75.43 111.127 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.9 t -155.24 20.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 75.31 111.125 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -164.72 138.46 5.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.873 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -151.71 160.19 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 73.24 111.204 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.8 mt -116.42 135.43 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.137 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.54 121.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 65.41 111.104 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.1 p -78.45 -33.27 48.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.3 111.115 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -167.95 -174.89 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.32 110.931 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -98.89 97.69 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 74.42 111.047 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -156.77 155.25 31.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 72.04 110.903 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.11 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 73.13 111.129 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.45 26.35 3.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 73.1 110.792 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.48 -74.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.848 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.09 8.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.4 111.121 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.14 -39.8 27.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.684 -0.77 . . . . 52.41 112.612 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.81 12.95 56.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 74.5 112.506 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 tt -54.38 -27.97 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 64.25 111.128 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.578 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 25.3 mmtp -56.66 -35.62 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 65.1 110.87 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.3 m -85.12 -22.57 28.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 73.42 111.114 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.3 mt -80.92 -30.19 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.95 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.91 21.9 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.909 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.86 -41.56 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.912 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -80.07 -50.1 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.912 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.09 39.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.795 -0.716 . . . . 63.13 112.525 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -101.77 126.19 55.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.894 0.378 . . . . 71.53 111.127 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -85.89 112.35 21.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.904 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.67 100.73 12.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.44 111.058 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.1 m-70 -71.61 132.33 44.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 73.44 110.858 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.5 166.13 29.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 75.54 110.961 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.724 ' HB ' ' HD2' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -81.98 156.75 24.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.158 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.31 -40.53 35.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 72.25 111.114 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.423 HD13 ' HE2' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -70.72 -40.88 72.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 72.32 110.982 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.6 m -58.55 -20.96 50.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.107 -0.497 . . . . 73.33 111.097 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.43 8.08 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 74.33 111.105 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.423 ' HE2' HD13 ' A' ' 110' ' ' LEU . 3.6 pt-20 -108.4 -31.98 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 71.43 110.849 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.1 -11.42 26.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.54 110.984 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.42 -37.58 77.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 63.41 111.049 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.67 60.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 72.44 110.904 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -57.18 -33.28 67.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.14 110.848 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -89.85 -23.43 21.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 74.35 110.901 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.44 23.82 4.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 75.42 112.464 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -98.04 172.63 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 74.14 110.906 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.0 170.58 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 71.21 110.878 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -101.94 108.63 57.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.581 0.705 . . . . 75.34 110.881 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.6 Cg_endo -69.69 -176.58 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.701 2.268 . . . . 73.14 112.362 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.8 mt -51.29 -42.56 61.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.869 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 27.58 23.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 51.24 112.458 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.03 26.1 11.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.891 0.377 . . . . 64.3 110.923 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.8 mt -103.87 -175.48 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 74.03 110.861 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.69 -172.86 4.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 72.33 110.893 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.2 m -51.02 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 73.32 111.096 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.62 104.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 74.15 111.134 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t -127.76 160.47 31.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 75.01 111.16 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.34 107.3 13.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.881 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.17 -172.7 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.905 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -176.15 112.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.3 110.871 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -106.73 74.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.031 0.444 . . . . 73.21 110.898 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.21 -86.91 0.18 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.749 . . . . 65.02 112.476 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -114.95 24.95 11.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 75.11 110.881 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.1 tpp -132.82 142.6 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.04 110.898 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.42 130.17 55.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.835 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.8 t -139.87 120.2 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 72.33 111.165 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -113.85 130.63 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 65.55 110.801 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.2 p -88.28 171.18 10.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 75.33 111.105 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -156.58 138.76 14.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.885 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -125.59 89.7 51.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.627 0.727 . . . . 74.45 110.842 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -7.89 22.21 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.599 2.199 . . . . 65.2 112.352 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.26 -154.31 20.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.866 -0.683 . . . . 74.34 112.548 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -90.01 139.96 30.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 72.3 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.52 -87.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 62.11 112.481 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -77.06 -25.93 52.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 64.01 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.1 p -146.47 -161.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.43 111.193 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -90.1 -17.72 27.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.911 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.724 ' HD2' ' HB ' ' A' ' 108' ' ' THR . 18.5 t0 -135.26 17.42 3.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 74.15 110.835 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.07 129.77 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 71.33 110.854 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.9 pt -135.3 -177.77 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 74.33 111.127 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.9 m -136.24 133.4 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.095 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.3 t -85.59 114.2 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 65.31 111.225 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -102.45 133.82 46.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.89 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.8 mt -113.59 97.76 44.87 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.575 0.702 . . . . 74.35 110.903 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 -4.11 13.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.719 2.279 . . . . 71.44 112.347 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -85.18 -23.28 28.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 74.11 110.967 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -142.04 13.01 2.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.41 110.954 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.37 27.42 8.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.882 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.13 124.67 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.462 . . . . 73.52 111.176 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 20.7 tp -106.08 146.97 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.884 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.15 80.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.44 111.115 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.53 -40.48 47.29 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.38 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 68.89 -165.09 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.799 -0.715 . . . . 71.41 112.505 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -27.45 25.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 61.33 110.916 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 23.3 tp -57.25 -61.14 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.826 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 35.1 t -75.28 112.38 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 72.21 111.054 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -54.0 151.15 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 63.33 110.839 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.8 p -99.74 157.28 16.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 74.01 110.85 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.3 t -51.53 -29.84 18.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 63.32 111.164 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 t -94.98 45.02 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 71.52 110.869 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -134.2 138.16 44.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 74.24 111.009 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -117.55 -0.03 11.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 74.2 110.916 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.24 154.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 74.01 110.857 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.44 -36.74 84.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 75.14 110.966 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.7 -140.73 17.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.673 -0.775 . . . . 74.54 112.441 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -58.94 98.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 62.41 110.87 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.6 m -98.29 24.47 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 73.32 111.129 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.65 81.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.44 111.088 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -106.61 20.71 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 73.41 110.903 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -133.06 154.39 50.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.106 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -107.44 86.79 2.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.931 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 24.0 t -61.16 -17.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 73.43 111.114 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -74.27 -25.91 59.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.958 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.66 -11.97 13.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 74.21 110.954 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -54.37 -61.7 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 72.44 110.972 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -24.29 16.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.855 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.92 -32.34 30.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.18 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -43.31 63.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.882 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 29.8 mm -62.15 -43.94 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 73.21 111.104 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.07 -24.07 62.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 65.25 110.956 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.31 -21.56 36.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.844 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.3 t -88.13 -8.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 74.53 111.1 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.36 -8.21 13.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.941 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -104.57 -30.93 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -104.31 -48.93 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 74.31 110.873 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -102.13 39.44 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 73.41 111.008 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.79 -47.9 76.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.502 . . . . 72.14 110.867 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -60.31 99.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.03 110.863 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.8 mt -140.16 123.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.047 -0.524 . . . . 74.43 111.107 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.94 -16.0 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.915 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -173.58 132.69 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 74.44 111.048 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.9 128.62 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 72.45 111.179 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 19.6 t -108.43 104.12 53.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.644 0.735 . . . . 72.31 111.083 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 52.9 Cg_endo -69.82 -169.54 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.274 . . . . 71.44 112.32 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.47 -15.5 66.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.701 -0.761 . . . . 45.21 112.476 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -152.01 139.72 19.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.976 0.417 . . . . 75.21 110.803 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 109.52 -117.29 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.812 -0.709 . . . . 60.01 112.543 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.65 173.44 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 75.11 110.897 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.1 t -70.5 144.85 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 72.52 111.154 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.66 -93.32 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.671 -0.775 . . . . 73.1 112.474 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -172.13 -167.17 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 72.54 110.899 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -19.37 38.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 71.42 110.864 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.72 -23.14 20.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.695 -0.764 . . . . 65.01 112.534 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 7.0 mt -76.87 -32.68 57.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.318 . . . . 73.55 110.882 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.12 -61.98 2.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.898 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.19 -22.24 60.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.939 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -62.0 -44.69 96.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.901 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.2 m -51.45 -53.97 31.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 63.22 111.12 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.28 -18.72 51.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 75.12 110.902 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 73.2 110.88 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.7 mt -126.01 -6.37 6.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 73.51 110.938 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.83 9.72 11.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.951 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.12 110.896 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.811 0.338 . . . . 71.15 110.898 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.67 179.43 0.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 75.41 110.893 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.1 mttm 58.67 179.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 75.23 110.913 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.8 m -81.03 -176.23 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 71.33 111.178 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -159.7 133.42 7.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.909 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 -177.71 3.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 75.42 110.932 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -93.99 -39.96 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 61.55 111.189 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.57 -176.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 75.53 111.114 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -136.38 94.41 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 74.41 111.131 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -112.53 115.26 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.34 110.919 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -57.64 167.88 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 65.01 110.894 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -51.71 -48.08 63.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.859 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.74 -37.84 83.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.103 -0.498 . . . . 74.31 111.158 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.16 60.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.784 -0.722 . . . . 65.02 112.528 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.3 m -80.92 -43.53 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 75.34 111.126 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.48 118.42 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 64.21 111.115 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 p -124.02 131.37 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.749 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.96 110.4 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 63.42 111.14 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -100.6 123.69 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 74.12 110.872 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.15 110.98 4.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 71.53 110.893 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.75 -31.83 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.11 110.818 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.472 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.02 -97.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 73.34 110.894 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -151.5 10.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 74.11 110.922 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.59 6.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.54 110.806 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -151.0 139.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 73.25 111.108 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -127.44 -173.99 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.937 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.2 t -137.27 97.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 74.44 111.092 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -81.47 121.36 26.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 70.53 110.888 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.2 m -116.19 92.27 3.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 72.11 111.136 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -72.97 117.6 14.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 71.25 110.85 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.34 111.49 21.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.898 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.25 -129.4 3.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 65.34 112.458 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 p -175.44 117.34 0.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.939 0.4 . . . . 63.41 110.893 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -107.92 78.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 64.31 110.872 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 69.76 2.77 3.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 65.35 110.874 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.68 -8.02 3.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 72.01 112.499 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -100.9 121.82 42.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 74.41 110.92 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 120.22 8.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 71.42 111.081 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 t -111.02 80.83 2.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.656 0.741 . . . . 75.24 111.084 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 118.27 5.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.581 2.187 . . . . 75.11 112.395 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -103.54 100.68 10.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 74.55 110.852 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -49.36 162.4 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 65.21 110.885 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -157.48 -166.8 17.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 70.2 112.477 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -153.12 113.27 3.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 72.03 110.903 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -97.59 117.98 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 74.44 111.049 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 24.7 mt -95.9 122.74 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 72.14 110.918 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.03 84.41 5.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 53.2 110.853 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.55 178.87 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 72.53 111.189 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.82 -26.66 14.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 74.03 110.837 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -18.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 75.33 110.864 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.79 151.33 5.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 35.51 112.476 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.5 mt -62.0 153.72 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 73.25 110.923 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.56 139.73 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 74.11 111.139 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -136.1 122.92 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.918 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.11 111.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 70.33 111.104 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.596 ' HD2' ' CG2' ' A' ' 85' ' ' THR . 1.6 m-20 72.98 125.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 73.25 110.905 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.7 p -69.6 -166.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 73.53 110.819 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -90.96 168.45 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 74.11 110.906 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -50.71 -60.42 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 74.13 110.945 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -126.03 160.87 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.806 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -53.63 -37.82 63.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 61.04 110.884 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.94 -37.52 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 72.34 110.878 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.4 mt -80.28 -43.55 21.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.2 110.91 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.58 62.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 73.41 111.125 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -52.71 -48.37 66.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.95 -18.79 65.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 72.5 110.835 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.1 tp -89.43 -25.45 21.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 74.23 110.879 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.3 mt -91.93 -24.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.057 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.87 12.36 19.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.911 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ptm -127.48 -39.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 71.21 110.923 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 m -79.84 -22.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 74.53 111.115 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -22.69 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 65.35 110.949 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -107.41 -31.08 8.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 72.11 110.826 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -73.15 -44.68 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 71.31 110.951 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -85.95 -13.11 48.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.873 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.72 15.35 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.936 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 139.5 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 65.22 111.002 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -77.76 139.21 39.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 74.13 110.937 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.39 134.67 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 71.35 111.137 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 t -160.37 20.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 72.2 111.124 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -155.37 143.6 20.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 65.55 110.902 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 t -156.84 105.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 73.24 111.076 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.8 mt -71.11 121.27 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 72.33 111.144 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mm -94.36 149.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 74.05 111.17 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.596 ' CG2' ' HD2' ' A' ' 56' ' ' ASP . 29.6 p -108.44 -42.12 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.13 111.15 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -164.54 -175.17 3.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 62.31 110.823 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.19 98.4 11.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 62.51 111.052 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.483 ' CE1' ' HE2' ' A' ' 149' ' ' HIS . 0.3 OUTLIER -153.81 153.81 32.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 64.43 110.868 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.19 -19.98 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 61.44 111.124 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -91.81 4.48 52.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 55.13 110.844 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -120.69 -78.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.02 110.932 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.78 7.08 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 73.1 111.176 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.36 -41.47 48.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 71.22 112.539 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.15 13.21 60.36 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.734 -0.746 . . . . 74.42 112.491 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.8 tt -54.79 -26.39 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 73.53 111.144 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -54.54 -35.35 63.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 73.35 110.932 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.6 m -88.92 -12.86 40.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 63.25 111.159 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.56 -35.86 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 74.13 110.95 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -84.24 2.67 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 74.42 110.912 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.68 -51.07 3.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.31 110.842 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -69.83 -59.91 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.2 110.835 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.87 43.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.722 . . . . 54.44 112.557 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -103.34 120.31 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 74.33 111.147 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -73.2 114.39 11.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 74.14 110.858 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.06 85.58 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 45.13 111.1 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -56.92 144.54 33.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.785 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.6 169.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.14 110.89 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.77 157.34 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 72.44 111.122 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.87 -40.41 29.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 73.3 111.062 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.14 -47.54 79.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 72.53 110.937 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 52.3 m -58.63 -20.73 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 74.54 111.094 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.76 12.39 36.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 73.3 111.191 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -114.97 -31.74 5.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 75.34 110.934 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.68 -13.87 23.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 75.22 110.866 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.44 78.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.971 0.415 . . . . 71.32 111.133 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -20.86 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 75.51 110.956 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.01 -32.43 74.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.826 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -90.25 -18.22 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 72.33 110.865 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.67 27.2 5.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 61.21 112.45 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.34 173.95 6.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 74.34 110.923 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -80.35 160.56 25.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 71.23 110.883 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -92.71 111.85 52.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.713 0.768 . . . . 74.31 110.954 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 72.53 112.393 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.8 mt -51.68 -45.54 63.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.13 110.885 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.49 34.94 43.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 73.14 112.527 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.12 36.26 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.827 0.346 . . . . 70.35 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.6 mt -120.07 -172.34 2.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.848 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.75 -171.84 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 73.03 110.921 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.0 m -50.56 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.02 111.121 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -119.39 103.88 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 73.12 111.131 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 t -135.37 175.63 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 71.14 111.193 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -120.34 131.36 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.849 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 31.4 mt -109.07 152.2 25.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.882 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -130.74 125.36 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 74.24 110.918 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -129.0 26.53 5.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.867 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.28 95.67 0.21 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 44.03 112.536 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 66.07 13.09 8.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.735 0.303 . . . . 74.24 110.882 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.9 tpp -133.71 106.29 7.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 75.21 110.97 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.98 127.43 37.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 74.25 110.87 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.69 113.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 61.22 111.142 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -109.74 131.41 55.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.798 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.7 p -85.09 178.65 7.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 71.02 111.189 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -161.05 133.27 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.843 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -122.82 86.45 50.15 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.699 0.761 . . . . 71.33 110.94 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -7.99 22.45 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.757 2.305 . . . . 60.01 112.373 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.39 -160.06 23.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.74 . . . . 54.43 112.536 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -87.61 140.63 29.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 74.14 110.924 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.66 -88.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 74.11 112.435 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.483 ' HE2' ' CE1' ' A' ' 88' ' ' HIS . 67.5 t60 -76.95 -22.97 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.31 110.815 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.4 p -151.18 -168.85 3.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 75.32 111.183 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -86.09 -5.53 59.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 72.52 110.902 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -147.07 16.47 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 54.43 110.857 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -49.33 127.38 14.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.8 pt -133.72 175.06 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 74.43 111.123 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.6 m -129.33 119.74 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 75.42 111.105 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.61 120.26 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 71.05 111.141 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -108.45 136.55 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.11 110.929 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 71.6 mt -118.59 98.64 51.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 72.33 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.1 Cg_endo -69.79 -3.87 12.91 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.635 2.223 . . . . 74.32 112.322 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -86.53 -23.42 25.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 74.02 110.86 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -139.35 11.13 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 75.23 110.968 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.4 m120 55.2 25.79 7.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 75.42 110.818 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 87.6 mt -90.8 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 75.41 111.086 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 15.1 tp -126.14 146.53 49.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 75.43 110.925 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 48.8 t -112.02 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 74.11 111.163 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.81 -29.45 26.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.771 -0.728 . . . . 60.13 112.458 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.95 -160.13 12.51 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.694 -0.765 . . . . 62.3 112.422 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -26.66 65.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 74.11 110.896 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.15 -35.67 71.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 73.33 110.843 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.66 111.78 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 63.44 111.132 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -51.79 164.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 73.32 110.904 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.2 p -103.18 163.47 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 72.42 110.836 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.5 t -56.81 -23.83 46.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.52 111.093 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.4 p -104.52 22.47 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.5 110.904 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -95.63 149.93 20.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 75.53 111.049 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -122.11 -5.5 8.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.863 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.26 175.86 0.9 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 62.22 110.903 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.9 mt -83.84 -32.51 25.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 75.11 110.954 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 127.66 -128.96 6.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.803 -0.713 . . . . 65.42 112.501 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 181' ' ' VAL . 0.5 OUTLIER -110.84 3.39 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 73.42 110.937 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 180' ' ' ASN . 27.4 m 36.77 44.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 74.0 111.105 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.32 68.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 72.22 111.008 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -138.64 30.66 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.42 110.895 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.02 165.95 17.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 71.23 111.133 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -119.88 91.94 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.928 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -62.8 -16.13 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 74.43 111.09 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -75.53 -22.58 56.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 64.13 110.878 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.67 -13.49 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 73.55 110.915 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -54.02 -62.46 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 74.41 110.941 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.81 -23.55 18.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 71.21 110.905 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.2 m -81.3 -31.11 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 72.41 111.164 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.51 -43.11 50.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.135 -0.484 . . . . 63.43 110.98 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.0 mm -62.09 -45.52 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 74.02 111.151 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -57.04 -24.1 51.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 64.21 110.799 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -81.68 -22.28 37.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 64.42 110.941 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.5 t -86.7 -9.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 75.51 111.126 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.69 -6.59 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.924 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.57 -31.15 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.925 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 -55.48 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.55 110.859 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.13 38.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 73.14 110.904 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -56.34 -47.66 78.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 74.31 110.814 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -59.59 99.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.842 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.7 mt -142.61 124.26 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 70.22 111.206 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.84 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 71.04 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.71 133.73 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 74.32 111.107 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.6 t -114.56 134.05 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 75.04 111.117 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.405 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 9.6 t -112.82 108.94 53.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.657 0.741 . . . . 74.14 111.146 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.73 -169.82 0.35 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 73.41 112.333 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.42 -17.88 63.44 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 73.45 112.474 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -152.49 151.28 30.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 75.15 110.868 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 102.68 -101.02 2.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 73.54 112.49 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -173.51 161.56 4.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 72.51 110.943 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 m -51.85 163.02 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 71.51 111.128 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.73 -106.81 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.666 -0.778 . . . . 61.32 112.443 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -169.48 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.34 . . . . 73.03 110.851 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -60.78 -18.25 53.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 62.12 110.878 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.42 -18.72 44.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 73.24 112.472 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.3 mt -71.53 -31.03 66.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 74.41 110.976 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.77 -56.93 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 74.23 110.87 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -16.3 60.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 71.15 110.785 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -68.36 -41.76 80.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 71.31 110.911 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 25.4 m -61.16 -50.22 74.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.161 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -24.41 67.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 73.22 110.887 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.49 -12.28 60.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.9 mt -117.85 -19.5 9.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.895 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.03 0.9 22.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 75.21 110.871 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.893 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.763 0.316 . . . . 64.24 110.869 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 61.79 95.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.94 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -120.8 149.38 42.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 75.14 110.897 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.5 152.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 73.14 111.12 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -143.87 135.59 26.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 72.42 110.941 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt -114.67 -177.11 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.901 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 m -100.38 -68.71 0.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 74.42 111.181 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.65 147.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 71.1 111.137 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -113.1 96.48 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 73.42 111.081 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -117.54 115.89 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.916 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -60.54 166.3 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.52 110.877 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.68 -48.31 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.885 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.0 p -61.66 -37.5 84.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.47 63.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 72.42 112.541 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.5 m -80.52 -44.2 19.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 75.41 111.131 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.6 mt -104.63 109.09 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 73.2 111.166 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -115.62 140.28 49.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 71.41 110.893 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mt -131.35 110.23 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 73.11 111.127 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -98.31 126.75 43.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 73.21 110.816 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -71.88 110.01 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 75.34 110.914 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.23 -33.81 76.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 72.22 110.905 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.45 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.1 -97.0 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.921 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.34 9.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.926 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.404 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.75 7.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.829 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 t -150.96 140.95 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.162 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 17.2 m95 -129.19 -176.26 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 74.13 110.927 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -134.15 89.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 72.32 111.115 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -73.03 125.24 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.886 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.8 m -121.57 103.49 8.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.04 111.076 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.75 118.7 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.15 110.955 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.34 127.9 34.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 72.34 110.931 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.2 -130.42 6.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 73.22 112.573 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 p -175.48 117.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 73.14 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.47 87.26 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.935 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 55.0 48.69 19.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 53.04 110.879 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 -11.9 68.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.683 -0.77 . . . . 72.13 112.542 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -87.68 -169.76 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 74.21 110.892 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.87 134.39 47.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 73.24 111.041 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t -125.73 81.48 65.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.729 . . . . 73.35 111.251 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 121.26 7.96 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.631 2.221 . . . . 73.1 112.422 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.05 96.99 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.86 167.05 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 73.23 110.923 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -157.83 -146.65 4.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 74.52 112.493 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.1 tp -159.16 120.02 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 73.24 110.927 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -103.8 123.0 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.156 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.6 mt -100.54 121.45 41.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 75.0 110.972 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.22 85.99 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.32 110.948 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -101.73 -179.87 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 75.32 111.176 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.4 m -99.98 -24.37 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 61.44 110.881 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -19.0 50.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.43 110.874 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.64 145.34 4.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 34.13 112.43 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 mt -58.23 155.04 12.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.921 0.391 . . . . 63.14 110.87 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.62 141.55 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 73.14 111.109 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -137.1 122.45 19.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 71.22 110.941 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.16 111.72 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.198 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 73.5 141.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 74.1 110.843 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -83.11 -164.72 0.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 70.15 110.838 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.8 t -96.25 169.78 9.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 65.22 110.8 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -50.61 -59.24 4.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.925 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.64 163.48 23.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 73.55 110.872 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.21 -37.17 71.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 72.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -57.44 -34.9 69.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.24 110.893 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.51 -48.13 12.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.991 0.424 . . . . 73.11 110.864 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.3 -49.06 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 74.41 111.133 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -52.31 -50.73 61.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.04 110.899 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.0 -20.62 66.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 72.1 110.959 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.09 -26.02 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 74.44 110.965 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.3 mt -92.39 -24.54 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 71.5 111.131 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.14 1.87 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 73.3 110.87 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ptm -119.61 -35.67 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 71.34 110.957 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.19 -26.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 75.22 111.062 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.94 -21.05 63.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 74.24 110.864 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.37 -32.01 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 74.43 110.837 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -44.02 59.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.914 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -85.91 -12.85 49.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 63.42 110.944 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.49 11.26 7.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.94 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 139.17 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.973 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -82.81 139.36 33.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.41 110.891 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.5 t -82.74 121.06 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.43 111.188 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.2 8.14 2.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 64.31 111.118 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -147.09 145.2 29.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.185 -0.461 . . . . 63.14 110.91 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 t -156.09 138.41 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 72.31 111.225 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.3 mt -94.09 136.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 75.44 111.18 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mm -100.94 149.47 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.111 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -115.39 -38.4 3.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.43 111.162 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -169.93 172.06 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.844 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.11 89.15 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 64.34 111.143 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -148.67 154.97 40.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 73.02 110.895 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.64 -23.5 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 74.52 111.131 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -92.23 27.23 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.25 110.85 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.435 ' HE ' HG22 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -152.24 -70.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.928 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.435 HG22 ' HE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -90.17 3.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 73.23 111.122 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -44.39 54.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 72.2 112.51 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.51 13.97 63.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 74.11 112.526 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 tt -57.61 -26.06 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 74.51 111.214 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -55.1 -27.43 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 74.41 110.847 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -95.33 -38.46 10.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 71.24 111.196 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.9 mt -56.22 -46.09 79.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.34 110.897 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -0.99 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.94 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.53 -44.97 8.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.94 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -79.48 -61.39 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.81 39.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 62.33 112.394 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -101.9 120.3 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.798 0.332 . . . . 74.35 111.164 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -78.5 118.02 20.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.868 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.35 85.01 4.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.024 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -55.01 110.43 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 74.04 110.849 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 t -139.67 -175.6 4.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.844 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.17 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 72.53 111.03 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.32 -36.75 44.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.062 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -48.45 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.921 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.9 m -59.09 -18.78 38.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 72.22 111.207 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -101.37 13.07 36.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 73.35 111.083 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -115.6 -27.44 7.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.889 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.37 -11.74 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.2 110.879 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.11 69.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 73.34 111.068 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -20.72 60.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 64.24 110.907 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.37 -32.41 73.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 71.12 110.946 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -88.48 -14.86 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.843 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 22.53 7.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.753 -0.737 . . . . 73.51 112.437 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -102.59 170.76 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.9 0.381 . . . . 64.14 110.844 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -72.78 -170.73 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 51.44 110.915 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.58 121.66 29.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.613 0.72 . . . . 74.44 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -169.96 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.692 2.261 . . . . 62.02 112.328 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mt -59.5 -39.87 85.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 72.02 110.925 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.69 26.0 30.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.729 -0.748 . . . . 70.13 112.471 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.35 39.97 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 62.43 110.926 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.8 mt -131.62 -172.81 2.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.948 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.65 -169.71 2.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 74.04 110.972 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.8 m -48.3 -67.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 73.33 111.199 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.7 t -120.53 109.31 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 70.2 111.13 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.2 t -138.68 176.15 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 74.23 111.049 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -122.87 137.39 54.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.2 mt -118.84 151.88 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 73.53 110.914 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.31 126.74 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 65.41 110.92 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.24 34.04 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 73.23 110.909 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.04 94.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 50.22 112.471 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.15 12.48 8.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.857 0.36 . . . . 72.42 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.5 tpp -134.76 101.11 4.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.147 -0.479 . . . . 75.32 110.878 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -89.34 130.3 35.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.15 110.909 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.6 t -138.41 115.56 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 70.25 111.12 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -110.5 130.15 55.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 71.4 110.872 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.9 p -84.87 -174.13 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 72.34 111.133 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -170.1 137.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.914 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -123.83 89.61 51.36 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.664 0.745 . . . . 71.34 110.89 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -8.25 23.12 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.717 2.278 . . . . 73.24 112.302 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.05 -149.11 19.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 74.3 112.566 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -97.11 138.97 33.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 74.34 110.853 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.15 -96.31 0.15 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 71.2 112.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.8 -24.9 63.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 72.4 110.901 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.8 p -152.2 -175.72 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 72.24 111.184 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.64 0.58 52.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 73.14 111.01 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -141.72 12.09 2.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 71.12 110.902 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.81 140.97 28.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 74.24 110.889 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.8 pt -146.32 -179.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 71.42 111.054 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.68 124.95 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 74.14 111.128 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.8 t -82.8 138.92 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 73.1 111.122 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -123.66 130.52 52.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 74.42 110.871 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.3 mt -111.84 98.17 40.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 74.24 110.89 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -4.21 13.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.802 2.334 . . . . 73.55 112.282 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -83.53 -23.32 32.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 72.31 110.841 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.27 14.29 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 74.42 110.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.5 m120 53.84 27.22 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.74 136.56 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.137 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 14.4 tp -119.6 144.42 47.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.981 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.13 76.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 74.34 111.074 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.92 49.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.733 . . . . 73.21 112.511 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.28 -162.56 51.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.74 . . . . 62.0 112.525 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 61.0 m -51.74 -29.64 19.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 62.54 110.815 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.4 tp -55.2 -53.96 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 74.43 110.889 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.6 t -83.39 114.68 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.32 111.128 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -57.08 149.79 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.977 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.1 p -95.14 158.56 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 73.22 110.978 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t -56.47 -25.03 49.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.2 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.1 t -98.34 43.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 54.31 110.864 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.13 145.43 47.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 71.01 111.045 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -122.55 2.05 9.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 72.24 110.863 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.33 154.04 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.227 -0.442 . . . . 71.33 110.89 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.65 -36.62 82.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 74.51 110.896 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.35 -143.24 20.08 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.731 -0.747 . . . . 75.01 112.55 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -52.43 103.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 75.2 110.856 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.88 22.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 74.13 111.164 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.35 72.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 71.12 111.125 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -110.44 24.23 13.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 75.02 110.819 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.33 153.32 50.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 73.14 111.152 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -106.59 86.26 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 74.13 110.936 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.37 -18.66 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 75.41 111.099 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.51 -29.27 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.861 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -108.87 -13.78 14.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.862 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -53.59 -62.23 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.123 -0.489 . . . . 74.23 110.999 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.56 -24.01 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.43 . . . . 73.42 110.862 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.0 m -81.73 -31.57 31.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 52.52 111.139 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -45.4 48.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.865 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mm -58.35 -46.62 89.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 73.33 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.68 -29.36 62.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 72.35 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.28 -20.35 55.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 72.4 110.873 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 38.3 t -87.58 -12.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 73.41 111.214 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.2 pp -108.9 -7.08 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 73.05 110.884 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.1 -30.78 10.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 74.44 110.871 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.83 -49.76 3.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.853 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.15 40.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 64.52 110.863 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -55.51 -47.76 75.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 63.34 110.766 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -59.07 103.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.44 110.944 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -146.06 126.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 71.11 111.085 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.83 -27.21 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.03 110.941 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -163.24 146.42 10.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 74.43 111.105 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.85 132.63 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 74.4 111.126 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 208' ' ' PRO . 10.8 t -113.69 107.58 52.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 64.53 111.068 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.8 Cg_endo -69.7 -176.27 1.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.708 2.272 . . . . 75.13 112.41 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.17 -14.27 80.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 64.42 112.573 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -152.36 130.66 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 73.1 110.811 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 118.59 -118.37 4.0 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 65.33 112.454 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -153.47 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 71.13 110.849 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.2 t -72.07 145.08 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.015 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -141.5 -91.25 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.812 -0.708 . . . . 64.12 112.552 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.82 -168.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 75.05 110.888 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -15.14 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.31 110.913 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.22 -18.59 42.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.658 -0.782 . . . . 75.54 112.602 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 11.0 mt -74.03 -44.35 54.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 71.31 110.878 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.06 -57.32 12.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 63.43 110.891 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.0 pp -58.22 -22.6 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.91 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.2 -34.98 75.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.12 110.918 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 m -57.77 -55.44 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 65.34 111.173 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.06 -19.69 61.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.851 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -12.01 58.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.822 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.4 mt -117.63 -16.59 10.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.874 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.73 3.85 19.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 75.44 110.878 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.4 110.968 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.749 0.309 . . . . 55.43 110.916 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.88 91.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 64.24 110.852 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -169.69 120.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.964 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.1 t -57.07 140.38 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.14 111.143 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -158.18 154.55 27.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 72.34 110.914 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -62.76 -179.71 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 71.22 110.927 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 m -82.49 -42.31 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 71.23 111.058 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.19 -177.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 73.34 111.208 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -135.83 91.76 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 74.44 111.091 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -111.76 118.13 34.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 75.35 110.95 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -61.38 168.34 2.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 73.14 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.78 -47.88 64.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 74.55 110.779 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.42 -37.87 82.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.4 111.082 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 13.4 61.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 62.31 112.493 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -80.79 -43.8 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.756 0.312 . . . . 72.43 111.15 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 mt -103.54 117.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.08 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -125.04 129.99 51.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 70.33 110.843 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.41 110.05 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 71.02 111.033 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -101.26 128.44 47.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 64.05 110.842 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -71.1 111.03 6.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 73.44 110.875 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.07 -32.08 73.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 74.33 110.855 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.47 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.12 -97.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 73.21 110.88 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' N ' HD21 ' A' ' 22' ' ' ASN . 1.5 tptp -151.52 9.98 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 71.03 110.926 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.52 6.19 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 71.44 110.899 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -150.99 139.73 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.437 . . . . 70.52 111.109 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -126.87 -174.97 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 71.42 110.966 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -135.85 95.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 73.33 111.175 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -80.33 122.24 26.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.775 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.9 m -118.2 100.36 7.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 71.04 111.133 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.9 117.08 23.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.15 110.937 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.41 115.31 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 75.04 110.95 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.29 -131.66 1.53 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.676 -0.773 . . . . 75.12 112.514 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 p -175.53 117.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 72.23 110.909 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.01 87.02 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.921 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 55.5 46.78 22.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 74.2 110.864 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.32 -12.75 65.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 72.32 112.498 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.4 -169.66 2.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 74.2 110.837 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.95 135.65 49.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 72.41 111.079 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.54 83.03 63.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.611 0.72 . . . . 53.43 111.092 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 118.16 5.52 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.615 2.21 . . . . 71.21 112.304 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.1 p -105.52 99.7 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 65.11 110.838 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.76 164.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 63.21 110.835 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -157.89 -164.32 13.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 74.2 112.447 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.0 tp -153.69 115.36 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 71.13 110.929 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.56 116.76 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.44 111.138 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.42 121.23 35.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 73.43 110.905 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -90.98 84.37 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 41.34 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -97.45 -177.03 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 75.35 111.117 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -103.97 -19.41 14.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.764 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -16.41 37.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 75.41 110.926 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 146.85 4.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.791 -0.719 . . . . 74.13 112.584 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.8 tp -60.13 155.26 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.37 . . . . 74.42 110.9 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.8 142.6 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 63.15 111.211 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mt -138.53 125.66 21.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.918 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 79.7 t -69.88 110.18 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 74.55 111.136 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.91 141.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 72.23 110.823 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.77 -160.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.949 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.6 t -98.44 170.06 9.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.881 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -53.06 -59.99 3.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 72.2 110.962 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.67 158.53 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.22 110.903 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 67.1 m-20 -52.85 -39.58 62.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 63.25 110.889 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -55.72 -25.79 42.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.2 110.958 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.11 -50.01 5.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 71.42 110.892 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.19 -43.6 52.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.152 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.4 -48.23 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.891 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.36 -21.08 66.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.926 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 tp -87.37 -27.3 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.87 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.56 -22.58 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 75.15 111.143 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -91.96 14.28 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 73.12 110.927 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ptm -129.49 -40.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 65.22 110.881 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.0 m -78.37 -22.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 75.32 111.096 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.721 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.82 -25.27 65.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 72.22 110.834 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -104.14 -32.73 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.13 110.85 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -47.01 58.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 75.4 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -82.61 -11.17 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 73.45 110.828 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 68.07 11.73 8.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 65.12 110.931 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -132.24 140.43 48.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.55 110.904 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.854 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.721 HG22 ' HE2' ' A' ' 72' ' ' GLU . 71.9 t -79.47 120.22 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 75.54 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.6 t -132.88 4.28 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 75.05 111.135 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -147.58 146.53 29.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.868 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.3 t -155.35 129.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 75.54 111.118 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.6 mt -84.5 133.33 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 73.32 111.132 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mm -97.44 147.55 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 54.51 111.172 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.7 p -110.91 -35.64 5.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 73.21 111.119 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -173.15 -176.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.841 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.88 84.74 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 74.13 111.112 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -145.05 154.46 42.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 75.52 110.907 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.84 -23.1 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 64.02 111.079 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.46 26.31 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.853 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.43 ' HE ' HG23 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -151.28 -70.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 75.2 110.89 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.43 HG23 ' HE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.9 2.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 72.53 111.18 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -45.06 43.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.803 -0.713 . . . . 72.23 112.395 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.43 15.93 58.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 71.33 112.54 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 tt -54.24 -26.77 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 71.12 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.412 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 32.9 mmtm -58.75 -27.61 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.35 110.979 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -90.16 -20.21 23.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 72.24 111.097 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.7 mt -82.45 -37.47 25.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 74.32 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -92.51 20.42 6.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.923 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -118.42 -43.07 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 71.55 110.821 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -84.43 -54.0 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.871 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.76 39.19 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 65.12 112.488 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -103.85 113.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.852 0.358 . . . . 71.11 111.179 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -79.74 113.96 18.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.904 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.88 91.4 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 63.23 111.058 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -64.38 112.09 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.85 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.05 -175.01 4.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.882 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.7 158.05 15.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 74.44 111.11 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.5 -40.36 51.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 74.52 111.098 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.9 tp -75.09 -39.12 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.24 110.937 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.0 m -58.84 -21.69 57.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.132 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.61 0.87 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 73.0 111.083 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.48 -50.62 3.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.905 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.31 110.92 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.45 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 64.43 111.121 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -26.23 61.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.51 110.902 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -31.93 62.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 75.53 110.882 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -93.23 -21.22 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 64.44 110.837 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.36 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 73.24 112.574 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.41 ' CD1' HG12 ' A' ' 92' ' ' ILE . 85.7 m-85 -97.34 178.47 5.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 71.01 110.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -76.17 -176.39 3.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 71.11 110.841 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -118.86 110.96 37.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 74.14 110.899 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -169.76 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.614 2.209 . . . . 71.31 112.398 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.6 mt -61.81 -49.49 76.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 64.21 110.913 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 60.19 20.26 53.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.75 . . . . 75.11 112.506 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.42 31.31 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 71.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.2 mt -116.51 -174.48 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.93 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.24 -171.02 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 75.51 110.915 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 54.1 m -50.79 -70.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.24 111.182 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.37 102.03 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 72.21 111.153 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -124.78 162.28 24.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 63.4 111.209 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.96 100.94 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 74.43 110.916 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 27.4 mt -78.71 -179.89 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 72.41 110.969 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -171.74 112.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 71.44 110.961 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -106.73 73.93 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 75.22 110.807 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.43 -84.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.843 -0.694 . . . . 73.24 112.445 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.19 26.95 9.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.352 . . . . 75.1 110.833 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.6 tpp -130.43 142.93 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 70.43 110.932 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.54 125.33 48.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 74.03 110.897 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.4 t -138.85 119.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 74.35 111.195 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -113.54 127.86 56.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.964 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.5 p -82.78 -173.6 4.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 74.22 111.145 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -170.89 135.9 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 73.12 110.861 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -125.12 90.34 51.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.816 0.817 . . . . 75.22 110.962 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.86 -7.78 21.94 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.662 2.241 . . . . 73.11 112.309 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.86 -150.8 18.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 73.35 112.554 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -91.63 139.7 30.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 74.42 110.957 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.67 -89.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.692 -0.765 . . . . 71.34 112.507 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -76.12 -25.47 55.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 74.13 110.933 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 46.9 p -146.95 -167.95 2.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 74.03 111.123 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -85.34 -16.25 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.925 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.99 25.83 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.883 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.08 131.83 48.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.909 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 10.3 pt -139.28 171.06 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 75.42 111.164 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.94 142.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 74.52 111.049 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.67 114.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 74.31 111.183 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -103.74 142.07 34.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 73.32 110.923 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 56.5 mt -122.41 98.69 43.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.631 0.729 . . . . 72.01 110.888 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.9 Cg_endo -69.74 -5.01 15.16 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.13 112.358 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.74 -31.36 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.08 11.6 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 75.41 110.901 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.3 27.49 9.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 71.33 110.8 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 87.2 mt -93.18 143.62 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 74.31 111.117 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 61.5 tp -124.81 153.68 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.92 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 76.0 t -123.16 79.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 75.1 111.137 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.83 -36.64 41.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 63.31 112.522 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 67.28 -165.09 43.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.712 -0.756 . . . . 75.35 112.437 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.7 m -51.95 -34.45 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 74.22 110.889 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 27.7 tp -51.64 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 72.41 110.888 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.25 109.19 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.22 111.122 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -51.29 169.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 75.43 110.895 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 89.2 p -117.78 157.26 26.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 62.5 110.847 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.5 t -49.43 157.29 0.52 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.107 -0.497 . . . . 64.2 111.173 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.1 m 69.4 11.8 8.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.927 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.408 ' H ' ' HE2' ' A' ' 221' ' ' HIS . . . -83.41 144.55 29.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.064 -0.516 . . . . 72.14 111.115 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -120.28 -10.32 9.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 73.3 110.944 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.83 158.78 0.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 63.31 110.923 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.31 -38.56 78.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 75.51 110.902 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.42 -124.53 7.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.797 -0.716 . . . . 62.13 112.527 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -70.52 130.38 41.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.859 0.362 . . . . 64.23 110.843 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.26 27.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 65.13 111.096 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.79 -33.18 75.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.34 111.04 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -114.45 28.06 9.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 73.25 110.839 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.74 153.56 49.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 74.53 111.138 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.42 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 72.1 110.919 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.56 -19.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.24 111.173 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.54 -27.16 61.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 64.45 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.37 -12.41 14.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.01 110.87 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -54.28 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.936 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.51 -24.5 13.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.818 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.0 m -81.45 -32.55 32.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.14 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -42.53 62.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 63.11 110.796 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.3 mm -62.47 -44.72 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 75.31 111.102 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.49 -23.49 50.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.868 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -81.74 -20.73 38.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.45 110.888 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.44 -9.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.33 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.69 -10.33 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 73.53 110.903 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -101.95 -31.91 10.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.888 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 -49.92 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 73.24 110.852 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -101.12 65.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.94 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -78.42 -55.49 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 74.11 110.838 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.15 100.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.828 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.1 mt -141.23 116.08 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 75.42 111.181 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.13 -26.07 64.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.32 110.96 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -171.99 137.76 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 74.03 111.093 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 85.7 t -113.91 144.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 63.35 111.093 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.68 109.19 38.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.722 . . . . 62.2 111.141 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -170.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.72 2.28 . . . . 74.12 112.327 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.07 -14.93 61.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 61.42 112.467 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.71 142.1 21.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 74.02 110.87 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.7 -101.81 1.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 64.51 112.497 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.81 162.76 4.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 55.55 110.972 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.6 m -51.56 163.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 75.53 111.141 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.67 -102.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.661 -0.781 . . . . 52.04 112.48 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.82 -172.24 3.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 75.35 110.841 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -61.87 -17.38 56.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.897 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.3 -17.59 46.84 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.715 -0.755 . . . . 44.41 112.491 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.01 -30.2 67.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 73.22 110.987 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.93 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -17.39 57.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.12 110.913 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.408 ' HE2' ' H ' ' A' ' 175' ' ' ALA . 1.6 t60 -65.86 -50.68 63.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 75.12 110.924 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 4.4 m -51.84 -51.7 54.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 74.25 111.129 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.52 -21.27 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.5 110.908 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -86.81 -2.96 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 74.04 110.843 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.25 -4.87 5.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 74.3 110.947 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.12 0.61 9.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.897 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 74.22 110.846 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.834 0.35 . . . . 75.25 110.855 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.82 47.81 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 73.15 110.834 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -149.31 91.8 1.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.1 110.926 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 p -51.54 151.87 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 74.05 111.142 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -140.27 160.66 39.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 74.32 110.876 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -107.19 -169.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.925 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -96.7 -68.3 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 74.42 111.167 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.8 t -49.37 147.14 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 73.21 111.086 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.08 99.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 72.03 111.082 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -118.43 114.87 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.962 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -59.42 165.61 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 74.13 110.856 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.01 -48.7 61.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.823 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -63.11 -36.75 84.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.051 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.58 13.63 62.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 72.23 112.582 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 m -78.26 -45.88 21.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 64.42 111.12 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.6 mt -103.27 113.92 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 70.51 111.159 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.0 p -118.08 138.12 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.904 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.25 112.14 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 75.52 111.041 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -98.22 125.8 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 74.21 110.801 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -69.14 109.17 3.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 53.04 110.916 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.4 -33.73 76.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 71.44 110.895 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.447 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.96 -96.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 74.32 110.958 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.447 ' N ' HD21 ' A' ' 22' ' ' ASN . 8.0 tttt -150.7 9.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.853 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.24 7.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 75.55 110.844 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 t -151.01 141.33 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.22 111.213 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.404 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 18.4 m95 -129.8 -174.76 3.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 72.45 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.64 90.49 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 75.3 111.13 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -73.55 124.47 25.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.84 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -121.03 104.58 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 64.51 111.142 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' HE2' ' C ' ' A' ' 63' ' ' LEU . 3.5 mm-40 -86.3 122.18 29.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.939 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.16 106.5 16.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 74.5 110.872 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.47 -134.14 2.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.728 . . . . 55.03 112.489 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 p -175.93 117.81 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.855 0.359 . . . . 71.2 110.857 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.73 81.59 1.69 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.5 . . . . 72.32 110.914 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 70.28 2.01 3.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 75.0 110.912 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.68 -6.49 3.53 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.688 -0.768 . . . . 72.02 112.403 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -100.76 123.0 44.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.22 110.877 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -51.36 123.28 9.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 55.54 111.116 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.96 81.94 10.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.618 0.723 . . . . 72.22 111.19 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 118.83 5.92 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.687 2.258 . . . . 73.44 112.268 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.4 p -109.7 96.27 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.891 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -60.32 167.96 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.526 . . . . 62.13 110.941 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -159.29 -147.23 4.81 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 62.01 112.504 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.9 tp -160.52 118.13 2.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.34 . . . . 74.25 110.969 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.8 t -100.88 122.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 75.1 111.093 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 26.2 mt -99.41 119.57 38.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.49 . . . . 72.03 110.952 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.91 87.08 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 52.45 110.899 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.54 -179.87 4.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.464 . . . . 63.22 111.205 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -101.05 -23.78 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 64.33 110.809 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 -13.58 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 70.44 110.854 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.5 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.798 . . . . 71.54 112.442 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.9 tp -63.18 154.96 29.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.858 0.361 . . . . 75.42 110.818 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.92 143.14 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.43 111.181 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -138.75 124.41 19.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 75.5 111.008 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.5 t -69.82 112.49 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 74.04 111.139 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 73.75 139.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 71.34 110.894 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -83.1 -165.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.89 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -94.89 165.77 12.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 64.41 110.951 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -50.3 -59.61 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.449 . . . . 75.44 110.927 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -123.96 160.59 27.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.832 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.05 -39.84 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.932 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.88 -40.55 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.41 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' C ' ' HE2' ' A' ' 30' ' ' GLU . 95.9 mt -74.46 -48.44 27.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 74.43 110.93 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.76 -44.39 58.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 74.0 111.12 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.43 -50.5 67.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -63.9 -18.79 64.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 71.21 110.907 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.71 -27.77 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.907 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -89.72 -23.12 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 74.13 111.169 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.57 16.4 12.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.865 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.5 ptm -130.75 -39.71 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 75.14 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.43 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 34.3 m -81.21 -22.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.207 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HE2' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -68.11 -22.05 64.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 74.33 110.868 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.85 -33.5 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 64.35 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.4 -39.56 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.45 110.905 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.31 -11.29 35.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.2 110.914 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 68.08 12.15 8.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.949 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -130.59 138.97 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 75.13 110.898 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -85.44 138.79 32.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.43 110.864 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.9 t -79.44 121.75 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 72.42 111.185 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 t -136.89 8.33 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 75.31 111.112 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -150.81 145.85 25.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.865 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.0 t -155.33 132.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 65.41 111.198 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.2 mt -86.4 133.61 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 74.12 111.159 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mm -98.43 147.69 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.108 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.7 p -111.61 -34.18 6.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.44 111.082 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -175.11 -175.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.921 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.83 93.49 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 62.34 111.085 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -153.79 154.96 34.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 73.33 110.875 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.67 -21.77 7.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 72.23 111.124 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.31 18.23 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 75.45 110.823 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.436 ' HE ' HG22 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -143.54 -70.75 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.52 110.855 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.436 HG22 ' HE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.88 3.89 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 74.31 111.086 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.44 -45.62 45.75 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.695 -0.764 . . . . 64.12 112.44 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.52 15.81 59.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.644 -0.788 . . . . 71.41 112.454 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -56.35 -25.97 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 75.25 111.143 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -59.7 -21.36 60.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 72.53 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.9 m -98.28 -20.62 17.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 72.02 111.166 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.98 -36.13 25.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.879 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -88.86 9.8 23.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 64.44 110.897 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -112.45 -55.29 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 71.13 110.879 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -65.16 -58.59 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 73.3 110.862 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.18 39.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 53.51 112.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.88 117.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.868 0.366 . . . . 74.34 111.104 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -82.03 117.92 22.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 72.42 110.88 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.26 94.65 9.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.33 111.139 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.18 113.49 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 75.0 110.831 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.66 -174.53 4.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 75.04 110.854 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.34 158.39 16.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 65.12 111.127 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.76 -38.89 50.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 71.34 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.5 tp -77.45 -37.61 51.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.948 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.9 m -58.37 -22.09 52.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 72.24 111.151 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.46 -3.16 47.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.099 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -95.8 -54.43 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.902 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -13.95 57.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 73.32 110.843 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.5 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 74.03 111.059 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.69 -25.99 60.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 74.54 110.83 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -55.93 -33.05 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 74.2 110.845 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -91.75 -20.96 20.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 63.23 110.9 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.91 25.42 5.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.808 -0.71 . . . . 75.21 112.491 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.29 -174.55 2.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 73.12 110.905 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.14 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 64.14 110.877 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -120.77 108.75 36.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.663 0.744 . . . . 73.01 110.853 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.7 Cg_endo -69.75 -169.84 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.711 2.274 . . . . 75.3 112.343 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.7 mt -61.48 -48.78 79.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 62.1 110.931 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 57.04 23.07 45.02 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.73 -0.748 . . . . 75.4 112.528 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.02 33.74 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 75.13 110.899 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.34 -175.04 2.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 71.42 110.917 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.73 -170.94 3.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 75.44 110.935 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.7 m -50.25 -70.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 71.3 111.111 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.0 t -119.91 104.03 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 71.13 111.131 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -135.48 165.53 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 71.34 111.167 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.59 133.03 54.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 64.42 110.814 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.0 mt -118.92 158.01 26.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.976 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -140.68 123.18 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.93 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -120.22 45.52 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 74.43 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.84 92.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 62.15 112.479 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.52 15.01 9.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.827 0.346 . . . . 73.42 110.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 tpp -136.72 94.9 3.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 74.33 110.863 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.4 131.23 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.861 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 20.2 t -137.52 119.0 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.12 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -111.62 131.11 55.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.842 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.9 p -84.96 -172.82 4.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.122 -0.49 . . . . 74.03 111.167 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -170.82 135.55 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.814 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -123.39 87.39 51.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 72.34 110.881 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -7.98 22.42 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 63.32 112.348 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.69 -155.67 21.51 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 71.11 112.435 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -92.12 140.34 29.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 73.53 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.17 -89.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.676 -0.773 . . . . 62.31 112.463 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -75.36 -25.16 57.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 75.3 110.823 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.9 p -147.26 -168.3 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 75.54 111.189 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -86.37 -15.2 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 74.43 110.798 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.42 23.06 2.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 63.03 110.803 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.05 130.42 41.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 71.15 110.882 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.0 pt -135.0 172.77 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 75.43 111.125 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.92 128.32 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 71.51 111.066 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.8 t -81.82 132.15 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 73.25 111.06 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -118.76 131.91 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 74.22 110.908 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 11.5 mt -113.45 98.28 46.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.644 0.735 . . . . 65.11 110.899 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.8 Cg_endo -69.87 -4.41 14.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 75.44 112.384 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -82.67 -23.92 33.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.843 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.72 14.11 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.911 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.6 m120 54.46 27.74 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 72.54 110.895 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.7 mt -93.46 130.26 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 75.11 111.079 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 50.0 tp -114.74 150.75 34.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.53 110.938 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.21 75.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.46 . . . . 72.51 111.069 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.54 -45.97 53.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 70.25 112.495 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 74.79 -161.26 53.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.747 . . . . 73.21 112.417 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 12.8 m -51.41 -34.73 35.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 62.42 110.803 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.9 tp -51.64 -39.78 58.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.966 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.3 t -104.65 111.31 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 74.41 111.07 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -53.49 155.76 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.883 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.7 p -101.78 160.44 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 62.51 110.845 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.4 t -51.28 -29.73 15.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 72.42 111.112 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.8 m -98.25 39.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 54.41 110.787 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -117.98 150.97 38.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 73.45 111.184 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.64 -3.32 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 72.04 110.931 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.21 176.24 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 54.32 110.821 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.6 mt -83.51 -30.94 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 73.01 110.964 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.69 -164.69 27.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.669 -0.777 . . . . 63.22 112.505 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -51.94 110.31 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 73.41 110.93 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 30.3 m -97.1 26.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 75.32 111.117 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.99 68.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 74.3 111.089 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -110.76 6.14 21.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 74.33 110.822 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -114.56 162.91 16.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 75.24 111.024 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -121.95 92.16 3.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.933 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.54 -20.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 63.4 111.191 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -73.92 -20.26 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 73.34 110.911 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.63 -17.42 10.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.949 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -53.76 -61.25 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.3 110.923 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -24.75 22.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.837 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.0 m -81.13 -29.91 34.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 72.45 111.167 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -43.97 39.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.856 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.3 mm -60.64 -47.25 93.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 75.31 111.173 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.15 -27.91 56.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.14 -0.482 . . . . 71.41 110.856 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -77.14 -22.46 52.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.826 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 18.2 t -85.47 -10.22 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.072 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.95 -8.06 13.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 54.34 110.926 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -31.16 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 75.32 110.887 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -104.47 -55.34 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 74.14 110.937 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -95.91 39.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.236 -0.438 . . . . 71.4 110.913 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -56.42 -47.69 78.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 74.04 110.888 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -60.72 102.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.901 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.6 mt -144.76 129.55 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.31 111.131 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.69 -24.75 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 65.44 110.907 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.21 126.66 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.15 111.111 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 87.0 t -107.14 129.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 74.24 111.177 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 16.4 t -104.41 111.63 65.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 75.32 111.093 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.82 -173.25 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 70.25 112.231 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.95 -12.21 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 72.43 112.47 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -152.56 131.28 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 74.12 110.853 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.23 -119.99 5.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.767 -0.73 . . . . 60.1 112.473 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.16 172.26 13.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 74.51 110.881 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.8 m -61.06 164.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.084 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.64 -115.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.714 . . . . 71.33 112.538 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.21 -169.97 3.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.377 . . . . 64.45 110.839 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -19.92 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 70.11 110.908 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -60.1 -18.22 47.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.721 . . . . 75.41 112.438 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 11.0 mt -72.12 -31.78 66.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 74.54 110.932 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.41 -58.62 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.959 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -19.66 55.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.884 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -44.02 95.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.827 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 16.1 m -57.11 -52.77 63.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 63.52 111.18 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -25.04 65.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 73.44 110.903 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -75.22 -11.75 60.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 74.41 110.887 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.7 mt -119.07 -15.56 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.22 110.871 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 2.22 15.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 74.54 110.903 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 74.21 110.846 179.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.833 0.349 . . . . 74.22 110.847 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.1 -69.85 0.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 74.13 110.911 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 61.7 100.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 71.21 110.939 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.68 148.32 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 70.11 111.105 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -123.88 155.66 37.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 74.01 110.853 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.78 -177.45 3.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 72.41 110.947 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -72.01 -68.37 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 73.12 111.09 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.4 t -49.52 147.25 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 73.24 111.128 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.69 103.33 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.33 111.088 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -122.08 116.87 25.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 73.12 110.872 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.486 ' ND2' ' HG1' ' A' ' 13' ' ' THR . 35.3 p-10 -62.46 166.72 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 72.51 110.895 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.23 -48.71 62.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.83 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.486 ' HG1' ' ND2' ' A' ' 11' ' ' ASN . 17.5 p -62.65 -36.7 83.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 63.14 111.206 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.34 14.56 63.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 70.34 112.572 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -80.4 -45.02 18.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 72.54 111.077 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.5 mt -102.55 107.98 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 75.33 111.077 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.2 p -113.14 137.01 52.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 71.05 110.887 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.79 109.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 74.1 111.154 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -99.96 123.84 44.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.03 110.896 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -67.5 109.55 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 72.53 110.939 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.62 -32.49 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.888 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' N ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.11 -97.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 71.35 110.843 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -151.15 9.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.03 110.969 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.55 6.47 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 75.2 110.859 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -150.96 140.48 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 74.34 111.158 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -127.7 -173.71 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.906 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.0 t -137.83 92.87 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 75.43 111.175 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -77.52 120.54 22.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.861 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.4 m -115.29 98.57 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 63.4 111.185 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.01 117.27 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 71.22 110.947 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.18 116.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.858 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.13 -141.32 8.13 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.731 . . . . 72.24 112.499 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 178.99 89.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.412 . . . . 75.12 110.866 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.23 84.21 3.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.064 -0.516 . . . . 73.1 110.899 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 66.61 12.56 8.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.083 -0.508 . . . . 75.03 110.94 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.73 -16.83 4.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 72.34 112.526 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -91.22 114.02 26.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 64.31 110.879 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.61 123.6 15.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 75.51 111.118 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.75 84.31 12.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.527 0.68 . . . . 74.32 111.162 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.658 2.238 . . . . 61.34 112.389 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.56 102.16 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 74.41 110.799 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.81 170.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.067 -0.515 . . . . 74.35 110.911 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -158.0 8.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 71.53 112.501 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.2 tp -156.18 113.49 3.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 72.41 110.87 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 t -99.25 113.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 74.41 111.161 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 18.9 mt -93.63 119.27 32.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 65.13 110.915 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.81 84.49 6.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.822 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -172.54 2.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 72.32 111.091 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -105.34 -25.79 12.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 63.41 110.906 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.4 -13.35 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.886 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.83 155.44 6.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 64.33 112.504 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.87 157.82 26.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 75.54 110.842 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 17.1 t -146.5 142.37 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 71.11 111.145 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mt -139.32 120.52 14.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.904 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.59 111.81 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.12 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.92 128.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 74.13 110.9 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 p -71.96 -164.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 71.22 110.906 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -93.08 171.67 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 75.32 110.898 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -55.53 -60.69 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 72.05 110.92 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.19 157.63 34.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 74.35 110.817 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -51.86 -39.97 59.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 74.41 110.889 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -53.42 -41.1 65.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 72.43 110.894 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.97 -45.55 34.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 74.0 110.924 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.97 -48.83 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.0 111.132 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -52.46 -50.01 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.906 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -64.06 -19.71 65.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 73.23 110.806 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 tp -89.18 -26.21 21.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 74.4 110.84 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.18 -23.07 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 71.12 111.103 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.05 15.4 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.875 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.2 ptm -130.43 -40.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.24 110.94 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.3 m -80.67 -21.7 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 71.43 111.146 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.715 ' HE2' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -69.04 -23.01 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.884 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.8 -33.07 7.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 73.22 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -43.52 67.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 74.44 110.859 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -87.1 -10.66 52.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.827 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.19 12.45 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 71.32 110.919 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.19 140.4 48.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 74.34 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.0 137.15 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.954 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.715 HG22 ' HE2' ' A' ' 72' ' ' GLU . 89.5 t -75.56 117.51 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 72.32 111.1 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -133.09 10.95 4.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 63.13 110.996 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.83 137.88 14.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 52.31 110.832 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.1 t -146.15 129.15 9.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 75.45 111.065 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.6 mt -92.95 125.21 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 72.41 111.104 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -94.24 158.36 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 74.3 111.08 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.7 p -115.31 -39.88 3.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 73.31 111.148 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.22 -174.36 4.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.824 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.32 97.37 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 74.14 111.127 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.98 154.96 26.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 71.14 110.932 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.64 -19.7 28.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 75.12 111.175 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.66 14.3 13.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 71.31 110.897 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -135.32 -76.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.53 110.973 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.405 ' O ' HG12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -92.35 11.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 74.24 111.079 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.81 -34.03 14.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.769 . . . . 73.21 112.483 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.38 17.77 23.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 63.05 112.497 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.534 HG12 ' CG ' ' A' ' 121' ' ' GLU . 4.5 tt -58.09 -33.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 75.1 111.085 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -55.82 -24.2 34.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.256 -0.429 . . . . 65.1 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m -95.84 -12.25 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 73.43 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.01 -30.6 17.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.901 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -88.09 -6.65 57.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 64.45 110.914 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -91.53 -52.7 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 73.0 110.966 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -61.86 -60.65 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.13 110.952 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.09 40.0 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.753 -0.737 . . . . 74.41 112.502 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.04 140.08 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 72.53 111.157 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -98.17 110.33 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.0 110.914 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.48 9.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 72.43 111.09 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -72.83 145.21 47.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.89 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -173.75 -175.12 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.33 110.919 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.41 154.96 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 62.3 111.21 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.08 39.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 71.42 111.036 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 61.2 tp -67.34 -41.63 84.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.89 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 86.9 m -61.96 -16.8 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 64.31 111.121 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.06 11.71 34.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 74.52 111.14 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.35 -26.07 9.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 54.44 110.767 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.25 -9.49 22.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 75.52 110.976 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.34 -36.88 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.45 111.057 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -28.14 60.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 73.25 110.983 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -55.44 -35.36 65.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 74.11 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -86.14 -25.65 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 72.43 110.941 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.73 14.6 4.69 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 71.44 112.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -95.1 177.36 5.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 74.11 110.977 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.534 ' CG ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.24 -171.86 3.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 75.22 110.853 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.1 mt-10 -115.49 111.95 43.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.72 0.772 . . . . 65.32 110.878 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.529 ' N ' ' HE2' ' A' ' 121' ' ' GLU . 54.2 Cg_endo -69.66 -178.89 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.772 2.314 . . . . 64.33 112.32 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.4 mt -53.57 -43.87 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 74.24 110.932 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.76 27.78 21.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 62.43 112.463 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -101.19 31.31 3.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 73.1 110.825 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.7 mt -116.13 -175.21 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 72.12 110.964 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.66 -170.93 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 72.52 110.894 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.2 m -50.43 -70.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 74.42 111.034 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.0 t -118.08 105.86 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 70.53 111.118 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -138.82 166.78 23.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.32 111.169 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.83 134.04 55.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.788 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.1 mt -113.08 167.46 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.933 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.48 134.39 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 71.23 110.939 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -137.21 36.15 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 75.01 110.869 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.74 93.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.736 . . . . 54.41 112.518 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.4 m120 65.55 13.67 9.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 74.22 110.917 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.7 tpp -135.37 105.34 6.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.941 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -96.45 130.62 43.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 74.5 110.879 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.67 117.39 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 74.42 111.13 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.99 129.5 55.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 53.4 110.89 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.36 -176.29 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 70.23 111.185 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -166.74 133.4 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 70.4 110.929 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -124.07 89.26 51.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.727 0.775 . . . . 73.52 110.941 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 -21.75 32.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 64.13 112.33 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.18 -157.64 27.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 75.25 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -88.02 138.14 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 75.15 110.837 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.23 -88.82 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 62.44 112.494 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -75.48 -25.62 57.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 72.54 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.3 p -146.82 -165.33 2.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 74.52 111.166 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -85.85 -19.67 30.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 75.13 110.89 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -137.87 24.27 2.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 73.43 110.863 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.83 129.29 33.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.837 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.21 174.47 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 72.55 111.105 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.19 136.24 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.14 111.161 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.5 121.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.4 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -110.02 139.14 45.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.509 . . . . 72.34 110.947 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 21.1 mt -120.14 99.21 48.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.529 0.68 . . . . 75.12 110.914 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.62 -4.53 14.12 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.711 2.274 . . . . 75.43 112.382 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -85.73 -22.81 27.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 74.34 110.937 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.3 12.15 2.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.4 110.97 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.36 25.17 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 75.12 110.939 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.3 mt -89.04 142.34 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 73.3 111.1 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 57.7 tp -122.32 156.39 33.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.3 t -123.56 74.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 64.15 111.157 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.99 -41.71 52.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.732 -0.747 . . . . 73.21 112.458 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.66 -162.54 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 74.22 112.494 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 16.7 m -51.84 -34.51 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 45.43 110.882 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.2 tp -51.76 -41.35 61.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.878 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.83 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 74.53 111.116 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.5 147.85 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.924 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.4 p -98.29 159.64 14.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.43 110.926 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t -56.89 -24.59 53.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.172 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.9 t -96.87 34.5 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.787 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -129.09 152.28 48.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 71.22 111.081 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.41 2.12 10.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 73.23 110.971 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.76 175.84 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.31 110.878 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.8 mt -82.89 -32.8 27.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 60.11 110.907 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.32 -162.44 27.03 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 62.22 112.562 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.97 113.06 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 75.21 110.927 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.69 26.24 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 73.21 111.138 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.13 -35.06 66.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 75.3 111.107 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -111.1 4.71 19.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 73.12 110.824 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -112.41 162.14 15.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.23 111.057 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.14 92.43 3.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 74.21 110.942 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.1 t -62.86 -18.43 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 72.24 111.165 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.62 -20.67 58.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 73.23 110.952 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.6 -14.72 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.887 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -55.0 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.498 . . . . 75.12 110.853 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -24.75 17.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 75.0 110.841 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -81.56 -31.46 32.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 72.32 111.127 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.67 -43.82 58.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 63.23 110.886 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.26 -44.61 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 75.31 111.18 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.97 -23.83 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.872 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.14 -21.43 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.758 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.5 t -87.97 -9.56 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.54 111.151 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.43 -8.5 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.881 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -104.11 -31.08 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 73.44 110.809 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 -53.84 2.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -98.1 60.3 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 74.02 110.868 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -72.57 -59.48 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.23 110.901 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -52.13 102.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.904 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.0 mt -139.43 116.72 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 74.43 111.138 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.95 -22.74 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.833 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.97 129.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 71.3 111.088 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 88.1 t -102.22 130.86 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 73.34 111.073 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 11.4 t -107.92 103.75 50.89 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.568 0.699 . . . . 73.31 111.077 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -170.64 0.41 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.736 2.291 . . . . 75.12 112.311 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.49 -11.74 59.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.838 -0.696 . . . . 74.25 112.57 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.44 144.43 23.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 65.04 110.881 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 100.77 -102.31 2.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.793 -0.718 . . . . 74.4 112.431 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -170.86 159.52 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.41 . . . . 74.22 110.905 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 6.0 m -53.39 163.29 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 75.41 111.176 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.78 -99.68 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 43.41 112.514 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -167.29 -168.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 65.44 110.825 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -20.25 42.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 65.54 110.961 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.17 -23.73 26.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 73.01 112.473 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.6 mt -73.17 -34.7 66.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 62.21 110.956 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.84 -59.34 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 75.12 110.964 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.54 -20.58 56.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.282 -0.417 . . . . 75.01 110.911 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.62 -34.35 77.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.22 110.811 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 7.7 m -62.52 -55.54 26.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 72.4 111.152 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -20.95 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 73.0 110.924 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.09 -12.11 60.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 64.42 110.879 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.7 mt -119.88 -26.34 5.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 73.23 110.935 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 75.24 110.964 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 mttt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.83 179.808 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.833 0.349 . . . . 61.32 110.814 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 63.14 163.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.84 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -166.75 150.98 7.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 63.31 110.897 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -104.05 148.03 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 74.43 111.112 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.0 167.66 21.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 61.31 110.846 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.1 mtmm -118.23 174.14 6.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.34 110.87 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.5 m -51.61 -54.09 31.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 74.21 111.127 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.3 m -58.11 -175.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 74.23 111.074 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.19 94.05 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 44.01 111.137 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -112.49 117.35 32.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.947 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -61.82 170.21 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 65.35 110.918 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.032 0.444 . . . . 74.41 110.899 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.7 p -60.98 -38.51 86.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 74.31 111.119 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.77 13.88 62.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.799 -0.715 . . . . 65.13 112.563 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.4 m -83.45 -35.56 24.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.363 . . . . 73.43 111.216 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -110.08 122.5 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 74.2 111.109 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 p -129.86 128.79 42.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 73.13 110.776 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.5 112.95 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 72.33 111.15 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 t -99.09 129.11 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 62.13 110.87 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -72.91 111.14 7.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 63.45 110.933 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.8 mt -64.62 -32.54 74.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.854 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.447 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.84 -97.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 72.31 110.874 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.447 ' N ' HD21 ' A' ' 22' ' ' ASN . 23.3 tttt -150.3 9.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 75.13 110.904 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.403 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.46 7.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 72.04 110.977 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.86 141.14 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 71.44 111.112 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.405 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 18.0 m95 -129.52 -179.42 5.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 74.35 110.929 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -131.43 90.2 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 65.02 111.118 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -74.15 125.19 27.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 62.32 110.907 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -124.45 105.54 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 63.53 111.181 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -91.64 124.39 35.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 74.11 110.869 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -80.32 127.55 32.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.905 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.28 -19.91 56.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.87 -0.681 . . . . 63.0 112.491 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 94.3 p 49.46 89.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.941 0.4 . . . . 71.45 110.918 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.15 -160.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 75.43 110.988 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -71.03 66.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.864 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.84 9.46 54.34 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.703 -0.76 . . . . 73.45 112.447 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -128.85 174.56 9.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.341 . . . . 73.31 110.884 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -112.77 122.67 48.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.133 -0.485 . . . . 62.1 111.127 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.13 74.76 1.95 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.666 0.746 . . . . 70.31 111.212 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.46 6.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.243 . . . . 72.04 112.336 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -101.55 89.09 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 63.4 110.877 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -56.66 158.66 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.42 110.877 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.94 -146.9 4.51 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.737 -0.744 . . . . 72.04 112.523 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp -160.22 117.32 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.84 0.352 . . . . 75.43 110.891 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.5 t -99.43 122.36 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.54 111.171 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.6 mt -100.0 119.14 37.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 71.24 110.942 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -89.31 86.68 6.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.439 . . . . 75.44 110.945 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -99.83 -172.31 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 74.13 111.212 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -20.76 12.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.823 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -86.89 -13.34 45.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.848 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.51 4.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 60.01 112.43 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 tp -63.13 156.01 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 73.55 110.994 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.31 142.59 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.55 111.087 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.1 mt -138.07 125.03 21.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 75.25 110.854 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.5 t -70.45 111.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 62.42 111.134 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 73.57 138.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 65.54 110.833 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 p -81.21 -164.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 71.43 110.816 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.7 t -95.36 168.34 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.909 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -50.32 -59.94 3.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 74.35 110.929 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -128.13 158.92 36.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.83 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -52.08 -34.75 45.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.891 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -57.5 -36.31 71.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 72.35 110.921 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.82 -46.64 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 72.24 110.971 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.67 -47.57 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.1 111.143 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -53.18 -50.36 64.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 75.41 110.887 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.56 -19.04 65.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.939 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.59 -26.16 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 75.52 110.862 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.17 -23.34 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 74.03 111.151 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.17 15.2 14.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 75.15 110.916 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.5 ptm -129.83 -39.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 75.21 110.879 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.433 ' CG2' ' HE2' ' A' ' 72' ' ' GLU . 31.9 m -80.44 -22.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.01 111.113 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HE2' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -68.35 -24.02 64.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 62.12 110.836 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -106.37 -33.23 7.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 73.53 110.942 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -70.21 -42.26 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 75.22 110.885 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -89.34 -11.17 44.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.874 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.95 12.03 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.924 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.67 139.56 50.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.877 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -85.45 138.62 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 75.33 110.97 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.8 t -79.18 122.29 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.4 111.093 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -137.33 8.14 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 70.43 111.215 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -149.89 145.84 26.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.941 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 t -155.7 131.68 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 75.41 111.069 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.0 mt -86.18 133.96 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.53 111.15 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.8 mm -98.96 148.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 72.22 111.125 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 79.8 p -114.57 -39.19 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 75.33 111.162 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 152' ' ' ASP . 2.1 p-80 -166.84 177.03 6.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.834 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.75 83.45 3.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 72.43 111.173 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 75.03 110.839 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.46 -22.03 7.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 75.2 111.078 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.06 19.69 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 51.5 110.919 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.438 ' HE ' HG22 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -144.33 -70.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.868 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.438 HG22 ' HE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.76 3.55 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 75.31 111.146 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.84 -45.12 49.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 62.13 112.565 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.14 15.17 60.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 75.55 112.425 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.8 tt -55.4 -28.48 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.879 0.371 . . . . 72.23 111.08 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -21.84 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 73.34 110.929 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -98.58 -14.57 19.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 75.41 111.191 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.5 mt -89.53 -35.85 15.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 74.44 110.92 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -94.44 23.97 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.85 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -124.94 -43.37 1.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 74.02 110.784 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -81.59 -52.51 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 72.51 110.891 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.27 41.01 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.713 -0.756 . . . . 72.14 112.485 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.59 112.82 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 72.14 111.132 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -79.79 116.65 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 63.12 110.92 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.2 90.15 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.429 . . . . 75.52 111.114 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -63.09 113.97 3.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.87 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.21 -174.71 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 64.5 110.849 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.68 157.14 16.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 72.22 111.133 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.08 -40.94 33.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 63.33 111.101 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -35.65 74.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 72.54 110.968 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.4 m -63.77 -21.54 66.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 73.22 111.129 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.37 11.63 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 74.25 111.154 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.79 -24.38 12.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 64.23 110.868 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.34 -7.4 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 72.43 110.958 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.63 -41.04 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.197 -0.456 . . . . 75.33 111.052 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -24.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.93 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -33.57 71.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 74.4 110.857 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -87.81 -22.87 24.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.841 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.45 23.15 4.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.795 -0.717 . . . . 74.51 112.57 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.54 -177.64 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 73.44 110.92 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -79.65 -172.19 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 74.03 110.895 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.47 112.99 32.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 75.31 110.915 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.28 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 72.11 112.27 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.0 mt -60.63 -51.52 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 70.41 110.899 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.81 18.22 45.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 43.3 112.489 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -96.79 33.01 1.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 71.13 110.847 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.7 mt -119.09 -175.09 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 73.5 110.944 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.68 -170.74 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 73.13 110.911 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.5 m -50.02 -70.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 65.41 111.138 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.7 t -116.6 96.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 74.2 111.148 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -117.78 169.37 9.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 71.23 111.167 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.21 103.9 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.931 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.1 mt -80.04 165.44 22.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.1 110.918 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -151.77 112.06 4.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.779 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.02 69.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.932 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.63 -93.29 0.3 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.834 -0.698 . . . . 75.14 112.42 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -110.01 24.39 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 75.13 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.9 tpp -132.48 135.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.886 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.86 130.53 56.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 72.4 110.989 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 t -139.59 121.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 72.41 111.124 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.31 126.07 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 72.42 110.898 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.8 p -83.34 -174.66 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.11 111.051 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -170.66 139.72 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 64.42 110.894 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -125.78 89.02 53.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.737 0.78 . . . . 71.51 110.976 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -8.05 22.61 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.291 . . . . 65.13 112.33 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.59 -149.04 19.42 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.673 -0.775 . . . . 74.42 112.448 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -98.47 140.22 33.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 73.13 110.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.06 -93.19 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.744 -0.741 . . . . 51.13 112.538 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.59 -23.66 61.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 75.22 110.83 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.2 p -151.71 -175.35 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.33 111.124 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.16 -3.38 58.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.855 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.487 ' HD2' ' HA ' ' A' ' 86' ' ' HIS . 7.4 p-10 -141.66 13.78 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 75.24 110.832 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.6 141.56 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.88 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.7 pt -146.91 176.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.3 111.078 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.1 m -132.53 129.02 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.32 111.11 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.9 t -86.84 133.1 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.33 111.101 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -120.16 137.48 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 73.14 110.951 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.5 99.28 50.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.647 0.737 . . . . 75.32 110.945 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -3.13 11.36 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 63.32 112.407 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -86.54 -24.6 25.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 73.53 110.827 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.32 13.01 2.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.942 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.4 m120 54.18 25.42 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.02 110.942 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 95.7 mt -89.69 133.45 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 74.22 111.162 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 6.0 tp -121.68 140.62 52.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 75.45 110.931 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.42 75.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 72.11 111.193 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.06 -35.88 42.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.692 -0.765 . . . . 72.52 112.607 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.27 -157.9 53.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.817 -0.706 . . . . 72.44 112.51 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 98.0 m -50.7 -33.68 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 61.31 110.922 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.45 -37.83 57.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 75.14 110.936 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 86.0 t -105.75 108.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.11 111.127 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -50.78 168.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 71.3 110.904 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.88 160.16 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.2 110.807 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 t -50.98 157.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 71.14 111.146 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m 69.46 11.78 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 71.0 110.817 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -84.77 143.06 29.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 73.13 111.064 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.83 -13.27 9.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.925 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.03 154.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 75.11 110.93 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 12.0 mt -59.4 -47.16 86.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 61.24 110.894 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.8 125.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.796 -0.716 . . . . 63.14 112.514 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.29 103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 73.43 110.933 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.76 20.34 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 75.23 111.134 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.78 -42.93 97.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.127 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -100.89 23.95 9.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 70.44 110.942 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.08 163.29 31.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 73.4 111.095 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.94 92.66 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.898 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.12 -25.95 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.0 111.089 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -69.5 -32.26 71.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.32 110.885 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.19 -14.44 18.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.4 110.849 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -57.34 -61.83 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.54 110.927 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.8 -24.46 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.873 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.6 m -80.15 -33.64 38.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 75.51 111.169 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -43.01 64.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.803 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.9 -47.17 92.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 73.11 111.175 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.33 -28.5 63.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 73.31 110.905 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -77.94 -20.93 51.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 54.45 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 22.8 t -87.08 -11.44 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 73.43 111.205 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.0 pp -110.36 -14.17 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 74.33 110.906 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.92 -30.95 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.964 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -103.46 -51.42 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 74.25 110.8 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -101.07 64.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 72.24 110.899 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -71.73 -59.9 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 74.33 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -50.97 107.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 70.2 110.854 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 91.3 mt -146.26 118.94 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 74.34 111.126 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.54 -29.6 52.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 72.44 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -159.65 146.4 16.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 52.21 111.118 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 49.9 t -121.92 122.37 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 72.51 111.088 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.21 101.94 22.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.723 . . . . 75.22 111.148 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 178.12 4.94 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 65.42 112.327 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.28 -17.97 76.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 63.31 112.536 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -152.52 148.98 28.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 75.52 110.915 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.9 -115.4 4.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.653 -0.784 . . . . 73.14 112.498 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -159.63 148.73 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 44.43 110.92 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.49 130.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 75.21 111.044 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -127.63 -98.13 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.689 -0.767 . . . . 35.13 112.443 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.84 -169.72 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.874 0.368 . . . . 74.04 110.918 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -16.96 55.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.902 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -58.29 -18.96 37.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.806 -0.712 . . . . 53.1 112.406 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.4 mt -75.08 -45.58 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 73.33 110.945 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.32 -56.24 18.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.983 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.3 pp -59.39 -20.36 54.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 64.23 110.919 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.173 -0.467 . . . . 75.21 110.82 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.1 m -63.86 -56.75 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 73.31 111.132 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.4 mt -54.55 -29.78 52.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 74.31 110.955 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -29.22 61.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 75.13 110.898 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.42 -16.43 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.925 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.3 18.19 15.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 74.04 110.95 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 74.43 110.845 179.947 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.783 0.325 . . . . 65.14 110.885 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -169.24 103.84 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 64.1 110.89 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 139.94 53.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.929 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.4 m -85.54 -178.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 75.42 111.075 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.56 66.88 1.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 73.22 110.893 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -131.94 172.43 12.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 73.02 110.854 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -88.77 -68.61 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.04 111.162 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.58 147.25 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 62.32 111.157 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.1 mt -112.66 101.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.41 111.121 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -120.52 115.03 22.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.55 110.997 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.47 ' ND2' ' HG1' ' A' ' 13' ' ' THR . 37.2 p-10 -58.25 165.04 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 73.41 110.894 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -51.62 -48.51 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 72.01 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.47 ' HG1' ' ND2' ' A' ' 11' ' ' ASN . 18.9 p -61.15 -37.72 83.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.13 111.06 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.1 62.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 71.12 112.486 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.2 m -75.92 -45.36 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 72.32 111.115 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.47 123.25 54.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 71.44 111.16 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.5 p -127.22 133.56 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 60.32 110.84 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.9 mt -127.22 110.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 75.12 111.127 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -98.83 126.58 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 73.45 110.846 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -71.14 108.85 4.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.848 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.07 -33.34 74.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.926 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.443 HD21 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.32 -96.74 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.911 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.4 OUTLIER -150.87 9.7 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 75.05 110.849 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.401 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.61 6.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 74.34 110.906 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -151.0 140.81 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 74.54 111.122 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.402 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 15.9 m95 -128.51 -173.25 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 71.15 110.947 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.1 t -137.79 88.2 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.079 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.43 124.13 23.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.792 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -123.65 105.29 9.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 73.14 111.166 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -91.89 125.8 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.864 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mt -83.53 123.79 30.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 72.22 110.935 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.42 -49.04 3.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 75.4 112.443 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.93 111.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.905 0.383 . . . . 55.21 110.856 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.4 147.65 32.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 74.41 110.884 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 48.52 30.22 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.866 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.66 37.24 52.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.674 -0.774 . . . . 74.3 112.537 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -146.51 121.35 9.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.329 . . . . 72.14 110.95 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.55 141.93 24.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 65.25 111.093 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.99 74.72 56.22 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.579 0.704 . . . . 72.41 111.119 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 121.81 8.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.741 2.294 . . . . 63.04 112.373 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.5 p -103.95 88.16 2.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 74.42 110.934 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -58.33 156.8 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.11 110.968 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -150.81 -142.54 3.55 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.81 -0.71 . . . . 72.54 112.515 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp -160.68 116.97 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 73.02 110.822 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 26' ' ' TRP . 1.7 t -100.94 122.82 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 71.24 111.114 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 17.7 mt -101.08 122.31 43.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 62.31 110.83 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.78 86.48 5.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.22 110.839 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.09 -174.59 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 73.31 111.135 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.3 t -105.69 -24.18 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 75.33 110.838 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -81.73 -10.63 59.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 73.41 110.867 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.39 153.78 5.99 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.702 -0.761 . . . . 65.3 112.53 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.86 154.59 41.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 71.33 110.889 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 2.5 t -142.09 137.44 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 73.1 111.096 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.29 121.73 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 70.33 110.914 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -66.82 111.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.54 111.104 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 72.56 146.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.01 110.939 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 p -85.52 -165.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 72.5 110.817 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 t -95.09 171.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 74.23 110.883 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -51.63 -60.07 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.34 110.952 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -129.5 159.59 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.917 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' HD2' ' HB2' ' A' ' 96' ' ' LYS . 65.0 m-20 -51.37 -33.41 29.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 61.15 110.902 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.65 -38.92 79.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.868 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.2 mt -82.34 -46.01 14.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.51 110.902 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.89 -49.11 60.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 72.54 111.069 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.64 -51.47 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 74.45 110.911 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.41 -21.91 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 75.45 110.872 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 tp -84.64 -29.83 25.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 73.44 110.886 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.4 mt -88.72 -26.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 72.53 111.171 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.14 -0.12 47.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.942 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.8 ptm -116.58 -36.62 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 65.44 110.908 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -78.23 -29.32 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 72.42 111.115 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.62 -32.31 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.892 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -97.2 -33.33 11.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 73.1 110.809 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -48.86 54.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 74.23 110.869 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -84.18 -11.96 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.864 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.76 12.05 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 73.34 110.924 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.56 137.7 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 72.4 110.899 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -84.84 136.18 33.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 64.14 110.865 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.6 128.98 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 74.2 111.087 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 t -146.53 14.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 74.12 111.082 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -159.58 136.04 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 64.43 110.871 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.14 153.17 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 75.13 111.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.11 143.55 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 72.43 111.11 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 mm -106.02 145.97 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.3 111.164 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.2 p -112.32 -37.28 5.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 64.14 111.224 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -168.41 177.97 5.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 73.4 110.807 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.02 79.63 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.42 111.158 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -137.69 155.35 49.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 73.24 110.897 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -20.62 10.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 63.22 111.012 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.99 11.45 18.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 55.14 110.913 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.409 ' HE ' HG22 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -135.97 -70.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 75.42 110.825 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.409 HG22 ' HE ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -88.9 2.87 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 74.42 111.163 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.02 -45.78 41.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.734 . . . . 73.35 112.517 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.19 15.91 57.43 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 74.44 112.55 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -52.87 -28.93 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 74.22 111.136 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 61' ' ' ASP . 29.4 mmtm -59.07 -28.38 66.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.895 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 m -88.22 -16.59 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 73.02 111.17 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.4 mt -90.38 -41.9 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 74.42 110.885 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -79.51 -5.34 54.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.915 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.06 -54.99 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.845 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -64.04 -62.27 1.73 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.859 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 152.92 39.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 43.02 112.497 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -97.57 139.21 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.11 111.202 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -96.67 111.0 23.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.4 110.931 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.89 93.7 9.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.044 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -66.49 113.85 5.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.282 -0.417 . . . . 74.15 110.865 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.45 179.67 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 64.43 110.838 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.87 157.58 17.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 74.02 111.1 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.55 -40.14 51.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 52.35 111.168 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.5 tp -75.14 -39.45 60.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 71.51 110.937 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 82.8 m -58.62 -21.81 54.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 73.35 111.136 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.06 -0.63 50.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 73.44 111.054 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -52.76 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 73.31 110.84 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.28 -13.53 60.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 73.3 110.925 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.55 -45.25 72.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 74.15 111.0 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.79 63.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -34.14 71.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.256 -0.429 . . . . 72.33 110.873 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -90.5 -19.1 24.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 71.45 110.894 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 24.62 5.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 72.55 112.561 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -99.66 177.82 5.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.864 0.364 . . . . 75.54 110.895 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -76.39 -172.95 2.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 70.31 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.11 113.8 32.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.686 0.755 . . . . 74.25 110.882 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.9 -168.33 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.595 2.196 . . . . 75.34 112.342 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.74 -44.36 93.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.913 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 54.79 25.29 36.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 60.52 112.434 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -108.0 36.25 2.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.915 0.388 . . . . 74.43 110.903 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.9 mt -122.57 -174.47 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.928 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.38 -170.05 3.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 75.31 110.912 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 52.5 m -50.08 -69.95 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.431 . . . . 61.43 111.14 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.3 t -118.51 99.75 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 63.34 111.138 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -127.91 174.8 8.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 54.44 111.144 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.47 133.92 53.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 74.02 110.93 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 39.0 mt -112.35 179.44 3.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 75.14 110.894 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 126.64 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.817 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -130.24 54.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 75.53 110.842 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.58 90.31 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 53.13 112.52 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.1 m120 64.39 14.72 9.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 73.45 110.896 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.0 tpp -133.91 97.57 3.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.15 110.936 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 136.49 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 73.35 110.954 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.04 117.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 73.24 111.052 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -109.11 129.96 55.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 71.54 110.883 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.8 p -85.37 -171.64 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 73.15 111.222 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -170.69 134.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 70.44 110.845 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -123.22 88.38 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.71 0.767 . . . . 72.52 110.917 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.99 22.47 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.607 2.205 . . . . 62.15 112.367 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.45 -151.7 19.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 74.23 112.485 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -92.15 140.01 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 73.35 110.936 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.34 -88.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.706 -0.759 . . . . 72.24 112.453 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -75.02 -24.02 58.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.877 0.37 . . . . 71.43 110.838 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 70.3 p -151.64 -170.23 3.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 73.33 111.097 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.64 -12.18 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.88 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -144.0 25.43 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 63.12 110.805 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 132.23 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 75.31 110.92 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 28.4 pt -136.89 169.88 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 74.44 111.089 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.0 m -126.37 134.13 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 75.34 111.129 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.03 133.89 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 72.04 111.163 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -121.48 130.94 53.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 72.22 110.902 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 10.6 mt -110.59 98.66 38.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.662 0.744 . . . . 73.14 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.4 Cg_endo -69.73 -4.53 14.19 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.719 2.279 . . . . 75.24 112.358 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -82.95 -24.14 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 75.34 110.938 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.63 14.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 74.43 110.877 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.25 27.52 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.856 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.2 mt -92.42 126.47 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 63.04 111.132 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 23.2 tp -110.89 148.26 32.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 73.54 110.852 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 72.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.42 111.148 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.46 -42.06 49.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 63.32 112.445 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.31 -155.95 44.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 72.55 112.493 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 66.1 m -51.51 -30.58 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 71.35 110.868 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 27.5 tp -57.51 -33.56 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 74.12 110.845 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 95.6 t -105.51 104.69 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 65.3 111.176 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -51.91 156.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.859 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.2 p -99.67 157.59 16.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.913 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t -51.83 -29.81 20.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 72.12 111.081 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.0 m -95.72 44.09 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 63.52 110.915 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.2 148.43 50.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 74.42 111.071 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -128.23 1.75 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 73.14 110.905 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.13 154.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 71.41 110.883 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.9 mt -66.33 -38.43 87.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.868 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.06 -144.39 17.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 74.54 112.427 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.1 100.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.339 . . . . 64.25 110.919 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.8 m -94.99 24.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 74.43 111.131 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.09 -24.47 65.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 74.24 111.138 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -119.27 24.28 10.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 62.44 110.796 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.21 154.13 49.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 74.4 111.059 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -107.49 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 34.5 t -60.85 -17.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 74.51 111.121 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.99 -21.14 59.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 72.51 110.85 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -117.79 -12.47 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.851 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -54.97 -60.78 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 74.02 110.929 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -24.93 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 72.31 110.819 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.4 m -81.36 -31.98 33.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 74.24 111.18 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -42.16 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 73.43 110.851 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.5 mm -61.85 -47.43 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.23 111.083 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -57.23 -28.07 62.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.911 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -76.59 -19.54 57.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.89 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.36 -16.09 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 75.54 111.187 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 4.2 pp -104.95 -5.74 20.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 74.33 110.994 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.61 -30.69 9.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 73.0 110.876 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -104.37 -51.18 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 65.52 110.835 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.14 39.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 73.42 110.882 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -52.56 -48.67 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 73.31 110.852 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -60.44 106.25 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.929 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 42.8 mt -145.95 123.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 72.2 111.146 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.41 -35.47 54.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 74.11 110.843 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -157.83 129.38 6.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 74.2 111.082 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.95 136.46 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 71.51 111.128 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.5 t -113.16 113.4 49.1 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.72 0.771 . . . . 75.15 111.082 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.86 -173.41 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 71.5 112.34 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.24 -15.38 69.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 74.13 112.47 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.71 139.45 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 74.1 110.884 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.62 -117.93 5.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.827 -0.701 . . . . 71.3 112.475 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -148.94 169.09 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 73.51 110.928 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.17 161.58 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 74.1 111.071 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.06 -88.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 64.21 112.429 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -179.8 -170.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 73.15 110.875 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -60.98 -18.0 54.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 74.31 110.955 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.98 52.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.671 -0.776 . . . . 74.15 112.455 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.6 -47.83 30.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.862 0.363 . . . . 74.14 110.903 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -55.16 32.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.96 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.83 -20.04 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 71.23 110.856 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -69.74 -39.32 76.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 72.44 110.851 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.8 m -53.19 -50.38 64.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 64.45 111.106 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.36 -17.73 55.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.919 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -87.44 -5.67 58.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.878 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.62 -5.28 6.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 75.44 110.968 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.87 4.87 11.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 73.42 110.965 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 75.45 110.857 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.6 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.807 0.337 . . . . 73.3 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.82 91.82 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.44 111.101 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -111.88 117.84 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 73.32 110.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -60.79 168.96 2.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.873 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.96 -47.94 64.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 62.31 110.881 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -61.08 -37.54 83.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.15 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.3 13.32 61.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.669 -0.777 . . . . 55.11 112.542 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.4 m -79.14 -44.8 21.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 75.24 111.092 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 67' ' ' LEU . 32.1 mt -103.59 117.46 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 44.21 111.176 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -124.46 129.12 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 74.45 110.843 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.694 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -120.44 112.55 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 53.53 111.105 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.443 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -98.31 128.76 44.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 71.42 110.86 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -73.55 110.93 8.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 72.21 110.89 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 213' ' ' VAL . 10.8 mt -65.37 -32.99 74.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 43.41 110.879 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.85 -97.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 64.44 110.872 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.09 9.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 73.15 110.864 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.53 8.25 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 75.4 110.829 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -150.89 141.14 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 71.52 111.095 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.694 ' HB3' HG22 ' A' ' 18' ' ' ILE . 19.6 m95 -130.0 -179.39 5.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 65.11 110.878 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 43' ' ' GLY . 93.0 t -132.0 89.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 64.5 111.096 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.406 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.3 p80 -72.78 124.38 25.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 65.51 110.834 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -119.93 104.2 9.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 70.1 111.128 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -88.13 123.27 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.8 117.8 28.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 72.14 110.874 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 52.22 112.514 179.836 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.58 0.705 . . . . 75.24 111.181 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 118.33 5.62 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.738 2.292 . . . . 71.25 112.348 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -110.21 99.91 8.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 71.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -62.42 170.37 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 75.42 110.93 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -159.28 -147.46 4.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 30.04 112.527 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.8 tp -159.58 116.28 2.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 73.55 110.885 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.652 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.52 121.83 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 54.01 111.155 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.46 HD22 ' SD ' ' A' ' 138' ' ' MET . 24.7 mt -98.7 118.23 34.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 64.2 110.966 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.39 85.93 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.936 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.78 177.15 4.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 73.03 111.092 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -97.94 -20.84 17.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 61.11 110.823 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -10.4 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 65.3 110.902 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.62 153.54 5.91 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 72.24 112.523 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.0 tp -68.54 154.95 40.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 64.14 110.905 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.3 t -145.15 142.99 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 73.13 111.107 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.652 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -137.56 124.61 21.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.905 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.538 HG12 ' OD1' ' A' ' 56' ' ' ASP . 74.1 t -71.51 112.44 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 54.42 111.137 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.8 m-20 73.4 121.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 71.0 110.882 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.67 ' CB ' HD11 ' A' ' 98' ' ' LEU . 2.8 p -66.12 -166.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 65.35 110.844 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.6 t -91.9 169.48 10.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.85 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.714 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.1 m95 -50.38 -60.25 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.828 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -129.82 158.51 39.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 75.15 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -51.37 -33.75 31.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.972 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.21 -38.11 76.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 71.23 110.926 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 59' ' ' TRP . 93.1 mt -81.15 -45.54 16.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.934 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -45.14 61.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.132 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -52.93 -51.59 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 74.35 110.952 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -63.71 -19.71 65.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 71.13 110.913 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.1 tp -87.94 -26.86 22.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.877 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.75 -23.09 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 72.42 111.265 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.09 18.18 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 74.33 110.865 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.3 ptm -132.9 -40.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 71.5 110.866 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.1 m -81.07 -22.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 70.2 111.163 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.623 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.81 -21.95 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.902 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -109.04 -33.27 6.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 73.15 110.851 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.93 -43.48 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.908 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.17 -10.87 48.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 62.3 110.895 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 67.42 13.27 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 73.13 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.545 ' HB2' HD13 ' A' ' 52' ' ' LEU . 5.3 mttm -131.33 138.76 49.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 62.22 110.954 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -85.8 137.94 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.22 110.833 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.623 HG23 ' OE1' ' A' ' 72' ' ' GLU . 98.8 t -76.91 126.39 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 71.21 111.103 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -143.79 13.89 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.11 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 53' ' ' VAL . 53.8 m-20 -155.89 144.15 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.04 110.906 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 54' ' ' LEU . 14.5 t -154.41 131.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.4 111.161 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.497 ' CD1' HG11 ' A' ' 140' ' ' VAL . 49.6 mt -89.4 130.73 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 61.32 111.105 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -106.28 124.94 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.12 111.157 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.472 HG23 ' OD2' ' A' ' 56' ' ' ASP . 30.7 p -82.53 -39.54 22.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 72.01 111.167 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.485 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.8 p80 -165.94 -175.29 3.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 71.11 110.931 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.808 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.24 95.83 10.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 71.21 111.108 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.88 154.08 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.35 110.832 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.13 -20.19 51.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 73.5 111.049 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.8 5.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 61.14 110.918 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.419 ' HD3' ' CE1' ' A' ' 86' ' ' HIS . 3.8 mpt_? -122.11 -77.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 73.12 110.791 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.14 8.48 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 62.33 111.086 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.38 -42.32 33.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 70.34 112.476 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.61 13.1 58.15 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 23.13 112.468 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.5 tt -51.42 -29.63 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 71.1 111.086 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -32.11 45.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 72.22 110.984 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.6 m -89.78 -22.72 22.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 74.42 111.132 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.67 HD11 ' CB ' ' A' ' 57' ' ' SER . 13.3 mt -80.54 -25.98 38.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.906 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.73 15.3 29.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.913 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.03 -40.93 3.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.24 110.89 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -83.19 -58.14 2.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 64.41 110.928 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.56 38.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 72.43 112.545 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.2 mp -106.05 115.12 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 74.34 111.111 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HB3' HD11 ' A' ' 124' ' ' LEU . 2.6 mttt -78.84 116.31 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 53.44 110.911 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.43 93.15 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 54.55 111.127 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.575 ' HA ' HD12 ' A' ' 124' ' ' LEU . 38.0 m-70 -67.66 129.44 39.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.912 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.627 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -159.11 -178.98 7.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 52.5 110.924 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.89 157.75 17.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.133 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.03 -36.94 30.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 63.43 111.109 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.614 HD21 ' HG2' ' A' ' 151' ' ' GLU . 0.3 OUTLIER -72.11 -39.42 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.99 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.742 ' HA ' HD11 ' A' ' 114' ' ' LEU . 83.6 m -57.87 -27.72 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 64.42 111.186 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.31 4.7 53.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 42.02 111.018 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -103.61 -44.81 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.889 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -85.07 -13.86 49.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.959 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.483 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -62.62 -43.12 99.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.097 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.15 62.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.944 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -35.55 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 64.54 110.838 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.39 -23.53 22.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.25 110.917 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.59 22.99 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 53.33 112.447 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -94.84 179.14 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.344 . . . . 64.32 110.883 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -77.41 -176.18 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 72.1 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mt-10 -115.35 101.52 54.37 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.634 0.73 . . . . 75.32 110.852 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.4 Cg_endo -69.76 -179.85 3.2 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.742 2.295 . . . . 65.14 112.341 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 106' ' ' HIS . 29.4 mt -51.24 -52.55 43.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 73.55 110.858 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 58.75 21.94 52.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 74.22 112.444 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.37 24.14 6.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 74.02 110.886 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.688 ' CD2' HD21 ' A' ' 133' ' ' LEU . 95.5 mt -103.99 -175.9 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 61.5 110.942 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -154.99 -171.55 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 52.13 110.826 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.934 HG22 HG23 ' A' ' 130' ' ' VAL . 36.6 m -50.94 -70.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 54.1 111.087 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.934 HG23 HG22 ' A' ' 129' ' ' THR . 44.4 t -119.11 104.06 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 70.2 111.218 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -135.15 164.2 28.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 73.12 111.22 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.93 126.61 54.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.283 -0.417 . . . . 75.13 111.0 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.688 HD21 ' CD2' ' A' ' 127' ' ' LEU . 67.0 mt -111.49 155.7 22.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.35 110.912 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -137.87 117.19 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 62.54 110.872 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.19 48.93 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 74.33 110.886 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.33 94.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.751 . . . . 65.11 112.45 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.35 15.36 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 43.31 110.887 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.46 ' SD ' HD22 ' A' ' 46' ' ' LEU . 54.8 tpp -137.45 101.37 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 62.23 110.898 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.464 ' O ' HD23 ' A' ' 158' ' ' LEU . 2.9 mptt -90.81 132.56 35.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 75.44 110.773 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.727 HG22 HD21 ' A' ' 158' ' ' LEU . 21.2 t -138.5 114.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.061 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -107.6 129.58 54.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 75.04 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 46.9 p -86.08 178.09 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 72.11 111.183 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.515 ' HD1' HG22 ' A' ' 130' ' ' VAL . 19.4 t80 -161.63 133.69 5.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 70.05 110.858 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.678 ' HB3' HG23 ' A' ' 129' ' ' THR . 9.1 t80 -121.78 86.48 45.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 75.33 110.872 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -8.04 22.6 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.767 2.311 . . . . 74.53 112.31 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.36 -160.94 24.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 73.51 112.434 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -87.77 140.76 29.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 74.24 110.844 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.537 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -154.6 -91.11 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 62.43 112.459 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -73.79 -23.51 59.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 71.33 110.959 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.485 HG21 ' HB2' ' A' ' 86' ' ' HIS . 47.2 p -150.29 -167.38 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 43.33 111.167 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.645 ' HB3' HD23 ' A' ' 114' ' ' LEU . 2.0 tt0 -86.32 -15.98 38.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 74.1 110.853 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.567 ' HB2' HD23 ' A' ' 110' ' ' LEU . 41.0 t0 -135.53 17.96 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.871 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.684 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -51.45 129.59 25.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 64.42 110.818 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 144' ' ' TYR . 5.8 pt -136.54 175.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.08 -0.509 . . . . 74.5 111.065 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -128.35 119.51 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.162 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.47 126.58 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 62.44 111.108 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -115.25 138.8 50.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 71.42 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.727 HD21 HG22 ' A' ' 140' ' ' VAL . 20.1 mt -121.34 98.91 46.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.652 0.739 . . . . 75.44 110.846 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -4.13 13.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.707 2.271 . . . . 63.1 112.287 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -85.16 -22.97 28.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.317 -0.401 . . . . 52.33 110.974 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.41 12.28 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 62.03 111.042 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.3 m120 54.68 25.68 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 41.54 110.819 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 93.5 mt -90.48 142.95 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 65.41 111.196 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.637 HD22 HD13 ' A' ' 203' ' ' ILE . 13.2 tp -128.43 146.38 50.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 64.25 110.917 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 55' ' ' VAL . 42.1 t -115.17 76.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 63.51 111.126 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.09 -28.99 19.91 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.808 -0.711 . . . . 70.22 112.49 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.41 -161.72 20.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 73.41 112.465 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -33.18 60.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 53.41 110.868 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.684 HD13 ' OD1' ' A' ' 153' ' ' ASN . 25.1 tp -51.85 -35.86 46.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.924 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.91 111.16 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.42 111.078 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.71 159.73 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 62.21 110.858 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.7 p -100.27 162.78 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.812 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 64.21 111.075 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.778 0.323 . . . . 34.42 111.104 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.98 90.49 3.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.959 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.96 -17.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 54.32 111.271 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -74.39 -27.81 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 71.31 110.949 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -110.97 -12.92 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 61.21 110.857 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.511 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.3 t90 -54.09 -62.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 64.5 110.918 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.687 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -54.56 -23.73 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 72.23 110.822 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.2 m -81.43 -30.48 33.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 70.31 111.168 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.22 -43.63 41.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.889 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.512 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.7 mm -61.83 -45.2 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 74.13 111.144 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.52 -23.96 53.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 54.43 110.883 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.99 -22.79 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 74.4 110.864 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 192' ' ' SER . 17.4 t -86.11 -9.0 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.41 111.137 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.69 -6.93 13.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 55.04 110.941 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.46 -31.06 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 72.14 110.939 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -55.98 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.856 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -94.89 38.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.84 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -55.53 -47.97 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 75.23 110.948 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -60.05 102.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 73.24 110.829 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.669 HG21 HG22 ' A' ' 206' ' ' VAL . 41.9 mt -144.69 125.12 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 75.03 111.151 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -24.2 41.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 55.25 110.905 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.721 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -168.15 133.71 1.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 64.33 111.089 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' A' ' 218' ' ' LEU . 88.8 t -115.02 131.61 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 65.41 111.092 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.069 HG22 HG22 ' A' ' 213' ' ' VAL . 13.6 t -110.15 108.88 58.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 74.34 111.13 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.7 Cg_endo -69.7 -176.01 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 72.13 112.353 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.41 -17.36 80.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 71.52 112.476 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -152.43 141.15 20.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 74.5 110.972 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 110.21 -117.64 4.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 74.05 112.488 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.63 176.16 11.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.358 . . . . 62.22 110.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.069 HG22 HG22 ' A' ' 207' ' ' VAL . 5.8 t -70.09 151.12 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 61.32 111.146 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.99 -102.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.737 -0.744 . . . . 65.15 112.447 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.67 -168.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 72.13 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -60.93 -18.14 55.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 72.33 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.499 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.77 -19.79 37.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.799 -0.715 . . . . 61.32 112.506 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.738 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.6 mt -73.23 -31.78 64.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 61.11 110.878 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.512 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -62.8 -57.3 11.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 72.21 111.027 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 223' ' ' LEU . 0.5 OUTLIER -62.12 -17.93 59.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 41.01 110.937 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.9 OUTLIER -66.24 -40.99 90.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.874 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.906 HG22 HD23 ' A' ' 226' ' ' LEU . 27.8 m -60.94 -47.98 83.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 63.22 111.169 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -67.97 -21.99 65.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.949 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -75.4 -6.54 50.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 72.23 110.905 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.411 HD11 ' CE1' ' A' ' 221' ' ' HIS . 4.7 mt -125.13 -35.68 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 44.45 110.859 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.906 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -85.45 -0.82 56.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.912 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 75.45 110.894 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.842 0.353 . . . . 71.01 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mt -110.48 97.17 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 71.21 111.201 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.94 121.01 39.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 65.4 110.906 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -66.78 168.16 10.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 71.42 110.837 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -52.18 -48.14 65.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.45 110.844 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.98 -37.83 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 72.5 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.93 13.12 62.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 55.14 112.55 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 m -80.47 -44.26 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.278 . . . . 72.42 111.134 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 67' ' ' LEU . 52.8 mt -101.97 113.02 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 73.43 111.097 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.4 p -121.15 129.06 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 51.23 110.871 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.808 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.1 mt -120.41 111.83 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 72.04 111.121 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.2 t -97.01 126.53 42.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 64.24 110.894 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -72.15 109.34 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.892 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.848 HD21 HG11 ' A' ' 213' ' ' VAL . 6.7 mt -63.0 -35.26 79.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.964 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.68 -96.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.915 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.24 9.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.944 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.15 8.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 75.31 110.981 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -150.91 140.34 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 62.31 111.245 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.808 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.7 m95 -129.58 -179.71 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.437 . . . . 74.03 110.973 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.28 88.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 75.32 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -71.3 123.17 21.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 52.44 110.851 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.1 m -119.78 105.1 10.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 63.14 111.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.408 ' CG ' HD22 ' A' ' 67' ' ' LEU . 3.5 mp0 -87.05 122.64 31.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.882 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.53 108.5 19.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 74.42 110.896 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.786 -0.721 . . . . 62.25 112.513 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.553 0.692 . . . . 71.23 111.228 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.63 116.9 4.76 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.738 2.292 . . . . 60.24 112.405 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.2 p -104.44 98.34 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 54.22 110.839 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.51 169.25 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.893 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -148.71 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.839 -0.696 . . . . 54.53 112.586 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.627 HD21 HD12 ' A' ' 158' ' ' LEU . 15.8 tp -158.62 115.19 2.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 54.53 110.943 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.685 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -98.56 121.8 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 63.51 111.139 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.736 HD21 HD11 ' A' ' 158' ' ' LEU . 19.4 mt -98.84 116.51 31.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.958 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -87.38 85.49 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.44 110.953 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.6 176.18 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 65.42 111.115 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -96.67 -21.5 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 43.55 110.831 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -11.18 57.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 74.22 110.868 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.08 153.67 5.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 72.1 112.466 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.2 tp -68.39 155.03 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 72.35 110.951 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.2 t -145.57 142.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 71.33 111.153 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.685 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -137.53 122.84 19.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 74.01 110.959 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 165' ' ' VAL . 76.3 t -69.2 110.51 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 72.32 111.109 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.2 129.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 70.13 110.91 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.677 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -72.52 -165.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 60.01 110.809 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -91.37 172.66 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 52.1 110.839 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.742 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.9 m95 -49.94 -52.04 36.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 70.03 110.978 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -141.63 162.6 35.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 74.33 110.874 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.71 -30.59 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.428 . . . . 64.04 110.832 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -59.74 -42.08 92.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 71.24 110.951 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.742 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.0 mt -83.08 -45.37 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 74.32 110.866 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -45.87 59.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 72.34 111.167 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -55.58 -48.12 75.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 61.03 110.872 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.98 -18.91 65.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.901 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.578 ' O ' HG22 ' A' ' 71' ' ' VAL . 19.1 tp -89.59 -27.14 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 54.14 110.915 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.08 -22.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 71.31 111.145 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.55 15.72 13.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.871 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.46 -39.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 63.34 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.9 m -80.39 -22.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 60.12 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.554 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.75 -23.07 65.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.842 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 -33.52 7.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 74.24 110.842 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -69.91 -39.24 76.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 65.33 110.894 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -92.71 -10.44 37.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.879 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.65 12.05 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 65.15 110.916 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.523 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -130.48 137.83 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 54.01 110.868 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -86.49 138.21 31.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 73.32 110.898 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 54' ' ' LEU . 71.4 t -76.4 121.94 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 55.43 111.134 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.7 t -134.32 6.59 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.134 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 53' ' ' VAL . 60.1 m-20 -151.23 145.7 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.31 110.837 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 54' ' ' LEU . 10.8 t -154.03 132.22 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.075 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -93.89 123.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 72.53 111.163 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.6 mm -96.55 143.45 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.175 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.0 p -94.11 -51.42 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 75.2 111.176 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -156.1 -175.88 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.829 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.86 97.13 10.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 72.01 111.117 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -158.11 150.92 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 71.34 110.858 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.07 -19.61 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 61.04 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -92.29 21.83 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.809 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -144.0 -77.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 71.55 110.837 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -88.87 8.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 64.3 111.136 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -41.8 38.37 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.709 -0.758 . . . . 65.2 112.503 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.45 12.04 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 72.24 112.458 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 92' ' ' ILE . 3.5 tt -51.97 -28.49 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 63.43 111.104 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -53.58 -39.84 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 75.04 110.87 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.9 m -79.94 -17.29 53.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 52.02 111.192 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.677 HD11 ' OG ' ' A' ' 57' ' ' SER . 17.3 mt -84.99 -32.34 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 75.54 110.906 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.71 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.87 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -119.63 -45.74 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -77.36 -53.41 7.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.31 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.31 44.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 41.23 112.474 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -109.0 121.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.945 0.403 . . . . 74.4 111.14 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.769 ' HE2' HD21 ' A' ' 124' ' ' LEU . 7.7 mtpt -82.05 111.42 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 70.3 110.968 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.12 91.28 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.077 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.561 ' HA ' HD12 ' A' ' 124' ' ' LEU . 56.2 m-70 -62.98 142.16 58.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.01 110.865 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.629 ' CA ' HD12 ' A' ' 127' ' ' LEU . 3.4 p -172.9 179.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 53.24 110.882 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.85 157.47 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.41 111.208 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.99 -31.74 13.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 64.42 111.029 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.567 HD23 ' HB3' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -77.76 -39.38 44.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 72.44 110.908 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.569 ' HA ' HD11 ' A' ' 114' ' ' LEU . 10.2 m -57.37 -27.7 62.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 74.12 111.151 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -98.33 8.58 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.12 111.084 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.99 -28.78 11.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 75.41 110.898 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -103.36 -8.64 20.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.884 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.46 79.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 71.43 111.146 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -26.68 57.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 72.42 110.901 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -57.58 -30.75 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 64.04 110.933 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -92.11 -24.8 19.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 74.43 110.947 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.18 25.76 4.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 72.12 112.48 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.33 -176.08 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 73.23 110.955 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.61 167.75 17.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 71.34 110.853 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.6 mt-10 -101.25 103.25 24.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.7 0.762 . . . . 64.24 110.818 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.0 Cg_endo -69.73 -178.63 2.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 71.12 112.313 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.769 HD21 ' HE2' ' A' ' 104' ' ' LYS . 28.9 mt -51.64 -51.29 56.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.92 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.11 24.72 36.7 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.729 . . . . 64.22 112.437 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.78 29.31 5.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 72.34 110.898 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.696 ' CD2' HD21 ' A' ' 133' ' ' LEU . 95.6 mt -108.91 -175.8 2.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 55.42 110.903 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.87 -172.63 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 74.45 110.938 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.867 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.91 -70.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 64.3 111.127 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 129' ' ' THR . 38.8 t -117.77 103.1 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 73.41 111.111 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -131.78 174.34 10.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 55.31 111.152 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.32 129.36 50.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 73.24 110.878 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.696 HD21 ' CD2' ' A' ' 127' ' ' LEU . 60.8 mt -113.29 156.98 22.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 65.31 110.934 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -139.36 115.31 10.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.869 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -113.36 48.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 65.52 110.918 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.43 94.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 72.12 112.382 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 m120 65.1 14.2 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 63.3 110.885 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.5 tpp -133.43 104.29 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 64.12 110.88 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.68 123.78 36.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 61.14 110.883 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.959 HG22 HD21 ' A' ' 158' ' ' LEU . 21.5 t -131.92 117.86 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 70.43 111.116 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -111.13 127.91 55.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.51 110.884 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.58 -172.49 4.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 61.34 111.175 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HB3' HG23 ' A' ' 155' ' ' VAL . 37.7 t80 -172.83 135.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 74.11 110.899 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.694 ' HB3' HG23 ' A' ' 129' ' ' THR . 90.2 t80 -120.95 89.63 46.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.742 . . . . 73.03 110.89 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.7 Cg_endo -69.76 -7.89 22.2 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.661 2.241 . . . . 75.1 112.401 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.28 -150.08 19.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 74.52 112.527 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -96.53 139.12 33.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 74.54 110.886 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.451 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -152.0 -95.22 0.12 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 41.0 112.461 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 84.7 t60 -69.6 -24.44 63.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 73.32 110.982 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 p -151.4 -171.45 3.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 52.31 111.145 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.91 -8.4 57.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 75.24 110.89 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.567 ' HB3' HD23 ' A' ' 110' ' ' LEU . 3.7 p-10 -136.86 14.98 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 60.33 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.414 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.3 OUTLIER -53.07 137.95 32.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 72.1 110.906 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.69 -179.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.114 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.573 HG12 ' HA2' ' A' ' 166' ' ' GLY . 6.5 m -135.12 126.58 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 71.42 111.16 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.414 ' O ' HD12 ' A' ' 164' ' ' LEU . 99.9 t -85.96 122.94 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.35 111.094 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -110.7 133.05 53.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 73.3 110.91 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.959 HD21 HG22 ' A' ' 140' ' ' VAL . 10.9 mt -115.01 98.65 50.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 71.14 110.978 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -4.02 13.14 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 61.12 112.339 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -83.36 -23.85 32.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.954 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.25 14.49 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 75.22 110.922 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.19 27.36 7.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 72.52 110.858 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.557 HD13 HD13 ' A' ' 21' ' ' LEU . 96.2 mt -92.54 129.87 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 71.03 111.166 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.547 HD11 ' HB ' ' A' ' 155' ' ' VAL . 23.0 tp -115.5 147.68 40.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 64.41 110.947 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 55' ' ' VAL . 37.6 t -117.73 74.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 72.42 111.124 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.573 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -51.79 -41.49 51.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 74.35 112.534 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.49 -160.48 53.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.832 -0.699 . . . . 54.31 112.419 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 45.8 m -51.72 -30.1 21.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.368 . . . . 71.22 110.893 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.725 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.6 tp -57.83 -32.49 67.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 70.4 110.947 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 219' ' ' LEU . 80.1 t -105.98 109.73 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 51.01 111.16 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.661 ' HG2' HG23 ' A' ' 222' ' ' THR . 2.5 mmpt? -51.54 161.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 73.35 110.884 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.544 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -100.86 168.62 9.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 55.14 110.907 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 73.42 111.107 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.879 0.371 . . . . 43.34 111.047 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.61 91.91 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 73.53 110.932 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.49 -21.31 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 62.13 111.088 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.41 -21.71 60.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 75.41 110.82 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -114.93 -12.9 11.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 61.3 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.725 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.9 t90 -56.73 -62.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 64.21 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.722 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.5 -23.63 17.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 70.14 110.865 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 58.0 m -80.66 -33.31 35.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 61.21 111.155 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.89 -43.75 62.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 72.11 110.885 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.1 mm -59.56 -47.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 74.12 111.143 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.41 -27.78 62.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 64.01 110.852 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -77.43 -20.69 54.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 73.3 110.86 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.513 HG11 HD21 ' A' ' 219' ' ' LEU . 18.4 t -86.57 -13.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 63.25 111.156 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -108.38 -16.55 14.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.867 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -93.35 -30.6 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 65.54 110.849 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 -50.4 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 72.13 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.84 66.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 71.11 110.847 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.3 mtm-85 -72.91 -59.78 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 74.14 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -51.63 107.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 54.11 110.9 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.615 HG21 HG22 ' A' ' 206' ' ' VAL . 85.0 mt -146.61 122.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 74.34 111.12 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.93 -32.13 45.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.863 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 213' ' ' VAL . . . -161.72 147.62 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 64.35 111.09 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.615 HG22 HG21 ' A' ' 203' ' ' ILE . 47.6 t -123.47 126.74 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 62.14 111.108 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.823 HG22 ' HB ' ' A' ' 213' ' ' VAL . 17.0 t -103.29 104.07 38.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.565 0.697 . . . . 64.25 111.166 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.553 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.7 Cg_endo -69.73 -174.78 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.784 2.323 . . . . 64.23 112.33 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.1 75.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.786 . . . . 52.13 112.548 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.33 140.64 20.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 71.33 110.86 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.6 -117.26 4.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 41.23 112.397 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -157.02 149.14 22.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 65.2 110.916 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.848 HG11 HD21 ' A' ' 21' ' ' LEU . 4.0 p -51.55 137.6 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 52.23 111.115 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -135.03 -88.58 0.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 60.11 112.469 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -171.65 -168.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.963 0.411 . . . . 65.15 110.829 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.445 ' HA ' HD12 ' A' ' 219' ' ' LEU . 3.1 pttm -61.73 -17.26 55.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 70.33 110.92 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.81 -19.93 38.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 55.23 112.46 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.569 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.7 mt -77.4 -47.13 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 73.31 110.82 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.618 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -53.72 -54.61 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.33 110.978 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 221' ' ' HIS . 4.2 pp -60.72 -21.24 62.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.01 110.913 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.49 ' N ' HD12 ' A' ' 220' ' ' LEU . 0.8 OUTLIER -69.61 -37.65 76.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 70.24 110.889 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.73 HG22 HD23 ' A' ' 226' ' ' LEU . 3.5 m -55.39 -54.88 38.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 72.3 111.15 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.88 -19.87 53.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 72.33 110.897 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -83.58 -5.17 59.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 61.14 110.897 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.422 HD12 ' HG3' ' A' ' 171' ' ' LYS . 2.8 mt -129.14 -4.56 4.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 63.34 110.869 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 222' ' ' THR . 0.5 OUTLIER -121.77 -0.19 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 74.14 110.961 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.098 -0.501 . . . . 63.51 110.988 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 19' ' ' SER . 4.9 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.728 0.299 . . . . 74.31 111.182 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 mt -136.43 92.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 64.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -113.79 115.09 27.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.493 . . . . 70.21 110.909 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -58.96 168.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 63.33 110.874 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -51.3 -47.79 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.42 110.912 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 34.5 p -61.24 -37.45 83.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 55.55 111.075 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.66 14.13 61.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.746 . . . . 72.52 112.527 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.3 m -80.14 -44.34 20.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.308 . . . . 61.42 111.118 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.54 114.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 71.21 111.14 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -121.55 127.52 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.838 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.689 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -120.97 112.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 74.5 111.13 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.41 ' HA ' HG12 ' A' ' 8' ' ' VAL . 17.5 t -99.05 125.97 44.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 63.1 110.84 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -69.83 111.3 5.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 64.51 110.872 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.678 HD21 HG11 ' A' ' 213' ' ' VAL . 11.2 mt -65.17 -32.69 74.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.907 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.04 -96.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.52 110.977 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.33 9.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.13 110.947 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.84 7.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.911 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.99 141.9 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.42 111.183 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.689 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.8 m95 -130.04 -177.81 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.94 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 43' ' ' GLY . 90.7 t -133.4 91.76 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.311 -0.404 . . . . 63.12 111.191 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -75.16 123.55 25.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 70.3 110.824 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.5 m -120.33 104.24 9.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 51.35 111.212 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 124.34 31.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 73.54 110.824 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.5 113.77 23.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 61.11 110.938 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 53.3 112.477 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.713 0.768 . . . . 55.44 111.163 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.65 117.43 5.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.735 2.29 . . . . 75.32 112.394 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -109.41 97.4 6.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 70.11 110.792 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -58.25 166.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 73.44 110.892 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -158.05 -149.39 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 52.25 112.477 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 158' ' ' LEU . 15.5 tp -158.28 119.31 3.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 63.05 110.917 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.661 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -103.16 122.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 63.24 111.07 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.88 HD21 HD11 ' A' ' 158' ' ' LEU . 23.5 mt -100.42 120.74 40.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 51.43 110.963 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -91.47 84.67 5.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 74.04 110.893 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.2 p -99.54 -176.53 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.169 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 -26.47 13.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.2 110.886 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -18.7 55.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 65.41 110.86 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.17 151.47 5.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 55.42 112.479 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.709 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.9 mt -62.94 154.8 29.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.339 . . . . 62.01 110.839 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.1 t -144.22 141.27 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 63.25 111.131 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -136.55 121.82 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 72.33 110.891 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.444 HG11 HG11 ' A' ' 165' ' ' VAL . 79.8 t -68.24 111.97 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 64.2 111.054 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.8 129.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 74.23 110.792 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.615 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -71.9 -167.14 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 64.13 110.917 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.465 ' H ' HG23 ' A' ' 64' ' ' THR . 8.3 t -91.24 170.53 9.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 64.12 110.864 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.714 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.4 m95 -51.07 -60.28 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 71.0 110.91 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.02 159.26 35.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.258 -0.428 . . . . 54.31 110.876 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -51.44 -32.8 28.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.872 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -58.57 -44.13 89.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 73.2 110.918 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.4 mt -75.53 -45.5 37.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 62.14 110.96 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.6 -48.52 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 75.44 111.14 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -53.54 -48.4 69.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.23 110.931 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -65.61 -18.97 65.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.47 . . . . 71.02 110.9 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.8 tp -88.62 -27.1 21.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 73.45 110.936 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.2 mt -90.47 -23.01 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 72.31 111.105 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -92.81 17.32 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 72.24 110.895 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.8 ptm -131.95 -39.89 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 62.34 110.867 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.4 m -80.18 -24.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 75.35 111.205 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.708 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.37 -23.14 66.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 65.11 110.929 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 -32.14 7.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 55.23 110.946 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -40.93 67.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.41 110.953 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 52' ' ' LEU . 15.8 m-85 -89.43 -12.12 41.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.53 110.923 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.34 11.71 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 63.41 110.861 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.464 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -131.8 141.4 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 72.13 110.936 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -86.2 140.99 29.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.275 -0.421 . . . . 74.13 110.846 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 52' ' ' LEU . 85.0 t -82.07 126.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.4 111.137 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -142.46 13.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 70.24 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 53' ' ' VAL . 61.7 m-20 -153.75 144.74 22.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 71.45 110.874 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 54' ' ' LEU . 16.5 t -154.31 132.61 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 72.01 111.167 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.506 ' CD1' HG11 ' A' ' 140' ' ' VAL . 46.9 mt -92.58 126.72 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 72.3 111.097 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -102.85 136.32 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 51.43 111.066 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 -44.59 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.1 111.265 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -152.46 174.94 13.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.901 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.479 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -95.65 88.9 5.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 44.24 111.061 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.95 156.04 43.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 73.01 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -21.72 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 50.52 111.04 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 20.49 7.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 62.22 110.883 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -140.62 -75.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -92.99 8.14 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 70.41 111.074 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -36.56 28.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 63.44 112.46 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.03 15.26 51.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 65.41 112.534 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 92' ' ' ILE . 19.1 tt -56.57 -29.98 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 75.34 111.087 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -30.67 62.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.23 110.86 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -90.0 -11.81 40.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 71.34 111.166 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 57' ' ' SER . 17.4 mt -91.01 -28.77 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 60.25 110.971 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -100.03 22.21 11.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 70.22 110.916 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -121.7 -36.51 3.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.32 110.932 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -87.41 -53.94 4.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.088 -0.505 . . . . 73.03 110.894 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.1 38.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 64.52 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.548 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.4 mp -110.25 124.36 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.35 . . . . 74.41 111.132 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.709 ' HE2' HD21 ' A' ' 124' ' ' LEU . 3.4 mtpp -89.79 118.44 29.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 65.04 110.894 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.9 92.05 8.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 50.4 111.113 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.526 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.6 m-70 -66.29 144.03 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.55 110.751 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.61 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -178.38 -174.19 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 55.22 110.857 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -94.97 155.37 16.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 74.21 111.144 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.62 -39.98 37.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.12 111.16 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.0 -43.45 87.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.934 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.65 ' HA ' HD11 ' A' ' 114' ' ' LEU . 93.5 m -58.77 -21.61 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 72.34 111.098 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.43 12.26 37.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 63.21 111.138 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -25.81 9.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 63.13 110.943 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -103.98 -7.61 20.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 70.14 110.961 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.02 64.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.23 111.093 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -21.69 52.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 75.4 110.843 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -31.32 72.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 54.32 110.904 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -90.22 -25.62 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.895 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 25.42 2.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 64.33 112.488 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.42 170.6 7.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 74.11 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.54 179.0 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.524 . . . . 74.35 110.912 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.5 mp0 -111.34 106.09 57.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.729 . . . . 55.2 110.938 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.72 178.42 4.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.699 2.266 . . . . 73.14 112.361 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HE2' ' A' ' 104' ' ' LYS . 14.0 mt -53.3 -47.44 69.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.915 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.17 27.82 24.51 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 72.31 112.487 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.845 0.355 . . . . 71.3 110.881 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.712 ' CD2' HD21 ' A' ' 133' ' ' LEU . 91.4 mt -113.76 -175.32 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 73.4 110.901 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.16 -171.64 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.964 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.861 HG22 HG23 ' A' ' 130' ' ' VAL . 53.1 m -50.86 -70.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 73.23 111.222 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.861 HG23 HG22 ' A' ' 129' ' ' THR . 40.1 t -118.58 102.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 71.13 111.12 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -132.25 169.12 16.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.151 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.27 132.84 56.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 75.53 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.712 HD21 ' CD2' ' A' ' 127' ' ' LEU . 50.2 mt -119.41 157.84 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 73.41 110.889 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -142.62 112.31 6.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 62.35 110.908 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -107.65 47.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 70.53 110.835 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.74 92.73 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 72.3 112.469 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.65 13.6 9.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 75.23 110.825 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.436 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.1 tpp -136.48 93.51 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.933 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -83.68 132.09 34.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.816 HG22 HD21 ' A' ' 158' ' ' LEU . 46.2 t -137.25 117.74 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 72.05 111.176 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -110.16 126.99 54.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 73.45 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.4 p -83.38 -174.05 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 71.23 111.126 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.588 ' HB3' HG23 ' A' ' 155' ' ' VAL . 33.9 t80 -171.82 133.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.877 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.699 ' HB3' HG23 ' A' ' 129' ' ' THR . 81.0 t80 -120.43 88.53 42.62 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.662 0.744 . . . . 74.32 110.937 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.2 Cg_endo -69.77 -7.93 22.3 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 72.24 112.333 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.2 -158.25 23.07 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 74.42 112.441 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -90.17 139.34 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 74.42 110.812 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -150.67 -95.56 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.727 -0.749 . . . . 73.51 112.435 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -70.36 -24.17 62.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 75.13 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.3 p -151.7 -175.24 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 75.25 111.111 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.77 -2.34 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 60.53 110.841 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.483 ' OD1' HG23 ' A' ' 111' ' ' THR . 12.9 p-10 -140.21 11.45 2.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 42.11 110.906 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.584 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -52.65 141.38 20.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 75.34 110.892 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.67 -178.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 73.05 111.106 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 143' ' ' PHE . 5.8 m -136.77 120.1 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 74.13 111.198 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.703 ' O ' HD12 ' A' ' 164' ' ' LEU . 93.6 t -79.25 133.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.161 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -118.69 131.34 56.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.987 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.88 HD11 HD21 ' A' ' 46' ' ' LEU . 10.4 mt -112.8 98.83 46.25 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.595 0.712 . . . . 73.33 110.917 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.5 Cg_endo -69.73 -4.26 13.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.279 . . . . 73.54 112.336 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -83.08 -23.8 32.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 55.51 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.82 14.05 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.95 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.4 m120 54.21 27.15 7.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 75.43 111.006 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 21' ' ' LEU . 96.1 mt -91.98 136.66 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 74.23 111.111 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 156' ' ' VAL . 26.6 tp -121.96 147.75 45.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 64.41 110.992 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.444 HG11 HG11 ' A' ' 55' ' ' VAL . 45.3 t -117.33 76.47 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 71.42 111.078 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.567 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -51.59 -40.77 48.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 71.11 112.556 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 71.6 -162.82 54.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 62.3 112.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 78.6 m -51.46 -33.1 29.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.77 0.319 . . . . 73.54 110.777 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.687 HD12 ' NE1' ' A' ' 189' ' ' TRP . 25.4 tp -51.63 -44.56 62.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 52.31 110.945 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.583 HG13 ' HA ' ' A' ' 219' ' ' LEU . 46.1 t -101.08 111.6 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.23 111.061 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.635 ' HG3' HD12 ' A' ' 225' ' ' LEU . 30.9 mmmt -55.31 164.85 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 72.45 110.864 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.9 p -114.98 170.33 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.14 110.835 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 63.11 111.088 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.808 0.337 . . . . 31.12 111.073 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -119.73 91.75 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 72.51 110.961 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.6 -19.07 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.15 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -74.78 -20.89 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.893 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -116.81 -16.18 10.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 72.22 110.85 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.687 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -55.0 -61.41 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.2 -0.455 . . . . 74.4 110.906 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.739 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.27 -24.64 19.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.858 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -80.72 -31.97 35.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 74.15 111.065 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -74.09 -45.45 49.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 64.43 110.848 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.6 mm -59.11 -47.63 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 75.41 111.087 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.33 -28.65 59.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.879 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -77.31 -22.48 51.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.3 110.848 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 192' ' ' SER . 11.0 t -85.37 -10.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 62.03 111.154 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -111.96 -10.28 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 64.41 110.936 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.8 -30.43 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 71.52 110.845 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 -45.73 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 64.03 110.835 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.41 37.06 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.93 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.61 -48.06 75.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 71.51 110.914 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -61.2 102.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.948 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.746 HG21 HG22 ' A' ' 206' ' ' VAL . 52.3 mt -144.86 126.53 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 72.03 111.139 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.75 -22.71 34.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 65.02 110.908 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.74 125.31 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 63.53 111.083 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.746 HG22 HG21 ' A' ' 203' ' ' ILE . 92.5 t -104.22 137.23 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 71.03 111.051 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.081 HG22 HG12 ' A' ' 213' ' ' VAL . 11.6 t -110.8 108.44 57.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.573 0.701 . . . . 63.42 111.146 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 173.33 11.17 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.66 2.24 . . . . 72.53 112.301 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.52 -13.81 74.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.602 -0.809 . . . . 54.2 112.525 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -152.61 147.6 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 72.13 110.785 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 99.47 -113.94 4.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 65.23 112.476 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -156.58 168.6 26.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 61.23 110.875 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.081 HG12 HG22 ' A' ' 207' ' ' VAL . 5.0 m -58.34 163.27 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 62.25 111.135 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.99 -104.72 0.2 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 71.12 112.492 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.95 -169.6 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.34 . . . . 62.51 110.874 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -59.81 -19.19 49.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 63.21 110.89 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.502 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -56.04 -22.69 36.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.74 . . . . 72.42 112.471 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.686 HD12 ' HB ' ' A' ' 206' ' ' VAL . 5.0 mt -72.56 -32.73 66.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 71.45 110.919 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.583 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.7 mp -62.03 -59.98 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 71.44 110.924 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.502 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -59.43 -20.66 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.912 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.26 -37.69 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 52.53 110.902 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.629 HG22 ' CD2' ' A' ' 226' ' ' LEU . 7.1 m -58.44 -51.62 69.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 72.31 111.126 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.5 mp -68.77 -16.71 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 71.22 110.972 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.86 -11.07 59.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 74.01 110.864 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.635 HD12 ' HG3' ' A' ' 171' ' ' LYS . 6.3 mt -121.24 -31.76 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 61.32 110.991 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.739 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -91.6 8.24 37.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 72.23 110.953 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.03 110.868 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.825 0.345 . . . . 75.0 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.02 92.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 70.41 111.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.27 119.46 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 65.25 110.894 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -61.87 168.47 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.31 110.861 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.85 -47.9 64.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.804 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.77 -37.75 82.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 74.1 111.079 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.04 12.72 61.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 44.24 112.539 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.409 HG23 ' CB ' ' A' ' 31' ' ' LEU . 23.0 m -80.39 -44.1 19.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 70.53 111.179 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -102.57 116.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 65.43 111.09 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.4 p -123.89 131.75 53.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 61.24 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.758 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -124.16 109.95 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 71.5 111.066 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.2 t -101.01 125.25 47.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.745 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.72 110.93 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 64.55 110.899 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.651 HD13 HD13 ' A' ' 163' ' ' ILE . 14.7 mt -65.41 -31.86 73.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 64.21 110.926 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.71 -97.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.879 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.47 9.89 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.897 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.58 6.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 71.53 110.931 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.2 t -151.09 139.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 70.4 111.138 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.758 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.6 m95 -126.92 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.864 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 43' ' ' GLY . 93.2 t -136.69 96.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 51.23 111.213 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -81.27 120.66 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 72.21 110.876 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -115.78 100.99 8.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 61.52 111.205 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.16 121.51 26.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 73.53 110.912 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' CB ' HG23 ' A' ' 15' ' ' THR . 0.6 OUTLIER -92.29 107.04 18.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 73.54 110.928 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 50.33 112.501 179.872 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.587 0.708 . . . . 64.1 111.007 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 118.24 5.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.264 . . . . 72.13 112.295 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.83 99.89 9.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 72.1 110.871 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -52.56 170.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.45 110.812 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.577 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -162.55 -164.01 16.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.416 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 26' ' ' TRP . 14.4 tp -153.04 114.16 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 74.12 110.902 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.623 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.8 t -97.28 116.8 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 55.23 111.113 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.596 HD21 HD21 ' A' ' 158' ' ' LEU . 13.5 mt -94.86 120.83 35.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 71.43 110.965 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -91.66 83.21 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.12 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 138' ' ' MET . 2.5 p -90.77 -178.5 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 72.34 111.126 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -105.26 -1.15 25.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 40.14 110.777 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -23.14 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.57 144.42 4.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 41.41 112.471 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.695 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.7 mt -59.51 154.54 17.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 71.32 110.93 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.4 t -145.11 142.94 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 73.42 111.122 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.3 mt -137.51 123.12 19.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.835 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.78 112.72 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 63.52 111.107 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.65 129.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.03 110.94 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.656 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -72.18 -167.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.854 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.406 ' H ' HG23 ' A' ' 64' ' ' THR . 8.0 t -92.34 170.27 9.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 63.43 110.853 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.736 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.7 m95 -50.34 -60.26 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.873 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -128.93 160.56 32.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 61.23 110.854 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -52.72 -31.24 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 72.15 110.864 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -59.82 -43.52 94.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 72.24 110.88 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.736 HD12 ' HB2' ' A' ' 59' ' ' TRP . 94.2 mt -75.47 -45.85 36.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 71.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -51.53 -47.11 63.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 73.42 111.169 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -50.98 61.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 63.54 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.37 -19.87 65.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 73.53 110.86 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.6 tp -87.45 -26.16 23.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 62.2 110.871 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.6 mt -90.87 -23.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 63.25 111.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.69 16.5 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.882 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.85 -39.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 71.33 110.783 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.9 m -80.85 -23.76 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 74.32 111.158 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.703 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.01 -23.43 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.51 110.866 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -106.8 -33.57 7.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.906 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -70.58 -44.12 68.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 61.15 110.783 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.9 m-85 -86.59 -12.8 47.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 74.13 110.907 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.43 11.75 8.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 53.34 110.89 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.95 141.1 50.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 71.3 110.894 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.41 140.4 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 74.43 110.883 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.703 HG23 ' OE1' ' A' ' 72' ' ' GLU . 86.3 t -81.95 121.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 53.52 111.111 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.78 9.65 2.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 63.34 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 53' ' ' VAL . 65.2 m-20 -148.86 145.02 27.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.87 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 54' ' ' LEU . 20.3 t -154.14 131.47 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 73.13 111.125 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.653 HD13 HG11 ' A' ' 140' ' ' VAL . 5.6 mt -94.66 123.49 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 72.43 111.077 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.7 mm -94.58 150.33 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 64.42 111.119 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 p -109.31 -40.82 4.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 64.11 111.149 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.606 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -159.62 -178.53 7.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 62.41 110.844 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.736 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -98.89 96.87 8.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 64.23 111.186 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -155.72 154.84 32.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 61.52 110.866 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.22 -20.59 28.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.3 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.92 16.25 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 74.25 110.838 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.02 -76.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 74.24 110.832 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.79 8.39 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.135 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.9 -36.38 33.66 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.698 -0.763 . . . . 73.43 112.476 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.24 16.16 49.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 64.2 112.401 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 92' ' ' ILE . 3.0 tt -58.16 -23.29 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 74.14 111.077 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -30.08 68.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 62.21 110.919 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.5 m -88.97 -19.92 25.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 62.41 111.1 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 57' ' ' SER . 15.0 mt -82.79 -32.44 27.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 74.42 110.892 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -95.15 23.76 5.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -122.13 -41.45 2.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 73.41 110.999 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -83.03 -49.8 9.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.805 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.45 39.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 51.3 112.479 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.551 HD13 ' HA ' ' A' ' 98' ' ' LEU . 3.6 mp -106.69 120.0 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 71.4 111.159 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.61 ' HB3' HD11 ' A' ' 124' ' ' LEU . 6.0 mttm -83.35 118.68 23.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.35 110.92 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.42 92.82 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 51.12 111.127 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.537 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.7 m-70 -64.98 143.3 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 71.01 110.841 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.583 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -178.49 -179.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 64.24 110.908 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.445 HG22 ' C ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -90.99 153.92 19.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 61.43 111.195 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.68 -35.1 13.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 74.02 111.105 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -69.17 -47.76 64.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 45.1 110.92 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.763 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.9 m -59.42 -18.61 40.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 73.53 111.081 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.57 11.4 39.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 74.1 111.049 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.499 ' CD ' HD22 ' A' ' 110' ' ' LEU . 3.5 pt-20 -113.91 -31.76 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 71.25 110.889 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.763 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -93.49 -13.33 27.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.866 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.453 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.049 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -24.95 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 75.4 110.928 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.59 -32.61 70.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 71.13 110.849 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -89.54 -24.82 21.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.897 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.24 23.16 3.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 30.34 112.484 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -98.38 177.59 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 75.03 110.973 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -76.34 178.99 6.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 72.03 110.885 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mp0 -112.58 105.66 55.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.609 0.718 . . . . 64.31 110.867 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.9 Cg_endo -69.82 178.68 4.37 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.709 2.273 . . . . 55.05 112.327 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 104' ' ' LYS . 20.1 mt -51.3 -48.34 62.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.52 110.862 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.09 38.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 74.04 112.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -107.11 41.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 75.34 110.9 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.583 HD12 ' CA ' ' A' ' 107' ' ' SER . 72.7 mt -124.93 -173.81 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 63.14 110.879 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -147.01 -172.92 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 65.22 110.842 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 144' ' ' TYR . 52.6 m -50.58 -71.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 73.23 111.161 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.756 HG23 HG22 ' A' ' 129' ' ' THR . 28.2 t -113.51 94.35 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 71.03 111.18 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.471 HG21 HD22 ' A' ' 127' ' ' LEU . 15.3 t -118.36 167.0 11.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 54.51 111.066 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.51 106.83 10.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 60.12 110.877 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.413 HD21 HD22 ' A' ' 127' ' ' LEU . 28.8 mt -79.72 -173.21 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 72.55 110.939 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.04 112.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 52.23 110.944 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' HE2' HD11 ' A' ' 83' ' ' ILE . 30.7 m-85 -110.49 74.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 74.34 110.83 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.51 -83.06 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 53.21 112.505 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -120.29 24.85 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.3 . . . . 64.44 110.893 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.401 ' HB2' HG22 ' A' ' 48' ' ' THR . 51.4 tpp -129.48 142.55 50.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.909 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.32 133.28 56.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 72.01 110.827 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.653 HG11 HD13 ' A' ' 83' ' ' ILE . 19.5 t -144.97 117.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 72.22 111.117 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -112.5 126.55 55.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 62.24 110.919 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 p -82.69 -178.19 7.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.183 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.404 ' HB3' HG23 ' A' ' 155' ' ' VAL . 19.4 t80 -166.49 134.06 2.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 73.13 110.929 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.772 ' HB3' HG23 ' A' ' 129' ' ' THR . 10.1 t80 -121.06 89.31 46.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.723 0.773 . . . . 73.32 110.971 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -8.12 22.8 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.706 2.27 . . . . 71.31 112.374 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.53 -157.67 20.38 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 52.03 112.495 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -84.66 137.69 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.724 0.297 . . . . 74.12 110.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.33 -89.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 63.54 112.516 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -75.1 -25.64 58.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 75.2 110.843 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 86' ' ' HIS . 29.9 p -147.32 -162.26 1.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.162 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.523 ' HB3' HD23 ' A' ' 114' ' ' LEU . 61.4 tt0 -84.53 -25.42 28.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 65.43 110.886 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 154' ' ' ILE . 19.2 t70 -135.8 24.05 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 65.53 110.961 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -50.41 128.06 18.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 62.4 110.88 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 152' ' ' ASP . 2.6 pt -135.12 173.0 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 72.51 111.074 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.8 m -124.42 150.0 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.41 111.076 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.87 111.77 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.15 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -101.28 132.83 46.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.596 HD21 HD21 ' A' ' 46' ' ' LEU . 6.3 mp -112.22 97.64 39.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 72.42 110.91 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.81 -4.86 14.91 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.619 2.212 . . . . 34.54 112.373 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.55 -26.56 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 72.44 110.958 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.53 19.14 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 71.3 111.005 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 50.51 29.28 3.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.524 . . . . 62.41 110.941 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.651 HD13 HD13 ' A' ' 21' ' ' LEU . 80.2 mt -91.64 120.01 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.117 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.576 HD23 HG22 ' A' ' 206' ' ' VAL . 34.3 tp -104.53 147.15 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 55.53 110.882 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.53 79.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 52.43 111.136 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.84 -49.81 46.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.734 -0.745 . . . . 54.4 112.456 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.32 -166.29 53.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 44.14 112.436 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -35.38 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 75.2 110.838 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.63 HD12 ' NE1' ' A' ' 189' ' ' TRP . 23.5 tp -51.59 -52.19 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 63.44 110.967 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 218' ' ' LEU . 21.2 t -84.02 109.44 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.31 111.161 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.72 ' HG2' HG23 ' A' ' 222' ' ' THR . 1.7 mmpt? -51.86 148.12 6.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.872 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 153.97 17.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 54.04 110.872 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 71.12 111.08 -179.912 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.755 0.312 . . . . 74.05 111.057 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.24 87.06 2.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.947 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.2 t -60.78 -18.18 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 53.01 111.141 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.28 -28.09 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 71.55 110.814 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.59 -12.34 14.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 40.41 110.796 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.63 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.7 t90 -53.28 -62.0 1.93 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.857 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.767 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -54.17 -24.09 16.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.831 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -82.39 -30.93 29.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 71.53 111.141 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -43.27 58.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 71.2 110.782 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.577 HG21 ' O ' ' A' ' 219' ' ' LEU . 28.9 mm -62.95 -43.0 98.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 73.52 111.172 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.44 -22.5 54.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.907 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -82.74 -22.4 34.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 53.12 110.94 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.14 -9.77 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 55.24 111.198 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.434 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.73 -12.49 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 62.44 110.933 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.404 ' N ' HD12 ' A' ' 197' ' ' LEU . 12.6 ptpt -100.51 -31.22 11.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.94 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.63 -49.28 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 73.32 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.416 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -95.81 60.73 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.926 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -71.28 -64.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.478 . . . . 74.03 110.819 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -51.49 104.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.916 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.677 HG21 ' CG2' ' A' ' 206' ' ' VAL . 89.9 mt -142.77 124.8 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.072 -0.513 . . . . 53.51 111.183 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -34.85 50.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.999 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.28 129.91 1.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 71.43 111.085 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 218' ' ' LEU . 95.5 t -103.52 133.58 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 73.23 111.181 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 213' ' ' VAL . 9.5 t -109.58 106.92 59.06 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.604 0.716 . . . . 72.42 111.029 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.1 Cg_endo -69.66 -168.61 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.679 2.253 . . . . 72.3 112.361 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.84 -13.43 57.94 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.68 -0.772 . . . . 62.42 112.574 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -152.32 138.52 18.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.853 0.358 . . . . 61.31 110.829 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.94 -106.41 2.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 74.35 112.539 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -167.47 162.12 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 71.24 110.923 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 207' ' ' VAL . 5.5 m -52.74 161.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.12 111.202 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.66 -98.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 64.42 112.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -169.01 -168.86 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.868 0.366 . . . . 75.11 110.937 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.464 ' HA ' HD23 ' A' ' 219' ' ' LEU . 15.7 pttm -61.69 -17.36 55.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.4 110.889 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.496 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.36 -19.21 39.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 62.22 112.463 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.734 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.9 mt -72.04 -32.92 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.859 0.361 . . . . 72.03 110.871 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.577 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.4 mm? -63.18 -58.52 6.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 62.32 110.986 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.496 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -61.02 -18.16 56.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.45 110.913 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -65.15 -51.42 61.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.861 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.72 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.7 m -52.22 -49.91 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 72.25 111.196 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.621 HD23 ' OG ' ' A' ' 190' ' ' SER . 0.9 OUTLIER -60.42 -18.31 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 51.14 110.932 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -92.1 -2.67 56.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 63.12 110.816 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.476 HD12 ' HG3' ' A' ' 171' ' ' LYS . 6.9 mt -126.25 -5.98 6.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 72.42 110.962 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.767 HD11 ' HB2' ' A' ' 190' ' ' SER . 0.4 OUTLIER -119.92 2.46 11.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 63.32 110.913 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 53.31 110.862 179.85 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.0 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.85 0.357 . . . . 71.33 111.104 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.9 mt -136.2 91.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 73.51 111.177 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 116.39 30.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.909 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -59.82 168.15 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.889 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.7 -47.9 63.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 65.12 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.8 p -60.68 -37.68 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.172 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.77 13.15 61.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.674 -0.774 . . . . 54.22 112.505 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -80.36 -43.96 20.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 75.15 111.108 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -102.95 116.54 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 71.51 111.135 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 71.35 110.851 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.73 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -121.87 112.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 54.24 111.087 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.412 ' HA ' HG12 ' A' ' 8' ' ' VAL . 13.7 t -98.82 125.66 44.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 41.13 110.82 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -68.6 110.57 4.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 73.14 110.94 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.073 HD21 HG21 ' A' ' 213' ' ' VAL . 14.2 mt -63.83 -31.35 72.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 62.42 110.971 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.48 -96.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 75.1 110.889 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.44 9.66 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.929 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.77 7.74 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 61.4 110.883 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.74 143.27 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 74.15 111.094 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.73 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.5 m95 -131.02 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 55.34 110.959 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 43' ' ' GLY . 98.7 t -135.43 89.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 64.44 111.19 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -72.27 121.66 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.871 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.4 m -119.62 104.67 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 62.44 111.143 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -87.59 125.78 34.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.944 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 110.39 21.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.878 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.702 -0.761 . . . . 72.13 112.468 179.862 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.614 0.721 . . . . 72.3 111.177 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 117.87 5.34 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.683 2.255 . . . . 72.11 112.31 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 p -109.67 97.63 7.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 35.41 110.811 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -63.22 164.62 8.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 65.54 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -153.99 -144.81 4.0 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.69 -0.767 . . . . 74.25 112.466 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.65 HD21 HD11 ' A' ' 158' ' ' LEU . 16.4 tp -158.81 120.12 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 71.2 110.862 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.658 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -105.29 122.29 58.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.168 -0.469 . . . . 71.41 111.126 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 16.0 mt -102.14 121.01 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 73.02 110.944 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.63 85.08 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 73.45 110.831 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.14 173.01 8.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 62.1 111.149 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.25 4.26 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 73.42 110.817 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 -20.58 9.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 53.34 110.91 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.31 138.36 2.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 34.22 112.5 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.691 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.9 mt -54.63 157.63 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 63.34 110.896 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 19.0 t -145.32 141.0 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 72.54 111.112 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.682 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.1 mt -137.61 124.16 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.54 110.945 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.649 HG12 ' OD1' ' A' ' 56' ' ' ASP . 53.6 t -68.57 107.66 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 63.24 111.034 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.649 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.5 m-20 71.51 134.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 60.34 110.927 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.587 ' CB ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -72.15 -165.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 62.24 110.806 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 t -92.37 175.01 7.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.41 110.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.734 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.0 m95 -51.27 -60.41 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.918 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -132.55 161.71 33.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.24 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -51.77 -33.47 35.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 54.1 110.854 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -59.03 -33.76 71.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.897 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.4 mt -89.25 -45.73 9.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.903 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.409 HG21 HD21 ' A' ' 98' ' ' LEU . 1.1 m -50.8 -47.45 59.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 73.23 111.147 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -54.45 -47.48 72.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 71.3 110.872 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.31 -19.4 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.863 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.5 tp -88.4 -27.96 21.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 71.51 110.881 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.5 mt -89.41 -22.99 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.35 111.12 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.88 16.84 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptm -131.01 -39.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 73.42 110.899 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 67' ' ' LEU . 35.1 m -80.95 -24.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 61.34 111.071 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.656 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.85 -21.86 66.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.861 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -109.49 -32.31 7.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.898 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -72.18 -41.95 66.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.826 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.5 m-85 -88.05 -12.35 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.855 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.37 13.73 8.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 71.54 110.983 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.15 140.14 46.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 75.33 110.863 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -86.1 140.45 30.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.885 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 52' ' ' LEU . 99.4 t -80.07 122.3 35.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.12 111.11 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -136.67 8.16 3.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 65.24 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -151.28 136.08 17.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 71.23 110.927 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 54' ' ' LEU . 15.0 t -147.68 127.75 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 72.22 111.09 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 140' ' ' VAL . 27.4 mt -93.49 122.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 73.21 111.132 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.447 HG21 HG22 ' A' ' 92' ' ' ILE . 20.3 mm -94.33 140.18 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 52.1 111.144 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.48 HG23 ' OD2' ' A' ' 56' ' ' ASP . 65.9 p -86.86 -55.83 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 63.13 111.12 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.586 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.4 p80 -152.15 -175.2 5.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.419 . . . . 64.02 110.96 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.861 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -89.21 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.42 111.054 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.72 149.84 22.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.3 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.45 -19.53 24.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 75.14 111.143 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.5 9.76 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 65.31 110.946 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.13 -77.27 0.52 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.81 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.447 HG22 HG21 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -88.71 8.14 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 63.3 111.048 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.39 -41.5 40.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 74.55 112.438 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 14.46 56.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.746 . . . . 32.51 112.498 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.7 tt -51.7 -29.92 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 74.5 111.139 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -35.56 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 73.3 110.87 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -79.94 -23.99 41.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 63.24 111.161 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HA ' HD13 ' A' ' 103' ' ' ILE . 9.2 mt -82.93 -28.25 30.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.989 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -94.04 19.47 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.956 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -121.71 -45.51 2.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 71.13 110.846 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -74.35 -52.39 12.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 75.12 110.856 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.8 42.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.683 -0.77 . . . . 62.11 112.463 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.609 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.6 mp -106.31 128.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 70.34 111.23 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.639 ' HB3' HD11 ' A' ' 124' ' ' LEU . 5.0 mtmm -84.19 105.86 15.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 72.32 110.937 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.02 92.83 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 73.12 111.205 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.669 ' HA ' HD12 ' A' ' 124' ' ' LEU . 48.1 m-70 -69.65 146.14 51.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 73.23 110.886 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.62 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -174.26 179.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 60.45 110.901 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.45 154.27 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 64.12 111.07 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.11 40.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 52.5 111.081 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -41.18 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.91 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.706 ' HA ' HD11 ' A' ' 114' ' ' LEU . 99.8 m -58.44 -20.69 46.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.02 111.123 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.56 8.44 41.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 74.04 111.055 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -107.81 -31.56 7.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 73.52 110.838 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.861 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -96.09 -12.83 24.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 71.43 110.967 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.402 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -67.98 -37.14 81.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 64.12 111.104 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.47 -24.45 59.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.927 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.52 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 73.42 110.898 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -90.29 -22.06 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 60.04 110.951 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.53 25.51 4.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.829 -0.7 . . . . 60.25 112.434 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.59 175.68 5.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.899 0.381 . . . . 74.13 110.935 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.83 162.17 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.951 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -94.89 108.4 37.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.57 0.7 . . . . 70.03 110.916 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.552 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.71 -177.42 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.282 . . . . 60.05 112.363 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 106' ' ' HIS . 81.8 mt -54.21 -54.46 39.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 62.22 110.878 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.52 73.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 62.11 112.428 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -99.03 33.54 2.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 74.44 110.848 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 107' ' ' SER . 86.7 mt -116.65 -174.6 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.923 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -159.36 -170.45 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 53.1 110.871 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.845 HG22 HG23 ' A' ' 130' ' ' VAL . 48.5 m -50.49 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.43 111.21 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.845 HG23 HG22 ' A' ' 129' ' ' THR . 38.2 t -116.22 93.56 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 70.55 111.1 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.688 HG22 ' OG1' ' A' ' 142' ' ' THR . 14.5 t -113.05 164.97 12.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 63.41 111.116 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -128.18 102.96 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 65.43 110.907 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 140' ' ' VAL . 28.4 mt -76.02 -173.06 2.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 73.32 110.918 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -171.31 110.23 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.843 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.92 -167.57 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 60.5 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -57.63 95.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.765 -0.731 . . . . 73.32 112.461 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 53.75 25.92 5.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.391 . . . . 42.54 110.912 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.4 tpp -129.19 140.03 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.47 135.91 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.53 110.912 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' A' ' 83' ' ' ILE . 6.1 t -143.72 116.88 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 61.33 111.179 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -112.88 126.58 55.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 63.2 110.893 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.688 ' OG1' HG22 ' A' ' 131' ' ' THR . 18.8 p -83.39 174.27 10.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.127 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.431 ' HB3' HG23 ' A' ' 155' ' ' VAL . 20.8 t80 -158.78 137.61 11.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.937 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.657 ' HB3' HG23 ' A' ' 129' ' ' THR . 90.5 t80 -127.82 89.31 51.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.738 0.78 . . . . 72.33 110.985 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.2 Cg_endo -69.69 -7.61 21.47 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.671 2.247 . . . . 70.11 112.374 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.03 -150.17 19.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 40.42 112.484 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -95.24 141.1 29.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 63.43 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.424 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -157.43 -90.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 62.53 112.535 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -74.76 -23.05 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.332 . . . . 73.41 110.759 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 86' ' ' HIS . 69.2 p -151.23 -171.39 3.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 60.03 111.177 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.546 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.1 tt0 -84.94 -3.32 58.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 75.12 110.893 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 154' ' ' ILE . 19.4 t0 -150.18 19.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 53.44 110.944 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.58 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.4 OUTLIER -50.57 130.72 24.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.11 110.887 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 152' ' ' ASP . 3.2 pt -135.17 175.48 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 42.53 111.138 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -132.87 123.93 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 65.05 111.03 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.96 119.04 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.129 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -107.79 139.12 42.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.65 HD11 HD21 ' A' ' 44' ' ' LEU . 87.7 mt -119.79 99.73 49.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.63 0.728 . . . . 73.04 110.862 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.1 Cg_endo -69.79 -4.79 14.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.688 2.259 . . . . 52.21 112.289 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -84.78 -30.38 24.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.947 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -131.49 11.21 4.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 70.41 110.923 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.5 m120 55.05 26.0 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.846 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.558 HD13 HD13 ' A' ' 21' ' ' LEU . 86.8 mt -90.95 143.83 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.129 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.557 HD22 HD13 ' A' ' 203' ' ' ILE . 15.2 tp -125.54 145.43 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 62.33 110.916 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.459 HG11 HG11 ' A' ' 55' ' ' VAL . 94.9 t -108.17 81.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 61.22 111.219 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.44 -31.42 28.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.703 -0.76 . . . . 75.45 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 56.69 -168.63 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 33.01 112.453 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -29.68 20.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.336 . . . . 72.52 110.842 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.58 HD13 ' OD1' ' A' ' 153' ' ' ASN . 24.8 tp -55.65 -55.14 35.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 75.1 110.946 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.513 HG13 ' HA ' ' A' ' 219' ' ' LEU . 19.9 t -87.55 107.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 75.1 111.13 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -52.15 170.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.53 110.904 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.31 158.63 26.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 44.41 110.883 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.081 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.796 0.332 . . . . 74.13 111.108 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.35 92.39 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 74.23 110.982 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.0 t -63.46 -22.92 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 44.25 111.134 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -71.65 -31.3 66.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 71.03 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.29 -13.05 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.03 110.916 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.501 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.4 t90 -55.09 -62.56 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 73.4 110.918 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.761 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.88 -24.51 16.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 61.35 110.829 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 57.7 m -80.39 -32.23 37.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 72.2 111.1 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -42.74 58.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.833 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.523 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.1 mm -62.91 -44.39 99.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.42 111.134 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.492 ' HG2' HD11 ' A' ' 223' ' ' LEU . 2.1 mm-40 -58.23 -22.89 53.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 41.05 110.807 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -82.45 -22.31 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 71.12 110.895 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 196' ' ' VAL . 16.1 t -87.19 -8.89 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 75.41 111.064 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -113.5 -6.79 13.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 71.4 110.946 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.6 -31.19 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 72.13 110.897 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -104.22 -55.95 2.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 75.35 110.871 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -94.99 38.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 75.34 110.827 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -55.97 -47.71 77.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.889 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -59.97 101.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.03 110.951 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.743 HG21 HG22 ' A' ' 206' ' ' VAL . 40.1 mt -143.65 127.54 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 63.33 111.161 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.01 -23.13 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 62.44 110.934 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.722 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -168.04 132.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.073 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.749 ' HB ' HD12 ' A' ' 218' ' ' LEU . 59.0 t -114.79 132.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 51.43 111.163 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 213' ' ' VAL . 9.7 t -110.35 109.33 58.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 62.44 111.111 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.8 Cg_endo -69.75 178.02 4.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.658 2.239 . . . . 42.02 112.381 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.51 -18.86 74.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 71.21 112.486 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -152.83 141.67 21.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 74.54 110.879 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.49 -117.48 4.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 70.15 112.474 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -152.25 174.07 14.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 72.53 110.918 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.073 HG21 HD21 ' A' ' 21' ' ' LEU . 5.4 t -69.31 149.98 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 50.31 111.129 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.81 -101.47 0.31 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 72.13 112.515 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.25 -169.0 1.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 71.0 110.823 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -17.83 54.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 71.51 110.872 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.473 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.37 -20.11 43.14 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.772 -0.727 . . . . 44.11 112.41 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.749 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.2 mt -73.48 -30.07 62.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 74.1 110.921 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.523 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.866 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.473 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.4 OUTLIER -59.12 -22.5 60.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.901 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.24 -44.67 95.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.12 110.826 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.698 HG22 HD23 ' A' ' 226' ' ' LEU . 11.5 m -56.48 -56.62 18.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 54.34 111.003 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' A' ' 194' ' ' GLU . 1.0 OUTLIER -52.82 -28.86 24.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.432 . . . . 72.31 110.929 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -32.52 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.92 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.9 mt -88.39 -18.18 28.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.849 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.761 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.3 OUTLIER -114.94 18.84 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.91 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 74.44 110.933 179.762 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.832 0.349 . . . . 51.33 111.147 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.3 mt -110.73 98.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 44.41 111.166 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -118.17 115.39 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 73.23 110.879 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -60.57 166.41 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 71.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -51.45 -48.43 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 74.21 110.923 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 p -62.57 -36.97 84.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 62.44 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 13.9 63.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 34.31 112.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 m -78.84 -45.4 20.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 62.23 111.197 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.554 HG21 HD13 ' A' ' 67' ' ' LEU . 39.6 mt -103.85 112.36 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 63.02 111.129 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -118.04 133.95 55.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 52.21 110.814 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.791 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -125.51 112.24 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 54.35 111.162 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -98.46 125.57 43.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.864 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -69.34 109.94 4.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 75.32 110.966 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.592 HD21 HG11 ' A' ' 213' ' ' VAL . 16.8 mt -63.51 -32.69 74.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.94 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.58 -96.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 72.52 110.884 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -150.24 9.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.873 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.75 8.17 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.861 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -150.89 141.82 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 70.32 111.086 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.791 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.9 m95 -130.21 -176.8 4.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 71.22 110.916 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.475 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.3 t -134.69 90.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 72.12 111.215 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -73.79 122.17 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 72.13 110.838 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.5 m -119.89 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.097 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.99 125.34 33.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 73.33 110.812 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.37 110.62 20.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 71.41 110.949 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 71.35 112.478 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.584 0.707 . . . . 64.45 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 117.67 5.23 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.736 2.291 . . . . 73.44 112.362 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.9 p -109.96 97.08 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 71.35 110.892 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -59.37 165.36 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 73.24 110.859 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -156.13 -148.89 5.19 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.712 -0.756 . . . . 62.45 112.437 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 158' ' ' LEU . 15.3 tp -158.49 118.34 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 74.01 110.909 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.671 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -103.16 122.31 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.084 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.802 HD21 HD11 ' A' ' 158' ' ' LEU . 14.4 mt -100.77 120.57 40.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.907 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -90.52 84.7 5.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.82 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -97.52 -175.32 3.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.33 111.194 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.4 -21.97 13.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 72.11 110.878 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -83.99 -15.73 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 60.14 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.4 150.25 5.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.815 -0.707 . . . . 51.44 112.539 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.714 ' HB3' HG22 ' A' ' 79' ' ' VAL . 2.0 mt -61.75 156.94 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.23 110.948 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 16.8 t -145.48 141.96 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 54.54 111.163 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.675 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.1 mt -137.87 124.62 21.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 73.13 110.895 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.647 HG12 ' OD1' ' A' ' 56' ' ' ASP . 54.7 t -67.59 106.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 72.15 111.162 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.647 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.4 m-20 70.81 131.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 55.3 110.893 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.638 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -69.41 -164.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 51.2 110.87 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -90.38 -179.85 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 61.1 110.876 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.726 ' HB2' HD12 ' A' ' 63' ' ' LEU . 96.7 m95 -57.86 -51.54 69.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.483 . . . . 74.23 110.937 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -139.69 161.81 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 60.43 110.77 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.04 -32.62 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.24 110.818 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -59.86 -42.53 93.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.5 mt -80.01 -46.89 15.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 54.35 110.898 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.12 -45.74 53.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 63.5 111.121 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -54.78 -48.39 72.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 72.43 110.848 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.49 -19.82 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.945 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.7 tp -88.2 -27.04 22.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 72.51 110.872 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -90.59 -23.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.14 111.181 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.16 15.0 14.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.496 . . . . 74.32 110.953 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.7 ptm -129.83 -39.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 62.14 110.889 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.1 m -80.45 -22.76 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.14 111.153 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.667 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.42 -21.93 65.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.22 110.822 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -109.2 -32.37 7.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.92 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -37.64 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 75.41 110.837 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.547 ' HB2' HD11 ' A' ' 52' ' ' LEU . 12.6 m-85 -92.58 -11.62 33.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 74.34 110.879 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.36 11.71 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.883 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -132.25 141.0 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 62.52 110.898 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -87.46 140.56 29.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 63.5 110.93 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' A' ' 52' ' ' LEU . 97.3 t -80.71 124.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 73.54 111.117 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -138.98 10.14 2.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 73.43 111.08 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -153.3 135.61 14.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 75.43 110.836 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 54' ' ' LEU . 17.2 t -148.02 125.55 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 71.43 111.13 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 140' ' ' VAL . 27.5 mt -91.28 124.59 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 72.34 111.097 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.486 HG21 HG22 ' A' ' 92' ' ' ILE . 18.6 mm -95.99 138.71 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 74.04 111.154 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.6 p -84.45 -49.13 8.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 72.44 111.176 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.1 p80 -159.71 -175.37 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 60.01 110.932 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -87.58 98.36 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 64.34 111.071 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.32 149.61 24.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.857 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.46 30.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 72.52 111.055 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.04 10.04 28.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.882 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 27.8 mmt180 -129.83 -77.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 64.44 110.91 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.486 HG22 HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -88.88 8.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 53.55 111.102 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.47 -41.75 41.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.703 -0.761 . . . . 65.04 112.494 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.9 12.71 62.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 71.43 112.374 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.8 tt -51.52 -28.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 54.25 111.132 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -38.26 64.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 61.45 110.834 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -79.86 -27.5 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.142 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.638 HD11 ' OG ' ' A' ' 57' ' ' SER . 10.8 mt -75.05 -30.74 61.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 72.54 110.9 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -92.51 16.26 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 72.32 110.859 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -119.48 -48.23 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.44 110.816 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -72.73 -56.13 5.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.243 -0.435 . . . . 62.32 110.855 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.95 42.63 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.807 -0.711 . . . . 55.04 112.447 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.8 mp -105.64 120.33 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.429 . . . . 74.34 111.17 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -78.1 109.76 12.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 51.33 110.911 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.63 101.25 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 72.34 111.054 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.569 ' HA ' HD12 ' A' ' 124' ' ' LEU . 40.4 m-70 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 54.31 110.91 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.644 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -176.64 -176.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.881 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 154.47 20.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 50.3 111.14 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.77 -40.65 55.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 72.41 111.068 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -67.95 -40.72 83.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.94 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.769 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.7 m -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 72.33 111.133 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.55 52.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 63.32 111.095 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.37 -59.23 1.74 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.11 110.893 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.39 -13.14 60.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.956 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -64.9 -43.43 92.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 43.11 111.072 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -26.3 63.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 74.42 110.895 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -55.2 -35.96 65.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 74.3 110.852 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -89.65 -20.85 23.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 72.45 110.872 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.85 21.75 5.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 73.25 112.401 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -94.65 170.46 9.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 74.52 110.883 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -70.83 -176.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 72.05 110.867 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -117.23 103.92 50.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 74.35 110.923 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.7 Cg_endo -69.8 -171.69 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.717 2.278 . . . . 63.24 112.391 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 106' ' ' HIS . 96.0 mt -59.39 -54.66 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 62.3 110.959 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.48 24.18 63.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.821 -0.704 . . . . 61.54 112.4 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 24.62 6.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 75.21 110.944 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.659 ' CD2' HD21 ' A' ' 133' ' ' LEU . 91.3 mt -107.09 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 65.35 110.935 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -155.33 -170.28 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 54.22 110.885 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.948 HG22 HG23 ' A' ' 130' ' ' VAL . 43.8 m -49.93 -70.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 70.54 111.154 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.948 HG23 HG22 ' A' ' 129' ' ' THR . 42.4 t -120.31 110.25 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.41 111.123 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -139.77 172.47 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 71.45 111.157 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 71.31 110.914 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.659 HD21 ' CD2' ' A' ' 127' ' ' LEU . 52.4 mt -115.34 167.35 10.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 73.3 110.898 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -147.64 137.09 22.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 71.03 110.93 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.504 ' HE2' HD11 ' A' ' 83' ' ' ILE . 36.9 m-85 -134.19 40.47 3.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.898 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 93.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 51.03 112.4 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.38 14.12 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 65.31 110.877 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.5 tpp -138.39 100.9 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 64.42 110.874 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -90.69 137.84 32.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.42 110.781 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 83' ' ' ILE . 57.8 t -139.67 117.42 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 71.35 111.099 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.96 129.17 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 74.22 110.942 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.8 p -85.54 -179.44 6.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 75.14 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.445 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.6 t80 -164.39 133.6 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.42 110.883 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.641 ' HB3' HG23 ' A' ' 129' ' ' THR . 88.4 t80 -123.96 88.44 52.42 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.796 0.808 . . . . 75.01 110.95 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.569 2.179 . . . . 75.23 112.352 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.92 -144.88 16.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.802 -0.713 . . . . 74.0 112.504 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -101.5 141.64 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 72.31 110.901 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.45 -90.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.705 -0.759 . . . . 71.13 112.475 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -74.78 -23.43 58.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 73.3 110.858 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.478 HG21 ' HB2' ' A' ' 86' ' ' HIS . 65.5 p -150.57 -169.36 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 52.02 111.153 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.627 ' HB3' HD23 ' A' ' 114' ' ' LEU . 2.7 tt0 -85.81 -12.94 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.871 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 154' ' ' ILE . 15.3 t0 -138.61 20.93 2.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 63.1 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.77 130.38 24.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.3 110.897 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 152' ' ' ASP . 6.6 pt -137.19 169.04 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 71.55 111.125 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -127.32 122.52 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 45.32 111.176 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.476 ' O ' HD12 ' A' ' 164' ' ' LEU . 80.5 t -75.72 131.76 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 73.03 111.148 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -117.54 130.07 56.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 65.51 110.826 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.802 HD11 HD21 ' A' ' 46' ' ' LEU . 9.8 mt -110.68 98.64 38.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 60.22 110.909 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.9 Cg_endo -69.75 -4.42 13.99 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.659 2.24 . . . . 60.13 112.336 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.21 -23.64 32.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 75.44 110.832 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -144.0 14.15 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 63.54 110.941 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.9 m120 54.26 26.79 7.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 74.51 110.844 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.547 HD13 HD13 ' A' ' 21' ' ' LEU . 97.4 mt -91.9 128.79 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 73.53 111.089 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 156' ' ' VAL . 17.6 tp -113.49 145.92 40.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.887 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.554 HG11 HG11 ' A' ' 55' ' ' VAL . 21.4 t -109.62 83.64 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 71.21 111.175 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.51 -34.84 35.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.617 -0.801 . . . . 62.25 112.58 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.33 -167.92 26.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 61.53 112.531 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -29.65 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 63.15 110.813 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.632 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.8 tp -54.84 -61.82 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 55.43 110.933 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.553 HG13 ' HA ' ' A' ' 219' ' ' LEU . 47.2 t -78.33 110.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 55.45 111.168 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.742 ' HG2' HG23 ' A' ' 222' ' ' THR . 19.5 mmmt -51.8 169.02 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.941 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.53 146.4 42.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 73.21 110.857 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 75.52 111.245 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.823 0.344 . . . . 74.32 111.067 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -106.74 86.76 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 72.22 110.911 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.7 -19.64 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 73.33 111.127 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -73.3 -31.21 63.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 65.21 110.886 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -104.84 -11.62 16.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 72.43 110.953 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.632 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.7 t90 -55.0 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 73.3 110.846 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.703 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.84 -24.71 16.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 33.25 110.865 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -81.08 -31.82 34.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 54.13 111.241 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -73.68 -42.77 60.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 55.14 110.826 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.9 mm -61.95 -44.69 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 70.5 111.106 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -58.44 -23.89 58.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 62.4 110.882 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -83.59 -22.19 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.766 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 192' ' ' SER . 5.4 t -87.61 -9.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 64.43 111.142 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -111.94 -8.4 14.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 64.14 110.958 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -104.09 -30.96 9.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.895 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.9 -52.27 2.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -97.24 37.78 1.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.95 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -56.46 -47.73 78.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 63.23 110.894 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -59.34 98.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 73.02 110.939 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.726 HG21 HG22 ' A' ' 206' ' ' VAL . 61.8 mt -140.23 127.89 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 71.44 111.18 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.18 -22.88 30.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 73.42 110.87 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.75 123.51 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 63.04 111.13 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.726 HG22 HG21 ' A' ' 203' ' ' ILE . 93.2 t -102.5 137.9 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 73.42 111.05 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.891 HG22 HG12 ' A' ' 213' ' ' VAL . 3.4 t -115.84 108.81 46.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.693 0.759 . . . . 45.52 111.129 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.503 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.6 Cg_endo -69.7 179.21 3.82 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.664 2.242 . . . . 74.25 112.348 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.74 -13.58 82.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.761 -0.733 . . . . 60.42 112.532 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -152.89 138.1 17.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 63.22 110.854 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.74 -118.67 5.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 73.21 112.5 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -150.91 163.93 37.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 72.34 110.95 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.891 HG12 HG22 ' A' ' 207' ' ' VAL . 4.3 m -60.3 161.43 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 64.25 111.127 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.13 -93.09 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 54.33 112.389 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -174.83 -167.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 72.21 110.895 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -58.05 -20.26 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.13 110.932 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.35 -23.45 26.5 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.647 -0.787 . . . . 70.12 112.452 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.8 mt -75.97 -33.1 59.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.894 0.378 . . . . 74.33 110.944 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.553 ' HA ' HG13 ' A' ' 170' ' ' VAL . 5.7 mp -61.58 -62.84 1.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.913 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -22.44 47.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 65.31 110.942 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -61.69 -46.67 88.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.83 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.742 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.4 m -51.27 -53.31 36.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.45 111.116 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.77 -20.15 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 72.21 110.971 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.41 -4.32 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 71.14 110.868 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.2 mt -125.27 -7.2 7.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.875 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.703 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -119.67 10.26 11.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 51.45 110.91 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 73.52 110.965 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.829 0.347 . . . . 72.41 111.145 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.4 mt -136.31 92.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 72.35 111.115 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -111.52 118.07 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 74.22 110.891 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -58.37 -176.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.856 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.21 -45.34 73.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 64.12 110.851 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.4 p -61.9 -37.67 85.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 73.12 111.133 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.05 12.32 60.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 52.21 112.533 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -80.78 -43.32 20.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.74 0.305 . . . . 73.4 111.175 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.36 125.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 55.22 111.17 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -133.02 129.92 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.54 110.836 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.769 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -120.9 111.12 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 62.31 111.138 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.5 t -100.76 127.6 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 62.21 110.862 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -71.23 111.64 6.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 65.42 110.873 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.6 ' HG ' HG23 ' A' ' 27' ' ' VAL . 27.3 mt -65.19 -31.55 72.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 75.3 110.955 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.73 -97.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 61.33 110.908 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.44 10.14 0.57 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.43 . . . . 55.1 110.975 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.51 6.37 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 64.51 110.856 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.84 139.46 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 74.54 111.126 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.769 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.5 m95 -127.23 -179.58 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 73.54 110.957 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.6 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.1 t -131.99 97.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 64.31 111.144 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -80.51 121.14 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 70.43 110.901 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -117.62 104.81 11.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.11 111.146 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.683 ' CD ' HD22 ' A' ' 67' ' ' LEU . 5.3 mp0 -89.27 120.94 31.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 73.42 110.865 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -85.43 101.55 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 44.13 110.831 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 65.02 112.448 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.445 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 1.5 t . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 121.613 0.72 . . . . 75.32 111.111 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 119.4 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.698 2.265 . . . . 72.05 112.417 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.1 p -99.76 96.92 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.866 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -49.51 159.8 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 63.02 110.845 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.591 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -155.65 -168.15 18.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.678 -0.772 . . . . 55.11 112.483 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.619 HD21 HD12 ' A' ' 158' ' ' LEU . 17.5 tp -152.49 113.56 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.354 . . . . 75.35 110.895 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.63 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -97.77 120.47 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.11 111.097 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.737 HD21 HD11 ' A' ' 158' ' ' LEU . 25.3 mt -97.78 115.95 29.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 64.23 110.903 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.42 87.44 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 60.52 110.92 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 179.8 4.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 54.01 111.17 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -100.28 -22.8 14.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 70.53 110.859 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -11.44 58.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 65.52 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.37 153.34 5.86 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.646 -0.787 . . . . 44.14 112.471 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.1 tp -67.25 155.04 39.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 75.42 110.957 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.6 t -145.91 142.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.11 111.104 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.63 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.3 mt -137.07 125.48 23.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.31 110.879 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -71.21 112.18 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 75.31 111.114 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.431 ' HB2' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 72.64 132.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 65.45 110.921 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.587 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -75.36 -166.98 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 54.53 110.853 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.48 ' H ' HG23 ' A' ' 64' ' ' THR . 13.1 t -91.41 169.1 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 70.45 110.911 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.688 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.1 m95 -49.5 -60.57 2.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.994 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -125.44 165.18 18.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 34.31 110.833 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.24 -37.69 75.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 62.44 110.852 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.21 -33.74 67.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 59' ' ' TRP . 83.7 mt -82.6 -47.2 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 65.24 110.956 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.61 -46.44 58.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.102 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.05 -49.63 65.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 71.24 110.89 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -64.76 -19.85 66.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.968 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD22 ' CD ' ' A' ' 30' ' ' GLU . 18.6 tp -87.8 -27.16 22.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 40.54 110.904 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.83 -23.13 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.081 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.69 16.0 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 64.33 110.901 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.87 -39.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 73.21 110.872 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.8 m -81.21 -22.43 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.112 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.577 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.89 -24.48 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 64.45 110.813 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -106.31 -34.24 7.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.471 . . . . 65.33 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -41.3 79.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.82 -10.75 38.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 65.31 110.886 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 67.52 11.97 8.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 61.23 110.875 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.549 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -128.93 137.62 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 64.41 110.856 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.74 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.2 110.875 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' OE2' ' A' ' 72' ' ' GLU . 80.0 t -76.26 121.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.146 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 t -135.68 7.78 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 75.44 111.118 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.544 ' O ' HG13 ' A' ' 53' ' ' VAL . 62.7 m-20 -150.8 145.03 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.14 110.877 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 54' ' ' LEU . 12.2 t -154.53 132.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 70.14 111.189 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.498 HD13 HG11 ' A' ' 140' ' ' VAL . 5.9 mt -95.19 125.84 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 61.13 111.158 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.35 147.7 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.215 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -98.16 -55.54 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 62.21 111.222 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.451 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.6 p80 -152.96 -175.16 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.812 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.866 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -90.01 97.46 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 50.45 111.139 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.18 150.13 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 70.05 110.792 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.38 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 75.52 111.046 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.12 23.6 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 61.02 110.791 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.431 ' HD3' ' HB2' ' A' ' 56' ' ' ASP . 27.3 mmt180 -144.89 -76.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.44 110.912 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.12 7.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 62.12 111.113 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.74 -40.08 40.4 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 75.32 112.477 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.41 14.88 59.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 51.15 112.492 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.2 tt -55.45 -27.33 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.397 . . . . 73.51 111.125 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -54.91 -34.36 63.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 74.2 110.928 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -84.57 -22.7 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.54 111.138 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.605 ' HA ' HD13 ' A' ' 103' ' ' ILE . 11.7 mt -82.13 -28.67 32.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.915 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -96.92 22.22 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 73.55 110.952 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -122.63 -43.14 2.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 75.11 110.94 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -80.36 -52.78 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 61.41 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.79 43.96 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 41.22 112.534 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.605 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -108.07 118.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 71.32 111.159 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HE3' HD21 ' A' ' 124' ' ' LEU . 19.6 mtpp -77.77 111.33 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.14 110.915 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.84 90.91 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 64.42 111.077 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.564 ' HA ' HD12 ' A' ' 124' ' ' LEU . 57.1 m-70 -62.47 143.15 57.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 71.21 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB2' HG21 ' A' ' 111' ' ' THR . 1.1 p -173.96 176.7 2.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.908 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.33 157.92 19.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 63.11 111.16 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.89 -38.96 52.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 52.31 111.097 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.649 HD21 ' HG2' ' A' ' 151' ' ' GLU . 28.9 tp -73.63 -37.52 65.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.894 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.744 ' HA ' HD11 ' A' ' 114' ' ' LEU . 98.1 m -57.82 -29.36 64.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 63.53 111.115 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.88 0.21 57.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 65.14 111.058 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -99.25 -58.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 73.34 110.792 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.866 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -67.32 -12.27 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 64.51 110.925 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -66.1 -44.58 83.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 71.33 111.162 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -28.82 65.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.878 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -37.26 49.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 65.43 110.886 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -88.9 -21.89 23.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 54.1 110.854 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.89 20.63 5.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.734 -0.746 . . . . 61.33 112.491 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.56 172.07 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 64.45 110.974 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -70.92 -176.16 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 74.55 110.905 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.3 mt-10 -117.05 102.13 52.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.614 0.721 . . . . 72.34 110.849 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.2 Cg_endo -69.85 -176.22 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.621 2.214 . . . . 63.02 112.321 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.717 HD21 ' HE3' ' A' ' 104' ' ' LYS . 25.4 mt -51.84 -60.08 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.02 110.913 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.43 21.37 72.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 55.32 112.527 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -99.53 28.41 4.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 72.35 110.849 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.624 HD22 HD21 ' A' ' 133' ' ' LEU . 62.8 mt -109.52 -175.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.916 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -154.25 -170.77 3.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.937 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 130' ' ' VAL . 54.8 m -50.79 -70.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.04 111.147 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.906 HG23 HG22 ' A' ' 129' ' ' THR . 44.7 t -119.82 103.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 74.11 111.165 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -135.42 163.33 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 64.33 111.124 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.13 132.49 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.32 110.864 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.624 HD21 HD22 ' A' ' 127' ' ' LEU . 24.1 mt -115.08 167.2 11.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.939 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 133.5 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.52 110.941 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -134.2 49.09 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 65.32 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.19 92.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 62.24 112.539 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.89 14.59 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 75.32 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.0 tpp -134.13 110.31 9.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.832 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 131.14 44.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.79 HG22 HD21 ' A' ' 158' ' ' LEU . 21.3 t -137.34 117.33 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 74.34 111.064 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -110.75 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 75.35 110.887 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 p -86.62 177.29 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 62.11 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.503 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.2 t80 -159.3 134.78 8.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.14 110.865 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.697 ' HB3' HG23 ' A' ' 129' ' ' THR . 9.3 t80 -124.41 87.23 54.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.648 0.737 . . . . 73.22 110.901 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -7.95 22.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.744 2.296 . . . . 64.32 112.313 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.68 -158.48 22.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 72.15 112.399 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -86.81 138.83 31.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 72.35 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.7 -87.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 54.33 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -78.39 -23.38 46.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 63.34 110.872 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 86' ' ' HIS . 34.5 p -149.61 -165.62 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 63.15 111.153 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.649 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.0 tt0 -86.08 -18.44 32.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 75.11 110.851 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 154' ' ' ILE . 8.6 t0 -136.54 20.38 3.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 71.55 110.884 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.411 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.3 OUTLIER -51.75 129.04 25.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 71.43 110.872 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.451 HG22 ' CD1' ' A' ' 144' ' ' TYR . 9.3 pt -135.8 176.47 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 70.55 111.177 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.435 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.8 m -131.49 123.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 71.34 111.13 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.25 122.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 73.34 111.137 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -109.24 132.18 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.41 . . . . 54.41 110.888 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 140' ' ' VAL . 11.4 mt -112.9 97.98 43.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.52 0.676 . . . . 55.21 110.893 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.75 -4.84 14.83 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 75.11 112.31 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -82.66 -23.32 34.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.949 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 13.88 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.909 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.6 m120 54.49 27.92 8.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 51.2 110.912 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.443 HD13 HD13 ' A' ' 21' ' ' LEU . 96.1 mt -93.41 126.69 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 51.34 111.141 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.513 HD22 HD13 ' A' ' 203' ' ' ILE . 19.6 tp -110.61 147.31 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.967 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.28 78.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 41.4 111.181 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.31 -32.02 21.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.723 -0.751 . . . . 50.35 112.55 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 61.23 -160.44 27.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 71.32 112.508 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -28.38 64.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.863 0.363 . . . . 72.43 110.885 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.658 HD12 ' NE1' ' A' ' 189' ' ' TRP . 28.0 tp -56.26 -56.97 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.878 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' A' ' 219' ' ' LEU . 38.2 t -81.01 107.65 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 61.33 111.073 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -50.81 161.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.919 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.47 156.65 25.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 73.01 110.9 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.9 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 72.44 111.102 -179.896 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.767 0.318 . . . . 72.3 111.063 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -110.06 88.78 2.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 75.22 110.924 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.63 -17.47 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.195 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.74 -25.68 60.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 71.41 110.861 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -114.16 -11.95 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 63.22 110.85 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.658 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.6 t90 -55.1 -61.33 2.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.227 -0.442 . . . . 75.55 110.92 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.751 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.1 -25.57 13.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 70.54 110.816 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -80.66 -32.68 36.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 62.34 111.14 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.632 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.42 -42.3 65.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 63.44 110.881 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.422 HG21 ' O ' ' A' ' 219' ' ' LEU . 29.9 mm -62.52 -47.83 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 63.31 111.111 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.481 ' HG2' HD11 ' A' ' 223' ' ' LEU . 1.5 mm-40 -57.4 -28.57 63.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.919 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.71 -21.86 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.44 110.941 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 192' ' ' SER . 9.9 t -85.74 -11.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 44.43 111.144 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -111.28 -8.4 14.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.476 . . . . 74.3 110.938 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -30.49 10.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 55.35 110.955 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 -48.76 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.07 37.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 62.22 110.936 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -51.82 -48.58 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 71.32 110.848 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -60.08 105.1 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 64.33 110.936 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.526 HG21 HG22 ' A' ' 206' ' ' VAL . 47.5 mt -145.95 125.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 60.4 111.093 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -26.83 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 55.45 110.899 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.6 134.6 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 70.11 111.163 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.707 ' HB ' HD12 ' A' ' 218' ' ' LEU . 98.0 t -109.92 134.58 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 71.23 111.029 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.939 HG22 HG12 ' A' ' 213' ' ' VAL . 13.1 t -110.82 104.22 55.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 53.2 111.129 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.8 Cg_endo -69.74 174.18 9.87 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.709 2.273 . . . . 72.43 112.36 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.6 -13.08 83.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 71.24 112.42 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -152.85 150.17 29.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 71.11 110.799 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.59 -99.67 2.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 64.2 112.406 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -175.43 158.82 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 73.14 110.88 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.939 HG12 HG22 ' A' ' 207' ' ' VAL . 6.1 m -51.63 163.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 71.21 111.116 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -162.64 -105.31 0.19 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.735 -0.745 . . . . 61.45 112.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 -167.69 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.782 0.325 . . . . 73.51 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -21.11 25.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.819 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.83 -22.79 27.94 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 72.03 112.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.8 mt -74.87 -33.76 62.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 50.41 110.956 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.497 ' HA ' HG13 ' A' ' 170' ' ' VAL . 5.3 mp -60.88 -62.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.974 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -22.13 51.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 43.34 110.945 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -63.27 -36.91 85.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.33 110.898 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.687 HG22 ' CD2' ' A' ' 226' ' ' LEU . 3.7 m -62.78 -56.95 12.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 55.52 111.137 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.481 HD11 ' HG2' ' A' ' 194' ' ' GLU . 1.4 mt -54.91 -29.47 56.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 53.33 110.859 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.04 -35.44 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 72.13 110.869 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.3 mt -86.66 -16.11 37.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 71.3 110.921 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.751 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -119.04 20.71 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.8 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 73.32 110.822 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.813 0.339 . . . . 73.54 111.147 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.6 mt -113.36 101.2 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.21 111.11 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -121.07 120.46 35.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.912 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -66.28 167.56 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 70.43 110.918 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -51.71 -48.46 63.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 70.54 110.919 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 p -61.69 -37.52 84.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.12 111.095 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 10.59 67.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.828 -0.701 . . . . 74.14 112.47 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -77.48 -45.33 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 51.24 111.132 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 67' ' ' LEU . 64.1 mt -101.7 110.9 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.257 -0.429 . . . . 63.5 111.155 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 p -117.83 138.13 52.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.4 110.819 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.789 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -129.74 109.81 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 74.31 111.113 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 t -100.27 124.63 45.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 73.1 110.849 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -68.74 109.64 3.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 71.24 110.914 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.791 HD21 HG11 ' A' ' 213' ' ' VAL . 15.9 mt -64.44 -33.38 75.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 71.04 110.848 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.02 -97.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 53.21 110.935 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -151.84 10.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 73.0 110.813 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.96 6.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 54.44 110.958 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.4 t -151.16 138.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 73.14 111.181 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.789 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.3 m95 -126.1 -174.51 3.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.95 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 43' ' ' GLY . 95.6 t -136.84 96.17 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 72.23 111.139 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -81.22 121.36 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.35 110.826 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.0 m -116.45 104.32 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 72.44 111.143 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.81 120.15 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 70.21 110.889 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.52 106.22 18.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 65.24 110.937 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.632 -0.794 . . . . 71.24 112.489 179.941 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.616 0.722 . . . . 72.51 111.092 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 116.72 4.7 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.632 2.221 . . . . 73.12 112.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.6 p -101.97 100.2 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.844 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -51.38 165.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 64.43 110.866 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.533 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -158.01 -163.61 12.97 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.683 -0.77 . . . . 24.43 112.43 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.638 HD21 HD12 ' A' ' 158' ' ' LEU . 13.9 tp -154.39 113.85 3.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 44.05 110.904 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 54' ' ' LEU . 1.8 t -97.37 115.34 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 73.53 111.144 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.778 HD21 HD11 ' A' ' 158' ' ' LEU . 29.9 mt -92.74 117.86 30.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 65.5 110.945 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -88.33 83.9 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 70.33 110.908 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.61 176.01 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 64.2 111.14 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.73 -22.97 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 75.3 110.895 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -12.85 59.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.908 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.2 155.21 6.46 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.727 -0.749 . . . . 61.31 112.542 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 52' ' ' LEU . 9.5 tp -68.66 154.26 42.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.923 0.392 . . . . 73.32 110.882 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.4 t -145.68 143.68 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.13 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 45' ' ' VAL . 1.4 mt -138.51 123.06 18.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 73.24 110.969 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 165' ' ' VAL . 91.1 t -68.62 111.07 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 74.03 111.211 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.37 128.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.448 . . . . 63.14 110.849 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.661 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -73.52 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.816 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 t -90.52 170.07 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 71.21 110.841 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.5 m95 -51.29 -60.74 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 65.24 110.967 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -125.33 159.46 31.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 72.13 110.891 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -51.99 -33.18 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 61.12 110.829 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -59.43 -42.14 91.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 75.51 110.902 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.0 mt -76.64 -48.88 17.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 70.51 110.957 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.07 -45.8 52.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.165 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -54.63 -49.09 71.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.31 110.893 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.13 -19.77 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.873 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.0 tp -88.23 -26.78 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 62.21 110.947 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.28 -22.44 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 70.11 111.11 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.4 15.66 13.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.928 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.0 ptm -130.32 -40.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.756 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.7 m -80.23 -22.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 74.54 111.153 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.575 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.1 -23.25 64.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 62.23 110.915 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -107.53 -33.09 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 73.53 110.859 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -40.47 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 72.41 110.863 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.541 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 15.1 m-85 -90.79 -10.48 42.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 71.22 110.908 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.41 12.15 8.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 72.22 110.959 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.88 138.34 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 71.14 110.932 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.08 138.14 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 74.42 110.834 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.575 HG23 ' OE2' ' A' ' 72' ' ' GLU . 71.9 t -74.59 124.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 71.44 111.088 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -137.67 8.34 2.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.123 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 53' ' ' VAL . 57.1 m-20 -154.54 146.18 23.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 72.02 110.767 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 54' ' ' LEU . 13.6 t -153.71 128.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 72.43 111.176 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.59 ' CD1' HG11 ' A' ' 140' ' ' VAL . 54.5 mt -84.88 129.08 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 64.5 111.182 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.57 123.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 73.5 111.125 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p -83.76 -45.85 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 54.42 111.196 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.5 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.2 p-80 -153.44 178.06 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 65.42 110.845 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.497 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -97.71 91.62 5.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 61.2 111.052 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.33 156.56 43.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.786 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.53 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 61.21 111.085 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.84 20.03 10.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 64.55 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.83 -77.43 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.896 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.79 7.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.32 111.096 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.45 -37.85 41.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 53.21 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 10.57 64.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 55.35 112.395 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.38 -28.41 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 71.12 111.201 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -38.81 67.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.887 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -84.07 -10.45 57.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 54.32 111.077 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.661 HD11 ' OG ' ' A' ' 57' ' ' SER . 22.9 mt -90.86 -33.94 15.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.34 110.925 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -94.42 17.9 12.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.973 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -116.3 -39.25 3.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.93 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -87.33 -55.75 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 64.14 110.848 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.91 47.87 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.75 -0.738 . . . . 71.34 112.524 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.3 mp -111.32 110.79 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 40.31 111.087 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.718 ' HB3' HD11 ' A' ' 124' ' ' LEU . 12.7 mtmt -72.1 107.88 5.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 72.31 110.861 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.62 89.41 7.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 61.04 111.093 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.546 ' HA ' HD12 ' A' ' 124' ' ' LEU . 58.1 m-70 -62.08 135.82 57.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.885 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.92 168.98 10.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 63.11 110.844 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.87 154.23 25.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.141 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.91 7.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 61.45 111.053 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -70.7 -46.38 63.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 61.14 111.011 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.752 ' HA ' HD11 ' A' ' 114' ' ' LEU . 32.7 m -57.03 -25.59 58.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 60.55 111.174 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.599 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -97.89 14.12 28.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 71.42 111.143 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -26.75 7.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.825 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -105.74 -10.35 16.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 55.44 110.911 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.53 70.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 71.24 111.061 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -24.54 55.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 64.11 110.889 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -61.48 -32.63 72.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 61.54 110.897 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -89.36 -24.82 21.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 52.32 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.05 24.06 3.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.696 -0.764 . . . . 71.34 112.443 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.72 166.48 10.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 74.23 110.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.99 162.95 28.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 73.51 110.928 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mp0 -95.09 111.93 56.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.607 0.718 . . . . 72.15 110.891 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.599 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.2 Cg_endo -69.79 -176.1 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.6 2.2 . . . . 75.35 112.323 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 104' ' ' LYS . 17.5 mt -51.79 -43.7 63.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.831 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.6 50.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 62.24 112.485 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.11 43.52 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 72.14 110.782 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.751 HD22 HD21 ' A' ' 133' ' ' LEU . 59.2 mt -129.14 -175.55 3.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 73.11 110.878 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -151.6 -171.72 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 63.12 110.871 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.853 HG22 HG23 ' A' ' 130' ' ' VAL . 52.9 m -50.62 -71.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 62.54 111.089 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 HG22 ' A' ' 129' ' ' THR . 31.2 t -116.85 102.79 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 63.32 111.04 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 t -135.63 170.56 15.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.1 111.156 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -117.68 133.88 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 64.11 110.884 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.751 HD21 HD22 ' A' ' 127' ' ' LEU . 25.9 mt -114.84 155.52 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 65.0 110.942 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -137.59 124.17 20.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.22 110.857 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -125.86 49.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.923 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.44 92.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 74.35 112.547 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.7 m120 64.6 15.05 9.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 70.31 110.941 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.3 tpp -135.16 108.65 7.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.863 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -98.33 129.06 45.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.823 HG22 HD21 ' A' ' 158' ' ' LEU . 20.2 t -134.91 115.15 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 64.31 111.184 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -107.64 130.63 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 61.4 110.814 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.5 p -86.75 -176.54 5.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 62.4 111.164 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.511 ' HB3' HG23 ' A' ' 155' ' ' VAL . 24.7 t80 -168.4 130.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.835 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.748 ' HB3' HG23 ' A' ' 129' ' ' THR . 11.0 t80 -115.57 88.01 18.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 71.03 110.957 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -7.99 22.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.646 2.231 . . . . 53.1 112.411 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.56 -162.29 21.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.674 -0.774 . . . . 62.23 112.381 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -81.04 137.61 36.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 71.32 110.878 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.13 -88.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.472 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -76.36 -25.21 54.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 62.2 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.5 HG21 ' HB2' ' A' ' 86' ' ' HIS . 17.2 p -147.15 -158.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 71.22 111.067 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HB3' HD23 ' A' ' 114' ' ' LEU . 40.6 tt0 -89.47 -22.01 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.872 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.759 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -132.18 8.66 4.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.853 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.472 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.0 OUTLIER -41.12 128.37 2.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.01 110.891 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 152' ' ' ASP . 7.0 pt -132.79 -176.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 71.34 111.101 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.529 ' HB ' HD11 ' A' ' 164' ' ' LEU . 9.2 m -133.82 131.76 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 64.41 111.043 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 164' ' ' LEU . 91.1 t -86.27 126.44 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 65.52 111.156 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -114.33 131.09 56.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.43 110.812 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.823 HD21 HG22 ' A' ' 140' ' ' VAL . 11.6 mt -111.84 97.19 36.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 74.31 110.885 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.4 Cg_endo -69.87 -5.1 15.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.664 2.242 . . . . 74.12 112.301 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -81.81 -23.63 36.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 62.33 110.952 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.4 13.76 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.917 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.42 29.75 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.41 110.907 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.498 HD13 HD13 ' A' ' 21' ' ' LEU . 98.3 mt -96.07 130.3 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.11 111.092 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' A' ' 155' ' ' VAL . 25.4 tp -112.67 146.0 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.867 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 55' ' ' VAL . 21.3 t -112.22 79.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 74.42 111.145 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.67 42.79 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.656 -0.783 . . . . 54.32 112.542 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.5 -163.85 53.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 41.22 112.515 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -33.55 35.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.361 . . . . 44.12 110.909 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.616 HD12 ' NE1' ' A' ' 189' ' ' TRP . 22.6 tp -53.69 -56.38 17.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.934 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 218' ' ' LEU . 14.7 t -82.55 114.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 64.42 111.076 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 150.57 19.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 72.53 110.889 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.0 p -97.96 155.11 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.865 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.123 -179.864 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.866 0.365 . . . . 54.34 111.091 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -113.73 90.94 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.35 110.94 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 t -67.12 -19.18 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 42.15 111.137 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -74.84 -24.83 58.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 64.23 110.876 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.39 -10.76 13.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 72.02 110.852 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.616 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.5 t90 -55.3 -61.44 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 62.12 110.93 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.7 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.63 -24.48 14.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 54.31 110.894 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.9 m -81.57 -31.97 32.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 63.01 111.058 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -43.1 61.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.859 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 219' ' ' LEU . 30.5 mm -61.68 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.35 111.14 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.39 -27.64 56.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 63.14 110.92 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -76.98 -22.27 53.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 73.34 110.939 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.18 -11.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 73.03 111.143 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.436 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -111.4 -10.02 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 65.21 110.916 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.86 -30.76 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.833 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -58.48 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.11 110.897 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.448 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -93.08 61.68 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 74.02 110.893 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -72.36 -58.14 3.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 74.32 110.94 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -53.03 102.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.3 110.845 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.646 HG21 ' CG2' ' A' ' 206' ' ' VAL . 73.9 mt -142.04 121.68 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 73.03 111.16 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -29.83 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.447 . . . . 70.11 110.84 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.06 143.18 2.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 63.21 111.178 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.756 ' HB ' HD12 ' A' ' 218' ' ' LEU . 98.1 t -121.48 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 45.23 111.1 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.963 HG22 HG12 ' A' ' 213' ' ' VAL . 11.9 t -108.48 112.57 60.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 63.23 111.274 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.62 -169.48 0.32 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.769 2.313 . . . . 53.22 112.397 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.65 -13.66 59.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.828 -0.701 . . . . 73.14 112.5 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.45 129.71 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.354 . . . . 72.41 110.838 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 116.78 -117.69 3.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.812 -0.709 . . . . 72.12 112.494 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -150.79 164.75 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 75.23 110.841 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.963 HG12 HG22 ' A' ' 207' ' ' VAL . 5.8 m -54.87 163.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.23 111.176 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.26 -111.58 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.803 -0.713 . . . . 70.34 112.522 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.15 -169.32 2.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.418 . . . . 75.32 110.809 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -18.31 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 72.2 110.856 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.494 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.88 -16.75 48.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.75 -0.738 . . . . 65.41 112.47 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.756 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.6 mt -71.95 -30.35 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 74.21 110.967 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.588 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.7 mm? -65.64 -57.5 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.52 110.899 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.494 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -61.54 -17.78 56.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 73.44 110.918 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -65.6 -50.42 65.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.1 110.873 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.543 ' C ' HD23 ' A' ' 226' ' ' LEU . 2.9 m -51.78 -51.43 56.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 74.13 111.138 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -18.74 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 75.04 110.915 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -87.53 -5.07 58.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 72.45 110.804 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.3 mt -126.09 -6.4 6.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 70.42 110.876 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.7 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -119.34 8.48 11.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.918 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 64.42 110.877 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.78 0.324 . . . . 70.24 111.131 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -114.2 100.23 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 65.2 111.127 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -121.4 116.3 24.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 63.02 110.906 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -58.52 165.23 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 71.22 110.96 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.8 -48.29 63.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 74.22 110.896 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -60.74 -38.01 83.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.13 111.206 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.97 64.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.728 -0.749 . . . . 73.22 112.525 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -71.34 -45.42 62.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.7 0.286 . . . . 75.51 111.085 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.96 123.3 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.419 . . . . 74.5 111.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.1 p -129.2 132.64 47.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 75.04 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -127.28 107.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 72.32 111.12 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -98.6 125.07 43.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.34 110.836 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -68.58 108.78 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.12 110.843 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.731 HD21 HG21 ' A' ' 213' ' ' VAL . 14.1 mt -62.61 -33.1 74.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 70.15 110.936 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.26 -96.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 52.21 110.883 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.42 9.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.925 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.98 6.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.892 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 t -150.69 139.74 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 63.2 111.126 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.788 ' HB3' HG22 ' A' ' 18' ' ' ILE . 16.0 m95 -128.03 -174.78 3.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 65.12 110.92 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG21 ' CG2' ' A' ' 213' ' ' VAL . 99.3 t -136.83 94.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 70.1 111.057 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -79.01 122.07 25.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 72.0 110.866 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.7 m -118.7 104.92 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 70.44 111.167 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.41 124.48 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 74.4 110.888 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.23 114.2 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.877 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.66 -0.781 . . . . 61.25 112.437 179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.641 0.734 . . . . 75.11 111.193 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 118.29 5.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 71.01 112.305 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.8 p -97.38 98.08 9.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.799 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -51.79 159.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.31 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -154.67 -167.3 16.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.77 . . . . 42.34 112.435 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 158' ' ' LEU . 14.3 tp -152.68 112.84 4.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 72.25 110.964 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.64 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -95.66 116.5 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.19 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.729 HD21 HD11 ' A' ' 158' ' ' LEU . 26.7 mt -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 73.55 110.906 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -86.86 86.64 7.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.888 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.47 179.98 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 62.54 111.112 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.4 -23.32 14.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.9 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -13.24 58.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 41.34 110.919 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.11 151.81 5.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 55.31 112.539 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.62 153.7 35.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.808 0.337 . . . . 73.34 110.969 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.638 HG13 ' CB ' ' A' ' 81' ' ' ASP . 2.3 t -143.74 141.09 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 64.34 111.031 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.64 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.3 mt -136.87 122.07 19.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.43 110.943 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.497 HG11 HG11 ' A' ' 165' ' ' VAL . 76.3 t -67.43 111.43 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.152 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' CG ' HG12 ' A' ' 55' ' ' VAL . 1.9 m-20 72.1 130.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.34 110.903 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -72.85 -166.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.228 -0.442 . . . . 75.11 110.914 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -91.62 169.19 10.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.12 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.718 ' HB2' HD12 ' A' ' 63' ' ' LEU . 96.5 m95 -48.98 -58.5 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.983 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -130.48 161.53 31.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.13 110.883 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -54.21 -32.83 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 60.22 110.815 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -59.22 -39.84 84.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 72.35 110.868 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.7 mt -78.91 -45.39 20.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 71.23 110.909 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -46.33 62.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 64.41 111.093 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.05 -49.46 66.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 74.24 110.905 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.08 -15.27 63.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 71.13 110.936 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.499 ' O ' HG22 ' A' ' 71' ' ' VAL . 17.3 tp -92.53 -24.89 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 65.05 110.958 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.821 HG12 HG11 ' A' ' 79' ' ' VAL . 15.3 mt -91.24 -26.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.42 111.125 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -86.55 7.77 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.857 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.7 ptm -123.53 -38.6 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 71.35 110.913 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 67' ' ' LEU . 23.0 m -79.55 -23.68 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 55.05 111.133 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -20.68 61.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.896 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -107.79 -30.71 8.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 63.54 110.873 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -45.79 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 27.5 m-85 -83.55 -11.97 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 71.31 110.838 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 67.65 12.78 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 62.22 110.916 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 139.7 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 65.21 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.97 136.8 38.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 62.41 110.799 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.821 HG11 HG12 ' A' ' 68' ' ' ILE . 14.4 p -77.02 128.75 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 72.41 111.12 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -155.41 19.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.159 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.638 ' CB ' HG13 ' A' ' 53' ' ' VAL . 28.0 m-20 -154.24 142.68 20.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 74.22 110.871 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 81' ' ' ASP . 10.4 t -156.58 104.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 62.51 111.16 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.616 HD11 ' HE2' ' A' ' 135' ' ' PHE . 8.5 mt -69.97 119.82 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.41 111.111 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.7 mm -93.45 147.46 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 72.43 111.106 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -104.24 -50.33 3.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 64.23 111.074 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.491 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.8 p-80 -155.84 -174.58 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 62.24 110.88 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.837 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -92.37 99.58 12.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 54.02 111.139 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.45 151.88 29.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 64.4 110.866 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.18 -19.94 49.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.401 . . . . 70.41 111.028 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.58 6.25 48.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 65.22 110.956 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.68 -77.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.875 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -92.13 7.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 73.35 111.188 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.78 -37.44 34.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.816 -0.707 . . . . 72.13 112.414 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.2 10.77 58.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.751 . . . . 74.12 112.534 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 92' ' ' ILE . 17.0 tt -53.89 -28.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.924 0.392 . . . . 71.41 111.159 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -53.64 -36.94 62.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 64.44 110.921 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -87.17 -13.71 43.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.42 111.147 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.578 ' HA ' HD13 ' A' ' 103' ' ' ILE . 20.2 mt -86.42 -31.55 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 75.21 110.923 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.92 15.73 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 65.24 110.88 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -116.46 -45.37 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 74.2 110.942 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -78.15 -56.86 4.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 71.51 110.804 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.816 -0.706 . . . . 62.55 112.498 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -109.98 119.24 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.928 0.394 . . . . 74.23 111.121 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.753 ' CE ' HD21 ' A' ' 124' ' ' LEU . 3.9 mtpp -76.17 119.32 19.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 71.14 110.852 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.0 93.53 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 51.53 111.116 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.426 ' HB3' HD11 ' A' ' 127' ' ' LEU . 76.9 m-70 -65.86 145.67 55.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.03 110.906 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.441 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -178.87 171.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 55.25 110.889 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.89 158.94 19.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 61.52 111.105 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -39.26 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.42 111.065 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -66.06 -44.17 85.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 72.43 110.906 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.741 ' HA ' HD11 ' A' ' 114' ' ' LEU . 51.6 m -57.5 -25.35 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 61.34 111.121 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.11 10.86 38.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 63.21 111.121 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.9 -33.2 6.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 71.15 110.892 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.837 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -97.59 -13.9 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.878 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.442 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -63.5 -41.57 98.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 73.25 111.105 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -24.41 58.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 62.25 110.925 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -32.5 70.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 64.44 110.826 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -89.87 -24.35 21.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 72.32 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.18 23.93 4.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 55.33 112.568 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -98.07 -175.5 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 72.22 110.923 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.429 ' HB2' HD13 ' A' ' 95' ' ' ILE . 6.3 mm-40 -85.5 176.14 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 73.43 110.93 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.9 mt-10 -106.59 104.38 50.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.684 0.754 . . . . 73.32 110.863 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.8 Cg_endo -69.77 -178.75 2.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.635 2.223 . . . . 62.3 112.367 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.753 HD21 ' CE ' ' A' ' 104' ' ' LYS . 10.2 mt -51.08 -47.04 61.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.981 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.07 26.55 28.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 71.5 112.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -107.84 45.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 72.33 110.817 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.587 HD22 HD21 ' A' ' 133' ' ' LEU . 86.4 mt -127.1 -174.96 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 75.03 110.972 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -152.57 -172.31 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 73.43 110.932 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.869 HG22 HG23 ' A' ' 130' ' ' VAL . 49.6 m -50.89 -70.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.33 111.166 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.869 HG23 HG22 ' A' ' 129' ' ' THR . 33.0 t -117.06 103.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 54.54 111.097 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t -135.42 175.23 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 64.23 111.122 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -120.64 136.39 54.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 62.24 110.901 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 127' ' ' LEU . 25.2 mt -115.23 154.34 29.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 60.13 110.844 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -134.08 126.89 31.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.857 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.616 ' HE2' HD11 ' A' ' 83' ' ' ILE . 12.2 m-85 -129.9 32.8 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.797 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.66 95.37 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.672 -0.775 . . . . 43.32 112.487 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.88 13.49 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 72.23 110.969 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.6 tpp -135.03 106.43 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 70.22 110.821 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.471 ' O ' HD23 ' A' ' 158' ' ' LEU . 3.4 mptp? -94.58 126.0 39.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 60.33 110.852 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.844 HG22 HD21 ' A' ' 158' ' ' LEU . 19.9 t -134.77 116.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.174 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.95 131.22 55.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 55.5 110.88 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.5 p -85.04 -176.03 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.33 111.199 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.443 ' HB3' HG23 ' A' ' 155' ' ' VAL . 24.7 t80 -166.67 133.08 2.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.877 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.694 ' HB3' HG23 ' A' ' 129' ' ' THR . 7.8 t80 -122.01 87.33 47.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.612 0.72 . . . . 73.53 110.87 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 -7.68 21.69 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.672 2.248 . . . . 70.33 112.335 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.48 -160.81 23.86 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.742 -0.742 . . . . 53.4 112.442 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -86.26 139.48 30.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.886 0.374 . . . . 74.41 110.91 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.17 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 61.04 112.435 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -75.6 -22.92 56.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 63.22 110.86 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 86' ' ' HIS . 59.3 p -150.69 -169.21 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 63.21 111.122 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.543 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.2 tt0 -86.63 -5.71 59.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 55.13 110.926 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 154' ' ' ILE . 47.6 t0 -145.75 16.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 52.53 110.838 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.69 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -49.8 126.14 13.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 53.12 110.904 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 152' ' ' ASP . 24.1 pt -133.72 174.92 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 70.25 111.15 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 143' ' ' PHE . 14.5 m -128.06 120.38 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 63.11 111.088 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.37 119.18 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 42.51 111.167 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.4 t-105 -107.94 136.45 47.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.33 110.816 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.844 HD21 HG22 ' A' ' 140' ' ' VAL . 13.3 mt -118.63 98.35 51.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 72.0 110.808 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -4.52 14.2 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.675 2.25 . . . . 73.11 112.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -85.12 -21.22 29.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.11 110.98 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -143.52 13.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 74.11 110.929 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.1 m120 53.12 27.54 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.952 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.468 HD13 HD13 ' A' ' 21' ' ' LEU . 95.9 mt -89.96 142.82 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 63.53 111.156 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.594 HD22 HD13 ' A' ' 203' ' ' ILE . 27.7 tp -125.62 147.79 49.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.53 110.915 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.497 HG11 HG11 ' A' ' 55' ' ' VAL . 53.3 t -115.02 79.2 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 63.21 111.074 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.03 -34.0 37.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.781 -0.723 . . . . 60.2 112.427 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.17 -163.31 16.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 61.21 112.478 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -32.65 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 54.42 110.892 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.69 HD13 ' OD1' ' A' ' 153' ' ' ASN . 23.0 tp -52.02 -51.38 57.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 70.13 110.929 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 219' ' ' LEU . 21.3 t -89.63 110.84 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 73.32 111.143 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.71 ' HG2' HG23 ' A' ' 222' ' ' THR . 0.4 OUTLIER -56.34 156.27 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 73.12 110.95 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 45.5 p -98.77 159.82 14.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 42.32 110.91 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 70.45 111.107 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.8 0.333 . . . . 73.34 111.135 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -114.01 90.69 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 71.44 110.89 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 27.3 t -62.0 -16.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 73.22 111.131 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -74.28 -23.43 59.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 70.45 110.877 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -117.12 -13.0 10.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 72.53 110.823 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.49 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.4 t90 -53.58 -62.01 1.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.108 -0.496 . . . . 73.54 110.881 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.759 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -55.25 -23.62 23.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 53.41 110.839 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.54 -30.07 33.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 70.11 111.176 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.7 -44.12 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 63.13 110.891 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.509 HG21 ' O ' ' A' ' 219' ' ' LEU . 33.6 mm -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 74.03 111.102 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.462 ' HG2' HD21 ' A' ' 223' ' ' LEU . 2.3 mm-40 -56.3 -27.4 55.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 64.31 110.918 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -77.66 -22.32 50.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 64.33 110.853 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 192' ' ' SER . 17.2 t -85.26 -10.84 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.012 0.434 . . . . 75.33 111.204 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.56 -12.7 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 61.44 110.914 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -98.75 -30.79 12.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 71.24 110.928 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -59.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 75.33 110.876 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.459 ' O ' HD11 ' A' ' 203' ' ' ILE . 3.9 m-30 -91.49 61.71 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 73.44 110.947 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -72.78 -58.52 3.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.903 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -52.64 101.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 60.14 110.905 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.64 HG21 HG22 ' A' ' 206' ' ' VAL . 71.6 mt -141.14 118.22 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 73.34 111.117 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.1 -28.08 63.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.825 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.649 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -166.9 145.08 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.438 . . . . 71.13 111.139 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.748 ' HB ' HD12 ' A' ' 218' ' ' LEU . 93.0 t -123.45 131.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.196 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.014 HG22 HG22 ' A' ' 213' ' ' VAL . 15.9 t -110.15 105.87 57.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 62.31 111.187 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.2 Cg_endo -69.82 -171.3 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 70.2 112.319 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.4 -20.24 67.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 71.34 112.54 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.46 144.48 23.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.795 0.331 . . . . 72.21 110.917 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.38 -101.86 1.36 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.772 -0.728 . . . . 74.53 112.544 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -172.03 170.98 5.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.92 0.391 . . . . 73.44 110.868 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.014 HG22 HG22 ' A' ' 207' ' ' VAL . 10.9 t -65.23 148.47 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 70.31 111.188 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.51 -101.96 0.31 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.768 -0.729 . . . . 60.34 112.559 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -163.57 -169.12 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 54.51 110.903 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -17.75 54.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 53.51 110.907 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.468 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.55 -20.72 39.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.771 -0.728 . . . . 61.12 112.511 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.748 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.6 mt -72.87 -29.84 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 73.02 110.949 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.509 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -64.52 -60.67 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 73.01 110.9 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.468 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.4 OUTLIER -58.76 -19.92 44.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 72.2 110.902 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.542 ' NE2' HD11 ' A' ' 225' ' ' LEU . 13.5 t-160 -61.86 -50.93 70.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 72.23 110.959 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.729 HG22 HD23 ' A' ' 226' ' ' LEU . 3.8 m -51.7 -51.02 59.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 63.25 111.173 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.636 HD23 ' OG ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -60.49 -18.23 50.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 74.22 110.936 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.69 -2.64 57.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.833 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.542 HD11 ' NE2' ' A' ' 221' ' ' HIS . 8.1 mt -125.22 -8.02 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 51.33 110.88 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.759 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -122.61 9.42 9.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 65.25 110.947 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.846 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 18' ' ' ILE . 3.8 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.681 0.277 . . . . 75.35 111.236 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.6 mt -135.78 102.55 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 54.54 111.184 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -110.71 122.64 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 75.3 110.95 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -65.62 166.39 10.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 72.43 110.849 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.65 -48.69 63.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 52.23 110.836 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -60.61 -37.72 82.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.476 . . . . 75.3 111.178 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.86 11.93 61.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.35 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 31' ' ' LEU . 41.9 m -84.55 -41.61 16.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 72.33 111.098 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.642 HD13 ' HB2' ' A' ' 67' ' ' LEU . 68.8 mt -101.22 103.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 74.11 111.107 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.1 p -120.62 125.97 49.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 70.12 110.852 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -101.52 -164.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.094 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.581 ' H ' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -178.23 115.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 62.1 110.876 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -68.17 106.48 2.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 74.21 110.904 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.688 ' HG ' HG23 ' A' ' 27' ' ' VAL . 28.8 mt -65.73 -32.62 74.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.01 110.96 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.43 -96.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 63.51 110.876 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.62 10.44 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 64.21 110.944 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.51 5.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 64.3 110.944 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.8 t -151.4 138.95 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 72.43 111.196 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.418 ' O ' HD12 ' A' ' 44' ' ' LEU . 13.2 m95 -125.02 -173.86 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 72.44 110.953 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.688 HG23 ' HG ' ' A' ' 21' ' ' LEU . 72.2 t -137.17 89.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 61.3 111.151 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CA ' HG23 ' A' ' 18' ' ' ILE . 14.2 p80 -73.96 125.16 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.776 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -118.97 96.76 5.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 63.02 111.076 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.22 117.68 18.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 71.14 110.954 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -84.16 114.77 22.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 75.43 110.915 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 73.21 112.43 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.553 0.692 . . . . 70.24 111.108 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.694 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.7 Cg_endo -69.71 117.69 5.23 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.688 2.259 . . . . 64.22 112.327 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -107.85 98.76 8.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.8 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -50.97 161.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.881 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -154.7 -155.81 7.44 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.739 . . . . 62.32 112.455 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 158' ' ' LEU . 13.1 tp -157.6 112.05 2.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 73.21 110.874 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.659 HG22 HD23 ' A' ' 54' ' ' LEU . 2.0 t -96.88 112.37 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.098 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.741 HD21 HD11 ' A' ' 158' ' ' LEU . 17.9 mt -90.86 120.01 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.973 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -90.75 82.17 5.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 73.23 110.886 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -97.22 -179.51 4.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 71.44 111.105 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -25.81 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 70.04 110.859 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -20.16 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.44 110.953 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.5 149.63 5.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.22 112.562 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.699 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.6 mt -61.56 154.16 25.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.817 0.342 . . . . 63.54 110.918 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.3 t -144.59 141.79 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 63.2 111.187 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.659 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -137.2 121.97 18.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 63.23 110.898 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.625 HG11 HG11 ' A' ' 165' ' ' VAL . 77.0 t -66.82 111.66 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.45 111.157 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.77 128.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.874 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.683 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.8 p -70.84 -167.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 52.51 110.833 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.58 ' H ' HG23 ' A' ' 64' ' ' THR . 8.1 t -89.94 166.84 13.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 53.13 110.907 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.8 m95 -49.69 -59.86 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 73.31 110.892 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.86 158.0 37.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 75.2 110.823 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -51.57 -33.36 32.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 73.33 110.955 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.05 -45.58 90.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 75.23 110.921 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.699 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.4 mt -72.32 -46.93 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.956 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.46 -47.71 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 55.4 111.164 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.07 -49.96 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.834 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG3' HD12 ' A' ' 16' ' ' ILE . 35.0 tp10 -64.76 -20.54 66.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 74.11 110.837 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.642 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.4 tp -87.24 -25.19 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 54.53 110.871 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.23 -24.03 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 62.01 111.145 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -92.17 16.18 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 54.32 110.882 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.8 ptm -131.65 -39.99 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.834 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 67' ' ' LEU . 20.1 m -80.23 -22.86 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 54.34 111.052 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.708 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.37 -24.81 65.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 65.14 110.858 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -105.36 -33.37 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 70.31 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -44.48 68.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 72.12 110.903 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.541 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.8 m-85 -85.81 -12.29 51.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 70.54 110.941 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 69.44 11.43 8.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.893 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -131.59 141.49 49.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.53 110.918 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.97 140.42 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 61.11 110.959 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.708 HG23 ' OE2' ' A' ' 72' ' ' GLU . 89.6 t -81.78 121.28 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 74.12 111.169 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -138.09 14.23 2.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 73.35 111.153 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 103' ' ' ILE . 60.8 m-20 -154.45 144.83 22.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 64.04 110.935 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 54' ' ' LEU . 21.3 t -153.85 132.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.13 111.046 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.555 HD11 ' HE2' ' A' ' 135' ' ' PHE . 43.7 mt -92.66 128.41 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 71.45 111.048 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.52 153.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.44 111.129 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.0 p -112.32 -49.87 2.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 64.14 111.154 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.6 -176.15 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 63.24 110.841 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -98.39 90.9 4.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 64.31 111.072 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.2 152.84 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 74.21 110.831 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.23 12.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 73.22 111.1 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.53 27.12 2.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.856 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -71.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 71.11 110.849 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -98.85 7.61 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 73.33 111.211 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.55 -42.22 43.45 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.722 -0.751 . . . . 71.13 112.451 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.61 16.89 58.3 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.639 -0.791 . . . . 51.2 112.491 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.4 tt -56.71 -30.23 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 62.31 111.186 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -30.01 60.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 64.34 110.864 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -89.11 -15.14 34.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 63.54 111.175 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 57' ' ' SER . 14.0 mt -89.88 -28.74 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.834 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -97.27 13.4 29.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.263 -0.426 . . . . 70.44 110.895 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -112.35 -43.01 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 73.3 110.868 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -78.84 -57.56 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.939 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.84 38.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.642 -0.789 . . . . 71.55 112.441 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.555 HD13 ' HA ' ' A' ' 98' ' ' LEU . 3.9 mp -108.27 124.53 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.39 . . . . 75.34 111.124 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.533 ' HB3' HD11 ' A' ' 124' ' ' LEU . 2.6 mttt -86.67 120.15 27.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 71.14 110.898 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.11 96.36 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.066 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.585 ' HA ' HD12 ' A' ' 124' ' ' LEU . 36.2 m-70 -68.99 144.7 54.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.41 . . . . 72.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.58 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -179.01 -177.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 52.43 110.895 -179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.58 155.83 17.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 73.21 111.161 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.83 -37.87 45.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 71.13 111.086 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.521 HD23 ' OD1' ' A' ' 152' ' ' ASP . 33.4 tp -67.94 -45.85 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 71.21 110.915 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.59 ' HA ' HD11 ' A' ' 114' ' ' LEU . 85.9 m -58.49 -21.61 52.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 34.02 111.136 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.26 12.06 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 75.52 111.186 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -111.68 -28.55 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.876 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -100.58 -9.57 21.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.958 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.426 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 61.52 110.998 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -27.13 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 75.13 110.917 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.34 -34.45 66.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 52.22 110.863 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.44 -23.7 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 54.54 110.808 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.81 21.79 4.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 71.44 112.557 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -95.73 177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 71.05 110.942 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HB2' HD13 ' A' ' 95' ' ' ILE . 66.5 mm-40 -78.12 176.03 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 72.32 110.904 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mt-10 -108.58 104.8 55.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 75.24 110.933 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.82 178.74 4.3 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.653 2.235 . . . . 70.44 112.358 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 106' ' ' HIS . 28.3 mt -51.37 -51.09 57.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 62.32 110.938 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.52 40.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 34.15 112.522 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -99.23 34.47 2.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 70.43 110.929 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.683 ' CD2' HD21 ' A' ' 133' ' ' LEU . 80.7 mt -117.96 -174.35 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 61.53 110.851 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.1 -171.12 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 71.33 110.835 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.804 HG22 HG23 ' A' ' 130' ' ' VAL . 99.5 m -50.56 -69.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 65.41 111.058 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.804 HG23 HG22 ' A' ' 129' ' ' THR . 34.5 t -120.49 102.61 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 65.41 111.121 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -132.71 164.29 27.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.507 . . . . 61.4 111.154 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.3 129.15 56.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 74.25 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.683 HD21 ' CD2' ' A' ' 127' ' ' LEU . 61.6 mt -115.89 157.97 23.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.998 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -136.99 112.15 9.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.92 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.555 ' HE2' HD11 ' A' ' 83' ' ' ILE . 19.0 m-85 -107.6 45.42 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.947 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.01 87.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 54.03 112.492 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.73 14.66 9.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 73.43 110.949 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.45 ' HB2' HG22 ' A' ' 48' ' ' THR . 50.2 tpp -131.31 89.87 2.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.86 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 130.58 38.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 70.15 110.924 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.687 HG22 HD21 ' A' ' 158' ' ' LEU . 21.2 t -139.55 117.02 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 70.22 111.145 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -108.24 132.73 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.9 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 37.7 p -90.14 171.01 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 42.23 111.112 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.4 t80 -154.29 130.28 10.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 72.25 110.865 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.653 ' HB3' HG23 ' A' ' 129' ' ' THR . 17.6 t80 -118.44 85.56 26.24 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.613 0.72 . . . . 73.44 110.868 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.56 23.9 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.705 2.27 . . . . 73.52 112.306 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.24 -169.62 15.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.8 -0.714 . . . . 73.22 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -76.79 147.81 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 73.52 110.868 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.26 -64.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.11 112.486 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 83.8 t60 -89.56 -30.93 17.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.873 0.368 . . . . 75.14 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.9 p -139.83 -87.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 63.5 111.162 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.412 ' OE1' HD23 ' A' ' 114' ' ' LEU . 71.5 tt0 -160.56 -32.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 75.11 110.812 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.521 ' OD1' HD23 ' A' ' 110' ' ' LEU . 12.5 t0 -127.58 14.56 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 74.2 110.795 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -50.41 125.57 13.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.14 110.861 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 144' ' ' TYR . 12.6 pt -123.36 164.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 64.03 111.107 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.6 m -115.74 118.99 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 71.15 111.139 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 83' ' ' ILE . 43.7 t -70.77 118.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 62.35 111.076 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -104.89 131.14 52.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.926 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.741 HD11 HD21 ' A' ' 46' ' ' LEU . 11.7 mt -113.1 97.02 41.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.573 0.702 . . . . 74.31 110.985 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.61 -4.68 14.41 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.781 2.321 . . . . 52.24 112.352 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -83.18 -23.03 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.914 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.46 13.4 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 74.51 110.922 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.46 29.13 10.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 73.15 110.981 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.1 130.14 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 73.52 111.16 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' A' ' 203' ' ' ILE . 24.8 tp -113.54 147.73 37.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 75.43 110.865 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.625 HG11 HG11 ' A' ' 55' ' ' VAL . 25.9 t -111.05 78.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 74.2 111.157 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.07 -35.37 41.06 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 74.4 112.49 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 63.04 -159.26 36.64 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.801 -0.714 . . . . 51.24 112.505 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.8 m -59.94 -30.82 69.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.876 0.369 . . . . 70.43 110.904 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.692 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.3 tp -53.63 -49.15 68.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.904 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.669 HG13 ' HA ' ' A' ' 219' ' ' LEU . 21.0 t -89.77 105.43 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 65.25 111.105 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.645 ' HD3' HG23 ' A' ' 222' ' ' THR . 0.2 OUTLIER -52.38 147.99 7.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.11 110.902 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 218' ' ' LEU . 54.2 p -99.92 167.11 10.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 72.32 110.882 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 54.31 111.149 -179.877 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 149' ' ' HIS . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.833 0.349 . . . . 55.15 111.12 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.4 85.99 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.95 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.22 -21.34 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.11 111.143 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -72.38 -28.11 62.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 53.04 110.878 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -106.75 -14.94 14.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.05 110.905 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.692 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.9 t90 -55.36 -61.05 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 71.33 110.876 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.739 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.15 -25.43 13.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.842 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -80.92 -32.86 34.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.077 -0.511 . . . . 64.34 111.116 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.61 -41.72 65.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 72.33 110.842 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 219' ' ' LEU . 27.4 mm -64.96 -46.89 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.24 111.162 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.27 -28.59 63.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 43.14 110.837 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -76.96 -22.78 52.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.889 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 192' ' ' SER . 11.0 t -85.19 -10.51 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 61.02 111.094 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -112.22 -10.15 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.439 . . . . 71.55 110.926 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.01 -30.73 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 75.14 110.872 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -46.68 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.823 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.06 37.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 71.33 110.909 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -48.07 69.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.946 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -59.92 103.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 62.04 110.85 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.585 HG21 HG22 ' A' ' 206' ' ' VAL . 40.8 mt -146.07 123.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 54.25 111.067 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -25.48 46.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.879 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.53 130.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 72.41 111.091 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.743 ' HB ' HD12 ' A' ' 218' ' ' LEU . 57.9 t -100.23 147.33 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.19 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 213' ' ' VAL . 20.2 t -122.57 101.12 40.54 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.639 0.733 . . . . 74.23 111.04 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 218' ' ' LEU . 54.5 Cg_endo -69.78 177.34 5.69 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.639 2.226 . . . . 73.2 112.385 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.68 -11.65 79.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 74.34 112.488 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -152.77 148.39 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 72.12 110.843 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.29 -99.89 2.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 73.42 112.436 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -174.39 153.87 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 74.21 110.95 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 207' ' ' VAL . 5.3 m -53.98 163.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 70.23 111.172 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.55 -93.84 0.1 OUTLIER Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.725 -0.75 . . . . 65.15 112.444 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -171.47 -166.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 71.14 110.884 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -56.8 -20.74 24.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.847 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.53 -23.0 18.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 54.51 112.455 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.743 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.6 mt -77.38 -32.5 54.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 74.11 110.857 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.669 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.0 mp -62.08 -62.33 1.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 64.21 110.885 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -22.74 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 62.44 110.864 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.423 ' NE2' HD11 ' A' ' 225' ' ' LEU . 9.8 t-160 -61.13 -45.86 92.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 70.31 110.877 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.645 HG23 ' HD3' ' A' ' 171' ' ' LYS . 3.5 m -51.28 -54.95 21.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 71.14 111.153 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 190' ' ' SER . 1.4 mt -60.58 -18.43 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 64.32 110.89 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.804 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.519 HD12 ' HG2' ' A' ' 171' ' ' LYS . 8.8 mt -124.68 -10.5 7.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 73.11 110.893 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.739 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -116.46 14.07 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.94 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 71.33 110.894 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.9 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.849 0.357 . . . . 53.33 111.114 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.14 93.69 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 53.21 111.154 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.01 115.3 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 75.05 110.872 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -59.28 166.36 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 54.02 110.858 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -51.77 -47.86 63.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.04 110.909 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p -60.26 -38.23 82.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.15 111.142 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.92 12.73 60.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 65.14 112.433 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.639 HG23 ' HB3' ' A' ' 31' ' ' LEU . 52.4 m -81.14 -42.95 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.679 0.276 . . . . 65.41 111.115 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.31 125.45 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 72.24 111.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -131.93 126.95 35.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 63.23 110.861 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.683 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -122.3 112.86 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 74.53 111.119 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.431 ' HA ' HG12 ' A' ' 8' ' ' VAL . 25.0 t -100.45 127.54 46.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 74.14 110.878 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -70.58 111.61 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 62.32 110.927 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 163' ' ' ILE . 12.7 mt -65.22 -32.29 73.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.89 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.06 -97.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 63.24 110.837 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 9.48 0.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 35.22 110.906 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.09 7.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.856 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.78 141.14 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 75.21 111.1 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.683 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.7 m95 -129.01 -178.32 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.937 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' A' ' 21' ' ' LEU . 92.3 t -133.04 89.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.384 . . . . 74.24 111.052 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.465 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.8 p80 -72.39 123.79 23.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.913 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -119.68 104.01 9.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 24.54 111.106 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -86.62 122.64 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.54 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -89.29 114.11 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.844 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 51.51 112.518 179.883 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.676 0.751 . . . . 54.53 111.107 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.695 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.4 Cg_endo -69.82 118.99 6.01 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.601 2.201 . . . . 65.24 112.364 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.3 p -112.3 96.95 6.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.888 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -57.83 164.74 2.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.04 110.813 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -155.49 -148.16 4.94 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.778 -0.725 . . . . 61.24 112.509 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.614 HD21 HD12 ' A' ' 158' ' ' LEU . 19.7 tp -159.85 115.27 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.856 0.36 . . . . 63.42 110.886 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.661 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.4 122.15 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.145 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.841 HD21 HD11 ' A' ' 158' ' ' LEU . 28.5 mt -99.39 115.42 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 73.12 110.891 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.55 87.59 7.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.89 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.14 179.58 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 72.33 111.157 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -100.33 -21.97 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.842 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -12.2 56.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 64.3 110.871 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.95 150.87 5.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.769 . . . . 73.32 112.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 77' ' ' LYS . 7.9 tp -65.72 154.58 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 54.23 110.925 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.76 141.57 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.112 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -136.84 125.13 23.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.33 110.946 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 165' ' ' VAL . 69.2 t -70.04 111.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 75.45 111.193 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.58 128.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 65.25 110.807 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.698 ' HB3' HD11 ' A' ' 98' ' ' LEU . 2.4 p -71.6 -167.1 0.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.832 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.439 ' H ' HG23 ' A' ' 64' ' ' THR . 6.9 t -90.28 168.87 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 72.33 110.882 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.707 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.1 m95 -50.35 -60.43 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 74.05 110.938 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -126.67 159.37 33.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 74.04 110.818 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -52.66 -35.06 54.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 73.1 110.862 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.79 -38.02 74.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.995 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.707 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.7 mt -79.62 -46.7 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 63.25 110.95 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.71 -45.44 58.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.12 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -57.79 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 74.43 110.946 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.99 -22.69 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 71.33 110.859 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 71' ' ' VAL . 17.3 tp -84.8 -25.88 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 61.43 110.924 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.46 -22.99 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 62.13 111.132 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -92.38 15.94 12.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 71.13 110.939 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.95 -40.03 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 67' ' ' LEU . 31.5 m -80.25 -22.2 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.12 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.653 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.22 -24.53 64.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 42.4 110.885 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -105.69 -33.85 7.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 71.42 110.924 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -43.29 73.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 33.2 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -88.69 -11.35 45.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.883 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.89 11.88 8.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 53.2 110.966 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.52 ' HB2' HD13 ' A' ' 52' ' ' LEU . 5.9 mttm -130.01 139.22 51.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.83 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -85.35 138.27 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.267 -0.424 . . . . 75.22 110.803 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.653 HG23 ' OE2' ' A' ' 72' ' ' GLU . 94.4 t -78.39 123.09 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.197 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -140.07 13.44 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 73.42 111.169 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -154.85 143.79 20.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.03 110.917 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 54' ' ' LEU . 16.3 t -154.07 128.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 70.41 111.081 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.551 ' CD1' HG11 ' A' ' 140' ' ' VAL . 55.3 mt -85.42 131.37 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 54.21 111.113 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.9 mm -109.91 136.62 45.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 73.12 111.145 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.0 p -96.17 -45.36 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.158 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -153.46 -175.52 5.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 63.02 110.845 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.13 86.73 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 51.43 111.162 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 70.14 110.859 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.24 -23.67 9.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.119 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -95.37 30.11 2.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 73.43 110.842 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.94 -70.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.878 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.16 7.34 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 73.44 111.127 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.69 -41.91 51.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.816 -0.707 . . . . 64.31 112.451 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.7 14.46 64.09 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.668 -0.777 . . . . 61.25 112.518 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.2 tt -55.12 -28.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 74.02 111.153 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -34.57 63.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.946 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.1 m -86.8 -12.53 47.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 72.04 111.181 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 57' ' ' SER . 16.7 mt -90.63 -24.92 20.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 72.03 110.927 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.13 20.19 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.883 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -120.97 -34.06 3.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 63.12 110.881 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -90.86 -42.56 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 70.02 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.79 37.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.769 -0.729 . . . . 70.05 112.492 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.576 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.0 mp -103.16 111.24 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 74.45 111.166 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.709 ' HE2' HD21 ' A' ' 124' ' ' LEU . 1.9 mtpp -72.74 112.05 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 72.51 110.923 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.54 90.56 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 42.31 111.107 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.567 ' HA ' HD12 ' A' ' 124' ' ' LEU . 51.8 m-70 -61.93 145.19 53.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 73.35 110.862 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.613 ' CA ' HD12 ' A' ' 127' ' ' LEU . 1.2 p -177.04 179.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.809 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.2 158.14 18.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 71.41 111.106 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.72 49.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.23 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.714 HD23 ' OD2' ' A' ' 152' ' ' ASP . 62.3 tp -72.27 -37.82 68.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 71.4 110.924 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.728 ' HA ' HD11 ' A' ' 114' ' ' LEU . 91.5 m -58.07 -28.1 64.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 72.15 111.192 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.59 0.95 57.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.21 111.073 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.52 -55.54 2.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 63.42 110.928 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.2 OUTLIER -70.21 -10.29 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 62.23 110.897 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.47 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.78 -46.24 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.081 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -29.51 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 72.21 110.866 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -52.14 -36.71 52.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.935 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -89.51 -17.19 29.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 75.14 110.848 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.64 19.63 8.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.706 -0.759 . . . . 75.03 112.475 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.74 171.83 8.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 74.51 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' HB2' HD13 ' A' ' 95' ' ' ILE . 13.9 mm-40 -70.63 -176.3 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 74.02 110.972 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -116.37 101.53 53.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 73.32 110.948 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.4 Cg_endo -69.67 -179.68 3.04 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.741 2.294 . . . . 70.33 112.351 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HE2' ' A' ' 104' ' ' LYS . 24.6 mt -51.1 -57.67 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 62.51 110.919 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.42 68.64 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.66 -0.781 . . . . 52.21 112.51 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.55 36.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 74.11 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.678 ' CD2' HD21 ' A' ' 133' ' ' LEU . 87.3 mt -119.23 -175.23 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.979 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.38 -171.13 3.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 51.34 110.898 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.903 HG22 HG23 ' A' ' 130' ' ' VAL . 52.6 m -50.73 -70.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.153 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 129' ' ' THR . 31.3 t -120.51 103.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.44 111.177 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -133.04 170.22 15.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 64.53 111.125 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.32 128.11 52.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 71.41 110.886 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.678 HD21 ' CD2' ' A' ' 127' ' ' LEU . 63.9 mt -116.08 155.95 27.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 65.54 110.914 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -136.1 114.83 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.887 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -110.08 51.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 61.1 110.866 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.44 89.46 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.718 -0.753 . . . . 75.35 112.574 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.96 14.57 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 75.33 110.845 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.432 ' SD ' HD22 ' A' ' 46' ' ' LEU . 50.4 tpp -133.13 98.22 4.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 71.52 110.844 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 131.13 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 72.02 110.908 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.847 HG22 HD21 ' A' ' 158' ' ' LEU . 90.1 t -136.78 119.09 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 71.41 111.114 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -111.66 125.55 54.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 70.41 110.914 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.3 p -81.0 -172.52 3.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 32.44 111.136 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.575 ' HD1' HG22 ' A' ' 130' ' ' VAL . 15.9 t80 -170.84 130.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.43 110.923 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.709 ' HB3' HG23 ' A' ' 129' ' ' THR . 12.2 t80 -119.93 86.13 35.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.763 0.792 . . . . 74.21 110.911 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.707 2.271 . . . . 72.33 112.351 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.39 -162.1 23.22 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 72.43 112.443 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.2 135.86 33.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.736 0.303 . . . . 74.43 110.921 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.416 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -148.68 -85.19 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 23.24 112.506 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -79.8 -24.3 41.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.393 . . . . 75.21 110.905 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.478 HG21 ' HB2' ' A' ' 86' ' ' HIS . 24.3 p -147.05 -162.97 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 74.4 111.111 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.56 ' HB3' HD23 ' A' ' 114' ' ' LEU . 36.2 tt0 -88.45 -20.94 24.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.927 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.714 ' OD2' HD23 ' A' ' 110' ' ' LEU . 3.4 t0 -133.22 18.27 4.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.86 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.579 ' ND2' HD13 ' A' ' 169' ' ' LEU . 6.1 p-10 -50.92 131.42 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 70.31 110.771 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.443 HG22 ' CD1' ' A' ' 144' ' ' TYR . 12.9 pt -140.72 169.95 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 65.21 111.09 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 143' ' ' PHE . 16.6 m -121.88 135.36 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 72.04 111.2 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.22 122.57 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.07 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -107.73 132.13 53.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.919 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.847 HD21 HG22 ' A' ' 140' ' ' VAL . 10.7 mt -112.06 98.55 42.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.542 0.687 . . . . 72.03 110.825 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.76 -4.93 15.03 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.272 . . . . 73.41 112.291 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.24 -23.64 35.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.42 110.951 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.04 14.6 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.908 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.7 m120 53.95 27.64 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 74.43 110.958 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.483 HD13 HD13 ' A' ' 21' ' ' LEU . 97.0 mt -92.75 125.93 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 74.41 111.078 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.2 148.68 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 64.24 110.908 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 55' ' ' VAL . 62.0 t -112.43 81.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 63.51 111.129 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.42 48.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 64.3 112.453 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.23 -167.5 46.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 51.31 112.522 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.02 -34.42 29.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 71.34 110.871 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.592 HD12 ' NE1' ' A' ' 189' ' ' TRP . 14.3 tp -51.26 -60.3 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 73.14 110.915 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 218' ' ' LEU . 14.2 t -82.2 116.17 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.144 -0.48 . . . . 71.44 111.076 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.679 ' HE3' HD11 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -51.66 171.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.907 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -121.34 138.11 54.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.0 110.883 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 44.32 111.168 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.794 0.33 . . . . 30.23 111.073 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -110.43 88.18 2.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.974 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 21.7 t -58.32 -20.08 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 54.12 111.133 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.66 -23.02 59.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.956 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -114.33 -13.78 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 71.23 110.891 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.592 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.8 t90 -54.19 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 55.44 110.947 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.78 ' HB3' HD11 ' A' ' 226' ' ' LEU . 3.2 p -54.24 -24.65 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 61.21 110.821 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.1 m -80.55 -30.21 37.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 52.21 111.163 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.413 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -77.34 -44.55 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 72.04 110.929 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 219' ' ' LEU . 34.9 mm -58.91 -46.19 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 62.32 111.086 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -55.62 -29.06 58.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.866 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -77.17 -22.3 52.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 74.02 110.862 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 219' ' ' LEU . 20.7 t -84.76 -11.13 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 55.2 111.122 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -111.12 -15.47 13.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 62.5 110.896 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.447 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -96.42 -30.98 13.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 65.23 110.98 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -50.13 3.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 73.25 110.843 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.452 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -97.41 61.59 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 63.32 110.961 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -74.33 -63.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 74.2 110.902 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -51.99 103.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 71.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.671 HG21 ' CG2' ' A' ' 206' ' ' VAL . 79.3 mt -141.42 123.22 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 73.13 111.182 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.57 -29.38 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.3 110.833 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.3 133.51 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.124 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.752 ' HB ' HD12 ' A' ' 218' ' ' LEU . 83.9 t -109.42 130.07 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 60.32 111.115 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 213' ' ' VAL . 4.2 t -105.73 111.17 64.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.561 0.696 . . . . 74.24 111.039 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -175.73 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.675 2.25 . . . . 64.33 112.349 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.75 -12.57 79.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.739 -0.743 . . . . 53.31 112.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -152.11 147.25 26.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 63.43 110.796 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.37 -117.93 5.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.7 -0.762 . . . . 51.34 112.454 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.85 175.26 10.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.945 0.402 . . . . 73.34 110.85 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 207' ' ' VAL . 3.2 m -72.07 156.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 72.54 111.059 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.51 -105.7 0.41 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.68 -0.771 . . . . 53.43 112.441 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.423 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.3 OUTLIER -153.82 -178.13 6.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 73.23 110.963 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.519 ' HA ' HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -61.97 -16.55 52.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 72.32 110.874 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.39 -23.7 42.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.75 -0.738 . . . . 75.05 112.473 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.752 HD12 ' HB ' ' A' ' 206' ' ' VAL . 4.6 mt -65.07 -25.66 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 65.23 110.834 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.524 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -70.36 -59.49 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.924 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -15.24 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 54.01 110.895 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 171' ' ' LYS . 1.2 t-80 -77.58 -42.57 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 71.55 110.954 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . 1.036 HG22 HD23 ' A' ' 226' ' ' LEU . 47.1 m -52.98 -48.59 67.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 74.52 111.16 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.64 -14.52 52.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.217 -0.447 . . . . 72.44 110.887 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -88.33 3.01 51.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.02 110.882 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.679 HD11 ' HE3' ' A' ' 171' ' ' LYS . 4.5 mt -133.62 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.912 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 1.036 HD23 HG22 ' A' ' 222' ' ' THR . 1.0 OUTLIER -77.06 -4.43 44.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 55.21 110.896 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 73.01 110.929 179.888 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.828 0.347 . . . . 74.03 111.077 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.4 mt -136.2 93.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 70.43 111.227 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.26 121.11 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.852 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -63.84 167.63 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 55.34 110.876 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.04 -44.86 64.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 52.41 110.86 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.0 p -62.04 -38.11 87.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 71.51 111.159 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.25 14.54 62.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.798 -0.715 . . . . 50.51 112.495 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.418 HG23 ' CB ' ' A' ' 31' ' ' LEU . 23.7 m -83.59 -39.25 20.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.818 0.342 . . . . 74.04 111.174 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.14 117.54 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 73.24 111.1 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -124.36 132.43 53.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.24 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.709 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.2 mt -124.92 108.63 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 54.13 111.101 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -100.95 127.53 47.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.866 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -69.77 111.21 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.909 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HG ' HG23 ' A' ' 27' ' ' VAL . 23.0 mt -64.23 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 63.51 110.915 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.07 -97.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.911 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.54 10.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.825 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.56 6.35 0.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.89 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -150.73 140.16 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 71.01 111.14 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.709 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.7 m95 -127.55 -178.05 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.909 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.551 HG23 ' HG ' ' A' ' 21' ' ' LEU . 69.3 t -133.67 95.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.156 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -77.56 118.32 19.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.813 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 m -113.67 107.34 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 70.33 111.157 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.24 126.93 38.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.44 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.418 ' CB ' HG23 ' A' ' 15' ' ' THR . 0.5 OUTLIER -91.47 105.04 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.916 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.537 179.822 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 2.1 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.599 0.714 . . . . 72.44 111.121 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.5 Cg_endo -69.81 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.703 2.269 . . . . 73.41 112.352 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.9 p -100.43 107.77 19.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 62.51 110.818 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.06 162.61 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.885 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.19 -155.27 6.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.743 -0.741 . . . . 74.43 112.472 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.598 HD21 ' CD1' ' A' ' 158' ' ' LEU . 19.8 tp -158.61 112.62 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 73.23 110.927 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.675 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -97.5 121.49 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.33 111.135 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.585 HD21 HD11 ' A' ' 158' ' ' LEU . 29.5 mt -99.67 118.0 35.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.985 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.2 85.83 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.02 110.826 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -100.81 -174.29 2.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 72.4 111.073 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -103.23 -27.79 12.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 71.42 110.844 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -18.16 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.52 110.873 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.4 150.73 5.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 63.54 112.484 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.711 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.8 mt -62.14 155.09 25.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 63.14 110.937 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 81' ' ' ASP . 2.1 t -144.78 141.84 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 72.31 111.099 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.675 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -136.61 122.91 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 43.44 110.893 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.68 112.23 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 65.05 111.139 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.94 128.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 74.5 110.852 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.673 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.8 p -71.92 -168.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 60.1 110.821 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -89.94 171.65 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.11 110.936 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.721 ' HB2' HD12 ' A' ' 63' ' ' LEU . 95.7 m95 -50.85 -60.77 2.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 74.21 110.96 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.47 159.04 36.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 52.12 110.896 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.56 -34.04 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.51 110.904 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.76 -39.47 77.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.798 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.721 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.1 mt -80.09 -43.83 21.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 73.02 110.939 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.25 -48.53 62.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.152 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.99 -49.43 66.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 72.04 110.931 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.75 -19.48 65.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 74.12 110.967 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.2 tp -88.65 -26.14 22.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 53.43 110.91 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.5 -23.11 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 73.23 111.15 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -92.29 15.54 13.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 61.41 110.872 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.6 ptm -130.5 -39.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 70.41 110.887 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 67' ' ' LEU . 32.7 m -79.76 -23.44 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 61.03 111.109 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.711 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.0 -25.03 66.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.3 110.827 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -104.77 -33.49 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 72.34 110.899 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -45.14 67.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.44 111.012 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.584 ' HB2' HD11 ' A' ' 52' ' ' LEU . 19.8 m-85 -85.21 -12.59 52.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 73.3 110.852 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.5 11.21 7.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.44 110.829 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.93 141.37 50.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.412 . . . . 64.54 110.899 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -85.82 140.55 30.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.55 110.819 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.711 HG22 ' HB3' ' A' ' 52' ' ' LEU . 87.4 t -82.04 125.01 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -140.89 12.11 2.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 75.1 111.13 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.539 ' N ' HG23 ' A' ' 103' ' ' ILE . 61.1 m-20 -152.48 146.12 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.849 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 54' ' ' LEU . 15.7 t -154.29 131.27 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.22 111.169 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.58 HD13 HG11 ' A' ' 140' ' ' VAL . 5.5 mt -92.68 126.75 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 62.01 111.082 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mm -101.85 150.42 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 54.12 111.16 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -45.43 3.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 61.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.643 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -149.32 175.76 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 73.4 110.872 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -98.27 87.07 3.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 72.03 111.047 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -143.73 156.23 44.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 70.31 110.897 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.79 -21.32 27.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 54.12 111.018 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.55 18.02 10.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 54.14 110.828 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -137.87 -76.52 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 63.32 110.796 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -92.5 7.42 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.32 111.072 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.68 -39.76 39.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 51.41 112.534 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.21 15.92 58.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.659 -0.781 . . . . 71.23 112.402 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.3 tt -57.14 -28.61 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 73.13 111.147 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -55.89 -30.22 61.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.939 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -88.87 -17.5 29.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 74.11 111.132 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 57' ' ' SER . 11.5 mt -88.5 -28.63 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 74.35 110.913 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -92.34 7.89 40.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.14 110.917 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -106.86 -55.27 2.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 70.13 110.917 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -63.97 -57.11 10.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 74.41 110.807 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.0 39.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.674 -0.774 . . . . 73.44 112.384 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.634 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.3 mp -104.99 126.56 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 71.13 111.095 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.534 ' HB3' HD11 ' A' ' 124' ' ' LEU . 5.3 mttm -86.05 117.59 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 70.53 110.94 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.27 94.95 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 70.33 111.127 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.583 ' HA ' HD12 ' A' ' 124' ' ' LEU . 41.3 m-70 -66.58 146.07 54.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 61.22 110.907 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.541 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -179.97 176.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 53.55 110.938 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -86.73 154.06 21.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 65.41 111.091 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.4 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 61.43 111.028 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.737 HD23 ' OD1' ' A' ' 152' ' ' ASP . 56.0 tp -67.25 -43.73 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.429 . . . . 74.54 110.861 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.699 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.0 m -59.65 -18.4 41.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 63.32 111.17 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -102.7 10.22 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.42 111.036 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.722 ' HG2' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.23 -27.31 8.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 54.52 110.917 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.699 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -99.14 -7.44 26.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 64.3 110.927 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.38 -38.39 63.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.01 111.068 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -26.84 61.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.862 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -58.74 -33.52 70.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.916 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -88.07 -21.35 24.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 75.12 110.93 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.36 5.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 75.01 112.466 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.38 175.2 6.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 74.11 110.9 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.555 ' HB2' HD13 ' A' ' 95' ' ' ILE . 78.3 mm-40 -74.17 -176.2 2.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.513 . . . . 52.2 110.933 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.8 OUTLIER -117.44 106.93 45.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 54.42 110.853 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.591 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.82 178.4 4.65 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 71.34 112.273 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' ' 106' ' ' HIS . 16.4 mt -51.78 -42.92 62.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 62.4 110.972 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.31 27.57 24.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.735 -0.745 . . . . 62.51 112.519 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -108.1 43.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 72.33 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.637 HD22 HD21 ' A' ' 133' ' ' LEU . 83.7 mt -126.86 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 72.35 110.918 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -150.47 -172.05 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.941 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.866 HG22 HG23 ' A' ' 130' ' ' VAL . 55.5 m -50.9 -70.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 72.0 111.083 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.866 HG23 HG22 ' A' ' 129' ' ' THR . 33.2 t -117.39 102.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 72.3 111.071 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t -132.45 174.7 9.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 64.43 111.106 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -120.96 134.44 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.903 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.637 HD21 HD22 ' A' ' 127' ' ' LEU . 26.4 mt -115.16 160.21 19.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 64.41 110.903 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -142.6 124.62 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 72.23 110.91 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.57 ' HE2' HD11 ' A' ' 83' ' ' ILE . 16.5 m-85 -125.1 44.36 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 75.35 110.868 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.1 94.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.741 . . . . 51.52 112.45 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 m120 66.22 12.94 8.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.748 0.309 . . . . 74.05 110.91 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.443 ' HB2' HG22 ' A' ' 48' ' ' THR . 53.5 tpp -135.74 109.8 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 74.05 110.777 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.81 133.34 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.886 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.705 HG22 HD21 ' A' ' 158' ' ' LEU . 20.0 t -138.79 115.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 54.44 111.122 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.6 129.98 55.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 72.1 110.844 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 p -86.8 -179.13 6.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 61.13 111.204 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.515 ' HD1' HG22 ' A' ' 130' ' ' VAL . 23.3 t80 -164.35 134.05 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.882 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.717 ' HB3' HG23 ' A' ' 129' ' ' THR . 12.6 t80 -121.83 89.79 48.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.647 0.737 . . . . 75.31 110.936 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.78 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.73 2.286 . . . . 72.32 112.338 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 125.99 -160.91 20.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 70.12 112.553 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -79.33 134.83 36.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.903 0.383 . . . . 72.32 110.829 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.17 -89.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.559 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -74.26 -27.8 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.43 110.83 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 86' ' ' HIS . 19.2 p -145.68 -159.96 1.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 71.34 111.091 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -86.79 -23.0 25.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 74.44 110.924 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.737 ' OD1' HD23 ' A' ' 110' ' ' LEU . 8.1 t0 -136.74 20.34 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 75.23 110.876 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.604 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.1 OUTLIER -51.8 129.88 27.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 51.21 110.926 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.592 HG22 ' CD1' ' A' ' 144' ' ' TYR . 14.5 pt -134.99 179.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 74.21 111.111 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 143' ' ' PHE . 5.6 m -129.24 152.06 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 65.04 111.101 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.8 t -103.21 119.18 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 50.5 111.144 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -107.62 138.09 44.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 74.02 110.9 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.705 HD21 HG22 ' A' ' 140' ' ' VAL . 32.3 mt -119.26 98.7 50.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.678 0.752 . . . . 65.31 110.911 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.89 -4.72 14.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.763 2.308 . . . . 73.32 112.312 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -85.39 -22.4 28.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.32 110.886 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.64 12.41 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 70.15 110.958 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.1 26.25 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 71.13 110.905 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 21' ' ' LEU . 99.4 mt -90.87 142.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 71.52 111.12 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.22 155.94 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 72.31 110.921 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.26 74.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.24 111.181 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.7 -39.49 46.59 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 75.31 112.547 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.44 -159.42 41.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.684 -0.77 . . . . 53.43 112.482 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 74.6 m -54.68 -38.37 66.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 74.52 110.83 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.731 HD12 ' NE1' ' A' ' 189' ' ' TRP . 24.2 tp -51.26 -33.49 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.3 110.937 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 218' ' ' LEU . 39.7 t -107.97 108.05 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 54.04 111.066 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.566 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -51.46 163.1 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.86 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.456 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -103.21 167.56 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 61.34 110.827 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.13 111.208 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.856 0.36 . . . . 74.5 111.108 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.77 88.19 2.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 65.41 110.981 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 21.1 t -63.0 -15.69 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 55.45 111.146 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.4 -22.14 52.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 64.04 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -118.42 -11.39 10.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 75.55 110.867 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.731 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.5 t90 -55.09 -60.91 2.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.959 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.649 ' HB3' HD11 ' A' ' 226' ' ' LEU . 1.7 p -53.8 -24.66 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.997 0.427 . . . . 73.51 110.927 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -81.58 -31.44 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 62.41 111.129 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -43.17 58.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 71.34 110.851 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.552 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.2 mm -61.58 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 65.33 111.133 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.31 -27.22 54.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 61.41 110.945 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -77.17 -22.19 52.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 71.34 110.891 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.26 -11.04 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 41.13 111.194 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.72 -12.09 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 70.32 110.883 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -31.03 11.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 72.13 110.888 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -59.41 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 75.21 110.907 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.452 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -91.83 62.5 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.966 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -72.78 -60.22 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 73.4 110.858 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -52.03 102.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 70.55 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.641 HG21 ' CG2' ' A' ' 206' ' ' VAL . 75.0 mt -141.21 116.93 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 62.33 111.209 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.06 -26.77 63.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.924 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.98 134.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 62.1 111.091 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.726 ' HB ' HD12 ' A' ' 218' ' ' LEU . 95.2 t -106.87 144.9 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 71.23 111.166 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 213' ' ' VAL . 14.2 t -117.84 104.77 48.56 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.594 0.711 . . . . 45.2 111.138 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -177.7 2.01 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.756 2.304 . . . . 62.32 112.322 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.3 -12.1 65.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.843 -0.694 . . . . 12.1 112.461 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -153.35 140.62 19.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.871 0.367 . . . . 71.43 110.83 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.32 -99.27 1.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 40.5 112.579 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.76 157.35 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.893 0.378 . . . . 72.43 110.882 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 207' ' ' VAL . 5.2 m -54.73 162.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 74.32 111.134 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.65 -95.03 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.73 -0.747 . . . . 72.04 112.463 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -168.34 -169.01 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 72.14 110.842 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.487 ' HA ' HD23 ' A' ' 219' ' ' LEU . 19.9 pttt -61.02 -18.09 55.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.858 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.72 -21.45 36.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 24.13 112.501 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.726 HD12 ' HB ' ' A' ' 206' ' ' VAL . 8.0 mt -71.25 -28.24 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 71.23 110.937 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.552 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.8 mm? -66.98 -59.61 3.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 63.15 110.877 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -17.32 55.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.422 . . . . 72.12 110.975 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -69.04 -46.8 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 74.14 110.894 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.824 HG22 HD23 ' A' ' 226' ' ' LEU . 19.6 m -51.73 -52.31 49.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.176 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.98 -18.47 46.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 72.41 110.941 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.88 -5.7 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 65.35 110.894 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 171' ' ' LYS . 7.6 mt -128.42 -5.4 5.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 55.03 110.874 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.824 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -117.5 -4.6 11.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 65.14 110.844 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.12 110.901 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.0 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.795 0.331 . . . . 75.0 111.082 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -135.88 92.66 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 71.13 111.096 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -112.73 115.01 27.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 63.31 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -58.22 169.47 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 51.35 110.815 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.46 -48.31 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 72.15 110.93 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -61.35 -37.42 83.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 75.11 111.114 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.43 61.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 75.43 112.43 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.3 m -79.56 -44.82 20.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 52.42 111.144 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -101.6 113.0 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.43 111.083 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 p -120.82 127.58 52.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.843 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.663 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -121.52 112.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 72.14 111.116 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.408 ' HA ' HG12 ' A' ' 8' ' ' VAL . 14.4 t -99.82 127.1 46.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.35 110.875 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -70.23 110.93 5.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 52.33 110.917 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 213' ' ' VAL . 15.5 mt -64.2 -31.74 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 64.41 110.878 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.93 -97.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.908 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -150.64 9.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 74.22 110.87 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.28 7.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 72.21 110.904 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.9 141.71 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 35.41 111.171 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.663 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.1 m95 -129.44 -177.25 4.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.967 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.478 HG23 ' HG ' ' A' ' 21' ' ' LEU . 85.9 t -133.83 91.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 75.01 111.134 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.425 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.7 p80 -74.1 123.78 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.894 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.5 m -120.02 105.87 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.42 111.143 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.01 122.43 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.894 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 116.88 28.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 55.52 110.967 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 43.41 112.514 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.588 0.709 . . . . 74.21 111.169 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 115.89 4.31 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.663 2.242 . . . . 62.05 112.342 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -103.0 98.16 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 73.12 110.829 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -59.19 163.75 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.816 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -153.81 -148.12 4.84 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.705 -0.759 . . . . 72.22 112.507 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.655 HD21 HD12 ' A' ' 158' ' ' LEU . 19.4 tp -159.08 115.2 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 74.42 110.949 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.675 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.67 122.27 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 62.4 111.108 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.466 HD12 ' HB ' ' A' ' 53' ' ' VAL . 12.3 mt -101.03 120.51 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 53.31 110.953 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -91.26 85.42 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 74.31 110.892 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -171.95 2.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 75.23 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.42 -15.06 14.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.862 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -5.77 43.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 74.11 110.864 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.13 8.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 72.13 112.439 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.0 tp -73.74 155.44 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.389 . . . . 61.44 110.932 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.6 t -143.07 138.14 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 70.2 111.128 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.675 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -136.05 123.46 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 70.12 110.904 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.96 114.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 55.31 111.142 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.54 127.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 73.02 110.827 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.655 ' CB ' HD11 ' A' ' 98' ' ' LEU . 3.4 p -72.35 -166.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 43.32 110.859 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -91.68 168.52 11.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 70.03 110.886 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.711 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.9 m95 -48.92 -60.31 2.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 72.12 110.863 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -129.57 159.51 36.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.32 110.751 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -50.91 -32.29 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 74.31 110.941 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -58.29 -46.66 85.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 75.34 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.3 mt -74.38 -43.14 57.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 63.53 110.908 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.19 -49.54 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 63.53 111.128 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -53.43 -48.38 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.1 110.956 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -65.09 -18.92 65.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 71' ' ' VAL . 19.5 tp -89.78 -26.82 20.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 74.31 110.892 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.9 mt -90.67 -22.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 74.54 111.222 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -92.56 16.25 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 55.34 110.907 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.9 ptm -131.35 -40.3 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.9 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.6 m -80.56 -22.06 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.5 111.213 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.12 -23.08 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 70.13 110.919 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -107.75 -33.01 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 60.3 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 -40.41 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.924 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.25 -10.22 42.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.52 110.952 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.12 12.49 8.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 72.4 110.886 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HB2' HD13 ' A' ' 52' ' ' LEU . 1.4 mttp -131.25 138.44 49.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 40.14 110.963 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.65 136.75 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.907 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG21 HD11 ' A' ' 54' ' ' LEU . 75.8 t -74.0 134.66 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 72.44 111.127 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.9 t -155.24 20.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.125 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.565 ' O ' HG13 ' A' ' 53' ' ' VAL . 4.0 m-20 -164.72 138.46 5.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.873 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -151.71 160.19 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 73.24 111.204 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.525 HG21 HG22 ' A' ' 156' ' ' VAL . 5.8 mt -116.42 135.43 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.137 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.54 121.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 65.41 111.104 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.1 p -78.45 -33.27 48.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.3 111.115 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.581 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.3 p-80 -167.95 -174.89 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.32 110.931 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.585 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -98.89 97.69 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 74.42 111.047 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -156.77 155.25 31.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 72.04 110.903 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.11 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 73.13 111.129 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.45 26.35 3.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 73.1 110.792 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.48 -74.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.848 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -95.09 8.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 64.42 111.121 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.14 -39.8 27.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.684 -0.77 . . . . 52.41 112.612 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.81 12.95 56.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.506 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.5 tt -54.38 -27.97 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 62.11 111.128 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -56.66 -35.62 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 61.44 110.87 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.3 m -85.12 -22.57 28.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 63.41 111.114 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.751 ' HA ' HD13 ' A' ' 103' ' ' ILE . 14.3 mt -80.92 -30.19 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 73.2 110.95 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.91 21.9 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.34 110.909 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.86 -41.56 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.912 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -80.07 -50.1 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 71.31 110.912 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.09 39.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.795 -0.716 . . . . 62.43 112.525 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.751 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -101.77 126.19 55.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.894 0.378 . . . . 65.32 111.127 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -85.89 112.35 21.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.2 110.904 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.67 100.73 12.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.44 111.058 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.446 ' HA ' HD12 ' A' ' 124' ' ' LEU . 61.1 m-70 -71.61 132.33 44.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 70.35 110.858 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -160.5 166.13 29.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 70.25 110.961 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.98 156.75 24.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.158 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.31 -40.53 35.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 63.22 111.114 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.72 -40.88 72.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 72.32 110.982 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 98.6 m -58.55 -20.96 50.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.107 -0.497 . . . . 73.33 111.097 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.411 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -100.43 8.08 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 74.33 111.105 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -108.4 -31.98 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 71.13 110.849 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -96.1 -11.42 26.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.15 110.984 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.411 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.42 -37.58 77.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 23.12 111.049 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.67 60.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 63.52 110.904 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -57.18 -33.28 67.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.14 110.848 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -89.85 -23.43 21.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.901 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.44 23.82 4.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 75.42 112.464 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -98.04 172.63 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 74.14 110.906 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.0 170.58 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 71.21 110.878 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -101.94 108.63 57.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.581 0.705 . . . . 75.34 110.881 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.6 Cg_endo -69.69 -176.58 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.701 2.268 . . . . 71.14 112.362 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 106' ' ' HIS . 9.8 mt -51.29 -42.56 61.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.869 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 27.58 23.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 34.02 112.458 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.03 26.1 11.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.891 0.377 . . . . 50.43 110.923 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 107' ' ' SER . 63.8 mt -103.87 -175.48 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 65.32 110.861 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -156.69 -172.86 4.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 72.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.889 HG22 HG23 ' A' ' 130' ' ' VAL . 54.2 m -51.02 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 72.15 111.096 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.889 HG23 HG22 ' A' ' 129' ' ' THR . 44.4 t -117.62 104.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 71.2 111.134 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.506 HG22 ' OG1' ' A' ' 142' ' ' THR . 14.1 t -127.76 160.47 31.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.16 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.34 107.3 13.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.881 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.17 -172.7 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 64.44 110.905 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -176.15 112.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.3 110.871 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -106.73 74.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.031 0.444 . . . . 73.21 110.898 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.21 -86.91 0.18 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.749 . . . . 65.02 112.476 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -114.95 24.95 11.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 75.11 110.881 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.1 tpp -132.82 142.6 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 61.25 110.898 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.42 130.17 55.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 64.51 110.835 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.652 HG22 HD21 ' A' ' 158' ' ' LEU . 13.8 t -139.87 120.2 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 72.33 111.165 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -113.85 130.63 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 65.55 110.801 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.506 ' OG1' HG22 ' A' ' 131' ' ' THR . 18.2 p -88.28 171.18 10.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 73.1 111.105 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.478 ' HB3' HG23 ' A' ' 155' ' ' VAL . 29.9 t80 -156.58 138.76 14.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 64.04 110.885 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.675 ' HB3' HG23 ' A' ' 129' ' ' THR . 74.3 t80 -125.59 89.7 51.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.627 0.727 . . . . 73.13 110.842 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -7.89 22.21 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.599 2.199 . . . . 65.2 112.352 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.26 -154.31 20.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.866 -0.683 . . . . 74.34 112.548 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -90.01 139.96 30.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 72.3 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.52 -87.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 34.1 112.481 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -77.06 -25.93 52.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 55.54 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 86' ' ' HIS . 23.1 p -146.47 -161.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 70.23 111.193 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.477 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.9 tt0 -90.1 -17.72 27.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.911 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 154' ' ' ILE . 18.5 t0 -135.26 17.42 3.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 72.04 110.835 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.51 ' ND2' HD13 ' A' ' 169' ' ' LEU . 6.5 p-10 -49.07 129.77 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 71.33 110.854 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 152' ' ' ASP . 10.9 pt -135.3 -177.77 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 74.33 111.127 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 143' ' ' PHE . 6.9 m -136.24 133.4 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 31.32 111.095 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.525 HG22 HG21 ' A' ' 83' ' ' ILE . 58.3 t -85.59 114.2 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 51.15 111.225 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -102.45 133.82 46.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 74.1 110.89 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.655 HD12 HD21 ' A' ' 44' ' ' LEU . 15.8 mt -113.59 97.76 44.87 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.575 0.702 . . . . 74.35 110.903 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.0 Cg_endo -69.79 -4.11 13.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.719 2.279 . . . . 71.44 112.347 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -85.18 -23.28 28.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 71.42 110.967 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -142.04 13.01 2.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.41 110.954 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.37 27.42 8.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.882 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.654 HD13 HD13 ' A' ' 21' ' ' LEU . 96.8 mt -93.13 124.67 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.462 . . . . 73.52 111.176 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 203' ' ' ILE . 20.7 tp -106.08 146.97 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 54.13 110.884 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.15 80.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.44 111.115 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.53 -40.48 47.29 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.38 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 68.89 -165.09 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.799 -0.715 . . . . 54.41 112.505 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -27.45 25.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 61.33 110.916 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.625 HD12 ' NE1' ' A' ' 189' ' ' TRP . 23.3 tp -57.25 -61.14 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 62.13 110.826 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.562 HG13 ' HA ' ' A' ' 219' ' ' LEU . 35.1 t -75.28 112.38 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.43 111.054 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.537 ' HG2' HG23 ' A' ' 222' ' ' THR . 2.8 mmpt? -54.0 151.15 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 63.33 110.839 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.8 p -99.74 157.28 16.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 74.01 110.85 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 60.54 111.164 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.814 0.34 . . . . 32.35 111.106 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -107.44 86.79 2.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.931 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 24.0 t -61.16 -17.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 72.1 111.114 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -74.27 -25.91 59.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.958 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.66 -11.97 13.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 65.34 110.954 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.625 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.6 t90 -54.37 -61.7 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 72.44 110.972 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.703 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.95 -24.29 16.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.855 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.92 -32.34 30.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.18 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.59 -43.31 63.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.882 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.528 HG21 ' O ' ' A' ' 219' ' ' LEU . 29.8 mm -62.15 -43.94 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 62.12 111.104 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.07 -24.07 62.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 64.52 110.956 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.31 -21.56 36.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.844 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 192' ' ' SER . 11.3 t -88.13 -8.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 74.13 111.1 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.42 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.36 -8.21 13.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.941 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -104.57 -30.93 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -104.31 -48.93 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 74.31 110.873 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -102.13 39.44 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 61.44 111.008 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.79 -47.9 76.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.502 . . . . 72.14 110.867 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -60.31 99.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.03 110.863 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.636 HG21 HG22 ' A' ' 206' ' ' VAL . 55.8 mt -140.16 123.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.047 -0.524 . . . . 64.41 111.107 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.94 -16.0 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.915 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.734 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -173.58 132.69 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 71.11 111.048 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.708 ' HB ' HD12 ' A' ' 218' ' ' LEU . 84.6 t -111.9 128.62 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 61.11 111.179 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 213' ' ' VAL . 19.6 t -108.43 104.12 53.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.644 0.735 . . . . 72.31 111.083 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.506 ' HD3' HD13 ' A' ' 218' ' ' LEU . 52.9 Cg_endo -69.82 -169.54 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.274 . . . . 71.44 112.32 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.47 -15.5 66.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.701 -0.761 . . . . 45.21 112.476 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -152.01 139.72 19.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.976 0.417 . . . . 75.21 110.803 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 109.52 -117.29 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.812 -0.709 . . . . 53.41 112.543 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.65 173.44 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 75.11 110.897 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 207' ' ' VAL . 6.1 t -70.5 144.85 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 71.32 111.154 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.66 -93.32 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.671 -0.775 . . . . 73.1 112.474 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -172.13 -167.17 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 72.54 110.899 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -19.37 38.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 61.21 110.864 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.72 -23.14 20.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.695 -0.764 . . . . 65.01 112.534 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 206' ' ' VAL . 7.0 mt -76.87 -32.68 57.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.318 . . . . 65.41 110.882 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.562 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.6 mp -61.12 -61.98 2.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.898 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.19 -22.24 60.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.939 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -62.0 -44.69 96.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.901 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.576 ' C ' HD23 ' A' ' 226' ' ' LEU . 2.2 m -51.45 -53.97 31.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 63.22 111.12 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.415 HD23 ' HB3' ' A' ' 190' ' ' SER . 1.2 mt -60.28 -18.72 51.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 72.34 110.902 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 70.11 110.88 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.483 HD12 ' HG3' ' A' ' 171' ' ' LYS . 9.7 mt -126.01 -6.37 6.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.03 110.938 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.703 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -119.83 9.72 11.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 65.1 110.951 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 62.0 110.896 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.818 0.342 . . . . 75.22 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -136.38 94.41 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 63.53 111.131 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -112.53 115.26 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.919 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -57.64 167.88 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 64.41 110.894 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -51.71 -48.08 63.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.859 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.74 -37.84 83.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.103 -0.498 . . . . 74.31 111.158 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.16 60.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.784 -0.722 . . . . 30.54 112.528 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 31' ' ' LEU . 49.3 m -80.92 -43.53 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 61.03 111.126 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.48 118.42 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 64.21 111.115 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 p -124.02 131.37 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.749 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -123.96 110.4 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 42.13 111.14 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -100.6 123.69 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 74.12 110.872 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -68.15 110.98 4.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 52.31 110.893 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.77 HD21 HG11 ' A' ' 213' ' ' VAL . 14.8 mt -65.75 -31.83 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 63.3 110.818 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.02 -97.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 72.31 110.894 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 10.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 71.24 110.922 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.59 6.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.54 110.806 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -151.0 139.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 62.02 111.108 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.8 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.1 m95 -127.44 -173.99 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.937 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 43' ' ' GLY . 94.2 t -137.27 97.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 74.44 111.092 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -81.47 121.36 26.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 70.53 110.888 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.2 m -116.19 92.27 3.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 72.11 111.136 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -72.97 117.6 14.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 71.25 110.85 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.752 HD12 ' HB3' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -88.34 111.49 21.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.898 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 55.42 112.458 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 121.656 0.741 . . . . 75.24 111.084 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.752 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.2 Cg_endo -69.74 118.27 5.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.581 2.187 . . . . 75.11 112.395 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -103.54 100.68 10.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 63.23 110.852 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.414 HD21 ' N ' ' A' ' 212' ' ' GLU . 16.3 m-20 -49.36 162.4 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 52.24 110.885 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.598 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.48 -166.8 17.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 33.14 112.477 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.595 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.7 tp -153.12 113.27 3.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 72.03 110.903 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 54' ' ' LEU . 1.9 t -97.59 117.98 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 74.44 111.049 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.4 HD22 ' SD ' ' A' ' 138' ' ' MET . 24.7 mt -95.9 122.74 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 62.01 110.918 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -91.03 84.41 5.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 53.2 110.853 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.0 OUTLIER -101.55 178.87 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 43.4 111.189 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.82 -26.66 14.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 71.11 110.837 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -18.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 64.33 110.864 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.79 151.33 5.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 35.51 112.476 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 75' ' ' PHE . 2.5 mt -62.0 153.72 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 73.25 110.923 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.644 HG13 ' CB ' ' A' ' 81' ' ' ASP . 2.2 t -143.56 139.73 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 74.11 111.139 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -136.1 122.92 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.918 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.497 HG12 ' OD1' ' A' ' 56' ' ' ASP . 78.5 t -69.11 111.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 53.42 111.104 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.622 ' OD2' HG23 ' A' ' 85' ' ' THR . 1.6 m-20 72.98 125.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 70.53 110.905 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.656 ' CB ' HD11 ' A' ' 98' ' ' LEU . 2.7 p -69.6 -166.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 44.43 110.819 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -90.96 168.45 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 61.42 110.906 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.687 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.4 m95 -50.71 -60.42 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 74.13 110.945 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -126.03 160.87 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 62.33 110.806 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -53.63 -37.82 63.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 61.04 110.884 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.94 -37.52 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 72.14 110.878 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.4 mt -80.28 -43.55 21.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 41.44 110.91 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.58 62.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 64.24 111.125 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -52.71 -48.37 66.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 63.42 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.95 -18.79 65.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 71.31 110.835 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 71' ' ' VAL . 19.1 tp -89.43 -25.45 21.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 65.23 110.879 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.414 HG23 ' OE1' ' A' ' 72' ' ' GLU . 71.3 mt -91.93 -24.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.23 111.057 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.87 12.36 19.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 74.02 110.911 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ptm -127.48 -39.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 61.54 110.923 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 67' ' ' LEU . 14.6 m -79.84 -22.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 63.35 111.115 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -70.38 -22.69 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 65.35 110.949 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -107.41 -31.08 8.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 71.23 110.826 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -73.15 -44.68 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 52.24 110.951 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.638 ' HB2' HD11 ' A' ' 52' ' ' LEU . 22.8 m-85 -85.95 -13.11 48.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.873 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.72 15.35 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.936 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 139.5 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 65.22 111.002 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -77.76 139.21 39.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 71.55 110.937 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.39 134.67 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 50.12 111.137 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 t -160.37 20.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 70.31 111.124 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.654 ' N ' HG23 ' A' ' 103' ' ' ILE . 48.4 m-20 -155.37 143.6 20.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 65.55 110.902 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 81' ' ' ASP . 6.7 t -156.84 105.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 65.22 111.076 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.716 ' CD1' HG11 ' A' ' 140' ' ' VAL . 68.8 mt -71.11 121.27 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 72.33 111.144 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mm -94.36 149.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 73.44 111.17 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.622 HG23 ' OD2' ' A' ' 56' ' ' ASP . 29.6 p -108.44 -42.12 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.13 111.15 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.545 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.8 p80 -164.54 -175.17 3.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 62.31 110.823 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.851 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.19 98.4 11.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 62.51 111.052 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.81 153.81 32.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 62.54 110.868 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.19 -19.98 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 54.01 111.124 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -91.81 4.48 52.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 55.13 110.844 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.412 ' HD3' ' CE1' ' A' ' 86' ' ' HIS . 3.7 mpt_? -120.69 -78.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.02 110.932 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.417 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -90.78 7.08 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 73.1 111.176 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.36 -41.47 48.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 32.33 112.539 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.15 13.21 60.36 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.734 -0.746 . . . . 52.34 112.491 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 121' ' ' GLU . 16.8 tt -54.79 -26.39 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 73.53 111.144 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -54.54 -35.35 63.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 73.35 110.932 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.6 m -88.92 -12.86 40.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 63.25 111.159 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.656 HD11 ' CB ' ' A' ' 57' ' ' SER . 18.3 mt -88.56 -35.86 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 74.13 110.95 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -84.24 2.67 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 74.42 110.912 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.68 -51.07 3.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.31 110.842 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -69.83 -59.91 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.2 110.835 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.87 43.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.722 . . . . 54.44 112.557 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.654 HG23 ' N ' ' A' ' 81' ' ' ASP . 4.3 mp -103.34 120.31 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 65.24 111.147 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.738 ' HE2' HD21 ' A' ' 124' ' ' LEU . 4.6 mttt -73.2 114.39 11.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 54.0 110.858 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.06 85.58 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 44.05 111.1 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.579 ' HB3' HD11 ' A' ' 127' ' ' LEU . 85.8 m-70 -56.92 144.54 33.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.785 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.6 169.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 44.22 110.89 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.77 157.34 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 61.25 111.122 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.87 -40.41 29.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 73.3 111.062 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.464 HD22 ' CD ' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -64.14 -47.54 79.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 72.53 110.937 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.784 ' HA ' HD11 ' A' ' 114' ' ' LEU . 52.3 m -58.63 -20.73 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 40.42 111.094 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -99.76 12.39 36.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 73.3 111.191 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.464 ' CD ' HD22 ' A' ' 110' ' ' LEU . 3.1 pt-20 -114.97 -31.74 5.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 73.13 110.934 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.851 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -95.68 -13.87 23.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 74.3 110.866 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.462 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.04 -37.44 78.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.971 0.415 . . . . 65.22 111.133 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -20.86 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 63.45 110.956 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.01 -32.43 74.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.826 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -90.25 -18.22 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 72.33 110.865 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.67 27.2 5.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 61.21 112.45 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.34 173.95 6.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 74.32 110.923 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.493 ' HB2' HD13 ' A' ' 95' ' ' ILE . 80.1 mm-40 -80.35 160.56 25.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 71.23 110.883 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.1 mp0 -92.71 111.85 52.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.713 0.768 . . . . 74.31 110.954 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.5 Cg_endo -69.72 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 61.33 112.393 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.738 HD21 ' HE2' ' A' ' 104' ' ' LYS . 13.8 mt -51.68 -45.54 63.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 65.34 110.885 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.49 34.94 43.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 72.32 112.527 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.12 36.26 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.827 0.346 . . . . 70.35 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 106' ' ' HIS . 47.6 mt -120.07 -172.34 2.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.848 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.75 -171.84 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 64.1 110.921 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.915 HG22 HG23 ' A' ' 130' ' ' VAL . 46.0 m -50.56 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 72.23 111.121 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.915 HG23 HG22 ' A' ' 129' ' ' THR . 44.0 t -119.39 103.88 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 63.53 111.131 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 t -135.37 175.63 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 71.14 111.193 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -120.34 131.36 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.849 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.523 HD21 HD22 ' A' ' 127' ' ' LEU . 31.4 mt -109.07 152.2 25.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.882 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -130.74 125.36 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 73.03 110.918 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.523 ' HE2' HD11 ' A' ' 83' ' ' ILE . 10.3 m-85 -129.0 26.53 5.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.867 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.28 95.67 0.21 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 44.03 112.536 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 66.07 13.09 8.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.735 0.303 . . . . 74.24 110.882 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.469 ' HB2' HG22 ' A' ' 48' ' ' THR . 52.9 tpp -133.71 106.29 7.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 75.21 110.97 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.98 127.43 37.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 74.25 110.87 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.716 HG11 ' CD1' ' A' ' 83' ' ' ILE . 18.2 t -138.69 113.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 61.22 111.142 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -109.74 131.41 55.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.798 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.7 p -85.09 178.65 7.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 71.02 111.189 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.485 ' HD1' HG22 ' A' ' 130' ' ' VAL . 19.9 t80 -161.05 133.27 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 73.44 110.843 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.692 ' HB3' HG23 ' A' ' 129' ' ' THR . 8.5 t80 -122.82 86.45 50.15 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.699 0.761 . . . . 71.33 110.94 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -7.99 22.45 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.757 2.305 . . . . 51.41 112.373 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.39 -160.06 23.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.74 . . . . 54.43 112.536 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -87.61 140.63 29.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 74.14 110.924 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -155.66 -88.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 74.11 112.435 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -76.95 -22.97 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.31 110.815 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.545 HG21 ' HB2' ' A' ' 86' ' ' HIS . 81.4 p -151.18 -168.85 3.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 74.23 111.183 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.571 ' HB3' HD23 ' A' ' 114' ' ' LEU . 43.6 tt0 -86.09 -5.53 59.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 72.52 110.902 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 154' ' ' ILE . 48.5 t0 -147.07 16.47 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 54.4 110.857 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.661 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -49.33 127.38 14.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' ASP . 4.8 pt -133.72 175.06 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 65.04 111.123 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 143' ' ' PHE . 14.6 m -129.33 119.74 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 73.3 111.105 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.61 120.26 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 71.02 111.141 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -108.45 136.55 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.11 110.929 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.644 ' CD2' HG22 ' A' ' 140' ' ' VAL . 71.6 mt -118.59 98.64 51.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 63.23 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.1 Cg_endo -69.79 -3.87 12.91 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.635 2.223 . . . . 64.44 112.322 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -86.53 -23.42 25.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 74.02 110.86 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -139.35 11.13 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 75.23 110.968 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.4 m120 55.2 25.79 7.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 73.31 110.818 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 21' ' ' LEU . 87.6 mt -90.8 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 75.41 111.086 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 203' ' ' ILE . 15.1 tp -126.14 146.53 49.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 72.32 110.925 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.478 HG11 HG11 ' A' ' 55' ' ' VAL . 48.8 t -112.02 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 62.12 111.163 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.81 -29.45 26.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.771 -0.728 . . . . 60.13 112.458 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.95 -160.13 12.51 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.694 -0.765 . . . . 42.13 112.422 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -26.66 65.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 72.24 110.896 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.661 HD13 ' OD1' ' A' ' 153' ' ' ASN . 21.5 tp -58.15 -35.67 71.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 71.24 110.843 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.66 111.78 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 63.44 111.132 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.549 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.4 mmpt? -51.79 164.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 53.2 110.904 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.2 p -103.18 163.47 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 72.42 110.836 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.52 111.093 -179.866 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.759 0.314 . . . . 43.12 111.133 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -119.88 91.94 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.928 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 21.9 t -62.8 -16.13 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 53.44 111.09 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -75.53 -22.58 56.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 64.13 110.878 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.67 -13.49 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 73.55 110.915 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.618 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.7 t90 -54.02 -62.46 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 74.41 110.941 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.72 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.81 -23.55 18.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 71.21 110.905 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.2 m -81.3 -31.11 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 72.41 111.164 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -75.51 -43.11 50.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.135 -0.484 . . . . 63.43 110.98 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.517 HG21 ' O ' ' A' ' 219' ' ' LEU . 34.0 mm -62.09 -45.52 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 63.12 111.151 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -57.04 -24.1 51.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 64.21 110.799 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -81.68 -22.28 37.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 64.42 110.941 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 192' ' ' SER . 17.5 t -86.7 -9.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 70.31 111.126 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.69 -6.59 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.924 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.57 -31.15 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.925 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 -55.48 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.55 110.859 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.13 38.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 73.14 110.904 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -56.34 -47.66 78.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 74.31 110.814 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -59.59 99.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.842 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.688 HG21 HG22 ' A' ' 206' ' ' VAL . 50.7 mt -142.61 124.26 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 63.32 111.206 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.84 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 54.23 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.71 133.73 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 74.32 111.107 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.744 ' HB ' HD12 ' A' ' 218' ' ' LEU . 97.6 t -114.56 134.05 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 74.22 111.117 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.034 HG22 HG12 ' A' ' 213' ' ' VAL . 9.6 t -112.82 108.94 53.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.657 0.741 . . . . 72.14 111.146 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.73 -169.82 0.35 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 65.24 112.333 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.42 -17.88 63.44 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 73.24 112.474 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -152.49 151.28 30.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 75.15 110.868 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 102.68 -101.02 2.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 73.54 112.49 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.414 ' N ' HD21 ' A' ' 42' ' ' ASN . 3.3 pt-20 -173.51 161.56 4.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 72.51 110.943 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.034 HG12 HG22 ' A' ' 207' ' ' VAL . 5.9 m -51.85 163.02 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.73 -106.81 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.666 -0.778 . . . . 61.32 112.443 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -169.48 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.34 . . . . 73.03 110.851 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -60.78 -18.25 53.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 62.12 110.878 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.42 -18.72 44.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 73.24 112.472 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.3 mt -71.53 -31.03 66.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 74.41 110.976 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.517 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.1 mm? -64.77 -56.93 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 53.42 110.87 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.618 ' HA ' HD12 ' A' ' 223' ' ' LEU . 0.6 OUTLIER -63.64 -16.3 60.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 71.15 110.785 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.645 ' CE1' HD11 ' A' ' 225' ' ' LEU . 3.0 t-80 -68.36 -41.76 80.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 71.31 110.911 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.904 HG22 HD23 ' A' ' 226' ' ' LEU . 25.4 m -61.16 -50.22 74.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.161 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -63.49 -24.41 67.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 61.51 110.887 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.49 -12.28 60.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.645 HD11 ' CE1' ' A' ' 221' ' ' HIS . 6.9 mt -117.85 -19.5 9.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.895 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.904 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -108.03 0.9 22.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 74.1 110.871 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.893 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.798 0.332 . . . . 64.42 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -113.1 96.48 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 72.12 111.081 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -117.54 115.89 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.916 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -60.54 166.3 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 54.24 110.877 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.68 -48.31 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.885 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.0 p -61.66 -37.5 84.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.47 63.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 72.13 112.541 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.5 m -80.52 -44.2 19.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 71.32 111.131 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 67' ' ' LEU . 25.6 mt -104.63 109.09 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 70.54 111.166 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -115.62 140.28 49.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 71.12 110.893 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.798 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -131.35 110.23 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 73.11 111.127 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -98.31 126.75 43.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 51.4 110.816 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -71.88 110.01 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 75.34 110.914 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.925 HD21 HG21 ' A' ' 213' ' ' VAL . 11.1 mt -64.23 -33.81 76.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 72.22 110.905 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.1 -97.0 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.921 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.34 9.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 64.01 110.926 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.75 7.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.829 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 t -150.96 140.95 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.162 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.798 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.2 m95 -129.19 -176.26 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.927 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 43' ' ' GLY . 90.5 t -134.15 89.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 72.32 111.115 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -73.03 125.24 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.886 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.8 m -121.57 103.49 8.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 71.32 111.076 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.496 ' HG3' HD22 ' A' ' 67' ' ' LEU . 2.4 mm-40 -86.75 118.7 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.15 110.955 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.34 127.9 34.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 72.34 110.931 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 63.35 112.573 179.82 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.632 0.729 . . . . 73.35 111.251 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 121.26 7.96 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.631 2.221 . . . . 73.1 112.422 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.05 96.99 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.86 167.05 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 53.31 110.923 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.83 -146.65 4.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 74.52 112.493 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.577 HD21 HD12 ' A' ' 158' ' ' LEU . 14.1 tp -159.16 120.02 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 71.55 110.927 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.664 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.7 t -103.8 123.0 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.156 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.771 HD21 HD11 ' A' ' 158' ' ' LEU . 16.6 mt -100.54 121.45 41.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 75.0 110.972 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -91.22 85.99 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.13 110.948 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -101.73 -179.87 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 70.51 111.176 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.4 m -99.98 -24.37 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 61.44 110.881 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -19.0 50.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.43 110.874 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.64 145.34 4.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 33.22 112.43 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.728 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.3 mt -58.23 155.04 12.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.921 0.391 . . . . 63.14 110.87 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.1 t -143.62 141.55 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 71.22 111.109 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.664 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -137.1 122.45 19.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 62.31 110.941 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 165' ' ' VAL . 54.2 t -68.16 111.72 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.198 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.5 141.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 74.1 110.843 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.74 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.4 p -83.11 -164.72 0.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 70.15 110.838 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.489 ' H ' HG23 ' A' ' 64' ' ' THR . 17.8 t -96.25 169.78 9.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 65.22 110.8 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.682 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.4 m95 -50.61 -59.24 4.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.925 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.64 163.48 23.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 73.55 110.872 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.21 -37.17 71.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 72.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -57.44 -34.9 69.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.24 110.893 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 59' ' ' TRP . 91.5 mt -81.51 -48.13 12.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.991 0.424 . . . . 73.11 110.864 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.3 -49.06 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 74.41 111.133 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -52.31 -50.73 61.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 73.25 110.899 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.0 -20.62 66.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 72.1 110.959 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.516 ' HB2' HD13 ' A' ' 16' ' ' ILE . 14.3 tp -87.09 -26.02 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 74.44 110.965 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.554 ' HA ' HG22 ' A' ' 71' ' ' VAL . 54.3 mt -92.39 -24.54 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 55.52 111.131 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.14 1.87 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 73.3 110.87 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ptm -119.61 -35.67 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 71.34 110.957 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 68' ' ' ILE . 31.6 m -79.19 -26.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 55.12 111.062 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.94 -21.05 63.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 71.44 110.864 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.37 -32.01 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 72.13 110.837 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -44.02 59.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.914 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.575 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 14.6 m-85 -85.91 -12.85 49.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 62.52 110.944 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.49 11.26 7.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.94 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -129.66 139.17 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.973 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -82.81 139.36 33.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 71.21 110.891 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 52' ' ' LEU . 92.5 t -82.74 121.06 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.2 111.188 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.2 8.14 2.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 61.15 111.118 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 82' ' ' VAL . 48.5 m-20 -147.09 145.2 29.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.185 -0.461 . . . . 54.44 110.91 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 54' ' ' LEU . 4.3 t -156.09 138.41 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 63.31 111.225 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.652 ' CD1' HG11 ' A' ' 140' ' ' VAL . 20.3 mt -94.09 136.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 75.44 111.18 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.056 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.1 mm -100.94 149.47 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 64.33 111.111 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -115.39 -38.4 3.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.162 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -169.93 172.06 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.844 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.622 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -91.11 89.15 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 64.34 111.143 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -148.67 154.97 40.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 73.02 110.895 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.64 -23.5 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 74.52 111.131 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -92.23 27.23 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.25 110.85 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.913 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -152.24 -70.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.928 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.722 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -90.17 3.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 73.23 111.122 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -44.39 54.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 72.2 112.51 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.51 13.97 63.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 74.11 112.526 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.61 HD12 HH22 ' A' ' 91' ' ' ARG . 2.6 tt -57.61 -26.06 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 52.21 111.214 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -55.1 -27.43 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 61.21 110.847 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -95.33 -38.46 10.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 65.21 111.196 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 57' ' ' SER . 14.9 mt -56.22 -46.09 79.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 63.1 110.897 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -0.99 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.4 110.94 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.53 -44.97 8.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.44 110.94 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -79.48 -61.39 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.81 39.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 61.42 112.394 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -101.9 120.3 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.798 0.332 . . . . 74.35 111.164 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.768 ' HD3' HD21 ' A' ' 124' ' ' LEU . 6.2 mttm -78.5 118.02 20.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.868 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 1.056 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -94.35 85.01 4.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.024 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.516 ' HB3' HD11 ' A' ' 127' ' ' LEU . 52.2 m-70 -55.01 110.43 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 74.04 110.849 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 t -139.67 -175.6 4.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.844 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.17 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 64.31 111.03 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.32 -36.75 44.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 61.53 111.062 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.7 HD22 ' OE1' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -68.4 -48.45 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.921 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.8 ' HA ' HD11 ' A' ' 114' ' ' LEU . 47.9 m -59.09 -18.78 38.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 72.22 111.207 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.633 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.37 13.07 36.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 73.35 111.083 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.7 ' OE1' HD22 ' A' ' 110' ' ' LEU . 2.1 pt-20 -115.6 -27.44 7.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.889 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.8 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -101.37 -11.74 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.2 110.879 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.11 69.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 42.43 111.068 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -20.72 60.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 64.24 110.907 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.37 -32.41 73.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 71.12 110.946 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -88.48 -14.86 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.843 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 22.53 7.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.753 -0.737 . . . . 72.11 112.437 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.402 ' CD1' HG12 ' A' ' 92' ' ' ILE . 80.9 m-85 -102.59 170.76 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.9 0.381 . . . . 64.14 110.844 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -72.78 -170.73 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 51.44 110.915 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.58 121.66 29.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.613 0.72 . . . . 73.22 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.633 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.4 Cg_endo -69.86 -169.96 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.692 2.261 . . . . 54.14 112.328 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.768 HD21 ' HD3' ' A' ' 104' ' ' LYS . 6.0 mt -59.5 -39.87 85.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 54.33 110.925 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.69 26.0 30.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.729 -0.748 . . . . 61.21 112.471 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.35 39.97 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 62.43 110.926 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.53 HD22 HD21 ' A' ' 133' ' ' LEU . 85.8 mt -131.62 -172.81 2.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.948 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -157.65 -169.71 2.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 63.33 110.972 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.928 HG22 HG23 ' A' ' 130' ' ' VAL . 33.8 m -48.3 -67.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 73.13 111.199 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.928 HG23 HG22 ' A' ' 129' ' ' THR . 41.7 t -120.53 109.31 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 64.43 111.13 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.499 HG21 HD22 ' A' ' 127' ' ' LEU . 13.2 t -138.68 176.15 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 73.35 111.049 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -122.87 137.39 54.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.53 HD21 HD22 ' A' ' 127' ' ' LEU . 25.2 mt -118.84 151.88 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 63.24 110.914 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.31 126.74 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 65.41 110.92 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.24 34.04 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 73.23 110.909 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.04 94.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 50.22 112.471 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.15 12.48 8.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.857 0.36 . . . . 63.51 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.437 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.5 tpp -134.76 101.11 4.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.147 -0.479 . . . . 75.32 110.878 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -89.34 130.3 35.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.15 110.909 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.735 HG22 HD21 ' A' ' 158' ' ' LEU . 19.6 t -138.41 115.56 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 70.25 111.12 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -110.5 130.15 55.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 65.45 110.872 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.9 p -84.87 -174.13 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 72.34 111.133 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.48 ' HB3' HG23 ' A' ' 155' ' ' VAL . 31.4 t80 -170.1 137.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.914 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.682 ' HB3' HG23 ' A' ' 129' ' ' THR . 89.8 t80 -123.83 89.61 51.36 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.664 0.745 . . . . 64.22 110.89 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.3 Cg_endo -69.82 -8.25 23.12 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.717 2.278 . . . . 73.24 112.302 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.05 -149.11 19.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 74.3 112.566 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -97.11 138.97 33.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 63.15 110.853 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.15 -96.31 0.15 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 61.24 112.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.8 -24.9 63.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 72.4 110.901 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.8 p -152.2 -175.72 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 62.22 111.184 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.64 0.58 52.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 62.13 111.01 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.583 ' HB3' HD12 ' A' ' 110' ' ' LEU . 16.8 p-10 -141.72 12.09 2.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 71.12 110.902 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.81 140.97 28.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 63.14 110.889 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.723 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.8 pt -146.32 -179.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 71.42 111.054 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 143' ' ' PHE . 26.9 m -138.68 124.95 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 74.02 111.128 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.654 ' O ' HD12 ' A' ' 164' ' ' LEU . 95.8 t -82.8 138.92 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 54.12 111.122 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -123.66 130.52 52.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 74.42 110.871 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.771 HD11 HD21 ' A' ' 46' ' ' LEU . 9.3 mt -111.84 98.17 40.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 44.32 110.89 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.3 Cg_endo -69.75 -4.21 13.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.802 2.334 . . . . 73.55 112.282 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -83.53 -23.32 32.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 70.41 110.841 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.27 14.29 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 74.42 110.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.5 m120 53.84 27.22 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.412 HD13 HD13 ' A' ' 21' ' ' LEU . 96.9 mt -91.74 136.56 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.137 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 156' ' ' VAL . 14.4 tp -119.6 144.42 47.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.981 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 55' ' ' VAL . 21.9 t -113.13 76.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 32.33 111.074 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.92 49.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.733 . . . . 73.21 112.511 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.28 -162.56 51.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.74 . . . . 50.11 112.525 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 61.0 m -51.74 -29.64 19.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 62.54 110.815 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.627 HD12 ' NE1' ' A' ' 189' ' ' TRP . 25.4 tp -55.2 -53.96 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 74.13 110.889 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 219' ' ' LEU . 47.6 t -83.39 114.68 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 50.33 111.128 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.429 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.6 mmpt? -57.08 149.79 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.977 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.1 p -95.14 158.56 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 64.22 110.978 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.2 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.807 0.337 . . . . 73.14 111.152 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -106.59 86.26 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 74.13 110.936 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.37 -18.66 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 73.12 111.099 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -72.51 -29.27 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.861 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -108.87 -13.78 14.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.862 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.627 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.5 t90 -53.59 -62.23 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.123 -0.489 . . . . 72.41 110.999 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.717 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.56 -24.01 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.43 . . . . 73.42 110.862 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.0 m -81.73 -31.57 31.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 52.52 111.139 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -74.18 -45.4 48.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.865 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mm -58.35 -46.62 89.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 64.43 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.68 -29.36 62.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 71.02 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.28 -20.35 55.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 72.14 110.873 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 192' ' ' SER . 38.3 t -87.58 -12.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 71.54 111.214 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -108.9 -7.08 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 63.11 110.884 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.1 -30.78 10.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 74.44 110.871 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.83 -49.76 3.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 71.31 110.853 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.15 40.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 64.52 110.863 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -55.51 -47.76 75.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 62.31 110.766 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -59.07 103.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.44 110.944 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.64 HD13 HD22 ' A' ' 164' ' ' LEU . 45.7 mt -146.06 126.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 71.11 111.085 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.83 -27.21 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.941 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.639 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -163.24 146.42 10.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 74.43 111.105 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 218' ' ' LEU . 99.1 t -122.85 132.63 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 74.04 111.126 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 213' ' ' VAL . 10.8 t -113.69 107.58 52.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 60.31 111.068 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.414 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.8 Cg_endo -69.7 -176.27 1.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.708 2.272 . . . . 75.13 112.41 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.17 -14.27 80.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 64.42 112.573 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -152.36 130.66 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 73.02 110.811 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 118.59 -118.37 4.0 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 64.45 112.454 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -153.47 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 51.52 110.849 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 207' ' ' VAL . 5.2 t -72.07 145.08 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.015 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -141.5 -91.25 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.812 -0.708 . . . . 64.12 112.552 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.82 -168.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 75.05 110.888 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.481 ' HA ' HD12 ' A' ' 219' ' ' LEU . 0.0 OUTLIER -63.87 -15.14 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.03 110.913 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.506 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.22 -18.59 42.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.658 -0.782 . . . . 71.55 112.602 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.75 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.0 mt -74.03 -44.35 54.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 71.31 110.878 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.615 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -55.06 -57.32 12.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 61.43 110.891 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.506 HD21 ' HA2' ' A' ' 217' ' ' GLY . 3.0 pp -58.22 -22.6 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.91 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.2 -34.98 75.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.12 110.918 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.849 HG22 HD23 ' A' ' 226' ' ' LEU . 8.8 m -57.77 -55.44 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 65.34 111.173 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.06 -19.69 61.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 62.11 110.851 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -12.01 58.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.822 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.429 HD12 ' HG3' ' A' ' 171' ' ' LYS . 10.4 mt -117.63 -16.59 10.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 70.31 110.874 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.849 HD23 HG22 ' A' ' 222' ' ' THR . 0.5 OUTLIER -110.73 3.85 19.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 60.33 110.878 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.4 110.968 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.79 0.328 . . . . 53.11 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -135.83 91.76 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 74.44 111.091 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -111.76 118.13 34.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 75.35 110.95 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -61.38 168.34 2.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.78 -47.88 64.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 74.55 110.779 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.42 -37.87 82.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 61.5 111.082 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 13.4 61.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 62.31 112.493 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -80.79 -43.8 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.756 0.312 . . . . 72.43 111.15 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 67' ' ' LEU . 27.5 mt -103.54 117.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.08 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -125.04 129.99 51.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 70.33 110.843 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.661 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.1 mt -123.41 110.05 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 63.15 111.033 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -101.26 128.44 47.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 64.05 110.842 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -71.1 111.03 6.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 72.15 110.875 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.561 HD21 HG11 ' A' ' 213' ' ' VAL . 14.2 mt -65.07 -32.08 73.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 72.42 110.855 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.12 -97.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 73.21 110.88 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -151.52 9.98 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 71.03 110.926 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.52 6.19 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 65.23 110.899 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -150.99 139.73 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.437 . . . . 62.4 111.109 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.661 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.1 m95 -126.87 -174.97 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 71.42 110.966 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 43' ' ' GLY . 99.6 t -135.85 95.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 72.11 111.175 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -80.33 122.24 26.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.775 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.9 m -118.2 100.36 7.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 54.43 111.133 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.9 117.08 23.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.15 110.937 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.41 115.31 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 63.14 110.95 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.676 -0.773 . . . . 72.43 112.514 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.611 0.72 . . . . 51.35 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 118.16 5.52 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.615 2.21 . . . . 70.41 112.304 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.1 p -105.52 99.7 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 65.11 110.838 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.76 164.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 54.13 110.835 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.89 -164.32 13.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 53.3 112.447 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.545 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.0 tp -153.69 115.36 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 55.21 110.929 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.689 HG22 HD23 ' A' ' 54' ' ' LEU . 2.0 t -99.56 116.76 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.44 111.138 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.42 121.23 35.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 73.34 110.905 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -90.98 84.37 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 34.33 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -97.45 -177.03 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 65.2 111.117 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -103.97 -19.41 14.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.764 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -16.41 37.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 73.02 110.926 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 146.85 4.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.791 -0.719 . . . . 61.24 112.584 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.42 ' HB3' HG22 ' A' ' 79' ' ' VAL . 10.8 tp -60.13 155.26 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.37 . . . . 73.24 110.9 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.8 142.6 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 63.14 111.211 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.689 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -138.53 125.66 21.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.918 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 165' ' ' VAL . 79.7 t -69.88 110.18 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 74.55 111.136 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.91 141.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 71.2 110.823 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.651 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -81.77 -160.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.949 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.576 ' H ' HG23 ' A' ' 64' ' ' THR . 13.6 t -98.44 170.06 9.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 43.44 110.881 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.618 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.9 m95 -53.06 -59.99 3.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 72.2 110.962 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.67 158.53 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.22 110.903 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -52.85 -39.58 62.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 63.25 110.889 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -55.72 -25.79 42.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.2 110.958 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 59' ' ' TRP . 94.6 mt -92.11 -50.01 5.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 71.01 110.892 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -50.19 -43.6 52.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.152 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.4 -48.23 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.891 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.36 -21.08 66.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.926 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.5 tp -87.37 -27.3 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.87 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.56 -22.58 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 62.34 111.143 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -91.96 14.28 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 73.12 110.927 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ptm -129.49 -40.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 61.1 110.881 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.0 m -78.37 -22.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 71.25 111.096 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.573 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.82 -25.27 65.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 72.22 110.834 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -104.14 -32.73 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.13 110.85 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -47.01 58.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 75.4 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 23.6 m-85 -82.61 -11.17 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 71.41 110.828 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 68.07 11.73 8.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 54.35 110.931 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -132.24 140.43 48.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.904 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.854 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG21 HD11 ' A' ' 54' ' ' LEU . 71.9 t -79.47 120.22 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 70.24 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.6 t -132.88 4.28 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 75.05 111.135 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.2 m-20 -147.58 146.53 29.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 71.33 110.868 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 54' ' ' LEU . 3.3 t -155.35 129.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 73.15 111.118 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.619 ' CD1' HG11 ' A' ' 140' ' ' VAL . 20.6 mt -84.5 133.33 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 65.42 111.132 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.97 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.3 mm -97.44 147.55 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 54.51 111.172 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.7 p -110.91 -35.64 5.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 70.31 111.119 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.594 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.5 p-80 -173.15 -176.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.841 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.88 84.74 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 52.44 111.112 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -145.05 154.46 42.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 75.52 110.907 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.84 -23.1 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 53.43 111.079 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.46 26.31 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 52.31 110.853 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.899 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -151.28 -70.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 75.2 110.89 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.728 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.9 2.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 72.53 111.18 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -45.06 43.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.803 -0.713 . . . . 72.23 112.395 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.43 15.93 58.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 45.33 112.54 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.9 tt -54.24 -26.77 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 70.11 111.135 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -58.75 -27.61 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.35 110.979 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -90.16 -20.21 23.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 54.12 111.097 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.651 HD11 ' OG ' ' A' ' 57' ' ' SER . 15.7 mt -82.45 -37.47 25.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.865 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -92.51 20.42 6.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 70.11 110.923 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -118.42 -43.07 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 71.55 110.821 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -84.43 -54.0 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.871 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.76 39.19 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 65.12 112.488 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.5 mp -103.85 113.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.852 0.358 . . . . 61.52 111.179 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.703 ' HB3' HD11 ' A' ' 124' ' ' LEU . 10.5 mtmt -79.74 113.96 18.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 65.32 110.904 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.97 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -87.88 91.4 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 63.23 111.058 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.478 ' HA ' HD12 ' A' ' 124' ' ' LEU . 42.4 m-70 -64.38 112.09 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.85 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.401 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -141.05 -175.01 4.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.882 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.7 158.05 15.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 64.21 111.11 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.5 -40.36 51.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 74.52 111.098 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.695 HD23 ' OD2' ' A' ' 152' ' ' ASP . 38.9 tp -75.09 -39.12 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 52.21 110.937 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.771 ' HA ' HD11 ' A' ' 114' ' ' LEU . 88.0 m -58.84 -21.69 57.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 71.2 111.132 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -96.61 0.87 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 73.0 111.083 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.48 -50.62 3.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.905 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -69.68 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.31 110.92 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.45 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 64.04 111.121 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -26.23 61.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.51 110.902 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -31.93 62.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 75.53 110.882 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -93.23 -21.22 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 64.44 110.837 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.36 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 73.24 112.574 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CD1' HG12 ' A' ' 92' ' ' ILE . 85.7 m-85 -97.34 178.47 5.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 65.31 110.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -76.17 -176.39 3.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 62.01 110.841 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.0 mp0 -118.86 110.96 37.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 74.14 110.899 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.83 -169.76 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.614 2.209 . . . . 71.01 112.398 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 104' ' ' LYS . 63.6 mt -61.81 -49.49 76.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 64.21 110.913 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 60.19 20.26 53.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.75 . . . . 75.11 112.506 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.42 31.31 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 71.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.568 ' CD2' HD21 ' A' ' 133' ' ' LEU . 90.2 mt -116.51 -174.48 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.93 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.24 -171.02 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 75.51 110.915 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.826 HG22 HG23 ' A' ' 130' ' ' VAL . 54.1 m -50.79 -70.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.182 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.826 HG23 HG22 ' A' ' 129' ' ' THR . 31.0 t -116.37 102.03 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 60.32 111.153 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.45 HG21 HD22 ' A' ' 127' ' ' LEU . 14.3 t -124.78 162.28 24.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 61.32 111.209 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.96 100.94 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 74.43 110.916 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.568 HD21 ' CD2' ' A' ' 127' ' ' LEU . 27.4 mt -78.71 -179.89 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 53.43 110.969 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -171.74 112.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 71.21 110.961 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -106.73 73.93 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 75.22 110.807 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.43 -84.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.843 -0.694 . . . . 73.24 112.445 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.19 26.95 9.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.352 . . . . 75.1 110.833 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.6 tpp -130.43 142.93 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 70.04 110.932 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.54 125.33 48.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 74.03 110.897 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.648 HG22 ' CD2' ' A' ' 158' ' ' LEU . 13.4 t -138.85 119.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 74.35 111.195 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -113.54 127.86 56.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.964 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.5 p -82.78 -173.6 4.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 74.22 111.145 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.421 ' HB3' HG23 ' A' ' 155' ' ' VAL . 21.6 t80 -170.89 135.9 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 72.42 110.861 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.69 ' HB3' HG23 ' A' ' 129' ' ' THR . 81.7 t80 -125.12 90.34 51.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.816 0.817 . . . . 75.22 110.962 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.1 Cg_endo -69.86 -7.78 21.94 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.662 2.241 . . . . 62.44 112.309 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.86 -150.8 18.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 73.35 112.554 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -91.63 139.7 30.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 74.42 110.957 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.67 -89.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.692 -0.765 . . . . 51.2 112.507 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -76.12 -25.47 55.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 74.13 110.933 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.594 HG21 ' HB2' ' A' ' 86' ' ' HIS . 46.9 p -146.95 -167.95 2.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 72.33 111.123 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.604 ' HB3' HD23 ' A' ' 114' ' ' LEU . 60.7 tt0 -85.34 -16.25 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.925 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.695 ' OD2' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -139.99 25.83 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.883 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.08 131.83 48.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.909 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 84' ' ' ILE . 10.3 pt -139.28 171.06 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 75.42 111.164 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.6 m -124.94 142.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 71.32 111.049 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.67 114.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 74.31 111.183 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -103.74 142.07 34.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 73.32 110.923 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.648 ' CD2' HG22 ' A' ' 140' ' ' VAL . 56.5 mt -122.41 98.69 43.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.631 0.729 . . . . 71.42 110.888 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -5.01 15.16 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.13 112.358 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.74 -31.36 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.08 11.6 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.901 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.3 27.49 9.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 54.21 110.8 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.502 HD13 HD13 ' A' ' 21' ' ' LEU . 87.2 mt -93.18 143.62 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 73.43 111.117 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.443 ' CD2' HD13 ' A' ' 203' ' ' ILE . 61.5 tp -124.81 153.68 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.92 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 55' ' ' VAL . 76.0 t -123.16 79.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 71.13 111.137 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.83 -36.64 41.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 54.44 112.522 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 67.28 -165.09 43.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.712 -0.756 . . . . 55.12 112.437 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.7 m -51.95 -34.45 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 74.22 110.889 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.611 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.7 tp -51.64 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.888 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.41 HG13 ' HA ' ' A' ' 219' ' ' LEU . 19.6 t -80.25 109.19 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.22 111.122 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.73 ' HG2' HG23 ' A' ' 222' ' ' THR . 32.0 mmmt -51.29 169.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 75.43 110.895 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 89.2 p -117.78 157.26 26.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 44.11 110.847 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.107 -0.497 . . . . 64.2 111.173 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.79 0.328 . . . . 54.33 111.138 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.42 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 64.4 110.919 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.56 -19.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.24 111.173 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.54 -27.16 61.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 63.11 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.37 -12.41 14.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.01 110.87 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.611 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.5 t90 -54.28 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.936 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.671 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.51 -24.5 13.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.818 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.0 m -81.45 -32.55 32.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.14 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -42.53 62.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 63.11 110.796 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.3 mm -62.47 -44.72 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 75.31 111.102 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.49 -23.49 50.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.868 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -81.74 -20.73 38.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.45 110.888 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.44 -9.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.33 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.69 -10.33 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 64.2 110.903 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -101.95 -31.91 10.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.888 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 -49.92 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 73.24 110.852 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.499 ' O ' HD11 ' A' ' 203' ' ' ILE . 3.9 m-30 -101.12 65.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.94 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -78.42 -55.49 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 74.11 110.838 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.15 100.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.828 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.704 HG21 HG22 ' A' ' 206' ' ' VAL . 57.1 mt -141.23 116.08 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 72.0 111.181 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.13 -26.07 64.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 70.02 110.96 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -171.99 137.76 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 74.03 111.093 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.732 ' HB ' HD12 ' A' ' 218' ' ' LEU . 85.7 t -113.91 144.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 62.0 111.093 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.128 HG22 HG12 ' A' ' 213' ' ' VAL . 13.5 t -119.68 109.19 38.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.722 . . . . 62.2 111.141 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -170.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.72 2.28 . . . . 74.12 112.327 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.07 -14.93 61.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 61.42 112.467 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.71 142.1 21.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 74.02 110.87 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.7 -101.81 1.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 55.35 112.497 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.81 162.76 4.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 55.55 110.972 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.128 HG12 HG22 ' A' ' 207' ' ' VAL . 6.6 m -51.56 163.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.141 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.67 -102.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.661 -0.781 . . . . 52.04 112.48 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.82 -172.24 3.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 64.13 110.841 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -61.87 -17.38 56.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.897 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.451 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.3 -17.59 46.84 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.715 -0.755 . . . . 44.41 112.491 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.8 mt -70.01 -30.2 67.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 61.54 110.987 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.559 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.9 mm? -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 61.22 110.93 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.451 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -62.14 -17.39 57.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 61.55 110.913 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -65.86 -50.68 63.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.52 110.924 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.738 HG22 HD23 ' A' ' 226' ' ' LEU . 4.4 m -51.84 -51.7 54.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 74.25 111.129 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.52 -21.27 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 43.23 110.908 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -86.81 -2.96 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 74.04 110.843 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.5 mt -128.25 -4.87 5.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 74.3 110.947 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.738 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -123.12 0.61 9.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.897 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 45.03 110.846 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.799 0.333 . . . . 73.21 111.086 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.08 99.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 72.03 111.082 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -118.43 114.87 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.962 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -59.42 165.61 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 63.45 110.856 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.01 -48.7 61.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.823 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -63.11 -36.75 84.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.051 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.58 13.63 62.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 71.33 112.582 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 m -78.26 -45.88 21.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 64.42 111.12 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 67' ' ' LEU . 40.6 mt -103.27 113.92 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 61.11 111.159 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.0 p -118.08 138.12 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.904 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.795 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -130.25 112.14 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 75.52 111.041 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -98.22 125.8 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 73.53 110.801 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -69.14 109.17 3.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 53.04 110.916 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.846 HD21 HG11 ' A' ' 213' ' ' VAL . 15.8 mt -63.4 -33.73 76.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 71.44 110.895 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.96 -96.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 74.32 110.958 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -150.7 9.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.853 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.24 7.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 73.31 110.844 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 t -151.01 141.33 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.22 111.213 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.795 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.4 m95 -129.8 -174.76 3.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 72.45 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 43' ' ' GLY . 98.2 t -136.64 90.49 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 61.14 111.13 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -73.55 124.47 25.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.84 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -121.03 104.58 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 64.51 111.142 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -86.3 122.18 29.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.939 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.16 106.5 16.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 72.42 110.872 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.728 . . . . 53.0 112.489 179.886 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.618 0.723 . . . . 62.0 111.19 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 118.83 5.92 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.687 2.258 . . . . 73.44 112.268 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.4 p -109.7 96.27 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.891 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -60.32 167.96 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.526 . . . . 62.13 110.941 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.458 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -159.29 -147.23 4.81 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 44.12 112.504 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 158' ' ' LEU . 14.9 tp -160.52 118.13 2.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.34 . . . . 74.25 110.969 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.653 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.8 t -100.88 122.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 75.1 111.093 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 158' ' ' LEU . 26.2 mt -99.41 119.57 38.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.49 . . . . 72.03 110.952 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.91 87.08 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 52.45 110.899 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.54 -179.87 4.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.464 . . . . 63.22 111.205 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -101.05 -23.78 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 25.43 110.809 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 -13.58 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 70.44 110.854 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.5 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.798 . . . . 71.54 112.442 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.485 ' HB3' HG22 ' A' ' 79' ' ' VAL . 8.9 tp -63.18 154.96 29.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.858 0.361 . . . . 75.42 110.818 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.92 143.14 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.43 111.181 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.653 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -138.75 124.41 19.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 63.43 111.008 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 165' ' ' VAL . 74.5 t -69.82 112.49 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 63.02 111.139 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.75 139.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 53.34 110.894 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.708 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.6 p -83.1 -165.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.89 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.489 ' H ' HG23 ' A' ' 64' ' ' THR . 8.5 t -94.89 165.77 12.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 61.22 110.951 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.644 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.5 m95 -50.3 -59.61 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.449 . . . . 75.44 110.927 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -123.96 160.59 27.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.832 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.05 -39.84 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.932 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.88 -40.55 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 62.44 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.9 mt -74.46 -48.44 27.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 73.14 110.93 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.76 -44.39 58.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 73.41 111.12 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.43 -50.5 67.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 72.04 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -63.9 -18.79 64.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 70.35 110.907 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 16' ' ' ILE . 11.1 tp -88.71 -27.77 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.907 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -89.72 -23.12 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 71.04 111.169 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.57 16.4 12.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.865 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.5 ptm -130.75 -39.71 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 70.12 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.3 m -81.21 -22.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.207 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.589 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.11 -22.05 64.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 74.33 110.868 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.85 -33.5 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 63.55 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.4 -39.56 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 63.51 110.905 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.31 -11.29 35.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.2 110.914 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 68.08 12.15 8.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.949 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HB2' HD13 ' A' ' 52' ' ' LEU . 6.7 mttt -130.59 138.97 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.898 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -85.44 138.79 32.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.43 110.864 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 54' ' ' LEU . 72.9 t -79.44 121.75 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 72.42 111.185 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 t -136.89 8.33 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 54.42 111.112 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 82' ' ' VAL . 64.7 m-20 -150.81 145.85 25.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.865 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 54' ' ' LEU . 4.0 t -155.33 132.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 62.25 111.198 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.631 ' CD1' HG11 ' A' ' 140' ' ' VAL . 23.2 mt -86.4 133.61 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 71.41 111.159 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.986 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.1 mm -98.43 147.69 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.108 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.7 p -111.61 -34.18 6.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.13 111.082 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.558 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.5 p-80 -175.11 -175.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.921 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.83 93.49 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 62.34 111.085 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.402 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.2 t-160 -153.79 154.96 34.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 73.33 110.875 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.67 -21.77 7.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 72.15 111.124 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.31 18.23 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 75.45 110.823 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.911 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -143.54 -70.75 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 64.13 110.855 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.711 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.88 3.89 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 74.31 111.086 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.44 -45.62 45.75 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.695 -0.764 . . . . 64.12 112.44 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.52 15.81 59.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.644 -0.788 . . . . 71.41 112.454 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.475 HD12 HH22 ' A' ' 91' ' ' ARG . 4.6 tt -56.35 -25.97 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 70.12 111.143 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -59.7 -21.36 60.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 72.53 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 ' HD2' ' A' ' 101' ' ' ARG . 81.9 m -98.28 -20.62 17.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 72.02 111.166 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.708 HD11 ' CB ' ' A' ' 57' ' ' SER . 13.7 mt -82.98 -36.13 25.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.879 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -88.86 9.8 23.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 64.44 110.897 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -112.45 -55.29 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 71.13 110.879 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.489 ' HD2' HG22 ' A' ' 97' ' ' THR . 7.1 mtt-85 -65.16 -58.59 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 73.3 110.862 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.18 39.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 53.51 112.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.2 mp -106.88 117.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.868 0.366 . . . . 74.34 111.104 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.734 ' CE ' HD21 ' A' ' 124' ' ' LEU . 3.2 mtpp -82.03 117.92 22.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 63.41 110.88 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.986 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -91.26 94.65 9.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 52.13 111.139 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.18 113.49 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 64.4 110.831 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 111' ' ' THR . 1.0 OUTLIER -142.66 -174.53 4.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 75.04 110.854 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.34 158.39 16.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 65.12 111.127 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.76 -38.89 50.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 60.12 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.7 HD23 ' OD1' ' A' ' 152' ' ' ASP . 55.5 tp -77.45 -37.61 51.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.948 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 88.9 m -58.37 -22.09 52.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 72.24 111.151 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -95.46 -3.16 47.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.099 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -95.8 -54.43 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.902 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.857 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -64.76 -13.95 57.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 73.23 110.843 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.5 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 63.33 111.059 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.69 -25.99 60.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 55.44 110.83 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -55.93 -33.05 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 72.42 110.845 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -91.75 -20.96 20.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 63.23 110.9 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.91 25.42 5.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.808 -0.71 . . . . 60.14 112.491 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.29 -174.55 2.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 63.21 110.905 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.14 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 64.14 110.877 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -120.77 108.75 36.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.663 0.744 . . . . 71.54 110.853 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.437 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.75 -169.84 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.711 2.274 . . . . 75.3 112.343 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.734 HD21 ' CE ' ' A' ' 104' ' ' LYS . 20.7 mt -61.48 -48.78 79.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 44.14 110.931 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 57.04 23.07 45.02 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.73 -0.748 . . . . 75.32 112.528 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.02 33.74 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 75.13 110.899 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.671 HD22 HD21 ' A' ' 133' ' ' LEU . 74.8 mt -119.34 -175.04 2.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 71.42 110.917 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -153.73 -170.94 3.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 72.34 110.935 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.951 HG22 HG23 ' A' ' 130' ' ' VAL . 34.7 m -50.25 -70.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 71.3 111.111 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.951 HG23 HG22 ' A' ' 129' ' ' THR . 48.0 t -119.91 104.03 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 71.13 111.131 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -135.48 165.53 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 71.34 111.167 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.59 133.03 54.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 64.42 110.814 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.671 HD21 HD22 ' A' ' 127' ' ' LEU . 23.0 mt -118.92 158.01 26.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.976 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -140.68 123.18 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.93 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -120.22 45.52 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 74.43 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.84 92.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 62.15 112.479 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.52 15.01 9.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.827 0.346 . . . . 62.33 110.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 tpp -136.72 94.9 3.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 71.3 110.863 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.4 131.23 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.861 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.759 HG22 HD21 ' A' ' 158' ' ' LEU . 20.2 t -137.52 119.0 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.12 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -111.62 131.11 55.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.842 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.9 p -84.96 -172.82 4.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.122 -0.49 . . . . 74.03 111.167 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.567 ' HD1' HG22 ' A' ' 130' ' ' VAL . 22.7 t80 -170.82 135.55 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.814 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.711 ' HB3' HG23 ' A' ' 129' ' ' THR . 21.0 t80 -123.39 87.39 51.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 71.1 110.881 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -7.98 22.42 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 63.32 112.348 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.69 -155.67 21.51 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 63.13 112.435 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -92.12 140.34 29.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 73.33 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.536 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -154.17 -89.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.676 -0.773 . . . . 62.31 112.463 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -75.36 -25.16 57.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 64.15 110.823 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 86' ' ' HIS . 52.9 p -147.26 -168.3 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 75.54 111.189 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 114' ' ' LEU . 42.4 tt0 -86.37 -15.2 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 74.43 110.798 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.7 ' OD1' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -138.42 23.06 2.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 63.02 110.803 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.687 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -55.05 130.42 41.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 64.3 110.882 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 84' ' ' ILE . 2.0 pt -135.0 172.77 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 75.43 111.125 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 143' ' ' PHE . 16.8 m -128.92 128.32 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 70.12 111.066 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.725 ' O ' HD12 ' A' ' 164' ' ' LEU . 95.8 t -81.82 132.15 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 73.25 111.06 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -118.76 131.91 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 74.22 110.908 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.908 HD11 HD21 ' A' ' 46' ' ' LEU . 11.5 mt -113.45 98.28 46.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.644 0.735 . . . . 65.11 110.899 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.8 Cg_endo -69.87 -4.41 14.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 75.44 112.384 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -82.67 -23.92 33.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.11 110.843 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.72 14.11 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.911 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.6 m120 54.46 27.74 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 72.54 110.895 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.557 HD13 HD13 ' A' ' 21' ' ' LEU . 96.7 mt -93.46 130.26 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 75.11 111.079 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 156' ' ' VAL . 50.0 tp -114.74 150.75 34.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.938 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 55' ' ' VAL . 21.9 t -119.21 75.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.46 . . . . 72.51 111.069 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.54 -45.97 53.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 70.25 112.495 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 74.79 -161.26 53.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.747 . . . . 73.21 112.417 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 12.8 m -51.41 -34.73 35.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 62.42 110.803 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.687 HD13 ' OD1' ' A' ' 153' ' ' ASN . 21.9 tp -51.64 -39.78 58.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.966 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 219' ' ' LEU . 17.3 t -104.65 111.31 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 74.3 111.07 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.551 ' HG3' HD12 ' A' ' 225' ' ' LEU . 9.9 mmpt? -53.49 155.76 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.883 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.7 p -101.78 160.44 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 62.51 110.845 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 72.31 111.112 -179.936 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.878 0.37 . . . . 75.24 111.024 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -121.95 92.16 3.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.933 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.54 -20.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 63.4 111.191 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.92 -20.26 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 73.34 110.911 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.63 -17.42 10.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 61.12 110.949 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.576 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -53.76 -61.25 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.3 110.923 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.771 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -54.53 -24.75 22.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.837 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.0 m -81.13 -29.91 34.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 42.44 111.167 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.28 -43.97 39.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.856 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 219' ' ' LEU . 35.3 mm -60.64 -47.25 93.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 75.31 111.173 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.462 ' HG2' HD21 ' A' ' 223' ' ' LEU . 2.0 mm-40 -56.15 -27.91 56.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.856 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -77.14 -22.46 52.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.03 110.826 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 192' ' ' SER . 18.2 t -85.47 -10.22 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.072 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.95 -8.06 13.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 54.34 110.926 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -31.16 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.887 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -104.47 -55.34 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 64.41 110.937 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -95.91 39.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.236 -0.438 . . . . 62.2 110.913 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -56.42 -47.69 78.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 61.31 110.888 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -60.72 102.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.901 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.7 HG21 HG22 ' A' ' 206' ' ' VAL . 37.6 mt -144.76 129.55 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.31 111.131 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.69 -24.75 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 65.44 110.907 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.21 126.66 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.15 111.111 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.712 ' HB ' HD12 ' A' ' 218' ' ' LEU . 87.0 t -107.14 129.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 74.14 111.177 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 213' ' ' VAL . 16.4 t -104.41 111.63 65.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 52.21 111.093 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.82 -173.25 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 70.25 112.231 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.95 -12.21 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 72.43 112.47 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -152.56 131.28 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 73.23 110.853 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.23 -119.99 5.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.767 -0.73 . . . . 60.1 112.473 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.16 172.26 13.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 74.51 110.881 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 207' ' ' VAL . 4.8 m -61.06 164.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.084 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.64 -115.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.714 . . . . 71.33 112.538 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.21 -169.97 3.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.377 . . . . 64.45 110.839 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -19.92 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 64.24 110.908 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.524 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.1 -18.22 47.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.721 . . . . 74.32 112.438 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.0 mt -72.12 -31.78 66.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 70.25 110.932 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.554 ' HA ' HG13 ' A' ' 170' ' ' VAL . 4.1 mm? -64.41 -58.62 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.959 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.524 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -60.21 -19.66 55.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.884 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.593 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.9 OUTLIER -63.41 -44.02 95.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.827 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.866 HG22 HD23 ' A' ' 226' ' ' LEU . 16.1 m -57.11 -52.77 63.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 53.13 111.18 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.75 HD23 ' OG ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -60.32 -25.04 65.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 62.52 110.903 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -75.22 -11.75 60.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 74.41 110.887 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.593 HD11 ' CE1' ' A' ' 221' ' ' HIS . 9.7 mt -119.07 -15.56 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.22 110.871 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.866 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -113.31 2.22 15.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 65.35 110.903 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 55.54 110.846 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.843 0.354 . . . . 72.33 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.69 103.33 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.33 111.088 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -122.08 116.87 25.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 73.12 110.872 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -62.46 166.72 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.895 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.23 -48.71 62.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.83 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 p -62.65 -36.7 83.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 63.14 111.206 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.34 14.56 63.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 70.34 112.572 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -80.4 -45.02 18.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 71.35 111.077 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' A' ' 67' ' ' LEU . 34.5 mt -102.55 107.98 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 74.05 111.077 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.2 p -113.14 137.01 52.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 71.05 110.887 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.778 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.5 mt -128.79 109.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 74.1 111.154 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -99.96 123.84 44.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.03 110.896 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -67.5 109.55 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 72.53 110.939 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.581 HD13 HD13 ' A' ' 163' ' ' ILE . 14.1 mt -63.62 -32.49 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.888 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.11 -97.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 65.11 110.843 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.15 9.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.969 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.55 6.47 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 75.2 110.859 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -150.96 140.48 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 72.21 111.158 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.778 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.8 m95 -127.7 -173.71 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.906 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG23 ' HG ' ' A' ' 21' ' ' LEU . 71.0 t -137.83 92.87 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.175 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -77.52 120.54 22.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.861 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.4 m -115.29 98.57 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 61.54 111.185 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.01 117.27 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 71.22 110.947 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.18 116.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.858 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.731 . . . . 72.24 112.499 179.864 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.527 0.68 . . . . 74.32 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.658 2.238 . . . . 53.03 112.389 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.56 102.16 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 53.41 110.799 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.81 170.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.067 -0.515 . . . . 74.35 110.911 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -158.0 8.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 71.53 112.501 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.588 HD21 HD12 ' A' ' 158' ' ' LEU . 13.2 tp -156.18 113.49 3.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 54.43 110.87 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.641 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -99.25 113.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 63.35 111.161 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 158' ' ' LEU . 18.9 mt -93.63 119.27 32.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 53.12 110.915 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -88.81 84.49 6.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.822 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -172.54 2.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 53.02 111.091 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -105.34 -25.79 12.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 63.41 110.906 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.4 -13.35 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.886 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.83 155.44 6.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 64.33 112.504 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HB3' HG22 ' A' ' 79' ' ' VAL . 11.2 tp -64.87 157.82 26.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 70.02 110.842 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 81' ' ' ASP . 17.1 t -146.5 142.37 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 61.41 111.145 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.649 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.7 mt -139.32 120.52 14.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.904 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.59 111.81 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.12 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.92 128.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 71.33 110.9 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.673 ' CB ' HD11 ' A' ' 98' ' ' LEU . 3.3 p -71.96 -164.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 71.22 110.906 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -93.08 171.67 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 70.44 110.898 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.627 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.8 m95 -55.53 -60.69 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 72.05 110.92 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.19 157.63 34.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 74.35 110.817 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -51.86 -39.97 59.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 74.41 110.889 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -53.42 -41.1 65.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 65.12 110.894 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 59' ' ' TRP . 93.9 mt -75.97 -45.55 34.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 62.22 110.924 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.403 HG21 HD21 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -50.97 -48.83 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.35 111.132 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -52.46 -50.01 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 65.25 110.906 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -64.06 -19.71 65.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 73.23 110.806 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.6 tp -89.18 -26.21 21.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 61.33 110.84 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.407 HG23 ' OE1' ' A' ' 72' ' ' GLU . 58.5 mt -91.18 -23.07 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 71.12 111.103 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.05 15.4 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.875 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.2 ptm -130.43 -40.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.23 110.94 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.3 m -80.67 -21.7 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 64.32 111.146 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.569 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -69.04 -23.01 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 63.44 110.884 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.8 -33.07 7.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 45.43 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -43.52 67.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 62.42 110.859 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.571 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 18.6 m-85 -87.1 -10.66 52.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.827 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.19 12.45 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 54.41 110.919 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.19 140.4 48.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 74.32 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.0 137.15 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 62.03 110.954 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.569 HG23 ' OE2' ' A' ' 72' ' ' GLU . 89.5 t -75.56 117.51 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 71.23 111.1 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -133.09 10.95 4.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 55.44 110.996 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.533 ' N ' HG23 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -155.83 137.88 14.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 52.31 110.832 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 54' ' ' LEU . 13.1 t -146.15 129.15 9.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 75.45 111.065 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.628 HD11 ' HE2' ' A' ' 135' ' ' PHE . 28.6 mt -92.95 125.21 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 70.3 111.104 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -94.24 158.36 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.08 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.7 p -115.31 -39.88 3.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 71.23 111.148 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.57 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -159.22 -174.36 4.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.824 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -102.32 97.37 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 41.25 111.127 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.98 154.96 26.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 64.4 110.932 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.64 -19.7 28.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 65.24 111.175 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.66 14.3 13.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 71.31 110.897 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -135.32 -76.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.53 110.973 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -92.35 11.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 74.24 111.079 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.81 -34.03 14.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.769 . . . . 73.21 112.483 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.38 17.77 23.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 60.04 112.497 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.5 tt -58.09 -33.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 75.1 111.085 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -55.82 -24.2 34.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.256 -0.429 . . . . 64.34 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m -95.84 -12.25 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 61.42 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 57' ' ' SER . 16.8 mt -90.01 -30.6 17.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.901 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -88.09 -6.65 57.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 64.45 110.914 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -91.53 -52.7 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 64.11 110.966 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -61.86 -60.65 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.13 110.952 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.09 40.0 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.753 -0.737 . . . . 44.23 112.502 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.632 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.4 mp -108.04 140.08 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 72.53 111.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 124' ' ' LEU . 5.0 mtmm -98.17 110.33 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 72.01 110.914 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.48 9.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 72.43 111.09 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.587 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.0 m-70 -72.83 145.21 47.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.89 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -173.75 -175.12 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.04 110.919 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.41 154.96 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 54.21 111.21 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.08 39.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 54.43 111.036 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.755 HD12 ' HG2' ' A' ' 113' ' ' GLU . 61.2 tp -67.34 -41.63 84.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.89 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 86.9 m -61.96 -16.8 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 54.45 111.121 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.632 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -104.06 11.71 34.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 25.45 111.14 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.755 ' HG2' HD12 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -111.35 -26.07 9.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 54.44 110.767 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -100.25 -9.49 22.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.976 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.34 -36.88 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.31 111.057 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -28.14 60.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 71.2 110.983 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -55.44 -35.36 65.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 63.22 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -86.14 -25.65 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 30.05 110.941 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.73 14.6 4.69 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 35.25 112.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 92' ' ' ILE . 69.7 m-85 -95.1 177.36 5.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 74.11 110.977 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.523 ' CG ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.24 -171.86 3.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 54.13 110.853 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.1 mt-10 -115.49 111.95 43.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.72 0.772 . . . . 65.32 110.878 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.2 Cg_endo -69.66 -178.89 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.772 2.314 . . . . 64.33 112.32 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 106' ' ' HIS . 31.4 mt -53.57 -43.87 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.932 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.76 27.78 21.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 62.43 112.463 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -101.19 31.31 3.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 73.1 110.825 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.56 HD22 HD21 ' A' ' 133' ' ' LEU . 62.7 mt -116.13 -175.21 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 44.54 110.964 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.66 -170.93 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 72.52 110.894 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 130' ' ' VAL . 41.2 m -50.43 -70.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 72.45 111.034 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.906 HG23 HG22 ' A' ' 129' ' ' THR . 41.0 t -118.08 105.86 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 63.12 111.118 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -138.82 166.78 23.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.32 111.169 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -113.83 134.04 55.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.788 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.56 HD21 HD22 ' A' ' 127' ' ' LEU . 25.1 mt -113.08 167.46 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.933 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.48 134.39 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 71.23 110.939 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.628 ' HE2' HD11 ' A' ' 83' ' ' ILE . 51.4 m-85 -137.21 36.15 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 75.01 110.869 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.74 93.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.736 . . . . 54.12 112.518 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.4 m120 65.55 13.67 9.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 74.22 110.917 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.7 tpp -135.37 105.34 6.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.941 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -96.45 130.62 43.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 74.5 110.879 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.843 HG22 HD21 ' A' ' 158' ' ' LEU . 20.7 t -135.67 117.39 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 74.42 111.13 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.99 129.5 55.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 53.4 110.89 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.36 -176.29 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 70.23 111.185 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.452 ' HD1' HG22 ' A' ' 130' ' ' VAL . 22.6 t80 -166.74 133.4 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 70.32 110.929 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.695 ' HB3' HG23 ' A' ' 129' ' ' THR . 10.0 t80 -124.07 89.26 51.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.727 0.775 . . . . 72.24 110.941 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 52.7 Cg_endo -69.81 -21.75 32.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 64.13 112.33 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.18 -157.64 27.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 53.54 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -88.02 138.14 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 72.13 110.837 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.23 -88.82 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 54.01 112.494 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -75.48 -25.62 57.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 72.54 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 86' ' ' HIS . 34.3 p -146.82 -165.33 2.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 74.52 111.166 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HG2' HD21 ' A' ' 110' ' ' LEU . 5.1 tt0 -85.85 -19.67 30.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 75.13 110.89 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.536 ' OD1' HD23 ' A' ' 110' ' ' LEU . 9.4 t0 -137.87 24.27 2.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 73.43 110.863 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.595 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -53.83 129.29 33.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.837 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.474 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.9 pt -135.21 174.47 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 64.04 111.105 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.8 m -127.19 136.24 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.14 111.161 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.5 121.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.4 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -110.02 139.14 45.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.509 . . . . 63.11 110.947 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.843 HD21 HG22 ' A' ' 140' ' ' VAL . 21.1 mt -120.14 99.21 48.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.529 0.68 . . . . 75.12 110.914 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.62 -4.53 14.12 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.711 2.274 . . . . 72.41 112.382 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -85.73 -22.81 27.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 62.13 110.937 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.3 12.15 2.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.97 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.36 25.17 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 52.5 110.939 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.581 HD13 HD13 ' A' ' 21' ' ' LEU . 95.3 mt -89.04 142.34 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 62.32 111.1 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 57.7 tp -122.32 156.39 33.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.3 t -123.56 74.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 64.15 111.157 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.99 -41.71 52.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.732 -0.747 . . . . 73.21 112.458 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.66 -162.54 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 71.22 112.494 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 16.7 m -51.84 -34.51 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 45.43 110.882 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.735 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.2 tp -51.76 -41.35 61.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.878 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 219' ' ' LEU . 18.1 t -100.83 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.116 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.3 OUTLIER -51.5 147.85 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.924 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.4 p -98.29 159.64 14.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.43 110.926 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.172 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.763 0.316 . . . . 63.13 111.057 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.14 92.43 3.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 74.21 110.942 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.1 t -62.86 -18.43 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 72.24 111.165 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.62 -20.67 58.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 73.23 110.952 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.6 -14.72 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 73.25 110.887 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.735 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.4 t90 -55.0 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.498 . . . . 75.12 110.853 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.742 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.97 -24.75 17.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.841 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -81.56 -31.46 32.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 71.33 111.127 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -73.67 -43.82 58.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 63.23 110.886 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.26 -44.61 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 75.31 111.18 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.97 -23.83 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.872 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.14 -21.43 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.758 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.455 HG12 HD21 ' A' ' 219' ' ' LEU . 11.5 t -87.97 -9.56 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.54 111.151 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.43 -8.5 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.881 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -104.11 -31.08 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 73.44 110.809 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 -53.84 2.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.48 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -98.1 60.3 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 74.02 110.868 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -72.57 -59.48 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 61.23 110.901 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -52.13 102.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 65.33 110.904 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.701 HG21 HG22 ' A' ' 206' ' ' VAL . 59.0 mt -139.43 116.72 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.32 111.138 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.95 -22.74 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.833 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.97 129.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 71.3 111.088 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.712 ' HB ' HD12 ' A' ' 218' ' ' LEU . 88.1 t -102.22 130.86 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 33.43 111.073 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 213' ' ' VAL . 11.4 t -107.92 103.75 50.89 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.568 0.699 . . . . 73.31 111.077 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.7 Cg_endo -69.83 -170.64 0.41 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.736 2.291 . . . . 73.24 112.311 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.49 -11.74 59.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.838 -0.696 . . . . 54.21 112.57 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.44 144.43 23.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 65.04 110.881 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 100.77 -102.31 2.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.793 -0.718 . . . . 74.4 112.431 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -170.86 159.52 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.41 . . . . 72.04 110.905 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 207' ' ' VAL . 6.0 m -53.39 163.29 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.13 111.176 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.78 -99.68 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 43.41 112.514 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -167.29 -168.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 65.44 110.825 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -20.25 42.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 63.31 110.961 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.516 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -54.17 -23.73 26.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 33.24 112.473 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.6 mt -73.17 -34.7 66.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 51.13 110.956 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.649 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.6 mp -59.84 -59.34 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 75.12 110.964 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.516 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -59.54 -20.58 56.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.282 -0.417 . . . . 74.04 110.911 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -66.62 -34.35 77.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.22 110.811 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.796 HG22 HD23 ' A' ' 226' ' ' LEU . 7.7 m -62.52 -55.54 26.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 72.4 111.152 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -20.95 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 63.31 110.924 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.09 -12.11 60.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 63.22 110.879 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.576 HD12 ' HG3' ' A' ' 171' ' ' LYS . 7.7 mt -119.88 -26.34 5.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 53.32 110.935 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.796 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 61.33 110.964 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 mttt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.83 179.808 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.3 m . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.841 0.353 . . . . 74.23 111.074 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.19 94.05 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 44.01 111.137 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -112.49 117.35 32.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.947 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -61.82 170.21 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 63.41 110.918 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.032 0.444 . . . . 72.12 110.899 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.7 p -60.98 -38.51 86.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 74.31 111.119 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.77 13.88 62.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.799 -0.715 . . . . 65.13 112.563 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.4 m -83.45 -35.56 24.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.363 . . . . 60.44 111.216 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -110.08 122.5 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 74.2 111.109 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 p -129.86 128.79 42.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 73.13 110.776 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.697 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -122.5 112.95 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 62.03 111.15 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.423 ' HA ' HG12 ' A' ' 8' ' ' VAL . 16.8 t -99.09 129.11 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 62.04 110.87 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -72.91 111.14 7.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 63.45 110.933 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.04 HD21 HG11 ' A' ' 213' ' ' VAL . 22.8 mt -64.62 -32.54 74.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.854 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.84 -97.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 71.43 110.874 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -150.3 9.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 75.13 110.904 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.46 7.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 72.04 110.977 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.86 141.14 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 71.44 111.112 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.697 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.0 m95 -129.52 -179.42 5.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 74.35 110.929 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.529 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.7 t -131.43 90.2 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 53.1 111.118 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.409 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.9 p80 -74.15 125.19 27.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 62.32 110.907 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -124.45 105.54 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 63.53 111.181 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.685 ' CD ' HD22 ' A' ' 67' ' ' LEU . 19.5 mp0 -91.64 124.39 35.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 72.54 110.869 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -80.32 127.55 32.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 64.33 110.905 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.87 -0.681 . . . . 63.0 112.491 179.844 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.473 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.0 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.666 0.746 . . . . 63.23 111.212 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.46 6.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.243 . . . . 72.04 112.336 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -101.55 89.09 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 53.33 110.877 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -56.66 158.66 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.42 110.877 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.94 -146.9 4.51 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.737 -0.744 . . . . 64.33 112.523 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.2 tp -160.22 117.32 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.84 0.352 . . . . 63.53 110.891 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.677 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.43 122.36 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.54 111.171 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 158' ' ' LEU . 16.6 mt -100.0 119.14 37.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 62.01 110.942 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -89.31 86.68 6.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.439 . . . . 75.44 110.945 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.2 p -99.83 -172.31 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 72.34 111.212 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -20.76 12.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.823 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -86.89 -13.34 45.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 73.41 110.848 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.51 4.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 60.01 112.43 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 79' ' ' VAL . 9.4 tp -63.13 156.01 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 73.55 110.994 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.31 142.59 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.55 111.087 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.677 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -138.07 125.03 21.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 75.25 110.854 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.41 HG11 HG11 ' A' ' 165' ' ' VAL . 74.5 t -70.45 111.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 53.02 111.134 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.57 138.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 65.54 110.833 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.694 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.9 p -81.21 -164.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 71.43 110.816 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.405 ' H ' HG23 ' A' ' 64' ' ' THR . 6.7 t -95.36 168.34 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.909 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.7 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.8 m95 -50.32 -59.94 3.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 74.1 110.929 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -128.13 158.92 36.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.83 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -52.08 -34.75 45.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.891 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -57.5 -36.31 71.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 71.11 110.921 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.8 mt -82.82 -46.64 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 72.24 110.971 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.67 -47.57 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.1 111.143 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -53.18 -50.36 64.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.887 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.56 -19.04 65.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.939 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.685 HD22 ' CD ' ' A' ' 30' ' ' GLU . 16.1 tp -88.59 -26.16 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 75.52 110.862 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.17 -23.34 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 73.44 111.151 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.17 15.2 14.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 73.32 110.916 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.5 ptm -129.83 -39.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 75.21 110.879 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 67' ' ' LEU . 31.9 m -80.44 -22.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 63.13 111.113 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.588 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.35 -24.02 64.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 44.21 110.836 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -106.37 -33.23 7.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 71.51 110.942 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -70.21 -42.26 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 62.43 110.885 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -89.34 -11.17 44.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.874 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.95 12.03 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.924 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.67 139.56 50.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.877 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -85.45 138.62 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.97 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 54' ' ' LEU . 72.8 t -79.18 122.29 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.4 111.093 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -137.33 8.14 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 53.42 111.215 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 82' ' ' VAL . 57.2 m-20 -149.89 145.84 26.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 71.32 110.941 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 54' ' ' LEU . 3.4 t -155.7 131.68 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 63.23 111.069 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.584 ' CD1' HG11 ' A' ' 140' ' ' VAL . 22.0 mt -86.18 133.96 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.53 111.15 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.004 HD11 ' HB1' ' A' ' 105' ' ' ALA . 4.8 mm -98.96 148.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 72.22 111.125 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 79.8 p -114.57 -39.19 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 65.11 111.162 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.502 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.1 p-80 -166.84 177.03 6.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 72.02 110.834 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -96.75 83.45 3.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 72.43 111.173 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 71.02 110.839 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.46 -22.03 7.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 75.2 111.078 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.06 19.69 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 44.13 110.919 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.894 ' NE ' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -144.33 -70.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.868 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.718 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.76 3.55 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 75.31 111.146 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.84 -45.12 49.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 62.13 112.565 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.14 15.17 60.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 75.55 112.425 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.554 HD12 HH22 ' A' ' 91' ' ' ARG . 2.8 tt -55.4 -28.48 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.879 0.371 . . . . 62.14 111.08 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -21.84 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 73.34 110.929 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -98.58 -14.57 19.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 64.41 111.191 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 57' ' ' SER . 14.5 mt -89.53 -35.85 15.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 72.42 110.92 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -94.44 23.97 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.85 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -124.94 -43.37 1.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 74.02 110.784 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -81.59 -52.51 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 72.51 110.891 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.27 41.01 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.713 -0.756 . . . . 60.12 112.485 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.9 mp -109.59 112.82 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 72.14 111.132 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.781 ' HE2' HD21 ' A' ' 124' ' ' LEU . 3.0 mtpp -79.79 116.65 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 63.12 110.92 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 1.004 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -89.2 90.15 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.429 . . . . 75.52 111.114 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.42 ' HA ' HD12 ' A' ' 124' ' ' LEU . 45.9 m-70 -63.09 113.97 3.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.87 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.21 -174.71 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 64.5 110.849 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.68 157.14 16.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 72.22 111.133 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.08 -40.94 33.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 63.33 111.101 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -35.65 74.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 71.41 110.968 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.568 ' HA ' HD11 ' A' ' 114' ' ' LEU . 75.4 m -63.77 -21.54 66.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 64.1 111.129 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -102.37 11.63 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 45.2 111.154 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.79 -24.38 12.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 64.23 110.868 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -104.34 -7.4 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 71.31 110.958 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.63 -41.04 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.197 -0.456 . . . . 42.31 111.052 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -24.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.93 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -33.57 71.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 73.12 110.857 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -87.81 -22.87 24.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.841 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.45 23.15 4.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.795 -0.717 . . . . 74.44 112.57 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.54 -177.64 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 73.44 110.92 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -79.65 -172.19 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 74.03 110.895 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.47 112.99 32.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 75.31 110.915 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.3 Cg_endo -69.81 -170.28 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 72.11 112.27 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.781 HD21 ' HE2' ' A' ' 104' ' ' LYS . 14.0 mt -60.63 -51.52 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 61.14 110.899 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.81 18.22 45.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 43.3 112.489 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -96.79 33.01 1.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 71.13 110.847 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 131' ' ' THR . 80.7 mt -119.09 -175.09 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 73.5 110.944 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -151.68 -170.74 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 73.13 110.911 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.821 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.02 -70.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 63.44 111.138 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.821 HG23 HG22 ' A' ' 129' ' ' THR . 38.7 t -116.6 96.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 74.2 111.148 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.582 HG21 HD22 ' A' ' 127' ' ' LEU . 14.5 t -117.78 169.37 9.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 71.23 111.167 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.21 103.9 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.931 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD21 ' CD2' ' A' ' 127' ' ' LEU . 29.1 mt -80.04 165.44 22.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.1 110.918 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -151.77 112.06 4.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.779 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.02 69.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.932 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.63 -93.29 0.3 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.834 -0.698 . . . . 45.54 112.42 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -110.01 24.39 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 75.13 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.414 ' HB2' HG22 ' A' ' 48' ' ' THR . 50.9 tpp -132.48 135.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.886 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.86 130.53 56.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 72.4 110.989 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.612 HG22 ' CD2' ' A' ' 158' ' ' LEU . 8.3 t -139.59 121.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 72.41 111.124 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.31 126.07 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 72.42 110.898 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.8 p -83.34 -174.66 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.11 111.051 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.509 ' HD1' HG22 ' A' ' 130' ' ' VAL . 36.6 t80 -170.66 139.72 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 62.43 110.894 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.708 ' HB3' HG23 ' A' ' 129' ' ' THR . 88.6 t80 -125.78 89.02 53.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.737 0.78 . . . . 61.13 110.976 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.6 Cg_endo -69.76 -8.05 22.61 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.291 . . . . 64.24 112.33 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.59 -149.04 19.42 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.673 -0.775 . . . . 74.42 112.448 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -98.47 140.22 33.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 63.34 110.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.06 -93.19 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.744 -0.741 . . . . 51.13 112.538 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.59 -23.66 61.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 75.22 110.83 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 86' ' ' HIS . 55.2 p -151.71 -175.35 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.33 111.124 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 114' ' ' LEU . 32.6 tt0 -85.16 -3.38 58.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 70.33 110.855 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.477 ' OD2' HG23 ' A' ' 111' ' ' THR . 7.4 p-10 -141.66 13.78 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 75.24 110.832 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.6 141.56 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.88 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.704 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.7 pt -146.91 176.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.3 111.078 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.485 HG12 ' HA2' ' A' ' 166' ' ' GLY . 22.1 m -132.53 129.02 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 74.42 111.11 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.9 t -86.84 133.1 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.33 111.101 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -120.16 137.48 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 71.42 110.951 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.612 ' CD2' HG22 ' A' ' 140' ' ' VAL . 41.6 mt -119.5 99.28 50.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.647 0.737 . . . . 72.34 110.945 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -3.13 11.36 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 63.32 112.407 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -86.54 -24.6 25.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 65.43 110.827 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.32 13.01 2.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.942 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.4 m120 54.18 25.42 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.0 110.942 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.698 HD13 HD13 ' A' ' 21' ' ' LEU . 95.7 mt -89.69 133.45 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 62.52 111.162 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.633 HD22 HD13 ' A' ' 203' ' ' ILE . 6.0 tp -121.68 140.62 52.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 75.45 110.931 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.41 HG11 HG11 ' A' ' 55' ' ' VAL . 21.7 t -113.42 75.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 72.11 111.193 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.485 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -52.06 -35.88 42.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.692 -0.765 . . . . 72.52 112.607 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.27 -157.9 53.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.817 -0.706 . . . . 72.44 112.51 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 98.0 m -50.7 -33.68 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 61.31 110.922 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.616 HD12 ' NE1' ' A' ' 189' ' ' TRP . 60.4 tp -52.45 -37.83 57.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.936 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 219' ' ' LEU . 86.0 t -105.75 108.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.11 111.127 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -50.78 168.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 71.3 110.904 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.502 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -119.88 160.16 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.2 110.807 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 71.14 111.146 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.783 0.325 . . . . 52.52 111.095 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.94 92.66 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 72.35 110.898 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.12 -25.95 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.0 111.089 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -69.5 -32.26 71.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.32 110.885 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.19 -14.44 18.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.4 110.849 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.616 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.9 t90 -57.34 -61.83 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.54 110.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.751 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.8 -24.46 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.33 110.873 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.6 m -80.15 -33.64 38.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 75.3 111.169 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.49 -43.01 64.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.803 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.9 -47.17 92.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 64.11 111.175 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.33 -28.5 63.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 65.01 110.905 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -77.94 -20.93 51.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 54.45 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 192' ' ' SER . 22.8 t -87.08 -11.44 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.205 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -110.36 -14.17 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 45.02 110.906 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.435 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -95.92 -30.95 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.964 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -103.46 -51.42 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 74.25 110.8 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -101.07 64.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 72.24 110.899 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -71.73 -59.9 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 74.2 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -50.97 107.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 70.2 110.854 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.662 HG21 HG22 ' A' ' 206' ' ' VAL . 91.3 mt -146.26 118.94 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 64.43 111.126 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.54 -29.6 52.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 72.44 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.706 ' HB1' ' CG2' ' A' ' 213' ' ' VAL . . . -159.65 146.4 16.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 52.21 111.118 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 218' ' ' LEU . 49.9 t -121.92 122.37 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 63.12 111.088 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.816 HG22 ' HB ' ' A' ' 213' ' ' VAL . 21.4 t -102.21 101.94 22.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.723 . . . . 74.1 111.148 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.539 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.4 Cg_endo -69.84 178.12 4.94 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 65.42 112.327 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.28 -17.97 76.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 63.31 112.536 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -152.52 148.98 28.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 74.2 110.915 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.9 -115.4 4.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.653 -0.784 . . . . 63.42 112.498 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -159.63 148.73 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 43.5 110.92 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.04 HG11 HD21 ' A' ' 21' ' ' LEU . 3.6 p -51.49 130.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 75.21 111.044 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -127.63 -98.13 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.689 -0.767 . . . . 35.13 112.443 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.84 -169.72 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.874 0.368 . . . . 71.1 110.918 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 219' ' ' LEU . 0.0 OUTLIER -62.05 -16.96 55.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.902 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.512 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.29 -18.96 37.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.806 -0.712 . . . . 53.1 112.406 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.4 mt -75.08 -45.58 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 73.33 110.945 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.649 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -53.32 -56.24 18.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 73.43 110.983 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.512 HD21 ' HA2' ' A' ' 217' ' ' GLY . 3.3 pp -59.39 -20.36 54.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 41.12 110.919 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.82 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.679 HG22 HD23 ' A' ' 226' ' ' LEU . 8.1 m -63.86 -56.75 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 55.32 111.132 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 190' ' ' SER . 2.4 mt -54.55 -29.78 52.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 72.22 110.955 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -29.22 61.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 75.13 110.898 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.42 -16.43 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 65.14 110.925 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.751 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -116.3 18.19 15.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 72.13 110.95 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 74.43 110.845 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.5 t . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.836 0.35 . . . . 54.3 111.157 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.442 HD13 ' HG2' ' A' ' 74' ' ' LYS . 22.1 mt -112.66 101.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.41 111.121 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -120.52 115.03 22.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.55 110.997 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -58.25 165.04 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 73.41 110.894 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -51.62 -48.51 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 72.01 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.9 p -61.15 -37.72 83.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 72.42 111.06 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.1 62.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 71.12 112.486 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.2 m -75.92 -45.36 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 72.32 111.115 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.47 123.25 54.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 63.52 111.16 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.5 p -127.22 133.56 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 41.33 110.84 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.778 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.9 mt -127.22 110.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 75.12 111.127 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -98.83 126.58 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 71.21 110.846 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -71.14 108.85 4.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.848 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.744 HD21 HG11 ' A' ' 213' ' ' VAL . 15.8 mt -62.07 -33.34 74.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.926 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.32 -96.74 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 71.42 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.87 9.7 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.849 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.61 6.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 70.44 110.906 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -151.0 140.81 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 61.52 111.122 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.778 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.9 m95 -128.51 -173.25 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 71.15 110.947 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.467 HG23 ' HG ' ' A' ' 21' ' ' LEU . 97.1 t -137.79 88.2 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.079 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.43 124.13 23.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 70.11 110.792 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -123.65 105.29 9.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 73.14 111.166 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.705 ' CD ' HD22 ' A' ' 67' ' ' LEU . 8.1 mp0 -91.89 125.8 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 62.34 110.864 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mt -83.53 123.79 30.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 71.2 110.935 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 75.4 112.443 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.462 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.2 t . . . . . 0 C--O 1.23 0.061 0 CA-C-O 121.579 0.704 . . . . 72.41 111.119 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 121.81 8.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.741 2.294 . . . . 63.04 112.373 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.5 p -103.95 88.16 2.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 74.42 110.934 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -58.33 156.8 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.11 110.968 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -150.81 -142.54 3.55 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.81 -0.71 . . . . 72.54 112.515 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.779 HD21 HD12 ' A' ' 158' ' ' LEU . 18.0 tp -160.68 116.97 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 73.02 110.822 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.669 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.7 t -100.94 122.82 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 62.34 111.114 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.753 HD21 HD11 ' A' ' 158' ' ' LEU . 17.7 mt -101.08 122.31 43.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 61.1 110.83 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -91.78 86.48 5.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.22 110.839 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.09 -174.59 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 73.31 111.135 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.3 t -105.69 -24.18 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 71.42 110.838 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -81.73 -10.63 59.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 65.42 110.867 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.39 153.78 5.99 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.702 -0.761 . . . . 54.05 112.53 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 79' ' ' VAL . 9.5 tp -67.86 154.59 41.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 71.33 110.889 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.5 t -142.09 137.44 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 73.1 111.096 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.669 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -136.29 121.73 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 44.21 110.914 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.47 HG12 ' CG ' ' A' ' 56' ' ' ASP . 60.1 t -66.82 111.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.54 111.104 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' CG ' HG12 ' A' ' 55' ' ' VAL . 1.3 m-20 72.56 146.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 73.42 110.939 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.713 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.5 p -85.52 -165.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 72.5 110.817 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.572 ' H ' HG23 ' A' ' 64' ' ' THR . 9.0 t -95.09 171.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 74.23 110.883 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.0 m95 -51.63 -60.07 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.34 110.952 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -129.5 159.59 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.917 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -51.37 -33.41 29.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 61.15 110.902 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.65 -38.92 79.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.868 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.2 mt -82.34 -46.01 14.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.51 110.902 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.89 -49.11 60.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 72.54 111.069 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.64 -51.47 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 73.33 110.911 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.41 -21.91 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 54.01 110.872 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.705 HD22 ' CD ' ' A' ' 30' ' ' GLU . 13.0 tp -84.64 -29.83 25.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 72.33 110.886 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.513 ' HA ' HG22 ' A' ' 71' ' ' VAL . 36.4 mt -88.72 -26.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 71.33 111.171 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.14 -0.12 47.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.942 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.8 ptm -116.58 -36.62 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 54.32 110.908 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 68' ' ' ILE . 33.5 m -78.23 -29.32 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 72.42 111.115 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.62 -32.31 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.892 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -97.2 -33.33 11.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 73.1 110.809 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HG2' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -70.34 -48.86 54.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 72.12 110.869 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 16.2 m-85 -84.18 -11.96 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.864 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.76 12.05 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 72.11 110.924 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -129.56 137.7 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 72.4 110.899 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -84.84 136.18 33.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 55.41 110.865 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 54' ' ' LEU . 57.5 t -76.6 128.98 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 73.31 111.087 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 t -146.53 14.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 74.12 111.082 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.6 ' O ' HG13 ' A' ' 53' ' ' VAL . 11.5 m-20 -159.58 136.04 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 64.24 110.871 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.14 153.17 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 75.13 111.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.558 HG21 HG22 ' A' ' 156' ' ' VAL . 4.1 mt -103.11 143.55 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 72.43 111.11 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.019 HD11 ' HB1' ' A' ' 105' ' ' ALA . 4.5 mm -106.02 145.97 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 72.23 111.164 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.2 p -112.32 -37.28 5.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 64.14 111.224 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.589 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.9 p-80 -168.41 177.97 5.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 73.4 110.807 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.943 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -96.02 79.63 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.31 111.158 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -137.69 155.35 49.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 71.24 110.897 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -20.62 10.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 63.22 111.012 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.99 11.45 18.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 53.12 110.913 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.894 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -135.97 -70.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.825 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.71 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -88.9 2.87 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 73.21 111.163 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.02 -45.78 41.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.734 . . . . 73.35 112.517 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.19 15.91 57.43 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 74.44 112.55 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.707 HD12 HH22 ' A' ' 91' ' ' ARG . 2.7 tt -52.87 -28.93 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 61.41 111.136 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.532 ' HD3' HG23 ' A' ' 95' ' ' ILE . 29.4 mmtm -59.07 -28.38 66.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 73.45 110.895 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 m -88.22 -16.59 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 73.02 111.17 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.723 ' HA ' HD13 ' A' ' 103' ' ' ILE . 10.4 mt -90.38 -41.9 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.885 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -79.51 -5.34 54.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.915 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.06 -54.99 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.845 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -64.04 -62.27 1.73 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.859 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 152.92 39.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 43.02 112.497 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -97.57 139.21 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.11 111.202 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -96.67 111.0 23.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 65.25 110.931 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 1.019 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -90.89 93.7 9.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.044 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.489 ' HB3' HD11 ' A' ' 127' ' ' LEU . 37.6 m-70 -66.49 113.85 5.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.282 -0.417 . . . . 74.15 110.865 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.45 179.67 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 63.31 110.838 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.87 157.58 17.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 64.52 111.1 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.55 -40.14 51.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 50.44 111.168 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.681 HD23 ' OD1' ' A' ' 152' ' ' ASP . 22.5 tp -75.14 -39.45 60.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 62.02 110.937 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.738 ' HA ' HD11 ' A' ' 114' ' ' LEU . 82.8 m -58.62 -21.81 54.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 73.35 111.136 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.529 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -96.06 -0.63 50.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 72.12 111.054 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -52.76 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 63.35 110.84 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.943 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.28 -13.53 60.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 73.3 110.925 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.414 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.55 -45.25 72.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 53.2 111.0 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.79 63.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -34.14 71.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.256 -0.429 . . . . 72.33 110.873 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -90.5 -19.1 24.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 44.25 110.894 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 24.62 5.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 72.55 112.561 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -99.66 177.82 5.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.864 0.364 . . . . 72.21 110.895 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -76.39 -172.95 2.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 70.31 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.11 113.8 32.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.686 0.755 . . . . 61.14 110.882 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.1 Cg_endo -69.9 -168.33 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.595 2.196 . . . . 75.34 112.342 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.74 -44.36 93.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.21 110.913 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 54.79 25.29 36.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 60.52 112.434 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -108.0 36.25 2.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.915 0.388 . . . . 72.14 110.903 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 106' ' ' HIS . 63.9 mt -122.57 -174.47 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.928 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.38 -170.05 3.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 73.41 110.912 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.853 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.08 -69.95 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.431 . . . . 50.41 111.14 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 HG22 ' A' ' 129' ' ' THR . 34.3 t -118.51 99.75 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 63.34 111.138 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.434 HG21 HD22 ' A' ' 127' ' ' LEU . 14.0 t -127.91 174.8 8.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 54.44 111.144 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.47 133.92 53.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 65.45 110.93 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 127' ' ' LEU . 39.0 mt -112.35 179.44 3.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 75.14 110.894 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 126.64 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.817 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -130.24 54.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 75.53 110.842 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.58 90.31 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 25.42 112.52 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.1 m120 64.39 14.72 9.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 73.45 110.896 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.0 tpp -133.91 97.57 3.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.15 110.936 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 136.49 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.954 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.686 HG22 HD21 ' A' ' 158' ' ' LEU . 21.7 t -139.04 117.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 73.24 111.052 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -109.11 129.96 55.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 71.41 110.883 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.8 p -85.37 -171.64 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 73.15 111.222 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -170.69 134.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 70.44 110.845 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.652 ' HB3' HG23 ' A' ' 129' ' ' THR . 76.9 t80 -123.22 88.38 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.71 0.767 . . . . 55.42 110.917 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.99 22.47 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.607 2.205 . . . . 62.15 112.367 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.45 -151.7 19.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 65.34 112.485 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -92.15 140.01 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 64.15 110.936 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.34 -88.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.706 -0.759 . . . . 72.24 112.453 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -75.02 -24.02 58.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.877 0.37 . . . . 71.43 110.838 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 86' ' ' HIS . 70.3 p -151.64 -170.23 3.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 64.45 111.097 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.64 -12.18 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.88 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.681 ' OD1' HD23 ' A' ' 110' ' ' LEU . 1.2 t0 -144.0 25.43 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 63.12 110.805 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.508 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.4 OUTLIER -56.76 132.23 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 75.31 110.92 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 84' ' ' ILE . 28.4 pt -136.89 169.88 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 74.44 111.089 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.439 ' CG1' HD23 ' A' ' 169' ' ' LEU . 24.0 m -126.37 134.13 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 65.24 111.129 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.558 HG22 HG21 ' A' ' 83' ' ' ILE . 90.6 t -86.03 133.89 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 71.32 111.163 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -121.48 130.94 53.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 60.3 110.902 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.779 HD12 HD21 ' A' ' 44' ' ' LEU . 10.6 mt -110.59 98.66 38.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.662 0.744 . . . . 54.54 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.4 Cg_endo -69.73 -4.53 14.19 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.719 2.279 . . . . 75.21 112.358 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -82.95 -24.14 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 75.34 110.938 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.63 14.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 63.04 110.877 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.25 27.52 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.856 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.546 HD13 HD13 ' A' ' 21' ' ' LEU . 96.2 mt -92.42 126.47 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 63.04 111.132 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.553 HD22 HD13 ' A' ' 203' ' ' ILE . 23.2 tp -110.89 148.26 32.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 73.54 110.852 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 72.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.0 111.148 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.46 -42.06 49.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 63.32 112.445 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.31 -155.95 44.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 63.32 112.493 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 66.1 m -51.51 -30.58 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 71.31 110.868 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.702 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.5 tp -57.51 -33.56 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 55.55 110.845 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 219' ' ' LEU . 95.6 t -105.51 104.69 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 65.3 111.176 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.539 ' HG2' HG23 ' A' ' 222' ' ' THR . 4.3 mmpt? -51.91 156.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.859 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.2 p -99.67 157.59 16.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.913 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 62.24 111.081 -179.901 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.781 0.324 . . . . 42.54 111.059 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -107.49 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 34.5 t -60.85 -17.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.32 111.121 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -74.99 -21.14 59.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 72.51 110.85 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -117.79 -12.47 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.851 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' TRP . . . . . 0.702 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.2 t90 -54.97 -60.78 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 74.02 110.929 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.684 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.81 -24.93 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 72.2 110.819 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.4 m -81.36 -31.98 33.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 74.0 111.18 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.76 -42.16 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 72.13 110.851 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.5 mm -61.85 -47.43 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.23 111.083 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -57.23 -28.07 62.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.911 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -76.59 -19.54 57.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.89 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.526 HG11 HD21 ' A' ' 219' ' ' LEU . 21.7 t -87.36 -16.09 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 71.2 111.187 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -104.95 -5.74 20.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.994 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.61 -30.69 9.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 72.45 110.876 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -104.37 -51.18 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 65.52 110.835 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.14 39.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 73.42 110.882 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -52.56 -48.67 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 73.31 110.852 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -60.44 106.25 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.929 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.721 HG21 HG22 ' A' ' 206' ' ' VAL . 42.8 mt -145.95 123.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 72.2 111.146 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.41 -35.47 54.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 74.11 110.843 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -157.83 129.38 6.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 61.12 111.082 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 203' ' ' ILE . 98.2 t -105.95 136.46 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 53.2 111.128 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 1.04 HG22 HG12 ' A' ' 213' ' ' VAL . 13.5 t -113.16 113.4 49.1 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.72 0.771 . . . . 64.34 111.082 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.511 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.0 Cg_endo -69.86 -173.41 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 63.0 112.34 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.24 -15.38 69.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 74.13 112.47 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.71 139.45 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 74.1 110.884 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.62 -117.93 5.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.827 -0.701 . . . . 71.3 112.475 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -148.94 169.09 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 73.51 110.928 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.04 HG12 HG22 ' A' ' 207' ' ' VAL . 4.3 m -61.17 161.58 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 74.1 111.071 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.06 -88.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 64.21 112.429 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -179.8 -170.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 73.15 110.875 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -60.98 -18.0 54.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 74.31 110.955 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.27 -20.98 52.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.671 -0.776 . . . . 42.14 112.455 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.511 HD13 ' HD3' ' A' ' 208' ' ' PRO . 10.8 mt -74.6 -47.83 30.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.862 0.363 . . . . 74.14 110.903 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.622 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -54.63 -55.16 32.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.96 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 221' ' ' HIS . 4.3 pp -60.83 -20.04 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 63.21 110.856 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.472 ' N ' HD12 ' A' ' 220' ' ' LEU . 1.5 t60 -69.74 -39.32 76.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 71.32 110.851 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.8 m -53.19 -50.38 64.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 64.45 111.106 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.36 -17.73 55.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 71.53 110.919 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -87.44 -5.67 58.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.878 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.62 -5.28 6.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 64.02 110.968 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.684 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -118.87 4.87 11.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 72.31 110.965 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 75.15 110.857 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.823 0.344 . . . . 72.14 110.81 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -85.61 121.41 28.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 75.14 110.918 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -150.55 156.56 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.843 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.55 168.01 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 74.2 111.261 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -118.42 72.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 74.12 110.851 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -122.06 173.38 7.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.7 m -114.66 -53.33 2.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 53.54 111.127 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.6 m -58.86 -176.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 73.3 111.067 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.82 91.82 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.44 111.101 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -111.88 117.84 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 73.32 110.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -60.79 168.96 2.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.873 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.96 -47.94 64.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 62.31 110.881 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -61.08 -37.54 83.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.15 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.3 13.32 61.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.669 -0.777 . . . . 55.11 112.542 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.4 m -79.14 -44.8 21.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 75.24 111.092 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 67' ' ' LEU . 32.1 mt -103.59 117.46 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 44.21 111.176 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -124.46 129.12 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 74.45 110.843 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.694 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -120.44 112.55 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 53.53 111.105 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.443 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -98.31 128.76 44.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 71.42 110.86 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -73.55 110.93 8.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 72.21 110.89 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 213' ' ' VAL . 10.8 mt -65.37 -32.99 74.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 43.41 110.879 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.85 -97.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 64.44 110.872 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.09 9.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 73.15 110.864 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.53 8.25 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 75.4 110.829 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -150.89 141.14 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 71.52 111.095 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.694 ' HB3' HG22 ' A' ' 18' ' ' ILE . 19.6 m95 -130.0 -179.39 5.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 65.11 110.878 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 43' ' ' GLY . 93.0 t -132.0 89.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 64.5 111.096 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.406 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.3 p80 -72.78 124.38 25.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 65.51 110.834 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -119.93 104.2 9.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 70.1 111.128 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -88.13 123.27 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.791 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -88.8 117.8 28.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 72.14 110.874 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.43 -124.87 3.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 52.22 112.514 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.2 p -175.18 116.71 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.893 0.378 . . . . 73.24 110.823 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.21 42.33 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 62.41 110.85 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 m120 64.2 69.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.907 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.17 -18.28 36.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.804 -0.712 . . . . 61.15 112.5 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -119.48 -177.42 3.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.83 0.347 . . . . 75.22 110.933 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.791 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -109.86 143.92 39.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 51.24 111.07 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.6 79.89 71.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.58 0.705 . . . . 75.24 111.181 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 118.33 5.62 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.738 2.292 . . . . 71.25 112.348 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -110.21 99.91 8.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 71.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -62.42 170.37 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 75.42 110.93 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -159.28 -147.46 4.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 30.04 112.527 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.8 tp -159.58 116.28 2.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 73.55 110.885 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.652 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.52 121.83 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 54.01 111.155 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.46 HD22 ' SD ' ' A' ' 138' ' ' MET . 24.7 mt -98.7 118.23 34.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 64.2 110.966 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.39 85.93 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.936 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.78 177.15 4.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 73.03 111.092 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -97.94 -20.84 17.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 61.11 110.823 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -10.4 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 65.3 110.902 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.62 153.54 5.91 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 72.24 112.523 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.0 tp -68.54 154.95 40.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 64.14 110.905 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.3 t -145.15 142.99 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 73.13 111.107 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.652 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -137.56 124.61 21.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.905 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.538 HG12 ' OD1' ' A' ' 56' ' ' ASP . 74.1 t -71.51 112.44 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 54.42 111.137 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.8 m-20 73.4 121.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 71.0 110.882 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.67 ' CB ' HD11 ' A' ' 98' ' ' LEU . 2.8 p -66.12 -166.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 65.35 110.844 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.6 t -91.9 169.48 10.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.85 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.714 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.1 m95 -50.38 -60.25 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.828 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -129.82 158.51 39.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 75.15 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -51.37 -33.75 31.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.972 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.21 -38.11 76.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 71.23 110.926 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 59' ' ' TRP . 93.1 mt -81.15 -45.54 16.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.934 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -45.14 61.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.132 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -52.93 -51.59 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 74.35 110.952 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -63.71 -19.71 65.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 71.13 110.913 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.1 tp -87.94 -26.86 22.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.877 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.75 -23.09 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 72.42 111.265 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.09 18.18 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 74.33 110.865 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.3 ptm -132.9 -40.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 71.5 110.866 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.1 m -81.07 -22.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 70.2 111.163 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.623 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.81 -21.95 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.902 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -109.04 -33.27 6.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 73.15 110.851 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.93 -43.48 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.908 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.17 -10.87 48.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 62.3 110.895 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 67.42 13.27 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 73.13 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.545 ' HB2' HD13 ' A' ' 52' ' ' LEU . 5.3 mttm -131.33 138.76 49.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 62.22 110.954 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -85.8 137.94 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.22 110.833 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.623 HG23 ' OE1' ' A' ' 72' ' ' GLU . 98.8 t -76.91 126.39 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 71.21 111.103 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -143.79 13.89 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.11 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 53' ' ' VAL . 53.8 m-20 -155.89 144.15 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.04 110.906 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 54' ' ' LEU . 14.5 t -154.41 131.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.4 111.161 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.497 ' CD1' HG11 ' A' ' 140' ' ' VAL . 49.6 mt -89.4 130.73 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 61.32 111.105 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -106.28 124.94 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.12 111.157 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.472 HG23 ' OD2' ' A' ' 56' ' ' ASP . 30.7 p -82.53 -39.54 22.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 72.01 111.167 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.485 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.8 p80 -165.94 -175.29 3.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 71.11 110.931 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.808 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.24 95.83 10.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 71.21 111.108 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.88 154.08 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.35 110.832 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.13 -20.19 51.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 73.5 111.049 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.8 5.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 61.14 110.918 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.419 ' HD3' ' CE1' ' A' ' 86' ' ' HIS . 3.8 mpt_? -122.11 -77.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 73.12 110.791 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.14 8.48 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 62.33 111.086 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.38 -42.32 33.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 70.34 112.476 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.61 13.1 58.15 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 23.13 112.468 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.5 tt -51.42 -29.63 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 71.1 111.086 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -32.11 45.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 72.22 110.984 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.6 m -89.78 -22.72 22.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 74.42 111.132 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.67 HD11 ' CB ' ' A' ' 57' ' ' SER . 13.3 mt -80.54 -25.98 38.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.906 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.73 15.3 29.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.913 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.03 -40.93 3.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.24 110.89 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -83.19 -58.14 2.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 64.41 110.928 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.56 38.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 72.43 112.545 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.2 mp -106.05 115.12 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 74.34 111.111 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HB3' HD11 ' A' ' 124' ' ' LEU . 2.6 mttt -78.84 116.31 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 53.44 110.911 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.43 93.15 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 54.55 111.127 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.575 ' HA ' HD12 ' A' ' 124' ' ' LEU . 38.0 m-70 -67.66 129.44 39.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.912 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.627 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -159.11 -178.98 7.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 52.5 110.924 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.89 157.75 17.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.133 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.03 -36.94 30.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 63.43 111.109 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.614 HD21 ' HG2' ' A' ' 151' ' ' GLU . 0.3 OUTLIER -72.11 -39.42 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.99 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.742 ' HA ' HD11 ' A' ' 114' ' ' LEU . 83.6 m -57.87 -27.72 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 64.42 111.186 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.31 4.7 53.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 42.02 111.018 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -103.61 -44.81 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.889 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -85.07 -13.86 49.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.959 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.483 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -62.62 -43.12 99.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.097 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.15 62.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.944 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -35.55 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 64.54 110.838 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.39 -23.53 22.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.25 110.917 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.59 22.99 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 53.33 112.447 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -94.84 179.14 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.344 . . . . 64.32 110.883 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -77.41 -176.18 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 72.1 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mt-10 -115.35 101.52 54.37 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.634 0.73 . . . . 75.32 110.852 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.4 Cg_endo -69.76 -179.85 3.2 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.742 2.295 . . . . 65.14 112.341 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 106' ' ' HIS . 29.4 mt -51.24 -52.55 43.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 73.55 110.858 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 58.75 21.94 52.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 74.22 112.444 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.37 24.14 6.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 74.02 110.886 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.688 ' CD2' HD21 ' A' ' 133' ' ' LEU . 95.5 mt -103.99 -175.9 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 61.5 110.942 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -154.99 -171.55 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 52.13 110.826 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.934 HG22 HG23 ' A' ' 130' ' ' VAL . 36.6 m -50.94 -70.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 54.1 111.087 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.934 HG23 HG22 ' A' ' 129' ' ' THR . 44.4 t -119.11 104.06 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 70.2 111.218 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -135.15 164.2 28.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 73.12 111.22 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.93 126.61 54.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.283 -0.417 . . . . 75.13 111.0 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.688 HD21 ' CD2' ' A' ' 127' ' ' LEU . 67.0 mt -111.49 155.7 22.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.35 110.912 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -137.87 117.19 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 62.54 110.872 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.19 48.93 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 74.33 110.886 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.33 94.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.751 . . . . 65.11 112.45 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.35 15.36 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 43.31 110.887 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.46 ' SD ' HD22 ' A' ' 46' ' ' LEU . 54.8 tpp -137.45 101.37 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 62.23 110.898 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.464 ' O ' HD23 ' A' ' 158' ' ' LEU . 2.9 mptt -90.81 132.56 35.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 75.44 110.773 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.727 HG22 HD21 ' A' ' 158' ' ' LEU . 21.2 t -138.5 114.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.061 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -107.6 129.58 54.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 75.04 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 46.9 p -86.08 178.09 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 72.11 111.183 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.515 ' HD1' HG22 ' A' ' 130' ' ' VAL . 19.4 t80 -161.63 133.69 5.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 70.05 110.858 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.678 ' HB3' HG23 ' A' ' 129' ' ' THR . 9.1 t80 -121.78 86.48 45.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 75.33 110.872 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -8.04 22.6 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.767 2.311 . . . . 74.53 112.31 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.36 -160.94 24.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 73.51 112.434 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -87.77 140.76 29.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 74.24 110.844 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.537 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -154.6 -91.11 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 62.43 112.459 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -73.79 -23.51 59.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 71.33 110.959 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.485 HG21 ' HB2' ' A' ' 86' ' ' HIS . 47.2 p -150.29 -167.38 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 43.33 111.167 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.645 ' HB3' HD23 ' A' ' 114' ' ' LEU . 2.0 tt0 -86.32 -15.98 38.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 74.1 110.853 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.567 ' HB2' HD23 ' A' ' 110' ' ' LEU . 41.0 t0 -135.53 17.96 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.871 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.684 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -51.45 129.59 25.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 64.42 110.818 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 144' ' ' TYR . 5.8 pt -136.54 175.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.08 -0.509 . . . . 74.5 111.065 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -128.35 119.51 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.162 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.47 126.58 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 62.44 111.108 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -115.25 138.8 50.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 71.42 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.727 HD21 HG22 ' A' ' 140' ' ' VAL . 20.1 mt -121.34 98.91 46.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.652 0.739 . . . . 75.44 110.846 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -4.13 13.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.707 2.271 . . . . 63.1 112.287 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -85.16 -22.97 28.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.317 -0.401 . . . . 52.33 110.974 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.41 12.28 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 62.03 111.042 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.3 m120 54.68 25.68 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 41.54 110.819 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 93.5 mt -90.48 142.95 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 65.41 111.196 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.637 HD22 HD13 ' A' ' 203' ' ' ILE . 13.2 tp -128.43 146.38 50.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 64.25 110.917 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 55' ' ' VAL . 42.1 t -115.17 76.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 63.51 111.126 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.09 -28.99 19.91 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.808 -0.711 . . . . 70.22 112.49 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.41 -161.72 20.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 73.41 112.465 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -33.18 60.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 53.41 110.868 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.684 HD13 ' OD1' ' A' ' 153' ' ' ASN . 25.1 tp -51.85 -35.86 46.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.924 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.91 111.16 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.42 111.078 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.57 ' HD2' ' HB1' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -57.71 159.73 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 62.21 110.858 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.7 p -100.27 162.78 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.812 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 t -54.63 -28.7 48.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 64.21 111.075 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.46 44.96 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 70.13 110.854 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.57 ' HB1' ' HD2' ' A' ' 171' ' ' LYS . . . -130.14 156.1 45.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 53.32 111.021 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.466 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -122.53 -4.94 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.44 110.832 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 0.8 OUTLIER -179.73 175.63 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.01 110.86 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.763 HD11 ' HB2' ' A' ' 226' ' ' LEU . 7.6 mt -74.77 -44.46 49.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 74.15 110.918 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.71 123.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.802 -0.713 . . . . 75.15 112.446 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.11 103.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 73.33 110.995 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.0 m -123.72 19.76 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 72.53 111.081 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.3 -44.02 84.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 54.23 111.061 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -98.25 13.76 30.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.874 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -123.64 167.01 14.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 34.42 111.104 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.98 90.49 3.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.959 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.96 -17.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 54.32 111.271 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -74.39 -27.81 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 71.31 110.949 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -110.97 -12.92 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 61.21 110.857 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.576 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.3 t90 -54.09 -62.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 64.5 110.918 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.687 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -54.56 -23.73 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 72.23 110.822 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.2 m -81.43 -30.48 33.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 70.31 111.168 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.22 -43.63 41.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.889 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.512 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.7 mm -61.83 -45.2 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 74.13 111.144 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.52 -23.96 53.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 54.43 110.883 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.99 -22.79 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 74.4 110.864 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 192' ' ' SER . 17.4 t -86.11 -9.0 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.41 111.137 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.69 -6.93 13.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 55.04 110.941 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.46 -31.06 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 72.14 110.939 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -55.98 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.856 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -94.89 38.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.84 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -55.53 -47.97 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 75.23 110.948 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -60.05 102.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 73.24 110.829 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.669 HG21 HG22 ' A' ' 206' ' ' VAL . 41.9 mt -144.69 125.12 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 75.03 111.151 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -24.2 41.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 55.25 110.905 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.721 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -168.15 133.71 1.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 64.33 111.089 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' A' ' 218' ' ' LEU . 88.8 t -115.02 131.61 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 65.41 111.092 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.069 HG22 HG22 ' A' ' 213' ' ' VAL . 13.6 t -110.15 108.88 58.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 74.34 111.13 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.7 Cg_endo -69.7 -176.01 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 72.13 112.353 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.41 -17.36 80.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 71.52 112.476 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -152.43 141.15 20.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 74.5 110.972 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 110.21 -117.64 4.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 74.05 112.488 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.63 176.16 11.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.358 . . . . 62.22 110.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.069 HG22 HG22 ' A' ' 207' ' ' VAL . 5.8 t -70.09 151.12 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 61.32 111.146 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.99 -102.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.737 -0.744 . . . . 65.15 112.447 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.67 -168.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 72.13 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -60.93 -18.14 55.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 72.33 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.499 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.77 -19.79 37.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.799 -0.715 . . . . 61.32 112.506 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.738 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.6 mt -73.23 -31.78 64.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 61.11 110.878 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.512 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -62.8 -57.3 11.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 72.21 111.027 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 223' ' ' LEU . 0.5 OUTLIER -62.12 -17.93 59.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 41.01 110.937 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.9 OUTLIER -66.24 -40.99 90.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.874 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.906 HG22 HD23 ' A' ' 226' ' ' LEU . 27.8 m -60.94 -47.98 83.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 63.22 111.169 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -67.97 -21.99 65.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.949 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -75.4 -6.54 50.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 72.23 110.905 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 176' ' ' LYS . 4.7 mt -125.13 -35.68 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 44.45 110.859 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.906 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -85.45 -0.82 56.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.912 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 75.45 110.894 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.742 0.306 . . . . 73.32 110.87 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -138.74 179.08 6.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 74.45 110.931 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -170.56 141.85 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 61.22 110.864 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -56.54 146.86 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 73.34 111.096 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.29 169.67 15.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.503 . . . . 74.11 110.874 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -68.74 -176.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.11 110.899 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -86.76 -68.68 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 70.22 111.141 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t -50.53 147.31 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 71.01 111.171 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mt -110.48 97.17 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 71.21 111.201 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.94 121.01 39.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 65.4 110.906 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -66.78 168.16 10.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 71.42 110.837 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -52.18 -48.14 65.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.45 110.844 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.98 -37.83 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 72.5 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.93 13.12 62.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 55.14 112.55 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 m -80.47 -44.26 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.278 . . . . 72.42 111.134 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 67' ' ' LEU . 52.8 mt -101.97 113.02 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 73.43 111.097 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.4 p -121.15 129.06 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 51.23 110.871 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.808 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.1 mt -120.41 111.83 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 72.04 111.121 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.2 t -97.01 126.53 42.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 64.24 110.894 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -72.15 109.34 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.892 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.848 HD21 HG11 ' A' ' 213' ' ' VAL . 6.7 mt -63.0 -35.26 79.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.964 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.68 -96.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.915 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.24 9.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.944 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.15 8.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 75.31 110.981 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -150.91 140.34 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 62.31 111.245 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.808 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.7 m95 -129.58 -179.71 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.437 . . . . 74.03 110.973 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.28 88.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 75.32 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -71.3 123.17 21.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 52.44 110.851 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.1 m -119.78 105.1 10.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 63.14 111.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.408 ' CG ' HD22 ' A' ' 67' ' ' LEU . 3.5 mp0 -87.05 122.64 31.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.882 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.738 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -90.53 108.5 19.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 74.42 110.896 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.69 -128.34 1.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.786 -0.721 . . . . 62.25 112.513 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 p -175.1 115.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 71.02 110.831 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.37 41.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 71.42 110.918 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 m120 64.31 68.23 0.56 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 74.05 110.909 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.49 -15.8 41.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 61.13 112.478 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -121.69 159.31 26.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 71.13 110.885 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.738 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -98.66 134.24 41.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 64.11 111.044 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.07 81.89 56.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.553 0.692 . . . . 71.23 111.228 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.63 116.9 4.76 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.738 2.292 . . . . 60.24 112.405 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.2 p -104.44 98.34 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 54.22 110.839 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.51 169.25 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.893 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -148.71 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.839 -0.696 . . . . 54.53 112.586 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.627 HD21 HD12 ' A' ' 158' ' ' LEU . 15.8 tp -158.62 115.19 2.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 54.53 110.943 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.685 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -98.56 121.8 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 63.51 111.139 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.736 HD21 HD11 ' A' ' 158' ' ' LEU . 19.4 mt -98.84 116.51 31.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.958 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -87.38 85.49 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.44 110.953 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.6 176.18 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 65.42 111.115 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -96.67 -21.5 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 43.55 110.831 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -11.18 57.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 74.22 110.868 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.08 153.67 5.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 72.1 112.466 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.2 tp -68.39 155.03 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 72.35 110.951 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.2 t -145.57 142.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 71.33 111.153 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.685 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -137.53 122.84 19.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 74.01 110.959 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 165' ' ' VAL . 76.3 t -69.2 110.51 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 72.32 111.109 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.2 129.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 70.13 110.91 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.677 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -72.52 -165.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 60.01 110.809 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -91.37 172.66 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 52.1 110.839 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.742 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.9 m95 -49.94 -52.04 36.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 70.03 110.978 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -141.63 162.6 35.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 74.33 110.874 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.71 -30.59 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.428 . . . . 64.04 110.832 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -59.74 -42.08 92.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 71.24 110.951 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.742 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.0 mt -83.08 -45.37 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 74.32 110.866 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -45.87 59.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 72.34 111.167 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -55.58 -48.12 75.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 61.03 110.872 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.98 -18.91 65.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.901 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.578 ' O ' HG22 ' A' ' 71' ' ' VAL . 19.1 tp -89.59 -27.14 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 54.14 110.915 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.08 -22.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 71.31 111.145 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.55 15.72 13.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.871 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.46 -39.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 63.34 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.9 m -80.39 -22.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 60.12 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.554 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.75 -23.07 65.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.842 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 -33.52 7.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 74.24 110.842 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -69.91 -39.24 76.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 65.33 110.894 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -92.71 -10.44 37.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.879 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.65 12.05 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 65.15 110.916 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.523 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -130.48 137.83 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 54.01 110.868 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -86.49 138.21 31.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 73.32 110.898 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 54' ' ' LEU . 71.4 t -76.4 121.94 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 55.43 111.134 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.7 t -134.32 6.59 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.134 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 53' ' ' VAL . 60.1 m-20 -151.23 145.7 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.31 110.837 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 54' ' ' LEU . 10.8 t -154.03 132.22 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.075 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -93.89 123.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 72.53 111.163 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.6 mm -96.55 143.45 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.175 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.0 p -94.11 -51.42 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 75.2 111.176 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -156.1 -175.88 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.829 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.86 97.13 10.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 72.01 111.117 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -158.11 150.92 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 71.34 110.858 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.07 -19.61 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 61.04 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -92.29 21.83 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.809 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -144.0 -77.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 71.55 110.837 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -88.87 8.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 64.3 111.136 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -41.8 38.37 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.709 -0.758 . . . . 65.2 112.503 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.45 12.04 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 72.24 112.458 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 92' ' ' ILE . 3.5 tt -51.97 -28.49 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 63.43 111.104 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -53.58 -39.84 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 75.04 110.87 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.9 m -79.94 -17.29 53.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 52.02 111.192 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.677 HD11 ' OG ' ' A' ' 57' ' ' SER . 17.3 mt -84.99 -32.34 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 75.54 110.906 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.71 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.87 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -119.63 -45.74 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -77.36 -53.41 7.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.31 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.31 44.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 41.23 112.474 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -109.0 121.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.945 0.403 . . . . 74.4 111.14 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.769 ' HE2' HD21 ' A' ' 124' ' ' LEU . 7.7 mtpt -82.05 111.42 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 70.3 110.968 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.12 91.28 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.077 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.561 ' HA ' HD12 ' A' ' 124' ' ' LEU . 56.2 m-70 -62.98 142.16 58.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.01 110.865 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.629 ' CA ' HD12 ' A' ' 127' ' ' LEU . 3.4 p -172.9 179.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 53.24 110.882 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.85 157.47 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.41 111.208 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.99 -31.74 13.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 64.42 111.029 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.567 HD23 ' HB3' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -77.76 -39.38 44.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 72.44 110.908 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.569 ' HA ' HD11 ' A' ' 114' ' ' LEU . 10.2 m -57.37 -27.7 62.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 74.12 111.151 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -98.33 8.58 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.12 111.084 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.99 -28.78 11.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 75.41 110.898 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -103.36 -8.64 20.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.884 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.46 79.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 71.43 111.146 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -26.68 57.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 72.42 110.901 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -57.58 -30.75 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 64.04 110.933 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -92.11 -24.8 19.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 74.43 110.947 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.18 25.76 4.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 72.12 112.48 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.33 -176.08 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 73.23 110.955 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.61 167.75 17.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 71.34 110.853 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.6 mt-10 -101.25 103.25 24.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.7 0.762 . . . . 64.24 110.818 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.0 Cg_endo -69.73 -178.63 2.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 71.12 112.313 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.769 HD21 ' HE2' ' A' ' 104' ' ' LYS . 28.9 mt -51.64 -51.29 56.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.92 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.11 24.72 36.7 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.729 . . . . 64.22 112.437 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.78 29.31 5.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 72.34 110.898 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.696 ' CD2' HD21 ' A' ' 133' ' ' LEU . 95.6 mt -108.91 -175.8 2.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 55.42 110.903 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -150.87 -172.63 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 74.45 110.938 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.867 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.91 -70.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 64.3 111.127 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 129' ' ' THR . 38.8 t -117.77 103.1 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 73.41 111.111 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -131.78 174.34 10.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 55.31 111.152 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.32 129.36 50.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 73.24 110.878 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.696 HD21 ' CD2' ' A' ' 127' ' ' LEU . 60.8 mt -113.29 156.98 22.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 65.31 110.934 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -139.36 115.31 10.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.869 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -113.36 48.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 65.52 110.918 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.43 94.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 72.12 112.382 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 m120 65.1 14.2 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 63.3 110.885 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.5 tpp -133.43 104.29 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 64.12 110.88 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.68 123.78 36.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 61.14 110.883 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.959 HG22 HD21 ' A' ' 158' ' ' LEU . 21.5 t -131.92 117.86 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 70.43 111.116 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -111.13 127.91 55.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.51 110.884 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.58 -172.49 4.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 61.34 111.175 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HB3' HG23 ' A' ' 155' ' ' VAL . 37.7 t80 -172.83 135.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 74.11 110.899 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.694 ' HB3' HG23 ' A' ' 129' ' ' THR . 90.2 t80 -120.95 89.63 46.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.742 . . . . 73.03 110.89 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.7 Cg_endo -69.76 -7.89 22.2 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.661 2.241 . . . . 75.1 112.401 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.28 -150.08 19.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 74.52 112.527 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -96.53 139.12 33.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 74.54 110.886 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.451 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -152.0 -95.22 0.12 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 41.0 112.461 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 84.7 t60 -69.6 -24.44 63.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 73.32 110.982 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 p -151.4 -171.45 3.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 52.31 111.145 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.91 -8.4 57.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 75.24 110.89 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.567 ' HB3' HD23 ' A' ' 110' ' ' LEU . 3.7 p-10 -136.86 14.98 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 60.33 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.414 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.3 OUTLIER -53.07 137.95 32.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 72.1 110.906 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.69 -179.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.114 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.573 HG12 ' HA2' ' A' ' 166' ' ' GLY . 6.5 m -135.12 126.58 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 71.42 111.16 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.414 ' O ' HD12 ' A' ' 164' ' ' LEU . 99.9 t -85.96 122.94 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.35 111.094 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -110.7 133.05 53.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 73.3 110.91 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.959 HD21 HG22 ' A' ' 140' ' ' VAL . 10.9 mt -115.01 98.65 50.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 71.14 110.978 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -4.02 13.14 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 61.12 112.339 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -83.36 -23.85 32.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.954 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.25 14.49 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 75.22 110.922 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.19 27.36 7.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 72.52 110.858 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.557 HD13 HD13 ' A' ' 21' ' ' LEU . 96.2 mt -92.54 129.87 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 71.03 111.166 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.547 HD11 ' HB ' ' A' ' 155' ' ' VAL . 23.0 tp -115.5 147.68 40.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 64.41 110.947 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 55' ' ' VAL . 37.6 t -117.73 74.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 72.42 111.124 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.573 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -51.79 -41.49 51.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 74.35 112.534 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.49 -160.48 53.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.832 -0.699 . . . . 54.31 112.419 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 45.8 m -51.72 -30.1 21.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.368 . . . . 71.22 110.893 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.725 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.6 tp -57.83 -32.49 67.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 70.4 110.947 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 219' ' ' LEU . 80.1 t -105.98 109.73 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 51.01 111.16 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.661 ' HG2' HG23 ' A' ' 222' ' ' THR . 2.5 mmpt? -51.54 161.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 73.35 110.884 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.544 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -100.86 168.62 9.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 55.14 110.907 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -62.14 146.85 49.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 73.42 111.107 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 m 65.7 20.78 11.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 70.14 110.882 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.509 ' HB3' HD11 ' A' ' 225' ' ' LEU . . . -72.81 153.84 40.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 34.02 111.165 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -118.8 -16.82 9.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 70.43 110.946 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 0.5 OUTLIER 179.95 176.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.853 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 226' ' ' LEU . 4.7 mt -83.39 -38.56 21.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 73.1 110.942 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 105.96 -152.41 17.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 75.41 112.514 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -57.41 107.38 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.902 0.382 . . . . 32.52 110.879 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.423 HG11 ' CG2' ' A' ' 186' ' ' VAL . 32.2 m -96.84 24.49 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 61.03 111.097 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -69.36 -27.82 65.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 74.44 111.087 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -114.1 24.94 11.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 75.31 110.81 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -141.73 164.86 29.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 43.34 111.047 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.61 91.91 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 73.53 110.932 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.423 ' CG2' HG11 ' A' ' 181' ' ' VAL . 11.7 t -62.49 -21.31 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 62.13 111.088 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.41 -21.71 60.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 75.41 110.82 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -114.93 -12.9 11.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 61.3 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.725 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.9 t90 -56.73 -62.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 64.21 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.722 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.5 -23.63 17.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 70.14 110.865 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 58.0 m -80.66 -33.31 35.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 61.21 111.155 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.89 -43.75 62.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 72.11 110.885 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.1 mm -59.56 -47.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 74.12 111.143 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.41 -27.78 62.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 64.01 110.852 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -77.43 -20.69 54.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 73.3 110.86 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.513 HG11 HD21 ' A' ' 219' ' ' LEU . 18.4 t -86.57 -13.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 63.25 111.156 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -108.38 -16.55 14.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.867 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -93.35 -30.6 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 65.54 110.849 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 -50.4 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 72.13 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.84 66.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 71.11 110.847 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.3 mtm-85 -72.91 -59.78 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 74.14 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -51.63 107.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 54.11 110.9 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.615 HG21 HG22 ' A' ' 206' ' ' VAL . 85.0 mt -146.61 122.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 74.34 111.12 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.93 -32.13 45.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.863 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 213' ' ' VAL . . . -161.72 147.62 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 64.35 111.09 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.615 HG22 HG21 ' A' ' 203' ' ' ILE . 47.6 t -123.47 126.74 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 62.14 111.108 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.823 HG22 ' HB ' ' A' ' 213' ' ' VAL . 17.0 t -103.29 104.07 38.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.565 0.697 . . . . 64.25 111.166 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.553 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.7 Cg_endo -69.73 -174.78 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.784 2.323 . . . . 64.23 112.33 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.1 75.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.786 . . . . 52.13 112.548 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.33 140.64 20.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 71.33 110.86 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.6 -117.26 4.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 41.23 112.397 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -157.02 149.14 22.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 65.2 110.916 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.848 HG11 HD21 ' A' ' 21' ' ' LEU . 4.0 p -51.55 137.6 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 52.23 111.115 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -135.03 -88.58 0.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 60.11 112.469 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -171.65 -168.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.963 0.411 . . . . 65.15 110.829 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.445 ' HA ' HD12 ' A' ' 219' ' ' LEU . 3.1 pttm -61.73 -17.26 55.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 70.33 110.92 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.81 -19.93 38.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 55.23 112.46 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.569 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.7 mt -77.4 -47.13 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 73.31 110.82 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.618 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -53.72 -54.61 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.33 110.978 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 221' ' ' HIS . 4.2 pp -60.72 -21.24 62.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.01 110.913 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.49 ' N ' HD12 ' A' ' 220' ' ' LEU . 0.8 OUTLIER -69.61 -37.65 76.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 70.24 110.889 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.73 HG22 HD23 ' A' ' 226' ' ' LEU . 3.5 m -55.39 -54.88 38.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 72.3 111.15 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.88 -19.87 53.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 72.33 110.897 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -83.58 -5.17 59.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 61.14 110.897 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 175' ' ' ALA . 2.8 mt -129.14 -4.56 4.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 63.34 110.869 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.808 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.5 OUTLIER -121.77 -0.19 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 74.14 110.961 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.098 -0.501 . . . . 63.51 110.988 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.841 0.353 . . . . 73.11 110.898 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -99.41 162.77 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 64.51 110.937 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 165.87 26.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 54.41 110.815 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.3 m -93.28 -179.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 41.15 111.118 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -137.24 72.39 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 71.33 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -136.64 169.24 18.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 73.12 110.926 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -88.47 -51.98 5.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 61.04 111.159 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 19' ' ' SER . 4.9 m -59.13 -175.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.31 111.182 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 mt -136.43 92.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 64.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -113.79 115.09 27.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.493 . . . . 70.21 110.909 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -58.96 168.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 63.33 110.874 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -51.3 -47.79 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.42 110.912 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 34.5 p -61.24 -37.45 83.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 55.55 111.075 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.66 14.13 61.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.746 . . . . 72.52 112.527 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.3 m -80.14 -44.34 20.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.308 . . . . 61.42 111.118 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.54 114.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 71.21 111.14 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -121.55 127.52 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.838 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.689 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -120.97 112.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 74.5 111.13 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.41 ' HA ' HG12 ' A' ' 8' ' ' VAL . 17.5 t -99.05 125.97 44.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 63.1 110.84 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -69.83 111.3 5.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 64.51 110.872 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.678 HD21 HG11 ' A' ' 213' ' ' VAL . 11.2 mt -65.17 -32.69 74.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.907 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.04 -96.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.52 110.977 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.33 9.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.13 110.947 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.84 7.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.911 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.99 141.9 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.42 111.183 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.689 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.8 m95 -130.04 -177.81 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.94 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 43' ' ' GLY . 90.7 t -133.4 91.76 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.311 -0.404 . . . . 63.12 111.191 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -75.16 123.55 25.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 70.3 110.824 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.5 m -120.33 104.24 9.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 51.35 111.212 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 124.34 31.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 73.54 110.824 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.759 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -87.5 113.77 23.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 61.11 110.938 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.77 -145.41 10.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 53.3 112.477 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.91 119.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 50.22 110.92 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -144.84 136.23 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 72.42 110.957 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 50.48 27.75 3.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 71.43 110.919 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 41.92 23.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.661 -0.781 . . . . 71.23 112.473 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -147.73 130.82 16.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.36 . . . . 72.2 110.818 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.759 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -60.02 149.09 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 44.41 111.081 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -139.41 79.65 24.55 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.713 0.768 . . . . 55.44 111.163 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.65 117.43 5.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.735 2.29 . . . . 75.32 112.394 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -109.41 97.4 6.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 70.11 110.792 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -58.25 166.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 73.44 110.892 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -158.05 -149.39 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 52.25 112.477 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 158' ' ' LEU . 15.5 tp -158.28 119.31 3.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 63.05 110.917 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.661 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -103.16 122.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 63.24 111.07 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.88 HD21 HD11 ' A' ' 158' ' ' LEU . 23.5 mt -100.42 120.74 40.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 51.43 110.963 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -91.47 84.67 5.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 74.04 110.893 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.2 p -99.54 -176.53 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.169 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 -26.47 13.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.2 110.886 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -18.7 55.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 65.41 110.86 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.17 151.47 5.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 55.42 112.479 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.709 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.9 mt -62.94 154.8 29.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.339 . . . . 62.01 110.839 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.1 t -144.22 141.27 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 63.25 111.131 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -136.55 121.82 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 72.33 110.891 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.444 HG11 HG11 ' A' ' 165' ' ' VAL . 79.8 t -68.24 111.97 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 64.2 111.054 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.8 129.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 74.23 110.792 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.615 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -71.9 -167.14 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 64.13 110.917 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.465 ' H ' HG23 ' A' ' 64' ' ' THR . 8.3 t -91.24 170.53 9.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 64.12 110.864 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.714 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.4 m95 -51.07 -60.28 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 71.0 110.91 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.02 159.26 35.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.258 -0.428 . . . . 54.31 110.876 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -51.44 -32.8 28.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.872 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -58.57 -44.13 89.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 73.2 110.918 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.4 mt -75.53 -45.5 37.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 62.14 110.96 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.6 -48.52 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 75.44 111.14 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -53.54 -48.4 69.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.23 110.931 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -65.61 -18.97 65.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.47 . . . . 71.02 110.9 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.8 tp -88.62 -27.1 21.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 73.45 110.936 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.2 mt -90.47 -23.01 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 72.31 111.105 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -92.81 17.32 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 72.24 110.895 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.8 ptm -131.95 -39.89 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 62.34 110.867 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.4 m -80.18 -24.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 75.35 111.205 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.708 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.37 -23.14 66.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 65.11 110.929 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 -32.14 7.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 55.23 110.946 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -40.93 67.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.41 110.953 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 52' ' ' LEU . 15.8 m-85 -89.43 -12.12 41.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.53 110.923 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.34 11.71 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 63.41 110.861 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.464 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -131.8 141.4 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 72.13 110.936 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -86.2 140.99 29.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.275 -0.421 . . . . 74.13 110.846 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 52' ' ' LEU . 85.0 t -82.07 126.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.4 111.137 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -142.46 13.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 70.24 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 53' ' ' VAL . 61.7 m-20 -153.75 144.74 22.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 71.45 110.874 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 54' ' ' LEU . 16.5 t -154.31 132.61 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 72.01 111.167 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.506 ' CD1' HG11 ' A' ' 140' ' ' VAL . 46.9 mt -92.58 126.72 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 72.3 111.097 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -102.85 136.32 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 51.43 111.066 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 -44.59 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.1 111.265 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -152.46 174.94 13.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.901 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.479 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -95.65 88.9 5.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 44.24 111.061 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.95 156.04 43.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 73.01 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -21.72 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 50.52 111.04 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 20.49 7.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 62.22 110.883 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -140.62 -75.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -92.99 8.14 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 70.41 111.074 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -36.56 28.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 63.44 112.46 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.03 15.26 51.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 65.41 112.534 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 92' ' ' ILE . 19.1 tt -56.57 -29.98 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 75.34 111.087 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -30.67 62.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.23 110.86 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -90.0 -11.81 40.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 71.34 111.166 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 57' ' ' SER . 17.4 mt -91.01 -28.77 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 60.25 110.971 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -100.03 22.21 11.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 70.22 110.916 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -121.7 -36.51 3.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.32 110.932 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -87.41 -53.94 4.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.088 -0.505 . . . . 73.03 110.894 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.1 38.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 64.52 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.548 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.4 mp -110.25 124.36 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.35 . . . . 74.41 111.132 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.709 ' HE2' HD21 ' A' ' 124' ' ' LEU . 3.4 mtpp -89.79 118.44 29.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 65.04 110.894 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.9 92.05 8.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 50.4 111.113 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.526 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.6 m-70 -66.29 144.03 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.55 110.751 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.61 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -178.38 -174.19 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 55.22 110.857 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -94.97 155.37 16.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 74.21 111.144 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.62 -39.98 37.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.12 111.16 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.0 -43.45 87.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.934 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.65 ' HA ' HD11 ' A' ' 114' ' ' LEU . 93.5 m -58.77 -21.61 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 72.34 111.098 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.43 12.26 37.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 63.21 111.138 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -25.81 9.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 63.13 110.943 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -103.98 -7.61 20.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 70.14 110.961 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.02 64.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.23 111.093 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -21.69 52.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 75.4 110.843 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -31.32 72.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 54.32 110.904 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -90.22 -25.62 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.895 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 25.42 2.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 64.33 112.488 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.42 170.6 7.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 74.11 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.54 179.0 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.524 . . . . 74.35 110.912 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.5 mp0 -111.34 106.09 57.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.729 . . . . 55.2 110.938 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.72 178.42 4.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.699 2.266 . . . . 73.14 112.361 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HE2' ' A' ' 104' ' ' LYS . 14.0 mt -53.3 -47.44 69.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.915 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.17 27.82 24.51 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 72.31 112.487 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.845 0.355 . . . . 71.3 110.881 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.712 ' CD2' HD21 ' A' ' 133' ' ' LEU . 91.4 mt -113.76 -175.32 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 73.4 110.901 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.16 -171.64 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.964 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.861 HG22 HG23 ' A' ' 130' ' ' VAL . 53.1 m -50.86 -70.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 73.23 111.222 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.861 HG23 HG22 ' A' ' 129' ' ' THR . 40.1 t -118.58 102.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 71.13 111.12 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -132.25 169.12 16.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.151 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.27 132.84 56.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 75.53 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.712 HD21 ' CD2' ' A' ' 127' ' ' LEU . 50.2 mt -119.41 157.84 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 73.41 110.889 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -142.62 112.31 6.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 62.35 110.908 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -107.65 47.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 70.53 110.835 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.74 92.73 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 72.3 112.469 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.65 13.6 9.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 75.23 110.825 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.436 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.1 tpp -136.48 93.51 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.933 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -83.68 132.09 34.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.816 HG22 HD21 ' A' ' 158' ' ' LEU . 46.2 t -137.25 117.74 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 72.05 111.176 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -110.16 126.99 54.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 73.45 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.4 p -83.38 -174.05 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 71.23 111.126 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.588 ' HB3' HG23 ' A' ' 155' ' ' VAL . 33.9 t80 -171.82 133.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.877 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.699 ' HB3' HG23 ' A' ' 129' ' ' THR . 81.0 t80 -120.43 88.53 42.62 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.662 0.744 . . . . 74.32 110.937 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.2 Cg_endo -69.77 -7.93 22.3 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 72.24 112.333 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.2 -158.25 23.07 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 74.42 112.441 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -90.17 139.34 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 74.42 110.812 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -150.67 -95.56 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.727 -0.749 . . . . 73.51 112.435 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -70.36 -24.17 62.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 75.13 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.3 p -151.7 -175.24 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 75.25 111.111 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.77 -2.34 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 60.53 110.841 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.483 ' OD1' HG23 ' A' ' 111' ' ' THR . 12.9 p-10 -140.21 11.45 2.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 42.11 110.906 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.584 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -52.65 141.38 20.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 75.34 110.892 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.67 -178.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 73.05 111.106 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 143' ' ' PHE . 5.8 m -136.77 120.1 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 74.13 111.198 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.703 ' O ' HD12 ' A' ' 164' ' ' LEU . 93.6 t -79.25 133.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.161 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -118.69 131.34 56.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.987 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.88 HD11 HD21 ' A' ' 46' ' ' LEU . 10.4 mt -112.8 98.83 46.25 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.595 0.712 . . . . 73.33 110.917 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.5 Cg_endo -69.73 -4.26 13.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.279 . . . . 73.54 112.336 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -83.08 -23.8 32.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 55.51 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.82 14.05 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.95 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.4 m120 54.21 27.15 7.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 75.43 111.006 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 21' ' ' LEU . 96.1 mt -91.98 136.66 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 74.23 111.111 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 156' ' ' VAL . 26.6 tp -121.96 147.75 45.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 64.41 110.992 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.444 HG11 HG11 ' A' ' 55' ' ' VAL . 45.3 t -117.33 76.47 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 71.42 111.078 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.567 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -51.59 -40.77 48.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 71.11 112.556 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 71.6 -162.82 54.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 62.3 112.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 78.6 m -51.46 -33.1 29.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.77 0.319 . . . . 73.54 110.777 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.687 HD12 ' NE1' ' A' ' 189' ' ' TRP . 25.4 tp -51.63 -44.56 62.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 52.31 110.945 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.583 HG13 ' HA ' ' A' ' 219' ' ' LEU . 46.1 t -101.08 111.6 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.23 111.061 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.635 ' HG3' HD12 ' A' ' 225' ' ' LEU . 30.9 mmmt -55.31 164.85 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 72.45 110.864 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 2.9 p -114.98 170.33 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.14 110.835 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.3 t -59.89 153.75 20.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 63.11 111.088 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.9 16.88 10.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 51.35 110.817 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 172' ' ' SER . . . -79.61 153.55 29.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.54 111.036 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -116.79 -22.21 8.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 72.22 110.92 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 0.6 OUTLIER 179.01 173.36 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.83 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.528 HD13 ' CE3' ' A' ' 189' ' ' TRP . 5.7 mt -71.86 -31.72 66.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 72.34 110.933 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 66.39 114.35 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 54.43 112.538 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 59.56 102.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.93 0.395 . . . . 70.21 110.923 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 29.5 m -114.04 13.93 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 74.35 111.163 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.42 88.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 75.12 111.15 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -90.04 10.59 23.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 75.15 110.898 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -126.79 165.0 20.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 31.12 111.073 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -119.73 91.75 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 72.51 110.961 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.6 -19.07 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.15 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -74.78 -20.89 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.893 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -116.81 -16.18 10.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 72.22 110.85 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.687 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -55.0 -61.41 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.2 -0.455 . . . . 74.4 110.906 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.739 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.27 -24.64 19.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.858 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -80.72 -31.97 35.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 74.15 111.065 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -74.09 -45.45 49.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 64.43 110.848 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.6 mm -59.11 -47.63 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 75.41 111.087 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.33 -28.65 59.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.879 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -77.31 -22.48 51.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.3 110.848 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 192' ' ' SER . 11.0 t -85.37 -10.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 62.03 111.154 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -111.96 -10.28 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 64.41 110.936 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.8 -30.43 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 71.52 110.845 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 -45.73 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 64.03 110.835 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.41 37.06 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.93 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.61 -48.06 75.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 71.51 110.914 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -61.2 102.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.948 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.746 HG21 HG22 ' A' ' 206' ' ' VAL . 52.3 mt -144.86 126.53 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 72.03 111.139 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.75 -22.71 34.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 65.02 110.908 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.74 125.31 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 63.53 111.083 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.746 HG22 HG21 ' A' ' 203' ' ' ILE . 92.5 t -104.22 137.23 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 71.03 111.051 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.081 HG22 HG12 ' A' ' 213' ' ' VAL . 11.6 t -110.8 108.44 57.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.573 0.701 . . . . 63.42 111.146 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 173.33 11.17 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.66 2.24 . . . . 72.53 112.301 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.52 -13.81 74.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.602 -0.809 . . . . 54.2 112.525 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -152.61 147.6 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 72.13 110.785 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 99.47 -113.94 4.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 65.23 112.476 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -156.58 168.6 26.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 61.23 110.875 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.081 HG12 HG22 ' A' ' 207' ' ' VAL . 5.0 m -58.34 163.27 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 62.25 111.135 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.99 -104.72 0.2 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 71.12 112.492 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.95 -169.6 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.34 . . . . 62.51 110.874 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -59.81 -19.19 49.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 63.21 110.89 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.502 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -56.04 -22.69 36.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.74 . . . . 72.42 112.471 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.686 HD12 ' HB ' ' A' ' 206' ' ' VAL . 5.0 mt -72.56 -32.73 66.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 71.45 110.919 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.583 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.7 mp -62.03 -59.98 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 71.44 110.924 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.502 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -59.43 -20.66 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.912 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.26 -37.69 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 52.53 110.902 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.629 HG22 ' CD2' ' A' ' 226' ' ' LEU . 7.1 m -58.44 -51.62 69.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 72.31 111.126 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.5 mp -68.77 -16.71 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 71.22 110.972 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.86 -11.07 59.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 74.01 110.864 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.635 HD12 ' HG3' ' A' ' 171' ' ' LYS . 6.3 mt -121.24 -31.76 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 61.32 110.991 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.739 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -91.6 8.24 37.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 72.23 110.953 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.03 110.868 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.811 0.339 . . . . 75.03 110.855 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.88 155.94 30.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 74.52 110.926 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -144.7 167.9 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.882 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.35 169.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.1 111.137 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -155.57 129.63 8.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.51 110.858 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -66.99 176.55 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 72.1 110.913 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -70.51 -40.77 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 60.12 111.19 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.57 -177.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 75.0 111.101 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.02 92.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 70.41 111.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.27 119.46 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 65.25 110.894 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -61.87 168.47 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.31 110.861 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.85 -47.9 64.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.804 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.77 -37.75 82.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 74.1 111.079 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.04 12.72 61.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 44.24 112.539 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.409 HG23 ' CB ' ' A' ' 31' ' ' LEU . 23.0 m -80.39 -44.1 19.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 70.53 111.179 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -102.57 116.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 65.43 111.09 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.4 p -123.89 131.75 53.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 61.24 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.758 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -124.16 109.95 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 71.5 111.066 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.2 t -101.01 125.25 47.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.745 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.72 110.93 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 64.55 110.899 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.651 HD13 HD13 ' A' ' 163' ' ' ILE . 14.7 mt -65.41 -31.86 73.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 64.21 110.926 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.71 -97.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.879 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.47 9.89 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.897 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.58 6.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 71.53 110.931 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.2 t -151.09 139.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 70.4 111.138 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.758 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.6 m95 -126.92 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.864 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 43' ' ' GLY . 93.2 t -136.69 96.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 51.23 111.213 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -81.27 120.66 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 72.21 110.876 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -115.78 100.99 8.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 61.52 111.205 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.16 121.51 26.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 73.53 110.912 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.754 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -92.29 107.04 18.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 73.54 110.928 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -127.97 1.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 50.33 112.501 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 p -175.17 116.18 0.16 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 73.03 110.858 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.15 41.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.807 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 m120 64.48 67.96 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.15 110.859 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.39 -15.57 42.33 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.791 -0.719 . . . . 72.55 112.425 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -121.52 159.15 26.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.373 . . . . 74.02 110.825 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.754 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -98.25 134.29 41.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 42.22 111.136 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.15 79.61 59.04 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.587 0.708 . . . . 64.1 111.007 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 118.24 5.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.264 . . . . 72.13 112.295 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.83 99.89 9.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 72.1 110.871 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -52.56 170.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.45 110.812 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.577 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -162.55 -164.01 16.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.416 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 26' ' ' TRP . 14.4 tp -153.04 114.16 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 74.12 110.902 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.623 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.8 t -97.28 116.8 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 55.23 111.113 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.596 HD21 HD21 ' A' ' 158' ' ' LEU . 13.5 mt -94.86 120.83 35.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 71.43 110.965 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -91.66 83.21 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.12 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 138' ' ' MET . 2.5 p -90.77 -178.5 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 72.34 111.126 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -105.26 -1.15 25.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 40.14 110.777 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -23.14 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.57 144.42 4.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 41.41 112.471 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.695 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.7 mt -59.51 154.54 17.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 71.32 110.93 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.4 t -145.11 142.94 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 73.42 111.122 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.3 mt -137.51 123.12 19.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.835 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.78 112.72 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 63.52 111.107 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.65 129.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.03 110.94 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.656 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -72.18 -167.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.854 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.406 ' H ' HG23 ' A' ' 64' ' ' THR . 8.0 t -92.34 170.27 9.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 63.43 110.853 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.736 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.7 m95 -50.34 -60.26 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.873 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -128.93 160.56 32.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 61.23 110.854 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -52.72 -31.24 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 72.15 110.864 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -59.82 -43.52 94.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 72.24 110.88 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.736 HD12 ' HB2' ' A' ' 59' ' ' TRP . 94.2 mt -75.47 -45.85 36.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 71.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -51.53 -47.11 63.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 73.42 111.169 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -50.98 61.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 63.54 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.37 -19.87 65.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 73.53 110.86 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.6 tp -87.45 -26.16 23.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 62.2 110.871 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.6 mt -90.87 -23.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 63.25 111.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.69 16.5 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.882 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.85 -39.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 71.33 110.783 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.9 m -80.85 -23.76 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 74.32 111.158 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.703 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.01 -23.43 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.51 110.866 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -106.8 -33.57 7.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.906 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -70.58 -44.12 68.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 61.15 110.783 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.9 m-85 -86.59 -12.8 47.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 74.13 110.907 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.43 11.75 8.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 53.34 110.89 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.95 141.1 50.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 71.3 110.894 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.41 140.4 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 74.43 110.883 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.703 HG23 ' OE1' ' A' ' 72' ' ' GLU . 86.3 t -81.95 121.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 53.52 111.111 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.78 9.65 2.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 63.34 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 53' ' ' VAL . 65.2 m-20 -148.86 145.02 27.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.87 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 54' ' ' LEU . 20.3 t -154.14 131.47 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 73.13 111.125 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.653 HD13 HG11 ' A' ' 140' ' ' VAL . 5.6 mt -94.66 123.49 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 72.43 111.077 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.7 mm -94.58 150.33 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 64.42 111.119 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 p -109.31 -40.82 4.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 64.11 111.149 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.606 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -159.62 -178.53 7.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 62.41 110.844 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.736 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -98.89 96.87 8.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 64.23 111.186 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -155.72 154.84 32.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 61.52 110.866 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.22 -20.59 28.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.3 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.92 16.25 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 74.25 110.838 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.02 -76.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 74.24 110.832 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.79 8.39 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.135 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.9 -36.38 33.66 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.698 -0.763 . . . . 73.43 112.476 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.24 16.16 49.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 64.2 112.401 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 92' ' ' ILE . 3.0 tt -58.16 -23.29 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 74.14 111.077 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -30.08 68.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 62.21 110.919 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.5 m -88.97 -19.92 25.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 62.41 111.1 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 57' ' ' SER . 15.0 mt -82.79 -32.44 27.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 74.42 110.892 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -95.15 23.76 5.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -122.13 -41.45 2.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 73.41 110.999 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -83.03 -49.8 9.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.805 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.45 39.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 51.3 112.479 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.551 HD13 ' HA ' ' A' ' 98' ' ' LEU . 3.6 mp -106.69 120.0 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 71.4 111.159 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.61 ' HB3' HD11 ' A' ' 124' ' ' LEU . 6.0 mttm -83.35 118.68 23.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.35 110.92 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.42 92.82 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 51.12 111.127 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.537 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.7 m-70 -64.98 143.3 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 71.01 110.841 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.583 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -178.49 -179.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 64.24 110.908 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.445 HG22 ' C ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -90.99 153.92 19.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 61.43 111.195 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.68 -35.1 13.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 74.02 111.105 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -69.17 -47.76 64.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 45.1 110.92 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.763 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.9 m -59.42 -18.61 40.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 73.53 111.081 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.57 11.4 39.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 74.1 111.049 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.499 ' CD ' HD22 ' A' ' 110' ' ' LEU . 3.5 pt-20 -113.91 -31.76 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 71.25 110.889 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.763 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -93.49 -13.33 27.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.866 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.453 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.049 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -24.95 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 75.4 110.928 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.59 -32.61 70.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 71.13 110.849 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -89.54 -24.82 21.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.897 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.24 23.16 3.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 30.34 112.484 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -98.38 177.59 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 75.03 110.973 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -76.34 178.99 6.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 72.03 110.885 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mp0 -112.58 105.66 55.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.609 0.718 . . . . 64.31 110.867 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.9 Cg_endo -69.82 178.68 4.37 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.709 2.273 . . . . 55.05 112.327 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 104' ' ' LYS . 20.1 mt -51.3 -48.34 62.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.52 110.862 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.09 38.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 74.04 112.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -107.11 41.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 75.34 110.9 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.583 HD12 ' CA ' ' A' ' 107' ' ' SER . 72.7 mt -124.93 -173.81 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 63.14 110.879 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -147.01 -172.92 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 65.22 110.842 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 144' ' ' TYR . 52.6 m -50.58 -71.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 73.23 111.161 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.756 HG23 HG22 ' A' ' 129' ' ' THR . 28.2 t -113.51 94.35 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 71.03 111.18 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.471 HG21 HD22 ' A' ' 127' ' ' LEU . 15.3 t -118.36 167.0 11.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 54.51 111.066 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.51 106.83 10.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 60.12 110.877 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.413 HD21 HD22 ' A' ' 127' ' ' LEU . 28.8 mt -79.72 -173.21 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 72.55 110.939 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.04 112.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 52.23 110.944 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' HE2' HD11 ' A' ' 83' ' ' ILE . 30.7 m-85 -110.49 74.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 74.34 110.83 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.51 -83.06 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 53.21 112.505 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -120.29 24.85 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.3 . . . . 64.44 110.893 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.401 ' HB2' HG22 ' A' ' 48' ' ' THR . 51.4 tpp -129.48 142.55 50.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.909 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.32 133.28 56.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 72.01 110.827 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.653 HG11 HD13 ' A' ' 83' ' ' ILE . 19.5 t -144.97 117.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 72.22 111.117 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -112.5 126.55 55.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 62.24 110.919 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 p -82.69 -178.19 7.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.183 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.404 ' HB3' HG23 ' A' ' 155' ' ' VAL . 19.4 t80 -166.49 134.06 2.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 73.13 110.929 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.772 ' HB3' HG23 ' A' ' 129' ' ' THR . 10.1 t80 -121.06 89.31 46.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.723 0.773 . . . . 73.32 110.971 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -8.12 22.8 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.706 2.27 . . . . 71.31 112.374 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.53 -157.67 20.38 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 52.03 112.495 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -84.66 137.69 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.724 0.297 . . . . 74.12 110.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.33 -89.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 63.54 112.516 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -75.1 -25.64 58.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 75.2 110.843 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 86' ' ' HIS . 29.9 p -147.32 -162.26 1.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.162 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.523 ' HB3' HD23 ' A' ' 114' ' ' LEU . 61.4 tt0 -84.53 -25.42 28.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 65.43 110.886 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 154' ' ' ILE . 19.2 t70 -135.8 24.05 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 65.53 110.961 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -50.41 128.06 18.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 62.4 110.88 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 152' ' ' ASP . 2.6 pt -135.12 173.0 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 72.51 111.074 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.8 m -124.42 150.0 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.41 111.076 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.87 111.77 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.15 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -101.28 132.83 46.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.596 HD21 HD21 ' A' ' 46' ' ' LEU . 6.3 mp -112.22 97.64 39.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 72.42 110.91 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.81 -4.86 14.91 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.619 2.212 . . . . 34.54 112.373 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.55 -26.56 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 72.44 110.958 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.53 19.14 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 71.3 111.005 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 50.51 29.28 3.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.524 . . . . 62.41 110.941 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.651 HD13 HD13 ' A' ' 21' ' ' LEU . 80.2 mt -91.64 120.01 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.117 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.576 HD23 HG22 ' A' ' 206' ' ' VAL . 34.3 tp -104.53 147.15 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 55.53 110.882 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.53 79.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 52.43 111.136 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.84 -49.81 46.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.734 -0.745 . . . . 54.4 112.456 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.32 -166.29 53.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 44.14 112.436 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -35.38 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 75.2 110.838 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.63 HD12 ' NE1' ' A' ' 189' ' ' TRP . 23.5 tp -51.59 -52.19 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 63.44 110.967 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 218' ' ' LEU . 21.2 t -84.02 109.44 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.31 111.161 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.72 ' HG2' HG23 ' A' ' 222' ' ' THR . 1.7 mmpt? -51.86 148.12 6.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.872 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 153.97 17.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 54.04 110.872 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.8 t -51.23 -28.95 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 71.12 111.08 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 27.6 m -93.49 41.39 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.88 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -137.28 150.95 48.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 64.31 111.108 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.561 ' HA ' HD22 ' A' ' 225' ' ' LEU . 10.6 tttp -130.29 10.73 5.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 64.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.53 156.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.867 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.809 HD11 ' HB2' ' A' ' 226' ' ' LEU . 7.8 mt -67.71 -36.9 81.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 75.24 110.957 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.97 -137.39 13.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.736 . . . . 63.11 112.58 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.34 110.75 3.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.366 . . . . 63.42 110.915 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.4 m -109.7 28.76 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 71.14 111.186 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.22 -30.01 70.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 75.0 111.081 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -116.8 22.15 12.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 74.12 110.827 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.66 155.3 46.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 74.05 111.057 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.24 87.06 2.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.947 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.2 t -60.78 -18.18 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 53.01 111.141 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.28 -28.09 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 71.55 110.814 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.59 -12.34 14.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 40.41 110.796 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.759 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.7 t90 -53.28 -62.0 1.93 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.857 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.767 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -54.17 -24.09 16.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.831 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -82.39 -30.93 29.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 71.53 111.141 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -43.27 58.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 71.2 110.782 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.577 HG21 ' O ' ' A' ' 219' ' ' LEU . 28.9 mm -62.95 -43.0 98.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 73.52 111.172 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.44 -22.5 54.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.907 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -82.74 -22.4 34.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 53.12 110.94 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.14 -9.77 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 55.24 111.198 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.434 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.73 -12.49 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 62.44 110.933 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.404 ' N ' HD12 ' A' ' 197' ' ' LEU . 12.6 ptpt -100.51 -31.22 11.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.94 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.63 -49.28 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 73.32 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.416 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -95.81 60.73 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.926 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -71.28 -64.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.478 . . . . 74.03 110.819 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -51.49 104.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.916 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.677 HG21 ' CG2' ' A' ' 206' ' ' VAL . 89.9 mt -142.77 124.8 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.072 -0.513 . . . . 53.51 111.183 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -34.85 50.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.999 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.28 129.91 1.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 71.43 111.085 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 218' ' ' LEU . 95.5 t -103.52 133.58 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 73.23 111.181 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 213' ' ' VAL . 9.5 t -109.58 106.92 59.06 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.604 0.716 . . . . 72.42 111.029 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.1 Cg_endo -69.66 -168.61 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.679 2.253 . . . . 72.3 112.361 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.84 -13.43 57.94 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.68 -0.772 . . . . 62.42 112.574 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -152.32 138.52 18.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.853 0.358 . . . . 61.31 110.829 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.94 -106.41 2.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 74.35 112.539 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -167.47 162.12 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 71.24 110.923 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 207' ' ' VAL . 5.5 m -52.74 161.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.12 111.202 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.66 -98.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 64.42 112.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -169.01 -168.86 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.868 0.366 . . . . 75.11 110.937 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.464 ' HA ' HD23 ' A' ' 219' ' ' LEU . 15.7 pttm -61.69 -17.36 55.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.4 110.889 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.496 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.36 -19.21 39.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 62.22 112.463 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.734 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.9 mt -72.04 -32.92 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.859 0.361 . . . . 72.03 110.871 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.577 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.4 mm? -63.18 -58.52 6.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 62.32 110.986 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.496 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -61.02 -18.16 56.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.45 110.913 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -65.15 -51.42 61.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.861 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.72 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.7 m -52.22 -49.91 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 72.25 111.196 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.621 HD23 ' OG ' ' A' ' 190' ' ' SER . 0.9 OUTLIER -60.42 -18.31 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 51.14 110.932 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -92.1 -2.67 56.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 63.12 110.816 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 176' ' ' LYS . 6.9 mt -126.25 -5.98 6.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 72.42 110.962 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.809 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -119.92 2.46 11.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 63.32 110.913 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 53.31 110.862 179.85 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.875 0.369 . . . . 73.34 110.871 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -117.48 85.12 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 52.51 110.895 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -126.19 93.48 3.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 64.34 110.895 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.74 147.37 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.53 111.135 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -151.04 137.97 19.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 72.14 110.987 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -114.14 172.43 7.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 72.53 110.858 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 m -73.5 -53.65 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 73.32 111.157 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.0 m -58.47 -176.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 71.33 111.104 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.9 mt -136.2 91.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 73.51 111.177 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 116.39 30.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.909 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -59.82 168.15 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.889 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.7 -47.9 63.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 65.12 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.8 p -60.68 -37.68 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.172 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.77 13.15 61.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.674 -0.774 . . . . 54.22 112.505 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -80.36 -43.96 20.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 75.15 111.108 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -102.95 116.54 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 71.51 111.135 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 71.35 110.851 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.73 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -121.87 112.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 54.24 111.087 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.412 ' HA ' HG12 ' A' ' 8' ' ' VAL . 13.7 t -98.82 125.66 44.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 41.13 110.82 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -68.6 110.57 4.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 73.14 110.94 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.073 HD21 HG21 ' A' ' 213' ' ' VAL . 14.2 mt -63.83 -31.35 72.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 62.42 110.971 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.48 -96.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 75.1 110.889 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.44 9.66 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.929 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.77 7.74 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 61.4 110.883 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.74 143.27 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 74.15 111.094 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.73 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.5 m95 -131.02 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 55.34 110.959 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 43' ' ' GLY . 98.7 t -135.43 89.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 64.44 111.19 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -72.27 121.66 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.871 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.4 m -119.62 104.67 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 62.44 111.143 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -87.59 125.78 34.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.944 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.803 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -90.85 110.39 21.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.878 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.53 -125.62 1.34 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.702 -0.761 . . . . 72.13 112.468 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 p -175.07 116.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.949 0.404 . . . . 74.01 110.835 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.49 43.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 71.21 110.826 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.3 m120 63.73 69.34 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 60.41 110.8 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.43 -17.37 40.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 61.54 112.528 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -118.27 -176.16 3.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.895 0.378 . . . . 74.12 110.922 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.803 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -110.6 145.48 37.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 54.11 111.131 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.72 79.5 58.5 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.614 0.721 . . . . 72.3 111.177 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 117.87 5.34 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.683 2.255 . . . . 72.11 112.31 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 p -109.67 97.63 7.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 35.41 110.811 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -63.22 164.62 8.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 65.54 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -153.99 -144.81 4.0 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.69 -0.767 . . . . 74.25 112.466 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.65 HD21 HD11 ' A' ' 158' ' ' LEU . 16.4 tp -158.81 120.12 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 71.2 110.862 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.658 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -105.29 122.29 58.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.168 -0.469 . . . . 71.41 111.126 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 16.0 mt -102.14 121.01 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 73.02 110.944 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.63 85.08 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 73.45 110.831 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.14 173.01 8.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 62.1 111.149 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.25 4.26 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 73.42 110.817 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 -20.58 9.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 53.34 110.91 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.31 138.36 2.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 34.22 112.5 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.691 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.9 mt -54.63 157.63 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 63.34 110.896 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 19.0 t -145.32 141.0 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 72.54 111.112 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.682 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.1 mt -137.61 124.16 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.54 110.945 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.649 HG12 ' OD1' ' A' ' 56' ' ' ASP . 53.6 t -68.57 107.66 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 63.24 111.034 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.649 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.5 m-20 71.51 134.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 60.34 110.927 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.587 ' CB ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -72.15 -165.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 62.24 110.806 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 t -92.37 175.01 7.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.41 110.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.734 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.0 m95 -51.27 -60.41 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.918 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -132.55 161.71 33.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.24 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -51.77 -33.47 35.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 54.1 110.854 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -59.03 -33.76 71.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.897 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.4 mt -89.25 -45.73 9.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.903 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.409 HG21 HD21 ' A' ' 98' ' ' LEU . 1.1 m -50.8 -47.45 59.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 73.23 111.147 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -54.45 -47.48 72.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 71.3 110.872 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.31 -19.4 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.863 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.5 tp -88.4 -27.96 21.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 71.51 110.881 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.5 mt -89.41 -22.99 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.35 111.12 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.88 16.84 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptm -131.01 -39.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 73.42 110.899 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 67' ' ' LEU . 35.1 m -80.95 -24.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 61.34 111.071 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.656 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.85 -21.86 66.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.861 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -109.49 -32.31 7.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.898 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -72.18 -41.95 66.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.826 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.583 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.5 m-85 -88.05 -12.35 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.855 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.37 13.73 8.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 71.54 110.983 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.15 140.14 46.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 75.33 110.863 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -86.1 140.45 30.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.885 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 52' ' ' LEU . 99.4 t -80.07 122.3 35.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.12 111.11 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -136.67 8.16 3.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 65.24 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -151.28 136.08 17.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 71.23 110.927 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 54' ' ' LEU . 15.0 t -147.68 127.75 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 72.22 111.09 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 140' ' ' VAL . 27.4 mt -93.49 122.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 73.21 111.132 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.447 HG21 HG22 ' A' ' 92' ' ' ILE . 20.3 mm -94.33 140.18 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 52.1 111.144 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.48 HG23 ' OD2' ' A' ' 56' ' ' ASP . 65.9 p -86.86 -55.83 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 63.13 111.12 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.586 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.4 p80 -152.15 -175.2 5.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.419 . . . . 64.02 110.96 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.861 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -89.21 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.42 111.054 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.72 149.84 22.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.3 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.45 -19.53 24.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 75.14 111.143 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.5 9.76 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 65.31 110.946 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.13 -77.27 0.52 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.81 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.447 HG22 HG21 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -88.71 8.14 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 63.3 111.048 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.39 -41.5 40.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 74.55 112.438 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 14.46 56.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.746 . . . . 32.51 112.498 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.7 tt -51.7 -29.92 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 74.5 111.139 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -35.56 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 73.3 110.87 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -79.94 -23.99 41.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 63.24 111.161 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HA ' HD13 ' A' ' 103' ' ' ILE . 9.2 mt -82.93 -28.25 30.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.989 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -94.04 19.47 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.956 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -121.71 -45.51 2.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 71.13 110.846 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -74.35 -52.39 12.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 75.12 110.856 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.8 42.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.683 -0.77 . . . . 62.11 112.463 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.609 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.6 mp -106.31 128.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 70.34 111.23 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.639 ' HB3' HD11 ' A' ' 124' ' ' LEU . 5.0 mtmm -84.19 105.86 15.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 72.32 110.937 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.02 92.83 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 73.12 111.205 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.669 ' HA ' HD12 ' A' ' 124' ' ' LEU . 48.1 m-70 -69.65 146.14 51.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 73.23 110.886 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.62 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -174.26 179.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 60.45 110.901 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.45 154.27 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 64.12 111.07 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.11 40.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 52.5 111.081 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -41.18 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.91 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.706 ' HA ' HD11 ' A' ' 114' ' ' LEU . 99.8 m -58.44 -20.69 46.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.02 111.123 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.56 8.44 41.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 74.04 111.055 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -107.81 -31.56 7.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 73.52 110.838 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.861 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -96.09 -12.83 24.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 71.43 110.967 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.402 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -67.98 -37.14 81.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 64.12 111.104 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.47 -24.45 59.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.927 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.52 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 73.42 110.898 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -90.29 -22.06 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 60.04 110.951 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.53 25.51 4.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.829 -0.7 . . . . 60.25 112.434 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.59 175.68 5.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.899 0.381 . . . . 74.13 110.935 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.83 162.17 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.951 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -94.89 108.4 37.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.57 0.7 . . . . 70.03 110.916 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.552 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.71 -177.42 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.282 . . . . 60.05 112.363 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 106' ' ' HIS . 81.8 mt -54.21 -54.46 39.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 62.22 110.878 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.52 73.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 62.11 112.428 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -99.03 33.54 2.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 74.44 110.848 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 107' ' ' SER . 86.7 mt -116.65 -174.6 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.923 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -159.36 -170.45 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 53.1 110.871 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.845 HG22 HG23 ' A' ' 130' ' ' VAL . 48.5 m -50.49 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.43 111.21 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.845 HG23 HG22 ' A' ' 129' ' ' THR . 38.2 t -116.22 93.56 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 70.55 111.1 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.688 HG22 ' OG1' ' A' ' 142' ' ' THR . 14.5 t -113.05 164.97 12.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 63.41 111.116 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -128.18 102.96 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 65.43 110.907 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 140' ' ' VAL . 28.4 mt -76.02 -173.06 2.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 73.32 110.918 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -171.31 110.23 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.843 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.92 -167.57 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 60.5 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -57.63 95.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.765 -0.731 . . . . 73.32 112.461 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 53.75 25.92 5.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.391 . . . . 42.54 110.912 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.4 tpp -129.19 140.03 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.47 135.91 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.53 110.912 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' A' ' 83' ' ' ILE . 6.1 t -143.72 116.88 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 61.33 111.179 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -112.88 126.58 55.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 63.2 110.893 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.688 ' OG1' HG22 ' A' ' 131' ' ' THR . 18.8 p -83.39 174.27 10.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.127 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.431 ' HB3' HG23 ' A' ' 155' ' ' VAL . 20.8 t80 -158.78 137.61 11.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.937 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.657 ' HB3' HG23 ' A' ' 129' ' ' THR . 90.5 t80 -127.82 89.31 51.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.738 0.78 . . . . 72.33 110.985 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.2 Cg_endo -69.69 -7.61 21.47 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.671 2.247 . . . . 70.11 112.374 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.03 -150.17 19.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 40.42 112.484 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -95.24 141.1 29.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 63.43 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.424 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -157.43 -90.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 62.53 112.535 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -74.76 -23.05 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.332 . . . . 73.41 110.759 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 86' ' ' HIS . 69.2 p -151.23 -171.39 3.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 60.03 111.177 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.546 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.1 tt0 -84.94 -3.32 58.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 75.12 110.893 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 154' ' ' ILE . 19.4 t0 -150.18 19.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 53.44 110.944 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.58 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.4 OUTLIER -50.57 130.72 24.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.11 110.887 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 152' ' ' ASP . 3.2 pt -135.17 175.48 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 42.53 111.138 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -132.87 123.93 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 65.05 111.03 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.96 119.04 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.129 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -107.79 139.12 42.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.65 HD11 HD21 ' A' ' 44' ' ' LEU . 87.7 mt -119.79 99.73 49.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.63 0.728 . . . . 73.04 110.862 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.1 Cg_endo -69.79 -4.79 14.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.688 2.259 . . . . 52.21 112.289 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -84.78 -30.38 24.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.947 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -131.49 11.21 4.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 70.41 110.923 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.5 m120 55.05 26.0 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.846 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.558 HD13 HD13 ' A' ' 21' ' ' LEU . 86.8 mt -90.95 143.83 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.129 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.557 HD22 HD13 ' A' ' 203' ' ' ILE . 15.2 tp -125.54 145.43 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 62.33 110.916 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.459 HG11 HG11 ' A' ' 55' ' ' VAL . 94.9 t -108.17 81.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 61.22 111.219 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.44 -31.42 28.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.703 -0.76 . . . . 75.45 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 56.69 -168.63 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 33.01 112.453 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -29.68 20.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.336 . . . . 72.52 110.842 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.58 HD13 ' OD1' ' A' ' 153' ' ' ASN . 24.8 tp -55.65 -55.14 35.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 75.1 110.946 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.513 HG13 ' HA ' ' A' ' 219' ' ' LEU . 19.9 t -87.55 107.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 75.1 111.13 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -52.15 170.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.53 110.904 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -120.31 158.63 26.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 44.41 110.883 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 13.7 t -50.03 158.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.081 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.01 10.93 7.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 75.12 110.817 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.581 ' HB3' HD11 ' A' ' 225' ' ' LEU . . . -85.74 146.07 26.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 61.31 111.116 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.517 ' C ' HD22 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -118.27 -16.81 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 63.32 110.862 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.68 158.54 7.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 63.22 110.919 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' A' ' 226' ' ' LEU . 9.7 mt -65.66 -31.97 73.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.182 -0.463 . . . . 72.21 110.978 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 100.05 -120.39 6.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 50.35 112.583 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.51 132.97 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 72.53 110.869 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.498 HG11 HG22 ' A' ' 186' ' ' VAL . 16.7 m -129.23 24.57 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.468 . . . . 64.44 111.153 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.04 80.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 74.23 111.045 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -112.84 25.17 11.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 71.05 110.875 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -130.12 164.96 23.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 74.13 111.108 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.35 92.39 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 74.23 110.982 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.498 HG22 HG11 ' A' ' 181' ' ' VAL . 11.0 t -63.46 -22.92 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 44.25 111.134 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -71.65 -31.3 66.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 71.03 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.29 -13.05 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.03 110.916 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.501 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.4 t90 -55.09 -62.56 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 73.4 110.918 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.761 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.88 -24.51 16.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 61.35 110.829 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 57.7 m -80.39 -32.23 37.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 72.2 111.1 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -42.74 58.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.833 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.523 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.1 mm -62.91 -44.39 99.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.42 111.134 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.492 ' HG2' HD11 ' A' ' 223' ' ' LEU . 2.1 mm-40 -58.23 -22.89 53.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 41.05 110.807 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -82.45 -22.31 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 71.12 110.895 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 196' ' ' VAL . 16.1 t -87.19 -8.89 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 75.41 111.064 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -113.5 -6.79 13.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 71.4 110.946 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.6 -31.19 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 72.13 110.897 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -104.22 -55.95 2.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 75.35 110.871 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -94.99 38.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 75.34 110.827 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -55.97 -47.71 77.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.889 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -59.97 101.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.03 110.951 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.743 HG21 HG22 ' A' ' 206' ' ' VAL . 40.1 mt -143.65 127.54 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 63.33 111.161 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.01 -23.13 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 62.44 110.934 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.722 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -168.04 132.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.073 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.749 ' HB ' HD12 ' A' ' 218' ' ' LEU . 59.0 t -114.79 132.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 51.43 111.163 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 213' ' ' VAL . 9.7 t -110.35 109.33 58.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 62.44 111.111 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.8 Cg_endo -69.75 178.02 4.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.658 2.239 . . . . 42.02 112.381 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.51 -18.86 74.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 71.21 112.486 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -152.83 141.67 21.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 74.54 110.879 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.49 -117.48 4.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 70.15 112.474 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -152.25 174.07 14.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 72.53 110.918 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.073 HG21 HD21 ' A' ' 21' ' ' LEU . 5.4 t -69.31 149.98 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 50.31 111.129 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.81 -101.47 0.31 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 72.13 112.515 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.25 -169.0 1.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 71.0 110.823 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -17.83 54.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 71.51 110.872 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.473 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.37 -20.11 43.14 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.772 -0.727 . . . . 44.11 112.41 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.749 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.2 mt -73.48 -30.07 62.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 74.1 110.921 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.523 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.866 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.473 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.4 OUTLIER -59.12 -22.5 60.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.901 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.24 -44.67 95.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.12 110.826 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.698 HG22 HD23 ' A' ' 226' ' ' LEU . 11.5 m -56.48 -56.62 18.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 54.34 111.003 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' A' ' 194' ' ' GLU . 1.0 OUTLIER -52.82 -28.86 24.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.432 . . . . 72.31 110.929 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -32.52 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.92 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 175' ' ' ALA . 12.9 mt -88.39 -18.18 28.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.849 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.761 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.3 OUTLIER -114.94 18.84 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.91 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 74.44 110.933 179.762 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.737 0.303 . . . . 61.32 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -116.2 89.52 3.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 54.22 110.952 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? 62.48 164.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 62.45 110.95 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.62 159.62 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 62.54 111.091 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.11 120.01 23.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 75.22 110.919 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -123.93 -171.07 2.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.071 -0.513 . . . . 75.52 110.926 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -115.66 -68.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 75.14 111.128 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -50.03 146.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 51.33 111.147 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.3 mt -110.73 98.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 44.41 111.166 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -118.17 115.39 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 73.23 110.879 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -60.57 166.41 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 71.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -51.45 -48.43 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 74.21 110.923 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 p -62.57 -36.97 84.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 62.44 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 13.9 63.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 34.31 112.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 m -78.84 -45.4 20.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 62.23 111.197 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.554 HG21 HD13 ' A' ' 67' ' ' LEU . 39.6 mt -103.85 112.36 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 63.02 111.129 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -118.04 133.95 55.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 52.21 110.814 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.791 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -125.51 112.24 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 54.35 111.162 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -98.46 125.57 43.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.864 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -69.34 109.94 4.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 75.32 110.966 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.592 HD21 HG11 ' A' ' 213' ' ' VAL . 16.8 mt -63.51 -32.69 74.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.94 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.58 -96.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 72.52 110.884 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -150.24 9.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.873 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.75 8.17 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.861 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -150.89 141.82 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 70.32 111.086 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.791 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.9 m95 -130.21 -176.8 4.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 71.22 110.916 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.475 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.3 t -134.69 90.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 72.12 111.215 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -73.79 122.17 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 72.13 110.838 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.5 m -119.89 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.097 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.99 125.34 33.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 73.33 110.812 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.755 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -87.37 110.62 20.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 71.41 110.949 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.17 -146.19 7.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 71.35 112.478 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.81 120.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 73.21 110.826 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.22 136.34 24.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.923 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 50.58 27.71 3.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.41 110.912 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.4 42.11 23.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.783 -0.722 . . . . 51.1 112.483 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -147.65 130.26 15.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.371 . . . . 64.01 110.872 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.755 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -59.13 149.55 27.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 64.43 111.108 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.44 79.91 19.91 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.584 0.707 . . . . 64.45 111.149 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 117.67 5.23 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.736 2.291 . . . . 73.44 112.362 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.9 p -109.96 97.08 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 71.35 110.892 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -59.37 165.36 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 73.24 110.859 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -156.13 -148.89 5.19 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.712 -0.756 . . . . 62.45 112.437 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 158' ' ' LEU . 15.3 tp -158.49 118.34 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 74.01 110.909 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.671 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -103.16 122.31 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.084 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.802 HD21 HD11 ' A' ' 158' ' ' LEU . 14.4 mt -100.77 120.57 40.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.907 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -90.52 84.7 5.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.82 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -97.52 -175.32 3.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.33 111.194 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.4 -21.97 13.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 72.11 110.878 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -83.99 -15.73 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 60.14 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.4 150.25 5.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.815 -0.707 . . . . 51.44 112.539 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.714 ' HB3' HG22 ' A' ' 79' ' ' VAL . 2.0 mt -61.75 156.94 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.23 110.948 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 16.8 t -145.48 141.96 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 54.54 111.163 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.675 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.1 mt -137.87 124.62 21.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 73.13 110.895 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.647 HG12 ' OD1' ' A' ' 56' ' ' ASP . 54.7 t -67.59 106.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 72.15 111.162 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.647 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.4 m-20 70.81 131.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 55.3 110.893 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.638 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -69.41 -164.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 51.2 110.87 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -90.38 -179.85 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 61.1 110.876 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.726 ' HB2' HD12 ' A' ' 63' ' ' LEU . 96.7 m95 -57.86 -51.54 69.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.483 . . . . 74.23 110.937 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -139.69 161.81 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 60.43 110.77 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.04 -32.62 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.24 110.818 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -59.86 -42.53 93.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.5 mt -80.01 -46.89 15.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 54.35 110.898 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.12 -45.74 53.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 63.5 111.121 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -54.78 -48.39 72.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 72.43 110.848 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.49 -19.82 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.945 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.7 tp -88.2 -27.04 22.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 72.51 110.872 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -90.59 -23.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.14 111.181 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.16 15.0 14.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.496 . . . . 74.32 110.953 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.7 ptm -129.83 -39.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 62.14 110.889 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.1 m -80.45 -22.76 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.14 111.153 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.667 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.42 -21.93 65.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.22 110.822 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -109.2 -32.37 7.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.92 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -37.64 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 75.41 110.837 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.547 ' HB2' HD11 ' A' ' 52' ' ' LEU . 12.6 m-85 -92.58 -11.62 33.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 74.34 110.879 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.36 11.71 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.883 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -132.25 141.0 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 62.52 110.898 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -87.46 140.56 29.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 63.5 110.93 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' A' ' 52' ' ' LEU . 97.3 t -80.71 124.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 73.54 111.117 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -138.98 10.14 2.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 73.43 111.08 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -153.3 135.61 14.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 75.43 110.836 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 54' ' ' LEU . 17.2 t -148.02 125.55 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 71.43 111.13 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 140' ' ' VAL . 27.5 mt -91.28 124.59 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 72.34 111.097 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.486 HG21 HG22 ' A' ' 92' ' ' ILE . 18.6 mm -95.99 138.71 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 74.04 111.154 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.6 p -84.45 -49.13 8.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 72.44 111.176 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.1 p80 -159.71 -175.37 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 60.01 110.932 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -87.58 98.36 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 64.34 111.071 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.32 149.61 24.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.857 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.46 30.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 72.52 111.055 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.04 10.04 28.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.882 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 27.8 mmt180 -129.83 -77.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 64.44 110.91 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.486 HG22 HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -88.88 8.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 53.55 111.102 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.47 -41.75 41.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.703 -0.761 . . . . 65.04 112.494 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.9 12.71 62.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 71.43 112.374 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.8 tt -51.52 -28.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 54.25 111.132 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -38.26 64.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 61.45 110.834 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -79.86 -27.5 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.142 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.638 HD11 ' OG ' ' A' ' 57' ' ' SER . 10.8 mt -75.05 -30.74 61.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 72.54 110.9 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -92.51 16.26 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 72.32 110.859 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -119.48 -48.23 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.44 110.816 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -72.73 -56.13 5.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.243 -0.435 . . . . 62.32 110.855 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.95 42.63 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.807 -0.711 . . . . 55.04 112.447 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.8 mp -105.64 120.33 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.429 . . . . 74.34 111.17 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -78.1 109.76 12.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 51.33 110.911 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.63 101.25 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 72.34 111.054 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.569 ' HA ' HD12 ' A' ' 124' ' ' LEU . 40.4 m-70 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 54.31 110.91 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.644 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -176.64 -176.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.881 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 154.47 20.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 50.3 111.14 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.77 -40.65 55.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 72.41 111.068 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -67.95 -40.72 83.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.94 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.769 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.7 m -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 72.33 111.133 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.55 52.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 63.32 111.095 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.37 -59.23 1.74 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.11 110.893 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.39 -13.14 60.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.956 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -64.9 -43.43 92.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 43.11 111.072 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -26.3 63.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 74.42 110.895 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -55.2 -35.96 65.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 74.3 110.852 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -89.65 -20.85 23.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 72.45 110.872 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.85 21.75 5.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 73.25 112.401 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -94.65 170.46 9.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 74.52 110.883 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -70.83 -176.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 72.05 110.867 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -117.23 103.92 50.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 74.35 110.923 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.7 Cg_endo -69.8 -171.69 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.717 2.278 . . . . 63.24 112.391 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 106' ' ' HIS . 96.0 mt -59.39 -54.66 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 62.3 110.959 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.48 24.18 63.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.821 -0.704 . . . . 61.54 112.4 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 24.62 6.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 75.21 110.944 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.659 ' CD2' HD21 ' A' ' 133' ' ' LEU . 91.3 mt -107.09 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 65.35 110.935 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -155.33 -170.28 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 54.22 110.885 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.948 HG22 HG23 ' A' ' 130' ' ' VAL . 43.8 m -49.93 -70.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 70.54 111.154 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.948 HG23 HG22 ' A' ' 129' ' ' THR . 42.4 t -120.31 110.25 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.41 111.123 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -139.77 172.47 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 71.45 111.157 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 71.31 110.914 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.659 HD21 ' CD2' ' A' ' 127' ' ' LEU . 52.4 mt -115.34 167.35 10.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 73.3 110.898 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -147.64 137.09 22.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 71.03 110.93 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.504 ' HE2' HD11 ' A' ' 83' ' ' ILE . 36.9 m-85 -134.19 40.47 3.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.898 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 93.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 51.03 112.4 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.38 14.12 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 65.31 110.877 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.5 tpp -138.39 100.9 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 64.42 110.874 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -90.69 137.84 32.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.42 110.781 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 83' ' ' ILE . 57.8 t -139.67 117.42 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 71.35 111.099 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.96 129.17 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 74.22 110.942 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.8 p -85.54 -179.44 6.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 75.14 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.445 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.6 t80 -164.39 133.6 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.42 110.883 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.641 ' HB3' HG23 ' A' ' 129' ' ' THR . 88.4 t80 -123.96 88.44 52.42 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.796 0.808 . . . . 75.01 110.95 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.569 2.179 . . . . 75.23 112.352 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.92 -144.88 16.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.802 -0.713 . . . . 74.0 112.504 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -101.5 141.64 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 72.31 110.901 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.45 -90.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.705 -0.759 . . . . 71.13 112.475 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -74.78 -23.43 58.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 73.3 110.858 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.478 HG21 ' HB2' ' A' ' 86' ' ' HIS . 65.5 p -150.57 -169.36 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 52.02 111.153 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.627 ' HB3' HD23 ' A' ' 114' ' ' LEU . 2.7 tt0 -85.81 -12.94 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.871 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 154' ' ' ILE . 15.3 t0 -138.61 20.93 2.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 63.1 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.77 130.38 24.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.3 110.897 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 152' ' ' ASP . 6.6 pt -137.19 169.04 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 71.55 111.125 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -127.32 122.52 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 45.32 111.176 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.476 ' O ' HD12 ' A' ' 164' ' ' LEU . 80.5 t -75.72 131.76 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 73.03 111.148 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -117.54 130.07 56.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 65.51 110.826 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.802 HD11 HD21 ' A' ' 46' ' ' LEU . 9.8 mt -110.68 98.64 38.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 60.22 110.909 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.9 Cg_endo -69.75 -4.42 13.99 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.659 2.24 . . . . 60.13 112.336 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.21 -23.64 32.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 75.44 110.832 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -144.0 14.15 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 63.54 110.941 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.9 m120 54.26 26.79 7.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 74.51 110.844 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.547 HD13 HD13 ' A' ' 21' ' ' LEU . 97.4 mt -91.9 128.79 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 73.53 111.089 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 156' ' ' VAL . 17.6 tp -113.49 145.92 40.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.887 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.554 HG11 HG11 ' A' ' 55' ' ' VAL . 21.4 t -109.62 83.64 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 71.21 111.175 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.51 -34.84 35.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.617 -0.801 . . . . 62.25 112.58 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.33 -167.92 26.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 61.53 112.531 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -29.65 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 63.15 110.813 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.632 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.8 tp -54.84 -61.82 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 55.43 110.933 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.553 HG13 ' HA ' ' A' ' 219' ' ' LEU . 47.2 t -78.33 110.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 55.45 111.168 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.742 ' HG2' HG23 ' A' ' 222' ' ' THR . 19.5 mmmt -51.8 169.02 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.941 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -116.53 146.4 42.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 73.21 110.857 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.04 156.68 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 75.52 111.245 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 t 70.29 11.08 7.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 74.04 110.831 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 172' ' ' SER . . . -82.85 147.68 28.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 74.13 111.187 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -119.12 -12.22 9.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 53.32 110.821 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.93 155.82 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.875 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.661 HD13 ' CZ3' ' A' ' 189' ' ' TRP . 11.2 mt -62.22 -45.23 94.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 70.41 110.912 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.35 119.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.842 -0.694 . . . . 60.54 112.448 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.08 104.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 72.31 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.412 HG11 ' CG2' ' A' ' 186' ' ' VAL . 24.9 m -131.97 27.53 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 51.43 111.08 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.47 -49.26 78.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 64.25 111.055 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.5 25.56 6.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.266 -0.425 . . . . 71.54 110.845 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.2 152.24 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 74.32 111.067 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -106.74 86.76 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 72.22 110.911 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.412 ' CG2' HG11 ' A' ' 181' ' ' VAL . 21.4 t -59.7 -19.64 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 73.33 111.127 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -73.3 -31.21 63.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 65.21 110.886 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -104.84 -11.62 16.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 72.43 110.953 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.661 ' CZ3' HD13 ' A' ' 178' ' ' LEU . 2.7 t90 -55.0 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 73.3 110.846 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.703 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.84 -24.71 16.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 33.25 110.865 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -81.08 -31.82 34.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 54.13 111.241 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -73.68 -42.77 60.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 55.14 110.826 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.9 mm -61.95 -44.69 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 70.5 111.106 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -58.44 -23.89 58.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 62.4 110.882 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -83.59 -22.19 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.766 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 192' ' ' SER . 5.4 t -87.61 -9.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 64.43 111.142 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -111.94 -8.4 14.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 64.14 110.958 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -104.09 -30.96 9.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.895 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.9 -52.27 2.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -97.24 37.78 1.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.95 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -56.46 -47.73 78.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 63.23 110.894 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -59.34 98.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 73.02 110.939 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.726 HG21 HG22 ' A' ' 206' ' ' VAL . 61.8 mt -140.23 127.89 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 71.44 111.18 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.18 -22.88 30.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 73.42 110.87 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.75 123.51 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 63.04 111.13 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.726 HG22 HG21 ' A' ' 203' ' ' ILE . 93.2 t -102.5 137.9 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 73.42 111.05 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.891 HG22 HG12 ' A' ' 213' ' ' VAL . 3.4 t -115.84 108.81 46.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.693 0.759 . . . . 45.52 111.129 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.503 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.6 Cg_endo -69.7 179.21 3.82 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.664 2.242 . . . . 74.25 112.348 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.74 -13.58 82.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.761 -0.733 . . . . 60.42 112.532 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -152.89 138.1 17.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 63.22 110.854 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.74 -118.67 5.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 73.21 112.5 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -150.91 163.93 37.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 72.34 110.95 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.891 HG12 HG22 ' A' ' 207' ' ' VAL . 4.3 m -60.3 161.43 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 64.25 111.127 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.13 -93.09 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 54.33 112.389 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -174.83 -167.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 72.21 110.895 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -58.05 -20.26 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.13 110.932 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.35 -23.45 26.5 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.647 -0.787 . . . . 70.12 112.452 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.8 mt -75.97 -33.1 59.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.894 0.378 . . . . 74.33 110.944 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.553 ' HA ' HG13 ' A' ' 170' ' ' VAL . 5.7 mp -61.58 -62.84 1.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.913 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -22.44 47.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 65.31 110.942 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.69 -46.67 88.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.83 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.742 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.4 m -51.27 -53.31 36.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.45 111.116 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.77 -20.15 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 72.21 110.971 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.41 -4.32 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 71.14 110.868 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 175' ' ' ALA . 6.2 mt -125.27 -7.2 7.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.875 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.703 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -119.67 10.26 11.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 51.45 110.91 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 73.52 110.965 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.787 0.327 . . . . 75.05 110.849 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -148.98 -65.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.929 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -154.22 154.79 34.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.879 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 m -103.14 155.2 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 70.41 111.117 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -145.35 143.41 30.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 72.1 110.864 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -81.93 -175.21 5.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.849 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 m -53.41 -55.94 20.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 60.43 111.145 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -59.12 -176.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 72.41 111.145 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.4 mt -136.31 92.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 72.35 111.115 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -111.52 118.07 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 74.22 110.891 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -58.37 -176.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.856 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.21 -45.34 73.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 64.12 110.851 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.4 p -61.9 -37.67 85.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 73.12 111.133 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.05 12.32 60.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 52.21 112.533 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -80.78 -43.32 20.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.74 0.305 . . . . 73.4 111.175 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.36 125.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 55.22 111.17 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -133.02 129.92 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.54 110.836 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.769 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -120.9 111.12 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 62.31 111.138 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.5 t -100.76 127.6 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 62.21 110.862 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -71.23 111.64 6.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 65.42 110.873 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.6 ' HG ' HG23 ' A' ' 27' ' ' VAL . 27.3 mt -65.19 -31.55 72.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 75.3 110.955 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.73 -97.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 61.33 110.908 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.44 10.14 0.57 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.43 . . . . 55.1 110.975 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.51 6.37 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 64.51 110.856 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.84 139.46 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 74.54 111.126 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.769 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.5 m95 -127.23 -179.58 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 73.54 110.957 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.6 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.1 t -131.99 97.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 64.31 111.144 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -80.51 121.14 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 70.43 110.901 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -117.62 104.81 11.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.11 111.146 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.683 ' CD ' HD22 ' A' ' 67' ' ' LEU . 5.3 mp0 -89.27 120.94 31.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 73.42 110.865 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.787 HD21 ' HB1' ' A' ' 38' ' ' ALA . 2.3 mt -85.43 101.55 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 44.13 110.831 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.57 -39.43 95.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 65.02 112.448 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.78 103.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 75.42 110.842 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.578 ' CD1' HG21 ' A' ' 39' ' ' VAL . 1.6 m-85 -88.51 46.65 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.911 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.1 m120 60.56 67.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 53.21 110.931 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.38 -30.11 6.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.789 -0.719 . . . . 42.04 112.558 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -110.12 118.99 37.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.864 0.364 . . . . 73.04 110.875 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -69.3 118.02 11.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 52.22 111.182 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' A' ' 34' ' ' PHE . 1.5 t -113.51 73.32 1.99 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.613 0.72 . . . . 75.32 111.111 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 119.4 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.698 2.265 . . . . 72.05 112.417 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.1 p -99.76 96.92 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.866 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -49.51 159.8 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 63.02 110.845 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.591 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -155.65 -168.15 18.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.678 -0.772 . . . . 55.11 112.483 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.619 HD21 HD12 ' A' ' 158' ' ' LEU . 17.5 tp -152.49 113.56 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.354 . . . . 75.35 110.895 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.63 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -97.77 120.47 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.11 111.097 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.737 HD21 HD11 ' A' ' 158' ' ' LEU . 25.3 mt -97.78 115.95 29.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 64.23 110.903 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.42 87.44 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 60.52 110.92 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 179.8 4.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 54.01 111.17 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -100.28 -22.8 14.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 70.53 110.859 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -11.44 58.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 65.52 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.37 153.34 5.86 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.646 -0.787 . . . . 44.14 112.471 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.1 tp -67.25 155.04 39.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 75.42 110.957 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.6 t -145.91 142.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.11 111.104 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.63 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.3 mt -137.07 125.48 23.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.31 110.879 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -71.21 112.18 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 75.31 111.114 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.431 ' HB2' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 72.64 132.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 65.45 110.921 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.587 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -75.36 -166.98 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 54.53 110.853 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.48 ' H ' HG23 ' A' ' 64' ' ' THR . 13.1 t -91.41 169.1 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 70.45 110.911 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.688 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.1 m95 -49.5 -60.57 2.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.994 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -125.44 165.18 18.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 34.31 110.833 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.24 -37.69 75.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 62.44 110.852 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.21 -33.74 67.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 59' ' ' TRP . 83.7 mt -82.6 -47.2 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 65.24 110.956 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.61 -46.44 58.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.102 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.05 -49.63 65.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 71.24 110.89 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -64.76 -19.85 66.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.968 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD22 ' CD ' ' A' ' 30' ' ' GLU . 18.6 tp -87.8 -27.16 22.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 40.54 110.904 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.83 -23.13 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.081 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.69 16.0 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 64.33 110.901 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.87 -39.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 73.21 110.872 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.8 m -81.21 -22.43 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.112 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.577 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.89 -24.48 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 64.45 110.813 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -106.31 -34.24 7.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.471 . . . . 65.33 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -41.3 79.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.82 -10.75 38.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 65.31 110.886 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 67.52 11.97 8.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 61.23 110.875 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.549 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -128.93 137.62 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 64.41 110.856 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.74 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.2 110.875 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' OE2' ' A' ' 72' ' ' GLU . 80.0 t -76.26 121.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.146 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 t -135.68 7.78 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 75.44 111.118 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.544 ' O ' HG13 ' A' ' 53' ' ' VAL . 62.7 m-20 -150.8 145.03 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.14 110.877 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 54' ' ' LEU . 12.2 t -154.53 132.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 70.14 111.189 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.498 HD13 HG11 ' A' ' 140' ' ' VAL . 5.9 mt -95.19 125.84 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 61.13 111.158 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.35 147.7 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.215 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -98.16 -55.54 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 62.21 111.222 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.451 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.6 p80 -152.96 -175.16 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.812 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.866 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -90.01 97.46 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 50.45 111.139 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.18 150.13 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 70.05 110.792 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.38 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 75.52 111.046 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.12 23.6 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 61.02 110.791 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.431 ' HD3' ' HB2' ' A' ' 56' ' ' ASP . 27.3 mmt180 -144.89 -76.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.44 110.912 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.12 7.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 62.12 111.113 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.74 -40.08 40.4 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 75.32 112.477 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.41 14.88 59.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 51.15 112.492 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.2 tt -55.45 -27.33 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.397 . . . . 73.51 111.125 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -54.91 -34.36 63.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 74.2 110.928 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -84.57 -22.7 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.54 111.138 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.605 ' HA ' HD13 ' A' ' 103' ' ' ILE . 11.7 mt -82.13 -28.67 32.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.915 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -96.92 22.22 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 73.55 110.952 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -122.63 -43.14 2.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 75.11 110.94 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -80.36 -52.78 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 61.41 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.79 43.96 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 41.22 112.534 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.605 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -108.07 118.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 71.32 111.159 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HE3' HD21 ' A' ' 124' ' ' LEU . 19.6 mtpp -77.77 111.33 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.14 110.915 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.84 90.91 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 64.42 111.077 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.564 ' HA ' HD12 ' A' ' 124' ' ' LEU . 57.1 m-70 -62.47 143.15 57.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 71.21 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB2' HG21 ' A' ' 111' ' ' THR . 1.1 p -173.96 176.7 2.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.908 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.33 157.92 19.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 63.11 111.16 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.89 -38.96 52.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 52.31 111.097 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.649 HD21 ' HG2' ' A' ' 151' ' ' GLU . 28.9 tp -73.63 -37.52 65.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.894 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.744 ' HA ' HD11 ' A' ' 114' ' ' LEU . 98.1 m -57.82 -29.36 64.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 63.53 111.115 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.88 0.21 57.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 65.14 111.058 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -99.25 -58.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 73.34 110.792 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.866 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -67.32 -12.27 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 64.51 110.925 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -66.1 -44.58 83.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 71.33 111.162 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -28.82 65.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.878 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -37.26 49.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 65.43 110.886 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -88.9 -21.89 23.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 54.1 110.854 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.89 20.63 5.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.734 -0.746 . . . . 61.33 112.491 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.56 172.07 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 64.45 110.974 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -70.92 -176.16 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 74.55 110.905 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.3 mt-10 -117.05 102.13 52.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.614 0.721 . . . . 72.34 110.849 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.2 Cg_endo -69.85 -176.22 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.621 2.214 . . . . 63.02 112.321 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.717 HD21 ' HE3' ' A' ' 104' ' ' LYS . 25.4 mt -51.84 -60.08 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.02 110.913 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.43 21.37 72.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 55.32 112.527 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -99.53 28.41 4.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 72.35 110.849 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.624 HD22 HD21 ' A' ' 133' ' ' LEU . 62.8 mt -109.52 -175.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.916 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -154.25 -170.77 3.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.937 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 130' ' ' VAL . 54.8 m -50.79 -70.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.04 111.147 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.906 HG23 HG22 ' A' ' 129' ' ' THR . 44.7 t -119.82 103.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 74.11 111.165 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -135.42 163.33 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 64.33 111.124 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.13 132.49 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.32 110.864 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.624 HD21 HD22 ' A' ' 127' ' ' LEU . 24.1 mt -115.08 167.2 11.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.939 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 133.5 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.52 110.941 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -134.2 49.09 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 65.32 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.19 92.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 62.24 112.539 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.89 14.59 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 75.32 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.0 tpp -134.13 110.31 9.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.832 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 131.14 44.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.79 HG22 HD21 ' A' ' 158' ' ' LEU . 21.3 t -137.34 117.33 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 74.34 111.064 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -110.75 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 75.35 110.887 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 p -86.62 177.29 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 62.11 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.503 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.2 t80 -159.3 134.78 8.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.14 110.865 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.697 ' HB3' HG23 ' A' ' 129' ' ' THR . 9.3 t80 -124.41 87.23 54.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.648 0.737 . . . . 73.22 110.901 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -7.95 22.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.744 2.296 . . . . 64.32 112.313 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.68 -158.48 22.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 72.15 112.399 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -86.81 138.83 31.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 72.35 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.7 -87.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 54.33 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -78.39 -23.38 46.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 63.34 110.872 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 86' ' ' HIS . 34.5 p -149.61 -165.62 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 63.15 111.153 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.649 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.0 tt0 -86.08 -18.44 32.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 75.11 110.851 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 154' ' ' ILE . 8.6 t0 -136.54 20.38 3.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 71.55 110.884 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.411 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.3 OUTLIER -51.75 129.04 25.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 71.43 110.872 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.451 HG22 ' CD1' ' A' ' 144' ' ' TYR . 9.3 pt -135.8 176.47 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 70.55 111.177 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.435 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.8 m -131.49 123.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 71.34 111.13 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.25 122.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 73.34 111.137 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -109.24 132.18 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.41 . . . . 54.41 110.888 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 140' ' ' VAL . 11.4 mt -112.9 97.98 43.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.52 0.676 . . . . 55.21 110.893 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.75 -4.84 14.83 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 75.11 112.31 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -82.66 -23.32 34.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.949 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 13.88 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.909 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.6 m120 54.49 27.92 8.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 51.2 110.912 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.443 HD13 HD13 ' A' ' 21' ' ' LEU . 96.1 mt -93.41 126.69 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 51.34 111.141 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.513 HD22 HD13 ' A' ' 203' ' ' ILE . 19.6 tp -110.61 147.31 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.967 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.28 78.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 41.4 111.181 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.31 -32.02 21.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.723 -0.751 . . . . 50.35 112.55 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 61.23 -160.44 27.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 71.32 112.508 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -28.38 64.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.863 0.363 . . . . 72.43 110.885 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.658 HD12 ' NE1' ' A' ' 189' ' ' TRP . 28.0 tp -56.26 -56.97 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.878 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' A' ' 219' ' ' LEU . 38.2 t -81.01 107.65 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 61.33 111.073 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.466 ' HD2' HD23 ' A' ' 178' ' ' LEU . 6.2 mmpt? -50.81 161.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.919 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -115.47 156.65 25.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 73.01 110.9 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.9 t -49.23 156.34 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 72.44 111.102 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.2 11.4 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 61.21 110.908 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.554 ' HB3' HD11 ' A' ' 225' ' ' LEU . . . -82.79 146.1 29.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 62.41 111.064 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.422 ' C ' HD22 ' A' ' 225' ' ' LEU . 8.3 ptpt -118.03 -16.56 9.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.22 110.852 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -177.86 168.55 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 74.33 110.89 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 226' ' ' LEU . 6.8 mt -81.96 -35.96 28.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 73.02 110.923 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 124.99 -157.65 19.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 71.44 112.485 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.722 ' OD1' ' HB2' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -79.59 -1.76 39.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 63.5 110.923 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.658 HG11 ' CG2' ' A' ' 186' ' ' VAL . 27.6 m 36.56 45.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 64.11 111.106 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.722 ' HB2' ' OD1' ' A' ' 180' ' ' ASN . . . -56.56 -29.63 62.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 70.34 111.048 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -129.53 26.49 5.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.316 -0.402 . . . . 65.25 110.937 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . . . -124.47 153.44 41.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 72.3 111.063 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -110.06 88.78 2.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 75.22 110.924 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.658 ' CG2' HG11 ' A' ' 181' ' ' VAL . 20.5 t -61.63 -17.47 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.195 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.74 -25.68 60.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 71.41 110.861 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -114.16 -11.95 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 63.22 110.85 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.678 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.6 t90 -55.1 -61.33 2.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.227 -0.442 . . . . 75.55 110.92 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.751 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.1 -25.57 13.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 70.54 110.816 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -80.66 -32.68 36.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 62.34 111.14 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.632 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.42 -42.3 65.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 63.44 110.881 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.422 HG21 ' O ' ' A' ' 219' ' ' LEU . 29.9 mm -62.52 -47.83 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 63.31 111.111 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.481 ' HG2' HD11 ' A' ' 223' ' ' LEU . 1.5 mm-40 -57.4 -28.57 63.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.919 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.71 -21.86 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.44 110.941 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 192' ' ' SER . 9.9 t -85.74 -11.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 44.43 111.144 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -111.28 -8.4 14.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.476 . . . . 74.3 110.938 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -30.49 10.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 55.35 110.955 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 -48.76 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.07 37.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 62.22 110.936 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -51.82 -48.58 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 71.32 110.848 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -60.08 105.1 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 64.33 110.936 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.526 HG21 HG22 ' A' ' 206' ' ' VAL . 47.5 mt -145.95 125.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 60.4 111.093 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -26.83 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 55.45 110.899 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.6 134.6 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 70.11 111.163 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.707 ' HB ' HD12 ' A' ' 218' ' ' LEU . 98.0 t -109.92 134.58 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 71.23 111.029 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.939 HG22 HG12 ' A' ' 213' ' ' VAL . 13.1 t -110.82 104.22 55.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 53.2 111.129 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.8 Cg_endo -69.74 174.18 9.87 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.709 2.273 . . . . 72.43 112.36 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.6 -13.08 83.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 71.24 112.42 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -152.85 150.17 29.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 71.11 110.799 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.59 -99.67 2.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 64.2 112.406 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -175.43 158.82 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 73.14 110.88 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.939 HG12 HG22 ' A' ' 207' ' ' VAL . 6.1 m -51.63 163.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 71.21 111.116 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -162.64 -105.31 0.19 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.735 -0.745 . . . . 61.45 112.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 -167.69 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.782 0.325 . . . . 73.51 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -21.11 25.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.819 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.83 -22.79 27.94 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 72.03 112.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.8 mt -74.87 -33.76 62.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 50.41 110.956 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.497 ' HA ' HG13 ' A' ' 170' ' ' VAL . 5.3 mp -60.88 -62.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.974 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -22.13 51.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 43.34 110.945 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -63.27 -36.91 85.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.33 110.898 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.687 HG22 ' CD2' ' A' ' 226' ' ' LEU . 3.7 m -62.78 -56.95 12.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 55.52 111.137 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.481 HD11 ' HG2' ' A' ' 194' ' ' GLU . 1.4 mt -54.91 -29.47 56.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 53.33 110.859 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.04 -35.44 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 72.13 110.869 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 175' ' ' ALA . 10.3 mt -86.66 -16.11 37.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 71.3 110.921 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.777 ' HB3' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -119.04 20.71 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.8 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 73.32 110.822 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.816 0.341 . . . . 72.42 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.73 73.13 1.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 75.13 110.977 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.14 155.67 45.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.852 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -102.35 177.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.42 111.064 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -178.17 160.42 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 63.14 110.9 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -65.43 -175.01 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 70.31 110.878 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -75.68 -68.59 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 72.45 111.153 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -49.4 146.99 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 73.54 111.147 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.6 mt -113.36 101.2 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.21 111.11 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -121.07 120.46 35.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.912 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -66.28 167.56 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 70.43 110.918 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -51.71 -48.46 63.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 70.54 110.919 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 p -61.69 -37.52 84.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.12 111.095 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 10.59 67.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.828 -0.701 . . . . 74.14 112.47 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -77.48 -45.33 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 51.24 111.132 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 67' ' ' LEU . 64.1 mt -101.7 110.9 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.257 -0.429 . . . . 63.5 111.155 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 p -117.83 138.13 52.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.4 110.819 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.789 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -129.74 109.81 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 74.31 111.113 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 t -100.27 124.63 45.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 73.1 110.849 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -68.74 109.64 3.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 71.24 110.914 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.791 HD21 HG11 ' A' ' 213' ' ' VAL . 15.9 mt -64.44 -33.38 75.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 71.04 110.848 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.02 -97.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 53.21 110.935 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -151.84 10.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 73.0 110.813 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.96 6.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 54.44 110.958 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.4 t -151.16 138.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 73.14 111.181 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.789 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.3 m95 -126.1 -174.51 3.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.95 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 43' ' ' GLY . 95.6 t -136.84 96.17 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 72.23 111.139 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -81.22 121.36 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.35 110.826 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.0 m -116.45 104.32 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 72.44 111.143 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.81 120.15 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 70.21 110.889 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.75 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -90.52 106.22 18.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 65.24 110.937 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.9 -141.12 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.632 -0.794 . . . . 71.24 112.489 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 93.8 p -175.27 83.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 73.23 110.895 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.76 84.26 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 74.51 110.887 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.1 m120 62.43 17.1 9.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 71.21 110.887 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.18 -0.17 9.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.676 -0.773 . . . . 34.34 112.449 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -103.77 120.16 40.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 44.32 110.895 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.75 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -60.98 121.25 11.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 62.14 111.072 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.83 81.79 55.52 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.616 0.722 . . . . 72.51 111.092 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 116.72 4.7 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.632 2.221 . . . . 73.12 112.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.6 p -101.97 100.2 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.844 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -51.38 165.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 64.43 110.866 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.533 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -158.01 -163.61 12.97 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.683 -0.77 . . . . 24.43 112.43 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.638 HD21 HD12 ' A' ' 158' ' ' LEU . 13.9 tp -154.39 113.85 3.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 44.05 110.904 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 54' ' ' LEU . 1.8 t -97.37 115.34 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 73.53 111.144 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.778 HD21 HD11 ' A' ' 158' ' ' LEU . 29.9 mt -92.74 117.86 30.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 65.5 110.945 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -88.33 83.9 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 70.33 110.908 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.61 176.01 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 64.2 111.14 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.73 -22.97 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 75.3 110.895 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -12.85 59.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.908 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.2 155.21 6.46 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.727 -0.749 . . . . 61.31 112.542 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 52' ' ' LEU . 9.5 tp -68.66 154.26 42.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.923 0.392 . . . . 73.32 110.882 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.4 t -145.68 143.68 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.13 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 45' ' ' VAL . 1.4 mt -138.51 123.06 18.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 73.24 110.969 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 165' ' ' VAL . 91.1 t -68.62 111.07 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 74.03 111.211 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.37 128.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.448 . . . . 63.14 110.849 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.661 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -73.52 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.816 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 t -90.52 170.07 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 71.21 110.841 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.5 m95 -51.29 -60.74 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 65.24 110.967 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -125.33 159.46 31.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 72.13 110.891 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -51.99 -33.18 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 61.12 110.829 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -59.43 -42.14 91.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 75.51 110.902 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.0 mt -76.64 -48.88 17.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 70.51 110.957 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.07 -45.8 52.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.165 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -54.63 -49.09 71.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.31 110.893 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.13 -19.77 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.873 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.0 tp -88.23 -26.78 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 62.21 110.947 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.28 -22.44 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 70.11 111.11 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.4 15.66 13.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.928 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.0 ptm -130.32 -40.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.756 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.7 m -80.23 -22.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 74.54 111.153 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.575 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.1 -23.25 64.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 62.23 110.915 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -107.53 -33.09 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 73.53 110.859 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -40.47 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 72.41 110.863 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.541 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 15.1 m-85 -90.79 -10.48 42.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 71.22 110.908 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.41 12.15 8.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 72.22 110.959 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.88 138.34 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 71.14 110.932 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.08 138.14 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 74.42 110.834 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.575 HG23 ' OE2' ' A' ' 72' ' ' GLU . 71.9 t -74.59 124.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 71.44 111.088 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -137.67 8.34 2.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.123 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 53' ' ' VAL . 57.1 m-20 -154.54 146.18 23.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 72.02 110.767 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 54' ' ' LEU . 13.6 t -153.71 128.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 72.43 111.176 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.59 ' CD1' HG11 ' A' ' 140' ' ' VAL . 54.5 mt -84.88 129.08 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 64.5 111.182 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.57 123.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 73.5 111.125 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p -83.76 -45.85 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 54.42 111.196 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.5 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.2 p-80 -153.44 178.06 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 65.42 110.845 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.497 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -97.71 91.62 5.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 61.2 111.052 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.33 156.56 43.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.786 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.53 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 61.21 111.085 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.84 20.03 10.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 64.55 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.83 -77.43 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.896 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.79 7.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.32 111.096 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.45 -37.85 41.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 53.21 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 10.57 64.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 55.35 112.395 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.38 -28.41 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 71.12 111.201 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -38.81 67.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.887 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -84.07 -10.45 57.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 54.32 111.077 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.661 HD11 ' OG ' ' A' ' 57' ' ' SER . 22.9 mt -90.86 -33.94 15.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.34 110.925 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -94.42 17.9 12.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.973 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -116.3 -39.25 3.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.93 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -87.33 -55.75 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 64.14 110.848 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.91 47.87 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.75 -0.738 . . . . 71.34 112.524 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.3 mp -111.32 110.79 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 40.31 111.087 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.718 ' HB3' HD11 ' A' ' 124' ' ' LEU . 12.7 mtmt -72.1 107.88 5.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 72.31 110.861 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.62 89.41 7.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 61.04 111.093 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.546 ' HA ' HD12 ' A' ' 124' ' ' LEU . 58.1 m-70 -62.08 135.82 57.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.885 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.92 168.98 10.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 63.11 110.844 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.87 154.23 25.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.141 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.91 7.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 61.45 111.053 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -70.7 -46.38 63.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 61.14 111.011 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.752 ' HA ' HD11 ' A' ' 114' ' ' LEU . 32.7 m -57.03 -25.59 58.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 60.55 111.174 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.599 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -97.89 14.12 28.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 71.42 111.143 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -26.75 7.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.825 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -105.74 -10.35 16.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 55.44 110.911 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.53 70.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 71.24 111.061 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -24.54 55.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 64.11 110.889 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -61.48 -32.63 72.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 61.54 110.897 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -89.36 -24.82 21.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 52.32 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.05 24.06 3.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.696 -0.764 . . . . 71.34 112.443 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.72 166.48 10.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 74.23 110.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.99 162.95 28.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 73.51 110.928 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mp0 -95.09 111.93 56.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.607 0.718 . . . . 72.15 110.891 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.599 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.2 Cg_endo -69.79 -176.1 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.6 2.2 . . . . 75.35 112.323 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 104' ' ' LYS . 17.5 mt -51.79 -43.7 63.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.831 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.6 50.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 62.24 112.485 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.11 43.52 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 72.14 110.782 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.751 HD22 HD21 ' A' ' 133' ' ' LEU . 59.2 mt -129.14 -175.55 3.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 73.11 110.878 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -151.6 -171.72 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 63.12 110.871 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.853 HG22 HG23 ' A' ' 130' ' ' VAL . 52.9 m -50.62 -71.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 62.54 111.089 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 HG22 ' A' ' 129' ' ' THR . 31.2 t -116.85 102.79 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 63.32 111.04 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 t -135.63 170.56 15.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.1 111.156 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -117.68 133.88 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 64.11 110.884 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.751 HD21 HD22 ' A' ' 127' ' ' LEU . 25.9 mt -114.84 155.52 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 65.0 110.942 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -137.59 124.17 20.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.22 110.857 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -125.86 49.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.923 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.44 92.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 74.35 112.547 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.7 m120 64.6 15.05 9.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 70.31 110.941 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.3 tpp -135.16 108.65 7.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.863 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -98.33 129.06 45.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.823 HG22 HD21 ' A' ' 158' ' ' LEU . 20.2 t -134.91 115.15 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 64.31 111.184 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -107.64 130.63 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 61.4 110.814 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.5 p -86.75 -176.54 5.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 62.4 111.164 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.511 ' HB3' HG23 ' A' ' 155' ' ' VAL . 24.7 t80 -168.4 130.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.835 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.748 ' HB3' HG23 ' A' ' 129' ' ' THR . 11.0 t80 -115.57 88.01 18.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 71.03 110.957 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -7.99 22.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.646 2.231 . . . . 53.1 112.411 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.56 -162.29 21.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.674 -0.774 . . . . 62.23 112.381 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -81.04 137.61 36.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 71.32 110.878 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.13 -88.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.472 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -76.36 -25.21 54.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 62.2 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.5 HG21 ' HB2' ' A' ' 86' ' ' HIS . 17.2 p -147.15 -158.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 71.22 111.067 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HB3' HD23 ' A' ' 114' ' ' LEU . 40.6 tt0 -89.47 -22.01 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.872 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.759 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -132.18 8.66 4.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.853 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.472 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.0 OUTLIER -41.12 128.37 2.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.01 110.891 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 152' ' ' ASP . 7.0 pt -132.79 -176.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 71.34 111.101 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.529 ' HB ' HD11 ' A' ' 164' ' ' LEU . 9.2 m -133.82 131.76 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 64.41 111.043 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 164' ' ' LEU . 91.1 t -86.27 126.44 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 65.52 111.156 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -114.33 131.09 56.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.43 110.812 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.823 HD21 HG22 ' A' ' 140' ' ' VAL . 11.6 mt -111.84 97.19 36.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 74.31 110.885 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.4 Cg_endo -69.87 -5.1 15.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.664 2.242 . . . . 74.12 112.301 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -81.81 -23.63 36.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 62.33 110.952 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.4 13.76 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.917 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.42 29.75 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.41 110.907 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.498 HD13 HD13 ' A' ' 21' ' ' LEU . 98.3 mt -96.07 130.3 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.11 111.092 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' A' ' 155' ' ' VAL . 25.4 tp -112.67 146.0 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.867 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 55' ' ' VAL . 21.3 t -112.22 79.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 74.42 111.145 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.67 42.79 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.656 -0.783 . . . . 54.32 112.542 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.5 -163.85 53.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 41.22 112.515 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -33.55 35.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.361 . . . . 44.12 110.909 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.616 HD12 ' NE1' ' A' ' 189' ' ' TRP . 22.6 tp -53.69 -56.38 17.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.934 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 218' ' ' LEU . 14.7 t -82.55 114.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 64.42 111.076 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 150.57 19.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 72.53 110.889 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.0 p -97.96 155.11 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.865 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t -51.44 -29.22 15.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.123 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.6 m -93.36 42.34 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 64.12 110.864 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -137.76 155.94 48.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 64.05 111.103 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.537 ' HA ' HD22 ' A' ' 225' ' ' LEU . 20.5 ttmt -136.59 11.26 3.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 64.33 110.859 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.73 157.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 63.14 110.913 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.744 HD13 ' CE3' ' A' ' 189' ' ' TRP . 6.1 mt -73.96 -32.88 63.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 53.33 110.891 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 87.95 -151.34 22.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.761 -0.733 . . . . 63.33 112.434 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -52.4 115.92 2.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 63.25 110.922 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.478 HG11 ' CG2' ' A' ' 186' ' ' VAL . 26.9 m -109.19 35.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 64.23 111.028 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.07 81.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 74.05 111.099 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -112.86 33.06 5.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 62.03 110.897 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.43 158.68 43.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 54.34 111.091 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -113.73 90.94 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.35 110.94 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.478 ' CG2' HG11 ' A' ' 181' ' ' VAL . 8.5 t -67.12 -19.18 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 42.15 111.137 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -74.84 -24.83 58.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 64.23 110.876 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.39 -10.76 13.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 72.02 110.852 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.744 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.5 t90 -55.3 -61.44 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 62.12 110.93 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.7 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.63 -24.48 14.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 54.31 110.894 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.9 m -81.57 -31.97 32.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 63.01 111.058 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -43.1 61.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.859 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 219' ' ' LEU . 30.5 mm -61.68 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.35 111.14 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.39 -27.64 56.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 63.14 110.92 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -76.98 -22.27 53.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 73.34 110.939 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.18 -11.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 73.03 111.143 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.436 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -111.4 -10.02 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 65.21 110.916 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.86 -30.76 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.833 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -58.48 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.11 110.897 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.448 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -93.08 61.68 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 74.02 110.893 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -72.36 -58.14 3.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 74.32 110.94 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -53.03 102.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.3 110.845 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.646 HG21 ' CG2' ' A' ' 206' ' ' VAL . 73.9 mt -142.04 121.68 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 73.03 111.16 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -29.83 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.447 . . . . 70.11 110.84 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.06 143.18 2.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 63.21 111.178 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.756 ' HB ' HD12 ' A' ' 218' ' ' LEU . 98.1 t -121.48 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 45.23 111.1 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.963 HG22 HG12 ' A' ' 213' ' ' VAL . 11.9 t -108.48 112.57 60.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 63.23 111.274 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.62 -169.48 0.32 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.769 2.313 . . . . 53.22 112.397 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.65 -13.66 59.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.828 -0.701 . . . . 73.14 112.5 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.45 129.71 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.354 . . . . 72.41 110.838 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 116.78 -117.69 3.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.812 -0.709 . . . . 72.12 112.494 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -150.79 164.75 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 75.23 110.841 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.963 HG12 HG22 ' A' ' 207' ' ' VAL . 5.8 m -54.87 163.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.23 111.176 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.26 -111.58 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.803 -0.713 . . . . 70.34 112.522 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.15 -169.32 2.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.418 . . . . 75.32 110.809 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -18.31 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 72.2 110.856 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.494 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.88 -16.75 48.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.75 -0.738 . . . . 65.41 112.47 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.756 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.6 mt -71.95 -30.35 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 74.21 110.967 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.588 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.7 mm? -65.64 -57.5 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.52 110.899 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.494 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -61.54 -17.78 56.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 73.44 110.918 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -65.6 -50.42 65.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.1 110.873 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.543 ' C ' HD23 ' A' ' 226' ' ' LEU . 2.9 m -51.78 -51.43 56.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 74.13 111.138 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -18.74 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 75.04 110.915 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -87.53 -5.07 58.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 72.45 110.804 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 176' ' ' LYS . 9.3 mt -126.09 -6.4 6.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 70.42 110.876 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.723 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -119.34 8.48 11.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.918 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 64.42 110.877 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.793 0.33 . . . . 44.3 110.844 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -117.71 152.93 34.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 75.13 110.868 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -166.56 160.11 14.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 70.24 110.965 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.6 147.62 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 64.14 111.107 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -148.33 96.38 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 65.53 110.886 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -93.68 -177.47 4.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 74.24 110.887 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -88.14 -68.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 74.23 111.196 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -49.7 147.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.48 . . . . 70.24 111.131 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -114.2 100.23 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 65.2 111.127 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -121.4 116.3 24.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 63.02 110.906 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -58.52 165.23 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 71.22 110.96 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.8 -48.29 63.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 74.22 110.896 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -60.74 -38.01 83.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.13 111.206 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.97 64.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.728 -0.749 . . . . 73.22 112.525 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -71.34 -45.42 62.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.7 0.286 . . . . 75.51 111.085 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.96 123.3 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.419 . . . . 74.5 111.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.1 p -129.2 132.64 47.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 75.04 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -127.28 107.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 72.32 111.12 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -98.6 125.07 43.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.34 110.836 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -68.58 108.78 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.12 110.843 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.731 HD21 HG21 ' A' ' 213' ' ' VAL . 14.1 mt -62.61 -33.1 74.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 70.15 110.936 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.26 -96.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 52.21 110.883 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.42 9.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.925 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.98 6.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.892 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 t -150.69 139.74 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 63.2 111.126 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.788 ' HB3' HG22 ' A' ' 18' ' ' ILE . 16.0 m95 -128.03 -174.78 3.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 65.12 110.92 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG21 ' CG2' ' A' ' 213' ' ' VAL . 99.3 t -136.83 94.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 70.1 111.057 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -79.01 122.07 25.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 72.0 110.866 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.7 m -118.7 104.92 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 70.44 111.167 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.41 124.48 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 74.4 110.888 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.769 HD21 ' HB1' ' A' ' 38' ' ' ALA . 1.6 mt -86.23 114.2 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.877 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.94 -35.99 53.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.66 -0.781 . . . . 61.25 112.437 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m 58.53 98.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 75.52 110.825 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.549 ' CE1' HG13 ' A' ' 39' ' ' VAL . 2.5 p90 -129.66 137.66 50.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.059 -0.519 . . . . 73.03 110.848 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 54.08 40.45 31.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 74.3 110.881 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.81 8.67 61.16 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.678 -0.772 . . . . 53.54 112.512 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -100.18 -166.46 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.343 . . . . 65.53 110.889 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.769 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -133.42 113.38 12.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 72.34 111.107 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.549 HG13 ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -112.44 77.63 2.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.641 0.734 . . . . 75.11 111.193 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 118.29 5.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 71.01 112.305 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.8 p -97.38 98.08 9.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.799 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -51.79 159.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.31 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -154.67 -167.3 16.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.77 . . . . 42.34 112.435 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 158' ' ' LEU . 14.3 tp -152.68 112.84 4.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 72.25 110.964 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.64 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -95.66 116.5 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.19 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.729 HD21 HD11 ' A' ' 158' ' ' LEU . 26.7 mt -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 73.55 110.906 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -86.86 86.64 7.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.888 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.47 179.98 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 62.54 111.112 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.4 -23.32 14.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.9 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -13.24 58.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 41.34 110.919 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.11 151.81 5.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 55.31 112.539 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.62 153.7 35.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.808 0.337 . . . . 73.34 110.969 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.638 HG13 ' CB ' ' A' ' 81' ' ' ASP . 2.3 t -143.74 141.09 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 64.34 111.031 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.64 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.3 mt -136.87 122.07 19.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.43 110.943 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG11 HG11 ' A' ' 165' ' ' VAL . 76.3 t -67.43 111.43 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.152 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' CG ' HG12 ' A' ' 55' ' ' VAL . 1.9 m-20 72.1 130.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.34 110.903 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -72.85 -166.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.228 -0.442 . . . . 75.11 110.914 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -91.62 169.19 10.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.12 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.718 ' HB2' HD12 ' A' ' 63' ' ' LEU . 96.5 m95 -48.98 -58.5 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.983 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -130.48 161.53 31.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.13 110.883 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -54.21 -32.83 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 60.22 110.815 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -59.22 -39.84 84.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 72.35 110.868 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.7 mt -78.91 -45.39 20.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 71.23 110.909 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -46.33 62.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 64.41 111.093 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.05 -49.46 66.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 74.24 110.905 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.08 -15.27 63.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 71.13 110.936 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.499 ' O ' HG22 ' A' ' 71' ' ' VAL . 17.3 tp -92.53 -24.89 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 65.05 110.958 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.821 HG12 HG11 ' A' ' 79' ' ' VAL . 15.3 mt -91.24 -26.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.42 111.125 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -86.55 7.77 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.857 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.7 ptm -123.53 -38.6 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 71.35 110.913 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 67' ' ' LEU . 23.0 m -79.55 -23.68 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 55.05 111.133 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -20.68 61.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.896 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -107.79 -30.71 8.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 63.54 110.873 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -45.79 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 27.5 m-85 -83.55 -11.97 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 71.31 110.838 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 67.65 12.78 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 62.22 110.916 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 139.7 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 65.21 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.97 136.8 38.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 62.41 110.799 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.821 HG11 HG12 ' A' ' 68' ' ' ILE . 14.4 p -77.02 128.75 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 72.41 111.12 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -155.41 19.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.159 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.638 ' CB ' HG13 ' A' ' 53' ' ' VAL . 28.0 m-20 -154.24 142.68 20.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 74.22 110.871 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 81' ' ' ASP . 10.4 t -156.58 104.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 62.51 111.16 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.616 HD11 ' HE2' ' A' ' 135' ' ' PHE . 8.5 mt -69.97 119.82 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.41 111.111 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.7 mm -93.45 147.46 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 72.43 111.106 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -104.24 -50.33 3.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 64.23 111.074 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.491 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.8 p-80 -155.84 -174.58 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 62.24 110.88 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.837 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -92.37 99.58 12.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 54.02 111.139 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.45 151.88 29.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 64.4 110.866 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.18 -19.94 49.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.401 . . . . 70.41 111.028 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.58 6.25 48.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 65.22 110.956 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.68 -77.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.875 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -92.13 7.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 73.35 111.188 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.78 -37.44 34.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.816 -0.707 . . . . 72.13 112.414 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.2 10.77 58.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.751 . . . . 74.12 112.534 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 92' ' ' ILE . 17.0 tt -53.89 -28.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.924 0.392 . . . . 71.41 111.159 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -53.64 -36.94 62.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 64.44 110.921 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -87.17 -13.71 43.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.42 111.147 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.578 ' HA ' HD13 ' A' ' 103' ' ' ILE . 20.2 mt -86.42 -31.55 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 75.21 110.923 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.92 15.73 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 65.24 110.88 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -116.46 -45.37 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 74.2 110.942 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -78.15 -56.86 4.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 71.51 110.804 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.816 -0.706 . . . . 62.55 112.498 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -109.98 119.24 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.928 0.394 . . . . 74.23 111.121 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.753 ' CE ' HD21 ' A' ' 124' ' ' LEU . 3.9 mtpp -76.17 119.32 19.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 71.14 110.852 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.0 93.53 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 51.53 111.116 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.426 ' HB3' HD11 ' A' ' 127' ' ' LEU . 76.9 m-70 -65.86 145.67 55.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.03 110.906 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.441 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -178.87 171.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 55.25 110.889 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.89 158.94 19.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 61.52 111.105 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -39.26 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.42 111.065 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -66.06 -44.17 85.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 72.43 110.906 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.741 ' HA ' HD11 ' A' ' 114' ' ' LEU . 51.6 m -57.5 -25.35 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 61.34 111.121 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.11 10.86 38.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 63.21 111.121 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.9 -33.2 6.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 71.15 110.892 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.837 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -97.59 -13.9 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.878 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.442 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -63.5 -41.57 98.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 73.25 111.105 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -24.41 58.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 62.25 110.925 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -32.5 70.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 64.44 110.826 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -89.87 -24.35 21.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 72.32 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.18 23.93 4.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 55.33 112.568 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -98.07 -175.5 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 72.22 110.923 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.429 ' HB2' HD13 ' A' ' 95' ' ' ILE . 6.3 mm-40 -85.5 176.14 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 73.43 110.93 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.9 mt-10 -106.59 104.38 50.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.684 0.754 . . . . 73.32 110.863 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.8 Cg_endo -69.77 -178.75 2.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.635 2.223 . . . . 62.3 112.367 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.753 HD21 ' CE ' ' A' ' 104' ' ' LYS . 10.2 mt -51.08 -47.04 61.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.981 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.07 26.55 28.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 71.5 112.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -107.84 45.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 72.33 110.817 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.587 HD22 HD21 ' A' ' 133' ' ' LEU . 86.4 mt -127.1 -174.96 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 75.03 110.972 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -152.57 -172.31 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 73.43 110.932 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.869 HG22 HG23 ' A' ' 130' ' ' VAL . 49.6 m -50.89 -70.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.33 111.166 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.869 HG23 HG22 ' A' ' 129' ' ' THR . 33.0 t -117.06 103.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 54.54 111.097 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t -135.42 175.23 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 64.23 111.122 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -120.64 136.39 54.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 62.24 110.901 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 127' ' ' LEU . 25.2 mt -115.23 154.34 29.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 60.13 110.844 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -134.08 126.89 31.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.857 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.616 ' HE2' HD11 ' A' ' 83' ' ' ILE . 12.2 m-85 -129.9 32.8 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.797 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.66 95.37 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.672 -0.775 . . . . 43.32 112.487 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.88 13.49 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 72.23 110.969 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.6 tpp -135.03 106.43 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 70.22 110.821 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.471 ' O ' HD23 ' A' ' 158' ' ' LEU . 3.4 mptp? -94.58 126.0 39.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 60.33 110.852 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.844 HG22 HD21 ' A' ' 158' ' ' LEU . 19.9 t -134.77 116.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.174 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.95 131.22 55.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 55.5 110.88 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.5 p -85.04 -176.03 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.33 111.199 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.443 ' HB3' HG23 ' A' ' 155' ' ' VAL . 24.7 t80 -166.67 133.08 2.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.877 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.694 ' HB3' HG23 ' A' ' 129' ' ' THR . 7.8 t80 -122.01 87.33 47.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.612 0.72 . . . . 73.53 110.87 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 -7.68 21.69 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.672 2.248 . . . . 70.33 112.335 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.48 -160.81 23.86 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.742 -0.742 . . . . 53.4 112.442 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -86.26 139.48 30.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.886 0.374 . . . . 74.41 110.91 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.17 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 61.04 112.435 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -75.6 -22.92 56.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 63.22 110.86 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 86' ' ' HIS . 59.3 p -150.69 -169.21 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 63.21 111.122 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.543 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.2 tt0 -86.63 -5.71 59.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 55.13 110.926 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 154' ' ' ILE . 47.6 t0 -145.75 16.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 52.53 110.838 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.69 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -49.8 126.14 13.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 53.12 110.904 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 152' ' ' ASP . 24.1 pt -133.72 174.92 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 70.25 111.15 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 143' ' ' PHE . 14.5 m -128.06 120.38 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 63.11 111.088 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.37 119.18 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 42.51 111.167 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.4 t-105 -107.94 136.45 47.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.33 110.816 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.844 HD21 HG22 ' A' ' 140' ' ' VAL . 13.3 mt -118.63 98.35 51.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 72.0 110.808 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -4.52 14.2 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.675 2.25 . . . . 73.11 112.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -85.12 -21.22 29.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.11 110.98 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -143.52 13.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 74.11 110.929 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.1 m120 53.12 27.54 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.952 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.468 HD13 HD13 ' A' ' 21' ' ' LEU . 95.9 mt -89.96 142.82 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 63.53 111.156 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.594 HD22 HD13 ' A' ' 203' ' ' ILE . 27.7 tp -125.62 147.79 49.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.53 110.915 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.497 HG11 HG11 ' A' ' 55' ' ' VAL . 53.3 t -115.02 79.2 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 63.21 111.074 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.03 -34.0 37.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.781 -0.723 . . . . 60.2 112.427 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.17 -163.31 16.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 61.21 112.478 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -32.65 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 54.42 110.892 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.69 HD13 ' OD1' ' A' ' 153' ' ' ASN . 23.0 tp -52.02 -51.38 57.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 70.13 110.929 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 219' ' ' LEU . 21.3 t -89.63 110.84 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 73.32 111.143 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.71 ' HG2' HG23 ' A' ' 222' ' ' THR . 0.4 OUTLIER -56.34 156.27 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 73.12 110.95 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 45.5 p -98.77 159.82 14.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 42.32 110.91 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -51.07 -29.91 14.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 70.45 111.107 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.6 m -93.5 46.3 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.288 -0.414 . . . . 72.13 110.818 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.77 48.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 74.41 111.055 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.582 ' HA ' HD22 ' A' ' 225' ' ' LEU . 22.3 tttt -124.82 -2.08 7.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 74.34 110.814 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -170.46 172.31 6.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.311 -0.404 . . . . 70.52 110.905 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 226' ' ' LEU . 3.3 mt -86.32 -36.29 19.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 73.32 110.976 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 125.52 -138.23 10.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.727 -0.749 . . . . 35.41 112.494 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.688 HD22 ' HB2' ' A' ' 182' ' ' ALA . 6.2 p-10 -97.87 -1.17 43.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 64.24 110.857 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.734 HG11 ' CG2' ' A' ' 186' ' ' VAL . 27.3 m 36.73 44.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.455 . . . . 72.21 111.079 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.688 ' HB2' HD22 ' A' ' 180' ' ' ASN . . . -60.3 -26.94 66.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 43.2 111.125 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -134.2 29.09 3.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 63.54 110.875 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.68 158.48 36.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 73.34 111.135 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -114.01 90.69 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 71.44 110.89 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.734 ' CG2' HG11 ' A' ' 181' ' ' VAL . 27.3 t -62.0 -16.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 73.22 111.131 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -74.28 -23.43 59.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 70.45 110.877 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -117.12 -13.0 10.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 72.53 110.823 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.608 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.4 t90 -53.58 -62.01 1.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.108 -0.496 . . . . 73.54 110.881 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.759 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -55.25 -23.62 23.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 53.41 110.839 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.54 -30.07 33.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 70.11 111.176 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.7 -44.12 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 63.13 110.891 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.509 HG21 ' O ' ' A' ' 219' ' ' LEU . 33.6 mm -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 74.03 111.102 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.462 ' HG2' HD21 ' A' ' 223' ' ' LEU . 2.3 mm-40 -56.3 -27.4 55.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 64.31 110.918 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -77.66 -22.32 50.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 64.33 110.853 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 192' ' ' SER . 17.2 t -85.26 -10.84 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.012 0.434 . . . . 75.33 111.204 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.56 -12.7 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 61.44 110.914 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -98.75 -30.79 12.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 71.24 110.928 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -59.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 75.33 110.876 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.459 ' O ' HD11 ' A' ' 203' ' ' ILE . 3.9 m-30 -91.49 61.71 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 73.44 110.947 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -72.78 -58.52 3.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.903 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -52.64 101.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 60.14 110.905 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.64 HG21 HG22 ' A' ' 206' ' ' VAL . 71.6 mt -141.14 118.22 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 73.34 111.117 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.1 -28.08 63.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.825 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.649 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -166.9 145.08 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.438 . . . . 71.13 111.139 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.748 ' HB ' HD12 ' A' ' 218' ' ' LEU . 93.0 t -123.45 131.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.196 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.014 HG22 HG22 ' A' ' 213' ' ' VAL . 15.9 t -110.15 105.87 57.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 62.31 111.187 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.2 Cg_endo -69.82 -171.3 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 70.2 112.319 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.4 -20.24 67.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 71.34 112.54 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.46 144.48 23.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.795 0.331 . . . . 72.21 110.917 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.38 -101.86 1.36 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.772 -0.728 . . . . 74.53 112.544 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -172.03 170.98 5.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.92 0.391 . . . . 73.44 110.868 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.014 HG22 HG22 ' A' ' 207' ' ' VAL . 10.9 t -65.23 148.47 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 70.31 111.188 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.51 -101.96 0.31 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.768 -0.729 . . . . 60.34 112.559 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -163.57 -169.12 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 54.51 110.903 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -17.75 54.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 53.51 110.907 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.468 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.55 -20.72 39.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.771 -0.728 . . . . 61.12 112.511 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.748 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.6 mt -72.87 -29.84 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 73.02 110.949 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.509 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -64.52 -60.67 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 73.01 110.9 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.468 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.4 OUTLIER -58.76 -19.92 44.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 72.2 110.902 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.542 ' NE2' HD11 ' A' ' 225' ' ' LEU . 13.5 t-160 -61.86 -50.93 70.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 72.23 110.959 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.729 HG22 HD23 ' A' ' 226' ' ' LEU . 3.8 m -51.7 -51.02 59.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 63.25 111.173 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.636 HD23 ' OG ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -60.49 -18.23 50.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 74.22 110.936 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.69 -2.64 57.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.833 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 176' ' ' LYS . 8.1 mt -125.22 -8.02 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 51.33 110.88 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.808 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -122.61 9.42 9.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 65.25 110.947 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.846 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.823 0.344 . . . . 62.15 110.853 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -128.3 -46.57 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.913 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.19 169.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 71.51 110.896 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.7 m -86.23 -177.67 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 73.13 111.134 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -116.36 55.95 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.874 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -124.74 168.02 13.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 60.03 110.915 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 m -82.57 -50.45 8.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 71.31 111.085 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 18' ' ' ILE . 3.8 m -60.16 179.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 75.35 111.236 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.6 mt -135.78 102.55 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 54.54 111.184 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -110.71 122.64 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 75.3 110.95 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -65.62 166.39 10.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 72.43 110.849 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.65 -48.69 63.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 52.23 110.836 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -60.61 -37.72 82.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.476 . . . . 75.3 111.178 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.86 11.93 61.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.35 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 31' ' ' LEU . 41.9 m -84.55 -41.61 16.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 72.33 111.098 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.642 HD13 ' HB2' ' A' ' 67' ' ' LEU . 68.8 mt -101.22 103.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 74.11 111.107 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.1 p -120.62 125.97 49.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 70.12 110.852 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -101.52 -164.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.094 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.581 ' H ' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -178.23 115.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 62.1 110.876 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -68.17 106.48 2.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 74.21 110.904 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.688 ' HG ' HG23 ' A' ' 27' ' ' VAL . 28.8 mt -65.73 -32.62 74.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.01 110.96 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.43 -96.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 63.51 110.876 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.62 10.44 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 64.21 110.944 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.51 5.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 64.3 110.944 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.8 t -151.4 138.95 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 72.43 111.196 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.418 ' O ' HD12 ' A' ' 44' ' ' LEU . 13.2 m95 -125.02 -173.86 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 72.44 110.953 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.688 HG23 ' HG ' ' A' ' 21' ' ' LEU . 72.2 t -137.17 89.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 61.3 111.151 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CA ' HG23 ' A' ' 18' ' ' ILE . 14.2 p80 -73.96 125.16 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.776 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -118.97 96.76 5.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 63.02 111.076 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.22 117.68 18.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 71.14 110.954 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -84.16 114.77 22.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 75.43 110.915 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.77 -139.64 5.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 73.21 112.43 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.7 119.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.904 0.383 . . . . 60.11 110.815 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -148.97 136.8 20.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 75.42 110.9 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 49.67 28.68 2.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 70.31 110.875 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.32 40.96 32.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.734 -0.746 . . . . 62.53 112.551 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -147.43 135.71 21.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 63.13 110.827 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -66.0 145.65 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 51.04 111.108 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.52 79.72 68.6 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.553 0.692 . . . . 70.24 111.108 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.694 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.7 Cg_endo -69.71 117.69 5.23 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.688 2.259 . . . . 64.22 112.327 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -107.85 98.76 8.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.8 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -50.97 161.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.881 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -154.7 -155.81 7.44 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.739 . . . . 62.32 112.455 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 158' ' ' LEU . 13.1 tp -157.6 112.05 2.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 73.21 110.874 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.659 HG22 HD23 ' A' ' 54' ' ' LEU . 2.0 t -96.88 112.37 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.098 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.741 HD21 HD11 ' A' ' 158' ' ' LEU . 17.9 mt -90.86 120.01 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.973 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -90.75 82.17 5.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 73.23 110.886 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -97.22 -179.51 4.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 71.44 111.105 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -25.81 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 70.04 110.859 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -20.16 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.44 110.953 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.5 149.63 5.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.22 112.562 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.699 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.6 mt -61.56 154.16 25.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.817 0.342 . . . . 63.54 110.918 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.3 t -144.59 141.79 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 63.2 111.187 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.659 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -137.2 121.97 18.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 63.23 110.898 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.625 HG11 HG11 ' A' ' 165' ' ' VAL . 77.0 t -66.82 111.66 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.45 111.157 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.77 128.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.874 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.683 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.8 p -70.84 -167.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 52.51 110.833 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.58 ' H ' HG23 ' A' ' 64' ' ' THR . 8.1 t -89.94 166.84 13.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 53.13 110.907 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.8 m95 -49.69 -59.86 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 73.31 110.892 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.86 158.0 37.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 75.2 110.823 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -51.57 -33.36 32.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 73.33 110.955 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.05 -45.58 90.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 75.23 110.921 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.699 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.4 mt -72.32 -46.93 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.956 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.46 -47.71 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 55.4 111.164 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.07 -49.96 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.834 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG3' HD12 ' A' ' 16' ' ' ILE . 35.0 tp10 -64.76 -20.54 66.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 74.11 110.837 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.642 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.4 tp -87.24 -25.19 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 54.53 110.871 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.23 -24.03 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 62.01 111.145 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -92.17 16.18 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 54.32 110.882 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.8 ptm -131.65 -39.99 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.834 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 67' ' ' LEU . 20.1 m -80.23 -22.86 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 54.34 111.052 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.708 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.37 -24.81 65.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 65.14 110.858 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -105.36 -33.37 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 70.31 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -44.48 68.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 72.12 110.903 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.541 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.8 m-85 -85.81 -12.29 51.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 70.54 110.941 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 69.44 11.43 8.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.893 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -131.59 141.49 49.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.53 110.918 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.97 140.42 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 61.11 110.959 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.708 HG23 ' OE2' ' A' ' 72' ' ' GLU . 89.6 t -81.78 121.28 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 74.12 111.169 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -138.09 14.23 2.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 73.35 111.153 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 103' ' ' ILE . 60.8 m-20 -154.45 144.83 22.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 64.04 110.935 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 54' ' ' LEU . 21.3 t -153.85 132.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.13 111.046 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.555 HD11 ' HE2' ' A' ' 135' ' ' PHE . 43.7 mt -92.66 128.41 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 71.45 111.048 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.52 153.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.44 111.129 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.0 p -112.32 -49.87 2.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 64.14 111.154 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.6 -176.15 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 63.24 110.841 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -98.39 90.9 4.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 64.31 111.072 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.2 152.84 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 74.21 110.831 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.23 12.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 73.22 111.1 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.53 27.12 2.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.856 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -71.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 71.11 110.849 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -98.85 7.61 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 73.33 111.211 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.55 -42.22 43.45 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.722 -0.751 . . . . 71.13 112.451 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.61 16.89 58.3 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.639 -0.791 . . . . 51.2 112.491 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.4 tt -56.71 -30.23 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 62.31 111.186 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -30.01 60.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 64.34 110.864 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -89.11 -15.14 34.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 63.54 111.175 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 57' ' ' SER . 14.0 mt -89.88 -28.74 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.834 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -97.27 13.4 29.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.263 -0.426 . . . . 70.44 110.895 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -112.35 -43.01 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 73.3 110.868 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -78.84 -57.56 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.939 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.84 38.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.642 -0.789 . . . . 71.55 112.441 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.555 HD13 ' HA ' ' A' ' 98' ' ' LEU . 3.9 mp -108.27 124.53 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.39 . . . . 75.34 111.124 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.533 ' HB3' HD11 ' A' ' 124' ' ' LEU . 2.6 mttt -86.67 120.15 27.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 71.14 110.898 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.11 96.36 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.066 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.585 ' HA ' HD12 ' A' ' 124' ' ' LEU . 36.2 m-70 -68.99 144.7 54.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.41 . . . . 72.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.58 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -179.01 -177.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 52.43 110.895 -179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.58 155.83 17.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 73.21 111.161 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.83 -37.87 45.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 71.13 111.086 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.521 HD23 ' OD1' ' A' ' 152' ' ' ASP . 33.4 tp -67.94 -45.85 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 71.21 110.915 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.59 ' HA ' HD11 ' A' ' 114' ' ' LEU . 85.9 m -58.49 -21.61 52.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 34.02 111.136 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.26 12.06 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 75.52 111.186 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -111.68 -28.55 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.876 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -100.58 -9.57 21.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.958 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.426 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 61.52 110.998 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -27.13 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 75.13 110.917 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.34 -34.45 66.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 52.22 110.863 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.44 -23.7 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 54.54 110.808 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.81 21.79 4.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 71.44 112.557 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -95.73 177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 71.05 110.942 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HB2' HD13 ' A' ' 95' ' ' ILE . 66.5 mm-40 -78.12 176.03 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 72.32 110.904 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mt-10 -108.58 104.8 55.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 75.24 110.933 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.82 178.74 4.3 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.653 2.235 . . . . 70.44 112.358 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 106' ' ' HIS . 28.3 mt -51.37 -51.09 57.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 62.32 110.938 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.52 40.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 34.15 112.522 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -99.23 34.47 2.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 70.43 110.929 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.683 ' CD2' HD21 ' A' ' 133' ' ' LEU . 80.7 mt -117.96 -174.35 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 61.53 110.851 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.1 -171.12 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 71.33 110.835 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.804 HG22 HG23 ' A' ' 130' ' ' VAL . 99.5 m -50.56 -69.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 65.41 111.058 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.804 HG23 HG22 ' A' ' 129' ' ' THR . 34.5 t -120.49 102.61 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 65.41 111.121 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -132.71 164.29 27.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.507 . . . . 61.4 111.154 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.3 129.15 56.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 74.25 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.683 HD21 ' CD2' ' A' ' 127' ' ' LEU . 61.6 mt -115.89 157.97 23.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.998 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -136.99 112.15 9.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.92 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.555 ' HE2' HD11 ' A' ' 83' ' ' ILE . 19.0 m-85 -107.6 45.42 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.947 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.01 87.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 54.03 112.492 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.73 14.66 9.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 73.43 110.949 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.45 ' HB2' HG22 ' A' ' 48' ' ' THR . 50.2 tpp -131.31 89.87 2.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.86 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 130.58 38.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 70.15 110.924 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.687 HG22 HD21 ' A' ' 158' ' ' LEU . 21.2 t -139.55 117.02 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 70.22 111.145 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -108.24 132.73 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.9 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 37.7 p -90.14 171.01 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 42.23 111.112 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.4 t80 -154.29 130.28 10.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 72.25 110.865 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.653 ' HB3' HG23 ' A' ' 129' ' ' THR . 17.6 t80 -118.44 85.56 26.24 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.613 0.72 . . . . 73.44 110.868 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.56 23.9 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.705 2.27 . . . . 73.52 112.306 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.24 -169.62 15.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.8 -0.714 . . . . 73.22 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -76.79 147.81 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 73.52 110.868 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.26 -64.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.11 112.486 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 83.8 t60 -89.56 -30.93 17.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.873 0.368 . . . . 75.14 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.9 p -139.83 -87.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 63.5 111.162 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.412 ' OE1' HD23 ' A' ' 114' ' ' LEU . 71.5 tt0 -160.56 -32.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 75.11 110.812 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.521 ' OD1' HD23 ' A' ' 110' ' ' LEU . 12.5 t0 -127.58 14.56 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 74.2 110.795 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -50.41 125.57 13.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.14 110.861 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 144' ' ' TYR . 12.6 pt -123.36 164.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 64.03 111.107 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.6 m -115.74 118.99 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 71.15 111.139 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 83' ' ' ILE . 43.7 t -70.77 118.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 62.35 111.076 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -104.89 131.14 52.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.926 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.741 HD11 HD21 ' A' ' 46' ' ' LEU . 11.7 mt -113.1 97.02 41.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.573 0.702 . . . . 74.31 110.985 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.61 -4.68 14.41 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.781 2.321 . . . . 52.24 112.352 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -83.18 -23.03 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.914 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.46 13.4 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 74.51 110.922 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.46 29.13 10.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 73.15 110.981 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.1 130.14 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 73.52 111.16 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' A' ' 203' ' ' ILE . 24.8 tp -113.54 147.73 37.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 75.43 110.865 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.625 HG11 HG11 ' A' ' 55' ' ' VAL . 25.9 t -111.05 78.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 74.2 111.157 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.07 -35.37 41.06 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 74.4 112.49 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 63.04 -159.26 36.64 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.801 -0.714 . . . . 51.24 112.505 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.8 m -59.94 -30.82 69.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.876 0.369 . . . . 70.43 110.904 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.692 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.3 tp -53.63 -49.15 68.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.904 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.669 HG13 ' HA ' ' A' ' 219' ' ' LEU . 21.0 t -89.77 105.43 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 65.25 111.105 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.645 ' HD3' HG23 ' A' ' 222' ' ' THR . 0.2 OUTLIER -52.38 147.99 7.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.11 110.902 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 218' ' ' LEU . 54.2 p -99.92 167.11 10.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 72.32 110.882 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t -54.13 -26.15 26.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 54.31 111.149 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 m -93.08 43.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 60.45 110.832 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.72 138.02 45.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 65.11 111.067 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.512 ' HA ' HD22 ' A' ' 225' ' ' LEU . 30.7 tttm -122.84 -4.22 8.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.896 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.99 151.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 70.11 110.909 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 226' ' ' LEU . 7.3 mt -65.73 -31.47 72.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 52.3 110.968 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.32 -138.1 21.34 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.735 -0.745 . . . . 65.21 112.456 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.38 95.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.894 0.378 . . . . 53.13 110.905 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.401 HG12 ' HZ3' ' A' ' 189' ' ' TRP . 15.6 m -100.94 21.85 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.44 111.164 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.26 -25.1 63.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 73.54 111.094 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -110.73 18.19 19.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.464 . . . . 52.43 110.883 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 149' ' ' HIS . . . -135.01 156.25 49.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 55.15 111.12 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.4 85.99 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.95 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.22 -21.34 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.11 111.143 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -72.38 -28.11 62.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 53.04 110.878 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -106.75 -14.94 14.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.05 110.905 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.73 ' CE3' HD13 ' A' ' 178' ' ' LEU . 1.9 t90 -55.36 -61.05 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 71.33 110.876 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.739 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.15 -25.43 13.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.842 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -80.92 -32.86 34.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.077 -0.511 . . . . 64.34 111.116 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.61 -41.72 65.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 72.33 110.842 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 219' ' ' LEU . 27.4 mm -64.96 -46.89 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.24 111.162 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.27 -28.59 63.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 43.14 110.837 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -76.96 -22.78 52.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.889 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 192' ' ' SER . 11.0 t -85.19 -10.51 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 61.02 111.094 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -112.22 -10.15 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.439 . . . . 71.55 110.926 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.01 -30.73 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 75.14 110.872 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -46.68 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.823 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.06 37.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 71.33 110.909 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -48.07 69.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.946 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -59.92 103.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 62.04 110.85 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.585 HG21 HG22 ' A' ' 206' ' ' VAL . 40.8 mt -146.07 123.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 54.25 111.067 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -25.48 46.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.879 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.53 130.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 72.41 111.091 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.743 ' HB ' HD12 ' A' ' 218' ' ' LEU . 57.9 t -100.23 147.33 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.19 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 213' ' ' VAL . 20.2 t -122.57 101.12 40.54 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.639 0.733 . . . . 74.23 111.04 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 218' ' ' LEU . 54.5 Cg_endo -69.78 177.34 5.69 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.639 2.226 . . . . 73.2 112.385 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.68 -11.65 79.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 74.34 112.488 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -152.77 148.39 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 72.12 110.843 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.29 -99.89 2.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 73.42 112.436 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -174.39 153.87 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 74.21 110.95 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 207' ' ' VAL . 5.3 m -53.98 163.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 70.23 111.172 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.55 -93.84 0.1 OUTLIER Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.725 -0.75 . . . . 65.15 112.444 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -171.47 -166.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 71.14 110.884 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -56.8 -20.74 24.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.847 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.53 -23.0 18.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 54.51 112.455 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.743 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.6 mt -77.38 -32.5 54.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 74.11 110.857 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.669 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.0 mp -62.08 -62.33 1.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 64.21 110.885 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -22.74 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 62.44 110.864 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.423 ' NE2' HD11 ' A' ' 225' ' ' LEU . 9.8 t-160 -61.13 -45.86 92.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 70.31 110.877 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.645 HG23 ' HD3' ' A' ' 171' ' ' LYS . 3.5 m -51.28 -54.95 21.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 71.14 111.153 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 190' ' ' SER . 1.4 mt -60.58 -18.43 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 64.32 110.89 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.804 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.519 HD12 ' HG2' ' A' ' 171' ' ' LYS . 8.8 mt -124.68 -10.5 7.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 73.11 110.893 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.742 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.5 OUTLIER -116.46 14.07 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.94 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 71.33 110.894 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.0 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.774 0.321 . . . . 64.02 110.804 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -121.63 170.05 10.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 75.41 110.924 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -137.18 141.17 42.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 62.44 110.899 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.4 p -51.65 147.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 70.14 111.178 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.37 171.49 20.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 53.42 110.866 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -73.05 179.8 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 64.12 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.4 m -62.02 -42.96 99.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 75.12 111.136 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.9 m -62.3 -177.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 53.33 111.114 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.14 93.69 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 53.21 111.154 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.01 115.3 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 75.05 110.872 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -59.28 166.36 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 54.02 110.858 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -51.77 -47.86 63.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.04 110.909 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p -60.26 -38.23 82.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.15 111.142 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.92 12.73 60.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 65.14 112.433 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.639 HG23 ' HB3' ' A' ' 31' ' ' LEU . 52.4 m -81.14 -42.95 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.679 0.276 . . . . 65.41 111.115 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.31 125.45 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 72.24 111.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -131.93 126.95 35.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 63.23 110.861 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.683 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -122.3 112.86 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 74.53 111.119 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.431 ' HA ' HG12 ' A' ' 8' ' ' VAL . 25.0 t -100.45 127.54 46.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 74.14 110.878 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -70.58 111.61 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 62.32 110.927 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 163' ' ' ILE . 12.7 mt -65.22 -32.29 73.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.89 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.06 -97.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 63.24 110.837 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.26 9.48 0.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 35.22 110.906 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.09 7.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.856 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.78 141.14 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 75.21 111.1 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.683 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.7 m95 -129.01 -178.32 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.937 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' A' ' 21' ' ' LEU . 92.3 t -133.04 89.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.384 . . . . 74.24 111.052 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.465 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.8 p80 -72.39 123.79 23.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.913 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -119.68 104.01 9.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 24.54 111.106 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -86.62 122.64 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.54 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -89.29 114.11 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.844 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.06 -139.13 4.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 51.51 112.518 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.3 119.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 72.11 110.826 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -147.49 136.71 22.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 72.32 110.83 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 49.92 28.93 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 74.12 110.979 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.87 41.44 33.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 61.53 112.507 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -147.21 134.36 20.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 73.2 110.87 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -63.48 146.83 52.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 74.43 111.142 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.48 80.61 56.91 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.676 0.751 . . . . 54.53 111.107 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.695 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.4 Cg_endo -69.82 118.99 6.01 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.601 2.201 . . . . 65.24 112.364 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.3 p -112.3 96.95 6.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.888 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -57.83 164.74 2.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.04 110.813 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -155.49 -148.16 4.94 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.778 -0.725 . . . . 61.24 112.509 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.614 HD21 HD12 ' A' ' 158' ' ' LEU . 19.7 tp -159.85 115.27 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.856 0.36 . . . . 63.42 110.886 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.661 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.4 122.15 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.145 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.841 HD21 HD11 ' A' ' 158' ' ' LEU . 28.5 mt -99.39 115.42 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 73.12 110.891 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.55 87.59 7.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.89 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.14 179.58 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 72.33 111.157 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -100.33 -21.97 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.842 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -12.2 56.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 64.3 110.871 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.95 150.87 5.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.769 . . . . 73.32 112.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 77' ' ' LYS . 7.9 tp -65.72 154.58 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 54.23 110.925 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.76 141.57 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.112 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -136.84 125.13 23.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.33 110.946 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 165' ' ' VAL . 69.2 t -70.04 111.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 75.45 111.193 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.58 128.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 65.25 110.807 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.698 ' HB3' HD11 ' A' ' 98' ' ' LEU . 2.4 p -71.6 -167.1 0.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.832 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.439 ' H ' HG23 ' A' ' 64' ' ' THR . 6.9 t -90.28 168.87 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 72.33 110.882 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.707 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.1 m95 -50.35 -60.43 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 74.05 110.938 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -126.67 159.37 33.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 74.04 110.818 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -52.66 -35.06 54.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 73.1 110.862 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.79 -38.02 74.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.995 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.707 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.7 mt -79.62 -46.7 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 63.25 110.95 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.71 -45.44 58.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.12 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -57.79 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 74.43 110.946 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.99 -22.69 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 71.33 110.859 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 71' ' ' VAL . 17.3 tp -84.8 -25.88 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 61.43 110.924 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.46 -22.99 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 62.13 111.132 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -92.38 15.94 12.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 71.13 110.939 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.95 -40.03 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 67' ' ' LEU . 31.5 m -80.25 -22.2 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.12 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.653 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.22 -24.53 64.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 42.4 110.885 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -105.69 -33.85 7.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 71.42 110.924 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -43.29 73.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 33.2 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -88.69 -11.35 45.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.883 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.89 11.88 8.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 53.2 110.966 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.52 ' HB2' HD13 ' A' ' 52' ' ' LEU . 5.9 mttm -130.01 139.22 51.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.83 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -85.35 138.27 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.267 -0.424 . . . . 75.22 110.803 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.653 HG23 ' OE2' ' A' ' 72' ' ' GLU . 94.4 t -78.39 123.09 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.197 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -140.07 13.44 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 73.42 111.169 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -154.85 143.79 20.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.03 110.917 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 54' ' ' LEU . 16.3 t -154.07 128.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 70.41 111.081 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.551 ' CD1' HG11 ' A' ' 140' ' ' VAL . 55.3 mt -85.42 131.37 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 54.21 111.113 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.9 mm -109.91 136.62 45.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 73.12 111.145 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.0 p -96.17 -45.36 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.158 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -153.46 -175.52 5.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 63.02 110.845 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.13 86.73 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 51.43 111.162 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 70.14 110.859 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.24 -23.67 9.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.119 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -95.37 30.11 2.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 73.43 110.842 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.94 -70.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.878 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.16 7.34 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 73.44 111.127 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.69 -41.91 51.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.816 -0.707 . . . . 64.31 112.451 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.7 14.46 64.09 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.668 -0.777 . . . . 61.25 112.518 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.2 tt -55.12 -28.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 74.02 111.153 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -34.57 63.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.946 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.1 m -86.8 -12.53 47.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 72.04 111.181 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 57' ' ' SER . 16.7 mt -90.63 -24.92 20.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 72.03 110.927 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.13 20.19 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.883 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -120.97 -34.06 3.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 63.12 110.881 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -90.86 -42.56 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 70.02 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.79 37.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.769 -0.729 . . . . 70.05 112.492 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.576 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.0 mp -103.16 111.24 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 74.45 111.166 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.709 ' HE2' HD21 ' A' ' 124' ' ' LEU . 1.9 mtpp -72.74 112.05 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 72.51 110.923 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.54 90.56 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 42.31 111.107 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.567 ' HA ' HD12 ' A' ' 124' ' ' LEU . 51.8 m-70 -61.93 145.19 53.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 73.35 110.862 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.613 ' CA ' HD12 ' A' ' 127' ' ' LEU . 1.2 p -177.04 179.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.809 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.2 158.14 18.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 71.41 111.106 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.72 49.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.23 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.714 HD23 ' OD2' ' A' ' 152' ' ' ASP . 62.3 tp -72.27 -37.82 68.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 71.4 110.924 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.728 ' HA ' HD11 ' A' ' 114' ' ' LEU . 91.5 m -58.07 -28.1 64.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 72.15 111.192 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.59 0.95 57.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.21 111.073 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.52 -55.54 2.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 63.42 110.928 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.2 OUTLIER -70.21 -10.29 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 62.23 110.897 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.47 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.78 -46.24 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.081 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -29.51 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 72.21 110.866 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -52.14 -36.71 52.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.935 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -89.51 -17.19 29.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 75.14 110.848 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.64 19.63 8.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.706 -0.759 . . . . 75.03 112.475 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.74 171.83 8.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 74.51 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' HB2' HD13 ' A' ' 95' ' ' ILE . 13.9 mm-40 -70.63 -176.3 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 74.02 110.972 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -116.37 101.53 53.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 73.32 110.948 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.4 Cg_endo -69.67 -179.68 3.04 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.741 2.294 . . . . 70.33 112.351 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HE2' ' A' ' 104' ' ' LYS . 24.6 mt -51.1 -57.67 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 62.51 110.919 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.42 68.64 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.66 -0.781 . . . . 52.21 112.51 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.55 36.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 74.11 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.678 ' CD2' HD21 ' A' ' 133' ' ' LEU . 87.3 mt -119.23 -175.23 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.979 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.38 -171.13 3.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 51.34 110.898 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.903 HG22 HG23 ' A' ' 130' ' ' VAL . 52.6 m -50.73 -70.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.153 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 129' ' ' THR . 31.3 t -120.51 103.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.44 111.177 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -133.04 170.22 15.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 64.53 111.125 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.32 128.11 52.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 71.41 110.886 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.678 HD21 ' CD2' ' A' ' 127' ' ' LEU . 63.9 mt -116.08 155.95 27.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 65.54 110.914 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -136.1 114.83 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.887 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -110.08 51.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 61.1 110.866 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.44 89.46 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.718 -0.753 . . . . 75.35 112.574 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.96 14.57 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 75.33 110.845 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.432 ' SD ' HD22 ' A' ' 46' ' ' LEU . 50.4 tpp -133.13 98.22 4.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 71.52 110.844 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 131.13 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 72.02 110.908 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.847 HG22 HD21 ' A' ' 158' ' ' LEU . 90.1 t -136.78 119.09 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 71.41 111.114 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -111.66 125.55 54.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 70.41 110.914 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.3 p -81.0 -172.52 3.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 32.44 111.136 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.575 ' HD1' HG22 ' A' ' 130' ' ' VAL . 15.9 t80 -170.84 130.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.43 110.923 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.709 ' HB3' HG23 ' A' ' 129' ' ' THR . 12.2 t80 -119.93 86.13 35.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.763 0.792 . . . . 74.21 110.911 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.707 2.271 . . . . 72.33 112.351 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.39 -162.1 23.22 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 72.43 112.443 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.2 135.86 33.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.736 0.303 . . . . 74.43 110.921 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.416 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -148.68 -85.19 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 23.24 112.506 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -79.8 -24.3 41.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.393 . . . . 75.21 110.905 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.478 HG21 ' HB2' ' A' ' 86' ' ' HIS . 24.3 p -147.05 -162.97 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 74.4 111.111 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.56 ' HB3' HD23 ' A' ' 114' ' ' LEU . 36.2 tt0 -88.45 -20.94 24.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.927 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.714 ' OD2' HD23 ' A' ' 110' ' ' LEU . 3.4 t0 -133.22 18.27 4.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.86 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.579 ' ND2' HD13 ' A' ' 169' ' ' LEU . 6.1 p-10 -50.92 131.42 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 70.31 110.771 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.443 HG22 ' CD1' ' A' ' 144' ' ' TYR . 12.9 pt -140.72 169.95 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 65.21 111.09 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 143' ' ' PHE . 16.6 m -121.88 135.36 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 72.04 111.2 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.22 122.57 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.07 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -107.73 132.13 53.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.919 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.847 HD21 HG22 ' A' ' 140' ' ' VAL . 10.7 mt -112.06 98.55 42.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.542 0.687 . . . . 72.03 110.825 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.76 -4.93 15.03 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.272 . . . . 73.41 112.291 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.24 -23.64 35.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.42 110.951 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.04 14.6 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.908 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.7 m120 53.95 27.64 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 74.43 110.958 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.483 HD13 HD13 ' A' ' 21' ' ' LEU . 97.0 mt -92.75 125.93 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 74.41 111.078 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.2 148.68 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 64.24 110.908 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 55' ' ' VAL . 62.0 t -112.43 81.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 63.51 111.129 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.42 48.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 64.3 112.453 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.23 -167.5 46.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 51.31 112.522 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.02 -34.42 29.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 71.34 110.871 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.592 HD12 ' NE1' ' A' ' 189' ' ' TRP . 14.3 tp -51.26 -60.3 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 73.14 110.915 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 218' ' ' LEU . 14.2 t -82.2 116.17 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.144 -0.48 . . . . 71.44 111.076 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.679 ' HE3' HD11 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -51.66 171.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.907 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -121.34 138.11 54.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.0 110.883 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.411 ' O ' ' CB ' ' A' ' 174' ' ' SER . 0.0 OUTLIER -39.49 149.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 44.32 111.168 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 173' ' ' THR . 0.9 OUTLIER 77.14 13.18 2.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 75.52 110.819 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -107.07 146.04 31.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 54.21 111.121 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -114.0 12.97 18.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 54.24 110.866 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.46 164.18 0.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 72.21 110.902 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 226' ' ' LEU . 18.5 mt -61.9 -48.01 82.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 63.51 110.903 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 129.82 -106.02 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.805 -0.712 . . . . 64.51 112.467 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -110.08 110.48 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.879 0.371 . . . . 74.1 110.853 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.495 HG12 ' HZ3' ' A' ' 189' ' ' TRP . 26.7 m -100.47 30.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 63.5 111.122 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.92 -28.68 67.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.141 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.36 24.04 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.868 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -118.98 157.13 28.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 30.23 111.073 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -110.43 88.18 2.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.974 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 21.7 t -58.32 -20.08 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 54.12 111.133 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.66 -23.02 59.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.956 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -114.33 -13.78 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 71.23 110.891 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.592 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.8 t90 -54.19 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 55.44 110.947 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.78 ' HB3' HD11 ' A' ' 226' ' ' LEU . 3.2 p -54.24 -24.65 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 61.21 110.821 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.1 m -80.55 -30.21 37.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 52.21 111.163 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.413 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -77.34 -44.55 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 72.04 110.929 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 219' ' ' LEU . 34.9 mm -58.91 -46.19 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 62.32 111.086 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -55.62 -29.06 58.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.866 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -77.17 -22.3 52.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 74.02 110.862 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 219' ' ' LEU . 20.7 t -84.76 -11.13 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 55.2 111.122 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -111.12 -15.47 13.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 62.5 110.896 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.447 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -96.42 -30.98 13.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 65.23 110.98 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -50.13 3.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 73.25 110.843 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.452 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -97.41 61.59 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 63.32 110.961 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -74.33 -63.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 74.2 110.902 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -51.99 103.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 71.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.671 HG21 ' CG2' ' A' ' 206' ' ' VAL . 79.3 mt -141.42 123.22 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 73.13 111.182 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.57 -29.38 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.3 110.833 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.3 133.51 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.124 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.752 ' HB ' HD12 ' A' ' 218' ' ' LEU . 83.9 t -109.42 130.07 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 60.32 111.115 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 213' ' ' VAL . 4.2 t -105.73 111.17 64.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.561 0.696 . . . . 74.24 111.039 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -175.73 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.675 2.25 . . . . 64.33 112.349 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.75 -12.57 79.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.739 -0.743 . . . . 53.31 112.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -152.11 147.25 26.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 63.43 110.796 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.37 -117.93 5.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.7 -0.762 . . . . 51.34 112.454 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.85 175.26 10.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.945 0.402 . . . . 73.34 110.85 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 207' ' ' VAL . 3.2 m -72.07 156.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 72.54 111.059 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.51 -105.7 0.41 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.68 -0.771 . . . . 53.43 112.441 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.423 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.3 OUTLIER -153.82 -178.13 6.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 73.23 110.963 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.519 ' HA ' HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -61.97 -16.55 52.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 72.32 110.874 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.39 -23.7 42.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.75 -0.738 . . . . 75.05 112.473 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.752 HD12 ' HB ' ' A' ' 206' ' ' VAL . 4.6 mt -65.07 -25.66 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 65.23 110.834 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.524 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -70.36 -59.49 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.924 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -15.24 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 54.01 110.895 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 171' ' ' LYS . 1.2 t-80 -77.58 -42.57 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 71.55 110.954 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . 1.036 HG22 HD23 ' A' ' 226' ' ' LEU . 47.1 m -52.98 -48.59 67.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 74.52 111.16 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.64 -14.52 52.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.217 -0.447 . . . . 72.44 110.887 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -88.33 3.01 51.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.02 110.882 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.679 HD11 ' HE3' ' A' ' 171' ' ' LYS . 4.5 mt -133.62 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.912 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 1.036 HD23 HG22 ' A' ' 222' ' ' THR . 1.0 OUTLIER -77.06 -4.43 44.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 55.21 110.896 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 73.01 110.929 179.888 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.791 0.329 . . . . 64.11 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -120.79 179.43 4.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 75.31 110.873 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -135.89 128.84 31.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.934 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 p -51.7 147.58 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 75.5 111.115 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.35 177.33 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 63.01 110.877 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -60.38 -174.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.942 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 m -84.7 -40.42 17.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 54.15 111.187 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.17 -177.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 74.03 111.077 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.4 mt -136.2 93.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 70.43 111.227 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.26 121.11 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.852 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -63.84 167.63 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 55.34 110.876 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.04 -44.86 64.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 52.41 110.86 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.0 p -62.04 -38.11 87.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 71.51 111.159 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.25 14.54 62.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.798 -0.715 . . . . 50.51 112.495 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.418 HG23 ' CB ' ' A' ' 31' ' ' LEU . 23.7 m -83.59 -39.25 20.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.818 0.342 . . . . 74.04 111.174 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.14 117.54 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 73.24 111.1 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -124.36 132.43 53.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.24 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.709 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.2 mt -124.92 108.63 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 54.13 111.101 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -100.95 127.53 47.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.866 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -69.77 111.21 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.909 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HG ' HG23 ' A' ' 27' ' ' VAL . 23.0 mt -64.23 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 63.51 110.915 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.07 -97.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.911 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.54 10.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.825 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.56 6.35 0.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.89 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -150.73 140.16 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 71.01 111.14 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.709 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.7 m95 -127.55 -178.05 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.909 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.551 HG23 ' HG ' ' A' ' 21' ' ' LEU . 69.3 t -133.67 95.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.156 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -77.56 118.32 19.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.813 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 m -113.67 107.34 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 70.33 111.157 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.24 126.93 38.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.44 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.598 HD22 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -91.47 105.04 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.916 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.13 -128.62 0.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.537 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.59 74.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 72.33 110.818 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CD2' HG11 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -59.78 96.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 73.24 110.856 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 m120 56.51 21.55 5.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.499 . . . . 63.54 110.88 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.58 6.56 23.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.638 -0.792 . . . . 54.44 112.424 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -108.63 113.98 27.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.852 0.358 . . . . 70.13 110.863 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.598 ' HB1' HD22 ' A' ' 31' ' ' LEU . . . -60.98 103.57 0.28 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.504 . . . . 54.5 111.159 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 34' ' ' PHE . 2.1 p -115.05 99.19 51.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.599 0.714 . . . . 72.44 111.121 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.5 Cg_endo -69.81 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.703 2.269 . . . . 73.41 112.352 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.9 p -100.43 107.77 19.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 62.51 110.818 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.06 162.61 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.885 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.19 -155.27 6.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.743 -0.741 . . . . 74.43 112.472 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.598 HD21 ' CD1' ' A' ' 158' ' ' LEU . 19.8 tp -158.61 112.62 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 73.23 110.927 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.675 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -97.5 121.49 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.33 111.135 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.585 HD21 HD11 ' A' ' 158' ' ' LEU . 29.5 mt -99.67 118.0 35.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.985 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.2 85.83 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.02 110.826 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -100.81 -174.29 2.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 72.4 111.073 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -103.23 -27.79 12.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 71.42 110.844 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -18.16 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.52 110.873 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.4 150.73 5.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 63.54 112.484 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.711 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.8 mt -62.14 155.09 25.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 63.14 110.937 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 81' ' ' ASP . 2.1 t -144.78 141.84 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 72.31 111.099 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.675 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -136.61 122.91 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 43.44 110.893 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.68 112.23 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 65.05 111.139 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.94 128.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 74.5 110.852 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.673 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.8 p -71.92 -168.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 60.1 110.821 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -89.94 171.65 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.11 110.936 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.721 ' HB2' HD12 ' A' ' 63' ' ' LEU . 95.7 m95 -50.85 -60.77 2.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 74.21 110.96 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.47 159.04 36.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 52.12 110.896 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.56 -34.04 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.51 110.904 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.76 -39.47 77.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.798 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.721 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.1 mt -80.09 -43.83 21.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 73.02 110.939 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.25 -48.53 62.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.152 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.99 -49.43 66.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 72.04 110.931 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.75 -19.48 65.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 74.12 110.967 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.2 tp -88.65 -26.14 22.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 53.43 110.91 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.5 -23.11 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 73.23 111.15 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -92.29 15.54 13.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 61.41 110.872 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.6 ptm -130.5 -39.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 70.41 110.887 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 67' ' ' LEU . 32.7 m -79.76 -23.44 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 61.03 111.109 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.711 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.0 -25.03 66.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.3 110.827 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -104.77 -33.49 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 72.34 110.899 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -45.14 67.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.44 111.012 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.584 ' HB2' HD11 ' A' ' 52' ' ' LEU . 19.8 m-85 -85.21 -12.59 52.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 73.3 110.852 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.5 11.21 7.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.44 110.829 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.93 141.37 50.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.412 . . . . 64.54 110.899 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -85.82 140.55 30.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.55 110.819 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.711 HG22 ' HB3' ' A' ' 52' ' ' LEU . 87.4 t -82.04 125.01 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -140.89 12.11 2.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 75.1 111.13 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.539 ' N ' HG23 ' A' ' 103' ' ' ILE . 61.1 m-20 -152.48 146.12 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.849 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 54' ' ' LEU . 15.7 t -154.29 131.27 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.22 111.169 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.58 HD13 HG11 ' A' ' 140' ' ' VAL . 5.5 mt -92.68 126.75 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 62.01 111.082 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mm -101.85 150.42 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 54.12 111.16 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -45.43 3.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 61.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.643 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -149.32 175.76 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 73.4 110.872 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -98.27 87.07 3.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 72.03 111.047 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -143.73 156.23 44.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 70.31 110.897 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.79 -21.32 27.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 54.12 111.018 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.55 18.02 10.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 54.14 110.828 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -137.87 -76.52 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 63.32 110.796 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -92.5 7.42 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.32 111.072 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.68 -39.76 39.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 51.41 112.534 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.21 15.92 58.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.659 -0.781 . . . . 71.23 112.402 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.3 tt -57.14 -28.61 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 73.13 111.147 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -55.89 -30.22 61.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.939 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -88.87 -17.5 29.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 74.11 111.132 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 57' ' ' SER . 11.5 mt -88.5 -28.63 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 74.35 110.913 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -92.34 7.89 40.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.14 110.917 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -106.86 -55.27 2.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 70.13 110.917 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -63.97 -57.11 10.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 74.41 110.807 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.0 39.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.674 -0.774 . . . . 73.44 112.384 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.634 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.3 mp -104.99 126.56 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 71.13 111.095 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.534 ' HB3' HD11 ' A' ' 124' ' ' LEU . 5.3 mttm -86.05 117.59 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 70.53 110.94 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.27 94.95 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 70.33 111.127 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.583 ' HA ' HD12 ' A' ' 124' ' ' LEU . 41.3 m-70 -66.58 146.07 54.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 61.22 110.907 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.541 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -179.97 176.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 53.55 110.938 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -86.73 154.06 21.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 65.41 111.091 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.4 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 61.43 111.028 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.737 HD23 ' OD1' ' A' ' 152' ' ' ASP . 56.0 tp -67.25 -43.73 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.429 . . . . 74.54 110.861 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.699 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.0 m -59.65 -18.4 41.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 63.32 111.17 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -102.7 10.22 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.42 111.036 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.722 ' HG2' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.23 -27.31 8.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 54.52 110.917 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.699 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -99.14 -7.44 26.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 64.3 110.927 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.38 -38.39 63.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.01 111.068 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -26.84 61.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.862 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -58.74 -33.52 70.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.916 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -88.07 -21.35 24.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 75.12 110.93 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.36 5.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 75.01 112.466 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.38 175.2 6.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 74.11 110.9 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' HB2' HD13 ' A' ' 95' ' ' ILE . 78.3 mm-40 -74.17 -176.2 2.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.513 . . . . 52.2 110.933 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.8 OUTLIER -117.44 106.93 45.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 54.42 110.853 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.591 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.82 178.4 4.65 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 71.34 112.273 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' ' 106' ' ' HIS . 16.4 mt -51.78 -42.92 62.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 62.4 110.972 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.31 27.57 24.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.735 -0.745 . . . . 62.51 112.519 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -108.1 43.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 72.33 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.637 HD22 HD21 ' A' ' 133' ' ' LEU . 83.7 mt -126.86 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 72.35 110.918 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -150.47 -172.05 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.941 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.866 HG22 HG23 ' A' ' 130' ' ' VAL . 55.5 m -50.9 -70.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 72.0 111.083 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.866 HG23 HG22 ' A' ' 129' ' ' THR . 33.2 t -117.39 102.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 72.3 111.071 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t -132.45 174.7 9.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 64.43 111.106 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -120.96 134.44 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.903 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.637 HD21 HD22 ' A' ' 127' ' ' LEU . 26.4 mt -115.16 160.21 19.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 64.41 110.903 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -142.6 124.62 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 72.23 110.91 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.57 ' HE2' HD11 ' A' ' 83' ' ' ILE . 16.5 m-85 -125.1 44.36 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 75.35 110.868 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.1 94.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.741 . . . . 51.52 112.45 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 m120 66.22 12.94 8.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.748 0.309 . . . . 74.05 110.91 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.443 ' HB2' HG22 ' A' ' 48' ' ' THR . 53.5 tpp -135.74 109.8 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 74.05 110.777 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.81 133.34 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.886 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.705 HG22 HD21 ' A' ' 158' ' ' LEU . 20.0 t -138.79 115.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 54.44 111.122 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.6 129.98 55.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 72.1 110.844 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 p -86.8 -179.13 6.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 61.13 111.204 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.515 ' HD1' HG22 ' A' ' 130' ' ' VAL . 23.3 t80 -164.35 134.05 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.882 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.717 ' HB3' HG23 ' A' ' 129' ' ' THR . 12.6 t80 -121.83 89.79 48.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.647 0.737 . . . . 75.31 110.936 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.78 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.73 2.286 . . . . 72.32 112.338 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 125.99 -160.91 20.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 70.12 112.553 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -79.33 134.83 36.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.903 0.383 . . . . 72.32 110.829 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.17 -89.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.559 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -74.26 -27.8 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.43 110.83 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 86' ' ' HIS . 19.2 p -145.68 -159.96 1.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 71.34 111.091 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -86.79 -23.0 25.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 74.44 110.924 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.737 ' OD1' HD23 ' A' ' 110' ' ' LEU . 8.1 t0 -136.74 20.34 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 75.23 110.876 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.604 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.1 OUTLIER -51.8 129.88 27.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 51.21 110.926 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.592 HG22 ' CD1' ' A' ' 144' ' ' TYR . 14.5 pt -134.99 179.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 74.21 111.111 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 143' ' ' PHE . 5.6 m -129.24 152.06 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 65.04 111.101 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.8 t -103.21 119.18 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 50.5 111.144 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -107.62 138.09 44.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 74.02 110.9 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.705 HD21 HG22 ' A' ' 140' ' ' VAL . 32.3 mt -119.26 98.7 50.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.678 0.752 . . . . 65.31 110.911 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.89 -4.72 14.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.763 2.308 . . . . 73.32 112.312 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -85.39 -22.4 28.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.32 110.886 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.64 12.41 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 70.15 110.958 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.1 26.25 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 71.13 110.905 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 21' ' ' LEU . 99.4 mt -90.87 142.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 71.52 111.12 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.22 155.94 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 72.31 110.921 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.26 74.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.24 111.181 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.7 -39.49 46.59 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 75.31 112.547 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.44 -159.42 41.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.684 -0.77 . . . . 53.43 112.482 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 74.6 m -54.68 -38.37 66.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 74.52 110.83 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.731 HD12 ' NE1' ' A' ' 189' ' ' TRP . 24.2 tp -51.26 -33.49 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.3 110.937 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 218' ' ' LEU . 39.7 t -107.97 108.05 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 54.04 111.066 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.566 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -51.46 163.1 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.86 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.456 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -103.21 167.56 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 61.34 110.827 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -62.46 147.24 49.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.13 111.208 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.62 20.65 10.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 61.13 110.839 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 225' ' ' LEU . . . -79.9 155.15 27.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 62.25 111.02 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -119.21 -13.7 9.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.41 110.82 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.9 159.68 0.84 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 51.11 110.831 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.76 -38.3 86.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 63.2 110.987 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.628 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 105.88 -148.91 16.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 74.05 112.451 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -52.07 105.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.873 0.368 . . . . 63.44 110.869 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 179' ' ' GLY . 34.7 m -107.18 24.4 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.35 111.176 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.36 62.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 71.05 111.069 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -116.33 24.71 11.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 72.33 110.846 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.53 172.65 11.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 74.5 111.108 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.77 88.19 2.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 65.41 110.981 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 21.1 t -63.0 -15.69 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 55.45 111.146 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.4 -22.14 52.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 64.04 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -118.42 -11.39 10.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 75.55 110.867 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.731 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.5 t90 -55.09 -60.91 2.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.959 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.649 ' HB3' HD11 ' A' ' 226' ' ' LEU . 1.7 p -53.8 -24.66 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.997 0.427 . . . . 73.51 110.927 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -81.58 -31.44 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 62.41 111.129 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -43.17 58.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 71.34 110.851 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.552 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.2 mm -61.58 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 65.33 111.133 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.31 -27.22 54.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 61.41 110.945 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -77.17 -22.19 52.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 71.34 110.891 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.26 -11.04 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 41.13 111.194 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.72 -12.09 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 70.32 110.883 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -31.03 11.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 72.13 110.888 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -59.41 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 75.21 110.907 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.452 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -91.83 62.5 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.966 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -72.78 -60.22 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 73.4 110.858 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -52.03 102.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 70.55 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.641 HG21 ' CG2' ' A' ' 206' ' ' VAL . 75.0 mt -141.21 116.93 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 62.33 111.209 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.06 -26.77 63.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.924 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.98 134.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 62.1 111.091 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.726 ' HB ' HD12 ' A' ' 218' ' ' LEU . 95.2 t -106.87 144.9 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 71.23 111.166 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 213' ' ' VAL . 14.2 t -117.84 104.77 48.56 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.594 0.711 . . . . 45.2 111.138 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -177.7 2.01 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.756 2.304 . . . . 62.32 112.322 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.3 -12.1 65.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.843 -0.694 . . . . 12.1 112.461 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -153.35 140.62 19.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.871 0.367 . . . . 71.43 110.83 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.32 -99.27 1.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 40.5 112.579 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.76 157.35 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.893 0.378 . . . . 72.43 110.882 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 207' ' ' VAL . 5.2 m -54.73 162.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 74.32 111.134 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.65 -95.03 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.73 -0.747 . . . . 72.04 112.463 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -168.34 -169.01 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 72.14 110.842 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.487 ' HA ' HD23 ' A' ' 219' ' ' LEU . 19.9 pttt -61.02 -18.09 55.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.858 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.72 -21.45 36.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 24.13 112.501 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.726 HD12 ' HB ' ' A' ' 206' ' ' VAL . 8.0 mt -71.25 -28.24 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 71.23 110.937 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.552 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.8 mm? -66.98 -59.61 3.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 63.15 110.877 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -17.32 55.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.422 . . . . 72.12 110.975 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.444 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -69.04 -46.8 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 74.14 110.894 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.824 HG22 HD23 ' A' ' 226' ' ' LEU . 19.6 m -51.73 -52.31 49.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.176 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.98 -18.47 46.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 72.41 110.941 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.88 -5.7 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 65.35 110.894 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 171' ' ' LYS . 7.6 mt -128.42 -5.4 5.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 55.03 110.874 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.824 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -117.5 -4.6 11.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 65.14 110.844 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.12 110.901 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.7 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.819 0.343 . . . . 62.34 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -111.3 153.32 26.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 61.24 110.836 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -167.08 131.31 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 74.51 110.833 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.05 156.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 72.35 111.093 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.67 167.5 21.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.889 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -85.95 167.14 15.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 60.55 110.896 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.1 m -57.77 -55.02 40.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 75.11 111.114 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.0 m -58.31 -176.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 75.0 111.082 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -135.88 92.66 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 71.13 111.096 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -112.73 115.01 27.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 63.31 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -58.22 169.47 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 51.35 110.815 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.46 -48.31 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 72.15 110.93 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -61.35 -37.42 83.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 75.11 111.114 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.43 61.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 75.43 112.43 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.3 m -79.56 -44.82 20.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 52.42 111.144 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -101.6 113.0 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.43 111.083 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 p -120.82 127.58 52.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.843 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.663 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -121.52 112.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 72.14 111.116 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.408 ' HA ' HG12 ' A' ' 8' ' ' VAL . 14.4 t -99.82 127.1 46.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.35 110.875 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -70.23 110.93 5.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 52.33 110.917 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 213' ' ' VAL . 15.5 mt -64.2 -31.74 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 64.41 110.878 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.93 -97.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.908 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -150.64 9.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 74.22 110.87 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.28 7.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 72.21 110.904 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.9 141.71 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 35.41 111.171 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.663 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.1 m95 -129.44 -177.25 4.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.967 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.478 HG23 ' HG ' ' A' ' 21' ' ' LEU . 85.9 t -133.83 91.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 75.01 111.134 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.425 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.7 p80 -74.1 123.78 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.894 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.5 m -120.02 105.87 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.42 111.143 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.01 122.43 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.894 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.674 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -90.02 116.88 28.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 55.52 110.967 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.41 -141.48 8.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 43.41 112.514 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.9 p -175.35 81.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 72.54 110.86 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' HD2' HG11 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -73.66 88.66 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 71.1 110.936 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.5 m120 63.63 18.47 11.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 65.25 110.866 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.34 -0.91 18.81 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.753 -0.737 . . . . 41.02 112.502 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -101.22 121.29 41.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 74.42 110.903 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -62.73 123.8 19.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 62.24 111.142 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.475 HG11 ' HD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -125.08 84.0 59.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 74.21 111.169 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 115.89 4.31 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.663 2.242 . . . . 62.05 112.342 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -103.0 98.16 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 73.12 110.829 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -59.19 163.75 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.816 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -153.81 -148.12 4.84 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.705 -0.759 . . . . 72.22 112.507 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.655 HD21 HD12 ' A' ' 158' ' ' LEU . 19.4 tp -159.08 115.2 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 74.42 110.949 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.675 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.67 122.27 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 62.4 111.108 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.466 HD12 ' HB ' ' A' ' 53' ' ' VAL . 12.3 mt -101.03 120.51 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 53.31 110.953 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -91.26 85.42 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 74.31 110.892 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -171.95 2.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 75.23 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.42 -15.06 14.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.862 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -5.77 43.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 74.11 110.864 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.13 8.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 72.13 112.439 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.0 tp -73.74 155.44 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.389 . . . . 61.44 110.932 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.6 t -143.07 138.14 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 70.2 111.128 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.675 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -136.05 123.46 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 70.12 110.904 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.96 114.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 55.31 111.142 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.54 127.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 73.02 110.827 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.655 ' CB ' HD11 ' A' ' 98' ' ' LEU . 3.4 p -72.35 -166.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 43.32 110.859 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -91.68 168.52 11.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 70.03 110.886 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.711 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.9 m95 -48.92 -60.31 2.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 72.12 110.863 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -129.57 159.51 36.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.32 110.751 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -50.91 -32.29 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 74.31 110.941 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -58.29 -46.66 85.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 75.34 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.3 mt -74.38 -43.14 57.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 63.53 110.908 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.19 -49.54 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 63.53 111.128 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -53.43 -48.38 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.1 110.956 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -65.09 -18.92 65.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 71' ' ' VAL . 19.5 tp -89.78 -26.82 20.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 74.31 110.892 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.9 mt -90.67 -22.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 74.54 111.222 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -92.56 16.25 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 55.34 110.907 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.9 ptm -131.35 -40.3 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.9 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.6 m -80.56 -22.06 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.5 111.213 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.12 -23.08 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 70.13 110.919 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -107.75 -33.01 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 60.3 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 -40.41 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.924 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.25 -10.22 42.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.52 110.952 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.12 12.49 8.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 72.4 110.886 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HB2' HD13 ' A' ' 52' ' ' LEU . 1.4 mttp -131.25 138.44 49.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 40.14 110.963 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.65 136.75 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.907 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG21 HD11 ' A' ' 54' ' ' LEU . 75.8 t -74.0 134.66 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 72.44 111.127 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.9 t -155.24 20.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.125 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.565 ' O ' HG13 ' A' ' 53' ' ' VAL . 4.0 m-20 -164.72 138.46 5.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.873 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -151.71 160.19 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 73.24 111.204 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.525 HG21 HG22 ' A' ' 156' ' ' VAL . 5.8 mt -116.42 135.43 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.137 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.54 121.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 65.41 111.104 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.1 p -78.45 -33.27 48.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.3 111.115 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.581 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.3 p-80 -167.95 -174.89 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.32 110.931 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.585 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -98.89 97.69 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 74.42 111.047 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -156.77 155.25 31.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 72.04 110.903 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.11 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 73.13 111.129 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.45 26.35 3.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 73.1 110.792 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.48 -74.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.848 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -95.09 8.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 64.42 111.121 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.14 -39.8 27.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.684 -0.77 . . . . 52.41 112.612 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.81 12.95 56.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.506 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.5 tt -54.38 -27.97 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 62.11 111.128 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -56.66 -35.62 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 61.44 110.87 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.3 m -85.12 -22.57 28.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 63.41 111.114 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.751 ' HA ' HD13 ' A' ' 103' ' ' ILE . 14.3 mt -80.92 -30.19 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 73.2 110.95 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.91 21.9 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.34 110.909 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.86 -41.56 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.912 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -80.07 -50.1 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 71.31 110.912 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.09 39.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.795 -0.716 . . . . 62.43 112.525 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.751 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -101.77 126.19 55.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.894 0.378 . . . . 65.32 111.127 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -85.89 112.35 21.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.2 110.904 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.67 100.73 12.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.44 111.058 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.446 ' HA ' HD12 ' A' ' 124' ' ' LEU . 61.1 m-70 -71.61 132.33 44.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 70.35 110.858 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -160.5 166.13 29.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 70.25 110.961 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.98 156.75 24.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.158 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.31 -40.53 35.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 63.22 111.114 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.72 -40.88 72.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 72.32 110.982 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 98.6 m -58.55 -20.96 50.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.107 -0.497 . . . . 73.33 111.097 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.411 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -100.43 8.08 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 74.33 111.105 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -108.4 -31.98 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 71.13 110.849 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -96.1 -11.42 26.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.15 110.984 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.411 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.42 -37.58 77.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 23.12 111.049 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.67 60.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 63.52 110.904 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -57.18 -33.28 67.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.14 110.848 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -89.85 -23.43 21.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.901 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.44 23.82 4.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 75.42 112.464 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -98.04 172.63 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 74.14 110.906 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.0 170.58 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 71.21 110.878 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -101.94 108.63 57.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.581 0.705 . . . . 75.34 110.881 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.6 Cg_endo -69.69 -176.58 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.701 2.268 . . . . 71.14 112.362 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 106' ' ' HIS . 9.8 mt -51.29 -42.56 61.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.869 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 27.58 23.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 34.02 112.458 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.03 26.1 11.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.891 0.377 . . . . 50.43 110.923 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 107' ' ' SER . 63.8 mt -103.87 -175.48 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 65.32 110.861 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -156.69 -172.86 4.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 72.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.889 HG22 HG23 ' A' ' 130' ' ' VAL . 54.2 m -51.02 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 72.15 111.096 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.889 HG23 HG22 ' A' ' 129' ' ' THR . 44.4 t -117.62 104.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 71.2 111.134 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.506 HG22 ' OG1' ' A' ' 142' ' ' THR . 14.1 t -127.76 160.47 31.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.16 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.34 107.3 13.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.881 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.17 -172.7 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 64.44 110.905 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -176.15 112.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.3 110.871 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -106.73 74.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.031 0.444 . . . . 73.21 110.898 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.21 -86.91 0.18 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.749 . . . . 65.02 112.476 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -114.95 24.95 11.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 75.11 110.881 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.1 tpp -132.82 142.6 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 61.25 110.898 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.42 130.17 55.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 64.51 110.835 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.652 HG22 HD21 ' A' ' 158' ' ' LEU . 13.8 t -139.87 120.2 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 72.33 111.165 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -113.85 130.63 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 65.55 110.801 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.506 ' OG1' HG22 ' A' ' 131' ' ' THR . 18.2 p -88.28 171.18 10.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 73.1 111.105 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.478 ' HB3' HG23 ' A' ' 155' ' ' VAL . 29.9 t80 -156.58 138.76 14.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 64.04 110.885 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.675 ' HB3' HG23 ' A' ' 129' ' ' THR . 74.3 t80 -125.59 89.7 51.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.627 0.727 . . . . 73.13 110.842 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -7.89 22.21 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.599 2.199 . . . . 65.2 112.352 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.26 -154.31 20.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.866 -0.683 . . . . 74.34 112.548 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -90.01 139.96 30.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 72.3 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.52 -87.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 34.1 112.481 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -77.06 -25.93 52.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 55.54 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 86' ' ' HIS . 23.1 p -146.47 -161.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 70.23 111.193 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.477 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.9 tt0 -90.1 -17.72 27.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.911 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 154' ' ' ILE . 18.5 t0 -135.26 17.42 3.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 72.04 110.835 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.51 ' ND2' HD13 ' A' ' 169' ' ' LEU . 6.5 p-10 -49.07 129.77 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 71.33 110.854 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 152' ' ' ASP . 10.9 pt -135.3 -177.77 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 74.33 111.127 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 143' ' ' PHE . 6.9 m -136.24 133.4 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 31.32 111.095 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.525 HG22 HG21 ' A' ' 83' ' ' ILE . 58.3 t -85.59 114.2 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 51.15 111.225 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -102.45 133.82 46.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 74.1 110.89 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.655 HD12 HD21 ' A' ' 44' ' ' LEU . 15.8 mt -113.59 97.76 44.87 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.575 0.702 . . . . 74.35 110.903 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.0 Cg_endo -69.79 -4.11 13.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.719 2.279 . . . . 71.44 112.347 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -85.18 -23.28 28.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 71.42 110.967 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -142.04 13.01 2.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.41 110.954 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.37 27.42 8.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.882 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.654 HD13 HD13 ' A' ' 21' ' ' LEU . 96.8 mt -93.13 124.67 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.462 . . . . 73.52 111.176 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 203' ' ' ILE . 20.7 tp -106.08 146.97 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 54.13 110.884 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.15 80.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.44 111.115 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.53 -40.48 47.29 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.38 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 68.89 -165.09 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.799 -0.715 . . . . 54.41 112.505 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -27.45 25.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 61.33 110.916 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.625 HD12 ' NE1' ' A' ' 189' ' ' TRP . 23.3 tp -57.25 -61.14 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 62.13 110.826 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.562 HG13 ' HA ' ' A' ' 219' ' ' LEU . 35.1 t -75.28 112.38 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.43 111.054 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.537 ' HG2' HG23 ' A' ' 222' ' ' THR . 2.8 mmpt? -54.0 151.15 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 63.33 110.839 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.8 p -99.74 157.28 16.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 74.01 110.85 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.3 t -51.53 -29.84 18.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 60.54 111.164 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 t -94.98 45.02 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 71.52 110.869 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -134.2 138.16 44.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 70.03 111.009 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.423 ' HA ' HD22 ' A' ' 225' ' ' LEU . 15.4 tttt -117.55 -0.03 11.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 73.14 110.916 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.24 154.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 74.01 110.857 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.764 HD11 ' HB2' ' A' ' 226' ' ' LEU . 8.3 mt -65.44 -36.74 84.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 75.14 110.966 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.7 -140.73 17.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.673 -0.775 . . . . 55.43 112.441 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -58.94 98.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 62.41 110.87 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 186' ' ' VAL . 21.6 m -98.29 24.47 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 73.32 111.129 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.65 81.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.44 111.088 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -106.61 20.71 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 63.44 110.903 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -133.06 154.39 50.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 32.35 111.106 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -107.44 86.79 2.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.931 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.456 ' CG2' HG11 ' A' ' 181' ' ' VAL . 24.0 t -61.16 -17.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 72.1 111.114 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -74.27 -25.91 59.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.958 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.66 -11.97 13.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 65.34 110.954 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.74 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.6 t90 -54.37 -61.7 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 72.44 110.972 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.703 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.95 -24.29 16.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.855 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.92 -32.34 30.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.18 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.59 -43.31 63.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.882 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.528 HG21 ' O ' ' A' ' 219' ' ' LEU . 29.8 mm -62.15 -43.94 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 62.12 111.104 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.07 -24.07 62.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 64.52 110.956 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.31 -21.56 36.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.844 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 192' ' ' SER . 11.3 t -88.13 -8.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 74.13 111.1 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.42 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.36 -8.21 13.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.941 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -104.57 -30.93 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -104.31 -48.93 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 74.31 110.873 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -102.13 39.44 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 61.44 111.008 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.79 -47.9 76.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.502 . . . . 72.14 110.867 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -60.31 99.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.03 110.863 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.636 HG21 HG22 ' A' ' 206' ' ' VAL . 55.8 mt -140.16 123.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.047 -0.524 . . . . 64.41 111.107 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.94 -16.0 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.915 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.734 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -173.58 132.69 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 71.11 111.048 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.708 ' HB ' HD12 ' A' ' 218' ' ' LEU . 84.6 t -111.9 128.62 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 61.11 111.179 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 213' ' ' VAL . 19.6 t -108.43 104.12 53.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.644 0.735 . . . . 72.31 111.083 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.506 ' HD3' HD13 ' A' ' 218' ' ' LEU . 52.9 Cg_endo -69.82 -169.54 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.274 . . . . 71.44 112.32 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.47 -15.5 66.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.701 -0.761 . . . . 45.21 112.476 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -152.01 139.72 19.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.976 0.417 . . . . 75.21 110.803 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 109.52 -117.29 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.812 -0.709 . . . . 53.41 112.543 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.65 173.44 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 75.11 110.897 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 207' ' ' VAL . 6.1 t -70.5 144.85 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 71.32 111.154 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.66 -93.32 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.671 -0.775 . . . . 73.1 112.474 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -172.13 -167.17 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 72.54 110.899 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -19.37 38.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 61.21 110.864 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.72 -23.14 20.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.695 -0.764 . . . . 65.01 112.534 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 206' ' ' VAL . 7.0 mt -76.87 -32.68 57.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.318 . . . . 65.41 110.882 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.562 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.6 mp -61.12 -61.98 2.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.898 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.19 -22.24 60.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.939 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -62.0 -44.69 96.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.901 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.576 ' C ' HD23 ' A' ' 226' ' ' LEU . 2.2 m -51.45 -53.97 31.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 63.22 111.12 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.415 HD23 ' HB3' ' A' ' 190' ' ' SER . 1.2 mt -60.28 -18.72 51.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 72.34 110.902 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 70.11 110.88 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.483 HD12 ' HG3' ' A' ' 171' ' ' LYS . 9.7 mt -126.01 -6.37 6.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.03 110.938 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.764 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -119.83 9.72 11.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 65.1 110.951 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 62.0 110.896 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.811 0.338 . . . . 60.02 110.898 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.67 179.43 0.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 75.41 110.893 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.1 mttm 58.67 179.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 75.23 110.913 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.8 m -81.03 -176.23 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 71.33 111.178 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -159.7 133.42 7.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 75.32 110.909 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 -177.71 3.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 50.35 110.932 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -93.99 -39.96 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 61.55 111.189 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.57 -176.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 75.22 111.114 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -136.38 94.41 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 63.53 111.131 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -112.53 115.26 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.919 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -57.64 167.88 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 64.41 110.894 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -51.71 -48.08 63.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.859 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.74 -37.84 83.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.103 -0.498 . . . . 74.31 111.158 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.16 60.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.784 -0.722 . . . . 30.54 112.528 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 31' ' ' LEU . 49.3 m -80.92 -43.53 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 61.03 111.126 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.48 118.42 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 64.21 111.115 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 p -124.02 131.37 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.749 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -123.96 110.4 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 42.13 111.14 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -100.6 123.69 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 74.12 110.872 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -68.15 110.98 4.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 52.31 110.893 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.77 HD21 HG11 ' A' ' 213' ' ' VAL . 14.8 mt -65.75 -31.83 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 63.3 110.818 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.02 -97.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 72.31 110.894 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 10.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 71.24 110.922 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.59 6.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.54 110.806 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -151.0 139.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 62.02 111.108 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.8 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.1 m95 -127.44 -173.99 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.937 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 43' ' ' GLY . 94.2 t -137.27 97.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 74.44 111.092 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -81.47 121.36 26.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 70.53 110.888 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.2 m -116.19 92.27 3.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 72.11 111.136 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -72.97 117.6 14.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 71.25 110.85 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.754 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -88.34 111.49 21.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.898 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.25 -129.4 3.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 55.42 112.458 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 p -175.44 117.34 0.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.939 0.4 . . . . 63.41 110.893 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.632 ' CD1' HG21 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -107.92 78.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 53.53 110.872 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 69.76 2.77 3.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 52.41 110.874 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.68 -8.02 3.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 45.02 112.499 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -100.9 121.82 42.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 74.41 110.92 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.754 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -58.6 120.22 8.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 33.43 111.081 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.632 HG21 ' CD1' ' A' ' 34' ' ' PHE . 3.0 t -111.02 80.83 2.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.656 0.741 . . . . 75.24 111.084 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.752 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.2 Cg_endo -69.74 118.27 5.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.581 2.187 . . . . 75.11 112.395 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -103.54 100.68 10.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 63.23 110.852 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.414 HD21 ' N ' ' A' ' 212' ' ' GLU . 16.3 m-20 -49.36 162.4 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 52.24 110.885 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.598 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.48 -166.8 17.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 33.14 112.477 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.595 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.7 tp -153.12 113.27 3.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 72.03 110.903 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 54' ' ' LEU . 1.9 t -97.59 117.98 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 74.44 111.049 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.4 HD22 ' SD ' ' A' ' 138' ' ' MET . 24.7 mt -95.9 122.74 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 62.01 110.918 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -91.03 84.41 5.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 53.2 110.853 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.0 OUTLIER -101.55 178.87 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 43.4 111.189 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.82 -26.66 14.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 71.11 110.837 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -18.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 64.33 110.864 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.79 151.33 5.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 35.51 112.476 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 75' ' ' PHE . 2.5 mt -62.0 153.72 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 73.25 110.923 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.644 HG13 ' CB ' ' A' ' 81' ' ' ASP . 2.2 t -143.56 139.73 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 74.11 111.139 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -136.1 122.92 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.918 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG12 ' OD1' ' A' ' 56' ' ' ASP . 78.5 t -69.11 111.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 53.42 111.104 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.622 ' OD2' HG23 ' A' ' 85' ' ' THR . 1.6 m-20 72.98 125.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 70.53 110.905 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.656 ' CB ' HD11 ' A' ' 98' ' ' LEU . 2.7 p -69.6 -166.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 44.43 110.819 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -90.96 168.45 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 61.42 110.906 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.687 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.4 m95 -50.71 -60.42 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 74.13 110.945 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -126.03 160.87 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 62.33 110.806 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -53.63 -37.82 63.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 61.04 110.884 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.94 -37.52 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 72.14 110.878 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.4 mt -80.28 -43.55 21.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 41.44 110.91 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.58 62.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 64.24 111.125 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -52.71 -48.37 66.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 63.42 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.95 -18.79 65.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 71.31 110.835 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 71' ' ' VAL . 19.1 tp -89.43 -25.45 21.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 65.23 110.879 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.414 HG23 ' OE1' ' A' ' 72' ' ' GLU . 71.3 mt -91.93 -24.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.23 111.057 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.87 12.36 19.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 74.02 110.911 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ptm -127.48 -39.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 61.54 110.923 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 67' ' ' LEU . 14.6 m -79.84 -22.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 63.35 111.115 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -70.38 -22.69 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 65.35 110.949 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -107.41 -31.08 8.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 71.23 110.826 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -73.15 -44.68 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 52.24 110.951 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.638 ' HB2' HD11 ' A' ' 52' ' ' LEU . 22.8 m-85 -85.95 -13.11 48.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.873 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.72 15.35 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.936 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 139.5 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 65.22 111.002 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -77.76 139.21 39.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 71.55 110.937 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.39 134.67 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 50.12 111.137 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 t -160.37 20.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 70.31 111.124 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.654 ' N ' HG23 ' A' ' 103' ' ' ILE . 48.4 m-20 -155.37 143.6 20.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 65.55 110.902 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 81' ' ' ASP . 6.7 t -156.84 105.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 65.22 111.076 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.716 ' CD1' HG11 ' A' ' 140' ' ' VAL . 68.8 mt -71.11 121.27 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 72.33 111.144 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mm -94.36 149.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 73.44 111.17 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.622 HG23 ' OD2' ' A' ' 56' ' ' ASP . 29.6 p -108.44 -42.12 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.13 111.15 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.545 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.8 p80 -164.54 -175.17 3.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 62.31 110.823 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.851 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.19 98.4 11.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 62.51 111.052 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.81 153.81 32.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 62.54 110.868 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.19 -19.98 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 54.01 111.124 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -91.81 4.48 52.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 55.13 110.844 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.412 ' HD3' ' CE1' ' A' ' 86' ' ' HIS . 3.7 mpt_? -120.69 -78.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.02 110.932 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.417 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -90.78 7.08 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 73.1 111.176 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.36 -41.47 48.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 32.33 112.539 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.15 13.21 60.36 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.734 -0.746 . . . . 52.34 112.491 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 121' ' ' GLU . 16.8 tt -54.79 -26.39 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 73.53 111.144 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -54.54 -35.35 63.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 73.35 110.932 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.6 m -88.92 -12.86 40.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 63.25 111.159 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.656 HD11 ' CB ' ' A' ' 57' ' ' SER . 18.3 mt -88.56 -35.86 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 74.13 110.95 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -84.24 2.67 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 74.42 110.912 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.68 -51.07 3.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.31 110.842 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -69.83 -59.91 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.2 110.835 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.87 43.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.722 . . . . 54.44 112.557 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.654 HG23 ' N ' ' A' ' 81' ' ' ASP . 4.3 mp -103.34 120.31 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 65.24 111.147 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.738 ' HE2' HD21 ' A' ' 124' ' ' LEU . 4.6 mttt -73.2 114.39 11.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 54.0 110.858 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.06 85.58 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 44.05 111.1 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.579 ' HB3' HD11 ' A' ' 127' ' ' LEU . 85.8 m-70 -56.92 144.54 33.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.785 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.6 169.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 44.22 110.89 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.77 157.34 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 61.25 111.122 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.87 -40.41 29.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 73.3 111.062 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.464 HD22 ' CD ' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -64.14 -47.54 79.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 72.53 110.937 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.784 ' HA ' HD11 ' A' ' 114' ' ' LEU . 52.3 m -58.63 -20.73 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 40.42 111.094 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -99.76 12.39 36.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 73.3 111.191 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.464 ' CD ' HD22 ' A' ' 110' ' ' LEU . 3.1 pt-20 -114.97 -31.74 5.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 73.13 110.934 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.851 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -95.68 -13.87 23.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 74.3 110.866 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.462 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.04 -37.44 78.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.971 0.415 . . . . 65.22 111.133 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -20.86 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 63.45 110.956 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.01 -32.43 74.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.826 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -90.25 -18.22 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 72.33 110.865 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.67 27.2 5.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 61.21 112.45 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.34 173.95 6.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 74.32 110.923 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.493 ' HB2' HD13 ' A' ' 95' ' ' ILE . 80.1 mm-40 -80.35 160.56 25.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 71.23 110.883 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.1 mp0 -92.71 111.85 52.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.713 0.768 . . . . 74.31 110.954 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.5 Cg_endo -69.72 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 61.33 112.393 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.738 HD21 ' HE2' ' A' ' 104' ' ' LYS . 13.8 mt -51.68 -45.54 63.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 65.34 110.885 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.49 34.94 43.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 72.32 112.527 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.12 36.26 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.827 0.346 . . . . 70.35 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 106' ' ' HIS . 47.6 mt -120.07 -172.34 2.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.848 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -155.75 -171.84 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 64.1 110.921 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.915 HG22 HG23 ' A' ' 130' ' ' VAL . 46.0 m -50.56 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 72.23 111.121 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.915 HG23 HG22 ' A' ' 129' ' ' THR . 44.0 t -119.39 103.88 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 63.53 111.131 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 t -135.37 175.63 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 71.14 111.193 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -120.34 131.36 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.849 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.523 HD21 HD22 ' A' ' 127' ' ' LEU . 31.4 mt -109.07 152.2 25.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.882 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -130.74 125.36 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 73.03 110.918 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.523 ' HE2' HD11 ' A' ' 83' ' ' ILE . 10.3 m-85 -129.0 26.53 5.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.867 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.28 95.67 0.21 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 44.03 112.536 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 66.07 13.09 8.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.735 0.303 . . . . 74.24 110.882 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.469 ' HB2' HG22 ' A' ' 48' ' ' THR . 52.9 tpp -133.71 106.29 7.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 75.21 110.97 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.98 127.43 37.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 74.25 110.87 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.716 HG11 ' CD1' ' A' ' 83' ' ' ILE . 18.2 t -138.69 113.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 61.22 111.142 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -109.74 131.41 55.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.798 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.7 p -85.09 178.65 7.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 71.02 111.189 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.485 ' HD1' HG22 ' A' ' 130' ' ' VAL . 19.9 t80 -161.05 133.27 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 73.44 110.843 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.692 ' HB3' HG23 ' A' ' 129' ' ' THR . 8.5 t80 -122.82 86.45 50.15 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.699 0.761 . . . . 71.33 110.94 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -7.99 22.45 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.757 2.305 . . . . 51.41 112.373 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.39 -160.06 23.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.74 . . . . 54.43 112.536 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -87.61 140.63 29.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 74.14 110.924 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -155.66 -88.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 74.11 112.435 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -76.95 -22.97 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.31 110.815 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.545 HG21 ' HB2' ' A' ' 86' ' ' HIS . 81.4 p -151.18 -168.85 3.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 74.23 111.183 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.571 ' HB3' HD23 ' A' ' 114' ' ' LEU . 43.6 tt0 -86.09 -5.53 59.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 72.52 110.902 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 154' ' ' ILE . 48.5 t0 -147.07 16.47 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 54.4 110.857 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.661 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -49.33 127.38 14.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' ASP . 4.8 pt -133.72 175.06 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 65.04 111.123 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 143' ' ' PHE . 14.6 m -129.33 119.74 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 73.3 111.105 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.61 120.26 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 71.02 111.141 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -108.45 136.55 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.11 110.929 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.644 ' CD2' HG22 ' A' ' 140' ' ' VAL . 71.6 mt -118.59 98.64 51.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 63.23 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.1 Cg_endo -69.79 -3.87 12.91 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.635 2.223 . . . . 64.44 112.322 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -86.53 -23.42 25.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 74.02 110.86 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -139.35 11.13 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 75.23 110.968 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.4 m120 55.2 25.79 7.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 73.31 110.818 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 21' ' ' LEU . 87.6 mt -90.8 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 75.41 111.086 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 203' ' ' ILE . 15.1 tp -126.14 146.53 49.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 72.32 110.925 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.478 HG11 HG11 ' A' ' 55' ' ' VAL . 48.8 t -112.02 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 62.12 111.163 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.81 -29.45 26.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.771 -0.728 . . . . 60.13 112.458 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.95 -160.13 12.51 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.694 -0.765 . . . . 42.13 112.422 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -26.66 65.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 72.24 110.896 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.661 HD13 ' OD1' ' A' ' 153' ' ' ASN . 21.5 tp -58.15 -35.67 71.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 71.24 110.843 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.66 111.78 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 63.44 111.132 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.549 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.4 mmpt? -51.79 164.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 53.2 110.904 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.2 p -103.18 163.47 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 72.42 110.836 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.5 t -56.81 -23.83 46.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.52 111.093 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.4 p -104.52 22.47 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.904 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -95.63 149.93 20.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 75.53 111.049 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -122.11 -5.5 8.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.863 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.26 175.86 0.9 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 62.22 110.903 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.773 HD11 ' HB2' ' A' ' 226' ' ' LEU . 5.9 mt -83.84 -32.51 25.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 75.11 110.954 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 127.66 -128.96 6.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.803 -0.713 . . . . 60.5 112.501 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 181' ' ' VAL . 0.8 OUTLIER -110.84 3.39 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 61.31 110.937 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.713 HG11 ' CG2' ' A' ' 186' ' ' VAL . 27.4 m 36.77 44.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 74.0 111.105 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.32 68.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 63.13 111.008 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -138.64 30.66 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.42 110.895 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -125.02 165.95 17.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 43.12 111.133 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -119.88 91.94 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.928 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.713 ' CG2' HG11 ' A' ' 181' ' ' VAL . 21.9 t -62.8 -16.13 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 53.44 111.09 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -75.53 -22.58 56.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 64.13 110.878 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.67 -13.49 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 73.55 110.915 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.642 ' HZ3' HG12 ' A' ' 181' ' ' VAL . 1.7 t90 -54.02 -62.46 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 74.41 110.941 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.72 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.81 -23.55 18.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 71.21 110.905 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.2 m -81.3 -31.11 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 72.41 111.164 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -75.51 -43.11 50.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.135 -0.484 . . . . 63.43 110.98 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.517 HG21 ' O ' ' A' ' 219' ' ' LEU . 34.0 mm -62.09 -45.52 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 63.12 111.151 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -57.04 -24.1 51.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 64.21 110.799 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -81.68 -22.28 37.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 64.42 110.941 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 192' ' ' SER . 17.5 t -86.7 -9.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 70.31 111.126 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.69 -6.59 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.924 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.57 -31.15 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.925 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 -55.48 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.55 110.859 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.13 38.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 73.14 110.904 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -56.34 -47.66 78.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 74.31 110.814 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -59.59 99.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.842 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.688 HG21 HG22 ' A' ' 206' ' ' VAL . 50.7 mt -142.61 124.26 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 63.32 111.206 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.84 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 54.23 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.71 133.73 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 74.32 111.107 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.744 ' HB ' HD12 ' A' ' 218' ' ' LEU . 97.6 t -114.56 134.05 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 74.22 111.117 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.034 HG22 HG12 ' A' ' 213' ' ' VAL . 9.6 t -112.82 108.94 53.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.657 0.741 . . . . 72.14 111.146 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.73 -169.82 0.35 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 65.24 112.333 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.42 -17.88 63.44 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 73.24 112.474 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -152.49 151.28 30.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 75.15 110.868 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 102.68 -101.02 2.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 73.54 112.49 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.414 ' N ' HD21 ' A' ' 42' ' ' ASN . 3.3 pt-20 -173.51 161.56 4.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 72.51 110.943 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.034 HG12 HG22 ' A' ' 207' ' ' VAL . 5.9 m -51.85 163.02 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.73 -106.81 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.666 -0.778 . . . . 61.32 112.443 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -169.48 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.34 . . . . 73.03 110.851 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -60.78 -18.25 53.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 62.12 110.878 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.42 -18.72 44.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 73.24 112.472 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.3 mt -71.53 -31.03 66.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 74.41 110.976 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.517 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.1 mm? -64.77 -56.93 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 53.42 110.87 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.618 ' HA ' HD12 ' A' ' 223' ' ' LEU . 0.6 OUTLIER -63.64 -16.3 60.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 71.15 110.785 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.645 ' CE1' HD11 ' A' ' 225' ' ' LEU . 3.0 t-80 -68.36 -41.76 80.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 71.31 110.911 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.904 HG22 HD23 ' A' ' 226' ' ' LEU . 25.4 m -61.16 -50.22 74.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.161 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -63.49 -24.41 67.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 61.51 110.887 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.49 -12.28 60.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.645 HD11 ' CE1' ' A' ' 221' ' ' HIS . 6.9 mt -117.85 -19.5 9.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.895 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.904 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -108.03 0.9 22.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 74.1 110.871 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.893 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.763 0.316 . . . . 54.1 110.869 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 61.79 95.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 64.3 110.94 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -120.8 149.38 42.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 75.14 110.897 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.5 152.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 71.24 111.12 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -143.87 135.59 26.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 72.42 110.941 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt -114.67 -177.11 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.901 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 m -100.38 -68.71 0.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 74.42 111.181 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.65 147.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 64.42 111.137 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -113.1 96.48 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 72.12 111.081 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -117.54 115.89 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.916 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -60.54 166.3 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 54.24 110.877 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.68 -48.31 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.885 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.0 p -61.66 -37.5 84.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.47 63.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 72.13 112.541 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.5 m -80.52 -44.2 19.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 71.32 111.131 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 67' ' ' LEU . 25.6 mt -104.63 109.09 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 70.54 111.166 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -115.62 140.28 49.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 71.12 110.893 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.798 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -131.35 110.23 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 73.11 111.127 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -98.31 126.75 43.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 51.4 110.816 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -71.88 110.01 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 75.34 110.914 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.925 HD21 HG21 ' A' ' 213' ' ' VAL . 11.1 mt -64.23 -33.81 76.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 72.22 110.905 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.1 -97.0 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.921 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.34 9.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 64.01 110.926 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.75 7.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.829 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 t -150.96 140.95 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.162 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.798 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.2 m95 -129.19 -176.26 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.927 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 43' ' ' GLY . 90.5 t -134.15 89.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 72.32 111.115 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -73.03 125.24 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.886 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.8 m -121.57 103.49 8.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 71.32 111.076 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.496 ' HG3' HD22 ' A' ' 67' ' ' LEU . 2.4 mm-40 -86.75 118.7 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.15 110.955 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.809 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -85.34 127.9 34.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 72.34 110.931 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.2 -130.42 6.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 63.35 112.573 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 p -175.48 117.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 73.14 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.482 ' CD1' HG21 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -114.47 87.26 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 71.34 110.935 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.4 m120 55.0 48.69 19.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 53.04 110.879 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 -11.9 68.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.683 -0.77 . . . . 72.13 112.542 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -87.68 -169.76 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 71.15 110.892 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.809 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -129.87 134.39 47.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 73.24 111.041 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' A' ' 34' ' ' PHE . 2.6 t -125.73 81.48 65.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.729 . . . . 73.35 111.251 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 121.26 7.96 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.631 2.221 . . . . 73.1 112.422 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.05 96.99 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.86 167.05 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 53.31 110.923 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.83 -146.65 4.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 74.52 112.493 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.577 HD21 HD12 ' A' ' 158' ' ' LEU . 14.1 tp -159.16 120.02 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 71.55 110.927 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.664 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.7 t -103.8 123.0 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.156 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.771 HD21 HD11 ' A' ' 158' ' ' LEU . 16.6 mt -100.54 121.45 41.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 75.0 110.972 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -91.22 85.99 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.13 110.948 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -101.73 -179.87 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 70.51 111.176 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.4 m -99.98 -24.37 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 61.44 110.881 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -19.0 50.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.43 110.874 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.64 145.34 4.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 33.22 112.43 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.728 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.3 mt -58.23 155.04 12.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.921 0.391 . . . . 63.14 110.87 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.1 t -143.62 141.55 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 71.22 111.109 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.664 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -137.1 122.45 19.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 62.31 110.941 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 165' ' ' VAL . 54.2 t -68.16 111.72 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.198 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.5 141.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 74.1 110.843 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.74 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.4 p -83.11 -164.72 0.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 70.15 110.838 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.489 ' H ' HG23 ' A' ' 64' ' ' THR . 17.8 t -96.25 169.78 9.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 65.22 110.8 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.682 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.4 m95 -50.61 -59.24 4.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.925 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.64 163.48 23.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 73.55 110.872 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.21 -37.17 71.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 72.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -57.44 -34.9 69.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.24 110.893 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 59' ' ' TRP . 91.5 mt -81.51 -48.13 12.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.991 0.424 . . . . 73.11 110.864 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.3 -49.06 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 74.41 111.133 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -52.31 -50.73 61.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 73.25 110.899 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.0 -20.62 66.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 72.1 110.959 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.516 ' HB2' HD13 ' A' ' 16' ' ' ILE . 14.3 tp -87.09 -26.02 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 74.44 110.965 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.554 ' HA ' HG22 ' A' ' 71' ' ' VAL . 54.3 mt -92.39 -24.54 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 55.52 111.131 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.14 1.87 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 73.3 110.87 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ptm -119.61 -35.67 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 71.34 110.957 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 68' ' ' ILE . 31.6 m -79.19 -26.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 55.12 111.062 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.94 -21.05 63.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 71.44 110.864 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.37 -32.01 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 72.13 110.837 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -44.02 59.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.914 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.575 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 14.6 m-85 -85.91 -12.85 49.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 62.52 110.944 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.49 11.26 7.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.94 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -129.66 139.17 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.973 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -82.81 139.36 33.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 71.21 110.891 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 52' ' ' LEU . 92.5 t -82.74 121.06 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.2 111.188 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.2 8.14 2.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 61.15 111.118 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 82' ' ' VAL . 48.5 m-20 -147.09 145.2 29.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.185 -0.461 . . . . 54.44 110.91 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 54' ' ' LEU . 4.3 t -156.09 138.41 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 63.31 111.225 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.652 ' CD1' HG11 ' A' ' 140' ' ' VAL . 20.3 mt -94.09 136.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 75.44 111.18 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.056 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.1 mm -100.94 149.47 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 64.33 111.111 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -115.39 -38.4 3.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.162 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -169.93 172.06 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.844 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.622 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -91.11 89.15 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 64.34 111.143 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -148.67 154.97 40.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 73.02 110.895 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.64 -23.5 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 74.52 111.131 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -92.23 27.23 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.25 110.85 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.913 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -152.24 -70.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.928 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.722 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -90.17 3.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 73.23 111.122 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -44.39 54.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 72.2 112.51 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.51 13.97 63.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 74.11 112.526 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.61 HD12 HH22 ' A' ' 91' ' ' ARG . 2.6 tt -57.61 -26.06 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 52.21 111.214 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -55.1 -27.43 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 61.21 110.847 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -95.33 -38.46 10.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 65.21 111.196 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 57' ' ' SER . 14.9 mt -56.22 -46.09 79.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 63.1 110.897 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -0.99 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.4 110.94 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.53 -44.97 8.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.44 110.94 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -79.48 -61.39 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.81 39.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 61.42 112.394 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -101.9 120.3 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.798 0.332 . . . . 74.35 111.164 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.768 ' HD3' HD21 ' A' ' 124' ' ' LEU . 6.2 mttm -78.5 118.02 20.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.868 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 1.056 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -94.35 85.01 4.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.024 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.516 ' HB3' HD11 ' A' ' 127' ' ' LEU . 52.2 m-70 -55.01 110.43 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 74.04 110.849 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 t -139.67 -175.6 4.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.844 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.17 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 64.31 111.03 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.32 -36.75 44.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 61.53 111.062 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.7 HD22 ' OE1' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -68.4 -48.45 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.921 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.8 ' HA ' HD11 ' A' ' 114' ' ' LEU . 47.9 m -59.09 -18.78 38.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 72.22 111.207 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.633 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.37 13.07 36.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 73.35 111.083 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.7 ' OE1' HD22 ' A' ' 110' ' ' LEU . 2.1 pt-20 -115.6 -27.44 7.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.889 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.8 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -101.37 -11.74 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.2 110.879 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.11 69.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 42.43 111.068 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -20.72 60.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 64.24 110.907 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.37 -32.41 73.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 71.12 110.946 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -88.48 -14.86 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.843 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 22.53 7.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.753 -0.737 . . . . 72.11 112.437 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.402 ' CD1' HG12 ' A' ' 92' ' ' ILE . 80.9 m-85 -102.59 170.76 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.9 0.381 . . . . 64.14 110.844 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -72.78 -170.73 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 51.44 110.915 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.58 121.66 29.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.613 0.72 . . . . 73.22 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.633 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.4 Cg_endo -69.86 -169.96 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.692 2.261 . . . . 54.14 112.328 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.768 HD21 ' HD3' ' A' ' 104' ' ' LYS . 6.0 mt -59.5 -39.87 85.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 54.33 110.925 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.69 26.0 30.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.729 -0.748 . . . . 61.21 112.471 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.35 39.97 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 62.43 110.926 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.53 HD22 HD21 ' A' ' 133' ' ' LEU . 85.8 mt -131.62 -172.81 2.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.948 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -157.65 -169.71 2.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 63.33 110.972 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.928 HG22 HG23 ' A' ' 130' ' ' VAL . 33.8 m -48.3 -67.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 73.13 111.199 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.928 HG23 HG22 ' A' ' 129' ' ' THR . 41.7 t -120.53 109.31 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 64.43 111.13 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.499 HG21 HD22 ' A' ' 127' ' ' LEU . 13.2 t -138.68 176.15 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 73.35 111.049 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -122.87 137.39 54.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.53 HD21 HD22 ' A' ' 127' ' ' LEU . 25.2 mt -118.84 151.88 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 63.24 110.914 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.31 126.74 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 65.41 110.92 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.24 34.04 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 73.23 110.909 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.04 94.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 50.22 112.471 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.15 12.48 8.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.857 0.36 . . . . 63.51 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.437 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.5 tpp -134.76 101.11 4.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.147 -0.479 . . . . 75.32 110.878 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -89.34 130.3 35.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.15 110.909 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.735 HG22 HD21 ' A' ' 158' ' ' LEU . 19.6 t -138.41 115.56 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 70.25 111.12 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -110.5 130.15 55.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 65.45 110.872 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.9 p -84.87 -174.13 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 72.34 111.133 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.48 ' HB3' HG23 ' A' ' 155' ' ' VAL . 31.4 t80 -170.1 137.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.914 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.682 ' HB3' HG23 ' A' ' 129' ' ' THR . 89.8 t80 -123.83 89.61 51.36 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.664 0.745 . . . . 64.22 110.89 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.3 Cg_endo -69.82 -8.25 23.12 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.717 2.278 . . . . 73.24 112.302 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.05 -149.11 19.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 74.3 112.566 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -97.11 138.97 33.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 63.15 110.853 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.15 -96.31 0.15 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 61.24 112.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.8 -24.9 63.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 72.4 110.901 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.8 p -152.2 -175.72 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 62.22 111.184 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.64 0.58 52.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 62.13 111.01 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.583 ' HB3' HD12 ' A' ' 110' ' ' LEU . 16.8 p-10 -141.72 12.09 2.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 71.12 110.902 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.81 140.97 28.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 63.14 110.889 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.723 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.8 pt -146.32 -179.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 71.42 111.054 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 143' ' ' PHE . 26.9 m -138.68 124.95 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 74.02 111.128 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.654 ' O ' HD12 ' A' ' 164' ' ' LEU . 95.8 t -82.8 138.92 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 54.12 111.122 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -123.66 130.52 52.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 74.42 110.871 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.771 HD11 HD21 ' A' ' 46' ' ' LEU . 9.3 mt -111.84 98.17 40.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 44.32 110.89 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.3 Cg_endo -69.75 -4.21 13.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.802 2.334 . . . . 73.55 112.282 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -83.53 -23.32 32.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 70.41 110.841 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.27 14.29 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 74.42 110.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.5 m120 53.84 27.22 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.412 HD13 HD13 ' A' ' 21' ' ' LEU . 96.9 mt -91.74 136.56 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.137 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 156' ' ' VAL . 14.4 tp -119.6 144.42 47.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.981 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 55' ' ' VAL . 21.9 t -113.13 76.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 32.33 111.074 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.92 49.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.733 . . . . 73.21 112.511 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.28 -162.56 51.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.74 . . . . 50.11 112.525 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 61.0 m -51.74 -29.64 19.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 62.54 110.815 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.627 HD12 ' NE1' ' A' ' 189' ' ' TRP . 25.4 tp -55.2 -53.96 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 74.13 110.889 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 219' ' ' LEU . 47.6 t -83.39 114.68 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 50.33 111.128 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.429 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.6 mmpt? -57.08 149.79 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.977 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.1 p -95.14 158.56 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 64.22 110.978 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t -56.47 -25.03 49.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.2 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.1 t -98.34 43.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 54.31 110.864 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.13 145.43 47.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 64.23 111.045 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.52 ' C ' HD22 ' A' ' 225' ' ' LEU . 3.4 tttt -122.55 2.05 9.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 63.43 110.863 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.33 154.04 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.227 -0.442 . . . . 71.33 110.89 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 226' ' ' LEU . 7.7 mt -66.65 -36.62 82.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 71.42 110.896 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 85.35 -143.24 20.08 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.731 -0.747 . . . . 61.03 112.55 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -52.43 103.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 75.2 110.856 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 179' ' ' GLY . 15.6 m -105.88 22.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 70.23 111.164 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.35 72.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 71.12 111.125 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -110.44 24.23 13.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 71.41 110.819 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.33 153.32 50.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 73.14 111.152 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -106.59 86.26 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 74.13 110.936 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.37 -18.66 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 73.12 111.099 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -72.51 -29.27 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.861 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -108.87 -13.78 14.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.862 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.627 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.5 t90 -53.59 -62.23 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.123 -0.489 . . . . 72.41 110.999 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.717 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.56 -24.01 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.43 . . . . 73.42 110.862 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.0 m -81.73 -31.57 31.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 52.52 111.139 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -74.18 -45.4 48.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.865 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mm -58.35 -46.62 89.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 64.43 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.68 -29.36 62.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 71.02 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.28 -20.35 55.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 72.14 110.873 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 192' ' ' SER . 38.3 t -87.58 -12.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 71.54 111.214 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -108.9 -7.08 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 63.11 110.884 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.1 -30.78 10.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 74.44 110.871 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.83 -49.76 3.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 71.31 110.853 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.15 40.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 64.52 110.863 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -55.51 -47.76 75.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 62.31 110.766 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -59.07 103.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.44 110.944 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.64 HD13 HD22 ' A' ' 164' ' ' LEU . 45.7 mt -146.06 126.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 71.11 111.085 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.83 -27.21 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.941 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.639 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -163.24 146.42 10.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 74.43 111.105 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 218' ' ' LEU . 99.1 t -122.85 132.63 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 74.04 111.126 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 213' ' ' VAL . 10.8 t -113.69 107.58 52.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 60.31 111.068 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.414 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.8 Cg_endo -69.7 -176.27 1.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.708 2.272 . . . . 75.13 112.41 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.17 -14.27 80.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 64.42 112.573 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -152.36 130.66 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 73.02 110.811 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 118.59 -118.37 4.0 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 64.45 112.454 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -153.47 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 51.52 110.849 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 207' ' ' VAL . 5.2 t -72.07 145.08 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.015 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -141.5 -91.25 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.812 -0.708 . . . . 64.12 112.552 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.82 -168.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 75.05 110.888 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.481 ' HA ' HD12 ' A' ' 219' ' ' LEU . 0.0 OUTLIER -63.87 -15.14 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.03 110.913 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.506 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.22 -18.59 42.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.658 -0.782 . . . . 71.55 112.602 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.75 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.0 mt -74.03 -44.35 54.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 71.31 110.878 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.615 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -55.06 -57.32 12.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 61.43 110.891 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.506 HD21 ' HA2' ' A' ' 217' ' ' GLY . 3.0 pp -58.22 -22.6 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.91 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.2 -34.98 75.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.12 110.918 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.849 HG22 HD23 ' A' ' 226' ' ' LEU . 8.8 m -57.77 -55.44 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 65.34 111.173 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.06 -19.69 61.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 62.11 110.851 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -12.01 58.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.822 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.52 HD22 ' C ' ' A' ' 176' ' ' LYS . 10.4 mt -117.63 -16.59 10.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 70.31 110.874 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.849 HD23 HG22 ' A' ' 222' ' ' THR . 0.5 OUTLIER -110.73 3.85 19.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 60.33 110.878 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.4 110.968 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.749 0.309 . . . . 55.43 110.916 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.88 91.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 61.12 110.852 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -169.69 120.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.964 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.1 t -57.07 140.38 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.14 111.143 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -158.18 154.55 27.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 72.34 110.914 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -62.76 -179.71 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 63.23 110.927 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 m -82.49 -42.31 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 61.22 111.058 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.19 -177.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 53.11 111.208 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -135.83 91.76 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 74.44 111.091 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -111.76 118.13 34.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 75.35 110.95 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -61.38 168.34 2.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.78 -47.88 64.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 74.55 110.779 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.42 -37.87 82.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 61.5 111.082 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 13.4 61.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 62.31 112.493 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -80.79 -43.8 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.756 0.312 . . . . 72.43 111.15 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 67' ' ' LEU . 27.5 mt -103.54 117.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.08 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -125.04 129.99 51.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 70.33 110.843 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.661 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.1 mt -123.41 110.05 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 63.15 111.033 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -101.26 128.44 47.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 64.05 110.842 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -71.1 111.03 6.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 72.15 110.875 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.561 HD21 HG11 ' A' ' 213' ' ' VAL . 14.2 mt -65.07 -32.08 73.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 72.42 110.855 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.12 -97.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 73.21 110.88 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -151.52 9.98 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 71.03 110.926 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.52 6.19 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 65.23 110.899 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -150.99 139.73 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.437 . . . . 62.4 111.109 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.661 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.1 m95 -126.87 -174.97 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 71.42 110.966 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 43' ' ' GLY . 99.6 t -135.85 95.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 72.11 111.175 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -80.33 122.24 26.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.775 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.9 m -118.2 100.36 7.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 54.43 111.133 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.9 117.08 23.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.15 110.937 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.786 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -83.41 115.31 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 63.14 110.95 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.29 -131.66 1.53 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.676 -0.773 . . . . 72.43 112.514 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 p -175.53 117.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 72.23 110.909 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.502 ' CD1' HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -112.01 87.02 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 63.52 110.921 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 m120 55.5 46.78 22.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 72.11 110.864 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.32 -12.75 65.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 32.14 112.498 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.4 -169.66 2.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 74.2 110.837 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.786 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -128.95 135.65 49.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 61.51 111.079 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 34' ' ' PHE . 2.4 t -130.54 83.03 63.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.611 0.72 . . . . 51.35 111.092 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 118.16 5.52 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.615 2.21 . . . . 70.41 112.304 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.1 p -105.52 99.7 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 65.11 110.838 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.76 164.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 54.13 110.835 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.89 -164.32 13.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 53.3 112.447 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.545 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.0 tp -153.69 115.36 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 55.21 110.929 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.689 HG22 HD23 ' A' ' 54' ' ' LEU . 2.0 t -99.56 116.76 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.44 111.138 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.42 121.23 35.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 73.34 110.905 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -90.98 84.37 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 34.33 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -97.45 -177.03 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 65.2 111.117 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -103.97 -19.41 14.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.764 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -16.41 37.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 73.02 110.926 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 146.85 4.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.791 -0.719 . . . . 61.24 112.584 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.42 ' HB3' HG22 ' A' ' 79' ' ' VAL . 10.8 tp -60.13 155.26 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.37 . . . . 73.24 110.9 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.8 142.6 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 63.14 111.211 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.689 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -138.53 125.66 21.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.918 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 165' ' ' VAL . 79.7 t -69.88 110.18 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 74.55 111.136 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.91 141.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 71.2 110.823 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.651 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -81.77 -160.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.949 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.576 ' H ' HG23 ' A' ' 64' ' ' THR . 13.6 t -98.44 170.06 9.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 43.44 110.881 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.618 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.9 m95 -53.06 -59.99 3.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 72.2 110.962 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.67 158.53 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.22 110.903 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -52.85 -39.58 62.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 63.25 110.889 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -55.72 -25.79 42.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.2 110.958 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 59' ' ' TRP . 94.6 mt -92.11 -50.01 5.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 71.01 110.892 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -50.19 -43.6 52.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.152 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.4 -48.23 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.891 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.36 -21.08 66.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.926 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.5 tp -87.37 -27.3 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.87 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.56 -22.58 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 62.34 111.143 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -91.96 14.28 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 73.12 110.927 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ptm -129.49 -40.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 61.1 110.881 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.0 m -78.37 -22.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 71.25 111.096 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.573 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.82 -25.27 65.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 72.22 110.834 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -104.14 -32.73 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.13 110.85 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -47.01 58.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 75.4 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 23.6 m-85 -82.61 -11.17 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 71.41 110.828 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 68.07 11.73 8.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 54.35 110.931 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -132.24 140.43 48.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.904 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.854 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG21 HD11 ' A' ' 54' ' ' LEU . 71.9 t -79.47 120.22 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 70.24 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.6 t -132.88 4.28 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 75.05 111.135 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.2 m-20 -147.58 146.53 29.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 71.33 110.868 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 54' ' ' LEU . 3.3 t -155.35 129.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 73.15 111.118 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.619 ' CD1' HG11 ' A' ' 140' ' ' VAL . 20.6 mt -84.5 133.33 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 65.42 111.132 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.97 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.3 mm -97.44 147.55 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 54.51 111.172 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.7 p -110.91 -35.64 5.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 70.31 111.119 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.594 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.5 p-80 -173.15 -176.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.841 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.88 84.74 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 52.44 111.112 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -145.05 154.46 42.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 75.52 110.907 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.84 -23.1 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 53.43 111.079 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.46 26.31 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 52.31 110.853 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.899 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -151.28 -70.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 75.2 110.89 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.728 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.9 2.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 72.53 111.18 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -45.06 43.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.803 -0.713 . . . . 72.23 112.395 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.43 15.93 58.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 45.33 112.54 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.9 tt -54.24 -26.77 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 70.11 111.135 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -58.75 -27.61 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.35 110.979 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -90.16 -20.21 23.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 54.12 111.097 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.651 HD11 ' OG ' ' A' ' 57' ' ' SER . 15.7 mt -82.45 -37.47 25.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.865 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -92.51 20.42 6.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 70.11 110.923 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -118.42 -43.07 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 71.55 110.821 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -84.43 -54.0 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.871 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.76 39.19 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 65.12 112.488 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.5 mp -103.85 113.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.852 0.358 . . . . 61.52 111.179 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.703 ' HB3' HD11 ' A' ' 124' ' ' LEU . 10.5 mtmt -79.74 113.96 18.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 65.32 110.904 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.97 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -87.88 91.4 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 63.23 111.058 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.478 ' HA ' HD12 ' A' ' 124' ' ' LEU . 42.4 m-70 -64.38 112.09 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.85 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.401 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -141.05 -175.01 4.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.882 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.7 158.05 15.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 64.21 111.11 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.5 -40.36 51.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 74.52 111.098 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.695 HD23 ' OD2' ' A' ' 152' ' ' ASP . 38.9 tp -75.09 -39.12 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 52.21 110.937 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.771 ' HA ' HD11 ' A' ' 114' ' ' LEU . 88.0 m -58.84 -21.69 57.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 71.2 111.132 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -96.61 0.87 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 73.0 111.083 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.48 -50.62 3.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.905 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -69.68 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.31 110.92 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.45 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 64.04 111.121 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -26.23 61.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.51 110.902 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -31.93 62.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 75.53 110.882 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -93.23 -21.22 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 64.44 110.837 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.36 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 73.24 112.574 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CD1' HG12 ' A' ' 92' ' ' ILE . 85.7 m-85 -97.34 178.47 5.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 65.31 110.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -76.17 -176.39 3.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 62.01 110.841 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.0 mp0 -118.86 110.96 37.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 74.14 110.899 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.83 -169.76 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.614 2.209 . . . . 71.01 112.398 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 104' ' ' LYS . 63.6 mt -61.81 -49.49 76.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 64.21 110.913 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 60.19 20.26 53.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.75 . . . . 75.11 112.506 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.42 31.31 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 71.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.568 ' CD2' HD21 ' A' ' 133' ' ' LEU . 90.2 mt -116.51 -174.48 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.93 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.24 -171.02 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 75.51 110.915 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.826 HG22 HG23 ' A' ' 130' ' ' VAL . 54.1 m -50.79 -70.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.182 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.826 HG23 HG22 ' A' ' 129' ' ' THR . 31.0 t -116.37 102.03 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 60.32 111.153 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.45 HG21 HD22 ' A' ' 127' ' ' LEU . 14.3 t -124.78 162.28 24.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 61.32 111.209 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.96 100.94 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 74.43 110.916 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.568 HD21 ' CD2' ' A' ' 127' ' ' LEU . 27.4 mt -78.71 -179.89 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 53.43 110.969 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -171.74 112.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 71.21 110.961 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -106.73 73.93 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 75.22 110.807 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.43 -84.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.843 -0.694 . . . . 73.24 112.445 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.19 26.95 9.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.352 . . . . 75.1 110.833 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.6 tpp -130.43 142.93 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 70.04 110.932 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.54 125.33 48.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 74.03 110.897 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.648 HG22 ' CD2' ' A' ' 158' ' ' LEU . 13.4 t -138.85 119.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 74.35 111.195 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -113.54 127.86 56.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.964 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.5 p -82.78 -173.6 4.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 74.22 111.145 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.421 ' HB3' HG23 ' A' ' 155' ' ' VAL . 21.6 t80 -170.89 135.9 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 72.42 110.861 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.69 ' HB3' HG23 ' A' ' 129' ' ' THR . 81.7 t80 -125.12 90.34 51.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.816 0.817 . . . . 75.22 110.962 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.1 Cg_endo -69.86 -7.78 21.94 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.662 2.241 . . . . 62.44 112.309 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.86 -150.8 18.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 73.35 112.554 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -91.63 139.7 30.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 74.42 110.957 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.67 -89.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.692 -0.765 . . . . 51.2 112.507 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -76.12 -25.47 55.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 74.13 110.933 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.594 HG21 ' HB2' ' A' ' 86' ' ' HIS . 46.9 p -146.95 -167.95 2.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 72.33 111.123 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.604 ' HB3' HD23 ' A' ' 114' ' ' LEU . 60.7 tt0 -85.34 -16.25 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.925 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.695 ' OD2' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -139.99 25.83 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.883 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.08 131.83 48.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.909 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 84' ' ' ILE . 10.3 pt -139.28 171.06 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 75.42 111.164 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.6 m -124.94 142.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 71.32 111.049 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.67 114.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 74.31 111.183 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -103.74 142.07 34.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 73.32 110.923 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.648 ' CD2' HG22 ' A' ' 140' ' ' VAL . 56.5 mt -122.41 98.69 43.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.631 0.729 . . . . 71.42 110.888 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -5.01 15.16 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.13 112.358 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.74 -31.36 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.08 11.6 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.901 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.3 27.49 9.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 54.21 110.8 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.502 HD13 HD13 ' A' ' 21' ' ' LEU . 87.2 mt -93.18 143.62 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 73.43 111.117 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.443 ' CD2' HD13 ' A' ' 203' ' ' ILE . 61.5 tp -124.81 153.68 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.92 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 55' ' ' VAL . 76.0 t -123.16 79.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 71.13 111.137 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.83 -36.64 41.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 54.44 112.522 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 67.28 -165.09 43.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.712 -0.756 . . . . 55.12 112.437 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.7 m -51.95 -34.45 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 74.22 110.889 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.611 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.7 tp -51.64 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.888 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.41 HG13 ' HA ' ' A' ' 219' ' ' LEU . 19.6 t -80.25 109.19 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.22 111.122 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.73 ' HG2' HG23 ' A' ' 222' ' ' THR . 32.0 mmmt -51.29 169.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 75.43 110.895 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 89.2 p -117.78 157.26 26.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 44.11 110.847 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.5 t -49.43 157.29 0.52 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.107 -0.497 . . . . 64.2 111.173 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.1 m 69.4 11.8 8.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 62.34 110.927 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 172' ' ' SER . . . -83.41 144.55 29.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.064 -0.516 . . . . 71.22 111.115 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -120.28 -10.32 9.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 73.15 110.944 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.83 158.78 0.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 63.31 110.923 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.769 HD11 ' HB2' ' A' ' 226' ' ' LEU . 8.8 mt -69.31 -38.56 78.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 75.51 110.902 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.42 -124.53 7.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.797 -0.716 . . . . 62.13 112.527 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -70.52 130.38 41.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.859 0.362 . . . . 40.25 110.843 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 186' ' ' VAL . 27.8 m -130.26 27.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 65.13 111.096 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.79 -33.18 75.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 70.53 111.04 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -114.45 28.06 9.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 73.25 110.839 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.74 153.56 49.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 54.33 111.138 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.42 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 64.4 110.919 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.456 ' CG2' HG11 ' A' ' 181' ' ' VAL . 21.2 t -59.56 -19.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.24 111.173 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.54 -27.16 61.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 63.11 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.37 -12.41 14.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.01 110.87 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.611 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.5 t90 -54.28 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.936 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.671 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.51 -24.5 13.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.818 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.0 m -81.45 -32.55 32.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.14 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -42.53 62.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 63.11 110.796 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.3 mm -62.47 -44.72 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 75.31 111.102 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.49 -23.49 50.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.868 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -81.74 -20.73 38.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.45 110.888 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.44 -9.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.33 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.69 -10.33 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 64.2 110.903 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -101.95 -31.91 10.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.888 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 -49.92 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 73.24 110.852 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.499 ' O ' HD11 ' A' ' 203' ' ' ILE . 3.9 m-30 -101.12 65.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.94 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -78.42 -55.49 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 74.11 110.838 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.15 100.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.828 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.704 HG21 HG22 ' A' ' 206' ' ' VAL . 57.1 mt -141.23 116.08 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 72.0 111.181 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.13 -26.07 64.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 70.02 110.96 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -171.99 137.76 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 74.03 111.093 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.732 ' HB ' HD12 ' A' ' 218' ' ' LEU . 85.7 t -113.91 144.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 62.0 111.093 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.128 HG22 HG12 ' A' ' 213' ' ' VAL . 13.5 t -119.68 109.19 38.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.722 . . . . 62.2 111.141 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -170.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.72 2.28 . . . . 74.12 112.327 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.07 -14.93 61.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 61.42 112.467 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.71 142.1 21.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 74.02 110.87 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.7 -101.81 1.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 55.35 112.497 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.81 162.76 4.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 55.55 110.972 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.128 HG12 HG22 ' A' ' 207' ' ' VAL . 6.6 m -51.56 163.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.141 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.67 -102.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.661 -0.781 . . . . 52.04 112.48 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.82 -172.24 3.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 64.13 110.841 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -61.87 -17.38 56.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.897 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.451 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.3 -17.59 46.84 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.715 -0.755 . . . . 44.41 112.491 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.8 mt -70.01 -30.2 67.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 61.54 110.987 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.559 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.9 mm? -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 61.22 110.93 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.451 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -62.14 -17.39 57.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 61.55 110.913 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 225' ' ' LEU . 1.6 t60 -65.86 -50.68 63.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.52 110.924 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.738 HG22 HD23 ' A' ' 226' ' ' LEU . 4.4 m -51.84 -51.7 54.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 74.25 111.129 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.52 -21.27 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 43.23 110.908 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -86.81 -2.96 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 74.04 110.843 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.411 HD11 ' CE1' ' A' ' 221' ' ' HIS . 5.5 mt -128.25 -4.87 5.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 74.3 110.947 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.769 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -123.12 0.61 9.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.897 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 45.03 110.846 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.834 0.35 . . . . 74.44 110.855 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.82 47.81 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 73.15 110.834 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -149.31 91.8 1.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.1 110.926 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 p -51.54 151.87 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 74.05 111.142 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -140.27 160.66 39.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 74.32 110.876 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -107.19 -169.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.925 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -96.7 -68.3 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 71.31 111.167 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.8 t -49.37 147.14 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 73.21 111.086 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.08 99.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 72.03 111.082 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -118.43 114.87 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.962 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -59.42 165.61 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 63.45 110.856 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.01 -48.7 61.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.823 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -63.11 -36.75 84.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.051 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.58 13.63 62.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 71.33 112.582 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 m -78.26 -45.88 21.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 64.42 111.12 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 67' ' ' LEU . 40.6 mt -103.27 113.92 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 61.11 111.159 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.0 p -118.08 138.12 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.904 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.795 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -130.25 112.14 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 75.52 111.041 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -98.22 125.8 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 73.53 110.801 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -69.14 109.17 3.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 53.04 110.916 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.846 HD21 HG11 ' A' ' 213' ' ' VAL . 15.8 mt -63.4 -33.73 76.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 71.44 110.895 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.96 -96.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 74.32 110.958 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -150.7 9.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.853 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.24 7.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 73.31 110.844 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 t -151.01 141.33 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.22 111.213 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.795 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.4 m95 -129.8 -174.76 3.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 72.45 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 43' ' ' GLY . 98.2 t -136.64 90.49 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 61.14 111.13 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -73.55 124.47 25.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.84 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -121.03 104.58 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 64.51 111.142 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -86.3 122.18 29.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.939 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.72 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 1.1 mt -85.16 106.5 16.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 72.42 110.872 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.47 -134.14 2.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.728 . . . . 53.0 112.489 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 p -175.93 117.81 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.855 0.359 . . . . 71.2 110.857 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.73 81.59 1.69 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.5 . . . . 72.32 110.914 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 70.28 2.01 3.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 75.0 110.912 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.68 -6.49 3.53 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.688 -0.768 . . . . 72.02 112.403 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -100.76 123.0 44.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.22 110.877 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.72 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -51.36 123.28 9.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 52.11 111.116 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.96 81.94 10.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.618 0.723 . . . . 62.0 111.19 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 118.83 5.92 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.687 2.258 . . . . 73.44 112.268 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.4 p -109.7 96.27 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.891 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -60.32 167.96 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.526 . . . . 62.13 110.941 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.458 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -159.29 -147.23 4.81 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 44.12 112.504 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 158' ' ' LEU . 14.9 tp -160.52 118.13 2.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.34 . . . . 74.25 110.969 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.653 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.8 t -100.88 122.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 75.1 111.093 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 158' ' ' LEU . 26.2 mt -99.41 119.57 38.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.49 . . . . 72.03 110.952 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.91 87.08 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 52.45 110.899 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.54 -179.87 4.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.464 . . . . 63.22 111.205 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -101.05 -23.78 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 25.43 110.809 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 -13.58 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 70.44 110.854 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.5 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.798 . . . . 71.54 112.442 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.485 ' HB3' HG22 ' A' ' 79' ' ' VAL . 8.9 tp -63.18 154.96 29.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.858 0.361 . . . . 75.42 110.818 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.92 143.14 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.43 111.181 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.653 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -138.75 124.41 19.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 63.43 111.008 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 165' ' ' VAL . 74.5 t -69.82 112.49 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 63.02 111.139 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.75 139.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 53.34 110.894 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.708 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.6 p -83.1 -165.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.89 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.489 ' H ' HG23 ' A' ' 64' ' ' THR . 8.5 t -94.89 165.77 12.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 61.22 110.951 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.644 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.5 m95 -50.3 -59.61 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.449 . . . . 75.44 110.927 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -123.96 160.59 27.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.832 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.05 -39.84 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.932 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.88 -40.55 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 62.44 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.9 mt -74.46 -48.44 27.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 73.14 110.93 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.76 -44.39 58.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 73.41 111.12 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.43 -50.5 67.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 72.04 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -63.9 -18.79 64.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 70.35 110.907 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 16' ' ' ILE . 11.1 tp -88.71 -27.77 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.907 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -89.72 -23.12 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 71.04 111.169 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.57 16.4 12.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.865 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.5 ptm -130.75 -39.71 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 70.12 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.3 m -81.21 -22.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.207 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.589 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.11 -22.05 64.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 74.33 110.868 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.85 -33.5 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 63.55 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.4 -39.56 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 63.51 110.905 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.31 -11.29 35.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.2 110.914 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 68.08 12.15 8.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.949 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HB2' HD13 ' A' ' 52' ' ' LEU . 6.7 mttt -130.59 138.97 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.898 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -85.44 138.79 32.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.43 110.864 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 54' ' ' LEU . 72.9 t -79.44 121.75 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 72.42 111.185 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 t -136.89 8.33 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 54.42 111.112 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 82' ' ' VAL . 64.7 m-20 -150.81 145.85 25.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.865 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 54' ' ' LEU . 4.0 t -155.33 132.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 62.25 111.198 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.631 ' CD1' HG11 ' A' ' 140' ' ' VAL . 23.2 mt -86.4 133.61 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 71.41 111.159 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.986 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.1 mm -98.43 147.69 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.108 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.7 p -111.61 -34.18 6.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.13 111.082 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.558 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.5 p-80 -175.11 -175.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.921 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.83 93.49 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 62.34 111.085 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.402 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.2 t-160 -153.79 154.96 34.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 73.33 110.875 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.67 -21.77 7.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 72.15 111.124 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.31 18.23 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 75.45 110.823 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.911 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -143.54 -70.75 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 64.13 110.855 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.711 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.88 3.89 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 74.31 111.086 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.44 -45.62 45.75 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.695 -0.764 . . . . 64.12 112.44 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.52 15.81 59.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.644 -0.788 . . . . 71.41 112.454 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.475 HD12 HH22 ' A' ' 91' ' ' ARG . 4.6 tt -56.35 -25.97 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 70.12 111.143 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -59.7 -21.36 60.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 72.53 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 ' HD2' ' A' ' 101' ' ' ARG . 81.9 m -98.28 -20.62 17.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 72.02 111.166 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.708 HD11 ' CB ' ' A' ' 57' ' ' SER . 13.7 mt -82.98 -36.13 25.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.879 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -88.86 9.8 23.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 64.44 110.897 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -112.45 -55.29 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 71.13 110.879 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.489 ' HD2' HG22 ' A' ' 97' ' ' THR . 7.1 mtt-85 -65.16 -58.59 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 73.3 110.862 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.18 39.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 53.51 112.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.2 mp -106.88 117.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.868 0.366 . . . . 74.34 111.104 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.734 ' CE ' HD21 ' A' ' 124' ' ' LEU . 3.2 mtpp -82.03 117.92 22.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 63.41 110.88 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.986 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -91.26 94.65 9.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 52.13 111.139 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.18 113.49 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 64.4 110.831 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 111' ' ' THR . 1.0 OUTLIER -142.66 -174.53 4.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 75.04 110.854 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.34 158.39 16.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 65.12 111.127 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.76 -38.89 50.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 60.12 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.7 HD23 ' OD1' ' A' ' 152' ' ' ASP . 55.5 tp -77.45 -37.61 51.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.948 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 88.9 m -58.37 -22.09 52.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 72.24 111.151 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -95.46 -3.16 47.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.099 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -95.8 -54.43 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.902 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.857 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -64.76 -13.95 57.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 73.23 110.843 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.5 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 63.33 111.059 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.69 -25.99 60.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 55.44 110.83 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -55.93 -33.05 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 72.42 110.845 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -91.75 -20.96 20.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 63.23 110.9 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.91 25.42 5.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.808 -0.71 . . . . 60.14 112.491 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.29 -174.55 2.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 63.21 110.905 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.14 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 64.14 110.877 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -120.77 108.75 36.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.663 0.744 . . . . 71.54 110.853 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.437 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.75 -169.84 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.711 2.274 . . . . 75.3 112.343 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.734 HD21 ' CE ' ' A' ' 104' ' ' LYS . 20.7 mt -61.48 -48.78 79.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 44.14 110.931 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 57.04 23.07 45.02 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.73 -0.748 . . . . 75.32 112.528 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.02 33.74 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 75.13 110.899 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.671 HD22 HD21 ' A' ' 133' ' ' LEU . 74.8 mt -119.34 -175.04 2.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 71.42 110.917 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -153.73 -170.94 3.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 72.34 110.935 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.951 HG22 HG23 ' A' ' 130' ' ' VAL . 34.7 m -50.25 -70.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 71.3 111.111 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.951 HG23 HG22 ' A' ' 129' ' ' THR . 48.0 t -119.91 104.03 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 71.13 111.131 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -135.48 165.53 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 71.34 111.167 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.59 133.03 54.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 64.42 110.814 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.671 HD21 HD22 ' A' ' 127' ' ' LEU . 23.0 mt -118.92 158.01 26.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.976 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -140.68 123.18 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.93 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -120.22 45.52 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 74.43 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.84 92.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 62.15 112.479 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.52 15.01 9.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.827 0.346 . . . . 62.33 110.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 tpp -136.72 94.9 3.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 71.3 110.863 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.4 131.23 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.861 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.759 HG22 HD21 ' A' ' 158' ' ' LEU . 20.2 t -137.52 119.0 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.12 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -111.62 131.11 55.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.842 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.9 p -84.96 -172.82 4.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.122 -0.49 . . . . 74.03 111.167 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.567 ' HD1' HG22 ' A' ' 130' ' ' VAL . 22.7 t80 -170.82 135.55 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.814 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.711 ' HB3' HG23 ' A' ' 129' ' ' THR . 21.0 t80 -123.39 87.39 51.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 71.1 110.881 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -7.98 22.42 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 63.32 112.348 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.69 -155.67 21.51 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 63.13 112.435 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -92.12 140.34 29.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 73.33 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.536 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -154.17 -89.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.676 -0.773 . . . . 62.31 112.463 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -75.36 -25.16 57.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 64.15 110.823 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 86' ' ' HIS . 52.9 p -147.26 -168.3 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 75.54 111.189 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 114' ' ' LEU . 42.4 tt0 -86.37 -15.2 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 74.43 110.798 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.7 ' OD1' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -138.42 23.06 2.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 63.02 110.803 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.687 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -55.05 130.42 41.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 64.3 110.882 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 84' ' ' ILE . 2.0 pt -135.0 172.77 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 75.43 111.125 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 143' ' ' PHE . 16.8 m -128.92 128.32 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 70.12 111.066 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.725 ' O ' HD12 ' A' ' 164' ' ' LEU . 95.8 t -81.82 132.15 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 73.25 111.06 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -118.76 131.91 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 74.22 110.908 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.908 HD11 HD21 ' A' ' 46' ' ' LEU . 11.5 mt -113.45 98.28 46.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.644 0.735 . . . . 65.11 110.899 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.8 Cg_endo -69.87 -4.41 14.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 75.44 112.384 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -82.67 -23.92 33.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.11 110.843 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.72 14.11 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.911 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.6 m120 54.46 27.74 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 72.54 110.895 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.557 HD13 HD13 ' A' ' 21' ' ' LEU . 96.7 mt -93.46 130.26 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 75.11 111.079 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 156' ' ' VAL . 50.0 tp -114.74 150.75 34.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.938 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 55' ' ' VAL . 21.9 t -119.21 75.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.46 . . . . 72.51 111.069 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.54 -45.97 53.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 70.25 112.495 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 74.79 -161.26 53.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.747 . . . . 73.21 112.417 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 12.8 m -51.41 -34.73 35.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 62.42 110.803 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.687 HD13 ' OD1' ' A' ' 153' ' ' ASN . 21.9 tp -51.64 -39.78 58.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.966 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 219' ' ' LEU . 17.3 t -104.65 111.31 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 74.3 111.07 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.551 ' HG3' HD12 ' A' ' 225' ' ' LEU . 9.9 mmpt? -53.49 155.76 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.883 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.7 p -101.78 160.44 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 62.51 110.845 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.4 t -51.28 -29.73 15.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 72.31 111.112 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.8 m -98.25 39.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 44.23 110.787 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -117.98 150.97 38.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 43.41 111.184 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.64 -3.32 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 54.43 110.931 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.21 176.24 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 54.32 110.821 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 226' ' ' LEU . 4.6 mt -83.51 -30.94 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 50.04 110.964 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.405 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 92.69 -164.69 27.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.669 -0.777 . . . . 63.22 112.505 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -51.94 110.31 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 73.41 110.93 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.495 HG11 ' CG2' ' A' ' 186' ' ' VAL . 30.3 m -97.1 26.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 64.44 111.117 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.99 68.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 54.11 111.089 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -110.76 6.14 21.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 74.33 110.822 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -114.56 162.91 16.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 75.24 111.024 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -121.95 92.16 3.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.933 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.495 ' CG2' HG11 ' A' ' 181' ' ' VAL . 24.6 t -58.54 -20.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 63.4 111.191 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -73.92 -20.26 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 73.34 110.911 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.63 -17.42 10.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 61.12 110.949 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.576 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -53.76 -61.25 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.3 110.923 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.771 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -54.53 -24.75 22.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.837 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.0 m -81.13 -29.91 34.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 42.44 111.167 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.28 -43.97 39.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.856 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 219' ' ' LEU . 35.3 mm -60.64 -47.25 93.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 75.31 111.173 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.462 ' HG2' HD21 ' A' ' 223' ' ' LEU . 2.0 mm-40 -56.15 -27.91 56.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.856 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -77.14 -22.46 52.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.03 110.826 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 192' ' ' SER . 18.2 t -85.47 -10.22 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.072 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.95 -8.06 13.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 54.34 110.926 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -31.16 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.887 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -104.47 -55.34 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 64.41 110.937 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -95.91 39.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.236 -0.438 . . . . 62.2 110.913 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -56.42 -47.69 78.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 61.31 110.888 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -60.72 102.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.901 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.7 HG21 HG22 ' A' ' 206' ' ' VAL . 37.6 mt -144.76 129.55 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.31 111.131 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.69 -24.75 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 65.44 110.907 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.21 126.66 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.15 111.111 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.712 ' HB ' HD12 ' A' ' 218' ' ' LEU . 87.0 t -107.14 129.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 74.14 111.177 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 213' ' ' VAL . 16.4 t -104.41 111.63 65.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 52.21 111.093 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.82 -173.25 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 70.25 112.231 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.95 -12.21 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 72.43 112.47 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -152.56 131.28 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 73.23 110.853 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.23 -119.99 5.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.767 -0.73 . . . . 60.1 112.473 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.16 172.26 13.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 74.51 110.881 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 207' ' ' VAL . 4.8 m -61.06 164.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.084 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.64 -115.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.714 . . . . 71.33 112.538 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.21 -169.97 3.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.377 . . . . 64.45 110.839 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -19.92 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 64.24 110.908 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.524 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.1 -18.22 47.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.721 . . . . 74.32 112.438 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.0 mt -72.12 -31.78 66.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 70.25 110.932 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.554 ' HA ' HG13 ' A' ' 170' ' ' VAL . 4.1 mm? -64.41 -58.62 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.959 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.524 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -60.21 -19.66 55.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.884 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.593 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.9 OUTLIER -63.41 -44.02 95.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.827 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.866 HG22 HD23 ' A' ' 226' ' ' LEU . 16.1 m -57.11 -52.77 63.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 53.13 111.18 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.75 HD23 ' OG ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -60.32 -25.04 65.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 62.52 110.903 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -75.22 -11.75 60.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 74.41 110.887 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.593 HD11 ' CE1' ' A' ' 221' ' ' HIS . 9.7 mt -119.07 -15.56 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.22 110.871 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.866 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -113.31 2.22 15.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 65.35 110.903 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 55.54 110.846 179.837 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.833 0.349 . . . . 74.14 110.847 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.1 -69.85 0.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 71.35 110.911 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 61.7 100.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 64.5 110.939 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.68 148.32 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 63.44 111.105 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -123.88 155.66 37.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 72.34 110.853 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.78 -177.45 3.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 63.4 110.947 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -72.01 -68.37 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 73.12 111.09 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.4 t -49.52 147.25 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 72.33 111.128 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.69 103.33 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.33 111.088 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -122.08 116.87 25.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 73.12 110.872 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -62.46 166.72 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.895 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.23 -48.71 62.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.83 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 p -62.65 -36.7 83.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 63.14 111.206 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.34 14.56 63.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 70.34 112.572 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -80.4 -45.02 18.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 71.35 111.077 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' A' ' 67' ' ' LEU . 34.5 mt -102.55 107.98 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 74.05 111.077 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.2 p -113.14 137.01 52.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 71.05 110.887 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.778 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.5 mt -128.79 109.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 74.1 111.154 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -99.96 123.84 44.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.03 110.896 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -67.5 109.55 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 72.53 110.939 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.581 HD13 HD13 ' A' ' 163' ' ' ILE . 14.1 mt -63.62 -32.49 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.888 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.11 -97.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 65.11 110.843 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.15 9.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.969 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.55 6.47 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 75.2 110.859 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -150.96 140.48 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 72.21 111.158 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.778 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.8 m95 -127.7 -173.71 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.906 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG23 ' HG ' ' A' ' 21' ' ' LEU . 71.0 t -137.83 92.87 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.175 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -77.52 120.54 22.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.861 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.4 m -115.29 98.57 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 61.54 111.185 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.01 117.27 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 71.22 110.947 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.746 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -84.18 116.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.858 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.13 -141.32 8.13 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.731 . . . . 72.24 112.499 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 178.99 89.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.412 . . . . 75.12 110.866 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.23 84.21 3.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.064 -0.516 . . . . 73.1 110.899 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.0 m120 66.61 12.56 8.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.083 -0.508 . . . . 75.03 110.94 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.73 -16.83 4.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 62.3 112.526 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -91.22 114.02 26.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 64.31 110.879 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -56.61 123.6 15.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 73.33 111.118 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.75 84.31 12.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.527 0.68 . . . . 74.32 111.162 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.658 2.238 . . . . 53.03 112.389 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.56 102.16 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 53.41 110.799 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.81 170.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.067 -0.515 . . . . 74.35 110.911 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -158.0 8.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 71.53 112.501 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.588 HD21 HD12 ' A' ' 158' ' ' LEU . 13.2 tp -156.18 113.49 3.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 54.43 110.87 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.641 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -99.25 113.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 63.35 111.161 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 158' ' ' LEU . 18.9 mt -93.63 119.27 32.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 53.12 110.915 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -88.81 84.49 6.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.822 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -172.54 2.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 53.02 111.091 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -105.34 -25.79 12.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 63.41 110.906 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.4 -13.35 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.886 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.83 155.44 6.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 64.33 112.504 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HB3' HG22 ' A' ' 79' ' ' VAL . 11.2 tp -64.87 157.82 26.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 70.02 110.842 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 81' ' ' ASP . 17.1 t -146.5 142.37 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 61.41 111.145 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.649 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.7 mt -139.32 120.52 14.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.904 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.59 111.81 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.12 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.92 128.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 71.33 110.9 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.673 ' CB ' HD11 ' A' ' 98' ' ' LEU . 3.3 p -71.96 -164.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 71.22 110.906 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -93.08 171.67 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 70.44 110.898 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.627 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.8 m95 -55.53 -60.69 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 72.05 110.92 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.19 157.63 34.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 74.35 110.817 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -51.86 -39.97 59.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 74.41 110.889 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -53.42 -41.1 65.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 65.12 110.894 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 59' ' ' TRP . 93.9 mt -75.97 -45.55 34.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 62.22 110.924 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.403 HG21 HD21 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -50.97 -48.83 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.35 111.132 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -52.46 -50.01 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 65.25 110.906 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -64.06 -19.71 65.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 73.23 110.806 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.6 tp -89.18 -26.21 21.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 61.33 110.84 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.407 HG23 ' OE1' ' A' ' 72' ' ' GLU . 58.5 mt -91.18 -23.07 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 71.12 111.103 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.05 15.4 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.875 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.2 ptm -130.43 -40.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.23 110.94 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.3 m -80.67 -21.7 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 64.32 111.146 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.569 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -69.04 -23.01 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 63.44 110.884 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.8 -33.07 7.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 45.43 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -43.52 67.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 62.42 110.859 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.571 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 18.6 m-85 -87.1 -10.66 52.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.827 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.19 12.45 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 54.41 110.919 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.19 140.4 48.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 74.32 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.0 137.15 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 62.03 110.954 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.569 HG23 ' OE2' ' A' ' 72' ' ' GLU . 89.5 t -75.56 117.51 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 71.23 111.1 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -133.09 10.95 4.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 55.44 110.996 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.533 ' N ' HG23 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -155.83 137.88 14.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 52.31 110.832 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 54' ' ' LEU . 13.1 t -146.15 129.15 9.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 75.45 111.065 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.628 HD11 ' HE2' ' A' ' 135' ' ' PHE . 28.6 mt -92.95 125.21 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 70.3 111.104 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -94.24 158.36 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.08 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.7 p -115.31 -39.88 3.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 71.23 111.148 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.57 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -159.22 -174.36 4.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.824 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -102.32 97.37 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 41.25 111.127 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.98 154.96 26.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 64.4 110.932 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.64 -19.7 28.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 65.24 111.175 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.66 14.3 13.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 71.31 110.897 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -135.32 -76.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.53 110.973 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -92.35 11.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 74.24 111.079 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.81 -34.03 14.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.769 . . . . 73.21 112.483 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.38 17.77 23.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 60.04 112.497 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.5 tt -58.09 -33.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 75.1 111.085 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -55.82 -24.2 34.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.256 -0.429 . . . . 64.34 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m -95.84 -12.25 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 61.42 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 57' ' ' SER . 16.8 mt -90.01 -30.6 17.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.901 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -88.09 -6.65 57.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 64.45 110.914 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -91.53 -52.7 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 64.11 110.966 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -61.86 -60.65 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.13 110.952 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.09 40.0 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.753 -0.737 . . . . 44.23 112.502 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.632 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.4 mp -108.04 140.08 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 72.53 111.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 124' ' ' LEU . 5.0 mtmm -98.17 110.33 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 72.01 110.914 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.48 9.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 72.43 111.09 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.587 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.0 m-70 -72.83 145.21 47.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.89 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -173.75 -175.12 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.04 110.919 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.41 154.96 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 54.21 111.21 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.08 39.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 54.43 111.036 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.755 HD12 ' HG2' ' A' ' 113' ' ' GLU . 61.2 tp -67.34 -41.63 84.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.89 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 86.9 m -61.96 -16.8 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 54.45 111.121 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.632 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -104.06 11.71 34.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 25.45 111.14 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.755 ' HG2' HD12 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -111.35 -26.07 9.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 54.44 110.767 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -100.25 -9.49 22.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.976 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.34 -36.88 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.31 111.057 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -28.14 60.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 71.2 110.983 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -55.44 -35.36 65.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 63.22 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -86.14 -25.65 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 30.05 110.941 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.73 14.6 4.69 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 35.25 112.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 92' ' ' ILE . 69.7 m-85 -95.1 177.36 5.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 74.11 110.977 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.523 ' CG ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.24 -171.86 3.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 54.13 110.853 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.1 mt-10 -115.49 111.95 43.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.72 0.772 . . . . 65.32 110.878 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.2 Cg_endo -69.66 -178.89 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.772 2.314 . . . . 64.33 112.32 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 106' ' ' HIS . 31.4 mt -53.57 -43.87 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.932 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.76 27.78 21.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 62.43 112.463 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -101.19 31.31 3.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 73.1 110.825 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.56 HD22 HD21 ' A' ' 133' ' ' LEU . 62.7 mt -116.13 -175.21 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 44.54 110.964 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.66 -170.93 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 72.52 110.894 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 130' ' ' VAL . 41.2 m -50.43 -70.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 72.45 111.034 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.906 HG23 HG22 ' A' ' 129' ' ' THR . 41.0 t -118.08 105.86 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 63.12 111.118 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -138.82 166.78 23.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.32 111.169 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -113.83 134.04 55.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.788 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.56 HD21 HD22 ' A' ' 127' ' ' LEU . 25.1 mt -113.08 167.46 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.933 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.48 134.39 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 71.23 110.939 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.628 ' HE2' HD11 ' A' ' 83' ' ' ILE . 51.4 m-85 -137.21 36.15 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 75.01 110.869 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.74 93.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.736 . . . . 54.12 112.518 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.4 m120 65.55 13.67 9.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 74.22 110.917 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.7 tpp -135.37 105.34 6.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.941 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -96.45 130.62 43.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 74.5 110.879 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.843 HG22 HD21 ' A' ' 158' ' ' LEU . 20.7 t -135.67 117.39 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 74.42 111.13 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.99 129.5 55.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 53.4 110.89 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.36 -176.29 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 70.23 111.185 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.452 ' HD1' HG22 ' A' ' 130' ' ' VAL . 22.6 t80 -166.74 133.4 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 70.32 110.929 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.695 ' HB3' HG23 ' A' ' 129' ' ' THR . 10.0 t80 -124.07 89.26 51.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.727 0.775 . . . . 72.24 110.941 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 52.7 Cg_endo -69.81 -21.75 32.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 64.13 112.33 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.18 -157.64 27.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 53.54 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -88.02 138.14 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 72.13 110.837 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.23 -88.82 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 54.01 112.494 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -75.48 -25.62 57.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 72.54 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 86' ' ' HIS . 34.3 p -146.82 -165.33 2.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 74.52 111.166 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HG2' HD21 ' A' ' 110' ' ' LEU . 5.1 tt0 -85.85 -19.67 30.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 75.13 110.89 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.536 ' OD1' HD23 ' A' ' 110' ' ' LEU . 9.4 t0 -137.87 24.27 2.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 73.43 110.863 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.595 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -53.83 129.29 33.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.837 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.474 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.9 pt -135.21 174.47 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 64.04 111.105 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.8 m -127.19 136.24 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.14 111.161 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.5 121.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.4 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -110.02 139.14 45.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.509 . . . . 63.11 110.947 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.843 HD21 HG22 ' A' ' 140' ' ' VAL . 21.1 mt -120.14 99.21 48.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.529 0.68 . . . . 75.12 110.914 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.62 -4.53 14.12 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.711 2.274 . . . . 72.41 112.382 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -85.73 -22.81 27.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 62.13 110.937 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.3 12.15 2.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.97 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.36 25.17 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 52.5 110.939 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.581 HD13 HD13 ' A' ' 21' ' ' LEU . 95.3 mt -89.04 142.34 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 62.32 111.1 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 57.7 tp -122.32 156.39 33.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.3 t -123.56 74.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 64.15 111.157 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.99 -41.71 52.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.732 -0.747 . . . . 73.21 112.458 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.66 -162.54 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 71.22 112.494 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 16.7 m -51.84 -34.51 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 45.43 110.882 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.735 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.2 tp -51.76 -41.35 61.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.878 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 219' ' ' LEU . 18.1 t -100.83 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.116 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.3 OUTLIER -51.5 147.85 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.924 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.4 p -98.29 159.64 14.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.43 110.926 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t -56.89 -24.59 53.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.172 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.9 t -96.87 34.5 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.787 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -129.09 152.28 48.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 45.21 111.081 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.41 2.12 10.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 60.12 110.971 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.76 175.84 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.31 110.878 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.734 HD11 ' CB ' ' A' ' 226' ' ' LEU . 5.8 mt -82.89 -32.8 27.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 51.21 110.907 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.32 -162.44 27.03 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 44.41 112.562 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -51.97 113.06 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 75.21 110.927 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.643 HG11 ' CG2' ' A' ' 186' ' ' VAL . 26.9 m -99.69 26.24 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 73.21 111.138 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.13 -35.06 66.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 75.3 111.107 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -111.1 4.71 19.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 71.53 110.824 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -112.41 162.14 15.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 63.13 111.057 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.14 92.43 3.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 74.21 110.942 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.643 ' CG2' HG11 ' A' ' 181' ' ' VAL . 11.1 t -62.86 -18.43 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 72.24 111.165 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.62 -20.67 58.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 73.23 110.952 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.6 -14.72 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 73.25 110.887 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.735 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.4 t90 -55.0 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.498 . . . . 75.12 110.853 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.742 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.97 -24.75 17.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.841 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -81.56 -31.46 32.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 71.33 111.127 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -73.67 -43.82 58.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 63.23 110.886 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.26 -44.61 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 75.31 111.18 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.97 -23.83 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.872 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.14 -21.43 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.758 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.455 HG12 HD21 ' A' ' 219' ' ' LEU . 11.5 t -87.97 -9.56 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.54 111.151 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.43 -8.5 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.881 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -104.11 -31.08 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 73.44 110.809 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 -53.84 2.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.48 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -98.1 60.3 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 74.02 110.868 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -72.57 -59.48 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 61.23 110.901 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -52.13 102.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 65.33 110.904 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.701 HG21 HG22 ' A' ' 206' ' ' VAL . 59.0 mt -139.43 116.72 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.32 111.138 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.95 -22.74 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.833 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.97 129.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 71.3 111.088 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.712 ' HB ' HD12 ' A' ' 218' ' ' LEU . 88.1 t -102.22 130.86 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 33.43 111.073 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 213' ' ' VAL . 11.4 t -107.92 103.75 50.89 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.568 0.699 . . . . 73.31 111.077 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.7 Cg_endo -69.83 -170.64 0.41 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.736 2.291 . . . . 73.24 112.311 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.49 -11.74 59.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.838 -0.696 . . . . 54.21 112.57 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.44 144.43 23.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 65.04 110.881 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 100.77 -102.31 2.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.793 -0.718 . . . . 74.4 112.431 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -170.86 159.52 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.41 . . . . 72.04 110.905 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 207' ' ' VAL . 6.0 m -53.39 163.29 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.13 111.176 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.78 -99.68 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 43.41 112.514 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -167.29 -168.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 65.44 110.825 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -20.25 42.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 63.31 110.961 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.516 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -54.17 -23.73 26.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 33.24 112.473 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.6 mt -73.17 -34.7 66.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 51.13 110.956 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.649 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.6 mp -59.84 -59.34 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 75.12 110.964 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.516 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -59.54 -20.58 56.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.282 -0.417 . . . . 74.04 110.911 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -66.62 -34.35 77.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.22 110.811 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.796 HG22 HD23 ' A' ' 226' ' ' LEU . 7.7 m -62.52 -55.54 26.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 72.4 111.152 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -20.95 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 63.31 110.924 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.09 -12.11 60.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 63.22 110.879 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.576 HD12 ' HG3' ' A' ' 171' ' ' LYS . 7.7 mt -119.88 -26.34 5.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 53.32 110.935 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.796 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 61.33 110.964 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 mttt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.83 179.808 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.833 0.349 . . . . 61.32 110.814 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 63.14 163.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.84 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -166.75 150.98 7.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 63.31 110.897 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -104.05 148.03 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 74.43 111.112 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.0 167.66 21.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 61.31 110.846 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.1 mtmm -118.23 174.14 6.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.34 110.87 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.5 m -51.61 -54.09 31.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 74.21 111.127 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.3 m -58.11 -175.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 74.23 111.074 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.19 94.05 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 44.01 111.137 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -112.49 117.35 32.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.947 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -61.82 170.21 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 63.41 110.918 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.032 0.444 . . . . 72.12 110.899 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.7 p -60.98 -38.51 86.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 74.31 111.119 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.77 13.88 62.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.799 -0.715 . . . . 65.13 112.563 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.4 m -83.45 -35.56 24.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.363 . . . . 60.44 111.216 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -110.08 122.5 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 74.2 111.109 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 p -129.86 128.79 42.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 73.13 110.776 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.697 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -122.5 112.95 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 62.03 111.15 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.423 ' HA ' HG12 ' A' ' 8' ' ' VAL . 16.8 t -99.09 129.11 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 62.04 110.87 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -72.91 111.14 7.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 63.45 110.933 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.04 HD21 HG11 ' A' ' 213' ' ' VAL . 22.8 mt -64.62 -32.54 74.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.854 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.84 -97.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 71.43 110.874 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -150.3 9.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 75.13 110.904 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.46 7.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 72.04 110.977 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.86 141.14 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 71.44 111.112 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.697 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.0 m95 -129.52 -179.42 5.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 74.35 110.929 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.529 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.7 t -131.43 90.2 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 53.1 111.118 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.409 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.9 p80 -74.15 125.19 27.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 62.32 110.907 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -124.45 105.54 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 63.53 111.181 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.685 ' CD ' HD22 ' A' ' 67' ' ' LEU . 19.5 mp0 -91.64 124.39 35.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 72.54 110.869 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.889 HD21 ' HB1' ' A' ' 38' ' ' ALA . 2.3 mt -80.32 127.55 32.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 64.33 110.905 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.28 -19.91 56.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.87 -0.681 . . . . 63.0 112.491 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 94.3 p 49.46 89.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.941 0.4 . . . . 71.42 110.918 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.15 -160.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 75.43 110.988 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -71.03 66.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 45.23 110.864 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.84 9.46 54.34 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.703 -0.76 . . . . 73.45 112.447 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -128.85 174.56 9.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.341 . . . . 73.31 110.884 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.889 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -112.77 122.67 48.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.133 -0.485 . . . . 53.44 111.127 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.473 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.0 t -113.13 74.76 1.95 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.666 0.746 . . . . 63.23 111.212 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.46 6.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.243 . . . . 72.04 112.336 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -101.55 89.09 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 53.33 110.877 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -56.66 158.66 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.42 110.877 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.94 -146.9 4.51 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.737 -0.744 . . . . 64.33 112.523 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.2 tp -160.22 117.32 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.84 0.352 . . . . 63.53 110.891 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.677 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.43 122.36 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.54 111.171 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 158' ' ' LEU . 16.6 mt -100.0 119.14 37.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 62.01 110.942 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -89.31 86.68 6.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.439 . . . . 75.44 110.945 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.2 p -99.83 -172.31 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 72.34 111.212 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -20.76 12.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.823 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -86.89 -13.34 45.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 73.41 110.848 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.51 4.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 60.01 112.43 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 79' ' ' VAL . 9.4 tp -63.13 156.01 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 73.55 110.994 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.31 142.59 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.55 111.087 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.677 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -138.07 125.03 21.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 75.25 110.854 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.41 HG11 HG11 ' A' ' 165' ' ' VAL . 74.5 t -70.45 111.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 53.02 111.134 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.57 138.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 65.54 110.833 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.694 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.9 p -81.21 -164.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 71.43 110.816 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.405 ' H ' HG23 ' A' ' 64' ' ' THR . 6.7 t -95.36 168.34 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.909 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.7 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.8 m95 -50.32 -59.94 3.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 74.1 110.929 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -128.13 158.92 36.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.83 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -52.08 -34.75 45.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.891 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -57.5 -36.31 71.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 71.11 110.921 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.8 mt -82.82 -46.64 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 72.24 110.971 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.67 -47.57 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.1 111.143 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -53.18 -50.36 64.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.887 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.56 -19.04 65.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.939 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.685 HD22 ' CD ' ' A' ' 30' ' ' GLU . 16.1 tp -88.59 -26.16 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 75.52 110.862 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.17 -23.34 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 73.44 111.151 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.17 15.2 14.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 73.32 110.916 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.5 ptm -129.83 -39.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 75.21 110.879 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 67' ' ' LEU . 31.9 m -80.44 -22.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 63.13 111.113 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.588 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.35 -24.02 64.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 44.21 110.836 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -106.37 -33.23 7.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 71.51 110.942 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -70.21 -42.26 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 62.43 110.885 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -89.34 -11.17 44.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.874 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.95 12.03 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.924 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.67 139.56 50.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.877 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -85.45 138.62 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.97 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 54' ' ' LEU . 72.8 t -79.18 122.29 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.4 111.093 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -137.33 8.14 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 53.42 111.215 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 82' ' ' VAL . 57.2 m-20 -149.89 145.84 26.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 71.32 110.941 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 54' ' ' LEU . 3.4 t -155.7 131.68 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 63.23 111.069 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.584 ' CD1' HG11 ' A' ' 140' ' ' VAL . 22.0 mt -86.18 133.96 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.53 111.15 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.004 HD11 ' HB1' ' A' ' 105' ' ' ALA . 4.8 mm -98.96 148.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 72.22 111.125 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 79.8 p -114.57 -39.19 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 65.11 111.162 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.502 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.1 p-80 -166.84 177.03 6.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 72.02 110.834 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -96.75 83.45 3.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 72.43 111.173 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 71.02 110.839 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.46 -22.03 7.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 75.2 111.078 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.06 19.69 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 44.13 110.919 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.894 ' NE ' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -144.33 -70.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.868 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.718 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.76 3.55 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 75.31 111.146 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.84 -45.12 49.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 62.13 112.565 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.14 15.17 60.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 75.55 112.425 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.554 HD12 HH22 ' A' ' 91' ' ' ARG . 2.8 tt -55.4 -28.48 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.879 0.371 . . . . 62.14 111.08 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -21.84 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 73.34 110.929 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -98.58 -14.57 19.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 64.41 111.191 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 57' ' ' SER . 14.5 mt -89.53 -35.85 15.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 72.42 110.92 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -94.44 23.97 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.85 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -124.94 -43.37 1.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 74.02 110.784 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -81.59 -52.51 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 72.51 110.891 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.27 41.01 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.713 -0.756 . . . . 60.12 112.485 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.9 mp -109.59 112.82 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 72.14 111.132 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.781 ' HE2' HD21 ' A' ' 124' ' ' LEU . 3.0 mtpp -79.79 116.65 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 63.12 110.92 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 1.004 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -89.2 90.15 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.429 . . . . 75.52 111.114 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.42 ' HA ' HD12 ' A' ' 124' ' ' LEU . 45.9 m-70 -63.09 113.97 3.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.87 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.21 -174.71 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 64.5 110.849 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.68 157.14 16.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 72.22 111.133 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.08 -40.94 33.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 63.33 111.101 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -35.65 74.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 71.41 110.968 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.568 ' HA ' HD11 ' A' ' 114' ' ' LEU . 75.4 m -63.77 -21.54 66.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 64.1 111.129 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -102.37 11.63 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 45.2 111.154 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.79 -24.38 12.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 64.23 110.868 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -104.34 -7.4 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 71.31 110.958 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.63 -41.04 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.197 -0.456 . . . . 42.31 111.052 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -24.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.93 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -33.57 71.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 73.12 110.857 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -87.81 -22.87 24.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.841 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.45 23.15 4.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.795 -0.717 . . . . 74.44 112.57 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.54 -177.64 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 73.44 110.92 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -79.65 -172.19 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 74.03 110.895 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.47 112.99 32.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 75.31 110.915 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.3 Cg_endo -69.81 -170.28 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 72.11 112.27 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.781 HD21 ' HE2' ' A' ' 104' ' ' LYS . 14.0 mt -60.63 -51.52 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 61.14 110.899 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.81 18.22 45.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 43.3 112.489 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -96.79 33.01 1.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 71.13 110.847 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 131' ' ' THR . 80.7 mt -119.09 -175.09 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 73.5 110.944 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -151.68 -170.74 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 73.13 110.911 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.821 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.02 -70.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 63.44 111.138 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.821 HG23 HG22 ' A' ' 129' ' ' THR . 38.7 t -116.6 96.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 74.2 111.148 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.582 HG21 HD22 ' A' ' 127' ' ' LEU . 14.5 t -117.78 169.37 9.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 71.23 111.167 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.21 103.9 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.931 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD21 ' CD2' ' A' ' 127' ' ' LEU . 29.1 mt -80.04 165.44 22.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.1 110.918 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -151.77 112.06 4.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.779 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.02 69.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.932 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.63 -93.29 0.3 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.834 -0.698 . . . . 45.54 112.42 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -110.01 24.39 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 75.13 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.414 ' HB2' HG22 ' A' ' 48' ' ' THR . 50.9 tpp -132.48 135.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.886 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.86 130.53 56.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 72.4 110.989 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.612 HG22 ' CD2' ' A' ' 158' ' ' LEU . 8.3 t -139.59 121.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 72.41 111.124 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.31 126.07 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 72.42 110.898 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.8 p -83.34 -174.66 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.11 111.051 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.509 ' HD1' HG22 ' A' ' 130' ' ' VAL . 36.6 t80 -170.66 139.72 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 62.43 110.894 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.708 ' HB3' HG23 ' A' ' 129' ' ' THR . 88.6 t80 -125.78 89.02 53.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.737 0.78 . . . . 61.13 110.976 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.6 Cg_endo -69.76 -8.05 22.61 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.291 . . . . 64.24 112.33 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.59 -149.04 19.42 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.673 -0.775 . . . . 74.42 112.448 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -98.47 140.22 33.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 63.34 110.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.06 -93.19 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.744 -0.741 . . . . 51.13 112.538 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.59 -23.66 61.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 75.22 110.83 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 86' ' ' HIS . 55.2 p -151.71 -175.35 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.33 111.124 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 114' ' ' LEU . 32.6 tt0 -85.16 -3.38 58.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 70.33 110.855 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.477 ' OD2' HG23 ' A' ' 111' ' ' THR . 7.4 p-10 -141.66 13.78 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 75.24 110.832 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.6 141.56 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.88 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.704 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.7 pt -146.91 176.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.3 111.078 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.485 HG12 ' HA2' ' A' ' 166' ' ' GLY . 22.1 m -132.53 129.02 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 74.42 111.11 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.9 t -86.84 133.1 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.33 111.101 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -120.16 137.48 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 71.42 110.951 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.612 ' CD2' HG22 ' A' ' 140' ' ' VAL . 41.6 mt -119.5 99.28 50.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.647 0.737 . . . . 72.34 110.945 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -3.13 11.36 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 63.32 112.407 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -86.54 -24.6 25.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 65.43 110.827 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.32 13.01 2.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.942 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.4 m120 54.18 25.42 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.0 110.942 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.698 HD13 HD13 ' A' ' 21' ' ' LEU . 95.7 mt -89.69 133.45 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 62.52 111.162 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.633 HD22 HD13 ' A' ' 203' ' ' ILE . 6.0 tp -121.68 140.62 52.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 75.45 110.931 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.41 HG11 HG11 ' A' ' 55' ' ' VAL . 21.7 t -113.42 75.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 72.11 111.193 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.485 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -52.06 -35.88 42.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.692 -0.765 . . . . 72.52 112.607 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.27 -157.9 53.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.817 -0.706 . . . . 72.44 112.51 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 98.0 m -50.7 -33.68 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 61.31 110.922 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.616 HD12 ' NE1' ' A' ' 189' ' ' TRP . 60.4 tp -52.45 -37.83 57.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.936 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 219' ' ' LEU . 86.0 t -105.75 108.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.11 111.127 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -50.78 168.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 71.3 110.904 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.502 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -119.88 160.16 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.2 110.807 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 t -50.98 157.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 71.14 111.146 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m 69.46 11.78 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 64.03 110.817 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 225' ' ' LEU . . . -84.77 143.06 29.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 73.13 111.064 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.523 ' C ' HD22 ' A' ' 225' ' ' LEU . 0.1 OUTLIER -118.83 -13.27 9.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.925 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.483 ' N ' HD22 ' A' ' 225' ' ' LEU . 0.6 OUTLIER -179.03 154.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 75.11 110.93 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' A' ' 226' ' ' LEU . 12.0 mt -59.4 -47.16 86.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 61.24 110.894 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.8 125.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.796 -0.716 . . . . 53.52 112.514 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.29 103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 64.32 110.933 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.76 20.34 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 74.35 111.134 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.78 -42.93 97.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.127 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -100.89 23.95 9.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 70.01 110.942 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.08 163.29 31.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 52.52 111.095 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.94 92.66 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 72.35 110.898 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.12 -25.95 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.0 111.089 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -69.5 -32.26 71.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.32 110.885 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.19 -14.44 18.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.4 110.849 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.616 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.9 t90 -57.34 -61.83 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.54 110.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.751 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.8 -24.46 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.33 110.873 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.6 m -80.15 -33.64 38.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 75.3 111.169 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.49 -43.01 64.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.803 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.9 -47.17 92.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 64.11 111.175 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.33 -28.5 63.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 65.01 110.905 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -77.94 -20.93 51.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 54.45 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 192' ' ' SER . 22.8 t -87.08 -11.44 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.205 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -110.36 -14.17 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 45.02 110.906 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.435 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -95.92 -30.95 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.964 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -103.46 -51.42 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 74.25 110.8 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -101.07 64.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 72.24 110.899 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -71.73 -59.9 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 74.2 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -50.97 107.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 70.2 110.854 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.662 HG21 HG22 ' A' ' 206' ' ' VAL . 91.3 mt -146.26 118.94 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 64.43 111.126 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.54 -29.6 52.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 72.44 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.706 ' HB1' ' CG2' ' A' ' 213' ' ' VAL . . . -159.65 146.4 16.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 52.21 111.118 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 218' ' ' LEU . 49.9 t -121.92 122.37 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 63.12 111.088 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.816 HG22 ' HB ' ' A' ' 213' ' ' VAL . 21.4 t -102.21 101.94 22.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.723 . . . . 74.1 111.148 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.539 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.4 Cg_endo -69.84 178.12 4.94 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 65.42 112.327 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.28 -17.97 76.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 63.31 112.536 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -152.52 148.98 28.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 74.2 110.915 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.9 -115.4 4.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.653 -0.784 . . . . 63.42 112.498 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -159.63 148.73 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 43.5 110.92 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.04 HG11 HD21 ' A' ' 21' ' ' LEU . 3.6 p -51.49 130.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 75.21 111.044 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -127.63 -98.13 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.689 -0.767 . . . . 35.13 112.443 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.84 -169.72 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.874 0.368 . . . . 71.1 110.918 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 219' ' ' LEU . 0.0 OUTLIER -62.05 -16.96 55.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.902 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.512 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.29 -18.96 37.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.806 -0.712 . . . . 53.1 112.406 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.4 mt -75.08 -45.58 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 73.33 110.945 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.649 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -53.32 -56.24 18.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 73.43 110.983 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.512 HD21 ' HA2' ' A' ' 217' ' ' GLY . 3.3 pp -59.39 -20.36 54.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 41.12 110.919 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.82 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.679 HG22 HD23 ' A' ' 226' ' ' LEU . 8.1 m -63.86 -56.75 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 55.32 111.132 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 190' ' ' SER . 2.4 mt -54.55 -29.78 52.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 72.22 110.955 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -29.22 61.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 75.13 110.898 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 175' ' ' ALA . 14.5 mt -92.42 -16.43 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 65.14 110.925 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.751 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -116.3 18.19 15.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 72.13 110.95 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 74.43 110.845 179.947 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.783 0.325 . . . . 65.11 110.885 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -169.24 103.84 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 63.2 110.89 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 139.94 53.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.929 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.4 m -85.54 -178.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 64.03 111.075 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.56 66.88 1.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 73.22 110.893 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -131.94 172.43 12.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 73.02 110.854 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -88.77 -68.61 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 45.53 111.162 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.58 147.25 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 54.3 111.157 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.442 HD13 ' HG2' ' A' ' 74' ' ' LYS . 22.1 mt -112.66 101.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.41 111.121 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -120.52 115.03 22.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.55 110.997 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -58.25 165.04 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 73.41 110.894 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -51.62 -48.51 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 72.01 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.9 p -61.15 -37.72 83.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 72.42 111.06 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.1 62.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 71.12 112.486 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.2 m -75.92 -45.36 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 72.32 111.115 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.47 123.25 54.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 63.52 111.16 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.5 p -127.22 133.56 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 41.33 110.84 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.778 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.9 mt -127.22 110.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 75.12 111.127 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -98.83 126.58 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 71.21 110.846 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -71.14 108.85 4.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.848 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.744 HD21 HG11 ' A' ' 213' ' ' VAL . 15.8 mt -62.07 -33.34 74.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.926 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.32 -96.74 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 71.42 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.87 9.7 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.849 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.61 6.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 70.44 110.906 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -151.0 140.81 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 61.52 111.122 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.778 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.9 m95 -128.51 -173.25 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 71.15 110.947 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.467 HG23 ' HG ' ' A' ' 21' ' ' LEU . 97.1 t -137.79 88.2 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.079 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.43 124.13 23.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 70.11 110.792 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -123.65 105.29 9.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 73.14 111.166 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.705 ' CD ' HD22 ' A' ' 67' ' ' LEU . 8.1 mp0 -91.89 125.8 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 62.34 110.864 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.636 HD21 ' HB1' ' A' ' 38' ' ' ALA . 3.2 mt -83.53 123.79 30.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 71.2 110.935 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.42 -49.04 3.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 75.4 112.443 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.93 111.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.905 0.383 . . . . 54.03 110.856 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.4 147.65 32.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 74.41 110.884 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 48.52 30.22 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 70.21 110.866 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.66 37.24 52.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.674 -0.774 . . . . 72.51 112.537 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -146.51 121.35 9.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.329 . . . . 61.44 110.95 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.636 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -53.55 141.93 24.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 65.25 111.093 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.462 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.2 t -135.99 74.72 56.22 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.579 0.704 . . . . 72.41 111.119 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 121.81 8.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.741 2.294 . . . . 63.04 112.373 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.5 p -103.95 88.16 2.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 74.42 110.934 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -58.33 156.8 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.11 110.968 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -150.81 -142.54 3.55 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.81 -0.71 . . . . 72.54 112.515 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.779 HD21 HD12 ' A' ' 158' ' ' LEU . 18.0 tp -160.68 116.97 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 73.02 110.822 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.669 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.7 t -100.94 122.82 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 62.34 111.114 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.753 HD21 HD11 ' A' ' 158' ' ' LEU . 17.7 mt -101.08 122.31 43.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 61.1 110.83 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -91.78 86.48 5.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.22 110.839 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.09 -174.59 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 73.31 111.135 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.3 t -105.69 -24.18 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 71.42 110.838 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -81.73 -10.63 59.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 65.42 110.867 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.39 153.78 5.99 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.702 -0.761 . . . . 54.05 112.53 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 79' ' ' VAL . 9.5 tp -67.86 154.59 41.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 71.33 110.889 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.5 t -142.09 137.44 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 73.1 111.096 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.669 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -136.29 121.73 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 44.21 110.914 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.47 HG12 ' CG ' ' A' ' 56' ' ' ASP . 60.1 t -66.82 111.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.54 111.104 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' CG ' HG12 ' A' ' 55' ' ' VAL . 1.3 m-20 72.56 146.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 73.42 110.939 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.713 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.5 p -85.52 -165.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 72.5 110.817 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.572 ' H ' HG23 ' A' ' 64' ' ' THR . 9.0 t -95.09 171.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 74.23 110.883 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.0 m95 -51.63 -60.07 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.34 110.952 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -129.5 159.59 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.917 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -51.37 -33.41 29.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 61.15 110.902 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.65 -38.92 79.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.868 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.2 mt -82.34 -46.01 14.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.51 110.902 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.89 -49.11 60.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 72.54 111.069 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.64 -51.47 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 73.33 110.911 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.41 -21.91 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 54.01 110.872 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.705 HD22 ' CD ' ' A' ' 30' ' ' GLU . 13.0 tp -84.64 -29.83 25.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 72.33 110.886 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.513 ' HA ' HG22 ' A' ' 71' ' ' VAL . 36.4 mt -88.72 -26.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 71.33 111.171 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.14 -0.12 47.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.942 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.8 ptm -116.58 -36.62 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 54.32 110.908 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 68' ' ' ILE . 33.5 m -78.23 -29.32 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 72.42 111.115 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.62 -32.31 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.892 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -97.2 -33.33 11.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 73.1 110.809 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HG2' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -70.34 -48.86 54.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 72.12 110.869 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 16.2 m-85 -84.18 -11.96 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.864 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.76 12.05 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 72.11 110.924 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -129.56 137.7 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 72.4 110.899 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -84.84 136.18 33.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 55.41 110.865 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 54' ' ' LEU . 57.5 t -76.6 128.98 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 73.31 111.087 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 t -146.53 14.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 74.12 111.082 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.6 ' O ' HG13 ' A' ' 53' ' ' VAL . 11.5 m-20 -159.58 136.04 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 64.24 110.871 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.14 153.17 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 75.13 111.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.558 HG21 HG22 ' A' ' 156' ' ' VAL . 4.1 mt -103.11 143.55 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 72.43 111.11 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.019 HD11 ' HB1' ' A' ' 105' ' ' ALA . 4.5 mm -106.02 145.97 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 72.23 111.164 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.2 p -112.32 -37.28 5.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 64.14 111.224 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.589 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.9 p-80 -168.41 177.97 5.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 73.4 110.807 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.943 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -96.02 79.63 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.31 111.158 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -137.69 155.35 49.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 71.24 110.897 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -20.62 10.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 63.22 111.012 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.99 11.45 18.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 53.12 110.913 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.894 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -135.97 -70.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.825 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.71 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -88.9 2.87 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 73.21 111.163 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.02 -45.78 41.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.734 . . . . 73.35 112.517 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.19 15.91 57.43 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 74.44 112.55 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.707 HD12 HH22 ' A' ' 91' ' ' ARG . 2.7 tt -52.87 -28.93 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 61.41 111.136 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.532 ' HD3' HG23 ' A' ' 95' ' ' ILE . 29.4 mmtm -59.07 -28.38 66.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 73.45 110.895 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 m -88.22 -16.59 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 73.02 111.17 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.723 ' HA ' HD13 ' A' ' 103' ' ' ILE . 10.4 mt -90.38 -41.9 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.885 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -79.51 -5.34 54.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.915 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.06 -54.99 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.845 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -64.04 -62.27 1.73 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.859 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 152.92 39.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 43.02 112.497 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -97.57 139.21 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.11 111.202 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -96.67 111.0 23.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 65.25 110.931 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 1.019 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -90.89 93.7 9.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.044 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.489 ' HB3' HD11 ' A' ' 127' ' ' LEU . 37.6 m-70 -66.49 113.85 5.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.282 -0.417 . . . . 74.15 110.865 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.45 179.67 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 63.31 110.838 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.87 157.58 17.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 64.52 111.1 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.55 -40.14 51.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 50.44 111.168 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.681 HD23 ' OD1' ' A' ' 152' ' ' ASP . 22.5 tp -75.14 -39.45 60.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 62.02 110.937 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.738 ' HA ' HD11 ' A' ' 114' ' ' LEU . 82.8 m -58.62 -21.81 54.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 73.35 111.136 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.529 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -96.06 -0.63 50.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 72.12 111.054 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -52.76 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 63.35 110.84 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.943 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.28 -13.53 60.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 73.3 110.925 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.414 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.55 -45.25 72.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 53.2 111.0 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.79 63.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -34.14 71.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.256 -0.429 . . . . 72.33 110.873 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -90.5 -19.1 24.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 44.25 110.894 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 24.62 5.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 72.55 112.561 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -99.66 177.82 5.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.864 0.364 . . . . 72.21 110.895 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -76.39 -172.95 2.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 70.31 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.11 113.8 32.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.686 0.755 . . . . 61.14 110.882 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.1 Cg_endo -69.9 -168.33 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.595 2.196 . . . . 75.34 112.342 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.74 -44.36 93.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.21 110.913 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 54.79 25.29 36.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 60.52 112.434 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -108.0 36.25 2.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.915 0.388 . . . . 72.14 110.903 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 106' ' ' HIS . 63.9 mt -122.57 -174.47 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.928 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.38 -170.05 3.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 73.41 110.912 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.853 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.08 -69.95 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.431 . . . . 50.41 111.14 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 HG22 ' A' ' 129' ' ' THR . 34.3 t -118.51 99.75 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 63.34 111.138 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.434 HG21 HD22 ' A' ' 127' ' ' LEU . 14.0 t -127.91 174.8 8.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 54.44 111.144 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.47 133.92 53.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 65.45 110.93 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 127' ' ' LEU . 39.0 mt -112.35 179.44 3.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 75.14 110.894 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 126.64 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.817 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -130.24 54.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 75.53 110.842 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.58 90.31 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 25.42 112.52 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.1 m120 64.39 14.72 9.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 73.45 110.896 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.0 tpp -133.91 97.57 3.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.15 110.936 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 136.49 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.954 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.686 HG22 HD21 ' A' ' 158' ' ' LEU . 21.7 t -139.04 117.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 73.24 111.052 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -109.11 129.96 55.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 71.41 110.883 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.8 p -85.37 -171.64 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 73.15 111.222 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -170.69 134.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 70.44 110.845 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.652 ' HB3' HG23 ' A' ' 129' ' ' THR . 76.9 t80 -123.22 88.38 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.71 0.767 . . . . 55.42 110.917 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.99 22.47 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.607 2.205 . . . . 62.15 112.367 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.45 -151.7 19.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 65.34 112.485 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -92.15 140.01 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 64.15 110.936 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.34 -88.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.706 -0.759 . . . . 72.24 112.453 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -75.02 -24.02 58.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.877 0.37 . . . . 71.43 110.838 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 86' ' ' HIS . 70.3 p -151.64 -170.23 3.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 64.45 111.097 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.64 -12.18 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.88 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.681 ' OD1' HD23 ' A' ' 110' ' ' LEU . 1.2 t0 -144.0 25.43 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 63.12 110.805 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.508 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.4 OUTLIER -56.76 132.23 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 75.31 110.92 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 84' ' ' ILE . 28.4 pt -136.89 169.88 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 74.44 111.089 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.439 ' CG1' HD23 ' A' ' 169' ' ' LEU . 24.0 m -126.37 134.13 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 65.24 111.129 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.558 HG22 HG21 ' A' ' 83' ' ' ILE . 90.6 t -86.03 133.89 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 71.32 111.163 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -121.48 130.94 53.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 60.3 110.902 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.779 HD12 HD21 ' A' ' 44' ' ' LEU . 10.6 mt -110.59 98.66 38.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.662 0.744 . . . . 54.54 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.4 Cg_endo -69.73 -4.53 14.19 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.719 2.279 . . . . 75.21 112.358 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -82.95 -24.14 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 75.34 110.938 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.63 14.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 63.04 110.877 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.25 27.52 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.856 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.546 HD13 HD13 ' A' ' 21' ' ' LEU . 96.2 mt -92.42 126.47 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 63.04 111.132 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.553 HD22 HD13 ' A' ' 203' ' ' ILE . 23.2 tp -110.89 148.26 32.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 73.54 110.852 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 72.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.0 111.148 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.46 -42.06 49.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 63.32 112.445 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.31 -155.95 44.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 63.32 112.493 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 66.1 m -51.51 -30.58 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 71.31 110.868 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.702 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.5 tp -57.51 -33.56 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 55.55 110.845 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 219' ' ' LEU . 95.6 t -105.51 104.69 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 65.3 111.176 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.539 ' HG2' HG23 ' A' ' 222' ' ' THR . 4.3 mmpt? -51.91 156.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.859 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.2 p -99.67 157.59 16.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.913 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t -51.83 -29.81 20.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 62.24 111.081 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.0 m -95.72 44.09 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 61.13 110.915 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.2 148.43 50.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 74.31 111.071 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.489 ' HA ' HD22 ' A' ' 225' ' ' LEU . 20.5 tttt -128.23 1.75 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 70.34 110.905 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.13 154.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 64.1 110.883 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.8 HD11 ' HB2' ' A' ' 226' ' ' LEU . 7.9 mt -66.33 -38.43 87.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.868 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.06 -144.39 17.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 72.25 112.427 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -59.1 100.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.339 . . . . 64.25 110.919 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 186' ' ' VAL . 18.8 m -94.99 24.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 72.4 111.131 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.09 -24.47 65.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 74.14 111.138 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -119.27 24.28 10.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 62.44 110.796 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.21 154.13 49.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 42.54 111.059 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -107.49 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.456 ' CG2' HG11 ' A' ' 181' ' ' VAL . 34.5 t -60.85 -17.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.32 111.121 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -74.99 -21.14 59.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 72.51 110.85 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -117.79 -12.47 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.851 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' TRP . . . . . 0.702 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.2 t90 -54.97 -60.78 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 74.02 110.929 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.684 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.81 -24.93 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 72.2 110.819 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.4 m -81.36 -31.98 33.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 74.0 111.18 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.76 -42.16 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 72.13 110.851 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.5 mm -61.85 -47.43 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.23 111.083 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -57.23 -28.07 62.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.911 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -76.59 -19.54 57.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.89 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.526 HG11 HD21 ' A' ' 219' ' ' LEU . 21.7 t -87.36 -16.09 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 71.2 111.187 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -104.95 -5.74 20.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.994 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.61 -30.69 9.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 72.45 110.876 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -104.37 -51.18 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 65.52 110.835 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.14 39.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 73.42 110.882 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -52.56 -48.67 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 73.31 110.852 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -60.44 106.25 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.929 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.721 HG21 HG22 ' A' ' 206' ' ' VAL . 42.8 mt -145.95 123.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 72.2 111.146 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.41 -35.47 54.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 74.11 110.843 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -157.83 129.38 6.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 61.12 111.082 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 203' ' ' ILE . 98.2 t -105.95 136.46 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 53.2 111.128 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 1.04 HG22 HG12 ' A' ' 213' ' ' VAL . 13.5 t -113.16 113.4 49.1 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.72 0.771 . . . . 64.34 111.082 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.511 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.0 Cg_endo -69.86 -173.41 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 63.0 112.34 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.24 -15.38 69.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 74.13 112.47 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.71 139.45 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 74.1 110.884 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.62 -117.93 5.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.827 -0.701 . . . . 71.3 112.475 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -148.94 169.09 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 73.51 110.928 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.04 HG12 HG22 ' A' ' 207' ' ' VAL . 4.3 m -61.17 161.58 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 74.1 111.071 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.06 -88.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 64.21 112.429 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -179.8 -170.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 73.15 110.875 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -60.98 -18.0 54.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 74.31 110.955 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.27 -20.98 52.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.671 -0.776 . . . . 42.14 112.455 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.511 HD13 ' HD3' ' A' ' 208' ' ' PRO . 10.8 mt -74.6 -47.83 30.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.862 0.363 . . . . 74.14 110.903 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.622 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -54.63 -55.16 32.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.96 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 221' ' ' HIS . 4.3 pp -60.83 -20.04 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 63.21 110.856 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.472 ' N ' HD12 ' A' ' 220' ' ' LEU . 1.5 t60 -69.74 -39.32 76.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 71.32 110.851 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.8 m -53.19 -50.38 64.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 64.45 111.106 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.36 -17.73 55.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 71.53 110.919 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -87.44 -5.67 58.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.878 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 176' ' ' LYS . 8.6 mt -126.62 -5.28 6.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 64.02 110.968 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.8 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.5 OUTLIER -118.87 4.87 11.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 72.31 110.965 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 75.15 110.857 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.6 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.807 0.337 . . . . 73.3 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.82 91.82 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.44 111.101 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -111.88 117.84 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 73.32 110.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -60.79 168.96 2.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.873 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.96 -47.94 64.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 62.31 110.881 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -61.08 -37.54 83.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.15 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.3 13.32 61.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.669 -0.777 . . . . 55.11 112.542 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.4 m -79.14 -44.8 21.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 75.24 111.092 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 67' ' ' LEU . 32.1 mt -103.59 117.46 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 44.21 111.176 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -124.46 129.12 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 74.45 110.843 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.694 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -120.44 112.55 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 53.53 111.105 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.443 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -98.31 128.76 44.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 71.42 110.86 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -73.55 110.93 8.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 72.21 110.89 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 213' ' ' VAL . 10.8 mt -65.37 -32.99 74.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 43.41 110.879 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.85 -97.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 64.44 110.872 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.8 OUTLIER -150.09 9.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 73.15 110.864 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.452 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.53 8.25 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 75.4 110.829 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -150.89 141.14 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 71.52 111.095 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.694 ' HB3' HG22 ' A' ' 18' ' ' ILE . 19.6 m95 -130.0 -179.39 5.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 65.11 110.878 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 43' ' ' GLY . 93.0 t -132.0 89.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 64.5 111.096 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.406 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.3 p80 -72.78 124.38 25.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 65.51 110.834 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -119.93 104.2 9.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 70.1 111.128 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -88.13 123.27 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.8 117.8 28.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 72.14 110.874 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 52.22 112.514 179.836 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.58 0.705 . . . . 75.24 111.181 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 118.33 5.62 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.738 2.292 . . . . 71.25 112.348 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -110.21 99.91 8.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 71.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -62.42 170.37 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 75.42 110.93 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -159.28 -147.46 4.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 30.04 112.527 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.8 tp -159.58 116.28 2.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 73.55 110.885 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.652 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.52 121.83 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 54.01 111.155 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.46 HD22 ' SD ' ' A' ' 138' ' ' MET . 24.7 mt -98.7 118.23 34.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 64.2 110.966 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.39 85.93 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.936 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.78 177.15 4.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 73.03 111.092 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -97.94 -20.84 17.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 61.11 110.823 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -10.4 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 65.3 110.902 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.62 153.54 5.91 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 72.24 112.523 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.0 tp -68.54 154.95 40.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 64.14 110.905 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.3 t -145.15 142.99 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 73.13 111.107 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.652 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -137.56 124.61 21.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.905 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.538 HG12 ' OD1' ' A' ' 56' ' ' ASP . 74.1 t -71.51 112.44 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 54.42 111.137 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.8 m-20 73.4 121.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 71.0 110.882 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.67 ' CB ' HD11 ' A' ' 98' ' ' LEU . 2.8 p -66.12 -166.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 65.35 110.844 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.6 t -91.9 169.48 10.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.85 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.714 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.1 m95 -50.38 -60.25 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.828 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -129.82 158.51 39.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 75.15 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -51.37 -33.75 31.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.972 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.21 -38.11 76.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 71.23 110.926 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 59' ' ' TRP . 93.1 mt -81.15 -45.54 16.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.934 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -45.14 61.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.132 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -52.93 -51.59 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 74.35 110.952 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -63.71 -19.71 65.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 71.13 110.913 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.1 tp -87.94 -26.86 22.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.877 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.75 -23.09 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 72.42 111.265 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.09 18.18 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 74.33 110.865 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.3 ptm -132.9 -40.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 71.5 110.866 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.1 m -81.07 -22.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 70.2 111.163 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.623 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.81 -21.95 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.902 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -109.04 -33.27 6.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 73.15 110.851 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.93 -43.48 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.908 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.17 -10.87 48.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 62.3 110.895 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 67.42 13.27 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 73.13 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.545 ' HB2' HD13 ' A' ' 52' ' ' LEU . 5.3 mttm -131.33 138.76 49.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 62.22 110.954 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -85.8 137.94 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.22 110.833 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.623 HG23 ' OE1' ' A' ' 72' ' ' GLU . 98.8 t -76.91 126.39 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 71.21 111.103 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -143.79 13.89 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.11 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 53' ' ' VAL . 53.8 m-20 -155.89 144.15 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.04 110.906 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 54' ' ' LEU . 14.5 t -154.41 131.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.4 111.161 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.497 ' CD1' HG11 ' A' ' 140' ' ' VAL . 49.6 mt -89.4 130.73 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 61.32 111.105 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -106.28 124.94 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.12 111.157 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.472 HG23 ' OD2' ' A' ' 56' ' ' ASP . 30.7 p -82.53 -39.54 22.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 72.01 111.167 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.485 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.6 p-80 -165.94 -175.29 3.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 71.11 110.931 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.808 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.24 95.83 10.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 71.21 111.108 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.88 154.08 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.35 110.832 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.13 -20.19 51.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 73.5 111.049 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.8 5.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 61.14 110.918 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -122.11 -77.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 73.12 110.791 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.14 8.48 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 62.33 111.086 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.38 -42.32 33.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 70.34 112.476 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.61 13.1 58.15 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 23.13 112.468 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.5 tt -51.42 -29.63 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 71.1 111.086 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -32.11 45.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 72.22 110.984 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.6 m -89.78 -22.72 22.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 74.42 111.132 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.67 HD11 ' CB ' ' A' ' 57' ' ' SER . 13.3 mt -80.54 -25.98 38.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.906 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.73 15.3 29.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.913 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.03 -40.93 3.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.24 110.89 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -83.19 -58.14 2.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 64.41 110.928 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.56 38.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 72.43 112.545 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.2 mp -106.05 115.12 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 74.34 111.111 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HB3' HD11 ' A' ' 124' ' ' LEU . 2.6 mttt -78.84 116.31 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 53.44 110.911 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.43 93.15 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 54.55 111.127 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.575 ' HA ' HD12 ' A' ' 124' ' ' LEU . 38.0 m-70 -67.66 129.44 39.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.912 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.627 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -159.11 -178.98 7.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 52.5 110.924 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.89 157.75 17.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.133 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.03 -36.94 30.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 63.43 111.109 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.614 HD21 ' HG2' ' A' ' 151' ' ' GLU . 0.3 OUTLIER -72.11 -39.42 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.99 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.742 ' HA ' HD11 ' A' ' 114' ' ' LEU . 83.6 m -57.87 -27.72 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 64.42 111.186 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.31 4.7 53.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 42.02 111.018 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -103.61 -44.81 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.889 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -85.07 -13.86 49.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.959 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.483 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -62.62 -43.12 99.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.097 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.15 62.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.944 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -35.55 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 64.54 110.838 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.39 -23.53 22.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.25 110.917 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.59 22.99 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 53.33 112.447 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -94.84 179.14 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.344 . . . . 64.32 110.883 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -77.41 -176.18 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 72.1 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mt-10 -115.35 101.52 54.37 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.634 0.73 . . . . 75.32 110.852 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.4 Cg_endo -69.76 -179.85 3.2 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.742 2.295 . . . . 65.14 112.341 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 106' ' ' HIS . 29.4 mt -51.24 -52.55 43.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 73.55 110.858 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 58.75 21.94 52.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 74.22 112.444 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.37 24.14 6.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 74.02 110.886 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.688 ' CD2' HD21 ' A' ' 133' ' ' LEU . 95.5 mt -103.99 -175.9 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 61.5 110.942 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.99 -171.55 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 52.13 110.826 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.934 HG22 HG23 ' A' ' 130' ' ' VAL . 36.6 m -50.94 -70.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 54.1 111.087 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.934 HG23 HG22 ' A' ' 129' ' ' THR . 44.4 t -119.11 104.06 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 70.2 111.218 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -135.15 164.2 28.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 73.12 111.22 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.93 126.61 54.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.283 -0.417 . . . . 75.13 111.0 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.688 HD21 ' CD2' ' A' ' 127' ' ' LEU . 67.0 mt -111.49 155.7 22.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.35 110.912 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -137.87 117.19 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 62.54 110.872 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.19 48.93 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 74.33 110.886 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.33 94.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.751 . . . . 65.11 112.45 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.35 15.36 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 43.31 110.887 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.46 ' SD ' HD22 ' A' ' 46' ' ' LEU . 54.8 tpp -137.45 101.37 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 62.23 110.898 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.464 ' O ' HD23 ' A' ' 158' ' ' LEU . 2.9 mptt -90.81 132.56 35.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 75.44 110.773 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.727 HG22 HD21 ' A' ' 158' ' ' LEU . 21.2 t -138.5 114.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.061 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -107.6 129.58 54.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 75.04 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 46.9 p -86.08 178.09 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 72.11 111.183 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.515 ' HD1' HG22 ' A' ' 130' ' ' VAL . 19.4 t80 -161.63 133.69 5.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 70.05 110.858 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.678 ' HB3' HG23 ' A' ' 129' ' ' THR . 9.1 t80 -121.78 86.48 45.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 75.33 110.872 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -8.04 22.6 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.767 2.311 . . . . 74.53 112.31 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.36 -160.94 24.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 73.51 112.434 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -87.77 140.76 29.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 74.24 110.844 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.537 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -154.6 -91.11 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 62.43 112.459 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -73.79 -23.51 59.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 71.33 110.959 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.485 HG21 ' HB2' ' A' ' 86' ' ' HIS . 47.2 p -150.29 -167.38 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 43.33 111.167 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.645 ' HB3' HD23 ' A' ' 114' ' ' LEU . 2.0 tt0 -86.32 -15.98 38.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 74.1 110.853 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.567 ' HB2' HD23 ' A' ' 110' ' ' LEU . 41.0 t0 -135.53 17.96 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.871 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.684 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -51.45 129.59 25.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 64.42 110.818 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 144' ' ' TYR . 5.8 pt -136.54 175.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.08 -0.509 . . . . 74.5 111.065 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -128.35 119.51 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.162 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.47 126.58 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 62.44 111.108 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -115.25 138.8 50.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 71.42 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.727 HD21 HG22 ' A' ' 140' ' ' VAL . 20.1 mt -121.34 98.91 46.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.652 0.739 . . . . 75.44 110.846 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -4.13 13.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.707 2.271 . . . . 63.1 112.287 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -85.16 -22.97 28.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.317 -0.401 . . . . 52.33 110.974 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.41 12.28 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 62.03 111.042 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.3 m120 54.68 25.68 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 41.54 110.819 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 93.5 mt -90.48 142.95 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 65.41 111.196 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.637 HD22 HD13 ' A' ' 203' ' ' ILE . 13.2 tp -128.43 146.38 50.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 64.25 110.917 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 55' ' ' VAL . 42.1 t -115.17 76.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 63.51 111.126 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.09 -28.99 19.91 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.808 -0.711 . . . . 70.22 112.49 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.41 -161.72 20.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 73.41 112.465 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -33.18 60.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 53.41 110.868 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.684 HD13 ' OD1' ' A' ' 153' ' ' ASN . 25.1 tp -51.85 -35.86 46.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.924 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.91 111.16 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.42 111.078 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.71 159.73 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 62.21 110.858 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.7 p -100.27 162.78 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.812 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 64.21 111.075 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.778 0.323 . . . . 34.42 111.104 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.98 90.49 3.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.959 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.96 -17.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 54.32 111.271 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -74.39 -27.81 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 71.31 110.949 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -110.97 -12.92 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 61.21 110.857 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.511 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.3 t90 -54.09 -62.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 64.5 110.918 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.687 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -54.56 -23.73 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 72.23 110.822 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.2 m -81.43 -30.48 33.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 70.31 111.168 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.22 -43.63 41.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.889 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.512 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.7 mm -61.83 -45.2 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 74.13 111.144 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.52 -23.96 53.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 54.43 110.883 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.99 -22.79 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 74.4 110.864 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 192' ' ' SER . 17.4 t -86.11 -9.0 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.41 111.137 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.69 -6.93 13.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 55.04 110.941 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.46 -31.06 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 72.14 110.939 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -55.98 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.856 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -94.89 38.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.84 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -55.53 -47.97 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 75.23 110.948 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -60.05 102.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 73.24 110.829 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.669 HG21 HG22 ' A' ' 206' ' ' VAL . 41.9 mt -144.69 125.12 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 75.03 111.151 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -24.2 41.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 55.25 110.905 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.721 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -168.15 133.71 1.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 64.33 111.089 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' A' ' 218' ' ' LEU . 88.8 t -115.02 131.61 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 65.41 111.092 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.069 HG22 HG22 ' A' ' 213' ' ' VAL . 13.6 t -110.15 108.88 58.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 74.34 111.13 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.7 Cg_endo -69.7 -176.01 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 72.13 112.353 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.41 -17.36 80.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 71.52 112.476 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -152.43 141.15 20.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 74.5 110.972 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 110.21 -117.64 4.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 74.05 112.488 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.63 176.16 11.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.358 . . . . 62.22 110.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.069 HG22 HG22 ' A' ' 207' ' ' VAL . 5.8 t -70.09 151.12 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 61.32 111.146 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.99 -102.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.737 -0.744 . . . . 65.15 112.447 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.67 -168.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 72.13 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -60.93 -18.14 55.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 72.33 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.499 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.77 -19.79 37.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.799 -0.715 . . . . 61.32 112.506 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.738 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.6 mt -73.23 -31.78 64.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 61.11 110.878 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.512 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -62.8 -57.3 11.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 72.21 111.027 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 223' ' ' LEU . 0.5 OUTLIER -62.12 -17.93 59.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 41.01 110.937 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.9 OUTLIER -66.24 -40.99 90.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.874 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.906 HG22 HD23 ' A' ' 226' ' ' LEU . 27.8 m -60.94 -47.98 83.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 63.22 111.169 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -67.97 -21.99 65.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.949 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -75.4 -6.54 50.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 72.23 110.905 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.411 HD11 ' CE1' ' A' ' 221' ' ' HIS . 4.7 mt -125.13 -35.68 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 44.45 110.859 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.906 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -85.45 -0.82 56.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.912 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 75.45 110.894 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.842 0.353 . . . . 71.01 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mt -110.48 97.17 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 71.21 111.201 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.94 121.01 39.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 65.4 110.906 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -66.78 168.16 10.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 71.42 110.837 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -52.18 -48.14 65.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.45 110.844 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.98 -37.83 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 72.5 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.93 13.12 62.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 55.14 112.55 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 m -80.47 -44.26 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.278 . . . . 72.42 111.134 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 67' ' ' LEU . 52.8 mt -101.97 113.02 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 73.43 111.097 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.4 p -121.15 129.06 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 51.23 110.871 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.808 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.1 mt -120.41 111.83 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 72.04 111.121 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.2 t -97.01 126.53 42.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 64.24 110.894 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -72.15 109.34 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.892 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.848 HD21 HG11 ' A' ' 213' ' ' VAL . 6.7 mt -63.0 -35.26 79.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.964 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.68 -96.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.915 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.24 9.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.944 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.446 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.15 8.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 75.31 110.981 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -150.91 140.34 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 62.31 111.245 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.808 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.7 m95 -129.58 -179.71 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.437 . . . . 74.03 110.973 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.28 88.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 75.32 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -71.3 123.17 21.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 52.44 110.851 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.1 m -119.78 105.1 10.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 63.14 111.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.408 ' CG ' HD22 ' A' ' 67' ' ' LEU . 3.5 mp0 -87.05 122.64 31.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.882 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.53 108.5 19.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 74.42 110.896 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.786 -0.721 . . . . 62.25 112.513 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.553 0.692 . . . . 71.23 111.228 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.63 116.9 4.76 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.738 2.292 . . . . 60.24 112.405 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.2 p -104.44 98.34 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 54.22 110.839 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.51 169.25 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.893 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -148.71 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.839 -0.696 . . . . 54.53 112.586 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.627 HD21 HD12 ' A' ' 158' ' ' LEU . 15.8 tp -158.62 115.19 2.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 54.53 110.943 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.685 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -98.56 121.8 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 63.51 111.139 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.736 HD21 HD11 ' A' ' 158' ' ' LEU . 19.4 mt -98.84 116.51 31.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.958 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -87.38 85.49 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.44 110.953 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.6 176.18 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 65.42 111.115 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -96.67 -21.5 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 43.55 110.831 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -11.18 57.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 74.22 110.868 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.08 153.67 5.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 72.1 112.466 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.2 tp -68.39 155.03 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 72.35 110.951 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.2 t -145.57 142.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 71.33 111.153 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.685 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -137.53 122.84 19.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 74.01 110.959 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 165' ' ' VAL . 76.3 t -69.2 110.51 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 72.32 111.109 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.2 129.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 70.13 110.91 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.677 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -72.52 -165.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 60.01 110.809 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -91.37 172.66 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 52.1 110.839 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.742 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.9 m95 -49.94 -52.04 36.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 70.03 110.978 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -141.63 162.6 35.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 74.33 110.874 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.71 -30.59 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.428 . . . . 64.04 110.832 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -59.74 -42.08 92.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 71.24 110.951 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.742 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.0 mt -83.08 -45.37 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 74.32 110.866 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -45.87 59.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 72.34 111.167 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -55.58 -48.12 75.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 61.03 110.872 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.98 -18.91 65.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.901 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.578 ' O ' HG22 ' A' ' 71' ' ' VAL . 19.1 tp -89.59 -27.14 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 54.14 110.915 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.08 -22.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 71.31 111.145 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.55 15.72 13.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.871 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.46 -39.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 63.34 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.9 m -80.39 -22.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 60.12 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.554 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.75 -23.07 65.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.842 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 -33.52 7.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 74.24 110.842 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -69.91 -39.24 76.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 65.33 110.894 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -92.71 -10.44 37.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.879 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.65 12.05 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 65.15 110.916 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.523 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -130.48 137.83 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 54.01 110.868 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -86.49 138.21 31.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 73.32 110.898 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 54' ' ' LEU . 71.4 t -76.4 121.94 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 55.43 111.134 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.7 t -134.32 6.59 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.134 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 53' ' ' VAL . 60.1 m-20 -151.23 145.7 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.31 110.837 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 54' ' ' LEU . 10.8 t -154.03 132.22 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.075 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -93.89 123.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 72.53 111.163 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.6 mm -96.55 143.45 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.175 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.0 p -94.11 -51.42 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 75.2 111.176 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -156.1 -175.88 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.829 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.86 97.13 10.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 72.01 111.117 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -158.11 150.92 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 71.34 110.858 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.07 -19.61 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 61.04 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -92.29 21.83 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.809 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -144.0 -77.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 71.55 110.837 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -88.87 8.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 64.3 111.136 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -41.8 38.37 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.709 -0.758 . . . . 65.2 112.503 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.45 12.04 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 72.24 112.458 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 92' ' ' ILE . 3.5 tt -51.97 -28.49 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 63.43 111.104 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -53.58 -39.84 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 75.04 110.87 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.9 m -79.94 -17.29 53.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 52.02 111.192 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.677 HD11 ' OG ' ' A' ' 57' ' ' SER . 17.3 mt -84.99 -32.34 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 75.54 110.906 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.71 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.87 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -119.63 -45.74 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -77.36 -53.41 7.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.31 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.31 44.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 41.23 112.474 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -109.0 121.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.945 0.403 . . . . 74.4 111.14 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.769 ' HE2' HD21 ' A' ' 124' ' ' LEU . 7.7 mtpt -82.05 111.42 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 70.3 110.968 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.12 91.28 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.077 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.561 ' HA ' HD12 ' A' ' 124' ' ' LEU . 56.2 m-70 -62.98 142.16 58.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.01 110.865 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.629 ' CA ' HD12 ' A' ' 127' ' ' LEU . 3.4 p -172.9 179.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 53.24 110.882 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.85 157.47 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.41 111.208 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.99 -31.74 13.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 64.42 111.029 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.567 HD23 ' HB3' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -77.76 -39.38 44.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 72.44 110.908 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.569 ' HA ' HD11 ' A' ' 114' ' ' LEU . 10.2 m -57.37 -27.7 62.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 74.12 111.151 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -98.33 8.58 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.12 111.084 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.99 -28.78 11.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 75.41 110.898 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -103.36 -8.64 20.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.884 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.46 79.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 71.43 111.146 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -26.68 57.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 72.42 110.901 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -57.58 -30.75 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 64.04 110.933 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -92.11 -24.8 19.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 74.43 110.947 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.18 25.76 4.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 72.12 112.48 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.33 -176.08 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 73.23 110.955 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.61 167.75 17.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 71.34 110.853 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.6 mt-10 -101.25 103.25 24.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.7 0.762 . . . . 64.24 110.818 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.0 Cg_endo -69.73 -178.63 2.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 71.12 112.313 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.769 HD21 ' HE2' ' A' ' 104' ' ' LYS . 28.9 mt -51.64 -51.29 56.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.92 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.11 24.72 36.7 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.729 . . . . 64.22 112.437 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.78 29.31 5.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 72.34 110.898 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.696 ' CD2' HD21 ' A' ' 133' ' ' LEU . 95.6 mt -108.91 -175.8 2.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 55.42 110.903 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.87 -172.63 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 74.45 110.938 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.867 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.91 -70.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 64.3 111.127 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 129' ' ' THR . 38.8 t -117.77 103.1 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 73.41 111.111 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -131.78 174.34 10.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 55.31 111.152 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.32 129.36 50.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 73.24 110.878 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.696 HD21 ' CD2' ' A' ' 127' ' ' LEU . 60.8 mt -113.29 156.98 22.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 65.31 110.934 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -139.36 115.31 10.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.869 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -113.36 48.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 65.52 110.918 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.43 94.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 72.12 112.382 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 m120 65.1 14.2 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 63.3 110.885 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.5 tpp -133.43 104.29 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 64.12 110.88 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.68 123.78 36.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 61.14 110.883 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.959 HG22 HD21 ' A' ' 158' ' ' LEU . 21.5 t -131.92 117.86 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 70.43 111.116 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -111.13 127.91 55.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.51 110.884 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.58 -172.49 4.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 61.34 111.175 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HB3' HG23 ' A' ' 155' ' ' VAL . 37.7 t80 -172.83 135.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 74.11 110.899 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.694 ' HB3' HG23 ' A' ' 129' ' ' THR . 90.2 t80 -120.95 89.63 46.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.742 . . . . 73.03 110.89 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.7 Cg_endo -69.76 -7.89 22.2 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.661 2.241 . . . . 75.1 112.401 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.28 -150.08 19.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 74.52 112.527 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -96.53 139.12 33.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 74.54 110.886 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.451 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -152.0 -95.22 0.12 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 41.0 112.461 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 84.7 t60 -69.6 -24.44 63.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 73.32 110.982 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 p -151.4 -171.45 3.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 52.31 111.145 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.91 -8.4 57.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 75.24 110.89 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.567 ' HB3' HD23 ' A' ' 110' ' ' LEU . 3.7 p-10 -136.86 14.98 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 60.33 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.414 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.3 OUTLIER -53.07 137.95 32.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 72.1 110.906 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.69 -179.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.114 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.573 HG12 ' HA2' ' A' ' 166' ' ' GLY . 6.5 m -135.12 126.58 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 71.42 111.16 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.414 ' O ' HD12 ' A' ' 164' ' ' LEU . 99.9 t -85.96 122.94 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.35 111.094 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -110.7 133.05 53.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 73.3 110.91 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.959 HD21 HG22 ' A' ' 140' ' ' VAL . 10.9 mt -115.01 98.65 50.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 71.14 110.978 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -4.02 13.14 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 61.12 112.339 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -83.36 -23.85 32.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.954 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.25 14.49 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 75.22 110.922 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.19 27.36 7.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 72.52 110.858 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.557 HD13 HD13 ' A' ' 21' ' ' LEU . 96.2 mt -92.54 129.87 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 71.03 111.166 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.547 HD11 ' HB ' ' A' ' 155' ' ' VAL . 23.0 tp -115.5 147.68 40.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 64.41 110.947 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 55' ' ' VAL . 37.6 t -117.73 74.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 72.42 111.124 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.573 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -51.79 -41.49 51.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 74.35 112.534 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.49 -160.48 53.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.832 -0.699 . . . . 54.31 112.419 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 45.8 m -51.72 -30.1 21.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.368 . . . . 71.22 110.893 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.725 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.6 tp -57.83 -32.49 67.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 70.4 110.947 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 219' ' ' LEU . 80.1 t -105.98 109.73 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 51.01 111.16 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.661 ' HG2' HG23 ' A' ' 222' ' ' THR . 2.5 mmpt? -51.54 161.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 73.35 110.884 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.544 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -100.86 168.62 9.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 55.14 110.907 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 73.42 111.107 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.879 0.371 . . . . 43.34 111.047 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.61 91.91 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 73.53 110.932 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.49 -21.31 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 62.13 111.088 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.41 -21.71 60.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 75.41 110.82 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -114.93 -12.9 11.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 61.3 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.725 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.9 t90 -56.73 -62.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 64.21 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.722 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.5 -23.63 17.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 70.14 110.865 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 58.0 m -80.66 -33.31 35.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 61.21 111.155 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.89 -43.75 62.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 72.11 110.885 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.1 mm -59.56 -47.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 74.12 111.143 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.41 -27.78 62.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 64.01 110.852 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -77.43 -20.69 54.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 73.3 110.86 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.513 HG11 HD21 ' A' ' 219' ' ' LEU . 18.4 t -86.57 -13.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 63.25 111.156 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -108.38 -16.55 14.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.867 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -93.35 -30.6 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 65.54 110.849 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 -50.4 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 72.13 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.84 66.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 71.11 110.847 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.3 mtm-85 -72.91 -59.78 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 74.14 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -51.63 107.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 54.11 110.9 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.615 HG21 HG22 ' A' ' 206' ' ' VAL . 85.0 mt -146.61 122.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 74.34 111.12 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.93 -32.13 45.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.863 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 213' ' ' VAL . . . -161.72 147.62 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 64.35 111.09 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.615 HG22 HG21 ' A' ' 203' ' ' ILE . 47.6 t -123.47 126.74 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 62.14 111.108 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.823 HG22 ' HB ' ' A' ' 213' ' ' VAL . 17.0 t -103.29 104.07 38.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.565 0.697 . . . . 64.25 111.166 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.553 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.7 Cg_endo -69.73 -174.78 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.784 2.323 . . . . 64.23 112.33 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.1 75.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.786 . . . . 52.13 112.548 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.33 140.64 20.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 71.33 110.86 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.6 -117.26 4.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 41.23 112.397 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -157.02 149.14 22.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 65.2 110.916 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.848 HG11 HD21 ' A' ' 21' ' ' LEU . 4.0 p -51.55 137.6 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 52.23 111.115 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -135.03 -88.58 0.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 60.11 112.469 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -171.65 -168.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.963 0.411 . . . . 65.15 110.829 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.445 ' HA ' HD12 ' A' ' 219' ' ' LEU . 3.1 pttm -61.73 -17.26 55.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 70.33 110.92 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.81 -19.93 38.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 55.23 112.46 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.569 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.7 mt -77.4 -47.13 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 73.31 110.82 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.618 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -53.72 -54.61 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.33 110.978 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 221' ' ' HIS . 4.2 pp -60.72 -21.24 62.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.01 110.913 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.49 ' N ' HD12 ' A' ' 220' ' ' LEU . 0.8 OUTLIER -69.61 -37.65 76.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 70.24 110.889 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.73 HG22 HD23 ' A' ' 226' ' ' LEU . 3.5 m -55.39 -54.88 38.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 72.3 111.15 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.88 -19.87 53.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 72.33 110.897 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -83.58 -5.17 59.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 61.14 110.897 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.422 HD12 ' HG3' ' A' ' 171' ' ' LYS . 2.8 mt -129.14 -4.56 4.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 63.34 110.869 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 222' ' ' THR . 0.5 OUTLIER -121.77 -0.19 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 74.14 110.961 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.098 -0.501 . . . . 63.51 110.988 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 19' ' ' SER . 4.9 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.728 0.299 . . . . 74.31 111.182 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 mt -136.43 92.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 64.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -113.79 115.09 27.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.493 . . . . 70.21 110.909 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -58.96 168.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 63.33 110.874 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -51.3 -47.79 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.42 110.912 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 34.5 p -61.24 -37.45 83.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 55.55 111.075 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.66 14.13 61.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.746 . . . . 72.52 112.527 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.3 m -80.14 -44.34 20.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.308 . . . . 61.42 111.118 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.54 114.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 71.21 111.14 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -121.55 127.52 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.838 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.689 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -120.97 112.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 74.5 111.13 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.41 ' HA ' HG12 ' A' ' 8' ' ' VAL . 17.5 t -99.05 125.97 44.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 63.1 110.84 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -69.83 111.3 5.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 64.51 110.872 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.678 HD21 HG11 ' A' ' 213' ' ' VAL . 11.2 mt -65.17 -32.69 74.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.907 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -152.04 -96.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.52 110.977 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.33 9.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.13 110.947 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.452 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.84 7.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.911 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.99 141.9 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.42 111.183 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.689 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.8 m95 -130.04 -177.81 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.94 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 43' ' ' GLY . 90.7 t -133.4 91.76 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.311 -0.404 . . . . 63.12 111.191 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -75.16 123.55 25.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 70.3 110.824 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.5 m -120.33 104.24 9.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 51.35 111.212 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 124.34 31.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 73.54 110.824 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.5 113.77 23.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 61.11 110.938 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 53.3 112.477 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.713 0.768 . . . . 55.44 111.163 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.65 117.43 5.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.735 2.29 . . . . 75.32 112.394 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -109.41 97.4 6.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 70.11 110.792 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -58.25 166.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 73.44 110.892 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -158.05 -149.39 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 52.25 112.477 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 158' ' ' LEU . 15.5 tp -158.28 119.31 3.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 63.05 110.917 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.661 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -103.16 122.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 63.24 111.07 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.88 HD21 HD11 ' A' ' 158' ' ' LEU . 23.5 mt -100.42 120.74 40.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 51.43 110.963 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.47 84.67 5.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 74.04 110.893 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.2 p -99.54 -176.53 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.169 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 -26.47 13.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.2 110.886 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -18.7 55.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 65.41 110.86 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.17 151.47 5.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 55.42 112.479 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.709 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.9 mt -62.94 154.8 29.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.339 . . . . 62.01 110.839 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.1 t -144.22 141.27 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 63.25 111.131 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -136.55 121.82 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 72.33 110.891 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.444 HG11 HG11 ' A' ' 165' ' ' VAL . 79.8 t -68.24 111.97 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 64.2 111.054 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.8 129.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 74.23 110.792 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.615 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -71.9 -167.14 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 64.13 110.917 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.465 ' H ' HG23 ' A' ' 64' ' ' THR . 8.3 t -91.24 170.53 9.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 64.12 110.864 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.714 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.4 m95 -51.07 -60.28 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 71.0 110.91 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.02 159.26 35.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.258 -0.428 . . . . 54.31 110.876 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -51.44 -32.8 28.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.872 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -58.57 -44.13 89.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 73.2 110.918 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.4 mt -75.53 -45.5 37.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 62.14 110.96 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.6 -48.52 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 75.44 111.14 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -53.54 -48.4 69.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.23 110.931 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -65.61 -18.97 65.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.47 . . . . 71.02 110.9 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.8 tp -88.62 -27.1 21.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 73.45 110.936 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.2 mt -90.47 -23.01 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 72.31 111.105 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -92.81 17.32 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 72.24 110.895 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.8 ptm -131.95 -39.89 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 62.34 110.867 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.4 m -80.18 -24.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 75.35 111.205 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.708 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.37 -23.14 66.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 65.11 110.929 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 -32.14 7.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 55.23 110.946 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -40.93 67.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.41 110.953 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 52' ' ' LEU . 15.8 m-85 -89.43 -12.12 41.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.53 110.923 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.34 11.71 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 63.41 110.861 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.464 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -131.8 141.4 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 72.13 110.936 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -86.2 140.99 29.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.275 -0.421 . . . . 74.13 110.846 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 52' ' ' LEU . 85.0 t -82.07 126.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.4 111.137 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -142.46 13.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 70.24 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 53' ' ' VAL . 61.7 m-20 -153.75 144.74 22.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 71.45 110.874 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 54' ' ' LEU . 16.5 t -154.31 132.61 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 72.01 111.167 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.506 ' CD1' HG11 ' A' ' 140' ' ' VAL . 46.9 mt -92.58 126.72 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 72.3 111.097 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -102.85 136.32 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 51.43 111.066 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 -44.59 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.1 111.265 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -152.46 174.94 13.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.901 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.479 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -95.65 88.9 5.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 44.24 111.061 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.95 156.04 43.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 73.01 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -21.72 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 50.52 111.04 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 20.49 7.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 62.22 110.883 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -140.62 -75.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -92.99 8.14 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 70.41 111.074 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -36.56 28.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 63.44 112.46 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.03 15.26 51.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 65.41 112.534 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 92' ' ' ILE . 19.1 tt -56.57 -29.98 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 75.34 111.087 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -30.67 62.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.23 110.86 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -90.0 -11.81 40.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 71.34 111.166 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 57' ' ' SER . 17.4 mt -91.01 -28.77 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 60.25 110.971 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -100.03 22.21 11.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 70.22 110.916 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -121.7 -36.51 3.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.32 110.932 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -87.41 -53.94 4.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.088 -0.505 . . . . 73.03 110.894 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.1 38.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 64.52 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.548 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.4 mp -110.25 124.36 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.35 . . . . 74.41 111.132 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.709 ' HE2' HD21 ' A' ' 124' ' ' LEU . 3.4 mtpp -89.79 118.44 29.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 65.04 110.894 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.9 92.05 8.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 50.4 111.113 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.526 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.6 m-70 -66.29 144.03 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.55 110.751 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.61 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -178.38 -174.19 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 55.22 110.857 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -94.97 155.37 16.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 74.21 111.144 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.62 -39.98 37.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.12 111.16 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.0 -43.45 87.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.934 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.65 ' HA ' HD11 ' A' ' 114' ' ' LEU . 93.5 m -58.77 -21.61 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 72.34 111.098 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.43 12.26 37.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 63.21 111.138 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -25.81 9.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 63.13 110.943 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -103.98 -7.61 20.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 70.14 110.961 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.02 64.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.23 111.093 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -21.69 52.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 75.4 110.843 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -31.32 72.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 54.32 110.904 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -90.22 -25.62 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.895 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 25.42 2.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 64.33 112.488 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.42 170.6 7.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 74.11 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.54 179.0 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.524 . . . . 74.35 110.912 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.5 mp0 -111.34 106.09 57.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.729 . . . . 55.2 110.938 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.72 178.42 4.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.699 2.266 . . . . 73.14 112.361 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HE2' ' A' ' 104' ' ' LYS . 14.0 mt -53.3 -47.44 69.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.915 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.17 27.82 24.51 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 72.31 112.487 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.845 0.355 . . . . 71.3 110.881 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.712 ' CD2' HD21 ' A' ' 133' ' ' LEU . 91.4 mt -113.76 -175.32 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 73.4 110.901 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.16 -171.64 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.964 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.861 HG22 HG23 ' A' ' 130' ' ' VAL . 53.1 m -50.86 -70.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 73.23 111.222 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.861 HG23 HG22 ' A' ' 129' ' ' THR . 40.1 t -118.58 102.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 71.13 111.12 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -132.25 169.12 16.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.151 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.27 132.84 56.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 75.53 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.712 HD21 ' CD2' ' A' ' 127' ' ' LEU . 50.2 mt -119.41 157.84 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 73.41 110.889 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -142.62 112.31 6.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 62.35 110.908 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -107.65 47.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 70.53 110.835 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.74 92.73 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 72.3 112.469 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.65 13.6 9.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 75.23 110.825 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.436 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.1 tpp -136.48 93.51 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.933 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -83.68 132.09 34.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.816 HG22 HD21 ' A' ' 158' ' ' LEU . 46.2 t -137.25 117.74 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 72.05 111.176 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -110.16 126.99 54.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 73.45 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.4 p -83.38 -174.05 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 71.23 111.126 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.588 ' HB3' HG23 ' A' ' 155' ' ' VAL . 33.9 t80 -171.82 133.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.877 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.699 ' HB3' HG23 ' A' ' 129' ' ' THR . 81.0 t80 -120.43 88.53 42.62 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.662 0.744 . . . . 74.32 110.937 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.2 Cg_endo -69.77 -7.93 22.3 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 72.24 112.333 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.2 -158.25 23.07 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 74.42 112.441 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -90.17 139.34 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 74.42 110.812 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -150.67 -95.56 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.727 -0.749 . . . . 73.51 112.435 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -70.36 -24.17 62.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 75.13 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.3 p -151.7 -175.24 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 75.25 111.111 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.77 -2.34 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 60.53 110.841 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.483 ' OD1' HG23 ' A' ' 111' ' ' THR . 12.9 p-10 -140.21 11.45 2.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 42.11 110.906 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.584 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -52.65 141.38 20.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 75.34 110.892 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.67 -178.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 73.05 111.106 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 143' ' ' PHE . 5.8 m -136.77 120.1 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 74.13 111.198 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.703 ' O ' HD12 ' A' ' 164' ' ' LEU . 93.6 t -79.25 133.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.161 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -118.69 131.34 56.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.987 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.88 HD11 HD21 ' A' ' 46' ' ' LEU . 10.4 mt -112.8 98.83 46.25 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.595 0.712 . . . . 73.33 110.917 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.5 Cg_endo -69.73 -4.26 13.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.279 . . . . 73.54 112.336 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -83.08 -23.8 32.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 55.51 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.82 14.05 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.95 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.4 m120 54.21 27.15 7.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 75.43 111.006 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 21' ' ' LEU . 96.1 mt -91.98 136.66 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 74.23 111.111 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 156' ' ' VAL . 26.6 tp -121.96 147.75 45.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 64.41 110.992 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.444 HG11 HG11 ' A' ' 55' ' ' VAL . 45.3 t -117.33 76.47 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 71.42 111.078 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.567 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -51.59 -40.77 48.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 71.11 112.556 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 71.6 -162.82 54.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 62.3 112.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 78.6 m -51.46 -33.1 29.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.77 0.319 . . . . 73.54 110.777 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.687 HD12 ' NE1' ' A' ' 189' ' ' TRP . 25.4 tp -51.63 -44.56 62.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 52.31 110.945 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.583 HG13 ' HA ' ' A' ' 219' ' ' LEU . 46.1 t -101.08 111.6 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.23 111.061 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.635 ' HG3' HD12 ' A' ' 225' ' ' LEU . 30.9 mmmt -55.31 164.85 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 72.45 110.864 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.9 p -114.98 170.33 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.14 110.835 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 63.11 111.088 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.808 0.337 . . . . 31.12 111.073 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -119.73 91.75 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 72.51 110.961 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.6 -19.07 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.15 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.78 -20.89 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.893 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -116.81 -16.18 10.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 72.22 110.85 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.687 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -55.0 -61.41 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.2 -0.455 . . . . 74.4 110.906 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.739 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.27 -24.64 19.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.858 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -80.72 -31.97 35.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 74.15 111.065 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -74.09 -45.45 49.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 64.43 110.848 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.6 mm -59.11 -47.63 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 75.41 111.087 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.33 -28.65 59.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.879 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -77.31 -22.48 51.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.3 110.848 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 192' ' ' SER . 11.0 t -85.37 -10.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 62.03 111.154 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -111.96 -10.28 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 64.41 110.936 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.8 -30.43 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 71.52 110.845 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 -45.73 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 64.03 110.835 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.41 37.06 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.93 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.61 -48.06 75.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 71.51 110.914 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -61.2 102.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.948 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.746 HG21 HG22 ' A' ' 206' ' ' VAL . 52.3 mt -144.86 126.53 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 72.03 111.139 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.75 -22.71 34.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 65.02 110.908 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.74 125.31 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 63.53 111.083 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.746 HG22 HG21 ' A' ' 203' ' ' ILE . 92.5 t -104.22 137.23 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 71.03 111.051 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.081 HG22 HG12 ' A' ' 213' ' ' VAL . 11.6 t -110.8 108.44 57.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.573 0.701 . . . . 63.42 111.146 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 173.33 11.17 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.66 2.24 . . . . 72.53 112.301 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.52 -13.81 74.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.602 -0.809 . . . . 54.2 112.525 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -152.61 147.6 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 72.13 110.785 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 99.47 -113.94 4.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 65.23 112.476 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -156.58 168.6 26.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 61.23 110.875 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.081 HG12 HG22 ' A' ' 207' ' ' VAL . 5.0 m -58.34 163.27 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 62.25 111.135 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.99 -104.72 0.2 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 71.12 112.492 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.95 -169.6 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.34 . . . . 62.51 110.874 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -59.81 -19.19 49.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 63.21 110.89 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.502 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -56.04 -22.69 36.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.74 . . . . 72.42 112.471 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.686 HD12 ' HB ' ' A' ' 206' ' ' VAL . 5.0 mt -72.56 -32.73 66.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 71.45 110.919 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.583 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.7 mp -62.03 -59.98 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 71.44 110.924 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.502 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -59.43 -20.66 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.912 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.26 -37.69 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 52.53 110.902 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.629 HG22 ' CD2' ' A' ' 226' ' ' LEU . 7.1 m -58.44 -51.62 69.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 72.31 111.126 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.5 mp -68.77 -16.71 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 71.22 110.972 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.86 -11.07 59.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 74.01 110.864 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.635 HD12 ' HG3' ' A' ' 171' ' ' LYS . 6.3 mt -121.24 -31.76 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 61.32 110.991 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.739 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -91.6 8.24 37.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 72.23 110.953 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.03 110.868 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.825 0.345 . . . . 75.0 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.02 92.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 70.41 111.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.27 119.46 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 65.25 110.894 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -61.87 168.47 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.31 110.861 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.85 -47.9 64.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.804 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.77 -37.75 82.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 74.1 111.079 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.04 12.72 61.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 44.24 112.539 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.409 HG23 ' CB ' ' A' ' 31' ' ' LEU . 23.0 m -80.39 -44.1 19.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 70.53 111.179 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -102.57 116.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 65.43 111.09 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.4 p -123.89 131.75 53.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 61.24 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.758 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -124.16 109.95 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 71.5 111.066 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.2 t -101.01 125.25 47.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.745 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.72 110.93 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 64.55 110.899 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.651 HD13 HD13 ' A' ' 163' ' ' ILE . 14.7 mt -65.41 -31.86 73.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 64.21 110.926 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.71 -97.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.879 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.3 OUTLIER -151.47 9.89 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.897 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.445 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.58 6.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 71.53 110.931 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.2 t -151.09 139.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 70.4 111.138 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.758 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.6 m95 -126.92 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.864 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 43' ' ' GLY . 93.2 t -136.69 96.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 51.23 111.213 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -81.27 120.66 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 72.21 110.876 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -115.78 100.99 8.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 61.52 111.205 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.16 121.51 26.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 73.53 110.912 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' CB ' HG23 ' A' ' 15' ' ' THR . 0.6 OUTLIER -92.29 107.04 18.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 73.54 110.928 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 50.33 112.501 179.872 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.587 0.708 . . . . 64.1 111.007 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 118.24 5.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.264 . . . . 72.13 112.295 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.83 99.89 9.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 72.1 110.871 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -52.56 170.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.45 110.812 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.577 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -162.55 -164.01 16.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.416 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 26' ' ' TRP . 14.4 tp -153.04 114.16 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 74.12 110.902 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.623 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.8 t -97.28 116.8 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 55.23 111.113 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.596 HD21 HD21 ' A' ' 158' ' ' LEU . 13.5 mt -94.86 120.83 35.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 71.43 110.965 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.66 83.21 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.12 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 138' ' ' MET . 2.5 p -90.77 -178.5 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 72.34 111.126 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -105.26 -1.15 25.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 40.14 110.777 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -23.14 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.57 144.42 4.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 41.41 112.471 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.695 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.7 mt -59.51 154.54 17.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 71.32 110.93 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.4 t -145.11 142.94 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 73.42 111.122 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.3 mt -137.51 123.12 19.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.835 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.78 112.72 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 63.52 111.107 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.65 129.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.03 110.94 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.656 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -72.18 -167.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.854 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.406 ' H ' HG23 ' A' ' 64' ' ' THR . 8.0 t -92.34 170.27 9.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 63.43 110.853 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.736 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.7 m95 -50.34 -60.26 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.873 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -128.93 160.56 32.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 61.23 110.854 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -52.72 -31.24 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 72.15 110.864 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -59.82 -43.52 94.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 72.24 110.88 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.736 HD12 ' HB2' ' A' ' 59' ' ' TRP . 94.2 mt -75.47 -45.85 36.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 71.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -51.53 -47.11 63.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 73.42 111.169 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -50.98 61.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 63.54 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.37 -19.87 65.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 73.53 110.86 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.6 tp -87.45 -26.16 23.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 62.2 110.871 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.6 mt -90.87 -23.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 63.25 111.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.69 16.5 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.882 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.85 -39.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 71.33 110.783 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.9 m -80.85 -23.76 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 74.32 111.158 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.703 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.01 -23.43 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.51 110.866 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -106.8 -33.57 7.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.906 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -70.58 -44.12 68.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 61.15 110.783 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.9 m-85 -86.59 -12.8 47.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 74.13 110.907 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.43 11.75 8.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 53.34 110.89 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.95 141.1 50.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 71.3 110.894 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.41 140.4 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 74.43 110.883 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.703 HG23 ' OE1' ' A' ' 72' ' ' GLU . 86.3 t -81.95 121.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 53.52 111.111 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.78 9.65 2.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 63.34 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 53' ' ' VAL . 65.2 m-20 -148.86 145.02 27.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.87 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 54' ' ' LEU . 20.3 t -154.14 131.47 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 73.13 111.125 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.653 HD13 HG11 ' A' ' 140' ' ' VAL . 5.6 mt -94.66 123.49 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 72.43 111.077 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.7 mm -94.58 150.33 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 64.42 111.119 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 p -109.31 -40.82 4.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 64.11 111.149 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.606 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -159.62 -178.53 7.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 62.41 110.844 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.736 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -98.89 96.87 8.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 64.23 111.186 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -155.72 154.84 32.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 61.52 110.866 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.22 -20.59 28.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.3 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.92 16.25 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 74.25 110.838 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.02 -76.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 74.24 110.832 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.79 8.39 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.135 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.9 -36.38 33.66 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.698 -0.763 . . . . 73.43 112.476 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.24 16.16 49.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 64.2 112.401 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 92' ' ' ILE . 3.0 tt -58.16 -23.29 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 74.14 111.077 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -30.08 68.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 62.21 110.919 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.5 m -88.97 -19.92 25.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 62.41 111.1 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 57' ' ' SER . 15.0 mt -82.79 -32.44 27.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 74.42 110.892 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -95.15 23.76 5.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -122.13 -41.45 2.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 73.41 110.999 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -83.03 -49.8 9.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.805 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.45 39.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 51.3 112.479 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.551 HD13 ' HA ' ' A' ' 98' ' ' LEU . 3.6 mp -106.69 120.0 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 71.4 111.159 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.61 ' HB3' HD11 ' A' ' 124' ' ' LEU . 6.0 mttm -83.35 118.68 23.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.35 110.92 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.42 92.82 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 51.12 111.127 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.537 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.7 m-70 -64.98 143.3 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 71.01 110.841 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.583 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -178.49 -179.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 64.24 110.908 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.445 HG22 ' C ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -90.99 153.92 19.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 61.43 111.195 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.68 -35.1 13.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 74.02 111.105 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -69.17 -47.76 64.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 45.1 110.92 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.763 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.9 m -59.42 -18.61 40.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 73.53 111.081 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.57 11.4 39.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 74.1 111.049 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.499 ' CD ' HD22 ' A' ' 110' ' ' LEU . 3.5 pt-20 -113.91 -31.76 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 71.25 110.889 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.763 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -93.49 -13.33 27.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.866 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.453 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.049 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -24.95 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 75.4 110.928 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.59 -32.61 70.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 71.13 110.849 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -89.54 -24.82 21.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.897 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.24 23.16 3.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 30.34 112.484 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -98.38 177.59 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 75.03 110.973 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -76.34 178.99 6.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 72.03 110.885 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mp0 -112.58 105.66 55.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.609 0.718 . . . . 64.31 110.867 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.9 Cg_endo -69.82 178.68 4.37 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.709 2.273 . . . . 55.05 112.327 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 104' ' ' LYS . 20.1 mt -51.3 -48.34 62.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.52 110.862 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.09 38.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 74.04 112.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -107.11 41.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 75.34 110.9 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.583 HD12 ' CA ' ' A' ' 107' ' ' SER . 72.7 mt -124.93 -173.81 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 63.14 110.879 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.408 HE21 ' N ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -147.01 -172.92 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 65.22 110.842 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 144' ' ' TYR . 52.6 m -50.58 -71.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 73.23 111.161 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.756 HG23 HG22 ' A' ' 129' ' ' THR . 28.2 t -113.51 94.35 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 71.03 111.18 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.471 HG21 HD22 ' A' ' 127' ' ' LEU . 15.3 t -118.36 167.0 11.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 54.51 111.066 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.51 106.83 10.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 60.12 110.877 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.413 HD21 HD22 ' A' ' 127' ' ' LEU . 28.8 mt -79.72 -173.21 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 72.55 110.939 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.04 112.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 52.23 110.944 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' HE2' HD11 ' A' ' 83' ' ' ILE . 30.7 m-85 -110.49 74.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 74.34 110.83 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.51 -83.06 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 53.21 112.505 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -120.29 24.85 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.3 . . . . 64.44 110.893 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.401 ' HB2' HG22 ' A' ' 48' ' ' THR . 51.4 tpp -129.48 142.55 50.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.909 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.32 133.28 56.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 72.01 110.827 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.653 HG11 HD13 ' A' ' 83' ' ' ILE . 19.5 t -144.97 117.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 72.22 111.117 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -112.5 126.55 55.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 62.24 110.919 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 p -82.69 -178.19 7.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.183 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.404 ' HB3' HG23 ' A' ' 155' ' ' VAL . 19.4 t80 -166.49 134.06 2.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 73.13 110.929 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.772 ' HB3' HG23 ' A' ' 129' ' ' THR . 10.1 t80 -121.06 89.31 46.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.723 0.773 . . . . 73.32 110.971 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -8.12 22.8 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.706 2.27 . . . . 71.31 112.374 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.53 -157.67 20.38 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 52.03 112.495 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -84.66 137.69 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.724 0.297 . . . . 74.12 110.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.33 -89.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 63.54 112.516 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -75.1 -25.64 58.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 75.2 110.843 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 86' ' ' HIS . 29.9 p -147.32 -162.26 1.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.162 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.523 ' HB3' HD23 ' A' ' 114' ' ' LEU . 61.4 tt0 -84.53 -25.42 28.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 65.43 110.886 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 154' ' ' ILE . 19.2 t70 -135.8 24.05 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 65.53 110.961 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -50.41 128.06 18.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 62.4 110.88 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 152' ' ' ASP . 2.6 pt -135.12 173.0 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 72.51 111.074 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.8 m -124.42 150.0 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.41 111.076 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.87 111.77 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.15 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -101.28 132.83 46.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.596 HD21 HD21 ' A' ' 46' ' ' LEU . 6.3 mp -112.22 97.64 39.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 72.42 110.91 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.81 -4.86 14.91 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.619 2.212 . . . . 34.54 112.373 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.55 -26.56 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 72.44 110.958 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.53 19.14 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 71.3 111.005 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 50.51 29.28 3.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.524 . . . . 62.41 110.941 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.651 HD13 HD13 ' A' ' 21' ' ' LEU . 80.2 mt -91.64 120.01 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.117 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.576 HD23 HG22 ' A' ' 206' ' ' VAL . 34.3 tp -104.53 147.15 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 55.53 110.882 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.53 79.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 52.43 111.136 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.84 -49.81 46.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.734 -0.745 . . . . 54.4 112.456 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.32 -166.29 53.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 44.14 112.436 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -35.38 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 75.2 110.838 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.63 HD12 ' NE1' ' A' ' 189' ' ' TRP . 23.5 tp -51.59 -52.19 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 63.44 110.967 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 218' ' ' LEU . 21.2 t -84.02 109.44 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.31 111.161 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.72 ' HG2' HG23 ' A' ' 222' ' ' THR . 1.7 mmpt? -51.86 148.12 6.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.872 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 153.97 17.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 54.04 110.872 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 71.12 111.08 -179.912 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.755 0.312 . . . . 74.05 111.057 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.24 87.06 2.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.947 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.2 t -60.78 -18.18 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 53.01 111.141 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -74.28 -28.09 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 71.55 110.814 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.59 -12.34 14.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 40.41 110.796 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.63 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.7 t90 -53.28 -62.0 1.93 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.857 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.767 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -54.17 -24.09 16.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.831 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -82.39 -30.93 29.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 71.53 111.141 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -43.27 58.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 71.2 110.782 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.577 HG21 ' O ' ' A' ' 219' ' ' LEU . 28.9 mm -62.95 -43.0 98.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 73.52 111.172 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.44 -22.5 54.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.907 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -82.74 -22.4 34.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 53.12 110.94 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.14 -9.77 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 55.24 111.198 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.434 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.73 -12.49 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 62.44 110.933 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.404 ' N ' HD12 ' A' ' 197' ' ' LEU . 12.6 ptpt -100.51 -31.22 11.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.94 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.63 -49.28 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 73.32 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.416 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -95.81 60.73 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.926 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -71.28 -64.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.478 . . . . 74.03 110.819 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -51.49 104.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.916 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.677 HG21 ' CG2' ' A' ' 206' ' ' VAL . 89.9 mt -142.77 124.8 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.072 -0.513 . . . . 53.51 111.183 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -34.85 50.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.999 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.28 129.91 1.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 71.43 111.085 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 218' ' ' LEU . 95.5 t -103.52 133.58 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 73.23 111.181 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 213' ' ' VAL . 9.5 t -109.58 106.92 59.06 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.604 0.716 . . . . 72.42 111.029 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.1 Cg_endo -69.66 -168.61 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.679 2.253 . . . . 72.3 112.361 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.84 -13.43 57.94 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.68 -0.772 . . . . 62.42 112.574 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -152.32 138.52 18.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.853 0.358 . . . . 61.31 110.829 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.94 -106.41 2.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 74.35 112.539 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -167.47 162.12 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 71.24 110.923 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 207' ' ' VAL . 5.5 m -52.74 161.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.12 111.202 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.66 -98.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 64.42 112.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -169.01 -168.86 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.868 0.366 . . . . 75.11 110.937 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.464 ' HA ' HD23 ' A' ' 219' ' ' LEU . 15.7 pttm -61.69 -17.36 55.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.4 110.889 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.496 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.36 -19.21 39.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 62.22 112.463 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.734 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.9 mt -72.04 -32.92 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.859 0.361 . . . . 72.03 110.871 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.577 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.4 mm? -63.18 -58.52 6.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 62.32 110.986 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.496 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -61.02 -18.16 56.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.45 110.913 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -65.15 -51.42 61.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.861 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.72 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.7 m -52.22 -49.91 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 72.25 111.196 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.621 HD23 ' OG ' ' A' ' 190' ' ' SER . 0.9 OUTLIER -60.42 -18.31 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 51.14 110.932 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -92.1 -2.67 56.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 63.12 110.816 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.476 HD12 ' HG3' ' A' ' 171' ' ' LYS . 6.9 mt -126.25 -5.98 6.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 72.42 110.962 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.767 HD11 ' HB2' ' A' ' 190' ' ' SER . 0.4 OUTLIER -119.92 2.46 11.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 63.32 110.913 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 53.31 110.862 179.85 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.0 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.85 0.357 . . . . 71.33 111.104 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.9 mt -136.2 91.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 73.51 111.177 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 116.39 30.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.909 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -59.82 168.15 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.889 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.7 -47.9 63.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 65.12 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.8 p -60.68 -37.68 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.172 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.77 13.15 61.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.674 -0.774 . . . . 54.22 112.505 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -80.36 -43.96 20.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 75.15 111.108 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -102.95 116.54 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 71.51 111.135 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 71.35 110.851 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.73 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -121.87 112.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 54.24 111.087 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.412 ' HA ' HG12 ' A' ' 8' ' ' VAL . 13.7 t -98.82 125.66 44.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 41.13 110.82 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -68.6 110.57 4.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 73.14 110.94 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.073 HD21 HG21 ' A' ' 213' ' ' VAL . 14.2 mt -63.83 -31.35 72.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 62.42 110.971 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -153.48 -96.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 75.1 110.889 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.44 9.66 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.929 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.448 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.77 7.74 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 61.4 110.883 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.74 143.27 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 74.15 111.094 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.73 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.5 m95 -131.02 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 55.34 110.959 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 43' ' ' GLY . 98.7 t -135.43 89.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 64.44 111.19 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -72.27 121.66 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.871 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.4 m -119.62 104.67 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 62.44 111.143 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -87.59 125.78 34.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.944 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 110.39 21.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.878 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.702 -0.761 . . . . 72.13 112.468 179.862 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.614 0.721 . . . . 72.3 111.177 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 117.87 5.34 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.683 2.255 . . . . 72.11 112.31 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 p -109.67 97.63 7.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 35.41 110.811 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -63.22 164.62 8.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 65.54 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -153.99 -144.81 4.0 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.69 -0.767 . . . . 74.25 112.466 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.65 HD21 HD11 ' A' ' 158' ' ' LEU . 16.4 tp -158.81 120.12 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 71.2 110.862 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.658 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -105.29 122.29 58.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.168 -0.469 . . . . 71.41 111.126 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 16.0 mt -102.14 121.01 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 73.02 110.944 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.63 85.08 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 73.45 110.831 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.14 173.01 8.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 62.1 111.149 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.25 4.26 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 73.42 110.817 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 -20.58 9.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 53.34 110.91 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.31 138.36 2.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 34.22 112.5 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.691 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.9 mt -54.63 157.63 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 63.34 110.896 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 19.0 t -145.32 141.0 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 72.54 111.112 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.682 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.1 mt -137.61 124.16 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.54 110.945 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.649 HG12 ' OD1' ' A' ' 56' ' ' ASP . 53.6 t -68.57 107.66 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 63.24 111.034 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.649 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.5 m-20 71.51 134.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 60.34 110.927 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.587 ' CB ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -72.15 -165.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 62.24 110.806 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 t -92.37 175.01 7.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.41 110.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.734 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.0 m95 -51.27 -60.41 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.918 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -132.55 161.71 33.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.24 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -51.77 -33.47 35.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 54.1 110.854 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -59.03 -33.76 71.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.897 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.4 mt -89.25 -45.73 9.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.903 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.409 HG21 HD21 ' A' ' 98' ' ' LEU . 1.1 m -50.8 -47.45 59.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 73.23 111.147 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -54.45 -47.48 72.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 71.3 110.872 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.31 -19.4 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.863 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.5 tp -88.4 -27.96 21.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 71.51 110.881 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.5 mt -89.41 -22.99 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.35 111.12 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.88 16.84 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptm -131.01 -39.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 73.42 110.899 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 67' ' ' LEU . 35.1 m -80.95 -24.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 61.34 111.071 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.656 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.85 -21.86 66.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.861 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -109.49 -32.31 7.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.898 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -72.18 -41.95 66.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.826 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.5 m-85 -88.05 -12.35 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.855 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.37 13.73 8.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 71.54 110.983 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.15 140.14 46.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 75.33 110.863 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -86.1 140.45 30.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.885 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 52' ' ' LEU . 99.4 t -80.07 122.3 35.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.12 111.11 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -136.67 8.16 3.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 65.24 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -151.28 136.08 17.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 71.23 110.927 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 54' ' ' LEU . 15.0 t -147.68 127.75 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 72.22 111.09 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 140' ' ' VAL . 27.4 mt -93.49 122.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 73.21 111.132 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.447 HG21 HG22 ' A' ' 92' ' ' ILE . 20.3 mm -94.33 140.18 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 52.1 111.144 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.48 HG23 ' OD2' ' A' ' 56' ' ' ASP . 65.9 p -86.86 -55.83 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 63.13 111.12 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.586 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.4 p-80 -152.15 -175.2 5.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.419 . . . . 64.02 110.96 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.861 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -89.21 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.42 111.054 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.72 149.84 22.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.3 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.45 -19.53 24.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 75.14 111.143 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.5 9.76 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 65.31 110.946 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.13 -77.27 0.52 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.81 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.447 HG22 HG21 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -88.71 8.14 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 63.3 111.048 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.39 -41.5 40.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 74.55 112.438 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 14.46 56.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.746 . . . . 32.51 112.498 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.7 tt -51.7 -29.92 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 74.5 111.139 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -35.56 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 73.3 110.87 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -79.94 -23.99 41.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 63.24 111.161 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HA ' HD13 ' A' ' 103' ' ' ILE . 9.2 mt -82.93 -28.25 30.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.989 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -94.04 19.47 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.956 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -121.71 -45.51 2.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 71.13 110.846 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -74.35 -52.39 12.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 75.12 110.856 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.8 42.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.683 -0.77 . . . . 62.11 112.463 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.609 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.6 mp -106.31 128.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 70.34 111.23 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.639 ' HB3' HD11 ' A' ' 124' ' ' LEU . 5.0 mtmm -84.19 105.86 15.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 72.32 110.937 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.02 92.83 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 73.12 111.205 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.669 ' HA ' HD12 ' A' ' 124' ' ' LEU . 48.1 m-70 -69.65 146.14 51.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 73.23 110.886 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.62 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -174.26 179.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 60.45 110.901 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.45 154.27 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 64.12 111.07 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.11 40.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 52.5 111.081 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -41.18 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.91 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.706 ' HA ' HD11 ' A' ' 114' ' ' LEU . 99.8 m -58.44 -20.69 46.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.02 111.123 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.56 8.44 41.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 74.04 111.055 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -107.81 -31.56 7.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 73.52 110.838 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.861 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -96.09 -12.83 24.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 71.43 110.967 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.402 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -67.98 -37.14 81.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 64.12 111.104 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.47 -24.45 59.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.927 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.52 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 73.42 110.898 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -90.29 -22.06 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 60.04 110.951 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.53 25.51 4.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.829 -0.7 . . . . 60.25 112.434 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.59 175.68 5.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.899 0.381 . . . . 74.13 110.935 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.83 162.17 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.951 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -94.89 108.4 37.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.57 0.7 . . . . 70.03 110.916 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.552 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.71 -177.42 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.282 . . . . 60.05 112.363 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 106' ' ' HIS . 81.8 mt -54.21 -54.46 39.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 62.22 110.878 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.52 73.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 62.11 112.428 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -99.03 33.54 2.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 74.44 110.848 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 107' ' ' SER . 86.7 mt -116.65 -174.6 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.923 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 -170.45 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 53.1 110.871 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.845 HG22 HG23 ' A' ' 130' ' ' VAL . 48.5 m -50.49 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.43 111.21 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.845 HG23 HG22 ' A' ' 129' ' ' THR . 38.2 t -116.22 93.56 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 70.55 111.1 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.688 HG22 ' OG1' ' A' ' 142' ' ' THR . 14.5 t -113.05 164.97 12.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 63.41 111.116 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.18 102.96 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 65.43 110.907 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 140' ' ' VAL . 28.4 mt -76.02 -173.06 2.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 73.32 110.918 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -171.31 110.23 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.843 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.92 -167.57 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 60.5 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -57.63 95.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.765 -0.731 . . . . 73.32 112.461 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 53.75 25.92 5.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.391 . . . . 42.54 110.912 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.4 tpp -129.19 140.03 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.47 135.91 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.53 110.912 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' A' ' 83' ' ' ILE . 6.1 t -143.72 116.88 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 61.33 111.179 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -112.88 126.58 55.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 63.2 110.893 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.688 ' OG1' HG22 ' A' ' 131' ' ' THR . 18.8 p -83.39 174.27 10.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.127 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.431 ' HB3' HG23 ' A' ' 155' ' ' VAL . 20.8 t80 -158.78 137.61 11.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.937 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.657 ' HB3' HG23 ' A' ' 129' ' ' THR . 90.5 t80 -127.82 89.31 51.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.738 0.78 . . . . 72.33 110.985 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.2 Cg_endo -69.69 -7.61 21.47 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.671 2.247 . . . . 70.11 112.374 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.03 -150.17 19.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 40.42 112.484 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -95.24 141.1 29.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 63.43 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.424 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -157.43 -90.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 62.53 112.535 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -74.76 -23.05 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.332 . . . . 73.41 110.759 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 86' ' ' HIS . 69.2 p -151.23 -171.39 3.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 60.03 111.177 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.546 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.1 tt0 -84.94 -3.32 58.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 75.12 110.893 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 154' ' ' ILE . 19.4 t0 -150.18 19.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 53.44 110.944 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.58 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.4 OUTLIER -50.57 130.72 24.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.11 110.887 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 152' ' ' ASP . 3.2 pt -135.17 175.48 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 42.53 111.138 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -132.87 123.93 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 65.05 111.03 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.96 119.04 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.129 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -107.79 139.12 42.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.65 HD11 HD21 ' A' ' 44' ' ' LEU . 87.7 mt -119.79 99.73 49.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.63 0.728 . . . . 73.04 110.862 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.1 Cg_endo -69.79 -4.79 14.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.688 2.259 . . . . 52.21 112.289 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -84.78 -30.38 24.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.947 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -131.49 11.21 4.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 70.41 110.923 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.5 m120 55.05 26.0 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.846 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.558 HD13 HD13 ' A' ' 21' ' ' LEU . 86.8 mt -90.95 143.83 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.129 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.557 HD22 HD13 ' A' ' 203' ' ' ILE . 15.2 tp -125.54 145.43 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 62.33 110.916 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.459 HG11 HG11 ' A' ' 55' ' ' VAL . 94.9 t -108.17 81.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 61.22 111.219 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.44 -31.42 28.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.703 -0.76 . . . . 75.45 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 56.69 -168.63 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 33.01 112.453 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -29.68 20.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.336 . . . . 72.52 110.842 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.58 HD13 ' OD1' ' A' ' 153' ' ' ASN . 24.8 tp -55.65 -55.14 35.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 75.1 110.946 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.513 HG13 ' HA ' ' A' ' 219' ' ' LEU . 19.9 t -87.55 107.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 75.1 111.13 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -52.15 170.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.53 110.904 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.31 158.63 26.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 44.41 110.883 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.081 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.796 0.332 . . . . 74.13 111.108 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.35 92.39 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 74.23 110.982 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.0 t -63.46 -22.92 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 44.25 111.134 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -71.65 -31.3 66.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 71.03 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.29 -13.05 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.03 110.916 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.501 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.4 t90 -55.09 -62.56 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 73.4 110.918 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.761 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.88 -24.51 16.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 61.35 110.829 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 57.7 m -80.39 -32.23 37.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 72.2 111.1 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -42.74 58.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.833 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.523 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.1 mm -62.91 -44.39 99.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.42 111.134 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.492 ' HG2' HD11 ' A' ' 223' ' ' LEU . 2.1 mm-40 -58.23 -22.89 53.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 41.05 110.807 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -82.45 -22.31 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 71.12 110.895 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 196' ' ' VAL . 16.1 t -87.19 -8.89 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 75.41 111.064 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -113.5 -6.79 13.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 71.4 110.946 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.6 -31.19 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 72.13 110.897 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -104.22 -55.95 2.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 75.35 110.871 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -94.99 38.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 75.34 110.827 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -55.97 -47.71 77.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.889 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -59.97 101.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.03 110.951 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.743 HG21 HG22 ' A' ' 206' ' ' VAL . 40.1 mt -143.65 127.54 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 63.33 111.161 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.01 -23.13 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 62.44 110.934 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.722 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -168.04 132.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.073 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.749 ' HB ' HD12 ' A' ' 218' ' ' LEU . 59.0 t -114.79 132.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 51.43 111.163 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 213' ' ' VAL . 9.7 t -110.35 109.33 58.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 62.44 111.111 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.8 Cg_endo -69.75 178.02 4.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.658 2.239 . . . . 42.02 112.381 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.51 -18.86 74.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 71.21 112.486 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -152.83 141.67 21.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 74.54 110.879 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.49 -117.48 4.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 70.15 112.474 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -152.25 174.07 14.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 72.53 110.918 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.073 HG21 HD21 ' A' ' 21' ' ' LEU . 5.4 t -69.31 149.98 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 50.31 111.129 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.81 -101.47 0.31 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 72.13 112.515 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.25 -169.0 1.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 71.0 110.823 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -17.83 54.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 71.51 110.872 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.473 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.37 -20.11 43.14 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.772 -0.727 . . . . 44.11 112.41 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.749 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.2 mt -73.48 -30.07 62.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 74.1 110.921 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.523 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.866 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.473 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.4 OUTLIER -59.12 -22.5 60.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.901 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.24 -44.67 95.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.12 110.826 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.698 HG22 HD23 ' A' ' 226' ' ' LEU . 11.5 m -56.48 -56.62 18.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 54.34 111.003 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' A' ' 194' ' ' GLU . 1.0 OUTLIER -52.82 -28.86 24.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.432 . . . . 72.31 110.929 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -32.52 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.92 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 12.9 mt -88.39 -18.18 28.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.849 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.761 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.3 OUTLIER -114.94 18.84 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.91 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 74.44 110.933 179.762 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.832 0.349 . . . . 51.33 111.147 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.3 mt -110.73 98.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 44.41 111.166 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -118.17 115.39 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 73.23 110.879 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -60.57 166.41 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 71.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -51.45 -48.43 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 74.21 110.923 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 p -62.57 -36.97 84.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 62.44 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 13.9 63.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 34.31 112.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 m -78.84 -45.4 20.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 62.23 111.197 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.554 HG21 HD13 ' A' ' 67' ' ' LEU . 39.6 mt -103.85 112.36 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 63.02 111.129 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -118.04 133.95 55.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 52.21 110.814 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.791 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -125.51 112.24 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 54.35 111.162 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -98.46 125.57 43.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.864 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -69.34 109.94 4.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 75.32 110.966 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.592 HD21 HG11 ' A' ' 213' ' ' VAL . 16.8 mt -63.51 -32.69 74.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.94 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.457 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -152.58 -96.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 72.52 110.884 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.457 ' N ' HD22 ' A' ' 22' ' ' ASN . 10.0 mttp -150.24 9.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.873 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.75 8.17 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.861 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -150.89 141.82 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 70.32 111.086 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.791 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.9 m95 -130.21 -176.8 4.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 71.22 110.916 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.475 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.3 t -134.69 90.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 72.12 111.215 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -73.79 122.17 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 72.13 110.838 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.5 m -119.89 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.097 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.99 125.34 33.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 73.33 110.812 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.37 110.62 20.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 71.41 110.949 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 71.35 112.478 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.584 0.707 . . . . 64.45 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 117.67 5.23 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.736 2.291 . . . . 73.44 112.362 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.9 p -109.96 97.08 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 71.35 110.892 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -59.37 165.36 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 73.24 110.859 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -156.13 -148.89 5.19 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.712 -0.756 . . . . 62.45 112.437 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 158' ' ' LEU . 15.3 tp -158.49 118.34 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 74.01 110.909 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.671 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -103.16 122.31 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.084 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.802 HD21 HD11 ' A' ' 158' ' ' LEU . 14.4 mt -100.77 120.57 40.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.907 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -90.52 84.7 5.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.82 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -97.52 -175.32 3.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.33 111.194 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.4 -21.97 13.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 72.11 110.878 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -83.99 -15.73 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 60.14 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.4 150.25 5.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.815 -0.707 . . . . 51.44 112.539 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.714 ' HB3' HG22 ' A' ' 79' ' ' VAL . 2.0 mt -61.75 156.94 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.23 110.948 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 16.8 t -145.48 141.96 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 54.54 111.163 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.675 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.1 mt -137.87 124.62 21.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 73.13 110.895 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.647 HG12 ' OD1' ' A' ' 56' ' ' ASP . 54.7 t -67.59 106.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 72.15 111.162 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.647 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.4 m-20 70.81 131.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 55.3 110.893 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.638 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -69.41 -164.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 51.2 110.87 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -90.38 -179.85 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 61.1 110.876 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.726 ' HB2' HD12 ' A' ' 63' ' ' LEU . 96.7 m95 -57.86 -51.54 69.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.483 . . . . 74.23 110.937 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -139.69 161.81 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 60.43 110.77 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.04 -32.62 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.24 110.818 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -59.86 -42.53 93.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.5 mt -80.01 -46.89 15.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 54.35 110.898 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.12 -45.74 53.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 63.5 111.121 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -54.78 -48.39 72.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 72.43 110.848 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.49 -19.82 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.945 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.7 tp -88.2 -27.04 22.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 72.51 110.872 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -90.59 -23.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.14 111.181 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.16 15.0 14.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.496 . . . . 74.32 110.953 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.7 ptm -129.83 -39.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 62.14 110.889 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.1 m -80.45 -22.76 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.14 111.153 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.667 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.42 -21.93 65.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.22 110.822 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -109.2 -32.37 7.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.92 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -37.64 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 75.41 110.837 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.547 ' HB2' HD11 ' A' ' 52' ' ' LEU . 12.6 m-85 -92.58 -11.62 33.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 74.34 110.879 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.36 11.71 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.883 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -132.25 141.0 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 62.52 110.898 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -87.46 140.56 29.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 63.5 110.93 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' A' ' 52' ' ' LEU . 97.3 t -80.71 124.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 73.54 111.117 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -138.98 10.14 2.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 73.43 111.08 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -153.3 135.61 14.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 75.43 110.836 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 54' ' ' LEU . 17.2 t -148.02 125.55 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 71.43 111.13 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 140' ' ' VAL . 27.5 mt -91.28 124.59 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 72.34 111.097 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.486 HG21 HG22 ' A' ' 92' ' ' ILE . 18.6 mm -95.99 138.71 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 74.04 111.154 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.6 p -84.45 -49.13 8.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 72.44 111.176 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.5 p-80 -159.71 -175.37 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 60.01 110.932 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -87.58 98.36 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 64.34 111.071 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.32 149.61 24.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.857 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.46 30.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 72.52 111.055 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.04 10.04 28.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.882 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 27.8 mmt180 -129.83 -77.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 64.44 110.91 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.486 HG22 HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -88.88 8.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 53.55 111.102 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.47 -41.75 41.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.703 -0.761 . . . . 65.04 112.494 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.9 12.71 62.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 71.43 112.374 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.8 tt -51.52 -28.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 54.25 111.132 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -38.26 64.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 61.45 110.834 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -79.86 -27.5 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.142 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.638 HD11 ' OG ' ' A' ' 57' ' ' SER . 10.8 mt -75.05 -30.74 61.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 72.54 110.9 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -92.51 16.26 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 72.32 110.859 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -119.48 -48.23 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.44 110.816 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -72.73 -56.13 5.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.243 -0.435 . . . . 62.32 110.855 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.95 42.63 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.807 -0.711 . . . . 55.04 112.447 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.8 mp -105.64 120.33 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.429 . . . . 74.34 111.17 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -78.1 109.76 12.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 51.33 110.911 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.63 101.25 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 72.34 111.054 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.569 ' HA ' HD12 ' A' ' 124' ' ' LEU . 40.4 m-70 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 54.31 110.91 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.644 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -176.64 -176.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.881 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 154.47 20.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 50.3 111.14 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.77 -40.65 55.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 72.41 111.068 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -67.95 -40.72 83.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.94 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.769 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.7 m -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 72.33 111.133 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.55 52.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 63.32 111.095 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.37 -59.23 1.74 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.11 110.893 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.39 -13.14 60.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.956 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -64.9 -43.43 92.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 43.11 111.072 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -26.3 63.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 74.42 110.895 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -55.2 -35.96 65.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 74.3 110.852 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -89.65 -20.85 23.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 72.45 110.872 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.85 21.75 5.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 73.25 112.401 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -94.65 170.46 9.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 74.52 110.883 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -70.83 -176.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 72.05 110.867 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -117.23 103.92 50.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 74.35 110.923 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.7 Cg_endo -69.8 -171.69 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.717 2.278 . . . . 63.24 112.391 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 106' ' ' HIS . 96.0 mt -59.39 -54.66 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 62.3 110.959 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.48 24.18 63.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.821 -0.704 . . . . 61.54 112.4 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 24.62 6.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 75.21 110.944 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.659 ' CD2' HD21 ' A' ' 133' ' ' LEU . 91.3 mt -107.09 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 65.35 110.935 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.33 -170.28 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 54.22 110.885 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.948 HG22 HG23 ' A' ' 130' ' ' VAL . 43.8 m -49.93 -70.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 70.54 111.154 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.948 HG23 HG22 ' A' ' 129' ' ' THR . 42.4 t -120.31 110.25 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.41 111.123 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -139.77 172.47 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 71.45 111.157 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 71.31 110.914 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.659 HD21 ' CD2' ' A' ' 127' ' ' LEU . 52.4 mt -115.34 167.35 10.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 73.3 110.898 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -147.64 137.09 22.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 71.03 110.93 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.504 ' HE2' HD11 ' A' ' 83' ' ' ILE . 36.9 m-85 -134.19 40.47 3.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.898 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 93.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 51.03 112.4 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.38 14.12 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 65.31 110.877 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.5 tpp -138.39 100.9 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 64.42 110.874 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -90.69 137.84 32.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.42 110.781 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 83' ' ' ILE . 57.8 t -139.67 117.42 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 71.35 111.099 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.96 129.17 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 74.22 110.942 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.8 p -85.54 -179.44 6.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 75.14 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.445 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.6 t80 -164.39 133.6 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.42 110.883 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.641 ' HB3' HG23 ' A' ' 129' ' ' THR . 88.4 t80 -123.96 88.44 52.42 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.796 0.808 . . . . 75.01 110.95 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.569 2.179 . . . . 75.23 112.352 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.92 -144.88 16.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.802 -0.713 . . . . 74.0 112.504 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -101.5 141.64 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 72.31 110.901 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.45 -90.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.705 -0.759 . . . . 71.13 112.475 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -74.78 -23.43 58.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 73.3 110.858 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.478 HG21 ' HB2' ' A' ' 86' ' ' HIS . 65.5 p -150.57 -169.36 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 52.02 111.153 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.627 ' HB3' HD23 ' A' ' 114' ' ' LEU . 2.7 tt0 -85.81 -12.94 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.871 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 154' ' ' ILE . 15.3 t0 -138.61 20.93 2.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 63.1 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.77 130.38 24.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.3 110.897 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 152' ' ' ASP . 6.6 pt -137.19 169.04 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 71.55 111.125 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -127.32 122.52 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 45.32 111.176 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.476 ' O ' HD12 ' A' ' 164' ' ' LEU . 80.5 t -75.72 131.76 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 73.03 111.148 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -117.54 130.07 56.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 65.51 110.826 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.802 HD11 HD21 ' A' ' 46' ' ' LEU . 9.8 mt -110.68 98.64 38.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 60.22 110.909 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.9 Cg_endo -69.75 -4.42 13.99 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.659 2.24 . . . . 60.13 112.336 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.21 -23.64 32.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 75.44 110.832 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -144.0 14.15 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 63.54 110.941 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.9 m120 54.26 26.79 7.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 74.51 110.844 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.547 HD13 HD13 ' A' ' 21' ' ' LEU . 97.4 mt -91.9 128.79 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 73.53 111.089 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 156' ' ' VAL . 17.6 tp -113.49 145.92 40.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.887 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.554 HG11 HG11 ' A' ' 55' ' ' VAL . 21.4 t -109.62 83.64 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 71.21 111.175 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.51 -34.84 35.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.617 -0.801 . . . . 62.25 112.58 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.33 -167.92 26.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 61.53 112.531 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -29.65 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 63.15 110.813 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.632 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.8 tp -54.84 -61.82 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 55.43 110.933 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.553 HG13 ' HA ' ' A' ' 219' ' ' LEU . 47.2 t -78.33 110.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 55.45 111.168 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.742 ' HG2' HG23 ' A' ' 222' ' ' THR . 19.5 mmmt -51.8 169.02 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.941 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.53 146.4 42.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 73.21 110.857 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 75.52 111.245 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.823 0.344 . . . . 74.32 111.067 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -106.74 86.76 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 72.22 110.911 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.7 -19.64 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 73.33 111.127 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -73.3 -31.21 63.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 65.21 110.886 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -104.84 -11.62 16.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 72.43 110.953 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.632 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.7 t90 -55.0 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 73.3 110.846 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.703 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.84 -24.71 16.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 33.25 110.865 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -81.08 -31.82 34.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 54.13 111.241 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -73.68 -42.77 60.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 55.14 110.826 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.9 mm -61.95 -44.69 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 70.5 111.106 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -58.44 -23.89 58.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 62.4 110.882 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -83.59 -22.19 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.766 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 192' ' ' SER . 5.4 t -87.61 -9.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 64.43 111.142 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -111.94 -8.4 14.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 64.14 110.958 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -104.09 -30.96 9.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.895 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.9 -52.27 2.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -97.24 37.78 1.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.95 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -56.46 -47.73 78.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 63.23 110.894 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -59.34 98.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 73.02 110.939 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.726 HG21 HG22 ' A' ' 206' ' ' VAL . 61.8 mt -140.23 127.89 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 71.44 111.18 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.18 -22.88 30.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 73.42 110.87 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.75 123.51 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 63.04 111.13 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.726 HG22 HG21 ' A' ' 203' ' ' ILE . 93.2 t -102.5 137.9 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 73.42 111.05 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.891 HG22 HG12 ' A' ' 213' ' ' VAL . 3.4 t -115.84 108.81 46.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.693 0.759 . . . . 45.52 111.129 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.503 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.6 Cg_endo -69.7 179.21 3.82 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.664 2.242 . . . . 74.25 112.348 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.74 -13.58 82.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.761 -0.733 . . . . 60.42 112.532 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -152.89 138.1 17.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 63.22 110.854 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.74 -118.67 5.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 73.21 112.5 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -150.91 163.93 37.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 72.34 110.95 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.891 HG12 HG22 ' A' ' 207' ' ' VAL . 4.3 m -60.3 161.43 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 64.25 111.127 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.13 -93.09 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 54.33 112.389 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -174.83 -167.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 72.21 110.895 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -58.05 -20.26 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.13 110.932 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.35 -23.45 26.5 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.647 -0.787 . . . . 70.12 112.452 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.8 mt -75.97 -33.1 59.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.894 0.378 . . . . 74.33 110.944 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.553 ' HA ' HG13 ' A' ' 170' ' ' VAL . 5.7 mp -61.58 -62.84 1.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.913 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -22.44 47.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 65.31 110.942 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.69 -46.67 88.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.83 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.742 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.4 m -51.27 -53.31 36.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.45 111.116 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.77 -20.15 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 72.21 110.971 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.41 -4.32 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 71.14 110.868 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.2 mt -125.27 -7.2 7.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.875 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.703 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -119.67 10.26 11.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 51.45 110.91 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 73.52 110.965 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.829 0.347 . . . . 72.41 111.145 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.4 mt -136.31 92.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 72.35 111.115 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -111.52 118.07 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 74.22 110.891 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -58.37 -176.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.856 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.21 -45.34 73.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 64.12 110.851 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.4 p -61.9 -37.67 85.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 73.12 111.133 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.05 12.32 60.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 52.21 112.533 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -80.78 -43.32 20.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.74 0.305 . . . . 73.4 111.175 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.36 125.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 55.22 111.17 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -133.02 129.92 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.54 110.836 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.769 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -120.9 111.12 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 62.31 111.138 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.5 t -100.76 127.6 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 62.21 110.862 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -71.23 111.64 6.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 65.42 110.873 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.6 ' HG ' HG23 ' A' ' 27' ' ' VAL . 27.3 mt -65.19 -31.55 72.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 75.3 110.955 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.73 -97.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 61.33 110.908 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.7 OUTLIER -151.44 10.14 0.57 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.43 . . . . 55.1 110.975 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.438 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.51 6.37 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 64.51 110.856 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.84 139.46 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 74.54 111.126 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.769 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.5 m95 -127.23 -179.58 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 73.54 110.957 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.6 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.1 t -131.99 97.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 64.31 111.144 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -80.51 121.14 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 70.43 110.901 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -117.62 104.81 11.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.11 111.146 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.683 ' CD ' HD22 ' A' ' 67' ' ' LEU . 5.3 mp0 -89.27 120.94 31.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 73.42 110.865 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -85.43 101.55 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 44.13 110.831 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 65.02 112.448 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.445 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 1.5 t . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 121.613 0.72 . . . . 75.32 111.111 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 119.4 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.698 2.265 . . . . 72.05 112.417 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.1 p -99.76 96.92 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.866 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -49.51 159.8 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 63.02 110.845 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.591 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -155.65 -168.15 18.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.678 -0.772 . . . . 55.11 112.483 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.619 HD21 HD12 ' A' ' 158' ' ' LEU . 17.5 tp -152.49 113.56 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.354 . . . . 75.35 110.895 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.63 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -97.77 120.47 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.11 111.097 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.737 HD21 HD11 ' A' ' 158' ' ' LEU . 25.3 mt -97.78 115.95 29.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 64.23 110.903 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.42 87.44 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 60.52 110.92 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 179.8 4.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 54.01 111.17 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -100.28 -22.8 14.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 70.53 110.859 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -11.44 58.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 65.52 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.37 153.34 5.86 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.646 -0.787 . . . . 44.14 112.471 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.1 tp -67.25 155.04 39.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 75.42 110.957 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.6 t -145.91 142.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.11 111.104 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.63 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.3 mt -137.07 125.48 23.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.31 110.879 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -71.21 112.18 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 75.31 111.114 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.431 ' HB2' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 72.64 132.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 65.45 110.921 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.587 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -75.36 -166.98 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 54.53 110.853 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.48 ' H ' HG23 ' A' ' 64' ' ' THR . 13.1 t -91.41 169.1 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 70.45 110.911 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.688 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.1 m95 -49.5 -60.57 2.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.994 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -125.44 165.18 18.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 34.31 110.833 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.24 -37.69 75.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 62.44 110.852 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.21 -33.74 67.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 59' ' ' TRP . 83.7 mt -82.6 -47.2 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 65.24 110.956 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.61 -46.44 58.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.102 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.05 -49.63 65.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 71.24 110.89 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -64.76 -19.85 66.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.968 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD22 ' CD ' ' A' ' 30' ' ' GLU . 18.6 tp -87.8 -27.16 22.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 40.54 110.904 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.83 -23.13 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.081 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.69 16.0 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 64.33 110.901 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.87 -39.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 73.21 110.872 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.8 m -81.21 -22.43 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.112 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.577 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.89 -24.48 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 64.45 110.813 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -106.31 -34.24 7.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.471 . . . . 65.33 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -41.3 79.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.82 -10.75 38.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 65.31 110.886 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 67.52 11.97 8.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 61.23 110.875 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.549 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -128.93 137.62 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 64.41 110.856 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.74 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.2 110.875 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' OE2' ' A' ' 72' ' ' GLU . 80.0 t -76.26 121.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.146 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 t -135.68 7.78 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 75.44 111.118 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.544 ' O ' HG13 ' A' ' 53' ' ' VAL . 62.7 m-20 -150.8 145.03 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.14 110.877 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 54' ' ' LEU . 12.2 t -154.53 132.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 70.14 111.189 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.498 HD13 HG11 ' A' ' 140' ' ' VAL . 5.9 mt -95.19 125.84 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 61.13 111.158 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.35 147.7 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.215 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -98.16 -55.54 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 62.21 111.222 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.451 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.4 p-80 -152.96 -175.16 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.812 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.866 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -90.01 97.46 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 50.45 111.139 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.18 150.13 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 70.05 110.792 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.38 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 75.52 111.046 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.12 23.6 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 61.02 110.791 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.431 ' HD3' ' HB2' ' A' ' 56' ' ' ASP . 27.3 mmt180 -144.89 -76.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.44 110.912 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.12 7.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 62.12 111.113 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.74 -40.08 40.4 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 75.32 112.477 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.41 14.88 59.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 51.15 112.492 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.2 tt -55.45 -27.33 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.397 . . . . 73.51 111.125 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -54.91 -34.36 63.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 74.2 110.928 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -84.57 -22.7 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.54 111.138 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.605 ' HA ' HD13 ' A' ' 103' ' ' ILE . 11.7 mt -82.13 -28.67 32.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.915 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -96.92 22.22 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 73.55 110.952 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -122.63 -43.14 2.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 75.11 110.94 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -80.36 -52.78 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 61.41 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.79 43.96 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 41.22 112.534 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.605 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -108.07 118.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 71.32 111.159 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HE3' HD21 ' A' ' 124' ' ' LEU . 19.6 mtpp -77.77 111.33 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.14 110.915 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.84 90.91 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 64.42 111.077 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.564 ' HA ' HD12 ' A' ' 124' ' ' LEU . 57.1 m-70 -62.47 143.15 57.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 71.21 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB2' HG21 ' A' ' 111' ' ' THR . 1.1 p -173.96 176.7 2.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.908 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.33 157.92 19.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 63.11 111.16 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.89 -38.96 52.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 52.31 111.097 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.649 HD21 ' HG2' ' A' ' 151' ' ' GLU . 28.9 tp -73.63 -37.52 65.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.894 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.744 ' HA ' HD11 ' A' ' 114' ' ' LEU . 98.1 m -57.82 -29.36 64.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 63.53 111.115 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.88 0.21 57.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 65.14 111.058 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -99.25 -58.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 73.34 110.792 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.866 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -67.32 -12.27 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 64.51 110.925 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -66.1 -44.58 83.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 71.33 111.162 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -28.82 65.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.878 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -37.26 49.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 65.43 110.886 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -88.9 -21.89 23.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 54.1 110.854 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.89 20.63 5.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.734 -0.746 . . . . 61.33 112.491 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.56 172.07 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 64.45 110.974 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -70.92 -176.16 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 74.55 110.905 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.3 mt-10 -117.05 102.13 52.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.614 0.721 . . . . 72.34 110.849 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.2 Cg_endo -69.85 -176.22 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.621 2.214 . . . . 63.02 112.321 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.717 HD21 ' HE3' ' A' ' 104' ' ' LYS . 25.4 mt -51.84 -60.08 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.02 110.913 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.43 21.37 72.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 55.32 112.527 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -99.53 28.41 4.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 72.35 110.849 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.624 HD22 HD21 ' A' ' 133' ' ' LEU . 62.8 mt -109.52 -175.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.916 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.25 -170.77 3.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.937 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 130' ' ' VAL . 54.8 m -50.79 -70.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.04 111.147 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.906 HG23 HG22 ' A' ' 129' ' ' THR . 44.7 t -119.82 103.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 74.11 111.165 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -135.42 163.33 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 64.33 111.124 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.13 132.49 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.32 110.864 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.624 HD21 HD22 ' A' ' 127' ' ' LEU . 24.1 mt -115.08 167.2 11.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.939 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 133.5 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.52 110.941 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -134.2 49.09 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 65.32 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.19 92.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 62.24 112.539 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.89 14.59 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 75.32 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.0 tpp -134.13 110.31 9.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.832 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 131.14 44.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.79 HG22 HD21 ' A' ' 158' ' ' LEU . 21.3 t -137.34 117.33 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 74.34 111.064 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -110.75 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 75.35 110.887 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 p -86.62 177.29 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 62.11 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.503 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.2 t80 -159.3 134.78 8.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.14 110.865 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.697 ' HB3' HG23 ' A' ' 129' ' ' THR . 9.3 t80 -124.41 87.23 54.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.648 0.737 . . . . 73.22 110.901 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -7.95 22.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.744 2.296 . . . . 64.32 112.313 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.68 -158.48 22.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 72.15 112.399 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -86.81 138.83 31.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 72.35 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.7 -87.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 54.33 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -78.39 -23.38 46.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 63.34 110.872 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 86' ' ' HIS . 34.5 p -149.61 -165.62 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 63.15 111.153 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.649 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.0 tt0 -86.08 -18.44 32.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 75.11 110.851 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 154' ' ' ILE . 8.6 t0 -136.54 20.38 3.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 71.55 110.884 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.411 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.3 OUTLIER -51.75 129.04 25.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 71.43 110.872 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.451 HG22 ' CD1' ' A' ' 144' ' ' TYR . 9.3 pt -135.8 176.47 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 70.55 111.177 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.435 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.8 m -131.49 123.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 71.34 111.13 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.25 122.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 73.34 111.137 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -109.24 132.18 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.41 . . . . 54.41 110.888 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 140' ' ' VAL . 11.4 mt -112.9 97.98 43.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.52 0.676 . . . . 55.21 110.893 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.75 -4.84 14.83 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 75.11 112.31 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -82.66 -23.32 34.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.949 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 13.88 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.909 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.6 m120 54.49 27.92 8.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 51.2 110.912 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.443 HD13 HD13 ' A' ' 21' ' ' LEU . 96.1 mt -93.41 126.69 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 51.34 111.141 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.513 HD22 HD13 ' A' ' 203' ' ' ILE . 19.6 tp -110.61 147.31 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.967 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.28 78.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 41.4 111.181 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.31 -32.02 21.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.723 -0.751 . . . . 50.35 112.55 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 61.23 -160.44 27.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 71.32 112.508 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -28.38 64.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.863 0.363 . . . . 72.43 110.885 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.658 HD12 ' NE1' ' A' ' 189' ' ' TRP . 28.0 tp -56.26 -56.97 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.878 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' A' ' 219' ' ' LEU . 38.2 t -81.01 107.65 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 61.33 111.073 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -50.81 161.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.919 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.47 156.65 25.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 73.01 110.9 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.9 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 72.44 111.102 -179.896 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.767 0.318 . . . . 72.3 111.063 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -110.06 88.78 2.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 75.22 110.924 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.5 t -61.63 -17.47 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.195 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.74 -25.68 60.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 71.41 110.861 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -114.16 -11.95 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 63.22 110.85 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.658 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.6 t90 -55.1 -61.33 2.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.227 -0.442 . . . . 75.55 110.92 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.751 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.1 -25.57 13.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 70.54 110.816 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -80.66 -32.68 36.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 62.34 111.14 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.632 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.42 -42.3 65.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 63.44 110.881 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.422 HG21 ' O ' ' A' ' 219' ' ' LEU . 29.9 mm -62.52 -47.83 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 63.31 111.111 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.481 ' HG2' HD11 ' A' ' 223' ' ' LEU . 1.5 mm-40 -57.4 -28.57 63.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.919 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.71 -21.86 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.44 110.941 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 192' ' ' SER . 9.9 t -85.74 -11.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 44.43 111.144 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -111.28 -8.4 14.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.476 . . . . 74.3 110.938 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -30.49 10.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 55.35 110.955 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 -48.76 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.07 37.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 62.22 110.936 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -51.82 -48.58 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 71.32 110.848 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -60.08 105.1 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 64.33 110.936 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.526 HG21 HG22 ' A' ' 206' ' ' VAL . 47.5 mt -145.95 125.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 60.4 111.093 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -26.83 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 55.45 110.899 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.6 134.6 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 70.11 111.163 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.707 ' HB ' HD12 ' A' ' 218' ' ' LEU . 98.0 t -109.92 134.58 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 71.23 111.029 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.939 HG22 HG12 ' A' ' 213' ' ' VAL . 13.1 t -110.82 104.22 55.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 53.2 111.129 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.8 Cg_endo -69.74 174.18 9.87 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.709 2.273 . . . . 72.43 112.36 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.6 -13.08 83.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 71.24 112.42 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -152.85 150.17 29.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 71.11 110.799 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.59 -99.67 2.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 64.2 112.406 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -175.43 158.82 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 73.14 110.88 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.939 HG12 HG22 ' A' ' 207' ' ' VAL . 6.1 m -51.63 163.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 71.21 111.116 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -162.64 -105.31 0.19 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.735 -0.745 . . . . 61.45 112.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 -167.69 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.782 0.325 . . . . 73.51 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -21.11 25.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.819 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.83 -22.79 27.94 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 72.03 112.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.8 mt -74.87 -33.76 62.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 50.41 110.956 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.497 ' HA ' HG13 ' A' ' 170' ' ' VAL . 5.3 mp -60.88 -62.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.974 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -22.13 51.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 43.34 110.945 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -63.27 -36.91 85.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.33 110.898 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.687 HG22 ' CD2' ' A' ' 226' ' ' LEU . 3.7 m -62.78 -56.95 12.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 55.52 111.137 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.481 HD11 ' HG2' ' A' ' 194' ' ' GLU . 1.4 mt -54.91 -29.47 56.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 53.33 110.859 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.04 -35.44 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 72.13 110.869 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 10.3 mt -86.66 -16.11 37.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 71.3 110.921 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.751 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -119.04 20.71 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.8 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 73.32 110.822 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.813 0.339 . . . . 73.54 111.147 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.6 mt -113.36 101.2 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.21 111.11 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -121.07 120.46 35.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.912 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -66.28 167.56 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 70.43 110.918 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -51.71 -48.46 63.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 70.54 110.919 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 p -61.69 -37.52 84.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.12 111.095 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 10.59 67.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.828 -0.701 . . . . 74.14 112.47 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -77.48 -45.33 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 51.24 111.132 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 67' ' ' LEU . 64.1 mt -101.7 110.9 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.257 -0.429 . . . . 63.5 111.155 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 p -117.83 138.13 52.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.4 110.819 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.789 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -129.74 109.81 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 74.31 111.113 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 t -100.27 124.63 45.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 73.1 110.849 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -68.74 109.64 3.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 71.24 110.914 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.791 HD21 HG11 ' A' ' 213' ' ' VAL . 15.9 mt -64.44 -33.38 75.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 71.04 110.848 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -149.02 -97.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 53.21 110.935 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.466 ' N ' HD22 ' A' ' 22' ' ' ASN . 2.9 tttm -151.84 10.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 73.0 110.813 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.446 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.96 6.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 54.44 110.958 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.4 t -151.16 138.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 73.14 111.181 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.789 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.3 m95 -126.1 -174.51 3.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.95 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 43' ' ' GLY . 95.6 t -136.84 96.17 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 72.23 111.139 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -81.22 121.36 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.35 110.826 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.0 m -116.45 104.32 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 72.44 111.143 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.81 120.15 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 70.21 110.889 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.52 106.22 18.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 65.24 110.937 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.632 -0.794 . . . . 71.24 112.489 179.941 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.616 0.722 . . . . 72.51 111.092 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 116.72 4.7 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.632 2.221 . . . . 73.12 112.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.6 p -101.97 100.2 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.844 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -51.38 165.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 64.43 110.866 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.533 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -158.01 -163.61 12.97 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.683 -0.77 . . . . 24.43 112.43 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.638 HD21 HD12 ' A' ' 158' ' ' LEU . 13.9 tp -154.39 113.85 3.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 44.05 110.904 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 54' ' ' LEU . 1.8 t -97.37 115.34 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 73.53 111.144 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.778 HD21 HD11 ' A' ' 158' ' ' LEU . 29.9 mt -92.74 117.86 30.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 65.5 110.945 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.33 83.9 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 70.33 110.908 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.61 176.01 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 64.2 111.14 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.73 -22.97 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 75.3 110.895 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -12.85 59.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.908 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.2 155.21 6.46 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.727 -0.749 . . . . 61.31 112.542 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 52' ' ' LEU . 9.5 tp -68.66 154.26 42.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.923 0.392 . . . . 73.32 110.882 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.4 t -145.68 143.68 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.13 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 45' ' ' VAL . 1.4 mt -138.51 123.06 18.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 73.24 110.969 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 165' ' ' VAL . 91.1 t -68.62 111.07 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 74.03 111.211 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.37 128.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.448 . . . . 63.14 110.849 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.661 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -73.52 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.816 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 t -90.52 170.07 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 71.21 110.841 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.5 m95 -51.29 -60.74 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 65.24 110.967 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -125.33 159.46 31.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 72.13 110.891 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -51.99 -33.18 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 61.12 110.829 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -59.43 -42.14 91.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 75.51 110.902 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.0 mt -76.64 -48.88 17.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 70.51 110.957 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.07 -45.8 52.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.165 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -54.63 -49.09 71.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.31 110.893 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.13 -19.77 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.873 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.0 tp -88.23 -26.78 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 62.21 110.947 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.28 -22.44 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 70.11 111.11 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.4 15.66 13.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.928 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.0 ptm -130.32 -40.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.756 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.7 m -80.23 -22.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 74.54 111.153 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.575 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.1 -23.25 64.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 62.23 110.915 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -107.53 -33.09 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 73.53 110.859 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -40.47 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 72.41 110.863 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.541 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 15.1 m-85 -90.79 -10.48 42.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 71.22 110.908 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.41 12.15 8.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 72.22 110.959 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.88 138.34 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 71.14 110.932 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.08 138.14 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 74.42 110.834 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.575 HG23 ' OE2' ' A' ' 72' ' ' GLU . 71.9 t -74.59 124.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 71.44 111.088 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -137.67 8.34 2.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.123 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 53' ' ' VAL . 57.1 m-20 -154.54 146.18 23.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 72.02 110.767 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 54' ' ' LEU . 13.6 t -153.71 128.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 72.43 111.176 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.59 ' CD1' HG11 ' A' ' 140' ' ' VAL . 54.5 mt -84.88 129.08 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 64.5 111.182 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.57 123.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 73.5 111.125 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p -83.76 -45.85 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 54.42 111.196 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.5 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.2 p-80 -153.44 178.06 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 65.42 110.845 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.497 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -97.71 91.62 5.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 61.2 111.052 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.33 156.56 43.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.786 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.53 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 61.21 111.085 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.84 20.03 10.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 64.55 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.83 -77.43 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.896 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.79 7.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.32 111.096 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.45 -37.85 41.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 53.21 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 10.57 64.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 55.35 112.395 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.38 -28.41 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 71.12 111.201 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -38.81 67.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.887 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -84.07 -10.45 57.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 54.32 111.077 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.661 HD11 ' OG ' ' A' ' 57' ' ' SER . 22.9 mt -90.86 -33.94 15.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.34 110.925 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -94.42 17.9 12.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.973 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -116.3 -39.25 3.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.93 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -87.33 -55.75 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 64.14 110.848 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.91 47.87 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.75 -0.738 . . . . 71.34 112.524 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.3 mp -111.32 110.79 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 40.31 111.087 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.718 ' HB3' HD11 ' A' ' 124' ' ' LEU . 12.7 mtmt -72.1 107.88 5.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 72.31 110.861 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.62 89.41 7.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 61.04 111.093 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.546 ' HA ' HD12 ' A' ' 124' ' ' LEU . 58.1 m-70 -62.08 135.82 57.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.885 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.92 168.98 10.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 63.11 110.844 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.87 154.23 25.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.141 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.91 7.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 61.45 111.053 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -70.7 -46.38 63.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 61.14 111.011 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.752 ' HA ' HD11 ' A' ' 114' ' ' LEU . 32.7 m -57.03 -25.59 58.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 60.55 111.174 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.599 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -97.89 14.12 28.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 71.42 111.143 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -26.75 7.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.825 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -105.74 -10.35 16.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 55.44 110.911 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.53 70.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 71.24 111.061 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -24.54 55.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 64.11 110.889 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -61.48 -32.63 72.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 61.54 110.897 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -89.36 -24.82 21.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 52.32 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.05 24.06 3.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.696 -0.764 . . . . 71.34 112.443 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.72 166.48 10.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 74.23 110.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.99 162.95 28.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 73.51 110.928 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mp0 -95.09 111.93 56.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.607 0.718 . . . . 72.15 110.891 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.599 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.2 Cg_endo -69.79 -176.1 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.6 2.2 . . . . 75.35 112.323 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 104' ' ' LYS . 17.5 mt -51.79 -43.7 63.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.831 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.6 50.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 62.24 112.485 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.11 43.52 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 72.14 110.782 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.751 HD22 HD21 ' A' ' 133' ' ' LEU . 59.2 mt -129.14 -175.55 3.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 73.11 110.878 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.6 -171.72 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 63.12 110.871 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.853 HG22 HG23 ' A' ' 130' ' ' VAL . 52.9 m -50.62 -71.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 62.54 111.089 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 HG22 ' A' ' 129' ' ' THR . 31.2 t -116.85 102.79 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 63.32 111.04 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 t -135.63 170.56 15.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.1 111.156 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.68 133.88 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 64.11 110.884 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.751 HD21 HD22 ' A' ' 127' ' ' LEU . 25.9 mt -114.84 155.52 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 65.0 110.942 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -137.59 124.17 20.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.22 110.857 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -125.86 49.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.923 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.44 92.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 74.35 112.547 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.7 m120 64.6 15.05 9.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 70.31 110.941 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.3 tpp -135.16 108.65 7.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.863 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -98.33 129.06 45.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.823 HG22 HD21 ' A' ' 158' ' ' LEU . 20.2 t -134.91 115.15 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 64.31 111.184 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -107.64 130.63 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 61.4 110.814 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.5 p -86.75 -176.54 5.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 62.4 111.164 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.511 ' HB3' HG23 ' A' ' 155' ' ' VAL . 24.7 t80 -168.4 130.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.835 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.748 ' HB3' HG23 ' A' ' 129' ' ' THR . 11.0 t80 -115.57 88.01 18.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 71.03 110.957 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -7.99 22.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.646 2.231 . . . . 53.1 112.411 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.56 -162.29 21.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.674 -0.774 . . . . 62.23 112.381 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -81.04 137.61 36.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 71.32 110.878 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.13 -88.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.472 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -76.36 -25.21 54.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 62.2 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.5 HG21 ' HB2' ' A' ' 86' ' ' HIS . 17.2 p -147.15 -158.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 71.22 111.067 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HB3' HD23 ' A' ' 114' ' ' LEU . 40.6 tt0 -89.47 -22.01 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.872 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.759 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -132.18 8.66 4.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.853 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.472 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.0 OUTLIER -41.12 128.37 2.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.01 110.891 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 152' ' ' ASP . 7.0 pt -132.79 -176.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 71.34 111.101 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.529 ' HB ' HD11 ' A' ' 164' ' ' LEU . 9.2 m -133.82 131.76 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 64.41 111.043 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 164' ' ' LEU . 91.1 t -86.27 126.44 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 65.52 111.156 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -114.33 131.09 56.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.43 110.812 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.823 HD21 HG22 ' A' ' 140' ' ' VAL . 11.6 mt -111.84 97.19 36.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 74.31 110.885 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.4 Cg_endo -69.87 -5.1 15.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.664 2.242 . . . . 74.12 112.301 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -81.81 -23.63 36.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 62.33 110.952 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.4 13.76 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.917 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.42 29.75 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.41 110.907 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.498 HD13 HD13 ' A' ' 21' ' ' LEU . 98.3 mt -96.07 130.3 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.11 111.092 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' A' ' 155' ' ' VAL . 25.4 tp -112.67 146.0 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.867 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 55' ' ' VAL . 21.3 t -112.22 79.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 74.42 111.145 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.67 42.79 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.656 -0.783 . . . . 54.32 112.542 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.5 -163.85 53.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 41.22 112.515 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -33.55 35.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.361 . . . . 44.12 110.909 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.616 HD12 ' NE1' ' A' ' 189' ' ' TRP . 22.6 tp -53.69 -56.38 17.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.934 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 218' ' ' LEU . 14.7 t -82.55 114.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 64.42 111.076 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 150.57 19.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 72.53 110.889 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.0 p -97.96 155.11 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.865 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.123 -179.864 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.866 0.365 . . . . 54.34 111.091 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -113.73 90.94 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.35 110.94 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 t -67.12 -19.18 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 42.15 111.137 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -74.84 -24.83 58.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 64.23 110.876 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.39 -10.76 13.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 72.02 110.852 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.616 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.5 t90 -55.3 -61.44 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 62.12 110.93 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.7 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.63 -24.48 14.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 54.31 110.894 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.9 m -81.57 -31.97 32.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 63.01 111.058 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -43.1 61.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.859 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 219' ' ' LEU . 30.5 mm -61.68 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.35 111.14 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.39 -27.64 56.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 63.14 110.92 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -76.98 -22.27 53.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 73.34 110.939 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.18 -11.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 73.03 111.143 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.436 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -111.4 -10.02 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 65.21 110.916 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.86 -30.76 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.833 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -58.48 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.11 110.897 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.448 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -93.08 61.68 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 74.02 110.893 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -72.36 -58.14 3.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 74.32 110.94 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -53.03 102.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.3 110.845 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.646 HG21 ' CG2' ' A' ' 206' ' ' VAL . 73.9 mt -142.04 121.68 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 73.03 111.16 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -29.83 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.447 . . . . 70.11 110.84 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.06 143.18 2.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 63.21 111.178 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.756 ' HB ' HD12 ' A' ' 218' ' ' LEU . 98.1 t -121.48 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 45.23 111.1 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.963 HG22 HG12 ' A' ' 213' ' ' VAL . 11.9 t -108.48 112.57 60.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 63.23 111.274 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.62 -169.48 0.32 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.769 2.313 . . . . 53.22 112.397 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.65 -13.66 59.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.828 -0.701 . . . . 73.14 112.5 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.45 129.71 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.354 . . . . 72.41 110.838 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 116.78 -117.69 3.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.812 -0.709 . . . . 72.12 112.494 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -150.79 164.75 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 75.23 110.841 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.963 HG12 HG22 ' A' ' 207' ' ' VAL . 5.8 m -54.87 163.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.23 111.176 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.26 -111.58 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.803 -0.713 . . . . 70.34 112.522 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.15 -169.32 2.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.418 . . . . 75.32 110.809 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -18.31 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 72.2 110.856 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.494 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.88 -16.75 48.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.75 -0.738 . . . . 65.41 112.47 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.756 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.6 mt -71.95 -30.35 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 74.21 110.967 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.588 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.7 mm? -65.64 -57.5 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.52 110.899 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.494 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -61.54 -17.78 56.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 73.44 110.918 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -65.6 -50.42 65.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.1 110.873 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.543 ' C ' HD23 ' A' ' 226' ' ' LEU . 2.9 m -51.78 -51.43 56.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 74.13 111.138 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -18.74 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 75.04 110.915 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -87.53 -5.07 58.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 72.45 110.804 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.3 mt -126.09 -6.4 6.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 70.42 110.876 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.7 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -119.34 8.48 11.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.918 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 64.42 110.877 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.78 0.324 . . . . 70.24 111.131 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -114.2 100.23 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 65.2 111.127 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -121.4 116.3 24.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 63.02 110.906 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -58.52 165.23 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 71.22 110.96 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.8 -48.29 63.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 74.22 110.896 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -60.74 -38.01 83.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.13 111.206 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.97 64.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.728 -0.749 . . . . 73.22 112.525 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -71.34 -45.42 62.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.7 0.286 . . . . 75.51 111.085 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.96 123.3 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.419 . . . . 74.5 111.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.1 p -129.2 132.64 47.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 75.04 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -127.28 107.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 72.32 111.12 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -98.6 125.07 43.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.34 110.836 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -68.58 108.78 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.12 110.843 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.731 HD21 HG21 ' A' ' 213' ' ' VAL . 14.1 mt -62.61 -33.1 74.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 70.15 110.936 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.461 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.26 -96.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 52.21 110.883 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.6 OUTLIER -151.42 9.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.925 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.443 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.98 6.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.892 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 t -150.69 139.74 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 63.2 111.126 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.788 ' HB3' HG22 ' A' ' 18' ' ' ILE . 16.0 m95 -128.03 -174.78 3.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 65.12 110.92 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG21 ' CG2' ' A' ' 213' ' ' VAL . 99.3 t -136.83 94.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 70.1 111.057 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -79.01 122.07 25.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 72.0 110.866 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.7 m -118.7 104.92 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 70.44 111.167 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.41 124.48 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 74.4 110.888 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -86.23 114.2 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.877 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.66 -0.781 . . . . 61.25 112.437 179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.641 0.734 . . . . 75.11 111.193 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 118.29 5.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 71.01 112.305 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.8 p -97.38 98.08 9.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.799 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -51.79 159.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.31 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -154.67 -167.3 16.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.77 . . . . 42.34 112.435 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 158' ' ' LEU . 14.3 tp -152.68 112.84 4.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 72.25 110.964 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.64 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -95.66 116.5 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.19 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.729 HD21 HD11 ' A' ' 158' ' ' LEU . 26.7 mt -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 73.55 110.906 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.86 86.64 7.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.888 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.47 179.98 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 62.54 111.112 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.4 -23.32 14.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.9 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -13.24 58.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 41.34 110.919 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.11 151.81 5.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 55.31 112.539 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.62 153.7 35.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.808 0.337 . . . . 73.34 110.969 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.638 HG13 ' CB ' ' A' ' 81' ' ' ASP . 2.3 t -143.74 141.09 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 64.34 111.031 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.64 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.3 mt -136.87 122.07 19.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.43 110.943 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.497 HG11 HG11 ' A' ' 165' ' ' VAL . 76.3 t -67.43 111.43 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.152 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' CG ' HG12 ' A' ' 55' ' ' VAL . 1.9 m-20 72.1 130.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.34 110.903 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -72.85 -166.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.228 -0.442 . . . . 75.11 110.914 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -91.62 169.19 10.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.12 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.718 ' HB2' HD12 ' A' ' 63' ' ' LEU . 96.5 m95 -48.98 -58.5 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.983 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -130.48 161.53 31.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.13 110.883 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -54.21 -32.83 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 60.22 110.815 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -59.22 -39.84 84.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 72.35 110.868 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.7 mt -78.91 -45.39 20.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 71.23 110.909 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -46.33 62.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 64.41 111.093 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.05 -49.46 66.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 74.24 110.905 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.08 -15.27 63.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 71.13 110.936 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.499 ' O ' HG22 ' A' ' 71' ' ' VAL . 17.3 tp -92.53 -24.89 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 65.05 110.958 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.821 HG12 HG11 ' A' ' 79' ' ' VAL . 15.3 mt -91.24 -26.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.42 111.125 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -86.55 7.77 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.857 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.7 ptm -123.53 -38.6 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 71.35 110.913 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 67' ' ' LEU . 23.0 m -79.55 -23.68 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 55.05 111.133 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -20.68 61.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.896 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -107.79 -30.71 8.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 63.54 110.873 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -45.79 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 27.5 m-85 -83.55 -11.97 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 71.31 110.838 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 67.65 12.78 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 62.22 110.916 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 139.7 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 65.21 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.97 136.8 38.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 62.41 110.799 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.821 HG11 HG12 ' A' ' 68' ' ' ILE . 14.4 p -77.02 128.75 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 72.41 111.12 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -155.41 19.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.159 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.638 ' CB ' HG13 ' A' ' 53' ' ' VAL . 28.0 m-20 -154.24 142.68 20.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 74.22 110.871 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 81' ' ' ASP . 10.4 t -156.58 104.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 62.51 111.16 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.616 HD11 ' HE2' ' A' ' 135' ' ' PHE . 8.5 mt -69.97 119.82 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.41 111.111 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.7 mm -93.45 147.46 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 72.43 111.106 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -104.24 -50.33 3.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 64.23 111.074 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.491 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.8 p-80 -155.84 -174.58 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 62.24 110.88 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.837 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -92.37 99.58 12.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 54.02 111.139 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.45 151.88 29.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 64.4 110.866 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.18 -19.94 49.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.401 . . . . 70.41 111.028 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.58 6.25 48.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 65.22 110.956 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.68 -77.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.875 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -92.13 7.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 73.35 111.188 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.78 -37.44 34.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.816 -0.707 . . . . 72.13 112.414 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.2 10.77 58.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.751 . . . . 74.12 112.534 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 92' ' ' ILE . 17.0 tt -53.89 -28.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.924 0.392 . . . . 71.41 111.159 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -53.64 -36.94 62.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 64.44 110.921 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -87.17 -13.71 43.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.42 111.147 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.578 ' HA ' HD13 ' A' ' 103' ' ' ILE . 20.2 mt -86.42 -31.55 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 75.21 110.923 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.92 15.73 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 65.24 110.88 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -116.46 -45.37 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 74.2 110.942 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -78.15 -56.86 4.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 71.51 110.804 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.816 -0.706 . . . . 62.55 112.498 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -109.98 119.24 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.928 0.394 . . . . 74.23 111.121 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.753 ' CE ' HD21 ' A' ' 124' ' ' LEU . 3.9 mtpp -76.17 119.32 19.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 71.14 110.852 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.0 93.53 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 51.53 111.116 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.426 ' HB3' HD11 ' A' ' 127' ' ' LEU . 76.9 m-70 -65.86 145.67 55.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.03 110.906 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.441 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -178.87 171.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 55.25 110.889 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.89 158.94 19.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 61.52 111.105 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -39.26 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.42 111.065 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -66.06 -44.17 85.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 72.43 110.906 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.741 ' HA ' HD11 ' A' ' 114' ' ' LEU . 51.6 m -57.5 -25.35 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 61.34 111.121 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.11 10.86 38.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 63.21 111.121 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.9 -33.2 6.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 71.15 110.892 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.837 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -97.59 -13.9 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.878 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.442 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -63.5 -41.57 98.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 73.25 111.105 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -24.41 58.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 62.25 110.925 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -32.5 70.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 64.44 110.826 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -89.87 -24.35 21.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 72.32 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.18 23.93 4.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 55.33 112.568 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -98.07 -175.5 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 72.22 110.923 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.429 ' HB2' HD13 ' A' ' 95' ' ' ILE . 6.3 mm-40 -85.5 176.14 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 73.43 110.93 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.9 mt-10 -106.59 104.38 50.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.684 0.754 . . . . 73.32 110.863 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.8 Cg_endo -69.77 -178.75 2.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.635 2.223 . . . . 62.3 112.367 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.753 HD21 ' CE ' ' A' ' 104' ' ' LYS . 10.2 mt -51.08 -47.04 61.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.981 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.07 26.55 28.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 71.5 112.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -107.84 45.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 72.33 110.817 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.587 HD22 HD21 ' A' ' 133' ' ' LEU . 86.4 mt -127.1 -174.96 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 75.03 110.972 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.57 -172.31 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 73.43 110.932 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.869 HG22 HG23 ' A' ' 130' ' ' VAL . 49.6 m -50.89 -70.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.33 111.166 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.869 HG23 HG22 ' A' ' 129' ' ' THR . 33.0 t -117.06 103.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 54.54 111.097 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t -135.42 175.23 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 64.23 111.122 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -120.64 136.39 54.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 62.24 110.901 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 127' ' ' LEU . 25.2 mt -115.23 154.34 29.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 60.13 110.844 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -134.08 126.89 31.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.857 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.616 ' HE2' HD11 ' A' ' 83' ' ' ILE . 12.2 m-85 -129.9 32.8 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.797 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.66 95.37 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.672 -0.775 . . . . 43.32 112.487 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.88 13.49 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 72.23 110.969 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.6 tpp -135.03 106.43 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 70.22 110.821 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.471 ' O ' HD23 ' A' ' 158' ' ' LEU . 3.4 mptp? -94.58 126.0 39.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 60.33 110.852 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.844 HG22 HD21 ' A' ' 158' ' ' LEU . 19.9 t -134.77 116.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.174 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.95 131.22 55.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 55.5 110.88 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.5 p -85.04 -176.03 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.33 111.199 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.443 ' HB3' HG23 ' A' ' 155' ' ' VAL . 24.7 t80 -166.67 133.08 2.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.877 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.694 ' HB3' HG23 ' A' ' 129' ' ' THR . 7.8 t80 -122.01 87.33 47.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.612 0.72 . . . . 73.53 110.87 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 -7.68 21.69 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.672 2.248 . . . . 70.33 112.335 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.48 -160.81 23.86 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.742 -0.742 . . . . 53.4 112.442 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -86.26 139.48 30.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.886 0.374 . . . . 74.41 110.91 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.17 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 61.04 112.435 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -75.6 -22.92 56.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 63.22 110.86 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 86' ' ' HIS . 59.3 p -150.69 -169.21 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 63.21 111.122 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.543 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.2 tt0 -86.63 -5.71 59.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 55.13 110.926 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 154' ' ' ILE . 47.6 t0 -145.75 16.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 52.53 110.838 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.69 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -49.8 126.14 13.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 53.12 110.904 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 152' ' ' ASP . 24.1 pt -133.72 174.92 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 70.25 111.15 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 143' ' ' PHE . 14.5 m -128.06 120.38 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 63.11 111.088 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.37 119.18 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 42.51 111.167 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.4 t-105 -107.94 136.45 47.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.33 110.816 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.844 HD21 HG22 ' A' ' 140' ' ' VAL . 13.3 mt -118.63 98.35 51.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 72.0 110.808 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -4.52 14.2 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.675 2.25 . . . . 73.11 112.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -85.12 -21.22 29.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.11 110.98 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -143.52 13.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 74.11 110.929 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.1 m120 53.12 27.54 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.952 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.468 HD13 HD13 ' A' ' 21' ' ' LEU . 95.9 mt -89.96 142.82 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 63.53 111.156 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.594 HD22 HD13 ' A' ' 203' ' ' ILE . 27.7 tp -125.62 147.79 49.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.53 110.915 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.497 HG11 HG11 ' A' ' 55' ' ' VAL . 53.3 t -115.02 79.2 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 63.21 111.074 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.03 -34.0 37.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.781 -0.723 . . . . 60.2 112.427 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.17 -163.31 16.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 61.21 112.478 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -32.65 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 54.42 110.892 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.69 HD13 ' OD1' ' A' ' 153' ' ' ASN . 23.0 tp -52.02 -51.38 57.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 70.13 110.929 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 219' ' ' LEU . 21.3 t -89.63 110.84 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 73.32 111.143 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.71 ' HG2' HG23 ' A' ' 222' ' ' THR . 0.4 OUTLIER -56.34 156.27 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 73.12 110.95 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 45.5 p -98.77 159.82 14.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 42.32 110.91 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 70.45 111.107 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.8 0.333 . . . . 73.34 111.135 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -114.01 90.69 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 71.44 110.89 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 27.3 t -62.0 -16.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 73.22 111.131 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.28 -23.43 59.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 70.45 110.877 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -117.12 -13.0 10.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 72.53 110.823 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.49 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.4 t90 -53.58 -62.01 1.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.108 -0.496 . . . . 73.54 110.881 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.759 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -55.25 -23.62 23.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 53.41 110.839 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.54 -30.07 33.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 70.11 111.176 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.7 -44.12 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 63.13 110.891 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.509 HG21 ' O ' ' A' ' 219' ' ' LEU . 33.6 mm -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 74.03 111.102 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.462 ' HG2' HD21 ' A' ' 223' ' ' LEU . 2.3 mm-40 -56.3 -27.4 55.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 64.31 110.918 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -77.66 -22.32 50.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 64.33 110.853 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 192' ' ' SER . 17.2 t -85.26 -10.84 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.012 0.434 . . . . 75.33 111.204 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.56 -12.7 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 61.44 110.914 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -98.75 -30.79 12.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 71.24 110.928 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -59.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 75.33 110.876 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.459 ' O ' HD11 ' A' ' 203' ' ' ILE . 3.9 m-30 -91.49 61.71 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 73.44 110.947 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -72.78 -58.52 3.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.903 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -52.64 101.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 60.14 110.905 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.64 HG21 HG22 ' A' ' 206' ' ' VAL . 71.6 mt -141.14 118.22 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 73.34 111.117 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.1 -28.08 63.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.825 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.649 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -166.9 145.08 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.438 . . . . 71.13 111.139 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.748 ' HB ' HD12 ' A' ' 218' ' ' LEU . 93.0 t -123.45 131.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.196 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.014 HG22 HG22 ' A' ' 213' ' ' VAL . 15.9 t -110.15 105.87 57.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 62.31 111.187 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.2 Cg_endo -69.82 -171.3 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 70.2 112.319 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.4 -20.24 67.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 71.34 112.54 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.46 144.48 23.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.795 0.331 . . . . 72.21 110.917 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.38 -101.86 1.36 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.772 -0.728 . . . . 74.53 112.544 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -172.03 170.98 5.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.92 0.391 . . . . 73.44 110.868 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.014 HG22 HG22 ' A' ' 207' ' ' VAL . 10.9 t -65.23 148.47 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 70.31 111.188 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.51 -101.96 0.31 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.768 -0.729 . . . . 60.34 112.559 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -163.57 -169.12 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 54.51 110.903 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -17.75 54.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 53.51 110.907 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.468 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.55 -20.72 39.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.771 -0.728 . . . . 61.12 112.511 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.748 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.6 mt -72.87 -29.84 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 73.02 110.949 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.509 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -64.52 -60.67 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 73.01 110.9 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.468 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.4 OUTLIER -58.76 -19.92 44.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 72.2 110.902 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.742 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -61.86 -50.93 70.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 72.23 110.959 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.729 HG22 HD23 ' A' ' 226' ' ' LEU . 3.8 m -51.7 -51.02 59.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 63.25 111.173 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.636 HD23 ' OG ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -60.49 -18.23 50.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 74.22 110.936 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.69 -2.64 57.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.833 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.742 HD11 ' CE1' ' A' ' 221' ' ' HIS . 8.1 mt -125.22 -8.02 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 51.33 110.88 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.759 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -122.61 9.42 9.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 65.25 110.947 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.846 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 18' ' ' ILE . 3.8 m . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.681 0.277 . . . . 75.35 111.236 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.6 mt -135.78 102.55 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 54.54 111.184 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -110.71 122.64 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 75.3 110.95 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -65.62 166.39 10.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 72.43 110.849 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.65 -48.69 63.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 52.23 110.836 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -60.61 -37.72 82.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.476 . . . . 75.3 111.178 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.86 11.93 61.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.35 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 31' ' ' LEU . 41.9 m -84.55 -41.61 16.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 72.33 111.098 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.642 HD13 ' HB2' ' A' ' 67' ' ' LEU . 68.8 mt -101.22 103.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 74.11 111.107 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.1 p -120.62 125.97 49.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 70.12 110.852 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -101.52 -164.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.094 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.581 ' H ' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -178.23 115.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 62.1 110.876 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -68.17 106.48 2.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 74.21 110.904 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.688 ' HG ' HG23 ' A' ' 27' ' ' VAL . 28.8 mt -65.73 -32.62 74.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.01 110.96 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.472 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -148.43 -96.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 63.51 110.876 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.5 OUTLIER -152.62 10.44 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 64.21 110.944 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.51 5.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 64.3 110.944 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.401 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 20.8 t -151.4 138.95 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 72.43 111.196 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.418 ' O ' HD12 ' A' ' 44' ' ' LEU . 13.2 m95 -125.02 -173.86 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 72.44 110.953 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.688 HG23 ' HG ' ' A' ' 21' ' ' LEU . 72.2 t -137.17 89.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 61.3 111.151 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CA ' HG23 ' A' ' 18' ' ' ILE . 14.2 p80 -73.96 125.16 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.776 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -118.97 96.76 5.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 63.02 111.076 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.22 117.68 18.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 71.14 110.954 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -84.16 114.77 22.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 75.43 110.915 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 73.21 112.43 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.553 0.692 . . . . 70.24 111.108 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.694 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.7 Cg_endo -69.71 117.69 5.23 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.688 2.259 . . . . 64.22 112.327 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -107.85 98.76 8.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.8 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.97 161.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.881 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -154.7 -155.81 7.44 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.739 . . . . 62.32 112.455 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 158' ' ' LEU . 13.1 tp -157.6 112.05 2.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 73.21 110.874 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.659 HG22 HD23 ' A' ' 54' ' ' LEU . 2.0 t -96.88 112.37 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.098 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.741 HD21 HD11 ' A' ' 158' ' ' LEU . 17.9 mt -90.86 120.01 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.973 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 47' ' ' ASN . 1.8 m-80 -90.75 82.17 5.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 73.23 110.886 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -97.22 -179.51 4.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 71.44 111.105 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -25.81 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 70.04 110.859 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -20.16 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.44 110.953 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.5 149.63 5.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.22 112.562 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.699 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.6 mt -61.56 154.16 25.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.817 0.342 . . . . 63.54 110.918 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.3 t -144.59 141.79 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 63.2 111.187 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.659 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -137.2 121.97 18.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 63.23 110.898 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.625 HG11 HG11 ' A' ' 165' ' ' VAL . 77.0 t -66.82 111.66 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.45 111.157 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.77 128.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.874 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.683 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.8 p -70.84 -167.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 52.51 110.833 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.58 ' H ' HG23 ' A' ' 64' ' ' THR . 8.1 t -89.94 166.84 13.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 53.13 110.907 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.8 m95 -49.69 -59.86 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 73.31 110.892 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.86 158.0 37.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 75.2 110.823 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -51.57 -33.36 32.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 73.33 110.955 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.05 -45.58 90.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 75.23 110.921 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.699 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.4 mt -72.32 -46.93 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.956 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.46 -47.71 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 55.4 111.164 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.07 -49.96 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.834 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG3' HD12 ' A' ' 16' ' ' ILE . 35.0 tp10 -64.76 -20.54 66.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 74.11 110.837 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.642 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.4 tp -87.24 -25.19 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 54.53 110.871 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.23 -24.03 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 62.01 111.145 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -92.17 16.18 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 54.32 110.882 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.8 ptm -131.65 -39.99 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.834 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 67' ' ' LEU . 20.1 m -80.23 -22.86 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 54.34 111.052 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.708 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.37 -24.81 65.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 65.14 110.858 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -105.36 -33.37 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 70.31 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -44.48 68.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 72.12 110.903 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.541 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.8 m-85 -85.81 -12.29 51.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 70.54 110.941 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 69.44 11.43 8.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.893 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -131.59 141.49 49.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.53 110.918 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.97 140.42 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 61.11 110.959 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.708 HG23 ' OE2' ' A' ' 72' ' ' GLU . 89.6 t -81.78 121.28 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 74.12 111.169 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -138.09 14.23 2.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 73.35 111.153 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 103' ' ' ILE . 60.8 m-20 -154.45 144.83 22.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 64.04 110.935 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 54' ' ' LEU . 21.3 t -153.85 132.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.13 111.046 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.555 HD11 ' HE2' ' A' ' 135' ' ' PHE . 43.7 mt -92.66 128.41 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 71.45 111.048 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.52 153.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.44 111.129 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.0 p -112.32 -49.87 2.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 64.14 111.154 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.6 -176.15 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 63.24 110.841 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -98.39 90.9 4.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 64.31 111.072 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.2 152.84 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 74.21 110.831 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.23 12.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 73.22 111.1 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.53 27.12 2.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.856 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -71.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 71.11 110.849 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -98.85 7.61 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 73.33 111.211 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.55 -42.22 43.45 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.722 -0.751 . . . . 71.13 112.451 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.61 16.89 58.3 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.639 -0.791 . . . . 51.2 112.491 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.4 tt -56.71 -30.23 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 62.31 111.186 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -30.01 60.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 64.34 110.864 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -89.11 -15.14 34.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 63.54 111.175 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 57' ' ' SER . 14.0 mt -89.88 -28.74 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.834 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -97.27 13.4 29.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.263 -0.426 . . . . 70.44 110.895 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -112.35 -43.01 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 73.3 110.868 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -78.84 -57.56 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.939 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.84 38.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.642 -0.789 . . . . 71.55 112.441 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.555 HD13 ' HA ' ' A' ' 98' ' ' LEU . 3.9 mp -108.27 124.53 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.39 . . . . 75.34 111.124 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.533 ' HB3' HD11 ' A' ' 124' ' ' LEU . 2.6 mttt -86.67 120.15 27.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 71.14 110.898 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.11 96.36 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.066 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.585 ' HA ' HD12 ' A' ' 124' ' ' LEU . 36.2 m-70 -68.99 144.7 54.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.41 . . . . 72.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.58 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -179.01 -177.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 52.43 110.895 -179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.58 155.83 17.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 73.21 111.161 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.83 -37.87 45.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 71.13 111.086 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.521 HD23 ' OD1' ' A' ' 152' ' ' ASP . 33.4 tp -67.94 -45.85 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 71.21 110.915 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.59 ' HA ' HD11 ' A' ' 114' ' ' LEU . 85.9 m -58.49 -21.61 52.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 34.02 111.136 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.26 12.06 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 75.52 111.186 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -111.68 -28.55 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.876 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -100.58 -9.57 21.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.958 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.426 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 61.52 110.998 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -27.13 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 75.13 110.917 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.34 -34.45 66.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 52.22 110.863 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.44 -23.7 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 54.54 110.808 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.81 21.79 4.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 71.44 112.557 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -95.73 177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 71.05 110.942 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HB2' HD13 ' A' ' 95' ' ' ILE . 66.5 mm-40 -78.12 176.03 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 72.32 110.904 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mt-10 -108.58 104.8 55.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 75.24 110.933 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.82 178.74 4.3 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.653 2.235 . . . . 70.44 112.358 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 106' ' ' HIS . 28.3 mt -51.37 -51.09 57.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 62.32 110.938 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.52 40.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 34.15 112.522 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -99.23 34.47 2.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 70.43 110.929 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.683 ' CD2' HD21 ' A' ' 133' ' ' LEU . 80.7 mt -117.96 -174.35 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 61.53 110.851 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.1 -171.12 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 71.33 110.835 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.804 HG22 HG23 ' A' ' 130' ' ' VAL . 99.5 m -50.56 -69.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 65.41 111.058 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.804 HG23 HG22 ' A' ' 129' ' ' THR . 34.5 t -120.49 102.61 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 65.41 111.121 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -132.71 164.29 27.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.507 . . . . 61.4 111.154 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.3 129.15 56.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 74.25 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.683 HD21 ' CD2' ' A' ' 127' ' ' LEU . 61.6 mt -115.89 157.97 23.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.998 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -136.99 112.15 9.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.92 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.555 ' HE2' HD11 ' A' ' 83' ' ' ILE . 19.0 m-85 -107.6 45.42 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.947 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.01 87.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 54.03 112.492 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.73 14.66 9.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 73.43 110.949 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.45 ' HB2' HG22 ' A' ' 48' ' ' THR . 50.2 tpp -131.31 89.87 2.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.86 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 130.58 38.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 70.15 110.924 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.687 HG22 HD21 ' A' ' 158' ' ' LEU . 21.2 t -139.55 117.02 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 70.22 111.145 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -108.24 132.73 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.9 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 37.7 p -90.14 171.01 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 42.23 111.112 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.4 t80 -154.29 130.28 10.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 72.25 110.865 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.653 ' HB3' HG23 ' A' ' 129' ' ' THR . 17.6 t80 -118.44 85.56 26.24 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.613 0.72 . . . . 73.44 110.868 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.56 23.9 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.705 2.27 . . . . 73.52 112.306 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.24 -169.62 15.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.8 -0.714 . . . . 73.22 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -76.79 147.81 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 73.52 110.868 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.26 -64.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.11 112.486 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 83.8 t60 -89.56 -30.93 17.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.873 0.368 . . . . 75.14 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.9 p -139.83 -87.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 63.5 111.162 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.412 ' OE1' HD23 ' A' ' 114' ' ' LEU . 71.5 tt0 -160.56 -32.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 75.11 110.812 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.521 ' OD1' HD23 ' A' ' 110' ' ' LEU . 12.5 t0 -127.58 14.56 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 74.2 110.795 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -50.41 125.57 13.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.14 110.861 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 144' ' ' TYR . 12.6 pt -123.36 164.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 64.03 111.107 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.6 m -115.74 118.99 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 71.15 111.139 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 83' ' ' ILE . 43.7 t -70.77 118.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 62.35 111.076 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -104.89 131.14 52.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.926 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.741 HD11 HD21 ' A' ' 46' ' ' LEU . 11.7 mt -113.1 97.02 41.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.573 0.702 . . . . 74.31 110.985 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.61 -4.68 14.41 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.781 2.321 . . . . 52.24 112.352 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -83.18 -23.03 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.914 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.46 13.4 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 74.51 110.922 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.46 29.13 10.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 73.15 110.981 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.1 130.14 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 73.52 111.16 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' A' ' 203' ' ' ILE . 24.8 tp -113.54 147.73 37.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 75.43 110.865 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.625 HG11 HG11 ' A' ' 55' ' ' VAL . 25.9 t -111.05 78.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 74.2 111.157 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.07 -35.37 41.06 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 74.4 112.49 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 63.04 -159.26 36.64 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.801 -0.714 . . . . 51.24 112.505 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.8 m -59.94 -30.82 69.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.876 0.369 . . . . 70.43 110.904 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.692 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.3 tp -53.63 -49.15 68.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.904 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.669 HG13 ' HA ' ' A' ' 219' ' ' LEU . 21.0 t -89.77 105.43 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 65.25 111.105 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.645 ' HD3' HG23 ' A' ' 222' ' ' THR . 0.2 OUTLIER -52.38 147.99 7.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.11 110.902 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 218' ' ' LEU . 54.2 p -99.92 167.11 10.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 72.32 110.882 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 54.31 111.149 -179.877 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 149' ' ' HIS . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.833 0.349 . . . . 55.15 111.12 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.4 85.99 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.95 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.22 -21.34 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.11 111.143 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -72.38 -28.11 62.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 53.04 110.878 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -106.75 -14.94 14.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.05 110.905 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.692 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.9 t90 -55.36 -61.05 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 71.33 110.876 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.739 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.15 -25.43 13.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.842 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -80.92 -32.86 34.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.077 -0.511 . . . . 64.34 111.116 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.61 -41.72 65.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 72.33 110.842 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 219' ' ' LEU . 27.4 mm -64.96 -46.89 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.24 111.162 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.27 -28.59 63.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 43.14 110.837 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -76.96 -22.78 52.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.889 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 192' ' ' SER . 11.0 t -85.19 -10.51 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 61.02 111.094 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -112.22 -10.15 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.439 . . . . 71.55 110.926 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.01 -30.73 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 75.14 110.872 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -46.68 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.823 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.06 37.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 71.33 110.909 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -48.07 69.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.946 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -59.92 103.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 62.04 110.85 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.585 HG21 HG22 ' A' ' 206' ' ' VAL . 40.8 mt -146.07 123.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 54.25 111.067 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -25.48 46.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.879 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.53 130.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 72.41 111.091 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.743 ' HB ' HD12 ' A' ' 218' ' ' LEU . 57.9 t -100.23 147.33 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.19 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 213' ' ' VAL . 20.2 t -122.57 101.12 40.54 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.639 0.733 . . . . 74.23 111.04 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 218' ' ' LEU . 54.5 Cg_endo -69.78 177.34 5.69 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.639 2.226 . . . . 73.2 112.385 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.68 -11.65 79.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 74.34 112.488 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -152.77 148.39 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 72.12 110.843 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.29 -99.89 2.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 73.42 112.436 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -174.39 153.87 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 74.21 110.95 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 207' ' ' VAL . 5.3 m -53.98 163.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 70.23 111.172 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.55 -93.84 0.1 OUTLIER Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.725 -0.75 . . . . 65.15 112.444 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -171.47 -166.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 71.14 110.884 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -56.8 -20.74 24.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.847 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.53 -23.0 18.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 54.51 112.455 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.743 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.6 mt -77.38 -32.5 54.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 74.11 110.857 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.669 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.0 mp -62.08 -62.33 1.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 64.21 110.885 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -22.74 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 62.44 110.864 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.627 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -61.13 -45.86 92.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 70.31 110.877 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.645 HG23 ' HD3' ' A' ' 171' ' ' LYS . 3.5 m -51.28 -54.95 21.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 71.14 111.153 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 190' ' ' SER . 1.4 mt -60.58 -18.43 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 64.32 110.89 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.804 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.627 HD11 ' CE1' ' A' ' 221' ' ' HIS . 8.8 mt -124.68 -10.5 7.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 73.11 110.893 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.739 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -116.46 14.07 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.94 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 71.33 110.894 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.9 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.849 0.357 . . . . 53.33 111.114 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.14 93.69 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 53.21 111.154 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.01 115.3 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 75.05 110.872 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -59.28 166.36 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 54.02 110.858 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -51.77 -47.86 63.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.04 110.909 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p -60.26 -38.23 82.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.15 111.142 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.92 12.73 60.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 65.14 112.433 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.639 HG23 ' HB3' ' A' ' 31' ' ' LEU . 52.4 m -81.14 -42.95 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.679 0.276 . . . . 65.41 111.115 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.31 125.45 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 72.24 111.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -131.93 126.95 35.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 63.23 110.861 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.683 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -122.3 112.86 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 74.53 111.119 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.431 ' HA ' HG12 ' A' ' 8' ' ' VAL . 25.0 t -100.45 127.54 46.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 74.14 110.878 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -70.58 111.61 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 62.32 110.927 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 163' ' ' ILE . 12.7 mt -65.22 -32.29 73.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.89 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.06 -97.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 63.24 110.837 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.26 9.48 0.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 35.22 110.906 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.454 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.09 7.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.856 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.78 141.14 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 75.21 111.1 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.683 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.7 m95 -129.01 -178.32 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.937 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' A' ' 21' ' ' LEU . 92.3 t -133.04 89.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.384 . . . . 74.24 111.052 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.465 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.8 p80 -72.39 123.79 23.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.913 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -119.68 104.01 9.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 24.54 111.106 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -86.62 122.64 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.54 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -89.29 114.11 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.844 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 51.51 112.518 179.883 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.676 0.751 . . . . 54.53 111.107 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.695 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.4 Cg_endo -69.82 118.99 6.01 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.601 2.201 . . . . 65.24 112.364 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.3 p -112.3 96.95 6.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.888 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -57.83 164.74 2.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.04 110.813 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -155.49 -148.16 4.94 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.778 -0.725 . . . . 61.24 112.509 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.614 HD21 HD12 ' A' ' 158' ' ' LEU . 19.7 tp -159.85 115.27 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.856 0.36 . . . . 63.42 110.886 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.661 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.4 122.15 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.145 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.841 HD21 HD11 ' A' ' 158' ' ' LEU . 28.5 mt -99.39 115.42 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 73.12 110.891 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.55 87.59 7.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.89 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.14 179.58 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 72.33 111.157 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -100.33 -21.97 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.842 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -12.2 56.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 64.3 110.871 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.95 150.87 5.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.769 . . . . 73.32 112.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 77' ' ' LYS . 7.9 tp -65.72 154.58 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 54.23 110.925 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.76 141.57 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.112 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -136.84 125.13 23.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.33 110.946 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 165' ' ' VAL . 69.2 t -70.04 111.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 75.45 111.193 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.58 128.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 65.25 110.807 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.698 ' HB3' HD11 ' A' ' 98' ' ' LEU . 2.4 p -71.6 -167.1 0.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.832 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.439 ' H ' HG23 ' A' ' 64' ' ' THR . 6.9 t -90.28 168.87 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 72.33 110.882 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.707 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.1 m95 -50.35 -60.43 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 74.05 110.938 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -126.67 159.37 33.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 74.04 110.818 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -52.66 -35.06 54.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 73.1 110.862 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.79 -38.02 74.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.995 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.707 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.7 mt -79.62 -46.7 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 63.25 110.95 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.71 -45.44 58.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.12 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -57.79 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 74.43 110.946 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.99 -22.69 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 71.33 110.859 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 71' ' ' VAL . 17.3 tp -84.8 -25.88 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 61.43 110.924 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.46 -22.99 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 62.13 111.132 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -92.38 15.94 12.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 71.13 110.939 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.95 -40.03 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 67' ' ' LEU . 31.5 m -80.25 -22.2 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.12 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.653 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.22 -24.53 64.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 42.4 110.885 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -105.69 -33.85 7.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 71.42 110.924 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -43.29 73.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 33.2 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -88.69 -11.35 45.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.883 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.89 11.88 8.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 53.2 110.966 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.52 ' HB2' HD13 ' A' ' 52' ' ' LEU . 5.9 mttm -130.01 139.22 51.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.83 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -85.35 138.27 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.267 -0.424 . . . . 75.22 110.803 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.653 HG23 ' OE2' ' A' ' 72' ' ' GLU . 94.4 t -78.39 123.09 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.197 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -140.07 13.44 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 73.42 111.169 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -154.85 143.79 20.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.03 110.917 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 54' ' ' LEU . 16.3 t -154.07 128.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 70.41 111.081 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.551 ' CD1' HG11 ' A' ' 140' ' ' VAL . 55.3 mt -85.42 131.37 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 54.21 111.113 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.9 mm -109.91 136.62 45.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 73.12 111.145 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.0 p -96.17 -45.36 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.158 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -153.46 -175.52 5.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 63.02 110.845 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.13 86.73 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 51.43 111.162 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 70.14 110.859 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.24 -23.67 9.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.119 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -95.37 30.11 2.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 73.43 110.842 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.94 -70.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.878 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.16 7.34 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 73.44 111.127 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.69 -41.91 51.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.816 -0.707 . . . . 64.31 112.451 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.7 14.46 64.09 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.668 -0.777 . . . . 61.25 112.518 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.2 tt -55.12 -28.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 74.02 111.153 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -34.57 63.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.946 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.1 m -86.8 -12.53 47.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 72.04 111.181 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 57' ' ' SER . 16.7 mt -90.63 -24.92 20.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 72.03 110.927 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.13 20.19 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.883 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -120.97 -34.06 3.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 63.12 110.881 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -90.86 -42.56 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 70.02 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.79 37.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.769 -0.729 . . . . 70.05 112.492 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.576 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.0 mp -103.16 111.24 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 74.45 111.166 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.709 ' HE2' HD21 ' A' ' 124' ' ' LEU . 1.9 mtpp -72.74 112.05 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 72.51 110.923 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.54 90.56 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 42.31 111.107 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.567 ' HA ' HD12 ' A' ' 124' ' ' LEU . 51.8 m-70 -61.93 145.19 53.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 73.35 110.862 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.613 ' CA ' HD12 ' A' ' 127' ' ' LEU . 1.2 p -177.04 179.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.809 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.2 158.14 18.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 71.41 111.106 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.72 49.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.23 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.714 HD23 ' OD2' ' A' ' 152' ' ' ASP . 62.3 tp -72.27 -37.82 68.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 71.4 110.924 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.728 ' HA ' HD11 ' A' ' 114' ' ' LEU . 91.5 m -58.07 -28.1 64.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 72.15 111.192 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.59 0.95 57.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.21 111.073 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.52 -55.54 2.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 63.42 110.928 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.2 OUTLIER -70.21 -10.29 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 62.23 110.897 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.47 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.78 -46.24 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.081 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -29.51 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 72.21 110.866 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -52.14 -36.71 52.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.935 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -89.51 -17.19 29.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 75.14 110.848 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.64 19.63 8.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.706 -0.759 . . . . 75.03 112.475 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.74 171.83 8.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 74.51 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' HB2' HD13 ' A' ' 95' ' ' ILE . 13.9 mm-40 -70.63 -176.3 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 74.02 110.972 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -116.37 101.53 53.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 73.32 110.948 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.4 Cg_endo -69.67 -179.68 3.04 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.741 2.294 . . . . 70.33 112.351 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HE2' ' A' ' 104' ' ' LYS . 24.6 mt -51.1 -57.67 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 62.51 110.919 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.42 68.64 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.66 -0.781 . . . . 52.21 112.51 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.55 36.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 74.11 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.678 ' CD2' HD21 ' A' ' 133' ' ' LEU . 87.3 mt -119.23 -175.23 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.979 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.38 -171.13 3.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 51.34 110.898 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.903 HG22 HG23 ' A' ' 130' ' ' VAL . 52.6 m -50.73 -70.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.153 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 129' ' ' THR . 31.3 t -120.51 103.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.44 111.177 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -133.04 170.22 15.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 64.53 111.125 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.32 128.11 52.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 71.41 110.886 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.678 HD21 ' CD2' ' A' ' 127' ' ' LEU . 63.9 mt -116.08 155.95 27.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 65.54 110.914 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -136.1 114.83 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.887 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -110.08 51.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 61.1 110.866 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.44 89.46 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.718 -0.753 . . . . 75.35 112.574 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.96 14.57 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 75.33 110.845 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.432 ' SD ' HD22 ' A' ' 46' ' ' LEU . 50.4 tpp -133.13 98.22 4.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 71.52 110.844 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 131.13 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 72.02 110.908 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.847 HG22 HD21 ' A' ' 158' ' ' LEU . 90.1 t -136.78 119.09 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 71.41 111.114 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -111.66 125.55 54.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 70.41 110.914 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.3 p -81.0 -172.52 3.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 32.44 111.136 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.575 ' HD1' HG22 ' A' ' 130' ' ' VAL . 15.9 t80 -170.84 130.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.43 110.923 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.709 ' HB3' HG23 ' A' ' 129' ' ' THR . 12.2 t80 -119.93 86.13 35.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.763 0.792 . . . . 74.21 110.911 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.707 2.271 . . . . 72.33 112.351 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.39 -162.1 23.22 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 72.43 112.443 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.2 135.86 33.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.736 0.303 . . . . 74.43 110.921 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.416 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -148.68 -85.19 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 23.24 112.506 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -79.8 -24.3 41.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.393 . . . . 75.21 110.905 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.478 HG21 ' HB2' ' A' ' 86' ' ' HIS . 24.3 p -147.05 -162.97 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 74.4 111.111 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.56 ' HB3' HD23 ' A' ' 114' ' ' LEU . 36.2 tt0 -88.45 -20.94 24.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.927 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.714 ' OD2' HD23 ' A' ' 110' ' ' LEU . 3.4 t0 -133.22 18.27 4.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.86 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.434 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.1 OUTLIER -50.92 131.42 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 70.31 110.771 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.443 HG22 ' CD1' ' A' ' 144' ' ' TYR . 12.9 pt -140.72 169.95 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 65.21 111.09 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 143' ' ' PHE . 16.6 m -121.88 135.36 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 72.04 111.2 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.22 122.57 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.07 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -107.73 132.13 53.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.919 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.847 HD21 HG22 ' A' ' 140' ' ' VAL . 10.7 mt -112.06 98.55 42.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.542 0.687 . . . . 72.03 110.825 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.76 -4.93 15.03 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.272 . . . . 73.41 112.291 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.24 -23.64 35.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.42 110.951 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.04 14.6 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.908 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.7 m120 53.95 27.64 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 74.43 110.958 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.483 HD13 HD13 ' A' ' 21' ' ' LEU . 97.0 mt -92.75 125.93 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 74.41 111.078 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.2 148.68 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 64.24 110.908 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 55' ' ' VAL . 62.0 t -112.43 81.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 63.51 111.129 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.42 48.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 64.3 112.453 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.23 -167.5 46.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 51.31 112.522 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.02 -34.42 29.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 71.34 110.871 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.592 HD12 ' NE1' ' A' ' 189' ' ' TRP . 14.3 tp -51.26 -60.3 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 73.14 110.915 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 218' ' ' LEU . 14.2 t -82.2 116.17 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.144 -0.48 . . . . 71.44 111.076 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.679 ' HE3' HD11 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -51.66 171.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.907 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -121.34 138.11 54.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.0 110.883 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 44.32 111.168 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.794 0.33 . . . . 30.23 111.073 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -110.43 88.18 2.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.974 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 21.7 t -58.32 -20.08 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 54.12 111.133 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.66 -23.02 59.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.956 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -114.33 -13.78 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 71.23 110.891 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.592 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.8 t90 -54.19 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 55.44 110.947 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.78 ' HB3' HD11 ' A' ' 226' ' ' LEU . 3.2 p -54.24 -24.65 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 61.21 110.821 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.1 m -80.55 -30.21 37.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 52.21 111.163 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.413 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -77.34 -44.55 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 72.04 110.929 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 219' ' ' LEU . 34.9 mm -58.91 -46.19 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 62.32 111.086 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -55.62 -29.06 58.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.866 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -77.17 -22.3 52.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 74.02 110.862 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 219' ' ' LEU . 20.7 t -84.76 -11.13 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 55.2 111.122 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -111.12 -15.47 13.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 62.5 110.896 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.447 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -96.42 -30.98 13.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 65.23 110.98 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -50.13 3.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 73.25 110.843 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.452 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -97.41 61.59 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 63.32 110.961 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -74.33 -63.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 74.2 110.902 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -51.99 103.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 71.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.671 HG21 ' CG2' ' A' ' 206' ' ' VAL . 79.3 mt -141.42 123.22 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 73.13 111.182 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.57 -29.38 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.3 110.833 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.3 133.51 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.124 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.752 ' HB ' HD12 ' A' ' 218' ' ' LEU . 83.9 t -109.42 130.07 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 60.32 111.115 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 213' ' ' VAL . 4.2 t -105.73 111.17 64.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.561 0.696 . . . . 74.24 111.039 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -175.73 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.675 2.25 . . . . 64.33 112.349 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.75 -12.57 79.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.739 -0.743 . . . . 53.31 112.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -152.11 147.25 26.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 63.43 110.796 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.37 -117.93 5.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.7 -0.762 . . . . 51.34 112.454 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.85 175.26 10.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.945 0.402 . . . . 73.34 110.85 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 207' ' ' VAL . 3.2 m -72.07 156.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 72.54 111.059 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.51 -105.7 0.41 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.68 -0.771 . . . . 53.43 112.441 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.423 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.3 OUTLIER -153.82 -178.13 6.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 73.23 110.963 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.519 ' HA ' HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -61.97 -16.55 52.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 72.32 110.874 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.39 -23.7 42.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.75 -0.738 . . . . 75.05 112.473 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.752 HD12 ' HB ' ' A' ' 206' ' ' VAL . 4.6 mt -65.07 -25.66 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 65.23 110.834 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.524 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -70.36 -59.49 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.924 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -15.24 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 54.01 110.895 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 171' ' ' LYS . 1.2 t-80 -77.58 -42.57 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 71.55 110.954 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 1.036 HG22 HD23 ' A' ' 226' ' ' LEU . 47.1 m -52.98 -48.59 67.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 74.52 111.16 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.64 -14.52 52.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.217 -0.447 . . . . 72.44 110.887 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -88.33 3.01 51.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.02 110.882 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.679 HD11 ' HE3' ' A' ' 171' ' ' LYS . 4.5 mt -133.62 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.912 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 1.036 HD23 HG22 ' A' ' 222' ' ' THR . 1.0 OUTLIER -77.06 -4.43 44.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 55.21 110.896 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 73.01 110.929 179.888 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.828 0.347 . . . . 74.03 111.077 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.4 mt -136.2 93.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 70.43 111.227 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.26 121.11 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.852 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -63.84 167.63 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 55.34 110.876 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.04 -44.86 64.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 52.41 110.86 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.0 p -62.04 -38.11 87.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 71.51 111.159 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.25 14.54 62.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.798 -0.715 . . . . 50.51 112.495 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.418 HG23 ' CB ' ' A' ' 31' ' ' LEU . 23.7 m -83.59 -39.25 20.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.818 0.342 . . . . 74.04 111.174 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.14 117.54 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 73.24 111.1 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -124.36 132.43 53.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.24 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.709 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.2 mt -124.92 108.63 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 54.13 111.101 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -100.95 127.53 47.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.866 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -69.77 111.21 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.909 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HG ' HG23 ' A' ' 27' ' ' VAL . 23.0 mt -64.23 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 63.51 110.915 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.07 -97.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.911 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.2 OUTLIER -151.54 10.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.825 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.438 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.56 6.35 0.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.89 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -150.73 140.16 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 71.01 111.14 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.709 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.7 m95 -127.55 -178.05 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.909 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.551 HG23 ' HG ' ' A' ' 21' ' ' LEU . 69.3 t -133.67 95.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.156 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -77.56 118.32 19.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.813 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 m -113.67 107.34 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 70.33 111.157 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.24 126.93 38.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.44 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.418 ' CB ' HG23 ' A' ' 15' ' ' THR . 0.5 OUTLIER -91.47 105.04 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.916 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.537 179.822 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 40' ' ' PRO . 2.1 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.599 0.714 . . . . 72.44 111.121 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.5 Cg_endo -69.81 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.703 2.269 . . . . 73.41 112.352 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.9 p -100.43 107.77 19.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 62.51 110.818 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.06 162.61 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.885 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.19 -155.27 6.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.743 -0.741 . . . . 74.43 112.472 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.598 HD21 ' CD1' ' A' ' 158' ' ' LEU . 19.8 tp -158.61 112.62 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 73.23 110.927 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.675 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -97.5 121.49 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.33 111.135 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.585 HD21 HD11 ' A' ' 158' ' ' LEU . 29.5 mt -99.67 118.0 35.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.985 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.2 85.83 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.02 110.826 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -100.81 -174.29 2.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 72.4 111.073 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -103.23 -27.79 12.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 71.42 110.844 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -18.16 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.52 110.873 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.4 150.73 5.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 63.54 112.484 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.711 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.8 mt -62.14 155.09 25.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 63.14 110.937 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 81' ' ' ASP . 2.1 t -144.78 141.84 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 72.31 111.099 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.675 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -136.61 122.91 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 43.44 110.893 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.68 112.23 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 65.05 111.139 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.94 128.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 74.5 110.852 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.673 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.8 p -71.92 -168.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 60.1 110.821 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -89.94 171.65 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.11 110.936 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.721 ' HB2' HD12 ' A' ' 63' ' ' LEU . 95.7 m95 -50.85 -60.77 2.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 74.21 110.96 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.47 159.04 36.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 52.12 110.896 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.56 -34.04 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.51 110.904 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.76 -39.47 77.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.798 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.721 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.1 mt -80.09 -43.83 21.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 73.02 110.939 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.25 -48.53 62.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.152 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.99 -49.43 66.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 72.04 110.931 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.75 -19.48 65.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 74.12 110.967 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.2 tp -88.65 -26.14 22.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 53.43 110.91 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.5 -23.11 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 73.23 111.15 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -92.29 15.54 13.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 61.41 110.872 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.6 ptm -130.5 -39.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 70.41 110.887 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 67' ' ' LEU . 32.7 m -79.76 -23.44 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 61.03 111.109 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.711 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.0 -25.03 66.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.3 110.827 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -104.77 -33.49 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 72.34 110.899 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -45.14 67.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.44 111.012 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.584 ' HB2' HD11 ' A' ' 52' ' ' LEU . 19.8 m-85 -85.21 -12.59 52.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 73.3 110.852 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.5 11.21 7.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.44 110.829 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.93 141.37 50.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.412 . . . . 64.54 110.899 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -85.82 140.55 30.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.55 110.819 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.711 HG22 ' HB3' ' A' ' 52' ' ' LEU . 87.4 t -82.04 125.01 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -140.89 12.11 2.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 75.1 111.13 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.539 ' N ' HG23 ' A' ' 103' ' ' ILE . 61.1 m-20 -152.48 146.12 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.849 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 54' ' ' LEU . 15.7 t -154.29 131.27 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.22 111.169 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.58 HD13 HG11 ' A' ' 140' ' ' VAL . 5.5 mt -92.68 126.75 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 62.01 111.082 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mm -101.85 150.42 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 54.12 111.16 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -45.43 3.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 61.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.643 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -149.32 175.76 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 73.4 110.872 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -98.27 87.07 3.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 72.03 111.047 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -143.73 156.23 44.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 70.31 110.897 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.79 -21.32 27.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 54.12 111.018 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.55 18.02 10.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 54.14 110.828 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -137.87 -76.52 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 63.32 110.796 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -92.5 7.42 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.32 111.072 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.68 -39.76 39.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 51.41 112.534 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.21 15.92 58.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.659 -0.781 . . . . 71.23 112.402 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.3 tt -57.14 -28.61 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 73.13 111.147 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -55.89 -30.22 61.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.939 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -88.87 -17.5 29.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 74.11 111.132 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 57' ' ' SER . 11.5 mt -88.5 -28.63 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 74.35 110.913 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -92.34 7.89 40.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.14 110.917 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -106.86 -55.27 2.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 70.13 110.917 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -63.97 -57.11 10.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 74.41 110.807 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.0 39.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.674 -0.774 . . . . 73.44 112.384 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.634 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.3 mp -104.99 126.56 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 71.13 111.095 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.534 ' HB3' HD11 ' A' ' 124' ' ' LEU . 5.3 mttm -86.05 117.59 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 70.53 110.94 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.27 94.95 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 70.33 111.127 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.583 ' HA ' HD12 ' A' ' 124' ' ' LEU . 41.3 m-70 -66.58 146.07 54.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 61.22 110.907 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.541 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -179.97 176.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 53.55 110.938 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -86.73 154.06 21.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 65.41 111.091 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.4 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 61.43 111.028 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.737 HD23 ' OD1' ' A' ' 152' ' ' ASP . 56.0 tp -67.25 -43.73 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.429 . . . . 74.54 110.861 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.699 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.0 m -59.65 -18.4 41.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 63.32 111.17 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -102.7 10.22 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.42 111.036 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.722 ' HG2' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.23 -27.31 8.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 54.52 110.917 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.699 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -99.14 -7.44 26.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 64.3 110.927 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.38 -38.39 63.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.01 111.068 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -26.84 61.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.862 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -58.74 -33.52 70.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.916 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -88.07 -21.35 24.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 75.12 110.93 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.36 5.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 75.01 112.466 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.38 175.2 6.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 74.11 110.9 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.555 ' HB2' HD13 ' A' ' 95' ' ' ILE . 78.3 mm-40 -74.17 -176.2 2.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.513 . . . . 52.2 110.933 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.8 OUTLIER -117.44 106.93 45.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 54.42 110.853 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.591 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.82 178.4 4.65 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 71.34 112.273 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' ' 106' ' ' HIS . 16.4 mt -51.78 -42.92 62.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 62.4 110.972 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.31 27.57 24.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.735 -0.745 . . . . 62.51 112.519 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -108.1 43.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 72.33 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.637 HD22 HD21 ' A' ' 133' ' ' LEU . 83.7 mt -126.86 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 72.35 110.918 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.47 -172.05 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.941 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.866 HG22 HG23 ' A' ' 130' ' ' VAL . 55.5 m -50.9 -70.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 72.0 111.083 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.866 HG23 HG22 ' A' ' 129' ' ' THR . 33.2 t -117.39 102.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 72.3 111.071 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t -132.45 174.7 9.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 64.43 111.106 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -120.96 134.44 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.903 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.637 HD21 HD22 ' A' ' 127' ' ' LEU . 26.4 mt -115.16 160.21 19.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 64.41 110.903 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -142.6 124.62 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 72.23 110.91 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.57 ' HE2' HD11 ' A' ' 83' ' ' ILE . 16.5 m-85 -125.1 44.36 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 75.35 110.868 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.1 94.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.741 . . . . 51.52 112.45 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 m120 66.22 12.94 8.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.748 0.309 . . . . 74.05 110.91 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.443 ' HB2' HG22 ' A' ' 48' ' ' THR . 53.5 tpp -135.74 109.8 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 74.05 110.777 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.81 133.34 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.886 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.705 HG22 HD21 ' A' ' 158' ' ' LEU . 20.0 t -138.79 115.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 54.44 111.122 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.6 129.98 55.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 72.1 110.844 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 p -86.8 -179.13 6.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 61.13 111.204 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.515 ' HD1' HG22 ' A' ' 130' ' ' VAL . 23.3 t80 -164.35 134.05 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.882 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.717 ' HB3' HG23 ' A' ' 129' ' ' THR . 12.6 t80 -121.83 89.79 48.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.647 0.737 . . . . 75.31 110.936 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.78 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.73 2.286 . . . . 72.32 112.338 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 125.99 -160.91 20.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 70.12 112.553 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -79.33 134.83 36.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.903 0.383 . . . . 72.32 110.829 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.17 -89.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.559 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -74.26 -27.8 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.43 110.83 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 86' ' ' HIS . 19.2 p -145.68 -159.96 1.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 71.34 111.091 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -86.79 -23.0 25.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 74.44 110.924 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.737 ' OD1' HD23 ' A' ' 110' ' ' LEU . 8.1 t0 -136.74 20.34 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 75.23 110.876 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.604 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.1 OUTLIER -51.8 129.88 27.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 51.21 110.926 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.592 HG22 ' CD1' ' A' ' 144' ' ' TYR . 14.5 pt -134.99 179.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 74.21 111.111 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 143' ' ' PHE . 5.6 m -129.24 152.06 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 65.04 111.101 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.8 t -103.21 119.18 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 50.5 111.144 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -107.62 138.09 44.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 74.02 110.9 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.705 HD21 HG22 ' A' ' 140' ' ' VAL . 32.3 mt -119.26 98.7 50.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.678 0.752 . . . . 65.31 110.911 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.89 -4.72 14.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.763 2.308 . . . . 73.32 112.312 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -85.39 -22.4 28.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.32 110.886 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.64 12.41 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 70.15 110.958 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.1 26.25 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 71.13 110.905 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 21' ' ' LEU . 99.4 mt -90.87 142.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 71.52 111.12 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.22 155.94 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 72.31 110.921 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.26 74.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.24 111.181 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.7 -39.49 46.59 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 75.31 112.547 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.44 -159.42 41.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.684 -0.77 . . . . 53.43 112.482 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 74.6 m -54.68 -38.37 66.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 74.52 110.83 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.731 HD12 ' NE1' ' A' ' 189' ' ' TRP . 24.2 tp -51.26 -33.49 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.3 110.937 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 218' ' ' LEU . 39.7 t -107.97 108.05 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 54.04 111.066 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.566 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -51.46 163.1 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.86 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.456 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -103.21 167.56 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 61.34 110.827 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.13 111.208 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.856 0.36 . . . . 74.5 111.108 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.77 88.19 2.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 65.41 110.981 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 21.1 t -63.0 -15.69 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 55.45 111.146 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -77.4 -22.14 52.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 64.04 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -118.42 -11.39 10.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 75.55 110.867 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.731 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.5 t90 -55.09 -60.91 2.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.959 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.649 ' HB3' HD11 ' A' ' 226' ' ' LEU . 1.7 p -53.8 -24.66 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.997 0.427 . . . . 73.51 110.927 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -81.58 -31.44 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 62.41 111.129 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -43.17 58.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 71.34 110.851 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.552 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.2 mm -61.58 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 65.33 111.133 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.31 -27.22 54.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 61.41 110.945 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -77.17 -22.19 52.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 71.34 110.891 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.26 -11.04 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 41.13 111.194 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.72 -12.09 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 70.32 110.883 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -31.03 11.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 72.13 110.888 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -59.41 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 75.21 110.907 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.452 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -91.83 62.5 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.966 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -72.78 -60.22 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 73.4 110.858 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -52.03 102.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 70.55 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.641 HG21 ' CG2' ' A' ' 206' ' ' VAL . 75.0 mt -141.21 116.93 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 62.33 111.209 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.06 -26.77 63.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.924 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.98 134.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 62.1 111.091 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.726 ' HB ' HD12 ' A' ' 218' ' ' LEU . 95.2 t -106.87 144.9 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 71.23 111.166 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 213' ' ' VAL . 14.2 t -117.84 104.77 48.56 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.594 0.711 . . . . 45.2 111.138 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -177.7 2.01 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.756 2.304 . . . . 62.32 112.322 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.3 -12.1 65.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.843 -0.694 . . . . 12.1 112.461 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -153.35 140.62 19.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.871 0.367 . . . . 71.43 110.83 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.32 -99.27 1.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 40.5 112.579 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.76 157.35 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.893 0.378 . . . . 72.43 110.882 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 207' ' ' VAL . 5.2 m -54.73 162.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 74.32 111.134 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.65 -95.03 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.73 -0.747 . . . . 72.04 112.463 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -168.34 -169.01 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 72.14 110.842 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.487 ' HA ' HD23 ' A' ' 219' ' ' LEU . 19.9 pttt -61.02 -18.09 55.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.858 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.72 -21.45 36.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 24.13 112.501 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.726 HD12 ' HB ' ' A' ' 206' ' ' VAL . 8.0 mt -71.25 -28.24 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 71.23 110.937 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.552 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.8 mm? -66.98 -59.61 3.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 63.15 110.877 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -17.32 55.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.422 . . . . 72.12 110.975 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.444 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -69.04 -46.8 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 74.14 110.894 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.824 HG22 HD23 ' A' ' 226' ' ' LEU . 19.6 m -51.73 -52.31 49.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.176 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.98 -18.47 46.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 72.41 110.941 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.88 -5.7 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 65.35 110.894 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 171' ' ' LYS . 7.6 mt -128.42 -5.4 5.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 55.03 110.874 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.824 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -117.5 -4.6 11.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 65.14 110.844 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.12 110.901 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.0 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.795 0.331 . . . . 75.0 111.082 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -135.88 92.66 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 71.13 111.096 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -112.73 115.01 27.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 63.31 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -58.22 169.47 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 51.35 110.815 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.46 -48.31 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 72.15 110.93 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -61.35 -37.42 83.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 75.11 111.114 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.43 61.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 75.43 112.43 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.3 m -79.56 -44.82 20.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 52.42 111.144 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -101.6 113.0 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.43 111.083 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 p -120.82 127.58 52.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.843 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.663 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -121.52 112.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 72.14 111.116 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.408 ' HA ' HG12 ' A' ' 8' ' ' VAL . 14.4 t -99.82 127.1 46.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.35 110.875 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -70.23 110.93 5.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 52.33 110.917 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 213' ' ' VAL . 15.5 mt -64.2 -31.74 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 64.41 110.878 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.93 -97.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.908 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.463 ' N ' HD22 ' A' ' 22' ' ' ASN . 18.6 tttt -150.64 9.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 74.22 110.87 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.448 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.28 7.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 72.21 110.904 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.9 141.71 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 35.41 111.171 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.663 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.1 m95 -129.44 -177.25 4.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.967 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.478 HG23 ' HG ' ' A' ' 21' ' ' LEU . 85.9 t -133.83 91.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 75.01 111.134 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.425 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.7 p80 -74.1 123.78 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.894 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.5 m -120.02 105.87 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.42 111.143 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.01 122.43 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.894 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 116.88 28.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 55.52 110.967 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 43.41 112.514 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.588 0.709 . . . . 74.21 111.169 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 115.89 4.31 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.663 2.242 . . . . 62.05 112.342 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -103.0 98.16 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 73.12 110.829 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -59.19 163.75 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.816 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -153.81 -148.12 4.84 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.705 -0.759 . . . . 72.22 112.507 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.655 HD21 HD12 ' A' ' 158' ' ' LEU . 19.4 tp -159.08 115.2 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 74.42 110.949 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.675 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.67 122.27 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 62.4 111.108 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.466 HD12 ' HB ' ' A' ' 53' ' ' VAL . 12.3 mt -101.03 120.51 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 53.31 110.953 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -91.26 85.42 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 74.31 110.892 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -171.95 2.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 75.23 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.42 -15.06 14.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.862 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -5.77 43.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 74.11 110.864 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.13 8.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 72.13 112.439 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.0 tp -73.74 155.44 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.389 . . . . 61.44 110.932 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.6 t -143.07 138.14 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 70.2 111.128 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.675 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -136.05 123.46 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 70.12 110.904 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.96 114.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 55.31 111.142 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.54 127.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 73.02 110.827 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.655 ' CB ' HD11 ' A' ' 98' ' ' LEU . 3.4 p -72.35 -166.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 43.32 110.859 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -91.68 168.52 11.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 70.03 110.886 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.711 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.9 m95 -48.92 -60.31 2.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 72.12 110.863 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -129.57 159.51 36.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.32 110.751 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -50.91 -32.29 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 74.31 110.941 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -58.29 -46.66 85.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 75.34 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.3 mt -74.38 -43.14 57.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 63.53 110.908 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.19 -49.54 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 63.53 111.128 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -53.43 -48.38 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.1 110.956 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -65.09 -18.92 65.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 71' ' ' VAL . 19.5 tp -89.78 -26.82 20.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 74.31 110.892 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.9 mt -90.67 -22.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 74.54 111.222 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -92.56 16.25 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 55.34 110.907 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.9 ptm -131.35 -40.3 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.9 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.6 m -80.56 -22.06 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.5 111.213 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.518 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.12 -23.08 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 70.13 110.919 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -107.75 -33.01 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 60.3 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 -40.41 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.924 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.25 -10.22 42.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.52 110.952 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.12 12.49 8.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 72.4 110.886 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HB2' HD13 ' A' ' 52' ' ' LEU . 1.4 mttp -131.25 138.44 49.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 40.14 110.963 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.65 136.75 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.907 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG21 HD11 ' A' ' 54' ' ' LEU . 75.8 t -74.0 134.66 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 72.44 111.127 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.9 t -155.24 20.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.125 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.565 ' O ' HG13 ' A' ' 53' ' ' VAL . 4.0 m-20 -164.72 138.46 5.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.873 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -151.71 160.19 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 73.24 111.204 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.525 HG21 HG22 ' A' ' 156' ' ' VAL . 5.8 mt -116.42 135.43 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.137 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.54 121.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 65.41 111.104 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.1 p -78.45 -33.27 48.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.3 111.115 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.581 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.3 p-80 -167.95 -174.89 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.32 110.931 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.585 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -98.89 97.69 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 74.42 111.047 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -156.77 155.25 31.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 72.04 110.903 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.11 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 73.13 111.129 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.45 26.35 3.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 73.1 110.792 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.48 -74.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.848 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -95.09 8.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 64.42 111.121 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.14 -39.8 27.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.684 -0.77 . . . . 52.41 112.612 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.81 12.95 56.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.506 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.5 tt -54.38 -27.97 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 62.11 111.128 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -56.66 -35.62 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 61.44 110.87 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.3 m -85.12 -22.57 28.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 63.41 111.114 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.751 ' HA ' HD13 ' A' ' 103' ' ' ILE . 14.3 mt -80.92 -30.19 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 73.2 110.95 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.91 21.9 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.34 110.909 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.86 -41.56 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.912 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -80.07 -50.1 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 71.31 110.912 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.09 39.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.795 -0.716 . . . . 62.43 112.525 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.751 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -101.77 126.19 55.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.894 0.378 . . . . 65.32 111.127 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -85.89 112.35 21.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.2 110.904 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.67 100.73 12.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.44 111.058 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.446 ' HA ' HD12 ' A' ' 124' ' ' LEU . 61.1 m-70 -71.61 132.33 44.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 70.35 110.858 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -160.5 166.13 29.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 70.25 110.961 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.98 156.75 24.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.158 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.31 -40.53 35.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 63.22 111.114 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.72 -40.88 72.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 72.32 110.982 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 98.6 m -58.55 -20.96 50.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.107 -0.497 . . . . 73.33 111.097 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.411 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -100.43 8.08 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 74.33 111.105 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -108.4 -31.98 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 71.13 110.849 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -96.1 -11.42 26.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.15 110.984 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.411 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.42 -37.58 77.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 23.12 111.049 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.67 60.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 63.52 110.904 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -57.18 -33.28 67.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.14 110.848 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -89.85 -23.43 21.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.901 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.44 23.82 4.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 75.42 112.464 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -98.04 172.63 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 74.14 110.906 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.0 170.58 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 71.21 110.878 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -101.94 108.63 57.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.581 0.705 . . . . 75.34 110.881 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.6 Cg_endo -69.69 -176.58 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.701 2.268 . . . . 71.14 112.362 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 106' ' ' HIS . 9.8 mt -51.29 -42.56 61.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.869 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 27.58 23.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 34.02 112.458 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.03 26.1 11.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.891 0.377 . . . . 50.43 110.923 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 107' ' ' SER . 63.8 mt -103.87 -175.48 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 65.32 110.861 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.409 HE21 ' N ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -156.69 -172.86 4.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 72.0 110.893 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.889 HG22 HG23 ' A' ' 130' ' ' VAL . 54.2 m -51.02 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 72.15 111.096 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.889 HG23 HG22 ' A' ' 129' ' ' THR . 44.4 t -117.62 104.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 71.2 111.134 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.506 HG22 ' OG1' ' A' ' 142' ' ' THR . 14.1 t -127.76 160.47 31.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.16 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.34 107.3 13.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.881 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.17 -172.7 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 64.44 110.905 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -176.15 112.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.3 110.871 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -106.73 74.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.031 0.444 . . . . 73.21 110.898 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.21 -86.91 0.18 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.749 . . . . 65.02 112.476 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -114.95 24.95 11.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 75.11 110.881 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.1 tpp -132.82 142.6 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 61.25 110.898 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.42 130.17 55.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 64.51 110.835 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.652 HG22 HD21 ' A' ' 158' ' ' LEU . 13.8 t -139.87 120.2 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 72.33 111.165 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -113.85 130.63 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 65.55 110.801 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.506 ' OG1' HG22 ' A' ' 131' ' ' THR . 18.2 p -88.28 171.18 10.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 73.1 111.105 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.478 ' HB3' HG23 ' A' ' 155' ' ' VAL . 29.9 t80 -156.58 138.76 14.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 64.04 110.885 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.675 ' HB3' HG23 ' A' ' 129' ' ' THR . 74.3 t80 -125.59 89.7 51.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.627 0.727 . . . . 73.13 110.842 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -7.89 22.21 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.599 2.199 . . . . 65.2 112.352 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.26 -154.31 20.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.866 -0.683 . . . . 74.34 112.548 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -90.01 139.96 30.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 72.3 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.52 -87.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 34.1 112.481 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -77.06 -25.93 52.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 55.54 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 86' ' ' HIS . 23.1 p -146.47 -161.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 70.23 111.193 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.477 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.9 tt0 -90.1 -17.72 27.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.911 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 154' ' ' ILE . 18.5 t0 -135.26 17.42 3.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 72.04 110.835 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.07 129.77 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 71.33 110.854 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 152' ' ' ASP . 10.9 pt -135.3 -177.77 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 74.33 111.127 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 143' ' ' PHE . 6.9 m -136.24 133.4 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 31.32 111.095 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.525 HG22 HG21 ' A' ' 83' ' ' ILE . 58.3 t -85.59 114.2 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 51.15 111.225 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -102.45 133.82 46.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 74.1 110.89 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.655 HD12 HD21 ' A' ' 44' ' ' LEU . 15.8 mt -113.59 97.76 44.87 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.575 0.702 . . . . 74.35 110.903 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.0 Cg_endo -69.79 -4.11 13.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.719 2.279 . . . . 71.44 112.347 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -85.18 -23.28 28.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 71.42 110.967 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -142.04 13.01 2.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.41 110.954 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.37 27.42 8.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.882 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.654 HD13 HD13 ' A' ' 21' ' ' LEU . 96.8 mt -93.13 124.67 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.462 . . . . 73.52 111.176 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 203' ' ' ILE . 20.7 tp -106.08 146.97 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 54.13 110.884 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.15 80.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.44 111.115 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.53 -40.48 47.29 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.38 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 68.89 -165.09 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.799 -0.715 . . . . 54.41 112.505 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -27.45 25.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 61.33 110.916 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.625 HD12 ' NE1' ' A' ' 189' ' ' TRP . 23.3 tp -57.25 -61.14 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 62.13 110.826 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.562 HG13 ' HA ' ' A' ' 219' ' ' LEU . 35.1 t -75.28 112.38 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.43 111.054 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.537 ' HG2' HG23 ' A' ' 222' ' ' THR . 2.8 mmpt? -54.0 151.15 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 63.33 110.839 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.8 p -99.74 157.28 16.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 74.01 110.85 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 60.54 111.164 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.814 0.34 . . . . 32.35 111.106 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -107.44 86.79 2.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.931 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 24.0 t -61.16 -17.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 72.1 111.114 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -74.27 -25.91 59.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.958 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.66 -11.97 13.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 65.34 110.954 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.625 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.6 t90 -54.37 -61.7 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 72.44 110.972 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.703 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.95 -24.29 16.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.855 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.92 -32.34 30.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.18 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.59 -43.31 63.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.882 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.528 HG21 ' O ' ' A' ' 219' ' ' LEU . 29.8 mm -62.15 -43.94 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 62.12 111.104 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.07 -24.07 62.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 64.52 110.956 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.31 -21.56 36.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.844 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 192' ' ' SER . 11.3 t -88.13 -8.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 74.13 111.1 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.42 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.36 -8.21 13.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.941 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -104.57 -30.93 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -104.31 -48.93 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 74.31 110.873 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -102.13 39.44 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 61.44 111.008 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.79 -47.9 76.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.502 . . . . 72.14 110.867 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -60.31 99.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.03 110.863 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.636 HG21 HG22 ' A' ' 206' ' ' VAL . 55.8 mt -140.16 123.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.047 -0.524 . . . . 64.41 111.107 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.94 -16.0 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.915 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.734 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -173.58 132.69 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 71.11 111.048 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.708 ' HB ' HD12 ' A' ' 218' ' ' LEU . 84.6 t -111.9 128.62 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 61.11 111.179 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 213' ' ' VAL . 19.6 t -108.43 104.12 53.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.644 0.735 . . . . 72.31 111.083 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.506 ' HD3' HD13 ' A' ' 218' ' ' LEU . 52.9 Cg_endo -69.82 -169.54 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.274 . . . . 71.44 112.32 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.47 -15.5 66.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.701 -0.761 . . . . 45.21 112.476 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -152.01 139.72 19.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.976 0.417 . . . . 75.21 110.803 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 109.52 -117.29 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.812 -0.709 . . . . 53.41 112.543 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.65 173.44 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 75.11 110.897 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 207' ' ' VAL . 6.1 t -70.5 144.85 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 71.32 111.154 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.66 -93.32 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.671 -0.775 . . . . 73.1 112.474 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -172.13 -167.17 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 72.54 110.899 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -19.37 38.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 61.21 110.864 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.72 -23.14 20.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.695 -0.764 . . . . 65.01 112.534 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 206' ' ' VAL . 7.0 mt -76.87 -32.68 57.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.318 . . . . 65.41 110.882 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.562 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.6 mp -61.12 -61.98 2.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.898 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.19 -22.24 60.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.939 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.409 ' CE1' HD11 ' A' ' 225' ' ' LEU . 1.2 t60 -62.0 -44.69 96.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.901 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.576 ' C ' HD23 ' A' ' 226' ' ' LEU . 2.2 m -51.45 -53.97 31.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 63.22 111.12 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.415 HD23 ' HB3' ' A' ' 190' ' ' SER . 1.2 mt -60.28 -18.72 51.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 72.34 110.902 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 70.11 110.88 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.483 HD12 ' HG3' ' A' ' 171' ' ' LYS . 9.7 mt -126.01 -6.37 6.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.03 110.938 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.703 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -119.83 9.72 11.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 65.1 110.951 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 62.0 110.896 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.818 0.342 . . . . 75.22 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -136.38 94.41 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 63.53 111.131 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -112.53 115.26 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.919 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -57.64 167.88 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 64.41 110.894 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -51.71 -48.08 63.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.859 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.74 -37.84 83.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.103 -0.498 . . . . 74.31 111.158 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.16 60.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.784 -0.722 . . . . 30.54 112.528 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 31' ' ' LEU . 49.3 m -80.92 -43.53 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 61.03 111.126 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.48 118.42 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 64.21 111.115 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 p -124.02 131.37 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.749 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -123.96 110.4 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 42.13 111.14 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -100.6 123.69 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 74.12 110.872 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.15 110.98 4.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 52.31 110.893 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.77 HD21 HG11 ' A' ' 213' ' ' VAL . 14.8 mt -65.75 -31.83 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 63.3 110.818 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.472 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.02 -97.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 72.31 110.894 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -151.5 10.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 71.24 110.922 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.442 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.59 6.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.54 110.806 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -151.0 139.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 62.02 111.108 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.8 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.1 m95 -127.44 -173.99 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.937 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 43' ' ' GLY . 94.2 t -137.27 97.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 74.44 111.092 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -81.47 121.36 26.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 70.53 110.888 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.2 m -116.19 92.27 3.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 72.11 111.136 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -72.97 117.6 14.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 71.25 110.85 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.752 HD12 ' HB3' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -88.34 111.49 21.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.898 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 55.42 112.458 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 121.656 0.741 . . . . 75.24 111.084 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.752 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.2 Cg_endo -69.74 118.27 5.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.581 2.187 . . . . 75.11 112.395 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -103.54 100.68 10.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 63.23 110.852 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.414 HD21 ' N ' ' A' ' 212' ' ' GLU . 16.3 m-20 -49.36 162.4 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 52.24 110.885 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.598 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.48 -166.8 17.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 33.14 112.477 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.595 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.7 tp -153.12 113.27 3.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 72.03 110.903 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 54' ' ' LEU . 1.9 t -97.59 117.98 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 74.44 111.049 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.4 HD22 ' SD ' ' A' ' 138' ' ' MET . 24.7 mt -95.9 122.74 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 62.01 110.918 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.03 84.41 5.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 53.2 110.853 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.0 OUTLIER -101.55 178.87 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 43.4 111.189 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.82 -26.66 14.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 71.11 110.837 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -18.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 64.33 110.864 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.79 151.33 5.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 35.51 112.476 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 75' ' ' PHE . 2.5 mt -62.0 153.72 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 73.25 110.923 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.644 HG13 ' CB ' ' A' ' 81' ' ' ASP . 2.2 t -143.56 139.73 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 74.11 111.139 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -136.1 122.92 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.918 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.497 HG12 ' OD1' ' A' ' 56' ' ' ASP . 78.5 t -69.11 111.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 53.42 111.104 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.622 ' OD2' HG23 ' A' ' 85' ' ' THR . 1.6 m-20 72.98 125.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 70.53 110.905 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.656 ' CB ' HD11 ' A' ' 98' ' ' LEU . 2.7 p -69.6 -166.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 44.43 110.819 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -90.96 168.45 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 61.42 110.906 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.687 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.4 m95 -50.71 -60.42 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 74.13 110.945 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -126.03 160.87 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 62.33 110.806 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -53.63 -37.82 63.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 61.04 110.884 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.94 -37.52 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 72.14 110.878 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.4 mt -80.28 -43.55 21.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 41.44 110.91 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.58 62.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 64.24 111.125 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -52.71 -48.37 66.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 63.42 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.95 -18.79 65.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 71.31 110.835 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 71' ' ' VAL . 19.1 tp -89.43 -25.45 21.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 65.23 110.879 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.414 HG23 ' OE1' ' A' ' 72' ' ' GLU . 71.3 mt -91.93 -24.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.23 111.057 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.87 12.36 19.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 74.02 110.911 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ptm -127.48 -39.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 61.54 110.923 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 67' ' ' LEU . 14.6 m -79.84 -22.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 63.35 111.115 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -70.38 -22.69 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 65.35 110.949 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -107.41 -31.08 8.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 71.23 110.826 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -73.15 -44.68 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 52.24 110.951 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.638 ' HB2' HD11 ' A' ' 52' ' ' LEU . 22.8 m-85 -85.95 -13.11 48.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.873 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.72 15.35 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.936 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 139.5 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 65.22 111.002 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -77.76 139.21 39.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 71.55 110.937 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.39 134.67 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 50.12 111.137 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 t -160.37 20.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 70.31 111.124 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.654 ' N ' HG23 ' A' ' 103' ' ' ILE . 48.4 m-20 -155.37 143.6 20.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 65.55 110.902 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 81' ' ' ASP . 6.7 t -156.84 105.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 65.22 111.076 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.716 ' CD1' HG11 ' A' ' 140' ' ' VAL . 68.8 mt -71.11 121.27 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 72.33 111.144 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mm -94.36 149.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 73.44 111.17 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.622 HG23 ' OD2' ' A' ' 56' ' ' ASP . 29.6 p -108.44 -42.12 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.13 111.15 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.545 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.6 p-80 -164.54 -175.17 3.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 62.31 110.823 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.851 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.19 98.4 11.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 62.51 111.052 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.81 153.81 32.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 62.54 110.868 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.19 -19.98 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 54.01 111.124 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -91.81 4.48 52.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 55.13 110.844 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.401 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 3.7 mpt_? -120.69 -78.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.02 110.932 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.417 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -90.78 7.08 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 73.1 111.176 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.36 -41.47 48.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 32.33 112.539 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.15 13.21 60.36 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.734 -0.746 . . . . 52.34 112.491 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 121' ' ' GLU . 16.8 tt -54.79 -26.39 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 73.53 111.144 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -54.54 -35.35 63.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 73.35 110.932 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.6 m -88.92 -12.86 40.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 63.25 111.159 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.656 HD11 ' CB ' ' A' ' 57' ' ' SER . 18.3 mt -88.56 -35.86 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 74.13 110.95 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -84.24 2.67 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 74.42 110.912 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.68 -51.07 3.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.31 110.842 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -69.83 -59.91 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.2 110.835 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.87 43.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.722 . . . . 54.44 112.557 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.654 HG23 ' N ' ' A' ' 81' ' ' ASP . 4.3 mp -103.34 120.31 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 65.24 111.147 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.738 ' HE2' HD21 ' A' ' 124' ' ' LEU . 4.6 mttt -73.2 114.39 11.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 54.0 110.858 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.06 85.58 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 44.05 111.1 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.579 ' HB3' HD11 ' A' ' 127' ' ' LEU . 85.8 m-70 -56.92 144.54 33.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.785 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.6 169.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 44.22 110.89 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.77 157.34 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 61.25 111.122 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.87 -40.41 29.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 73.3 111.062 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.464 HD22 ' CD ' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -64.14 -47.54 79.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 72.53 110.937 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.784 ' HA ' HD11 ' A' ' 114' ' ' LEU . 52.3 m -58.63 -20.73 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 40.42 111.094 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -99.76 12.39 36.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 73.3 111.191 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.464 ' CD ' HD22 ' A' ' 110' ' ' LEU . 3.1 pt-20 -114.97 -31.74 5.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 73.13 110.934 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.851 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -95.68 -13.87 23.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 74.3 110.866 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.462 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.04 -37.44 78.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.971 0.415 . . . . 65.22 111.133 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -20.86 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 63.45 110.956 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.01 -32.43 74.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.826 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -90.25 -18.22 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 72.33 110.865 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.67 27.2 5.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 61.21 112.45 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.34 173.95 6.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 74.32 110.923 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.493 ' HB2' HD13 ' A' ' 95' ' ' ILE . 80.1 mm-40 -80.35 160.56 25.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 71.23 110.883 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.1 mp0 -92.71 111.85 52.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.713 0.768 . . . . 74.31 110.954 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.5 Cg_endo -69.72 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 61.33 112.393 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.738 HD21 ' HE2' ' A' ' 104' ' ' LYS . 13.8 mt -51.68 -45.54 63.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 65.34 110.885 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.49 34.94 43.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 72.32 112.527 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.12 36.26 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.827 0.346 . . . . 70.35 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 106' ' ' HIS . 47.6 mt -120.07 -172.34 2.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.848 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.75 -171.84 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 64.1 110.921 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.915 HG22 HG23 ' A' ' 130' ' ' VAL . 46.0 m -50.56 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 72.23 111.121 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.915 HG23 HG22 ' A' ' 129' ' ' THR . 44.0 t -119.39 103.88 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 63.53 111.131 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 t -135.37 175.63 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 71.14 111.193 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -120.34 131.36 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.849 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.523 HD21 HD22 ' A' ' 127' ' ' LEU . 31.4 mt -109.07 152.2 25.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.882 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -130.74 125.36 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 73.03 110.918 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.523 ' HE2' HD11 ' A' ' 83' ' ' ILE . 10.3 m-85 -129.0 26.53 5.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.867 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.28 95.67 0.21 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 44.03 112.536 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 66.07 13.09 8.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.735 0.303 . . . . 74.24 110.882 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.469 ' HB2' HG22 ' A' ' 48' ' ' THR . 52.9 tpp -133.71 106.29 7.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 75.21 110.97 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.98 127.43 37.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 74.25 110.87 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.716 HG11 ' CD1' ' A' ' 83' ' ' ILE . 18.2 t -138.69 113.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 61.22 111.142 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -109.74 131.41 55.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.798 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.7 p -85.09 178.65 7.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 71.02 111.189 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.485 ' HD1' HG22 ' A' ' 130' ' ' VAL . 19.9 t80 -161.05 133.27 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 73.44 110.843 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.692 ' HB3' HG23 ' A' ' 129' ' ' THR . 8.5 t80 -122.82 86.45 50.15 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.699 0.761 . . . . 71.33 110.94 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -7.99 22.45 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.757 2.305 . . . . 51.41 112.373 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.39 -160.06 23.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.74 . . . . 54.43 112.536 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -87.61 140.63 29.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 74.14 110.924 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -155.66 -88.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 74.11 112.435 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -76.95 -22.97 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.31 110.815 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.545 HG21 ' HB2' ' A' ' 86' ' ' HIS . 81.4 p -151.18 -168.85 3.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 74.23 111.183 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.571 ' HB3' HD23 ' A' ' 114' ' ' LEU . 43.6 tt0 -86.09 -5.53 59.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 72.52 110.902 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 154' ' ' ILE . 48.5 t0 -147.07 16.47 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 54.4 110.857 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.661 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -49.33 127.38 14.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' ASP . 4.8 pt -133.72 175.06 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 65.04 111.123 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 143' ' ' PHE . 14.6 m -129.33 119.74 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 73.3 111.105 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.61 120.26 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 71.02 111.141 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -108.45 136.55 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.11 110.929 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.644 ' CD2' HG22 ' A' ' 140' ' ' VAL . 71.6 mt -118.59 98.64 51.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 63.23 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.1 Cg_endo -69.79 -3.87 12.91 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.635 2.223 . . . . 64.44 112.322 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -86.53 -23.42 25.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 74.02 110.86 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -139.35 11.13 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 75.23 110.968 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.4 m120 55.2 25.79 7.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 73.31 110.818 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 21' ' ' LEU . 87.6 mt -90.8 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 75.41 111.086 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 203' ' ' ILE . 15.1 tp -126.14 146.53 49.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 72.32 110.925 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.478 HG11 HG11 ' A' ' 55' ' ' VAL . 48.8 t -112.02 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 62.12 111.163 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.81 -29.45 26.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.771 -0.728 . . . . 60.13 112.458 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.95 -160.13 12.51 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.694 -0.765 . . . . 42.13 112.422 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -26.66 65.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 72.24 110.896 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.661 HD13 ' OD1' ' A' ' 153' ' ' ASN . 21.5 tp -58.15 -35.67 71.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 71.24 110.843 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.66 111.78 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 63.44 111.132 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.549 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.4 mmpt? -51.79 164.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 53.2 110.904 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.2 p -103.18 163.47 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 72.42 110.836 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.52 111.093 -179.866 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.759 0.314 . . . . 43.12 111.133 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -119.88 91.94 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.928 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 21.9 t -62.8 -16.13 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 53.44 111.09 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -75.53 -22.58 56.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 64.13 110.878 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.67 -13.49 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 73.55 110.915 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.618 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.7 t90 -54.02 -62.46 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 74.41 110.941 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.72 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.81 -23.55 18.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 71.21 110.905 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.2 m -81.3 -31.11 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 72.41 111.164 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -75.51 -43.11 50.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.135 -0.484 . . . . 63.43 110.98 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.517 HG21 ' O ' ' A' ' 219' ' ' LEU . 34.0 mm -62.09 -45.52 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 63.12 111.151 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -57.04 -24.1 51.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 64.21 110.799 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -81.68 -22.28 37.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 64.42 110.941 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 192' ' ' SER . 17.5 t -86.7 -9.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 70.31 111.126 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.69 -6.59 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.924 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.57 -31.15 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.925 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 -55.48 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.55 110.859 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.13 38.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 73.14 110.904 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -56.34 -47.66 78.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 74.31 110.814 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -59.59 99.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.842 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.688 HG21 HG22 ' A' ' 206' ' ' VAL . 50.7 mt -142.61 124.26 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 63.32 111.206 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.84 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 54.23 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.71 133.73 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 74.32 111.107 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.744 ' HB ' HD12 ' A' ' 218' ' ' LEU . 97.6 t -114.56 134.05 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 74.22 111.117 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.034 HG22 HG12 ' A' ' 213' ' ' VAL . 9.6 t -112.82 108.94 53.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.657 0.741 . . . . 72.14 111.146 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.73 -169.82 0.35 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 65.24 112.333 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.42 -17.88 63.44 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 73.24 112.474 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -152.49 151.28 30.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 75.15 110.868 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 102.68 -101.02 2.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 73.54 112.49 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.414 ' N ' HD21 ' A' ' 42' ' ' ASN . 3.3 pt-20 -173.51 161.56 4.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 72.51 110.943 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.034 HG12 HG22 ' A' ' 207' ' ' VAL . 5.9 m -51.85 163.02 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.73 -106.81 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.666 -0.778 . . . . 61.32 112.443 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -169.48 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.34 . . . . 73.03 110.851 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -60.78 -18.25 53.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 62.12 110.878 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.42 -18.72 44.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 73.24 112.472 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.3 mt -71.53 -31.03 66.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 74.41 110.976 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.517 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.1 mm? -64.77 -56.93 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 53.42 110.87 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.618 ' HA ' HD12 ' A' ' 223' ' ' LEU . 0.6 OUTLIER -63.64 -16.3 60.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 71.15 110.785 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.645 ' CE1' HD11 ' A' ' 225' ' ' LEU . 3.0 t-80 -68.36 -41.76 80.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 71.31 110.911 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.904 HG22 HD23 ' A' ' 226' ' ' LEU . 25.4 m -61.16 -50.22 74.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.161 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -63.49 -24.41 67.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 61.51 110.887 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.49 -12.28 60.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.645 HD11 ' CE1' ' A' ' 221' ' ' HIS . 6.9 mt -117.85 -19.5 9.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.895 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.904 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -108.03 0.9 22.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 74.1 110.871 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.893 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.798 0.332 . . . . 64.42 111.137 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -113.1 96.48 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 72.12 111.081 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -117.54 115.89 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.916 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -60.54 166.3 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 54.24 110.877 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.68 -48.31 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.885 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.0 p -61.66 -37.5 84.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.47 63.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 72.13 112.541 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.5 m -80.52 -44.2 19.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 71.32 111.131 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 67' ' ' LEU . 25.6 mt -104.63 109.09 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 70.54 111.166 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -115.62 140.28 49.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 71.12 110.893 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.798 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -131.35 110.23 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 73.11 111.127 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -98.31 126.75 43.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 51.4 110.816 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -71.88 110.01 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 75.34 110.914 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.925 HD21 HG21 ' A' ' 213' ' ' VAL . 11.1 mt -64.23 -33.81 76.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 72.22 110.905 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.461 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.1 -97.0 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.921 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.34 9.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 64.01 110.926 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.451 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.75 7.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.829 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 t -150.96 140.95 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.162 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.798 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.2 m95 -129.19 -176.26 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.927 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 43' ' ' GLY . 90.5 t -134.15 89.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 72.32 111.115 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -73.03 125.24 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.886 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.8 m -121.57 103.49 8.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 71.32 111.076 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.496 ' HG3' HD22 ' A' ' 67' ' ' LEU . 2.4 mm-40 -86.75 118.7 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.15 110.955 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.34 127.9 34.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 72.34 110.931 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 63.35 112.573 179.82 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.632 0.729 . . . . 73.35 111.251 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 121.26 7.96 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.631 2.221 . . . . 73.1 112.422 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.05 96.99 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.86 167.05 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 53.31 110.923 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.83 -146.65 4.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 74.52 112.493 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.577 HD21 HD12 ' A' ' 158' ' ' LEU . 14.1 tp -159.16 120.02 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 71.55 110.927 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.664 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.7 t -103.8 123.0 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.156 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.771 HD21 HD11 ' A' ' 158' ' ' LEU . 16.6 mt -100.54 121.45 41.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 75.0 110.972 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.22 85.99 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.13 110.948 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -101.73 -179.87 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 70.51 111.176 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.4 m -99.98 -24.37 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 61.44 110.881 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -19.0 50.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.43 110.874 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.64 145.34 4.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 33.22 112.43 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.728 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.3 mt -58.23 155.04 12.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.921 0.391 . . . . 63.14 110.87 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.1 t -143.62 141.55 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 71.22 111.109 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.664 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -137.1 122.45 19.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 62.31 110.941 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 165' ' ' VAL . 54.2 t -68.16 111.72 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.198 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.5 141.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 74.1 110.843 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.74 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.4 p -83.11 -164.72 0.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 70.15 110.838 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.489 ' H ' HG23 ' A' ' 64' ' ' THR . 17.8 t -96.25 169.78 9.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 65.22 110.8 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.682 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.4 m95 -50.61 -59.24 4.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.925 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.64 163.48 23.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 73.55 110.872 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.21 -37.17 71.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 72.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -57.44 -34.9 69.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.24 110.893 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 59' ' ' TRP . 91.5 mt -81.51 -48.13 12.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.991 0.424 . . . . 73.11 110.864 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.3 -49.06 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 74.41 111.133 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -52.31 -50.73 61.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 73.25 110.899 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.0 -20.62 66.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 72.1 110.959 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.516 ' HB2' HD13 ' A' ' 16' ' ' ILE . 14.3 tp -87.09 -26.02 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 74.44 110.965 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.554 ' HA ' HG22 ' A' ' 71' ' ' VAL . 54.3 mt -92.39 -24.54 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 55.52 111.131 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.14 1.87 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 73.3 110.87 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ptm -119.61 -35.67 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 71.34 110.957 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 68' ' ' ILE . 31.6 m -79.19 -26.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 55.12 111.062 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.94 -21.05 63.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 71.44 110.864 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.37 -32.01 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 72.13 110.837 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -44.02 59.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.914 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.575 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 14.6 m-85 -85.91 -12.85 49.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 62.52 110.944 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.49 11.26 7.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.94 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -129.66 139.17 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.973 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -82.81 139.36 33.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 71.21 110.891 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 52' ' ' LEU . 92.5 t -82.74 121.06 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.2 111.188 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.2 8.14 2.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 61.15 111.118 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 82' ' ' VAL . 48.5 m-20 -147.09 145.2 29.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.185 -0.461 . . . . 54.44 110.91 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 54' ' ' LEU . 4.3 t -156.09 138.41 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 63.31 111.225 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.652 ' CD1' HG11 ' A' ' 140' ' ' VAL . 20.3 mt -94.09 136.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 75.44 111.18 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.056 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.1 mm -100.94 149.47 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 64.33 111.111 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -115.39 -38.4 3.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.162 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -169.93 172.06 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.844 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.622 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -91.11 89.15 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 64.34 111.143 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -148.67 154.97 40.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 73.02 110.895 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.64 -23.5 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 74.52 111.131 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -92.23 27.23 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.25 110.85 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.913 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -152.24 -70.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.928 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.722 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -90.17 3.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 73.23 111.122 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -44.39 54.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 72.2 112.51 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.51 13.97 63.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 74.11 112.526 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.61 HD12 HH22 ' A' ' 91' ' ' ARG . 2.6 tt -57.61 -26.06 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 52.21 111.214 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -55.1 -27.43 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 61.21 110.847 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -95.33 -38.46 10.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 65.21 111.196 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 57' ' ' SER . 14.9 mt -56.22 -46.09 79.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 63.1 110.897 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -0.99 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.4 110.94 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.53 -44.97 8.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.44 110.94 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -79.48 -61.39 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.81 39.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 61.42 112.394 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -101.9 120.3 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.798 0.332 . . . . 74.35 111.164 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.768 ' HD3' HD21 ' A' ' 124' ' ' LEU . 6.2 mttm -78.5 118.02 20.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.868 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 1.056 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -94.35 85.01 4.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.024 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.516 ' HB3' HD11 ' A' ' 127' ' ' LEU . 52.2 m-70 -55.01 110.43 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 74.04 110.849 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 t -139.67 -175.6 4.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.844 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.17 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 64.31 111.03 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.32 -36.75 44.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 61.53 111.062 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.7 HD22 ' OE1' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -68.4 -48.45 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.921 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.8 ' HA ' HD11 ' A' ' 114' ' ' LEU . 47.9 m -59.09 -18.78 38.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 72.22 111.207 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.633 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.37 13.07 36.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 73.35 111.083 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.7 ' OE1' HD22 ' A' ' 110' ' ' LEU . 2.1 pt-20 -115.6 -27.44 7.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.889 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.8 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -101.37 -11.74 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.2 110.879 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.11 69.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 42.43 111.068 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -20.72 60.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 64.24 110.907 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.37 -32.41 73.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 71.12 110.946 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -88.48 -14.86 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.843 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 22.53 7.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.753 -0.737 . . . . 72.11 112.437 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.402 ' CD1' HG12 ' A' ' 92' ' ' ILE . 80.9 m-85 -102.59 170.76 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.9 0.381 . . . . 64.14 110.844 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -72.78 -170.73 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 51.44 110.915 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.58 121.66 29.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.613 0.72 . . . . 73.22 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.633 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.4 Cg_endo -69.86 -169.96 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.692 2.261 . . . . 54.14 112.328 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.768 HD21 ' HD3' ' A' ' 104' ' ' LYS . 6.0 mt -59.5 -39.87 85.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 54.33 110.925 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.69 26.0 30.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.729 -0.748 . . . . 61.21 112.471 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.35 39.97 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 62.43 110.926 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.53 HD22 HD21 ' A' ' 133' ' ' LEU . 85.8 mt -131.62 -172.81 2.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.948 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.65 -169.71 2.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 63.33 110.972 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.928 HG22 HG23 ' A' ' 130' ' ' VAL . 33.8 m -48.3 -67.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 73.13 111.199 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.928 HG23 HG22 ' A' ' 129' ' ' THR . 41.7 t -120.53 109.31 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 64.43 111.13 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.499 HG21 HD22 ' A' ' 127' ' ' LEU . 13.2 t -138.68 176.15 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 73.35 111.049 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -122.87 137.39 54.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.53 HD21 HD22 ' A' ' 127' ' ' LEU . 25.2 mt -118.84 151.88 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 63.24 110.914 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.31 126.74 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 65.41 110.92 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.24 34.04 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 73.23 110.909 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.04 94.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 50.22 112.471 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.15 12.48 8.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.857 0.36 . . . . 63.51 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.437 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.5 tpp -134.76 101.11 4.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.147 -0.479 . . . . 75.32 110.878 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -89.34 130.3 35.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.15 110.909 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.735 HG22 HD21 ' A' ' 158' ' ' LEU . 19.6 t -138.41 115.56 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 70.25 111.12 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -110.5 130.15 55.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 65.45 110.872 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.9 p -84.87 -174.13 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 72.34 111.133 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.48 ' HB3' HG23 ' A' ' 155' ' ' VAL . 31.4 t80 -170.1 137.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.914 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.682 ' HB3' HG23 ' A' ' 129' ' ' THR . 89.8 t80 -123.83 89.61 51.36 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.664 0.745 . . . . 64.22 110.89 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.3 Cg_endo -69.82 -8.25 23.12 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.717 2.278 . . . . 73.24 112.302 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.05 -149.11 19.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 74.3 112.566 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -97.11 138.97 33.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 63.15 110.853 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.15 -96.31 0.15 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 61.24 112.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.8 -24.9 63.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 72.4 110.901 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.8 p -152.2 -175.72 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 62.22 111.184 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.64 0.58 52.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 62.13 111.01 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.583 ' HB3' HD12 ' A' ' 110' ' ' LEU . 16.8 p-10 -141.72 12.09 2.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 71.12 110.902 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.81 140.97 28.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 63.14 110.889 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.723 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.8 pt -146.32 -179.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 71.42 111.054 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 143' ' ' PHE . 26.9 m -138.68 124.95 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 74.02 111.128 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.654 ' O ' HD12 ' A' ' 164' ' ' LEU . 95.8 t -82.8 138.92 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 54.12 111.122 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -123.66 130.52 52.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 74.42 110.871 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.771 HD11 HD21 ' A' ' 46' ' ' LEU . 9.3 mt -111.84 98.17 40.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 44.32 110.89 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.3 Cg_endo -69.75 -4.21 13.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.802 2.334 . . . . 73.55 112.282 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -83.53 -23.32 32.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 70.41 110.841 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.27 14.29 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 74.42 110.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.5 m120 53.84 27.22 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.412 HD13 HD13 ' A' ' 21' ' ' LEU . 96.9 mt -91.74 136.56 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.137 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 156' ' ' VAL . 14.4 tp -119.6 144.42 47.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.981 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 55' ' ' VAL . 21.9 t -113.13 76.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 32.33 111.074 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.92 49.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.733 . . . . 73.21 112.511 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.28 -162.56 51.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.74 . . . . 50.11 112.525 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 61.0 m -51.74 -29.64 19.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 62.54 110.815 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.627 HD12 ' NE1' ' A' ' 189' ' ' TRP . 25.4 tp -55.2 -53.96 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 74.13 110.889 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 219' ' ' LEU . 47.6 t -83.39 114.68 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 50.33 111.128 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.429 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.6 mmpt? -57.08 149.79 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.977 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.1 p -95.14 158.56 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 64.22 110.978 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.2 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.807 0.337 . . . . 73.14 111.152 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -106.59 86.26 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 74.13 110.936 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.37 -18.66 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 73.12 111.099 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.51 -29.27 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.861 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -108.87 -13.78 14.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.862 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.627 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.5 t90 -53.59 -62.23 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.123 -0.489 . . . . 72.41 110.999 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.717 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.56 -24.01 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.43 . . . . 73.42 110.862 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.0 m -81.73 -31.57 31.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 52.52 111.139 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -74.18 -45.4 48.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.865 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mm -58.35 -46.62 89.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 64.43 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.68 -29.36 62.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 71.02 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.28 -20.35 55.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 72.14 110.873 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 192' ' ' SER . 38.3 t -87.58 -12.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 71.54 111.214 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -108.9 -7.08 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 63.11 110.884 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.1 -30.78 10.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 74.44 110.871 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.83 -49.76 3.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 71.31 110.853 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.15 40.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 64.52 110.863 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -55.51 -47.76 75.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 62.31 110.766 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -59.07 103.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.44 110.944 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.64 HD13 HD22 ' A' ' 164' ' ' LEU . 45.7 mt -146.06 126.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 71.11 111.085 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.83 -27.21 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.941 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.639 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -163.24 146.42 10.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 74.43 111.105 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 218' ' ' LEU . 99.1 t -122.85 132.63 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 74.04 111.126 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 213' ' ' VAL . 10.8 t -113.69 107.58 52.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 60.31 111.068 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.414 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.8 Cg_endo -69.7 -176.27 1.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.708 2.272 . . . . 75.13 112.41 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.17 -14.27 80.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 64.42 112.573 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -152.36 130.66 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 73.02 110.811 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 118.59 -118.37 4.0 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 64.45 112.454 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -153.47 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 51.52 110.849 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 207' ' ' VAL . 5.2 t -72.07 145.08 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.015 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -141.5 -91.25 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.812 -0.708 . . . . 64.12 112.552 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.82 -168.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 75.05 110.888 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.481 ' HA ' HD12 ' A' ' 219' ' ' LEU . 0.0 OUTLIER -63.87 -15.14 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.03 110.913 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.506 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.22 -18.59 42.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.658 -0.782 . . . . 71.55 112.602 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.75 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.0 mt -74.03 -44.35 54.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 71.31 110.878 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.615 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -55.06 -57.32 12.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 61.43 110.891 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.506 HD21 ' HA2' ' A' ' 217' ' ' GLY . 3.0 pp -58.22 -22.6 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.91 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.2 -34.98 75.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.12 110.918 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.849 HG22 HD23 ' A' ' 226' ' ' LEU . 8.8 m -57.77 -55.44 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 65.34 111.173 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.06 -19.69 61.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 62.11 110.851 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -12.01 58.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.822 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.429 HD12 ' HG3' ' A' ' 171' ' ' LYS . 10.4 mt -117.63 -16.59 10.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 70.31 110.874 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.849 HD23 HG22 ' A' ' 222' ' ' THR . 0.5 OUTLIER -110.73 3.85 19.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 60.33 110.878 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.4 110.968 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.79 0.328 . . . . 53.11 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -135.83 91.76 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 74.44 111.091 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -111.76 118.13 34.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 75.35 110.95 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -61.38 168.34 2.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.78 -47.88 64.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 74.55 110.779 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.42 -37.87 82.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 61.5 111.082 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 13.4 61.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 62.31 112.493 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -80.79 -43.8 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.756 0.312 . . . . 72.43 111.15 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 67' ' ' LEU . 27.5 mt -103.54 117.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.08 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -125.04 129.99 51.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 70.33 110.843 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.661 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.1 mt -123.41 110.05 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 63.15 111.033 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -101.26 128.44 47.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 64.05 110.842 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -71.1 111.03 6.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 72.15 110.875 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.561 HD21 HG11 ' A' ' 213' ' ' VAL . 14.2 mt -65.07 -32.08 73.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 72.42 110.855 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.12 -97.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 73.21 110.88 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.463 ' N ' HD22 ' A' ' 22' ' ' ASN . 1.5 tptp -151.52 9.98 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 71.03 110.926 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.447 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.52 6.19 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 65.23 110.899 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -150.99 139.73 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.437 . . . . 62.4 111.109 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.661 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.1 m95 -126.87 -174.97 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 71.42 110.966 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 43' ' ' GLY . 99.6 t -135.85 95.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 72.11 111.175 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -80.33 122.24 26.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.775 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.9 m -118.2 100.36 7.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 54.43 111.133 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.9 117.08 23.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.15 110.937 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.41 115.31 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 63.14 110.95 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.676 -0.773 . . . . 72.43 112.514 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.611 0.72 . . . . 51.35 111.092 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 118.16 5.52 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.615 2.21 . . . . 70.41 112.304 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.1 p -105.52 99.7 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 65.11 110.838 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.76 164.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 54.13 110.835 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.89 -164.32 13.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 53.3 112.447 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.545 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.0 tp -153.69 115.36 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 55.21 110.929 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.689 HG22 HD23 ' A' ' 54' ' ' LEU . 2.0 t -99.56 116.76 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.44 111.138 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.42 121.23 35.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 73.34 110.905 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -90.98 84.37 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 34.33 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -97.45 -177.03 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 65.2 111.117 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -103.97 -19.41 14.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.764 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -16.41 37.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 73.02 110.926 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 146.85 4.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.791 -0.719 . . . . 61.24 112.584 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.42 ' HB3' HG22 ' A' ' 79' ' ' VAL . 10.8 tp -60.13 155.26 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.37 . . . . 73.24 110.9 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.8 142.6 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 63.14 111.211 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.689 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -138.53 125.66 21.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.918 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 165' ' ' VAL . 79.7 t -69.88 110.18 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 74.55 111.136 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.91 141.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 71.2 110.823 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.651 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -81.77 -160.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.949 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.576 ' H ' HG23 ' A' ' 64' ' ' THR . 13.6 t -98.44 170.06 9.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 43.44 110.881 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.618 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.9 m95 -53.06 -59.99 3.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 72.2 110.962 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.67 158.53 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.22 110.903 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -52.85 -39.58 62.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 63.25 110.889 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -55.72 -25.79 42.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.2 110.958 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 59' ' ' TRP . 94.6 mt -92.11 -50.01 5.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 71.01 110.892 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -50.19 -43.6 52.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.152 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.4 -48.23 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.891 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.36 -21.08 66.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.926 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.5 tp -87.37 -27.3 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.87 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.56 -22.58 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 62.34 111.143 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -91.96 14.28 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 73.12 110.927 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ptm -129.49 -40.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 61.1 110.881 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.0 m -78.37 -22.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 71.25 111.096 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.573 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.82 -25.27 65.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 72.22 110.834 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -104.14 -32.73 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.13 110.85 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -47.01 58.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 75.4 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 23.6 m-85 -82.61 -11.17 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 71.41 110.828 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 68.07 11.73 8.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 54.35 110.931 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -132.24 140.43 48.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.904 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.854 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG21 HD11 ' A' ' 54' ' ' LEU . 71.9 t -79.47 120.22 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 70.24 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.6 t -132.88 4.28 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 75.05 111.135 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.2 m-20 -147.58 146.53 29.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 71.33 110.868 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 54' ' ' LEU . 3.3 t -155.35 129.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 73.15 111.118 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.619 ' CD1' HG11 ' A' ' 140' ' ' VAL . 20.6 mt -84.5 133.33 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 65.42 111.132 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.97 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.3 mm -97.44 147.55 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 54.51 111.172 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.7 p -110.91 -35.64 5.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 70.31 111.119 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.594 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.5 p-80 -173.15 -176.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.841 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.88 84.74 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 52.44 111.112 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -145.05 154.46 42.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 75.52 110.907 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.84 -23.1 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 53.43 111.079 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.46 26.31 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 52.31 110.853 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.899 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -151.28 -70.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 75.2 110.89 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.728 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.9 2.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 72.53 111.18 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -45.06 43.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.803 -0.713 . . . . 72.23 112.395 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.43 15.93 58.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 45.33 112.54 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.9 tt -54.24 -26.77 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 70.11 111.135 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -58.75 -27.61 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.35 110.979 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -90.16 -20.21 23.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 54.12 111.097 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.651 HD11 ' OG ' ' A' ' 57' ' ' SER . 15.7 mt -82.45 -37.47 25.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.865 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -92.51 20.42 6.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 70.11 110.923 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -118.42 -43.07 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 71.55 110.821 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -84.43 -54.0 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.871 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.76 39.19 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 65.12 112.488 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.5 mp -103.85 113.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.852 0.358 . . . . 61.52 111.179 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.703 ' HB3' HD11 ' A' ' 124' ' ' LEU . 10.5 mtmt -79.74 113.96 18.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 65.32 110.904 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.97 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -87.88 91.4 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 63.23 111.058 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.478 ' HA ' HD12 ' A' ' 124' ' ' LEU . 42.4 m-70 -64.38 112.09 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.85 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.401 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -141.05 -175.01 4.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.882 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.7 158.05 15.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 64.21 111.11 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.5 -40.36 51.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 74.52 111.098 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.695 HD23 ' OD2' ' A' ' 152' ' ' ASP . 38.9 tp -75.09 -39.12 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 52.21 110.937 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.771 ' HA ' HD11 ' A' ' 114' ' ' LEU . 88.0 m -58.84 -21.69 57.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 71.2 111.132 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -96.61 0.87 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 73.0 111.083 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.48 -50.62 3.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.905 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -69.68 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.31 110.92 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.45 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 64.04 111.121 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -26.23 61.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.51 110.902 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -31.93 62.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 75.53 110.882 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -93.23 -21.22 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 64.44 110.837 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.36 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 73.24 112.574 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CD1' HG12 ' A' ' 92' ' ' ILE . 85.7 m-85 -97.34 178.47 5.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 65.31 110.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -76.17 -176.39 3.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 62.01 110.841 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.0 mp0 -118.86 110.96 37.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 74.14 110.899 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.83 -169.76 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.614 2.209 . . . . 71.01 112.398 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 104' ' ' LYS . 63.6 mt -61.81 -49.49 76.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 64.21 110.913 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 60.19 20.26 53.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.75 . . . . 75.11 112.506 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.42 31.31 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 71.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.568 ' CD2' HD21 ' A' ' 133' ' ' LEU . 90.2 mt -116.51 -174.48 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.93 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.24 -171.02 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 75.51 110.915 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.826 HG22 HG23 ' A' ' 130' ' ' VAL . 54.1 m -50.79 -70.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.182 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.826 HG23 HG22 ' A' ' 129' ' ' THR . 31.0 t -116.37 102.03 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 60.32 111.153 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.45 HG21 HD22 ' A' ' 127' ' ' LEU . 14.3 t -124.78 162.28 24.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 61.32 111.209 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.96 100.94 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 74.43 110.916 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.568 HD21 ' CD2' ' A' ' 127' ' ' LEU . 27.4 mt -78.71 -179.89 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 53.43 110.969 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -171.74 112.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 71.21 110.961 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -106.73 73.93 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 75.22 110.807 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.43 -84.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.843 -0.694 . . . . 73.24 112.445 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.19 26.95 9.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.352 . . . . 75.1 110.833 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.6 tpp -130.43 142.93 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 70.04 110.932 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.54 125.33 48.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 74.03 110.897 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.648 HG22 ' CD2' ' A' ' 158' ' ' LEU . 13.4 t -138.85 119.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 74.35 111.195 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -113.54 127.86 56.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.964 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.5 p -82.78 -173.6 4.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 74.22 111.145 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.421 ' HB3' HG23 ' A' ' 155' ' ' VAL . 21.6 t80 -170.89 135.9 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 72.42 110.861 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.69 ' HB3' HG23 ' A' ' 129' ' ' THR . 81.7 t80 -125.12 90.34 51.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.816 0.817 . . . . 75.22 110.962 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.1 Cg_endo -69.86 -7.78 21.94 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.662 2.241 . . . . 62.44 112.309 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.86 -150.8 18.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 73.35 112.554 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -91.63 139.7 30.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 74.42 110.957 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.67 -89.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.692 -0.765 . . . . 51.2 112.507 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -76.12 -25.47 55.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 74.13 110.933 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.594 HG21 ' HB2' ' A' ' 86' ' ' HIS . 46.9 p -146.95 -167.95 2.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 72.33 111.123 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.604 ' HB3' HD23 ' A' ' 114' ' ' LEU . 60.7 tt0 -85.34 -16.25 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.925 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.695 ' OD2' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -139.99 25.83 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.883 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.08 131.83 48.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.909 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 84' ' ' ILE . 10.3 pt -139.28 171.06 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 75.42 111.164 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.6 m -124.94 142.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 71.32 111.049 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.67 114.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 74.31 111.183 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -103.74 142.07 34.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 73.32 110.923 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.648 ' CD2' HG22 ' A' ' 140' ' ' VAL . 56.5 mt -122.41 98.69 43.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.631 0.729 . . . . 71.42 110.888 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -5.01 15.16 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.13 112.358 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.74 -31.36 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.08 11.6 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.901 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.3 27.49 9.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 54.21 110.8 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.502 HD13 HD13 ' A' ' 21' ' ' LEU . 87.2 mt -93.18 143.62 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 73.43 111.117 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.443 ' CD2' HD13 ' A' ' 203' ' ' ILE . 61.5 tp -124.81 153.68 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.92 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 55' ' ' VAL . 76.0 t -123.16 79.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 71.13 111.137 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.83 -36.64 41.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 54.44 112.522 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 67.28 -165.09 43.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.712 -0.756 . . . . 55.12 112.437 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.7 m -51.95 -34.45 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 74.22 110.889 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.611 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.7 tp -51.64 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.888 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.41 HG13 ' HA ' ' A' ' 219' ' ' LEU . 19.6 t -80.25 109.19 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.22 111.122 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.73 ' HG2' HG23 ' A' ' 222' ' ' THR . 32.0 mmmt -51.29 169.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 75.43 110.895 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 89.2 p -117.78 157.26 26.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 44.11 110.847 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.107 -0.497 . . . . 64.2 111.173 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.79 0.328 . . . . 54.33 111.138 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.42 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 64.4 110.919 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.56 -19.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.24 111.173 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.54 -27.16 61.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 63.11 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.37 -12.41 14.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.01 110.87 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.611 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.5 t90 -54.28 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.936 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.671 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.51 -24.5 13.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.818 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.0 m -81.45 -32.55 32.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.14 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -42.53 62.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 63.11 110.796 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.3 mm -62.47 -44.72 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 75.31 111.102 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.49 -23.49 50.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.868 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -81.74 -20.73 38.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.45 110.888 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.44 -9.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.33 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.69 -10.33 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 64.2 110.903 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -101.95 -31.91 10.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.888 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 -49.92 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 73.24 110.852 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.499 ' O ' HD11 ' A' ' 203' ' ' ILE . 3.9 m-30 -101.12 65.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.94 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -78.42 -55.49 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 74.11 110.838 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.15 100.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.828 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.704 HG21 HG22 ' A' ' 206' ' ' VAL . 57.1 mt -141.23 116.08 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 72.0 111.181 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.13 -26.07 64.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 70.02 110.96 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -171.99 137.76 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 74.03 111.093 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.732 ' HB ' HD12 ' A' ' 218' ' ' LEU . 85.7 t -113.91 144.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 62.0 111.093 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.128 HG22 HG12 ' A' ' 213' ' ' VAL . 13.5 t -119.68 109.19 38.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.722 . . . . 62.2 111.141 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -170.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.72 2.28 . . . . 74.12 112.327 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.07 -14.93 61.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 61.42 112.467 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.71 142.1 21.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 74.02 110.87 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.7 -101.81 1.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 55.35 112.497 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.81 162.76 4.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 55.55 110.972 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.128 HG12 HG22 ' A' ' 207' ' ' VAL . 6.6 m -51.56 163.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.141 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.67 -102.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.661 -0.781 . . . . 52.04 112.48 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.82 -172.24 3.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 64.13 110.841 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -61.87 -17.38 56.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.897 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.451 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.3 -17.59 46.84 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.715 -0.755 . . . . 44.41 112.491 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.8 mt -70.01 -30.2 67.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 61.54 110.987 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.559 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.9 mm? -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 61.22 110.93 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.451 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -62.14 -17.39 57.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 61.55 110.913 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 225' ' ' LEU . 1.6 t60 -65.86 -50.68 63.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.52 110.924 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.738 HG22 HD23 ' A' ' 226' ' ' LEU . 4.4 m -51.84 -51.7 54.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 74.25 111.129 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.52 -21.27 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 43.23 110.908 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -86.81 -2.96 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 74.04 110.843 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.411 HD11 ' CE1' ' A' ' 221' ' ' HIS . 5.5 mt -128.25 -4.87 5.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 74.3 110.947 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.738 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -123.12 0.61 9.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.897 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 45.03 110.846 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.799 0.333 . . . . 73.21 111.086 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.08 99.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 72.03 111.082 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -118.43 114.87 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.962 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -59.42 165.61 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 63.45 110.856 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.01 -48.7 61.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.823 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -63.11 -36.75 84.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.051 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.58 13.63 62.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 71.33 112.582 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 m -78.26 -45.88 21.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 64.42 111.12 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 67' ' ' LEU . 40.6 mt -103.27 113.92 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 61.11 111.159 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.0 p -118.08 138.12 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.904 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.795 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -130.25 112.14 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 75.52 111.041 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -98.22 125.8 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 73.53 110.801 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -69.14 109.17 3.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 53.04 110.916 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.846 HD21 HG11 ' A' ' 213' ' ' VAL . 15.8 mt -63.4 -33.73 76.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 71.44 110.895 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.96 -96.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 74.32 110.958 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 22' ' ' ASN . 8.0 tttt -150.7 9.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.853 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.447 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.24 7.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 73.31 110.844 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 t -151.01 141.33 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.22 111.213 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.795 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.4 m95 -129.8 -174.76 3.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 72.45 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 43' ' ' GLY . 98.2 t -136.64 90.49 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 61.14 111.13 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -73.55 124.47 25.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.84 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -121.03 104.58 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 64.51 111.142 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -86.3 122.18 29.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.939 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.16 106.5 16.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 72.42 110.872 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.728 . . . . 53.0 112.489 179.886 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.618 0.723 . . . . 62.0 111.19 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 118.83 5.92 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.687 2.258 . . . . 73.44 112.268 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.4 p -109.7 96.27 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.891 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -60.32 167.96 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.526 . . . . 62.13 110.941 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.458 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -159.29 -147.23 4.81 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 44.12 112.504 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 158' ' ' LEU . 14.9 tp -160.52 118.13 2.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.34 . . . . 74.25 110.969 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.653 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.8 t -100.88 122.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 75.1 111.093 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 158' ' ' LEU . 26.2 mt -99.41 119.57 38.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.49 . . . . 72.03 110.952 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.91 87.08 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 52.45 110.899 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.54 -179.87 4.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.464 . . . . 63.22 111.205 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -101.05 -23.78 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 25.43 110.809 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 -13.58 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 70.44 110.854 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.5 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.798 . . . . 71.54 112.442 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.485 ' HB3' HG22 ' A' ' 79' ' ' VAL . 8.9 tp -63.18 154.96 29.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.858 0.361 . . . . 75.42 110.818 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.92 143.14 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.43 111.181 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.653 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -138.75 124.41 19.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 63.43 111.008 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 165' ' ' VAL . 74.5 t -69.82 112.49 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 63.02 111.139 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.75 139.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 53.34 110.894 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.708 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.6 p -83.1 -165.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.89 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.489 ' H ' HG23 ' A' ' 64' ' ' THR . 8.5 t -94.89 165.77 12.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 61.22 110.951 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.644 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.5 m95 -50.3 -59.61 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.449 . . . . 75.44 110.927 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -123.96 160.59 27.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.832 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.05 -39.84 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.932 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.88 -40.55 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 62.44 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.9 mt -74.46 -48.44 27.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 73.14 110.93 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.76 -44.39 58.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 73.41 111.12 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.43 -50.5 67.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 72.04 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -63.9 -18.79 64.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 70.35 110.907 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 16' ' ' ILE . 11.1 tp -88.71 -27.77 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.907 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -89.72 -23.12 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 71.04 111.169 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.57 16.4 12.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.865 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.5 ptm -130.75 -39.71 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 70.12 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.3 m -81.21 -22.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.207 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.589 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.11 -22.05 64.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 74.33 110.868 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.85 -33.5 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 63.55 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.4 -39.56 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 63.51 110.905 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.31 -11.29 35.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.2 110.914 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 68.08 12.15 8.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.949 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HB2' HD13 ' A' ' 52' ' ' LEU . 6.7 mttt -130.59 138.97 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.898 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -85.44 138.79 32.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.43 110.864 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 54' ' ' LEU . 72.9 t -79.44 121.75 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 72.42 111.185 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 t -136.89 8.33 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 54.42 111.112 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 82' ' ' VAL . 64.7 m-20 -150.81 145.85 25.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.865 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 54' ' ' LEU . 4.0 t -155.33 132.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 62.25 111.198 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.631 ' CD1' HG11 ' A' ' 140' ' ' VAL . 23.2 mt -86.4 133.61 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 71.41 111.159 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.986 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.1 mm -98.43 147.69 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.108 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.7 p -111.61 -34.18 6.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.13 111.082 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.558 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.5 p-80 -175.11 -175.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.921 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.83 93.49 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 62.34 111.085 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.402 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.2 t-160 -153.79 154.96 34.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 73.33 110.875 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.67 -21.77 7.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 72.15 111.124 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.31 18.23 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 75.45 110.823 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.911 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -143.54 -70.75 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 64.13 110.855 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.711 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.88 3.89 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 74.31 111.086 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.44 -45.62 45.75 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.695 -0.764 . . . . 64.12 112.44 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.52 15.81 59.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.644 -0.788 . . . . 71.41 112.454 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.475 HD12 HH22 ' A' ' 91' ' ' ARG . 4.6 tt -56.35 -25.97 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 70.12 111.143 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -59.7 -21.36 60.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 72.53 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 ' HD2' ' A' ' 101' ' ' ARG . 81.9 m -98.28 -20.62 17.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 72.02 111.166 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.708 HD11 ' CB ' ' A' ' 57' ' ' SER . 13.7 mt -82.98 -36.13 25.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.879 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -88.86 9.8 23.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 64.44 110.897 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -112.45 -55.29 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 71.13 110.879 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.489 ' HD2' HG22 ' A' ' 97' ' ' THR . 7.1 mtt-85 -65.16 -58.59 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 73.3 110.862 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.18 39.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 53.51 112.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.2 mp -106.88 117.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.868 0.366 . . . . 74.34 111.104 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.734 ' CE ' HD21 ' A' ' 124' ' ' LEU . 3.2 mtpp -82.03 117.92 22.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 63.41 110.88 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.986 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -91.26 94.65 9.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 52.13 111.139 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.18 113.49 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 64.4 110.831 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 111' ' ' THR . 1.0 OUTLIER -142.66 -174.53 4.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 75.04 110.854 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.34 158.39 16.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 65.12 111.127 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.76 -38.89 50.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 60.12 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.7 HD23 ' OD1' ' A' ' 152' ' ' ASP . 55.5 tp -77.45 -37.61 51.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.948 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 88.9 m -58.37 -22.09 52.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 72.24 111.151 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -95.46 -3.16 47.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.099 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -95.8 -54.43 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.902 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.857 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -64.76 -13.95 57.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 73.23 110.843 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.5 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 63.33 111.059 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.69 -25.99 60.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 55.44 110.83 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -55.93 -33.05 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 72.42 110.845 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -91.75 -20.96 20.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 63.23 110.9 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.91 25.42 5.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.808 -0.71 . . . . 60.14 112.491 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.29 -174.55 2.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 63.21 110.905 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.14 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 64.14 110.877 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -120.77 108.75 36.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.663 0.744 . . . . 71.54 110.853 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.437 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.75 -169.84 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.711 2.274 . . . . 75.3 112.343 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.734 HD21 ' CE ' ' A' ' 104' ' ' LYS . 20.7 mt -61.48 -48.78 79.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 44.14 110.931 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 57.04 23.07 45.02 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.73 -0.748 . . . . 75.32 112.528 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.02 33.74 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 75.13 110.899 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.671 HD22 HD21 ' A' ' 133' ' ' LEU . 74.8 mt -119.34 -175.04 2.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 71.42 110.917 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.4 HE21 ' N ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -153.73 -170.94 3.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 72.34 110.935 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.951 HG22 HG23 ' A' ' 130' ' ' VAL . 34.7 m -50.25 -70.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 71.3 111.111 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.951 HG23 HG22 ' A' ' 129' ' ' THR . 48.0 t -119.91 104.03 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 71.13 111.131 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -135.48 165.53 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 71.34 111.167 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.59 133.03 54.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 64.42 110.814 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.671 HD21 HD22 ' A' ' 127' ' ' LEU . 23.0 mt -118.92 158.01 26.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.976 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -140.68 123.18 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.93 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -120.22 45.52 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 74.43 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.84 92.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 62.15 112.479 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.52 15.01 9.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.827 0.346 . . . . 62.33 110.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 tpp -136.72 94.9 3.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 71.3 110.863 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.4 131.23 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.861 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.759 HG22 HD21 ' A' ' 158' ' ' LEU . 20.2 t -137.52 119.0 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.12 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -111.62 131.11 55.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.842 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.9 p -84.96 -172.82 4.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.122 -0.49 . . . . 74.03 111.167 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.567 ' HD1' HG22 ' A' ' 130' ' ' VAL . 22.7 t80 -170.82 135.55 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.814 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.711 ' HB3' HG23 ' A' ' 129' ' ' THR . 21.0 t80 -123.39 87.39 51.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 71.1 110.881 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -7.98 22.42 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 63.32 112.348 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.69 -155.67 21.51 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 63.13 112.435 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -92.12 140.34 29.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 73.33 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.536 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -154.17 -89.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.676 -0.773 . . . . 62.31 112.463 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -75.36 -25.16 57.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 64.15 110.823 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 86' ' ' HIS . 52.9 p -147.26 -168.3 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 75.54 111.189 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 114' ' ' LEU . 42.4 tt0 -86.37 -15.2 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 74.43 110.798 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.7 ' OD1' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -138.42 23.06 2.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 63.02 110.803 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.687 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -55.05 130.42 41.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 64.3 110.882 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 84' ' ' ILE . 2.0 pt -135.0 172.77 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 75.43 111.125 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 143' ' ' PHE . 16.8 m -128.92 128.32 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 70.12 111.066 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.725 ' O ' HD12 ' A' ' 164' ' ' LEU . 95.8 t -81.82 132.15 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 73.25 111.06 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -118.76 131.91 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 74.22 110.908 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.908 HD11 HD21 ' A' ' 46' ' ' LEU . 11.5 mt -113.45 98.28 46.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.644 0.735 . . . . 65.11 110.899 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.8 Cg_endo -69.87 -4.41 14.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 75.44 112.384 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -82.67 -23.92 33.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.11 110.843 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.72 14.11 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.911 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.6 m120 54.46 27.74 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 72.54 110.895 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.557 HD13 HD13 ' A' ' 21' ' ' LEU . 96.7 mt -93.46 130.26 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 75.11 111.079 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 156' ' ' VAL . 50.0 tp -114.74 150.75 34.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.938 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 55' ' ' VAL . 21.9 t -119.21 75.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.46 . . . . 72.51 111.069 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.54 -45.97 53.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 70.25 112.495 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 74.79 -161.26 53.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.747 . . . . 73.21 112.417 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 12.8 m -51.41 -34.73 35.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 62.42 110.803 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.687 HD13 ' OD1' ' A' ' 153' ' ' ASN . 21.9 tp -51.64 -39.78 58.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.966 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 219' ' ' LEU . 17.3 t -104.65 111.31 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 74.3 111.07 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.551 ' HG3' HD12 ' A' ' 225' ' ' LEU . 9.9 mmpt? -53.49 155.76 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.883 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.7 p -101.78 160.44 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 62.51 110.845 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 72.31 111.112 -179.936 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.878 0.37 . . . . 75.24 111.024 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -121.95 92.16 3.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.933 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.54 -20.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 63.4 111.191 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -73.92 -20.26 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 73.34 110.911 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.63 -17.42 10.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 61.12 110.949 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.576 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -53.76 -61.25 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.3 110.923 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.771 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -54.53 -24.75 22.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.837 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.0 m -81.13 -29.91 34.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 42.44 111.167 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.28 -43.97 39.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.856 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 219' ' ' LEU . 35.3 mm -60.64 -47.25 93.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 75.31 111.173 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.462 ' HG2' HD21 ' A' ' 223' ' ' LEU . 2.0 mm-40 -56.15 -27.91 56.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.856 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -77.14 -22.46 52.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.03 110.826 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 192' ' ' SER . 18.2 t -85.47 -10.22 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.072 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.95 -8.06 13.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 54.34 110.926 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -31.16 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.887 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -104.47 -55.34 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 64.41 110.937 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -95.91 39.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.236 -0.438 . . . . 62.2 110.913 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -56.42 -47.69 78.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 61.31 110.888 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -60.72 102.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.901 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.7 HG21 HG22 ' A' ' 206' ' ' VAL . 37.6 mt -144.76 129.55 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.31 111.131 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.69 -24.75 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 65.44 110.907 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.21 126.66 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.15 111.111 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.712 ' HB ' HD12 ' A' ' 218' ' ' LEU . 87.0 t -107.14 129.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 74.14 111.177 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 213' ' ' VAL . 16.4 t -104.41 111.63 65.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 52.21 111.093 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.82 -173.25 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 70.25 112.231 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.95 -12.21 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 72.43 112.47 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -152.56 131.28 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 73.23 110.853 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.23 -119.99 5.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.767 -0.73 . . . . 60.1 112.473 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.16 172.26 13.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 74.51 110.881 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 207' ' ' VAL . 4.8 m -61.06 164.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.084 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.64 -115.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.714 . . . . 71.33 112.538 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.21 -169.97 3.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.377 . . . . 64.45 110.839 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -19.92 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 64.24 110.908 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.524 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.1 -18.22 47.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.721 . . . . 74.32 112.438 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.0 mt -72.12 -31.78 66.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 70.25 110.932 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.554 ' HA ' HG13 ' A' ' 170' ' ' VAL . 4.1 mm? -64.41 -58.62 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.959 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.524 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -60.21 -19.66 55.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.884 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.593 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.9 OUTLIER -63.41 -44.02 95.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.827 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.866 HG22 HD23 ' A' ' 226' ' ' LEU . 16.1 m -57.11 -52.77 63.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 53.13 111.18 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.75 HD23 ' OG ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -60.32 -25.04 65.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 62.52 110.903 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -75.22 -11.75 60.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 74.41 110.887 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.593 HD11 ' CE1' ' A' ' 221' ' ' HIS . 9.7 mt -119.07 -15.56 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.22 110.871 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.866 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -113.31 2.22 15.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 65.35 110.903 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 55.54 110.846 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.843 0.354 . . . . 72.33 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.69 103.33 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.33 111.088 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -122.08 116.87 25.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 73.12 110.872 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -62.46 166.72 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.895 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.23 -48.71 62.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.83 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 p -62.65 -36.7 83.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 63.14 111.206 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.34 14.56 63.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 70.34 112.572 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -80.4 -45.02 18.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 71.35 111.077 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' A' ' 67' ' ' LEU . 34.5 mt -102.55 107.98 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 74.05 111.077 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.2 p -113.14 137.01 52.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 71.05 110.887 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.778 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.5 mt -128.79 109.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 74.1 111.154 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -99.96 123.84 44.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.03 110.896 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -67.5 109.55 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 72.53 110.939 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.581 HD13 HD13 ' A' ' 163' ' ' ILE . 14.1 mt -63.62 -32.49 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.888 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.11 -97.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 65.11 110.843 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -151.15 9.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.969 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.445 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.55 6.47 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 75.2 110.859 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -150.96 140.48 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 72.21 111.158 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.778 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.8 m95 -127.7 -173.71 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.906 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG23 ' HG ' ' A' ' 21' ' ' LEU . 71.0 t -137.83 92.87 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.175 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -77.52 120.54 22.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.861 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.4 m -115.29 98.57 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 61.54 111.185 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.01 117.27 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 71.22 110.947 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.18 116.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.858 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.731 . . . . 72.24 112.499 179.864 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.527 0.68 . . . . 74.32 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.658 2.238 . . . . 53.03 112.389 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.56 102.16 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 53.41 110.799 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.81 170.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.067 -0.515 . . . . 74.35 110.911 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -158.0 8.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 71.53 112.501 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.588 HD21 HD12 ' A' ' 158' ' ' LEU . 13.2 tp -156.18 113.49 3.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 54.43 110.87 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.641 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -99.25 113.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 63.35 111.161 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 158' ' ' LEU . 18.9 mt -93.63 119.27 32.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 53.12 110.915 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.81 84.49 6.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.822 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -172.54 2.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 53.02 111.091 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -105.34 -25.79 12.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 63.41 110.906 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.4 -13.35 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.886 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.83 155.44 6.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 64.33 112.504 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HB3' HG22 ' A' ' 79' ' ' VAL . 11.2 tp -64.87 157.82 26.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 70.02 110.842 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 81' ' ' ASP . 17.1 t -146.5 142.37 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 61.41 111.145 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.649 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.7 mt -139.32 120.52 14.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.904 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.59 111.81 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.12 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.92 128.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 71.33 110.9 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.673 ' CB ' HD11 ' A' ' 98' ' ' LEU . 3.3 p -71.96 -164.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 71.22 110.906 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -93.08 171.67 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 70.44 110.898 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.627 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.8 m95 -55.53 -60.69 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 72.05 110.92 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.19 157.63 34.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 74.35 110.817 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -51.86 -39.97 59.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 74.41 110.889 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -53.42 -41.1 65.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 65.12 110.894 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 59' ' ' TRP . 93.9 mt -75.97 -45.55 34.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 62.22 110.924 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.403 HG21 HD21 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -50.97 -48.83 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.35 111.132 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -52.46 -50.01 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 65.25 110.906 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -64.06 -19.71 65.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 73.23 110.806 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.6 tp -89.18 -26.21 21.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 61.33 110.84 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.407 HG23 ' OE1' ' A' ' 72' ' ' GLU . 58.5 mt -91.18 -23.07 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 71.12 111.103 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.05 15.4 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.875 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.2 ptm -130.43 -40.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.23 110.94 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.3 m -80.67 -21.7 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 64.32 111.146 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.569 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -69.04 -23.01 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 63.44 110.884 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.8 -33.07 7.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 45.43 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -43.52 67.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 62.42 110.859 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.571 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 18.6 m-85 -87.1 -10.66 52.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.827 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.19 12.45 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 54.41 110.919 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.19 140.4 48.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 74.32 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.0 137.15 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 62.03 110.954 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.569 HG23 ' OE2' ' A' ' 72' ' ' GLU . 89.5 t -75.56 117.51 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 71.23 111.1 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -133.09 10.95 4.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 55.44 110.996 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.533 ' N ' HG23 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -155.83 137.88 14.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 52.31 110.832 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 54' ' ' LEU . 13.1 t -146.15 129.15 9.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 75.45 111.065 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.628 HD11 ' HE2' ' A' ' 135' ' ' PHE . 28.6 mt -92.95 125.21 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 70.3 111.104 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -94.24 158.36 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.08 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.7 p -115.31 -39.88 3.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 71.23 111.148 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.57 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -159.22 -174.36 4.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.824 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -102.32 97.37 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 41.25 111.127 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.98 154.96 26.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 64.4 110.932 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.64 -19.7 28.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 65.24 111.175 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.66 14.3 13.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 71.31 110.897 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -135.32 -76.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.53 110.973 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -92.35 11.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 74.24 111.079 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.81 -34.03 14.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.769 . . . . 73.21 112.483 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.38 17.77 23.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 60.04 112.497 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.5 tt -58.09 -33.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 75.1 111.085 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -55.82 -24.2 34.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.256 -0.429 . . . . 64.34 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m -95.84 -12.25 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 61.42 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 57' ' ' SER . 16.8 mt -90.01 -30.6 17.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.901 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -88.09 -6.65 57.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 64.45 110.914 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -91.53 -52.7 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 64.11 110.966 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -61.86 -60.65 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.13 110.952 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.09 40.0 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.753 -0.737 . . . . 44.23 112.502 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.632 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.4 mp -108.04 140.08 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 72.53 111.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 124' ' ' LEU . 5.0 mtmm -98.17 110.33 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 72.01 110.914 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.48 9.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 72.43 111.09 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.587 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.0 m-70 -72.83 145.21 47.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.89 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -173.75 -175.12 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.04 110.919 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.41 154.96 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 54.21 111.21 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.08 39.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 54.43 111.036 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.755 HD12 ' HG2' ' A' ' 113' ' ' GLU . 61.2 tp -67.34 -41.63 84.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.89 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 86.9 m -61.96 -16.8 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 54.45 111.121 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.632 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -104.06 11.71 34.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 25.45 111.14 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.755 ' HG2' HD12 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -111.35 -26.07 9.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 54.44 110.767 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -100.25 -9.49 22.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.976 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.34 -36.88 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.31 111.057 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -28.14 60.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 71.2 110.983 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -55.44 -35.36 65.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 63.22 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -86.14 -25.65 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 30.05 110.941 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.73 14.6 4.69 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 35.25 112.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 92' ' ' ILE . 69.7 m-85 -95.1 177.36 5.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 74.11 110.977 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.523 ' CG ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.24 -171.86 3.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 54.13 110.853 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.1 mt-10 -115.49 111.95 43.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.72 0.772 . . . . 65.32 110.878 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.2 Cg_endo -69.66 -178.89 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.772 2.314 . . . . 64.33 112.32 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 106' ' ' HIS . 31.4 mt -53.57 -43.87 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.932 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.76 27.78 21.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 62.43 112.463 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -101.19 31.31 3.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 73.1 110.825 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.56 HD22 HD21 ' A' ' 133' ' ' LEU . 62.7 mt -116.13 -175.21 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 44.54 110.964 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.66 -170.93 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 72.52 110.894 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 130' ' ' VAL . 41.2 m -50.43 -70.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 72.45 111.034 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.906 HG23 HG22 ' A' ' 129' ' ' THR . 41.0 t -118.08 105.86 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 63.12 111.118 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -138.82 166.78 23.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.32 111.169 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.83 134.04 55.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.788 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.56 HD21 HD22 ' A' ' 127' ' ' LEU . 25.1 mt -113.08 167.46 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.933 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.48 134.39 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 71.23 110.939 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.628 ' HE2' HD11 ' A' ' 83' ' ' ILE . 51.4 m-85 -137.21 36.15 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 75.01 110.869 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.74 93.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.736 . . . . 54.12 112.518 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.4 m120 65.55 13.67 9.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 74.22 110.917 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.7 tpp -135.37 105.34 6.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.941 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -96.45 130.62 43.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 74.5 110.879 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.843 HG22 HD21 ' A' ' 158' ' ' LEU . 20.7 t -135.67 117.39 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 74.42 111.13 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.99 129.5 55.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 53.4 110.89 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.36 -176.29 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 70.23 111.185 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.452 ' HD1' HG22 ' A' ' 130' ' ' VAL . 22.6 t80 -166.74 133.4 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 70.32 110.929 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.695 ' HB3' HG23 ' A' ' 129' ' ' THR . 10.0 t80 -124.07 89.26 51.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.727 0.775 . . . . 72.24 110.941 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 52.7 Cg_endo -69.81 -21.75 32.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 64.13 112.33 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.18 -157.64 27.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 53.54 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -88.02 138.14 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 72.13 110.837 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.23 -88.82 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 54.01 112.494 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -75.48 -25.62 57.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 72.54 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 86' ' ' HIS . 34.3 p -146.82 -165.33 2.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 74.52 111.166 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HG2' HD21 ' A' ' 110' ' ' LEU . 5.1 tt0 -85.85 -19.67 30.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 75.13 110.89 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.536 ' OD1' HD23 ' A' ' 110' ' ' LEU . 9.4 t0 -137.87 24.27 2.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 73.43 110.863 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.595 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -53.83 129.29 33.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.837 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.474 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.9 pt -135.21 174.47 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 64.04 111.105 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.8 m -127.19 136.24 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.14 111.161 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.5 121.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.4 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -110.02 139.14 45.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.509 . . . . 63.11 110.947 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.843 HD21 HG22 ' A' ' 140' ' ' VAL . 21.1 mt -120.14 99.21 48.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.529 0.68 . . . . 75.12 110.914 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.62 -4.53 14.12 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.711 2.274 . . . . 72.41 112.382 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -85.73 -22.81 27.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 62.13 110.937 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.3 12.15 2.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.97 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.36 25.17 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 52.5 110.939 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.581 HD13 HD13 ' A' ' 21' ' ' LEU . 95.3 mt -89.04 142.34 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 62.32 111.1 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 57.7 tp -122.32 156.39 33.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.3 t -123.56 74.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 64.15 111.157 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.99 -41.71 52.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.732 -0.747 . . . . 73.21 112.458 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.66 -162.54 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 71.22 112.494 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 16.7 m -51.84 -34.51 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 45.43 110.882 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.735 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.2 tp -51.76 -41.35 61.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.878 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 219' ' ' LEU . 18.1 t -100.83 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.116 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.3 OUTLIER -51.5 147.85 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.924 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.4 p -98.29 159.64 14.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.43 110.926 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.172 -179.883 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.763 0.316 . . . . 63.13 111.057 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.14 92.43 3.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 74.21 110.942 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 11.1 t -62.86 -18.43 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 72.24 111.165 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.62 -20.67 58.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 73.23 110.952 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.6 -14.72 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 73.25 110.887 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.735 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.4 t90 -55.0 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.498 . . . . 75.12 110.853 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.742 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.97 -24.75 17.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.841 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -81.56 -31.46 32.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 71.33 111.127 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -73.67 -43.82 58.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 63.23 110.886 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.26 -44.61 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 75.31 111.18 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.97 -23.83 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.872 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.14 -21.43 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.758 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.455 HG12 HD21 ' A' ' 219' ' ' LEU . 11.5 t -87.97 -9.56 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.54 111.151 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.43 -8.5 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.881 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -104.11 -31.08 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 73.44 110.809 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 -53.84 2.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.48 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -98.1 60.3 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 74.02 110.868 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -72.57 -59.48 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 61.23 110.901 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -52.13 102.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 65.33 110.904 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.701 HG21 HG22 ' A' ' 206' ' ' VAL . 59.0 mt -139.43 116.72 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.32 111.138 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.95 -22.74 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.833 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.97 129.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 71.3 111.088 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.712 ' HB ' HD12 ' A' ' 218' ' ' LEU . 88.1 t -102.22 130.86 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 33.43 111.073 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 213' ' ' VAL . 11.4 t -107.92 103.75 50.89 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.568 0.699 . . . . 73.31 111.077 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.7 Cg_endo -69.83 -170.64 0.41 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.736 2.291 . . . . 73.24 112.311 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.49 -11.74 59.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.838 -0.696 . . . . 54.21 112.57 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.44 144.43 23.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 65.04 110.881 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 100.77 -102.31 2.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.793 -0.718 . . . . 74.4 112.431 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -170.86 159.52 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.41 . . . . 72.04 110.905 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 207' ' ' VAL . 6.0 m -53.39 163.29 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.13 111.176 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.78 -99.68 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 43.41 112.514 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -167.29 -168.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 65.44 110.825 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -20.25 42.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 63.31 110.961 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.516 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -54.17 -23.73 26.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 33.24 112.473 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.6 mt -73.17 -34.7 66.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 51.13 110.956 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.649 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.6 mp -59.84 -59.34 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 75.12 110.964 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.516 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -59.54 -20.58 56.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.282 -0.417 . . . . 74.04 110.911 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.453 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -66.62 -34.35 77.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.22 110.811 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.796 HG22 HD23 ' A' ' 226' ' ' LEU . 7.7 m -62.52 -55.54 26.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 72.4 111.152 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -20.95 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 63.31 110.924 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.09 -12.11 60.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 63.22 110.879 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.576 HD12 ' HG3' ' A' ' 171' ' ' LYS . 7.7 mt -119.88 -26.34 5.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 53.32 110.935 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.796 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 61.33 110.964 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 mttt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.83 179.808 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.3 m . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.841 0.353 . . . . 74.23 111.074 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.19 94.05 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 44.01 111.137 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -112.49 117.35 32.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.947 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -61.82 170.21 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 63.41 110.918 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.032 0.444 . . . . 72.12 110.899 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.7 p -60.98 -38.51 86.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 74.31 111.119 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.77 13.88 62.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.799 -0.715 . . . . 65.13 112.563 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.4 m -83.45 -35.56 24.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.363 . . . . 60.44 111.216 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -110.08 122.5 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 74.2 111.109 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 p -129.86 128.79 42.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 73.13 110.776 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.697 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -122.5 112.95 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 62.03 111.15 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.423 ' HA ' HG12 ' A' ' 8' ' ' VAL . 16.8 t -99.09 129.11 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 62.04 110.87 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -72.91 111.14 7.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 63.45 110.933 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.04 HD21 HG11 ' A' ' 213' ' ' VAL . 22.8 mt -64.62 -32.54 74.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.854 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.84 -97.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 71.43 110.874 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' N ' HD22 ' A' ' 22' ' ' ASN . 23.3 tttt -150.3 9.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 75.13 110.904 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.46 7.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 72.04 110.977 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.86 141.14 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 71.44 111.112 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.697 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.0 m95 -129.52 -179.42 5.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 74.35 110.929 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.529 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.7 t -131.43 90.2 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 53.1 111.118 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.409 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.9 p80 -74.15 125.19 27.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 62.32 110.907 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -124.45 105.54 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 63.53 111.181 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.685 ' CD ' HD22 ' A' ' 67' ' ' LEU . 19.5 mp0 -91.64 124.39 35.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 72.54 110.869 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 mt -80.32 127.55 32.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 64.33 110.905 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.87 -0.681 . . . . 63.0 112.491 179.844 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.473 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.0 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.666 0.746 . . . . 63.23 111.212 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.46 6.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.243 . . . . 72.04 112.336 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -101.55 89.09 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 53.33 110.877 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -56.66 158.66 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.42 110.877 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.94 -146.9 4.51 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.737 -0.744 . . . . 64.33 112.523 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.2 tp -160.22 117.32 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.84 0.352 . . . . 63.53 110.891 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.677 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.43 122.36 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.54 111.171 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 158' ' ' LEU . 16.6 mt -100.0 119.14 37.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 62.01 110.942 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -89.31 86.68 6.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.439 . . . . 75.44 110.945 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.2 p -99.83 -172.31 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 72.34 111.212 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -20.76 12.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.823 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -86.89 -13.34 45.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 73.41 110.848 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.51 4.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 60.01 112.43 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 79' ' ' VAL . 9.4 tp -63.13 156.01 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 73.55 110.994 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.31 142.59 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.55 111.087 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.677 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -138.07 125.03 21.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 75.25 110.854 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.41 HG11 HG11 ' A' ' 165' ' ' VAL . 74.5 t -70.45 111.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 53.02 111.134 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.57 138.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 65.54 110.833 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.694 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.9 p -81.21 -164.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 71.43 110.816 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.405 ' H ' HG23 ' A' ' 64' ' ' THR . 6.7 t -95.36 168.34 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.909 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.7 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.8 m95 -50.32 -59.94 3.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 74.1 110.929 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -128.13 158.92 36.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.83 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -52.08 -34.75 45.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.891 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -57.5 -36.31 71.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 71.11 110.921 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.8 mt -82.82 -46.64 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 72.24 110.971 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.67 -47.57 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.1 111.143 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -53.18 -50.36 64.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.887 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.56 -19.04 65.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.939 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.685 HD22 ' CD ' ' A' ' 30' ' ' GLU . 16.1 tp -88.59 -26.16 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 75.52 110.862 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.17 -23.34 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 73.44 111.151 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.17 15.2 14.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 73.32 110.916 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.5 ptm -129.83 -39.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 75.21 110.879 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 67' ' ' LEU . 31.9 m -80.44 -22.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 63.13 111.113 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.588 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.35 -24.02 64.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 44.21 110.836 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -106.37 -33.23 7.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 71.51 110.942 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -70.21 -42.26 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 62.43 110.885 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -89.34 -11.17 44.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.874 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.95 12.03 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.924 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.67 139.56 50.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.877 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -85.45 138.62 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.97 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 54' ' ' LEU . 72.8 t -79.18 122.29 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.4 111.093 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -137.33 8.14 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 53.42 111.215 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 82' ' ' VAL . 57.2 m-20 -149.89 145.84 26.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 71.32 110.941 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 54' ' ' LEU . 3.4 t -155.7 131.68 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 63.23 111.069 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.584 ' CD1' HG11 ' A' ' 140' ' ' VAL . 22.0 mt -86.18 133.96 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.53 111.15 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.004 HD11 ' HB1' ' A' ' 105' ' ' ALA . 4.8 mm -98.96 148.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 72.22 111.125 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 79.8 p -114.57 -39.19 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 65.11 111.162 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.502 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.1 p-80 -166.84 177.03 6.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 72.02 110.834 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -96.75 83.45 3.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 72.43 111.173 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 71.02 110.839 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.46 -22.03 7.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 75.2 111.078 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.06 19.69 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 44.13 110.919 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.894 ' NE ' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -144.33 -70.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.868 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.718 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.76 3.55 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 75.31 111.146 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.84 -45.12 49.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 62.13 112.565 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.14 15.17 60.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 75.55 112.425 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.554 HD12 HH22 ' A' ' 91' ' ' ARG . 2.8 tt -55.4 -28.48 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.879 0.371 . . . . 62.14 111.08 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -21.84 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 73.34 110.929 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -98.58 -14.57 19.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 64.41 111.191 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 57' ' ' SER . 14.5 mt -89.53 -35.85 15.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 72.42 110.92 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -94.44 23.97 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.85 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -124.94 -43.37 1.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 74.02 110.784 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -81.59 -52.51 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 72.51 110.891 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.27 41.01 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.713 -0.756 . . . . 60.12 112.485 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.9 mp -109.59 112.82 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 72.14 111.132 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.781 ' HE2' HD21 ' A' ' 124' ' ' LEU . 3.0 mtpp -79.79 116.65 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 63.12 110.92 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 1.004 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -89.2 90.15 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.429 . . . . 75.52 111.114 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.42 ' HA ' HD12 ' A' ' 124' ' ' LEU . 45.9 m-70 -63.09 113.97 3.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.87 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.21 -174.71 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 64.5 110.849 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.68 157.14 16.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 72.22 111.133 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.08 -40.94 33.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 63.33 111.101 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -35.65 74.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 71.41 110.968 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.568 ' HA ' HD11 ' A' ' 114' ' ' LEU . 75.4 m -63.77 -21.54 66.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 64.1 111.129 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -102.37 11.63 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 45.2 111.154 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.79 -24.38 12.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 64.23 110.868 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -104.34 -7.4 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 71.31 110.958 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.63 -41.04 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.197 -0.456 . . . . 42.31 111.052 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -24.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.93 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -33.57 71.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 73.12 110.857 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -87.81 -22.87 24.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.841 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.45 23.15 4.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.795 -0.717 . . . . 74.44 112.57 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.54 -177.64 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 73.44 110.92 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -79.65 -172.19 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 74.03 110.895 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.47 112.99 32.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 75.31 110.915 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.3 Cg_endo -69.81 -170.28 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 72.11 112.27 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.781 HD21 ' HE2' ' A' ' 104' ' ' LYS . 14.0 mt -60.63 -51.52 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 61.14 110.899 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.81 18.22 45.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 43.3 112.489 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -96.79 33.01 1.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 71.13 110.847 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 131' ' ' THR . 80.7 mt -119.09 -175.09 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 73.5 110.944 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.68 -170.74 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 73.13 110.911 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.821 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.02 -70.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 63.44 111.138 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.821 HG23 HG22 ' A' ' 129' ' ' THR . 38.7 t -116.6 96.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 74.2 111.148 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.582 HG21 HD22 ' A' ' 127' ' ' LEU . 14.5 t -117.78 169.37 9.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 71.23 111.167 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.21 103.9 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.931 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD21 ' CD2' ' A' ' 127' ' ' LEU . 29.1 mt -80.04 165.44 22.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.1 110.918 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -151.77 112.06 4.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.779 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.02 69.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.932 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.63 -93.29 0.3 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.834 -0.698 . . . . 45.54 112.42 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -110.01 24.39 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 75.13 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.414 ' HB2' HG22 ' A' ' 48' ' ' THR . 50.9 tpp -132.48 135.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.886 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.86 130.53 56.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 72.4 110.989 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.612 HG22 ' CD2' ' A' ' 158' ' ' LEU . 8.3 t -139.59 121.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 72.41 111.124 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.31 126.07 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 72.42 110.898 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.8 p -83.34 -174.66 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.11 111.051 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.509 ' HD1' HG22 ' A' ' 130' ' ' VAL . 36.6 t80 -170.66 139.72 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 62.43 110.894 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.708 ' HB3' HG23 ' A' ' 129' ' ' THR . 88.6 t80 -125.78 89.02 53.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.737 0.78 . . . . 61.13 110.976 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.6 Cg_endo -69.76 -8.05 22.61 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.291 . . . . 64.24 112.33 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.59 -149.04 19.42 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.673 -0.775 . . . . 74.42 112.448 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -98.47 140.22 33.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 63.34 110.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.06 -93.19 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.744 -0.741 . . . . 51.13 112.538 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.59 -23.66 61.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 75.22 110.83 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 86' ' ' HIS . 55.2 p -151.71 -175.35 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.33 111.124 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 114' ' ' LEU . 32.6 tt0 -85.16 -3.38 58.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 70.33 110.855 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.477 ' OD2' HG23 ' A' ' 111' ' ' THR . 7.4 p-10 -141.66 13.78 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 75.24 110.832 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.6 141.56 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.88 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.704 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.7 pt -146.91 176.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.3 111.078 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.485 HG12 ' HA2' ' A' ' 166' ' ' GLY . 22.1 m -132.53 129.02 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 74.42 111.11 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.9 t -86.84 133.1 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.33 111.101 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -120.16 137.48 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 71.42 110.951 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.612 ' CD2' HG22 ' A' ' 140' ' ' VAL . 41.6 mt -119.5 99.28 50.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.647 0.737 . . . . 72.34 110.945 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -3.13 11.36 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 63.32 112.407 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -86.54 -24.6 25.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 65.43 110.827 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.32 13.01 2.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.942 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.4 m120 54.18 25.42 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.0 110.942 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.698 HD13 HD13 ' A' ' 21' ' ' LEU . 95.7 mt -89.69 133.45 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 62.52 111.162 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.633 HD22 HD13 ' A' ' 203' ' ' ILE . 6.0 tp -121.68 140.62 52.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 75.45 110.931 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.41 HG11 HG11 ' A' ' 55' ' ' VAL . 21.7 t -113.42 75.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 72.11 111.193 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.485 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -52.06 -35.88 42.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.692 -0.765 . . . . 72.52 112.607 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.27 -157.9 53.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.817 -0.706 . . . . 72.44 112.51 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 98.0 m -50.7 -33.68 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 61.31 110.922 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.616 HD12 ' NE1' ' A' ' 189' ' ' TRP . 60.4 tp -52.45 -37.83 57.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.936 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 219' ' ' LEU . 86.0 t -105.75 108.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.11 111.127 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -50.78 168.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 71.3 110.904 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.502 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -119.88 160.16 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.2 110.807 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 71.14 111.146 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.783 0.325 . . . . 52.52 111.095 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.94 92.66 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 72.35 110.898 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.12 -25.95 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.0 111.089 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -69.5 -32.26 71.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.32 110.885 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.19 -14.44 18.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.4 110.849 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.616 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.9 t90 -57.34 -61.83 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.54 110.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.751 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.8 -24.46 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.33 110.873 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.6 m -80.15 -33.64 38.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 75.3 111.169 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.49 -43.01 64.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.803 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.9 -47.17 92.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 64.11 111.175 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.33 -28.5 63.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 65.01 110.905 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -77.94 -20.93 51.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 54.45 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 192' ' ' SER . 22.8 t -87.08 -11.44 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.205 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -110.36 -14.17 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 45.02 110.906 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.435 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -95.92 -30.95 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.964 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -103.46 -51.42 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 74.25 110.8 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -101.07 64.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 72.24 110.899 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -71.73 -59.9 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 74.2 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -50.97 107.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 70.2 110.854 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.662 HG21 HG22 ' A' ' 206' ' ' VAL . 91.3 mt -146.26 118.94 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 64.43 111.126 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.54 -29.6 52.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 72.44 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.706 ' HB1' ' CG2' ' A' ' 213' ' ' VAL . . . -159.65 146.4 16.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 52.21 111.118 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 218' ' ' LEU . 49.9 t -121.92 122.37 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 63.12 111.088 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.816 HG22 ' HB ' ' A' ' 213' ' ' VAL . 21.4 t -102.21 101.94 22.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.723 . . . . 74.1 111.148 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.539 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.4 Cg_endo -69.84 178.12 4.94 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 65.42 112.327 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.28 -17.97 76.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 63.31 112.536 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -152.52 148.98 28.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 74.2 110.915 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.9 -115.4 4.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.653 -0.784 . . . . 63.42 112.498 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -159.63 148.73 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 43.5 110.92 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.04 HG11 HD21 ' A' ' 21' ' ' LEU . 3.6 p -51.49 130.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 75.21 111.044 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -127.63 -98.13 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.689 -0.767 . . . . 35.13 112.443 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.84 -169.72 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.874 0.368 . . . . 71.1 110.918 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 219' ' ' LEU . 0.0 OUTLIER -62.05 -16.96 55.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.902 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.512 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.29 -18.96 37.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.806 -0.712 . . . . 53.1 112.406 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.4 mt -75.08 -45.58 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 73.33 110.945 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.649 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -53.32 -56.24 18.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 73.43 110.983 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.512 HD21 ' HA2' ' A' ' 217' ' ' GLY . 3.3 pp -59.39 -20.36 54.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 41.12 110.919 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.82 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.679 HG22 HD23 ' A' ' 226' ' ' LEU . 8.1 m -63.86 -56.75 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 55.32 111.132 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 190' ' ' SER . 2.4 mt -54.55 -29.78 52.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 72.22 110.955 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -29.22 61.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 75.13 110.898 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.42 -16.43 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 65.14 110.925 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.751 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -116.3 18.19 15.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 72.13 110.95 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 74.43 110.845 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.5 t . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.836 0.35 . . . . 54.3 111.157 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.442 HD13 ' HG2' ' A' ' 74' ' ' LYS . 22.1 mt -112.66 101.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.41 111.121 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -120.52 115.03 22.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.55 110.997 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -58.25 165.04 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 73.41 110.894 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -51.62 -48.51 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 72.01 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.9 p -61.15 -37.72 83.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 72.42 111.06 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.1 62.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 71.12 112.486 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.2 m -75.92 -45.36 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 72.32 111.115 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.47 123.25 54.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 63.52 111.16 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.5 p -127.22 133.56 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 41.33 110.84 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.778 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.9 mt -127.22 110.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 75.12 111.127 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -98.83 126.58 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 71.21 110.846 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -71.14 108.85 4.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.848 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.744 HD21 HG11 ' A' ' 213' ' ' VAL . 15.8 mt -62.07 -33.34 74.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.926 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.32 -96.74 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 71.42 110.911 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.4 OUTLIER -150.87 9.7 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.849 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.442 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.61 6.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 70.44 110.906 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -151.0 140.81 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 61.52 111.122 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.778 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.9 m95 -128.51 -173.25 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 71.15 110.947 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.467 HG23 ' HG ' ' A' ' 21' ' ' LEU . 97.1 t -137.79 88.2 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.079 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.43 124.13 23.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 70.11 110.792 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -123.65 105.29 9.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 73.14 111.166 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.705 ' CD ' HD22 ' A' ' 67' ' ' LEU . 8.1 mp0 -91.89 125.8 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 62.34 110.864 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 mt -83.53 123.79 30.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 71.2 110.935 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 75.4 112.443 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.462 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.2 t . . . . . 0 C--O 1.23 0.061 0 CA-C-O 121.579 0.704 . . . . 72.41 111.119 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 121.81 8.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.741 2.294 . . . . 63.04 112.373 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.5 p -103.95 88.16 2.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 74.42 110.934 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -58.33 156.8 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.11 110.968 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -150.81 -142.54 3.55 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.81 -0.71 . . . . 72.54 112.515 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.779 HD21 HD12 ' A' ' 158' ' ' LEU . 18.0 tp -160.68 116.97 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 73.02 110.822 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.669 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.7 t -100.94 122.82 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 62.34 111.114 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.753 HD21 HD11 ' A' ' 158' ' ' LEU . 17.7 mt -101.08 122.31 43.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 61.1 110.83 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.78 86.48 5.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.22 110.839 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.09 -174.59 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 73.31 111.135 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.3 t -105.69 -24.18 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 71.42 110.838 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -81.73 -10.63 59.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 65.42 110.867 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.39 153.78 5.99 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.702 -0.761 . . . . 54.05 112.53 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 79' ' ' VAL . 9.5 tp -67.86 154.59 41.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 71.33 110.889 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.5 t -142.09 137.44 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 73.1 111.096 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.669 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -136.29 121.73 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 44.21 110.914 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.47 HG12 ' CG ' ' A' ' 56' ' ' ASP . 60.1 t -66.82 111.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.54 111.104 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' CG ' HG12 ' A' ' 55' ' ' VAL . 1.3 m-20 72.56 146.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 73.42 110.939 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.713 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.5 p -85.52 -165.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 72.5 110.817 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.572 ' H ' HG23 ' A' ' 64' ' ' THR . 9.0 t -95.09 171.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 74.23 110.883 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.0 m95 -51.63 -60.07 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.34 110.952 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -129.5 159.59 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.917 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -51.37 -33.41 29.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 61.15 110.902 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.65 -38.92 79.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.868 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.2 mt -82.34 -46.01 14.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.51 110.902 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.89 -49.11 60.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 72.54 111.069 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.64 -51.47 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 73.33 110.911 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.41 -21.91 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 54.01 110.872 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.705 HD22 ' CD ' ' A' ' 30' ' ' GLU . 13.0 tp -84.64 -29.83 25.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 72.33 110.886 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.513 ' HA ' HG22 ' A' ' 71' ' ' VAL . 36.4 mt -88.72 -26.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 71.33 111.171 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.14 -0.12 47.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.942 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.8 ptm -116.58 -36.62 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 54.32 110.908 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 68' ' ' ILE . 33.5 m -78.23 -29.32 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 72.42 111.115 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.62 -32.31 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.892 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -97.2 -33.33 11.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 73.1 110.809 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HG2' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -70.34 -48.86 54.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 72.12 110.869 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 16.2 m-85 -84.18 -11.96 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.864 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.76 12.05 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 72.11 110.924 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -129.56 137.7 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 72.4 110.899 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -84.84 136.18 33.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 55.41 110.865 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 54' ' ' LEU . 57.5 t -76.6 128.98 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 73.31 111.087 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 t -146.53 14.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 74.12 111.082 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.6 ' O ' HG13 ' A' ' 53' ' ' VAL . 11.5 m-20 -159.58 136.04 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 64.24 110.871 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.14 153.17 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 75.13 111.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.558 HG21 HG22 ' A' ' 156' ' ' VAL . 4.1 mt -103.11 143.55 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 72.43 111.11 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.019 HD11 ' HB1' ' A' ' 105' ' ' ALA . 4.5 mm -106.02 145.97 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 72.23 111.164 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.2 p -112.32 -37.28 5.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 64.14 111.224 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.589 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.9 p-80 -168.41 177.97 5.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 73.4 110.807 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.943 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -96.02 79.63 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.31 111.158 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -137.69 155.35 49.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 71.24 110.897 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -20.62 10.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 63.22 111.012 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.99 11.45 18.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 53.12 110.913 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.894 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -135.97 -70.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.825 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.71 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -88.9 2.87 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 73.21 111.163 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.02 -45.78 41.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.734 . . . . 73.35 112.517 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.19 15.91 57.43 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 74.44 112.55 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.707 HD12 HH22 ' A' ' 91' ' ' ARG . 2.7 tt -52.87 -28.93 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 61.41 111.136 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.532 ' HD3' HG23 ' A' ' 95' ' ' ILE . 29.4 mmtm -59.07 -28.38 66.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 73.45 110.895 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 m -88.22 -16.59 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 73.02 111.17 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.723 ' HA ' HD13 ' A' ' 103' ' ' ILE . 10.4 mt -90.38 -41.9 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.885 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -79.51 -5.34 54.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.915 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.06 -54.99 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.845 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -64.04 -62.27 1.73 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.859 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 152.92 39.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 43.02 112.497 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -97.57 139.21 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.11 111.202 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -96.67 111.0 23.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 65.25 110.931 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 1.019 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -90.89 93.7 9.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.044 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.489 ' HB3' HD11 ' A' ' 127' ' ' LEU . 37.6 m-70 -66.49 113.85 5.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.282 -0.417 . . . . 74.15 110.865 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.45 179.67 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 63.31 110.838 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.87 157.58 17.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 64.52 111.1 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.55 -40.14 51.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 50.44 111.168 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.681 HD23 ' OD1' ' A' ' 152' ' ' ASP . 22.5 tp -75.14 -39.45 60.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 62.02 110.937 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.738 ' HA ' HD11 ' A' ' 114' ' ' LEU . 82.8 m -58.62 -21.81 54.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 73.35 111.136 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.529 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -96.06 -0.63 50.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 72.12 111.054 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -52.76 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 63.35 110.84 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.943 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.28 -13.53 60.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 73.3 110.925 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.414 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.55 -45.25 72.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 53.2 111.0 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.79 63.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -34.14 71.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.256 -0.429 . . . . 72.33 110.873 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -90.5 -19.1 24.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 44.25 110.894 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 24.62 5.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 72.55 112.561 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -99.66 177.82 5.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.864 0.364 . . . . 72.21 110.895 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -76.39 -172.95 2.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 70.31 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.11 113.8 32.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.686 0.755 . . . . 61.14 110.882 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.1 Cg_endo -69.9 -168.33 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.595 2.196 . . . . 75.34 112.342 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.74 -44.36 93.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.21 110.913 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 54.79 25.29 36.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 60.52 112.434 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -108.0 36.25 2.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.915 0.388 . . . . 72.14 110.903 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 106' ' ' HIS . 63.9 mt -122.57 -174.47 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.928 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.38 -170.05 3.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 73.41 110.912 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.853 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.08 -69.95 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.431 . . . . 50.41 111.14 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 HG22 ' A' ' 129' ' ' THR . 34.3 t -118.51 99.75 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 63.34 111.138 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.434 HG21 HD22 ' A' ' 127' ' ' LEU . 14.0 t -127.91 174.8 8.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 54.44 111.144 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.47 133.92 53.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 65.45 110.93 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 127' ' ' LEU . 39.0 mt -112.35 179.44 3.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 75.14 110.894 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 126.64 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.817 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -130.24 54.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 75.53 110.842 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.58 90.31 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 25.42 112.52 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.1 m120 64.39 14.72 9.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 73.45 110.896 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.0 tpp -133.91 97.57 3.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.15 110.936 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 136.49 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.954 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.686 HG22 HD21 ' A' ' 158' ' ' LEU . 21.7 t -139.04 117.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 73.24 111.052 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -109.11 129.96 55.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 71.41 110.883 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.8 p -85.37 -171.64 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 73.15 111.222 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -170.69 134.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 70.44 110.845 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.652 ' HB3' HG23 ' A' ' 129' ' ' THR . 76.9 t80 -123.22 88.38 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.71 0.767 . . . . 55.42 110.917 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.99 22.47 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.607 2.205 . . . . 62.15 112.367 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.45 -151.7 19.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 65.34 112.485 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -92.15 140.01 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 64.15 110.936 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.34 -88.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.706 -0.759 . . . . 72.24 112.453 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -75.02 -24.02 58.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.877 0.37 . . . . 71.43 110.838 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 86' ' ' HIS . 70.3 p -151.64 -170.23 3.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 64.45 111.097 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.64 -12.18 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.88 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.681 ' OD1' HD23 ' A' ' 110' ' ' LEU . 1.2 t0 -144.0 25.43 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 63.12 110.805 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.508 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.4 OUTLIER -56.76 132.23 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 75.31 110.92 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 84' ' ' ILE . 28.4 pt -136.89 169.88 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 74.44 111.089 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.439 ' CG1' HD23 ' A' ' 169' ' ' LEU . 24.0 m -126.37 134.13 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 65.24 111.129 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.558 HG22 HG21 ' A' ' 83' ' ' ILE . 90.6 t -86.03 133.89 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 71.32 111.163 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -121.48 130.94 53.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 60.3 110.902 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.779 HD12 HD21 ' A' ' 44' ' ' LEU . 10.6 mt -110.59 98.66 38.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.662 0.744 . . . . 54.54 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.4 Cg_endo -69.73 -4.53 14.19 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.719 2.279 . . . . 75.21 112.358 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -82.95 -24.14 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 75.34 110.938 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.63 14.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 63.04 110.877 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.25 27.52 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.856 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.546 HD13 HD13 ' A' ' 21' ' ' LEU . 96.2 mt -92.42 126.47 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 63.04 111.132 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.553 HD22 HD13 ' A' ' 203' ' ' ILE . 23.2 tp -110.89 148.26 32.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 73.54 110.852 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 72.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.0 111.148 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.46 -42.06 49.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 63.32 112.445 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.31 -155.95 44.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 63.32 112.493 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 66.1 m -51.51 -30.58 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 71.31 110.868 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.702 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.5 tp -57.51 -33.56 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 55.55 110.845 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 219' ' ' LEU . 95.6 t -105.51 104.69 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 65.3 111.176 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.539 ' HG2' HG23 ' A' ' 222' ' ' THR . 4.3 mmpt? -51.91 156.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.859 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.2 p -99.67 157.59 16.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.913 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 62.24 111.081 -179.901 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.781 0.324 . . . . 42.54 111.059 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -107.49 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 34.5 t -60.85 -17.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.32 111.121 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.99 -21.14 59.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 72.51 110.85 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -117.79 -12.47 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.851 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . 0.702 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.2 t90 -54.97 -60.78 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 74.02 110.929 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.684 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.81 -24.93 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 72.2 110.819 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.4 m -81.36 -31.98 33.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 74.0 111.18 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.76 -42.16 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 72.13 110.851 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.5 mm -61.85 -47.43 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.23 111.083 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -57.23 -28.07 62.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.911 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -76.59 -19.54 57.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.89 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.526 HG11 HD21 ' A' ' 219' ' ' LEU . 21.7 t -87.36 -16.09 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 71.2 111.187 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -104.95 -5.74 20.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.994 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.61 -30.69 9.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 72.45 110.876 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -104.37 -51.18 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 65.52 110.835 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.14 39.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 73.42 110.882 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -52.56 -48.67 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 73.31 110.852 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -60.44 106.25 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.929 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.721 HG21 HG22 ' A' ' 206' ' ' VAL . 42.8 mt -145.95 123.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 72.2 111.146 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.41 -35.47 54.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 74.11 110.843 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -157.83 129.38 6.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 61.12 111.082 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 203' ' ' ILE . 98.2 t -105.95 136.46 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 53.2 111.128 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 1.04 HG22 HG12 ' A' ' 213' ' ' VAL . 13.5 t -113.16 113.4 49.1 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.72 0.771 . . . . 64.34 111.082 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.511 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.0 Cg_endo -69.86 -173.41 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 63.0 112.34 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.24 -15.38 69.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 74.13 112.47 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.71 139.45 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 74.1 110.884 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.62 -117.93 5.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.827 -0.701 . . . . 71.3 112.475 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -148.94 169.09 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 73.51 110.928 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.04 HG12 HG22 ' A' ' 207' ' ' VAL . 4.3 m -61.17 161.58 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 74.1 111.071 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.06 -88.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 64.21 112.429 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -179.8 -170.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 73.15 110.875 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -60.98 -18.0 54.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 74.31 110.955 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.27 -20.98 52.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.671 -0.776 . . . . 42.14 112.455 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.511 HD13 ' HD3' ' A' ' 208' ' ' PRO . 10.8 mt -74.6 -47.83 30.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.862 0.363 . . . . 74.14 110.903 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.622 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -54.63 -55.16 32.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.96 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 221' ' ' HIS . 4.3 pp -60.83 -20.04 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 63.21 110.856 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.472 ' N ' HD12 ' A' ' 220' ' ' LEU . 1.5 t60 -69.74 -39.32 76.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 71.32 110.851 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.8 m -53.19 -50.38 64.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 64.45 111.106 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.36 -17.73 55.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 71.53 110.919 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -87.44 -5.67 58.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.878 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.62 -5.28 6.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 64.02 110.968 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.684 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -118.87 4.87 11.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 72.31 110.965 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 75.15 110.857 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.823 0.344 . . . . 72.14 110.81 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -85.61 121.41 28.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 75.14 110.918 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -150.55 156.56 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.843 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.0 m -97.55 168.01 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 74.2 111.261 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -118.42 72.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 74.12 110.851 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -122.06 173.38 7.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.7 m -114.66 -53.33 2.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 53.54 111.127 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.6 m -58.86 -176.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 73.3 111.067 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.82 91.82 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.44 111.101 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -111.88 117.84 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 73.32 110.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -60.79 168.96 2.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.873 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.96 -47.94 64.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 62.31 110.881 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -61.08 -37.54 83.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.15 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.3 13.32 61.92 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.669 -0.777 . . . . 55.11 112.542 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.4 m -79.14 -44.8 21.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 75.24 111.092 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 67' ' ' LEU . 32.1 mt -103.59 117.46 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 44.21 111.176 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.5 p -124.46 129.12 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 74.45 110.843 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.694 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -120.44 112.55 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 53.53 111.105 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.443 ' HA ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -98.31 128.76 44.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 71.42 110.86 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -73.55 110.93 8.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 72.21 110.89 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.0 HD21 HG21 ' A' ' 213' ' ' VAL . 10.8 mt -65.37 -32.99 74.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 43.41 110.879 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.85 -97.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 64.44 110.872 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.8 OUTLIER -150.09 9.45 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 73.15 110.864 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.452 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.53 8.25 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.318 -0.401 . . . . 75.4 110.829 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -150.89 141.14 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.253 -0.43 . . . . 71.52 111.095 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.694 ' HB3' HG22 ' A' ' 18' ' ' ILE . 19.6 m95 -130.0 -179.39 5.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 65.11 110.878 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 43' ' ' GLY . 93.0 t -132.0 89.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 64.5 111.096 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.406 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.3 p80 -72.78 124.38 25.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 65.51 110.834 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -119.93 104.2 9.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 70.1 111.128 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -88.13 123.27 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.891 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.791 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -88.8 117.8 28.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 72.14 110.874 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.43 -124.87 3.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 52.22 112.514 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.2 p -175.18 116.71 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.893 0.378 . . . . 73.24 110.823 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.21 42.33 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 62.41 110.85 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 64.2 69.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.907 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.17 -18.28 36.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.804 -0.712 . . . . 61.15 112.5 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -119.48 -177.42 3.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.83 0.347 . . . . 75.22 110.933 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.791 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -109.86 143.92 39.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 51.24 111.07 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.6 79.89 71.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.58 0.705 . . . . 75.24 111.181 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 118.33 5.62 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.738 2.292 . . . . 71.25 112.348 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -110.21 99.91 8.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 71.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -62.42 170.37 2.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 75.42 110.93 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -159.28 -147.46 4.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 30.04 112.527 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.8 tp -159.58 116.28 2.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 73.55 110.885 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.652 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.52 121.83 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 54.01 111.155 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.46 HD22 ' SD ' ' A' ' 138' ' ' MET . 24.7 mt -98.7 118.23 34.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 64.2 110.966 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.39 85.93 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.936 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.78 177.15 4.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 73.03 111.092 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -97.94 -20.84 17.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 61.11 110.823 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -10.4 57.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 65.3 110.902 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.62 153.54 5.91 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.731 -0.747 . . . . 72.24 112.523 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.0 tp -68.54 154.95 40.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.934 0.397 . . . . 64.14 110.905 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.3 t -145.15 142.99 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 73.13 111.107 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.652 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -137.56 124.61 21.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.905 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.538 HG12 ' OD1' ' A' ' 56' ' ' ASP . 74.1 t -71.51 112.44 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 54.42 111.137 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.8 m-20 73.4 121.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 71.0 110.882 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.67 ' CB ' HD11 ' A' ' 98' ' ' LEU . 2.8 p -66.12 -166.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 65.35 110.844 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.6 t -91.9 169.48 10.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.85 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.714 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.1 m95 -50.38 -60.25 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.828 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -129.82 158.51 39.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 75.15 110.964 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -51.37 -33.75 31.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.972 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.21 -38.11 76.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 71.23 110.926 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 59' ' ' TRP . 93.1 mt -81.15 -45.54 16.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.934 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -45.14 61.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.132 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -52.93 -51.59 60.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 74.35 110.952 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -63.71 -19.71 65.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 71.13 110.913 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 71' ' ' VAL . 12.1 tp -87.94 -26.86 22.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.877 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.75 -23.09 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.475 . . . . 72.42 111.265 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -93.09 18.18 9.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.11 -0.496 . . . . 74.33 110.865 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.3 ptm -132.9 -40.11 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 71.5 110.866 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.1 m -81.07 -22.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 70.2 111.163 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.623 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.81 -21.95 65.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.902 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -109.04 -33.27 6.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 73.15 110.851 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.93 -43.48 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.908 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -88.17 -10.87 48.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 62.3 110.895 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 67.42 13.27 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 73.13 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.545 ' HB2' HD13 ' A' ' 52' ' ' LEU . 5.3 mttm -131.33 138.76 49.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 62.22 110.954 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -85.8 137.94 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 75.22 110.833 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.623 HG23 ' OE1' ' A' ' 72' ' ' GLU . 98.8 t -76.91 126.39 37.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 71.21 111.103 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -143.79 13.89 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.11 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.471 ' O ' HG13 ' A' ' 53' ' ' VAL . 53.8 m-20 -155.89 144.15 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 74.04 110.906 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 54' ' ' LEU . 14.5 t -154.41 131.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.4 111.161 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.497 ' CD1' HG11 ' A' ' 140' ' ' VAL . 49.6 mt -89.4 130.73 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 61.32 111.105 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -106.28 124.94 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 71.12 111.157 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.472 HG23 ' OD2' ' A' ' 56' ' ' ASP . 30.7 p -82.53 -39.54 22.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 72.01 111.167 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.485 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.6 p-80 -165.94 -175.29 3.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 71.11 110.931 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.808 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.24 95.83 10.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 71.21 111.108 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.88 154.08 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.35 110.832 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.13 -20.19 51.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 73.5 111.049 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -91.8 5.08 51.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 61.14 110.918 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -122.11 -77.61 0.59 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 73.12 110.791 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.14 8.48 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 62.33 111.086 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.38 -42.32 33.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.76 . . . . 70.34 112.476 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.61 13.1 58.15 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 23.13 112.468 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.5 tt -51.42 -29.63 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.855 0.36 . . . . 71.1 111.086 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -32.11 45.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 72.22 110.984 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.6 m -89.78 -22.72 22.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 74.42 111.132 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.67 HD11 ' CB ' ' A' ' 57' ' ' SER . 13.3 mt -80.54 -25.98 38.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.906 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.73 15.3 29.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.913 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.03 -40.93 3.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.14 -0.482 . . . . 75.24 110.89 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -83.19 -58.14 2.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.069 -0.514 . . . . 64.41 110.928 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.56 38.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 72.43 112.545 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.2 mp -106.05 115.12 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 74.34 111.111 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HB3' HD11 ' A' ' 124' ' ' LEU . 2.6 mttt -78.84 116.31 19.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 53.44 110.911 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.43 93.15 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 54.55 111.127 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.575 ' HA ' HD12 ' A' ' 124' ' ' LEU . 38.0 m-70 -67.66 129.44 39.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.912 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.627 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -159.11 -178.98 7.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 52.5 110.924 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.89 157.75 17.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 72.3 111.133 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.03 -36.94 30.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 63.43 111.109 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.614 HD21 ' HG2' ' A' ' 151' ' ' GLU . 0.3 OUTLIER -72.11 -39.42 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.99 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.742 ' HA ' HD11 ' A' ' 114' ' ' LEU . 83.6 m -57.87 -27.72 63.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 64.42 111.186 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.31 4.7 53.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 42.02 111.018 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -103.61 -44.81 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.889 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -85.07 -13.86 49.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.959 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.483 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -62.62 -43.12 99.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.097 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.15 62.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.41 110.944 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.01 -35.55 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 64.54 110.838 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.39 -23.53 22.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 73.25 110.917 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.59 22.99 4.89 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 53.33 112.447 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -94.84 179.14 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.344 . . . . 64.32 110.883 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -77.41 -176.18 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 72.1 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mt-10 -115.35 101.52 54.37 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.634 0.73 . . . . 75.32 110.852 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.4 Cg_endo -69.76 -179.85 3.2 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.742 2.295 . . . . 65.14 112.341 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 106' ' ' HIS . 29.4 mt -51.24 -52.55 43.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 73.55 110.858 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 58.75 21.94 52.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 74.22 112.444 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.37 24.14 6.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.801 0.334 . . . . 74.02 110.886 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.688 ' CD2' HD21 ' A' ' 133' ' ' LEU . 95.5 mt -103.99 -175.9 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 61.5 110.942 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.99 -171.55 3.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 52.13 110.826 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.934 HG22 HG23 ' A' ' 130' ' ' VAL . 36.6 m -50.94 -70.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 54.1 111.087 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.934 HG23 HG22 ' A' ' 129' ' ' THR . 44.4 t -119.11 104.06 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 70.2 111.218 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -135.15 164.2 28.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 73.12 111.22 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.93 126.61 54.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.283 -0.417 . . . . 75.13 111.0 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.688 HD21 ' CD2' ' A' ' 127' ' ' LEU . 67.0 mt -111.49 155.7 22.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.35 110.912 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -137.87 117.19 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 62.54 110.872 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -115.19 48.93 1.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 74.33 110.886 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.33 94.1 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.751 . . . . 65.11 112.45 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.35 15.36 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.358 . . . . 43.31 110.887 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.46 ' SD ' HD22 ' A' ' 46' ' ' LEU . 54.8 tpp -137.45 101.37 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 62.23 110.898 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.464 ' O ' HD23 ' A' ' 158' ' ' LEU . 2.9 mptt -90.81 132.56 35.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.276 -0.42 . . . . 75.44 110.773 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.727 HG22 HD21 ' A' ' 158' ' ' LEU . 21.2 t -138.5 114.87 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.061 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -107.6 129.58 54.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 75.04 110.872 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 46.9 p -86.08 178.09 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 72.11 111.183 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.515 ' HD1' HG22 ' A' ' 130' ' ' VAL . 19.4 t80 -161.63 133.69 5.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 70.05 110.858 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.678 ' HB3' HG23 ' A' ' 129' ' ' THR . 9.1 t80 -121.78 86.48 45.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 75.33 110.872 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -8.04 22.6 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.767 2.311 . . . . 74.53 112.31 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.36 -160.94 24.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.767 -0.73 . . . . 73.51 112.434 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -87.77 140.76 29.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 74.24 110.844 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.537 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -154.6 -91.11 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 62.43 112.459 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -73.79 -23.51 59.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 71.33 110.959 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.485 HG21 ' HB2' ' A' ' 86' ' ' HIS . 47.2 p -150.29 -167.38 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 43.33 111.167 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.645 ' HB3' HD23 ' A' ' 114' ' ' LEU . 2.0 tt0 -86.32 -15.98 38.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 74.1 110.853 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.567 ' HB2' HD23 ' A' ' 110' ' ' LEU . 41.0 t0 -135.53 17.96 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 74.22 110.871 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.684 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -51.45 129.59 25.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 64.42 110.818 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 144' ' ' TYR . 5.8 pt -136.54 175.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.08 -0.509 . . . . 74.5 111.065 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -128.35 119.51 50.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.14 111.162 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.47 126.58 34.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 62.44 111.108 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -115.25 138.8 50.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 71.42 110.904 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.727 HD21 HG22 ' A' ' 140' ' ' VAL . 20.1 mt -121.34 98.91 46.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.652 0.739 . . . . 75.44 110.846 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -4.13 13.43 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.707 2.271 . . . . 63.1 112.287 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -85.16 -22.97 28.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.317 -0.401 . . . . 52.33 110.974 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.41 12.28 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 62.03 111.042 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.3 m120 54.68 25.68 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 41.54 110.819 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 93.5 mt -90.48 142.95 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 65.41 111.196 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.637 HD22 HD13 ' A' ' 203' ' ' ILE . 13.2 tp -128.43 146.38 50.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 64.25 110.917 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.466 HG11 HG11 ' A' ' 55' ' ' VAL . 42.1 t -115.17 76.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.433 . . . . 63.51 111.126 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.09 -28.99 19.91 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.808 -0.711 . . . . 70.22 112.49 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.41 -161.72 20.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.666 -0.778 . . . . 73.41 112.465 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.71 -33.18 60.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 53.41 110.868 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.684 HD13 ' OD1' ' A' ' 153' ' ' ASN . 25.1 tp -51.85 -35.86 46.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.924 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.91 111.16 34.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 72.42 111.078 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.57 ' HD2' ' HB1' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -57.71 159.73 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 62.21 110.858 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.7 p -100.27 162.78 12.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.812 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 t -54.63 -28.7 48.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 64.21 111.075 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.46 44.96 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 70.13 110.854 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.57 ' HB1' ' HD2' ' A' ' 171' ' ' LYS . . . -130.14 156.1 45.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 53.32 111.021 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.466 ' O ' HD22 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -122.53 -4.94 8.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.44 110.832 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 0.8 OUTLIER -179.73 175.63 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.01 110.86 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.763 HD11 ' HB2' ' A' ' 226' ' ' LEU . 7.6 mt -74.77 -44.46 49.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 74.15 110.918 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.71 123.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.802 -0.713 . . . . 75.15 112.446 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.11 103.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.382 . . . . 73.33 110.995 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.0 m -123.72 19.76 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 72.53 111.081 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.3 -44.02 84.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 54.23 111.061 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -98.25 13.76 30.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.874 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -123.64 167.01 14.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 34.42 111.104 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.98 90.49 3.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.959 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.96 -17.1 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 54.32 111.271 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -74.39 -27.81 60.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 71.31 110.949 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -110.97 -12.92 14.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 61.21 110.857 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.576 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.3 t90 -54.09 -62.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 64.5 110.918 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.687 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -54.56 -23.73 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 72.23 110.822 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.2 m -81.43 -30.48 33.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 70.31 111.168 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.22 -43.63 41.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.889 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.512 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.7 mm -61.83 -45.2 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 74.13 111.144 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.52 -23.96 53.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 54.43 110.883 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.99 -22.79 36.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 74.4 110.864 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 192' ' ' SER . 17.4 t -86.11 -9.0 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.41 111.137 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.69 -6.93 13.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 55.04 110.941 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.46 -31.06 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 72.14 110.939 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -55.98 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.856 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -94.89 38.66 1.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 73.21 110.84 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -55.53 -47.97 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 75.23 110.948 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -60.05 102.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 73.24 110.829 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.669 HG21 HG22 ' A' ' 206' ' ' VAL . 41.9 mt -144.69 125.12 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 75.03 111.151 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.97 -24.2 41.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.122 -0.49 . . . . 55.25 110.905 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.721 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -168.15 133.71 1.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 64.33 111.089 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' A' ' 218' ' ' LEU . 88.8 t -115.02 131.61 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 65.41 111.092 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.069 HG22 HG22 ' A' ' 213' ' ' VAL . 13.6 t -110.15 108.88 58.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 74.34 111.13 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.7 Cg_endo -69.7 -176.01 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 72.13 112.353 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.41 -17.36 80.01 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 71.52 112.476 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -152.43 141.15 20.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.833 0.349 . . . . 74.5 110.972 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 110.21 -117.64 4.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 74.05 112.488 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.63 176.16 11.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.853 0.358 . . . . 62.22 110.901 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.069 HG22 HG22 ' A' ' 207' ' ' VAL . 5.8 t -70.09 151.12 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 61.32 111.146 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.99 -102.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.737 -0.744 . . . . 65.15 112.447 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.67 -168.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 72.13 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -60.93 -18.14 55.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 72.33 110.882 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.499 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.77 -19.79 37.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.799 -0.715 . . . . 61.32 112.506 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.738 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.6 mt -73.23 -31.78 64.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 61.11 110.878 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.512 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -62.8 -57.3 11.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 72.21 111.027 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 223' ' ' LEU . 0.5 OUTLIER -62.12 -17.93 59.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 41.01 110.937 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.9 OUTLIER -66.24 -40.99 90.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.874 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.906 HG22 HD23 ' A' ' 226' ' ' LEU . 27.8 m -60.94 -47.98 83.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 63.22 111.169 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -67.97 -21.99 65.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.949 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -75.4 -6.54 50.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 72.23 110.905 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 176' ' ' LYS . 4.7 mt -125.13 -35.68 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 44.45 110.859 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.906 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -85.45 -0.82 56.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.243 -0.435 . . . . 75.41 110.912 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 75.45 110.894 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.742 0.306 . . . . 73.32 110.87 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -138.74 179.08 6.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 74.45 110.931 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -170.56 141.85 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 61.22 110.864 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -56.54 146.86 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 73.34 111.096 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.29 169.67 15.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.503 . . . . 74.11 110.874 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -68.74 -176.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.11 110.899 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -86.76 -68.68 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 70.22 111.141 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.2 t -50.53 147.31 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 71.01 111.171 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mt -110.48 97.17 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 71.21 111.201 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.94 121.01 39.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 65.4 110.906 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -66.78 168.16 10.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 71.42 110.837 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -52.18 -48.14 65.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.45 110.844 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.98 -37.83 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 72.5 111.061 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.93 13.12 62.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 55.14 112.55 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 m -80.47 -44.26 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.278 . . . . 72.42 111.134 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 67' ' ' LEU . 52.8 mt -101.97 113.02 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 73.43 111.097 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.4 p -121.15 129.06 53.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 51.23 110.871 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.808 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.1 mt -120.41 111.83 33.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 72.04 111.121 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.2 t -97.01 126.53 42.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 64.24 110.894 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -72.15 109.34 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.892 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.848 HD21 HG11 ' A' ' 213' ' ' VAL . 6.7 mt -63.0 -35.26 79.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.964 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.68 -96.47 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.915 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.24 9.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.944 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.15 8.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 75.31 110.981 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -150.91 140.34 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 62.31 111.245 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.808 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.7 m95 -129.58 -179.71 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.437 . . . . 74.03 110.973 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.9 t -132.28 88.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 75.32 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -71.3 123.17 21.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 52.44 110.851 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.1 m -119.78 105.1 10.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 63.14 111.124 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.408 ' CG ' HD22 ' A' ' 67' ' ' LEU . 3.5 mp0 -87.05 122.64 31.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 73.21 110.882 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.738 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -90.53 108.5 19.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 74.42 110.896 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.69 -128.34 1.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.786 -0.721 . . . . 62.25 112.513 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 p -175.1 115.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 71.02 110.831 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.37 41.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 71.42 110.918 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 64.31 68.23 0.56 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 74.05 110.909 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.49 -15.8 41.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 61.13 112.478 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -121.69 159.31 26.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.836 0.351 . . . . 71.13 110.885 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.738 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -98.66 134.24 41.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 64.11 111.044 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.07 81.89 56.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.553 0.692 . . . . 71.23 111.228 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.63 116.9 4.76 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.738 2.292 . . . . 60.24 112.405 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.2 p -104.44 98.34 8.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 54.22 110.839 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -61.51 169.25 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 73.24 110.893 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -148.71 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.839 -0.696 . . . . 54.53 112.586 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.627 HD21 HD12 ' A' ' 158' ' ' LEU . 15.8 tp -158.62 115.19 2.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 54.53 110.943 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.685 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -98.56 121.8 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 63.51 111.139 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.736 HD21 HD11 ' A' ' 158' ' ' LEU . 19.4 mt -98.84 116.51 31.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.958 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -87.38 85.49 7.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.44 110.953 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.6 176.18 5.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 65.42 111.115 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.8 m -96.67 -21.5 17.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 43.55 110.831 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.42 -11.18 57.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 74.22 110.868 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.08 153.67 5.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 72.1 112.466 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.2 tp -68.39 155.03 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 72.35 110.951 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.2 t -145.57 142.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 71.33 111.153 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.685 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -137.53 122.84 19.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 74.01 110.959 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 165' ' ' VAL . 76.3 t -69.2 110.51 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 72.32 111.109 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.2 129.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 70.13 110.91 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.677 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -72.52 -165.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 60.01 110.809 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -91.37 172.66 8.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 52.1 110.839 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.742 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.9 m95 -49.94 -52.04 36.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 70.03 110.978 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -141.63 162.6 35.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 74.33 110.874 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.71 -30.59 22.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.428 . . . . 64.04 110.832 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -59.74 -42.08 92.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 71.24 110.951 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.742 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.0 mt -83.08 -45.37 14.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 74.32 110.866 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -45.87 59.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.281 -0.418 . . . . 72.34 111.167 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -55.58 -48.12 75.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 61.03 110.872 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -65.98 -18.91 65.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.901 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.578 ' O ' HG22 ' A' ' 71' ' ' VAL . 19.1 tp -89.59 -27.14 20.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 54.14 110.915 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.08 -22.54 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 71.31 111.145 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.55 15.72 13.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.871 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.46 -39.92 1.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 63.34 110.873 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.9 m -80.39 -22.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 60.12 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.554 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.75 -23.07 65.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.842 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.84 -33.52 7.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 74.24 110.842 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -69.91 -39.24 76.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 65.33 110.894 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -92.71 -10.44 37.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.879 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.65 12.05 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 65.15 110.916 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.523 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -130.48 137.83 49.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 54.01 110.868 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -86.49 138.21 31.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 73.32 110.898 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 54' ' ' LEU . 71.4 t -76.4 121.94 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.413 . . . . 55.43 111.134 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.7 t -134.32 6.59 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.134 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 53' ' ' VAL . 60.1 m-20 -151.23 145.7 25.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.31 110.837 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 54' ' ' LEU . 10.8 t -154.03 132.22 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.075 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.9 mt -93.89 123.46 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 72.53 111.163 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.6 mm -96.55 143.45 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.175 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.0 p -94.11 -51.42 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 75.2 111.176 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -156.1 -175.88 5.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.829 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.86 97.13 10.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 72.01 111.117 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -158.11 150.92 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 71.34 110.858 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.07 -19.61 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 61.04 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -92.29 21.83 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.809 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -144.0 -77.34 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 71.55 110.837 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -88.87 8.21 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 64.3 111.136 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.05 -41.8 38.37 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.709 -0.758 . . . . 65.2 112.503 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.45 12.04 61.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 72.24 112.458 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 92' ' ' ILE . 3.5 tt -51.97 -28.49 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 63.43 111.104 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -53.58 -39.84 65.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 75.04 110.87 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.9 m -79.94 -17.29 53.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.205 -0.452 . . . . 52.02 111.192 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.677 HD11 ' OG ' ' A' ' 57' ' ' SER . 17.3 mt -84.99 -32.34 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 75.54 110.906 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.71 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.87 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -119.63 -45.74 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.88 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -77.36 -53.41 7.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.31 110.868 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.31 44.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 41.23 112.474 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.597 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -109.0 121.11 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.945 0.403 . . . . 74.4 111.14 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.769 ' HE2' HD21 ' A' ' 124' ' ' LEU . 7.7 mtpt -82.05 111.42 18.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 70.3 110.968 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.12 91.28 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.077 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.561 ' HA ' HD12 ' A' ' 124' ' ' LEU . 56.2 m-70 -62.98 142.16 58.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.01 110.865 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.629 ' CA ' HD12 ' A' ' 127' ' ' LEU . 3.4 p -172.9 179.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 53.24 110.882 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.85 157.47 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.41 111.208 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.99 -31.74 13.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 64.42 111.029 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.567 HD23 ' HB3' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -77.76 -39.38 44.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 72.44 110.908 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.569 ' HA ' HD11 ' A' ' 114' ' ' LEU . 10.2 m -57.37 -27.7 62.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 74.12 111.151 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -98.33 8.58 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.12 111.084 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.99 -28.78 11.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 75.41 110.898 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -103.36 -8.64 20.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 73.53 110.884 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.46 79.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 71.43 111.146 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 -26.68 57.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 72.42 110.901 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -57.58 -30.75 65.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 64.04 110.933 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -92.11 -24.8 19.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 74.43 110.947 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.18 25.76 4.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 72.12 112.48 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.33 -176.08 3.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.855 0.359 . . . . 73.23 110.955 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.61 167.75 17.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 71.34 110.853 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.6 mt-10 -101.25 103.25 24.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.7 0.762 . . . . 64.24 110.818 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.0 Cg_endo -69.73 -178.63 2.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 71.12 112.313 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.769 HD21 ' HE2' ' A' ' 104' ' ' LYS . 28.9 mt -51.64 -51.29 56.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.92 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 55.11 24.72 36.7 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.729 . . . . 64.22 112.437 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -101.78 29.31 5.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 72.34 110.898 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.696 ' CD2' HD21 ' A' ' 133' ' ' LEU . 95.6 mt -108.91 -175.8 2.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 55.42 110.903 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.87 -172.63 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 74.45 110.938 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.867 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.91 -70.94 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 64.3 111.127 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 129' ' ' THR . 38.8 t -117.77 103.1 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 73.41 111.111 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -131.78 174.34 10.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 55.31 111.152 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.32 129.36 50.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 73.24 110.878 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.696 HD21 ' CD2' ' A' ' 127' ' ' LEU . 60.8 mt -113.29 156.98 22.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 65.31 110.934 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -139.36 115.31 10.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 74.31 110.869 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -113.36 48.01 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 65.52 110.918 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.43 94.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 72.12 112.382 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.0 m120 65.1 14.2 9.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 63.3 110.885 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.5 tpp -133.43 104.29 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.067 -0.515 . . . . 64.12 110.88 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.68 123.78 36.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 61.14 110.883 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.959 HG22 HD21 ' A' ' 158' ' ' LEU . 21.5 t -131.92 117.86 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 70.43 111.116 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -111.13 127.91 55.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.51 110.884 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.58 -172.49 4.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 61.34 111.175 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HB3' HG23 ' A' ' 155' ' ' VAL . 37.7 t80 -172.83 135.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 74.11 110.899 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.694 ' HB3' HG23 ' A' ' 129' ' ' THR . 90.2 t80 -120.95 89.63 46.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.657 0.742 . . . . 73.03 110.89 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.7 Cg_endo -69.76 -7.89 22.2 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.661 2.241 . . . . 75.1 112.401 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.28 -150.08 19.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.77 -0.728 . . . . 74.52 112.527 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -96.53 139.12 33.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.801 0.334 . . . . 74.54 110.886 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.451 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -152.0 -95.22 0.12 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 41.0 112.461 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 84.7 t60 -69.6 -24.44 63.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 73.32 110.982 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 p -151.4 -171.45 3.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 52.31 111.145 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.91 -8.4 57.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 75.24 110.89 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.567 ' HB3' HD23 ' A' ' 110' ' ' LEU . 3.7 p-10 -136.86 14.98 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 60.33 110.863 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.414 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.3 OUTLIER -53.07 137.95 32.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 72.1 110.906 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.69 -179.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 74.31 111.114 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.573 HG12 ' HA2' ' A' ' 166' ' ' GLY . 6.5 m -135.12 126.58 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 71.42 111.16 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.414 ' O ' HD12 ' A' ' 164' ' ' LEU . 99.9 t -85.96 122.94 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 75.35 111.094 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -110.7 133.05 53.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 73.3 110.91 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.959 HD21 HG22 ' A' ' 140' ' ' VAL . 10.9 mt -115.01 98.65 50.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.738 . . . . 71.14 110.978 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -4.02 13.14 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 61.12 112.339 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -83.36 -23.85 32.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.954 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -144.25 14.49 1.64 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 75.22 110.922 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.19 27.36 7.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 72.52 110.858 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.557 HD13 HD13 ' A' ' 21' ' ' LEU . 96.2 mt -92.54 129.87 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 71.03 111.166 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.547 HD11 ' HB ' ' A' ' 155' ' ' VAL . 23.0 tp -115.5 147.68 40.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 64.41 110.947 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 55' ' ' VAL . 37.6 t -117.73 74.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 72.42 111.124 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.573 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -51.79 -41.49 51.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.696 -0.764 . . . . 74.35 112.534 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 73.49 -160.48 53.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.832 -0.699 . . . . 54.31 112.419 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 45.8 m -51.72 -30.1 21.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.874 0.368 . . . . 71.22 110.893 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.725 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.6 tp -57.83 -32.49 67.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 70.4 110.947 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 219' ' ' LEU . 80.1 t -105.98 109.73 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 51.01 111.16 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.661 ' HG2' HG23 ' A' ' 222' ' ' THR . 2.5 mmpt? -51.54 161.15 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 73.35 110.884 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.544 ' HA ' HD22 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -100.86 168.62 9.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.209 -0.45 . . . . 55.14 110.907 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -62.14 146.85 49.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 73.42 111.107 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 m 65.7 20.78 11.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 70.14 110.882 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.509 ' HB3' HD11 ' A' ' 225' ' ' LEU . . . -72.81 153.84 40.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 34.02 111.165 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -118.8 -16.82 9.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 70.43 110.946 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 0.5 OUTLIER 179.95 176.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.853 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 226' ' ' LEU . 4.7 mt -83.39 -38.56 21.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 73.1 110.942 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 105.96 -152.41 17.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.715 -0.755 . . . . 75.41 112.514 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -57.41 107.38 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.902 0.382 . . . . 32.52 110.879 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.423 HG11 ' CG2' ' A' ' 186' ' ' VAL . 32.2 m -96.84 24.49 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 61.03 111.097 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -69.36 -27.82 65.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 74.44 111.087 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -114.1 24.94 11.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 75.31 110.81 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -141.73 164.86 29.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 43.34 111.047 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.61 91.91 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 73.53 110.932 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.423 ' CG2' HG11 ' A' ' 181' ' ' VAL . 11.7 t -62.49 -21.31 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 62.13 111.088 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -73.41 -21.71 60.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 75.41 110.82 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -114.93 -12.9 11.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 61.3 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.725 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.9 t90 -56.73 -62.28 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.066 -0.515 . . . . 64.21 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.722 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.5 -23.63 17.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 70.14 110.865 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 58.0 m -80.66 -33.31 35.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 61.21 111.155 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.89 -43.75 62.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 72.11 110.885 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.1 mm -59.56 -47.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 74.12 111.143 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.41 -27.78 62.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 64.01 110.852 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -77.43 -20.69 54.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 73.3 110.86 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.513 HG11 HD21 ' A' ' 219' ' ' LEU . 18.4 t -86.57 -13.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 63.25 111.156 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -108.38 -16.55 14.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.867 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -93.35 -30.6 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 65.54 110.849 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 -50.4 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 72.13 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.84 66.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 71.11 110.847 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.3 mtm-85 -72.91 -59.78 2.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 74.14 110.92 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -51.63 107.73 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 54.11 110.9 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.615 HG21 HG22 ' A' ' 206' ' ' VAL . 85.0 mt -146.61 122.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 74.34 111.12 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.93 -32.13 45.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 64.41 110.863 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.679 ' HB1' ' CG2' ' A' ' 213' ' ' VAL . . . -161.72 147.62 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 64.35 111.09 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.615 HG22 HG21 ' A' ' 203' ' ' ILE . 47.6 t -123.47 126.74 73.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 62.14 111.108 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.823 HG22 ' HB ' ' A' ' 213' ' ' VAL . 17.0 t -103.29 104.07 38.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.565 0.697 . . . . 64.25 111.166 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.553 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.7 Cg_endo -69.73 -174.78 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.784 2.323 . . . . 64.23 112.33 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.95 -17.1 75.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.786 . . . . 52.13 112.548 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.33 140.64 20.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 71.33 110.86 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.6 -117.26 4.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 41.23 112.397 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -157.02 149.14 22.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.862 0.363 . . . . 65.2 110.916 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.848 HG11 HD21 ' A' ' 21' ' ' LEU . 4.0 p -51.55 137.6 9.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 52.23 111.115 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -135.03 -88.58 0.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 60.11 112.469 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -171.65 -168.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.963 0.411 . . . . 65.15 110.829 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.445 ' HA ' HD12 ' A' ' 219' ' ' LEU . 3.1 pttm -61.73 -17.26 55.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 70.33 110.92 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.81 -19.93 38.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 55.23 112.46 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.569 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.7 mt -77.4 -47.13 20.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 73.31 110.82 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.618 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -53.72 -54.61 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.33 110.978 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 221' ' ' HIS . 4.2 pp -60.72 -21.24 62.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.01 110.913 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.49 ' N ' HD12 ' A' ' 220' ' ' LEU . 0.8 OUTLIER -69.61 -37.65 76.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 70.24 110.889 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.73 HG22 HD23 ' A' ' 226' ' ' LEU . 3.5 m -55.39 -54.88 38.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 72.3 111.15 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.88 -19.87 53.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 72.33 110.897 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -83.58 -5.17 59.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 61.14 110.897 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 175' ' ' ALA . 2.8 mt -129.14 -4.56 4.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 63.34 110.869 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.808 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.5 OUTLIER -121.77 -0.19 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 74.14 110.961 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.098 -0.501 . . . . 63.51 110.988 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.841 0.353 . . . . 73.11 110.898 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -99.41 162.77 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 64.51 110.937 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.2 165.87 26.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 54.41 110.815 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.3 m -93.28 -179.19 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 41.15 111.118 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -137.24 72.39 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 71.33 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -136.64 169.24 18.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 73.12 110.926 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -88.47 -51.98 5.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 61.04 111.159 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 19' ' ' SER . 4.9 m -59.13 -175.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.31 111.182 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.8 mt -136.43 92.74 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 64.33 111.125 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -113.79 115.09 27.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.493 . . . . 70.21 110.909 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -58.96 168.98 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 63.33 110.874 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -51.3 -47.79 62.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 74.42 110.912 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 34.5 p -61.24 -37.45 83.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 55.55 111.075 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.66 14.13 61.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.746 . . . . 72.52 112.527 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.3 m -80.14 -44.34 20.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.748 0.308 . . . . 61.42 111.118 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -102.54 114.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.274 -0.421 . . . . 71.21 111.14 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -121.55 127.52 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.838 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.689 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.7 OUTLIER -120.97 112.63 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.169 -0.469 . . . . 74.5 111.13 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.41 ' HA ' HG12 ' A' ' 8' ' ' VAL . 17.5 t -99.05 125.97 44.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 63.1 110.84 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -69.83 111.3 5.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 64.51 110.872 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.678 HD21 HG11 ' A' ' 213' ' ' VAL . 11.2 mt -65.17 -32.69 74.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 75.2 110.907 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -152.04 -96.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.52 110.977 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.33 9.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.13 110.947 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.452 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.84 7.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.911 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.2 t -150.99 141.9 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.42 111.183 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.689 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.8 m95 -130.04 -177.81 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.94 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 43' ' ' GLY . 90.7 t -133.4 91.76 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.311 -0.404 . . . . 63.12 111.191 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -75.16 123.55 25.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 70.3 110.824 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.5 m -120.33 104.24 9.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 51.35 111.212 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 124.34 31.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 73.54 110.824 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.759 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -87.5 113.77 23.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 61.11 110.938 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.77 -145.41 10.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 53.3 112.477 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.91 119.78 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.927 0.394 . . . . 50.22 110.92 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -144.84 136.23 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 72.42 110.957 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 50.48 27.75 3.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 71.43 110.919 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 41.92 23.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.661 -0.781 . . . . 71.23 112.473 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -147.73 130.82 16.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.36 . . . . 72.2 110.818 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.759 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -60.02 149.09 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 44.41 111.081 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -139.41 79.65 24.55 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.713 0.768 . . . . 55.44 111.163 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.65 117.43 5.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.735 2.29 . . . . 75.32 112.394 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.7 p -109.41 97.4 6.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 70.11 110.792 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -58.25 166.84 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 73.44 110.892 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -158.05 -149.39 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 52.25 112.477 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 158' ' ' LEU . 15.5 tp -158.28 119.31 3.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 63.05 110.917 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.661 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -103.16 122.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 63.24 111.07 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.88 HD21 HD11 ' A' ' 158' ' ' LEU . 23.5 mt -100.42 120.74 40.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 51.43 110.963 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.47 84.67 5.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 74.04 110.893 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.2 p -99.54 -176.53 3.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.169 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 -26.47 13.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.2 110.886 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.88 -18.7 55.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 65.41 110.86 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.17 151.47 5.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.732 . . . . 55.42 112.479 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.709 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.9 mt -62.94 154.8 29.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.813 0.339 . . . . 62.01 110.839 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.1 t -144.22 141.27 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 63.25 111.131 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -136.55 121.82 19.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 72.33 110.891 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.444 HG11 HG11 ' A' ' 165' ' ' VAL . 79.8 t -68.24 111.97 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 64.2 111.054 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.8 129.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.531 . . . . 74.23 110.792 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.615 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -71.9 -167.14 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 64.13 110.917 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.465 ' H ' HG23 ' A' ' 64' ' ' THR . 8.3 t -91.24 170.53 9.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 64.12 110.864 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.714 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.4 m95 -51.07 -60.28 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 71.0 110.91 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -128.02 159.26 35.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.258 -0.428 . . . . 54.31 110.876 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -51.44 -32.8 28.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.872 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -58.57 -44.13 89.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 73.2 110.918 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.4 mt -75.53 -45.5 37.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 62.14 110.96 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.6 -48.52 57.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 75.44 111.14 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -53.54 -48.4 69.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.216 -0.447 . . . . 74.23 110.931 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -65.61 -18.97 65.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.47 . . . . 71.02 110.9 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.8 tp -88.62 -27.1 21.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.103 -0.499 . . . . 73.45 110.936 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.2 mt -90.47 -23.01 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 72.31 111.105 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -92.81 17.32 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 72.24 110.895 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.8 ptm -131.95 -39.89 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 62.34 110.867 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.4 m -80.18 -24.77 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 75.35 111.205 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.708 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.37 -23.14 66.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 65.11 110.929 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.73 -32.14 7.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 55.23 110.946 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -40.93 67.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.41 110.953 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 52' ' ' LEU . 15.8 m-85 -89.43 -12.12 41.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.53 110.923 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.34 11.71 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 63.41 110.861 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.464 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -131.8 141.4 49.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 72.13 110.936 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 19.8 ptt-85 -86.2 140.99 29.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.275 -0.421 . . . . 74.13 110.846 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 52' ' ' LEU . 85.0 t -82.07 126.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.4 111.137 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -142.46 13.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 70.24 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 53' ' ' VAL . 61.7 m-20 -153.75 144.74 22.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 71.45 110.874 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 54' ' ' LEU . 16.5 t -154.31 132.61 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 72.01 111.167 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.506 ' CD1' HG11 ' A' ' 140' ' ' VAL . 46.9 mt -92.58 126.72 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 72.3 111.097 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -102.85 136.32 35.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 51.43 111.066 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -96.22 -44.59 7.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.1 111.265 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -152.46 174.94 13.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.901 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.479 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -95.65 88.9 5.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 44.24 111.061 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -145.95 156.04 43.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 73.01 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.98 -21.72 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 50.52 111.04 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 20.49 7.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 62.22 110.883 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -140.62 -75.72 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -92.99 8.14 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 70.41 111.074 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -36.56 28.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 63.44 112.46 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.03 15.26 51.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 65.41 112.534 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 92' ' ' ILE . 19.1 tt -56.57 -29.98 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 75.34 111.087 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -30.67 62.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 71.23 110.86 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -90.0 -11.81 40.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.282 -0.417 . . . . 71.34 111.166 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.615 HD11 ' HB3' ' A' ' 57' ' ' SER . 17.4 mt -91.01 -28.77 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 60.25 110.971 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -100.03 22.21 11.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 70.22 110.916 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -121.7 -36.51 3.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.32 110.932 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -87.41 -53.94 4.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.088 -0.505 . . . . 73.03 110.894 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.1 38.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 64.52 112.476 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.548 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.4 mp -110.25 124.36 66.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.35 . . . . 74.41 111.132 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.709 ' HE2' HD21 ' A' ' 124' ' ' LEU . 3.4 mtpp -89.79 118.44 29.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 65.04 110.894 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.9 92.05 8.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 50.4 111.113 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.526 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.6 m-70 -66.29 144.03 56.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.55 110.751 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.61 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -178.38 -174.19 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 55.22 110.857 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -94.97 155.37 16.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 74.21 111.144 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.62 -39.98 37.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 74.12 111.16 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.0 -43.45 87.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.934 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.65 ' HA ' HD11 ' A' ' 114' ' ' LEU . 93.5 m -58.77 -21.61 56.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 72.34 111.098 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.43 12.26 37.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 63.21 111.138 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -25.81 9.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 63.13 110.943 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -103.98 -7.61 20.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 70.14 110.961 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.02 64.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.23 111.093 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -21.69 52.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 75.4 110.843 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -31.32 72.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 54.32 110.904 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -90.22 -25.62 20.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.895 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 118.36 25.42 2.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 64.33 112.488 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -102.42 170.6 7.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 74.11 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.54 179.0 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.046 -0.524 . . . . 74.35 110.912 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.5 mp0 -111.34 106.09 57.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.729 . . . . 55.2 110.938 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.72 178.42 4.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.699 2.266 . . . . 73.14 112.361 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HE2' ' A' ' 104' ' ' LYS . 14.0 mt -53.3 -47.44 69.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.915 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.17 27.82 24.51 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.739 -0.743 . . . . 72.31 112.487 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -102.84 31.12 4.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.845 0.355 . . . . 71.3 110.881 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.712 ' CD2' HD21 ' A' ' 133' ' ' LEU . 91.4 mt -113.76 -175.32 2.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 73.4 110.901 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.16 -171.64 3.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.964 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.861 HG22 HG23 ' A' ' 130' ' ' VAL . 53.1 m -50.86 -70.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 73.23 111.222 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.861 HG23 HG22 ' A' ' 129' ' ' THR . 40.1 t -118.58 102.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 71.13 111.12 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -132.25 169.12 16.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 64.12 111.151 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.27 132.84 56.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 75.53 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.712 HD21 ' CD2' ' A' ' 127' ' ' LEU . 50.2 mt -119.41 157.84 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 73.41 110.889 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -142.62 112.31 6.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 62.35 110.908 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -107.65 47.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 70.53 110.835 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.74 92.73 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 72.3 112.469 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.65 13.6 9.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 75.23 110.825 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.436 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.1 tpp -136.48 93.51 2.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.933 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -83.68 132.09 34.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 73.13 110.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.816 HG22 HD21 ' A' ' 158' ' ' LEU . 46.2 t -137.25 117.74 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 72.05 111.176 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -110.16 126.99 54.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 73.45 110.811 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.4 p -83.38 -174.05 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 71.23 111.126 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.588 ' HB3' HG23 ' A' ' 155' ' ' VAL . 33.9 t80 -171.82 133.5 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 74.3 110.877 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.699 ' HB3' HG23 ' A' ' 129' ' ' THR . 81.0 t80 -120.43 88.53 42.62 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.662 0.744 . . . . 74.32 110.937 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 54.2 Cg_endo -69.77 -7.93 22.3 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 72.24 112.333 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.2 -158.25 23.07 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 74.42 112.441 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -90.17 139.34 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 74.42 110.812 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -150.67 -95.56 0.13 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.727 -0.749 . . . . 73.51 112.435 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -70.36 -24.17 62.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 75.13 110.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.3 p -151.7 -175.24 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 75.25 111.111 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.77 -2.34 58.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 60.53 110.841 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.483 ' OD1' HG23 ' A' ' 111' ' ' THR . 12.9 p-10 -140.21 11.45 2.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 42.11 110.906 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.584 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -52.65 141.38 20.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.059 -0.519 . . . . 75.34 110.892 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.67 -178.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 73.05 111.106 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 143' ' ' PHE . 5.8 m -136.77 120.1 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 74.13 111.198 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.703 ' O ' HD12 ' A' ' 164' ' ' LEU . 93.6 t -79.25 133.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.42 111.161 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -118.69 131.34 56.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.987 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.88 HD11 HD21 ' A' ' 46' ' ' LEU . 10.4 mt -112.8 98.83 46.25 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.595 0.712 . . . . 73.33 110.917 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.5 Cg_endo -69.73 -4.26 13.65 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.279 . . . . 73.54 112.336 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -83.08 -23.8 32.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 55.51 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.82 14.05 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.95 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.4 m120 54.21 27.15 7.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 75.43 111.006 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.491 HD13 HD13 ' A' ' 21' ' ' LEU . 96.1 mt -91.98 136.66 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 74.23 111.111 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 156' ' ' VAL . 26.6 tp -121.96 147.75 45.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 64.41 110.992 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.444 HG11 HG11 ' A' ' 55' ' ' VAL . 45.3 t -117.33 76.47 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 71.42 111.078 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.567 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -51.59 -40.77 48.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 71.11 112.556 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 71.6 -162.82 54.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 62.3 112.508 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 78.6 m -51.46 -33.1 29.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.77 0.319 . . . . 73.54 110.777 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.687 HD12 ' NE1' ' A' ' 189' ' ' TRP . 25.4 tp -51.63 -44.56 62.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 52.31 110.945 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.583 HG13 ' HA ' ' A' ' 219' ' ' LEU . 46.1 t -101.08 111.6 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.23 111.061 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.635 ' HG3' HD12 ' A' ' 225' ' ' LEU . 30.9 mmmt -55.31 164.85 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 72.45 110.864 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 2.9 p -114.98 170.33 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.14 110.835 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.3 t -59.89 153.75 20.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.096 -0.502 . . . . 63.11 111.088 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.9 16.88 10.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 51.35 110.817 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 172' ' ' SER . . . -79.61 153.55 29.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.54 111.036 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -116.79 -22.21 8.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 72.22 110.92 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 225' ' ' LEU . 0.6 OUTLIER 179.01 173.36 0.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.83 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.528 HD13 ' CE3' ' A' ' 189' ' ' TRP . 5.7 mt -71.86 -31.72 66.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 72.34 110.933 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 66.39 114.35 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 54.43 112.538 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 59.56 102.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.93 0.395 . . . . 70.21 110.923 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 29.5 m -114.04 13.93 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 74.35 111.163 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.42 88.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 75.12 111.15 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -90.04 10.59 23.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 75.15 110.898 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -126.79 165.0 20.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 31.12 111.073 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -119.73 91.75 3.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.282 -0.417 . . . . 72.51 110.961 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.6 -19.07 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.15 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.78 -20.89 59.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.893 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -116.81 -16.18 10.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 72.22 110.85 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.687 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -55.0 -61.41 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.2 -0.455 . . . . 74.4 110.906 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.739 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.27 -24.64 19.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.858 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -80.72 -31.97 35.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 74.15 111.065 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -74.09 -45.45 49.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 64.43 110.848 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.6 mm -59.11 -47.63 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 75.41 111.087 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -56.33 -28.65 59.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.879 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -77.31 -22.48 51.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.3 110.848 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 192' ' ' SER . 11.0 t -85.37 -10.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 62.03 111.154 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -111.96 -10.28 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 64.41 110.936 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.8 -30.43 11.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 71.52 110.845 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 -45.73 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 64.03 110.835 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -101.41 37.06 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.93 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.61 -48.06 75.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 71.51 110.914 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -61.2 102.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.948 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.746 HG21 HG22 ' A' ' 206' ' ' VAL . 52.3 mt -144.86 126.53 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 72.03 111.139 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.75 -22.71 34.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 65.02 110.908 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.74 125.31 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 63.53 111.083 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.746 HG22 HG21 ' A' ' 203' ' ' ILE . 92.5 t -104.22 137.23 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 71.03 111.051 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.081 HG22 HG12 ' A' ' 213' ' ' VAL . 11.6 t -110.8 108.44 57.86 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.573 0.701 . . . . 63.42 111.146 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 173.33 11.17 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.66 2.24 . . . . 72.53 112.301 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.52 -13.81 74.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.602 -0.809 . . . . 54.2 112.525 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -152.61 147.6 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 72.13 110.785 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 99.47 -113.94 4.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 65.23 112.476 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -156.58 168.6 26.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.827 0.346 . . . . 61.23 110.875 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.081 HG12 HG22 ' A' ' 207' ' ' VAL . 5.0 m -58.34 163.27 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 62.25 111.135 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.99 -104.72 0.2 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 71.12 112.492 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.95 -169.6 2.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.34 . . . . 62.51 110.874 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -59.81 -19.19 49.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 63.21 110.89 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.502 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -56.04 -22.69 36.34 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.74 . . . . 72.42 112.471 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.686 HD12 ' HB ' ' A' ' 206' ' ' VAL . 5.0 mt -72.56 -32.73 66.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 71.45 110.919 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.583 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.7 mp -62.03 -59.98 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 71.44 110.924 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.502 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -59.43 -20.66 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.912 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.26 -37.69 87.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 52.53 110.902 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.629 HG22 ' CD2' ' A' ' 226' ' ' LEU . 7.1 m -58.44 -51.62 69.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 72.31 111.126 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.5 mp -68.77 -16.71 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 71.22 110.972 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.86 -11.07 59.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 74.01 110.864 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.635 HD12 ' HG3' ' A' ' 171' ' ' LYS . 6.3 mt -121.24 -31.76 4.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 61.32 110.991 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.739 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -91.6 8.24 37.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 72.23 110.953 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.03 110.868 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.811 0.339 . . . . 75.03 110.855 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.88 155.94 30.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 74.52 110.926 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -144.7 167.9 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.882 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.35 169.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.1 111.137 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -155.57 129.63 8.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.51 110.858 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -66.99 176.55 2.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 72.1 110.913 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -70.51 -40.77 73.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 60.12 111.19 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.57 -177.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 75.0 111.101 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.02 92.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 70.41 111.191 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.27 119.46 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 65.25 110.894 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -61.87 168.47 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.31 110.861 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.85 -47.9 64.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.804 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.77 -37.75 82.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 74.1 111.079 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.04 12.72 61.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.75 -0.738 . . . . 44.24 112.539 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.409 HG23 ' CB ' ' A' ' 31' ' ' LEU . 23.0 m -80.39 -44.1 19.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 70.53 111.179 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -102.57 116.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 65.43 111.09 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.4 p -123.89 131.75 53.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 61.24 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.758 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -124.16 109.95 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 71.5 111.066 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.2 t -101.01 125.25 47.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.745 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.72 110.93 4.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 64.55 110.899 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.651 HD13 HD13 ' A' ' 163' ' ' ILE . 14.7 mt -65.41 -31.86 73.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 64.21 110.926 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.71 -97.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.879 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.3 OUTLIER -151.47 9.89 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.41 110.897 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.445 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.58 6.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 71.53 110.931 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.2 t -151.09 139.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 70.4 111.138 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.758 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.6 m95 -126.92 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.864 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 43' ' ' GLY . 93.2 t -136.69 96.03 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 51.23 111.213 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -81.27 120.66 25.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.132 -0.485 . . . . 72.21 110.876 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.5 m -115.78 100.99 8.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 61.52 111.205 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.16 121.51 26.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 73.53 110.912 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.754 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -92.29 107.04 18.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 73.54 110.928 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -127.97 1.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 50.33 112.501 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 p -175.17 116.18 0.16 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 73.03 110.858 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.15 41.4 1.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.807 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 64.48 67.96 0.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 73.15 110.859 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.39 -15.57 42.33 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.791 -0.719 . . . . 72.55 112.425 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -121.52 159.15 26.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.373 . . . . 74.02 110.825 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.754 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -98.25 134.29 41.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 42.22 111.136 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.15 79.61 59.04 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.587 0.708 . . . . 64.1 111.007 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 118.24 5.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.264 . . . . 72.13 112.295 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.83 99.89 9.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 72.1 110.871 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -52.56 170.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 71.45 110.812 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.577 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -162.55 -164.01 16.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.416 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 26' ' ' TRP . 14.4 tp -153.04 114.16 4.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 74.12 110.902 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.623 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.8 t -97.28 116.8 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 55.23 111.113 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.596 HD21 HD21 ' A' ' 158' ' ' LEU . 13.5 mt -94.86 120.83 35.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 71.43 110.965 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -91.66 83.21 5.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 75.12 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 138' ' ' MET . 2.5 p -90.77 -178.5 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 72.34 111.126 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.6 p -105.26 -1.15 25.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 40.14 110.777 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.9 -23.14 12.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.57 144.42 4.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 41.41 112.471 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.695 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.7 mt -59.51 154.54 17.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.804 0.335 . . . . 71.32 110.93 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.4 t -145.11 142.94 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 73.42 111.122 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.3 mt -137.51 123.12 19.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.835 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.78 112.72 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 63.52 111.107 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.65 129.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.03 110.94 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.656 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -72.18 -167.41 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.854 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.406 ' H ' HG23 ' A' ' 64' ' ' THR . 8.0 t -92.34 170.27 9.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 63.43 110.853 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.736 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.7 m95 -50.34 -60.26 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.873 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -128.93 160.56 32.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 61.23 110.854 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -52.72 -31.24 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 72.15 110.864 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -59.82 -43.52 94.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 72.24 110.88 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.736 HD12 ' HB2' ' A' ' 59' ' ' TRP . 94.2 mt -75.47 -45.85 36.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 71.0 110.947 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -51.53 -47.11 63.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 73.42 111.169 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -50.98 61.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 63.54 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.37 -19.87 65.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 73.53 110.86 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.6 tp -87.45 -26.16 23.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 62.2 110.871 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.6 mt -90.87 -23.27 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 63.25 111.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.69 16.5 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.882 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.85 -39.75 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 71.33 110.783 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.9 m -80.85 -23.76 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 74.32 111.158 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.703 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.01 -23.43 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.51 110.866 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -106.8 -33.57 7.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.906 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -70.58 -44.12 68.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 61.15 110.783 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.9 m-85 -86.59 -12.8 47.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.413 . . . . 74.13 110.907 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.43 11.75 8.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 53.34 110.89 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.95 141.1 50.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 71.3 110.894 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.41 140.4 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 74.43 110.883 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.703 HG23 ' OE1' ' A' ' 72' ' ' GLU . 86.3 t -81.95 121.39 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 53.52 111.111 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.78 9.65 2.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 63.34 111.108 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 53' ' ' VAL . 65.2 m-20 -148.86 145.02 27.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 74.51 110.87 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 54' ' ' LEU . 20.3 t -154.14 131.47 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 73.13 111.125 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.653 HD13 HG11 ' A' ' 140' ' ' VAL . 5.6 mt -94.66 123.49 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 72.43 111.077 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.7 mm -94.58 150.33 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 64.42 111.119 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 p -109.31 -40.82 4.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 64.11 111.149 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.606 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -159.62 -178.53 7.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 62.41 110.844 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.736 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -98.89 96.87 8.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 64.23 111.186 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -155.72 154.84 32.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 61.52 110.866 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.22 -20.59 28.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.3 111.128 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.92 16.25 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 74.25 110.838 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -136.02 -76.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 74.24 110.832 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.79 8.39 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.11 111.135 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.9 -36.38 33.66 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.698 -0.763 . . . . 73.43 112.476 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.24 16.16 49.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 64.2 112.401 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 92' ' ' ILE . 3.0 tt -58.16 -23.29 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 74.14 111.077 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -30.08 68.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 62.21 110.919 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.5 m -88.97 -19.92 25.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 62.41 111.1 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 57' ' ' SER . 15.0 mt -82.79 -32.44 27.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 74.42 110.892 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -95.15 23.76 5.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -122.13 -41.45 2.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 73.41 110.999 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -83.03 -49.8 9.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.805 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.45 39.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 51.3 112.479 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.551 HD13 ' HA ' ' A' ' 98' ' ' LEU . 3.6 mp -106.69 120.0 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 71.4 111.159 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.61 ' HB3' HD11 ' A' ' 124' ' ' LEU . 6.0 mttm -83.35 118.68 23.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.35 110.92 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.42 92.82 8.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 51.12 111.127 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.537 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.7 m-70 -64.98 143.3 58.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 71.01 110.841 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.583 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -178.49 -179.88 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 64.24 110.908 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.445 HG22 ' C ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -90.99 153.92 19.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.482 . . . . 61.43 111.195 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.68 -35.1 13.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 74.02 111.105 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -69.17 -47.76 64.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 45.1 110.92 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.763 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.9 m -59.42 -18.61 40.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 73.53 111.081 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.57 11.4 39.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 74.1 111.049 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.499 ' CD ' HD22 ' A' ' 110' ' ' LEU . 3.5 pt-20 -113.91 -31.76 6.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 71.25 110.889 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.763 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -93.49 -13.33 27.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.866 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.453 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.049 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -24.95 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 75.4 110.928 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.59 -32.61 70.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 71.13 110.849 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -89.54 -24.82 21.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.897 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.24 23.16 3.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 30.34 112.484 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -98.38 177.59 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 75.03 110.973 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -76.34 178.99 6.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 72.03 110.885 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mp0 -112.58 105.66 55.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.609 0.718 . . . . 64.31 110.867 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.9 Cg_endo -69.82 178.68 4.37 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.709 2.273 . . . . 55.05 112.327 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' A' ' 104' ' ' LYS . 20.1 mt -51.3 -48.34 62.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.52 110.862 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.49 29.09 38.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 74.04 112.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -107.11 41.98 1.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 75.34 110.9 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.583 HD12 ' CA ' ' A' ' 107' ' ' SER . 72.7 mt -124.93 -173.81 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 63.14 110.879 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.408 HE21 ' N ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -147.01 -172.92 4.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 65.22 110.842 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 144' ' ' TYR . 52.6 m -50.58 -71.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.088 -0.505 . . . . 73.23 111.161 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.756 HG23 HG22 ' A' ' 129' ' ' THR . 28.2 t -113.51 94.35 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 71.03 111.18 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.471 HG21 HD22 ' A' ' 127' ' ' LEU . 15.3 t -118.36 167.0 11.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 54.51 111.066 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.51 106.83 10.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 60.12 110.877 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.413 HD21 HD22 ' A' ' 127' ' ' LEU . 28.8 mt -79.72 -173.21 3.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 72.55 110.939 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.04 112.56 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 52.23 110.944 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' HE2' HD11 ' A' ' 83' ' ' ILE . 30.7 m-85 -110.49 74.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 74.34 110.83 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.51 -83.06 0.36 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 53.21 112.505 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -120.29 24.85 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.3 . . . . 64.44 110.893 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.401 ' HB2' HG22 ' A' ' 48' ' ' THR . 51.4 tpp -129.48 142.55 50.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.909 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.32 133.28 56.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 72.01 110.827 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.653 HG11 HD13 ' A' ' 83' ' ' ILE . 19.5 t -144.97 117.68 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 72.22 111.117 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -112.5 126.55 55.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 62.24 110.919 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 p -82.69 -178.19 7.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.183 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.404 ' HB3' HG23 ' A' ' 155' ' ' VAL . 19.4 t80 -166.49 134.06 2.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 73.13 110.929 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.772 ' HB3' HG23 ' A' ' 129' ' ' THR . 10.1 t80 -121.06 89.31 46.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.723 0.773 . . . . 73.32 110.971 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -8.12 22.8 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.706 2.27 . . . . 71.31 112.374 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.53 -157.67 20.38 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 52.03 112.495 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -84.66 137.69 33.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.724 0.297 . . . . 74.12 110.938 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.33 -89.02 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 63.54 112.516 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -75.1 -25.64 58.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.897 0.379 . . . . 75.2 110.843 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.606 HG21 ' HB2' ' A' ' 86' ' ' HIS . 29.9 p -147.32 -162.26 1.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.162 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.523 ' HB3' HD23 ' A' ' 114' ' ' LEU . 61.4 tt0 -84.53 -25.42 28.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 65.43 110.886 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 154' ' ' ILE . 19.2 t70 -135.8 24.05 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 65.53 110.961 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -50.41 128.06 18.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 62.4 110.88 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 152' ' ' ASP . 2.6 pt -135.12 173.0 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 72.51 111.074 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 143' ' ' PHE . 12.8 m -124.42 150.0 28.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.41 111.076 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.87 111.77 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.204 -0.453 . . . . 73.5 111.15 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -101.28 132.83 46.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.596 HD21 HD21 ' A' ' 46' ' ' LEU . 6.3 mp -112.22 97.64 39.95 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 72.42 110.91 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.81 -4.86 14.91 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.619 2.212 . . . . 34.54 112.373 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.55 -26.56 29.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 72.44 110.958 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.53 19.14 2.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 71.3 111.005 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 50.51 29.28 3.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.524 . . . . 62.41 110.941 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.651 HD13 HD13 ' A' ' 21' ' ' LEU . 80.2 mt -91.64 120.01 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.117 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.576 HD23 HG22 ' A' ' 206' ' ' VAL . 34.3 tp -104.53 147.15 27.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 55.53 110.882 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.53 79.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 52.43 111.136 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.84 -49.81 46.46 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.734 -0.745 . . . . 54.4 112.456 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.32 -166.29 53.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 44.14 112.436 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -35.38 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.863 0.363 . . . . 75.2 110.838 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.63 HD12 ' NE1' ' A' ' 189' ' ' TRP . 23.5 tp -51.59 -52.19 49.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 63.44 110.967 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 218' ' ' LEU . 21.2 t -84.02 109.44 17.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 73.31 111.161 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.72 ' HG2' HG23 ' A' ' 222' ' ' THR . 1.7 mmpt? -51.86 148.12 6.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.872 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.89 153.97 17.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 54.04 110.872 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.8 t -51.23 -28.95 12.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 71.12 111.08 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 27.6 m -93.49 41.39 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 73.03 110.88 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -137.28 150.95 48.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.51 . . . . 64.31 111.108 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.561 ' HA ' HD22 ' A' ' 225' ' ' LEU . 10.6 tttp -130.29 10.73 5.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 64.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.53 156.86 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.867 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.809 HD11 ' HB2' ' A' ' 226' ' ' LEU . 7.8 mt -67.71 -36.9 81.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 75.24 110.957 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 91.97 -137.39 13.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.753 -0.736 . . . . 63.11 112.58 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -67.34 110.75 3.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.366 . . . . 63.42 110.915 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.4 m -109.7 28.76 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 71.14 111.186 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.22 -30.01 70.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 75.0 111.081 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -116.8 22.15 12.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 74.12 110.827 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.66 155.3 46.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 74.05 111.057 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.24 87.06 2.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.947 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.2 t -60.78 -18.18 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 53.01 111.141 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -74.28 -28.09 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 71.55 110.814 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -109.59 -12.34 14.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 40.41 110.796 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.759 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.7 t90 -53.28 -62.0 1.93 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.857 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.767 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -54.17 -24.09 16.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.831 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.6 m -82.39 -30.93 29.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 71.53 111.141 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -43.27 58.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 71.2 110.782 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.577 HG21 ' O ' ' A' ' 219' ' ' LEU . 28.9 mm -62.95 -43.0 98.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 73.52 111.172 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.44 -22.5 54.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.04 110.907 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -82.74 -22.4 34.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 53.12 110.94 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.14 -9.77 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 55.24 111.198 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.434 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.73 -12.49 13.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 62.44 110.933 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.404 ' N ' HD12 ' A' ' 197' ' ' LEU . 12.6 ptpt -100.51 -31.22 11.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 64.34 110.94 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.63 -49.28 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 73.32 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.416 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -95.81 60.73 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 75.34 110.926 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -71.28 -64.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.478 . . . . 74.03 110.819 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -51.49 104.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 73.14 110.916 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.677 HG21 ' CG2' ' A' ' 206' ' ' VAL . 89.9 mt -142.77 124.8 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.072 -0.513 . . . . 53.51 111.183 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -34.85 50.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.999 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.28 129.91 1.38 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 71.43 111.085 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 218' ' ' LEU . 95.5 t -103.52 133.58 47.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 73.23 111.181 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 213' ' ' VAL . 9.5 t -109.58 106.92 59.06 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.604 0.716 . . . . 72.42 111.029 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 54.1 Cg_endo -69.66 -168.61 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.679 2.253 . . . . 72.3 112.361 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -91.84 -13.43 57.94 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.68 -0.772 . . . . 62.42 112.574 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -152.32 138.52 18.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.853 0.358 . . . . 61.31 110.829 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.94 -106.41 2.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.669 -0.777 . . . . 74.35 112.539 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -167.47 162.12 14.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 71.24 110.923 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 207' ' ' VAL . 5.5 m -52.74 161.73 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 74.12 111.202 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.66 -98.35 0.14 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 64.42 112.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -169.01 -168.86 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.868 0.366 . . . . 75.11 110.937 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.464 ' HA ' HD23 ' A' ' 219' ' ' LEU . 15.7 pttm -61.69 -17.36 55.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.4 110.889 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.496 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.36 -19.21 39.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.751 -0.738 . . . . 62.22 112.463 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.734 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.9 mt -72.04 -32.92 67.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.859 0.361 . . . . 72.03 110.871 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.577 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.4 mm? -63.18 -58.52 6.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 62.32 110.986 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.496 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -61.02 -18.16 56.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.45 110.913 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -65.15 -51.42 61.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.861 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.72 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.7 m -52.22 -49.91 63.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 72.25 111.196 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.621 HD23 ' OG ' ' A' ' 190' ' ' SER . 0.9 OUTLIER -60.42 -18.31 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 51.14 110.932 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -92.1 -2.67 56.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 63.12 110.816 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 176' ' ' LYS . 6.9 mt -126.25 -5.98 6.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 72.42 110.962 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.809 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -119.92 2.46 11.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 63.32 110.913 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 53.31 110.862 179.85 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.875 0.369 . . . . 73.34 110.871 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -117.48 85.12 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 52.51 110.895 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -126.19 93.48 3.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 64.34 110.895 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.74 147.37 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.53 111.135 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -151.04 137.97 19.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 72.14 110.987 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -114.14 172.43 7.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 72.53 110.858 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 m -73.5 -53.65 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 73.32 111.157 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.0 m -58.47 -176.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 71.33 111.104 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.9 mt -136.2 91.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 73.51 111.177 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 116.39 30.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.909 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -59.82 168.15 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.889 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -51.7 -47.9 63.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 65.12 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.8 p -60.68 -37.68 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.172 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.77 13.15 61.4 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.674 -0.774 . . . . 54.22 112.505 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -80.36 -43.96 20.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 75.15 111.108 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -102.95 116.54 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 71.51 111.135 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 71.35 110.851 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.73 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -121.87 112.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 54.24 111.087 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.412 ' HA ' HG12 ' A' ' 8' ' ' VAL . 13.7 t -98.82 125.66 44.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 41.13 110.82 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -68.6 110.57 4.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 73.14 110.94 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.073 HD21 HG21 ' A' ' 213' ' ' VAL . 14.2 mt -63.83 -31.35 72.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 62.42 110.971 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -153.48 -96.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 75.1 110.889 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.44 9.66 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.929 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.448 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.77 7.74 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 61.4 110.883 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 t -150.74 143.27 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 74.15 111.094 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.73 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.5 m95 -131.02 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 55.34 110.959 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 43' ' ' GLY . 98.7 t -135.43 89.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 64.44 111.19 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -72.27 121.66 19.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.871 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.4 m -119.62 104.67 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 62.44 111.143 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -87.59 125.78 34.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.944 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.803 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -90.85 110.39 21.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.878 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.53 -125.62 1.34 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.702 -0.761 . . . . 72.13 112.468 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.2 p -175.07 116.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.949 0.404 . . . . 74.01 110.835 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.49 43.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 71.21 110.826 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 63.73 69.34 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 60.41 110.8 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.43 -17.37 40.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 61.54 112.528 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -118.27 -176.16 3.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.895 0.378 . . . . 74.12 110.922 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.803 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -110.6 145.48 37.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 54.11 111.131 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.72 79.5 58.5 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.614 0.721 . . . . 72.3 111.177 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 117.87 5.34 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.683 2.255 . . . . 72.11 112.31 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.7 p -109.67 97.63 7.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 35.41 110.811 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -63.22 164.62 8.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 65.54 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -153.99 -144.81 4.0 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.69 -0.767 . . . . 74.25 112.466 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.65 HD21 HD11 ' A' ' 158' ' ' LEU . 16.4 tp -158.81 120.12 3.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 71.2 110.862 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.658 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -105.29 122.29 58.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.168 -0.469 . . . . 71.41 111.126 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 16.0 mt -102.14 121.01 41.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 73.02 110.944 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.63 85.08 7.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 73.45 110.831 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.14 173.01 8.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 62.1 111.149 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.25 4.26 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 73.42 110.817 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 -20.58 9.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 53.34 110.91 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.31 138.36 2.39 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 34.22 112.5 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.691 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.9 mt -54.63 157.63 2.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.368 . . . . 63.34 110.896 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 19.0 t -145.32 141.0 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 72.54 111.112 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.682 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.1 mt -137.61 124.16 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.54 110.945 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.649 HG12 ' OD1' ' A' ' 56' ' ' ASP . 53.6 t -68.57 107.66 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 63.24 111.034 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.649 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.5 m-20 71.51 134.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 60.34 110.927 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.587 ' CB ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -72.15 -165.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 62.24 110.806 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 t -92.37 175.01 7.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 74.41 110.921 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.734 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.0 m95 -51.27 -60.41 3.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.918 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -132.55 161.71 33.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.24 110.911 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -51.77 -33.47 35.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 54.1 110.854 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -59.03 -33.76 71.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.897 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.4 mt -89.25 -45.73 9.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.03 110.903 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.409 HG21 HD21 ' A' ' 98' ' ' LEU . 1.1 m -50.8 -47.45 59.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 73.23 111.147 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -54.45 -47.48 72.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 71.3 110.872 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.31 -19.4 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.863 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.5 tp -88.4 -27.96 21.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 71.51 110.881 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.5 mt -89.41 -22.99 6.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.35 111.12 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.88 16.84 11.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptm -131.01 -39.74 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 73.42 110.899 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 67' ' ' LEU . 35.1 m -80.95 -24.43 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 61.34 111.071 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.656 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -65.85 -21.86 66.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.861 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -109.49 -32.31 7.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.898 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -72.18 -41.95 66.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.03 110.826 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.583 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.5 m-85 -88.05 -12.35 44.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.855 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.37 13.73 8.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 71.54 110.983 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.15 140.14 46.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 75.33 110.863 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -86.1 140.45 30.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.885 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 52' ' ' LEU . 99.4 t -80.07 122.3 35.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.12 111.11 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -136.67 8.16 3.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 65.24 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -151.28 136.08 17.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.277 -0.42 . . . . 71.23 110.927 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 54' ' ' LEU . 15.0 t -147.68 127.75 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 72.22 111.09 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 140' ' ' VAL . 27.4 mt -93.49 122.8 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 73.21 111.132 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.447 HG21 HG22 ' A' ' 92' ' ' ILE . 20.3 mm -94.33 140.18 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 52.1 111.144 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.48 HG23 ' OD2' ' A' ' 56' ' ' ASP . 65.9 p -86.86 -55.83 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 63.13 111.12 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.586 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.4 p-80 -152.15 -175.2 5.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.419 . . . . 64.02 110.96 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.861 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -89.21 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 64.42 111.054 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.72 149.84 22.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.3 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.45 -19.53 24.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 75.14 111.143 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.5 9.76 25.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 65.31 110.946 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -131.13 -77.27 0.52 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.81 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.447 HG22 HG21 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -88.71 8.14 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 63.3 111.048 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.39 -41.5 40.66 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 74.55 112.438 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.57 14.46 56.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.746 . . . . 32.51 112.498 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.7 tt -51.7 -29.92 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.904 0.383 . . . . 74.5 111.139 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.43 -35.56 63.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 73.3 110.87 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -79.94 -23.99 41.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 63.24 111.161 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HA ' HD13 ' A' ' 103' ' ' ILE . 9.2 mt -82.93 -28.25 30.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.989 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -94.04 19.47 9.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.956 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -121.71 -45.51 2.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 71.13 110.846 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -74.35 -52.39 12.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.504 . . . . 75.12 110.856 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.8 42.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.683 -0.77 . . . . 62.11 112.463 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.609 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.6 mp -106.31 128.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 70.34 111.23 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.639 ' HB3' HD11 ' A' ' 124' ' ' LEU . 5.0 mtmm -84.19 105.86 15.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.231 -0.441 . . . . 72.32 110.937 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.02 92.83 8.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 73.12 111.205 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.669 ' HA ' HD12 ' A' ' 124' ' ' LEU . 48.1 m-70 -69.65 146.14 51.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 73.23 110.886 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.62 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -174.26 179.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 60.45 110.901 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.45 154.27 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 64.12 111.07 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -41.11 40.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 52.5 111.081 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -41.18 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.91 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.706 ' HA ' HD11 ' A' ' 114' ' ' LEU . 99.8 m -58.44 -20.69 46.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 73.02 111.123 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.552 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.56 8.44 41.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 74.04 111.055 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -107.81 -31.56 7.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 73.52 110.838 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.861 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -96.09 -12.83 24.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 71.43 110.967 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.402 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -67.98 -37.14 81.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 64.12 111.104 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.47 -24.45 59.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.927 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -32.52 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 73.42 110.898 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -90.29 -22.06 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 60.04 110.951 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.53 25.51 4.59 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.829 -0.7 . . . . 60.25 112.434 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -98.59 175.68 5.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.899 0.381 . . . . 74.13 110.935 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.83 162.17 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.951 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -94.89 108.4 37.67 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.57 0.7 . . . . 70.03 110.916 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.552 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.71 -177.42 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.282 . . . . 60.05 112.363 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 106' ' ' HIS . 81.8 mt -54.21 -54.46 39.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 62.22 110.878 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.52 73.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 62.11 112.428 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -99.03 33.54 2.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.844 0.354 . . . . 74.44 110.848 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 107' ' ' SER . 86.7 mt -116.65 -174.6 2.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 73.44 110.923 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 -170.45 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 53.1 110.871 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.845 HG22 HG23 ' A' ' 130' ' ' VAL . 48.5 m -50.49 -70.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.43 111.21 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.845 HG23 HG22 ' A' ' 129' ' ' THR . 38.2 t -116.22 93.56 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 70.55 111.1 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.688 HG22 ' OG1' ' A' ' 142' ' ' THR . 14.5 t -113.05 164.97 12.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 63.41 111.116 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.18 102.96 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 65.43 110.907 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 140' ' ' VAL . 28.4 mt -76.02 -173.06 2.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 73.32 110.918 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -171.31 110.23 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.843 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -117.92 -167.57 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 60.5 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -57.63 95.42 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.765 -0.731 . . . . 73.32 112.461 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 53.75 25.92 5.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.391 . . . . 42.54 110.912 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.4 tpp -129.19 140.03 51.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.47 135.91 54.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.53 110.912 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' A' ' 83' ' ' ILE . 6.1 t -143.72 116.88 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 61.33 111.179 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -112.88 126.58 55.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 63.2 110.893 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.688 ' OG1' HG22 ' A' ' 131' ' ' THR . 18.8 p -83.39 174.27 10.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.127 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.431 ' HB3' HG23 ' A' ' 155' ' ' VAL . 20.8 t80 -158.78 137.61 11.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.35 110.937 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.657 ' HB3' HG23 ' A' ' 129' ' ' THR . 90.5 t80 -127.82 89.31 51.02 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.738 0.78 . . . . 72.33 110.985 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.2 Cg_endo -69.69 -7.61 21.47 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.671 2.247 . . . . 70.11 112.374 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.03 -150.17 19.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 40.42 112.484 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -95.24 141.1 29.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.821 0.343 . . . . 63.43 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.424 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -157.43 -90.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.751 -0.737 . . . . 62.53 112.535 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -74.76 -23.05 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.332 . . . . 73.41 110.759 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 86' ' ' HIS . 69.2 p -151.23 -171.39 3.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 60.03 111.177 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.546 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.1 tt0 -84.94 -3.32 58.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 75.12 110.893 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 154' ' ' ILE . 19.4 t0 -150.18 19.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 53.44 110.944 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.58 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.4 OUTLIER -50.57 130.72 24.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 71.11 110.887 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 152' ' ' ASP . 3.2 pt -135.17 175.48 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 42.53 111.138 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -132.87 123.93 49.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 65.05 111.03 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.5 t -75.96 119.04 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.129 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -107.79 139.12 42.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.65 HD11 HD21 ' A' ' 44' ' ' LEU . 87.7 mt -119.79 99.73 49.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.63 0.728 . . . . 73.04 110.862 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.1 Cg_endo -69.79 -4.79 14.75 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.688 2.259 . . . . 52.21 112.289 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -84.78 -30.38 24.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.947 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -131.49 11.21 4.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 70.41 110.923 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.5 m120 55.05 26.0 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.846 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.558 HD13 HD13 ' A' ' 21' ' ' LEU . 86.8 mt -90.95 143.83 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.129 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.557 HD22 HD13 ' A' ' 203' ' ' ILE . 15.2 tp -125.54 145.43 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 62.33 110.916 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.459 HG11 HG11 ' A' ' 55' ' ' VAL . 94.9 t -108.17 81.28 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.167 -0.47 . . . . 61.22 111.219 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.44 -31.42 28.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.703 -0.76 . . . . 75.45 112.543 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 56.69 -168.63 3.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.775 -0.726 . . . . 33.01 112.453 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -29.68 20.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.336 . . . . 72.52 110.842 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.58 HD13 ' OD1' ' A' ' 153' ' ' ASN . 24.8 tp -55.65 -55.14 35.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 75.1 110.946 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.513 HG13 ' HA ' ' A' ' 219' ' ' LEU . 19.9 t -87.55 107.59 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 75.1 111.13 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -52.15 170.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.53 110.904 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -120.31 158.63 26.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 44.41 110.883 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 13.7 t -50.03 158.35 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.081 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.01 10.93 7.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 75.12 110.817 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.581 ' HB3' HD11 ' A' ' 225' ' ' LEU . . . -85.74 146.07 26.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 61.31 111.116 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.517 ' C ' HD22 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -118.27 -16.81 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 63.32 110.862 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.68 158.54 7.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 63.22 110.919 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' A' ' 226' ' ' LEU . 9.7 mt -65.66 -31.97 73.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.182 -0.463 . . . . 72.21 110.978 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 100.05 -120.39 6.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 50.35 112.583 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.51 132.97 33.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 72.53 110.869 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.498 HG11 HG22 ' A' ' 186' ' ' VAL . 16.7 m -129.23 24.57 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.468 . . . . 64.44 111.153 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.04 80.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.106 -0.497 . . . . 74.23 111.045 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -112.84 25.17 11.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 71.05 110.875 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -130.12 164.96 23.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 74.13 111.108 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.35 92.39 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 74.23 110.982 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.498 HG22 HG11 ' A' ' 181' ' ' VAL . 11.0 t -63.46 -22.92 32.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 44.25 111.134 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -71.65 -31.3 66.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 71.03 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.29 -13.05 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.03 110.916 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.501 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.4 t90 -55.09 -62.56 1.58 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 73.4 110.918 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.761 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.88 -24.51 16.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 61.35 110.829 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 57.7 m -80.39 -32.23 37.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 72.2 111.1 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -42.74 58.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.833 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.523 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.1 mm -62.91 -44.39 99.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.42 111.134 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.492 ' HG2' HD11 ' A' ' 223' ' ' LEU . 2.1 mm-40 -58.23 -22.89 53.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 41.05 110.807 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -82.45 -22.31 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 71.12 110.895 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 196' ' ' VAL . 16.1 t -87.19 -8.89 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 75.41 111.064 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -113.5 -6.79 13.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 71.4 110.946 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.6 -31.19 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 72.13 110.897 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -104.22 -55.95 2.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 75.35 110.871 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -94.99 38.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 75.34 110.827 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -55.97 -47.71 77.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.889 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -59.97 101.68 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.03 110.951 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.743 HG21 HG22 ' A' ' 206' ' ' VAL . 40.1 mt -143.65 127.54 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 63.33 111.161 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.01 -23.13 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 62.44 110.934 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.722 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -168.04 132.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.13 111.073 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.749 ' HB ' HD12 ' A' ' 218' ' ' LEU . 59.0 t -114.79 132.37 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 51.43 111.163 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.046 HG22 HG22 ' A' ' 213' ' ' VAL . 9.7 t -110.35 109.33 58.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 62.44 111.111 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.8 Cg_endo -69.75 178.02 4.98 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.658 2.239 . . . . 42.02 112.381 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.51 -18.86 74.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 71.21 112.486 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -152.83 141.67 21.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 74.54 110.879 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.49 -117.48 4.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.692 -0.766 . . . . 70.15 112.474 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -152.25 174.07 14.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 72.53 110.918 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.073 HG21 HD21 ' A' ' 21' ' ' LEU . 5.4 t -69.31 149.98 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.494 . . . . 50.31 111.129 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -145.81 -101.47 0.31 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.742 -0.742 . . . . 72.13 112.515 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.25 -169.0 1.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 71.0 110.823 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -17.83 54.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 71.51 110.872 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.473 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.37 -20.11 43.14 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.772 -0.727 . . . . 44.11 112.41 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.749 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.2 mt -73.48 -30.07 62.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 74.1 110.921 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.523 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.866 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.473 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.4 OUTLIER -59.12 -22.5 60.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.901 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.24 -44.67 95.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 70.12 110.826 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.698 HG22 HD23 ' A' ' 226' ' ' LEU . 11.5 m -56.48 -56.62 18.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 54.34 111.003 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' A' ' 194' ' ' GLU . 1.0 OUTLIER -52.82 -28.86 24.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.432 . . . . 72.31 110.929 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -32.52 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.92 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 175' ' ' ALA . 12.9 mt -88.39 -18.18 28.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.849 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.761 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.3 OUTLIER -114.94 18.84 16.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.91 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 74.44 110.933 179.762 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.737 0.303 . . . . 61.32 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -116.2 89.52 3.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 54.22 110.952 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? 62.48 164.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 62.45 110.95 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.62 159.62 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 62.54 111.091 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.11 120.01 23.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 75.22 110.919 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -123.93 -171.07 2.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.071 -0.513 . . . . 75.52 110.926 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -115.66 -68.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 75.14 111.128 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -50.03 146.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 51.33 111.147 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.3 mt -110.73 98.41 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 44.41 111.166 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -118.17 115.39 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 73.23 110.879 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -60.57 166.41 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 71.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -51.45 -48.43 62.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 74.21 110.923 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 p -62.57 -36.97 84.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 62.44 111.118 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.18 13.9 63.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 34.31 112.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 m -78.84 -45.4 20.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 62.23 111.197 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.554 HG21 HD13 ' A' ' 67' ' ' LEU . 39.6 mt -103.85 112.36 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 63.02 111.129 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 p -118.04 133.95 55.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 52.21 110.814 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.791 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -125.51 112.24 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 54.35 111.162 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -98.46 125.57 43.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 73.0 110.864 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -69.34 109.94 4.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 75.32 110.966 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.592 HD21 HG11 ' A' ' 213' ' ' VAL . 16.8 mt -63.51 -32.69 74.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.94 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.457 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -152.58 -96.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 72.52 110.884 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.457 ' N ' HD22 ' A' ' 22' ' ' ASN . 10.0 mttp -150.24 9.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.873 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.75 8.17 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.861 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -150.89 141.82 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 70.32 111.086 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.791 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.9 m95 -130.21 -176.8 4.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 71.22 110.916 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.475 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.3 t -134.69 90.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 72.12 111.215 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -73.79 122.17 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 72.13 110.838 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.5 m -119.89 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.097 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.99 125.34 33.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 73.33 110.812 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.755 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -87.37 110.62 20.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 71.41 110.949 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.17 -146.19 7.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.773 . . . . 71.35 112.478 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.81 120.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 73.21 110.826 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -145.22 136.34 24.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.923 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 50.58 27.71 3.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.41 110.912 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.4 42.11 23.7 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.783 -0.722 . . . . 51.1 112.483 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -147.65 130.26 15.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.371 . . . . 64.01 110.872 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.755 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -59.13 149.55 27.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 64.43 111.108 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.44 79.91 19.91 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.584 0.707 . . . . 64.45 111.149 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 117.67 5.23 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.736 2.291 . . . . 73.44 112.362 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.9 p -109.96 97.08 6.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 71.35 110.892 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -59.37 165.36 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 73.24 110.859 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -156.13 -148.89 5.19 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.712 -0.756 . . . . 62.45 112.437 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 158' ' ' LEU . 15.3 tp -158.49 118.34 3.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.353 . . . . 74.01 110.909 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.671 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -103.16 122.31 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.084 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.802 HD21 HD11 ' A' ' 158' ' ' LEU . 14.4 mt -100.77 120.57 40.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.42 110.907 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -90.52 84.7 5.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.82 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -97.52 -175.32 3.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 75.33 111.194 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.4 -21.97 13.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 72.11 110.878 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -83.99 -15.73 46.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 60.14 110.944 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.4 150.25 5.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.815 -0.707 . . . . 51.44 112.539 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.714 ' HB3' HG22 ' A' ' 79' ' ' VAL . 2.0 mt -61.75 156.94 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 74.23 110.948 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 46' ' ' LEU . 16.8 t -145.48 141.96 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 54.54 111.163 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.675 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.1 mt -137.87 124.62 21.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 73.13 110.895 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.647 HG12 ' OD1' ' A' ' 56' ' ' ASP . 54.7 t -67.59 106.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 72.15 111.162 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.647 ' OD1' HG12 ' A' ' 55' ' ' VAL . 1.4 m-20 70.81 131.65 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.086 -0.506 . . . . 55.3 110.893 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.638 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -69.41 -164.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 51.2 110.87 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -90.38 -179.85 5.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.059 -0.519 . . . . 61.1 110.876 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.726 ' HB2' HD12 ' A' ' 63' ' ' LEU . 96.7 m95 -57.86 -51.54 69.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.483 . . . . 74.23 110.937 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -139.69 161.81 36.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 60.43 110.77 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -52.04 -32.62 35.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 75.24 110.818 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -59.86 -42.53 93.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 72.43 110.897 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.5 mt -80.01 -46.89 15.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.192 -0.458 . . . . 54.35 110.898 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.12 -45.74 53.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 63.5 111.121 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -54.78 -48.39 72.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 72.43 110.848 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.49 -19.82 66.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.945 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.7 tp -88.2 -27.04 22.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 72.51 110.872 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -90.59 -23.03 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.14 111.181 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.16 15.0 14.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.496 . . . . 74.32 110.953 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.7 ptm -129.83 -39.72 1.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 62.14 110.889 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.1 m -80.45 -22.76 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.14 111.153 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.667 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.42 -21.93 65.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 74.22 110.822 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -109.2 -32.37 7.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.92 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -37.64 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 75.41 110.837 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.547 ' HB2' HD11 ' A' ' 52' ' ' LEU . 12.6 m-85 -92.58 -11.62 33.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 74.34 110.879 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.36 11.71 8.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.41 110.883 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -132.25 141.0 48.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 62.52 110.898 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -87.46 140.56 29.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 63.5 110.93 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' A' ' 52' ' ' LEU . 97.3 t -80.71 124.7 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 73.54 111.117 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -138.98 10.14 2.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.44 . . . . 73.43 111.08 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -153.3 135.61 14.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 75.43 110.836 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 54' ' ' LEU . 17.2 t -148.02 125.55 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 71.43 111.13 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.574 HD13 HG11 ' A' ' 140' ' ' VAL . 27.5 mt -91.28 124.59 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 72.34 111.097 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.486 HG21 HG22 ' A' ' 92' ' ' ILE . 18.6 mm -95.99 138.71 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 74.04 111.154 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.6 p -84.45 -49.13 8.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 72.44 111.176 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.5 p-80 -159.71 -175.37 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 60.01 110.932 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -87.58 98.36 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 64.34 111.071 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.32 149.61 24.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.33 110.857 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.93 -19.46 30.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 72.52 111.055 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.04 10.04 28.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.882 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 27.8 mmt180 -129.83 -77.37 0.54 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 64.44 110.91 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.486 HG22 HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -88.88 8.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 53.55 111.102 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.47 -41.75 41.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.703 -0.761 . . . . 65.04 112.494 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.9 12.71 62.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.688 -0.768 . . . . 71.43 112.374 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.8 tt -51.52 -28.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.832 0.348 . . . . 54.25 111.132 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -38.26 64.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 61.45 110.834 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.2 m -79.86 -27.5 40.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.142 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.638 HD11 ' OG ' ' A' ' 57' ' ' SER . 10.8 mt -75.05 -30.74 61.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 72.54 110.9 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -92.51 16.26 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 72.32 110.859 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -119.48 -48.23 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.44 110.816 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.5 mtt-85 -72.73 -56.13 5.73 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.243 -0.435 . . . . 62.32 110.855 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.95 42.63 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.807 -0.711 . . . . 55.04 112.447 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.8 mp -105.64 120.33 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.429 . . . . 74.34 111.17 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 mtmm -78.1 109.76 12.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 51.33 110.911 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.63 101.25 13.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 72.34 111.054 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.569 ' HA ' HD12 ' A' ' 124' ' ' LEU . 40.4 m-70 -79.61 146.44 32.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 54.31 110.91 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.644 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.2 OUTLIER -176.64 -176.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.881 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 154.47 20.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 50.3 111.14 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.77 -40.65 55.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 72.41 111.068 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -67.95 -40.72 83.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.94 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.769 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.7 m -58.49 -28.53 65.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 72.33 111.133 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.58 2.55 52.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 63.32 111.095 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.37 -59.23 1.74 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.11 110.893 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.39 -13.14 60.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.956 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -64.9 -43.43 92.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 43.11 111.072 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -26.3 63.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 74.42 110.895 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -55.2 -35.96 65.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 74.3 110.852 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -89.65 -20.85 23.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 72.45 110.872 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 112.85 21.75 5.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 73.25 112.401 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -94.65 170.46 9.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 74.52 110.883 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -70.83 -176.1 1.26 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 72.05 110.867 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -117.23 103.92 50.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.655 0.741 . . . . 74.35 110.923 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.7 Cg_endo -69.8 -171.69 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.717 2.278 . . . . 63.24 112.391 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 106' ' ' HIS . 96.0 mt -59.39 -54.66 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.389 . . . . 62.3 110.959 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.48 24.18 63.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.821 -0.704 . . . . 61.54 112.4 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.41 24.62 6.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 75.21 110.944 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.659 ' CD2' HD21 ' A' ' 133' ' ' LEU . 91.3 mt -107.09 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 65.35 110.935 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.33 -170.28 3.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 54.22 110.885 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.948 HG22 HG23 ' A' ' 130' ' ' VAL . 43.8 m -49.93 -70.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 70.54 111.154 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.948 HG23 HG22 ' A' ' 129' ' ' THR . 42.4 t -120.31 110.25 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.41 111.123 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.4 t -139.77 172.47 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 71.45 111.157 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 71.31 110.914 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.659 HD21 ' CD2' ' A' ' 127' ' ' LEU . 52.4 mt -115.34 167.35 10.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 73.3 110.898 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -147.64 137.09 22.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 71.03 110.93 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.504 ' HE2' HD11 ' A' ' 83' ' ' ILE . 36.9 m-85 -134.19 40.47 3.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.898 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.31 93.14 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 51.03 112.4 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.38 14.12 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.336 . . . . 65.31 110.877 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.5 tpp -138.39 100.9 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 64.42 110.874 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -90.69 137.84 32.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.42 110.781 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 83' ' ' ILE . 57.8 t -139.67 117.42 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 71.35 111.099 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -110.96 129.17 55.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 74.22 110.942 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.8 p -85.54 -179.44 6.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 75.14 111.161 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.445 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.6 t80 -164.39 133.6 3.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.42 110.883 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.641 ' HB3' HG23 ' A' ' 129' ' ' THR . 88.4 t80 -123.96 88.44 52.42 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.796 0.808 . . . . 75.01 110.95 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.82 -7.76 21.9 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.569 2.179 . . . . 75.23 112.352 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.92 -144.88 16.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.802 -0.713 . . . . 74.0 112.504 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -101.5 141.64 34.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.874 0.369 . . . . 72.31 110.901 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -156.45 -90.99 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.705 -0.759 . . . . 71.13 112.475 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -74.78 -23.43 58.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.399 . . . . 73.3 110.858 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.478 HG21 ' HB2' ' A' ' 86' ' ' HIS . 65.5 p -150.57 -169.36 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 52.02 111.153 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.627 ' HB3' HD23 ' A' ' 114' ' ' LEU . 2.7 tt0 -85.81 -12.94 49.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 72.52 110.871 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 154' ' ' ILE . 15.3 t0 -138.61 20.93 2.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 63.1 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -50.77 130.38 24.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.3 110.897 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 152' ' ' ASP . 6.6 pt -137.19 169.04 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 71.55 111.125 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.7 m -127.32 122.52 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 45.32 111.176 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.476 ' O ' HD12 ' A' ' 164' ' ' LEU . 80.5 t -75.72 131.76 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 73.03 111.148 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -117.54 130.07 56.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 65.51 110.826 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.802 HD11 HD21 ' A' ' 46' ' ' LEU . 9.8 mt -110.68 98.64 38.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 60.22 110.909 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.9 Cg_endo -69.75 -4.42 13.99 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.659 2.24 . . . . 60.13 112.336 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -83.21 -23.64 32.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 75.44 110.832 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -144.0 14.15 1.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.179 -0.464 . . . . 63.54 110.941 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.9 m120 54.26 26.79 7.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 74.51 110.844 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.547 HD13 HD13 ' A' ' 21' ' ' LEU . 97.4 mt -91.9 128.79 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 73.53 111.089 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.476 HD12 ' O ' ' A' ' 156' ' ' VAL . 17.6 tp -113.49 145.92 40.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.887 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.554 HG11 HG11 ' A' ' 55' ' ' VAL . 21.4 t -109.62 83.64 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 71.21 111.175 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.51 -34.84 35.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.617 -0.801 . . . . 62.25 112.58 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.33 -167.92 26.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 61.53 112.531 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -29.65 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 63.15 110.813 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.632 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.8 tp -54.84 -61.82 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.124 -0.489 . . . . 55.43 110.933 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.553 HG13 ' HA ' ' A' ' 219' ' ' LEU . 47.2 t -78.33 110.23 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 55.45 111.168 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.742 ' HG2' HG23 ' A' ' 222' ' ' THR . 19.5 mmmt -51.8 169.02 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.941 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -116.53 146.4 42.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 73.21 110.857 -179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.04 156.68 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 75.52 111.245 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 t 70.29 11.08 7.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 74.04 110.831 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 172' ' ' SER . . . -82.85 147.68 28.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 74.13 111.187 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -119.12 -12.22 9.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 53.32 110.821 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.93 155.82 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 74.12 110.875 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.661 HD13 ' CZ3' ' A' ' 189' ' ' TRP . 11.2 mt -62.22 -45.23 94.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 70.41 110.912 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.35 119.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.842 -0.694 . . . . 60.54 112.448 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.08 104.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 72.31 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.412 HG11 ' CG2' ' A' ' 186' ' ' VAL . 24.9 m -131.97 27.53 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 51.43 111.08 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -60.47 -49.26 78.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 64.25 111.055 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.5 25.56 6.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.266 -0.425 . . . . 71.54 110.845 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.2 152.24 51.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 74.32 111.067 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -106.74 86.76 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 72.22 110.911 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.412 ' CG2' HG11 ' A' ' 181' ' ' VAL . 21.4 t -59.7 -19.64 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 73.33 111.127 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -73.3 -31.21 63.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 65.21 110.886 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -104.84 -11.62 16.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 72.43 110.953 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.661 ' CZ3' HD13 ' A' ' 178' ' ' LEU . 2.7 t90 -55.0 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 73.3 110.846 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.703 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.84 -24.71 16.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 33.25 110.865 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -81.08 -31.82 34.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.51 . . . . 54.13 111.241 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -73.68 -42.77 60.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 55.14 110.826 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 219' ' ' LEU . 31.9 mm -61.95 -44.69 99.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 70.5 111.106 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -58.44 -23.89 58.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 62.4 110.882 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -83.59 -22.19 32.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.766 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 192' ' ' SER . 5.4 t -87.61 -9.5 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 64.43 111.142 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -111.94 -8.4 14.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 64.14 110.958 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -104.09 -30.96 9.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 71.13 110.895 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.9 -52.27 2.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 73.11 110.877 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -97.24 37.78 1.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.95 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -56.46 -47.73 78.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 63.23 110.894 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -59.34 98.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 73.02 110.939 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.726 HG21 HG22 ' A' ' 206' ' ' VAL . 61.8 mt -140.23 127.89 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 71.44 111.18 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.18 -22.88 30.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 73.42 110.87 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.75 123.51 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 63.04 111.13 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.726 HG22 HG21 ' A' ' 203' ' ' ILE . 93.2 t -102.5 137.9 28.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 73.42 111.05 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.891 HG22 HG12 ' A' ' 213' ' ' VAL . 3.4 t -115.84 108.81 46.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.693 0.759 . . . . 45.52 111.129 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.503 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.6 Cg_endo -69.7 179.21 3.82 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.664 2.242 . . . . 74.25 112.348 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.74 -13.58 82.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.761 -0.733 . . . . 60.42 112.532 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -152.89 138.1 17.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 63.22 110.854 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 108.74 -118.67 5.38 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 73.21 112.5 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -150.91 163.93 37.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 72.34 110.95 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.891 HG12 HG22 ' A' ' 207' ' ' VAL . 4.3 m -60.3 161.43 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 64.25 111.127 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.13 -93.09 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 54.33 112.389 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -174.83 -167.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 72.21 110.895 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -58.05 -20.26 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.13 110.932 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.35 -23.45 26.5 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.647 -0.787 . . . . 70.12 112.452 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.8 mt -75.97 -33.1 59.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.894 0.378 . . . . 74.33 110.944 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.553 ' HA ' HG13 ' A' ' 170' ' ' VAL . 5.7 mp -61.58 -62.84 1.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.913 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -22.44 47.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 65.31 110.942 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.69 -46.67 88.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.83 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.742 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.4 m -51.27 -53.31 36.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 74.45 111.116 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.77 -20.15 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 72.21 110.971 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.41 -4.32 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 71.14 110.868 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 175' ' ' ALA . 6.2 mt -125.27 -7.2 7.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.875 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.703 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -119.67 10.26 11.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 51.45 110.91 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 73.52 110.965 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.787 0.327 . . . . 75.05 110.849 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -148.98 -65.67 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.929 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -154.22 154.79 34.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.879 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 m -103.14 155.2 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 70.41 111.117 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -145.35 143.41 30.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 72.1 110.864 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -81.93 -175.21 5.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.849 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 m -53.41 -55.94 20.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 60.43 111.145 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -59.12 -176.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 72.41 111.145 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.4 mt -136.31 92.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 72.35 111.115 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -111.52 118.07 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 74.22 110.891 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -58.37 -176.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.856 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -68.21 -45.34 73.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 64.12 110.851 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 50.4 p -61.9 -37.67 85.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 73.12 111.133 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.05 12.32 60.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 52.21 112.533 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.6 m -80.78 -43.32 20.31 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.74 0.305 . . . . 73.4 111.175 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.36 125.22 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 55.22 111.17 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.6 p -133.02 129.92 38.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.54 110.836 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.769 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -120.9 111.12 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 62.31 111.138 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.5 t -100.76 127.6 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.258 -0.428 . . . . 62.21 110.862 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -71.23 111.64 6.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 65.42 110.873 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.6 ' HG ' HG23 ' A' ' 27' ' ' VAL . 27.3 mt -65.19 -31.55 72.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 75.3 110.955 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.73 -97.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 61.33 110.908 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.7 OUTLIER -151.44 10.14 0.57 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.255 -0.43 . . . . 55.1 110.975 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.438 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.51 6.37 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 64.51 110.856 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.84 139.46 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 74.54 111.126 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.769 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.5 m95 -127.23 -179.58 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 73.54 110.957 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.6 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.1 t -131.99 97.39 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 64.31 111.144 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -80.51 121.14 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 70.43 110.901 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.1 m -117.62 104.81 11.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.11 111.146 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.683 ' CD ' HD22 ' A' ' 67' ' ' LEU . 5.3 mp0 -89.27 120.94 31.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 73.42 110.865 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.787 HD21 ' HB1' ' A' ' 38' ' ' ALA . 2.3 mt -85.43 101.55 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 44.13 110.831 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.57 -39.43 95.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 65.02 112.448 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.78 103.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 75.42 110.842 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.578 ' CD1' HG21 ' A' ' 39' ' ' VAL . 1.6 m-85 -88.51 46.65 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.911 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 60.56 67.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 53.21 110.931 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.38 -30.11 6.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.789 -0.719 . . . . 42.04 112.558 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -110.12 118.99 37.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.864 0.364 . . . . 73.04 110.875 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.787 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -69.3 118.02 11.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 52.22 111.182 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' A' ' 34' ' ' PHE . 1.5 t -113.51 73.32 1.99 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.613 0.72 . . . . 75.32 111.111 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 119.4 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.698 2.265 . . . . 72.05 112.417 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.1 p -99.76 96.92 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.866 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -49.51 159.8 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 63.02 110.845 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.591 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -155.65 -168.15 18.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.678 -0.772 . . . . 55.11 112.483 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.619 HD21 HD12 ' A' ' 158' ' ' LEU . 17.5 tp -152.49 113.56 4.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.354 . . . . 75.35 110.895 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.63 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -97.77 120.47 47.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.11 111.097 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.737 HD21 HD11 ' A' ' 158' ' ' LEU . 25.3 mt -97.78 115.95 29.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.103 -0.499 . . . . 64.23 110.903 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.42 87.44 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 60.52 110.92 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.11 179.8 4.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 54.01 111.17 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -100.28 -22.8 14.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 70.53 110.859 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -11.44 58.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 65.52 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.37 153.34 5.86 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.646 -0.787 . . . . 44.14 112.471 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.1 tp -67.25 155.04 39.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 75.42 110.957 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.6 t -145.91 142.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 73.11 111.104 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.63 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.3 mt -137.07 125.48 23.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 75.31 110.879 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -71.21 112.18 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 75.31 111.114 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.431 ' HB2' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 72.64 132.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 65.45 110.921 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.587 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -75.36 -166.98 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 54.53 110.853 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.48 ' H ' HG23 ' A' ' 64' ' ' THR . 13.1 t -91.41 169.1 11.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 70.45 110.911 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.688 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.1 m95 -49.5 -60.57 2.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.994 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -125.44 165.18 18.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 34.31 110.833 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.24 -37.69 75.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 62.44 110.852 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 mmtt -57.21 -33.74 67.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 74.31 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 59' ' ' TRP . 83.7 mt -82.6 -47.2 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 65.24 110.956 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.61 -46.44 58.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.102 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.05 -49.63 65.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 71.24 110.89 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -64.76 -19.85 66.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.968 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD22 ' CD ' ' A' ' 30' ' ' GLU . 18.6 tp -87.8 -27.16 22.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 40.54 110.904 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.83 -23.13 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 74.52 111.081 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.69 16.0 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 64.33 110.901 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.3 ptm -130.87 -39.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 73.21 110.872 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.8 m -81.21 -22.43 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.43 111.112 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.577 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.89 -24.48 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 64.45 110.813 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -106.31 -34.24 7.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.471 . . . . 65.33 110.917 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -41.3 79.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 75.43 110.925 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.82 -10.75 38.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 65.31 110.886 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 67.52 11.97 8.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 61.23 110.875 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.549 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -128.93 137.62 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 64.41 110.856 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.74 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 71.2 110.875 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' OE2' ' A' ' 72' ' ' GLU . 80.0 t -76.26 121.7 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.146 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 t -135.68 7.78 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 75.44 111.118 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.544 ' O ' HG13 ' A' ' 53' ' ' VAL . 62.7 m-20 -150.8 145.03 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.14 110.877 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 54' ' ' LEU . 12.2 t -154.53 132.65 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 70.14 111.189 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.498 HD13 HG11 ' A' ' 140' ' ' VAL . 5.9 mt -95.19 125.84 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 61.13 111.158 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.5 mm -100.35 147.7 7.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.215 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.4 p -98.16 -55.54 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 62.21 111.222 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.451 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.4 p-80 -152.96 -175.16 5.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.812 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.866 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -90.01 97.46 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 50.45 111.139 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.18 150.13 23.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 70.05 110.792 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.38 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 75.52 111.046 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.12 23.6 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 61.02 110.791 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.431 ' HD3' ' HB2' ' A' ' 56' ' ' ASP . 27.3 mmt180 -144.89 -76.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.44 110.912 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.411 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.12 7.11 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 62.12 111.113 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.74 -40.08 40.4 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.749 -0.739 . . . . 75.32 112.477 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.41 14.88 59.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 51.15 112.492 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.2 tt -55.45 -27.33 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.397 . . . . 73.51 111.125 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -54.91 -34.36 63.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 74.2 110.928 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -84.57 -22.7 29.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.54 111.138 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.605 ' HA ' HD13 ' A' ' 103' ' ' ILE . 11.7 mt -82.13 -28.67 32.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.915 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -96.92 22.22 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 73.55 110.952 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -122.63 -43.14 2.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 75.11 110.94 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -80.36 -52.78 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 61.41 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.79 43.96 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.794 -0.717 . . . . 41.22 112.534 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.605 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -108.07 118.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 71.32 111.159 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HE3' HD21 ' A' ' 124' ' ' LEU . 19.6 mtpp -77.77 111.33 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.14 110.915 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.84 90.91 8.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 64.42 111.077 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.564 ' HA ' HD12 ' A' ' 124' ' ' LEU . 57.1 m-70 -62.47 143.15 57.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 71.21 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB2' HG21 ' A' ' 111' ' ' THR . 1.1 p -173.96 176.7 2.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.908 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.33 157.92 19.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 63.11 111.16 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.89 -38.96 52.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 52.31 111.097 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.649 HD21 ' HG2' ' A' ' 151' ' ' GLU . 28.9 tp -73.63 -37.52 65.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 72.33 110.894 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.744 ' HA ' HD11 ' A' ' 114' ' ' LEU . 98.1 m -57.82 -29.36 64.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 63.53 111.115 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.88 0.21 57.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 65.14 111.058 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -99.25 -58.24 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.286 -0.415 . . . . 73.34 110.792 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.866 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -67.32 -12.27 59.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 64.51 110.925 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -66.1 -44.58 83.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 71.33 111.162 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -28.82 65.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.878 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.59 -37.26 49.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 65.43 110.886 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -88.9 -21.89 23.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 54.1 110.854 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.89 20.63 5.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.734 -0.746 . . . . 61.33 112.491 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.56 172.07 8.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 64.45 110.974 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -70.92 -176.16 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 74.55 110.905 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.3 mt-10 -117.05 102.13 52.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.614 0.721 . . . . 72.34 110.849 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.2 Cg_endo -69.85 -176.22 1.44 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.621 2.214 . . . . 63.02 112.321 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.717 HD21 ' HE3' ' A' ' 104' ' ' LYS . 25.4 mt -51.84 -60.08 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.02 110.913 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 67.43 21.37 72.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.729 -0.748 . . . . 55.32 112.527 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -99.53 28.41 4.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 72.35 110.849 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.624 HD22 HD21 ' A' ' 133' ' ' LEU . 62.8 mt -109.52 -175.69 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.916 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.25 -170.77 3.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.125 -0.489 . . . . 72.33 110.937 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 130' ' ' VAL . 54.8 m -50.79 -70.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.04 111.147 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.906 HG23 HG22 ' A' ' 129' ' ' THR . 44.7 t -119.82 103.53 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 74.11 111.165 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.5 t -135.42 163.33 30.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 64.33 111.124 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.13 132.49 54.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 74.32 110.864 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.624 HD21 HD22 ' A' ' 127' ' ' LEU . 24.1 mt -115.08 167.2 11.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.939 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.26 133.5 19.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.52 110.941 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -134.2 49.09 2.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 65.32 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.19 92.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 62.24 112.539 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.89 14.59 9.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.339 . . . . 75.32 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.0 tpp -134.13 110.31 9.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.832 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.15 131.14 44.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.872 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.79 HG22 HD21 ' A' ' 158' ' ' LEU . 21.3 t -137.34 117.33 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 74.34 111.064 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -110.75 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 75.35 110.887 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 28.9 p -86.62 177.29 7.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 62.11 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.503 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.2 t80 -159.3 134.78 8.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 74.14 110.865 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.697 ' HB3' HG23 ' A' ' 129' ' ' THR . 9.3 t80 -124.41 87.23 54.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.648 0.737 . . . . 73.22 110.901 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -7.95 22.38 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.744 2.296 . . . . 64.32 112.313 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.68 -158.48 22.56 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.737 -0.744 . . . . 72.15 112.399 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -86.81 138.83 31.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 72.35 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.7 -87.32 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 54.33 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -78.39 -23.38 46.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 63.34 110.872 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 86' ' ' HIS . 34.5 p -149.61 -165.62 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 63.15 111.153 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.649 ' HG2' HD21 ' A' ' 110' ' ' LEU . 2.0 tt0 -86.08 -18.44 32.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 75.11 110.851 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 154' ' ' ILE . 8.6 t0 -136.54 20.38 3.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 71.55 110.884 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.411 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.3 OUTLIER -51.75 129.04 25.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 71.43 110.872 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.451 HG22 ' CD1' ' A' ' 144' ' ' TYR . 9.3 pt -135.8 176.47 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 70.55 111.177 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.435 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.8 m -131.49 123.13 51.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 71.34 111.13 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.25 122.56 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 73.34 111.137 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -109.24 132.18 54.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.297 -0.41 . . . . 54.41 110.888 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 140' ' ' VAL . 11.4 mt -112.9 97.98 43.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.52 0.676 . . . . 55.21 110.893 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.75 -4.84 14.83 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 75.11 112.31 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -82.66 -23.32 34.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.949 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.63 13.88 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.909 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.6 m120 54.49 27.92 8.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.467 . . . . 51.2 110.912 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.443 HD13 HD13 ' A' ' 21' ' ' LEU . 96.1 mt -93.41 126.69 45.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.118 -0.492 . . . . 51.34 111.141 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.513 HD22 HD13 ' A' ' 203' ' ' ILE . 19.6 tp -110.61 147.31 34.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.967 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 40.9 t -111.28 78.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 41.4 111.181 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.31 -32.02 21.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.723 -0.751 . . . . 50.35 112.55 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 61.23 -160.44 27.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 71.32 112.508 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -28.38 64.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.863 0.363 . . . . 72.43 110.885 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.658 HD12 ' NE1' ' A' ' 189' ' ' TRP . 28.0 tp -56.26 -56.97 14.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.878 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' A' ' 219' ' ' LEU . 38.2 t -81.01 107.65 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 61.33 111.073 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.466 ' HD2' HD23 ' A' ' 178' ' ' LEU . 6.2 mmpt? -50.81 161.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.919 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -115.47 156.65 25.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 73.01 110.9 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.9 t -49.23 156.34 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 72.44 111.102 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.2 11.4 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 61.21 110.908 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.554 ' HB3' HD11 ' A' ' 225' ' ' LEU . . . -82.79 146.1 29.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 62.41 111.064 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.422 ' C ' HD22 ' A' ' 225' ' ' LEU . 8.3 ptpt -118.03 -16.56 9.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 70.22 110.852 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -177.86 168.55 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 74.33 110.89 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 226' ' ' LEU . 6.8 mt -81.96 -35.96 28.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 73.02 110.923 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 124.99 -157.65 19.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 71.44 112.485 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.722 ' OD1' ' HB2' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -79.59 -1.76 39.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.97 0.414 . . . . 63.5 110.923 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.658 HG11 ' CG2' ' A' ' 186' ' ' VAL . 27.6 m 36.56 45.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 64.11 111.106 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.722 ' HB2' ' OD1' ' A' ' 180' ' ' ASN . . . -56.56 -29.63 62.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 70.34 111.048 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -129.53 26.49 5.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.316 -0.402 . . . . 65.25 110.937 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 181' ' ' VAL . . . -124.47 153.44 41.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 72.3 111.063 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -110.06 88.78 2.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 75.22 110.924 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.658 ' CG2' HG11 ' A' ' 181' ' ' VAL . 20.5 t -61.63 -17.47 17.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.195 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.74 -25.68 60.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 71.41 110.861 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -114.16 -11.95 12.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 63.22 110.85 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.678 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.6 t90 -55.1 -61.33 2.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.227 -0.442 . . . . 75.55 110.92 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.751 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.1 -25.57 13.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 70.54 110.816 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.7 m -80.66 -32.68 36.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 62.34 111.14 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.632 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.42 -42.3 65.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 63.44 110.881 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.422 HG21 ' O ' ' A' ' 219' ' ' LEU . 29.9 mm -62.52 -47.83 91.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 63.31 111.111 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.481 ' HG2' HD11 ' A' ' 223' ' ' LEU . 1.5 mm-40 -57.4 -28.57 63.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.919 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.71 -21.86 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 74.44 110.941 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 192' ' ' SER . 9.9 t -85.74 -11.69 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 44.43 111.144 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -111.28 -8.4 14.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.154 -0.476 . . . . 74.3 110.938 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -30.49 10.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 55.35 110.955 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.46 -48.76 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.844 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.07 37.56 1.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 62.22 110.936 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -51.82 -48.58 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 71.32 110.848 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -60.08 105.1 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.465 . . . . 64.33 110.936 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.526 HG21 HG22 ' A' ' 206' ' ' VAL . 47.5 mt -145.95 125.67 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 60.4 111.093 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.86 -26.83 33.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 55.45 110.899 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -168.6 134.6 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 70.11 111.163 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.707 ' HB ' HD12 ' A' ' 218' ' ' LEU . 98.0 t -109.92 134.58 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 71.23 111.029 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.939 HG22 HG12 ' A' ' 213' ' ' VAL . 13.1 t -110.82 104.22 55.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 53.2 111.129 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.8 Cg_endo -69.74 174.18 9.87 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.709 2.273 . . . . 72.43 112.36 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.6 -13.08 83.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 71.24 112.42 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -152.85 150.17 29.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 71.11 110.799 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.59 -99.67 2.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 64.2 112.406 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -175.43 158.82 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 73.14 110.88 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.939 HG12 HG22 ' A' ' 207' ' ' VAL . 6.1 m -51.63 163.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 71.21 111.116 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -162.64 -105.31 0.19 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.735 -0.745 . . . . 61.45 112.507 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 -167.69 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.782 0.325 . . . . 73.51 110.913 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -21.11 25.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.819 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -54.83 -22.79 27.94 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 72.03 112.527 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.707 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.8 mt -74.87 -33.76 62.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 50.41 110.956 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.497 ' HA ' HG13 ' A' ' 170' ' ' VAL . 5.3 mp -60.88 -62.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.974 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -22.13 51.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 43.34 110.945 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -63.27 -36.91 85.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 65.33 110.898 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.687 HG22 ' CD2' ' A' ' 226' ' ' LEU . 3.7 m -62.78 -56.95 12.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 55.52 111.137 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.481 HD11 ' HG2' ' A' ' 194' ' ' GLU . 1.4 mt -54.91 -29.47 56.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 53.33 110.859 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.04 -35.44 66.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 72.13 110.869 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 175' ' ' ALA . 10.3 mt -86.66 -16.11 37.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 71.3 110.921 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.777 ' HB3' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -119.04 20.71 12.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 75.52 110.8 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.32 -0.4 . . . . 73.32 110.822 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.816 0.341 . . . . 72.42 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.73 73.13 1.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 75.13 110.977 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.14 155.67 45.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.852 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -102.35 177.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.42 111.064 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -178.17 160.42 1.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 63.14 110.9 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -65.43 -175.01 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 70.31 110.878 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -75.68 -68.59 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 72.45 111.153 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.9 t -49.4 146.99 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 73.54 111.147 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.6 mt -113.36 101.2 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.21 111.11 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -121.07 120.46 35.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.912 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -66.28 167.56 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 70.43 110.918 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -51.71 -48.46 63.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 70.54 110.919 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.1 p -61.69 -37.52 84.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 74.12 111.095 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.45 10.59 67.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.828 -0.701 . . . . 74.14 112.47 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -77.48 -45.33 25.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 51.24 111.132 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 67' ' ' LEU . 64.1 mt -101.7 110.9 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.257 -0.429 . . . . 63.5 111.155 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.3 p -117.83 138.13 52.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.4 110.819 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.789 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.6 mt -129.74 109.81 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 74.31 111.113 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.9 t -100.27 124.63 45.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 73.1 110.849 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -68.74 109.64 3.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 71.24 110.914 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.791 HD21 HG11 ' A' ' 213' ' ' VAL . 15.9 mt -64.44 -33.38 75.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 71.04 110.848 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -149.02 -97.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 53.21 110.935 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.466 ' N ' HD22 ' A' ' 22' ' ' ASN . 2.9 tttm -151.84 10.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 73.0 110.813 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.446 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.96 6.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 54.44 110.958 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.4 t -151.16 138.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 73.14 111.181 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.789 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.3 m95 -126.1 -174.51 3.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.95 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 43' ' ' GLY . 95.6 t -136.84 96.17 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 72.23 111.139 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -81.22 121.36 26.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.35 110.826 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.0 m -116.45 104.32 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 72.44 111.143 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.81 120.15 25.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 70.21 110.889 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.75 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -90.52 106.22 18.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 65.24 110.937 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.9 -141.12 2.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.632 -0.794 . . . . 71.24 112.489 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 93.8 p -175.27 83.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 73.23 110.895 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.76 84.26 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 74.51 110.887 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 62.43 17.1 9.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 71.21 110.887 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.18 -0.17 9.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.676 -0.773 . . . . 34.34 112.449 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -103.77 120.16 40.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 44.32 110.895 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.75 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -60.98 121.25 11.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 62.14 111.072 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.83 81.79 55.52 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.616 0.722 . . . . 72.51 111.092 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 116.72 4.7 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.632 2.221 . . . . 73.12 112.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.6 p -101.97 100.2 10.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.844 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -51.38 165.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.082 -0.508 . . . . 64.43 110.866 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.533 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -158.01 -163.61 12.97 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.683 -0.77 . . . . 24.43 112.43 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.638 HD21 HD12 ' A' ' 158' ' ' LEU . 13.9 tp -154.39 113.85 3.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 44.05 110.904 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 54' ' ' LEU . 1.8 t -97.37 115.34 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 73.53 111.144 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.778 HD21 HD11 ' A' ' 158' ' ' LEU . 29.9 mt -92.74 117.86 30.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 65.5 110.945 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.33 83.9 6.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 70.33 110.908 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.61 176.01 5.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 64.2 111.14 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.73 -22.97 17.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 75.3 110.895 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -12.85 59.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.908 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.2 155.21 6.46 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.727 -0.749 . . . . 61.31 112.542 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 52' ' ' LEU . 9.5 tp -68.66 154.26 42.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.923 0.392 . . . . 73.32 110.882 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.4 t -145.68 143.68 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.13 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 45' ' ' VAL . 1.4 mt -138.51 123.06 18.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 73.24 110.969 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 165' ' ' VAL . 91.1 t -68.62 111.07 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 74.03 111.211 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.37 128.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.448 . . . . 63.14 110.849 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.661 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -73.52 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.816 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 t -90.52 170.07 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 71.21 110.841 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.5 m95 -51.29 -60.74 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 65.24 110.967 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -125.33 159.46 31.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 72.13 110.891 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -51.99 -33.18 36.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 61.12 110.829 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -59.43 -42.14 91.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 75.51 110.902 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.0 mt -76.64 -48.88 17.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 70.51 110.957 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.07 -45.8 52.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.165 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -54.63 -49.09 71.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.31 110.893 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.13 -19.77 66.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 72.33 110.873 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.0 tp -88.23 -26.78 22.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 62.21 110.947 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.28 -22.44 6.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 70.11 111.11 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.4 15.66 13.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 64.33 110.928 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.0 ptm -130.32 -40.07 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 74.42 110.756 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.7 m -80.23 -22.04 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 74.54 111.153 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.575 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.1 -23.25 64.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 62.23 110.915 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -107.53 -33.09 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 73.53 110.859 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -40.47 72.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 72.41 110.863 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.541 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 15.1 m-85 -90.79 -10.48 42.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 71.22 110.908 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.41 12.15 8.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 72.22 110.959 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.88 138.34 49.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 71.14 110.932 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.08 138.14 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 74.42 110.834 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.575 HG23 ' OE2' ' A' ' 72' ' ' GLU . 71.9 t -74.59 124.9 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 71.44 111.088 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -137.67 8.34 2.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 73.33 111.123 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 53' ' ' VAL . 57.1 m-20 -154.54 146.18 23.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 72.02 110.767 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 54' ' ' LEU . 13.6 t -153.71 128.37 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 72.43 111.176 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.59 ' CD1' HG11 ' A' ' 140' ' ' VAL . 54.5 mt -84.88 129.08 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 64.5 111.182 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.9 mm -107.57 123.84 63.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 73.5 111.125 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p -83.76 -45.85 12.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 54.42 111.196 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.5 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.2 p-80 -153.44 178.06 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 65.42 110.845 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.497 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -97.71 91.62 5.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 61.2 111.052 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -146.33 156.56 43.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.786 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.53 26.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 61.21 111.085 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.84 20.03 10.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 64.55 110.916 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.83 -77.43 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.896 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.79 7.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.32 111.096 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.45 -37.85 41.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 53.21 112.459 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.78 10.57 64.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.725 -0.75 . . . . 55.35 112.395 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.38 -28.41 11.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 71.12 111.201 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -38.81 67.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.887 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -84.07 -10.45 57.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 54.32 111.077 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.661 HD11 ' OG ' ' A' ' 57' ' ' SER . 22.9 mt -90.86 -33.94 15.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 74.34 110.925 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -94.42 17.9 12.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.973 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -116.3 -39.25 3.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.93 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -87.33 -55.75 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 64.14 110.848 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.91 47.87 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.75 -0.738 . . . . 71.34 112.524 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.3 mp -111.32 110.79 33.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 40.31 111.087 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.718 ' HB3' HD11 ' A' ' 124' ' ' LEU . 12.7 mtmt -72.1 107.88 5.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 72.31 110.861 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.62 89.41 7.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 61.04 111.093 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.546 ' HA ' HD12 ' A' ' 124' ' ' LEU . 58.1 m-70 -62.08 135.82 57.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.885 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.92 168.98 10.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 63.11 110.844 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.87 154.23 25.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.141 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.91 7.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 61.45 111.053 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 152' ' ' ASP . 0.3 OUTLIER -70.7 -46.38 63.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 61.14 111.011 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.752 ' HA ' HD11 ' A' ' 114' ' ' LEU . 32.7 m -57.03 -25.59 58.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 60.55 111.174 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.599 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -97.89 14.12 28.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 71.42 111.143 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -26.75 7.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.825 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -105.74 -10.35 16.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 55.44 110.911 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.53 70.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 71.24 111.061 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -24.54 55.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 64.11 110.889 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -61.48 -32.63 72.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 61.54 110.897 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -89.36 -24.82 21.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 52.32 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.05 24.06 3.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.696 -0.764 . . . . 71.34 112.443 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -100.72 166.48 10.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 74.23 110.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.99 162.95 28.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 73.51 110.928 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mp0 -95.09 111.93 56.58 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.607 0.718 . . . . 72.15 110.891 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.599 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.2 Cg_endo -69.79 -176.1 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.6 2.2 . . . . 75.35 112.323 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 104' ' ' LYS . 17.5 mt -51.79 -43.7 63.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 73.4 110.831 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.2 39.6 50.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 62.24 112.485 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.11 43.52 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.752 0.31 . . . . 72.14 110.782 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.751 HD22 HD21 ' A' ' 133' ' ' LEU . 59.2 mt -129.14 -175.55 3.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 73.11 110.878 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.6 -171.72 4.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 63.12 110.871 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.853 HG22 HG23 ' A' ' 130' ' ' VAL . 52.9 m -50.62 -71.1 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 62.54 111.089 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 HG22 ' A' ' 129' ' ' THR . 31.2 t -116.85 102.79 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 63.32 111.04 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.2 t -135.63 170.56 15.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.1 111.156 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.68 133.88 55.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 64.11 110.884 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.751 HD21 HD22 ' A' ' 127' ' ' LEU . 25.9 mt -114.84 155.52 26.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 65.0 110.942 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.3 pttt -137.59 124.17 20.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.22 110.857 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -125.86 49.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.923 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.44 92.98 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 74.35 112.547 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.7 m120 64.6 15.05 9.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 70.31 110.941 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.3 tpp -135.16 108.65 7.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.863 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -98.33 129.06 45.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.281 -0.418 . . . . 74.11 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.823 HG22 HD21 ' A' ' 158' ' ' LEU . 20.2 t -134.91 115.15 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 64.31 111.184 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -107.64 130.63 54.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.499 . . . . 61.4 110.814 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.5 p -86.75 -176.54 5.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 62.4 111.164 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.511 ' HB3' HG23 ' A' ' 155' ' ' VAL . 24.7 t80 -168.4 130.35 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.835 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.748 ' HB3' HG23 ' A' ' 129' ' ' THR . 11.0 t80 -115.57 88.01 18.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 71.03 110.957 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -7.99 22.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.646 2.231 . . . . 53.1 112.411 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.56 -162.29 21.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.674 -0.774 . . . . 62.23 112.381 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -81.04 137.61 36.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 71.32 110.878 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.13 -88.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.747 -0.739 . . . . 63.55 112.472 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -76.36 -25.21 54.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.905 0.383 . . . . 62.2 110.9 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.5 HG21 ' HB2' ' A' ' 86' ' ' HIS . 17.2 p -147.15 -158.31 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 71.22 111.067 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HB3' HD23 ' A' ' 114' ' ' LEU . 40.6 tt0 -89.47 -22.01 22.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.872 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.759 ' HB3' HD12 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -132.18 8.66 4.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.853 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.472 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.0 OUTLIER -41.12 128.37 2.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.01 110.891 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 152' ' ' ASP . 7.0 pt -132.79 -176.45 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 71.34 111.101 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.529 ' HB ' HD11 ' A' ' 164' ' ' LEU . 9.2 m -133.82 131.76 56.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 64.41 111.043 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 164' ' ' LEU . 91.1 t -86.27 126.44 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 65.52 111.156 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -114.33 131.09 56.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 74.43 110.812 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.823 HD21 HG22 ' A' ' 140' ' ' VAL . 11.6 mt -111.84 97.19 36.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 74.31 110.885 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.4 Cg_endo -69.87 -5.1 15.47 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.664 2.242 . . . . 74.12 112.301 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -81.81 -23.63 36.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 62.33 110.952 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.4 13.76 1.79 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.917 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.2 m120 54.42 29.75 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 73.41 110.907 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.498 HD13 HD13 ' A' ' 21' ' ' LEU . 98.3 mt -96.07 130.3 44.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.11 111.092 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' A' ' 155' ' ' VAL . 25.4 tp -112.67 146.0 39.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.867 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 55' ' ' VAL . 21.3 t -112.22 79.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 74.42 111.145 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.67 42.79 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.656 -0.783 . . . . 54.32 112.542 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 76.5 -163.85 53.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.672 -0.775 . . . . 41.22 112.515 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -33.55 35.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.361 . . . . 44.12 110.909 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.616 HD12 ' NE1' ' A' ' 189' ' ' TRP . 22.6 tp -53.69 -56.38 17.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.934 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 218' ' ' LEU . 14.7 t -82.55 114.28 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 64.42 111.076 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 150.57 19.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 72.53 110.889 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.0 p -97.96 155.11 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.865 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t -51.44 -29.22 15.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.123 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.6 m -93.36 42.34 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 64.12 110.864 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -137.76 155.94 48.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 64.05 111.103 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.537 ' HA ' HD22 ' A' ' 225' ' ' LEU . 20.5 ttmt -136.59 11.26 3.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.248 -0.433 . . . . 64.33 110.859 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.73 157.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 63.14 110.913 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.744 HD13 ' CE3' ' A' ' 189' ' ' TRP . 6.1 mt -73.96 -32.88 63.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 53.33 110.891 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 87.95 -151.34 22.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.761 -0.733 . . . . 63.33 112.434 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -52.4 115.92 2.0 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 63.25 110.922 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.478 HG11 ' CG2' ' A' ' 186' ' ' VAL . 26.9 m -109.19 35.67 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 64.23 111.028 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.07 81.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 74.05 111.099 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -112.86 33.06 5.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 62.03 110.897 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.43 158.68 43.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 54.34 111.091 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -113.73 90.94 3.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 72.35 110.94 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.478 ' CG2' HG11 ' A' ' 181' ' ' VAL . 8.5 t -67.12 -19.18 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 42.15 111.137 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -74.84 -24.83 58.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 64.23 110.876 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -113.39 -10.76 13.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.062 -0.517 . . . . 72.02 110.852 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.744 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.5 t90 -55.3 -61.44 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 62.12 110.93 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.7 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.63 -24.48 14.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.033 0.444 . . . . 54.31 110.894 -179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.9 m -81.57 -31.97 32.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 63.01 111.058 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -43.1 61.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.859 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 219' ' ' LEU . 30.5 mm -61.68 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.35 111.14 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.39 -27.64 56.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 63.14 110.92 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -76.98 -22.27 53.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 73.34 110.939 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 20.4 t -85.18 -11.37 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 73.03 111.143 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.436 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -111.4 -10.02 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 65.21 110.916 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.86 -30.76 11.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.833 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.33 -58.48 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.11 110.897 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.448 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -93.08 61.68 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 74.02 110.893 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -72.36 -58.14 3.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 74.32 110.94 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -53.03 102.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.3 110.845 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.646 HG21 ' CG2' ' A' ' 206' ' ' VAL . 73.9 mt -142.04 121.68 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 73.03 111.16 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -29.83 61.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.447 . . . . 70.11 110.84 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.06 143.18 2.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.258 -0.428 . . . . 63.21 111.178 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.756 ' HB ' HD12 ' A' ' 218' ' ' LEU . 98.1 t -121.48 130.94 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 45.23 111.1 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.963 HG22 HG12 ' A' ' 213' ' ' VAL . 11.9 t -108.48 112.57 60.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.641 0.734 . . . . 63.23 111.274 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.62 -169.48 0.32 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.769 2.313 . . . . 53.22 112.397 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.65 -13.66 59.3 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.828 -0.701 . . . . 73.14 112.5 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.45 129.71 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.354 . . . . 72.41 110.838 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 116.78 -117.69 3.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.812 -0.709 . . . . 72.12 112.494 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -150.79 164.75 35.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 75.23 110.841 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.963 HG12 HG22 ' A' ' 207' ' ' VAL . 5.8 m -54.87 163.57 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.23 111.176 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -157.26 -111.58 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.803 -0.713 . . . . 70.34 112.522 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.15 -169.32 2.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.979 0.418 . . . . 75.32 110.809 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -18.31 52.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 72.2 110.856 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.494 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.88 -16.75 48.26 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.75 -0.738 . . . . 65.41 112.47 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.756 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.6 mt -71.95 -30.35 65.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.919 0.39 . . . . 74.21 110.967 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.588 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.7 mm? -65.64 -57.5 7.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 74.52 110.899 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.494 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -61.54 -17.78 56.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 73.44 110.918 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -65.6 -50.42 65.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.1 110.873 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.543 ' C ' HD23 ' A' ' 226' ' ' LEU . 2.9 m -51.78 -51.43 56.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 74.13 111.138 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -18.74 49.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 75.04 110.915 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -87.53 -5.07 58.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 72.45 110.804 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 176' ' ' LYS . 9.3 mt -126.09 -6.4 6.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 70.42 110.876 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.723 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -119.34 8.48 11.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.918 179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 64.42 110.877 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.793 0.33 . . . . 44.3 110.844 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -117.71 152.93 34.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 75.13 110.868 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -166.56 160.11 14.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 70.24 110.965 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.6 147.62 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 64.14 111.107 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -148.33 96.38 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 65.53 110.886 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -93.68 -177.47 4.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 74.24 110.887 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -88.14 -68.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 74.23 111.196 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.0 t -49.7 147.26 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.48 . . . . 70.24 111.131 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 mt -114.2 100.23 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 65.2 111.127 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -121.4 116.3 24.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 63.02 110.906 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.7 p-10 -58.52 165.23 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 71.22 110.96 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -51.8 -48.29 63.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 74.22 110.896 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -60.74 -38.01 83.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.13 111.206 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.97 64.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.728 -0.749 . . . . 73.22 112.525 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -71.34 -45.42 62.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.7 0.286 . . . . 75.51 111.085 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.1 mt -100.96 123.3 53.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.419 . . . . 74.5 111.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.1 p -129.2 132.64 47.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 75.04 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -127.28 107.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 72.32 111.12 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -98.6 125.07 43.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.34 110.836 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -68.58 108.78 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 74.12 110.843 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.731 HD21 HG21 ' A' ' 213' ' ' VAL . 14.1 mt -62.61 -33.1 74.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 70.15 110.936 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.461 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.26 -96.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 52.21 110.883 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.6 OUTLIER -151.42 9.9 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.925 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.443 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.98 6.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 71.32 110.892 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 t -150.69 139.74 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 63.2 111.126 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.788 ' HB3' HG22 ' A' ' 18' ' ' ILE . 16.0 m95 -128.03 -174.78 3.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 65.12 110.92 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG21 ' CG2' ' A' ' 213' ' ' VAL . 99.3 t -136.83 94.84 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 70.1 111.057 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -79.01 122.07 25.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 72.0 110.866 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.7 m -118.7 104.92 11.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 70.44 111.167 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -91.41 124.48 35.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 74.4 110.888 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.769 HD21 ' HB1' ' A' ' 38' ' ' ALA . 1.6 mt -86.23 114.2 22.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.45 110.877 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.94 -35.99 53.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.66 -0.781 . . . . 61.25 112.437 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m 58.53 98.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 75.52 110.825 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.549 ' CE1' HG13 ' A' ' 39' ' ' VAL . 2.5 p90 -129.66 137.66 50.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.059 -0.519 . . . . 73.03 110.848 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 54.08 40.45 31.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 74.3 110.881 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.81 8.67 61.16 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.678 -0.772 . . . . 53.54 112.512 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -100.18 -166.46 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.343 . . . . 65.53 110.889 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.769 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -133.42 113.38 12.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 72.34 111.107 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.549 HG13 ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -112.44 77.63 2.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.641 0.734 . . . . 75.11 111.193 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 118.29 5.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 71.01 112.305 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 91.8 p -97.38 98.08 9.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.799 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -51.79 159.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.31 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -154.67 -167.3 16.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.684 -0.77 . . . . 42.34 112.435 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 158' ' ' LEU . 14.3 tp -152.68 112.84 4.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 72.25 110.964 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.64 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -95.66 116.5 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.19 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.729 HD21 HD11 ' A' ' 158' ' ' LEU . 26.7 mt -95.27 118.6 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 73.55 110.906 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.86 86.64 7.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.888 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.47 179.98 4.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 62.54 111.112 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.4 -23.32 14.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.9 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -13.24 58.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 41.34 110.919 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.11 151.81 5.5 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 55.31 112.539 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.62 153.7 35.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.808 0.337 . . . . 73.34 110.969 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.638 HG13 ' CB ' ' A' ' 81' ' ' ASP . 2.3 t -143.74 141.09 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 64.34 111.031 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.64 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.3 mt -136.87 122.07 19.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.43 110.943 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG11 HG11 ' A' ' 165' ' ' VAL . 76.3 t -67.43 111.43 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.42 111.152 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' CG ' HG12 ' A' ' 55' ' ' VAL . 1.9 m-20 72.1 130.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.34 110.903 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -72.85 -166.65 0.31 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.228 -0.442 . . . . 75.11 110.914 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -91.62 169.19 10.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.12 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.718 ' HB2' HD12 ' A' ' 63' ' ' LEU . 96.5 m95 -48.98 -58.5 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.983 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -130.48 161.53 31.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.13 110.883 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -54.21 -32.83 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 60.22 110.815 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -59.22 -39.84 84.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.406 . . . . 72.35 110.868 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.718 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.7 mt -78.91 -45.39 20.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 71.23 110.909 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.31 -46.33 62.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 64.41 111.093 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.05 -49.46 66.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 74.24 110.905 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -67.08 -15.27 63.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 71.13 110.936 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.499 ' O ' HG22 ' A' ' 71' ' ' VAL . 17.3 tp -92.53 -24.89 18.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 65.05 110.958 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.821 HG12 HG11 ' A' ' 79' ' ' VAL . 15.3 mt -91.24 -26.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.42 111.125 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -86.55 7.77 24.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.857 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.7 ptm -123.53 -38.6 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 71.35 110.913 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 67' ' ' LEU . 23.0 m -79.55 -23.68 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 55.05 111.133 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.62 -20.68 61.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.896 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -107.79 -30.71 8.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 63.54 110.873 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -45.79 41.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.86 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 27.5 m-85 -83.55 -11.97 56.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.278 -0.419 . . . . 71.31 110.838 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 67.65 12.78 9.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 62.22 110.916 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 139.7 52.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.246 -0.434 . . . . 65.21 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.97 136.8 38.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 62.41 110.799 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.821 HG11 HG12 ' A' ' 68' ' ' ILE . 14.4 p -77.02 128.75 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 72.41 111.12 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -155.41 19.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.159 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.638 ' CB ' HG13 ' A' ' 53' ' ' VAL . 28.0 m-20 -154.24 142.68 20.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 74.22 110.871 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 81' ' ' ASP . 10.4 t -156.58 104.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 62.51 111.16 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.616 HD11 ' HE2' ' A' ' 135' ' ' PHE . 8.5 mt -69.97 119.82 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.41 111.111 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.7 mm -93.45 147.46 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 72.43 111.106 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 p -104.24 -50.33 3.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 64.23 111.074 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.491 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.8 p-80 -155.84 -174.58 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 62.24 110.88 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.837 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -92.37 99.58 12.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 54.02 111.139 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.45 151.88 29.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 64.4 110.866 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.18 -19.94 49.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.401 . . . . 70.41 111.028 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.58 6.25 48.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.442 . . . . 65.22 110.956 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.68 -77.34 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.875 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -92.13 7.71 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 73.35 111.188 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.78 -37.44 34.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.816 -0.707 . . . . 72.13 112.414 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.2 10.77 58.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.751 . . . . 74.12 112.534 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 92' ' ' ILE . 17.0 tt -53.89 -28.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.924 0.392 . . . . 71.41 111.159 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -53.64 -36.94 62.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 64.44 110.921 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -87.17 -13.71 43.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.42 111.147 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.578 ' HA ' HD13 ' A' ' 103' ' ' ILE . 20.2 mt -86.42 -31.55 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 75.21 110.923 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -93.92 15.73 16.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 65.24 110.88 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -116.46 -45.37 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 74.2 110.942 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -78.15 -56.86 4.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 71.51 110.804 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.96 45.46 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.816 -0.706 . . . . 62.55 112.498 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -109.98 119.24 58.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.928 0.394 . . . . 74.23 111.121 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.753 ' CE ' HD21 ' A' ' 124' ' ' LEU . 3.9 mtpp -76.17 119.32 19.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 71.14 110.852 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.0 93.53 6.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 51.53 111.116 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.426 ' HB3' HD11 ' A' ' 127' ' ' LEU . 76.9 m-70 -65.86 145.67 55.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 73.03 110.906 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.441 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -178.87 171.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 55.25 110.889 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.89 158.94 19.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 61.52 111.105 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.51 -39.26 33.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.42 111.065 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -66.06 -44.17 85.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 72.43 110.906 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.741 ' HA ' HD11 ' A' ' 114' ' ' LEU . 51.6 m -57.5 -25.35 59.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 61.34 111.121 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.11 10.86 38.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 63.21 111.121 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -110.9 -33.2 6.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 71.15 110.892 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.837 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -97.59 -13.9 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.878 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.442 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -63.5 -41.57 98.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 73.25 111.105 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -24.41 58.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 62.25 110.925 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.85 -32.5 70.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.441 . . . . 64.44 110.826 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -89.87 -24.35 21.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.291 -0.413 . . . . 72.32 110.888 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.18 23.93 4.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 55.33 112.568 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -98.07 -175.5 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 72.22 110.923 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.429 ' HB2' HD13 ' A' ' 95' ' ' ILE . 6.3 mm-40 -85.5 176.14 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 73.43 110.93 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.9 mt-10 -106.59 104.38 50.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.684 0.754 . . . . 73.32 110.863 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 53.8 Cg_endo -69.77 -178.75 2.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.635 2.223 . . . . 62.3 112.367 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.753 HD21 ' CE ' ' A' ' 104' ' ' LYS . 10.2 mt -51.08 -47.04 61.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.981 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.07 26.55 28.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 71.5 112.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -107.84 45.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.867 0.365 . . . . 72.33 110.817 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.587 HD22 HD21 ' A' ' 133' ' ' LEU . 86.4 mt -127.1 -174.96 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 75.03 110.972 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.57 -172.31 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 73.43 110.932 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.869 HG22 HG23 ' A' ' 130' ' ' VAL . 49.6 m -50.89 -70.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 75.33 111.166 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.869 HG23 HG22 ' A' ' 129' ' ' THR . 33.0 t -117.06 103.42 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 54.54 111.097 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t -135.42 175.23 9.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 64.23 111.122 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -120.64 136.39 54.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 62.24 110.901 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 127' ' ' LEU . 25.2 mt -115.23 154.34 29.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 60.13 110.844 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -134.08 126.89 31.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.857 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.616 ' HE2' HD11 ' A' ' 83' ' ' ILE . 12.2 m-85 -129.9 32.8 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.44 110.797 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.66 95.37 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.672 -0.775 . . . . 43.32 112.487 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 65.88 13.49 9.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 72.23 110.969 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.6 tpp -135.03 106.43 6.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 70.22 110.821 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.471 ' O ' HD23 ' A' ' 158' ' ' LEU . 3.4 mptp? -94.58 126.0 39.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 60.33 110.852 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.844 HG22 HD21 ' A' ' 158' ' ' LEU . 19.9 t -134.77 116.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.5 111.174 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -109.95 131.22 55.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 55.5 110.88 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 36.5 p -85.04 -176.03 6.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 74.33 111.199 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.443 ' HB3' HG23 ' A' ' 155' ' ' VAL . 24.7 t80 -166.67 133.08 2.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.877 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.694 ' HB3' HG23 ' A' ' 129' ' ' THR . 7.8 t80 -122.01 87.33 47.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.612 0.72 . . . . 73.53 110.87 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 -7.68 21.69 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.672 2.248 . . . . 70.33 112.335 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.48 -160.81 23.86 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.742 -0.742 . . . . 53.4 112.442 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -86.26 139.48 30.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.886 0.374 . . . . 74.41 110.91 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.17 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 61.04 112.435 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -75.6 -22.92 56.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 63.22 110.86 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 86' ' ' HIS . 59.3 p -150.69 -169.21 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 63.21 111.122 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.543 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.2 tt0 -86.63 -5.71 59.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 55.13 110.926 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 154' ' ' ILE . 47.6 t0 -145.75 16.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 52.53 110.838 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.69 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -49.8 126.14 13.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.455 . . . . 53.12 110.904 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 152' ' ' ASP . 24.1 pt -133.72 174.92 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 70.25 111.15 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 143' ' ' PHE . 14.5 m -128.06 120.38 53.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 63.11 111.088 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.37 119.18 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 42.51 111.167 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 33.4 t-105 -107.94 136.45 47.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 75.33 110.816 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.844 HD21 HG22 ' A' ' 140' ' ' VAL . 13.3 mt -118.63 98.35 51.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.648 0.737 . . . . 72.0 110.808 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -4.52 14.2 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.675 2.25 . . . . 73.11 112.415 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -85.12 -21.22 29.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.11 110.98 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -143.52 13.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 74.11 110.929 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.1 m120 53.12 27.54 5.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.952 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.468 HD13 HD13 ' A' ' 21' ' ' LEU . 95.9 mt -89.96 142.82 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 63.53 111.156 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.594 HD22 HD13 ' A' ' 203' ' ' ILE . 27.7 tp -125.62 147.79 49.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.53 110.915 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.497 HG11 HG11 ' A' ' 55' ' ' VAL . 53.3 t -115.02 79.2 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 63.21 111.074 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.03 -34.0 37.98 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.781 -0.723 . . . . 60.2 112.427 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 60.17 -163.31 16.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 61.21 112.478 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -32.65 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 54.42 110.892 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.69 HD13 ' OD1' ' A' ' 153' ' ' ASN . 23.0 tp -52.02 -51.38 57.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 70.13 110.929 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 219' ' ' LEU . 21.3 t -89.63 110.84 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 73.32 111.143 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.71 ' HG2' HG23 ' A' ' 222' ' ' THR . 0.4 OUTLIER -56.34 156.27 6.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 73.12 110.95 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 45.5 p -98.77 159.82 14.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 42.32 110.91 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -51.07 -29.91 14.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 70.45 111.107 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.6 m -93.5 46.3 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.288 -0.414 . . . . 72.13 110.818 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.77 48.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 74.41 111.055 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.582 ' HA ' HD22 ' A' ' 225' ' ' LEU . 22.3 tttt -124.82 -2.08 7.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 74.34 110.814 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -170.46 172.31 6.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.311 -0.404 . . . . 70.52 110.905 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 226' ' ' LEU . 3.3 mt -86.32 -36.29 19.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 73.32 110.976 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 125.52 -138.23 10.78 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.727 -0.749 . . . . 35.41 112.494 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.688 HD22 ' HB2' ' A' ' 182' ' ' ALA . 6.2 p-10 -97.87 -1.17 43.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 64.24 110.857 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.734 HG11 ' CG2' ' A' ' 186' ' ' VAL . 27.3 m 36.73 44.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.455 . . . . 72.21 111.079 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.688 ' HB2' HD22 ' A' ' 180' ' ' ASN . . . -60.3 -26.94 66.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 43.2 111.125 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -134.2 29.09 3.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 63.54 110.875 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.68 158.48 36.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 73.34 111.135 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -114.01 90.69 3.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 71.44 110.89 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.734 ' CG2' HG11 ' A' ' 181' ' ' VAL . 27.3 t -62.0 -16.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 73.22 111.131 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.28 -23.43 59.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 70.45 110.877 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -117.12 -13.0 10.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 72.53 110.823 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.608 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.4 t90 -53.58 -62.01 1.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.108 -0.496 . . . . 73.54 110.881 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.759 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -55.25 -23.62 23.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 53.41 110.839 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.54 -30.07 33.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 70.11 111.176 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.7 -44.12 34.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 63.13 110.891 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.509 HG21 ' O ' ' A' ' 219' ' ' LEU . 33.6 mm -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 74.03 111.102 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.462 ' HG2' HD21 ' A' ' 223' ' ' LEU . 2.3 mm-40 -56.3 -27.4 55.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 64.31 110.918 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -77.66 -22.32 50.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 64.33 110.853 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 192' ' ' SER . 17.2 t -85.26 -10.84 11.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.012 0.434 . . . . 75.33 111.204 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.56 -12.7 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 61.44 110.914 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -98.75 -30.79 12.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 71.24 110.928 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -59.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 75.33 110.876 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.459 ' O ' HD11 ' A' ' 203' ' ' ILE . 3.9 m-30 -91.49 61.71 4.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.278 -0.419 . . . . 73.44 110.947 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -72.78 -58.52 3.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.903 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -52.64 101.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 60.14 110.905 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.64 HG21 HG22 ' A' ' 206' ' ' VAL . 71.6 mt -141.14 118.22 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 73.34 111.117 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.1 -28.08 63.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 64.13 110.825 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.649 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -166.9 145.08 5.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.438 . . . . 71.13 111.139 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.748 ' HB ' HD12 ' A' ' 218' ' ' LEU . 93.0 t -123.45 131.46 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.196 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.014 HG22 HG22 ' A' ' 213' ' ' VAL . 15.9 t -110.15 105.87 57.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.602 0.715 . . . . 62.31 111.187 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.2 Cg_endo -69.82 -171.3 0.46 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 70.2 112.319 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.4 -20.24 67.17 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 71.34 112.54 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -152.46 144.48 23.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.795 0.331 . . . . 72.21 110.917 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 111.38 -101.86 1.36 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.772 -0.728 . . . . 74.53 112.544 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -172.03 170.98 5.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.92 0.391 . . . . 73.44 110.868 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.014 HG22 HG22 ' A' ' 207' ' ' VAL . 10.9 t -65.23 148.47 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 70.31 111.188 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -146.51 -101.96 0.31 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.768 -0.729 . . . . 60.34 112.559 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -163.57 -169.12 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.873 0.368 . . . . 54.51 110.903 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -17.75 54.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 53.51 110.907 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.468 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -57.55 -20.72 39.47 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.771 -0.728 . . . . 61.12 112.511 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.748 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.6 mt -72.87 -29.84 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 73.02 110.949 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.509 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -64.52 -60.67 2.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 73.01 110.9 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.468 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.4 OUTLIER -58.76 -19.92 44.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 72.2 110.902 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.742 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -61.86 -50.93 70.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 72.23 110.959 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.729 HG22 HD23 ' A' ' 226' ' ' LEU . 3.8 m -51.7 -51.02 59.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 63.25 111.173 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.636 HD23 ' OG ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -60.49 -18.23 50.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 74.22 110.936 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.69 -2.64 57.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.833 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.742 HD11 ' CE1' ' A' ' 221' ' ' HIS . 8.1 mt -125.22 -8.02 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 51.33 110.88 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.808 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -122.61 9.42 9.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.149 -0.478 . . . . 65.25 110.947 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.846 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.2 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.823 0.344 . . . . 62.15 110.853 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -128.3 -46.57 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.913 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.19 169.98 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 71.51 110.896 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.7 m -86.23 -177.67 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 73.13 111.134 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -116.36 55.95 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.874 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -124.74 168.02 13.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 60.03 110.915 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 m -82.57 -50.45 8.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 71.31 111.085 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 18' ' ' ILE . 3.8 m -60.16 179.8 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 75.35 111.236 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.6 mt -135.78 102.55 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 54.54 111.184 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -110.71 122.64 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 75.3 110.95 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -65.62 166.39 10.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 72.43 110.849 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.65 -48.69 63.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 52.23 110.836 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -60.61 -37.72 82.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.476 . . . . 75.3 111.178 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.86 11.93 61.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 75.35 112.454 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 31' ' ' LEU . 41.9 m -84.55 -41.61 16.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.794 0.331 . . . . 72.33 111.098 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.642 HD13 ' HB2' ' A' ' 67' ' ' LEU . 68.8 mt -101.22 103.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 74.11 111.107 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.1 p -120.62 125.97 49.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 70.12 110.852 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -101.52 -164.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 73.44 111.094 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.581 ' H ' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -178.23 115.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 62.1 110.876 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -68.17 106.48 2.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 74.21 110.904 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.688 ' HG ' HG23 ' A' ' 27' ' ' VAL . 28.8 mt -65.73 -32.62 74.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.01 110.96 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.472 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -148.43 -96.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 63.51 110.876 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.5 OUTLIER -152.62 10.44 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 64.21 110.944 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.51 5.6 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 64.3 110.944 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.401 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 20.8 t -151.4 138.95 13.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.09 -0.504 . . . . 72.43 111.196 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.418 ' O ' HD12 ' A' ' 44' ' ' LEU . 13.2 m95 -125.02 -173.86 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 72.44 110.953 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.688 HG23 ' HG ' ' A' ' 21' ' ' LEU . 72.2 t -137.17 89.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 61.3 111.151 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CA ' HG23 ' A' ' 18' ' ' ILE . 14.2 p80 -73.96 125.16 27.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.776 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.7 m -118.97 96.76 5.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 63.02 111.076 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.22 117.68 18.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 71.14 110.954 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -84.16 114.77 22.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 75.43 110.915 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.77 -139.64 5.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.763 -0.732 . . . . 73.21 112.43 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.7 119.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.904 0.383 . . . . 60.11 110.815 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -148.97 136.8 20.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 75.42 110.9 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 49.67 28.68 2.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 70.31 110.875 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.32 40.96 32.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.734 -0.746 . . . . 62.53 112.551 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -147.43 135.71 21.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 63.13 110.827 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -66.0 145.65 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 51.04 111.108 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.52 79.72 68.6 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.553 0.692 . . . . 70.24 111.108 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.694 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.7 Cg_endo -69.71 117.69 5.23 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.688 2.259 . . . . 64.22 112.327 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.1 p -107.85 98.76 8.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.8 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.97 161.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.881 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -154.7 -155.81 7.44 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.739 . . . . 62.32 112.455 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 158' ' ' LEU . 13.1 tp -157.6 112.05 2.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.885 0.374 . . . . 73.21 110.874 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.659 HG22 HD23 ' A' ' 54' ' ' LEU . 2.0 t -96.88 112.37 28.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 72.42 111.098 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.741 HD21 HD11 ' A' ' 158' ' ' LEU . 17.9 mt -90.86 120.01 31.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.973 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 47' ' ' ASN . 1.8 m-80 -90.75 82.17 5.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 73.23 110.886 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -97.22 -179.51 4.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 71.44 111.105 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.75 -25.81 14.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 70.04 110.859 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.79 -20.16 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.44 110.953 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.5 149.63 5.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.22 112.562 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.699 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.6 mt -61.56 154.16 25.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.817 0.342 . . . . 63.54 110.918 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.3 t -144.59 141.79 23.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 63.2 111.187 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.659 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -137.2 121.97 18.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 63.23 110.898 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.625 HG11 HG11 ' A' ' 165' ' ' VAL . 77.0 t -66.82 111.66 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.45 111.157 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.77 128.22 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.874 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.683 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.8 p -70.84 -167.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 52.51 110.833 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.58 ' H ' HG23 ' A' ' 64' ' ' THR . 8.1 t -89.94 166.84 13.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 53.13 110.907 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.699 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.8 m95 -49.69 -59.86 3.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 73.31 110.892 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.86 158.0 37.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 75.2 110.823 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -51.57 -33.36 32.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 73.33 110.955 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.05 -45.58 90.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 75.23 110.921 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.699 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.4 mt -72.32 -46.93 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.956 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.46 -47.71 56.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 55.4 111.164 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.07 -49.96 62.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 75.5 110.834 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG3' HD12 ' A' ' 16' ' ' ILE . 35.0 tp10 -64.76 -20.54 66.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 74.11 110.837 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.642 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.4 tp -87.24 -25.19 24.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 54.53 110.871 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.23 -24.03 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 62.01 111.145 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -92.17 16.18 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 54.32 110.882 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.8 ptm -131.65 -39.99 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.834 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 67' ' ' LEU . 20.1 m -80.23 -22.86 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 54.34 111.052 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.708 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.37 -24.81 65.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 65.14 110.858 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -105.36 -33.37 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 70.31 110.87 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -44.48 68.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.334 -0.394 . . . . 72.12 110.903 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.541 ' HB2' HD11 ' A' ' 52' ' ' LEU . 13.8 m-85 -85.81 -12.29 51.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 70.54 110.941 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 69.44 11.43 8.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.893 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -131.59 141.49 49.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 71.53 110.918 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.97 140.42 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 61.11 110.959 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.708 HG23 ' OE2' ' A' ' 72' ' ' GLU . 89.6 t -81.78 121.28 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 74.12 111.169 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -138.09 14.23 2.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 73.35 111.153 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.509 ' N ' HG23 ' A' ' 103' ' ' ILE . 60.8 m-20 -154.45 144.83 22.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 64.04 110.935 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 54' ' ' LEU . 21.3 t -153.85 132.81 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.13 111.046 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.555 HD11 ' HE2' ' A' ' 135' ' ' PHE . 43.7 mt -92.66 128.41 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 71.45 111.048 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -104.52 153.16 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.44 111.129 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 36.0 p -112.32 -49.87 2.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 64.14 111.154 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.6 -176.15 5.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 63.24 110.841 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -98.39 90.9 4.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 64.31 111.072 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.2 152.84 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 74.21 110.831 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.23 12.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 73.22 111.1 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.53 27.12 2.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.856 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.13 -71.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 71.11 110.849 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -98.85 7.61 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 73.33 111.211 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.55 -42.22 43.45 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.722 -0.751 . . . . 71.13 112.451 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.61 16.89 58.3 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.639 -0.791 . . . . 51.2 112.491 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.4 tt -56.71 -30.23 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.924 0.392 . . . . 62.31 111.186 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -30.01 60.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 64.34 110.864 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -89.11 -15.14 34.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 63.54 111.175 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 57' ' ' SER . 14.0 mt -89.88 -28.74 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.834 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -97.27 13.4 29.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.263 -0.426 . . . . 70.44 110.895 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -112.35 -43.01 3.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 73.3 110.868 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -78.84 -57.56 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.41 110.939 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.84 38.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.642 -0.789 . . . . 71.55 112.441 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.555 HD13 ' HA ' ' A' ' 98' ' ' LEU . 3.9 mp -108.27 124.53 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.39 . . . . 75.34 111.124 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.533 ' HB3' HD11 ' A' ' 124' ' ' LEU . 2.6 mttt -86.67 120.15 27.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 71.14 110.898 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.11 96.36 10.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.066 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.585 ' HA ' HD12 ' A' ' 124' ' ' LEU . 36.2 m-70 -68.99 144.7 54.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.41 . . . . 72.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.58 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.3 OUTLIER -179.01 -177.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 52.43 110.895 -179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.58 155.83 17.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 73.21 111.161 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.83 -37.87 45.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 71.13 111.086 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.521 HD23 ' OD1' ' A' ' 152' ' ' ASP . 33.4 tp -67.94 -45.85 73.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 71.21 110.915 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.59 ' HA ' HD11 ' A' ' 114' ' ' LEU . 85.9 m -58.49 -21.61 52.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 34.02 111.136 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.26 12.06 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 75.52 111.186 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -111.68 -28.55 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.876 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -100.58 -9.57 21.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.958 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.426 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.03 -38.81 79.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 61.52 110.998 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -27.13 61.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 75.13 110.917 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.34 -34.45 66.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 52.22 110.863 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -88.44 -23.7 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 54.54 110.808 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.81 21.79 4.88 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.801 -0.714 . . . . 71.44 112.557 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -95.73 177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.785 0.326 . . . . 71.05 110.942 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HB2' HD13 ' A' ' 95' ' ' ILE . 66.5 mm-40 -78.12 176.03 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.514 . . . . 72.32 110.904 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.9 mt-10 -108.58 104.8 55.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 75.24 110.933 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.82 178.74 4.3 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.653 2.235 . . . . 70.44 112.358 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 106' ' ' HIS . 28.3 mt -51.37 -51.09 57.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 62.32 110.938 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.52 40.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 34.15 112.522 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -99.23 34.47 2.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 70.43 110.929 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.683 ' CD2' HD21 ' A' ' 133' ' ' LEU . 80.7 mt -117.96 -174.35 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 61.53 110.851 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.1 -171.12 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 71.33 110.835 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.804 HG22 HG23 ' A' ' 130' ' ' VAL . 99.5 m -50.56 -69.75 0.1 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 65.41 111.058 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.804 HG23 HG22 ' A' ' 129' ' ' THR . 34.5 t -120.49 102.61 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 65.41 111.121 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -132.71 164.29 27.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.507 . . . . 61.4 111.154 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.3 129.15 56.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 74.25 110.881 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.683 HD21 ' CD2' ' A' ' 127' ' ' LEU . 61.6 mt -115.89 157.97 23.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.998 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -136.99 112.15 9.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.92 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.555 ' HE2' HD11 ' A' ' 83' ' ' ILE . 19.0 m-85 -107.6 45.42 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.947 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.01 87.94 0.18 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 54.03 112.492 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.73 14.66 9.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.854 0.359 . . . . 73.43 110.949 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.45 ' HB2' HG22 ' A' ' 48' ' ' THR . 50.2 tpp -131.31 89.87 2.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 73.54 110.86 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.0 130.58 38.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 70.15 110.924 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.687 HG22 HD21 ' A' ' 158' ' ' LEU . 21.2 t -139.55 117.02 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 70.22 111.145 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -108.24 132.73 53.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.9 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 37.7 p -90.14 171.01 9.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 42.23 111.112 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HD1' HG22 ' A' ' 130' ' ' VAL . 20.4 t80 -154.29 130.28 10.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 72.25 110.865 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.653 ' HB3' HG23 ' A' ' 129' ' ' THR . 17.6 t80 -118.44 85.56 26.24 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.613 0.72 . . . . 73.44 110.868 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.56 23.9 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.705 2.27 . . . . 73.52 112.306 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.24 -169.62 15.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.8 -0.714 . . . . 73.22 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -76.79 147.81 37.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.839 0.352 . . . . 73.52 110.868 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.26 -64.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 72.11 112.486 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 83.8 t60 -89.56 -30.93 17.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.873 0.368 . . . . 75.14 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.9 p -139.83 -87.14 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 63.5 111.162 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.412 ' OE1' HD23 ' A' ' 114' ' ' LEU . 71.5 tt0 -160.56 -32.91 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 75.11 110.812 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.521 ' OD1' HD23 ' A' ' 110' ' ' LEU . 12.5 t0 -127.58 14.56 7.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 74.2 110.795 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -50.41 125.57 13.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.14 110.861 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 144' ' ' TYR . 12.6 pt -123.36 164.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 64.03 111.107 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 143' ' ' PHE . 9.6 m -115.74 118.99 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 71.15 111.139 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 83' ' ' ILE . 43.7 t -70.77 118.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 62.35 111.076 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -104.89 131.14 52.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.926 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.741 HD11 HD21 ' A' ' 46' ' ' LEU . 11.7 mt -113.1 97.02 41.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.573 0.702 . . . . 74.31 110.985 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.61 -4.68 14.41 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.781 2.321 . . . . 52.24 112.352 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -83.18 -23.03 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 74.34 110.914 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.46 13.4 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 74.51 110.922 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.46 29.13 10.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 73.15 110.981 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.1 130.14 44.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 73.52 111.16 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' A' ' 203' ' ' ILE . 24.8 tp -113.54 147.73 37.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 75.43 110.865 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.625 HG11 HG11 ' A' ' 55' ' ' VAL . 25.9 t -111.05 78.72 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 74.2 111.157 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -52.07 -35.37 41.06 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.755 . . . . 74.4 112.49 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 63.04 -159.26 36.64 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.801 -0.714 . . . . 51.24 112.505 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 35.8 m -59.94 -30.82 69.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.876 0.369 . . . . 70.43 110.904 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.692 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.3 tp -53.63 -49.15 68.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.904 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.669 HG13 ' HA ' ' A' ' 219' ' ' LEU . 21.0 t -89.77 105.43 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 65.25 111.105 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.645 ' HD3' HG23 ' A' ' 222' ' ' THR . 0.2 OUTLIER -52.38 147.99 7.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.11 110.902 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.507 ' HA ' HD22 ' A' ' 218' ' ' LEU . 54.2 p -99.92 167.11 10.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 72.32 110.882 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t -54.13 -26.15 26.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 54.31 111.149 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 m -93.08 43.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 60.45 110.832 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -133.72 138.02 45.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 65.11 111.067 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.512 ' HA ' HD22 ' A' ' 225' ' ' LEU . 30.7 tttm -122.84 -4.22 8.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.896 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.99 151.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 70.11 110.909 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 226' ' ' LEU . 7.3 mt -65.73 -31.47 72.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 52.3 110.968 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.32 -138.1 21.34 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.735 -0.745 . . . . 65.21 112.456 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.38 95.95 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.894 0.378 . . . . 53.13 110.905 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.401 HG12 ' HZ3' ' A' ' 189' ' ' TRP . 15.6 m -100.94 21.85 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.44 111.164 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -59.26 -25.1 63.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 73.54 111.094 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -110.73 18.19 19.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.464 . . . . 52.43 110.883 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 149' ' ' HIS . . . -135.01 156.25 49.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 55.15 111.12 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -105.4 85.99 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.95 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.22 -21.34 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.11 111.143 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -72.38 -28.11 62.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 53.04 110.878 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -106.75 -14.94 14.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.05 110.905 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.73 ' CE3' HD13 ' A' ' 178' ' ' LEU . 1.9 t90 -55.36 -61.05 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 71.33 110.876 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.739 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.15 -25.43 13.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 70.42 110.842 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -80.92 -32.86 34.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.077 -0.511 . . . . 64.34 111.116 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.61 -41.72 65.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 72.33 110.842 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 219' ' ' LEU . 27.4 mm -64.96 -46.89 90.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 73.24 111.162 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.27 -28.59 63.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 43.14 110.837 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -76.96 -22.78 52.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 75.5 110.889 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 192' ' ' SER . 11.0 t -85.19 -10.51 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 61.02 111.094 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.0 pp -112.22 -10.15 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.439 . . . . 71.55 110.926 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.01 -30.73 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 75.14 110.872 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 -46.68 4.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.823 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.06 37.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 71.33 110.909 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -48.07 69.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.946 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -59.92 103.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 62.04 110.85 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.585 HG21 HG22 ' A' ' 206' ' ' VAL . 40.8 mt -146.07 123.3 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 54.25 111.067 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -25.48 46.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.879 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -172.53 130.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 72.41 111.091 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.743 ' HB ' HD12 ' A' ' 218' ' ' LEU . 57.9 t -100.23 147.33 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.19 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 213' ' ' VAL . 20.2 t -122.57 101.12 40.54 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.639 0.733 . . . . 74.23 111.04 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 218' ' ' LEU . 54.5 Cg_endo -69.78 177.34 5.69 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.639 2.226 . . . . 73.2 112.385 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.68 -11.65 79.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 74.34 112.488 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -152.77 148.39 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 72.12 110.843 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 98.29 -99.89 2.26 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 73.42 112.436 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -174.39 153.87 2.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 74.21 110.95 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 207' ' ' VAL . 5.3 m -53.98 163.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 70.23 111.172 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -163.55 -93.84 0.1 OUTLIER Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.725 -0.75 . . . . 65.15 112.444 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -171.47 -166.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.907 0.384 . . . . 71.14 110.884 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -56.8 -20.74 24.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.847 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.53 -23.0 18.25 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 54.51 112.455 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.743 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.6 mt -77.38 -32.5 54.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.772 0.32 . . . . 74.11 110.857 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.669 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.0 mp -62.08 -62.33 1.85 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 64.21 110.885 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -22.74 48.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 62.44 110.864 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.627 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -61.13 -45.86 92.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 70.31 110.877 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.645 HG23 ' HD3' ' A' ' 171' ' ' LYS . 3.5 m -51.28 -54.95 21.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.273 -0.421 . . . . 71.14 111.153 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 190' ' ' SER . 1.4 mt -60.58 -18.43 52.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 64.32 110.89 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.804 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.627 HD11 ' CE1' ' A' ' 221' ' ' HIS . 8.8 mt -124.68 -10.5 7.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 73.11 110.893 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.742 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.5 OUTLIER -116.46 14.07 15.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.94 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 71.33 110.894 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.0 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.774 0.321 . . . . 64.02 110.804 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -121.63 170.05 10.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 75.41 110.924 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -137.18 141.17 42.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 62.44 110.899 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.4 p -51.65 147.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 70.14 111.178 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.37 171.49 20.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 53.42 110.866 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -73.05 179.8 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 64.12 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.4 m -62.02 -42.96 99.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 75.12 111.136 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.9 m -62.3 -177.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 53.33 111.114 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.14 93.69 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 53.21 111.154 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.01 115.3 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 75.05 110.872 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -59.28 166.36 2.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.284 -0.416 . . . . 54.02 110.858 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -51.77 -47.86 63.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 73.04 110.909 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.3 p -60.26 -38.23 82.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.15 111.142 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.92 12.73 60.07 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.799 -0.715 . . . . 65.14 112.433 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.639 HG23 ' HB3' ' A' ' 31' ' ' LEU . 52.4 m -81.14 -42.95 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.679 0.276 . . . . 65.41 111.115 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.5 mt -102.31 125.45 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 72.24 111.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.9 p -131.93 126.95 35.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 63.23 110.861 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.683 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.9 OUTLIER -122.3 112.86 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 74.53 111.119 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.431 ' HA ' HG12 ' A' ' 8' ' ' VAL . 25.0 t -100.45 127.54 46.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 74.14 110.878 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -70.58 111.61 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 62.32 110.927 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 163' ' ' ILE . 12.7 mt -65.22 -32.29 73.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.89 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.06 -97.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 63.24 110.837 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -150.26 9.48 0.65 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 35.22 110.906 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.454 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.09 7.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.856 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -150.78 141.14 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 75.21 111.1 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.683 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.7 m95 -129.01 -178.32 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.937 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' A' ' 21' ' ' LEU . 92.3 t -133.04 89.75 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.384 . . . . 74.24 111.052 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.465 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.8 p80 -72.39 123.79 23.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.913 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.6 m -119.68 104.01 9.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 24.54 111.106 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -86.62 122.64 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 72.54 110.841 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 40' ' ' PRO . 0.4 OUTLIER -89.29 114.11 25.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.844 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -85.06 -139.13 4.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 51.51 112.518 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.3 119.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.931 0.396 . . . . 72.11 110.826 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -147.49 136.71 22.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 72.32 110.83 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 49.92 28.93 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 74.12 110.979 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.87 41.44 33.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.748 -0.739 . . . . 61.53 112.507 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -147.21 134.36 20.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 73.2 110.87 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -63.48 146.83 52.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 74.43 111.142 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 t -133.48 80.61 56.91 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.676 0.751 . . . . 54.53 111.107 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.695 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.4 Cg_endo -69.82 118.99 6.01 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.601 2.201 . . . . 65.24 112.364 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.3 p -112.3 96.95 6.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.888 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -57.83 164.74 2.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.04 110.813 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -155.49 -148.16 4.94 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.778 -0.725 . . . . 61.24 112.509 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.614 HD21 HD12 ' A' ' 158' ' ' LEU . 19.7 tp -159.85 115.27 2.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.856 0.36 . . . . 63.42 110.886 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.661 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.4 122.15 50.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.31 111.145 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.841 HD21 HD11 ' A' ' 158' ' ' LEU . 28.5 mt -99.39 115.42 29.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 73.12 110.891 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.55 87.59 7.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.89 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.14 179.58 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 72.33 111.157 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -100.33 -21.97 15.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.842 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -12.2 56.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 64.3 110.871 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.95 150.87 5.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.686 -0.769 . . . . 73.32 112.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 77' ' ' LYS . 7.9 tp -65.72 154.58 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 54.23 110.925 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.76 141.57 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.112 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -136.84 125.13 23.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.33 110.946 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 165' ' ' VAL . 69.2 t -70.04 111.15 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 75.45 111.193 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.58 128.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 65.25 110.807 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.698 ' HB3' HD11 ' A' ' 98' ' ' LEU . 2.4 p -71.6 -167.1 0.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.22 110.832 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.439 ' H ' HG23 ' A' ' 64' ' ' THR . 6.9 t -90.28 168.87 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 72.33 110.882 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.707 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.1 m95 -50.35 -60.43 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 74.05 110.938 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -126.67 159.37 33.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 74.04 110.818 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -52.66 -35.06 54.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 73.1 110.862 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -57.79 -38.02 74.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.995 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.707 HD12 ' HB2' ' A' ' 59' ' ' TRP . 92.7 mt -79.62 -46.7 16.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 63.25 110.95 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.71 -45.44 58.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.12 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -57.79 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 74.43 110.946 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.99 -22.69 50.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 71.33 110.859 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 71' ' ' VAL . 17.3 tp -84.8 -25.88 27.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 61.43 110.924 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.3 mt -91.46 -22.99 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 62.13 111.132 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -92.38 15.94 12.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 71.13 110.939 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.1 ptm -130.95 -40.03 1.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.884 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 67' ' ' LEU . 31.5 m -80.25 -22.2 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.12 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.653 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.22 -24.53 64.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 42.4 110.885 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -105.69 -33.85 7.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 71.42 110.924 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 -43.29 73.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 33.2 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -88.69 -11.35 45.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.883 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.89 11.88 8.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 53.2 110.966 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.52 ' HB2' HD13 ' A' ' 52' ' ' LEU . 5.9 mttm -130.01 139.22 51.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.83 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -85.35 138.27 32.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.267 -0.424 . . . . 75.22 110.803 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.653 HG23 ' OE2' ' A' ' 72' ' ' GLU . 94.4 t -78.39 123.09 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.197 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 t -140.07 13.44 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 73.42 111.169 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -154.85 143.79 20.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 73.03 110.917 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 54' ' ' LEU . 16.3 t -154.07 128.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 70.41 111.081 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.551 ' CD1' HG11 ' A' ' 140' ' ' VAL . 55.3 mt -85.42 131.37 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 54.21 111.113 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.9 mm -109.91 136.62 45.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 73.12 111.145 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.0 p -96.17 -45.36 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.158 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -153.46 -175.52 5.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 63.02 110.845 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.13 86.73 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 51.43 111.162 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -143.68 153.22 42.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 70.14 110.859 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.24 -23.67 9.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.119 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -95.37 30.11 2.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 73.43 110.842 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.94 -70.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.878 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.16 7.34 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 73.44 111.127 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.69 -41.91 51.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.816 -0.707 . . . . 64.31 112.451 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.7 14.46 64.09 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.668 -0.777 . . . . 61.25 112.518 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.2 tt -55.12 -28.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 74.02 111.153 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -34.57 63.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.946 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.1 m -86.8 -12.53 47.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 72.04 111.181 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 57' ' ' SER . 16.7 mt -90.63 -24.92 20.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 72.03 110.927 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.13 20.19 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.883 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -120.97 -34.06 3.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 63.12 110.881 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -90.86 -42.56 10.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 70.02 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.79 37.96 0.16 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.769 -0.729 . . . . 70.05 112.492 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.576 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.0 mp -103.16 111.24 32.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.954 0.407 . . . . 74.45 111.166 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.709 ' HE2' HD21 ' A' ' 124' ' ' LEU . 1.9 mtpp -72.74 112.05 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 72.51 110.923 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.54 90.56 8.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 42.31 111.107 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.567 ' HA ' HD12 ' A' ' 124' ' ' LEU . 51.8 m-70 -61.93 145.19 53.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 73.35 110.862 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.613 ' CA ' HD12 ' A' ' 127' ' ' LEU . 1.2 p -177.04 179.79 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.809 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.2 158.14 18.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 71.41 111.106 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.51 -39.72 49.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.23 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.714 HD23 ' OD2' ' A' ' 152' ' ' ASP . 62.3 tp -72.27 -37.82 68.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 71.4 110.924 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.728 ' HA ' HD11 ' A' ' 114' ' ' LEU . 91.5 m -58.07 -28.1 64.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 72.15 111.192 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.59 0.95 57.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.21 111.073 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.52 -55.54 2.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.455 . . . . 63.42 110.928 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.2 OUTLIER -70.21 -10.29 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 62.23 110.897 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.47 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.78 -46.24 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.081 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -29.51 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 72.21 110.866 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -52.14 -36.71 52.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.935 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -89.51 -17.19 29.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 75.14 110.848 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.64 19.63 8.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.706 -0.759 . . . . 75.03 112.475 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.74 171.83 8.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.883 0.373 . . . . 74.51 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' HB2' HD13 ' A' ' 95' ' ' ILE . 13.9 mm-40 -70.63 -176.3 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 74.02 110.972 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -116.37 101.53 53.74 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 73.32 110.948 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.4 Cg_endo -69.67 -179.68 3.04 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.741 2.294 . . . . 70.33 112.351 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HE2' ' A' ' 104' ' ' LYS . 24.6 mt -51.1 -57.67 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 62.51 110.919 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.42 68.64 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.66 -0.781 . . . . 52.21 112.51 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.55 36.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 74.11 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.678 ' CD2' HD21 ' A' ' 133' ' ' LEU . 87.3 mt -119.23 -175.23 2.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.979 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.38 -171.13 3.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 51.34 110.898 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.903 HG22 HG23 ' A' ' 130' ' ' VAL . 52.6 m -50.73 -70.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 73.34 111.153 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.903 HG23 HG22 ' A' ' 129' ' ' THR . 31.3 t -120.51 103.17 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.44 111.177 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -133.04 170.22 15.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 64.53 111.125 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.32 128.11 52.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 71.41 110.886 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.678 HD21 ' CD2' ' A' ' 127' ' ' LEU . 63.9 mt -116.08 155.95 27.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 65.54 110.914 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -136.1 114.83 12.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.887 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -110.08 51.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 61.1 110.866 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.44 89.46 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.718 -0.753 . . . . 75.35 112.574 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.96 14.57 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 75.33 110.845 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.432 ' SD ' HD22 ' A' ' 46' ' ' LEU . 50.4 tpp -133.13 98.22 4.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 71.52 110.844 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 131.13 34.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 72.02 110.908 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.847 HG22 HD21 ' A' ' 158' ' ' LEU . 90.1 t -136.78 119.09 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 71.41 111.114 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -111.66 125.55 54.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 70.41 110.914 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.3 p -81.0 -172.52 3.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 32.44 111.136 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.575 ' HD1' HG22 ' A' ' 130' ' ' VAL . 15.9 t80 -170.84 130.83 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.43 110.923 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.709 ' HB3' HG23 ' A' ' 129' ' ' THR . 12.2 t80 -119.93 86.13 35.84 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.763 0.792 . . . . 74.21 110.911 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.707 2.271 . . . . 72.33 112.351 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.39 -162.1 23.22 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.722 -0.751 . . . . 72.43 112.443 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -85.2 135.86 33.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.736 0.303 . . . . 74.43 110.921 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.416 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -148.68 -85.19 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 23.24 112.506 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -79.8 -24.3 41.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.393 . . . . 75.21 110.905 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.478 HG21 ' HB2' ' A' ' 86' ' ' HIS . 24.3 p -147.05 -162.97 1.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 74.4 111.111 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.56 ' HB3' HD23 ' A' ' 114' ' ' LEU . 36.2 tt0 -88.45 -20.94 24.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.927 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.714 ' OD2' HD23 ' A' ' 110' ' ' LEU . 3.4 t0 -133.22 18.27 4.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.86 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.434 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.1 OUTLIER -50.92 131.42 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 70.31 110.771 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.443 HG22 ' CD1' ' A' ' 144' ' ' TYR . 12.9 pt -140.72 169.95 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 65.21 111.09 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 143' ' ' PHE . 16.6 m -121.88 135.36 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 72.04 111.2 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.22 122.57 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.07 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -107.73 132.13 53.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 75.23 110.919 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.847 HD21 HG22 ' A' ' 140' ' ' VAL . 10.7 mt -112.06 98.55 42.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.542 0.687 . . . . 72.03 110.825 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.5 Cg_endo -69.76 -4.93 15.03 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.707 2.272 . . . . 73.41 112.291 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.24 -23.64 35.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.42 110.951 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.04 14.6 1.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.908 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.7 m120 53.95 27.64 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 74.43 110.958 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.483 HD13 HD13 ' A' ' 21' ' ' LEU . 97.0 mt -92.75 125.93 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 74.41 111.078 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.3 tp -108.2 148.68 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 64.24 110.908 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.443 HG11 HG11 ' A' ' 55' ' ' VAL . 62.0 t -112.43 81.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 63.51 111.129 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.47 -41.42 48.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 64.3 112.453 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.23 -167.5 46.54 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 51.31 112.522 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.02 -34.42 29.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 71.34 110.871 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.592 HD12 ' NE1' ' A' ' 189' ' ' TRP . 14.3 tp -51.26 -60.3 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 73.14 110.915 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 218' ' ' LEU . 14.2 t -82.2 116.17 25.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.144 -0.48 . . . . 71.44 111.076 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.679 ' HE3' HD11 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -51.66 171.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.907 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -121.34 138.11 54.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.0 110.883 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.411 ' O ' ' CB ' ' A' ' 174' ' ' SER . 0.0 OUTLIER -39.49 149.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 44.32 111.168 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 173' ' ' THR . 0.9 OUTLIER 77.14 13.18 2.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 75.52 110.819 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -107.07 146.04 31.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 54.21 111.121 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -114.0 12.97 18.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 54.24 110.866 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.46 164.18 0.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 72.21 110.902 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 226' ' ' LEU . 18.5 mt -61.9 -48.01 82.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.249 -0.432 . . . . 63.51 110.903 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 129.82 -106.02 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.805 -0.712 . . . . 64.51 112.467 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -110.08 110.48 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.879 0.371 . . . . 74.1 110.853 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.495 HG12 ' HZ3' ' A' ' 189' ' ' TRP . 26.7 m -100.47 30.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 63.5 111.122 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.92 -28.68 67.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 72.33 111.141 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.36 24.04 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.868 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -118.98 157.13 28.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 30.23 111.073 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -110.43 88.18 2.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.974 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 21.7 t -58.32 -20.08 14.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 54.12 111.133 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -73.66 -23.02 59.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.956 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -114.33 -13.78 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 71.23 110.891 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.592 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.8 t90 -54.19 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 55.44 110.947 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.78 ' HB3' HD11 ' A' ' 226' ' ' LEU . 3.2 p -54.24 -24.65 19.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 61.21 110.821 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.1 m -80.55 -30.21 37.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 52.21 111.163 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.413 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -77.34 -44.55 29.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 72.04 110.929 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 219' ' ' LEU . 34.9 mm -58.91 -46.19 91.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.027 -0.533 . . . . 62.32 111.086 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -55.62 -29.06 58.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.866 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -77.17 -22.3 52.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 74.02 110.862 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 219' ' ' LEU . 20.7 t -84.76 -11.13 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 55.2 111.122 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -111.12 -15.47 13.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 62.5 110.896 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.447 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -96.42 -30.98 13.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 65.23 110.98 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -50.13 3.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 73.25 110.843 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.452 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -97.41 61.59 1.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 63.32 110.961 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -74.33 -63.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 74.2 110.902 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -51.99 103.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 71.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.671 HG21 ' CG2' ' A' ' 206' ' ' VAL . 79.3 mt -141.42 123.22 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.452 . . . . 73.13 111.182 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.57 -29.38 52.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.3 110.833 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -169.3 133.51 1.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.124 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.752 ' HB ' HD12 ' A' ' 218' ' ' LEU . 83.9 t -109.42 130.07 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.437 . . . . 60.32 111.115 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 213' ' ' VAL . 4.2 t -105.73 111.17 64.71 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.561 0.696 . . . . 74.24 111.039 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -175.73 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.675 2.25 . . . . 64.33 112.349 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.75 -12.57 79.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.739 -0.743 . . . . 53.31 112.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -152.11 147.25 26.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 63.43 110.796 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 97.37 -117.93 5.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.7 -0.762 . . . . 51.34 112.454 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -145.85 175.26 10.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.945 0.402 . . . . 73.34 110.85 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 207' ' ' VAL . 3.2 m -72.07 156.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 72.54 111.059 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -147.51 -105.7 0.41 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.68 -0.771 . . . . 53.43 112.441 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.423 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.3 OUTLIER -153.82 -178.13 6.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 73.23 110.963 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.519 ' HA ' HG21 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -61.97 -16.55 52.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 72.32 110.874 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.39 -23.7 42.87 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.75 -0.738 . . . . 75.05 112.473 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.752 HD12 ' HB ' ' A' ' 206' ' ' VAL . 4.6 mt -65.07 -25.66 67.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.321 . . . . 65.23 110.834 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.524 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.2 mm? -70.36 -59.49 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.924 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.67 -15.24 57.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 54.01 110.895 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 171' ' ' LYS . 1.2 t-80 -77.58 -42.57 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 71.55 110.954 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 1.036 HG22 HD23 ' A' ' 226' ' ' LEU . 47.1 m -52.98 -48.59 67.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 74.52 111.16 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.64 -14.52 52.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.217 -0.447 . . . . 72.44 110.887 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -88.33 3.01 51.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 75.02 110.882 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.679 HD11 ' HE3' ' A' ' 171' ' ' LYS . 4.5 mt -133.62 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.912 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 1.036 HD23 HG22 ' A' ' 222' ' ' THR . 1.0 OUTLIER -77.06 -4.43 44.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 55.21 110.896 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 73.01 110.929 179.888 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.791 0.329 . . . . 64.11 110.869 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -120.79 179.43 4.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 75.31 110.873 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -135.89 128.84 31.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.934 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 p -51.7 147.58 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.261 -0.427 . . . . 75.5 111.115 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.35 177.33 10.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 63.01 110.877 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -60.38 -174.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 75.43 110.942 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 m -84.7 -40.42 17.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 54.15 111.187 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.17 -177.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 74.03 111.077 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.4 mt -136.2 93.37 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 70.43 111.227 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.26 121.11 43.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.852 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -63.84 167.63 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 55.34 110.876 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.04 -44.86 64.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 52.41 110.86 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.0 p -62.04 -38.11 87.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 71.51 111.159 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.25 14.54 62.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.798 -0.715 . . . . 50.51 112.495 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.418 HG23 ' CB ' ' A' ' 31' ' ' LEU . 23.7 m -83.59 -39.25 20.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.818 0.342 . . . . 74.04 111.174 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.1 mt -108.14 117.54 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 73.24 111.1 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -124.36 132.43 53.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.24 110.88 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.709 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.2 mt -124.92 108.63 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 54.13 111.101 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -100.95 127.53 47.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.866 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -69.77 111.21 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.909 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HG ' HG23 ' A' ' 27' ' ' VAL . 23.0 mt -64.23 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 63.51 110.915 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.07 -97.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.42 110.911 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.2 OUTLIER -151.54 10.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.825 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.438 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.56 6.35 0.55 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.89 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 t -150.73 140.16 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 71.01 111.14 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.709 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.7 m95 -127.55 -178.05 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.909 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.551 HG23 ' HG ' ' A' ' 21' ' ' LEU . 69.3 t -133.67 95.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.156 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -77.56 118.32 19.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 73.55 110.813 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 m -113.67 107.34 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 70.33 111.157 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -93.24 126.93 38.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.44 110.881 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.598 HD22 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -91.47 105.04 17.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.916 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.13 -128.62 0.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.803 -0.713 . . . . 73.32 112.537 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.59 74.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 72.33 110.818 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.48 ' CD2' HG11 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -59.78 96.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 73.24 110.856 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 56.51 21.55 5.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.499 . . . . 63.54 110.88 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.58 6.56 23.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.638 -0.792 . . . . 54.44 112.424 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -108.63 113.98 27.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.852 0.358 . . . . 70.13 110.863 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.598 ' HB1' HD22 ' A' ' 31' ' ' LEU . . . -60.98 103.57 0.28 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.504 . . . . 54.5 111.159 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 34' ' ' PHE . 2.1 p -115.05 99.19 51.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.599 0.714 . . . . 72.44 111.121 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 39' ' ' VAL . 53.5 Cg_endo -69.81 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.703 2.269 . . . . 73.41 112.352 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.9 p -100.43 107.77 19.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 62.51 110.818 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.06 162.61 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.885 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.19 -155.27 6.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.743 -0.741 . . . . 74.43 112.472 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.598 HD21 ' CD1' ' A' ' 158' ' ' LEU . 19.8 tp -158.61 112.62 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 73.23 110.927 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.675 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.4 t -97.5 121.49 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 72.33 111.135 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.585 HD21 HD11 ' A' ' 158' ' ' LEU . 29.5 mt -99.67 118.0 35.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.985 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.2 85.83 6.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.02 110.826 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -100.81 -174.29 2.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.194 -0.457 . . . . 72.4 111.073 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -103.23 -27.79 12.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 71.42 110.844 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -18.16 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.52 110.873 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.4 150.73 5.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 63.54 112.484 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.711 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.8 mt -62.14 155.09 25.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 63.14 110.937 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.437 HG13 ' C ' ' A' ' 81' ' ' ASP . 2.1 t -144.78 141.84 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 72.31 111.099 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.675 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -136.61 122.91 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 43.44 110.893 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -69.68 112.23 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 65.05 111.139 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.94 128.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 74.5 110.852 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.673 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.8 p -71.92 -168.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 60.1 110.821 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -89.94 171.65 9.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.11 110.936 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.721 ' HB2' HD12 ' A' ' 63' ' ' LEU . 95.7 m95 -50.85 -60.77 2.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.085 -0.507 . . . . 74.21 110.96 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.47 159.04 36.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 52.12 110.896 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -51.56 -34.04 35.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.51 110.904 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -57.76 -39.47 77.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.798 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.721 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.1 mt -80.09 -43.83 21.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 73.02 110.939 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.25 -48.53 62.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.07 -0.514 . . . . 75.13 111.152 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.99 -49.43 66.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 72.04 110.931 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.75 -19.48 65.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 74.12 110.967 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.559 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.2 tp -88.65 -26.14 22.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 53.43 110.91 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.0 mt -91.5 -23.11 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 73.23 111.15 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -92.29 15.54 13.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 61.41 110.872 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.6 ptm -130.5 -39.95 1.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 70.41 110.887 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 67' ' ' LEU . 32.7 m -79.76 -23.44 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 61.03 111.109 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.711 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.0 -25.03 66.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.3 110.827 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -104.77 -33.49 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 72.34 110.899 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -45.14 67.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.44 111.012 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.584 ' HB2' HD11 ' A' ' 52' ' ' LEU . 19.8 m-85 -85.21 -12.59 52.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 73.3 110.852 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 69.5 11.21 7.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.44 110.829 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.93 141.37 50.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.412 . . . . 64.54 110.899 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -85.82 140.55 30.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.55 110.819 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.711 HG22 ' HB3' ' A' ' 52' ' ' LEU . 87.4 t -82.04 125.01 39.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 70.14 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -140.89 12.11 2.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 75.1 111.13 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.539 ' N ' HG23 ' A' ' 103' ' ' ILE . 61.1 m-20 -152.48 146.12 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 71.21 110.849 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 54' ' ' LEU . 15.7 t -154.29 131.27 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.22 111.169 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.58 HD13 HG11 ' A' ' 140' ' ' VAL . 5.5 mt -92.68 126.75 45.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 62.01 111.082 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.8 mm -101.85 150.42 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 54.12 111.16 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -45.43 3.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 61.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.643 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -149.32 175.76 11.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 73.4 110.872 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -98.27 87.07 3.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 72.03 111.047 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -143.73 156.23 44.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 70.31 110.897 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.79 -21.32 27.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 54.12 111.018 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.55 18.02 10.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 54.14 110.828 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -137.87 -76.52 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 63.32 110.796 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -92.5 7.42 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.32 111.072 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.68 -39.76 39.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.737 -0.744 . . . . 51.41 112.534 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.21 15.92 58.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.659 -0.781 . . . . 71.23 112.402 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.555 HD13 ' HB2' ' A' ' 121' ' ' GLU . 18.3 tt -57.14 -28.61 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 73.13 111.147 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -55.89 -30.22 61.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 74.11 110.939 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -88.87 -17.5 29.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 74.11 111.132 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 57' ' ' SER . 11.5 mt -88.5 -28.63 20.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 74.35 110.913 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -92.34 7.89 40.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.14 110.917 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -106.86 -55.27 2.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 70.13 110.917 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -63.97 -57.11 10.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 74.41 110.807 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.0 39.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.674 -0.774 . . . . 73.44 112.384 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.634 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.3 mp -104.99 126.56 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 71.13 111.095 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.534 ' HB3' HD11 ' A' ' 124' ' ' LEU . 5.3 mttm -86.05 117.59 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 70.53 110.94 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.27 94.95 9.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 70.33 111.127 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.583 ' HA ' HD12 ' A' ' 124' ' ' LEU . 41.3 m-70 -66.58 146.07 54.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 61.22 110.907 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.541 ' CA ' HD12 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -179.97 176.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 53.55 110.938 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -86.73 154.06 21.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 65.41 111.091 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.13 -41.4 36.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 61.43 111.028 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.737 HD23 ' OD1' ' A' ' 152' ' ' ASP . 56.0 tp -67.25 -43.73 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.429 . . . . 74.54 110.861 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.699 ' HA ' HD11 ' A' ' 114' ' ' LEU . 89.0 m -59.65 -18.4 41.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 63.32 111.17 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -102.7 10.22 38.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.42 111.036 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.722 ' HG2' HD12 ' A' ' 110' ' ' LEU . 0.1 OUTLIER -111.23 -27.31 8.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 54.52 110.917 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.699 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -99.14 -7.44 26.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 64.3 110.927 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.38 -38.39 63.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.01 111.068 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -26.84 61.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.15 110.862 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -58.74 -33.52 70.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.916 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -88.07 -21.35 24.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 75.12 110.93 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.36 5.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.697 -0.763 . . . . 75.01 112.466 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -98.38 175.2 6.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 74.11 110.9 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' HB2' HD13 ' A' ' 95' ' ' ILE . 78.3 mm-40 -74.17 -176.2 2.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.513 . . . . 52.2 110.933 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.8 OUTLIER -117.44 106.93 45.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.638 0.732 . . . . 54.42 110.853 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.591 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.5 Cg_endo -69.82 178.4 4.65 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.679 2.253 . . . . 71.34 112.273 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.583 HD12 ' HA ' ' A' ' 106' ' ' HIS . 16.4 mt -51.78 -42.92 62.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 62.4 110.972 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.31 27.57 24.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.735 -0.745 . . . . 62.51 112.519 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -108.1 43.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 72.33 110.872 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.637 HD22 HD21 ' A' ' 133' ' ' LEU . 83.7 mt -126.86 -174.09 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 72.35 110.918 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.47 -172.05 4.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.941 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.866 HG22 HG23 ' A' ' 130' ' ' VAL . 55.5 m -50.9 -70.82 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 72.0 111.083 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.866 HG23 HG22 ' A' ' 129' ' ' THR . 33.2 t -117.39 102.17 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 72.3 111.071 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.1 t -132.45 174.7 9.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 64.43 111.106 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -120.96 134.44 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.34 110.903 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.637 HD21 HD22 ' A' ' 127' ' ' LEU . 26.4 mt -115.16 160.21 19.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 64.41 110.903 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -142.6 124.62 15.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 72.23 110.91 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.57 ' HE2' HD11 ' A' ' 83' ' ' ILE . 16.5 m-85 -125.1 44.36 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 75.35 110.868 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 67.1 94.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.741 . . . . 51.52 112.45 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 m120 66.22 12.94 8.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.748 0.309 . . . . 74.05 110.91 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.443 ' HB2' HG22 ' A' ' 48' ' ' THR . 53.5 tpp -135.74 109.8 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 74.05 110.777 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.81 133.34 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.886 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.705 HG22 HD21 ' A' ' 158' ' ' LEU . 20.0 t -138.79 115.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 54.44 111.122 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.6 129.98 55.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 72.1 110.844 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 p -86.8 -179.13 6.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 61.13 111.204 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.515 ' HD1' HG22 ' A' ' 130' ' ' VAL . 23.3 t80 -164.35 134.05 3.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 75.43 110.882 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.717 ' HB3' HG23 ' A' ' 129' ' ' THR . 12.6 t80 -121.83 89.79 48.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.647 0.737 . . . . 75.31 110.936 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.78 -7.84 22.08 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.73 2.286 . . . . 72.32 112.338 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 125.99 -160.91 20.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.722 -0.751 . . . . 70.12 112.553 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 11.6 mttp -79.33 134.83 36.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.903 0.383 . . . . 72.32 110.829 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.17 -89.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.559 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -74.26 -27.8 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.43 110.83 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.643 HG21 ' HB2' ' A' ' 86' ' ' HIS . 19.2 p -145.68 -159.96 1.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 71.34 111.091 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -86.79 -23.0 25.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 74.44 110.924 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.737 ' OD1' HD23 ' A' ' 110' ' ' LEU . 8.1 t0 -136.74 20.34 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 75.23 110.876 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.604 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.1 OUTLIER -51.8 129.88 27.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 51.21 110.926 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.592 HG22 ' CD1' ' A' ' 144' ' ' TYR . 14.5 pt -134.99 179.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 74.21 111.111 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 143' ' ' PHE . 5.6 m -129.24 152.06 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 65.04 111.101 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.8 t -103.21 119.18 51.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 50.5 111.144 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -107.62 138.09 44.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 74.02 110.9 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.705 HD21 HG22 ' A' ' 140' ' ' VAL . 32.3 mt -119.26 98.7 50.59 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.678 0.752 . . . . 65.31 110.911 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.89 -4.72 14.68 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.763 2.308 . . . . 73.32 112.312 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -85.39 -22.4 28.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.32 110.886 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.64 12.41 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 70.15 110.958 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.1 26.25 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 71.13 110.905 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 21' ' ' LEU . 99.4 mt -90.87 142.1 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 71.52 111.12 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.22 155.94 34.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 72.31 110.921 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.26 74.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.24 111.181 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.7 -39.49 46.59 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 75.31 112.547 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 64.44 -159.42 41.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.684 -0.77 . . . . 53.43 112.482 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 74.6 m -54.68 -38.37 66.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 74.52 110.83 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.731 HD12 ' NE1' ' A' ' 189' ' ' TRP . 24.2 tp -51.26 -33.49 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.3 110.937 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 218' ' ' LEU . 39.7 t -107.97 108.05 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 54.04 111.066 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.566 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.0 OUTLIER -51.46 163.1 0.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.86 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.456 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -103.21 167.56 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 61.34 110.827 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -62.46 147.24 49.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.13 111.208 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.62 20.65 10.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 61.13 110.839 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 225' ' ' LEU . . . -79.9 155.15 27.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 62.25 111.02 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -119.21 -13.7 9.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.41 110.82 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.9 159.68 0.84 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 51.11 110.831 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.6 mt -66.76 -38.3 86.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 63.2 110.987 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.628 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 105.88 -148.91 16.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 74.05 112.451 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 182' ' ' ALA . 7.7 t-20 -52.07 105.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.873 0.368 . . . . 63.44 110.869 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 179' ' ' GLY . 34.7 m -107.18 24.4 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.35 111.176 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.426 ' HB3' HD21 ' A' ' 180' ' ' ASN . . . -70.91 -25.36 62.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 71.05 111.069 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -116.33 24.71 11.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 72.33 110.846 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.53 172.65 11.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 74.5 111.108 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -122.77 88.19 2.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 65.41 110.981 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 189' ' ' TRP . 21.1 t -63.0 -15.69 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 55.45 111.146 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -77.4 -22.14 52.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 64.04 110.906 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -118.42 -11.39 10.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 75.55 110.867 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.731 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.5 t90 -55.09 -60.91 2.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.959 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.649 ' HB3' HD11 ' A' ' 226' ' ' LEU . 1.7 p -53.8 -24.66 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.997 0.427 . . . . 73.51 110.927 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 51.9 m -81.58 -31.44 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.506 . . . . 62.41 111.129 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -43.17 58.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 71.34 110.851 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.552 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.2 mm -61.58 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 65.33 111.133 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.31 -27.22 54.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 61.41 110.945 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -77.17 -22.19 52.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 71.34 110.891 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 t -85.26 -11.04 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 41.13 111.194 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 197' ' ' LEU . 3.9 pp -111.72 -12.09 13.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 70.32 110.883 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -31.03 11.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 72.13 110.888 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 -59.41 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 75.21 110.907 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.452 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -91.83 62.5 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.966 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -72.78 -60.22 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.519 . . . . 73.4 110.858 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -52.03 102.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 70.55 110.869 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.641 HG21 ' CG2' ' A' ' 206' ' ' VAL . 75.0 mt -141.21 116.93 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 62.33 111.209 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.06 -26.77 63.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.924 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.98 134.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 62.1 111.091 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.726 ' HB ' HD12 ' A' ' 218' ' ' LEU . 95.2 t -106.87 144.9 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 71.23 111.166 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 213' ' ' VAL . 14.2 t -117.84 104.77 48.56 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.594 0.711 . . . . 45.2 111.138 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -177.7 2.01 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.756 2.304 . . . . 62.32 112.322 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.3 -12.1 65.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.843 -0.694 . . . . 12.1 112.461 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -153.35 140.62 19.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.871 0.367 . . . . 71.43 110.83 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.32 -99.27 1.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.757 -0.735 . . . . 40.5 112.579 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.76 157.35 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.893 0.378 . . . . 72.43 110.882 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 207' ' ' VAL . 5.2 m -54.73 162.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 74.32 111.134 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.65 -95.03 0.1 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.73 -0.747 . . . . 72.04 112.463 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -168.34 -169.01 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 72.14 110.842 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.487 ' HA ' HD23 ' A' ' 219' ' ' LEU . 19.9 pttt -61.02 -18.09 55.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 75.11 110.858 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -56.72 -21.45 36.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 24.13 112.501 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.726 HD12 ' HB ' ' A' ' 206' ' ' VAL . 8.0 mt -71.25 -28.24 64.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 71.23 110.937 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.552 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.8 mm? -66.98 -59.61 3.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 63.15 110.877 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -17.32 55.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.422 . . . . 72.12 110.975 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.444 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -69.04 -46.8 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 74.14 110.894 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.824 HG22 HD23 ' A' ' 226' ' ' LEU . 19.6 m -51.73 -52.31 49.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 75.41 111.176 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.98 -18.47 46.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 72.41 110.941 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.88 -5.7 59.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 65.35 110.894 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 171' ' ' LYS . 7.6 mt -128.42 -5.4 5.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 55.03 110.874 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.824 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -117.5 -4.6 11.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.191 -0.459 . . . . 65.14 110.844 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.12 110.901 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.7 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.819 0.343 . . . . 62.34 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -111.3 153.32 26.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 61.24 110.836 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -167.08 131.31 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 74.51 110.833 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.05 156.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 72.35 111.093 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.67 167.5 21.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.889 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -85.95 167.14 15.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 60.55 110.896 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.1 m -57.77 -55.02 40.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 75.11 111.114 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.0 m -58.31 -176.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 75.0 111.082 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -135.88 92.66 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 71.13 111.096 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -112.73 115.01 27.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 63.31 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -58.22 169.47 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.418 . . . . 51.35 110.815 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.46 -48.31 62.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 72.15 110.93 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.6 p -61.35 -37.42 83.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 75.11 111.114 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.39 13.43 61.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 75.43 112.43 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.3 m -79.56 -44.82 20.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.337 . . . . 52.42 111.144 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -101.6 113.0 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.43 111.083 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 p -120.82 127.58 52.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.843 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.663 HG22 ' HB3' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -121.52 112.54 35.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 72.14 111.116 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.408 ' HA ' HG12 ' A' ' 8' ' ' VAL . 14.4 t -99.82 127.1 46.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.35 110.875 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -70.23 110.93 5.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 52.33 110.917 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 213' ' ' VAL . 15.5 mt -64.2 -31.74 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 64.41 110.878 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.93 -97.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.908 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' N ' HD22 ' A' ' 22' ' ' ASN . 18.6 tttt -150.64 9.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 74.22 110.87 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.448 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.28 7.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 72.21 110.904 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.9 141.71 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 35.41 111.171 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.663 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.1 m95 -129.44 -177.25 4.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.967 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.478 HG23 ' HG ' ' A' ' 21' ' ' LEU . 85.9 t -133.83 91.48 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 75.01 111.134 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.425 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.7 p80 -74.1 123.78 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.894 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.5 m -120.02 105.87 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 74.42 111.143 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -87.01 122.43 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.12 110.894 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.674 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -90.02 116.88 28.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 55.52 110.967 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.41 -141.48 8.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 43.41 112.514 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.9 p -175.35 81.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 72.54 110.86 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.475 ' HD2' HG11 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -73.66 88.66 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 71.1 110.936 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 63.63 18.47 11.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 65.25 110.866 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.34 -0.91 18.81 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.753 -0.737 . . . . 41.02 112.502 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -101.22 121.29 41.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.899 0.381 . . . . 74.42 110.903 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -62.73 123.8 19.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 62.24 111.142 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.475 HG11 ' HD2' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -125.08 84.0 59.78 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 74.21 111.169 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 115.89 4.31 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.663 2.242 . . . . 62.05 112.342 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -103.0 98.16 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 73.12 110.829 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -59.19 163.75 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 71.41 110.816 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -153.81 -148.12 4.84 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.705 -0.759 . . . . 72.22 112.507 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.655 HD21 HD12 ' A' ' 158' ' ' LEU . 19.4 tp -159.08 115.2 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 74.42 110.949 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.675 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.67 122.27 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 62.4 111.108 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.466 HD12 ' HB ' ' A' ' 53' ' ' VAL . 12.3 mt -101.03 120.51 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.49 . . . . 53.31 110.953 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -91.26 85.42 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 74.31 110.892 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.51 -171.95 2.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 75.23 111.117 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.42 -15.06 14.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.862 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.07 -5.77 43.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 74.11 110.864 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.13 8.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.721 -0.752 . . . . 72.13 112.439 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.61 HD13 ' HB2' ' A' ' 77' ' ' LYS . 8.0 tp -73.74 155.44 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.389 . . . . 61.44 110.932 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.6 t -143.07 138.14 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.154 -0.475 . . . . 70.2 111.128 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.675 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -136.05 123.46 22.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 70.12 110.904 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.96 114.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 55.31 111.142 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.54 127.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 73.02 110.827 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.655 ' CB ' HD11 ' A' ' 98' ' ' LEU . 3.4 p -72.35 -166.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 43.32 110.859 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -91.68 168.52 11.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.127 -0.488 . . . . 70.03 110.886 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.711 ' HB2' HD12 ' A' ' 63' ' ' LEU . 97.9 m95 -48.92 -60.31 2.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.132 -0.486 . . . . 72.12 110.863 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -129.57 159.51 36.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.32 110.751 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -50.91 -32.29 20.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 74.31 110.941 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -58.29 -46.66 85.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 75.34 110.884 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.3 mt -74.38 -43.14 57.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 63.53 110.908 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.19 -49.54 60.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 63.53 111.128 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -53.43 -48.38 68.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.1 110.956 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -65.09 -18.92 65.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.858 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 71' ' ' VAL . 19.5 tp -89.78 -26.82 20.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 74.31 110.892 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.9 mt -90.67 -22.94 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 74.54 111.222 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -92.56 16.25 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 55.34 110.907 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.9 ptm -131.35 -40.3 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.9 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.6 m -80.56 -22.06 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 73.5 111.213 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.518 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.12 -23.08 64.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 70.13 110.919 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -107.75 -33.01 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 60.3 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.82 -40.41 72.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.924 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.25 -10.22 42.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.52 110.952 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.12 12.49 8.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 72.4 110.886 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.61 ' HB2' HD13 ' A' ' 52' ' ' LEU . 1.4 mttp -131.25 138.44 49.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 40.14 110.963 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.65 136.75 32.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.907 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG21 HD11 ' A' ' 54' ' ' LEU . 75.8 t -74.0 134.66 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 72.44 111.127 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.9 t -155.24 20.64 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.125 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.565 ' O ' HG13 ' A' ' 53' ' ' VAL . 4.0 m-20 -164.72 138.46 5.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.873 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -151.71 160.19 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 73.24 111.204 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.525 HG21 HG22 ' A' ' 156' ' ' VAL . 5.8 mt -116.42 135.43 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 74.34 111.137 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.54 121.14 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 65.41 111.104 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.1 p -78.45 -33.27 48.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.3 111.115 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.581 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.3 p-80 -167.95 -174.89 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.32 110.931 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.585 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -98.89 97.69 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 74.42 111.047 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -156.77 155.25 31.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 72.04 110.903 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.0 -22.11 14.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 73.13 111.129 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.45 26.35 3.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 73.1 110.792 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.48 -74.81 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.848 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.432 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -95.09 8.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 64.42 111.121 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -49.14 -39.8 27.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.684 -0.77 . . . . 52.41 112.612 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -102.81 12.95 56.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 71.23 112.506 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 92' ' ' ILE . 1.5 tt -54.38 -27.97 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.92 0.39 . . . . 62.11 111.128 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -56.66 -35.62 68.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 61.44 110.87 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.3 m -85.12 -22.57 28.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 63.41 111.114 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.751 ' HA ' HD13 ' A' ' 103' ' ' ILE . 14.3 mt -80.92 -30.19 35.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 73.2 110.95 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.91 21.9 7.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 73.34 110.909 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.86 -41.56 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.912 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -80.07 -50.1 10.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 71.31 110.912 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.09 39.55 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.795 -0.716 . . . . 62.43 112.525 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.751 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -101.77 126.19 55.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.894 0.378 . . . . 65.32 111.127 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.4 mtmm -85.89 112.35 21.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.2 110.904 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.67 100.73 12.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.44 111.058 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.446 ' HA ' HD12 ' A' ' 124' ' ' LEU . 61.1 m-70 -71.61 132.33 44.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 70.35 110.858 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.45 ' HA ' HD12 ' A' ' 127' ' ' LEU . 0.9 OUTLIER -160.5 166.13 29.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 70.25 110.961 -179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.98 156.75 24.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.158 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.31 -40.53 35.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 63.22 111.114 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.72 -40.88 72.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 72.32 110.982 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 98.6 m -58.55 -20.96 50.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.107 -0.497 . . . . 73.33 111.097 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.411 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -100.43 8.08 43.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 74.33 111.105 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -108.4 -31.98 7.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 71.13 110.849 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -96.1 -11.42 26.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.15 110.984 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.411 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.42 -37.58 77.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 23.12 111.049 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.67 60.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 63.52 110.904 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -57.18 -33.28 67.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.14 110.848 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -89.85 -23.43 21.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.901 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.44 23.82 4.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 75.42 112.464 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -98.04 172.63 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 74.14 110.906 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -76.0 170.58 15.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 71.21 110.878 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.4 mt-10 -101.94 108.63 57.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.581 0.705 . . . . 75.34 110.881 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 122' ' ' GLU . 54.6 Cg_endo -69.69 -176.58 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.701 2.268 . . . . 71.14 112.362 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 106' ' ' HIS . 9.8 mt -51.29 -42.56 61.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.869 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.16 27.58 23.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 34.02 112.458 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -111.03 26.1 11.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.891 0.377 . . . . 50.43 110.923 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 107' ' ' SER . 63.8 mt -103.87 -175.48 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 65.32 110.861 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.409 HE21 ' N ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -156.69 -172.86 4.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 72.0 110.893 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.889 HG22 HG23 ' A' ' 130' ' ' VAL . 54.2 m -51.02 -70.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 72.15 111.096 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.889 HG23 HG22 ' A' ' 129' ' ' THR . 44.4 t -117.62 104.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.177 -0.465 . . . . 71.2 111.134 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.506 HG22 ' OG1' ' A' ' 142' ' ' THR . 14.1 t -127.76 160.47 31.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.16 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.34 107.3 13.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 74.53 110.881 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.17 -172.7 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 64.44 110.905 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.2 pttt -176.15 112.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 65.3 110.871 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -106.73 74.84 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.031 0.444 . . . . 73.21 110.898 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.21 -86.91 0.18 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.749 . . . . 65.02 112.476 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -114.95 24.95 11.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.837 0.351 . . . . 75.11 110.881 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 51.1 tpp -132.82 142.6 49.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 61.25 110.898 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.42 130.17 55.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 64.51 110.835 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.652 HG22 HD21 ' A' ' 158' ' ' LEU . 13.8 t -139.87 120.2 13.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 72.33 111.165 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -113.85 130.63 56.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 65.55 110.801 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.506 ' OG1' HG22 ' A' ' 131' ' ' THR . 18.2 p -88.28 171.18 10.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 73.1 111.105 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.478 ' HB3' HG23 ' A' ' 155' ' ' VAL . 29.9 t80 -156.58 138.76 14.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 64.04 110.885 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.675 ' HB3' HG23 ' A' ' 129' ' ' THR . 74.3 t80 -125.59 89.7 51.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.627 0.727 . . . . 73.13 110.842 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -7.89 22.21 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.599 2.199 . . . . 65.2 112.352 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.26 -154.31 20.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.866 -0.683 . . . . 74.34 112.548 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -90.01 139.96 30.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 72.3 110.895 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.52 -87.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 34.1 112.481 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -77.06 -25.93 52.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 55.54 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.581 HG21 ' HB2' ' A' ' 86' ' ' HIS . 23.1 p -146.47 -161.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 70.23 111.193 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.477 ' HB3' HD23 ' A' ' 114' ' ' LEU . 72.9 tt0 -90.1 -17.72 27.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.911 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 154' ' ' ILE . 18.5 t0 -135.26 17.42 3.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 72.04 110.835 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -49.07 129.77 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 71.33 110.854 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 152' ' ' ASP . 10.9 pt -135.3 -177.77 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 74.33 111.127 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 143' ' ' PHE . 6.9 m -136.24 133.4 49.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 31.32 111.095 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.525 HG22 HG21 ' A' ' 83' ' ' ILE . 58.3 t -85.59 114.2 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 51.15 111.225 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -102.45 133.82 46.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.161 -0.472 . . . . 74.1 110.89 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.655 HD12 HD21 ' A' ' 44' ' ' LEU . 15.8 mt -113.59 97.76 44.87 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.575 0.702 . . . . 74.35 110.903 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.0 Cg_endo -69.79 -4.11 13.39 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.719 2.279 . . . . 71.44 112.347 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -85.18 -23.28 28.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 71.42 110.967 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -142.04 13.01 2.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.41 110.954 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.37 27.42 8.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.882 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.654 HD13 HD13 ' A' ' 21' ' ' LEU . 96.8 mt -93.13 124.67 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.462 . . . . 73.52 111.176 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 203' ' ' ILE . 20.7 tp -106.08 146.97 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 54.13 110.884 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.15 80.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 73.44 111.115 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.53 -40.48 47.29 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.694 -0.765 . . . . 72.32 112.38 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 68.89 -165.09 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.799 -0.715 . . . . 54.41 112.505 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.53 -27.45 25.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 61.33 110.916 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.625 HD12 ' NE1' ' A' ' 189' ' ' TRP . 23.3 tp -57.25 -61.14 2.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 62.13 110.826 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.562 HG13 ' HA ' ' A' ' 219' ' ' LEU . 35.1 t -75.28 112.38 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.43 111.054 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.537 ' HG2' HG23 ' A' ' 222' ' ' THR . 2.8 mmpt? -54.0 151.15 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 63.33 110.839 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.8 p -99.74 157.28 16.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 74.01 110.85 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.3 t -51.53 -29.84 18.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 60.54 111.164 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.9 t -94.98 45.02 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 71.52 110.869 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -134.2 138.16 44.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 70.03 111.009 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.423 ' HA ' HD22 ' A' ' 225' ' ' LEU . 15.4 tttt -117.55 -0.03 11.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 73.14 110.916 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -179.24 154.4 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 74.01 110.857 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.764 HD11 ' HB2' ' A' ' 226' ' ' LEU . 8.3 mt -65.44 -36.74 84.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 75.14 110.966 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.7 -140.73 17.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.673 -0.775 . . . . 55.43 112.441 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -58.94 98.03 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 62.41 110.87 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 186' ' ' VAL . 21.6 m -98.29 24.47 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 73.32 111.129 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.65 81.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.44 111.088 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -106.61 20.71 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 63.44 110.903 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -133.06 154.39 50.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 32.35 111.106 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -107.44 86.79 2.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.931 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.456 ' CG2' HG11 ' A' ' 181' ' ' VAL . 24.0 t -61.16 -17.65 16.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 72.1 111.114 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -74.27 -25.91 59.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.958 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.66 -11.97 13.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 65.34 110.954 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.74 ' CE3' HD13 ' A' ' 178' ' ' LEU . 2.6 t90 -54.37 -61.7 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 72.44 110.972 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.703 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.95 -24.29 16.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.855 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.2 m -81.92 -32.34 30.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.18 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.59 -43.31 63.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.882 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.528 HG21 ' O ' ' A' ' 219' ' ' LEU . 29.8 mm -62.15 -43.94 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 62.12 111.104 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -59.07 -24.07 62.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 64.52 110.956 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.31 -21.56 36.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.844 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 192' ' ' SER . 11.3 t -88.13 -8.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 74.13 111.1 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.42 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.36 -8.21 13.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.941 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -104.57 -30.93 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.42 110.869 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -104.31 -48.93 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 74.31 110.873 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -102.13 39.44 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 61.44 111.008 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.79 -47.9 76.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.502 . . . . 72.14 110.867 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -60.31 99.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.03 110.863 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.636 HG21 HG22 ' A' ' 206' ' ' VAL . 55.8 mt -140.16 123.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.047 -0.524 . . . . 64.41 111.107 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.94 -16.0 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.915 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.734 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -173.58 132.69 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 71.11 111.048 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.708 ' HB ' HD12 ' A' ' 218' ' ' LEU . 84.6 t -111.9 128.62 68.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 61.11 111.179 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 213' ' ' VAL . 19.6 t -108.43 104.12 53.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.644 0.735 . . . . 72.31 111.083 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.506 ' HD3' HD13 ' A' ' 218' ' ' LEU . 52.9 Cg_endo -69.82 -169.54 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.71 2.274 . . . . 71.44 112.32 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -85.47 -15.5 66.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.701 -0.761 . . . . 45.21 112.476 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -152.01 139.72 19.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.976 0.417 . . . . 75.21 110.803 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 109.52 -117.29 4.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.812 -0.709 . . . . 53.41 112.543 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -153.65 173.44 15.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 75.11 110.897 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 207' ' ' VAL . 6.1 t -70.5 144.85 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 71.32 111.154 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -142.66 -93.32 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.671 -0.775 . . . . 73.1 112.474 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -172.13 -167.17 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 72.54 110.899 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -19.37 38.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 61.21 110.864 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -53.72 -23.14 20.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.695 -0.764 . . . . 65.01 112.534 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 206' ' ' VAL . 7.0 mt -76.87 -32.68 57.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.318 . . . . 65.41 110.882 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.562 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.6 mp -61.12 -61.98 2.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.898 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.19 -22.24 60.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.939 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.409 ' CE1' HD11 ' A' ' 225' ' ' LEU . 1.2 t60 -62.0 -44.69 96.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.901 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.576 ' C ' HD23 ' A' ' 226' ' ' LEU . 2.2 m -51.45 -53.97 31.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 63.22 111.12 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.415 HD23 ' HB3' ' A' ' 190' ' ' SER . 1.2 mt -60.28 -18.72 51.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 72.34 110.902 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 70.11 110.88 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.483 HD12 ' HG3' ' A' ' 171' ' ' LYS . 9.7 mt -126.01 -6.37 6.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.03 110.938 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.764 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -119.83 9.72 11.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 65.1 110.951 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 62.0 110.896 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.811 0.338 . . . . 60.02 110.898 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.67 179.43 0.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 75.41 110.893 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.1 mttm 58.67 179.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 75.23 110.913 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.8 m -81.03 -176.23 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 71.33 111.178 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -159.7 133.42 7.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 75.32 110.909 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 -177.71 3.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 50.35 110.932 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -93.99 -39.96 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 61.55 111.189 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -66.57 -176.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 75.22 111.114 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -136.38 94.41 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 63.53 111.131 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -112.53 115.26 28.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.919 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -57.64 167.88 0.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 64.41 110.894 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -51.71 -48.08 63.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.859 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -60.74 -37.84 83.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.103 -0.498 . . . . 74.31 111.158 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.07 13.16 60.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.784 -0.722 . . . . 30.54 112.528 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 31' ' ' LEU . 49.3 m -80.92 -43.53 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 61.03 111.126 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.48 118.42 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 64.21 111.115 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 p -124.02 131.37 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.749 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.8 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -123.96 110.4 25.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.526 . . . . 42.13 111.14 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 t -100.6 123.69 45.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 74.12 110.872 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.15 110.98 4.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 52.31 110.893 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.77 HD21 HG11 ' A' ' 213' ' ' VAL . 14.8 mt -65.75 -31.83 73.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 63.3 110.818 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.472 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.02 -97.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 72.31 110.894 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -151.5 10.04 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 71.24 110.922 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.442 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.59 6.13 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 74.54 110.806 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -151.0 139.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 62.02 111.108 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.8 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.1 m95 -127.44 -173.99 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.937 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 43' ' ' GLY . 94.2 t -137.27 97.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 74.44 111.092 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -81.47 121.36 26.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 70.53 110.888 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.2 m -116.19 92.27 3.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 72.11 111.136 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -72.97 117.6 14.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 71.25 110.85 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.754 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -88.34 111.49 21.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.898 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.25 -129.4 3.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 55.42 112.458 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 p -175.44 117.34 0.16 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.939 0.4 . . . . 63.41 110.893 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.632 ' CD1' HG21 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -107.92 78.18 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 53.53 110.872 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 69.76 2.77 3.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 52.41 110.874 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.68 -8.02 3.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 45.02 112.499 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -100.9 121.82 42.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.322 . . . . 74.41 110.92 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.754 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -58.6 120.22 8.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 33.43 111.081 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.632 HG21 ' CD1' ' A' ' 34' ' ' PHE . 3.0 t -111.02 80.83 2.42 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.656 0.741 . . . . 75.24 111.084 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.752 ' HB3' HD12 ' A' ' 31' ' ' LEU . 54.2 Cg_endo -69.74 118.27 5.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.581 2.187 . . . . 75.11 112.395 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -103.54 100.68 10.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 63.23 110.852 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.414 HD21 ' N ' ' A' ' 212' ' ' GLU . 16.3 m-20 -49.36 162.4 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 52.24 110.885 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.598 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.48 -166.8 17.54 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.689 -0.767 . . . . 33.14 112.477 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.595 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.7 tp -153.12 113.27 3.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 72.03 110.903 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 54' ' ' LEU . 1.9 t -97.59 117.98 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 74.44 111.049 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.4 HD22 ' SD ' ' A' ' 138' ' ' MET . 24.7 mt -95.9 122.74 39.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 62.01 110.918 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.03 84.41 5.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 53.2 110.853 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.0 OUTLIER -101.55 178.87 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 43.4 111.189 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.82 -26.66 14.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 71.11 110.837 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -18.53 58.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 64.33 110.864 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.79 151.33 5.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 35.51 112.476 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' A' ' 75' ' ' PHE . 2.5 mt -62.0 153.72 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 73.25 110.923 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.644 HG13 ' CB ' ' A' ' 81' ' ' ASP . 2.2 t -143.56 139.73 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 74.11 111.139 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -136.1 122.92 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.918 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG12 ' OD1' ' A' ' 56' ' ' ASP . 78.5 t -69.11 111.89 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.441 . . . . 53.42 111.104 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.622 ' OD2' HG23 ' A' ' 85' ' ' THR . 1.6 m-20 72.98 125.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 70.53 110.905 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.656 ' CB ' HD11 ' A' ' 98' ' ' LEU . 2.7 p -69.6 -166.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 44.43 110.819 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -90.96 168.45 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 61.42 110.906 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.687 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.4 m95 -50.71 -60.42 3.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.142 -0.481 . . . . 74.13 110.945 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -126.03 160.87 28.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 62.33 110.806 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -53.63 -37.82 63.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 61.04 110.884 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.94 -37.52 66.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 72.14 110.878 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.4 mt -80.28 -43.55 21.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 41.44 110.91 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -48.58 62.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 64.24 111.125 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -52.71 -48.37 66.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 63.42 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.95 -18.79 65.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 71.31 110.835 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 71' ' ' VAL . 19.1 tp -89.43 -25.45 21.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 65.23 110.879 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.414 HG23 ' OE1' ' A' ' 72' ' ' GLU . 71.3 mt -91.93 -24.27 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.23 111.057 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -90.87 12.36 19.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 74.02 110.911 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ptm -127.48 -39.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 61.54 110.923 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 67' ' ' LEU . 14.6 m -79.84 -22.32 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.488 . . . . 63.35 111.115 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -70.38 -22.69 62.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 65.35 110.949 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -107.41 -31.08 8.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 71.23 110.826 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -73.15 -44.68 59.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 52.24 110.951 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.638 ' HB2' HD11 ' A' ' 52' ' ' LEU . 22.8 m-85 -85.95 -13.11 48.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.873 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 68.72 15.35 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.936 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 139.5 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 65.22 111.002 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -77.76 139.21 39.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 71.55 110.937 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.39 134.67 27.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 50.12 111.137 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 t -160.37 20.62 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 70.31 111.124 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.654 ' N ' HG23 ' A' ' 103' ' ' ILE . 48.4 m-20 -155.37 143.6 20.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.26 -0.427 . . . . 65.55 110.902 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 81' ' ' ASP . 6.7 t -156.84 105.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 65.22 111.076 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.716 ' CD1' HG11 ' A' ' 140' ' ' VAL . 68.8 mt -71.11 121.27 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 72.33 111.144 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.5 mm -94.36 149.96 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 73.44 111.17 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.622 HG23 ' OD2' ' A' ' 56' ' ' ASP . 29.6 p -108.44 -42.12 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.13 111.15 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.545 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.6 p-80 -164.54 -175.17 3.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 62.31 110.823 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.851 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -91.19 98.4 11.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 62.51 111.052 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.81 153.81 32.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 62.54 110.868 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.19 -19.98 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 54.01 111.124 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -91.81 4.48 52.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 55.13 110.844 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' HA ' ' HB3' ' A' ' 56' ' ' ASP . 3.7 mpt_? -120.69 -78.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.02 110.932 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.417 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -90.78 7.08 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 73.1 111.176 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.36 -41.47 48.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.672 -0.775 . . . . 32.33 112.539 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.15 13.21 60.36 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.734 -0.746 . . . . 52.34 112.491 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.493 HD13 ' HB2' ' A' ' 121' ' ' GLU . 16.8 tt -54.79 -26.39 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 73.53 111.144 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -54.54 -35.35 63.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 73.35 110.932 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.6 m -88.92 -12.86 40.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 63.25 111.159 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.656 HD11 ' CB ' ' A' ' 57' ' ' SER . 18.3 mt -88.56 -35.86 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 74.13 110.95 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -84.24 2.67 38.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 74.42 110.912 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -101.68 -51.07 3.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.31 110.842 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -69.83 -59.91 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 73.2 110.835 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.87 43.3 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.722 . . . . 54.44 112.557 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.654 HG23 ' N ' ' A' ' 81' ' ' ASP . 4.3 mp -103.34 120.31 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 65.24 111.147 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.738 ' HE2' HD21 ' A' ' 124' ' ' LEU . 4.6 mttt -73.2 114.39 11.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 54.0 110.858 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.06 85.58 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 44.05 111.1 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.579 ' HB3' HD11 ' A' ' 127' ' ' LEU . 85.8 m-70 -56.92 144.54 33.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.785 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.6 169.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 44.22 110.89 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.77 157.34 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 61.25 111.122 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.87 -40.41 29.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 73.3 111.062 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.464 HD22 ' CD ' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -64.14 -47.54 79.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 72.53 110.937 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.784 ' HA ' HD11 ' A' ' 114' ' ' LEU . 52.3 m -58.63 -20.73 50.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 40.42 111.094 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -99.76 12.39 36.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 73.3 111.191 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.464 ' CD ' HD22 ' A' ' 110' ' ' LEU . 3.1 pt-20 -114.97 -31.74 5.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 73.13 110.934 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.851 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -95.68 -13.87 23.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 74.3 110.866 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.462 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -69.04 -37.44 78.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.971 0.415 . . . . 65.22 111.133 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -20.86 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 63.45 110.956 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -65.01 -32.43 74.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.826 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -90.25 -18.22 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 72.33 110.865 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.67 27.2 5.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 61.21 112.45 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.34 173.95 6.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.847 0.356 . . . . 74.32 110.923 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.493 ' HB2' HD13 ' A' ' 95' ' ' ILE . 80.1 mm-40 -80.35 160.56 25.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 71.23 110.883 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 1.1 mp0 -92.71 111.85 52.97 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.713 0.768 . . . . 74.31 110.954 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.5 Cg_endo -69.72 -176.1 1.36 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 61.33 112.393 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.738 HD21 ' HE2' ' A' ' 104' ' ' LYS . 13.8 mt -51.68 -45.54 63.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 65.34 110.885 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 52.49 34.94 43.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 72.32 112.527 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.12 36.26 4.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.827 0.346 . . . . 70.35 110.848 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 106' ' ' HIS . 47.6 mt -120.07 -172.34 2.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.848 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.75 -171.84 3.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 64.1 110.921 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.915 HG22 HG23 ' A' ' 130' ' ' VAL . 46.0 m -50.56 -70.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 72.23 111.121 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.915 HG23 HG22 ' A' ' 129' ' ' THR . 44.0 t -119.39 103.88 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 63.53 111.131 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 t -135.37 175.63 9.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 71.14 111.193 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -120.34 131.36 54.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.849 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.523 HD21 HD22 ' A' ' 127' ' ' LEU . 31.4 mt -109.07 152.2 25.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 74.22 110.882 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -130.74 125.36 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 73.03 110.918 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.523 ' HE2' HD11 ' A' ' 83' ' ' ILE . 10.3 m-85 -129.0 26.53 5.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.867 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.28 95.67 0.21 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 44.03 112.536 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 66.07 13.09 8.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.735 0.303 . . . . 74.24 110.882 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.469 ' HB2' HG22 ' A' ' 48' ' ' THR . 52.9 tpp -133.71 106.29 7.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 75.21 110.97 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.98 127.43 37.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 74.25 110.87 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.716 HG11 ' CD1' ' A' ' 83' ' ' ILE . 18.2 t -138.69 113.11 8.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 61.22 111.142 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -109.74 131.41 55.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.798 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.7 p -85.09 178.65 7.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 71.02 111.189 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.485 ' HD1' HG22 ' A' ' 130' ' ' VAL . 19.9 t80 -161.05 133.27 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 73.44 110.843 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.692 ' HB3' HG23 ' A' ' 129' ' ' THR . 8.5 t80 -122.82 86.45 50.15 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.699 0.761 . . . . 71.33 110.94 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -7.99 22.45 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.757 2.305 . . . . 51.41 112.373 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.39 -160.06 23.83 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.74 . . . . 54.43 112.536 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -87.61 140.63 29.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.381 . . . . 74.14 110.924 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.518 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -155.66 -88.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 74.11 112.435 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -76.95 -22.97 52.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 74.31 110.815 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.545 HG21 ' HB2' ' A' ' 86' ' ' HIS . 81.4 p -151.18 -168.85 3.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 74.23 111.183 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.571 ' HB3' HD23 ' A' ' 114' ' ' LEU . 43.6 tt0 -86.09 -5.53 59.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 72.52 110.902 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 154' ' ' ILE . 48.5 t0 -147.07 16.47 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 54.4 110.857 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.661 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.2 OUTLIER -49.33 127.38 14.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' ASP . 4.8 pt -133.72 175.06 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.442 . . . . 65.04 111.123 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 143' ' ' PHE . 14.6 m -129.33 119.74 49.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 73.3 111.105 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 60.5 t -71.61 120.26 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 71.02 111.141 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -108.45 136.55 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.11 110.929 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.644 ' CD2' HG22 ' A' ' 140' ' ' VAL . 71.6 mt -118.59 98.64 51.32 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.591 0.71 . . . . 63.23 110.918 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.1 Cg_endo -69.79 -3.87 12.91 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.635 2.223 . . . . 64.44 112.322 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -86.53 -23.42 25.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 74.02 110.86 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -139.35 11.13 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 75.23 110.968 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 9.4 m120 55.2 25.79 7.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 73.31 110.818 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.494 HD13 HD13 ' A' ' 21' ' ' LEU . 87.6 mt -90.8 143.62 10.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 75.41 111.086 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 203' ' ' ILE . 15.1 tp -126.14 146.53 49.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 72.32 110.925 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.478 HG11 HG11 ' A' ' 55' ' ' VAL . 48.8 t -112.02 76.94 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 62.12 111.163 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.81 -29.45 26.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.771 -0.728 . . . . 60.13 112.458 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 57.95 -160.13 12.51 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.694 -0.765 . . . . 42.13 112.422 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -26.66 65.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 72.24 110.896 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.661 HD13 ' OD1' ' A' ' 153' ' ' ASN . 21.5 tp -58.15 -35.67 71.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 71.24 110.843 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.66 111.78 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 63.44 111.132 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.549 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.4 mmpt? -51.79 164.85 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 53.2 110.904 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 85.2 p -103.18 163.47 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 72.42 110.836 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.5 t -56.81 -23.83 46.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.52 111.093 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.4 p -104.52 22.47 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.904 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -95.63 149.93 20.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 75.53 111.049 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -122.11 -5.5 8.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.863 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.26 175.86 0.9 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 62.22 110.903 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.773 HD11 ' HB2' ' A' ' 226' ' ' LEU . 5.9 mt -83.84 -32.51 25.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 75.11 110.954 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 127.66 -128.96 6.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.803 -0.713 . . . . 60.5 112.501 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 181' ' ' VAL . 0.5 OUTLIER -110.84 3.39 18.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 61.31 110.937 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.713 HG11 ' CG2' ' A' ' 186' ' ' VAL . 27.4 m 36.77 44.53 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 74.0 111.105 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.32 68.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 63.13 111.008 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -138.64 30.66 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.42 110.895 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -125.02 165.95 17.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 43.12 111.133 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -119.88 91.94 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.928 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.713 ' CG2' HG11 ' A' ' 181' ' ' VAL . 21.9 t -62.8 -16.13 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 53.44 111.09 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -75.53 -22.58 56.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 64.13 110.878 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -117.67 -13.49 10.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 73.55 110.915 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.642 ' HZ3' HG12 ' A' ' 181' ' ' VAL . 1.7 t90 -54.02 -62.46 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 74.41 110.941 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.72 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.81 -23.55 18.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 71.21 110.905 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 55.2 m -81.3 -31.11 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.506 . . . . 72.41 111.164 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -75.51 -43.11 50.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.135 -0.484 . . . . 63.43 110.98 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.517 HG21 ' O ' ' A' ' 219' ' ' LEU . 34.0 mm -62.09 -45.52 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 63.12 111.151 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -57.04 -24.1 51.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 64.21 110.799 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -81.68 -22.28 37.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 64.42 110.941 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 192' ' ' SER . 17.5 t -86.7 -9.23 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 70.31 111.126 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -113.69 -6.59 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.924 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -107.57 -31.15 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 71.44 110.925 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 -55.48 2.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.55 110.859 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -95.13 38.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 73.14 110.904 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -56.34 -47.66 78.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 74.31 110.814 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -59.59 99.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.842 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.688 HG21 HG22 ' A' ' 206' ' ' VAL . 50.7 mt -142.61 124.26 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 63.32 111.206 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -22.84 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 54.23 110.92 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.71 133.73 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 74.32 111.107 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.744 ' HB ' HD12 ' A' ' 218' ' ' LEU . 97.6 t -114.56 134.05 58.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 74.22 111.117 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.034 HG22 HG12 ' A' ' 213' ' ' VAL . 9.6 t -112.82 108.94 53.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.657 0.741 . . . . 72.14 111.146 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.9 Cg_endo -69.73 -169.82 0.35 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.678 2.252 . . . . 65.24 112.333 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.42 -17.88 63.44 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 73.24 112.474 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -152.49 151.28 30.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 75.15 110.868 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 102.68 -101.02 2.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 73.54 112.49 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.414 ' N ' HD21 ' A' ' 42' ' ' ASN . 3.3 pt-20 -173.51 161.56 4.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 72.51 110.943 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.034 HG12 HG22 ' A' ' 207' ' ' VAL . 5.9 m -51.85 163.02 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.73 -106.81 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.666 -0.778 . . . . 61.32 112.443 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -169.48 2.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.34 . . . . 73.03 110.851 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -60.78 -18.25 53.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 62.12 110.878 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.42 -18.72 44.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 73.24 112.472 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.3 mt -71.53 -31.03 66.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 74.41 110.976 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.517 ' O ' HG21 ' A' ' 193' ' ' ILE . 4.1 mm? -64.77 -56.93 10.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 53.42 110.87 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.618 ' HA ' HD12 ' A' ' 223' ' ' LEU . 0.6 OUTLIER -63.64 -16.3 60.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 71.15 110.785 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.645 ' CE1' HD11 ' A' ' 225' ' ' LEU . 3.0 t-80 -68.36 -41.76 80.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 71.31 110.911 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.904 HG22 HD23 ' A' ' 226' ' ' LEU . 25.4 m -61.16 -50.22 74.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.161 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -63.49 -24.41 67.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 61.51 110.887 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -75.49 -12.28 60.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.899 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.645 HD11 ' CE1' ' A' ' 221' ' ' HIS . 6.9 mt -117.85 -19.5 9.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.895 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.904 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -108.03 0.9 22.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 74.1 110.871 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.893 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.763 0.316 . . . . 54.1 110.869 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 61.79 95.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 64.3 110.94 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -120.8 149.38 42.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 75.14 110.897 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.5 152.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 71.24 111.12 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -143.87 135.59 26.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 72.42 110.941 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt -114.67 -177.11 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.901 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 m -100.38 -68.71 0.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 74.42 111.181 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.65 147.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 64.42 111.137 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -113.1 96.48 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 72.12 111.081 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -117.54 115.89 26.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.916 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -60.54 166.3 3.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 54.24 110.877 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -51.68 -48.31 63.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.885 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.0 p -61.66 -37.5 84.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.36 13.47 63.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 72.13 112.541 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.5 m -80.52 -44.2 19.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 71.32 111.131 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 67' ' ' LEU . 25.6 mt -104.63 109.09 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 70.54 111.166 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 89.1 p -115.62 140.28 49.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 71.12 110.893 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.798 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.7 mt -131.35 110.23 17.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 73.11 111.127 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -98.31 126.75 43.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 51.4 110.816 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -71.88 110.01 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 75.34 110.914 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.925 HD21 HG21 ' A' ' 213' ' ' VAL . 11.1 mt -64.23 -33.81 76.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 72.22 110.905 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.461 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.1 -97.0 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.921 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.34 9.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 64.01 110.926 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.451 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.75 7.76 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.829 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 t -150.96 140.95 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.162 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.798 ' HB3' HG22 ' A' ' 18' ' ' ILE . 17.2 m95 -129.19 -176.26 3.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.927 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 43' ' ' GLY . 90.5 t -134.15 89.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 72.32 111.115 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -73.03 125.24 27.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.886 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.8 m -121.57 103.49 8.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 71.32 111.076 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.496 ' HG3' HD22 ' A' ' 67' ' ' LEU . 2.4 mm-40 -86.75 118.7 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.15 110.955 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.809 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -85.34 127.9 34.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 72.34 110.931 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.2 -130.42 6.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 63.35 112.573 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 p -175.48 117.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 73.14 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.482 ' CD1' HG21 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -114.47 87.26 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 71.34 110.935 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 55.0 48.69 19.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 53.04 110.879 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.05 -11.9 68.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.683 -0.77 . . . . 72.13 112.542 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -87.68 -169.76 2.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.339 . . . . 71.15 110.892 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.809 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -129.87 134.39 47.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 73.24 111.041 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' A' ' 34' ' ' PHE . 2.6 t -125.73 81.48 65.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.729 . . . . 73.35 111.251 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 121.26 7.96 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.631 2.221 . . . . 73.1 112.422 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.05 96.99 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.86 167.05 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 53.31 110.923 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.83 -146.65 4.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 74.52 112.493 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.577 HD21 HD12 ' A' ' 158' ' ' LEU . 14.1 tp -159.16 120.02 3.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 71.55 110.927 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.664 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.7 t -103.8 123.0 57.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.156 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.771 HD21 HD11 ' A' ' 158' ' ' LEU . 16.6 mt -100.54 121.45 41.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 75.0 110.972 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.22 85.99 6.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.13 110.948 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.3 p -101.73 -179.87 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 70.51 111.176 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.4 m -99.98 -24.37 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 61.44 110.881 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -19.0 50.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.43 110.874 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.64 145.34 4.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 33.22 112.43 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.728 ' HB3' HG22 ' A' ' 79' ' ' VAL . 1.3 mt -58.23 155.04 12.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.921 0.391 . . . . 63.14 110.87 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.1 t -143.62 141.55 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 71.22 111.109 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.664 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -137.1 122.45 19.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.19 -0.459 . . . . 62.31 110.941 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 165' ' ' VAL . 54.2 t -68.16 111.72 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.198 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.5 141.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 74.1 110.843 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.74 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.4 p -83.11 -164.72 0.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 70.15 110.838 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.489 ' H ' HG23 ' A' ' 64' ' ' THR . 17.8 t -96.25 169.78 9.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 65.22 110.8 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.682 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.4 m95 -50.61 -59.24 4.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.925 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -126.64 163.48 23.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 73.55 110.872 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.21 -37.17 71.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 72.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mmtm -57.44 -34.9 69.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.24 110.893 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' A' ' 59' ' ' TRP . 91.5 mt -81.51 -48.13 12.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.991 0.424 . . . . 73.11 110.864 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.3 -49.06 54.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 74.41 111.133 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -52.31 -50.73 61.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 73.25 110.899 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -64.0 -20.62 66.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 72.1 110.959 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.516 ' HB2' HD13 ' A' ' 16' ' ' ILE . 14.3 tp -87.09 -26.02 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 74.44 110.965 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.554 ' HA ' HG22 ' A' ' 71' ' ' VAL . 54.3 mt -92.39 -24.54 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 55.52 111.131 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -83.14 1.87 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 73.3 110.87 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ptm -119.61 -35.67 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 71.34 110.957 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 68' ' ' ILE . 31.6 m -79.19 -26.94 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 55.12 111.062 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.94 -21.05 63.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 71.44 110.864 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.37 -32.01 7.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 72.13 110.837 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -44.02 59.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 74.32 110.914 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.575 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 14.6 m-85 -85.91 -12.85 49.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 62.52 110.944 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 69.49 11.26 7.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.94 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -129.66 139.17 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.973 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -82.81 139.36 33.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 71.21 110.891 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 52' ' ' LEU . 92.5 t -82.74 121.06 35.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.2 111.188 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.3 t -137.2 8.14 2.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 61.15 111.118 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 82' ' ' VAL . 48.5 m-20 -147.09 145.2 29.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.185 -0.461 . . . . 54.44 110.91 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 54' ' ' LEU . 4.3 t -156.09 138.41 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 63.31 111.225 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.652 ' CD1' HG11 ' A' ' 140' ' ' VAL . 20.3 mt -94.09 136.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 75.44 111.18 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.056 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.1 mm -100.94 149.47 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 64.33 111.111 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -115.39 -38.4 3.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.162 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -169.93 172.06 6.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.844 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.622 ' CB ' HD13 ' A' ' 114' ' ' LEU . . . -91.11 89.15 7.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 64.34 111.143 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -148.67 154.97 40.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 73.02 110.895 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.64 -23.5 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 74.52 111.131 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -92.23 27.23 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.25 110.85 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.913 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -152.24 -70.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.928 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.722 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -90.17 3.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 73.23 111.122 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -51.73 -44.39 54.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.802 -0.713 . . . . 72.2 112.51 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.51 13.97 63.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 74.11 112.526 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.61 HD12 HH22 ' A' ' 91' ' ' ARG . 2.6 tt -57.61 -26.06 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 52.21 111.214 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -55.1 -27.43 45.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 61.21 110.847 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.4 m -95.33 -38.46 10.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 65.21 111.196 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.74 HD11 ' HB3' ' A' ' 57' ' ' SER . 14.9 mt -56.22 -46.09 79.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 63.1 110.897 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -0.99 51.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.4 110.94 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.53 -44.97 8.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.44 110.94 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -79.48 -61.39 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.81 39.58 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 61.42 112.394 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -101.9 120.3 51.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.798 0.332 . . . . 74.35 111.164 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.768 ' HD3' HD21 ' A' ' 124' ' ' LEU . 6.2 mttm -78.5 118.02 20.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.868 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 1.056 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -94.35 85.01 4.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.024 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.516 ' HB3' HD11 ' A' ' 127' ' ' LEU . 52.2 m-70 -55.01 110.43 0.66 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 74.04 110.849 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 t -139.67 -175.6 4.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 72.42 110.844 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.17 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 64.31 111.03 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.32 -36.75 44.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 61.53 111.062 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.7 HD22 ' OE1' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -68.4 -48.45 64.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.921 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.8 ' HA ' HD11 ' A' ' 114' ' ' LEU . 47.9 m -59.09 -18.78 38.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 72.22 111.207 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.633 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -101.37 13.07 36.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 73.35 111.083 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.7 ' OE1' HD22 ' A' ' 110' ' ' LEU . 2.1 pt-20 -115.6 -27.44 7.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.889 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.8 HD11 ' HA ' ' A' ' 111' ' ' THR . 0.3 OUTLIER -101.37 -11.74 19.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.2 110.879 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.11 69.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.291 -0.413 . . . . 42.43 111.068 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.35 -20.72 60.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 64.24 110.907 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -66.37 -32.41 73.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 71.12 110.946 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -88.48 -14.86 36.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 75.31 110.843 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.81 22.53 7.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.753 -0.737 . . . . 72.11 112.437 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.402 ' CD1' HG12 ' A' ' 92' ' ' ILE . 80.9 m-85 -102.59 170.76 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.9 0.381 . . . . 64.14 110.844 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -72.78 -170.73 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 51.44 110.915 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -120.58 121.66 29.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.613 0.72 . . . . 73.22 110.905 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.633 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.4 Cg_endo -69.86 -169.96 0.37 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.692 2.261 . . . . 54.14 112.328 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.768 HD21 ' HD3' ' A' ' 104' ' ' LYS . 6.0 mt -59.5 -39.87 85.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 54.33 110.925 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 53.69 26.0 30.74 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.729 -0.748 . . . . 61.21 112.471 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -111.35 39.97 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 62.43 110.926 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.53 HD22 HD21 ' A' ' 133' ' ' LEU . 85.8 mt -131.62 -172.81 2.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.948 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.65 -169.71 2.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.289 -0.414 . . . . 63.33 110.972 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.928 HG22 HG23 ' A' ' 130' ' ' VAL . 33.8 m -48.3 -67.15 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 73.13 111.199 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.928 HG23 HG22 ' A' ' 129' ' ' THR . 41.7 t -120.53 109.31 25.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 64.43 111.13 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.499 HG21 HD22 ' A' ' 127' ' ' LEU . 13.2 t -138.68 176.15 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 73.35 111.049 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -122.87 137.39 54.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.53 HD21 HD22 ' A' ' 127' ' ' LEU . 25.2 mt -118.84 151.88 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 63.24 110.914 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.31 126.74 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 65.41 110.92 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -127.24 34.04 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 73.23 110.909 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.04 94.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 50.22 112.471 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.15 12.48 8.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.857 0.36 . . . . 63.51 110.902 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.437 ' HB2' HG22 ' A' ' 48' ' ' THR . 54.5 tpp -134.76 101.11 4.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.147 -0.479 . . . . 75.32 110.878 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -89.34 130.3 35.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.15 110.909 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.735 HG22 HD21 ' A' ' 158' ' ' LEU . 19.6 t -138.41 115.56 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 70.25 111.12 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -110.5 130.15 55.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 65.45 110.872 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 39.9 p -84.87 -174.13 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 72.34 111.133 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.48 ' HB3' HG23 ' A' ' 155' ' ' VAL . 31.4 t80 -170.1 137.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 74.23 110.914 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.682 ' HB3' HG23 ' A' ' 129' ' ' THR . 89.8 t80 -123.83 89.61 51.36 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.664 0.745 . . . . 64.22 110.89 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.3 Cg_endo -69.82 -8.25 23.12 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.717 2.278 . . . . 73.24 112.302 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.05 -149.11 19.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 74.3 112.566 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -97.11 138.97 33.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 63.15 110.853 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.15 -96.31 0.15 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 61.24 112.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.8 -24.9 63.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 72.4 110.901 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.8 p -152.2 -175.72 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.485 . . . . 62.22 111.184 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.64 0.58 52.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 62.13 111.01 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.583 ' HB3' HD12 ' A' ' 110' ' ' LEU . 16.8 p-10 -141.72 12.09 2.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 71.12 110.902 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.81 140.97 28.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 63.14 110.889 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.723 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.8 pt -146.32 -179.17 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 71.42 111.054 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 143' ' ' PHE . 26.9 m -138.68 124.95 24.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 74.02 111.128 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.654 ' O ' HD12 ' A' ' 164' ' ' LEU . 95.8 t -82.8 138.92 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 54.12 111.122 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -123.66 130.52 52.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 74.42 110.871 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.771 HD11 HD21 ' A' ' 46' ' ' LEU . 9.3 mt -111.84 98.17 40.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.624 0.726 . . . . 44.32 110.89 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.3 Cg_endo -69.75 -4.21 13.57 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.802 2.334 . . . . 73.55 112.282 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -83.53 -23.32 32.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 70.41 110.841 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.27 14.29 1.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 74.42 110.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.5 m120 53.84 27.22 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.412 HD13 HD13 ' A' ' 21' ' ' LEU . 96.9 mt -91.74 136.56 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.44 111.137 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 156' ' ' VAL . 14.4 tp -119.6 144.42 47.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 71.54 110.981 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.674 HG11 HG11 ' A' ' 55' ' ' VAL . 21.9 t -113.13 76.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 32.33 111.074 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -50.89 -46.92 49.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.733 . . . . 73.21 112.511 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.28 -162.56 51.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.74 . . . . 50.11 112.525 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 61.0 m -51.74 -29.64 19.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 62.54 110.815 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.627 HD12 ' NE1' ' A' ' 189' ' ' TRP . 25.4 tp -55.2 -53.96 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 74.13 110.889 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 219' ' ' LEU . 47.6 t -83.39 114.68 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 50.33 111.128 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.429 ' HG3' HD12 ' A' ' 225' ' ' LEU . 3.6 mmpt? -57.08 149.79 18.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.977 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 80.1 p -95.14 158.56 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 64.22 110.978 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t -56.47 -25.03 49.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.2 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.1 t -98.34 43.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 54.31 110.864 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.13 145.43 47.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 64.23 111.045 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.52 ' C ' HD22 ' A' ' 225' ' ' LEU . 3.4 tttt -122.55 2.05 9.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 63.43 110.863 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -179.33 154.04 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.227 -0.442 . . . . 71.33 110.89 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 226' ' ' LEU . 7.7 mt -66.65 -36.62 82.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 71.42 110.896 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 85.35 -143.24 20.08 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.731 -0.747 . . . . 61.03 112.55 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -52.43 103.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 75.2 110.856 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 179' ' ' GLY . 15.6 m -105.88 22.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 70.23 111.164 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.03 -31.35 72.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 71.12 111.125 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -110.44 24.23 13.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 71.41 110.819 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.33 153.32 50.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 73.14 111.152 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -106.59 86.26 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 74.13 110.936 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.37 -18.66 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 73.12 111.099 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.51 -29.27 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.861 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -108.87 -13.78 14.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.862 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.627 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.5 t90 -53.59 -62.23 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.123 -0.489 . . . . 72.41 110.999 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.717 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -54.56 -24.01 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.43 . . . . 73.42 110.862 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.0 m -81.73 -31.57 31.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 52.52 111.139 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -74.18 -45.4 48.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 75.03 110.865 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.9 mm -58.35 -46.62 89.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 64.43 111.109 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.68 -29.36 62.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 71.02 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -77.28 -20.35 55.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 72.14 110.873 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 192' ' ' SER . 38.3 t -87.58 -12.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.448 . . . . 71.54 111.214 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.446 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -108.9 -7.08 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 63.11 110.884 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.1 -30.78 10.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.277 -0.419 . . . . 74.44 110.871 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.83 -49.76 3.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 71.31 110.853 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.15 40.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 64.52 110.863 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -55.51 -47.76 75.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 62.31 110.766 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -59.07 103.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 63.44 110.944 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.64 HD13 HD22 ' A' ' 164' ' ' LEU . 45.7 mt -146.06 126.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 71.11 111.085 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.83 -27.21 33.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.941 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.639 ' HB1' ' CG1' ' A' ' 213' ' ' VAL . . . -163.24 146.42 10.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 74.43 111.105 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 218' ' ' LEU . 99.1 t -122.85 132.63 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 74.04 111.126 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 213' ' ' VAL . 10.8 t -113.69 107.58 52.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 60.31 111.068 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.414 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.8 Cg_endo -69.7 -176.27 1.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.708 2.272 . . . . 75.13 112.41 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.17 -14.27 80.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 64.42 112.573 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -152.36 130.66 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.806 0.336 . . . . 73.02 110.811 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 118.59 -118.37 4.0 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 64.45 112.454 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -153.47 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 51.52 110.849 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 207' ' ' VAL . 5.2 t -72.07 145.08 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.015 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -141.5 -91.25 0.17 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.812 -0.708 . . . . 64.12 112.552 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.82 -168.89 0.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 75.05 110.888 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.481 ' HA ' HD12 ' A' ' 219' ' ' LEU . 0.0 OUTLIER -63.87 -15.14 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 74.03 110.913 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.506 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.22 -18.59 42.79 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.658 -0.782 . . . . 71.55 112.602 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.75 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.0 mt -74.03 -44.35 54.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.751 0.31 . . . . 71.31 110.878 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.615 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -55.06 -57.32 12.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 61.43 110.891 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.506 HD21 ' HA2' ' A' ' 217' ' ' GLY . 3.0 pp -58.22 -22.6 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.91 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -69.2 -34.98 75.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 72.12 110.918 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.849 HG22 HD23 ' A' ' 226' ' ' LEU . 8.8 m -57.77 -55.44 34.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 65.34 111.173 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.06 -19.69 61.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 62.11 110.851 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -12.01 58.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.431 . . . . 73.43 110.822 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.52 HD22 ' C ' ' A' ' 176' ' ' LYS . 10.4 mt -117.63 -16.59 10.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 70.31 110.874 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.849 HD23 HG22 ' A' ' 222' ' ' THR . 0.5 OUTLIER -110.73 3.85 19.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 60.33 110.878 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 75.4 110.968 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.749 0.309 . . . . 55.43 110.916 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.88 91.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 61.12 110.852 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -169.69 120.47 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.964 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.1 t -57.07 140.38 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.14 111.143 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -158.18 154.55 27.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 72.34 110.914 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -62.76 -179.71 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 63.23 110.927 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 m -82.49 -42.31 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 61.22 111.058 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.19 -177.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 53.11 111.208 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 mt -135.83 91.76 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 74.44 111.091 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -111.76 118.13 34.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 75.35 110.95 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -61.38 168.34 2.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -51.78 -47.88 64.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 74.55 110.779 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -60.42 -37.87 82.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 61.5 111.082 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.44 13.4 61.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.721 -0.752 . . . . 62.31 112.493 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.0 m -80.79 -43.8 19.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.756 0.312 . . . . 72.43 111.15 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 67' ' ' LEU . 27.5 mt -103.54 117.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.08 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -125.04 129.99 51.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 70.33 110.843 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.661 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.1 mt -123.41 110.05 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 63.15 111.033 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.5 t -101.26 128.44 47.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 64.05 110.842 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -71.1 111.03 6.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 72.15 110.875 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.561 HD21 HG11 ' A' ' 213' ' ' VAL . 14.2 mt -65.07 -32.08 73.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.274 -0.421 . . . . 72.42 110.855 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.12 -97.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 73.21 110.88 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' N ' HD22 ' A' ' 22' ' ' ASN . 1.5 tptp -151.52 9.98 0.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 71.03 110.926 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.447 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.52 6.19 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 65.23 110.899 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 t -150.99 139.73 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.437 . . . . 62.4 111.109 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.661 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.1 m95 -126.87 -174.97 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 71.42 110.966 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 43' ' ' GLY . 99.6 t -135.85 95.16 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 72.11 111.175 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -80.33 122.24 26.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.775 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.9 m -118.2 100.36 7.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 54.43 111.133 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -83.9 117.08 23.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 74.15 110.937 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.786 HD21 ' HB1' ' A' ' 38' ' ' ALA . 0.5 OUTLIER -83.41 115.31 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 63.14 110.95 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.29 -131.66 1.53 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.676 -0.773 . . . . 72.43 112.514 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 p -175.53 117.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 72.23 110.909 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.502 ' CD1' HG21 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -112.01 87.02 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 63.52 110.921 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 55.5 46.78 22.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 72.11 110.864 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.32 -12.75 65.0 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 32.14 112.498 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.4 -169.66 2.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 74.2 110.837 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.786 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -128.95 135.65 49.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 61.51 111.079 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 34' ' ' PHE . 2.4 t -130.54 83.03 63.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.611 0.72 . . . . 51.35 111.092 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 118.16 5.52 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.615 2.21 . . . . 70.41 112.304 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.1 p -105.52 99.7 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 65.11 110.838 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -51.76 164.83 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 54.13 110.835 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.488 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -157.89 -164.32 13.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 53.3 112.447 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.545 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.0 tp -153.69 115.36 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 55.21 110.929 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.689 HG22 HD23 ' A' ' 54' ' ' LEU . 2.0 t -99.56 116.76 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 73.44 111.138 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 mt -94.42 121.23 35.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 73.34 110.905 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -90.98 84.37 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 34.33 110.904 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -97.45 -177.03 3.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 65.2 111.117 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -103.97 -19.41 14.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 75.52 110.764 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -16.41 37.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 73.02 110.926 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 152.24 146.85 4.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.791 -0.719 . . . . 61.24 112.584 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.42 ' HB3' HG22 ' A' ' 79' ' ' VAL . 10.8 tp -60.13 155.26 17.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.37 . . . . 73.24 110.9 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.8 142.6 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 63.14 111.211 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.689 HD23 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -138.53 125.66 21.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.918 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 165' ' ' VAL . 79.7 t -69.88 110.18 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 74.55 111.136 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.91 141.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 71.2 110.823 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.651 ' OG ' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -81.77 -160.5 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.949 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.576 ' H ' HG23 ' A' ' 64' ' ' THR . 13.6 t -98.44 170.06 9.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 43.44 110.881 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.618 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.9 m95 -53.06 -59.99 3.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 72.2 110.962 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.67 158.53 36.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.22 110.903 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -52.85 -39.58 62.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 63.25 110.889 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -55.72 -25.79 42.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 71.2 110.958 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 59' ' ' TRP . 94.6 mt -92.11 -50.01 5.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 71.01 110.892 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.576 HG23 ' H ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -50.19 -43.6 52.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 74.42 111.152 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.4 -48.23 74.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.891 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.36 -21.08 66.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.926 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 71' ' ' VAL . 18.5 tp -87.37 -27.3 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 75.51 110.87 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.56 -22.58 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 62.34 111.143 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -91.96 14.28 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 73.12 110.927 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ptm -129.49 -40.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 61.1 110.881 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 67' ' ' LEU . 33.0 m -78.37 -22.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 71.25 111.096 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.573 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -67.82 -25.27 65.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.235 -0.438 . . . . 72.22 110.834 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -104.14 -32.73 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.13 110.85 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -47.01 58.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 75.4 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 23.6 m-85 -82.61 -11.17 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 71.41 110.828 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 68.07 11.73 8.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 54.35 110.931 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -132.24 140.43 48.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.904 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.854 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG21 HD11 ' A' ' 54' ' ' LEU . 71.9 t -79.47 120.22 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 70.24 111.121 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.6 t -132.88 4.28 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 75.05 111.135 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.2 m-20 -147.58 146.53 29.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 71.33 110.868 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 54' ' ' LEU . 3.3 t -155.35 129.7 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 73.15 111.118 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.619 ' CD1' HG11 ' A' ' 140' ' ' VAL . 20.6 mt -84.5 133.33 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 65.42 111.132 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.97 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.3 mm -97.44 147.55 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 54.51 111.172 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.7 p -110.91 -35.64 5.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 70.31 111.119 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.594 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.5 p-80 -173.15 -176.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.841 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.88 84.74 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 52.44 111.112 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -145.05 154.46 42.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 75.52 110.907 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -51.84 -23.1 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 53.43 111.079 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.46 26.31 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 52.31 110.853 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.899 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -151.28 -70.4 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 75.2 110.89 -179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.728 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.9 2.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 72.53 111.18 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.17 -45.06 43.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.803 -0.713 . . . . 72.23 112.395 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.43 15.93 58.36 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 45.33 112.54 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.9 tt -54.24 -26.77 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.872 0.368 . . . . 70.11 111.135 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -58.75 -27.61 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 74.35 110.979 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.6 m -90.16 -20.21 23.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 54.12 111.097 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.651 HD11 ' OG ' ' A' ' 57' ' ' SER . 15.7 mt -82.45 -37.47 25.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.865 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmt -92.51 20.42 6.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 70.11 110.923 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -118.42 -43.07 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 71.55 110.821 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -84.43 -54.0 5.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.871 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.76 39.19 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.767 -0.73 . . . . 65.12 112.488 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 103' ' ' ILE . 4.5 mp -103.85 113.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.852 0.358 . . . . 61.52 111.179 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.703 ' HB3' HD11 ' A' ' 124' ' ' LEU . 10.5 mtmt -79.74 113.96 18.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 65.32 110.904 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.97 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -87.88 91.4 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 63.23 111.058 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.478 ' HA ' HD12 ' A' ' 124' ' ' LEU . 42.4 m-70 -64.38 112.09 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.85 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.401 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -141.05 -175.01 4.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.882 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.7 158.05 15.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 64.21 111.11 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.5 -40.36 51.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 74.52 111.098 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.695 HD23 ' OD2' ' A' ' 152' ' ' ASP . 38.9 tp -75.09 -39.12 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 52.21 110.937 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.771 ' HA ' HD11 ' A' ' 114' ' ' LEU . 88.0 m -58.84 -21.69 57.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 71.2 111.132 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -96.61 0.87 50.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 73.0 111.083 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.48 -50.62 3.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.905 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -69.68 -11.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.31 110.92 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.06 -42.45 72.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 64.04 111.121 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -26.23 61.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.51 110.902 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.67 -31.93 62.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 75.53 110.882 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -93.23 -21.22 19.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 64.44 110.837 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.76 23.36 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 73.24 112.574 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CD1' HG12 ' A' ' 92' ' ' ILE . 85.7 m-85 -97.34 178.47 5.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.926 0.393 . . . . 65.31 110.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -76.17 -176.39 3.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 62.01 110.841 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.0 mp0 -118.86 110.96 37.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 74.14 110.899 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.83 -169.76 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.614 2.209 . . . . 71.01 112.398 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 104' ' ' LYS . 63.6 mt -61.81 -49.49 76.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 64.21 110.913 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 60.19 20.26 53.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.726 -0.75 . . . . 75.11 112.506 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.42 31.31 2.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 71.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.568 ' CD2' HD21 ' A' ' 133' ' ' LEU . 90.2 mt -116.51 -174.48 2.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.93 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.24 -171.02 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 75.51 110.915 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.826 HG22 HG23 ' A' ' 130' ' ' VAL . 54.1 m -50.79 -70.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.182 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.826 HG23 HG22 ' A' ' 129' ' ' THR . 31.0 t -116.37 102.03 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 60.32 111.153 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.45 HG21 HD22 ' A' ' 127' ' ' LEU . 14.3 t -124.78 162.28 24.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 61.32 111.209 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.96 100.94 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 74.43 110.916 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.568 HD21 ' CD2' ' A' ' 127' ' ' LEU . 27.4 mt -78.71 -179.89 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 53.43 110.969 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -171.74 112.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 71.21 110.961 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -106.73 73.93 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.297 -0.41 . . . . 75.22 110.807 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.43 -84.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.843 -0.694 . . . . 73.24 112.445 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.19 26.95 9.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.84 0.352 . . . . 75.1 110.833 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.6 tpp -130.43 142.93 50.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 70.04 110.932 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.54 125.33 48.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 74.03 110.897 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.648 HG22 ' CD2' ' A' ' 158' ' ' LEU . 13.4 t -138.85 119.53 15.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 74.35 111.195 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -113.54 127.86 56.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.964 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.5 p -82.78 -173.6 4.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 74.22 111.145 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.421 ' HB3' HG23 ' A' ' 155' ' ' VAL . 21.6 t80 -170.89 135.9 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 72.42 110.861 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.69 ' HB3' HG23 ' A' ' 129' ' ' THR . 81.7 t80 -125.12 90.34 51.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.816 0.817 . . . . 75.22 110.962 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.1 Cg_endo -69.86 -7.78 21.94 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.662 2.241 . . . . 62.44 112.309 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.86 -150.8 18.85 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 73.35 112.554 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -91.63 139.7 30.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 74.42 110.957 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.67 -89.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.692 -0.765 . . . . 51.2 112.507 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -76.12 -25.47 55.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 74.13 110.933 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.594 HG21 ' HB2' ' A' ' 86' ' ' HIS . 46.9 p -146.95 -167.95 2.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 72.33 111.123 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.604 ' HB3' HD23 ' A' ' 114' ' ' LEU . 60.7 tt0 -85.34 -16.25 40.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.925 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.695 ' OD2' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -139.99 25.83 2.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.883 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.08 131.83 48.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.909 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 84' ' ' ILE . 10.3 pt -139.28 171.06 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 75.42 111.164 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.6 m -124.94 142.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 71.32 111.049 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 87.2 t -95.67 114.98 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.087 -0.506 . . . . 74.31 111.183 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -103.74 142.07 34.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 73.32 110.923 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.648 ' CD2' HG22 ' A' ' 140' ' ' VAL . 56.5 mt -122.41 98.69 43.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.631 0.729 . . . . 71.42 110.888 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -5.01 15.16 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 74.13 112.358 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.74 -31.36 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.42 110.924 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.08 11.6 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.33 110.901 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.3 27.49 9.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 54.21 110.8 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.502 HD13 HD13 ' A' ' 21' ' ' LEU . 87.2 mt -93.18 143.62 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 73.43 111.117 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.443 ' CD2' HD13 ' A' ' 203' ' ' ILE . 61.5 tp -124.81 153.68 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.92 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.435 HG11 HG11 ' A' ' 55' ' ' VAL . 76.0 t -123.16 79.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 71.13 111.137 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.83 -36.64 41.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 54.44 112.522 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 67.28 -165.09 43.66 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.712 -0.756 . . . . 55.12 112.437 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 83.7 m -51.95 -34.45 42.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 74.22 110.889 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.611 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.7 tp -51.64 -59.87 3.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 71.41 110.888 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.41 HG13 ' HA ' ' A' ' 219' ' ' LEU . 19.6 t -80.25 109.19 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 73.22 111.122 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.73 ' HG2' HG23 ' A' ' 222' ' ' THR . 32.0 mmmt -51.29 169.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 75.43 110.895 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 175' ' ' ALA . 89.2 p -117.78 157.26 26.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.039 0.447 . . . . 44.11 110.847 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.5 t -49.43 157.29 0.52 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.107 -0.497 . . . . 64.2 111.173 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.1 m 69.4 11.8 8.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 62.34 110.927 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 172' ' ' SER . . . -83.41 144.55 29.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.064 -0.516 . . . . 71.22 111.115 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -120.28 -10.32 9.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 73.15 110.944 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 179.83 158.78 0.73 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 63.31 110.923 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.769 HD11 ' HB2' ' A' ' 226' ' ' LEU . 8.8 mt -69.31 -38.56 78.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 75.51 110.902 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.42 -124.53 7.94 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.797 -0.716 . . . . 62.13 112.527 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -70.52 130.38 41.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.859 0.362 . . . . 40.25 110.843 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 186' ' ' VAL . 27.8 m -130.26 27.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 65.13 111.096 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -65.79 -33.18 75.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 70.53 111.04 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -114.45 28.06 9.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 73.25 110.839 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.74 153.56 49.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 54.33 111.138 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -107.42 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 64.4 110.919 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.456 ' CG2' HG11 ' A' ' 181' ' ' VAL . 21.2 t -59.56 -19.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.24 111.173 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -73.54 -27.16 61.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 63.11 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.37 -12.41 14.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.01 110.87 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.611 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.5 t90 -54.28 -62.34 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.936 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.671 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.51 -24.5 13.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.818 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.0 m -81.45 -32.55 32.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.14 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -42.53 62.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 63.11 110.796 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 219' ' ' LEU . 32.3 mm -62.47 -44.72 99.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 75.31 111.102 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.49 -23.49 50.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.868 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -81.74 -20.73 38.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.45 110.888 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.44 -9.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 73.33 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.69 -10.33 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 64.2 110.903 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -101.95 -31.91 10.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.888 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 -49.92 3.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 73.24 110.852 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.499 ' O ' HD11 ' A' ' 203' ' ' ILE . 3.9 m-30 -101.12 65.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.94 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -78.42 -55.49 5.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 74.11 110.838 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.15 100.16 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.828 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.704 HG21 HG22 ' A' ' 206' ' ' VAL . 57.1 mt -141.23 116.08 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 72.0 111.181 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.13 -26.07 64.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 70.02 110.96 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -171.99 137.76 0.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 74.03 111.093 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.732 ' HB ' HD12 ' A' ' 218' ' ' LEU . 85.7 t -113.91 144.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 62.0 111.093 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.128 HG22 HG12 ' A' ' 213' ' ' VAL . 13.5 t -119.68 109.19 38.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.617 0.722 . . . . 62.2 111.141 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 -170.76 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.72 2.28 . . . . 74.12 112.327 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.07 -14.93 61.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 61.42 112.467 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -152.71 142.1 21.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 74.02 110.87 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.7 -101.81 1.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 55.35 112.497 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -172.81 162.76 4.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 55.55 110.972 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.128 HG12 HG22 ' A' ' 207' ' ' VAL . 6.6 m -51.56 163.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 72.12 111.141 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -159.67 -102.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.661 -0.781 . . . . 52.04 112.48 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -161.82 -172.24 3.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 64.13 110.841 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -61.87 -17.38 56.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.897 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.451 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.3 -17.59 46.84 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.715 -0.755 . . . . 44.41 112.491 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 206' ' ' VAL . 10.8 mt -70.01 -30.2 67.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 61.54 110.987 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.559 ' O ' HG21 ' A' ' 193' ' ' ILE . 3.9 mm? -66.64 -58.22 5.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 61.22 110.93 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.451 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.6 OUTLIER -62.14 -17.39 57.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 61.55 110.913 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 225' ' ' LEU . 1.6 t60 -65.86 -50.68 63.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.52 110.924 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.738 HG22 HD23 ' A' ' 226' ' ' LEU . 4.4 m -51.84 -51.7 54.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.151 -0.477 . . . . 74.25 111.129 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.52 -21.27 59.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 43.23 110.908 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -86.81 -2.96 58.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 74.04 110.843 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.411 HD11 ' CE1' ' A' ' 221' ' ' HIS . 5.5 mt -128.25 -4.87 5.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 74.3 110.947 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.769 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -123.12 0.61 9.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.897 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 45.03 110.846 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.834 0.35 . . . . 74.44 110.855 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.82 47.81 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 73.15 110.834 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -149.31 91.8 1.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.1 110.926 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 p -51.54 151.87 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 74.05 111.142 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -140.27 160.66 39.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 74.32 110.876 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -107.19 -169.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.925 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -96.7 -68.3 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 71.31 111.167 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.8 t -49.37 147.14 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 73.21 111.086 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.1 mt -111.08 99.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 72.03 111.082 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -118.43 114.87 23.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.962 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -59.42 165.61 2.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.271 -0.422 . . . . 63.45 110.856 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.01 -48.7 61.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.823 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -63.11 -36.75 84.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.051 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.58 13.63 62.8 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.691 -0.766 . . . . 71.33 112.582 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.0 m -78.26 -45.88 21.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.829 0.347 . . . . 64.42 111.12 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 67' ' ' LEU . 40.6 mt -103.27 113.92 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 61.11 111.159 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.0 p -118.08 138.12 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.904 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.795 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -130.25 112.14 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 75.52 111.041 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.8 t -98.22 125.8 43.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 73.53 110.801 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -69.14 109.17 3.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 53.04 110.916 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.846 HD21 HG11 ' A' ' 213' ' ' VAL . 15.8 mt -63.4 -33.73 76.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 71.44 110.895 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.46 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.96 -96.57 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 74.32 110.958 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' N ' HD22 ' A' ' 22' ' ' ASN . 8.0 tttt -150.7 9.79 0.62 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.853 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.447 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.24 7.99 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 73.31 110.844 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 t -151.01 141.33 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.22 111.213 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.795 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.4 m95 -129.8 -174.76 3.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 72.45 110.866 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 43' ' ' GLY . 98.2 t -136.64 90.49 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 61.14 111.13 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -73.55 124.47 25.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.84 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.8 m -121.03 104.58 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 64.51 111.142 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -86.3 122.18 29.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.939 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.72 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 1.1 mt -85.16 106.5 16.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.467 . . . . 72.42 110.872 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.47 -134.14 2.77 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.728 . . . . 53.0 112.489 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 p -175.93 117.81 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.855 0.359 . . . . 71.2 110.857 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.73 81.59 1.69 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.5 . . . . 72.32 110.914 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 70.28 2.01 3.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 75.0 110.912 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 137.68 -6.49 3.53 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.688 -0.768 . . . . 72.02 112.403 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -100.76 123.0 44.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.22 110.877 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.72 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -51.36 123.28 9.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 52.11 111.116 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.96 81.94 10.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.618 0.723 . . . . 62.0 111.19 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 118.83 5.92 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.687 2.258 . . . . 73.44 112.268 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.4 p -109.7 96.27 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.891 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -60.32 167.96 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.526 . . . . 62.13 110.941 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.458 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -159.29 -147.23 4.81 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 44.12 112.504 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 158' ' ' LEU . 14.9 tp -160.52 118.13 2.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.815 0.34 . . . . 74.25 110.969 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.653 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.8 t -100.88 122.11 52.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.179 -0.464 . . . . 75.1 111.093 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 158' ' ' LEU . 26.2 mt -99.41 119.57 38.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.49 . . . . 72.03 110.952 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.91 87.08 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 52.45 110.899 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.54 -179.87 4.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.464 . . . . 63.22 111.205 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -101.05 -23.78 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 25.43 110.809 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 -13.58 58.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 70.44 110.854 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.5 148.03 4.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.625 -0.798 . . . . 71.54 112.442 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.485 ' HB3' HG22 ' A' ' 79' ' ' VAL . 8.9 tp -63.18 154.96 29.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.858 0.361 . . . . 75.42 110.818 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.92 143.14 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.43 111.181 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.653 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -138.75 124.41 19.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 63.43 111.008 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 165' ' ' VAL . 74.5 t -69.82 112.49 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 63.02 111.139 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.75 139.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 53.34 110.894 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.708 ' CB ' HD11 ' A' ' 98' ' ' LEU . 1.6 p -83.1 -165.05 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.89 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.489 ' H ' HG23 ' A' ' 64' ' ' THR . 8.5 t -94.89 165.77 12.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 61.22 110.951 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.644 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.5 m95 -50.3 -59.61 3.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.449 . . . . 75.44 110.927 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -123.96 160.59 27.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.832 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -55.05 -39.84 69.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.932 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -54.88 -40.55 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 62.44 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.9 mt -74.46 -48.44 27.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 73.14 110.93 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.76 -44.39 58.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 73.41 111.12 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.43 -50.5 67.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 72.04 110.861 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -63.9 -18.79 64.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 70.35 110.907 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 16' ' ' ILE . 11.1 tp -88.71 -27.77 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.907 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.8 mt -89.72 -23.12 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 71.04 111.169 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -92.57 16.4 12.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.865 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 19.5 ptm -130.75 -39.71 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 70.12 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 67' ' ' LEU . 34.3 m -81.21 -22.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.207 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.589 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.11 -22.05 64.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 74.33 110.868 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.85 -33.5 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.102 -0.499 . . . . 63.55 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.4 -39.56 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 63.51 110.905 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -92.31 -11.29 35.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.2 110.914 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 68.08 12.15 8.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.949 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' HB2' HD13 ' A' ' 52' ' ' LEU . 6.7 mttt -130.59 138.97 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.898 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -85.44 138.79 32.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.43 110.864 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 54' ' ' LEU . 72.9 t -79.44 121.75 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 72.42 111.185 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 t -136.89 8.33 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 54.42 111.112 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 82' ' ' VAL . 64.7 m-20 -150.81 145.85 25.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.865 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 54' ' ' LEU . 4.0 t -155.33 132.53 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 62.25 111.198 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.631 ' CD1' HG11 ' A' ' 140' ' ' VAL . 23.2 mt -86.4 133.61 29.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 71.41 111.159 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.986 HD11 ' HB1' ' A' ' 105' ' ' ALA . 5.1 mm -98.43 147.69 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.108 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.7 p -111.61 -34.18 6.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 70.13 111.082 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.558 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.5 p-80 -175.11 -175.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.921 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -100.83 93.49 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 62.34 111.085 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.402 ' O ' HD13 ' A' ' 92' ' ' ILE . 1.2 t-160 -153.79 154.96 34.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 73.33 110.875 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.67 -21.77 7.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 72.15 111.124 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.31 18.23 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 75.45 110.823 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.911 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -143.54 -70.75 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 64.13 110.855 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.711 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.88 3.89 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 74.31 111.086 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.44 -45.62 45.75 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.695 -0.764 . . . . 64.12 112.44 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.52 15.81 59.54 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.644 -0.788 . . . . 71.41 112.454 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.475 HD12 HH22 ' A' ' 91' ' ' ARG . 4.6 tt -56.35 -25.97 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.814 0.34 . . . . 70.12 111.143 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -59.7 -21.36 60.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 72.53 110.851 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 ' HD2' ' A' ' 101' ' ' ARG . 81.9 m -98.28 -20.62 17.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 72.02 111.166 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.708 HD11 ' CB ' ' A' ' 57' ' ' SER . 13.7 mt -82.98 -36.13 25.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.879 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -88.86 9.8 23.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 64.44 110.897 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -112.45 -55.29 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 71.13 110.879 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.489 ' HD2' HG22 ' A' ' 97' ' ' THR . 7.1 mtt-85 -65.16 -58.59 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 73.3 110.862 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 153.18 39.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 53.51 112.413 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.2 mp -106.88 117.8 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.868 0.366 . . . . 74.34 111.104 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.734 ' CE ' HD21 ' A' ' 124' ' ' LEU . 3.2 mtpp -82.03 117.92 22.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 63.41 110.88 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.986 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -91.26 94.65 9.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 52.13 111.139 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -68.18 113.49 5.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 64.4 110.831 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 111' ' ' THR . 1.0 OUTLIER -142.66 -174.53 4.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 75.04 110.854 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.34 158.39 16.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 65.12 111.127 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.76 -38.89 50.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 60.12 111.134 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.7 HD23 ' OD1' ' A' ' 152' ' ' ASP . 55.5 tp -77.45 -37.61 51.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.948 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 88.9 m -58.37 -22.09 52.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 72.24 111.151 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -95.46 -3.16 47.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 75.31 111.099 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -95.8 -54.43 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.902 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.857 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -64.76 -13.95 57.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 73.23 110.843 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.5 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 63.33 111.059 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.69 -25.99 60.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 55.44 110.83 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -55.93 -33.05 64.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 72.42 110.845 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -91.75 -20.96 20.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 63.23 110.9 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.91 25.42 5.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.808 -0.71 . . . . 60.14 112.491 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.29 -174.55 2.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 63.21 110.905 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -81.14 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 64.14 110.877 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -120.77 108.75 36.67 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.663 0.744 . . . . 71.54 110.853 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.437 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.7 Cg_endo -69.75 -169.84 0.35 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.711 2.274 . . . . 75.3 112.343 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.734 HD21 ' CE ' ' A' ' 104' ' ' LYS . 20.7 mt -61.48 -48.78 79.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 44.14 110.931 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 57.04 23.07 45.02 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.73 -0.748 . . . . 75.32 112.528 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -100.02 33.74 2.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 75.13 110.899 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.671 HD22 HD21 ' A' ' 133' ' ' LEU . 74.8 mt -119.34 -175.04 2.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 71.42 110.917 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.4 HE21 ' N ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -153.73 -170.94 3.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 72.34 110.935 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.951 HG22 HG23 ' A' ' 130' ' ' VAL . 34.7 m -50.25 -70.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.291 -0.413 . . . . 71.3 111.111 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.951 HG23 HG22 ' A' ' 129' ' ' THR . 48.0 t -119.91 104.03 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 71.13 111.131 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 t -135.48 165.53 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 71.34 111.167 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.59 133.03 54.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 64.42 110.814 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.671 HD21 HD22 ' A' ' 127' ' ' LEU . 23.0 mt -118.92 158.01 26.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.976 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 mttt -140.68 123.18 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.93 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -120.22 45.52 2.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 74.43 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.84 92.36 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 62.15 112.479 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.52 15.01 9.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.827 0.346 . . . . 62.33 110.878 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 55.1 tpp -136.72 94.9 3.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 71.3 110.863 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.4 131.23 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.861 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.759 HG22 HD21 ' A' ' 158' ' ' LEU . 20.2 t -137.52 119.0 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.22 111.12 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -111.62 131.11 55.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 73.2 110.842 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.9 p -84.96 -172.82 4.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.122 -0.49 . . . . 74.03 111.167 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.567 ' HD1' HG22 ' A' ' 130' ' ' VAL . 22.7 t80 -170.82 135.55 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.814 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.711 ' HB3' HG23 ' A' ' 129' ' ' THR . 21.0 t80 -123.39 87.39 51.83 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 71.1 110.881 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -7.98 22.42 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 63.32 112.348 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.69 -155.67 21.51 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 63.13 112.435 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -92.12 140.34 29.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.36 . . . . 73.33 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.536 ' O ' ' HB1' ' A' ' 184' ' ' ALA . . . -154.17 -89.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.676 -0.773 . . . . 62.31 112.463 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -75.36 -25.16 57.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 64.15 110.823 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.558 HG21 ' HB2' ' A' ' 86' ' ' HIS . 52.9 p -147.26 -168.3 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 75.54 111.189 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 114' ' ' LEU . 42.4 tt0 -86.37 -15.2 41.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 74.43 110.798 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.7 ' OD1' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -138.42 23.06 2.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 63.02 110.803 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.687 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -55.05 130.42 41.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 64.3 110.882 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 84' ' ' ILE . 2.0 pt -135.0 172.77 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 75.43 111.125 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 143' ' ' PHE . 16.8 m -128.92 128.32 67.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 70.12 111.066 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.725 ' O ' HD12 ' A' ' 164' ' ' LEU . 95.8 t -81.82 132.15 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.099 -0.5 . . . . 73.25 111.06 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -118.76 131.91 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 74.22 110.908 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.908 HD11 HD21 ' A' ' 46' ' ' LEU . 11.5 mt -113.45 98.28 46.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.644 0.735 . . . . 65.11 110.899 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.8 Cg_endo -69.87 -4.41 14.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.672 2.248 . . . . 75.44 112.384 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -82.67 -23.92 33.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.11 110.843 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.72 14.11 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.911 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.6 m120 54.46 27.74 8.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 72.54 110.895 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.557 HD13 HD13 ' A' ' 21' ' ' LEU . 96.7 mt -93.46 130.26 42.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 75.11 111.079 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 156' ' ' VAL . 50.0 tp -114.74 150.75 34.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.938 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 55' ' ' VAL . 21.9 t -119.21 75.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.187 -0.46 . . . . 72.51 111.069 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.54 -45.97 53.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 70.25 112.495 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 74.79 -161.26 53.37 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.747 . . . . 73.21 112.417 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 12.8 m -51.41 -34.73 35.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 62.42 110.803 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.687 HD13 ' OD1' ' A' ' 153' ' ' ASN . 21.9 tp -51.64 -39.78 58.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.966 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 219' ' ' LEU . 17.3 t -104.65 111.31 33.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 74.3 111.07 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.551 ' HG3' HD12 ' A' ' 225' ' ' LEU . 9.9 mmpt? -53.49 155.76 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.883 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 97.7 p -101.78 160.44 14.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 62.51 110.845 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.4 t -51.28 -29.73 15.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 72.31 111.112 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.8 m -98.25 39.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 44.23 110.787 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -117.98 150.97 38.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 43.41 111.184 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.64 -3.32 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 54.43 110.931 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -179.21 176.24 0.88 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 54.32 110.821 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 226' ' ' LEU . 4.6 mt -83.51 -30.94 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 50.04 110.964 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.405 ' O ' HG13 ' A' ' 181' ' ' VAL . . . 92.69 -164.69 27.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.669 -0.777 . . . . 63.22 112.505 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -51.94 110.31 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 73.41 110.93 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.495 HG11 ' CG2' ' A' ' 186' ' ' VAL . 30.3 m -97.1 26.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 64.44 111.117 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -57.03 -34.99 68.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 54.11 111.089 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -110.76 6.14 21.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.414 . . . . 74.33 110.822 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 148' ' ' GLY . . . -114.56 162.91 16.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 75.24 111.024 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -121.95 92.16 3.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.933 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.495 ' CG2' HG11 ' A' ' 181' ' ' VAL . 24.6 t -58.54 -20.11 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 63.4 111.191 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -73.92 -20.26 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 73.34 110.911 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.63 -17.42 10.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 61.12 110.949 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.576 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.3 t90 -53.76 -61.25 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.3 110.923 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.771 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -54.53 -24.75 22.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.24 -0.436 . . . . 75.23 110.837 -179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 53.0 m -81.13 -29.91 34.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 42.44 111.167 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.454 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -76.28 -43.97 39.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.856 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 219' ' ' LEU . 35.3 mm -60.64 -47.25 93.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 75.31 111.173 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.462 ' HG2' HD21 ' A' ' 223' ' ' LEU . 2.0 mm-40 -56.15 -27.91 56.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.856 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -77.14 -22.46 52.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.03 110.826 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 192' ' ' SER . 18.2 t -85.47 -10.22 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 74.33 111.072 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.95 -8.06 13.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 54.34 110.926 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.24 -31.16 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.887 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -104.47 -55.34 2.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 64.41 110.937 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -95.91 39.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.236 -0.438 . . . . 62.2 110.913 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -56.42 -47.69 78.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 61.31 110.888 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -60.72 102.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.901 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.7 HG21 HG22 ' A' ' 206' ' ' VAL . 37.6 mt -144.76 129.55 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.31 111.131 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.69 -24.75 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 65.44 110.907 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -170.21 126.66 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.15 111.111 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.712 ' HB ' HD12 ' A' ' 218' ' ' LEU . 87.0 t -107.14 129.13 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 74.14 111.177 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.059 HG22 HG12 ' A' ' 213' ' ' VAL . 16.4 t -104.41 111.63 65.23 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 52.21 111.093 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.82 -173.25 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 70.25 112.231 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -86.95 -12.21 68.8 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.799 -0.715 . . . . 72.43 112.47 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -152.56 131.28 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.819 0.342 . . . . 73.23 110.853 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 112.23 -119.99 5.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.767 -0.73 . . . . 60.1 112.473 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.16 172.26 13.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 74.51 110.881 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.059 HG12 HG22 ' A' ' 207' ' ' VAL . 4.8 m -61.06 164.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.084 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -156.64 -115.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.802 -0.714 . . . . 71.33 112.538 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.21 -169.97 3.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.377 . . . . 64.45 110.839 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -19.92 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 64.24 110.908 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.524 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -60.1 -18.22 47.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.721 . . . . 74.32 112.438 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 206' ' ' VAL . 11.0 mt -72.12 -31.78 66.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 70.25 110.932 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.554 ' HA ' HG13 ' A' ' 170' ' ' VAL . 4.1 mm? -64.41 -58.62 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.959 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.524 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -60.21 -19.66 55.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.884 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.593 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.9 OUTLIER -63.41 -44.02 95.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.827 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.866 HG22 HD23 ' A' ' 226' ' ' LEU . 16.1 m -57.11 -52.77 63.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 53.13 111.18 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.75 HD23 ' OG ' ' A' ' 190' ' ' SER . 1.0 OUTLIER -60.32 -25.04 65.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 62.52 110.903 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -75.22 -11.75 60.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 74.41 110.887 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.593 HD11 ' CE1' ' A' ' 221' ' ' HIS . 9.7 mt -119.07 -15.56 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.22 110.871 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.866 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -113.31 2.22 15.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 65.35 110.903 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.238 -0.437 . . . . 55.54 110.846 179.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.833 0.349 . . . . 74.14 110.847 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.1 -69.85 0.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 71.35 110.911 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 61.7 100.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 64.5 110.939 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 p -51.68 148.32 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 63.44 111.105 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -123.88 155.66 37.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 72.34 110.853 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.78 -177.45 3.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 63.4 110.947 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -72.01 -68.37 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 73.12 111.09 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.4 t -49.52 147.25 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 72.33 111.128 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -113.69 103.33 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 74.33 111.088 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -122.08 116.87 25.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 73.12 110.872 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -62.46 166.72 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.895 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.23 -48.71 62.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.83 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 p -62.65 -36.7 83.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 63.14 111.206 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.34 14.56 63.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 70.34 112.572 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -80.4 -45.02 18.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 71.35 111.077 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' A' ' 67' ' ' LEU . 34.5 mt -102.55 107.98 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 74.05 111.077 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.2 p -113.14 137.01 52.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 71.05 110.887 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.778 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.5 mt -128.79 109.76 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 74.1 111.154 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -99.96 123.84 44.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 74.03 110.896 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -67.5 109.55 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 72.53 110.939 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.581 HD13 HD13 ' A' ' 163' ' ' ILE . 14.1 mt -63.62 -32.49 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 73.45 110.888 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -151.11 -97.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 65.11 110.843 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.0 OUTLIER -151.15 9.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.969 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.445 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.55 6.47 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 75.2 110.859 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 t -150.96 140.48 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 72.21 111.158 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.778 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.8 m95 -127.7 -173.71 2.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.906 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG23 ' HG ' ' A' ' 21' ' ' LEU . 71.0 t -137.83 92.87 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.175 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -77.52 120.54 22.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.861 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.4 m -115.29 98.57 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 61.54 111.185 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.01 117.27 20.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 71.22 110.947 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.746 ' CD2' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -84.18 116.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.858 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.13 -141.32 8.13 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.766 -0.731 . . . . 72.24 112.499 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 178.99 89.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.412 . . . . 75.12 110.866 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.23 84.21 3.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.064 -0.516 . . . . 73.1 110.899 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 66.61 12.56 8.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.083 -0.508 . . . . 75.03 110.94 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.73 -16.83 4.74 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.732 . . . . 62.3 112.526 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -91.22 114.02 26.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 64.31 110.879 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB1' ' CD2' ' A' ' 31' ' ' LEU . . . -56.61 123.6 15.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 73.33 111.118 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.75 84.31 12.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.527 0.68 . . . . 74.32 111.162 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 117.14 4.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.658 2.238 . . . . 53.03 112.389 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.56 102.16 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 53.41 110.799 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.81 170.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.067 -0.515 . . . . 74.35 110.911 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.76 -158.0 8.81 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 71.53 112.501 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.588 HD21 HD12 ' A' ' 158' ' ' LEU . 13.2 tp -156.18 113.49 3.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.868 0.366 . . . . 54.43 110.87 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.641 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.6 t -99.25 113.59 34.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 63.35 111.161 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.671 HD21 HD11 ' A' ' 158' ' ' LEU . 18.9 mt -93.63 119.27 32.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 53.12 110.915 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.81 84.49 6.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.22 110.822 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -172.54 2.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 53.02 111.091 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -105.34 -25.79 12.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.212 -0.449 . . . . 63.41 110.906 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.4 -13.35 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.886 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.83 155.44 6.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.714 -0.755 . . . . 64.33 112.504 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HB3' HG22 ' A' ' 79' ' ' VAL . 11.2 tp -64.87 157.82 26.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 70.02 110.842 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 81' ' ' ASP . 17.1 t -146.5 142.37 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 61.41 111.145 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.649 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.7 mt -139.32 120.52 14.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.904 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.59 111.81 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 73.12 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.92 128.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 71.33 110.9 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.673 ' CB ' HD11 ' A' ' 98' ' ' LEU . 3.3 p -71.96 -164.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 71.22 110.906 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -93.08 171.67 8.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 70.44 110.898 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.627 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.8 m95 -55.53 -60.69 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 72.05 110.92 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -124.19 157.63 34.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 74.35 110.817 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -51.86 -39.97 59.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 74.41 110.889 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -53.42 -41.1 65.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 65.12 110.894 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 59' ' ' TRP . 93.9 mt -75.97 -45.55 34.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 62.22 110.924 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.403 HG21 HD21 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -50.97 -48.83 61.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.35 111.132 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -52.46 -50.01 63.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 65.25 110.906 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -64.06 -19.71 65.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 73.23 110.806 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.6 tp -89.18 -26.21 21.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 61.33 110.84 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.407 HG23 ' OE1' ' A' ' 72' ' ' GLU . 58.5 mt -91.18 -23.07 6.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 71.12 111.103 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.05 15.4 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.875 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.2 ptm -130.43 -40.32 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.23 110.94 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 67' ' ' LEU . 29.3 m -80.67 -21.7 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 64.32 111.146 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.569 ' OE2' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -69.04 -23.01 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 63.44 110.884 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.8 -33.07 7.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 45.43 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.27 -43.52 67.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 62.42 110.859 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.571 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 18.6 m-85 -87.1 -10.66 52.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.827 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 67.19 12.45 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 54.41 110.919 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.19 140.4 48.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 74.32 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.0 137.15 32.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 62.03 110.954 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.569 HG23 ' OE2' ' A' ' 72' ' ' GLU . 89.5 t -75.56 117.51 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 71.23 111.1 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -133.09 10.95 4.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 55.44 110.996 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.533 ' N ' HG23 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -155.83 137.88 14.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 52.31 110.832 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 54' ' ' LEU . 13.1 t -146.15 129.15 9.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 75.45 111.065 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.628 HD11 ' HE2' ' A' ' 135' ' ' PHE . 28.6 mt -92.95 125.21 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 70.3 111.104 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -94.24 158.36 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.08 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.7 p -115.31 -39.88 3.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 71.23 111.148 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.57 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.0 p-80 -159.22 -174.36 4.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.824 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -102.32 97.37 7.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 41.25 111.127 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.98 154.96 26.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 64.4 110.932 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.64 -19.7 28.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 65.24 111.175 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.66 14.3 13.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 71.31 110.897 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -135.32 -76.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.53 110.973 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -92.35 11.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 74.24 111.079 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -48.81 -34.03 14.26 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.769 . . . . 73.21 112.483 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.38 17.77 23.58 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 60.04 112.497 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.5 tt -58.09 -33.68 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 75.1 111.085 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -55.82 -24.2 34.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.256 -0.429 . . . . 64.34 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 m -95.84 -12.25 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 61.42 111.182 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.673 HD11 ' CB ' ' A' ' 57' ' ' SER . 16.8 mt -90.01 -30.6 17.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.901 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -88.09 -6.65 57.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 64.45 110.914 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -91.53 -52.7 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 64.11 110.966 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -61.86 -60.65 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.13 110.952 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 155.09 40.0 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.753 -0.737 . . . . 44.23 112.502 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.632 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.4 mp -108.04 140.08 27.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 72.53 111.157 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 124' ' ' LEU . 5.0 mtmm -98.17 110.33 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 72.01 110.914 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.6 95.48 9.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 72.43 111.09 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.587 ' HA ' HD12 ' A' ' 124' ' ' LEU . 43.0 m-70 -72.83 145.21 47.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.89 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -173.75 -175.12 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 72.04 110.919 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.41 154.96 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 54.21 111.21 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.08 39.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.364 -0.38 . . . . 54.43 111.036 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.755 HD12 ' HG2' ' A' ' 113' ' ' GLU . 61.2 tp -67.34 -41.63 84.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 73.41 110.89 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' ' 114' ' ' LEU . 86.9 m -61.96 -16.8 53.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 54.45 111.121 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.632 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -104.06 11.71 34.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 25.45 111.14 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.755 ' HG2' HD12 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -111.35 -26.07 9.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 54.44 110.767 -179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.836 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -100.25 -9.49 22.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.976 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.34 -36.88 82.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.31 111.057 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.79 -28.14 60.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 71.2 110.983 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -55.44 -35.36 65.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.086 -0.506 . . . . 63.22 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -86.14 -25.65 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 30.05 110.941 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.73 14.6 4.69 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 35.25 112.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 92' ' ' ILE . 69.7 m-85 -95.1 177.36 5.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 74.11 110.977 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.523 ' CG ' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.24 -171.86 3.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 54.13 110.853 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 2.1 mt-10 -115.49 111.95 43.77 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.72 0.772 . . . . 65.32 110.878 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 54.2 Cg_endo -69.66 -178.89 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.772 2.314 . . . . 64.33 112.32 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 106' ' ' HIS . 31.4 mt -53.57 -43.87 68.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.932 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 51.76 27.78 21.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 62.43 112.463 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -101.19 31.31 3.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 73.1 110.825 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.56 HD22 HD21 ' A' ' 133' ' ' LEU . 62.7 mt -116.13 -175.21 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 44.54 110.964 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.66 -170.93 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 72.52 110.894 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.906 HG22 HG23 ' A' ' 130' ' ' VAL . 41.2 m -50.43 -70.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 72.45 111.034 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.906 HG23 HG22 ' A' ' 129' ' ' THR . 41.0 t -118.08 105.86 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 63.12 111.118 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -138.82 166.78 23.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 72.32 111.169 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.83 134.04 55.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.788 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.56 HD21 HD22 ' A' ' 127' ' ' LEU . 25.1 mt -113.08 167.46 10.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.933 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.48 134.39 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 71.23 110.939 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.628 ' HE2' HD11 ' A' ' 83' ' ' ILE . 51.4 m-85 -137.21 36.15 2.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 75.01 110.869 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.74 93.34 0.21 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.736 . . . . 54.12 112.518 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.4 m120 65.55 13.67 9.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.826 0.346 . . . . 74.22 110.917 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.7 tpp -135.37 105.34 6.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.941 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -96.45 130.62 43.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 74.5 110.879 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.843 HG22 HD21 ' A' ' 158' ' ' LEU . 20.7 t -135.67 117.39 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 74.42 111.13 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -109.99 129.5 55.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 53.4 110.89 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 33.5 p -84.36 -176.29 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 70.23 111.185 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.452 ' HD1' HG22 ' A' ' 130' ' ' VAL . 22.6 t80 -166.74 133.4 2.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 70.32 110.929 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.695 ' HB3' HG23 ' A' ' 129' ' ' THR . 10.0 t80 -124.07 89.26 51.92 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.727 0.775 . . . . 72.24 110.941 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 52.7 Cg_endo -69.81 -21.75 32.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 64.13 112.33 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.18 -157.64 27.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.801 -0.714 . . . . 53.54 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -88.02 138.14 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 72.13 110.837 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.23 -88.82 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 54.01 112.494 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -75.48 -25.62 57.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 72.54 110.866 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.57 HG21 ' HB2' ' A' ' 86' ' ' HIS . 34.3 p -146.82 -165.33 2.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 74.52 111.166 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HG2' HD21 ' A' ' 110' ' ' LEU . 5.1 tt0 -85.85 -19.67 30.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.422 . . . . 75.13 110.89 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.536 ' OD1' HD23 ' A' ' 110' ' ' LEU . 9.4 t0 -137.87 24.27 2.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 73.43 110.863 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.595 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.5 OUTLIER -53.83 129.29 33.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 74.21 110.837 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.474 HG22 ' CD1' ' A' ' 144' ' ' TYR . 2.9 pt -135.21 174.47 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 64.04 111.105 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 143' ' ' PHE . 15.8 m -127.19 136.24 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.14 111.161 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.1 t -87.5 121.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.4 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -110.02 139.14 45.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.509 . . . . 63.11 110.947 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.843 HD21 HG22 ' A' ' 140' ' ' VAL . 21.1 mt -120.14 99.21 48.72 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.529 0.68 . . . . 75.12 110.914 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 54.6 Cg_endo -69.62 -4.53 14.12 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.711 2.274 . . . . 72.41 112.382 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -85.73 -22.81 27.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 62.13 110.937 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -140.3 12.15 2.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.97 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.36 25.17 5.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 52.5 110.939 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.581 HD13 HD13 ' A' ' 21' ' ' LEU . 95.3 mt -89.04 142.34 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 62.32 111.1 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 57.7 tp -122.32 156.39 33.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.909 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.3 t -123.56 74.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 64.15 111.157 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.99 -41.71 52.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.732 -0.747 . . . . 73.21 112.458 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 65.66 -162.54 41.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 71.22 112.494 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 16.7 m -51.84 -34.51 40.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 45.43 110.882 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.735 HD12 ' NE1' ' A' ' 189' ' ' TRP . 26.2 tp -51.76 -41.35 61.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.878 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 219' ' ' LEU . 18.1 t -100.83 109.61 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 64.44 111.116 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.576 ' HG3' HD12 ' A' ' 225' ' ' LEU . 0.3 OUTLIER -51.5 147.85 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 75.12 110.924 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 2.4 p -98.29 159.64 14.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 74.43 110.926 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t -56.89 -24.59 53.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.172 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.9 t -96.87 34.5 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.787 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -129.09 152.28 48.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 45.21 111.081 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.41 2.12 10.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 60.12 110.971 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.76 175.84 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.31 110.878 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.734 HD11 ' CB ' ' A' ' 226' ' ' LEU . 5.8 mt -82.89 -32.8 27.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 51.21 110.907 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 92.32 -162.44 27.03 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 44.41 112.562 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.97 113.06 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 75.21 110.927 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.643 HG11 ' CG2' ' A' ' 186' ' ' VAL . 26.9 m -99.69 26.24 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 73.21 111.138 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -56.13 -35.06 66.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 75.3 111.107 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -111.1 4.71 19.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 71.53 110.824 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -112.41 162.14 15.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 63.13 111.057 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.14 92.43 3.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.25 -0.432 . . . . 74.21 110.942 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.643 ' CG2' HG11 ' A' ' 181' ' ' VAL . 11.1 t -62.86 -18.43 21.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 72.24 111.165 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -75.62 -20.67 58.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 73.23 110.952 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.6 -14.72 10.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 73.25 110.887 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.735 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.4 t90 -55.0 -60.57 3.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.498 . . . . 75.12 110.853 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.742 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.97 -24.75 17.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 74.33 110.841 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.3 m -81.56 -31.46 32.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 71.33 111.127 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -73.67 -43.82 58.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 63.23 110.886 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.26 -44.61 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 75.31 111.18 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.97 -23.83 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.872 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -82.14 -21.43 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.758 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.455 HG12 HD21 ' A' ' 219' ' ' LEU . 11.5 t -87.97 -9.56 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.54 111.151 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.1 pp -112.43 -8.5 13.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.881 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -104.11 -31.08 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 73.44 110.809 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.4 -53.84 2.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.883 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.48 ' O ' HD11 ' A' ' 203' ' ' ILE . 4.0 m-30 -98.1 60.3 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 74.02 110.868 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -72.57 -59.48 2.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 61.23 110.901 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -52.13 102.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 65.33 110.904 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.701 HG21 HG22 ' A' ' 206' ' ' VAL . 59.0 mt -139.43 116.72 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 73.32 111.138 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.95 -22.74 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.833 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -174.97 129.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 71.3 111.088 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.712 ' HB ' HD12 ' A' ' 218' ' ' LEU . 88.1 t -102.22 130.86 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 33.43 111.073 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 213' ' ' VAL . 11.4 t -107.92 103.75 50.89 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 121.568 0.699 . . . . 73.31 111.077 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 207' ' ' VAL . 53.7 Cg_endo -69.83 -170.64 0.41 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.736 2.291 . . . . 73.24 112.311 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -92.49 -11.74 59.15 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.838 -0.696 . . . . 54.21 112.57 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.44 144.43 23.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.837 0.351 . . . . 65.04 110.881 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 100.77 -102.31 2.42 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.793 -0.718 . . . . 74.4 112.431 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -170.86 159.52 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.41 . . . . 72.04 110.905 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 207' ' ' VAL . 6.0 m -53.39 163.29 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.13 111.176 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -161.78 -99.68 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 43.41 112.514 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -167.29 -168.04 1.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.88 0.371 . . . . 65.44 110.825 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.41 -20.25 42.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 63.31 110.961 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.516 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -54.17 -23.73 26.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 33.24 112.473 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.6 mt -73.17 -34.7 66.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 51.13 110.956 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.649 ' HA ' HG13 ' A' ' 170' ' ' VAL . 6.6 mp -59.84 -59.34 5.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 75.12 110.964 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.516 HD21 ' HA2' ' A' ' 217' ' ' GLY . 0.5 OUTLIER -59.54 -20.58 56.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.282 -0.417 . . . . 74.04 110.911 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.453 ' CE1' HD11 ' A' ' 225' ' ' LEU . 0.8 OUTLIER -66.62 -34.35 77.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.22 110.811 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.796 HG22 HD23 ' A' ' 226' ' ' LEU . 7.7 m -62.52 -55.54 26.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 72.4 111.152 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.58 -20.95 66.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 63.31 110.924 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -75.09 -12.11 60.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 63.22 110.879 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.576 HD12 ' HG3' ' A' ' 171' ' ' LYS . 7.7 mt -119.88 -26.34 5.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 53.32 110.935 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.796 HD23 HG22 ' A' ' 222' ' ' THR . 0.4 OUTLIER -100.13 5.46 44.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 61.33 110.964 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 mttt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.83 179.808 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.833 0.349 . . . . 61.32 110.814 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 63.14 163.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.84 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -166.75 150.98 7.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 63.31 110.897 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -104.05 148.03 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 74.43 111.112 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.0 167.66 21.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 61.31 110.846 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.1 mtmm -118.23 174.14 6.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 74.34 110.87 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.5 m -51.61 -54.09 31.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 74.21 111.127 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 19' ' ' SER . 5.3 m -58.11 -175.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 74.23 111.074 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.19 94.05 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 44.01 111.137 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -112.49 117.35 32.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.947 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -61.82 170.21 2.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 63.41 110.918 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -55.13 -46.1 75.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.032 0.444 . . . . 72.12 110.899 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.7 p -60.98 -38.51 86.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 74.31 111.119 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.77 13.88 62.03 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.799 -0.715 . . . . 65.13 112.563 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.4 m -83.45 -35.56 24.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.363 . . . . 60.44 111.216 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.9 mt -110.08 122.5 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 74.2 111.109 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 p -129.86 128.79 42.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 73.13 110.776 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.697 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.0 OUTLIER -122.5 112.95 36.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 62.03 111.15 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.423 ' HA ' HG12 ' A' ' 8' ' ' VAL . 16.8 t -99.09 129.11 45.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 62.04 110.87 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -72.91 111.14 7.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 63.45 110.933 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.04 HD21 HG11 ' A' ' 213' ' ' VAL . 22.8 mt -64.62 -32.54 74.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.854 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.84 -97.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 71.43 110.874 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' N ' HD22 ' A' ' 22' ' ' ASN . 23.3 tttt -150.3 9.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 75.13 110.904 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.46 7.78 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 72.04 110.977 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.86 141.14 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 71.44 111.112 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.697 ' HB3' HG22 ' A' ' 18' ' ' ILE . 18.0 m95 -129.52 -179.42 5.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.21 -0.45 . . . . 74.35 110.929 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.529 HG23 ' HG ' ' A' ' 21' ' ' LEU . 89.7 t -131.43 90.2 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 53.1 111.118 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.409 ' CA ' HG23 ' A' ' 18' ' ' ILE . 16.9 p80 -74.15 125.19 27.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 62.32 110.907 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -124.45 105.54 9.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 63.53 111.181 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.685 ' CD ' HD22 ' A' ' 67' ' ' LEU . 19.5 mp0 -91.64 124.39 35.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 72.54 110.869 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.889 HD21 ' HB1' ' A' ' 38' ' ' ALA . 2.3 mt -80.32 127.55 32.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 64.33 110.905 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.28 -19.91 56.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.87 -0.681 . . . . 63.0 112.491 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 94.3 p 49.46 89.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.941 0.4 . . . . 71.42 110.918 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.15 -160.88 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 75.43 110.988 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -71.03 66.82 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 45.23 110.864 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.84 9.46 54.34 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.703 -0.76 . . . . 73.45 112.447 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -128.85 174.56 9.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.341 . . . . 73.31 110.884 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.889 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -112.77 122.67 48.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.133 -0.485 . . . . 53.44 111.127 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.473 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.0 t -113.13 74.76 1.95 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.666 0.746 . . . . 63.23 111.212 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 119.46 6.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.243 . . . . 72.04 112.336 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -101.55 89.09 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 53.33 110.877 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -56.66 158.66 4.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.42 110.877 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.94 -146.9 4.51 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.737 -0.744 . . . . 64.33 112.523 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 ' CD1' ' A' ' 158' ' ' LEU . 14.2 tp -160.22 117.32 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.84 0.352 . . . . 63.53 110.891 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.677 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.5 t -99.43 122.36 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.54 111.171 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 158' ' ' LEU . 16.6 mt -100.0 119.14 37.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.441 . . . . 62.01 110.942 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -89.31 86.68 6.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.439 . . . . 75.44 110.945 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 138' ' ' MET . 1.2 p -99.83 -172.31 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 72.34 111.212 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -20.76 12.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.823 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -86.89 -13.34 45.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 73.41 110.848 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.54 147.51 4.56 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 60.01 112.43 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 79' ' ' VAL . 9.4 tp -63.13 156.01 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 73.55 110.994 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.31 142.59 23.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.55 111.087 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.677 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.1 mt -138.07 125.03 21.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 75.25 110.854 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.41 HG11 HG11 ' A' ' 165' ' ' VAL . 74.5 t -70.45 111.51 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 53.02 111.134 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER 73.57 138.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 65.54 110.833 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.694 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.9 p -81.21 -164.15 0.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 71.43 110.816 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.405 ' H ' HG23 ' A' ' 64' ' ' THR . 6.7 t -95.36 168.34 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.909 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.7 ' HB2' HD12 ' A' ' 63' ' ' LEU . 98.8 m95 -50.32 -59.94 3.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 74.1 110.929 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -128.13 158.92 36.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.83 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -52.08 -34.75 45.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.891 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -57.5 -36.31 71.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 71.11 110.921 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 59' ' ' TRP . 95.8 mt -82.82 -46.64 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 72.24 110.971 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.67 -47.57 58.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 72.1 111.143 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -53.18 -50.36 64.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.887 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.56 -19.04 65.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.14 110.939 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.685 HD22 ' CD ' ' A' ' 30' ' ' GLU . 16.1 tp -88.59 -26.16 22.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 75.52 110.862 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.17 -23.34 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 73.44 111.151 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.17 15.2 14.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 73.32 110.916 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.5 ptm -129.83 -39.77 1.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 75.21 110.879 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 67' ' ' LEU . 31.9 m -80.44 -22.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 63.13 111.113 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.588 ' OE1' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -68.35 -24.02 64.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 44.21 110.836 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -106.37 -33.23 7.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 71.51 110.942 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -70.21 -42.26 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 62.43 110.885 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -89.34 -11.17 44.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.874 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 67.95 12.03 8.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.924 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.67 139.56 50.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.877 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -85.45 138.62 32.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.97 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 54' ' ' LEU . 72.8 t -79.18 122.29 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.4 111.093 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -137.33 8.14 2.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 53.42 111.215 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 82' ' ' VAL . 57.2 m-20 -149.89 145.84 26.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 71.32 110.941 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 54' ' ' LEU . 3.4 t -155.7 131.68 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 63.23 111.069 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.584 ' CD1' HG11 ' A' ' 140' ' ' VAL . 22.0 mt -86.18 133.96 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.53 111.15 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.004 HD11 ' HB1' ' A' ' 105' ' ' ALA . 4.8 mm -98.96 148.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 72.22 111.125 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 79.8 p -114.57 -39.19 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 65.11 111.162 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.502 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.1 p-80 -166.84 177.03 6.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 72.02 110.834 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -96.75 83.45 3.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 72.43 111.173 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 71.02 110.839 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.46 -22.03 7.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 75.2 111.078 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.06 19.69 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 44.13 110.919 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.894 ' NE ' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -144.33 -70.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.868 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.718 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -89.76 3.55 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 75.31 111.146 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.84 -45.12 49.61 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 62.13 112.565 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.14 15.17 60.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 75.55 112.425 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.554 HD12 HH22 ' A' ' 91' ' ' ARG . 2.8 tt -55.4 -28.48 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.879 0.371 . . . . 62.14 111.08 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -21.84 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 73.34 110.929 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -98.58 -14.57 19.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 64.41 111.191 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 57' ' ' SER . 14.5 mt -89.53 -35.85 15.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 72.42 110.92 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -94.44 23.97 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 72.25 110.85 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -124.94 -43.37 1.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 74.02 110.784 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -81.59 -52.51 7.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 72.51 110.891 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.27 41.01 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.713 -0.756 . . . . 60.12 112.485 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 98' ' ' LEU . 4.9 mp -109.59 112.82 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 72.14 111.132 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.781 ' HE2' HD21 ' A' ' 124' ' ' LEU . 3.0 mtpp -79.79 116.65 20.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 63.12 110.92 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 1.004 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -89.2 90.15 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.257 -0.429 . . . . 75.52 111.114 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.42 ' HA ' HD12 ' A' ' 124' ' ' LEU . 45.9 m-70 -63.09 113.97 3.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.87 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.21 -174.71 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 64.5 110.849 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.68 157.14 16.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.066 -0.515 . . . . 72.22 111.133 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.08 -40.94 33.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 63.33 111.101 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -35.65 74.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 71.41 110.968 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.568 ' HA ' HD11 ' A' ' 114' ' ' LEU . 75.4 m -63.77 -21.54 66.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 64.1 111.129 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -102.37 11.63 37.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 45.2 111.154 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.79 -24.38 12.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 64.23 110.868 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -104.34 -7.4 19.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 71.31 110.958 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.63 -41.04 65.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.197 -0.456 . . . . 42.31 111.052 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -24.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.93 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -33.57 71.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 73.12 110.857 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -87.81 -22.87 24.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.32 110.841 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.45 23.15 4.88 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.795 -0.717 . . . . 74.44 112.57 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.54 -177.64 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.781 0.324 . . . . 73.44 110.92 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -79.65 -172.19 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 74.03 110.895 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.47 112.99 32.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.624 0.726 . . . . 75.31 110.915 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.3 Cg_endo -69.81 -170.28 0.39 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 72.11 112.27 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.781 HD21 ' HE2' ' A' ' 104' ' ' LYS . 14.0 mt -60.63 -51.52 69.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 61.14 110.899 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.81 18.22 45.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 43.3 112.489 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -96.79 33.01 1.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 71.13 110.847 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.582 HD22 HG21 ' A' ' 131' ' ' THR . 80.7 mt -119.09 -175.09 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 73.5 110.944 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.68 -170.74 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.252 -0.431 . . . . 73.13 110.911 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.821 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.02 -70.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 63.44 111.138 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.821 HG23 HG22 ' A' ' 129' ' ' THR . 38.7 t -116.6 96.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 74.2 111.148 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.582 HG21 HD22 ' A' ' 127' ' ' LEU . 14.5 t -117.78 169.37 9.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.464 . . . . 71.23 111.167 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.21 103.9 8.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.409 . . . . 73.43 110.931 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD21 ' CD2' ' A' ' 127' ' ' LEU . 29.1 mt -80.04 165.44 22.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 72.1 110.918 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -151.77 112.06 4.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.779 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.02 69.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.932 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.63 -93.29 0.3 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.834 -0.698 . . . . 45.54 112.42 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -110.01 24.39 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 75.13 110.833 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.414 ' HB2' HG22 ' A' ' 48' ' ' THR . 50.9 tpp -132.48 135.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.886 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.86 130.53 56.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 72.4 110.989 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.612 HG22 ' CD2' ' A' ' 158' ' ' LEU . 8.3 t -139.59 121.0 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 72.41 111.124 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -113.31 126.07 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 72.42 110.898 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 18.8 p -83.34 -174.66 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.11 111.051 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.509 ' HD1' HG22 ' A' ' 130' ' ' VAL . 36.6 t80 -170.66 139.72 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 62.43 110.894 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.708 ' HB3' HG23 ' A' ' 129' ' ' THR . 88.6 t80 -125.78 89.02 53.24 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.737 0.78 . . . . 61.13 110.976 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 144' ' ' TYR . 53.6 Cg_endo -69.76 -8.05 22.61 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.737 2.291 . . . . 64.24 112.33 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.59 -149.04 19.42 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.673 -0.775 . . . . 74.42 112.448 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -98.47 140.22 33.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.815 0.34 . . . . 63.34 110.907 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.06 -93.19 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.744 -0.741 . . . . 51.13 112.538 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -71.59 -23.66 61.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.352 . . . . 75.22 110.83 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 86' ' ' HIS . 55.2 p -151.71 -175.35 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.33 111.124 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 114' ' ' LEU . 32.6 tt0 -85.16 -3.38 58.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 70.33 110.855 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.477 ' OD2' HG23 ' A' ' 111' ' ' THR . 7.4 p-10 -141.66 13.78 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 75.24 110.832 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.6 141.56 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.88 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.704 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.7 pt -146.91 176.25 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.3 111.078 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.485 HG12 ' HA2' ' A' ' 166' ' ' GLY . 22.1 m -132.53 129.02 58.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 74.42 111.11 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.9 t -86.84 133.1 30.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.33 111.101 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -120.16 137.48 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 71.42 110.951 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.612 ' CD2' HG22 ' A' ' 140' ' ' VAL . 41.6 mt -119.5 99.28 50.01 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.647 0.737 . . . . 72.34 110.945 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -3.13 11.36 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 63.32 112.407 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -86.54 -24.6 25.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 65.43 110.827 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.32 13.01 2.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 72.42 110.942 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.4 m120 54.18 25.42 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 74.0 110.942 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.698 HD13 HD13 ' A' ' 21' ' ' LEU . 95.7 mt -89.69 133.45 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.504 . . . . 62.52 111.162 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.633 HD22 HD13 ' A' ' 203' ' ' ILE . 6.0 tp -121.68 140.62 52.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 75.45 110.931 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.41 HG11 HG11 ' A' ' 55' ' ' VAL . 21.7 t -113.42 75.22 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 72.11 111.193 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.485 ' HA2' HG12 ' A' ' 155' ' ' VAL . . . -52.06 -35.88 42.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.692 -0.765 . . . . 72.52 112.607 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 69.27 -157.9 53.37 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.817 -0.706 . . . . 72.44 112.51 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 98.0 m -50.7 -33.68 23.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.841 0.353 . . . . 61.31 110.922 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.616 HD12 ' NE1' ' A' ' 189' ' ' TRP . 60.4 tp -52.45 -37.83 57.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.936 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 219' ' ' LEU . 86.0 t -105.75 108.18 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 74.11 111.127 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -50.78 168.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 71.3 110.904 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.502 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -119.88 160.16 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 73.2 110.807 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 t -50.98 157.67 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 71.14 111.146 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m 69.46 11.78 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 64.03 110.817 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 225' ' ' LEU . . . -84.77 143.06 29.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 73.13 111.064 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.523 ' C ' HD22 ' A' ' 225' ' ' LEU . 0.1 OUTLIER -118.83 -13.27 9.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.925 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.483 ' N ' HD22 ' A' ' 225' ' ' LEU . 0.6 OUTLIER -179.03 154.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 75.11 110.93 179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' A' ' 226' ' ' LEU . 12.0 mt -59.4 -47.16 86.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 61.24 110.894 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 67.8 125.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.796 -0.716 . . . . 53.52 112.514 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.29 103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 64.32 110.933 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.76 20.34 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 74.35 111.134 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -63.78 -42.93 97.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.127 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -100.89 23.95 9.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 70.01 110.942 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -137.08 163.29 31.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 52.52 111.095 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -115.94 92.66 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 72.35 110.898 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.12 -25.95 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 72.0 111.089 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -69.5 -32.26 71.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.32 110.885 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -100.19 -14.44 18.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.4 110.849 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.616 ' NE1' HD12 ' A' ' 169' ' ' LEU . 1.9 t90 -57.34 -61.83 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.54 110.927 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.751 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -53.8 -24.46 15.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 62.33 110.873 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 60.6 m -80.15 -33.64 38.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 75.3 111.169 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.527 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.49 -43.01 64.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.803 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.7 mm -59.9 -47.17 92.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 64.11 111.175 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -57.33 -28.5 63.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 65.01 110.905 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -77.94 -20.93 51.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 54.45 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 192' ' ' SER . 22.8 t -87.08 -11.44 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.205 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 198' ' ' LYS . 4.0 pp -110.36 -14.17 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 45.02 110.906 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.435 ' N ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -95.92 -30.95 13.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.964 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -103.46 -51.42 3.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 74.25 110.8 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -101.07 64.31 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 72.24 110.899 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -71.73 -59.9 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.102 -0.499 . . . . 74.2 110.869 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -50.97 107.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 70.2 110.854 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.662 HG21 HG22 ' A' ' 206' ' ' VAL . 91.3 mt -146.26 118.94 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 64.43 111.126 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.54 -29.6 52.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 72.44 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.706 ' HB1' ' CG2' ' A' ' 213' ' ' VAL . . . -159.65 146.4 16.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 52.21 111.118 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.792 ' HB ' HD12 ' A' ' 218' ' ' LEU . 49.9 t -121.92 122.37 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 63.12 111.088 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.816 HG22 ' HB ' ' A' ' 213' ' ' VAL . 21.4 t -102.21 101.94 22.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.619 0.723 . . . . 74.1 111.148 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.539 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.4 Cg_endo -69.84 178.12 4.94 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.666 2.244 . . . . 65.42 112.327 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.28 -17.97 76.38 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.712 -0.756 . . . . 63.31 112.536 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -152.52 148.98 28.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 74.2 110.915 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 105.9 -115.4 4.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.653 -0.784 . . . . 63.42 112.498 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -159.63 148.73 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.864 0.364 . . . . 43.5 110.92 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.04 HG11 HD21 ' A' ' 21' ' ' LEU . 3.6 p -51.49 130.11 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 75.21 111.044 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -127.63 -98.13 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.689 -0.767 . . . . 35.13 112.443 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.84 -169.72 2.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.874 0.368 . . . . 71.1 110.918 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 219' ' ' LEU . 0.0 OUTLIER -62.05 -16.96 55.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.902 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.512 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -58.29 -18.96 37.79 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.806 -0.712 . . . . 53.1 112.406 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 206' ' ' VAL . 9.4 mt -75.08 -45.58 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 73.33 110.945 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.649 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -53.32 -56.24 18.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 73.43 110.983 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.512 HD21 ' HA2' ' A' ' 217' ' ' GLY . 3.3 pp -59.39 -20.36 54.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 41.12 110.919 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.82 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.679 HG22 HD23 ' A' ' 226' ' ' LEU . 8.1 m -63.86 -56.75 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 55.32 111.132 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 190' ' ' SER . 2.4 mt -54.55 -29.78 52.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.432 . . . . 72.22 110.955 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.98 -29.22 61.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 75.13 110.898 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 175' ' ' ALA . 14.5 mt -92.42 -16.43 25.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 65.14 110.925 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.751 HD11 ' CB ' ' A' ' 190' ' ' SER . 0.4 OUTLIER -116.3 18.19 15.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 72.13 110.95 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 74.43 110.845 179.947 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.783 0.325 . . . . 65.11 110.885 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -169.24 103.84 0.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.086 -0.506 . . . . 63.2 110.89 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 139.94 53.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.929 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.4 m -85.54 -178.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 64.03 111.075 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -135.56 66.88 1.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 73.22 110.893 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -131.94 172.43 12.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 73.02 110.854 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -88.77 -68.61 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 45.53 111.162 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.58 147.25 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 54.3 111.157 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.442 HD13 ' HG2' ' A' ' 74' ' ' LYS . 22.1 mt -112.66 101.44 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.41 111.121 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -120.52 115.03 22.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 70.55 110.997 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 -58.25 165.04 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 73.41 110.894 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -51.62 -48.51 63.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 72.01 110.896 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.9 p -61.15 -37.72 83.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 72.42 111.06 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 10.1 62.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 71.12 112.486 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.2 m -75.92 -45.36 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 72.32 111.115 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.47 123.25 54.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 63.52 111.16 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.5 p -127.22 133.56 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 41.33 110.84 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.778 HG22 ' HB3' ' A' ' 26' ' ' TRP . 1.9 mt -127.22 110.53 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 75.12 111.127 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -98.83 126.58 44.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 71.21 110.846 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -71.14 108.85 4.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.848 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.744 HD21 HG11 ' A' ' 213' ' ' VAL . 15.8 mt -62.07 -33.34 74.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.14 110.926 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -151.32 -96.74 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 71.42 110.911 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' N ' HD22 ' A' ' 22' ' ' ASN . 0.4 OUTLIER -150.87 9.7 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.849 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.442 ' H ' ' ND2' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -150.61 6.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 70.44 110.906 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -151.0 140.81 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 61.52 111.122 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.778 ' HB3' HG22 ' A' ' 18' ' ' ILE . 15.9 m95 -128.51 -173.25 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 71.15 110.947 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.467 HG23 ' HG ' ' A' ' 21' ' ' LEU . 97.1 t -137.79 88.2 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.079 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -69.43 124.13 23.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 70.11 110.792 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.1 m -123.65 105.29 9.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 73.14 111.166 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.705 ' CD ' HD22 ' A' ' 67' ' ' LEU . 8.1 mp0 -91.89 125.8 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 62.34 110.864 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.636 HD21 ' HB1' ' A' ' 38' ' ' ALA . 3.2 mt -83.53 123.79 30.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 71.2 110.935 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.42 -49.04 3.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 75.4 112.443 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.93 111.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.905 0.383 . . . . 54.03 110.856 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.4 147.65 32.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 74.41 110.884 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 48.52 30.22 2.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 70.21 110.866 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.66 37.24 52.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.674 -0.774 . . . . 72.51 112.537 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -146.51 121.35 9.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.329 . . . . 61.44 110.95 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.636 ' HB1' HD21 ' A' ' 31' ' ' LEU . . . -53.55 141.93 24.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 65.25 111.093 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.462 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.2 t -135.99 74.72 56.22 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.579 0.704 . . . . 72.41 111.119 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 121.81 8.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.741 2.294 . . . . 63.04 112.373 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.5 p -103.95 88.16 2.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 74.42 110.934 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -58.33 156.8 9.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.11 110.968 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' VAL . . . -150.81 -142.54 3.55 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.81 -0.71 . . . . 72.54 112.515 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.779 HD21 HD12 ' A' ' 158' ' ' LEU . 18.0 tp -160.68 116.97 2.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 73.02 110.822 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.669 HG13 ' CD2' ' A' ' 54' ' ' LEU . 1.7 t -100.94 122.82 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 62.34 111.114 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.753 HD21 HD11 ' A' ' 158' ' ' LEU . 17.7 mt -101.08 122.31 43.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 61.1 110.83 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.78 86.48 5.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.22 110.839 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.09 -174.59 2.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 73.31 111.135 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.3 t -105.69 -24.18 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 71.42 110.838 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -81.73 -10.63 59.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 65.42 110.867 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.39 153.78 5.99 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.702 -0.761 . . . . 54.05 112.53 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 79' ' ' VAL . 9.5 tp -67.86 154.59 41.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.867 0.365 . . . . 71.33 110.889 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 81' ' ' ASP . 2.5 t -142.09 137.44 30.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 73.1 111.096 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.669 ' CD2' HG13 ' A' ' 45' ' ' VAL . 1.2 mt -136.29 121.73 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 44.21 110.914 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.47 HG12 ' CG ' ' A' ' 56' ' ' ASP . 60.1 t -66.82 111.22 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 71.54 111.104 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' CG ' HG12 ' A' ' 55' ' ' VAL . 1.3 m-20 72.56 146.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 73.42 110.939 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.713 ' HB3' HD11 ' A' ' 98' ' ' LEU . 1.5 p -85.52 -165.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 72.5 110.817 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.572 ' H ' HG23 ' A' ' 64' ' ' THR . 9.0 t -95.09 171.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 74.23 110.883 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.702 ' HB2' HD12 ' A' ' 63' ' ' LEU . 99.0 m95 -51.63 -60.07 3.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.34 110.952 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -129.5 159.59 35.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.917 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -51.37 -33.41 29.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 61.15 110.902 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.65 -38.92 79.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.868 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' A' ' 59' ' ' TRP . 96.2 mt -82.34 -46.01 14.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.51 110.902 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -50.89 -49.11 60.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 72.54 111.069 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -54.64 -51.47 65.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 73.33 110.911 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -62.41 -21.91 65.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 54.01 110.872 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.705 HD22 ' CD ' ' A' ' 30' ' ' GLU . 13.0 tp -84.64 -29.83 25.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.067 -0.515 . . . . 72.33 110.886 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.513 ' HA ' HG22 ' A' ' 71' ' ' VAL . 36.4 mt -88.72 -26.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 71.33 111.171 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -83.14 -0.12 47.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 72.03 110.942 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.8 ptm -116.58 -36.62 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 54.32 110.908 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 68' ' ' ILE . 33.5 m -78.23 -29.32 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 72.42 111.115 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.62 -32.31 73.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.892 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -97.2 -33.33 11.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 73.1 110.809 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HG2' HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -70.34 -48.86 54.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 72.12 110.869 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 18' ' ' ILE . 16.2 m-85 -84.18 -11.96 55.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.864 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 67.76 12.05 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 72.11 110.924 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' HB2' HD13 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -129.56 137.7 50.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 72.4 110.899 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -84.84 136.18 33.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 55.41 110.865 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 54' ' ' LEU . 57.5 t -76.6 128.98 37.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 73.31 111.087 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.4 t -146.53 14.33 1.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 74.12 111.082 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.6 ' O ' HG13 ' A' ' 53' ' ' VAL . 11.5 m-20 -159.58 136.04 9.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 64.24 110.871 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -149.14 153.17 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 75.13 111.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.558 HG21 HG22 ' A' ' 156' ' ' VAL . 4.1 mt -103.11 143.55 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 72.43 111.11 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.019 HD11 ' HB1' ' A' ' 105' ' ' ALA . 4.5 mm -106.02 145.97 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 72.23 111.164 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.2 p -112.32 -37.28 5.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 64.14 111.224 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.589 ' HB2' HG21 ' A' ' 150' ' ' THR . 1.9 p-80 -168.41 177.97 5.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 73.4 110.807 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.943 ' HB2' HD13 ' A' ' 114' ' ' LEU . . . -96.02 79.63 3.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 65.31 111.158 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -137.69 155.35 49.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 71.24 110.897 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -20.62 10.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 63.22 111.012 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.99 11.45 18.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 53.12 110.913 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.894 ' CZ ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -135.97 -70.41 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.825 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.71 HG22 HH21 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -88.9 2.87 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 73.21 111.163 179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -50.02 -45.78 41.88 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.76 -0.734 . . . . 73.35 112.517 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -101.19 15.91 57.43 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.691 -0.766 . . . . 74.44 112.55 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.707 HD12 HH22 ' A' ' 91' ' ' ARG . 2.7 tt -52.87 -28.93 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 61.41 111.136 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.532 ' HD3' HG23 ' A' ' 95' ' ' ILE . 29.4 mmtm -59.07 -28.38 66.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 73.45 110.895 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.8 m -88.22 -16.59 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 73.02 111.17 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.723 ' HA ' HD13 ' A' ' 103' ' ' ILE . 10.4 mt -90.38 -41.9 11.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.885 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -79.51 -5.34 54.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.915 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -92.06 -54.99 3.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.845 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -64.04 -62.27 1.73 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 73.11 110.859 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 152.92 39.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 43.02 112.497 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.723 HD13 ' HA ' ' A' ' 98' ' ' LEU . 5.1 mp -97.57 139.21 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 74.11 111.202 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -96.67 111.0 23.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 65.25 110.931 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 1.019 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -90.89 93.7 9.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 75.42 111.044 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.489 ' HB3' HD11 ' A' ' 127' ' ' LEU . 37.6 m-70 -66.49 113.85 5.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.282 -0.417 . . . . 74.15 110.865 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.45 179.67 6.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 63.31 110.838 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.87 157.58 17.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 64.52 111.1 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.55 -40.14 51.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 50.44 111.168 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.681 HD23 ' OD1' ' A' ' 152' ' ' ASP . 22.5 tp -75.14 -39.45 60.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 62.02 110.937 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.738 ' HA ' HD11 ' A' ' 114' ' ' LEU . 82.8 m -58.62 -21.81 54.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 73.35 111.136 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.529 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . . . -96.06 -0.63 50.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 72.12 111.054 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.73 -52.76 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 63.35 110.84 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.943 HD13 ' HB2' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -66.28 -13.53 60.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 73.3 110.925 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.414 ' N ' HD12 ' A' ' 114' ' ' LEU . . . -68.55 -45.25 72.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 53.2 111.0 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -23.79 63.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.872 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -34.14 71.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.256 -0.429 . . . . 72.33 110.873 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -90.5 -19.1 24.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 44.25 110.894 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 24.62 5.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 72.55 112.561 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -99.66 177.82 5.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.864 0.364 . . . . 72.21 110.895 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -76.39 -172.95 2.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 70.31 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -121.11 113.8 32.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.686 0.755 . . . . 61.14 110.882 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 112' ' ' ALA . 53.1 Cg_endo -69.9 -168.33 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.595 2.196 . . . . 75.34 112.342 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.74 -44.36 93.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.21 110.913 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 54.79 25.29 36.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.787 -0.72 . . . . 60.52 112.434 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -108.0 36.25 2.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.915 0.388 . . . . 72.14 110.903 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 106' ' ' HIS . 63.9 mt -122.57 -174.47 2.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.928 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.38 -170.05 3.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 73.41 110.912 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.853 HG22 HG23 ' A' ' 130' ' ' VAL . 52.5 m -50.08 -69.95 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.431 . . . . 50.41 111.14 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.853 HG23 HG22 ' A' ' 129' ' ' THR . 34.3 t -118.51 99.75 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 63.34 111.138 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.434 HG21 HD22 ' A' ' 127' ' ' LEU . 14.0 t -127.91 174.8 8.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 54.44 111.144 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.47 133.92 53.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 65.45 110.93 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 127' ' ' LEU . 39.0 mt -112.35 179.44 3.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 75.14 110.894 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.5 126.64 3.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.817 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -130.24 54.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 75.53 110.842 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 62.58 90.31 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.713 -0.756 . . . . 25.42 112.52 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.1 m120 64.39 14.72 9.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 73.45 110.896 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.0 tpp -133.91 97.57 3.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.15 110.936 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 136.49 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.469 . . . . 72.32 110.954 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.686 HG22 HD21 ' A' ' 158' ' ' LEU . 21.7 t -139.04 117.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 73.24 111.052 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -109.11 129.96 55.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 71.41 110.883 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 31.8 p -85.37 -171.64 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 73.15 111.222 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -170.69 134.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 70.44 110.845 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.652 ' HB3' HG23 ' A' ' 129' ' ' THR . 76.9 t80 -123.22 88.38 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.71 0.767 . . . . 55.42 110.917 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.99 22.47 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.607 2.205 . . . . 62.15 112.367 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.45 -151.7 19.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 65.34 112.485 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 10.6 mttp -92.15 140.01 30.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 64.15 110.936 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.34 -88.47 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.706 -0.759 . . . . 72.24 112.453 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -75.02 -24.02 58.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.877 0.37 . . . . 71.43 110.838 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 86' ' ' HIS . 70.3 p -151.64 -170.23 3.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 64.45 111.097 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.64 -12.18 57.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.88 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.681 ' OD1' HD23 ' A' ' 110' ' ' LEU . 1.2 t0 -144.0 25.43 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 63.12 110.805 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.508 ' OD1' HD13 ' A' ' 169' ' ' LEU . 0.4 OUTLIER -56.76 132.23 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 75.31 110.92 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 84' ' ' ILE . 28.4 pt -136.89 169.88 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 74.44 111.089 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.439 ' CG1' HD23 ' A' ' 169' ' ' LEU . 24.0 m -126.37 134.13 67.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 65.24 111.129 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.558 HG22 HG21 ' A' ' 83' ' ' ILE . 90.6 t -86.03 133.89 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 71.32 111.163 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -121.48 130.94 53.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.481 . . . . 60.3 110.902 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.779 HD12 HD21 ' A' ' 44' ' ' LEU . 10.6 mt -110.59 98.66 38.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.662 0.744 . . . . 54.54 110.892 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 158' ' ' LEU . 53.4 Cg_endo -69.73 -4.53 14.19 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.719 2.279 . . . . 75.21 112.358 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -82.95 -24.14 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 75.34 110.938 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.63 14.32 1.76 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 63.04 110.877 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 10.2 m120 54.25 27.52 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.856 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.546 HD13 HD13 ' A' ' 21' ' ' LEU . 96.2 mt -92.42 126.47 44.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 63.04 111.132 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.553 HD22 HD13 ' A' ' 203' ' ' ILE . 23.2 tp -110.89 148.26 32.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 73.54 110.852 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.6 72.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.0 111.148 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -51.46 -42.06 49.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 63.32 112.445 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 77.31 -155.95 44.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 63.32 112.493 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 66.1 m -51.51 -30.58 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 71.31 110.868 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.702 HD12 ' NE1' ' A' ' 189' ' ' TRP . 27.5 tp -57.51 -33.56 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 55.55 110.845 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 219' ' ' LEU . 95.6 t -105.51 104.69 17.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 65.3 111.176 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.539 ' HG2' HG23 ' A' ' 222' ' ' THR . 4.3 mmpt? -51.91 156.66 1.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.859 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 38.2 p -99.67 157.59 16.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.449 . . . . 75.24 110.913 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t -51.83 -29.81 20.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 62.24 111.081 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.0 m -95.72 44.09 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 61.13 110.915 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.2 148.43 50.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 74.31 111.071 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.489 ' HA ' HD22 ' A' ' 225' ' ' LEU . 20.5 tttt -128.23 1.75 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 70.34 110.905 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -179.13 154.47 0.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 64.1 110.883 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.8 HD11 ' HB2' ' A' ' 226' ' ' LEU . 7.9 mt -66.33 -38.43 87.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.868 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.06 -144.39 17.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 72.25 112.427 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.1 100.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.339 . . . . 64.25 110.919 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 186' ' ' VAL . 18.8 m -94.99 24.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 72.4 111.131 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -67.09 -24.47 65.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 74.14 111.138 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -119.27 24.28 10.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 62.44 110.796 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.21 154.13 49.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 42.54 111.059 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -107.49 87.01 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.456 ' CG2' HG11 ' A' ' 181' ' ' VAL . 34.5 t -60.85 -17.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 73.32 111.121 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.99 -21.14 59.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 72.51 110.85 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -117.79 -12.47 10.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.851 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . 0.702 ' NE1' HD12 ' A' ' 169' ' ' LEU . 2.2 t90 -54.97 -60.78 2.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 74.02 110.929 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.684 ' CB ' HD11 ' A' ' 226' ' ' LEU . 0.2 OUTLIER -53.81 -24.93 17.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 72.2 110.819 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 52.4 m -81.36 -31.98 33.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 74.0 111.18 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -72.76 -42.16 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 72.13 110.851 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 31.5 mm -61.85 -47.43 93.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.23 111.083 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -57.23 -28.07 62.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.911 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -76.59 -19.54 57.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.89 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.526 HG11 HD21 ' A' ' 219' ' ' LEU . 21.7 t -87.36 -16.09 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 71.2 111.187 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 197' ' ' LEU . 4.2 pp -104.95 -5.74 20.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.994 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.61 -30.69 9.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 72.45 110.876 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -104.37 -51.18 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 65.52 110.835 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.14 39.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 73.42 110.882 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -52.56 -48.67 66.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 73.31 110.852 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -60.44 106.25 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.43 110.929 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.721 HG21 HG22 ' A' ' 206' ' ' VAL . 42.8 mt -145.95 123.04 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 72.2 111.146 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.41 -35.47 54.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 74.11 110.843 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -157.83 129.38 6.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 61.12 111.082 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 203' ' ' ILE . 98.2 t -105.95 136.46 40.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 53.2 111.128 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 1.04 HG22 HG12 ' A' ' 213' ' ' VAL . 13.5 t -113.16 113.4 49.1 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.72 0.771 . . . . 64.34 111.082 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.511 ' HD3' HD13 ' A' ' 218' ' ' LEU . 53.0 Cg_endo -69.86 -173.41 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 63.0 112.34 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.24 -15.38 69.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 74.13 112.47 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -152.71 139.45 18.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.351 . . . . 74.1 110.884 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.62 -117.93 5.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.827 -0.701 . . . . 71.3 112.475 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -148.94 169.09 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.359 . . . . 73.51 110.928 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.04 HG12 HG22 ' A' ' 207' ' ' VAL . 4.3 m -61.17 161.58 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 74.1 111.071 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -155.06 -88.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 64.21 112.429 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -179.8 -170.3 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 73.15 110.875 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -60.98 -18.0 54.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 74.31 110.955 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . 0.454 ' HA2' HD21 ' A' ' 220' ' ' LEU . . . -59.27 -20.98 52.6 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.671 -0.776 . . . . 42.14 112.455 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.511 HD13 ' HD3' ' A' ' 208' ' ' PRO . 10.8 mt -74.6 -47.83 30.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.862 0.363 . . . . 74.14 110.903 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.622 ' HA ' HG13 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -54.63 -55.16 32.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.96 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 221' ' ' HIS . 4.3 pp -60.83 -20.04 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 63.21 110.856 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.472 ' N ' HD12 ' A' ' 220' ' ' LEU . 1.5 t60 -69.74 -39.32 76.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 71.32 110.851 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 171' ' ' LYS . 2.8 m -53.19 -50.38 64.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 64.45 111.106 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.36 -17.73 55.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 71.53 110.919 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -87.44 -5.67 58.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.878 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 176' ' ' LYS . 8.6 mt -126.62 -5.28 6.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 64.02 110.968 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.8 ' HB2' HD11 ' A' ' 178' ' ' LEU . 0.5 OUTLIER -118.87 4.87 11.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 72.31 110.965 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 75.15 110.857 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_